PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonnin, DAA; Havrda, MC; Lee, MC; Liu, H; Zhang, Z; Nguyen, LN; Harrington, LX; Hassanpour, S; Cheng, C; Israel, MA				Bonnin, D. A. Almiron; Havrda, M. C.; Lee, M. C.; Liu, H.; Zhang, Z.; Nguyen, L. N.; Harrington, L. X.; Hassanpour, S.; Cheng, C.; Israel, M. A.			Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; INDUCIBLE FACTOR-1-ALPHA; INSULIN-SECRETION; IL-6 SECRETION; NERVOUS-SYSTEM; TUMOR HYPOXIA; CANCER-CELLS; MOUSE MODEL; RAC1; GLIOBLASTOMA	High-grade gliomas (HGGs) include the most common and the most aggressive primary brain tumor of adults and children. Despite multimodality treatment, most high-grade gliomas eventually recur and are ultimately incurable. Several studies suggest that the initiation, progression, and recurrence of gliomas are driven, at least partly, by cancer stem-like cells. A defining characteristic of these cancer stem-like cells is their capacity to self-renew. We have identified a hypoxia-induced pathway that utilizes the Hypoxia Inducible Factor 1 alpha (HIF-1 alpha) transcription factor and the JAK1/2-STAT3 (Janus Kinase 1/2 -Signal Transducer and Activator of Transcription 3) axis to enhance the self-renewal of glioma stem-like cells. Hypoxia is a commonly found pathologic feature of HGGs. Under hypoxic conditions, HIF-1 alpha levels are greatly increased in glioma stem-like cells. Increased HIF-1 alpha activates the JAK1/2-STAT3 axis and enhances tumor stem-like cell self-renewal. Our data further demonstrate the importance of Vascular Endothelial Growth Factor (VEGF) secretion for this pathway of hypoxia-mediated self-renewal. Brefeldin A and EHT-1864, agents that significantly inhibit VEGF secretion, decreased stem cell self-renewal, inhibited tumor growth, and increased the survival of mice allografted with S100 beta-v-erbB/p53(-/-) glioma stem-like cells. These agents also inhibit the expression of a hypoxia gene expression signature that is associated with decreased survival of HGG patients. These findings suggest that targeting the secretion of extracellular, autocrine/paracrine mediators of glioma stem-like cell self-renewal could potentially contribute to the treatment of HGGs.	[Bonnin, D. A. Almiron; Havrda, M. C.; Liu, H.; Zhang, Z.; Cheng, C.; Israel, M. A.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA; [Bonnin, D. A. Almiron; Havrda, M. C.; Liu, H.; Zhang, Z.; Hassanpour, S.; Cheng, C.; Israel, M. A.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Hanover, NH USA; [Lee, M. C.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA; [Nguyen, L. N.] Geisel Sch Med Dartmouth, Dept Pathol & Lab Med, Hanover, NH USA; [Nguyen, L. N.; Harrington, L. X.; Hassanpour, S.] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Hanover, NH USA; [Israel, M. A.] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Israel, M. A.] Geisel Sch Med Dartmouth, Dept Pediat, Hanover, NH USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Israel, MA (corresponding author), Norris Cotton Canc Ctr Dartmouth, One Med Ctr Dr, Lebanon, NH 03756 USA.	Mark.A.Israel@Dartmouth.edu		Lee, Myung Chang/0000-0002-7051-5822	NIH; NSF; Cancer Center Core Grant from the National Cancer Institute [P30CA023108]; COBRE Grant from the National Institute of General Medical Sciences [P30GM10315-15]; Theodora B. Betz Foundation; Jordan and Kyra Memorial Foundation; Andrea Clark Nelson Medical Research Endowment; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Cancer Center Core Grant from the National Cancer Institute; COBRE Grant from the National Institute of General Medical Sciences; Theodora B. Betz Foundation; Jordan and Kyra Memorial Foundation; Andrea Clark Nelson Medical Research Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Tor Tosteson and Dr Jiang Gui from the Biostatistics Shared Resource at Norris Cotton Cancer Center at Dartmouth for their consultation regarding statistical analysis, and Tabatha Richardson for her administrative support. Microarray processing and data normalization was carried out at Norris Cotton Cancer Center in the Genomics Shared Resource, which was established by equipment grants from the NIH and NSF and is supported in part by a Cancer Center Core Grant (P30CA023108) from the National Cancer Institute. Multiplex Luminex Cytokine Assay was performed in DartLab, the Immune Monitoring and Flow Cytometry Shared Resource at Norris Cotton Cancer Center, supported by a Cancer Center Core Grant (P30CA023108) from the National Cancer Institute and an Immunology COBRE Grant (P30GM10315-15) from the National Institute of General Medical Sciences. Financial support was generously provided by the Theodora B. Betz Foundation, the Jordan and Kyra Memorial Foundation and the Andrea Clark Nelson Medical Research Endowment. Support was generously provided by the Theodora B. Betz Foundation (M.A. Israel), the Jordan and Kyra Memorial Foundation (M.A. Israel), and the Andrea Clark Nelson Medical Research Endowment (M. A. Israel).	Agro L, 2015, BIO-PROTOCOL, V5, pe1659; Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asahara S, 2013, DIABETOLOGIA, V56, P1088, DOI 10.1007/s00125-013-2849-5; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bonnin DAA, 2017, MOL CANCER THER, V16, P705, DOI 10.1158/1535-7163.MCT-16-0616; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Davila J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005458; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Dwivedi S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-128; Dzaye ODA, 2016, J NEUROPATH EXP NEUR, V75, P429, DOI 10.1093/jnen/nlw016; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finucane Mariel M, 2007, Epidemiol Perspect Innov, V4, P8, DOI 10.1186/1742-5573-4-8; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Garabed RB, 2008, J R STAT SOC A STAT, V171, P699, DOI 10.1111/j.1467-985X.2008.00534.x; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Hwaiz R, 2015, BRIT J PHARMACOL, V172, P5347, DOI 10.1111/bph.13325; Hwaiz R, 2015, J LEUKOCYTE BIOL, V97, P975, DOI 10.1189/jlb.4A1214-603R; Jackson M, 2015, CARCINOGENESIS, V36, P177, DOI 10.1093/carcin/bgu243; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kang SH, 2010, NEUROSURGERY, V67, P1386, DOI 10.1227/NEU.0b013e3181f1c0cd; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005; Li HZ, 2004, BIOINFORMATICS, V20, P208, DOI 10.1093/bioinformatics/bth900; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li QW, 2003, J PHYSIOL-LONDON, V550, P431, DOI 10.1113/jphysiol.2003.039073; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Q, 2015, INT J CLIN EXP MED, V8, P22073; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Man JH, 2014, CELL REP, V9, P1812, DOI 10.1016/j.celrep.2014.10.055; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sausville E A, 1996, Cancer J Sci Am, V2, P52; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sondergaard KL, 2002, NEUROPATH APPL NEURO, V28, P210, DOI 10.1046/j.1365-2990.2002.00391.x; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stanley AC, 2014, IMMUNOL CELL BIOL, V92, P275, DOI 10.1038/icb.2013.90; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vordermark D, 2003, STRAHLENTHER ONKOL, V179, P801, DOI 10.1007/s00066-003-1150-9; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Weiss WA, 2003, CANCER RES, V63, P1589; Williams JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE405, DOI 10.1152/ajpendo.90874.2008; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yan K, 2014, GENE DEV, V28, P1085, DOI 10.1101/gad.235515.113; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yun Z, 2014, ADV EXP MED BIOL, V772, P41, DOI 10.1007/978-1-4614-5915-6_2; Zhao D, 2015, ONCOGENE, V34, P3107, DOI 10.1038/onc.2014.257	92	49	49	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1107	1118		10.1038/onc.2017.404	http://dx.doi.org/10.1038/onc.2017.404			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29155422	Green Published, hybrid			2022-12-26	WOS:000425905700013
J	McFall, T; McKnight, B; Rosati, R; Kim, S; Huang, YF; Viola-Villegas, N; Ratnam, M				McFall, Thomas; McKnight, Brooke; Rosati, Rayna; Kim, Seongho; Huang, Yanfang; Viola-Villegas, Nerissa; Ratnam, Manohar			Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; estrogen; estrogen receptor; microRNA (miRNA); progesterone; tumor metastasis; luminal breast cancer; progesterone receptor	POSTMENOPAUSAL WOMEN; CELL AGGRESSIVENESS; MENSTRUAL-CYCLE; B-RECEPTORS; GROWTH; PROGESTINS; ISOFORMS; EXPRESSION; MDA-MB-231; MIGRATION	Distal metastasis of luminal breast cancer is frequent and incurable, yet the metastasis mechanisms are poorly understood. Estrogen, even at postmenopausal concentrations, suppresses invasiveness of luminal breast cancer cells through the estrogen receptor (ER). Invasive tumors overexpress the short progesterone receptor A (PR-A) isoform. Even at postmenopausal concentrations, progesterone activates PR-A, inducing invasiveness by counteracting estrogen's effects, particularly when cells are hypersensitized to progesterone by PR-A overexpression. To interrogate the role of this cross-talk in metastasis, we investigated selective cross-talk mechanisms of PR-A with ER. We developed a quantitative PCR-based lymph node infiltration assay to address the slowness of metastasis of tumor xenografts. We found that 15 microRNAs (miRNAs) are regulated by progesterone via PR-A, but not the longer PR-B isoform, with increased progesterone sensitivity when PR-A was overexpressed. Two of these miRNAs whose induction (miR-92a-3p) or repression (miR-26b-5p) by estrogen was suppressed by progesterone plus PR-A were critical for the PR-A-ER cross-talk causing a gene-regulatory pattern of invasiveness and metastasis and complete rescue of invasiveness in vitro. Constitutive expression of miR-92a-3p or inhibition of miR-26b-5p profoundly suppressed metastasis. Finally, in primary breast tumors, PR-A expression was correlated negatively with miR-92a-3p expression and positively with miR-26b-5p expression. Therefore, hormonal cross-talk of PR-A with ER is probably a fundamental mechanism that enables metastasis of luminal breast cancer. Moreover, miRNA biomarkers of hyperactive PR-A may help predict metastatic potential of luminal breast tumors. Further, miR-92a-3p and miR-26b-5p may reveal target pathways for selective intervention to suppress hormone-regulated metastasis, both pre- and postmenopause.	Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; Wayne State Univ, Dept Oncol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Ratnam, M (corresponding author), 4100 John R,HWCRC 840-1, Detroit, MI 48201 USA.	ratnamm@karmanos.org		Viola, Nerissa/0000-0003-4253-5639	National Institutes of Health R01 Grant [CA 140690]; NCI T-32 Fellowship [CA009531]; NATIONAL CANCER INSTITUTE [R01CA140690, T32CA009370, P30CA022453, T32CA009531] Funding Source: NIH RePORTER	National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI T-32 Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 Grant CA 140690 (to M. R.) and NCI T-32 Fellowship CA009531 (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	American Cancer Society, 2008, CANC FACTS FIG 2015; BAKKER GH, 1990, J STEROID BIOCHEM, V37, P789, DOI 10.1016/0960-0760(90)90421-G; Barnett JB, 2004, J CLIN ENDOCR METAB, V89, P776, DOI 10.1210/jc.2003-030506; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Chlebowski RT, 2013, JNCI-J NATL CANCER I, V105, P526, DOI 10.1093/jnci/djt043; Dai D, 2002, CANCER RES, V62, P881; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Gilam A, 2017, ONCOTARGET, V8, P25963, DOI 10.18632/oncotarget.15657; Gomez-Fernandez C, 2008, AM J CLIN PATHOL, V130, P879, DOI 10.1309/AJCPD1AO3YSYQYNW; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Ibrahim YH, 2008, MOL CANCER RES, V6, P1491, DOI 10.1158/1541-7786.MCR-07-2173; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P592, DOI 10.1530/acta.0.0610592; Kariagina A, 2013, HORM CANCER-US, V4, P371, DOI 10.1007/s12672-013-0158-6; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang YY, 2010, MENOPAUSE, V17, P1040, DOI 10.1097/gme.0b013e3181d3dd0c; Lin VCL, 2001, CLIN CANCER RES, V7, P2880; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; MCDONNELL DP, 1994, J BIOL CHEM, V269, P11945; McFall T, 2015, ONCOTARGET, V6, P33146, DOI 10.18632/oncotarget.5082; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Miyamoto K, 2016, BRIT J CANCER, V115, P354, DOI 10.1038/bjc.2016.179; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; NEWTON CJ, 1986, J STEROID BIOCHEM, V24, P1033, DOI 10.1016/0022-4731(86)90356-0; Nilsson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036051; Oetken K., 2013, EFFECTS DIFFERENT ES; Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Ries LAG, 2007, SEER CANC STAT REV 1; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Shatnawi A, 2007, MOL ENDOCRINOL, V21, P635, DOI 10.1210/me.2006-0274; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Yamashita H., 2011, BREAST CANC CARCINOG, P331; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zhu AS, 2016, J CELL BIOCHEM, V117, P1370, DOI 10.1002/jcb.25428	49	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1163	1177		10.1074/jbc.M117.812438	http://dx.doi.org/10.1074/jbc.M117.812438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29162724	hybrid, Green Published			2022-12-26	WOS:000423515000006
J	Yang, TH; Fang, LL; Sanders, S; Jayanthi, S; Rajan, G; Podicheti, R; Thallapuranam, SK; Mockaitis, K; Medina-Bolivar, F				Yang, Tianhong; Fang, Lingling; Sanders, Sheri; Jayanthi, Srinivas; Rajan, Gayathri; Podicheti, Ram; Thallapuranam, Suresh Kumar; Mockaitis, Keithanne; Medina-Bolivar, Fabricio			Stilbenoid prenyltransferases define key steps in the diversification of peanut phytoalexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIS-HYPOGAEA SEEDS; RNA-SEQ; ASPERGILLUS-FLAVUS; IN-VIVO; MOLECULAR CHARACTERIZATION; ACCURATE ALGORITHM; SOPHORA-FLAVESCENS; NMR-SPECTRA; RESVERATROL; ALIGNMENT	Defense responses of peanut (Arachis hypogaea) to biotic and abiotic stresses include the synthesis of prenylated stilbenoids. Members of this compound class show several protective activities in human disease studies, and the list of potential therapeutic targets continues to expand. Despite their medical and biological importance, the biosynthetic pathways of prenylated stilbenoids remain to be elucidated, and the genes encoding stilbenoid-specific prenyltransferases have yet to be identified in any plant species. In this study, we combined targeted transcriptomic and metabolomic analyses to discover prenyltransferase genes in elicitor-treated peanut hairy root cultures. Transcripts encoding five enzymes were identified, and two of these were functionally characterized in a transient expression system consisting of Agrobacterium-infiltrated leaves of Nicotiana benthamiana. We observed that one of these prenyltransferases, AhR4DT-1, catalyzes a key reaction in the biosynthesis of prenylated stilbenoids, in which resveratrol is prenylated at its C-4 position to form arachidin-2, whereas another, AhR3'DT-1, added the prenyl group to C-3' of resveratrol. Each of these prenyltransferases was highly specific for stilbenoid substrates, and we confirmed their subcellular location in the plastid by fluorescence microscopy. Structural analysis of the prenylated stilbenoids suggested that these two prenyltransferase activities represent the first committed steps in the biosynthesis of a large number of prenylated stilbenoids and their derivatives in peanut. In summary, we have identified five candidate prenyltransferases in peanut and confirmed that two of them are stilbenoid-specific, advancing our understanding of this specialized enzyme family and shedding critical light onto the biosynthesis of bioactive stilbenoids.	[Yang, Tianhong; Fang, Lingling; Medina-Bolivar, Fabricio] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA; [Yang, Tianhong] Arkansas State Univ, Mol Biosci Grad Program, Jonesboro, AR 72401 USA; [Medina-Bolivar, Fabricio] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Sanders, Sheri; Mockaitis, Keithanne] Indiana Univ, Pervas Technol Inst, Bloomington, IN 47408 USA; [Rajan, Gayathri; Podicheti, Ram] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Mockaitis, Keithanne] Indiana Univ, Dept Biol, Bloomington, IN 47408 USA; [Jayanthi, Srinivas; Thallapuranam, Suresh Kumar] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 47408 USA	Arkansas State University; Arkansas State University; Arkansas State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Arkansas System; University of Arkansas Fayetteville	Medina-Bolivar, F (corresponding author), Arkansas Biosci Inst, POB 639, State Univ, AR 72467 USA.	fmedinabolivar@astate.edu	Jayanthi, Srinivas/AAD-2808-2019	Podicheti, Ram/0000-0003-3449-5155; Jayanthi, Srinivas/0000-0001-7357-760X	National Science Foundation-EPSCoR [EPS 0701890]; National Science Foundation [DBI-1458641, ABI-1062432]	National Science Foundation-EPSCoR(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The Center for Plant-Powered Production-P3 was funded by National Science Foundation-EPSCoR Grant EPS 0701890. The Indiana University, National Center for Genome Analysis Support was funded by the National Science Foundation Grants DBI-1458641 and ABI-1062432 (to Indiana University, National Center for Genome Analysis Support). Facility support was also received from the Arkansas Science and Technology Authority and the Arkansas Biosciences Institute.	AGUAMAH GE, 1981, PHYTOCHEMISTRY, V20, P1381, DOI 10.1016/0031-9422(81)80044-1; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araya-Cloutier C, 2017, FOOD CHEM, V226, P193, DOI 10.1016/j.foodchem.2017.01.026; Ball JM, 2015, ADV VIROL, V2015, DOI 10.1155/2015/293524; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Castillo AM, 2011, J MAGN RESON, V209, P123, DOI 10.1016/j.jmr.2010.12.008; Chang JC, 2006, J AGR FOOD CHEM, V54, P10281, DOI 10.1021/jf0620766; Chen RD, 2013, ADV SYNTH CATAL, V355, P1817, DOI 10.1002/adsc.201300196; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Condori J, 2010, PLANT PHYSIOL BIOCH, V48, P310, DOI 10.1016/j.plaphy.2010.01.008; COOKSEY CJ, 1988, PHYTOCHEMISTRY, V27, P1015, DOI 10.1016/0031-9422(88)80263-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gambini J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/837042; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Huang CP, 2010, J AGR FOOD CHEM, V58, P12123, DOI 10.1021/jf102993j; Huang H, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001911; INGHAM JL, 1976, PHYTOCHEMISTRY, V15, P1791, DOI 10.1016/S0031-9422(00)97494-6; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; KEEN NT, 1976, PHYTOCHEMISTRY, V15, P1794, DOI 10.1016/S0031-9422(00)97495-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JH, 2014, CHEMBIOCHEM, V15, P1672, DOI 10.1002/cbic.201402160; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Medina-Bolivar Fabricio, 2004, Methods Mol Biol, V267, P351; Medrano Giuliana, 2009, V483, P51, DOI 10.1007/978-1-59745-407-0_4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Puksasook T, 2017, J NAT MED-TOKYO, V71, P665, DOI 10.1007/s11418-017-1097-2; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shen GA, 2012, PLANT PHYSIOL, V159, P70, DOI 10.1104/pp.112.195271; Sobolev VS, 2006, PHYTOCHEM ANALYSIS, V17, P312, DOI 10.1002/pca.920; Sobolev VS, 2016, J AGR FOOD CHEM, V64, P579, DOI 10.1021/acs.jafc.5b04753; Sobolev VS, 2013, J AGR FOOD CHEM, V61, P1850, DOI 10.1021/jf3054752; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Sobolev VS, 2010, J AGR FOOD CHEM, V58, P875, DOI 10.1021/jf903410e; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Wang HM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0513-6; Wang RS, 2014, J BIOL CHEM, V289, P35815, DOI 10.1074/jbc.M114.608265; WOTTON HR, 1985, J GEN MICROBIOL, V131, P487; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu ZY, 2011, J AGR FOOD CHEM, V59, P5993, DOI 10.1021/jf200776w; Yang TH, 2016, PLANT PHYSIOL, V171, P2483, DOI 10.1104/pp.16.00610; Yang T, 2015, J AGR FOOD CHEM, V63, P3942, DOI 10.1021/jf5050266; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023	63	24	24	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					28	46		10.1074/jbc.RA117.000564	http://dx.doi.org/10.1074/jbc.RA117.000564			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158266	Green Published, hybrid			2022-12-26	WOS:000419453200003
J	Chandran, V; Reyes, M; Zysset, P				Chandran, Vimal; Reyes, Mauricio; Zysset, Philippe			A novel registration-based methodology for prediction of trabecular bone fabric from clinical QCT: A comprehensive analysis	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; IMAGE REGISTRATION; PROXIMAL FEMUR; CT DATA; TENSORS; ANISOTROPY; MODELS; FRAMEWORK; DATABASE; SCANS	Osteoporosis leads to hip fractures in aging populations and is diagnosed by modern medical imaging techniques such as quantitative computed tomography (QCT). Hip fracture sites involve trabecular bone, whose strength is determined by volume fraction and orientation, known as fabric. However, bone fabric cannot be reliably assessed in clinical OCT images of proximal femur. Accordingly, we propose a novel registration-based estimation of bone fabric designed to preserve tensor properties of bone fabric and to map bone fabric by a global and local decomposition of the gradient of a non-rigid image registration transformation. Furthermore, no comprehensive analysis on the critical components of this methodology has been previously conducted. Hence, the aim of this work was to identify the best registration-based strategy to assign bone fabric to the OCT image of a patient's proximal femur. The normalized correlation coefficient and curvature-based regularization were used for image-based registration and the Frobenius norm of the stretch tensor of the local gradient was selected to quantify the distance among the proximal femora in the population. Based on this distance, closest, farthest and mean femora with a distinction of sex were chosen as alternative atlases to evaluate their influence on bone fabric prediction. Second, we analyzed different tensor mapping schemes for bone fabric prediction: identity, rotation only, rotation and stretch tensor. Third, we investigated the use of a population average fabric atlas. A leave one out (LOO) evaluation study was performed with a dual OCT and HRpOCT database of 36 pairs of human femora. The quality of the fabric prediction was assessed with three metrics, the tensor norm (TN) error, the degree of anisotropy (DA) error and the angular deviation of the principal tensor direction (PTD). The closest femur atlas (CTP) with a full rotation (CR) for fabric mapping delivered the best results with a TN error of 7.3 +/- 0.9%, a DA error of 6.6 +/- 1.3% and a PTD error of 25 +/- 2 degrees. The closest to the population mean femur atlas (MTP) using the same mapping scheme yielded only slightly higher errors than CTP for substantially less computing efforts. The population average fabric atlas yielded substantially higher errors than the MTP with the CR mapping scheme. Accounting for sex did not bring any significant improvements. The identified fabric mapping methodology will be exploited in patient-specific QCT-based finite element analysis of the proximal femur to improve the prediction of hip fracture risk.	[Chandran, Vimal; Reyes, Mauricio; Zysset, Philippe] Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland	University of Bern	Chandran, V (corresponding author), Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland.	vimalc@ieee.org	Zysset, Philippe/AAF-8637-2020; Zysset, Philippe K/B-2997-2018	Zysset, Philippe/0000-0002-4712-7047; Zysset, Philippe K/0000-0002-4712-7047; Chandran, Vimal/0000-0002-2331-776X	Swiss National Science Foundation [143769]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by the Swiss National Science Foundation (http://p3.snf.ch/Project-143769.; This work is supported by the Swiss National Science Foundation, Project number-143769. The authors thank Dr. Ghislain Maquer for his comments on mechanical aspects and proof reading. The authors would like to thank Enrico Dall'Ara and Dieter H. Pahr (TU Wien, Austria) for sharing their QCT and HRpQCT images.	Bergot C, 2002, OSTEOPOROSIS INT, V13, P542, DOI 10.1007/s001980200071; Bonaretti S, 2014, MED ENG PHYS, V36, P1626, DOI 10.1016/j.medengphy.2014.09.006; Chandran V, 2015, LECT NOTES COMPUT SC, V9349, P621, DOI 10.1007/978-3-319-24553-9_76; Dall'Ara E, 2013, BONE, V52, P27, DOI 10.1016/j.bone.2012.09.006; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Elhawary H, 2010, ACAD RADIOL, V17, P1334, DOI 10.1016/j.acra.2010.06.004; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Frechet M., 1948, ANN I H POINCARE, V10, P215; Geng XJ, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P684, DOI 10.1109/ISBI.2012.6235640; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kalinic H., 2009, CROATIAN SCI BIBLIO, P1; Kang Y, 2005, COMPUT MED IMAG GRAP, V29, P533, DOI 10.1016/j.compmedimag.2005.05.002; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lekadir K, 2016, ANN BIOMED ENG, V44, P234, DOI 10.1007/s10439-015-1432-2; Lekadir K, 2015, J BIOMECH, V48, P598, DOI 10.1016/j.jbiomech.2015.01.002; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Luisier B, 2014, J MECH BEHAV BIOMED, V32, P287, DOI 10.1016/j.jmbbm.2014.01.006; Marangalou JH, 2015, BIOMECH MODEL MECHAN, V14, P39, DOI 10.1007/s10237-014-0584-6; Marangalou JH, 2013, J BIOMECH, V46, P2356, DOI 10.1016/j.jbiomech.2013.07.042; McLeod K, 2015, IEEE T MED IMAGING, V34, P1562, DOI 10.1109/TMI.2015.2405579; Pahr DH, 2009, COMPUT METHOD BIOMEC, V12, P45, DOI [10.1080/10255840802144105, 10.1080/10255840903065399]; Peyrat JM, 2007, IEEE T MED IMAGING, V26, P1500, DOI 10.1109/TMI.2007.907286; Peyrat JM, 2006, LECT NOTES COMPUT SC, V4190, P297; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rueckert D., 2001, P MICCAI, V2208, P77; Seiler C, 2012, LECT NOTES COMPUT SC, V7511, P130, DOI 10.1007/978-3-642-33418-4_17; Seiler C, 2011, LECT NOTES COMPUT SC, V6892, P631, DOI 10.1007/978-3-642-23629-7_77; Taghizadeh E, 2014, CMBBE; Taghizadeh E, 2017, BONE, V103, P252, DOI 10.1016/j.bone.2017.07.012; Taghizadeh E, 2016, ANN BIOMED ENG, V44, P2505, DOI 10.1007/s10439-016-1551-4; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Wolff J, 1892, GESETZ TRANSFORMATIO	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187874	10.1371/journal.pone.0187874	http://dx.doi.org/10.1371/journal.pone.0187874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176881	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900019
J	Lara, B; Enberg, L; Ortega, M; Leon, P; Kripper, C; Aguilera, P; Kattan, E; Castro, R; Bakker, J; Hernandez, G				Lara, Barbara; Enberg, Luis; Ortega, Marcos; Leon, Paula; Kripper, Cristobal; Aguilera, Pablo; Kattan, Eduardo; Castro, Ricardo; Bakker, Jan; Hernandez, Glenn			Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality	PLOS ONE			English	Article							INDUCED TISSUE HYPOPERFUSION; PERIPHERAL PERFUSION; SEPTIC SHOCK; CONSENSUS; SEVERITY; LACTATE	Introduction Acute circulatory dysfunction in patients with sepsis can evolve rapidly into a progressive stage associated with high mortality. Early recognition and adequate resuscitation could improve outcome. However, since the spectrum of clinical presentation is quite variable, signs of hypoperfusion are frequently unrecognized in patients just admitted to the emergency department (ED). Hyperlactatemia is considered a key parameter to disclose tissue hypoxia but it is not universally available and getting timely results can be challenging in low resource settings. In addition, non-hypoxic sources can be involved in hyperlactatemia, and a misinterpretation could lead to over-resuscitation in an unknown number of cases. Capillary refill time (CRT) is a marker of peripheral perfusion that worsens during circulatory failure. An abnormal CRT in septic shock patients after ICU-based resuscitation has been associated with poor outcome. The aim of this study was to determine the prevalence of abnormal CRT in patients with sepsis-related hyperlactatemia in the early phase after ED admission, and its relationship with outcome. Methods We performed a prospective observational study. Septic patients with hyperlactemia at ED admission subjected to an initial fluid resuscitation (FR) were included. CRT and other parameters were assessed before and after FR. CRT-normal or CRT-abnormal subgroups were defined according to the status of CRT following initial FR, and major outcomes were registered. Results Ninety-five hyperlactatemic septic patients were included. Thirty-one percent had abnormal CRT at ED arrival. After FR, 87 patients exhibited normal CRT, and 8 an abnormal one. Patients with abnormal CRT had an increased risk of adverse outcomes (88% vs. 20% p<0.001; RR 4.4 [2.7-7.4]), and hospital mortality (63% vs. 9% p<0.001; RR 6.7 [2.9-16]) as compared to those with normal CRT after FR. Specifically, CRT-normal patients required less frequently mechanical ventilation, renal replacement therapy, and ICU admission, and exhibited a lower hospital mortality. Conclusions Hyperlactatemic sepsis patients with abnormal CRT after initial fluid resuscitation exhibit higher mortality and worse clinical outcomes than patients with normal CRT.	[Lara, Barbara; Enberg, Luis; Kripper, Cristobal; Aguilera, Pablo] Pontificia Univ Catolica Chile, Fac Med, Programa Med Urgencia, Santiago, Chile; [Ortega, Marcos; Leon, Paula; Kattan, Eduardo; Castro, Ricardo; Bakker, Jan; Hernandez, Glenn] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile; [Bakker, Jan] Erasmus MC Univ, Med Ctr, Dept Intens Care Adults, Rotterdam, CA, Netherlands; [Bakker, Jan] Columbia Univ, Dept Med, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Bakker, Jan] New York Univ Langone, Div Pulm & Crit Care Med, New York, NY USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Erasmus University Rotterdam; Erasmus MC; Columbia University; New York University	Hernandez, G (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile.	glennguru@gmail.com	Lara, Barbara/GWZ-9082-2022; Kattan, Eduardo/GSJ-4141-2022; Bakker, Jan/A-4011-2009	Kattan, Eduardo/0000-0002-1997-6893; Bakker, Jan/0000-0003-2236-7391; Gomez Rodriguez, Diego Manuel/0000-0003-2128-9854; Lara, Barbara/0000-0002-0265-808X				Ait-Oufella H, 2014, INTENS CARE MED, V40, P958, DOI 10.1007/s00134-014-3326-4; Ait-Oufella H, 2011, INTENS CARE MED, V37, P801, DOI 10.1007/s00134-011-2163-y; Alsma J, 2017, CHEST, V151, P1106, DOI 10.1016/j.chest.2016.11.035; BAILEY JM, 1990, CRIT CARE MED, V18, P1353, DOI 10.1097/00003246-199012000-00008; Bakker J, 2015, CRIT CARE MED, V43, P705, DOI 10.1097/CCM.0000000000000870; Brabrand M, 2011, EUR J EMERG MED, V18, P46, DOI 10.1097/MEJ.0b013e32833b4fba; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; CHAMPION HR, 1980, CRIT CARE MED, V8, P201, DOI 10.1097/00003246-198004000-00001; Coudroy R, 2015, INTENS CARE MED, V41, P452, DOI 10.1007/s00134-014-3600-5; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser MW, 2013, CRIT CARE, V17, DOI 10.1186/cc12727; Espinoza Emilio Daniel Valenzuela, 2014, Rev Bras Ter Intensiva, V26, P269; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Gu WJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0570-5; Hernandez G, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0030-z; Hernandez G, 2012, J CRIT CARE, V27, P283, DOI 10.1016/j.jcrc.2011.05.024; Hernandez G, 2012, CURR OPIN CRIT CARE, V18, P280, DOI 10.1097/MCC.0b013e3283532c08; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lima A, 2005, INTENS CARE MED, V31, P1316, DOI 10.1007/s00134-005-2790-2; Lima A, 2015, CURR OPIN CRIT CARE, V21, P226, DOI 10.1097/MCC.0000000000000194; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; Otieno H, 2004, ARCH DIS CHILD, V89, P977, DOI 10.1136/adc.2003.043901; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Roland D, 2010, J PAEDIATR CHILD H, V46, P103, DOI 10.1111/j.1440-1754.2009.01646.x; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; van Genderen ME, 2015, AM J RESP CRIT CARE, V191, P477, DOI 10.1164/rccm.201408-1575LE; van Genderen ME, 2014, CRIT CARE, V18, DOI 10.1186/cc13905; Vincent JL, 2012, CRIT CARE, V16, DOI 10.1186/cc11510; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	31	50	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188548	10.1371/Journal.pone.0188548	http://dx.doi.org/10.1371/Journal.pone.0188548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176794	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900095
J	Alisauskaite, N; Spitzbarth, I; Baumgartner, W; Dziallas, P; Kramer, S; Dening, R; Stein, VM; Tipold, A				Alisauskaite, Neringa; Spitzbarth, Ingo; Baumgaertner, Wolfgang; Dziallas, Peter; Kramer, Sabine; Dening, Ricarda; Stein, Veronika Maria; Tipold, Andrea			Chronic post-traumatic intramedullary lesions in dogs, a translational model	PLOS ONE			English	Article							SPINAL-CORD-INJURY; DISC DISEASE; IMAGING FINDINGS; CLINICAL SIGNS; SYRINGOMYELIA; MYELOPATHY; HEMILAMINECTOMY; TRANSPLANTATION; PATHOLOGY; RECOVERY	Objectives Post-traumatic intramedullary myelopathies and cavitations are well described lesions following spinal cord injury (SCI) in humans and have been described in histopathological evaluations in dogs. Human intramedullary myelopathies/cavitations are associated with severe initial SCI and deterioration of clinical signs. Canine intervertebral disc extrusions share similarities with SCI in humans. In this descriptive study, magnetic resonance imaging (MRI) findings in spinal cords of dogs suffering from chronic post-traumatic myelopathies, including cavitations, are elucidated. An additional aim of the study was to compare diagnostic imaging and histopathological findings and identify similarities between human and canine chronic post-traumatic spinal cord lesions. Methods Thirty-seven dogs with thoracolumbar SCI and one or more 3Tesla MRI investigations more than 3 weeks after SCI were included. Extent of intramedullary lesions and particularly cavitations were evaluated and measured in sagittal and transverse MRI planes. These data were compared with clinical data. Results A total of 91.9% of study patients developed chronic intramedullary lesions, and 86.5% developed intramedullary cavitations. Paraplegia without deep pain perception at initial examination was significantly associated with longer chronic myelopathies/cavitations (P = 0.002/P = 0.008), and with larger maximal cross-sectional area (mCSA) of the lesions (P = 0.041/0.005). In addition, a non-ambulatory status after decompressive surgery was also associated with the development of longer intramedullary lesions/cavitations (P<0.001) and larger lesion mCSA (P<0.001/P = 0.012). All dogs with negative outcome developed myelopathies/cavitations. In the group of 21 dogs with positive outcome, 3 did not develop any myelopathies, and 5 did not develop cavitations. Conclusions Development of chronic intramedullary lesions/cavitations are common findings in canine SCI. Extensive chronic intramedullary lesions/cavitations reflect a severe initial SCI and negative clinical outcome. This supports the hypothesis that chronic spinal cord changes following SCI in humans share similarities with canine chronic spinal cord changes after spontaneous intervertebral disc extrusion.	[Alisauskaite, Neringa; Dziallas, Peter; Kramer, Sabine; Dening, Ricarda; Stein, Veronika Maria; Tipold, Andrea] Univ Vet Med Hannover, Dept Small Anim Med & Surg Univ, Hannover, Germany; [Spitzbarth, Ingo; Baumgaertner, Wolfgang] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Spitzbarth, Ingo; Baumgaertner, Wolfgang; Stein, Veronika Maria; Tipold, Andrea] Univ Vet Med Hannover, Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Alisauskaite, N (corresponding author), Univ Vet Med Hannover, Dept Small Anim Med & Surg Univ, Hannover, Germany.	neringavet@gmail.com		Alisauskaite, Neringa/0000-0003-1820-4717	German Research Foundation [FOR 1103, TI 309/4-1]	German Research Foundation(German Research Foundation (DFG))	The present project was partly supported by the German Research Foundation (FOR 1103, project TI 309/4-1). It covered the MRI examination and decompressive surgery expenses of the plegic dogs. No financial support was provided to the authors of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arseni C, 1963, ACTA NEUROCHIR, V11, P3; BACKE HA, 1991, PARAPLEGIA, V29, P607, DOI 10.1038/sc.1991.89; Bennaim M, 2017, AM J VET RES, V78, P195, DOI 10.2460/ajvr.78.2.195; CHO KH, 1994, J NEUROSURG, V80, P133, DOI 10.3171/jns.1994.80.1.0133; Coates JR, 2012, SMALL ANIMAL NEUROLO, P399; CURATI WL, 1992, NEURORADIOLOGY, V35, P30, DOI 10.1007/BF00588274; De Risio L, 2007, J VET INTERN MED, V21, P1290, DOI 10.1892/06-273.1; EDGAR R, 1994, BRIT J NEUROSURG, V8, P7, DOI 10.3109/02688699409002388; Ensinger EM, 2010, KLEINTIERPRAXIS, V55, P537; FALCONE S, 1994, AM J NEURORADIOL, V15, P747; Forterre F, 2010, VET SURG, V39, P165, DOI 10.1111/j.1532-950X.2009.00633.x; Gavin PR, 2009, PRACTICAL SMALL ANIM; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; Griffin JF, 2015, SPINAL CORD, V53, P278, DOI 10.1038/sc.2014.244; GRIFFITHS IR, 1972, J NEUROL NEUROSUR PS, V35, P403, DOI 10.1136/jnnp.35.3.403; Henke D, 2013, VET J, V198, P70, DOI 10.1016/j.tvjl.2013.04.003; Hettlich BF, 2012, VET SURG, V41, P215, DOI 10.1111/j.1532-950X.2011.00920.x; Hu HZ, 2012, J COMP PATHOL, V146, P192, DOI 10.1016/j.jcpa.2011.07.002; Hu HZ, 2012, RES VET SCI, V93, P318, DOI 10.1016/j.rvsc.2011.08.012; Ito D, 2005, JAVMA-J AM VET MED A, V227, P1454, DOI 10.2460/javma.2005.227.1454; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Klekamp J., 2002, SYRINGOMYELIA DIAGNO; Ko HY, 2012, SPINAL CORD, V50, P695, DOI 10.1038/sc.2012.35; Krammer KM, 1997, CLIN ORTHOP RELAT R, P190; Kumar R, 2007, CHILD NERV SYST, V23, P1295, DOI 10.1007/s00381-007-0370-1; Levine JM, 2009, J VET INTERN MED, V23, P1220, DOI 10.1111/j.1939-1676.2009.0393.x; Levine JM, 2011, J NEUROTRAUM, V28, P675, DOI 10.1089/neu.2010.1645; Ma DY, 2013, CLIN INTERV AGING, V8, P1047, DOI 10.2147/CIA.S49698; Escalhao CCM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3053759; MCRAE DL, 1956, ACTA RADIOL, V46, P9, DOI 10.3109/00016925609170806; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mohanty SP, 2013, SPINAL CORD, V51, P815, DOI 10.1038/sc.2013.87; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; OBEIRNE J, 1993, INJURY, V24, P149, DOI 10.1016/0020-1383(93)90278-E; Okada M, 2010, JAVMA-J AM VET MED A, V237, P1160, DOI 10.2460/javma.237.10.1160; Penha EM, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/437521; Perrouin-Verbe B, 1998, SPINAL CORD, V36, P137, DOI 10.1038/sj.sc.3100625; Platt S, 2013, BSAVA MANUAL FELINE, P260; Plessas IN, 2012, VET REC, V171, DOI 10.1136/vr.100449; Potter K, 2003, BRIT J RADIOL, V76, P347, DOI 10.1259/bjr/11881183; Ryu HH, 2012, J VET MED SCI, V74, P1617, DOI 10.1292/jvms.12-0065; Schurch B, 1996, J NEUROL NEUROSUR PS, V60, P61, DOI 10.1136/jnnp.60.1.61; Sharp NJH., 2005, SMALL ANIMAL SPINAL, P388; Shields CB, 2002, HDB CLIN NEUROLOGY, V109; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; SILBERSTEIN M, 1993, PARAPLEGIA, V31, P160, DOI 10.1038/sc.1993.31; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; SQUIER MV, 1994, J NEUROL NEUROSUR PS, V57, P1095, DOI 10.1136/jnnp.57.9.1095; Feitosa MLT, 2017, ACTA CIR BRAS, V32, P540, DOI 10.1590/s0102-865020170070000005; Vannemreddy SSVP, 2002, BRIT J NEUROSURG, V16, P276, DOI 10.1080/02688690220148879; Vaquero J, 2013, CLIN TRANSPLANT, V27, P968, DOI 10.1111/ctr.12267; Wang DJ, 1996, PARAPLEGIA, V34, P65, DOI 10.1038/sc.1996.13; WILLIAMS B, 1992, BRIT J NEUROSURG, V6, P517, DOI 10.3109/02688699209002367; WRIGHT F, 1969, PATHOL VET, V6, P355, DOI 10.1177/030098586900600405	55	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187746	10.1371/journal.pone.0187746	http://dx.doi.org/10.1371/journal.pone.0187746			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166400	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300018
J	Bras, JP; Silva, AM; Calin, GA; Barbosa, MA; Santos, SG; Almeida, MI				Bras, Joao Paulo; Silva, Andreia Machado; Calin, George A.; Barbosa, Mario Adolfo; Santos, Susana Gomes; Almeida, Maria Ines			miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; EXPRESSION; POLARIZATION; TLR2; ATHEROSCLEROSIS; ACTIVATION; PROLIFERATION; INVOLVEMENT; MODULATION; PHENOTYPE	Macrophages are a main component of atherosclerotic plaques. Recent studies suggest that pro-inflammatory M1 macrophages are pro-atherogenic while M2 macrophages promote plaque stability. Moreover, toll-like receptor signalling pathways are implicated in atherosclerotic plaque formation, evolution and regression. We propose microRNAs as key regulators of these processes. In this context, our goal is to promote inflammation resolution using miR-195 to reduce M1-like macrophage polarization and to evaluate the molecular mechanisms underlying such effect, as well as to explore the functional consequences for smooth muscle cell recruitment. Human primary macrophages were differentiated from peripheral blood monocytes and stimulated with LPS or IL-10 to promote M1 or M2c polarization, respectively. miR-195 levels were upregulated in M2c macrophages compared with M1 macrophages. In THP-1 macrophages stimulated with LPS and IFN-gamma, results show that TLR2 levels were reduced by miR-195 overexpression compared with scrambled control. In addition, phosphorylated forms of p54 JNK, p46 JNK and p38 MAPK were decreased by miR-195 in macrophages following M1 stimulation. Moreover, miR-195 significantly decreased levels of IL-1 beta, IL-6 and TNF-alpha pro-inflammatory cytokines in the supernatants of M1-stimulated macrophage cultures. At the functional level, results from smooth muscle cell recruitment and migration models showed that miR-195 impairs the capacity of M1 macrophages to promote smooth muscle cells migration. In conclusion, miR-195 is involved in macrophage polarization and inhibits TLR2 inflammatory pathway mediators. Moreover, miR-195 impairs the effect of macrophages on smooth muscle cells recruitment capacity and migration profile. Thus, miR-195 might be used as a new potential tool to promote inflammation resolution in cardiovascular research.	[Bras, Joao Paulo; Silva, Andreia Machado; Barbosa, Mario Adolfo; Santos, Susana Gomes; Almeida, Maria Ines] Univ Porto, Inst Invest & Inovacao Saude, Oporto, Portugal; [Bras, Joao Paulo; Silva, Andreia Machado; Barbosa, Mario Adolfo; Santos, Susana Gomes; Almeida, Maria Ines] Univ Porto, Inst Engn Biomed, Oporto, Portugal; [Bras, Joao Paulo] Univ Porto, Fac Engn, Oporto, Portugal; [Bras, Joao Paulo; Silva, Andreia Machado; Barbosa, Mario Adolfo] Univ Porto, Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; University of Texas System; UTMD Anderson Cancer Center	Almeida, MI (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Oporto, Portugal.; Almeida, MI (corresponding author), Univ Porto, Inst Engn Biomed, Oporto, Portugal.	ines.almeida@ineb.up.pt	Brás, João/AAI-5050-2020; Santos, Susana G/L-9351-2013; Silva, Andreia M./AAY-1152-2021; Calin, George/E-9390-2011; Almeida, Maria Ines/AAP-2376-2021; Almeida, Maria Ines/AAP-3249-2021; Barbosa, Mario/F-5964-2011	Brás, João/0000-0003-1867-0486; Santos, Susana G/0000-0002-8604-2978; Silva, Andreia M./0000-0001-6365-1407; Almeida, Maria Ines/0000-0003-2072-8587; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578; Barbosa, Mario/0000-0003-3568-7482	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000012]; FCT Fundacao para a Ciencia e a Tecnologia [PD/BI/128356/2017, SFRH/BD/85968/2012, SFRH/BPD/91011/2012]	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL through the European Regional Development Fund (ERDF); FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was funded by the project (NORTE-01-0145-FEDER-000012), supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). JPB, AMS and MIA were supported by FCT Fundacao para a Ciencia e a Tecnologia, through fellowships PD/BI/128356/2017, SFRH/BD/85968/2012 and SFRH/BPD/91011/2012, respectively. JPB would like to thank to BiotechHealth PhD Programme and MIA to L'Oreal-UNESCO-FCT for the Medal of Honor for Women in Science.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Almeida MI, 2016, ONCOTARGET, V7, P7, DOI 10.18632/oncotarget.6589; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Banerjee S, 2012, J IMMUNOL, V29, P997; Banerjee S, 2013, J BIOL CHEM, V288, P35428, DOI 10.1074/jbc.M112.426866; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Bosisio D, 2002, BLOOD, V99, P3427, DOI 10.1182/blood.V99.9.3427; Burdon KP, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/170153; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chavez-Sanchez L, 2014, HUM IMMUNOL, V75, P322, DOI 10.1016/j.humimm.2014.01.012; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Fernandez-Velasco M, 2014, BIOCHEM J, V458, P187, DOI 10.1042/BJ20131501; Frink RJ, 2002, INFLAMMATORY ATHEROS, P1; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Islam K., 2016, SM J BIOMED ENG, V2, P1008; Jimenez VC, 2014, PHYSIOL GENOMICS, V46, P91, DOI 10.1152/physiolgenomics.00140.2013; Koga J, 2012, VASC PHARMACOL, V57, P24, DOI 10.1016/j.vph.2012.02.011; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Mazza G, 2016, CYTOTECHNOLOGY, V68, P701, DOI 10.1007/s10616-014-9822-0; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oliveira MI, 2017, ACTA BIOMATER, V49, P296, DOI 10.1016/j.actbio.2016.11.034; Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Qu Q, 2017, CELL BIOL INT, V41, P287, DOI 10.1002/cbin.10723; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Seneviratne AN, 2012, CLIN CHIM ACTA, V413, P3, DOI 10.1016/j.cca.2011.08.021; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thulin P, 2013, INT J MOL MED, V31, P1003, DOI 10.3892/ijmm.2013.1311; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wang Q, 2001, INFECT IMMUN, V69, P2; Wang YS, 2012, CARDIOVASC RES, V95, P517, DOI 10.1093/cvr/cvs223; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang ZG, 2017, CANCER LETT, V393, P1, DOI 10.1016/j.canlet.2017.02.008	49	44	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188530	10.1371/journal.pone.0188530	http://dx.doi.org/10.1371/journal.pone.0188530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166412	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300046
J	Foreman, KW				Foreman, Kenneth W.			A general model for predicting the binding affinity of reversibly and irreversibly dimerized ligands	PLOS ONE			English	Article							BIVALENT LIGANDS; ALLOSTERIC PROTEINS; FREE-ENERGY; INHIBITORS; DRUGGABILITY; DESIGN; SITES; EXPRESSION; CHEMISTRY; POTENT	Empirical data has shown that bivalent inhibitors can bind a given target protein significantly better than their monomeric counterparts. However, predicting the corresponding theoretical fold improvements has been challenging. The current work builds off the reacted-site probability approach to provide a straightforward baseline reference model for predicting fold-improvements in effective affinity of dimerized ligands over their monomeric counterparts. For the more familiar irreversibly linked bivalents, the model predicts a weak dependence on tether length and a scaling of the effective affinity with the 3/2 power of the monomer's affinity. For the previously untreated case of the emerging technology of reversibly linking dimers, the effective affinity is also significantly improved over the affinity of the non-dimerizing monomers. The model is related back to experimental quantities, such as EC(50)s, and the approaches to fully characterize the system given the assumptions of the model. Because of the predicted significant potency gains, both irreversibly and reversibly linked bivalent ligands offer the potential to be a disruptive technology in pharmaceutical research.	[Foreman, Kenneth W.] BlinkBio Inc, Jupiter, FL 33458 USA; [Foreman, Kenneth W.] Ars Exemplar LLC, Syosset, NY 11791 USA		Foreman, KW (corresponding author), BlinkBio Inc, Jupiter, FL 33458 USA.; Foreman, KW (corresponding author), Ars Exemplar LLC, Syosset, NY 11791 USA.	kwforeman@mailaps.org	Foreman, Kenneth/AAI-2249-2020					Andersen J, 2016, ACS CHEM NEUROSCI, V7, P1406, DOI 10.1021/acschemneuro.6b00164; Bakan A, 2012, J CHEM THEORY COMPUT, V8, P2435, DOI 10.1021/ct300117j; Barany F, 2009, Coferons and methods of making and using them patent WO, Patent No. 2009126290A2; Buchwald P, 2010, IUBMB LIFE, V62, P724, DOI 10.1002/iub.383; Busnelli M, 2016, J MED CHEM, V59, P7152, DOI 10.1021/acs.jmedchem.6b00564; CALVERT PD, 1979, J THEOR BIOL, V80, P233, DOI 10.1016/0022-5193(79)90208-X; Cang SD, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0224-3; Debets MF, 2013, ORG BIOMOL CHEM, V11, P6439, DOI 10.1039/c3ob41329b; Diestler DJ, 2010, J PHYS CHEM C, V114, P5287, DOI 10.1021/jp904258c; Diestler DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.178101; Gower CM, 2014, CRIT REV BIOCHEM MOL, V49, P102, DOI 10.3109/10409238.2013.875513; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hubble J, 1999, MOL IMMUNOL, V36, P13, DOI 10.1016/S0161-5890(98)00116-3; Jahromi AH, 2013, J MED CHEM, V56, P9471, DOI 10.1021/jm400794z; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kerns RJ, 2003, BIOORG MED CHEM LETT, V13, P2109, DOI 10.1016/S0960-894X(03)00376-7; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lollar P, 2014, J MOL RECOGNIT, V27, P73, DOI 10.1002/jmr.2335; Machida S, 2011, J AM CHEM SOC, V133, P958, DOI 10.1021/ja1086112; Mack ET, 2012, J AM CHEM SOC, V134, P333, DOI 10.1021/ja2073033; Mack ET, 2011, ANAL BIOANAL CHEM, V399, P1641, DOI 10.1007/s00216-010-4477-y; Monine MI, 2010, BIOPHYS J, V98, P48, DOI 10.1016/j.bpj.2009.09.043; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Saiz L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000355; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; Sun HY, 2011, J MED CHEM, V54, P3306, DOI 10.1021/jm101651b; Tanaka M, 2016, NAT CHEM BIOL, V12, P1089, DOI [10.1038/NCHEMBIO.2209, 10.1038/nchembio.2209]; Vilar JMG, 2013, ACS SYNTH BIOL, V2, P576, DOI 10.1021/sb400013w; Vilar JMG, 2011, NUCLEIC ACIDS RES, V39, P6854, DOI 10.1093/nar/gkr272; Vilar JMG, 2010, BIOINFORMATICS, V26, P2060, DOI 10.1093/bioinformatics/btq328; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wanner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121793; Waring MJ, 2016, NAT CHEM BIOL, V12, P1097, DOI [10.1038/NCHEMBIO.2210, 10.1038/nchembio.2210]; Yu F, 2014, EUR J MED CHEM, V77, P258, DOI 10.1016/j.ejmech.2014.03.017; Zhou HX, 2009, CHEM REV, V109, P4092, DOI 10.1021/cr800551w	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188134	10.1371/journal.pone.0188134	http://dx.doi.org/10.1371/journal.pone.0188134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166663	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300026
J	Kalan, L; Zhou, M; Labbie, M; Willing, B				Kalan, Lindsay; Zhou, Mi; Labbie, Michele; Willing, Benjamin			Measuring the microbiome of chronic wounds with use of a topical antimicrobial dressing - A feasibility study	PLOS ONE			English	Article							HUMAN SKIN MICROBIOME; STAPHYLOCOCCUS-AUREUS; SILVER OXYNITRATE; DIABETIC FOOT; EFFICACY; INFECTION; BACTERIA; DIVERSITY	Background Polymicrobial communities colonize all wounds, and biofilms are hypothesized to be a key link to the chronic state and stalled healing. Molecular methods offer greater insight when studying microbial ecology in chronic wounds, as only a small fraction of wound bacteria are cultured by currently available methods and studies have shown little agreement between culture and molecular based approaches. Some interventions, like dressings with oxidized silver, are reported to help the stalled wounds move to a normal healing trajectory but the underlying mechanisms are difficult to measure. One hypothesis is that the use of topical antimicrobial dressings targets the wound microbiome and reduces bioburden. Objectives Our objective was to determine if culture-independent molecular methods could be used to identify the microbial composition in chronic wounds, and measure the microbiome over time when a topical antimicrobial dressing is used to reduce bioburden. Methods Patients with chronic wounds defined as >6 weeks in duration and not taking systemic antibiotics were recruited to participate. A wound contact layer containing silver oxynitrate was applied immediately after routine sharp debridement material was collected and swabs of the wound bed taken. Next-generation sequencing of the bacterial 16S rRNA gene in each specimen was used to measure the microbiome. Results Distinct bacterial communities were observed between swab and debridement samples, highlighting spatial differences and the importance of sampling consistency. The microbial communities appeared to be similar between different diabetes statuses, but different among the three wound categories included. Conclusions Culture-independent methods can be applied to measure the microbiome of chronic wounds even when a topical antimicrobial dressing is applied to the wound.	[Kalan, Lindsay] Exciton Technol Inc, Edmonton, AB, Canada; [Zhou, Mi; Willing, Benjamin] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Labbie, Michele] Westview Hlth Ctr, Stony Plain, AB, Canada; [Kalan, Lindsay] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Alberta; University of Pennsylvania; Pennsylvania Medicine	Willing, B (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	willing@ualberta.ca	Willing, Benjamin/AAA-9650-2019	Kalan, Lindsay/0000-0003-4980-5128	Alberta Innovates Technology Futures R&D Associate Fellowship; NSERC ENGAGE; Exciton Technologies Inc (ETI); Canada Research Chairs Program	Alberta Innovates Technology Futures R&D Associate Fellowship; NSERC ENGAGE(Natural Sciences and Engineering Research Council of Canada (NSERC)); Exciton Technologies Inc (ETI); Canada Research Chairs Program(Canada Research Chairs)	L.K was supported by Alberta Innovates Technology Futures R&D Associate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The current study was funded by an NSERC ENGAGE grant to B.W, which was supported by in-kind contributions from Exciton Technologies Inc (ETI) in the form of dressing materials. L.K was employed as a research scientist at ETI during the time this study was completed. The funder provided support in the form of salaries for authors [LK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. B.P.W recognizes the Canada Research Chairs Program for funding and support.; The authors would like to thank staff at Westview Health Centre Wound Clinic (Stony Plain, AB, CAN) for patient care and sample collection. L.K was supported by Alberta Innovates Technology Futures R&D Associate Fellowship. The current study was funded by an NSERC ENGAGE grant to B.W, which was supported by in-kind contributions from Exciton Technologies Inc (ETI) in the form of dressing materials. L.K was employed as a research scientist at ETI during the time this study was completed. The funder provided support in the form of salaries for authors [LK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. B.P.W recognizes the Canada Research Chairs Program for funding and support.	Ammons MCB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126735; Angel DE, 2011, INT WOUND J, V8, P176, DOI 10.1111/j.1742-481X.2010.00765.x; [Anonymous], 1983, Can Med Assoc J, V129, P554; [Anonymous], 2012, AM FAM PHYSICIAN, V85, P195; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavanagh MH, 2010, INT WOUND J, V7, P394, DOI 10.1111/j.1742-481X.2010.00705.x; Coletti D, 2013, REGEN MED RES, V1, DOI 10.1186/2050-490X-1-4; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Frieden T., 2013, ANT RES THREATS US; Ganesh K, 2015, ADV WOUND CARE, V4, P382, DOI 10.1089/wound.2014.0587; Gardner SE, 2006, WOUND REPAIR REGEN, V14, P548, DOI 10.1111/j.1743-6109.2006.00162.x; Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771; GOLDENHEIM PD, 1993, POSTGRAD MED J, V69, pS62; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HALSTED WS, 1895, AM J MED SCI, V110, P13; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris C, 2010, J WOUND OSTOMY CONT, V37, P253, DOI 10.1097/WON.0b013e3181d73aab; Higginbottom J, 1866, AM J MED SCI, V51, P502; Higginbottom J, 1826, ESSAY APPL LUNAR CAU; Iacopi E, 2015, INT J LOW EXTR WOUND, V14, P316, DOI 10.1177/1534734615606534; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Kalan LR, 2017, INT J ANTIMICROB AG, V49, P719, DOI 10.1016/j.ijantimicag.2017.01.019; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lansdown ABG, 2010, ISSUES TOXICOL, V6, P1; Lemire JA, 2017, BIOFOULING, P1; Lemire JA, 2015, ANTIMICROB AGENTS CH, V59, P4031, DOI 10.1128/AAC.05177-14; Loesche M, 2016, J INVEST DERMATOL; Loesche M, 2016, AM SOC MICROBIOLOGY, V7; Loesche M, J INVESTIGATIVE DERM; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Nguyen CT, 2015, J MICROBIOL, V53, P741, DOI 10.1007/s12275-015-5432-6; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Percival SL, 2011, INT WOUND J, V8, P237, DOI 10.1111/j.1742-481X.2011.00774.x; Perez GIP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151990; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Rantala S, 2014, EUR J CLIN MICROBIOL, V33, P1303, DOI 10.1007/s10096-014-2092-0; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535; Swanson T., 2016, WOUND INFECT CLIN PR; Takeo M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023267; Thomas JG, 2011, J WOUND CARE, V20, P580, DOI 10.12968/jowc.2011.20.12.580; U. S. Preventive Services Task Force, 2012, AM FAM PHYSICIAN, P197; White R.J., 2001, BR J COMMUNITY NURS, V6, P3, DOI DOI 10.12968/BJCN.2001.6.SUP1.12619; Wolcott R D, 2009, J Wound Care, V18, P317; Wolcott R D, 2009, J Wound Care, V18, P54; World Health Organization, 2014, ANT RES GLOB REP SUR; ZANONI D, 1992, CLIN PEDIATR, V31, P295, DOI 10.1177/000992289203100506	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187728	10.1371/journal.pone.0187728	http://dx.doi.org/10.1371/journal.pone.0187728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155834	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700014
J	Malinova, I; Fettke, J				Malinova, Irina; Fettke, Joerg			Reduced starch granule number per chloroplast in the dpe2/phs1 mutant is dependent on initiation of starch degradation	PLOS ONE			English	Article							MALTOSE METABOLISM; ARABIDOPSIS LEAVES; HETEROGLYCANS SHG; WATER DIKINASE; ALPHA-GLUCAN; PHOSPHORYLATION; CYTOSOL; NIGHT	An Arabidopsis double knock-out mutant lacking cytosolic disproportionating enzyme 2 (DPE2) and the plastidial phosphorylase (PHS1) revealed a dwarf-growth phenotype, reduced starch content, an uneven distribution of starch within the plant rosette, and a reduced number of starch granules per chloroplast under standard growth conditions. In contrast, the wild type contained 5-7 starch granules per chloroplast. Mature and old leaves of the double mutant were essentially starch free and showed plastidial disintegration. Several analyses revealed that the number of starch granules per chloroplast was affected by the dark phase. So far, it was unclear if it was the dark phase per se or starch degradation in the dark that was connected to the observed decrease in the number of starch granules per chloroplast. Therefore, in the background of the double mutant dpe2/phs1, a triple mutant was generated lacking the initial starch degrading enzyme glucan, water dikinase (GWD). The triple mutant showed improved plant growth, a starch-excess phenotype, and a homogeneous starch distribution. Furthermore, the number of starch granules per chloroplast was increased and was similar to wild type. However, starch granule morphology was only slightly affected by the lack of GWD as in the triple mutant and, like in dpe2/phs1, more spherical starch granules were observed. The characterized triple mutant was discussed in the context of the generation of starch granules and the formation of starch granule morphology.	[Malinova, Irina; Fettke, Joerg] Univ Potsdam, Biopolymer Analyt, Potsdam, Germany	University of Potsdam	Fettke, J (corresponding author), Univ Potsdam, Biopolymer Analyt, Potsdam, Germany.	fettke@uni-potsdam.de		Fettke, Joerg/0000-0003-0137-7611				Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Crumpton-Taylor M, 2013, NEW PHYTOL, V200, P1064, DOI 10.1111/nph.12455; Crumpton-Taylor M, 2012, PLANT PHYSIOL, V158, P905, DOI 10.1104/pp.111.186957; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Hejazi M, 2012, ESSENTIAL REV EXPT B, V5, P279; Hejazi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28892; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Mahlow S, 2014, NEW PHYTOL, V203, P495, DOI 10.1111/nph.12801; Malinova I, 2017, PLANT PHYSIOL, V174, P73, DOI 10.1104/pp.16.01859; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	19	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187985	10.1371/journal.pone.0187985	http://dx.doi.org/10.1371/journal.pone.0187985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155859	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700024
J	Maydych, V; Claus, M; Dychus, N; Ebel, M; Damaschke, J; Diestel, S; Wolf, OT; Kleinsorge, T; Watzl, C				Maydych, Viktoriya; Claus, Maren; Dychus, Nicole; Ebel, Melanie; Damaschke, Juergen; Diestel, Stefan; Wolf, Oliver T.; Kleinsorge, Thomas; Watzl, Carsten			Impact of chronic and acute academic stress on lymphocyte subsets and monocyte function	PLOS ONE			English	Article							BECK-DEPRESSION-INVENTORY; SELF-CONTROL DEMANDS; SALIVARY CORTISOL; CYTOKINE PRODUCTION; CELLULAR-IMMUNITY; STRENGTH MODEL; EGO DEPLETION; LIFE STRESS; CELLS; VALIDATION	This study investigated the effects of a temporally confined naturalistic stressor (academic stress) on immune functions. Furthermore, moderating influences of a number of psychological variables were assessed. Five blood samples were obtained from 20 students during an observation period of 8 weeks, starting 4.5 weeks before an exam period up to 1 week following the last exam. The analysis of 45 immune parameters revealed several time-dependent changes attributable to examination stress. We observed a reduction in the absolute numbers of natural killer (NK) cells and monocytes in peripheral blood and a shift towards more immature and naive cells within NK and T cell populations. In addition, IL-6 and TNF-alpha production by LPS-stimulated monocytes was increased. Psychological variables were grouped by means of factor analyses into two factors. One factor, which was interpreted as an indication of chronic stress, moderated the relationships between academic stress and percentages of mature CD57(+) NK cells. This chronic stress factor was also associated with an increase in memory and a decrease in naive CD8 T cells and increased serum levels of IL-17. The present study identifies important potential psychological mediators of stress-induced changes in specific immunological parameters.	[Maydych, Viktoriya; Diestel, Stefan; Kleinsorge, Thomas] TU Dortmund, IfADo, Dept Psychol & Neurosci, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Claus, Maren; Dychus, Nicole; Ebel, Melanie; Damaschke, Juergen; Watzl, Carsten] TU Dortmund, IfADo, Dept Immunol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Wolf, Oliver T.] Ruhr Univ Bochum, Inst Cognit Neurosci, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Ruhr University Bochum	Kleinsorge, T (corresponding author), TU Dortmund, IfADo, Dept Psychol & Neurosci, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.; Watzl, C (corresponding author), TU Dortmund, IfADo, Dept Immunol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	kleinsorge@ifado.de; watzl@ifado.de	Watzl, Carsten/B-4911-2013; Kleinsorge, Thomas/A-2801-2008; Claus, Maren/AAO-5187-2021	Watzl, Carsten/0000-0001-5195-0995; Kleinsorge, Thomas/0000-0002-4913-1728; Claus, Maren/0000-0001-8732-0645; Wolf, Oliver T./0000-0002-9320-2124	Leibniz Association	Leibniz Association	The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all volunteer participants of this study and Manfred Schedlowski for his discussions and the critical reading of the manuscript. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Borella P, 1999, PSYCHONEUROENDOCRINO, V24, P613, DOI 10.1016/S0306-4530(99)00016-5; BROSSCHOT JF, 1994, PSYCHOSOM MED, V56, P216, DOI 10.1097/00006842-199405000-00007; Bussing A., 1992, DIAGNOSTICA; Cardinal J, 2010, J CLIN ENDOCR METAB, V95, P3657, DOI 10.1210/jc.2009-2720; Claus M, 2016, ARCH TOXICOL, V90, P2481, DOI 10.1007/s00204-016-1809-5; Cohen S, 2012, OXFORD HDB PSYCHONEU; De Gucht V, 1999, PSYCHIAT RES, V85, P105, DOI 10.1016/S0165-1781(98)00131-0; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; DOBBIN JP, 1991, BRAIN BEHAV IMMUN, V5, P339, DOI 10.1016/0889-1591(91)90029-A; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; GLASER R, 1985, PSYCHIAT RES, V16, P233; GLASER R, 1994, PSYCHONEUROENDOCRINO, V19, P765, DOI 10.1016/0306-4530(94)90023-X; Goldstein DS, 2001, AUTONOMIC NERVOUS SY, Vxii; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; HALVORSEN R, 1987, J PSYCHOSOM RES, V31, P693, DOI 10.1016/0022-3999(87)90018-3; Hamaker EL, 2007, J RES PERS, V41, P295, DOI 10.1016/j.jrp.2006.04.003; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Hoglund CO, 2006, CLIN EXP ALLERGY, V36, P982, DOI 10.1111/j.1365-2222.2006.02529.x; IRWIN M, 1990, BIOL PSYCHIAT, V27, P22, DOI 10.1016/0006-3223(90)90016-U; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Katsuura S, 2010, INT J PSYCHOPHYSIOL, V77, P135, DOI 10.1016/j.ijpsycho.2010.05.004; KIECOLTGLASER JK, 1986, J BEHAV MED, V9, P5, DOI 10.1007/BF00844640; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P523, DOI 10.1097/00006842-198709000-00008; KIECOLTGLASER JK, 1984, PSYCHOSOM MED, V46, P7, DOI 10.1097/00006842-198401000-00003; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; LATACK JC, 1992, J ORGAN BEHAV, V13, P479, DOI 10.1002/job.4030130505; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Marshall GD, 1998, BRAIN BEHAV IMMUN, V12, P297, DOI 10.1006/brbi.1998.0537; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Murphy L, 2010, STRESS, V13, P366, DOI 10.3109/10253891003615473; Nakamura H, 1999, J PSYCHOSOM RES, V46, P569, DOI 10.1016/S0022-3999(99)00009-4; Neubach B, 2006, Z ARB ORGAN, V50, P103, DOI 10.1026/0932-4089.50.2.103; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Pehlivanoglu B, 2001, Arch Physiol Biochem, V109, P383, DOI 10.1076/apab.109.3.383.9338; Preuss D, 2010, STRESS, V13, P221, DOI 10.3109/10253890903277579; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; PRUMPER J, 1995, Z ARB ORGAN, V39, P125; Schmidt KH, 2015, J PERS PSYCHOL, V14, P49, DOI 10.1027/1866-5888/a000123; Schmidt KH, 2012, WORK STRESS, V26, P21, DOI 10.1080/02678373.2012.660367; Schmitt M, 2000, DIAGNOSTICA, V46, P38, DOI 10.1026//0012-1924.46.1.38; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Segerstrom SC, 2010, ANN BEHAV MED, V40, P114, DOI 10.1007/s12160-010-9195-3; Slattery M, 2012, BRAIN BEHAVIOR AND I, V26, pS44; Steckler T., TECHNIQUES BEHAV NEU, V152005, P25; Stowell JR, 2003, PSYCHOSOM MED, V65, P1055, DOI 10.1097/01.PSY.0000097349.84109.1F; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Urlaub D, 2017, J IMMUNOL, V198, P1944, DOI 10.4049/jimmunol.1601004; Van Heck GL, 2007, PSIHOLOGIJSKE TEME, V16, P178; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weekes N, 2006, STRESS, V9, P199, DOI 10.1080/10253890601029751; Weekes NY, 2008, PSYCHONEUROENDOCRINO, V33, P766, DOI 10.1016/j.psyneuen.2008.03.003; Wirtz PH, 2007, BRAIN BEHAV IMMUN, V21, P851, DOI 10.1016/j.bbi.2007.02.003; Xu WL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081742; Yang JF, 2014, TRENDS PHARMACOL SCI, V35, P493, DOI 10.1016/j.tips.2014.07.006	64	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188108	10.1371/journal.pone.0188108	http://dx.doi.org/10.1371/journal.pone.0188108			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145439	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800066
J	Marneros, AG				Marneros, Alexander G.			Effects of chronically increased VEGF-A on the aging heart	FASEB JOURNAL			English	Article						myocardial hypertrophy; angiogenesis; NLRP3; cardiac failure	INDUCED CARDIAC-HYPERTROPHY; GROWTH-FACTOR; PRESSURE-OVERLOAD; ANGIOTENSIN-II; IN-VIVO; MICE; FAILURE; ANGIOGENESIS; ACTIVATION; INFLAMMASOME	Whether approaches to chronically increase VEGF-A in the heart may have beneficial effects and prevent the development of heart failure, in part by improving cardiac perfusion, or whether this increase could have detrimental effects on cardiac performance in the aging heart, has not been tested yet. In this study, a genetic mouse model with a chronic increase in VEGF-A in the heart is shown to have increased cardiac angiogenesis and develop cardiac hypertrophy with enhanced basal cardiac performance with age progression. However, in aged hearts, this increase in VEGF-A was associated with higher expression of fetal cardiac genes and reduced cardiac performance after beta-agonistic stress, features consistent with pathologic cardiac hypertrophy. Expression of Nod-like receptor protein (NLRP)-3 was increased in the hearts of the mice, and its genetic inactivation prevented increased fetal cardiac gene expression and partially rescued the impaired cardiac performance after beta-agonistic stimulation in aged hearts without reducing cardiac angiogenesis or hypertrophy. Thus, although a chronic increase in cardiac VEGF-A may improve cardiac perfusion, long-term upregulation of VEGF-A leads to reduced cardiac performance under stress, an effect that can be partially inhibited by NLRP3 inactivation. Targeting NLRP3 shifts the VEGF-A-induced cardiac hypertrophy from a pathologic toward a more physiologic hypertrophy.	[Marneros, Alexander G.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Marneros, Alexander G.] Harvard Med Sch, Dept Dermatol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Marneros, AG (corresponding author), Massachusetts Gen Hosp, CNY-149,13th St, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Marneros, Alexander/0000-0003-3866-020X	Massachusetts General Hospital	Massachusetts General Hospital(General Electric)	The author thanks Karin Strittmatter, and Peter Kang and Qingen Ke (Beth Israel Deaconess Medical Center Cardiac Physiology Core Facility) for technical help, and Dr. Peter Kang for helpful discussions of the findings. This study was supported by institutional funds from Massachusetts General Hospital (to A.G.M.). The author declares no conflicts of interest.	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abraham D, 2000, CIRC RES, V87, P644, DOI 10.1161/01.RES.87.8.644; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bry M, 2010, CIRCULATION, V122, P1725, DOI 10.1161/CIRCULATIONAHA.110.957332; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Jaba IM, 2013, J CLIN INVEST, V123, P1718, DOI 10.1172/JCI65112; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kivela R, 2014, EMBO MOL MED, V6, P307, DOI 10.1002/emmm.201303147; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Manukyan I, 2010, J CELL MOL MED, V14, P1707, DOI 10.1111/j.1582-4934.2009.00804.x; Marneros AG, 2016, EMBO MOL MED, V8, P208, DOI 10.15252/emmm.201505613; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Ohtsuka T, 2005, EUR J HEART FAIL, V7, P689, DOI 10.1016/j.ejheart.2004.09.011; Pacher P, 2004, AM J PHYSIOL-HEART C, V287, pH2132, DOI 10.1152/ajpheart.00405.2004; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tirziu D, 2007, J CLIN INVEST, V117, P3188, DOI 10.1172/JCI32024; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Xu XH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-54; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zolk O, 2008, BIOCHEM BIOPH RES CO, V376, P315, DOI 10.1016/j.bbrc.2008.08.152	45	14	17	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1550	1565		10.1096/fj.201700761RR	http://dx.doi.org/10.1096/fj.201700761RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146733				2022-12-26	WOS:000427246000034
J	Prodanovic, D; Keenan, CR; Langenbach, S; Li, MN; Chen, QY; Lew, MJ; Stewart, AG				Prodanovic, Danica; Keenan, Christine R.; Langenbach, Shenna; Li, Meina; Chen, Qianyu; Lew, Michael J.; Stewart, Alastair G.			Cortisol limits selected actions of synthetic glucocorticoids in the airway epithelium	FASEB JOURNAL			English	Article						partial agonist; steroid resistance; asthma; stress; inhaled corticosteroids	PERIPHERAL-BLOOD NEUTROPHILS; FINGER PROTEIN PLZF; GM-CSF; INDUCED APOPTOSIS; CELL LINE; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; SODIUM-CHANNEL; SMOOTH-MUSCLE; IN-VITRO	Cortisol, a physiologic glucocorticoid (GC), is essential for growth and differentiation of the airway epithelium. Epithelial function influences inflammation in chronic respiratory diseases. Synthetic GCs, including inhaled corticosteroids, exert anti-inflammatory effects in airway epithelium by transactivation of genes and by inhibition of proinflammatory cytokine release. We examined the effect of cortisol on the actions of synthetic GCs in the airway epithelium, demonstrating that cortisol acts like a partial agonist at the GC receptor (GR), limiting GC-induced GR-dependent transcription in the BEAS-2B human bronchial epithelial cell line. Cortisol also limited the inhibition of granulocyte macrophage colony-stimulating factor release by synthetic GCs in TNF-alpha-activated BEAS-2B cells. The relevance of these findings is supported by observations on tracheal epithelium obtained from mice treated for 5 d with systemic GC, showing limitations in selected GC effects, including inhibition of IL-6. Moreover, gene transactivation by synthetic GCs was compromised by standard air-liquid interface (ALI) growth medium cortisol concentration (1.4 mu M) in the ALI-differentiated organotypic culture of primary human airway epithelial cells. These findings suggest that endogenous corticosteroids may limit certain actions of synthetic pharmacological GCs and contribute to GC insensitivity, particularly when corticosteroid levels are elevated by stress.	[Prodanovic, Danica; Keenan, Christine R.; Langenbach, Shenna; Li, Meina; Chen, Qianyu; Lew, Michael J.; Stewart, Alastair G.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic, Australia; [Stewart, Alastair G.] Univ Melbourne, Australian Res Council ARC Ctr Personalised Thera, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Stewart, AG (corresponding author), Univ Melbourne, 181 Grattan St,Med Bldg, Parkville, Vic 3010, Australia.	astew@unimelb.edu.au		Lew, Michael/0000-0002-2523-7990; stewart, alastair/0000-0002-2271-5942; Keenan, Christine/0000-0002-6057-1855	Asthma Australia; National Health and Medical Research Council (NHMRC) [1059665]	Asthma Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Asthma Australia and the National Health and Medical Research Council (NHMRC) Grant 1059665. The authors declare no conflicts of interest.	Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; COECK C, 1991, NEW ENGL J MED, V325, P738; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Daley-Yates PT, 2015, BRIT J CLIN PHARMACO, V80, P372, DOI 10.1111/bcp.12637; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; deCastro M, 1996, MOL MED, V2, P597, DOI 10.1007/BF03401643; Dorscheid DR, 2006, AM J PHYSIOL-LUNG C, V291, pL794, DOI 10.1152/ajplung.00322.2005; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fahnenstich J, 2003, MOL HUM REPROD, V9, P611, DOI 10.1093/molehr/gag080; Fossati G, 1998, INT J MOL MED, V1, P943; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; HARDING SM, 1990, RESP MED, V84, P25, DOI 10.1016/S0954-6111(08)80004-2; Heijink IH, 2016, RESP RES, V17, DOI 10.1186/s12931-015-0318-z; Henley D, 2016, PHARMACOL THERAPEUT, V166, P128, DOI 10.1016/j.pharmthera.2016.06.020; Holliday MA, 1999, PEDIATR NEPHROL, V13, P989, DOI 10.1007/s004670050741; Joshi T, 2015, BRIT J PHARMACOL, V172, P1360, DOI 10.1111/bph.13014; Jung C, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-91; Kapoor Upender, 2003, Indian Journal of Pediatrics, V70, P965, DOI 10.1007/BF02723822; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keenan CR, 2015, PHARMACOL THERAPEUT, V150, P81, DOI 10.1016/j.pharmthera.2015.01.006; Keenan CR, 2015, CAN J PHYSIOL PHARM, V93, P203, DOI 10.1139/cjpp-2014-0391; Keenan CR, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-55; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Landstra AM, 2002, AM J RESP CRIT CARE, V165, P708, DOI 10.1164/ajrccm.165.5.2102115; Laube BL, 2002, RESP MED, V96, P823, DOI 10.1053/rmed.2002.1366; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; LeVan TD, 1997, AM J PHYSIOL-LUNG C, V272, pL838, DOI 10.1152/ajplung.1997.272.5.L838; LEVINE SJ, 1993, AM J PHYSIOL, V265, pL360, DOI 10.1152/ajplung.1993.265.4.L360; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Menshanov PN, 2013, PHYSIOL RES, V62, P205, DOI 10.33549/physiolres.932339; Morjaria JB, 2011, THORAX, V66, P537, DOI 10.1136/thx.2010.136523; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Orsida BE, 2002, AM J RESP CRIT CARE, V165, P1010, DOI 10.1164/ajrccm.165.7.2105003; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pelaia G, 2003, AM J RESP CELL MOL, V29, P12, DOI 10.1165/rcmb.2002-0074OC; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rider CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116773; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sadler AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7795; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; SOUSA AR, 1993, AM REV RESPIR DIS, V147, P1557, DOI 10.1164/ajrccm/147.6_Pt_1.1557; Stellato C, 2007, J ALLERGY CLIN IMMUN, V120, P1247, DOI 10.1016/j.jaci.2007.10.041; Strandberg K, 2008, J ASTHMA, V45, P201, DOI 10.1080/02770900801890372; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P52, DOI 10.1067/mai.2003.1608; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; TRAPP T, 1994, NEURON, V13, P1457, DOI 10.1016/0896-6273(94)90431-6; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Vink NM, 2013, EUR RESPIR J, V41, P846, DOI 10.1183/09031936.00021212; Wasim M, 2012, PAK J PHARM SCI, V25, P617; Wasim M, 2010, J STEROID BIOCHEM, V120, P218, DOI 10.1016/j.jsbmb.2010.04.019; Wen LP, 1997, AM J PHYSIOL-LUNG C, V273, pL921, DOI 10.1152/ajplung.1997.273.5.L921; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Wine E, 2013, J CROHNS COLITIS, V7, P916, DOI 10.1016/j.crohns.2012.12.012; Xia YXC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006138	76	6	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1692	1704		10.1096/fj.201700730R	http://dx.doi.org/10.1096/fj.201700730R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29167235				2022-12-26	WOS:000427246000045
J	Dursun, E; Gezen-Ak, D				Dursun, Erdinc; Gezen-Ak, Duygu			Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin	PLOS ONE			English	Article							VDR PATHWAY DISRUPTION; N-CADHERIN; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CELL-ADHESION; IN-VIVO; BETA; CALCIUM; EXPRESSION; MECHANISM	Our recent study indicated that vitamin D and its receptors are important parts of the amyloid processing pathway in neurons. Yet the role of vitamin D receptor (VDR) in amyloid pathogenesis is complex and all regulations over the production of amyloid beta cannot be explained solely with the transcriptional regulatory properties of VDR. Given that we hypothesized that VDR might exist on the neuronal plasma membrane in close proximity with amyloid precursor protein (APP) and secretase complexes. The present study primarily focused on the localization of VDR in neurons and its interaction with amyloid pathology-related proteins. The localization of VDR on neuronal membranes and its co-localization with target proteins were investigated with cell surface staining followed by immunofluorescence labelling. The FpClass was used for protein-protein interaction prediction. Our results demonstrated the localization of VDR on the neuronal plasma membrane and the co-localization of VDR and APP or ADAM10 or Nicastrin and limited co-localization of VDR and PS1. E-cadherin interaction with APP or the secretase complex may involve NOTCH1, NUMB, or FHL2, according to FpClass. This suggested complex might also include VDR, which greatly contributes to Ca+2 hemostasis with its ligand vitamin D. Consequently, we suggested that VDR might be a member of this complex also with its own non-genomic action and that it can regulate the APP processing pathway in this way in neurons.	[Dursun, Erdinc; Gezen-Ak, Duygu] Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Brain & Neurodegenerat Disorders Res Lab, Istanbul, Turkey	Istanbul University; Istanbul University - Cerrahpasa	Gezen-Ak, D (corresponding author), Istanbul Univ, Cerrahpasa Fac Med, Dept Med Biol, Brain & Neurodegenerat Disorders Res Lab, Istanbul, Turkey.	duygugezenak@gmail.com	Dursun, Erdinc/AAH-9516-2019; Dursun, Erdinc/D-2666-2019; Gezen-Ak, Duygu/D-2679-2019	Dursun, Erdinc/0000-0003-3701-6674; Dursun, Erdinc/0000-0003-3701-6674; Gezen-Ak, Duygu/0000-0001-7611-2111	Research Fund of Istanbul University [22285]; Scientific and Technological Research Council of Turkey-TUBITAK [214S586]	Research Fund of Istanbul University(Istanbul University); Scientific and Technological Research Council of Turkey-TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The present work was supported by the Research Fund of Istanbul University (Project No. 22285, D.Gezen-Ak) and by the Scientific and Technological Research Council of Turkey-TUBITAK (Project No. 214S586, D.Gezen-Ak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work was supported by the Research Fund of Istanbul University (Project No. 22285) and by the Scientific and Technological Research Council of Turkey-TUBITAK (Project No. 214S586).	Altiokka-Uzun G, 2017, NEUROL SCI, V38, P1817, DOI 10.1007/s10072-017-3066-7; Andreyeva A, 2012, BRAIN, V135, P2140, DOI 10.1093/brain/aws120; Asada-Utsugi M, 2011, J NEUROCHEM, V119, P354, DOI 10.1111/j.1471-4159.2011.07364.x; Bartoccini E, 2011, MOL BIOL CELL, V22, P3022, DOI 10.1091/mbc.E11-03-0196; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Capiati D, 2002, J CELL BIOCHEM, V86, P128, DOI 10.1002/jcb.10191; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cui X, 2015, NEUROSCIENCE, V304, P90, DOI 10.1016/j.neuroscience.2015.07.048; Dixon KM, 2007, J STEROID BIOCHEM, V103, P451, DOI 10.1016/j.jsbmb.2006.11.016; Domingues-Faria C, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-47; Dries DR, 2016, J BIOL CHEM, V291, P11647, DOI 10.1074/jbc.M116.715078; Dursun E, 2016, NEUROL SCI, V37, P1633, DOI 10.1007/s10072-016-2647-1; Dursun E, 2013, DEMENT GERIATR COGN, V36, P76, DOI 10.1159/000350319; Dursun E, 2013, J ALZHEIMERS DIS, V36, P459, DOI 10.3233/JAD-130416; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Fleet JC, 2004, J NUTR, V134, P3215, DOI 10.1093/jn/134.12.3215; Gezen-Ak D, 2017, ACS CHEM NEUROSCI; Gezen-Ak D, 2013, ARCH NEUROPSYCH; Gezen-Ak D, 2017, NEUROMOL MED, V19, P24, DOI 10.1007/s12017-016-8415-9; Gezen-Ak D, 2014, J ALZHEIMERS DIS, V40, P257, DOI 10.3233/JAD-131970; Gezen-Ak D, 2013, NEUROL SCI, V34, P1453, DOI 10.1007/s10072-012-1268-6; Gezen-Ak D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017553; Hatakeyama J, 2014, DEVELOPMENT, V141, P1671, DOI 10.1242/dev.102988; Ho A, 2011, TRENDS MOL MED, V17, P617, DOI 10.1016/j.molmed.2011.06.002; Hou YF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081285; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Ito T, 2017, HUM CELL, V30, P1, DOI 10.1007/s13577-016-0149-3; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kang MJ, 2006, EXP MOL MED, V38, P126, DOI 10.1038/emm.2006.16; Ko KS, 2001, J CELL SCI, V114, P1155; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/NMETH.3178, 10.1038/nmeth.3178]; Kuzuya A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0248-3; Li J, 2017, PAIN MED, V18, P1752, DOI 10.1093/pm/pnw316; Mazzaferro S, 2016, NEPHROL DIAL TRANSPL, V31, P23, DOI 10.1093/ndt/gfv340; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; Montagna E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00136; Nemere I, 2012, ENDOCRINOLOGY, V153, P1609, DOI 10.1210/en.2011-1850; Nierzwicki L, 2015, J PHYS CHEM LETT, V6, P784, DOI 10.1021/acs.jpclett.5b00197; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Oda Y, 2017, ENDOCRINOLOGY, V158, P1929, DOI 10.1210/en.2017-00061; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Price P., 1998, PROTOCOLS NEURAL CEL, P255; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Richard CL, 2010, EXP CELL RES, V316, P695, DOI 10.1016/j.yexcr.2009.12.015; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Sidera C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-25; Tran MK, 2016, BBA-MOL CELL RES, V1863, P219, DOI 10.1016/j.bbamcr.2015.11.002; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Zhang YG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23118	55	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188605	10.1371/journal.pone.0188605	http://dx.doi.org/10.1371/journal.pone.0188605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176823	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900107
J	Magalhaes, LMD; Viana, A; de Jesus, AC; Chiari, E; Galvao, L; Gomes, JA; Gollob, KJ; Dutra, WO				Magalhaes, Luisa M. D.; Viana, Agostinho; de Jesus, Augusto C.; Chiari, Egler; Galvao, Lucia; Gomes, Juliana A.; Gollob, Kenneth J.; Dutra, Walderez O.			Distinct Trypanosoma cruzi isolates induce activation and apoptosis of human neutrophils	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CHAGAS-DISEASE; INTRACELLULAR PATHOGENS; LEISHMANIA-MAJOR; MECHANISMS; MONOCYTES; PHAGOCYTOSIS; INDETERMINATE; GRANULOCYTES; EOSINOPHILS	Neutrophils are critical players in the first line of defense against pathogens and in the activation of subsequent cellular responses. We aimed to determine the effects of the interaction of Trypanosoma cruzi with human neutrophils, using isolates of the two major discrete type units (DTUs) associated with Chagas' disease in Latin America (clone Col1.7G2 and Y strain, DTU I and II, respectively). Thus, we used CFSE-stained trypomastigotes to measure neutrophil-T. cruzi interaction, neutrophil activation, cytokine expression and death, after infection with Col1.7G2 and Y strain. Our results show that the frequency of CFSE+ neutrophils, indicative of interaction, and CFSE intensity on a cell-per-cell basis were similar when comparing Col1.7G2 and Y strains. Interaction with T. cruzi increased neutrophil activation, as measured by CD282, CD284, TNF and IL-12 expression, although at different levels between the two strains. No change in IL-10 expression was observed after interaction of neutrophils with either strain. We observed that exposure to Y and Col1.7G2 caused marked neutrophil death. This was specific to neutrophils, since interaction of either strain with monocytes did not cause death. Our further analysis showed that neutrophil death was a result of apoptosis, which was associated with an upregulation of TNF-receptor, TNF and FasLigand, but not of Fas. Induction of TNF-associated neutrophil apoptosis by the different T. cruzi isolates may act as an effective common mechanism to decrease the host's immune response and favor parasite survival.	[Magalhaes, Luisa M. D.; Viana, Agostinho; de Jesus, Augusto C.; Gomes, Juliana A.; Dutra, Walderez O.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Chiari, Egler; Galvao, Lucia] Inst Ciencias Biol, Dept Parasitol, Lab Biol Trypanosoma Cruzi & Doenc Chagas, Belo Horizonte, MG, Brazil; [Gollob, Kenneth J.] Inst Mario Pena, Nucleo Ensino & Pesquisa, Belo Horizonte, MG, Brazil; [Gollob, Kenneth J.] BRISA Diagnost, Belo Horizonte, MG, Brazil; [Gollob, Kenneth J.] Int Ctr Res, AC Camargo Canc Ctr, Sao Paulo, SP, Brazil; [Dutra, Walderez O.] INCT DT, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; A.C.Camargo Cancer Center	Dutra, WO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.; Dutra, WO (corresponding author), INCT DT, Belo Horizonte, MG, Brazil.	waldutra@gmail.com	Gollob, Kenneth J/GPX-8434-2022; Gollob, Kenneth J/C-1341-2008; da Cunha Galvão, Lúcia Maria/A-1512-2014; Dutra, Walderez Ornelas/CAH-1502-2022; Viana, Agostinho AGV Gonçalves/C-8281-2014; Gomes, Juliana A. S./M-4083-2017	Gollob, Kenneth J/0000-0003-4184-3867; Dutra, Walderez Ornelas/0000-0002-7586-9996; Gomes, Juliana A. S./0000-0002-8332-2907; Mourao Dias Magalhaes, Luisa/0000-0001-9957-3295; Galvao, Lucia/0000-0002-6207-4502	CNPq Universal; FAPEMIG Universal; CNPq	CNPq Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG Universal(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by CNPq Universal 2014; FAPEMIG Universal 2015; EC, LMCG, JASG, KJG and WOD are CNPq fellows; LMDM is a CAPES fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00382; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Aoki Maria Pilar, 2012, J Parasitol Res, V2012, P737324, DOI 10.1155/2012/737324; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bannai H, 2009, J VET MED SCI, V71, P1183, DOI 10.1292/jvms.71.1183; BARON EJ, 1982, J IMMUNOL METHODS, V49, P305, DOI 10.1016/0022-1759(82)90130-2; Becker SM, 2010, AM J PATHOL, V176, P1316, DOI 10.2353/ajpath.2010.090740; Blankenberg FG, 2008, J NUCL MED, V49, p81S, DOI 10.2967/jnumed.107.045898; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968; Cabral-Piccin MP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.135; Carlsen ED, 2013, INFECT IMMUN, V81, P3966, DOI 10.1128/IAI.00770-13; Chaves AT, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1523-1; COLOTTA F, 1992, BLOOD, V80, P2012; Pinto AYD, 2009, REV PANAM SALUD PUBL, V25, P77, DOI 10.1590/S1020-49892009000100012; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Ferreira MS, 1997, CLIN INFECT DIS, V25, P1397, DOI 10.1086/516130; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Gomes JAS, 2012, IMMUNOBIOLOGY, V217, P1005, DOI 10.1016/j.imbio.2012.01.014; Gravina HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063100; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kemp K, 2001, CLIN EXP IMMUNOL, V126, P69, DOI 10.1046/j.1365-2249.2001.01657.x; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Laskay T, 2008, IMMUNOBIOLOGY, V213, P183, DOI 10.1016/j.imbio.2007.11.010; Lula JF, 2009, EUR J HEART FAIL, V11, P825, DOI 10.1093/eurjhf/hfp105; Luna-Gomes T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090582; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Magalhaes LMD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003816; Manda A, 2014, CENT EUR J IMMUNOL, V39, P116, DOI 10.5114/ceji.2014.42136; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870; Riarte A, 1999, CLIN INFECT DIS, V29, P561, DOI 10.1086/598634; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Riise RE, 2015, J IMMUNOL; Rodrigues Mauricio M., 2012, Journal of Parasitology Research, P507874, DOI 10.1155/2012/507874; Rodrigues V, 2008, MICROBES INFECT, V10, P29, DOI 10.1016/j.micinf.2007.09.015; SANDERSON CJ, 1979, J CELL SCI, V37, P275; Silva MT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00174; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Stern M, 1996, AM J PATHOL, V149, P911; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Tibayrenc M., 1999, GENET EPIDEMIOL; VILLALTA F, 1983, J IMMUNOL, V131, P1504; VILLALTA F, 1986, J IMMUNOL, V137, P1703; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Yamashiro S, 2001, J LEUKOCYTE BIOL, V69, P698; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	53	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188083	10.1371/journal.pone.0188083	http://dx.doi.org/10.1371/journal.pone.0188083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176759	Green Submitted, gold, Green Published			2022-12-26	WOS:000416291900035
J	Xia, X; Lin, T; Chen, Z; Xu, HY				Xia, Xin; Lin, Tao; Chen, Zhi; Xu, Hongyan			Salient object segmentation based on active contouring	PLOS ONE			English	Article							IMAGE SEGMENTATION	Traditional saliency detection algorithms lack object semantic character, and the segmentation algorithms cannot highlight the saliency of the segmentation regions. In order to compensate for the defects of these two algorithms, the salient object segmentation model, which is a novel combination of two algorithms, is established in this paper. With the help of a priori knowledge of image boundary background traits, the K-means++ algorithm is used to cluster the pixels for each region; in line with the sensitivity of the human eye to color and with its attention mechanism, the joint probability distribution of the regional contrast ratio and spatial saliency is established. The selection of the salient area is based on the probabilities, for which the region boundary is taken as the initial curve, and the level-set algorithm is used to perform the salient object segmentation of the image. The curve convergence condition is established according to the confidence level for the segmented region, thus avoiding over-convergence of the segmentation curve. With this method, the salient region boundary is adjacent to the object contour, so the curve evolution time is shorter, and compared with the traditional Li algorithm, the proposed algorithm has higher segmentation evaluation scores, with the additional benefit of emphasizing the importance of the object.	[Xia, Xin; Lin, Tao; Chen, Zhi; Xu, Hongyan] Sichuan Univ, Coll Comp Sci, Chengdu, Sichuan, Peoples R China	Sichuan University	Lin, T (corresponding author), Sichuan Univ, Coll Comp Sci, Chengdu, Sichuan, Peoples R China.	sculintao@gmail.com						Achanta Radhakrishna, 2009, COMP VIS PATT REC 20, P1597; Borenstein E, 2004, COMP VIS PATT REC WO; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; Fu HZ, 2015, IEEE T IMAGE PROCESS, V24, P3415, DOI 10.1109/TIP.2015.2442915; Fu HZ, 2013, IEEE T IMAGE PROCESS, V22, P3766, DOI 10.1109/TIP.2013.2260166; Han JW, 2016, IEEE T CYBERNETICS, V46, P487, DOI 10.1109/TCYB.2015.2404432; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Kadir T, 2001, INT J COMPUT VISION, V45, P83, DOI 10.1023/A:1012460413855; Khan Muhammad Waseem, 2014, International Journal of Future Computer and Communication, V3, P89, DOI 10.7763/IJFCC.2014.V3.274; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Levin A, 2006, COMP VIS ECCV 2006 E; Li C, 2005, COMP VIS PATT REC 20; Liu Tie, 2007, COMP VIS PATT REC 20; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Sen YK, 2014, J BIOMECH, V47, P1014, DOI 10.1016/j.jbiomech.2013.12.035; Toet A, 2011, IEEE T PATTERN ANAL, V33, P2131, DOI 10.1109/TPAMI.2011.53; Tsai A, 2001, IEEE T IMAGE PROCESS, V10, P1169, DOI 10.1109/83.935033; Wang X, 2015, HIGH POWER LASER PAR	19	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188118	10.1371/journal.pone.0188118	http://dx.doi.org/10.1371/journal.pone.0188118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176841	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900040
J	Van Dam, MH; Lam, AW; Sagata, K; Gewa, B; Laufa, R; Balke, M; Faircloth, BC; Riedel, A				Van Dam, Matthew H.; Lam, Athena W.; Sagata, Katayo; Gewa, Bradley; Laufa, Raymond; Balke, Michael; Faircloth, Brant C.; Riedel, Alexander			Ultraconserved elements (UCEs) resolve the phylogeny of Australasian smurf-weevils	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; TARGET-ENRICHMENT; TREE; MODEL; COMPUTATION; THOUSANDS; INFERENCE; PACKAGE; MARKERS; SISTER	Weevils (Curculionoidea) comprise one of the most diverse groups of organisms on earth. There is hardly a vascular plant or plant part without its own species of weevil feeding on it and weevil species diversity is greater than the number of fishes, birds, reptiles, amphibians and mammals combined. Here, we employ ultraconserved elements (UCEs) designed for beetles and a novel partitioning strategy of loci to help resolve phylogenetic relationships within the radiation of Australasian smurf-weevils (Eupholini). Despite being emblematic of the New Guinea fauna, no previous phylogenetic studies have been conducted on the Eupholini. In addition to a comprehensive collection of fresh specimens, we supplement our taxon sampling with museum specimens, and this study is the first target enrichment phylogenomic dataset incorporating beetle specimens from museum collections. We use both concatenated and species tree analyses to examine the relationships and taxonomy of this group. For species tree analyses we present a novel partitioning strategy to better model the molecular evolutionary process in UCEs. We found that the current taxonomy is problematic, largely grouping species on the basis of similar color patterns. Finally, our results show that most loci required multiple partitions for nucleotide rate substitution, suggesting that single partitions may not be the optimal partitioning strategy to accommodate rate heterogeneity for UCE loci.	[Van Dam, Matthew H.; Lam, Athena W.; Balke, Michael] SNSB Zool State Collect, Munchhausenstr 21, Munich, Germany; [Sagata, Katayo] Univ Papua New Guinea, Sch Nat & Phys Sci, Univ 134, Natl Capital Dist, Papua N Guinea; [Gewa, Bradley; Laufa, Raymond] New Guinea Binatang Res Ctr, Madang, Papua N Guinea; [Balke, Michael] Ludwig Maximilians Univ Munchen, GeoBioCtr, Munich, Germany; [Faircloth, Brant C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Faircloth, Brant C.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Riedel, Alexander] State Museum Nat Hist Karlsruhe, Karlsruhe, Germany; [Van Dam, Matthew H.; Lam, Athena W.] Calif Acad Sci, Entomol Dept, San Francisco, CA 94118 USA	University of Papua New Guinea; University of Munich; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; California Academy of Sciences	Van Dam, MH (corresponding author), SNSB Zool State Collect, Munchhausenstr 21, Munich, Germany.	matthewhvandam@gmail.com	Riedel, Alexander/V-2608-2019; Faircloth, Brant C/Y-3978-2019	Riedel, Alexander/0000-0002-8291-4425; 	NSF award DBI [1402102]; DFG [BA2152/10-1, 3 / RI1718/3-1]	NSF award DBI; DFG(German Research Foundation (DFG))	M.H.V.D. and R.L. (salary and lab work/sequencing) were funded by NSF award DBI #1402102 and A.R. by DFG BA2152/10-1 & 3 / RI1718/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Joe Russack and Brian Simison for help with using the linux cluster and software installs at the CAS. We would also like to thank Misha Leong and Jun Ying Lim for their help with statistical analyses. We would like to thank Marek Borowiec and the other 3 anonymous reviewers for their comments that helped to improve this manuscript. The New Guinea Binatang Research Center has provided extremely valuable assistance with collections in Papua New Guinea. Moreover, Bega Inaho (Goroka) and Agus Faknik (Abepura) helped collect specimens. The field work in New Guinea would not have been possible without the generous hospitality and help of many local people, and we thank all of them very warmly. M.H.V.D. and R.L. (salary and lab work/sequencing) were funded by NSF award DBI #1402102, A.R. by DFG BA2152/10-1 & 3 / RI1718/3-1. We are indebted to the PNG Department of Environment and Conservation for issuing permits (#014282) in PNG; to the Queensland Government, Department of Environment and Heritage Protection for granting collecting permits in many Australian National Parks, and the Australian Government, Department of Environment for an export permit.	Alexander AM, 2017, EVOLUTION, V71, P475, DOI 10.1111/evo.13133; Arnoldi L., 1977, MESOZOIC COLEOPTERA, P195; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baca SM, 2017, SYST ENTOMOL; Bazinet AL, 2017, SYST ENTOMOL, V42, P305, DOI 10.1111/syen.12217; Bazinet AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082615; Bethoux O, 2009, J PALEONTOL, V83, P931, DOI 10.1666/08-158.1; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Blaimer BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161531; Blaimer BB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0552-5; Blumenstiel B, 2010, CURRENT PROTOCOLS HU; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bossert S, 2017, MOL PHYLOGENET EVOL, V111, P149, DOI 10.1016/j.ympev.2017.03.022; Branstetter MG, 2016, BIORXIV; Branstetter MG, 2017, NATURE ECOLOGY EVOLU, V27, P1019, DOI DOI 10.1016/J.CUB.2017.03.027; Branstetter MG, 2017, METHODS ECOL EVOL, V8, P768, DOI 10.1111/2041-210X.12742; Brewer MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068005, 10.1371/journal.pone.0079935]; Carlson DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174102; Chifman J, 2015, J THEOR BIOL, V374, P35, DOI 10.1016/j.jtbi.2015.03.006; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Martins LD, 2016, SYST BIOL, V65, P397, DOI 10.1093/sysbio/syu082; Del Fabbro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085024; Faircloth B.C., 2011, ILLUMIPROCESSOR SOFT; Faircloth BC, 2017, METHODS ECOL EVOL; Faircloth BC, 2016, BIOINFORMATICS, V32, P786, DOI 10.1093/bioinformatics/btv646; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Garrison NL, 2016, PEERJ, V4, DOI 10.7717/peerj.1719; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Gilbert PS, 2015, MOL PHYLOGENET EVOL, V92, P140, DOI 10.1016/j.ympev.2015.05.027; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRESSITT JL, 1967, PAC INSECTS, V9, P481; GRESSITT JL, 1965, SCIENCE, V150, P1833, DOI 10.1126/science.150.3705.1833; Hedin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042888; Heibl C., PHYLOCH R LANGUAGE T; Hickey G, 2008, EVOL BIOINFORM, V4, P17; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jesovnik A, 2017, SYST ENTOMOL, V42, P523, DOI 10.1111/syen.12228; Kanda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143929; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lanfear R, 2016, MOL BIOL EVOL, V11; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; McCormack JE, 2016, MOL ECOL RESOUR, V16, P1189, DOI 10.1111/1755-0998.12466; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McKenna DD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1088-8; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Misof B, 2014, SCIENCE, P346, DOI [DOI 10.1126/SCIENCE.1257570, 10.1126/science.1257570]; Moyle RG, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12709; Oberprieler RG, 2007, ZOOTAXA, P491; Oswald JA, 2016, AUK, V133, P593, DOI 10.1642/AUK-15-232.1; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Reaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104008; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Riedel Alexander, 2002, Zootaxa, V90, P1; Riedel Alexander, 2009, Zootaxa, V2224, P1; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sayyari E, 2016, MOL BIOL EVOL, V33, P1654, DOI 10.1093/molbev/msw079; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Setliff Gregory P., 2007, Zootaxa, V1536, P1; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smith DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0060; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starrett J, 2017, MOL ECOL RESOUR, V17, P812, DOI 10.1111/1755-0998.12621; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tanzler R, 2016, SCI REP-UK, V6, DOI 10.1038/srep18793; Tarver JE, 2016, GENOME BIOL EVOL, V8, P330, DOI 10.1093/gbe/evv261; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793	78	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188044	10.1371/journal.pone.0188044	http://dx.doi.org/10.1371/journal.pone.0188044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166661	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300022
J	Bu, X; Sun, L; Shang, F; Yan, GL				Bu, Xiao; Sun, Liang; Shang, Fei; Yan, Guoliang			Comparative metabolomics profiling of engineered Saccharomyces cerevisiae lead to a strategy that improving beta-carotene production by acetate supplementation	PLOS ONE			English	Article							ACETYL-COA; PHAFFIA-RHODOZYMA; ESCHERICHIA-COLI; GENE-EXPRESSION; BIOSYNTHESIS; STRESS; ASTAXANTHIN; IMPROVEMENT; RESISTANCE; TRANSPORT	A comparative metabolomic analysis was conducted on recombinant Saccharomyces cerevisiae strain producing beta-carotene and the parent strain cultivated with glucose as carbon source using gas chromatography-mass spectrometry (GC-MS), high performance liquid chromatography-mass spectrometry (HPLC-MS) and ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) based approach. The results showed that most of the central intermediates associated with amino acids, carbohydrates, glycolysis and TCA cycle intermediates (acetic acid, glycerol, citric acid, pyruvic acid and succinic acid), fatty acids, ergosterol and energy metabolites were produced in a lower amount in recombinant strain, as compared to the parent strain. To increase beta-carotene production in recombinant strain, a strategy that exogenous addition of acetate (10 g/l) in exponential phase was developed, which could enhance most intracellular metabolites levels and result in 39.3% and 14.2% improvement of beta-carotene concentration and production, respectively, which was accompanied by the enhancement of acetyl-CoA, fatty acids, ergosterol and ATP contents in cells. These results indicated that the amounts of intracellular metabolites in engineered strain are largely consumed by carotenoid formation. Therefore, maintaining intracellular metabolites pool at normal levels is essential for carotenoid biosynthesis. To relieve this limitation, rational supplementation of acetate could be a potential way because it can partially restore the levels of intracellular metabolites and improve the production of carotenoid compounds in recombinant S. cerevisiae.	[Bu, Xiao; Sun, Liang; Yan, Guoliang] China Agr Univ, Coll Food Sci & Nutr Engn, Ctr Viticulture & Enol, Beijing, Peoples R China; [Bu, Xiao; Sun, Liang; Yan, Guoliang] Minist Agr, Key Lab Viticulture & Enol, Beijing, Peoples R China; [Shang, Fei] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing University of Chemical Technology	Yan, GL (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Ctr Viticulture & Enol, Beijing, Peoples R China.; Yan, GL (corresponding author), Minist Agr, Key Lab Viticulture & Enol, Beijing, Peoples R China.	glyan@cau.edu.cn	Sun, Liang/AAY-6618-2021	Sun, Liang/0000-0001-8826-7276	National Natural Science Foundation of China [31671841, 31371818, 31000811/C200207]; China Agriculture Research System [CARS-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	Funding was provided by National Natural Science Foundation of China (No. 31671841, 31371818, 31000811/C200207) (http.//www.nsfc.gov.cn/) GY and China Agriculture Research System (CARS-30)(http://cars.wmelon.org/)GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Bandara A, 2009, FEMS YEAST RES, V9, P1208, DOI 10.1111/j.1567-1364.2009.00569.x; Cardenas J, 2016, METAB ENG, V36, P80, DOI 10.1016/j.ymben.2016.02.009; Cardona F, 2007, INT J FOOD MICROBIOL, V114, P83, DOI 10.1016/j.ijfoodmicro.2006.10.043; Cardoso LAC, 2016, BIORESOURCE TECHNOL, V200, P374, DOI 10.1016/j.biortech.2015.09.108; Chen Y, 2013, METAB ENG, V15, P48, DOI 10.1016/j.ymben.2012.11.002; Flores-Cotera LB, 2001, APPL MICROBIOL BIOT, V55, P341, DOI 10.1007/s002530000498; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Jaswir I, 2011, J MED PLANTS RES, V5, P7119, DOI 10.5897/JMPRx11.011; Kim SW, 2009, PROCESS BIOCHEM, V44, P899, DOI 10.1016/j.procbio.2009.04.018; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Krivoruchko A, 2015, METAB ENG, V28, P28, DOI 10.1016/j.ymben.2014.11.009; Lee JJL, 2016, APPL MICROBIOL BIOT, V100, P869, DOI 10.1007/s00253-015-7102-3; LEE JJL, 2014, J AGR FOOD CHEM, V62, P1020, DOI DOI 10.1111/J.1567-1364.2009.00569.X; Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x; Liu PT, 2016, J IND MICROBIOL BIOT, V43, P525, DOI 10.1007/s10295-015-1728-0; Liu YS, 2006, J APPL MICROBIOL, V101, P1033, DOI 10.1111/j.1365-2672.2006.03009.x; Lopez EF, 2015, METAB ENG, V34, P254; Luo HH, 2013, PROCESS BIOCHEM, V48, P195, DOI 10.1016/j.procbio.2013.01.005; Martinez-Moya P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1484-6; Miao LL, 2011, FEMS YEAST RES, V11, P192, DOI 10.1111/j.1567-1364.2010.00705.x; Nam HK, 2013, BIOTECHNOL LETT, V35, P265, DOI 10.1007/s10529-012-1072-7; Nugroho RH, 2015, J BIOSCI BIOENG, V120, P396, DOI 10.1016/j.jbiosc.2015.02.011; Parveen M, 2004, J ANTIMICROB CHEMOTH, V54, P46, DOI 10.1093/jac/dkh245; Rodriguez S, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0447-1; Rodriguez SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105594; Runguphan W, 2014, METAB ENG, V21, P103, DOI 10.1016/j.ymben.2013.07.003; SANDMANN G, 1994, EUR J BIOCHEM, V223, P7, DOI 10.1111/j.1432-1033.1994.tb18961.x; Seker T, 2005, APPL MICROBIOL BIOT, V67, P119, DOI 10.1007/s00253-004-1697-0; Shao SQ, 2012, APPL MICROBIOL BIOT, V94, P789, DOI 10.1007/s00253-011-3739-8; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; Sun YX, 2016, PROCESS BIOCHEM, V51, P568, DOI 10.1016/j.procbio.2016.02.004; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342; Verwaal R, 2010, YEAST, V27, P983, DOI 10.1002/yea.1807; Wen ZW, 2015, ENZYME MICROB TECH, V78, P10, DOI 10.1016/j.enzmictec.2015.06.010; Wozniak A, 2011, FEMS YEAST RES, V11, P252, DOI 10.1111/j.1567-1364.2010.00711.x; Yan GL, 2012, CURR MICROBIOL, V64, P152, DOI 10.1007/s00284-011-0047-6; Yang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0530-7; Zhao J, 2013, METAB ENG, V17, P42, DOI 10.1016/j.ymben.2013.02.002	40	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188385	10.1371/journal.pone.0188385	http://dx.doi.org/10.1371/journal.pone.0188385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161329	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000045
J	Baptista, AMG; Serra, PM; McAlinden, C; Barrett, BT				Goncalves Baptista, Antonio Manuel; Serra, Pedro M.; McAlinden, Colm; Barrett, Brendan T.			Vision in high-level football officials	PLOS ONE			English	Article							VISUAL-ACUITY; CONTRAST SENSITIVITY; CLINICAL-TESTS; PRECISION REPEATABILITY; SUBJECTIVE QUALITY; SPORTS VISION; LETTER-CHART; QUESTIONNAIRE; DESIGN; AGE	Officiating in football depends, at least to some extent, upon adequate visual function. However, there is no vision standard for football officiating and the nature of the relationship between officiating performance and level of vision is unknown. As a first step in characterising this relationship, we report on the clinically-measured vision and on the perceived level of vision in elite-level, Portuguese football officials. Seventy-one referees (R) and assistant referees (AR) participated in the study, representing 92% of the total population of elite level football officials in Portugal in the 2013/2014 season. Nine of the 22 Rs (40.9%) and ten of the 49 ARs (20.4%) were international-level. Information about visual history was also gathered. Perceived vision was assessed using the preference-values-assigned-to-globalvisual-status (PVVS) and the Quality-of-Vision (QoV) questionnaire. Standard clinical vision measures (including visual acuity, contrast sensitivity and stereopsis) were gathered in a subset (n = 44, 62%) of the participants. Data were analysed according to the type (R/AR) and level (international/national) of official, and Bonferroni corrections were applied to reduce the risk of type I errors. Adopting criterion for statistical significance of p<0.01, PVVS scores did not differ between R and AR (p = 0.88), or between national-and international-level officials (p = 0.66). Similarly, QoV scores did not differ between R and AR in frequency (p = 0.50), severity (p = 0.71) or bothersomeness (p = 0.81) of symptoms, or between international-level vs national-level officials for frequency (p = 0.03) or bothersomeness (p = 0.07) of symptoms. However, international-level officials reported less severe symptoms than their national-level counterparts (p<0.01). Overall, 18.3% of officials had either never had an eye examination or if they had, it was more than 3 years previously. Regarding refractive correction, 4.2% had undergone refractive surgery and 23.9% wear contact lenses when officiating. Clinical vision measures in the football officials were similar to published normative values for young, adult populations and similar between R and AR. Clinically-measured vision did not differ according to officiating level. Visual acuity measured with and without a pinhole disc indicated that around one quarter of participants may be capable of better vision when officiating, as evidenced by better acuity (>= 1 line of letters) using the pinhole. Amongst the clinical visual tests we used, we did not find evidence for above-average performance in elite-level football officials. Although the impact of uncorrected mild to moderate refractive error upon officiating performance is unknown, with a greater uptake of eye examinations, visual acuity may be improved in around a quarter of officials.	[Goncalves Baptista, Antonio Manuel] Univ Minho, Ctr Phys Optometry, Campus Gualtar, Braga, Portugal; [Serra, Pedro M.] Univ Plymouth, Fac Hlth & Human Sci, Sch Hlth Profess, Plymouth, Devon, England; [McAlinden, Colm] Hywel Dda Univ Hlth Board, Glangwili Hosp, Dept Ophthalmol, Carmarthen, Dyfed, Wales; [McAlinden, Colm] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Barrett, Brendan T.] Univ Bradford, Sch Optometry & Vis Sci, Richmond Rd, Bradford, W Yorkshire, England	Universidade do Minho; University of Plymouth; Wenzhou Medical University; University of Bradford	Baptista, AMG (corresponding author), Univ Minho, Ctr Phys Optometry, Campus Gualtar, Braga, Portugal.	abaptista@fisica.uminho.pt	Baptista, Antonio M. G./G-9176-2014; Serra, Pedro/AAG-3569-2021	Baptista, Antonio M. G./0000-0002-7304-8756; Serra, Pedro/0000-0003-0471-0213	Portuguese Foundation for Science and Technology (FCT) [UID/FIS/04650/2013]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UID/FIS/04650/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDITI A, 1993, INVEST OPHTH VIS SCI, V34, P120; BAILEY IL, 1991, INVEST OPHTH VIS SCI, V32, P422; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bailey IL, 2006, BORISHS CLIN REFRACT, V2nd, P217; Barrett BT., 2014, CLIN PROCEDURES PRIM; Bass EB, 2004, ARCH OPHTHALMOL-CHIC, V122, P1856; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BECK RW, 1993, CLIN VISION SCI, V8, P207; Branco MJ, 2006, ECOS SENTIDOS SAUDE; Bulson RC, 2015, CLIN EXP OPTOM; Cabot F, 2013, AM J OPHTHALMOL, V155, P629, DOI 10.1016/j.ajo.2012.11.005; CEGEA, 2011, COMP FOR 4 LINH REFL; Coffey B., 1990, PROBL OPTOM, V2, P32; Elliott D. B, 2006, BORISHS CLIN REFRACT; ELLIOTT DB, 1990, OPHTHAL PHYSL OPT, V10, P21, DOI 10.1111/j.1475-1313.1990.tb01100.x; ELLIOTT DB, 1990, EYE, V4, P712, DOI 10.1038/eye.1990.100; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Elliott DB., 2014, CLIN PROCEDURES PRIM, V3rd ed, P32; Elmurr P, 2011, EYE CONTACT LENS, V37, P164, DOI 10.1097/ICL.0b013e318217cc09; Erickson GB., 2007, VISUAL TASK ANAL SPO, P8; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Gardner JJ, 1995, SPORTS VISION, P22; Garnham L, 2006, BRIT J OPHTHALMOL, V90, P91, DOI 10.1136/bjo.2005.077719; Ghasemi A, 2011, PERCEPT MOTOR SKILL, V112, P161, DOI 10.2466/05.22.24.27.PMS.112.1.161-171; Ghasemi A, 2009, J HUM KINET, V22, P15; GREENE HA, 1987, AM J OPTOM PHYS OPT, V64, P749; Haymes SA, 2006, INVEST OPHTH VIS SCI, V47, P2739, DOI 10.1167/iovs.05-1419; Helsen W, 2004, J SPORT SCI, V22, P179, DOI 10.1080/02640410310001641502; HERON G, 1985, AM J OPTOM PHYS OPT, V62, P505; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, INVEST OPHTH VIS SCI, V53, P4042, DOI 10.1167/iovs.12-9728; Kirschen D, 2014, INVEST OPHTH VIS SCI, V55; Kirschen DG, 2011, EYE CONTACT LENS, V37, P127, DOI 10.1097/ICL.0b013e3182126a08; Laby DM, 2011, EYE CONTACT LENS, V37, P116, DOI 10.1097/ICL.0b013e31820c5002; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; MarketProbe, 2015, VIS NEEDS MON; McAlinden C, 2015, J CATARACT REFR SURG, V41, P2598, DOI 10.1016/j.jcrs.2015.06.029; McAlinden C, 2013, OPTOMETRY VISION SCI, V90, P760, DOI 10.1097/OPX.0b013e3182993856; McAlinden C, 2012, OPHTHALMOLOGY, V119, P1715, DOI 10.1016/j.ophtha.2012.03.035; McAlinden C, 2012, J REFRACT SURG, V28, P313, DOI 10.3928/1081597X-20120501-06; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P5685, DOI 10.1167/iovs.10-67951; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; McAlinden C, 2011, J CATARACT REFR SURG, V37, P1097, DOI 10.1016/j.jcrs.2010.10.061; McAlinden C, 2010, INVEST OPHTH VIS SCI, V51, P5537, DOI 10.1167/iovs.10-5341; Ohlsson J, 2005, ACTA OPHTHALMOL SCAN, V83, P487, DOI 10.1111/j.1600-0420.2005.00516.x; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Piano MEF, 2016, STRABISMUS, V24, P169, DOI 10.1080/09273972.2016.1242636; PORTADA, 2016, PRAT DESP FED TOT AL; Rosa AM, 2017, OPHTHALMOLOGY, V124, P1280, DOI 10.1016/j.ophtha.2017.03.033; Scheiman M, 2008, CLIN MANAGEMENT BINO; Schwab S, 2012, J SPORT SCI MED, V11, P624; Simunovic MP, 2010, EYE, V24, P747, DOI 10.1038/eye.2009.251; Skiadaresi E, 2012, ARCH OPHTHALMOL-CHIC, V130, P1377, DOI 10.1001/archophthalmol.2012.1603; Spitz J, 2016, COGN RES, V1, DOI 10.1186/s41235-016-0013-8; Stifter E, 2006, INVEST OPHTH VIS SCI, V47, P5412, DOI 10.1167/iovs.05-1564; UEFA, 2014, FIN REP 2012 13 38 O; Wobbrock JO, 2011, P SIGCHI C HUM FACT, DOI DOI 10.1145/1978942; Wobbrock JO, 2017, ARTOOL 1 6; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x; Zellers J A, 1984, J Am Optom Assoc, V55, P31	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188463	10.1371/journal.pone.0188463	http://dx.doi.org/10.1371/journal.pone.0188463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161310	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000060
J	Munoz, RC; Buckel, CA; Whitfield, PE; Viehman, S; Clark, R; Taylor, JC; Degan, BP; Hickerson, EL				Munoz, Roldan C.; Buckel, Christine A.; Whitfield, Paula E.; Viehman, Shay; Clark, Randy; Taylor, J. Christopher; Degan, Brian P.; Hickerson, Emma L.			Conventional and technical diving surveys reveal elevated biomass and differing fish community composition from shallow and upper mesophotic zones of a remote United States coral reef	PLOS ONE			English	Article							GULF-OF-MEXICO; MARINE PROTECTED AREAS; FLOWER GARDEN BANKS; CLIMATE-CHANGE; NORTHWESTERN GULF; ATLANTIC-OCEAN; PUERTO-RICO; BASE-LINES; ECOLOGY; ASSEMBLAGES	The world's coral reefs appear to be in a global decline, yet most previous research on coral reefs has taken place at depths shallower than 30 m. Mesophotic coral ecosystem (depths deeper than similar to 30 m) studies have revealed extensive, productive habitats and rich communities. Despite recent advances, mesophotic coral ecosystems remain understudied due to challenges with sampling at deeper depths. The few previous studies of mesophotic coral ecosystems have shown variation across locations in depth-specific species composition and assemblage shifts, potentially a response to differences in habitat or light availability/ water clarity. This study utilized scuba to examine fish and benthic communities from shallow and upper mesophotic (to 45 m) zones of Flower Garden Banks National Marine Sanctuary (FGBNMS, 28 degrees 0 'N; 93 degrees 50 'W) from 2010-2012. Dominant planktivores were ubiquitous in shallow and upper mesophotic habitats, and comparisons with previous shallow research suggest this community distribution has persisted for over 30 years. Planktivores were abundant in shallow low-relief habitats on the periphery of the coral reef, and some of these sites that contained habitat transitioning from high to low relief supported high biomass of benthic predators. These peripheral sites at FGBNMS may be important for the trophic transfer of oceanic energy to the benthic coral reef. Distinct differences between upper mesophotic and shallow communities were also observed. These included greater overall fish (as well as apex predator) biomass in the upper mesophotic, differences in apex predator community composition between depth zones, and greater percent cover of algae, rubble, sand, and sponges in the upper mesophotic. Greater fish biomass in the upper mesophotic and similar fish community composition between depth zones provide preliminary support that upper mesophotic habitats at FGBNMS have the capacity to serve as refugia for the shallow-water reefs. Diving surveys of the upper mesophotic and shallow-water coral reef have revealed valuable information concerning the reef fish community in the northern Gulf of Mexico, with implications for the conservation of apex predators, oceanic coral reefs, and the future management of FGBNMS.	[Munoz, Roldan C.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA; [Buckel, Christine A.; Whitfield, Paula E.; Viehman, Shay; Taylor, J. Christopher; Degan, Brian P.] NOAA, Natl Ocean Serv, Beaufort Lab, Beaufort, NC 28516 USA; [Clark, Randy] NOAA, Natl Ocean Serv, Ctr Coastal Monitoring & Assessment, Stennis Space Ctr, Mississippi State, MS USA; [Hickerson, Emma L.] NOAA, Natl Ocean Serv, Off Natl Marine Sanctuaries Flower Garden Banks N, Galveston, TX USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Mississippi State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Munoz, RC (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA.	roldan.munoz@noaa.gov			National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Flower Garden Banks National Marine Sanctuary; National Centers for Coastal Ocean Science; NOAA's Coral Reef Conservation Program; FGBNMS; National Centers for Coastal Ocean Science (NCCOS); Southeast Fisheries Science Center	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Flower Garden Banks National Marine Sanctuary; National Centers for Coastal Ocean Science(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); FGBNMS; National Centers for Coastal Ocean Science (NCCOS); Southeast Fisheries Science Center	This study was funded by the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program, https://coralreef.noaa.gov, with in-kind support from Flower Garden Banks National Marine Sanctuary and the National Centers for Coastal Ocean Science. Recipients: RC, JCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by NOAA's Coral Reef Conservation Program with in-kind support from FGBNMS and the National Centers for Coastal Ocean Science (NCCOS). The Southeast Fisheries Science Center provided support to RCM during manuscript preparation. We thank M. Burton, A. Chester, A. Hohn, C. Kane, T. Kellison, W. Mitchell, R. Pyle, and G. Schmahl for comments that improved the manuscript. Dive support was provided from the crews of the NOAA ship Nancy Foster, RV Manta, and L. Arbuckle, L. Bauer, K. Buch, E. Ebert, R. Eckert, K. Edwards, J. Embesi, D. Field, S. Henry, Z. Hileman, M. Johnston, D. Kesling, R. Mays, G. McFall, M. Nuttall, M. Ruiz, W. Sautter, G. Schmahl, M. Tartt, T. Tysall, A. Uhrin, J. Vander Pluym, J. Voss, J. Waddell, and M. Winfield.	Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Andradi-Brown DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156641; Appeldoorn R, 2016, CORAL REEFS, V35, P63, DOI 10.1007/s00338-015-1360-5; Asher J, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00098; Asher J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03568-1; Baker E, 2016, MESOPHOTIC CORAL ECO, P11; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bosscher H, 1992, P 7 INT COR REEF S, V1; Bridge TCL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2332; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Bruno JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29778; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Buckel CA, 2014, FISH BENTHIC COMMUNI, V179, P20; Buckel CA, 2014, 179 NOAA NOS NCCOS, P74; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Caldow C, 2009, 81 NOAA NOS NCCOS, V81, P134; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Clark R.D., 2014, 179 NOS NCCOS NOAA, V179, P317; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Collins AB, 2015, B MAR SCI, V91, P399, DOI 10.5343/bms.2015.1001; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; DeMartini EE, 2007, B MAR SCI, V81, P139; DENNIS GD, 1988, B MAR SCI, V43, P280; Deslarzes K.J.P, 1998, 980010 MMS OCS US DE; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Espinoza M, 2015, ECOL APPL, V25, P2101; Feitoza BM, 2005, B MAR SCI, V76, P725; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisch AJ, 2016, CORAL REEFS, V35, P375, DOI 10.1007/s00338-016-1401-8; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Hamner WM, 2012, FISH FISH SER, V35, P159, DOI 10.1007/978-94-007-1980-4_6; HAMNER WM, 1988, B MAR SCI, V42, P459; Harborne AR, 2012, CORAL REEFS, V31, P977, DOI 10.1007/s00338-012-0938-4; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Hedley JD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020118; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hobson E.S., 1991, P69; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Johnston MA, 2015, LONG TERM MONITORING, V1; Johnston MA, 2016, CORAL REEFS, V35, P821, DOI 10.1007/s00338-016-1452-x; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Koeck B, 2014, MAR ENVIRON RES, V94, P38, DOI 10.1016/j.marenvres.2013.12.002; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Laverick JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183075; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lindeman KC, 2000, B MAR SCI, V66, P929; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McGovern JC, 2005, B MAR SCI, V76, P47; McMahon KW, 2012, P NATL ACAD SCI USA, V109, P15372, DOI 10.1073/pnas.1206378109; Momigliano P, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00016; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; O'Toole AC, 2011, MAR BIOL, V158, P2227, DOI 10.1007/s00227-011-1728-1; Osgood GJ, 2015, J FISH BIOL, V87, P1489, DOI 10.1111/jfb.12839; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Pickard AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151221; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pyle RL, 2016, PEERJ, V4, DOI 10.7717/peerj.2475; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Russ GR, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12442; Sandin Stuart A., 2010, P71; Schmahl George R., 2008, V1, P221, DOI 10.1007/978-1-4020-6847-8_6; Semmler R. F., 2016, CORAL REEFS; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Sluka R, 1998, B MAR SCI, V62, P219; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; Valdivia A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601303; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; WARWICK RM, 1993, AUST J ECOL, V18, P63, DOI 10.1111/j.1442-9993.1993.tb00435.x; Weinstein DK, 2014, GEOMORPHOLOGY, V222, P14, DOI 10.1016/j.geomorph.2014.03.005; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; 2012, FISH FISH SER, V35, P1	100	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188598	10.1371/journal.pone.0188598	http://dx.doi.org/10.1371/journal.pone.0188598			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161314	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000066
J	Abdel-Naby, W; Cole, B; Liu, AH; Liu, JB; Wan, PX; Schreiner, R; Infanger, DW; Paulson, NB; Lawrence, BD; Rosenblatt, MI				Abdel-Naby, Waleed; Cole, Brigette; Liu, Aihong; Liu, Jingbo; Wan, Pengxia; Schreiner, Ryan; Infanger, David W.; Paulson, Nicholas B.; Lawrence, Brian D.; Rosenblatt, Mark I.			Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; FIBROIN; MATRIX; BIOMATERIALS; ARCHITECTURE; SUBSTRATE	There is a significant clinical need to improve current therapeutic approaches to treat ocular surface injuries and disease, which affect hundreds of millions of people annually worldwide. The work presented here demonstrates that the presence of Silk-Derived Protein (SDP) on the healing rabbit corneal surface, administered in an eye drop formulation, corresponds with an enhanced epithelial wound healing profile. Rabbit corneas were denuded of their epithelial surface, and then treated for 72-hours with either PBS or PBS containing 5 or 20 mg/mL SDP in solution four times per day. Post-injury treatment with SDP formulations was found to accelerate the acute healing phase of the injured rabbit corneal epithelium. In addition, the use of SDP corresponded with an enhanced tissue healing profile through the formation of a multi-layered epithelial surface with increased tight junction formation. Additional biological effects were also revealed that included increased epithelial proliferation, and increased focal adhesion formation with a corresponding reduction in the presence of MMP-9 enzyme. These in vivo findings demonstrate for the first time that the presence of SDP on the injured ocular surface may aid to improve various steps of rabbit corneal wound healing, and provides evidence that SDP may have applicability as an ingredient in therapeutic ophthalmic formulations.	[Abdel-Naby, Waleed] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Abdel-Naby, Waleed; Cole, Brigette; Liu, Aihong; Liu, Jingbo; Wan, Pengxia; Schreiner, Ryan] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Infanger, David W.; Paulson, Nicholas B.; Lawrence, Brian D.] Silk Technol Ltd, Dept Res, Plymouth, MN 55447 USA; [Rosenblatt, Mark I.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	Cornell University; Cornell University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lawrence, BD (corresponding author), Silk Technol Ltd, Dept Res, Plymouth, MN 55447 USA.; Rosenblatt, MI (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	brianlawrence@silk-tech.com; mrosenbl@uic.edu	Lawrence, Brian David/AAI-9088-2020	Schreiner, Ryan/0000-0002-7457-6606	Silk Technologies, Ltd.; Research to Prevent Blindness; NSF [DGE-1144153]; NSF SBIR [IIP-1013484]; DOD-DHA SBIR [W81XWH-16-C-0063]; Army SBIR [A151-061-0107]	Silk Technologies, Ltd.; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NSF(National Science Foundation (NSF)); NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); DOD-DHA SBIR; Army SBIR	Three of the authors (BL, DI, NP) are employed by the commercial company Silk Technologies, Ltd. Silk Technologies, Ltd. provided support in the form of salaries for authors (BL, DI, NP), institutional overhead, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section. This work was supported by a Research to Prevent Blindness Career Development ward to MR, NSF Graduate Research Fellowship Award DGE-1144153 to WA, NSF SBIR Phase II award number IIP-1013484 to BL, DOD-DHA SBIR Phase II award number W81XWH-16-C-0063 to BL, Army SBIR Phase I award number A151-061-0107 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was from Research to Prevent Blindness Career Development Award, NSF Graduate Research Fellowship Award DGE-1144153, NSF SBIR Phase II award number IIP-1013484, DOD-DHA SBIR Phase II award number W81XWH-16-C-0063, Army SBIR Phase I award number A151-061-0107. hCLE cell line provided courtesy of Dr. Ilene Gipson. Silk Technologies, Ltd. kindly provided the SDP solution.	Abdel-Naby W., 2017, INVESTIGATIVE OPHTHA, V58; Agrawal Vinay B, 2003, Indian J Ophthalmol, V51, P5; Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068; Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]; Chon JW, 2012, INT J MOL MED, V30, P1203, DOI 10.3892/ijmm.2012.1120; Cutler TJ, 2004, VET CLIN N AM-EQUINE, V20, P319, DOI 10.1016/j.cveq.2004.04.014; Dieckow J., 2011, OCUL SURF, V9, P3; Fraunfelder FW, 2006, CORNEA, V25, P1133, DOI 10.1097/01.ico.0000240084.27663.fd; Garrett Q, 2008, CURR EYE RES, V33, P567, DOI 10.1080/02713680802140213; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432; Gong Y., 2016, PLOS ONE, V11; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041; Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415; Hu CL, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1298; Irina S. Barequet, 2014, CORNEA, V33; Jia L, 2016, J BIOMED MATER RES B, V104, P431, DOI 10.1002/jbm.b.33408; Kim DW, 2012, J MICROBIOL BIOTECHN, V22, P494, DOI 10.4014/jmb.1111.11024; Kim JC, 2014, PFLUGERS ARCH, V7, P1; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lawrence B, 2016, US Patent Office, Patent No. [US9394355, 9394355]; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876; Market Scope, 2016, DRY EYE PROD REP GLO; Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; RHEE D, 1999, WILLS EYE MANUAL OFF; Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875; Zainuddin, 2008, BIOMATERIALS, V29	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188154	10.1371/journal.pone.0188154	http://dx.doi.org/10.1371/journal.pone.0188154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155856	gold, Green Published, Green Submitted			2022-12-26	WOS:000415756700032
J	Bispo, PD; Balzter, H; Malhi, Y; Slik, JWF; dos Santos, JR; Renno, CD; Espirito-Santo, FD; Aragao, LEOC; Ximenes, AC; Bispo, PD				Bispo, Polyanna da Conceicao; Balzter, Heiko; Malhi, Yadvinder; Slik, J. W. Ferry; dos Santos, Joao Roberto; Renno, Camilo Daleles; Espirito-Santo, Fernando D.; Aragao, Luiz E. O. C.; Ximenes, Arimatea C.; Bispo, Pitagoras da Conceicao			Drivers of metacommunity structure diverge for common and rare Amazonian tree species	PLOS ONE			English	Article							RADAR TOPOGRAPHY MISSION; LOCAL GEOMORPHOMETRIC VARIABLES; NEUTRAL THEORY; TROPICAL FORESTS; SPATIAL PROCESSES; BETA-DIVERSITY; PATTERNS; VEGETATION; ECOLOGY; TRAITS	We analysed the flora of 46 forest inventory plots (25 m x 100 m) in old growth forests from the Amazonian region to identify the role of environmental (topographic) and spatial variables (obtained using PCNM, Principal Coordinates of Neighbourhood Matrix analysis) for common and rare species. For the analyses, we used multiple partial regression to partition the specific effects of the topographic and spatial variables on the univariate data (standardised richness, total abundance and total biomass) and partial RDA (Redundancy Analysis) to partition these effects on composition (multivariate data) based on incidence, abundance and biomass. The different attributes (richness, abundance, biomass and composition based on incidence, abundance and biomass) used to study this metacommunity responded differently to environmental and spatial processes. Considering standardised richness, total abundance (univariate) and composition based on biomass, the results for common species differed from those obtained for all species. On the other hand, for total biomass (univariate) and for compositions based on incidence and abundance, there was a correspondence between the data obtained for the total community and for common species. Our data also show that in general, environmental and/ or spatial components are important to explain the variability in tree communities for total and common species. However, with the exception of the total abundance, the environmental and spatial variables measured were insufficient to explain the attributes of the communities of rare species. These results indicate that predicting the attributes of rare tree species communities based on environmental and spatial variables is a substantial challenge. As the spatial component was relevant for several community attributes, our results demonstrate the importance of using a metacommunities approach when attempting to understand the main ecological processes underlying the diversity of tropical forest communities.	[Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester Inst Space & Earth Observ, Leicester, Leics, England; [Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Natl Ctr Earth Observ, NERC, Leicester, Leics, England; [Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Slik, J. W. Ferry] Univ Brunei Darussalam, Fac Sci, Gadong, Brunei; [dos Santos, Joao Roberto; Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, Brazil; [Renno, Camilo Daleles] Natl Inst Space Res INPE, Image Proc Div, Sao Jose Dos Campos, Brazil; [Espirito-Santo, Fernando D.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Ximenes, Arimatea C.] Univ Libre Bruxelles, Dept Biol Organisms, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Ximenes, Arimatea C.] Vrije Univ Brussel, Lab Plant Biol & Nat Management Ecol & Biodivers, Brussels, Belgium; [Bispo, Pitagoras da Conceicao] State Univ Sao Paulo UNESP, Fac Sci & Languages Assis, Dept Biol Sci, Assis, Brazil	University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; University of Leicester; University of Oxford; University Brunei Darussalam; Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE); Lancaster University; University of Exeter; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universidade Estadual Paulista	Bispo, PD (corresponding author), Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester Inst Space & Earth Observ, Leicester, Leics, England.; Bispo, PD (corresponding author), Univ Leicester, Natl Ctr Earth Observ, NERC, Leicester, Leics, England.	polybispo@gmail.com	aragao, luiz eoc/G-8387-2012; Espirito-Santo, Fernando/O-4371-2014; Balzter, Heiko/B-5976-2008; Rennó, Camilo Daleles/B-9070-2014	aragao, luiz eoc/0000-0002-4134-6708; Espirito-Santo, Fernando/0000-0001-7497-3639; Balzter, Heiko/0000-0002-9053-4684; Rennó, Camilo Daleles/0000-0001-9920-4473; da Conceicao Bispo, Polyanna/0000-0003-0247-8449; /0000-0002-7356-8882; Ximenes, Arimatea C./0000-0002-9111-5481	European Unions Horizon research and innovation programme under the Marie Sklodowska-Curie grant [660020]; Royal Society Wolfson Research Merit Award [2011/R3]; Natural Environment Research Councils National Centre for Earth Observation; CNPq National Council for Scientific and Technological Development [305275/2014-3, 303228/2013-0, 305054/2016-3]; Natural Environment Research Council (NERC) grants [BIO-RED NE/N012542/1, AFIRE NE/P004512/1]; Newton Fund (The UK Academies/FAPESP) [2015/50392-8]; NERC [NE/N012542/1, nceo020005] Funding Source: UKRI; Natural Environment Research Council [NE/N012542/1, nceo020005] Funding Source: researchfish	European Unions Horizon research and innovation programme under the Marie Sklodowska-Curie grant; Royal Society Wolfson Research Merit Award(Royal Society of London); Natural Environment Research Councils National Centre for Earth Observation; CNPq National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environment Research Council (NERC) grants(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Newton Fund (The UK Academies/FAPESP); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PCB was supported by European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 660020. HB was supported by Royal Society Wolfson Research Merit Award (2011/R3) and by the Natural Environment Research Councils National Centre for Earth Observation. PITCB, JRS and LEOCA were supported by CNPq National Council for Scientific and Technological Development) productivity fellowships (grants 305275/2014-3, 303228/2013-0 and 305054/2016-3, respectively). FES was supported by Natural Environment Research Council (NERC) grants (BIO-RED NE/N012542/1 and AFIRE NE/P004512/1) and Newton Fund (The UK Academies/FAPESP Proc. No: 2015/50392-8 Fellowship and Research Mobility).	Alahuhta J, 2014, ECOL COMPLEX, V20, P61, DOI 10.1016/j.ecocom.2014.08.003; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Balvanera P, 2011, BIOTROPICA, V43, P414, DOI 10.1111/j.1744-7429.2010.00712.x; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bispo PC, 2014, CAN J REMOTE SENS, V40, P26, DOI 10.1080/07038992.2014.913477; Bispo PD, 2010, REV BRAS ENG AGR AMB, V14, P523, DOI 10.1590/S1415-43662010000500010; Bispo PD, 2012, AUSTRAL ECOL, V37, P491, DOI 10.1111/j.1442-9993.2011.02310.x; Bispo PD, 2010, ACTA BOT BRAS, V24, P96; Bispo Polyanna da Conceição, 2009, Acta Amaz., V39, P81, DOI 10.1590/S0044-59672009000100008; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Branco CCZ, 2014, HYDROBIOLOGIA, V732, P123, DOI 10.1007/s10750-014-1852-2; BROWN S, 1989, FOREST SCI, V35, P881; Chase JM, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P335; Clark JS, 2012, TRENDS ECOL EVOL, V27, P364, DOI 10.1016/j.tree.2012.04.009; Clark JS, 2012, TRENDS ECOL EVOL, V27, P198, DOI 10.1016/j.tree.2012.02.001; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; dos Santos AS, 2015, PERSPECT PLANT ECOL, V17, P96, DOI 10.1016/j.ppees.2015.01.002; Dray, 2011, PACKFOR FORWARD SELE, P46; Espeland EK, 2011, BIODIVERS CONSERV, V20, P963, DOI 10.1007/s10531-011-0007-2; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Furniss TJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1847; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Guadagnin PMA, 2015, GEOGR DEP U SAO PAUL, V29, P246; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Heino J, 2010, LIMNOL OCEANOGR, V55, P2397, DOI 10.4319/lo.2010.55.6.2397; Hubbell S.P., 2001, MG POP BIOL, V32; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kellndorfer J, 2004, REMOTE SENS ENVIRON, V93, P339, DOI 10.1016/j.rse.2004.07.017; Kunin WE, 1997, CONSERV BIOL, V11, P183, DOI 10.1046/j.1523-1739.1997.95469.x; Laszlo Z, 2014, J INSECT CONSERV, V18, P1203, DOI 10.1007/s10841-014-9734-5; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; Markham J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06012; Mazaris A, 2008, BIODIVERS CONSERV, V17, P3567, DOI 10.1007/s10531-008-9480-7; MUNOZ V, 2013, GEOGRATIA, V38, P139; Murphy SJ, 2015, ECOLOGY, V96, P705, DOI 10.1890/14-0695.1; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2016, R FDN STAT COMP; RADAMBRASIL Departamento Nacional de Produc Mineral, 1976, LEVANTAMENTO RECURSO, V10; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Saito VS, 2015, J BIOGEOGR, V42, P2101, DOI 10.1111/jbi.12577; Simard M, 2008, REMOTE SENS ENVIRON, V112, P2131, DOI 10.1016/j.rse.2007.10.012; Siqueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043626; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Spasojevic MJ, 2014, ECOGRAPHY, V37, P939, DOI 10.1111/ecog.00711; Spitale D, 2012, ECOSCIENCE, V19, P80, DOI 10.2980/19-1-3435; TOKESHI M, 1990, J ANIM ECOL, V59, P1129, DOI 10.2307/5036; Tsang TPN, 2017, LANDSCAPE ECOL, V32, P47, DOI 10.1007/s10980-016-0427-1; Valeriano MD, 2012, APPL GEOGR, V32, P300, DOI 10.1016/j.apgeog.2011.05.004; Veloso HP, 1991, CLASSIFICAC TEMA UNI; Wang QG, 2017, J PLANT ECOL, V10, P440, DOI 10.1093/jpe/rtw047; Wennekes PL, 2012, ACTA BIOTHEOR, V60, P257, DOI 10.1007/s10441-012-9144-6	74	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188300	10.1371/journal.pone.0188300	http://dx.doi.org/10.1371/journal.pone.0188300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155865	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000415756700044
J	Tsuda, M; Cho, K; Ooka, M; Shimizu, N; Watanabe, R; Yasui, A; Nakazawa, Y; Ogi, T; Harada, H; Agama, K; Nakamura, J; Asada, R; Fujiike, H; Sakuma, T; Yamamoto, T; Murai, J; Hiraoka, M; Koike, K; Pommier, Y; Takeda, S; Hirota, K				Tsuda, Masataka; Cho, Kosai; Ooka, Masato; Shimizu, Naoto; Watanabe, Reiko; Yasui, Akira; Nakazawa, Yuka; Ogi, Tomoo; Harada, Hiroshi; Agama, Keli; Nakamura, Jun; Asada, Ryuta; Fujiike, Haruna; Sakuma, Tetsushi; Yamamoto, Takashi; Murai, Junko; Hiraoka, Masahiro; Koike, Kaoru; Pommier, Yves; Takeda, Shunichi; Hirota, Kouji			ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; TRANSLESION SYNTHESIS; CELLULAR-RESPONSES; SNF2 FAMILY; POLY(ADP-RIBOSE); RECRUITMENT; PARP1; ALC1	ALC1/CHD1L is a member of the SNF2 superfamily of ATPases carrying a macrodomain that binds poly(ADP-ribose). Poly(ADP-ribose) polymerase (PARP) 1 and 2 synthesize poly(ADP-ribose) at DNA-strand cleavage sites, promoting base excision repair (BER). Although depletion of ALC1 causes increased sensitivity to various DNA-damaging agents (H2O2, UV, and phleomycin), the role played by ALC1 in BER has not yet been established. To explore this role, as well as the role of ALC1's ATPase activity in BER, we disrupted the ALC1 gene and inserted the ATPase-dead (E165Q) mutation into the ALC1 gene in chicken DT40 cells, which do not express PARP2. The resulting ALC1(-/-) and ALC1(-/E165Q) cells displayed an indistinguishable hypersensitivity to methylmethane sulfonate (MMS), an alkylating agent, and to H2O2, indicating that ATPase plays an essential role in the DNA-damage response. PARP1(-/-) and ALC1(-/-)/PARP1(-/-) cells exhibited a very similar sensitivity to MMS, suggesting that ALC1 and PARP1 collaborate in BER. Following pulse-exposure to H2O2, PARP1(-/-) and ALC1(-/-)/PARP1(-/-) cells showed similarly delayed kinetics in the repair of single- strand breaks, which arise as BER intermediates. To ascertain ALC1's role in BER in mammalian cells, we disrupted the ALC1 gene in human TK6 cells. Following exposure to MMS and to H2O2, the ALC1(-/-) TK6 cell line showed a delay in single-strand-break repair. We therefore conclude that ALC1 plays a role in BER. Following exposure to H2O2, ALC1(-/-) cells showed compromised chromatin relaxation. We thus propose that ALC1 is a unique BER factor that functions in a chromatin context, most likely as a chromatin-remodeling enzyme.	[Tsuda, Masataka; Cho, Kosai; Shimizu, Naoto; Fujiike, Haruna; Murai, Junko; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Cho, Kosai; Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Sakyo Ku, Kyoto, Japan; [Ooka, Masato; Asada, Ryuta; Hirota, Kouji] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan; [Watanabe, Reiko; Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Aoba Ku, Seiryomachi 4-1, Sendai, Miyagi, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagasaki Univ Sakamoto, Atom Bomb Dis Inst, Dept Genome Repair, Nagasaki, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Harada, Hiroshi] Kyoto Univ, Radiat Biol Ctr, Lab Canc Cell Biol, Sakyo Ku, Kyoto, Japan; [Agama, Keli; Murai, Junko; Pommier, Yves] NCI, Ctr Canc Res, NIH, Dev Therapeut Branch,Lab Mol Pharmacol, Bethesda, MD USA; [Nakamura, Jun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Japan; [Hiraoka, Masahiro] Japanese Red Cross Soc Wakayama Med Ctr, Dept Radiat Oncol, Wakayama, Japan; [Watanabe, Reiko] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan	Kyoto University; Kyoto University; Tokyo Metropolitan University; Tohoku University; Nagasaki University; Nagoya University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Hiroshima University	Takeda, S; Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.; Hirota, K (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan.	stakeda@rg.med.kyoto-u.ac.jp; khirota@tmu.ac.jp	Murai, Junko/AAU-9516-2021; Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017; Tsuda, Masataka/G-2505-2019; Ooka, Masato/HHN-0222-2022	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903; Ooka, Masato/0000-0002-2729-2619; Asada, Ryuta/0000-0001-8360-6355; Tsuda, Masataka/0000-0002-1267-3777; Nakazawa, Yuka/0000-0002-3835-3093; Ogi, Tomoo/0000-0002-5492-9072; Takeda, Shunichi/0000-0002-7924-7991; Nakamura, Jun/0000-0002-1756-7199	JSPS KAKENHI [JP16K12598, JP16H02957, JP16H01314, JP16H06306, JP16J02252]; JSPS; Takeda Science Foundation; Yamada Science Foundation; Center for Cancer Research; US National Cancer Institute [Z01 BC 006150]; Grants-in-Aid for Scientific Research [15H05333, 16J02252] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the JSPS KAKENHI Grant Number (JP16K12598, JP16H02957 and JP16H01314 to KH, JP16H06306 to ST and JP16J02252 to RA), the JSPS Core-to-Core Program (A) Advanced Research Networks (to ST), the Takeda Science Foundation and Yamada Science Foundation (to KH), and the Center for Cancer Research, Intramural Program of the US National Cancer Institute (Z01 BC 006150 to KA and YP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2016, FREE RADIC BIOL MED; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Asada R, 2015, MOL CELL BIOL, V35, P847, DOI 10.1128/MCB.00924-14; Ball LG, 2005, ACTA PHARMACOL SIN, V26, P897, DOI 10.1111/j.1745-7254.2005.00165.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Braafladt S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32162; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Breslin C, 2006, METHOD ENZYMOL, V409, P410, DOI 10.1016/S0076-6879(05)09024-5; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Dantzer F, 1999, CARCINOGENESIS, V20, P177, DOI 10.1093/carcin/20.1.177; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hanzlikova H, 2016, NUCL ACIDS RES; Hirota K., 2010, PLOS GENET, V6, P10, DOI DOI 10.1371/J0URNAL.PGEN.1001151; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2016, NUCLEIC ACIDS RES, V44, P7242, DOI 10.1093/nar/gkw439; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Honma M, 2005, ENVIRON MOL MUTAGEN, V45, P162, DOI 10.1002/em.20113; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kohn KW, 1996, BIOESSAYS, V18, P505, DOI 10.1002/bies.950180613; KOHN KW, 1991, PHARMACOL THERAPEUT, V49, P55, DOI 10.1016/0163-7258(91)90022-E; Kulkarni A, 2013, J BIOL CHEM, V288, P32357, DOI 10.1074/jbc.M113.459164; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LEVY JA, 1968, CANCER-AM CANCER SOC, V22, P517, DOI 10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng105; Okano S, 2000, J BIOL CHEM, V275, P32635, DOI 10.1074/jbc.M004085200; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pachkowski BF, 2009, MUTAT RES-FUND MOL M, V671, P93, DOI 10.1016/j.mrfmmm.2009.09.006; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	46	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188320	10.1371/journal.pone.0188320	http://dx.doi.org/10.1371/journal.pone.0188320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149203	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100037
J	Seo, SR; Lee, HM; Choi, HS; Kim, WT; Cho, EW; Ryu, CJ				Seo, Se-Ri; Lee, Hyun Min; Choi, Hong Seo; Kim, Won-Tae; Cho, Eun-Wie; Ryu, Chun Jeih			Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOPLASMIC-RETICULUM; BAP31; IDENTIFICATION; APOPTOSIS; MOLECULE; COMPLEX; SYSTEM; GRP78; A549	B-cell receptor-associated protein 31 (BAP31) is an endoplasmic reticulum (ER) membrane protein which plays a role as a molecular chaperone for the newly synthesized transmembrane proteins. BAP31 is also an important apoptosis regulator for extrinsic apoptosis induction in the ER membrane. Recent studies have shown that BAP31 is also expressed on the surface of embryonic stem cells. However, the function of cell surface BAP31 (csBAP31) still remains unclarified. In an attempt to search for surface markers on tumorspheres, here, we generated monoclonal antibodies (MAbs) against the sphere cells from the non-small cell lung carcinoma cell (NSCLC) line A549. SP1-B7, one of the MAbs, recognized csBAP31 whose expression was further increased on A549 sphere cells, as compared with A549 adherent cells. To investigate the role of csBAP31 in A549 cells, A549 adherent and sphere cells were stained with annexin V, propidium iodide, and SP1-B7. Interestingly, annexin V-high cells showed increased expression of csBAP31 as compared with annexin V-low cells. Caspase-3/7 activity was also increased in csBAP31-high cells as compared with csBAP31-low cells, suggesting that csBAP31-high cells are more sensitive to apoptosis. To further demonstrate the survival of csBAP31-positive A549 cells, csBAP31-positive and -negative A549 cells were sorted and subjected to the clonogenic survival assay. The colony number of csBAP31-positive A549 cells was decreased by approximately 1.7-fold, as compared that of csBAP31-negative A549 cells, suggesting that csBAP31-positve cells are sensitive to cell death indeed. The results suggest that enhanced expression of csBAP31 contributes to poor survival of NSCLC cells.	[Seo, Se-Ri; Lee, Hyun Min; Choi, Hong Seo; Kim, Won-Tae; Ryu, Chun Jeih] Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Antiancer Med Dev, Seoul, South Korea; [Cho, Eun-Wie] Korea Res Inst Biosci & Biotechnol, Epigenom Res Ctr, Daejeon, South Korea	Sejong University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ryu, CJ (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Antiancer Med Dev, Seoul, South Korea.	cjryu@sejong.ac.kr			National Research Foundation of Korea [2016008610, 2016903249]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported in part by the National Research Foundation of Korea (2016008610 and 2016903249). There was no additional external funding received for this further study.; This study was supported in part by the National Research Foundation of Korea (2016008610 and 2016903249).	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Choi HS, 2008, CELL TISSUE RES, V333, P197, DOI 10.1007/s00441-008-0632-6; Choi HS, 2013, STEM CELLS, V31, P2647, DOI 10.1002/stem.1366; Choi HS, 2011, STEM CELLS DEV, V20, P609, DOI 10.1089/scd.2010.0265; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kim WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167527; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Kim WT, 2014, STEM CELLS, V32, P2626, DOI 10.1002/stem.1765; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Meng XJ, 2009, ONCOL REP, V21, P995, DOI 10.3892/or_00000314; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Raiter A, 2014, ONCOTARGET, V5, P11452, DOI 10.18632/oncotarget.2576; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh SK, 2003, CANCER RES, V63, P5821; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Yerushalmi R, 2015, ONCOL LETT, V10, P2149, DOI 10.3892/ol.2015.3579; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188075	10.1371/journal.pone.0188075	http://dx.doi.org/10.1371/journal.pone.0188075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145450	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800060
J	Sullivan, EM; Pennington, ER; Sparagna, GC; Torres, MJ; Neufer, PD; Harris, M; Washington, J; Anderson, EJ; Zeczycki, TN; Brown, DA; Shaikh, SR				Sullivan, E. Madison; Pennington, Edward Ross; Sparagna, Genevieve C.; Torres, Maria J.; Neufer, P. Darrell; Harris, Mitchel; Washington, James; Anderson, Ethan J.; Zeczycki, Tonya N.; Brown, David A.; Shaikh, Saame Raza			Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; lipid vesicle; mass spectrometry (MS); membrane; mitochondria; phospholipid; polyunsaturated fatty acid (PUFA)	CYTOCHROME-C-OXIDASE; POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; INDUCED-OBESE MICE; BARTH-SYNDROME; RESPIRATORY-CHAIN; COMPLEX-I; ATP SYNTHASE; TETRALINOLEOYL-CARDIOLIPIN; CARDIOVASCULAR-DISEASES	Cardiac mitochondrial phospholipid acyl chains regulate respiratory enzymatic activity. In several diseases, the rodent cardiac phospholipidome is extensively rearranged; however, whether specific acyl chains impair respiratory enzyme function is unknown. One unique remodeling event in the myocardium of obese and diabetic rodents is an increase in docosahexaenoic acid (DHA) levels. Here, we first confirmed that cardiac DHA levels are elevated in diabetic humans relative to controls. We then used dietary supplementation of a Western diet with DHA as a tool to promote cardiac acyl chain remodeling and to study its influence on respiratory enzyme function. DHA extensively remodeled the acyl chains of cardiolipin (CL), monolyso-CL, phosphatidylcholine, and phosphatidylethanolamine. Moreover, DHA lowered enzyme activities of respiratory complexes I, IV, V, and I + III. Mechanistically, the reduction in enzymatic activities was not driven by a dramatic reduction in the abundance of supercomplexes. Instead, replacement of tetralinoleoyl-CL with tetradocosahexaenoyl-CL in biomimetic membranes prevented formation of phospholipid domains that regulate enzyme activity. Tetradocosahexaenoyl-CL inhibited domain organization due to favorable Gibbs free energy of phospholipid mixing. Furthermore, in vitro substitution of tetralinoleoyl-CL with tetradocosahexaenoyl-CL blocked complex IV binding. Finally, reintroduction of linoleic acid, via fusion of phospholipid vesicles to mitochondria isolated from DHA-fed mice, rescued the major losses in the mitochondrial phospholipidome and complexes I, IV, and V activities. Altogether, our results show that replacing linoleic acid with DHA lowers select cardiac enzyme activities by potentially targeting domain organization and phospholipid-protein binding, which has implications for the ongoing debate about	[Sullivan, E. Madison; Pennington, Edward Ross; Harris, Mitchel; Washington, James; Zeczycki, Tonya N.; Shaikh, Saame Raza] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Sullivan, E. Madison; Pennington, Edward Ross; Torres, Maria J.; Neufer, P. Darrell; Washington, James; Zeczycki, Tonya N.; Shaikh, Saame Raza] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Neufer, P. Darrell] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Pennington, Edward Ross; Shaikh, Saame Raza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Pennington, Edward Ross; Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Med, Div Cardiol, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Anderson, Ethan J.] Univ Iowa, Coll Pharm, Fraternal Order Eagles Diabet Res Ctr, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA; [Brown, David A.] Virginia Tech, Corp Res Ctr, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24060 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; Virginia Polytechnic Institute & State University	Shaikh, SR (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.; Shaikh, SR (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu		Torres, Maria J./0000-0002-7551-8053; Zeczycki, Tonya/0000-0002-5216-1960	National Institutes of Health [R01HL123647, R01AT008375, P30DK056350, R01HL122863, R01DK110656]; National Center for Complementary & Integrative Health [R01AT008375] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123647, R01HL122863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK110656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG057006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01HL123647 (to S. R. S. and D. A. B.), R01AT008375 (to S. R. S.), P30DK056350 (to S. R. S.), R01HL122863 (E. J. A.), and R01DK110656 (to P. D. N). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander DD, 2017, MAYO CLIN PROC, V92, P15, DOI 10.1016/j.mayocp.2016.10.018; Anderson EJ, 2014, ANTIOXID REDOX SIGN, V21, P1156, DOI 10.1089/ars.2014.5888; Anderson EJ, 2012, BIOCHEM J, V441, P359, DOI 10.1042/BJ20110626; Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X; Arnarez C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01263; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; FRY M, 1981, J BIOL CHEM, V256, P1874; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gomez LA, 2009, ARCH BIOCHEM BIOPHYS, V490, P30, DOI 10.1016/j.abb.2009.08.002; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Harris WS, 2017, ATHEROSCLEROSIS, V262, P51, DOI 10.1016/j.atherosclerosis.2017.05.007; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; Hodnik Vesna, 2013, Methods Mol Biol, V974, P23, DOI 10.1007/978-1-62703-275-9_2; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hu XY, 2017, COMPR PHYSIOL, V7, P693, DOI 10.1002/cphy.c160021; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Jeckel KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051994; KATAN MB, 1995, AM J CLIN NUTR, V61, p1368S, DOI 10.1093/ajcn/61.6.1368S; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kosaraju R, 2017, J IMMUNOL, V198, P4738, DOI 10.4049/jimmunol.1601031; Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2; LeMieux MJ, 2015, J NUTR, V145, P411, DOI 10.3945/jn.114.202952; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; Liu XF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-109; Lombardo YB, 2007, LIPIDS, V42, P427, DOI 10.1007/s11745-007-3039-3; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Madingou N, 2016, PROSTAG LEUKOTR ESS, V111, P11, DOI 10.1016/j.plefa.2016.06.001; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pennington ER, 2017, BBA-BIOMEMBRANES, V1859, P257, DOI 10.1016/j.bbamem.2016.11.012; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Pinel A, 2016, J LIPID RES, V57, P1382, DOI 10.1194/jlr.M065458; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; RAMSDEN CE, 2013, BMJ-BRIT MED J, V346, pe8707, DOI DOI 10.1136/BMJ.E8707; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Rangel-Huerta O. D., 2017, CLIN NUTR, V2017, pS0261; ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Rockett BD, 2012, J LIPID RES, V53, P674, DOI 10.1194/jlr.M021782; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Sedlak E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shaikh SR, 2009, BBA-BIOMEMBRANES, V1788, P2421, DOI 10.1016/j.bbamem.2009.08.019; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Sullivan EM, 2017, J NUTR BIOCHEM, V45, P94, DOI 10.1016/j.jnutbio.2017.04.004; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; WHEELDON LW, 1965, J LIPID RES, V6, P481; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	86	32	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					466	483		10.1074/jbc.M117.812834	http://dx.doi.org/10.1074/jbc.M117.812834			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162722	Green Published, hybrid			2022-12-26	WOS:000419915400005
J	Bruxelle, JF; Mizrahi, A; Hoys, S; Collignon, A; Janoir, C; Pechine, S				Bruxelle, Jean-Francois; Mizrahi, Assaf; Hoys, Sandra; Collignon, Anne; Janoir, Claire; Pechine, Severine			Clostridium difficile flagellin FIiC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSES; SURFACE-PROTEINS; INFECTION; IMMUNIZATION; HAMSTERS; MICE; COLONIZATION; PATHOGENESIS; ACTIVATION	The immunogenicity of bacterial flagellin has been reported in different studies. By its close interaction with the immune system, the flagellin represents an interesting adjuvant and vaccine candidate. Salmonella Typhimurium flagellin has already been tested as adjuvant to stimulate mucosal immunity. Here, we assessed the ability of Clostridium difficile flagellin FIiC to act as a mucosal adjuvant, first combined with ovalbumin as antigen and second with a C. difficile surface protein, the precursor of the S-layer proteins SIpA. Using ovalbumin as antigen, we compared the gut mucosal adjuvanticity of FIiC to Salmonella Typhimurium flagellin and cholera toxin. Two routes of immunization were tested in a mouse model: intra-rectal and intra-peritoneal, following which, gut mucosal and systemic antibody responses against ovalbumin (Immunoglobulins G and Immunoglobulins A) were analyzed by Enzyme-Linked Immuno Assay in intestinal contents and in sera. In addition, ovalbumin-specific immunoglobulin producing cells were detected in the intestinal lamina propria by Enzyme-Linked Immunospot. Results showed that FIiC as adjuvant for immunization targeting ovalbumin was able to stimulate a gut mucosal and systemic antibody response independently of the immunization route. In order to develop a mucosal vaccine to prevent C. difficile intestinal colonization, we assessed in a mouse model the efficacy of FIiC as adjuvant compared with cholera toxin co-administrated with the C. difficile S-layer precursor SIpA as antigen. After challenge, a significant decrease of C. difficile intestinal colonization was observed in immunized groups compared to the control group. Our results showed that C. difficile FIiC could be used as adjuvant in mucosal vaccination strategy against C. difficile infections.	[Bruxelle, Jean-Francois; Mizrahi, Assaf; Hoys, Sandra; Collignon, Anne; Janoir, Claire; Pechine, Severine] Univ Paris Saclay, Univ Paris Sud, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, Chatenay Malabry, France; [Mizrahi, Assaf] Grp Hosp Paris St Joseph, Serv Microbiol Clin, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite	Pechine, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, Unite Bacteries Pathogenes & Sante UBaPS, EA4043, Chatenay Malabry, France.	severine.pechine@u-psud.fr	PÉCHINÉ, SÉVERINE/ABD-1960-2021; Mizrahi, Assaf/L-8217-2018	Mizrahi, Assaf/0000-0003-3135-5093; Bruxelle, Jean-Francois/0000-0001-7180-8611				Aoshi T, 2017, VIRAL IMMUNOL; Aoshi T, 2017, VIRAL IMMUNOL, V30, P463, DOI 10.1089/vim.2017.0026; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Batah J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03621-z; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bruxelle JF, 2016, ANAEROBE, V37, P78, DOI 10.1016/j.anaerobe.2015.10.010; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Flores-Langarica A, 2012, J IMMUNOL, V189, P5745, DOI 10.4049/jimmunol.1202283; Fougeron D, 2015, VACCINE, V33, P3331, DOI 10.1016/j.vaccine.2015.05.022; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8; Ghose C, 2015, INFECT DIS CLIN N AM, V29, P145, DOI 10.1016/j.idc.2014.11.013; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kociolek LK, 2016, NAT REV GASTRO HEPAT, V13, P150, DOI 10.1038/nrgastro.2015.220; Lardeux F, 2016, MEM I OSWALDO CRUZ, V111, P501, DOI 10.1590/0074-02760160119; Larrazet C, 2016, ANAEROBE, V38, P116; Lavelle EC, 2005, CELL MOL LIFE SCI, V62, P2750, DOI 10.1007/s00018-005-5290-1; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizrahi A, 2014, ANAEROBE, V30, P210, DOI 10.1016/j.anaerobe.2014.07.006; Monaghan TM, 2015, INFECT DIS CLIN N AM, V29, P1, DOI 10.1016/j.idc.2014.11.007; Natt J, 2015, METHODS MOL BIOL, V1291, P87, DOI 10.1007/978-1-4939-2498-1_8; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Pechine S, 2007, VACCINE, V25, P3946, DOI 10.1016/j.vaccine.2007.02.055; Pechine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081112; Pechine S, 2011, FEMS IMMUNOL MED MIC, V63, P73, DOI 10.1111/j.1574-695X.2011.00832.x; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sandolo C, 2011, EUR J PHARM BIOPHARM, V79, P566, DOI 10.1016/j.ejpb.2011.05.011; Shen Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01619-1; Srivastava A, 2015, APMIS, V123, P275, DOI 10.1111/apm.12351; Stapleton NM, 2015, IMMUNOL REV, V268, P253, DOI 10.1111/imr.12331; Stevenson E, 2015, TRENDS MICROBIOL, V23, P275, DOI 10.1016/j.tim.2015.01.004; Stratmann T, 2015, VACCINES-BASEL, V3, P579, DOI 10.3390/vaccines3030579; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yoshino Y, 2013, LIFE SCI, V92, P211, DOI 10.1016/j.lfs.2012.11.017; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995	46	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187212	10.1371/journal.pone.0187212	http://dx.doi.org/10.1371/journal.pone.0187212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176760	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900006
J	Robles, MD; Turner, DS; Haney, JA				Robles, Marcos D.; Turner, Dale S.; Haney, Jeanmarie A.			A century of changing flows: Forest management changed flow magnitudes and warming advanced the timing of flow in a southwestern US river	PLOS ONE			English	Article							WESTERN UNITED-STATES; PONDEROSA PINE FORESTS; PEARSON NATURAL AREA; CLIMATE-CHANGE; WATER YIELD; CENTRAL ARIZONA; NORTH-AMERICA; RESTORATION TREATMENTS; STREAMFLOW RESPONSE; MOUNTAIN SNOWPACK	The continued provision of water from rivers in the southwestern United States to downstream cities, natural communities and species is at risk due to higher temperatures and drought conditions in recent decades. Snowpack and snowfall levels have declined, snow melt and peak spring flows are arriving earlier, and summer flows have declined. Concurrent to climate change and variation, a century of fire suppression has resulted in dramatic changes to forest conditions, and yet, few studies have focused on determining the degree to which changing forests have altered flows. In this study, we evaluated changes in flow, climate, and forest conditions in the Salt River in central Arizona from 1914-2012 to compare and evaluate the effects of changing forest conditions and temperatures on flows. After using linear regression models to remove the influence of precipitation and temperature, we estimated that annual flows declined by 8-29% from 1914-1963, coincident with a 2-fold increase in basal area, a 2-3-fold increase in canopy cover, and at least a 10-fold increase in forest density within ponderosa pine forests. Streamflow volumes declined by 37-56% in summer and fall months during this period. Declines in climate-adjusted flows reversed at mid-century when spring and annual flows increased by 10-31% from 1964-2012, perhaps due to more winter rainfall. Additionally, peak spring flows occurred about 12 days earlier in this period than in the previous period, coincident with winter and spring temperatures that increased by 1-2 degrees C. While uncertainties remain, this study adds to the knowledge gained in other regions that forest change has had effects on flow that were on par with climate variability and, in the case of mid-century declines, well before the influence of anthropogenic warming. Current large-scale forest restoration projects hold some promise of recovering seasonal flows.	[Robles, Marcos D.; Turner, Dale S.; Haney, Jeanmarie A.] Nature Conservancy, Ctr Sci & Publ Policy, Tucson, AZ 85719 USA	Nature Conservancy	Robles, MD (corresponding author), Nature Conservancy, Ctr Sci & Publ Policy, Tucson, AZ 85719 USA.	mrobles@tnc.org						Andreassian V, 2004, J HYDROL, V291, P1, DOI 10.1016/j.jhydrol.2003.12.015; [Anonymous], 2005, GEN TECHNICAL REPORT; BAKER MB, 1986, WATER RESOUR RES, V22, P67, DOI 10.1029/WR022i001p00067; Baker MB, 2003, ECOLOGICAL RESTORATION OF SOUTHWESTERN PONDEROSA PINE FORESTS, P161; BAKER MB, 1999, RMRSGTR29 USDA FOR S, P56; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Belmecheri S, 2016, NAT CLIM CHANGE, V6, P2; Beyers JL, 2005, WILDLAND FIRE ECOSYS, DOI 10.1021/ac102195x; Biederman JA, 2014, WATER RESOUR RES, V50, P5395, DOI 10.1002/2013WR014994; Biederman JA, 2015, WATER RESOUR RES, V51, P9775, DOI 10.1002/2015WR017401; Biondi F, 1996, CAN J FOREST RES, V26, P1397, DOI 10.1139/x26-156; Block W. M., 1997, General Technical Report - Rocky Mountain Forest and Range Experiment Station, USDA Forest Service, piv; Bonfils C, 2008, J CLIMATE, V21, P6404, DOI 10.1175/2008JCLI2397.1; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brandes D, 2000, J AM WATER RESOUR AS, V36, P965, DOI 10.1111/j.1752-1688.2000.tb05702.x; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Brown H., 1974, OPPORTUNITIES INCREA, P36; Broxton PD, 2015, ECOHYDROLOGY, V8, P1073, DOI 10.1002/eco.1565; Cayan DR, 2013, NCA REGION INPUT REP, P101, DOI 10.5822/978-1-61091-484-0_6; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Cocke AE, 2005, J APPL ECOL, V42, P814, DOI 10.1111/j.1365-2664.2005.01077.x; COOPER CF, 1960, ECOL MONOGR, V30, P130, DOI 10.2307/1948549; COVINGTON WW, 1994, J FOREST, V92, P39; Cui X, 2012, HYDROL EARTH SYST SC, V16, P4279, DOI 10.5194/hess-16-4279-2012; Demaria EMC, 2017, WATER RESOU IN PRESS; Dettinger M, 2015, ECOL APPL, V25, P2069, DOI 10.1890/15-0938.1; Doba R, 2011, WATER RESOURCES DEV, P334; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; Dore S, 2012, GLOBAL CHANGE BIOL, V18, P3171, DOI 10.1111/j.1365-2486.2012.02775.x; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Ellis AW, 2008, CLIM RES, V35, P227, DOI 10.3354/cr00727; Ellis AW, 2017, PHYS GEOGR, V38, P211, DOI 10.1080/02723646.2017.1281014; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; Feeney SR, 1998, CAN J FOREST RES, V28, P1295, DOI 10.1139/cjfr-28-9-1295; Ffolliott Peter F., 2010, Journal of the Arizona-Nevada Academy of Science, V42, P1, DOI 10.2181/036.042.0101; FRITTS HC, 1974, ECOL MONOGR, V44, P411, DOI 10.2307/1942448; Fritze H, 2011, J HYDROMETEOROL, V12, P989, DOI 10.1175/2011JHM1360.1; Fule PZ, 1997, ECOL APPL, V7, P895, DOI 10.1890/1051-0761(1997)007[0895:DRCFEM]2.0.CO;2; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Halofsky J. E., 2014, PNWGTR896 USDA FOR S, P206; Hamlet AF, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005099; Hamon W. R., 1961, J HYDRAUL DIV, V87, P107, DOI [10.1061/JYCEAJ.0000599, DOI 10.1061/JYCEAJ.0000599]; Hardaway GD, 1962, 70 USDA FOR SERV ROC, P18; Harpold A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011949; Harpold AA, 2014, ECOHYDROLOGY, V7, P440, DOI 10.1002/eco.1363; Helsel D. R., 2002, 4A3 USGS, V4, pA3, DOI DOI 10.3133/TWRI04A3; Hensel DR, 2006, ENVIRON SCI TECHNOL, V40, P4066, DOI 10.1021/es051650b; Hibbert AR, 1979, RM66 USDA FOR SERV R; House P. K., 1997, REV ENG GEOL, VXI, P1; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jaeger KL, 2014, P NATL ACAD SCI USA, V111, P13894, DOI 10.1073/pnas.1320890111; Kampf SK, 2016, WATER RESOUR RES, V52, P407, DOI 10.1002/2015WR017784; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Laughlin DC, 2011, ECOLOGY, V92, P556, DOI 10.1890/09-2103.1; Leppi JC, 2012, CLIMATIC CHANGE, V112, P997, DOI 10.1007/s10584-011-0235-1; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Marshall RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011687; Mayer TD, 2011, J AM WATER RESOUR AS, V47, P724, DOI 10.1111/j.1752-1688.2011.00537.x; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell NG, 2006, ECOL APPL, V16, P1164, DOI 10.1890/1051-0761(2006)016[1164:HMOPPG]2.0.CO;2; Meador AJS, 2011, RESTOR ECOL, V19, P490, DOI 10.1111/j.1526-100X.2010.00652.x; Miller WP, 2008, J HYDROMETEOROL, V9, P1020, DOI 10.1175/2008JHM988.1; Moore MM, 2004, FOREST SCI, V50, P162; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Murphy KW, 2014, J HYDROL, V509, P454, DOI 10.1016/j.jhydrol.2013.11.056; Natural Resources Conservation Service National Water and Climate Center, 2014, SNOW COURS DAT PROD; Nayak A, 2010, WATER RESOUR RES, V46, DOI 10.1029/2008WR007525; Neiman PJ, 2013, J HYDROMETEOROL, V14, P460, DOI 10.1175/JHM-D-12-0101.1; O'Connell B.M., 2016, FOREST INVENTORY ANA, P892; O'Donnell F, 2015, P 12 BIENN C RES COL, P79; Pierce DW, 2008, J CLIMATE, V21, P6425, DOI 10.1175/2008JCLI2405.1; Pool DR, 2011, 20105180 US GEOL SUR, P116; Propst DL, 2008, ECOL APPL, V18, P1236, DOI 10.1890/07-1489.1; Rauscher SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034424; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; Reynolds R.T., 2013, RESTORING COMPOSITIO, P76; Robles MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111092; Ronco F. Jr., 1985, Research Paper, Rocky Mountain Forest and Range Experiment Station, USDA Forest Service; Rood SB, 2003, TREE PHYSIOL, V23, P1113, DOI 10.1093/treephys/23.16.1113; Rood SB, 2008, J HYDROL, V349, P397, DOI 10.1016/j.jhydrol.2007.11.012; Safeeq M, 2013, HYDROL PROCESS, V27, P655, DOI 10.1002/hyp.9628; Sankey T, 2015, REMOTE SENS ENVIRON, V169, P307, DOI 10.1016/j.rse.2015.08.028; Savage M, 1996, ECOSCIENCE, V3, P310, DOI 10.1080/11956860.1996.11682348; Schneider EE, 2012, REFERENCE CONDITIONS; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sheppard PR, 2002, CLIM RES, V21, P219, DOI 10.3354/cr021219; Skov KR, 2005, WEST J APPL FOR, V20, P36, DOI 10.1093/wjaf/20.1.36; Smith DM, 2016, J ARID ENVIRON, V135, P120, DOI 10.1016/j.jaridenv.2016.08.016; Stednick JD, 1996, J HYDROL, V176, P79, DOI 10.1016/0022-1694(95)02780-7; Stefferud JA, 2011, FRESHWATER BIOL, V56, P1403, DOI 10.1111/j.1365-2427.2011.02577.x; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Stone JE, 1999, RESTOR ECOL, V7, P172, DOI 10.1046/j.1526-100X.1999.72009.x; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Svoma BM, 2011, INT J CLIMATOL, V31, P87, DOI 10.1002/joc.2062; Svoma BM, 2010, THEOR APPL CLIMATOL, V102, P159, DOI 10.1007/s00704-010-0255-1; Tague C, 2010, GEOGR COMPASS, V4, P1648, DOI 10.1111/j.1749-8198.2010.00400.x; Tarancon AA, 2014, ECOL APPL, V24, P1626, DOI 10.1890/13-1787.1; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Tiller V, 1990, FORT APACHE FORESTRY; United States Department of Agriculture,, 2015, FIN ENV IMP STAT 4 F, V1; United States Department of Agriculture Forest Service, 2016, GIS DAT SW REG; United States Department of Agriculture Natural Resources Conservation Service, 2008, WAT BOUND DAT AR; US Department of the Interior Bureau of Reclamation, 2012, COL RIV BAS WAT SUPP, P95; US Geological Survey, 2011, GAP AN PROGR VERS 1; US Geological Survey, 2013, SURF WAT DAT AR; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Veatch W, 2009, ECOHYDROLOGY, V2, P115, DOI 10.1002/eco.45; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; Wei XH, 2013, WATER-SUI, V5, P728, DOI 10.3390/w5020728; Wei XH, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009250; Western Regional Climate Center, 2013, COOP CLIM DAT SUMM; Wilcox BP, 1997, WATER RESOUR RES, V33, P2301, DOI 10.1029/97WR01691; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wine ML, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/8/085006; Wyatt CJW, 2015, GROUNDWATER, V53, P207, DOI 10.1111/gwat.12184; Yao YF, 2012, HYDROL PROCESS, V26, P1208, DOI 10.1002/hyp.8204; Zhang MF, 2012, J HYDROL, V464, P1, DOI 10.1016/j.jhydrol.2012.05.050; Zou CB, 2010, FOREST ECOL MANAG, V259, P1268, DOI 10.1016/j.foreco.2009.08.005; Zou CB, 2008, ECOHYDROLOGY, V1, P309, DOI 10.1002/eco.17	122	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187875	10.1371/journal.pone.0187875	http://dx.doi.org/10.1371/journal.pone.0187875			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176868	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900020
J	Tamura, M; Hoshi, C; Kobori, M; Takahashi, S; Tomita, J; Nishimura, M; Nishihira, J				Tamura, Motoi; Hoshi, Chigusa; Kobori, Masuko; Takahashi, Shunsuke; Tomita, Junko; Nishimura, Mie; Nishihira, Jun			Quercetin metabolism by fecal microbiota from healthy elderly human subjects	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; BLOOD-PRESSURE; LIVER; JAPANESE; OBESITY; CARCINOGENESIS; DEGRADATION; POLYPHENOLS; ADULTS	Quercetin is a polyphenol found in food that has numerous health benefits. This study investigated the relationship between quercetin metabolism, gut microbiota composition, and dietary intake in elderly Japanese subjects. A food frequency questionnaire was used to assess dietary intake during the week prior to stool sample collection. Fecal suspensions from 56 subjects were anaerobically incubated with quercetin and fecal microbiota composition was analyzed by next-generation sequencing. Inter-individual variations in quercetin concentration and fecal microbiota composition at family level suggested differences in microbial quercetin metabolism. The abundance of Sutterellaceae (r = -0.292) and Oscillospiraceae (r = -0.334) was negatively correlated whereas that of Fusobacteriaceae (r = 0.361) and Enterobacteriaceae (r = 0.321) was positively correlated with quercetin concentration. Niacin (r = -0.313), vitamin B6 (r = -0.297), vitamin B12 (r = -0.266), vitamin D (r = -0.301), and ratio of animal protein to total protein (r = -0.27) were also negatively correlated with quercetin concentration. Bacterial abundance was positively or negatively related to intake of food components. This is the first report describing the relationship between fecal quercetin metabolism, human microbiota, and dietary intake in the elderly.	[Tamura, Motoi; Hoshi, Chigusa; Kobori, Masuko] Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki, Japan; [Takahashi, Shunsuke; Tomita, Junko] TechnoSuruga Lab Co Ltd, Shizuoka, Shizuoka, Japan; [Nishimura, Mie; Nishihira, Jun] Hokkaido Informat Univ, Dept Med Management & Informat, Ebetsu, Hokkaido, Japan	National Agriculture & Food Research Organization - Japan	Tamura, M (corresponding author), Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki, Japan.	motoita@affrc.go.jp		Tamura, Motoi/0000-0003-0911-0524; Takahashi, Shunsuke/0000-0002-4186-8119	Research Project on Development of Agricultural Products and Foods with Health promoting Benefits; Japanese government agencies of Ministry of Agriculture, Forestry and Fisheries; TechnoSuruga Laboratory Co.	Research Project on Development of Agricultural Products and Foods with Health promoting Benefits; Japanese government agencies of Ministry of Agriculture, Forestry and Fisheries; TechnoSuruga Laboratory Co.	Research Project on Development of Agricultural Products and Foods with Health promoting Benefits provided financial support in the form of research materials. This research project was funded by Japanese government agencies of Ministry of Agriculture, Forestry and Fisheries. ST and JT received salary support from TechnoSuruga Laboratory Co. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159236; Bernini LJ, 2016, NUTRITION, V32, P716, DOI 10.1016/j.nut.2015.11.001; Braune A, 2001, APPL ENVIRON MICROB, V67, P5558, DOI 10.1128/AEM.67.12.5558-5567.2001; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Egert S, 2010, J NUTR, V140, P278, DOI 10.3945/jn.109.117655; Erik A, 2011, EA UTILS COMMAND LIN; Eteberria U, 2015, J NUTR BIOCHEM, V26, P651, DOI 10.1016/j.jnutbio.2015.01.002; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hisada T, 2015, ARCH MICROBIOL, V197, P919, DOI 10.1007/s00203-015-1125-0; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kondo T, 2009, J AGR FOOD CHEM, V57, P5982, DOI 10.1021/jf900470c; Lau E, 2015, HORM-INT J ENDOCRINO, V14, P358, DOI 10.14310/horm.2002.1571; Casella ML, 2014, MOL NUTR FOOD RES, V58, P289, DOI 10.1002/mnfr.201300362; Lee KH, 2011, NUTR RES PRACT, V5, P28, DOI 10.4162/nrp.2011.5.1.28; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lopez-Legarrea P, 2014, ASIA PAC J CLIN NUTR, V23, P360, DOI 10.6133/apjcn.2014.23.3.16; Lu TM, 2015, PLANT FOOD HUM NUTR, V70, P395, DOI 10.1007/s11130-015-0507-4; Marques TM, 2015, BRIT J NUTR, V113, P728, DOI 10.1017/S0007114514004206; Ok E, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-163; Oki K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0898-x; Porras D, 2017, FREE RADICAL BIO MED, V102, P188, DOI 10.1016/j.freeradbiomed.2016.11.037; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003; Shkoporov AN, 2015, INT J SYST EVOL MICR, V65, P4580, DOI 10.1099/ijsem.0.000617; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turner ND, 2009, ACTA HORTIC, V841, P237; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090531	35	24	24	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188271	10.1371/journal.pone.0188271	http://dx.doi.org/10.1371/journal.pone.0188271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176866	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900053
J	Yuan, FF; Gu, X; Huang, X; Hou, YW; Zhong, Y; Lin, J; Wu, J				Yuan, Fang-Fen; Gu, Xue; Huang, Xin; Hou, Yu-Wei; Zhong, Yan; Lin, Jun; Wu, Jing			Attention-deficit/hyperactivity disorder associated with KChIP1 rs1541665 in Kv channels accessory proteins	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; GENE-ENVIRONMENT INTERACTION; BLOOD LEAD LEVELS; POTASSIUM CHANNELS; CANDIDATE GENE; MATERNAL STRESS; MAMMALIAN BRAIN; BIRTH COHORT; ADULT ADHD	Attention-deficit/hyperactivity disorder (ADHD) is an early onset childhood neurodevelopmental disorder with high heritability. A number of genetic risk factors and environment factors have been implicated in the pathogenesis of ADHD. Genes encoding for subtypes of voltage-dependent K channels (Kv) and accessory proteins to these channels have been identified in genome-wide association studies (GWAS) of ADHD. We conducted a two stage case control study to investigate the associations between five key genes (KChIP4, KChIP1, DPP10, FHIT, and KCNC1) and the risk of developing ADHD. In the discovery stage comprising 256 cases and 372 controls, KChIP1 rs1541665 and FHITrs3772475 were identified; they were further genotyped in the validation stage containing 328cases and 431 controls. KChIP1 rs1541665 showed significant association with a risk of ADHD at both stages, with CC vs TT odds ratio (OR) = 1.961, 95% confidence interval (CI) = 1.366-2.497, in combined analyses (P-FDR = 0.007). Moreover, we also found rs1541665 involvement in ADHD-I subtype (OR (95% CI) = 2.341(1.713, 3.282), and Hyperactive index score (P = 0.005) in combined samples. Intriguingly, gene-environmental interactions analysis consistently revealed the potential interactionsof rs1541665 collaboratingwith maternal stress pregnancy (P-mul = 0.021) and blood lead (P-add = 0.017) to modify ADHD risk. In conclusion, the current study provides evidence that genetic variants of Kv accessory proteins may contribute to the susceptibility of ADHD. Further studies with different ethnicitiesare warranted to produce definitive conclusions.	[Yuan, Fang-Fen; Gu, Xue; Huang, Xin; Hou, Yu-Wei; Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Yuan, Fang-Fen; Gu, Xue; Huang, Xin; Hou, Yu-Wei; Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [Zhong, Yan] Hunan Childrens Hosp, Dept Child Hlth Care, Changsha, Hunan, Peoples R China; [Lin, Jun] Wuhan Med & Hlth Ctr Women & Children, Dept Rehabil Med, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China.; Wu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.	wujingrlh@163.com			National Natural Science Foundation of China [81101016]; Fundamental Research Funds for the Central Universities, HUST [2016 YXMS218]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	This study is supported partially by the National Natural Science Foundation of China (81101016), The Fundamental Research Funds for the Central Universities, HUST (2016 YXMS218) to Dr. Jing Wu.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Antonucci F, 2012, J NEUROSCI, V32, P1989, DOI 10.1523/JNEUROSCI.2720-11.2012; Basha MR, 2005, J NEUROSCI, V25, P823, DOI 10.1523/JNEUROSCI.4335-04.2005; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bezerra GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08769; Biederman J, 2005, AM J PSYCHIAT, V162, P1083, DOI 10.1176/appi.ajp.162.6.1083; Bourdeau ML, 2011, NEUROSCIENCE, V176, P173, DOI 10.1016/j.neuroscience.2010.11.051; Branch SY, 2012, J NEUROPHYSIOL, V108, P802, DOI 10.1152/jn.00094.2012; Choudhry Z, 2012, J CHILD PSYCHOL PSYC, V53, P892, DOI 10.1111/j.1469-7610.2012.02551.x; Courvoisie H, 2004, J NEUROPSYCH CLIN N, V16, P63, DOI 10.1176/appi.neuropsych.16.1.63; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Del Pino J, 2015, TOXICOLOGY, V333, P107, DOI 10.1016/j.tox.2015.04.013; Dosunmu R, 2009, J ALZHEIMERS DIS, V18, P211, DOI 10.3233/JAD-2009-1138; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; Fan J, 2005, SHANGHAI ARCH PSYCHI, V17; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; Gaub M, 1997, J ABNORM CHILD PSYCH, V25, P103, DOI 10.1023/A:1025775311259; Goldstein S, 2011, CONNERS PARENT RATIN; Gomez L, 2014, GENES BRAIN BEHAV, V13, P535, DOI 10.1111/gbb.12141; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Gong Y., 1993, CHINESE WECHSLER INT; Gordon HA, 2015, J CHILD ADOL PSYCHOP, V25, P783, DOI 10.1089/cap.2015.0105; Grammatikopoulos G, 2002, BEHAV BRAIN RES, V130, P127, DOI 10.1016/S0166-4328(01)00424-7; Grizenko N, 2012, J CAN ACAD CHILD ADO, V21, P9; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Henderson Z, 2010, NEUROSCIENCE, V166, P952, DOI 10.1016/j.neuroscience.2010.01.020; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Howells FM, 2008, BRAIN RES, V1200, P107, DOI 10.1016/j.brainres.2008.01.033; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Joo H, 2016, NICOTINE TOBACCO RES; Karwowski MP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-77; Kessler RC, 2005, J OCCUP ENVIRON MED, V47, P565, DOI 10.1097/01.jom.0000166863.33541.39; Kidani Yuri, 2005, No To Hattatsu, V37, P31; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Li YT, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0972-2; Lin L, 2010, MOL CELL NEUROSCI, V43, P315, DOI 10.1016/j.mcn.2009.12.005; LUBIN JH, 1990, AM J EPIDEMIOL, V131, P552, DOI 10.1093/oxfordjournals.aje.a115530; Luo M, 2014, TOXICOL LETT, V225, P78, DOI 10.1016/j.toxlet.2013.11.025; Martel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020402; McCarthy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032091; Mooney MA, 2016, AM J MED GENET B; Morgan AE, 1996, J AM ACAD CHILD PSY, V35, P325, DOI 10.1097/00004583-199603000-00014; Morgan JE, 2016, J CLIN CHILD ADOLESC, P1; Morgan JF, 2007, EVID-BASED MENT HEAL, V10, P34, DOI 10.1136/ebmh.10.2.34; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Nigg JT, 2016, PSYCHOL SCI, V27, P257, DOI 10.1177/0956797615618365; Nyman ES, 2012, PSYCHIAT GENET, V22, P197, DOI 10.1097/YPG.0b013e32834c0cc8; Oh JE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.130; Pan Y-L, 2003, J NURSING SCI, V18, P891; Pan YQ, 2015, NEUROSCI LETT, V590, P101, DOI 10.1016/j.neulet.2015.01.076; Plomp E, 2009, NEUROSCIENCE, V164, P230, DOI 10.1016/j.neuroscience.2009.07.024; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Ruocco LA, 2009, EUR NEUROPSYCHOPHARM, V19, P693, DOI 10.1016/j.euroneuro.2009.02.005; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Souza RP, 2008, NEUROCHEM INT, V53, P12, DOI 10.1016/j.neuint.2008.04.007; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Spencer T, 1999, PEDIATR CLIN N AM, V46, P915, DOI 10.1016/S0031-3955(05)70163-2; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Vacher H, 2011, PFLUG ARCH EUR J PHY, V462, P631, DOI 10.1007/s00424-011-1004-8; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Wankerl B, 2014, FORTSCHR NEUROL PSYC, V82, DOI 10.1055/s-0033-1355710; Weissflog L, 2013, EUR NEUROPSYCHOPHARM, V23, P436, DOI 10.1016/j.euroneuro.2012.07.017; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005; Xia K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-23; Xiong H, 2004, MOL BRAIN RES, V128, P103, DOI 10.1016/j.molbrainres.2004.06.024; Xiong H, 2009, ACTA BIOCH BIOPH SIN, V41, P295, DOI 10.1093/abbs/gmp013; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhou JM, 2011, BIOL TRACE ELEM RES, V143, P131, DOI 10.1007/s12011-010-8856-1	82	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188678	10.1371/journal.pone.0188678	http://dx.doi.org/10.1371/journal.pone.0188678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176790	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900114
J	Tsai, MC; Cheng, WL; Sheu, JJ; Huang, CC; Shia, BC; Kao, LT; Lin, HC				Tsai, Ming-Chieh; Cheng, Wan-Ling; Sheu, Jau-Jiuan; Huang, Chung-Chien; Shia, Ben-Chang; Kao, Li-Ting; Lin, Herng-Ching			Increased risk of dementia following herpes zoster ophthalmicus	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GENDER-DIFFERENCES; VASCULAR DEMENTIA; STROKE; PREVALENCE; COMMUNITY; ETIOLOGY; FEATURES; SUBTYPES; TAIWAN	This retrospective cohort study aimed to examine the relationship between herpes zoster ophthalmicus (HZO) and the subsequent risk of dementia using a population-based database. We retrieved the study sample from the Taiwan Longitudinal Health Insurance Database 2005. The study group included 846 patients with HZO, and the comparison group included 2538 patients without HZO. Each patient was individually followed for a 5-year period to identify those patients who subsequently received a diagnosis of dementia. We performed a Cox proportional hazards regression to calculate the hazard ratios (HRs) along with 95% confidence intervals (CIs) for dementia during the follow-up period between patients with HZO and comparison patients. The respective incidence rates of dementia per 1000 person-years were 10.15 (95% CI: 7.22 similar to 13.87) and 3.61 (95% CI: 2.61 similar to 4.89) for patients with HZO and comparison patients. The Cox proportional analysis showed that the crude HR of dementia during the 5-year follow-up period was 2.83 (95% CI: 1.83-4.37) for patients with HZO than comparison patients. After adjusting for patients' characteristics and comorbidities, HZO patients were still at a 2.97-fold greater risk than comparison patients for developing dementia. Furthermore, we found that of sampled male patients, the crude HR of dementia for patients with HZO was as high as 3.35 (95% CI = 1.79-6.28) compared to comparison patients. This study demonstrated an association between HZO and dementia. Clinicians must be alert to suspect dementia in patients with cognitive impairment who had prior HZO.	[Tsai, Ming-Chieh] Hsinchu Cathay Gen Hosp, Dept Internal Med, Hsinchu, Taiwan; [Tsai, Ming-Chieh; Huang, Chung-Chien; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Cheng, Wan-Ling] Hsinchu Cathay Gen Hosp, Dept Infect Dis, Hsinchu, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ, Sch Med, Dept Neurol, Coll Med, Taipei, Taiwan; [Shia, Ben-Chang] Taipei Med Univ, Big Data Res Ctr, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Cathay General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; National Defense Medical Center	Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.	henry11111@tmu.edu.tw	Kao, Li-Ting/W-9287-2018; Huang, CC/AAX-5872-2021	Kao, Li-Ting/0000-0003-0692-7408; Huang, CC/0000-0003-0818-7175				[Anonymous], 2013, BIOGENET J; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Bandeira F, 2016, ARQ BRAS OFTALMOL, V79, P126, DOI 10.5935/0004-2749.20160038; Censori B, 1996, STROKE, V27, P1205, DOI 10.1161/01.STR.27.7.1205; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gilden DH, 2002, NEW ENGL J MED, V347, P1500, DOI 10.1056/NEJMoa020841; Gilden D, 2010, CURR TOP MICROBIOL, V342, P243, DOI 10.1007/82_2009_3; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Hellenbrand W, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0160126, 10.1371/journal.pone.0166554]; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kleinschmidt-Demasters BK, 2001, BRAIN PATHOL, V11, P440, DOI 10.1111/j.1750-3639.2001.tb00413.x; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin RT, 1998, J NEUROL SCI, V160, P67, DOI 10.1016/S0022-510X(98)00225-1; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Lopez-Pousa S, 2004, NEUROEPIDEMIOLOGY, V23, P170, DOI 10.1159/000078502; Moroney JT, 1996, STROKE, V27, P1283, DOI 10.1161/01.STR.27.8.1283; Nagel MA, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0407-z; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Ravaglia G, 2005, NEUROLOGY, V64, P1525, DOI 10.1212/01.WNL.0000160107.02316.BF; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; TATEMICHI TK, 1992, NEUROLOGY, V42, P1185, DOI 10.1212/WNL.42.6.1185; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Wiesmann M, 2013, J CEREB BLOOD FLOW M, V33	30	50	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188490	10.1371/journal.pone.0188490	http://dx.doi.org/10.1371/journal.pone.0188490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166672	Green Submitted, gold, Green Published			2022-12-26	WOS:000416035300041
J	Udayappan, SD; Kovatcheva-Datchary, P; Bakker, GJ; Havik, SR; Herrema, H; Cani, PD; Bouter, KE; Belzer, C; Witjes, JJ; Vrieze, A; de Sonnaville, N; Chaplin, A; van Raalte, DH; Aalvink, S; Dallinga-Thie, GM; Heilig, HGHJ; Bergstrom, G; van der Meij, S; van Wagensveld, BA; Hoekstra, JBL; Holleman, F; Stroes, ESG; Groen, AK; Backhed, F; de Vos, WM; Nieuwdorp, M				Udayappan, Shanthadevi D.; Kovatcheva-Datchary, Petia; Bakker, Guido J.; Havik, Stefan R.; Herrema, Hilde; Cani, Patrice D.; Bouter, Kristien E.; Belzer, Clara; Witjes, Julia J.; Vrieze, Anne; de Sonnaville, Noor; Chaplin, Alice; van Raalte, Daniel H.; Aalvink, Steven; Dallinga-Thie, Geesje M.; Heilig, Hans G. H. J.; Bergstrom, Goran; van der Meij, Suzan; van Wagensveld, Bart A.; Hoekstra, Joost B. L.; Holleman, Frits; Stroes, Erik S. G.; Groen, Albert K.; Backhed, Fredrik; de Vos, Willem M.; Nieuwdorp, Max			Intestinal Ralstonia pickettii augments glucose intolerance in obesity	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; GUT MICROBIOTA; GASTROINTESTINAL-TRACT; INSULIN SENSITIVITY; METABOLIC SYNDROME; FAT; IMMUNITY; BACTERIA; TRANSLOCATION; INNATE	An altered intestinal microbiota composition has been implicated in the pathogenesis of metabolic disease including obesity and type 2 diabetes mellitus (T2DM). Low grade inflammation, potentially initiated by the intestinal microbiota, has been suggested to be a driving force in the development of insulin resistance in obesity. Here, we report that bacterial DNA is present in mesenteric adipose tissue of obese but otherwise healthy human subjects. Pyrosequencing of bacterial 16S rRNA genes revealed that DNA from the Gram-negative species Ralstonia was most prevalent. Interestingly, fecal abundance of Ralstonia pickettii was increased in obese subjects with pre-diabetes and T2DM. To assess if R. pickettii was causally involved in development of obesity and T2DM, we performed a proof-of-concept study in diet-induced obese (DIO) mice. Compared to vehicle-treated control mice, R. pickettii-treated DIO mice had reduced glucose tolerance. In addition, circulating levels of endotoxin were increased in R. pickettii-treated mice. In conclusion, this study suggests that intestinal Ralstonia is increased in obese human subjects with T2DM and reciprocally worsens glucose tolerance in DIO mice.	[Udayappan, Shanthadevi D.; Bakker, Guido J.; Havik, Stefan R.; Herrema, Hilde; Bouter, Kristien E.; Witjes, Julia J.; Chaplin, Alice; Dallinga-Thie, Geesje M.; Stroes, Erik S. G.; Groen, Albert K.; Nieuwdorp, Max] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Kovatcheva-Datchary, Petia; Bergstrom, Goran; Backhed, Fredrik; Nieuwdorp, Max] Univ Gothenburg, Sahlgrenska Univ Hosp, Wallenberg Lab, Gothenburg, Sweden; [Cani, Patrice D.] Catholic Univ Louvain, WELBIO Walloon Excellence Life Sci & BIOtechnol, Louvain Drug Res Inst, Brussels, Belgium; [Belzer, Clara; Aalvink, Steven; Heilig, Hans G. H. J.] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Vrieze, Anne; de Sonnaville, Noor; Hoekstra, Joost B. L.; Holleman, Frits; Nieuwdorp, Max] Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [van Raalte, Daniel H.; Nieuwdorp, Max] Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands; [van Raalte, Daniel H.; Nieuwdorp, Max] Vrije Univ Amsterdam, Med Ctr, ICAR, Amsterdam, Netherlands; [van der Meij, Suzan] Flevo Hosp, Dept Surg, Almere, Netherlands; [van Wagensveld, Bart A.] Sint Lucas Andreas Hosp, Dept Surg, Amsterdam, Netherlands; [Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Backhed, Fredrik] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [de Vos, Willem M.] Univ Helsinki, RPU Immunobiol, Helsinki, Finland	University of Amsterdam; Academic Medical Center Amsterdam; Sahlgrenska University Hospital; University of Gothenburg; Universite Catholique Louvain; WELBIO; Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Sint Lucas Andreas Hospital; University of Groningen; Novo Nordisk Foundation; University of Copenhagen; University of Helsinki	Herrema, H; Nieuwdorp, M (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Wallenberg Lab, Gothenburg, Sweden.; Nieuwdorp, M (corresponding author), Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Diabet Ctr, Dept Internal Med, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, ICAR, Amsterdam, Netherlands.	h.j.herrema@amc.uva.nl; m.nieuwdorp@amc.uva.nl	D., Cani Patrice/M-8055-2016; Chaplin, Alice/R-5067-2019; Belzer, Clara/P-6500-2018; Bakker, Guido J./AAE-2743-2020; Backhed, Fredrik/ABE-6613-2020	D., Cani Patrice/0000-0003-2040-2448; Belzer, Clara/0000-0001-6922-836X; Bakker, Guido J./0000-0002-2819-9395; Backhed, Fredrik/0000-0002-4871-8818; Herrema, Hilde/0000-0002-0112-6348; dallinga-thie, geesje/0000-0001-5412-5923; Bergstrom, Goran/0000-0003-4289-5722; Aalvink, Steven/0000-0001-7554-1723; van Raalte, Daniel/0000-0003-2894-6124; Chaplin, Alice/0000-0003-0685-4237	Swedish Research Council; Swedish Diabetes Foundation; Swedish Heart Lung Foundation; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg foundation; Goran Gustafsson Foundation; Ingbritt and Arne Lundberg's foundation; Torsten Soderberg's Foundation; Ragnar Soderberg's Foundation; NovoNordisk Foundation; AFA insurances; LUA-ALF grant from Vastra Gotalandsregionen; LUA-ALF grant from Stockholm County Council; FRFS-WELBIO [WELBIO-CR-2012S-02R]; Funds Baillet Latour; ERC [336452-ENIGMO]; ERC (European Research Council) [615362 - METABASE]; Finland Academy of Sciences [137389, 141140, 1272870]; Netherlands Organization for Scientific Research; European Research Council (ERC) [250172, 632241]; ZONMW-VIDI [016.146.327]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Ingbritt and Arne Lundberg's foundation; Torsten Soderberg's Foundation; Ragnar Soderberg's Foundation; NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); AFA insurances; LUA-ALF grant from Vastra Gotalandsregionen; LUA-ALF grant from Stockholm County Council; FRFS-WELBIO(WELBIO); Funds Baillet Latour; ERC(European Research Council (ERC)European Commission); ERC (European Research Council)(European Research Council (ERC)); Finland Academy of Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)European Commission); ZONMW-VIDI(Netherlands Organization for Health Research and Development); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	F. Backhed is supported by Swedish Research Council, Swedish Diabetes Foundation, Swedish Heart Lung Foundation, Swedish Foundation for Strategic Research, Knut and Alice Wallenberg foundation, Goran Gustafsson Foundation, Ingbritt and Arne Lundberg's foundation, Swedish Heart Lung Foundation, Torsten Soderberg's Foundation, Ragnar Soderberg's Foundation, NovoNordisk Foundation, AFA insurances, and LUA-ALF grants from Vastra Gotalandsregionen and Stockholm County Council. P.D.Cani is a research associate from the FRS-FNRS in Belgium. P.D. Cani is the recipient of FRFS-WELBIO under grant: WELBIO-CR-2012S-02R, the Funds Baillet Latour (Grant for Medical Research 2015), and ERC Starting Grant 2013 (Starting grant 336452-ENIGMO). FB is a recipient of ERC Consolidator Grant (European Research Council, Consolidator grant 615362 - METABASE). WM de Vos is supported by the Finland Academy of Sciences (grants 137389, 141140 and 1272870), the Netherlands Organization for Scientific Research (Spinoza Award and SIAM Gravity Grant) and the European Research Council (ERC Advanced Grant 250172 Microbeslnside and a POC Grant 632241) M. Nieuwdorp is supported by a ZONMW-VIDI grant 2013 (016.146.327). F.B. and G.B. received support in the form of equity from MetaboGen AB, Sweden. M.N. and W.M.deV. received support in the form of equity from Scientific Advisory Board of Caelus Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Bergmark L, 2012, FEMS MICROBIOL LETT, V333, P77, DOI 10.1111/j.1574-6968.2012.02601.x; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Denou E, 2015, EMBO MOL MED, V7, P259, DOI 10.15252/emmm.201404169; Everard A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6648; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fagerberg B, 2011, J INTERN MED, V269, P636, DOI 10.1111/j.1365-2796.2010.02336.x; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kredel LL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00462; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Ryan MP, 2014, EUR J CLIN MICROBIOL, V33, P291, DOI 10.1007/s10096-013-1975-9; Ryan MP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-194; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi L, 2013, BRIT J NUTR, V109, P263, DOI 10.1017/S000711451200116X; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	43	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0181693	10.1371/journal.pone.0181693	http://dx.doi.org/10.1371/journal.pone.0181693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166392	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300001
J	Gibbons, SJ; Grover, M; Choi, KM; Wadhwa, A; Zubair, A; Wilson, LA; Wu, YH; Abell, TL; Hasler, WL; Koch, KL; McCallum, RW; Nguyen, LAB; Parkman, HP; Sarosiek, I; Snape, WJ; Tonascia, J; Hamilton, FA; Pasricha, PJ; Farrugia, G				Gibbons, Simon J.; Grover, Madhusudan; Choi, Kyoung Moo; Wadhwa, Akhilesh; Zubair, Adeel; Wilson, Laura A.; Wu, Yanhong; Abell, Thomas L.; Hasler, William L.; Koch, Kenneth L.; McCallum, Richard W.; Nguyen, Linda A. B.; Parkman, Henry P.; Sarosiek, Irene; Snape, William J.; Tonascia, James; Hamilton, Frank A.; Pasricha, Pankaj J.; Farrugia, Gianrico			Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis	PLOS ONE			English	Article							CHRONIC UNEXPLAINED NAUSEA; MICROSATELLITE POLYMORPHISM; INTERSTITIAL-CELLS; PROMOTER POLYMORPHISMS; ATHEROSCLEROSIS RISK; SYMPTOM SEVERITY; CARBON-MONOXIDE; ASSOCIATION; SUSCEPTIBILITY; SEQUENCES	Background Idiopathic and diabetic gastroparesis in Homo sapiens cause significant morbidity. Etiology or risk factors have not been clearly identified. Failure to sustain elevated heme oxygenase-1 (HO1) expression is associated with delayed gastric emptying in diabetic mice and polymorphisms in the HO1 gene (HMOX1, NCBI Gene ID: 3162) are associated with worse outcomes in other diseases. Aim Our hypothesis was that longer polyGT alleles are more common in the HMOX1 genes of individuals with gastroparesis than in controls without upper gastrointestinal motility disorders. Methods Repeat length was determined in genomic DNA. Controls with diabetes (84 type 1, 84 type 2) and without diabetes (n = 170) were compared to diabetic gastroparetics (99 type 1, 72 type 2) and idiopathic gastroparetics (n = 234). Correlations of repeat lengths with clinical symptom sub-scores on the gastroparesis cardinal symptom index (GCSI) were done. Statistical analyses of short (<29), medium and long (>32) repeat alleles and differences in allele length were used to test for associations with gastroparesis. Results The distribution of allele lengths was different between groups (P = 0.016). Allele lengths were longest in type 2 diabetics with gastroparesis (29.18 +/- 0.35, mean +/- SEM) and longer in gastroparetics compared to non-diabetic controls (28.50 +/- 0.14 vs 27.64 +/- 0.20 GT repeats/allele, P = 0.0008). Type 2 diabetic controls had longer alleles than non-diabetic controls. In all gastroparetic groups, allele lengths were longer in African Americans compared to other racial groups, differences in the proportion of African Americans in the groups accounted for the differences between gastroparetics and controls. Diabetic gastroparetics with 1 or 2 long alleles had worse GCSI nausea sub-scores (3.30 +/- 0.23) as compared to those with 0 long alleles (2.66 +/- 0.12), P = 0.022. Conclusions Longer poly-GT repeats in the HMOX1 gene are more common in African Americans with gastroparesis. Nausea symptoms are worse in subjects with longer alleles.	[Gibbons, Simon J.; Grover, Madhusudan; Choi, Kyoung Moo; Wadhwa, Akhilesh; Zubair, Adeel; Farrugia, Gianrico] Mayo Clin, Enter NeuroSci Program, Rochester, MN 55902 USA; [Wilson, Laura A.; Tonascia, James] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wu, Yanhong] Mayo Clin, Med Genom Program, Rochester, MN USA; [Abell, Thomas L.] Univ Louisville, Louisville, KY 40292 USA; [Hasler, William L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Koch, Kenneth L.] Wake Forest Univ, Winston Salem, NC 27109 USA; [McCallum, Richard W.; Sarosiek, Irene] Texas Tech Univ, El Paso, TX USA; [Nguyen, Linda A. B.] Stanford Univ, Palo Alto, CA 94304 USA; [Parkman, Henry P.] Temple Univ, Philadelphia, PA 19122 USA; [Snape, William J.] Calif Pacific Med Ctr, San Francisco, CA USA; [Hamilton, Frank A.] NIDDK, Bethesda, MD 20892 USA; [Pasricha, Pankaj J.] Johns Hopkins Sch Med, Baltimore, MD USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mayo Clinic; University of Louisville; University of Michigan System; University of Michigan; Wake Forest University; Texas Tech University System; Texas Tech University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; California Pacific Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Farrugia, G (corresponding author), Mayo Clin, Enter NeuroSci Program, Rochester, MN 55902 USA.	Farrugia.gianrico@mayo.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK073974, P01DK068055, U01DK074035, R01DK057061, K23DK103911, P30DK084567, U01DK112193, U24DK074008, U24DK076169, U01DK074008, U01DK074007] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK073974, R01 DK057061, P30 DK084567, U24 DK074008, U01 DK074007, U01 DK112193, U01 DK074008, U01 DK074035, K23 DK103911, P01 DK068055, U24 DK076169] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Angeli TR, 2015, GASTROENTEROLOGY, V149, P56, DOI 10.1053/j.gastro.2015.04.003; Arredondo M, 2007, AM J CLIN NUTR, V86, P1347, DOI 10.1093/ajcn/86.5.1347; Ayuso P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00298; Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; Bernard CE, 2014, NEUROGASTROENT MOTIL, V26, P1275, DOI 10.1111/nmo.12389; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Cherian D, 2012, NEUROGASTROENT MOTIL, V24, P217, DOI 10.1111/j.1365-2982.2011.01828.x; Cherian D, 2010, CLIN GASTROENTEROL H, V8, P676, DOI 10.1016/j.cgh.2010.04.027; Choi KM, 2016, CELL MOL GASTROENTER, V2, P454, DOI 10.1016/j.jcmgh.2016.04.006; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Choung RS, 2012, AM J GASTROENTEROL, V107, P82, DOI 10.1038/ajg.2011.310; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Friedenberg FK, 2013, J CLIN GASTROENTEROL, V47, P757, DOI 10.1097/MCG.0b013e3182819aae; Gibbons SJ, 2013, ALIMENT PHARM THER, V38, P689, DOI 10.1111/apt.12467; Grover M, 2012, NEUROGASTROENT MOTIL, V24, P531, DOI 10.1111/j.1365-2982.2012.01894.x; Guenegou A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039743; Hansson HH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0668-5; Hasler WL, 2007, GASTROENTEROL CLIN N, V36, P619, DOI 10.1016/j.gtc.2007.07.004; Jung HK, 2009, GASTROENTEROLOGY, V136, P1225, DOI 10.1053/j.gastro.2008.12.047; Kashyap PC, 2010, AM J PHYSIOL-GASTR L, V298, pG1013, DOI 10.1152/ajpgi.00069.2010; Kikuchi A, 2005, HUM GENET, V116, P354, DOI 10.1007/s00439-004-1162-2; Kramer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077224; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Ordog T, 2009, Minerva Gastroenterol Dietol, V55, P315; Parkman HP, 2015, GASTROENTEROL CLIN N, V44, P59, DOI 10.1016/j.gtc.2014.11.015; Parkman HP, 2013, JAMA-J AM MED ASSOC, V310, P2640, DOI 10.1001/jama.2013.282833; Parkman HP, 2011, CLIN GASTROENTEROL H, V9, P1056, DOI 10.1016/j.cgh.2011.08.013; Parkman HP, 2004, GASTROENTEROLOGY, V127, P1592, DOI 10.1053/j.gastro.2004.09.055; Pasricha PJ, 2011, CLIN GASTROENTEROL H, V9, P567, DOI 10.1016/j.cgh.2011.03.003; Quinn M, 1996, DIABETOLOGIA, V39, P940; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sambo MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011141; Seu L, 2012, GENES IMMUN, V13, P258, DOI 10.1038/gene.2011.76; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Tiroch K, 2007, EUR HEART J, V28, P968, DOI 10.1093/eurheartj/ehm036; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; WINTERO AK, 1992, GENOMICS, V12, P281, DOI 10.1016/0888-7543(92)90375-3; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	52	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187772	10.1371/journal.pone.0187772	http://dx.doi.org/10.1371/journal.pone.0187772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161307	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000019
J	Grier, MD; West, KL; Kelm, ND; Fu, C; Does, MD; Parker, B; McBrier, E; Lagrange, AH; Ess, KC; Carson, RP				Grier, Mark D.; West, Kathryn L.; Kelm, Nathaniel D.; Fu, Cary; Does, Mark D.; Parker, Brittany; McBrier, Eleanor; Lagrange, Andre H.; Ess, Kevin C.; Carson, Robert P.			Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; CNS MYELINATION; WHITE-MATTER; MAMMALIAN TARGET; RAPAMYCIN; AKT; RICTOR; DIFFERENTIATION; REMYELINATION; INTEGRITY	Myelin abnormalities are increasingly being recognized as an important component of a number of neurologic developmental disorders. The integration of many signaling pathways and cell types are critical for correct myelinogenesis. The PI3-K and mechanistic target of rapamycin (mTOR) pathways have been found to play key roles. mTOR is found within two distinct complexes, mTORC1 and mTORC2. mTORC1 activity has been shown to play a major role during myelination, while the role of mTORC2 is not yet well understood. To determine the role of mTORC2 signaling in myelinogenesis, we generated a mouse lacking the critical mTORC2 component Rictor in oligodendrocyte precursors (OPCs). Targeted deletion of Rictor in these cells decreases and delays the expression of myelin related proteins and reduces the size of cerebral white matter tracts. This is developmentally manifest as a transient reduction in myelinated axon density and g-ratio. OPC cell number is reduced at birth without detectable change in proliferation with proportional reductions in mature oligodendrocyte number at P15. The total number of oligodendrocytes as well as extent of myelination, does improve over time. Adult conditional knock-out (CKO) animals do not demonstrate a behavioral phenotype likely due in part to preserved axonal conduction velocities. These data support and extend prior studies demonstrating an important but transient contribution of mTORC2 signaling to myelin development.	[Grier, Mark D.; Fu, Cary; Parker, Brittany; McBrier, Eleanor; Ess, Kevin C.; Carson, Robert P.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [West, Kathryn L.; Kelm, Nathaniel D.; Does, Mark D.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Lagrange, Andre H.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Carson, RP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	robert.carson@vanderbilt.edu		Fu, Cary/0000-0001-7720-9249; carson, robert/0000-0002-0430-0831	NIH [K08NS083710, R01 NS078289, R01 EB001744]; VA [1101BX001189]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB019980, T32EB014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083710, R01NS078289] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH K08NS083710 to RPC, NIH R01 NS078289 to KCE, NIH R01 EB001744 to MDD, VA 1101BX001189 to AHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Carson RP, 2015, ANN CLIN TRANSL NEUR, V2, P1041, DOI 10.1002/acn3.254; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Ess KC, 2005, NEUROLOGY, V64, P1446, DOI 10.1212/01.WNL.0000158653.81008.49; Fu C, 2012, CEREB CORTEX, V22, P2111, DOI 10.1093/cercor/bhr300; GILLESPIE MJ, 1983, BRAIN RES, V259, P41, DOI 10.1016/0006-8993(83)91065-X; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lundgaard I, 2011, GLIA, V59, pS62; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Peters JM, 2012, ACAD RADIOL, V19, P17, DOI 10.1016/j.acra.2011.08.016; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Simao G, 2010, AM J NEURORADIOL, V31, P1273, DOI 10.3174/ajnr.A2033; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; West K. L., 2016, NEUROIMAGE; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	30	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188417	10.1371/journal.pone.0188417	http://dx.doi.org/10.1371/journal.pone.0188417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161318	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000052
J	Haase, H; Jordan, L; Keitel, L; Keil, C; Mahltig, B				Haase, Hajo; Jordan, Lisa; Keitel, Laura; Keil, Claudia; Mahltig, Boris			Comparison of methods for determining the effectiveness of antibacterial functionalized textiles	PLOS ONE			English	Article							EFFECT PIGMENTS; COTTON FABRICS; SILVER IONS; COATINGS; BACTERIA; GROWTH; COPPER; CELLS; ZINC	Antimicrobial functionalization of textiles is important for various applications, such as protection of textile materials from decomposition, generation of more effective wound dressings, and the prevention of infections or malodors resulting from bacterial growth. In order to test the efficacy of new products, their antibacterial activity needs to be evaluated. At present, several different procedures are being used for this purpose, hindering comparisons among different studies. The present paper compares five of these assays using a sample panel of different textiles functionalized with copper (Cu) and silver (Ag) as antibacterial agents, and discusses the suitability of these methods for different analytical requirements. Bacterial viability was determined by measuring the optical density at 600 nm, a colorimetric assay based on MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide) conversion, an agar diffusion assay, and colony formation, either after culturing in media containing textile samples, or after recovery from textiles soaked with bacterial suspension. All experiments were performed with a Gram-negative (Escherichia coli) and a Gram-positive (Staphylococcus warneri) model organism. In general, the results yielded by the different methods were of good comparability. To identify the most suitable test system for the particular type of antibacterial coating, several factors need to be taken into account, such as choosing appropriate endpoints for analyzing passive or active antibacterial effects, selection of relevant microorganisms, correcting for potential interference by leaching of colored textile coatings, required hands on time, and the necessary sensitivity.	[Haase, Hajo; Jordan, Lisa; Keitel, Laura; Keil, Claudia] Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Chem & Toxicol, Berlin, Germany; [Mahltig, Boris] Univ Appl Sci, Hsch Niederrhein, Fac Text & Clothing Technol, Monchengladbach, Germany	Technical University of Berlin	Haase, H (corresponding author), Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Chem & Toxicol, Berlin, Germany.	Haase@TU-Berlin.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718; Keil, Claudia/0000-0003-0317-0905	German Research Foundation; Technische Universitat Berlin	German Research Foundation(German Research Foundation (DFG)); Technische Universitat Berlin	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of Technische Universitat Berlin.	Aggarwal P, 2010, J BIOMED MATER RES B, V95B, P118, DOI 10.1002/jbm.b.31690; American Association of Textile Chemists and Colorists, 2010, AATCC TECHN MAN, V76, P142; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BOMAN A, 1983, CONTACT DERMATITIS, V9, P159, DOI 10.1111/j.1600-0536.1983.tb04337.x; Du WL, 2009, CARBOHYD POLYM, V75, P385, DOI 10.1016/j.carbpol.2008.07.039; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fernandes JC, 2010, J MICROBIOL BIOTECHN, V20, P311, DOI 10.4014/jmb.0904.04038; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Grethe T, 2015, J COAT TECHNOL RES, V12, P1133, DOI 10.1007/s11998-015-9709-9; Hofer Dirk, 2006, Curr Probl Dermatol, V33, P42; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Li Z, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145702; Mahltig B, 2013, MAT SCI ENG C-MATER, V33, P979, DOI 10.1016/j.msec.2012.11.033; Mahltig B, 2015, J FASHION TEXTILE EN, P1; Mahltig B, 2016, HDB SOL GEL SCI TECH, P1; Mahltig B, 2017, J COAT TECHNOL RES, V14, P35, DOI 10.1007/s11998-016-9854-9; Mahltig B, 2012, J TEXT I, V103, P1262, DOI 10.1080/00405000.2012.665245; Mahltig B, 2011, Z NATURFORSCH B, V66, P905, DOI 10.5560/ZNB.2011.66b0905; Martin A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Hanlon SJ, 2009, INT J ANTIMICROB AG, V33, P427, DOI 10.1016/j.ijantimicag.2008.10.020; Ringot C, 2011, BIOMACROMOLECULES, V12, P1716, DOI 10.1021/bm200082d; Rutala WA, 2004, INFECT CONT HOSP EP, V25, P333, DOI 10.1086/502401; Shrestha R, 2010, NEPAL J SCI TECHNOL, V10, P189; Topp K, 2014, J COAT TECHNOL RES, V11, P943, DOI 10.1007/s11998-014-9605-8; Vilcnik A, 2009, LANGMUIR, V25, P5869, DOI 10.1021/la803742c; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Windler L, 2013, ENVIRON INT, V53, P62, DOI 10.1016/j.envint.2012.12.010	31	32	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188304	10.1371/journal.pone.0188304	http://dx.doi.org/10.1371/journal.pone.0188304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161306	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000042
J	Feito, Y; Hornbuckle, LM; Reid, LA; Crouter, SE				Feito, Yuri; Hornbuckle, Lyndsey M.; Reid, Lauren A.; Crouter, Scott E.			Effect of ActiGraph's low frequency extension for estimating steps and physical activity intensity	PLOS ONE			English	Article							FREE-LIVING ENVIRONMENTS; AFRICAN-AMERICAN WOMEN; ACTIVITY MONITORS; UNITED-STATES; PEDOMETER; ACCELEROMETER; ACCURACY; VALIDITY; WALKING; FILTER	This study examined the effects of the ActiGraph's (AG) low-frequency extension (LFE) filter on steps and physical activity classification in the free-living environment. Thirty-four African-American women (age, 24.5 +/- 5.2 years; BMI, 24.9 +/- 4.5 kg/m(2)) had daily activity measured simultaneously with an AG-GT3X(+) accelerometer and a New Lifestyles NL-800 pedometer for seven days. Steps per day (steps/day) and time (minutes/day) spent in sedentary, light, and moderate-to-vigorous physical activity (MVPA) were examined with and without the LFE filter (AG-LFE and AG-N, respectively). The AG-LFE recorded more total steps (13,723 +/- 4,983 steps/day) compared to AG-N and NL-800 (6,172 +/- 2,838 and 5,817 +/- 3,037 steps/day, respectively; p<0.001). Compared to the AG-N, the AG-LFE estimated less time in sedentary behaviors (518.7 +/- 92.1 vs. 504.2 +/- 105.4 min/day, respectively; p<0.001), and more time in light (247.7 +/- 70.4 vs. 279.1 +/- 74.7 min/day, respectively; p<0.001) and MVPA (18.9 +/- 16.9 vs. 21.5 +/- 18.2 min/day, respectively; p<0.001), respectively. These data suggest that steps and physical activity classifications will be affected when using the ActiGraph with and without the LFE filter. Future research should investigate the accuracy of these measures using the LFE filter.	[Feito, Yuri] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Hornbuckle, Lyndsey M.; Crouter, Scott E.] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Reid, Lauren A.] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University System of Georgia; Kennesaw State University; University of Tennessee System; University of Tennessee Knoxville; University of South Carolina System; University of South Carolina Columbia	Feito, Y (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	yfeito@kennesaw.edu	Crouter, Scott/H-4852-2011; Feito, Yuri/D-8255-2013	Crouter, Scott/0000-0003-1297-9538; Feito, Yuri/0000-0001-6790-6294; Reid, Lauren/0000-0003-1021-8364	Kennesaw State University Office of the Vice President for Research	Kennesaw State University Office of the Vice President for Research	The Kennesaw State University Office of the Vice President for Research funded this project; however, neither the Vice President of research, nor his staff had any role in the data collection or the preparation of this manuscript.	ActiGraph, LOW FREQ EXT EXPL 20; Barreira TV, 2013, J AGING PHYS ACTIV, V21, P402, DOI 10.1123/japa.21.4.402; Bassett DR, 2010, PHYS THER REV, V15, P135, DOI 10.1179/1743288X10Y.0000000004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cain KL, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-51; Crouter SE, 2005, MED SCI SPORT EXER, V37, P1673, DOI 10.1249/01.mss.0000181677.36658.a8; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Feito Y, 2015, MED SCI SPORT EXER, V47, P211, DOI 10.1249/MSS.0000000000000395; Feito Y, 2012, MED SCI SPORT EXER, V44, P733, DOI 10.1249/MSS.0b013e3182351913; Hornbuckle LM, 2005, MED SCI SPORT EXER, V37, P1069, DOI 10.1249/01.mss.0000166575.35311.07; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Newton RL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-44; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Rothney MP, 2008, J APPL PHYSIOL, V105, P1091, DOI 10.1152/japplphysiol.90641.2008; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Swartz AM, 2003, INT J SPORTS MED, V24, P588, DOI 10.1055/s-2003-43272; Toth LP, 2017, GAIT POSTURE, V52, P165, DOI 10.1016/j.gaitpost.2016.11.035; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Wallen MB, 2014, PHYSIOL MEAS, V35, P2287, DOI 10.1088/0967-3334/35/11/2287; Webber SC, 2016, J AGING PHYS ACTIV, V24, P451, DOI 10.1123/japa.2015-0234; Whitt M, 2003, MED SCI SPORT EXER, V35, P1887, DOI 10.1249/01.MSS.0000093618.60631.C3; Whitt-Glover MC, 2017, ETHNIC DIS, V27, P257, DOI 10.18865/ed.27.3.257	27	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188242	10.1371/journal.pone.0188242	http://dx.doi.org/10.1371/journal.pone.0188242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155845	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700037
J	Calvez, ML; Benz, N; Huguet, F; Saint-Pierre, A; Rouille, E; Coraux, C; Ferec, C; Kerbiriou, M; Trouve, P				Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Coraux, Christelle; Ferec, Claude; Kerbiriou, Mathieu; Trouve, Pascal			Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GONADOTROPIN-RELEASING-HORMONE; IN-VITRO; MITOCHONDRIAL-FUNCTION; RECEPTOR EXPRESSION; DELTA-F508 MUTATION; CFTR; CHANNEL; RESCUE; CHAPERONES	Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasians caused by mutations in the gene encoding the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) chloride (Cl-) channel regulated by protein kinases, phosphatases, divalent cations and by protein-protein interactions. Among protein-protein interactions, we previously showed that Annexin A5 (AnxA5) binds to CFTR and is involved in the channel localization within membranes and in its Cl-channel function. The deletion of phenylalanine at position 508 (F508del) is the most common mutation in CF which leads to an altered protein (F508del-CFTR) folding with a nascent protein retained within the ER and is quickly degraded. We previously showed that AnxA5 binds to F508del-CFTR and that its increased expression due to a Gonadoliberin (GnRH) augments Cl-efflux in cells expressing F508del/CFTR. The aim of the present work was to use the GnRH analog buserelin which is already used in medicine. Human nasal epithelial cells from controls and CF patients (F508del/F508del) were treated with buserelin and we show here that the treatment alleviates Clchannel defects in CF cells. Using proteomics we highlighted some proteins explaining this result. Finally, we propose that buserelin is a potential new pharmaceutical compound that can be used in CF and that bronchus can be targeted since we show here that they express GnRH-R.	[Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Ferec, Claude; Kerbiriou, Mathieu; Trouve, Pascal] Univ Brest, INSERM, IBSAM, EFS,Genet Genom Fonct & Biotechnol UMR1078, Brest, France; [Calvez, Marie-Laure; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Ferec, Claude; Kerbiriou, Mathieu] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin] Assoc G Saleun, Brest, France; [Coraux, Christelle] CHU Maison Blanche, Inserm UMRS903, Reims, France; [Ferec, Claude] CHRU Brest, Hop Morvan, Lab Genet Mol, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU de Reims; CHU Brest; Universite de Bretagne Occidentale	Trouve, P (corresponding author), Univ Brest, INSERM, IBSAM, EFS,Genet Genom Fonct & Biotechnol UMR1078, Brest, France.	pascal.trouve@univ-brest.fr	Ferec, Claude/ABG-9699-2020; CORAUX, Christelle/P-5668-2016	Ferec, Claude/0000-0002-2325-0710; CORAUX, Christelle/0000-0001-5345-5074; Huguet, Florentin/0000-0001-5377-8973	association Gaetan Salaun	association Gaetan Salaun	We thank the association Gaetan Salaun for its financial support.	Adam D, 2015, J PATHOL, V235, P408, DOI 10.1002/path.4471; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Atlante A, 2016, J BIOENERG BIOMEMBR, V48, P197, DOI 10.1007/s10863-016-9663-y; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Benz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088964; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bozoky Z, 2017, P NATL ACAD SCI USA, V114, pE2086, DOI 10.1073/pnas.1613546114; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Carlile GW, 2012, CHEM BIOL, V19, P1288, DOI 10.1016/j.chembiol.2012.08.014; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Ciscato F, 2014, ONCOTARGET, V5, P2418, DOI 10.18632/oncotarget.1411; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Farre C, 2007, EXPERT OPIN THER TAR, V11, P557, DOI 10.1517/14728222.11.4.557; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; Valdivieso AG, 2013, REDOX BIOL, V1, P190, DOI 10.1016/j.redox.2012.11.007; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huguet F, 2016, CELL MOL LIFE SCI, V73, P3351, DOI 10.1007/s00018-016-2149-6; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jeanson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108671; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; KERTSCHER U, 1995, J PHARMACOL EXP THER, V273, P709; Khadivi B, 2017, ACTA CIR BRAS, V32, P140, DOI 10.1590/s0102-865020170206; Koushik K, 2004, PHARM RES-DORDR, V21, P1034, DOI 10.1023/B:PHAM.0000029294.70707.74; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; LEMAY A, 1982, FERTIL STERIL, V37, P193; LEMAY A, 1988, AM J OBSTET GYNECOL, V158, P233, DOI 10.1016/0002-9378(88)90128-7; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Naghdi S, 2016, BBA-MOL CELL RES, V1863, P2503, DOI 10.1016/j.bbamcr.2016.04.020; Nederpelt I, 2016, BIOSENS BIOELECTRON, V79, P721, DOI 10.1016/j.bios.2015.12.066; Nederpelt I., 2015, BRIT J PHARMACOL, V173, P128; Nederpelt I, 2016, BRIT J PHARMACOL, V173, P128, DOI 10.1111/bph.13342; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Ohlsson B., 2016, EUR SURG RES, V57, P1; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Perrett Rebecca M, 2013, Front Endocrinol (Lausanne), V4, P180, DOI 10.3389/fendo.2013.00180; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Sun Y, 2017, SEMIN CELL DEV BIOL, V62, P170, DOI 10.1016/j.semcdb.2016.09.005; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tieva A, 2001, PROSTATE, V47, P276; Trouve P, 2007, BBA-MOL BASIS DIS, V1772, P1121, DOI 10.1016/j.bbadis.2007.06.006; Valdivieso AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048059; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wei QQ, 2013, GEN COMP ENDOCR, V189, P15, DOI 10.1016/j.ygcen.2013.04.019; WELSH MJ, 1993, J CELL SCI, P235; Zegarra-Moran O, 2016, CELL MOL LIFE SCI; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187774	10.1371/journal.pone.0187774	http://dx.doi.org/10.1371/journal.pone.0187774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145426	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800029
J	Chang, CK; Chen, CJ; Wu, CC; Chen, SW; Shih, SR; Kuo, RL				Chang, Cheng-Kai; Chen, Chi-Jene; Wu, Chih-Ching; Chen, Shiau-Wen; Shih, Shin-Ru; Kuo, Rei-Lin			Cellular hnRNP A2/B1 interacts with the NP of influenza A virus and impacts viral replication	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; NUCLEOPROTEIN; TRAFFICKING; LOCALIZATION; CARCINOMA; SEQUENCE; MODEL; NS1	The viral ribonucleoprotein (vRNP) of influenza A virus is formed by virion RNA (vRNA), viral polymerase complex, and nucleoprotein (NP). The NP plays an important role in facilitating the replication and stabilization of viral RNA. To explore host factors that may be involved in the regulation of viral replication through interactions with NP, we conducted an immunoprecipitation experiment followed by mass spectrometry to identify NP-associated cellular proteins. Here, we demonstrate that NP can interact and colocalize with heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 in mammalian cells and that the interaction may occur via direct binding to the glycine-rich domain (GRD) of hnRNP A2/B1. In addition, two residues in the tail loop of NP, F412 and R422, are required for the interaction of hnRNP A2/B1. Because the knockdown of hnRNP A2/B1 expression reduces viral RNP activity, hnRNP A2/B1 may act as a positive regulator in viral RNA synthesis of influenza A virus. More importantly, the findings in this research demonstrate that host proteins can regulate the replication of influenza A virus by interacting with NP.	[Chang, Cheng-Kai; Wu, Chih-Ching; Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Chen, Chi-Jene; Chen, Shiau-Wen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Chen, Chi-Jene] China Med Univ Hosp, Res Ctr Emerging Viruses, Taichung, Taiwan; [Wu, Chih-Ching; Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Wu, Chih-Ching] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Mem Hosp, Clin Virol Lab, Taoyuan, Taiwan; [Kuo, Rei-Lin] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.; Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.; Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Shih, SR (corresponding author), Chang Gung Mem Hosp, Clin Virol Lab, Taoyuan, Taiwan.; Kuo, RL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	srshih@mail.cgu.edu.tw; rlkuo@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016	Shih, Shin-Ru/0000-0003-4874-401X; Wu, Chih-Ching/0000-0002-7264-9672	Chang Gung Memorial Hospital [CMRPD1D0041similar to43, BMRP367, CMRPD1E0441similar to43, BMRPC09]; Chang Gung Memorial Hospital (CGMH) [CMRPD1D0041similar to43, BMRP367]; CGMH [CMRPD1E0441similar to43, BMRPC09]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital); CGMH(Chang Gung Memorial Hospital)	This research was supported by grants from Chang Gung Memorial Hospital (https://www.cgmh.org.tw): to SRS (grant numbers: CMRPD1D0041 similar to 43 and BMRP367), and to RLK (grant numbers: CMRPD1E0441 similar to 43 and BMRPC09). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Yizhi Jane Tao and Dr. Ching-Ho Wang for reagents. This research was supported by grants to S.-R. Shih from Chang Gung Memorial Hospital (CGMH) (CMRPD1D0041 similar to 43 and BMRP367), and grants to R.-L. Kuo from the CGMH (CMRPD1E0441 similar to 43 and BMRPC09).	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Han QL, 2014, J VIROL, V88, P9379, DOI 10.1128/JVI.00509-14; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kuo RL, 2016, J VIROL, V90, P4696, DOI 10.1128/JVI.02843-15; Lei KF, 2015, ANAL CHIM ACTA, V883, P37, DOI 10.1016/j.aca.2015.02.071; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Minakuchi M, 2017, J VIROL, V91, DOI 10.1128/JVI.01398-16; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang YM, 2014, VIROLOGY, V449, P53, DOI 10.1016/j.virol.2013.11.009; Wu CC, 2005, PROTEOMICS, V5, P3173, DOI 10.1002/pmic.200401133; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Ye QZ, 2013, MBIO, V4, DOI 10.1128/mBio.00467-12; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhang JS, 2016, J VIROL, V90, P3966, DOI 10.1128/JVI.03137-15	31	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188214	10.1371/journal.pone.0188214	http://dx.doi.org/10.1371/journal.pone.0188214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145464	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800090
J	Shuping, LL; Kuonza, L; Musekiwa, A; Iyaloo, S; Perovic, O				Shuping, Liliwe L.; Kuonza, Lazarus; Musekiwa, Alfred; Iyaloo, Samantha; Perovic, Olga			Hospital-associated methicillin-resistant Staphylococcus aureus: A cross-sectional analysis of risk factors in South African tertiary public hospitals	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; ACTIVE SURVEILLANCE; CLINICAL-OUTCOMES; MRSA INFECTION; BURNS UNIT; BACTEREMIA; COLONIZATION; EPIDEMIOLOGY; PREVALENCE	Introduction Hospital-associated methicillin-resistant S. aureus (HA-MRSA) remains a significant cause of morbidity and mortality worldwide. We conducted a study to determine risk factors for HA-MRSA in order to inform control strategies in South Africa. Methods We used surveillance data collected from five tertiary hospitals in Gauteng and Western Cape provinces during 2014 for analysis. A case of HA-MRSA was defined as isolation of MRSA from a blood culture 48 hours after admission and/or if the patient was hospitalised in the six months prior to the current culture. Multivariable logistic regression modelling was used to determine risk factors for HA-MRSA. Results Of the 9971 patients with positive blood cultures, 7.7% (772) had S. aureus bacteraemia (SAB). The overall prevalence of MRSA among those with SAB was 30.9% (231/747; 95% confidence interval [CI] 27.6%-34.3%). HA-MRSA infections accounted for 28.3% of patients with SAB (207/731; 95% CI 25.1%-31.7%). Burns (adjusted odds ratio [aOR] 12.7; 95% CI 4.7-34.4), age <= 1 month (aOR 8.7; 95% CI 3.0-24.6), residency at a long-term care facility (aOR 5.2; 95% CI, 1.5-17.4), antibiotic use within two months of the current SAB episode (aOR 5.1; 95% CI 2.8-9.1), hospital stay of 13 days or more (aOR 2.8; 95% CI 1.3-5.6) and mechanical ventilation (aOR 2.2; 95% CI 1.07-4.6), were independent risk factors for HA-MRSA infection. Conclusion The prevalence of MRSA remains high in South African tertiary public hospitals. Several identified risk factors of HA-MRSA infections should be considered when instituting infection and prevention strategies in public-sector hospitals, including intensifying the implementation of antimicrobial stewardship programmes. There is an urgent need to strengthen infection prevention and control in burn wards, neonatal wards, and intensive care units which house mechanically ventilated patients.	[Shuping, Liliwe L.; Kuonza, Lazarus] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Shuping, Liliwe L.; Kuonza, Lazarus] Natl Inst Communicable Dis, Natl Hlth Lab Serv, South African Field Epidemiol Training Programme, Johannesburg, South Africa; [Shuping, Liliwe L.; Perovic, Olga] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Res, Johannesburg, South Africa; [Musekiwa, Alfred] Ctr Dis Control & Prevent, Pretoria, South Africa; [Iyaloo, Samantha] Natl Hlth Lab Serv, Natl Inst Occupat Hlth, Johannesburg, South Africa; [Perovic, Olga] Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; University of Witwatersrand	Perovic, O (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Res, Johannesburg, South Africa.; Perovic, O (corresponding author), Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa.	olgap@nicd.ac.za	Perovic, Olga/AAN-8276-2021	Musekiwa, Alfred/0000-0001-5880-3680; Iyaloo, Samantha/0000-0003-3332-9235; Shuping, Liliwe/0000-0002-1428-779X; Kuonza, Lazarus/0000-0001-5338-320X				Abbasi-Montazeri E, 2013, BURNS, V39, P650, DOI 10.1016/j.burns.2013.02.005; Antonanzas F, 2015, PHARMACOECONOMICS, V33, P285, DOI 10.1007/s40273-014-0242-y; Bahemia IA, 2015, BURNS, V41, P1536, DOI 10.1016/j.burns.2015.05.007; Barbut F, 2013, BURNS, V39, P395, DOI 10.1016/j.burns.2012.07.007; Bhat V. G., 2010, Southern African Journal of Epidemiology & Infection, V25, P16; Boyles TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079747; Brink AJ, 2016, LANCET INFECT DIS, P30012; Campbell RS, 2015, SURG INFECT, V16, P543, DOI 10.1089/sur.2013.250; Carnicer-Pont D, 2006, EPIDEMIOL INFECT, V134, P1167, DOI 10.1017/S0950268806006327; Catry B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089579; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; Fortuin-de Smidt MC, 2015, INT J INFECT DIS, V30, P41, DOI 10.1016/j.ijid.2014.10.011; Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009; Hu BJ, 2013, AM J INFECT CONTROL, V41, P301, DOI 10.1016/j.ajic.2012.03.037; Issler-Fisher AC, 2015, BURNS, V41, P1212, DOI 10.1016/j.burns.2015.03.003; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaiser ML, 2011, J BURN CARE RES, V32, P429, DOI 10.1097/BCR.0b013e318217f92d; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Lawes T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000797; Luzzaro F, 2011, DIAGN MICR INFEC DIS, V69, P363, DOI 10.1016/j.diagmicrobio.2010.10.016; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mendelson M, 2015, MONITORING SURVEILLA, P54; Morrill HJ, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.013; Naidoo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078396; Nelson MU, 2012, SEMIN PERINATOL, V36, P424, DOI 10.1053/j.semperi.2012.06.004; Oztoprak N, 2006, AM J INFECT CONTROL, V34, P1, DOI 10.1016/j.ajic.2005.07.005; Perovic O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145429; Popoola VO, 2014, INFECT CONT HOSP EP, V35, P412, DOI 10.1086/675594; Safdar N, 2006, AM J INFECT CONTROL, V34, P476, DOI 10.1016/j.ajic.2006.01.011; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Swe Swe-Han K, 2010, INT J INFECT CONTROL, V6, P2; Tekin R, 2013, PEDIATR NEONATOL, V54, P303, DOI 10.1016/j.pedneo.2013.03.011; Thampi N, 2015, AM J INFECT CONTROL, V43, P739, DOI 10.1016/j.ajic.2015.01.031; Traa MX, 2014, CRIT CARE MED, V42, P2151, DOI 10.1097/CCM.0000000000000501; Wayne P.A., 2014, M100S24 CLSI; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x; WHO, 2011, WHO LIB CAT PUBL DAT; Zigmond J, 2014, INT J INFECT DIS, V21, P391, DOI 10.1016/j.ijid.2014.03.1227	41	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188216	10.1371/journal.pone.0188216	http://dx.doi.org/10.1371/journal.pone.0188216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145465	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800091
J	Hashiramoto, A; Konishi, Y; Murayama, K; Kawasaki, H; Yoshida, K; Tsumiyama, K; Tanaka, K; Mizuhara, M; Shiotsuki, T; Kitamura, H; Komai, K; Kimura, T; Yagita, H; Shiozawa, K; Shiozawa, S				Hashiramoto, Akira; Konishi, Yoshitake; Murayama, Koichi; Kawasaki, Hiroki; Yoshida, Kohsuke; Tsumiyama, Ken; Tanaka, Kimie; Mizuhara, Masaru; Shiotsuki, Toshio; Kitamura, Hitomi; Komai, Koichiro; Kimura, Tomoatsu; Yagita, Hideo; Shiozawa, Kazuko; Shiozawa, Shunichi			A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; arthritis; caspase; death domain; lymphocyte	TNF-LIKE LIGAND; DOMAIN-CONTAINING RECEPTOR; GENOME-WIDE ASSOCIATION; CYTOKINE 1A TL1A; DECOY RECEPTOR-3; FAS GENE; SUSCEPTIBILITY LOCI; CIRCULATING LEVELS; CROHNS-DISEASE; DR3	Rheumatoid arthritis (RA) is a chronic polyarthritis of unknown etiology. To unravel the molecular mechanisms in RA, we performed targeted DNA sequencing analysis of patients with RA. This analysis identified a variant of the death receptor 3 (DR3) gene, a member of the family of apoptosis-inducing Fas genes, which contains four single-nucleotide polymorphisms (SNPs) and a 14-nucleotide deletion within exon 5 and intron 5. We found that the deletion causes the binding of splicing regulatory proteins to DR3 pre-mRNA intron 5, resulting in a portion of intron 5 becoming part of the coding sequence, thereby generating a premature stop codon. We also found that this truncated DR3 protein product lacks the death domain and forms a heterotrimer complex with wildtype DR3 that dominant-negatively inhibits ligand-induced apoptosis in lymphocytes. Myelocytes from transgenic mice expressing the human DR3 variant produced soluble truncated DR3, forming a complex with TNF-like ligand 1A (TL1A), which inhibited apoptosis induction. In summary, our results reveal that a DR3 splice variant that interferes with ligand-induced T cell responses and apoptosis may contribute to RA pathogenesis.	[Hashiramoto, Akira; Konishi, Yoshitake; Murayama, Koichi; Kawasaki, Hiroki; Yoshida, Kohsuke; Tanaka, Kimie; Mizuhara, Masaru; Shiotsuki, Toshio; Kitamura, Hitomi; Komai, Koichiro] Kobe Univ, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Tsumiyama, Ken; Shiozawa, Shunichi] Kyushu Univ, Beppu Hosp, Rheumat Dis Unit, Dept Med, 4546 Tsurumihara, Beppu, Oita 8740838, Japan; [Kimura, Tomoatsu] Toyama Univ, Dept Orthoped Surg, Fac Med, 3190 Gofuku, Toyama 9300194, Japan; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138431, Japan; [Shiozawa, Kazuko] Hyogo Prefectural Kakogawa Med Ctr, Dept Rheumatol, Kakogawa, Hyogo 6758555, Japan	Kobe University; Kyushu University; University of Toyama; Juntendo University	Shiozawa, S (corresponding author), Kyushu Univ, Beppu Hosp, Rheumat Dis Unit, Dept Med, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	shiozawa@port.kobe-u.ac.jp	Komai, Koichiro/L-1633-2019; Shiozawa, Shunichi/W-2992-2019	Komai, Koichiro/0000-0003-0015-5283; 				Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bamias G, 2013, CLIN IMMUNOL, V147, P144, DOI 10.1016/j.clim.2013.03.002; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Borysenko CW, 2005, BIOCHEM BIOPH RES CO, V328, P794, DOI 10.1016/j.bbrc.2005.01.017; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fukao T, 2010, MOL GENET METAB, V100, P339, DOI 10.1016/j.ymgme.2010.03.012; Genetta T, 2001, J BIOL CHEM, V276, P25589, DOI 10.1074/jbc.M011637200; Hayashi S, 2007, ARTHRITIS RHEUM, V56, P1067, DOI 10.1002/art.22494; Jin S, 2013, MUCOSAL IMMUNOL, V6, P886, DOI 10.1038/mi.2012.124; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Konsta M, 2013, RHEUMATOLOGY, V52, P448, DOI 10.1093/rheumatology/kes316; Li L, 2014, ARCH DERMATOL RES, V306, P927, DOI 10.1007/s00403-014-1497-z; Liu JH, 2002, BLOOD, V100, P1449, DOI 10.1182/blood.V100.4.1449.h81602001449_1449_1453; Lu ZX, 2007, HUM MUTAT, V28, P978, DOI 10.1002/humu.20547; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meusch U, 2015, ARTHRITIS RHEUMATOL, V67, P1760, DOI 10.1002/art.39138; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Osawa K, 2004, GENES IMMUN, V5, P439, DOI 10.1038/sj.gene.6364097; Otsuki T, 2000, IMMUNOL LETT, V72, P137, DOI 10.1016/S0165-2478(00)00177-2; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Peng R, 2002, RNA, V8, P1334, DOI 10.1017/S1355838202022070; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Schreiber TH, 2010, J CLIN INVEST, V120, P3629, DOI 10.1172/JCI42933; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Siakavellas SI, 2015, SEMIN ARTHRITIS RHEU, V45, P1, DOI 10.1016/j.semarthrit.2015.02.007; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sun X, 2013, SCAND J RHEUMATOL, V42, P97, DOI 10.3109/03009742.2012.727026; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takami N, 2006, ARTHRITIS RHEUM-US, V54, P779, DOI 10.1002/art.21637; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; van Doorn R, 2002, CANCER RES, V62, P5389; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Xiu ZJ, 2015, CYTOKINE, V72, P185, DOI 10.1016/j.cyto.2014.12.026; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zinovieva E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000528	62	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1933	1943		10.1074/jbc.M117.798884	http://dx.doi.org/10.1074/jbc.M117.798884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29180447	hybrid, Green Published			2022-12-26	WOS:000424948000009
J	Zhou, L; Todorovic, V; Kakavas, S; Sielaff, B; Medina, L; Wang, LY; Sadhukhan, R; Stockmann, H; Richardson, PL; DiGiammarino, E; Sun, CH; Scott, V				Zhou, Li; Todorovic, Viktor; Kakavas, Steve; Sielaff, Bernhard; Medina, Limary; Wang, Leyu; Sadhukhan, Ramkrishna; Stockmann, Henning; Richardson, Paul L.; DiGiammarino, Enrico; Sun, Chaohong; Scott, Victoria			Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; kinetics; protein-protein interaction; signaling; surface plasmon resonance (SPR); IL-1Rrp2; IL-36R	PSORIASIS; SKIN; INFLAMMATION; IL-36-GAMMA; AGONIST; IL-1F9	IL-36 cytokines signal through the IL-36 receptor (IL-36R) and a shared subunit, IL-1RAcP (IL-1 receptor accessory protein). The activation mechanism for the IL-36 pathway is proposed to be similar to that of IL-1 in that an IL-36R agonist (IL-36, IL-36, or IL-36) forms a binary complex with IL-36R, which then recruits IL-1RAcP. Recent studies have shown that IL-36R interacts with IL-1RAcP even in the absence of an agonist. To elucidate the IL-36 activation mechanism, we considered all possible binding events for IL-36 ligands/receptors and examined these events in direct binding assays. Our results indicated that the agonists bind the IL-36R extracellular domain with micromolar affinity but do not detectably bind IL-1RAcP. Using surface plasmon resonance (SPR), we found that IL-1RAcP also does not bind IL-36R when no agonist is present. In the presence of IL-36, however, IL-1RAcP bound IL-36R strongly. These results suggested that the main pathway to the IL-36R<bold>IL</bold>-36<bold>IL</bold>-1RAcP ternary complex is through the IL-36R<bold>IL</bold>-36 binary complex, which recruits IL-1RAcP. We could not measure the binding affinity of IL-36R to IL-1RAcP directly, so we engineered a fragment crystallizable-linked construct to induce IL-36R<bold>IL</bold>-1RAcP heterodimerization and predicted the binding affinity during a complete thermodynamic cycle to be 74 m. The SPR analysis also indicated that the IL-36R antagonist IL-36Ra binds IL-36R with higher affinity and a much slower off rate than the IL-36R agonists, shedding light on IL-36 pathway inhibition. Our results reveal the landscape of IL-36 ligand and receptor interactions, improving our understanding of IL-36 pathway activation and inhibition.	[Zhou, Li; Sielaff, Bernhard; Medina, Limary; Wang, Leyu; Sadhukhan, Ramkrishna] AbbVie Biores Ctr, Worcester, MA 01605 USA; [Todorovic, Viktor; Kakavas, Steve; Stockmann, Henning; Richardson, Paul L.; DiGiammarino, Enrico; Sun, Chaohong; Scott, Victoria] AbbVie Inc, Abbott Pk, IL 60064 USA	AbbVie; AbbVie	Zhou, L (corresponding author), AbbVie, 100 Res Dr, Worcester, MA 01605 USA.	li.zhou@abbvie.com	Zhou, Li/S-5449-2019; Stockmann, Henning/A-1891-2012	Zhou, Li/0000-0002-9683-3562; Todorovic, Viktor/0000-0002-1428-6973; Stockmann, Henning/0000-0002-2409-5476	AbbVie Inc.; AbbVie	AbbVie Inc.(AbbVie); AbbVie(AbbVie)	This work was supported by AbbVie Inc. All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Dietrich D, 2014, NAT REV RHEUMATOL, V10, P639, DOI 10.1038/nrrheum.2014.156; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; JOBLING SA, 1988, J BIOL CHEM, V263, P16372; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Sims JE, 2010, NAT IMMUNOL, V11, P883, DOI 10.1038/ni1010-883; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stockmann H, 2017, J AM CHEM SOC, V139, P16822, DOI 10.1021/jacs.7b09359; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Yi GH, 2016, J BIOL CHEM, V291, P16597, DOI 10.1074/jbc.M116.723064	20	23	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					403	411		10.1074/jbc.M117.805739	http://dx.doi.org/10.1074/jbc.M117.805739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29180446	Green Published, hybrid			2022-12-26	WOS:000419915400001
J	Al-Rubeaan, K; Almashouq, MK; Youssef, AM; Al-Qumaidi, H; Al Derwish, M; Ouizi, S; Al-Shehri, K; Masoodi, SN				Al-Rubeaan, Khalid; Almashouq, Mohammad K.; Youssef, Amira M.; Al-Qumaidi, Hamid; Al Derwish, Mohammad; Ouizi, Samir; Al-Shehri, Khalid; Masoodi, Saba N.			All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; DISEASE; PRESERVATION; ULCERATION; NEUROPATHY; SURVIVAL; ILLNESS	Background Although Diabetes mellitus is a major public health problem in the Middle East and North Africa (MENA) region with high rates of diabetic foot complications, there are only limited data concerning mortality among such a high risk group. Therefore, the main aim of the current study was to assess all-cause mortality and its related predictors among diabetic patients with and without diabetic foot complications. Methods Using data from the Saudi National Diabetes Registry (SNDR), a total of 840 patients with type 1 or type 2 diabetes aged >= 25 years with current or past history of diabetic foot ulcer (DFU) or diabetes related lower extremity amputation (LEA) were recruited in 2007 from active patients' files and followed up to 2013. These patients were compared with an equal number of age and gender matched diabetic patients without foot complication recruited at the same period. All patients were subjected to living status verification at 31st December 2013. Results The all-cause mortality rate among patients with DFU was 42.54 per 1000 person-years and among LEA patients was 86.80 per 1000 person-years among LEA patients for a total of 2280 and 1129 person-years of follow up respectively. The standardized mortality ratio (SMR) (95% CI) was 4.39 (3.55-5.23) and 7.21 (5.70-8.72) for cases with foot ulcer and LEA respectively. The percentage of deceased patients increased by almost twofold (18.5%) among patients with diabetic foot ulcer and more than threefold (32.2%) among patients with LEA compared with patients without diabetic foot complications (10.7%). The worst survival was among patients with LEA at 0.679 and the presence of diabetic nephropathy was the only significant independent risk factor for all-cause mortality among patients with diabetic foot complications. On the other hand, obese patients have demonstrated significantly reduced all-cause mortality rate. Conclusions Diabetic patients with diabetic foot complications have an excess mortality rate when compared with diabetic counterparts without foot complications and the general population. Early interventions to prevent foot ulceration and consequent LEA as well as all the measurements for reducing the prevalence of microvascular and macrovascular complications should be considered.	[Al-Rubeaan, Khalid; Al-Qumaidi, Hamid; Al-Shehri, Khalid; Masoodi, Saba N.] King Saud Univ, Univ Diabet Ctr, Coll Med, Riyadh, Saudi Arabia; [Almashouq, Mohammad K.] King Saud Univ, Coll Med, Riyadh, Saudi Arabia; [Youssef, Amira M.] King Saud Univ, Univ Diabet Ctr, Registry Dept, Riyadh, Saudi Arabia; [Al Derwish, Mohammad; Ouizi, Samir] King Saud Univ, Univ Diabet Ctr, Diabet Foot Unit, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Saud University	Al-Rubeaan, K (corresponding author), King Saud Univ, Univ Diabet Ctr, Coll Med, Riyadh, Saudi Arabia.	krubeaan@dsrcenter.org	Youssef, Amira/AAZ-8030-2021	Youssef, Amira/0000-0002-8407-0924; Al-Rubeaan, Khalid/0000-0003-3615-7192	King Abdulaziz city for science and technology (KACST)	King Abdulaziz city for science and technology (KACST)	This project was funded by King Abdulaziz city for science and technology (KACST). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2005, DIABETES CARE, V28, P1869, DOI 10.2337/diacare.28.8.1869; Akbar DH, 2000, SAUDI MED J, V21, P433; Al-Rubeaan K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4132589; Al-Rubeaan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124446; Al-Rubeaan KA, 2013, J MED INTERNET RES, V15, P291, DOI 10.2196/jmir.2722; Al-Wahbi AM, 2006, SAUDI MED J, V27, P147; Alwakeel JS, 2009, SAUDI J KIDNEY DIS T, V20, P402; [Anonymous], 2015, WORLD REP 2015; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; Bassiony MM, 2009, SAUDI MED J, V30, P876; Biasucci LM, 2010, AM J MED, V123, P727, DOI 10.1016/j.amjmed.2010.02.016; Brownrigg JRW, 2012, DIABETOLOGIA, V55, P2906, DOI 10.1007/s00125-012-2673-3; Brownrigg JRW, 2014, J VASC SURG, V60, P982, DOI 10.1016/j.jvs.2014.04.052; Chammas NK, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2879809; Chaturvedi N, 2001, DIABETOLOGIA, V44, pS65, DOI 10.1007/PL00002941; Cheng YLJ, 2006, AM J EPIDEMIOL, V164, P873, DOI 10.1093/aje/kwj281; Ebskov LB, 1996, PROSTHET ORTHOT INT, V20, P147; El-Asrar AMA, 1998, INT OPHTHALMOL, V22, P155, DOI 10.1023/A:1006240928938; Gu YJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060559; Hjelm K, 2002, J ADV NURS, V40, P673, DOI 10.1046/j.1365-2648.2002.02427.x; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Cardenas MK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1141-4; Lacle A, 2012, REV PANAM SALUD PUBL, V32, P192, DOI 10.1590/S1020-49892012000900004; LARSSON LG, 1987, ARTHRITIS RHEUM, V30, P1426, DOI 10.1002/art.1780301216; Lavery LA, 2010, DIABETES CARE, V33, P2365, DOI 10.2337/dc10-1213; Lin CW, 2017, J DIABETES COMPLICAT, V31, P180, DOI 10.1016/j.jdiacomp.2016.09.011; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; NEIL HAW, 1989, DIABETIC MED, V6, P608, DOI 10.1111/j.1464-5491.1989.tb01237.x; Nelzen O, 1997, EUR J VASC ENDOVASC, V13, P500, DOI 10.1016/S1078-5884(97)80179-7; Resnick HE, 2004, DIABETES CARE, V27, P1286, DOI 10.2337/diacare.27.6.1286; Sohn MW, 2012, OBESITY, V20, P460, DOI 10.1038/oby.2011.301; Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598; Tseng Chin-Hsiao, 1994, Journal of the Formosan Medical Association, V93, P842; Walsh JW, 2016, DIABETIC MED, V33, P1493, DOI 10.1111/dme.13054; World Health Organization, 2014, NONC DIS NCD COUNTR	35	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188097	10.1371/journal.pone.0188097	http://dx.doi.org/10.1371/journal.pone.0188097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176889	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900037
J	Spina, A; Lenglet, A; Beversluis, D; de Jong, M; Vernier, L; Spencer, C; Andayi, F; Kamau, C; Vollmer, S; Hogema, B; Irwin, A; Yary, RN; Ali, AM; Moussa, A; Alfani, P; Sang, S				Spina, Alexander; Lenglet, Annick; Beversluis, David; de Jong, Marja; Vernier, Larissa; Spencer, Craig; Andayi, Fred; Kamau, Charity; Vollmer, Simone; Hogema, Boris; Irwin, Andrea; Yary, Roger Ngueremi; Ali, Acyl Mahamat; Moussa, Ali; Alfani, Prince; Sang, Sibylle			A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017	PLOS ONE			English	Article							NORTHERN UGANDA; SOUTH SUDAN; MORTALITY; REFUGEES; DARFUR	Background In September 2016, three acutely jaundiced (AJS) pregnant women were admitted to Am Timan Hospital, eastern Chad. We described the outbreak and conducted a case test-negative study to identify risk factors for this genotype of HEV in an acute outbreak setting. Methods Active case finding using a community based surveillance network identified suspected AJS cases. Pregnant or visibly ill AJS cases presenting at hospital were tested with Assure (R) IgM HEV rapid diagnostic tests (RDTs) and some with Polymerase Chain Reaction (PCR) in Amsterdam; confirmed cases were RDT-positive and controls were RDT-negative. All answered questions around: demographics, household makeup, area of residence, handwashing practices, water collection behaviour and clinical presentation. We calculated unadjusted odds ratios (ORs) and 95% confidence intervals (95% CI). Results Between September and April 2017, 1443 AJS cases (1293 confirmed) were detected in the town(attack rate: 2%; estimated 65,000 population). PCR testing confirmed HEV genotype 1e. HEV RDTs were used for 250 AJS cases; 100 (40%) were confirmed. Risk factors for HEV infection, included: having at least two children under the age of 5 years (OR 2.1, 95% CI 1.1-4.3), having another household member with jaundice (OR 2.4, 95% CI 0.90-6.3) and, with borderline significance, living in the neighbourhoods of Riad (OR 3.8, 95% CI 1.0-1.8) or Ridina (OR 3.3, 95% CI 1.0-12.6). Cases were more likely to present with vomiting (OR 3.2, 9% CI 1.4-7.9)than controls; possibly due to selection bias. Cases were non-significantly less likely to report always washing hands before meals compared with controls (OR 0.33, 95% CI 0.1-1.1). Discussion Our study suggests household factors and area of residence (possibly linked to access to water and sanitation) play a role in HEV transmission; which could inform future outbreak responses. Ongoing sero-prevalence studies will elucidate more aspects of transmission dynamics of this virus with genotype 1e.	[Spina, Alexander; Beversluis, David; de Jong, Marja; Vernier, Larissa; Spencer, Craig; Andayi, Fred; Vollmer, Simone; Irwin, Andrea; Yary, Roger Ngueremi; Alfani, Prince] OCA, Med Sans Frontieres, Ndjamena, Chad; [Spina, Alexander] EPIET, European Ctr Dis Prevent & Control, ECDC, Stockholm, Sweden; [Spina, Alexander] Austrian Agcy Hlth & Food Safety, Dept Infect Dis Epidemiol & Surveillance, Vienna, Austria; [Lenglet, Annick; Kamau, Charity; Sang, Sibylle] OCA, Med Sans Frontieres, Amsterdam, Netherlands; [Hogema, Boris] Sanquin Blood Supply, Dept Virol, Amsterdam, Netherlands; [Ali, Acyl Mahamat; Moussa, Ali] Minist Sante Publ, Ndjamena, Chad	European Centre for Disease Prevention & Control; Doctors Without Borders	Lenglet, A (corresponding author), OCA, Med Sans Frontieres, Amsterdam, Netherlands.	annick.lenglet@amsterdam.msf.org	Lenglet, Annick/R-2309-2019; ANDAYI, Fred/ABF-2652-2020	Lenglet, Annick/0000-0003-2013-8405; ANDAYI, Fred/0000-0003-0768-9894; Spina, Alexander/0000-0001-8425-1867	MSF-OCA	MSF-OCA	All outbreak response activities described in this article were funded by MSF-OCA. Thus the surveillance data that we used for this study was from this humanitarian outbreak response activity. We designed the study within the operational context of this outbreak of hepatitis E. MSF-OCA had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors received no specific funding for this work.	Ahmed JA, 2013, EMERG INFECT DIS, V19, P1010, DOI 10.3201/eid1906.130275; Bechir M, 2012, ECOHEALTH, V9, P122, DOI 10.1007/s10393-011-0727-5; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Browne LB, 2015, MMWR-MORBID MORTAL W, V64, P537; Coursaget P, 1998, AM J TROP MED HYG, V58, P330, DOI 10.4269/ajtmh.1998.58.330; COURSAGET P, 1993, J MED VIROL, V39, P163, DOI 10.1002/jmv.1890390214; Cummings MJ, 2014, T ROY SOC TROP MED H, V108, P648, DOI 10.1093/trstmh/tru123; Fogeda M, 2009, J CLIN VIROL, V45, P259, DOI 10.1016/j.jcv.2009.05.022; Gerbi GB, 2015, AM J TROP MED HYG, V92, P411, DOI 10.4269/ajtmh.14-0196; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Haffar S, 2015, LIVER INT, V35, P311, DOI 10.1111/liv.12590; Hepatitis E, 2004, WKLY EPIDEMIOL REC, V79, P313; Howard CM, 2010, AM J TROP MED HYG, V83, P1170, DOI 10.4269/ajtmh.2010.10-0384; Kumar S, 2013, INT J INFECT DIS, V17, pE228, DOI 10.1016/j.ijid.2012.11.026; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; Lee GH, 2016, GASTROENTEROLOGY, V150, P355, DOI 10.1053/j.gastro.2015.10.048; Mast EE., 1994, HEPATITIS REFUGEES K, P375; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Patel RC, 2015, J CLIN VIROL, V73, P112, DOI 10.1016/j.jcv.2015.11.001; Pischke S, 2017, ANN HEPATOL, V16, P57, DOI 10.5604/16652681.1226815; Skowronski DM, 2013, EURO SURVEILL, V18; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764; Thomson K, 2013, MMWR-MORBID MORTAL W, V62, P581; van Cuyck H, 2003, FEMS IMMUNOL MED MIC, V39, P133, DOI 10.1016/S0928-8244(03)00241-4	26	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188240	10.1371/journal.pone.0188240	http://dx.doi.org/10.1371/journal.pone.0188240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176816	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900048
J	Surie, D; Yuhas, K; Wilson, K; Masese, LN; Shafi, J; Kinuthia, J; Jaoko, W; McClelland, RS				Surie, Diya; Yuhas, Krista; Wilson, Kate; Masese, Linnet N.; Shafi, Juma; Kinuthia, John; Jaoko, Walter; McClelland, R. Scott			Association between non-barrier modern contraceptive use and condomless sex among HIV-positive female sex workers in Mombasa, Kenya: A prospective cohort analysis	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; UNPROTECTED SEX; ALCOHOL-USE; RISK; IDENTIFICATION; BEHAVIORS; HEALTH	Background As access to antiretroviral therapy in sub-Saharan Africa continues to expand, more women with HIV can expect to survive through their reproductive years. Modern contraceptives can help women choose the timing and spacing of childbearing. However, concerns remain that women with HIV who use non-barrier forms of modern contraception may engage in more condomless sex because of their decreased risk of unintended pregnancy. We examined whether non-barrier modern contraceptive use by HIV-positive female sex workers was associated with increased frequency of recent condomless sex, measured by detection of prostate-specific antigen (PSA) in vaginal secretions. Methods Women who were HIV-positive and reported transactional sex were included in this analysis. Pregnant and post-menopausal follow-up time was excluded, as were visits at which women reported trying to get pregnant. At enrollment and quarterly follow-up visits, a pelvic speculum examination with collection of vaginal secretions was conducted for detection of PSA. In addition, women completed a structured face-to-face interview about their current contraceptive methods and sexual risk behavior at enrollment and monthly follow-up visits. Log-binomial generalized estimating equations regression was used to test for associations between non-barrier modern contraceptive use and detection of PSA in vaginal secretions and self-reported condomless sex. Data from October 2012 through September 2014 were included in this analysis. Results Overall, 314 women contributed 1,583 quarterly examination visits. There was minimal difference in PSA detection at contraceptive-exposed versus contraceptive-unexposed visits (adjusted relative risk [aRR] 1.28, 95% confidence interval [95% CI] 0.93-1.76). There was a higher rate of self-reported condomless sex at visits where women reported using modern contraceptives, but this difference was not statistically significant after adjustment for potential confounding factors (aRR 1.59, 95% CI 0.98-2.58). Conclusion Non-barrier methods of modern contraception were not associated with increased risk of objective evidence of condomless sex.	[Surie, Diya; Masese, Linnet N.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Yuhas, Krista; Wilson, Kate; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Shafi, Juma; McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Kinuthia, John] Kenyatta Natl Hosp, Dept Res & Programs, Nairobi, Kenya; [Kinuthia, John] Kenyatta Natl Hosp, Dept Reprod Hlth, Nairobi, Kenya; [Jaoko, Walter] Univ Nairobi, Kenya AIDS Vaccine Initiat Inst, Nairobi, Kenya; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenyatta National Hospital; Kenyatta National Hospital; University of Nairobi; University of Washington; University of Washington Seattle	McClelland, RS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; McClelland, RS (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; McClelland, RS (corresponding author), Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.; McClelland, RS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	mcclell@uw.edu	Jaoko, Walter/AAN-5048-2020	Jaoko, Walter/0000-0002-7134-6581; Masese, Linnet/0000-0003-4704-9154; McClelland, Raymond Scott/0000-0003-2574-4201	National Institutes of Health [R01-HD72617]; University of Washington Center for AIDS Research [P30-A1-27757]; NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NIA); NIH (NIGMS); NIH (NIDDK)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (grant R01-HD72617)-RSM. Additional support for the Mombasa Field Site was received from the University of Washington Center for AIDS Research (grant P30-A1-27757), an NIH funded program, which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GUIDELINES USE ANTIR; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Goyette MS, 2016, J ACQUIR IMMUNE DEFI; Heffron R, 2010, SEX TRANSM DIS, V37, P621, DOI 10.1097/OLQ.0b013e3181e1a162; Hochmeister MN, 1999, J FORENSIC SCI, V44, P1057; Joint United Nations Programme on HIV/ AIDS, 2016, PREV GAP REP; Joint United Nations Programme on HIV/AIDS, 2014, CONS GUID HIV PREV D; Joint United Nations Programme on HIV/ AIDS ( UNAIDS), 2014, FOC WOM KEY STRAT PR; (Kenya National AIDS and STI Control Programme (NASCOP), 2011, GUIDELINES ANTIRETRO, V4th; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; McClelland RS, 2006, AIDS, V20, P1969, DOI 10.1097/01.aids.0000247119.12327.e6; McClelland RS, 2011, SEX TRANSM DIS, V38, P429, DOI 10.1097/OLQ.0b013e31820369f6; Norwood MS, 2016, ANN EPIDEMIOL, V26, P612, DOI 10.1016/j.annepidem.2016.07.011; Omoro SAO, 2006, INT J PSYCHIAT MED, V36, P367, DOI 10.2190/8W7Y-0TPM-JVGV-QW6M; Onono Maricianah, 2015, J AIDS Clin Res, V6; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Reynolds HW, 2005, SEX TRANSM INFECT, V81, P184, DOI 10.1136/sti.2004.012013; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; The Joint United Nations Programme on HIV/AIDS, 2016, GLOB AIDS UPD; White D, 2016, SEX TRANSM DIS, V43, P642, DOI 10.1097/OLQ.0000000000000502; WHO, 2016, CONGUID UANT DRU; Wilson KS, 2016, AIDS BEHAV, V20, P2054, DOI 10.1007/s10461-016-1399-5; Yam EA, 2016, CONTRACEPTION, V93, P222, DOI 10.1016/j.contraception.2015.11.010; Yam EA, 2013, SEX TRANSM DIS, V40, P406, DOI 10.1097/OLQ.0b013e318283c16d; Yam EA, 2013, HEALTH CARE WOMEN IN, V34, P249, DOI 10.1080/07399332.2012.736576	27	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187444	10.1371/journal.pone.0187444	http://dx.doi.org/10.1371/journal.pone.0187444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176849	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900010
J	Wang, SX; Zhu, YL; Zhang, DX; Shao, H; Liu, P; Hu, JB; Zhang, H; Zhang, HP; Chang, C; Lu, J; Xia, XC; Sun, GL; Ma, CX				Wang, Sheng-Xing; Zhu, Yu-Lei; Zhang, De-Xin; Shao, Hui; Liu, Peng; Hu, Jian-Bang; Zhang, Heng; Zhang, Hai-Ping; Chang, Cheng; Lu, Jie; Xia, Xian-Chun; Sun, Gen-Lou; Ma, Chuan-Xi			Genome-wide association study for grain yield and related traits in elite wheat varieties and advanced lines using SNP markers	PLOS ONE			English	Article							SPRING WHEAT; BREAD WHEAT; POPULATION-STRUCTURE; MODEL; QTL; COMPONENTS; WEIGHT; IDENTIFICATION; INFERENCE; LENGTH	Genetic improvement of grain yield is always an important objective in wheat breeding. Here, a genome-wide association study was conducted to parse the complex genetic composition of yield-related traits of 105 elite wheat varieties (lines) using the Wheat 90K Illumina iSelect SNP array. Nine yield-related traits, including maximum number of shoots per square meter (MSN), effective number of spikes per square meter (ESN), percentage of effective spike (PES), number of kernels per spike (KPS), thousand-kernel weight (TKW), the ratio of kernel length/kernel width (RLW), leaf-area index (LAI), plant height (PH), and grain yield (GY), were evaluated across four environments. Twenty four highly significant marker-trait associations (MTAs) (P < 0.001) were identified for nine yield-related traits on chromosomes 1A, 1D, 2A (2), 3B, 4A (2), 4B, 5A (4), 5B (4), 5D, 6B (2), 7A (2), and 7B (3), explaining 10.86-20.27% of the phenotypic variations. Of these, four major loci were identified in more than three environments, including one locus for RLW (6B), one locus for TKW (7A), and two loci for PH (7B). A cleaved amplified polymorphic sequence (CAPS) marker Td99211 for TKW on chromosome 5A was developed and validated in both a natural population composed of 372 wheat varieties (lines) and a RIL population derived from the cross of Yangxiaomai x Zhongyou 9507. The CAPS marker developed can be directly used for marker-assisted selection in wheat breeding, and the major MTAs identified can provide useful information for fine-mapping of the target genes in future studies.	[Wang, Sheng-Xing; Zhu, Yu-Lei; Zhang, De-Xin; Shao, Hui; Liu, Peng; Hu, Jian-Bang; Zhang, Heng; Zhang, Hai-Ping; Chang, Cheng; Lu, Jie; Sun, Gen-Lou; Ma, Chuan-Xi] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Wang, Sheng-Xing; Zhu, Yu-Lei; Zhang, De-Xin; Shao, Hui; Liu, Peng; Hu, Jian-Bang; Zhang, Heng; Zhang, Hai-Ping; Chang, Cheng; Lu, Jie; Sun, Gen-Lou; Ma, Chuan-Xi] Minist Agr, Key Lab Wheat Biol & Genet Improvement Southern Y, Hefei, Anhui, Peoples R China; [Xia, Xian-Chun] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing, Peoples R China; [Sun, Gen-Lou] St Marys Univ, Dept Biol, Halifax, NS, Canada	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Saint Marys University - Canada	Zhang, HP; Chang, C (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.; Zhang, HP; Chang, C (corresponding author), Minist Agr, Key Lab Wheat Biol & Genet Improvement Southern Y, Hefei, Anhui, Peoples R China.	zhhp20@163.com; changtgw@126.com			Natural Science Foundation of Anhui province [1508085MC57]; China Agriculture Research System [CARS-03]; introduced leading talent research team for Universities in Anhui Province; Promotion project of high education of Anhui province "Team construction of high level teacher of crop discipline", Wheat genetics and breeding research platform innovation team of Anhui's university; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP)	Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); China Agriculture Research System; introduced leading talent research team for Universities in Anhui Province; Promotion project of high education of Anhui province "Team construction of high level teacher of crop discipline", Wheat genetics and breeding research platform innovation team of Anhui's university; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP)	This work was supported by grants from the Natural Science Foundation of Anhui province (1508085MC57), the China Agriculture Research System (CARS-03), the introduced leading talent research team for Universities in Anhui Province, the Promotion project of high education of Anhui province "Team construction of high level teacher of crop discipline", Wheat genetics and breeding research platform innovation team of Anhui's university, and Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP).	Addison CK, 2016, EUPHYTICA, V209, P665, DOI 10.1007/s10681-016-1650-1; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bates D, 2015, J STAT SOFTWARE; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chen GF, 2016, EUPHYTICA, V212, P173, DOI 10.1007/s10681-016-1750-y; Claeskens G, 2015, WORKING PAPERS DEP D; Cui F, 2014, THEOR APPL GENET, V127, P659, DOI 10.1007/s00122-013-2249-8; Dong LL, 2014, MOL BREEDING, V34, P937, DOI 10.1007/s11032-014-0087-2; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; George AW, 2015, THEOR APPL GENET, V128, P1163, DOI 10.1007/s00122-015-2497-x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Jiang YM, 2015, THEOR APPL GENET, V128, P131, DOI 10.1007/s00122-014-2417-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Li CL, 2015, EUPHYTICA, V206, P89, DOI 10.1007/s10681-015-1475-3; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mason RE, 2013, EUPHYTICA, V194, P243, DOI 10.1007/s10681-013-0951-x; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Merk HL, 2014, PLANT BREEDING GENOM; Mi XF, 2011, THEOR APPL GENET, V123, P1, DOI 10.1007/s00122-011-1561-4; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Pritchard JK, 2000, GENETICS, V155, P945; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Viana JMS, 2010, EUPHYTICA, V174, P31, DOI 10.1007/s10681-009-0094-2; Su ZQ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0436-4; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Wang JS, 2011, EUPHYTICA, V177, P277, DOI 10.1007/s10681-010-0267-z; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; [王升星 Wang Shengxing], 2014, [麦类作物学报, Journal of Triticeae Crops], V34, P621; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu YL, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0598-0	44	47	53	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188662	10.1371/journal.pone.0188662	http://dx.doi.org/10.1371/journal.pone.0188662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176820	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900112
J	Zhang, SB; Wang, XQ; Ai, S; Ouyang, W; Le, Y; Tong, JB				Zhang, Shuibing; Wang, Xueqin; Ai, Sha; Ouyang, Wen; Le, Yuan; Tong, Jianbin			Sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in surviving septic mice	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; MOUSE MODEL; DYSFUNCTION; BRAIN; ACTIVATION; DISABILITY; HMGB1	Background Sepsis-induced neuroinflammation plays an important role in sepsis-related brain dysfunction. However, the molecules that are targeted during neuroinflammation resulting from sepsis-induced brain dysfunction remain unclear. Herein, we tried to investigate the expression and roles of NMDA receptor subunits during sepsis-related brain dysfunction. Methods Sepsis was induced by cecal ligation and perforation (CLP) or by a single intraperitoneal injection of lipopolysaccharide (LPS, 8 mg/kg) in C57BL/6J mice. The NMDA receptor co-agonist D-serine was injected intraperitoneally for 3 days (500 mg/kg/day) to compensate for the loss of NMDA receptors. The behaviors of mice were tested in the Barnes maze and in the open field test. The mice were euthanized at the indicated time points. The brains were collected to detect the following: the levels of synaptophysin and NMDA receptor subunits GluN2A, GluN2B and GluN1 (by Western blot and RT-PCR); the number of CA1 neurons (by Nissl staining); neuronal activity (by p-CREB staining); neuroinflammation (by staining of Iba-1 and inflammatory factors IL-1 beta, TNF-alpha, NLRP3); and the levels of oxidative stress [by dihydroethidium (DHE)]. Results Sepsis selectively decreased the protein and mRNA levels of GluN2A, GluN2B and GluN1 but not the levels of synaptophysin or the neuronal number in the hippocampus of mice in either of the classic CLP-induced or LPS-induced sepsis models during the first 7 days after sepsis. Intraperitoneal injection of D-serine obviously limited the lipopolysaccharide-induced changes, including the impairment of learning and memory, the loss of NMDA receptor subunits, robust neuroinflammation, the levels of ROS stress and the decrease of p-CREB in the hippocampus of mice. Conclusion These data suggest that the sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in the mice that survived sepsis, and the data show that NMDA receptors are potential targets for the improvement of brain dysfunction in sepsis survivors.	[Zhang, Shuibing; Wang, Xueqin; Ai, Sha; Ouyang, Wen; Le, Yuan; Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Wang, Xueqin; Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Ctr Expt Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Le, Y; Tong, JB (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.; Tong, JB (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Expt Med, Changsha, Hunan, Peoples R China.	leyuanxy@csu.edu.cn; jianbintong@csu.edu.cn			National Natural Science Foundation of China [81371216, 81471107, 81400896]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China: WOY, No. 81371216; JBT, No. 81471107; and YL, No. 81400896. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Bermejo-Martin JF, 2016, J INFECTION, V72, P525, DOI 10.1016/j.jinf.2016.01.010; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chisholm KI, 2016, J CEREBR BLOOD F MET, V36, P1955, DOI 10.1177/0271678X15606457; Comim CM, 2011, NEUROCHEM RES, V36, P304, DOI 10.1007/s11064-010-0320-2; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Farooq A, 2014, AM J PHYSIOL-GASTR L, V307, pG732, DOI 10.1152/ajpgi.00073.2014; Goddard SL, 2016, JAMA-J AM MED ASSOC, V315, P2671, DOI 10.1001/jama.2016.7211; Guercio GD, 2014, NEUROPHARMACOLOGY, V86, P1, DOI 10.1016/j.neuropharm.2014.06.021; Imamura Y, 2016, SHOCK, V45, P660, DOI 10.1097/SHK.0000000000000547; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jones C, 2013, MINERVA ANESTESIOL, V79, P1306; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Lauro C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00472; Lazosky A, 2010, J CRIT CARE, V25, P406, DOI 10.1016/j.jcrc.2009.10.001; Li D, 2016, CRIT CARE MED, V44, pE289, DOI 10.1097/CCM.0000000000001566; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Ma JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-33; Oddo M, 2015, MINERVA ANESTESIOL, V81, P776; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Pytel P, 2009, CURR OPIN NEUROL, V22, P283, DOI 10.1097/WCO.0b013e32832b3101; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Savignac HM, 2016, BRAIN BEHAV IMMUN, V52, P120, DOI 10.1016/j.bbi.2015.10.007; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Steckert AV, 2013, SYNAPSE, V67, P786, DOI 10.1002/syn.21686; Tang YT, 2016, ANTIOXID REDOX SIGN, V24, P620, DOI 10.1089/ars.2015.6409; Terrando N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00441; Umberger R, 2015, CRIT CARE NURS Q, V38, P259, DOI 10.1097/CNQ.0000000000000078; Yin S, 2015, PLOS ONE, V10; Zhao T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36696; Zurek AA, 2016, ANN CLIN TRANSL NEUR, V3, P392, DOI 10.1002/acn3.303	34	27	28	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188273	10.1371/journal.pone.0188273	http://dx.doi.org/10.1371/journal.pone.0188273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176858	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900054
J	Adiya, T; Johnson, CL; Loewen, MA; Ritterbush, KA; Constenius, KN; Dinter, CM				Adiya, Tsolmon; Johnson, Cari L.; Loewen, Mark A.; Ritterbush, Kathleen A.; Constenius, Kurt N.; Dinter, Cory M.			Microbial-caddisfly bioherm association from the Lower Cretaceous Shinekhudag Formation, Mongolia: Earliest record of plant armoring in fossil caddisfly cases	PLOS ONE			English	Article							GREEN RIVER FORMATION; EAST GOBI BASIN; SOUTHERN MONGOLIA; STRUCTURAL RECORDS; LAKE ENVIRONMENTS; CALCIUM-CARBONATE; SOURCE ROCKS; CENTRAL-ASIA; ALGAL MATS; EVOLUTION	Caddisfly larvae construct underwater protective cases using surrounding materials, thus providing information on environmental conditions in both modern and ancient systems. Microbial bioherms associated with caddisfly cases are found in the Berriassian-Hauterivian (similar to 140-130 Ma) Shinekhudag Formation of Mongolia, and yield new insights into aspects of lacustrine paleoecosystems and paleoenvironments. This formation contains the earliest record of plant-armored caddisfly cases and a rare occurrence of microbial-caddisfly association from the Mesozoic. The bioherms are investigated within the context of stratigraphic correlations, depositional environment interpretations, and basin-evolution models of the sedimentary fill. The bioherms form 0.5-2.0 m diameter mound-shaped bodies and are concentrated within a single, oil shale-bound stratigraphic interval. Each bioherm is composed of up to 40% caddisfly cases along with stromatolites of millimeter-scale, micritic laminations. Petrographic analyses reveal these bioherms are composed of non-systematic associations of columnar and oncoidal microbialites, constructed around colonies of caddisfly cases. The cases are straight to curved, slightly tapered, and tube-shaped, with a progressively increasing length and width trend (7-21 mm by 1.5-2.5 mm). Despite these variations, the case architectures reveal similar construction materials; the particles used for cases are dominated by plant fragments, ostracod valves, carbonate rocks, and rare mica and feldspar grains. Allochems within the bioherms include ooids, ostracods, plant fragments, rare gastropods, feldspar grains bound in micritic matrices, and are consolidated by carbonate dominated cements. The combination of microbial-caddisfly association, plant fragment case particles, and ooids/oncoids are indicative of a shallow, littoral lake setting. Stratigraphic juxtaposition of nearshore bioherms and the bounding distal oil-shale facies suggests that the bioherms developed in an underfilled lake basin, resulting from an abrupt and short-lived lake desiccation event. Lake chemistry is believed to have been relatively alkaline, saline to hypersaline, and rich in Ca, Mg, and HCO3 ions. Through analyzing bioherm characteristics, caddisfly case architecture, carbonate microfacies, and stratigraphic variability, we infer larger-scale processes that controlled basin development during their formation.	[Adiya, Tsolmon; Johnson, Cari L.; Loewen, Mark A.; Ritterbush, Kathleen A.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Loewen, Mark A.] Nat Hist Museum Utah, Salt Lake City, UT USA; [Dinter, Cory M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Constenius, Kurt N.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Dinter, Cory M.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa	Utah System of Higher Education; University of Utah; University of Witwatersrand; University of Arizona; University of Witwatersrand	Adiya, T (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	tsolmon.adiya@utah.edu			Fulbright Association	Fulbright Association	The Fulbright Association fully funded the education of the first author, Tsolmon Adiya, at the University of Utah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariunchimeg Y, 2012, GEOLOGY MINERAL RESO, P408; Awramik SM, 2015, GEOLOGY, V43, P691, DOI 10.1130/G36793.1; Badarch G, 2002, J ASIAN EARTH SCI, V21, P87, DOI 10.1016/S1367-9120(02)00017-2; Baskin R.L., 2014, THESIS; Bhattacharya JP., 2010, SOC SEDIMENTARY GEOL, V6, P233, DOI DOI 10.2110/PEC.06.84.0237; Bohacs K.M., 2007, MT GEOL, V44, P79; Bohacs K. M., 2000, LAKE BASINS SPACE TI, V46, P3; Botosaneanu L, 2004, ANN LIMNOL-INT J LIM, V40, P15, DOI 10.1051/limn/2004002; BRAITHWAITE C. J. R., 1991, EARTH SCI, V82, P99; BRIDGE JS, 1993, SEDIMENTOLOGY, V40, P801, DOI 10.1111/j.1365-3091.1993.tb01361.x; Buchheim H. P., 2012, AAPG HEDB C MICR CAR; Buchheim HP, 2009, 2009 PORTL GSA ANN M; Bull WB, 1972, RECOGNITION ANCIENT, V16, P63, DOI DOI 10.2110/PEC.72.02.0063; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Carroll AR, 1999, GEOLOGY, V27, P99, DOI 10.1130/0091-7613(1999)027<0099:SCOALB>2.3.CO;2; Carroll AR, 2001, AAPG BULL, V85, P1033; Chafetz HS, 2013, AAPG BULL, V97, P2103, DOI 10.1306/04231312173; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; COHEN AS, 1989, PALAEOGEOGR PALAEOCL, V70, P65, DOI 10.1016/0031-0182(89)90080-1; Coleman JM., 1982, SANDSTONE DEPOSITION, P139; Cunningham D, 2005, EARTH PLANET SC LETT, V240, P436, DOI 10.1016/j.epsl.2005.09.013; Cunningham D, 2011, GEOL SOC SPEC PUBL, V338, P361, DOI 10.1144/SP338.17; DICKSON JAD, 1966, J SEDIMENT PETROL, V36, P491; Drysdale RN, 2003, SEDIMENT GEOL, V161, P207, DOI 10.1016/S0037-0738(03)00114-3; Dumitru TA, 2001, FISSION TRACK CONSTR, P215; Dunham R.J., 1962, CLASSIFICATION CARBO, V1, P108; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; ELIAS SA, 1991, BIOSCIENCE, V41, P552, DOI 10.2307/1311608; EMBRY A.F., 1971, THESIS U CALGARY CAL, V19, P730, DOI DOI 10.11575/PRISM/22817; Eugster H. P., 1983, LACUSTRINE CHEM SEDI, P321; Fleet AJ, 1988, LACUSTRINE PETROLEUM; Flugel E., 2004, MICROFACIES CARBONAT, P177, DOI 10.1007/978-3-662-08726-8; Flugel E., 2010, MICROFACIES CARBONAT, DOI DOI 10.1007/978-3-642-03796-2; Flugel E., 1982, MICROFACIES ANAL LIM, DOI DOI 10.1007/978-3-642-68423-4; FOLK RL, 1975, AAPG BULL, V59, P60; FOLK RL, 1974, J SEDIMENT PETROL, V44, P40; Frantz CM, 2015, GEOBIOLOGY, V13, P409, DOI 10.1111/gbi.12145; Frantz CM, 2013, STROMATOLITES BIOSIG; Friedman G, 1959, J SEDIMENT PETROL, V29, P87, DOI DOI 10.1306/74D70894-2B21-11D7-86480001020C1865D; Gierlowski-Kordesch E.H., 2010, FACIES ENV PROCESSES, V61, P1, DOI DOI 10.1016/S0070-4571(09)06101-9; Graham SA, 2012, REGIONAL GEOLOGY AND TECTONICS: PHANEROZOIC RIFT SYSTEMS AND SEDIMENTARY BASINS, VOL 1B, P443, DOI 10.1016/B978-0-444-56356-9.00016-X; Graham SA, 2001, GEOL SOC AM BULL, V113, P1560, DOI 10.1130/0016-7606(2001)113<1560:SRATIO>2.0.CO;2; Hinchliffe R, 2010, INTEGR COMP BIOL, V50, P606, DOI 10.1093/icb/icq069; Holzenthal RW, 2007, ZOOTAXA, P639; Horton BK, 2013, AAPG ANN CONV EXH DE; HUGUENEY M, 1990, PALAEONTOLOGY, V33, P495; Ivanov VD, 2002, TRICHOPTERA PHRYGANE, P199; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Johnson CL, 2015, BASIN RES, V27, P272, DOI 10.1111/bre.12073; Johnson CL, 2015, GEOL SOC AM SPEC PAP, V513, P543, DOI 10.1130/2015.2513(17); Johnson CL, 2004, BASIN RES, V16, P79, DOI 10.1111/j.1365-2117.2004.00221.x; Johnson CL, 2003, AAPG BULL, V87, P817, DOI 10.1306/12170201073; Johnson CL, 2001, GEOL SOC AM MEM, V194, P413; KARLO KELTS K., 1978, LAKES, P295; KEDDY PA, 1986, J GREAT LAKES RES, V12, P25, DOI 10.1016/S0380-1330(86)71697-3; Keller AM, 1997, PALAIOS, V12, P282, DOI 10.2307/3515428; Kelty TK, 2008, TECTONOPHYSICS, V451, P290, DOI 10.1016/j.tecto.2007.11.052; Klement, 1967, AAPG BULL, V51, P167; Kuzmina S, 2008, PALAEOGEOGR PALAEOCL, V267, P245, DOI 10.1016/j.palaeo.2008.07.007; Leggitt VL, 2007, SEDIMENTOLOGY, V54, P661, DOI 10.1111/j.1365-3091.2007.00854.x; Leggitt VL, 2001, SEDIMENT GEOL, V145, P377, DOI 10.1016/S0037-0738(01)00155-5; Leggitt VL, 2002, SEDIMENT GEOL, V148, P139, DOI 10.1016/S0037-0738(01)00214-7; Lloyd JT, 1921, BIOL N AM CADDIS FLY; Loewen M. A., 1999, NATL PARK SERVICE PA, V4, P72; MACKAY RJ, 1979, ANNU REV ENTOMOL, V24, P185, DOI 10.1146/annurev.en.24.010179.001153; Mancini EA, 2013, AAPG BULL, V97, P1835, DOI 10.1306/intro070913; McCafferty WP, 1983, AQUATIC ENTOMOLOGY F; MCPHERSON JG, 1987, GEOL SOC AM BULL, V99, P331, DOI 10.1130/0016-7606(1987)99<331:FABDVO>2.0.CO;2; MEADOWS A, 1994, SEDIMENTOLOGY, V41, P423, DOI 10.1111/j.1365-3091.1994.tb02004.x; Meng QR, 2003, TECTONOPHYSICS, V369, P155, DOI 10.1016/S0040-1951(03)00195-1; MERRILL D, 1969, ANIM BEHAV, V17, P486, DOI 10.1016/0003-3472(69)90151-1; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; NEAL J., 1997, GEOLOGICAL SOC AM, V29, P239; Nemec W., 1988, FAN DELTAS SEDIMENTO, P3, DOI DOI 10.1111/J.1365-2117.1988.TB00021.X; Paik IS, 2005, PALAEOGEOGR PALAEOCL, V218, P301, DOI 10.1016/j.palaeo.2004.12.020; Philip H, 1999, GEOLOGY, V27, P211, DOI 10.1130/0091-7613(1999)027<0211:GPAWAF>2.3.CO;2; Platt, 1991, LACUSTRINE FACIES AN; Postma G., 1990, COARSE GRAINED DELTA, V10, P13; POWELL TG, 1986, MAR PETROL GEOL, V3, P200, DOI 10.1016/0264-8172(86)90045-0; Prost GL, 2004, AAPG BULL, V88, P483, DOI 10.1306/11150303042; Renault R.W., 2010, FACIES MODELS 4; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; Rosenberg MJ, 2015, SYNTH LIMNOGEOL, V1, P211, DOI 10.1007/978-94-017-9906-5_9; ROSS HH, 1967, ANNU REV ENTOMOL, V12, P169, DOI 10.1146/annurev.en.12.010167.001125; S A Ali, 2010, OILFIELD REV, V22, P14; Schieber J, 2013, J SEDIMENT RES, V83, P1026, DOI 10.2110/jsr.2013.77; Schnurrenberger D, 2003, J PALEOLIMNOL, V29, P141, DOI 10.1023/A:1023270324800; Scholle P., 2003, AM ASS PETROLEUM GEO, V77, P473, DOI [10.1306/M77973, DOI 10.1306/M77973]; Seard C, 2013, PALAEOGEOGR PALAEOCL, V381, P128, DOI 10.1016/j.palaeo.2013.04.023; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; Shapiro RS, 2000, PALAIOS, V15, P166, DOI 10.2307/3515503; Shapley MD, 2005, GEOCHIM COSMOCHIM AC, V69, P2517, DOI 10.1016/j.gca.2004.12.001; Shcherbakov Dmitry E., 2008, Alavesia, V2, P125; SIBLEY DF, 1991, GEOLOGY, V19, P151, DOI 10.1130/0091-7613(1991)019<0151:SCITAA>2.3.CO;2; SIBLEY DF, 1987, J SEDIMENT PETROL, V57, P967; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Statzner B, 2011, LIMNOLOGICA, V41, P266, DOI 10.1016/j.limno.2011.04.002; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Sukatcheva I. D, 1968, PALEONTOLOGY J, V2, P59; Sukatsheva ID, 2016, PALEONTOL J+, V50, P396, DOI 10.1134/S0031030116040134; Tanavsuu-Milkeviciene K, 2012, SEDIMENTOLOGY, V59, P1735, DOI 10.1111/j.1365-3091.2012.01324.x; THOMPSON JB, 1990, GEOLOGY, V18, P995, DOI 10.1130/0091-7613(1990)018<0995:CPOGCA>2.3.CO;2; TRAYNOR JJ, 1995, MAR PETROL GEOL, V12, P35, DOI 10.1016/0264-8172(95)90386-X; Tully J, 2015, GEOEXPRO, V11, P48; Vincent SJ, 2001, MEMOIRS GEOLOGICAL S, P341; Warren J, 2000, EARTH-SCI REV, V52, P1, DOI 10.1016/S0012-8252(00)00022-2; WATSON MP, 1987, MAR PETROL GEOL, V4, P205, DOI 10.1016/0264-8172(87)90045-6; Webb LE, 1999, GEOLOGY, V27, P143, DOI 10.1130/0091-7613(1999)027<0143:OAAIOT>2.3.CO;2; Wells JT, 1999, J SEDIMENT RES, V69, P816, DOI 10.2110/jsr.69.816; Wiggins G, 2015, LARVAE N AM CADDISFL; Wiggins G.B., 2004, CADDISFLIES UNDERWAT; Wiggins GB, 1998, CADDISFLY FAMILY PHR; WILSON MVH, 1980, PALAEOGEOGR PALAEOCL, V32, P21, DOI 10.1016/0031-0182(80)90029-2; WILSON MVH, 1988, PALAEOGEOGR PALAEOCL, V62, P609, DOI 10.1016/0031-0182(88)90074-0; Wright VP, 2012, GEOL SOC SPEC PUBL, V370, P39, DOI 10.1144/SP370.2; Zheng Y, 1996, J STRUCT GEOL, V18, P1111, DOI 10.1016/0191-8141(96)00038-7	117	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188194	10.1371/journal.pone.0188194	http://dx.doi.org/10.1371/journal.pone.0188194			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161280	Green Published, Green Accepted, gold			2022-12-26	WOS:000415987000035
J	Hsieh, MS; Chen, MY; Hsieh, CH; Pan, CH; Yu, GY; Chen, HW				Hsieh, Ming-Shu; Chen, Mei-Yu; Hsieh, Chun-Hsiang; Pan, Chien-Hsiung; Yu, Guann-Yi; Chen, Hsin-Wei			Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity	PLOS ONE			English	Article							SIMIAN CELL SYSTEMS; MYCOPHENOLIC-ACID; SERINE-PROTEASE; NONSTRUCTURAL PROTEINS; PLAQUE DEVELOPMENT; RECOMBINANT NS3; RNA REPLICATION; REPLICON SYSTEM; OVERLAY MEDIUM; VIRAL-RNA	Background The traditional methods, plaque assays and immuno-focus assays, used to titrate infectious dengue virus (DENV) particles are time consuming and labor intensive. Here, we developed a DENV protease activity detection system (DENPADS) to visualize DENV infection in cells based on dengue protease activity. Methodology/Principal findings Dengue NS3 protease cleaves NS4B-NS5. BHK-21 cells stably expressing the sensor module comprising DENV-2 NS4 and the 10 amino-terminal amino acids of NS5 ((N10)NS5) fused with the SV40 nuclear localization signal (NLS) and Cre recombinase (Cre), were generated. Cre is constrained outside the nucleus in the absence of NS3 activity but translocates into the nucleus through NS4B-NS5 cleavage when cells are infected with DENV. Nuclear translocation of Cre can trigger the reporter system, which contains a cis-loxP-flanked mCherry with three continuous stop codons following an SV40 polyA tail cDNA upstream of EGFP or mHRP cDNA. Our results show that DENPADS is an efficient and accurate method to titrate 4 DENV serotypes in 24 hours. Compared with current virus titration methods, the entire process is easy to perform, and the data are easily acquired. Conclusions/Significance In this study, we demonstrate that DENPADS can be used to detect dengue viral infection through a fluorescence switch or HRP activity in the infected cells. This approach is sensitive with less incubation time and labor input. In addition, DENPADS can simultaneously evaluate the efficacy and cytotoxicity of potential anti-DENV candidates. Overall, DENPADS is a useful tool for dengue research.	[Hsieh, Ming-Shu; Chen, Hsin-Wei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsieh, Ming-Shu; Chen, Mei-Yu; Hsieh, Chun-Hsiang; Pan, Chien-Hsiung; Yu, Guann-Yi; Chen, Hsin-Wei] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Pan, Chien-Hsiung; Chen, Hsin-Wei] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; China Medical University Taiwan	Chen, HW (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chen, HW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.; Chen, HW (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	chenhw@nhri.org.tw	Chen, Hsin-Wei/ABA-7436-2021; Yu, Guann-Yi/O-5139-2019	Chen, Hsin-Wei/0000-0002-3207-2397; Yu, Guann-Yi/0000-0002-0580-8282	National Health Research Institutes [IV-105-PP-03, IV-104-PP-16]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institutes (IV-105-PP-03, IV-104-PP-16).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; CASS CE, 1977, CANCER RES, V37, P3314; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Che PL, 2009, INT J CLIN EXP MED, V2, P363; Chen HW, 2014, J GEN VIROL, V95, P1983, DOI 10.1099/vir.0.067280-0; Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011; Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4; Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084; KANTOCH M, 1980, ACTA VIROL, V24, P335; Kato F, 2014, JPN J INFECT DIS, V67, P209, DOI 10.7883/yoken.67.209; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022553; Li XQ, 2013, APPL MICROBIOL BIOT, V97, P6503, DOI 10.1007/s00253-013-5021-8; Liao FH, 2016, CELL CYCLE, V15, P1073, DOI 10.1080/15384101.2016.1156267; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; MALEWICZ B, 1979, J CLIN MICROBIOL, V9, P609; Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010; Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; PLANTEROSE DN, 1969, J GEN VIROL, V4, P629, DOI 10.1099/0022-1317-4-4-629; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Smith KM, 2012, AM J TROP MED HYG, V87, P743, DOI 10.4269/ajtmh.2012.12-0004; STIM TB, 1969, J GEN VIROL, V5, P329, DOI 10.1099/0022-1317-5-3-329; STIM TB, 1970, APPL MICROBIOL, V19, P757, DOI 10.1128/AEM.19.5.757-762.1970; STIM TB, 1970, APPL MICROBIOL, V19, P751, DOI 10.1128/AEM.19.5.751-756.1970; Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S; Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13; Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188170	10.1371/journal.pone.0188170	http://dx.doi.org/10.1371/journal.pone.0188170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161301	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000032
J	Wang, B; Tran, H; Smith, MA; Kostanyan, T; Schmitt, SE; Bilonick, RA; Jan, NJ; Kagemann, L; Tyler-Kabara, EC; Ishikawa, H; Schuman, JS; Sigal, IA; Wollstein, G				Wang, Bo; Tran, Huong; Smith, Matthew A.; Kostanyan, Tigran; Schmitt, Samantha E.; Bilonick, Richard A.; Jan, Ning-Jiun; Kagemann, Larry; Tyler-Kabara, Elizabeth C.; Ishikawa, Hiroshi; Schuman, Joel S.; Sigal, Ian A.; Wollstein, Gadi			In-vivo effects of intraocular and intracranial pressures on the lamina cribrosa microstructure	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; CEREBROSPINAL-FLUID PRESSURE; NORMAL-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; MONKEY; EYES; MICROARCHITECTURE; HYPERTENSION; BIOMECHANICS	There is increasing clinical evidence that the eye is not only affected by intraocular pressure (IOP), but also by intracranial pressure (ICP). Both pressures meet at the optic nerve head of the eye, specifically the lamina cribrosa (LC). The LC is a collagenous meshwork through which all retinal ganglion cell axons pass on their way to the brain. Distortion of the LC causes a biological cascade leading to neuropathy and impaired vision in situations such as glaucoma and idiopathic intracranial hypertension. While the effect of IOP on the LC has been studied extensively, the coupled effects of IOP and ICP on the LC remain poorly understood. We investigated in-vivo the effects of IOP and ICP, controlled via cannulation of the eye and lateral ventricle in the brain, on the LC microstructure of anesthetized rhesus monkeys eyes using the Bioptigen spectral-domain optical coherence tomography (OCT) device (Research Triangle, NC). The animals were imaged with their head upright and the rest of their body lying prone on a surgical table. The LC was imaged at a variety of IOP/ICP combinations, and microstructural parameters, such as the thickness of the LC collagenous beams and diameter of the pores were analyzed. LC microstructure was confirmed by histology. We determined that LC microstructure deformed in response to both IOP and ICP changes, with significant interaction between the two. These findings emphasize the importance of considering both IOP and ICP when assessing optic nerve health.	[Wang, Bo; Tran, Huong; Smith, Matthew A.; Kostanyan, Tigran; Schmitt, Samantha E.; Bilonick, Richard A.; Jan, Ning-Jiun; Sigal, Ian A.] Univ Pittsburgh, Med Ctr, Sch Med, Dept Ophthalmol,Eye Ctr,Eye & Ear Inst,Ophthalmol, Pittsburgh, PA 15260 USA; [Wang, Bo; Tran, Huong; Jan, Ning-Jiun; Sigal, Ian A.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA; [Kagemann, Larry; Ishikawa, Hiroshi; Schuman, Joel S.; Wollstein, Gadi] NYU, Sch Med, Langone Eye Ctr, New York, NY USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sigal, IA (corresponding author), Univ Pittsburgh, Med Ctr, Sch Med, Dept Ophthalmol,Eye Ctr,Eye & Ear Inst,Ophthalmol, Pittsburgh, PA 15260 USA.; Sigal, IA (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA.	ian@OcularBiomechanics.com	Schuman, Joel S/M-2389-2019; Tyler-Kabara, Elizabeth/H-4930-2013; Schuman, Joel S/K-7304-2012; Ishikawa, Hiroshi/ABC-6293-2020	Schuman, Joel S/0000-0002-8885-3766; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Schuman, Joel S/0000-0002-8885-3766; Ishikawa, Hiroshi/0000-0001-6310-5748; Wang, Bo/0000-0003-4785-3361; Kagemann, Larry/0000-0001-8961-0187; Smith, Matthew A/0000-0003-1192-9942	National Institutes of Health (Bethesda, MD) [R01-EY025011, R01-EY013178, R01-EY023966, R01-EY022928, T32-EY017271, P30-EY008098]; Glaucoma Research Foundation (San Francisco, CA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [R01EY025011, R01EY023966] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation (San Francisco, CA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health R01-EY025011, R01-EY013178, R01-EY023966, R01-EY022928, T32-EY017271, P30-EY008098 (Bethesda, MD, nei.nih.gov), Glaucoma Research Foundation (San Francisco, CA, www.glaucoma.org), Eye and Ear Foundation (Pittsburgh, PA, eyeandear.org), and Research to Prevent Blindness (New York, NY, www:rpbusa.org/). The funding organizations had no role in the design, data collection and analysis, decision to publish or preparation of the manuscript.	Agoumi Y, 2011, OPHTHALMOLOGY, V118, P52, DOI 10.1016/j.ophtha.2010.05.016; Alperin N, 2013, AM J NEURORADIOL, V34, P2354, DOI 10.3174/ajnr.A3600; Berdahl JP, 2010, CURR OPIN OPHTHALMOL, V21, P106, DOI 10.1097/ICU.0b013e32833651d8; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; CORBETT JJ, 1982, ARCH NEUROL-CHICAGO, V39, P461, DOI 10.1001/archneur.1982.00510200003001; Coudrillier B, 2016, IEEE T MED IMAGING, V35, P988, DOI 10.1109/TMI.2015.2504440; Dougherty R., 2007, MICROSC MICROANAL, V13, P1678, DOI DOI 10.1017/S1431927607074430; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; FRYCZKOWSKI AW, 1984, INT OPHTHALMOL, V7, P95, DOI 10.1007/BF00165110; GUCER G, 1979, J NEUROSURG, V51, P206, DOI 10.3171/jns.1979.51.2.0206; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Hua Y, 2016, J MED DEVICES, V10, DOI 10.1115/1.4033852; Jan NJ, 2015, BIOMED OPT EXPRESS, V6, P4705, DOI 10.1364/BOE.6.004705; Kirwan RP, 2005, MOL VIS, V11, P798; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Morgan WH, 2015, BR J OPHTHALMOL, P1163; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigal IA, 2014, IEEE T MED IMAGING, V33, P1381, DOI 10.1109/TMI.2014.2312133; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sigal Ian A, 2005, Technol Health Care, V13, P313; Sigal IA, 2014, BRIT J OPHTHALMOL, V98, P34, DOI 10.1136/bjophthalmol-2013-304751; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Team RDC, 2019, R LANG ENV STAT COMP; Tran H, 2017, SCIENTIFIC REPORTS A; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1458, DOI 10.1001/archopht.1977.04450080168023; Wang B, 2013, INVEST OPHTH VIS SCI, V54, P8270, DOI 10.1167/iovs.13-13109; Wostyn P, 2014, PROG RETIN EYE RES, V39, P107, DOI 10.1016/j.preteyeres.2013.12.002; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; Yang HL, 2009, INVEST OPHTH VIS SCI, V50, P224, DOI 10.1167/iovs.08-2464	39	31	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188302	10.1371/journal.pone.0188302	http://dx.doi.org/10.1371/journal.pone.0188302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161320	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000041
J	Hannibal, J; Georg, B; Fahrenkrug, J				Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan			PAC1-and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; 2-DEFICIENT MICE; DEFICIENT MICE; PACAP; LACKING; VIP; ENTRAINMENT	The two sister peptides, pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) and their receptors, the PAC1- and the VPAC2 receptors, are involved in regulation of the circadian timing system. PACAP as a neurotransmitter in the retinohypothalamic tract (RHT) and VIP as a neurotransmitter, involved in synchronization of SCN neurons. Behavior and physiology in VPAC2 deficient mice are strongly regulated by light most likely as a result of masking. Consequently, we used VPAC2 and PAC1/VPAC2 double mutant mice in comparison with PAC1 receptor deficient mice to further elucidate the role of PACAP in the light mediated regulation of behavior and physiology of the circadian system. We compared circadian rhythms in mice equipped with running wheels or implanted radio-transmitter measuring core body temperature kept in a full photoperiod ((FPP)(12: 12 h light dark-cycles (LD)) and skeleton photo periods (SPP) at high and low light intensity. Furthermore, we examined the expression of PAC1- and VPAC2 receptors in the SCN of the different genotypes in combination with visualization of PACAP and VIP and determined whether compensatory changes in peptide and/or receptor expression in the reciprocal knockouts (KO) (PAC1 and VPAC2) had occurred. Our data demonstrate that in although being closely related at both ligand and receptor structure/sequence, PACAP/PAC1 receptor signaling are independent of VIP/VPAC2 receptor signaling and vice versa. Furthermore, lack of either of the receptors does not result in compensatory changes at neither the physiological or anatomical level. PACAP/PAC1 signaling is important for light regulated behavior, VIP/VPAC2signaling for stable clock function and both signaling pathways may play a role in shaping diurnality versus nocturnality.	[Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Hannibal, J (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark.	j.hannibal@dadlnet.dk	Hannibal, Jens/H-5482-2019	Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication	Danish Biotechnology Center for Cellular Communication	The Danish Biotechnology Center for Cellular Communication supported this work.; The Danish Biotechnology Center for Cellular Communication supported this work. We would also like to express our gratitude to Anita Hansen for excellent technical assistance.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; An S, 2012, J COMP NEUROL, V520, P2730, DOI 10.1002/cne.23078; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beaule C, 2009, J BIOL RHYTHM, V24, P126, DOI 10.1177/0748730409332037; Bechtold DA, 2008, AM J PHYSIOL-REG I, V294, pR344, DOI 10.1152/ajpregu.00667.2007; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; FAHRENKRUG J, 1995, REGUL PEPTIDES, V58, P89, DOI 10.1016/0167-0115(95)00052-D; Fahrenkrug J, 2012, J MOL NEUROSCI, V48, P584, DOI 10.1007/s12031-012-9804-7; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gompf HS, 2014, J BIOL RHYTHM; Hannibal J, 2014, J COMP NEUROL, V522, P2231, DOI [10.1002/cne.23588, 10.1002/cne.23555]; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; HANNIBAL J, 1995, REGUL PEPTIDES, V55, P133, DOI 10.1016/0167-0115(94)00099-J; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hannibal J, 2011, AM J PHYSIOL-REG I, V300, pR519, DOI 10.1152/ajpregu.00599.2010; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hughes ATL, 2008, J BIOL RHYTHM, V23, P211, DOI 10.1177/0748730408316290; Hughes ATL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14044; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188166	10.1371/journal.pone.0188166	http://dx.doi.org/10.1371/journal.pone.0188166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155851	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700033
J	Jung, HS; Hong, SM				Jung, Hyung-Sup; Hong, Soo-Min			Mapping three-dimensional surface deformation caused by the 2010 Haiti earthquake using advanced satellite radar interferometry	PLOS ONE			English	Article							MULTIPLE-APERTURE INTERFEROMETRY; SAR INTERFEROMETRY; IMPROVEMENT; RUPTURE; COMPLEX; NOISE; FAULT	Mapping three-dimensional (3D) surface deformation caused by an earthquake is very important for the environmental, cultural, economic and social sustainability of human beings. Synthetic aperture radar (SAR) systems made it possible to measure precise 3D deformations by combining SAR interferometry (InSAR) and multiple aperture interferometry (MAI). In this paper, we retrieve the 3D surface deformation field of the 2010 Haiti earthquake which occurred on January 12, 2010 by a magnitude 7.0 Mw by using the advanced interferometric technique that integrates InSAR and MAI data. The surface deformation has been observed by previous researchers using the InSAR and GPS method, but 3D deformation has not been measured yet due to low interferometric coherence. The combination of InSAR and MAI were applied to the ALOS PALSAR ascending and descending pairs, and were validated with the GPS in-situ measurements. The archived measurement accuracy was as little as 1.85, 5.49 and 3.08 cm in the east, north and up directions, respectively. This result indicates that the InSAR/MAI-derived 3D deformations are well matched with the GPS deformations. The 3D deformations are expected to allow us to improve estimation of the area affected by the 2010 Haiti earthquake.	[Jung, Hyung-Sup] Univ Seoul, Dept Geoinformat, Seoul, South Korea; [Hong, Soo-Min] Univ Seoul, Dept English Language & Literature, Seoul, South Korea	University of Seoul; University of Seoul	Hong, SM (corresponding author), Univ Seoul, Dept English Language & Literature, Seoul, South Korea.	soomhong@uos.ac.kr			Korea Meteorological Administration Research and Development Program [KMIPA2015-3071]	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA))	This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-3071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-3071.	Agram PS, 2015, J GEOPHYS RES-SOL EA, V120, P2752, DOI 10.1002/2014JB011271; Bechor NBD, 2006, GEOPHYS RES LETT, P33, DOI DOI 10.1029/2006G1026883; Boncori JPM, 2014, SEISMOL RES LETT, V86, P1; Calais E, 2010, NAT GEOSCI, V3, P794, DOI [10.1038/ngeo992, 10.1038/NGEO992]; Cavallo EA, 2010, IDB WORKING PAPERS S; Chae SH, 2017, IEEE J-STARS, V10, P3591, DOI 10.1109/JSTARS.2017.2690799; DesRoches R, 2011, EARTHQUAKE SPEC, V27, P325; Douilly R, 2015, J GEOPHYS RES-SOL EA, V120, P1108, DOI 10.1002/2014JB011595; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; Grandin R, 2016, GEOPHYS RES LETT, V43, P2552, DOI 10.1002/2016GL067954; Hashimoto M, 2011, NAT GEOSCI, V4, P255, DOI [10.1038/ngeo1115, 10.1038/NGEO1115]; Hayes GP, 2010, NAT GEOSCI, V3, P800, DOI [10.1038/ngeo977, 10.1038/NGEO977]; He LM, 2015, REMOTE SENS-BASEL, V7, P12440, DOI 10.3390/rs70912440; Hu J, 2013, IEEE T GEOSCI REMOTE, V51, P4226, DOI 10.1109/TGRS.2012.2227759; Jo MJ, 2015, REMOTE SENS-BASEL, V7, P14386, DOI 10.3390/rs71114386; Jo MJ, 2015, REMOTE SENS ENVIRON, V169, P176, DOI 10.1016/j.rse.2015.08.003; Jo MJ, 2015, J GEODESY, V89, P411, DOI 10.1007/s00190-014-0786-9; Jung HS, 2011, IEEE GEOSCI REMOTE S, V8, P34, DOI 10.1109/LGRS.2010.2051793; Jung HS, 2015, IEEE T GEOSCI REMOTE, V53, P6196, DOI 10.1109/TGRS.2015.2435776; Jung HS, 2015, IEEE J-STARS, V8, P1743, DOI 10.1109/JSTARS.2015.2399249; Jung HS, 2015, IEEE T GEOSCI REMOTE, V53, P4952, DOI 10.1109/TGRS.2015.2413948; Jung HS, 2014, SENSORS-BASEL, V14, P17703, DOI 10.3390/s140917703; Jung HS, 2013, IEEE T GEOSCI REMOTE, V51, P3191, DOI 10.1109/TGRS.2012.2218660; Jung HS, 2013, IEEE T GEOSCI REMOTE, V51, P573, DOI 10.1109/TGRS.2012.2197861; Jung HS, 2009, IEEE T GEOSCI REMOTE, V47, P2859, DOI 10.1109/TGRS.2009.2016554; Kocel E, 2016, INTERPRETATION-J SUB, V4, pT49, DOI 10.1190/INT-2015-0038.1; Liu Z, 2014, IEEE T GEOSCI REMOTE, V52, P3421, DOI 10.1109/TGRS.2013.2272791; Morishita Y, 2016, GEOPHYS RES LETT, V43, P4197, DOI 10.1002/2016GL068293; Prentice CS, 2010, NAT GEOSCI, V3, P789, DOI [10.1038/ngeo991, 10.1038/NGEO991]; Wang XW, 2015, REMOTE SENS ENVIRON, V170, P388, DOI 10.1016/j.rse.2015.09.024; Wang XW, 2014, REMOTE SENS ENVIRON, V152, P174, DOI 10.1016/j.rse.2014.06.014; Wdowinski S, 2010, POSTSEISMIC DEFORMAT; Wright TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018827; Zhou W, 2015, SUSTAINABILITY-BASEL, V7, P1712, DOI 10.3390/su7021712	34	25	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188286	10.1371/journal.pone.0188286	http://dx.doi.org/10.1371/journal.pone.0188286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145475	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800105
J	Savic, M; Dembinski, JL; Laake, I; Hungnes, O; Cox, R; Oftung, F; Trogstad, L; Mjaaland, S				Savic, Miloje; Dembinski, Jennifer L.; Laake, Ida; Hungnes, Olav; Cox, Rebecca; Oftung, Fredrik; Trogstad, Lill; Mjaaland, Siri			Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELL; A VIRUS; RESPONSES; SUBSET	' Maternal influenza infection during pregnancy is associated with increased risk of morbidity and mortality. However, the link between the anti-influenza immune responses and health-related risks during infection is not well understood. We have analyzed memory T and NK cell mediated immunity (CMI) responses in pandemic influenza A(H1N1) pdm09 (pdm09) virus infected non-vaccinated pregnant women participating in the Norwegian Influenza Pregnancy Cohort (NorFlu). The cohort includes information on immunization, self-reported health and disease status, and biological samples (plasma and PBMC). Infected cases (N = 75) were defined by having a serum hemagglutination inhibition (HI) titer > = 20 to influenza pdm09 virus at the time of delivery, while controls (N = 75) were randomly selected among non-infected pregnant women (HI titer < 10). In ELISpot assays cases had higher frequencies of IFN gamma(+) CD8(+) T cells responding to pdm09 virus or conserved CD8 T cell-restricted influenza A virus epitopes, compared to controls. Within this T cell population, frequencies of CD95(+) late effector (CD45RA(+)CCR7(-)) and naive (CD45RA(+)CCR7(+)) CD8(+) memory T cells correlated inversely with self-reported influenza illness (ILI) symptoms. ILI symptoms in infected women were also associated with lower numbers of poly-functional (IFN gamma(+) TNF alpha(+), IL2+IFN gamma(+), IL2(+)IFN gamma+TNF alpha(+)) CD4(+) T cells and increased frequencies of IFN gamma(+)CD3(-)CD7(+) NK cells compared to asymptomatic cases, or controls, after stimulation with the pdm09 virus. Taken together, virus specific and functionally distinct T and NK cell populations may serve as cellular immune correlates of clinical outcomes of pandemic influenza disease in pregnant women. Our results may provide information important for future universal influenza vaccine design.	[Savic, Miloje; Dembinski, Jennifer L.; Laake, Ida; Hungnes, Olav; Oftung, Fredrik; Trogstad, Lill; Mjaaland, Siri] Norwegian Inst Publ Hlth, Infect Control & Environm Hlth, Oslo, Norway; [Savic, Miloje; Dembinski, Jennifer L.; Cox, Rebecca; Oftung, Fredrik; Mjaaland, Siri] KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway; [Cox, Rebecca] Univ Bergen, Influenza Ctr, Dept Clin Sci, Bergen, Norway; [Cox, Rebecca] Haukeland Hosp, Dept Res & Dev, Bergen, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; Haukeland University Hospital	Savic, M; Mjaaland, S (corresponding author), Norwegian Inst Publ Hlth, Infect Control & Environm Hlth, Oslo, Norway.; Savic, M; Mjaaland, S (corresponding author), KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway.	miloje.savic@fhi.no; siri.mjaaland@fhi.no		Mjaaland, Siri/0000-0002-3870-5861; Dembinski, Jennifer/0000-0001-9259-9572	Research Council of Norway [221122/H10]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway Award Grant No. 221122/H10.	Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; BENNETT S, 1992, J IMMUNOL METHODS, V146, P229, DOI 10.1016/0022-1759(92)90232-I; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dembinski JL, 2014, J VIROL METHODS, V207, P232, DOI 10.1016/j.jviromet.2014.07.003; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kay AW, 2014, P NATL ACAD SCI USA, V111, P14506, DOI 10.1073/pnas.1416569111; Kim JC, 2014, VIROLOGY, V448, P74, DOI 10.1016/j.virol.2013.10.001; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Savic M, 2016, IMMUNOLOGY, V147, P165, DOI 10.1111/imm.12548; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tilburgs T, 2013, AM J REPROD IMMUNOL, V69, P395, DOI 10.1111/aji.12094; Tilburgs T, 2010, J IMMUNOL, V185, P4470, DOI 10.4049/jimmunol.0903597; Trifonov V, 2009, EURO SURVEILL, V14; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yao Y, 2015, IMMUNOL CELL BIOL; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121; [No title captured]	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188055	10.1371/journal.pone.0188055	http://dx.doi.org/10.1371/journal.pone.0188055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145441	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800058
J	Zou, L; Linck, V; Zhai, YJ; Galarza-Paez, L; Li, LD; Yue, Q; Al-Khalili, O; Bao, HF; Ma, HP; Thai, TL; Jiao, JD; Eaton, DC				Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Jiao, Jundong; Eaton, Douglas C.			Knockout of mitochondrial voltage-dependent anion channel type 3 increases reactive oxygen species (ROS) levels and alters renal sodium transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); hypertension; mitochondria; reactive oxygen species (ROS); voltage-dependent anion channel (VDAC); VDAC3-knockout mice; dietary salt	INTERMEMBRANE SPACE; ENAC ACTIVITY; HYPERTENSION; RELEASE; MECHANISMS; SUBUNIT; MUSCLES; DAMAGE; CELLS; VDAC3	It has been suggested that voltage-dependent anion channels (VDACs) control the release of superoxide from mitochondria. We have previously shown that reactive oxygen species (ROS) such as superoxide (O2.) and hydrogen peroxide (H2O2) stimulate epithelial sodium channels (ENaCs) in sodium-transporting epithelial tissue, including cortical collecting duct (CCD) principal cells. Therefore, we hypothesized that VDACs could regulate ENaC by modulating cytosolic ROS levels. Herein, we find that VDAC3-knockout(KO) mice can maintain normal salt and water balance on low-salt and high-salt diets. However, on a high-salt diet for 2 weeks, VDAC3-KO mice had significantly higher systolic blood pressure than wildtype mice. Consistent with this observation, after a high-salt diet for 2 weeks, ENaC activity in VDAC3-KO mice was significantly higher than wildtype mice. EM analysis disclosed a significant morphological change of mitochondria in the CCD cells of VDAC3-KO mice compared with wildtype mice, which may have been caused by mitochondrial superoxide overload. Of note, compared with wildtype animals, ROS levels in VDAC3-KO animals fed a normal or high-salt diet were consistently and significantly increased in renal tubules. Both the ROS scavenger 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine (TEMPOL) and the mitochondrial ROS scavenger (2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride (mito-TEMPO) could reverse the effect of high-salt on ENaC activity and systolic blood pressure in the VDAC3-KO mice. Mito-TEMPO partially correct the morphological changes in VDAC3-KO mice. Our results suggest that knocking out mitochondrial VDAC3 increases ROS, alters renal sodium transport, and leads to hypertension.	[Zou, Li; Jiao, Jundong] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China; [Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Sch Med, Ctr Cell & Mol Signaling, Atlanta, GA 30322 USA; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Emory University; Emory University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Eaton, DC (corresponding author), Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	jiaojundong@163.com; deaton@emory.edu		Linck, Valerie/0000-0001-8029-3461	National Institutes of Health [R37DK037963, R01-DK100582]; Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC); Emory College of Arts and Sciences; Emory University School of Medicine; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000454, S10 RR025679]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR002378] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037963, R25DK101390, R01DK100582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC); Emory College of Arts and Sciences; Emory University School of Medicine; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R37DK037963 (to D. C. E.) and R01-DK100582 (to H.-P. M.), in part by the Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC), which is subsidized by the Emory College of Arts and Sciences and the Emory University School of Medicine and is one of the Emory Integrated Core Facilities, and National Center for Advancing Translational Sciences, National Institutes of Health Grants UL1TR000454 and S10 RR025679. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Anflous-Pharayra K, 2011, BBA-BIOENERGETICS, V1807, P150, DOI 10.1016/j.bbabio.2010.09.007; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Downs CA, 2015, AM J PHYSIOL-LUNG C, V308, pL943, DOI 10.1152/ajplung.00213.2014; Downs CA, 2013, AM J PHYSIOL-LUNG C, V305, pL595, DOI 10.1152/ajplung.00212.2013; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063; Imaizumi Y, 2016, J CLIN HYPERTENS, V18, P315, DOI 10.1111/jch.12668; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Ling BN, 1997, J BIOL CHEM, V272, P594; Loperena R, 2017, MED CLIN N AM, V101, P169, DOI 10.1016/j.mcna.2016.08.004; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Mironova Elena, 2013, Methods Mol Biol, V998, P341, DOI 10.1007/978-1-62703-351-0_27; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Owusu-Ansah E., 2008, RES SQ; Pagano A, 2004, AM J PHYSIOL-LUNG C, V286, pL275, DOI 10.1152/ajplung.00181.2003; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Thai TL, 2015, J BIOL CHEM, V290, P28805, DOI 10.1074/jbc.M115.668293; Uetake Y, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0002-9; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	35	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1666	1675		10.1074/jbc.M117.798645	http://dx.doi.org/10.1074/jbc.M117.798645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29180450	Green Published, hybrid			2022-12-26	WOS:000424201700018
J	Cocuzza, CE; Martinelli, M; Sina, F; Piana, A; Sotgiu, G; Dell'Anna, T; Musumeci, R				Cocuzza, Clementina Elvezia; Martinelli, Marianna; Sina, Federica; Piana, Andrea; Sotgiu, Giovanni; Dell'Anna, Tiziana; Musumeci, Rosario			Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia	PLOS ONE			English	Article							VIRAL LOAD; PERIPHERAL-BLOOD; HPV DNA; CANCER PATIENTS; LUNG-CANCER; QUANTITATION; INFECTION; PCR; HEAD; CARCINOMA	Circulating HPV DNA has been previously described in women with advanced stages of cervical cancer and has been suggested to be a prognostic marker of disease recurrences and metastases. Only a few studies have reported the presence of HPV DNA in bloodstream of patients with low grade or precancerous cervical lesions. This study aimed to define if HPV DNA could be detected in plasma samples of 120 women referred for a recent history of cervical dysplasia who presented with lesions ranging from High Squamous Intraepithelial Lesion (H-SIL) to regressed normal cytology. HPV DNA detection was carried out in both plasma and cervical samples using type-specific real-time quantitative PCR assays identifying oncogenic HPV 16, 18, 31, 33, 45, 51 and 52. Overall, 34.2% (41/120) of plasma samples were shown to be positive for HPV DNA detection; HPV 45 (46.3%), HPV-51 (29.6%), and HPV 16 (18.5%) were the most frequently identified genotypes. The rate of HPV detection in paired cervical and plasma samples increased with advancing disease stage, ranging from 15.4% in women with regressed lesions to 38.9% in women with HSIL; HPV 16 resulted the most common genotype identified in women found to be HPV DNA positive in both cervical and plasma samples. Moreover, HPV 16 showed the highest median viral load value in both cervical and plasma samples, with 48,313 copies/10(4) cells and 1,099 copies/ml, respectively. Results obtained in this study confirm that HPV DNA can be detected and quantified in plasma samples of women with asymptomatic cervical infection. Further knowledge on HPV dissemination through the blood stream of women with cervical lesions would be very important in better understanding the natural history of HPV infection as well as its potential role in other distant tumors.	[Cocuzza, Clementina Elvezia; Martinelli, Marianna; Musumeci, Rosario] Univ Milano Bicocca, Sch Med, Dept Med & Surg, Monza, Italy; [Sina, Federica; Dell'Anna, Tiziana] ASST Monza, San Gerardo Hosp, Obstet & Gynaecol Dept, Monza, Italy; [Piana, Andrea; Sotgiu, Giovanni] Univ Sassari, Dept Biomed Sci, Sassari, Italy	University of Milano-Bicocca; San Gerardo Hospital; University of Sassari	Cocuzza, CE (corresponding author), Univ Milano Bicocca, Sch Med, Dept Med & Surg, Monza, Italy.	clementina.cocuzza@unimib.it	Martinelli, Marianna/AAD-5306-2019; Musumeci, Rosario/B-8306-2008; Cocuzza, Clementina Elvezia/AAE-2064-2019; Sotgiu, Giovanni/N-1032-2017	Martinelli, Marianna/0000-0003-2273-6986; Musumeci, Rosario/0000-0003-0143-3601; Cocuzza, Clementina Elvezia/0000-0001-6166-1134; Sotgiu, Giovanni/0000-0002-1600-4474; PIANA, Andrea Fausto/0000-0002-6609-8886				Bodaghi S, 2005, J CLIN MICROBIOL, V43, P5428, DOI 10.1128/JCM.43.11.5428-5434.2005; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Broccolo F, 2009, J MED VIROL, V81, P278, DOI 10.1002/jmv.21395; Broccolo F, 2008, J VIROL METHODS, V148, P48, DOI 10.1016/j.jviromet.2007.10.003; Capone RB, 2000, CLIN CANCER RES, V6, P4171; Chen ACH, 2009, J MED VIROL, V81, P1792, DOI 10.1002/jmv.21592; Chiou HL, 2003, CANCER, V97, P1558, DOI 10.1002/cncr.11191; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Cocuzza CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094497; Cuzick J, 2000, JAMA-J AM MED ASSOC, V283, P108, DOI 10.1001/jama.283.1.108; Dong SM, 2002, CANCER EPIDEM BIOMAR, V11, P3; Flores-Munguia R, 2004, J MOL DIAGN, V6, P115, DOI 10.1016/S1525-1578(10)60499-0; Foresta C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-593; Gnanamony M, 2010, GYNECOL ONCOL, V116, P447, DOI 10.1016/j.ygyno.2009.10.081; Ho CM, 2005, GYNECOL ONCOL, V99, P615, DOI 10.1016/j.ygyno.2005.07.004; Ilahi NE, 2016, J CANCER RES CLIN, V142, P2497, DOI 10.1007/s00432-016-2251-z; Jeannot E, 2016, J PATHOL CLIN RES, V2, P201, DOI 10.1002/cjp2.47; Kay P, 2005, J MED VIROL, V75, P435, DOI 10.1002/jmv.20294; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Ludmir EB, 2015, J GASTROINTEST ONCOL, V6, P287, DOI 10.3978/j.issn.2078-6891.2015.001; Luo HX, 2017, J LOW GENIT TRACT DI, V21, P12, DOI 10.1097/LGT.0000000000000277; Mazurek AM, 2016, ORAL ONCOL, V54, P36, DOI 10.1016/j.oraloncology.2015.12.002; PAO CC, 1991, AM J CLIN PATHOL, V95, P540, DOI 10.1093/ajcp/95.4.540; Piana AF, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0190-3; Pornthanakasem W, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-2; Rintala MAM, 2004, INT J STD AIDS, V15, P740, DOI 10.1258/0956462042395122; Roperto S, 2011, J GEN VIROL, V92, P1787, DOI 10.1099/vir.0.031740-0; Sathish N, 2004, J CLIN VIROL, V31, P204, DOI 10.1016/j.jcv.2004.03.013; Smith JHF, 2002, CYTOPATHOLOGY, V13, P4, DOI 10.1046/j.1365-2303.2002.00397.x; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; TSENG CJ, 1992, AM J OBSTET GYNECOL, V166, P35, DOI 10.1016/0002-9378(92)91825-U; van der Weele P, 2016, J CLIN VIROL, V83, P6, DOI 10.1016/j.jcv.2016.07.020; Wei YC, 2007, INT J GYNECOL OBSTET, V96, P112, DOI 10.1016/j.ijgo.2006.08.012; Widschwendter A, 2003, CANCER LETT, V202, P231, DOI 10.1016/j.canlet.2003.09.006; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	36	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188592	10.1371/journal.pone.0188592	http://dx.doi.org/10.1371/journal.pone.0188592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182627	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000041
J	Woodcock, TM; Frugier, T; Nguyen, TT; Semple, BD; Bye, N; Massara, M; Savino, B; Besio, R; Sobacchi, C; Locati, M; Morganti-Kossmann, MC				Woodcock, Thomas M.; Frugier, Tony; Tan Thanh Nguyen; Semple, Bridgette Deanne; Bye, Nicole; Massara, Matteo; Savino, Benedetta; Besio, Roberta; Sobacchi, Cristina; Locati, Massimo; Morganti-Kossmann, Maria Cristina			The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CLOSED-HEAD INJURY; AXONAL INJURY; CUTTING EDGE; D6; INFLAMMATION; EXPRESSION; ASTROCYTES; MCP-1; MICE	The atypical chemokine receptor ACKR2 promotes resolution of acute inflammation by operating as a scavenger receptor for inflammatory CC chemokines in several experimental models of inflammatory disorders, however its role in the brain remains unclear. Based on our previous reports of increased expression of inflammatory chemokines and their corresponding receptors following traumatic brain injury (TBI), we hypothesised that ACKR2 modulates neuroinflammation following brain trauma and that its deletion exacerbates cellular inflammation and chemokine production. We demonstrate increased CCL2 and ACKR2 mRNA expression in post-mortem human brain, whereby ACKR2 mRNA levels correlated with later times post-TBI. This data is consistent with the transient upregulation of ACKR2 observed in mouse brain after closed head injury (CHI). As compared to WT animals, ACKR2(-/-) mice showed a higher mortality rate after CHI, while the neurological outcome in surviving mice was similar. At day 1 post-injury, ACKR2(-/-) mice displayed aggravated lesion volume and no differences in CCL2 expression and macrophage recruitment relative to WT mice. Reciprocal regulation of ACKR2 and CCL2 expression was explored in cultured astrocytes, which are recognized as the major source of CCL2 and also express ACKR2. ACKR2 mRNA increased as early as 2 hours after an inflammatory challenge in WT astrocytes. As expected, CCL2 expression also dramatically increased at 4 hours in WT astrocytes but was significantly lower in ACKR2(-/-) astrocytes, possibly indicating a co-regulation of CCL2 and ACKR2 in these cells. Conversely, in vivo, CCL2 mRNA/ protein levels were increased similarly in ACKR2(-/-) and WT brains at 4 and 12 hours after CHI, in line with the lack of differences in cerebral macrophage recruitment and neurological recovery. In conclusion, ACKR2 is induced after TBI and has a significant impact on mortality and lesion development acutely following CHI, while its role in chemokine expression, macrophage activation, brain pathology, and neurological recovery at later time-points is minor. Concordant to evidence in multiple sclerosis experimental models, our data corroborate a distinct role for ACKR2 in cerebral inflammatory processes compared to its reported functions in peripheral tissues.	[Woodcock, Thomas M.; Tan Thanh Nguyen] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Woodcock, Thomas M.; Tan Thanh Nguyen] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Frugier, Tony] Univ Melbourne, Sch Biomed Sci, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Semple, Bridgette Deanne] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Bye, Nicole] Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas, Australia; [Massara, Matteo; Savino, Benedetta; Sobacchi, Cristina; Locati, Massimo] Humanitas Clin & Res Ctr, Rozzano, Italy; [Massara, Matteo; Savino, Benedetta; Locati, Massimo] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Besio, Roberta] Univ Pavia, Dept Mol Med, Pavia, Italy; [Sobacchi, Cristina] CNR, Ist Ric Genet, Milan, Italy; [Sobacchi, Cristina] CNR, Biomed Milan Unit, Milan, Italy; [Morganti-Kossmann, Maria Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria Cristina] Monash Univ, Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria Cristina] Univ Arizona, Barrow Neurol Inst, Dept Child Hlth, Phoenix, AZ 85004 USA	Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Tasmania; IRCCS Humanitas Research Hospital; University of Milan; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Monash University; Monash University; Barrow Neurological Institute; University of Arizona	Locati, M (corresponding author), Humanitas Clin & Res Ctr, Rozzano, Italy.; Locati, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.; Morganti-Kossmann, MC (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Morganti-Kossmann, MC (corresponding author), Monash Univ, Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia.; Morganti-Kossmann, MC (corresponding author), Univ Arizona, Barrow Neurol Inst, Dept Child Hlth, Phoenix, AZ 85004 USA.	massimo.locati@unimi.it; cristina.morganti-kossmann@monash.edu	Besio, Roberta/AAQ-7151-2020; SOBACCHI, CRISTINA/J-9345-2018; Locati, Massimo/ABF-6807-2021; Massara, Matteo/P-5023-2018; Savino, Benedetta/AGP-4952-2022; Savino, Benedetta/K-4488-2014; Locati, Massimo/H-8404-2015	Besio, Roberta/0000-0003-1430-2934; SOBACCHI, CRISTINA/0000-0002-2684-7184; Massara, Matteo/0000-0001-6724-5633; Savino, Benedetta/0000-0002-2996-9515; Savino, Benedetta/0000-0002-2996-9515; Locati, Massimo/0000-0003-3077-590X; Semple, Bridgette/0000-0002-2535-0491; Morganti-Kossmann, Cristina/0000-0002-0807-2063	Victorian Neurotrauma Initiative/Traffic Accident Commission; Neurotrauma Tissue/Fluid bank within the National Neural Tissue Resource Centre [D003]; European Community; Australian Postgraduate Award	Victorian Neurotrauma Initiative/Traffic Accident Commission; Neurotrauma Tissue/Fluid bank within the National Neural Tissue Resource Centre; European Community(European Commission); Australian Postgraduate Award(Australian Government)	The Victorian Neurotrauma Initiative/Traffic Accident Commission provided funding for Research Fellowships to MCM-K and NB, and for the establishment of the Neurotrauma Tissue/Fluid bank within the National Neural Tissue Resource Centre, Project Grant D003. The European Community's Seventh Framework Program (FP7/2007-2013, SYBIL and TIMER projects) provided funding to CS and ML, and the Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche (Aging project) to CS. BS was the recipient of the Australian Postgraduate Award during the course of her PhD.	ALOISI F, 1992, J IMMUNOL, V149, P2358; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Berres ML, 2009, BIOL CHEM, V390, P1039, DOI 10.1515/BC.2009.119; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bordon Y, 2009, J IMMUNOL, V182, P5032, DOI 10.4049/jimmunol.0802802; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calvo CF, 1996, EUR J NEUROSCI, V8, P1725, DOI 10.1111/j.1460-9568.1996.tb01316.x; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fouillet A, 2012, BRAIN RES, V1437, P115, DOI 10.1016/j.brainres.2011.11.049; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hansell CAH, 2011, BLOOD, V117, P5413, DOI 10.1182/blood-2010-11-317115; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kiyota T, 2013, NEUROBIOL AGING, V34, P1060, DOI 10.1016/j.neurobiolaging.2012.08.009; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Lo Iacono N, 2012, J BONE MINER RES, V27, P2501, DOI 10.1002/jbmr.1712; Long YS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8749417; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; McKimmie CS, 2006, BIOCHEM SOC T, V34, P1002, DOI 10.1042/BST0341002; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; McKimmie CS, 2008, J IMMUNOL, V181, P8170, DOI 10.4049/jimmunol.181.11.8170-a; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Otto VI, 2002, J NEUROCHEM, V80, P824, DOI 10.1046/j.0022-3042.2001.00748.x; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Semple BD, 2010, J CEREBRAL BLOOD FLO, P30; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Sul OJ, 2012, J CELL PHYSIOL, V227, P1619, DOI 10.1002/jcp.22879; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Wang Lei, 2002, Hematology, V7, P113; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yoshimura T, 1992, Cytokines, V4, P131; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188305	10.1371/journal.pone.0188305	http://dx.doi.org/10.1371/journal.pone.0188305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176798	Green Published, Green Accepted, gold			2022-12-26	WOS:000416291900059
J	Swaminathan, S; Qirko, K; Smith, T; Corcoran, E; Wysham, NG; Bazaz, G; Kappel, G; Gerber, AN				Swaminathan, Sumanth; Qirko, Klajdi; Smith, Ted; Corcoran, Ethan; Wysham, Nicholas G.; Bazaz, Gaurav; Kappel, George; Gerber, Anthony N.			A machine learning approach to triaging patients with chronic obstructive pulmonary disease	PLOS ONE			English	Article							SELF-MANAGEMENT; LUNG-FUNCTION; COPD; EXACERBATION; PREDICTION	COPD patients are burdened with a daily risk of acute exacerbation and loss of control, which could be mitigated by effective, on-demand decision support tools. In this study, we present a machine learning-based strategy for early detection of exacerbations and subsequent triage. Our application uses physician opinion in a statistically and clinically comprehensive set of patient cases to train a supervised prediction algorithm. The accuracy of the model is assessed against a panel of physicians each triaging identical cases in a representative patient validation set. Our results show that algorithm accuracy and safety indicators surpass all individual pulmonologists in both identifying exacerbations and predicting the consensus triage in a 101 case validation set. The algorithm is also the top performer in sensitivity, specificity, and ppv when predicting a patient's need for emergency care.	[Swaminathan, Sumanth; Qirko, Klajdi; Smith, Ted; Bazaz, Gaurav; Kappel, George] Revon Syst Inc, Louisville, KY 40014 USA; [Swaminathan, Sumanth; Qirko, Klajdi] Univ Delaware, Dept Math, Newark, DE 19716 USA; [Corcoran, Ethan] Kaiser Permanente, Dept Pulmonol, Clackamas, OR 97015 USA; [Wysham, Nicholas G.] Vancouver Clin, Div Pulmonol & Crit Care, Vancouver, WA 98664 USA; [Wysham, Nicholas G.] Washington State Univ, Sch Med, Spokane, WA 99210 USA; [Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Delaware; Kaiser Permanente; Washington State University; National Jewish Health	Swaminathan, S (corresponding author), Revon Syst Inc, Louisville, KY 40014 USA.; Swaminathan, S (corresponding author), Univ Delaware, Dept Math, Newark, DE 19716 USA.	sumanth@revonsystems.net	Smith, Ted/GQQ-7242-2022	Smith, Ted/0000-0003-2804-4294				Alwashmi M, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5921; Ambrosino N, 2016, BREATHE, V12, P351, DOI 10.1183/20734735.014616; American Thoracic Society, 2016, COPD ASS TEST CAT; Ardestani ME, 2014, J RES MED SCI, V19, P257; Australian Lung Foundation, 2015, COPD ACT PLAN; Bahadori K, 2007, INT J CHRONIC OBSTR, V2, P241; Balkissoon R, 2011, MED CLIN N AM, V95, P1125, DOI 10.1016/j.mcna.2011.08.009; Canadian Lung Association, 2016, BCMJ, V58, P39; Cavailles A, 2013, EUR RESPIR REV, V22, P454, DOI 10.1183/09059180.00008612; DocTot and Global Initiative for Chronic Obstructive Lung Disease, 2016, GOLD COPD STRATEGY; Dransfield MT, 2017, AM J RESP CRIT CARE, V195, P324, DOI 10.1164/rccm.201605-1014OC; Falaschetti E, 2004, EUR RESPIR J, V23, P456, DOI 10.1183/09031936.04.00055204; Finkelstein J, 2017, ANN NY ACAD SCI, V1387, P153, DOI 10.1111/nyas.13218; Guerra B, 2017, EUROPEAN RESP REV, V26, P1; Gupta SS, 2017, LUNG INDIA, V31, P29; Hamine Saee, 2015, J Med Internet Res, V17, pe52, DOI 10.2196/jmir.3951; Henny S, 2016, EUROPEAN RESP J, V48; Kaplan A, 2009, CAN FAM PHYSICIAN, V55, P58; Keene JD, 2017, AJRCCM, V195; Kerkhof M, 2015, INT J CHRONIC OBSTR, V10, P2439, DOI 10.2147/COPD.S94259; Lange P, 2014, EUR RESPIR J, V43, P1590, DOI 10.1183/09031936.00196713; Launois C, 2012, BMC PULM MED, V12, P1; Makris S, 2009, BMC PULM MED, V9, P1; Mcsharry DG, 2012, RESPIROLOGY, V17, P1119, DOI 10.1111/j.1440-1843.2012.02217.x; Mt Sinai & National Jewish Health Respiratory Institute, 2016, COPD NAV; Nici Linda, 2014, Ann Am Thorac Soc, V11, P101, DOI 10.1513/AnnalsATS.201306-150FR; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pedone Claudio, 2015, Pneumonol Alergol Pol, V83, P476, DOI 10.5603/PiAP.2015.0077; Pinnock H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6070; Porter Joan, 2007, Healthc Q, V10, P26; Rennard Stephen I, 2004, Proc Am Thorac Soc, V1, P88, DOI 10.1513/pats.2306026; Roche N, 2008, EUR RESPIR J, V32, P953, DOI 10.1183/09031936.00129507; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Sobnath DD, 2017, JMIR MHEALTH UHEALTH, V5, P1; Sohrabi K, 2015, STUD HEALTH TECHNOL, V212, P141, DOI 10.3233/978-1-61499-524-1-141; Song XW, 2004, STUD HEALTH TECHNOL, V107, P736; Stiell IG, 2014, CAN MED ASSOC J, V186, pE193, DOI 10.1503/cmaj.130968; Turnock AC, 2005, COCKRANE DATABASE SY, V19; Urwyler P, 2016, EUROPEAN RESP J, V48; Velickovski F, 2014, J TRANSL MED, V12, P81; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vianello A, 2016, BMC PULM MED, V16, P1; Walters JAE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005074.pub3; Watson PB, 1997, EUR RESPIR J, V10, P1267, DOI 10.1183/09031936.97.10061267; Watz H, 2016, LANCET RESP MED, V4, P390, DOI 10.1016/S2213-2600(16)00100-4; Weng S F, 2017, PLOS ONE, V12; World Health Organization, 2011, 2 GLOB SURV EHEALTH; World Health Organization, 2007, 2021 CURR STAT ISS C	48	37	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188532	10.1371/journal.pone.0188532	http://dx.doi.org/10.1371/journal.pone.0188532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166411	Green Submitted, Green Published, gold			2022-12-26	WOS:000416035300047
J	Soscia, D; Belle, A; Fischer, N; Enright, H; Sales, A; Osburn, J; Benett, W; Mukerjee, E; Kulp, K; Pannu, S; Wheeler, E				Soscia, D.; Belle, A.; Fischer, N.; Enright, H.; Sales, A.; Osburn, J.; Benett, W.; Mukerjee, E.; Kulp, K.; Pannu, S.; Wheeler, E.			Controlled placement of multiple CNS cell populations to create complex neuronal cultures	PLOS ONE			English	Article							HIPPOCAMPAL; NETWORKS; PATTERNS; BIOLOGY; TISSUES; SYSTEMS; ORGANS; CHIP; DRUG	In vitro brain-on-a-chip platforms hold promise in many areas including: drug discovery, evaluating effects of toxicants and pathogens, and disease modelling. A more accurate recapitulation of the intricate organization of the brain in vivo may require a complex in vitro system including organization of multiple neuronal cell types in an anatomically-relevant manner. Most approaches for compartmentalizing or segregating multiple cell types on microfabricated substrates use either permanent physical surface features or chemical surface functionalization. This study describes a removable insert that successfully deposits neurons from different brain areas onto discrete regions of a microelectrode array (MEA) surface, achieving a separation distance of 100 mu m. The regional seeding area on the substrate is significantly smaller than current platforms using comparable placement methods. The non-permanent barrier between cell populations allows the cells to remain localized and attach to the substrate while the insert is in place and interact with neighboring regions after removal. The insert was used to simultaneously seed primary rodent hippocampal and cortical neurons onto MEAs. These cells retained their morphology, viability, and function after seeding through the cell insert through 28 days in vitro (DIV). Co-cultures of the two neuron types developed processes and formed integrated networks between the different MEA regions. Electrophysiological data demonstrated characteristic bursting features and waveform shapes that were consistent for each neuron type in both mono-and co-culture. Additionally, hippocampal cells co-cultured with cortical neurons showed an increase in within-burst firing rate (p = 0.013) and percent spikes in bursts (p = 0.002), changes that imply communication exists between the two cell types in co-culture. The cell seeding insert described in this work is a simple but effective method of separating distinct neuronal populations on microfabricated devices, and offers a unique approach to developing the types of complex in vitro cellular environments required for anatomically-relevant brain-on-a-chip devices.	[Soscia, D.; Belle, A.; Benett, W.; Mukerjee, E.; Pannu, S.; Wheeler, E.] Lawrence Livermore Natl Lab, Engn Directorate, Livermore, CA 94550 USA; [Fischer, N.; Enright, H.; Sales, A.; Osburn, J.; Kulp, K.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Wheeler, E (corresponding author), Lawrence Livermore Natl Lab, Engn Directorate, Livermore, CA 94550 USA.; Kulp, K (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	kulp2@llnl.gov; wheeler16@llnl.gov	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390; Enright, Heather/0000-0001-6422-0481	U.S. Department of Energy, LDRD [14-SI-001]; U.S. Department of Energy by Lawrence Livermore National Laboratory through LDRD [14-SI-001, DE-AC52-07NA27344]	U.S. Department of Energy, LDRD(United States Department of Energy (DOE)); U.S. Department of Energy by Lawrence Livermore National Laboratory through LDRD(United States Department of Energy (DOE))	This study was supported by the U.S. Department of Energy, LDRD award 14-SI-001, https://st.llnl.gov/foundations/strategies/investments, to authors SP and EW.; We would like to thank Monica Moya for providing and staining hCMEC/D3 cells for use in the four-cell type funnel seeding. We would also like to thank Mona Huang and Ed Kuhn for their help in cell maintenance and electrophysiological recordings, respectively. Lastly, we would like to thank Julie Hamilton, Kerry Bettencourt, Ronnie Alferos, and Jeff Robinson for their microfabrication efforts. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 through LDRD award 14-SI-001. LLNL IM release # LLNL-JRNL-728613.	Bajaj P, 2016, ACS BIOMATER SCI ENG, V2, P473, DOI 10.1021/acsbiomaterials.5b00480; Bakkum DJ, 2013, NAT COMMUN, P4; Berdichevsky Y, 2010, LAB CHIP, V10, P999, DOI 10.1039/b922365g; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Boehler MD, 2012, J NEUROSCI METH, V203, P344, DOI 10.1016/j.jneumeth.2011.09.020; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Charlesworth P, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-014-0028-0; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Das AM, 2015, NAT PROTOC, V10, P904, DOI 10.1038/nprot.2015.056; Dauth S, 2016, JOURNAL OF NEUROPHYS; Defranchi E, 2011, FRONTIERS IN NEUROEN, V4; Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Enright HA, 2016, ANALYST, V141, P5346, DOI 10.1039/c5an01728a; Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Garcia-Munoz M, 2015, FRONTIERS IN SYSTEMS, P9; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Gullo F, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00087; Hammond MW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-38; Hannachi IE, 2009, BIOMATERIALS, V30, P5427, DOI 10.1016/j.biomaterials.2009.06.033; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024; Johnson BN, 2016, LAB CHIP, V16, P1393, DOI 10.1039/c5lc01270h; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mukai Y, 2003, ELECTR ENG JPN, V145, P28, DOI 10.1002/eej.10216; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Pimashkin A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00087; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Suzuki M, 2005, CEREB CORTEX, V15, P187, DOI 10.1093/cercor/bhh121; Suzuki M, 2008, BIOSENS BIOELECTRON, V24, P1043, DOI 10.1016/j.bios.2008.06.051; Swanson LW, 1995, TRENDS NEUROSCI, V23, P519; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Whalley BJ, 2006, NEUROSCIENCE, P140; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Yum K, 2014, BIOTECHNOL J, V9, P16, DOI 10.1002/biot.201300187; Zhu G, 2016, SCI REPORTS, P6	48	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188146	10.1371/journal.pone.0188146	http://dx.doi.org/10.1371/journal.pone.0188146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161298	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000031
J	Wybrecht, D; Reuter, F; Pariollaud, F; Zaaraoui, W; Le Troter, A; Rico, A; Confort-Gouny, S; Soulier, E; Guye, M; Maarouf, A; Ranjeva, JP; Pelletier, J; Audoin, B				Wybrecht, D.; Reuter, F.; Pariollaud, F.; Zaaraoui, W.; Le Troter, A.; Rico, A.; Confort-Gouny, S.; Soulier, E.; Guye, M.; Maarouf, A.; Ranjeva, J-P.; Pelletier, J.; Audoin, B.			New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; NEUROPSYCHOLOGICAL ASSESSMENT; IMPAIRMENT; MRI; DYSFUNCTION; DISCONNECTION; PATHOLOGY; ATROPHY; BURDEN	Objective In early multiple sclerosis, although brain T2 lesions accrual are hallmark of the disease, only weak correlations were found between T2 lesions accrual and EDSS progression, the disability scale commonly used in multiple sclerosis studies. This may be related to the very poor sensitivity of EDSS to cognitive dysfunctions that may occur and progress from the first stage of the disease. In the present study, we aimed to demonstrate that cognitive deficits progress during the first ten years of MS and are significantly impacted by new T2 lesions. Methods EDSS and extensive neuropsychological battery (22 measures) exploring memory, attention/ speed of information processing and executive functions were assessed at baseline, Year 1 and Year 10 in 26 patients enrolled after their first clinical attack. To limit the bias of test-retest effect, only measures obtained at Year 1 and Year 10 were reported in the analysis. Raw scores of patients were transformed into z-scores using published normative data when available or scores of matched controls. Lesion probability mapping was used to assess the potential relationships between T2 lesions accumulation, cognitive decline and EDSS progression (P<0.05, FWE-corrected). Results At Year 1, 27% of patients showed attention/speed of information processing deficits, 11.5% executive dysfunction and 11.5% memory impairment. During the follow-up, frequency and severity of executive dysfunction increased (from 11.5% of patients at Year 1 to 42% at Year 10, p<0.01) while no significant changes were evidenced for the other cognitive domains. Median EDSS increased from 0.5 [range: 0-3] at Year 1 to 2.5 [range: 0-6.5] at Year 10 (p<0.001). During the ten-year follow-up, lesions accumulation in the left cerebellum and semi-ovale centers was associated with EDSS progression. In contrast, most lesions accumulation in the frontal, parietal and temporal lobes were associated with cognitive decline but had no effect on EDSS progression. Conclusion The present study provides strong evidence that clinically silent T2 lesions impact cognition in early MS. In daily practice, early prevention of T2 lesions accrual may be useful to limit cognitive decline.	[Wybrecht, D.; Reuter, F.; Pariollaud, F.; Zaaraoui, W.; Le Troter, A.; Rico, A.; Confort-Gouny, S.; Soulier, E.; Guye, M.; Maarouf, A.; Ranjeva, J-P.; Pelletier, J.; Audoin, B.] Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France; [Wybrecht, D.] Hop Instruct Armees St Anne, Toulon, France; [Reuter, F.; Pariollaud, F.; Rico, A.; Maarouf, A.; Pelletier, J.; Audoin, B.] Hop La Timone, AP HM, Pole Neurosci Clin, Serv Neurol, Marseille, France; [Guye, M.] Hop La Timone, AP HM, Pole Imagerie Med, CEMEREM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Hospital Instruction Of Armees Sainte-Anne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Wybrecht, D (corresponding author), Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France.; Wybrecht, D (corresponding author), Hop Instruct Armees St Anne, Toulon, France.	delphinewybrecht@gmail.com		le troter, arnaud/0000-0002-7897-9672	Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP); CNRS; Merck Serono France	Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP); CNRS(Centre National de la Recherche Scientifique (CNRS)); Merck Serono France	Dr. Pelletier serves on scientific advisory boards for Biogen Idec, Genzyme, Novartis and Teva. This study was supported by grants from the Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP) and CNRS, and was funded by an unconditional grant from Merck Serono France. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The data are ethically restricted because of medical confidentiality. Any request needs to be approved by our local Committee, named "Comite d'Ethique de la Timone." Requests for the data should be sent to the corresponding author. Dr Wybrecht, Dr Reuter, Dr Pariollaud, Dr Zaaraoui, Dr Le Troter, Dr Rico, Dr Maarouf, Dr Confort-Gouny, Dr Soulier, Dr Ranjeva, Dr Audoin, Dr Guye report no disclosures.	Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Adam S., 2004, EVALUATION TROUBLES; Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Bellmann-Strobl J, 2009, NEUROLOGY, V73, P1624, DOI 10.1212/WNL.0b013e3181c1de4f; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; CALLANAN MM, 1989, BRAIN, V112, P361, DOI 10.1093/brain/112.2.361; Garcia MC, 2015, ACTA NEUROL SCAND, V131, P313, DOI 10.1111/ane.12345; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Deloire MSA, 2011, NEUROLOGY, V76, P1161, DOI 10.1212/WNL.0b013e318212a8be; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; Hohol MJ, 1997, ARCH NEUROL-CHICAGO, V54, P1018, DOI 10.1001/archneur.1997.00550200074013; Hynicova E, 2017, J NEUROL, V264, P482, DOI 10.1007/s00415-016-8368-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li DKB, 2006, NEUROLOGY, V66, P1384, DOI 10.1212/01.wnl.0000210506.00078.5c; Lin X, 2008, J NEUROL NEUROSUR PS, V79, P437, DOI 10.1136/jnnp.2006.112177; Louapre C, 2014, HUM BRAIN MAPP, V35, P4706, DOI 10.1002/hbm.22505; LYONCAEN O, 1986, ARCH NEUROL-CHICAGO, V43, P1138, DOI 10.1001/archneur.1986.00520110034010; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Reuter F, 2011, J NEUROL NEUROSUR PS, V82, P1157, DOI 10.1136/jnnp.2010.213744; Reuter F, 2009, NEUROIMAGE, V44, P590, DOI 10.1016/j.neuroimage.2008.08.024; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Rovaris M, 2003, AM J NEURORADIOL, V24, P75; Rovaris M, 2002, J NEUROL SCI, V195, P103, DOI 10.1016/S0022-510X(01)00690-6; Sanchez MP, 2008, EUR J NEUROL, V15, P1091, DOI 10.1111/j.1468-1331.2008.02259.x; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Uher T, 2014, J NEUROL, V261, P1735, DOI 10.1007/s00415-014-7413-9; Wechsler DA, 1991, ECHELLE CLIN MEMOIRE; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0184650	10.1371/journal.pone.0184650	http://dx.doi.org/10.1371/journal.pone.0184650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149177	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100001
J	Brunner, SN; Bogert, NV; Schnitzbauer, AA; Juengel, E; Moritz, A; Werner, I; Kornberger, A; Beiras-Fernandez, A				Brunner, Stefanie N.; Bogert, Nicolai V.; Schnitzbauer, Andreas A.; Juengel, Eva; Moritz, Anton; Werner, Isabella; Kornberger, Angela; Beiras-Fernandez, Andres			Levosimendan protects human hepatocytes from ischemia-reperfusion injury	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; HEART-TRANSPLANTATION; PRESERVATION INJURY; LIVER ISCHEMIA; APOPTOSIS; FAILURE; BCL-2; MITOCHONDRIA; PROTEINS; CHANNELS	Background Ischemia-reperfusion injury (IRI) is a major challenge in liver transplantation. The mitochondrial pathway plays a pivotal role in hepatic IRI. Levosimendan, a calcium channel sensitizer, was shown to attenuate apoptosis after IRI in animal livers. The aim of this study was to investigate the effect of levosimendan on apoptosis in human hepatocytes. Methods Primary human hepatocytes were either exposed to hypoxia or cultured under normoxic conditions. After the hypoxic phase, reoxygenation was implemented and cells were treated with different concentrations of levosimendan (10ng/ml, 100ng/ml, 1000ng/ml). The overall metabolic activity of the cells was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and aspartate aminotransferase (AST) levels were determined in order to quantify hepatic injury. Fluorescence-activated cell sorting (FACS) analysis was applied to measure necrosis and apoptosis. Finally, Western blotting was performed to analyze apoptotic pathway proteins. Results Administration of levosimendan during reperfusion increases the metabolic activity of human hepatocytes and decreases AST levels. Moreover, apoptosis after IRI is reduced in treated vs. untreated hepatocytes, and levosimendan prevents down-regulation of the anti-apoptotic protein Bcl-2 as well as up-regulation of the pro-apoptotic protein BAX. Conclusion The present study suggests a protective effect of levosimendan on human hepatocytes. Our findings suggest that treatment with levosimendan during reperfusion attenuates apoptosis of human hepatocytes by influencing BAX and Bcl-2 levels.	[Brunner, Stefanie N.; Moritz, Anton; Werner, Isabella] Goethe Univ, Univ Hosp Frankfurt, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany; [Bogert, Nicolai V.] Ruprecht Karls Univ Heidelberg, Dept Cardiol, Univ Hosp Heidelberg, Heidelberg, Germany; [Schnitzbauer, Andreas A.] Goethe Univ, Univ Hosp Frankfurt, Clin Gen & Visceral Surg, Frankfurt, Germany; [Juengel, Eva] Johannes Gutenberg Univ Mainz, Dept Urol, Univ Hosp Mainz, Mainz, Germany; [Kornberger, Angela; Beiras-Fernandez, Andres] Johannes Gutenberg Univ Mainz, Dept Thorac & Cardiovasc Surg, Univ Hosp Mainz, Mainz, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Johannes Gutenberg University of Mainz; University Hospital Mainz; Johannes Gutenberg University of Mainz; University Hospital Mainz	Kornberger, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Thorac & Cardiovasc Surg, Univ Hosp Mainz, Mainz, Germany.	Angela.Kornberger@unimedizin-mainz.de	Beiras, Andres/AAE-4864-2020					Beiras-Fernandez A, 2008, TRANSPL P, V40, P951, DOI 10.1016/j.transproceed.2008.03.106; Beiras-Fernandez A, 2006, TRANSPLANTATION, V82, P1101, DOI 10.1097/01.tp.0000233845.15508.89; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Caimmi PP, 2011, EUR J CARDIO-THORAC, V39, pE59, DOI 10.1016/j.ejcts.2010.11.044; FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Grossini E, 2014, LIVER TRANSPLANT, V20, P361, DOI 10.1002/lt.23799; Grossini E, 2010, CARDIOVASC DRUG THER, V24, P5, DOI 10.1007/s10557-010-6217-0; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Heusch G, 2015, COMPR PHYSIOL, V5, P1123, DOI 10.1002/cphy.c140075; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Jaeschke H, 1996, J HEPATOL, V25, P774, DOI 10.1016/S0168-8278(96)80253-4; Kaheinen P, 2001, J CARDIOVASC PHARM, V37, P367, DOI 10.1097/00005344-200104000-00003; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; KAWAMURA E, 1995, HEPATOLOGY, V21, P1138, DOI 10.1002/hep.1840210437; Ke B, 2006, CURR PHARM DESIGN, V12, P2969, DOI 10.2174/138161206777947669; Malmberg M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00017; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2; Ng CSH, 2005, EUR RESPIR J, V25, P356, DOI 10.1183/09031936.05.00030304; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073758; Ozturk T, 2010, J CARDIOTHOR VASC AN, V24, P624, DOI 10.1053/j.jvca.2009.08.003; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Scheiermann Patrick, 2011, Recent Pat Cardiovasc Drug Discov, V6, P20, DOI 10.2174/157489011794578482; Selzner M, 2002, J HEPATOL, V36, P218, DOI 10.1016/S0168-8278(01)00259-8; Torraco A, 2014, BIOCHIMIE, V102, P166, DOI 10.1016/j.biochi.2014.03.006; Uberti F, 2011, J CARDIOVASC PHARM, V57, P246, DOI 10.1097/FJC.0b013e318204bb55; VOLLMAR B, 1994, AM J PATHOL, V145, P1421	30	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187839	10.1371/journal.pone.0187839	http://dx.doi.org/10.1371/journal.pone.0187839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145424	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800032
J	Rocco, CJ; Wetterhorn, KM; Garvey, GS; Rayment, I; Escalante-Semerena, JC				Rocco, Christopher J.; Wetterhorn, Karl M.; Garvey, Graeme S.; Rayment, Ivan; Escalante-Semerena, Jorge C.			The PrpF protein of Shewanella oneidensis MR1 catalyzes the isomerization of 2-methyl-cis-aconitate during the catabolism of propionate via the AcnD-dependent 2-methylcitric acid cycle	PLOS ONE			English	Article							2-METHYLISOCITRATE LYASE PRPB; SALMONELLA-ENTERICA; METHYLCITRATE CYCLE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; MYCOBACTERIUM-TUBERCULOSIS; DEHYDRATASE; METABOLISM; ACONITASE	The 2-methylcitric acid cycle (2-MCC) is a common route of propionate catabolism in microorganisms. In Salmonella enterica, the prpBCDE operon encodes most of the 2-MCC enzymes. In other organisms, e.g., Shewanella oneidensis MR-1, two genes, acnD and prpF replace prpD, which encodes 2-methylcitrate dehydratase. We showed that together, S. oneidensis AcnD and PrpF (SoAcnD, SoPrpF) compensated for the absence of PrpD in a S. enterica prpD strain. We also showed that SoAcnD had 2-methylcitrate dehydratase activity and that PrpF has aconitate isomerase activity. Here we report in vitro evidence that the product of the SoAcnD reaction is an isomer of 2-methyl-cis-aconitate (2-MCA], the product of the SePrpD reaction. We show that the SoPrpF protein isomerizes the product of the AcnD reaction into the PrpD product (2-MCA], a known substrate of the housekeeping aconitase (AcnB]. Given that SoPrpF is an isomerase, that SoAcnD is a dehydratase, and the results from in vivo and in vitro experiments reported here, it is likely that 4-methylaconitate is the product of the AcnD enzyme. Results from in vivo studies using a S. enterica prpD strain show that SoPrpF variants with substitutions of residues K73 or C107 failed to support growth with propionate as the sole source of carbon and energy. High-resolution (1.22 angstrom) three-dimensional crystal structures of PrpF(K73E) in complex with trans-aconitate or malonate provide insights into the mechanism of catalysis of the wild-type protein.	[Rocco, Christopher J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Wetterhorn, Karl M.; Garvey, Graeme S.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Rocco, Christopher J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [Garvey, Graeme S.] Monsanto Vegetable Seeds, Woodland, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Monsanto	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Escalante-Semerena, Jorge C./0000-0001-7428-2811	National Institute of General Medical Sciences [R01 GM062203, R01 GM086351]; National Institute of Allergy and Infectious Diseases [R21 AI082916]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx), grant R01 GM062203 to JCES; National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov), grant R21 AI082916 to JCES; National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx), grant R01 GM086351 to IR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1825, DOI 10.1271/bbb.59.1825; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Bramer CO, 2002, APPL ENVIRON MICROB, V68, P271, DOI 10.1128/AEM.68.1.271-279.2002; Bramer CO, 2001, MICROBIOL-SGM, V147, P2203, DOI 10.1099/00221287-147-8-2203; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Claes WA, 2002, J BACTERIOL, V184, P2728, DOI 10.1128/JB.184.10.2728-2739.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; GAWRON O, 1961, NATURE, V189, P1004, DOI 10.1038/1891004a0; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; Grimek TL, 2003, J BACTERIOL, V185, P4837, DOI 10.1128/JB.185.16.4837-4843.2003; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; GUNSALUS RP, 1980, ANAL BIOCHEM, V101, P327, DOI 10.1016/0003-2697(80)90195-5; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANSON KR, 1963, P NATL ACAD SCI USA, V50, P981, DOI 10.1073/pnas.50.5.981; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; Horswill AR, 1997, J BACTERIOL, V179, P928, DOI 10.1128/jb.179.3.928-940.1997; Horswill AR, 2001, BIOCHEMISTRY-US, V40, P4703, DOI 10.1021/bi015503b; Huser AT, 2003, J BIOTECHNOL, V106, P269, DOI 10.1016/j.jbiotec.2003.08.006; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENNEDY MC, 1988, J BIOL CHEM, V263, P8190; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2259, DOI 10.1021/bi00788a012; Koo HM, 2000, ARCH BIOCHEM BIOPHYS, V378, P167, DOI 10.1006/abbi.2000.1813; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAUBLE H, 1995, PROTEINS, V22, P1, DOI 10.1002/prot.340220102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Roth JR, 1980, ADV BACTERIAL GENET; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SCHLOSS JV, 1984, BIOCHEMISTRY-US, V23, P4572, DOI 10.1021/bi00315a010; TABUCHI T, 1974, AGR BIOL CHEM TOKYO, V38, P1105, DOI 10.1080/00021369.1974.10861293; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Velarde M, 2009, J MOL BIOL, V391, P609, DOI 10.1016/j.jmb.2009.06.052	46	6	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188130	10.1371/journal.pone.0188130	http://dx.doi.org/10.1371/journal.pone.0188130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145506	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800071
J	Suzuki, H; Gao, H; Bai, WJ; Evangelou, E; Glocker, B; O'Regan, DP; Elliott, P; Matthews, PM				Suzuki, Hideaki; Gao, He; Bai, Wenjia; Evangelou, Evangelos; Glocker, Ben; O'Regan, Declan P.; Elliott, Paul; Matthews, Paul M.			Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; INTEGRITY; ADULTS; DAMAGE; RAT; MR; METAANALYSIS; PROGRESSION	Objectives To characterize effects of chronically elevated blood pressure on the brain, we tested for brain white matter microstructural differences associated with normotension, pre-hypertension and hypertension in recently available brain magnetic resonance imaging data from 4659 participants without known neurological or psychiatric disease (62.3 +/- 7.4 yrs, 47.0% male) in UK Biobank. Methods For assessment of white matter microstructure, we used measures derived from neurite orientation dispersion and density imaging (NODDI) including the intracellular volume fraction (an estimate of neurite density) and isotropic volume fraction (an index of the relative extracellular water diffusion). To estimate differences associated specifically with blood pressure, we applied propensity score matching based on age, sex, educational level, body mass index, and history of smoking, diabetes mellitus and cardiovascular disease to perform separate contrasts of non-hypertensive (normotensive or pre-hypertensive, N = 2332) and hypertensive (N = 2337) individuals and of normotensive (N = 741) and pre-hypertensive (N = 1581) individuals (p<0.05 after Bonferroni correction). Results The brain white matter intracellular volume fraction was significantly lower, and isotropic volume fraction was higher in hypertensive relative to non-hypertensive individuals (N = 1559, each). The white matter isotropic volume fraction also was higher in pre-hypertensive than in normotensive individuals (N = 694, each) in the right superior longitudinal fasciculus and the right superior thalamic radiation, where the lower intracellular volume fraction was observed in the hypertensives relative to the non-hypertensive group. Significance Pathological processes associated with chronically elevated blood pressure are associated with imaging differences suggesting chronic alterations of white matter axonal structure that may affect cognitive functions even with pre-hypertension.	[Suzuki, Hideaki; Matthews, Paul M.] Imperial Coll London, Hammersmith Hosp, Dept Med, Div Brain Sci, London, England; [Gao, He; Evangelou, Evangelos; Elliott, Paul] Imperial Coll London, MRC, Sch Publ Hlth, Dept Epidemiol & Biostat,Publ Hlth England,Ctr Env, London, England; [Bai, Wenjia; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, Dept Comp, London, England; [O'Regan, Declan P.] Imperial Coll London, Hammersmith Hosp, MRC, London Inst Med Sci, London, England	Imperial College London; Imperial College London; Public Health England; Imperial College London; Imperial College London	Suzuki, H (corresponding author), Imperial Coll London, Hammersmith Hosp, Dept Med, Div Brain Sci, London, England.	hd.suzuki.1870031@cardio.med.tohoku.ac.jp	Bai, Wenjia/ABH-6023-2020; Evangelou, Evangelos/C-3033-2013	Bai, Wenjia/0000-0003-2943-7698; Evangelou, Evangelos/0000-0002-5488-2999; Elliott, Paul/0000-0002-7511-5684; O'Regan, Declan/0000-0002-0691-0270	NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Public Health England [MR/L01341X/1]; Medical Research Council [MR/L01632X/1]; Uehara Memorial Foundation; Medical Research Council; MRC [MR/L01341X/1, MR/M024903/1, G9409634, UKDRI-5003, MR/L01632X/1, MC_PC_17114] Funding Source: UKRI; British Heart Foundation [SP/13/2/30111] Funding Source: researchfish; Medical Research Council [UKDRI-5003, MC_qA137853, MR/L01341X/1, MC_PC_17114, MR/M024903/1, G9409634] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10022] Funding Source: researchfish	NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Uehara Memorial Foundation(Uehara Memorial Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is supported by Research Fellowship from the Uehara Memorial Foundation, Medical Research Council and Public Health England (MR/L01341X/1), the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been conducted using the UK Biobank Resource under the Application 18545. We thank the UKB participants for their participation, and the UKB team for their work in collecting, processing and disseminating these data for analysis. We want to acknowledge particularly the importance to this paper of the image derived brain phenotypes generated for the benefit of the whole UK Biobank research community by Fidel Alfaro Almagro, Steve Smith, Karla Miller and their colleagues in the Oxford FMRIB Centre. This study is supported by Research Fellowship from the Uehara Memorial Foundation, Medical Research Council and Public Health England (MR/L01341X/1), the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computing resources of the UK MEDical BlOinformatics partnership for aggregation, integration, visualisation and analysis of large, complex data (UK MED-BIO) which is supported by the Medical Research Council (MR/L01632X/1).	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Balk LJ, 2016, J NEUROL, V263, P1323, DOI 10.1007/s00415-016-8127-y; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Calabrese E, 2013, NEUROIMAGE, V79, P329, DOI 10.1016/j.neuroimage.2013.04.101; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Gons RAR, 2012, J ALZHEIMERS DIS, V32, P623, DOI 10.3233/JAD-2012-121006; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Iadecola C, 2014, HYPERTENSION, V64, P3, DOI 10.1161/HYPERTENSIONAHA.114.03040; Jochemsen HM, 2013, JAMA NEUROL, V70, P1046, DOI 10.1001/jamaneurol.2013.217; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Madan Christopher R, 2015, F1000Res, V4, P466, DOI 10.12688/f1000research.6838.1; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; Mallik S, 2014, J NEUROL NEUROSUR PS, V85, P1396, DOI 10.1136/jnnp-2014-307650; Mancia Giuseppe, 2016, Eur Heart J, V37, P955, DOI 10.1093/eurheartj/ehv633; McEvoy LK, 2015, HYPERTENSION, V66, P317, DOI 10.1161/HYPERTENSIONAHA.115.05336; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Miwa K, 2014, NEUROLOGY, V83, P646, DOI 10.1212/WNL.0000000000000692; Mohammadi MT, 2014, PATHOL RES PRACT, V210, P985, DOI 10.1016/j.prp.2014.05.007; MOODY DM, 1990, AM J NEURORADIOL, V11, P431; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Rosano C, 2015, AM J HYPERTENS, V28, P326, DOI 10.1093/ajh/hpu134; Rosenberg GA, 2009, STROKE, V40, pS20, DOI 10.1161/STROKEAHA.108.533133; Salat DH, 2012, NEUROIMAGE, V59, P181, DOI 10.1016/j.neuroimage.2011.07.033; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schneider T, 2017, FUNCT NEUROL, V32, P97; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suzuki H, 2013, NEUROIMAGE, V77, P215, DOI 10.1016/j.neuroimage.2013.03.042; Veglio F, 2009, ATHEROSCLEROSIS, V205, P331, DOI 10.1016/j.atherosclerosis.2008.10.028; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	37	30	30	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187600	10.1371/journal.pone.0187600	http://dx.doi.org/10.1371/journal.pone.0187600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145428	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800023
J	Tsuang, FY; Hsieh, YY; Kuo, YJ; Chen, CH; Lin, FH; Chen, CS; Chiang, CJ				Tsuang, Fon-Yih; Hsieh, Yueh-Ying; Kuo, Yi-Jie; Chen, Chia-Hsien; Lin, Feng-Huei; Chen, Chen-Sheng; Chiang, Chang-Jung			Assessment of the suitability of biodegradable rods for use in posterior lumbar fusion: An in-vitro biomechanical evaluation and finite element analysis	PLOS ONE			English	Article							INTERBODY FUSION; SPINE SURGERY; FACET JOINTS; ADJACENT; THORACOLUMBAR; FIXATION; DEGENERATION; STRESS; CAGES	Interbody fusion with posterior instrumentation is a common method for treating lumbar degenerative disc diseases. However, the high rigidity of the fusion construct may produce abnormal stresses at the adjacent segment and lead to adjacent segment degeneration (ASD). As such, biodegradable implants are becoming more popular for use in orthopaedic surgery. These implants offer sufficient stability for fusion but at a reduced stiffness. Tailored to degrade over a specific timeframe, biodegradable implants could potentially mitigate the drawbacks of conventional stiff constructs and reduce the loading on adjacent segments. Six finite element models were developed in this study to simulate a spine with and without fixators. The spinal fixators used both titanium rods and biodegradable rods. The models were subjected to axial loading and pure moments. The range of motion (ROM), disc stresses, and contact forces of facet joints at adjacent segments were recorded. A 3-point bending test was performed on the biodegradable rods and a dynamic bending test was performed on the spinal fixators according to ASTM F1717-11a. The finite element simulation showed that lumbar spinal fusion using biodegradable implants had a similar ROM at the fusion level as at adjacent levels. As the rods degraded over time, this produced a decrease in the contact force at adjacent facet joints, less stress in the adjacent disc and greater loading on the anterior bone graft region. The mechanical tests showed the initial average fatigue strength of the biodegradable rods was 145 N, but this decreased to 115N and 55N after 6 months and 12 months of soaking in solution. Also, both the spinal fixator with biodegradable rods and with titanium rods was strong enough to withstand 5,000,000 dynamic compression cycles under a 145 N axial load. The results of this study demonstrated that biodegradable rods may present more favourable clinical outcomes for lumbar fusion. These polymer rods could not only provide sufficient initial stability, but the loss in rigidity of the fixation construct over time gradually transfers loading to adjacent segments.	[Tsuang, Fon-Yih; Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Hsieh, Yueh-Ying; Chen, Chia-Hsien; Chiang, Chang-Jung] Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan; [Kuo, Yi-Jie] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Kuo, Yi-Jie; Chen, Chia-Hsien; Chiang, Chang-Jung] Taipei Med Univ, Sch Med, Dept Orthoped, Coll Med, Taipei, Taiwan; [Lin, Feng-Huei] Natl Hlth Res Inst, Div Med Engn, Zhunan Township, Miaoli County, Taiwan; [Chen, Chen-Sheng] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan; [Chiang, Chang-Jung] Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan; [Kuo, Yi-Jie] Taipei Med Univ, Wan Fang Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Chiang, Chang-Jung] Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital	Chiang, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan.; Chiang, CJ (corresponding author), Taipei Med Univ, Sch Med, Dept Orthoped, Coll Med, Taipei, Taiwan.; Chiang, CJ (corresponding author), Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan.	chiang.spine@gmail.com		Chiang, Chang-Jung/0000-0002-2269-8337; Tsuang, Fon-Yih/0000-0001-5797-1885				Bastian L, 2001, EUR SPINE J, V10, P295, DOI 10.1007/s005860100278; Bezer M, 2005, EUR SPINE J, V14, P227, DOI 10.1007/s00586-004-0781-6; Chang UK, 2007, J NEUROSURG-SPINE, V7, P33, DOI 10.3171/SPI-07/07/033; Diwan AD, 2003, ORTHOP CLIN N AM, V34, P309, DOI 10.1016/S0030-5898(03)00028-2; Dreischarf M, 2014, J BIOMECH, V47, P1757, DOI 10.1016/j.jbiomech.2014.04.002; Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163; Faizan A, 2012, CLIN BIOMECH, V27, P226, DOI 10.1016/j.clinbiomech.2011.09.014; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Fritzell P, 2002, SPINE, V27, P1131, DOI 10.1097/00007632-200206010-00002; Gercek E, 2003, EUR SPINE J, V12, P513, DOI 10.1007/s00586-003-0539-6; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; Hsieh YY, 2017, CLIN BIOMECH, V43, P115, DOI 10.1016/j.clinbiomech.2017.02.011; Jeon CH, 2015, SPINE, V40, pE627, DOI 10.1097/BRS.0000000000000870; Johnsson R, 1997, Eur Spine J, V6, P144, DOI 10.1007/BF01358748; Kim D, C NEUR SURG BOST OCT; Kok D, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-269; Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239; LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029; Li H, 2015, CHINESE MED J-PEKING, V128, P1042, DOI 10.4103/0366-6999.155080; Ma JX, 2014, P I MECH ENG H, V228, P665, DOI 10.1177/0954411914541435; Panjabi MM, 2007, CLIN BIOMECH, V22, P257, DOI 10.1016/j.clinbiomech.2006.08.006; PATEL A, 2000, OPER TECH ORTHOP, V10, P311; Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020; Savage K, 2014, J SPINAL DISORD TECH, V27, pE66, DOI 10.1097/BSD.0b013e318299c6d8; Schlegel JD, 1996, SPINE, V21, P970, DOI 10.1097/00007632-199604150-00013; Shang XP, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-314; Shih SL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-191; Shih SL, 2012, J SPINAL DISORD TECH, V25, pE140, DOI 10.1097/BSD.0b013e31824e5e10; van Dijk M, 2002, SPINE, V27, P682, DOI 10.1097/00007632-200204010-00003; Waguespack A, 2002, PAIN MED, V3, P18, DOI 10.1046/j.1526-4637.2002.02007.x; Zotti Mario G, 2015, J Spine Surg, V1, P50, DOI 10.3978/j.issn.2414-469X.2015.08.02	31	7	7	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188034	10.1371/journal.pone.0188034	http://dx.doi.org/10.1371/journal.pone.0188034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145437	Green Submitted, gold, Green Published			2022-12-26	WOS:000415378800054
J	Miyazaki, R; Myougo, N; Mori, H; Akiyama, Y				Miyazaki, Ryoji; Myougo, Naomi; Mori, Hiroyuki; Akiyama, Yoshinori			A photo-cross-linking approach to monitor folding and assembly of newly synthesized proteins in a living cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); protein assembly; protein dynamic; protein synthesis; protein-protein interaction; amber suppression; p-benzoyl-L-phenylalanine (pBPA); unnatural amino acid	BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; AMINO-ACID; IN-VIVO; ALKALINE-PHOSPHATASE; LIPOPOLYSACCHARIDE INSERTION; STRUCTURAL BASIS; GENETIC-CODE; SECY; TRANSLOCATION	Many proteins form multimeric complexes that play crucial roles in various cellular processes. Studying how proteins are correctly folded and assembled into such complexes in a living cell is important for understanding the physiological roles and the qualitative and quantitative regulation of the complex. However, few methods are suitable for analyzing these rapidly occurring processes. Site-directed in vivo photo-cross-linking is an elegant technique that enables analysis of protein-protein interactions in living cells with high spatial resolution. However, the conventional site-directed in vivo photo-cross-linking method is unsuitable for analyzing dynamic processes. Here, by combining an improved site-directed in vivo photo-cross-linking technique with a pulse-chase approach, we developed a new method that can analyze the folding and assembly of a newly synthesized protein with high spatiotemporal resolution. We demonstrate that this method, named the pulse-chase and in vivo photo-cross-linking experiment (PiXie), enables the kinetic analysis of the formation of an Escherichia coli periplasmic (soluble) protein complex (PhoA). We also used our new technique to investigate assembly/folding processes of two membrane complexes (SecD-SecF in the inner membrane and LptD-LptE in the outer membrane), which provided new insights into the biogenesis of these complexes. Our PiXie method permits analysis of the dynamic behavior of various proteins and enables examination of protein-protein interactions at the level of individual amino acid residues. We anticipate that our new technique will have valuable utility for studies of protein dynamics in many organisms.	[Miyazaki, Ryoji; Myougo, Naomi; Mori, Hiroyuki; Akiyama, Yoshinori] Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kyoto 6068507, Japan.	yakiyama@infront.kyoto-u.ac.jp		Mori, Hiroyuki/0000-0002-0429-1269; Miyazaki, Ryoji/0000-0003-1626-2569	JSPS KAKENHI [15J05262, 15H04350, 17K07334]; MEXT KAKENHI [24117003, 15H01532, 17H05666, 17H05879]; Grants-in-Aid for Scientific Research [17K07334] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Hizukuri for helpful comments, and M. Sano and Y. Fujimoto (Machida) for technical support, S. Urin for helpful advices about UV irradiators and National BioResource Project (NBRP)-E. coli at National Institute of Genetics, Japan for strains. This study was supported by JSPS KAKENHI Grants 15J05262 (to R. M.), 15H04350 (to Y. A.), and 17K07334 (to H. M.) and MEXT KAKENHI Grants 24117003 (to H. M.), 15H01532 (to Y. A.), 17H05666 (to H. M.), and 17H05879 (to H. M.).	Akiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08928; AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Furukawa A, 2017, CELL REP, V19, P895, DOI 10.1016/j.celrep.2017.04.030; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ishii E, 2015, P NATL ACAD SCI USA, V112, pE5513, DOI 10.1073/pnas.1513001112; Jubb HC, 2017, PROG BIOPHYS MOL BIO, V128, P3, DOI 10.1016/j.pbiomolbio.2016.10.002; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Lee HS, 2009, BIOORG MED CHEM LETT, V19, P5222, DOI 10.1016/j.bmcl.2009.07.011; Lee J, 2016, P NATL ACAD SCI USA, V113, P8717, DOI 10.1073/pnas.1604100113; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Miyazaki R, 2016, SCI REP-UK, V6, DOI 10.1038/srep24147; Mori H, 2002, J BIOL CHEM, V277, P48550, DOI 10.1074/jbc.M204436200; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Narita S, 2013, P NATL ACAD SCI USA, V110, pE3612, DOI 10.1073/pnas.1312012110; Nichols BP, 1998, J BACTERIOL, V180, P6408; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Tanaka Keiji, 2013, Keio Journal of Medicine, V62, P1, DOI 10.2302/kjm.2012-0006-RE; TANI K, 1989, J BIOL CHEM, V264, P18582; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Yamamoto K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21909; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12299; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	42	12	13	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					677	686		10.1074/jbc.M117.817270	http://dx.doi.org/10.1074/jbc.M117.817270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158258	Green Published, hybrid			2022-12-26	WOS:000419915400022
J	Yan, XF; Xin, LY; Yen, JT; Zeng, YK; Jin, SY; Cheang, QW; Fong, RACY; Chiam, KH; Liang, ZX; Gao, YG				Yan, Xin-Fu; Xin, Lingyi; Yen, Jackie Tan; Zeng, Yukai; Jin, Shengyang; Cheang, Qing Wei; Fong, Rachel Andrea Chea Yuen; Chiam, Keng-Hwee; Liang, Zhao-Xun; Gao, Yong-Gui			Structural analyses unravel the molecular mechanism of cyclic di-GMP regulation of bacterial chemotaxis via a PilZ adaptor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; DOMAIN PROTEINS; CRYSTAL-STRUCTURE; BINDING; METHYLTRANSFERASE; REVEALS; RECEPTOR; DIVERSE; DIGUANYLATE; INTERACTS	The bacterial second messenger cyclic di-GMP (c-di-GMP) has emerged as a prominent mediator of bacterial physiology, motility, and pathogenicity. c-di-GMP often regulates the function of its protein targets through a unique mechanism that involves a discrete PilZ adaptor protein. However, the molecular mechanism for PilZ protein-mediated protein regulation is unclear. Here, we present the structure of the PilZ adaptor protein MapZ cocrystallized in complex with c-di-GMP and its protein target CheR1, a chemotaxis-regulating methyltransferase in Pseudomonas aeruginosa. This cocrystal structure, together with the structure of free CheR1, revealed that the binding of c-di-GMP induces dramatic structural changes inMapZthat are crucial for CheR1 binding. Importantly, we found that restructuring and repositioning of two C-terminal helices enable MapZ to disrupt the CheR1 active site by dislodging a structural domain. The crystallographic observations are reinforced by protein-protein binding and single cell-based flagellar motor switching analyses. Our studies further suggest that the regulation of chemotaxis by c-di-GMP through MapZ orthologs/ homologs is widespread in proteobacteria and that the use of allosterically regulated C-terminal motifs could be a common mechanism for PilZ adaptor proteins. Together, the findings provide detailed structural insights into how c-di-GMP controls the activity of an enzyme target indirectly through a PilZ adaptor protein.	[Yan, Xin-Fu; Xin, Lingyi; Yen, Jackie Tan; Jin, Shengyang; Cheang, Qing Wei; Fong, Rachel Andrea Chea Yuen; Liang, Zhao-Xun; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Yan, Xin-Fu; Yen, Jackie Tan; Jin, Shengyang; Gao, Yong-Gui] Nanyang Technol Univ, NTU Inst Struct Biol, 59 Nanyang Dr, Singapore 639798, Singapore; [Zeng, Yukai; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, S-138671 Singapore, Singapore; [Gao, Yong-Gui] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liang, ZX; Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, 59 Nanyang Dr, Singapore 639798, Singapore.; Gao, YG (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	zxliang@ntu.edu.sg; ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011; Liang, Zhao-Xun/A-2191-2011	Gao, Yonggui/0000-0001-7298-0835; Zeng, Yukai/0000-0003-1337-5912; Yan, Xin-Fu/0000-0001-6248-2349; Liang, Zhao-Xun/0000-0002-3128-1330	Ministry of Education of Singapore Tier I Grants [RG40/17, RG43/15]	Ministry of Education of Singapore Tier I Grants(Ministry of Education, Singapore)	This work was supported by Ministry of Education of Singapore Tier I Grants RG40/17 (to Z.-X. L.) and RG43/15 (to Y.-G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alicia TGG, 2016, LAB CHIP, V16, P368, DOI 10.1039/c5lc01137j; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Batra M, 2016, J STRUCT BIOL, V196, P364, DOI 10.1016/j.jsb.2016.08.005; Boriack-Sjodin PA, 2016, BIOCHEMISTRY-US, V55, P1557, DOI 10.1021/acs.biochem.5b01129; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Fujiwara T, 2013, BIOCHEM BIOPH RES CO, V431, P802, DOI 10.1016/j.bbrc.2012.12.103; Garcia-Fontana C, 2013, J BIOL CHEM, V288, P18987, DOI 10.1074/jbc.M113.472605; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang ZX, 2015, NAT PROD REP, V32, P663, DOI 10.1039/c4np00086b; Long ZC, 2014, ANALYST, V139, P5254, DOI 10.1039/c4an00877d; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Qian C, 2013, APPL ENVIRON MICROB, V79, P4734, DOI 10.1128/AEM.01027-13; Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P10067, DOI 10.1073/pnas.1607503113; Shin JS, 2011, PROTEIN SCI, V20, P270, DOI 10.1002/pro.557; Venkataramani P, 2017, METHODS MOL BIOL, V1657, P11, DOI 10.1007/978-1-4939-7240-1_2; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Xu LH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7584; Xu LH, 2016, J BIOL CHEM, V291, P16112, DOI 10.1074/jbc.M116.730887	40	15	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					100	111		10.1074/jbc.M117.815704	http://dx.doi.org/10.1074/jbc.M117.815704			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29146598	hybrid, Green Published			2022-12-26	WOS:000419453200007
J	Parkkola, A; Laine, AP; Karhunen, M; Harkonen, T; Ryhanen, SJ; Ilonen, J; Knip, M				Parkkola, Anna; Laine, Antti-Pekka; Karhunen, Markku; Harkonen, Taina; Ryhanen, Samppa J.; Ilonen, Jorma; Knip, Mikael		Finnish Pediat Diabet Register	HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK LOCI; SHARED GENETICS; MULTIPLE COMMON; PATHOGENESIS; METAANALYSIS; PHENOTYPE; VARIANTS; INNATE	Genetic predisposition could be assumed to be causing clustering of autoimmunity in individuals and families. We tested whether HLA and non-HLA loci associate with such clustering of autoimmunity. We included 1,745 children with type 1 diabetes from the Finnish Pediatric Diabetes Register. Data on personal or family history of autoimmune diseases were collected with a structured questionnaire and, for a subset, with a detailed search for celiac disease and autoimmune thyroid disease. Children with multiple autoimmune diseases or with multiple affected first-or second-degree relatives were identified. We analysed type 1 diabetes related HLA class II haplotypes and genotyped 41 single nucleotide polymorphisms (SNPs) outside the HLA region. The HLA-DR4-DQ8 haplotype was associated with having type 1 diabetes only whereas the HLA-DR3-DQ2 haplotype was more common in children with multiple autoimmune diseases. Children with multiple autoimmune diseases showed nominal association with RGS1 (rs2816316), and children coming from an autoimmune family with rs11711054 (CCR3-CCR5). In multivariate analyses, the overall effect of non-HLA SNPs on both phenotypes was evident, associations with RGS1 and CCR3-CCR5 region were confirmed and additional associations were implicated: NRP1, FUT2, and CD69 for children with multiple autoimmune diseases. In conclusion, HLA-DR3-DQ2 haplotype and some non-HLA SNPs contribute to the clustering of autoimmune diseases in children with type 1 diabetes and in their families.	[Parkkola, Anna; Harkonen, Taina; Ryhanen, Samppa J.; Knip, Mikael] Univ Helsinki, Childrens Hosp, Sci Lab, Helsinki, Finland; [Parkkola, Anna; Harkonen, Taina; Ryhanen, Samppa J.; Knip, Mikael] Helsinki Univ Hosp, Helsinki, Finland; [Parkkola, Anna; Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Parkkola, Anna; Harkonen, Taina; Ryhanen, Samppa J.; Knip, Mikael] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Laine, Antti-Pekka; Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Laine, Antti-Pekka; Ilonen, Jorma] Turku Univ Hosp, Turku, Finland; [Karhunen, Markku] Univ Helsinki, Dept Polit & Econ Studies, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Turku; University of Turku; University of Helsinki; Tampere University; Tampere University Hospital	Knip, M (corresponding author), Univ Helsinki, Childrens Hosp, Sci Lab, Helsinki, Finland.; Knip, M (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Knip, M (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.; Knip, M (corresponding author), Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland.; Knip, M (corresponding author), Tampere Univ Hosp, Dept Pediat, Tampere, Finland.	mikael.knip@helsinki.fi	Ryhänen, Samppa/AAM-2879-2021; Knip, Mikael/AAL-3773-2020	Ryhänen, Samppa/0000-0003-4431-643X; Ilonen, Jorma/0000-0002-9973-2062; Knip, Mikael/0000-0003-0474-0033; Karhunen, Markku/0000-0001-9086-8214	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114, 250124]; Sigrid Juselius Foundation; Novo Nordisk Foundation; Liv and Halsa Fund; Finnish Medical Foundation; Biomedicum Helsinki Foundation; National Graduate School of Clinical Investigation	Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Liv and Halsa Fund; Finnish Medical Foundation; Biomedicum Helsinki Foundation; National Graduate School of Clinical Investigation	This work was supported by the Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-2017, Decision No. 250114 and Decision No. 250124) (MK), the Sigrid Juselius Foundation (MK), the Novo Nordisk Foundation (MK), the Liv and Halsa Fund (MK), the Finnish Medical Foundation (AP), the Biomedicum Helsinki Foundation (AP), and the National Graduate School of Clinical Investigation (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Betz RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6966; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Deitiker P, 2015, CRIT REV IMMUNOL, V35, P203, DOI 10.1615/CritRevImmunol.2015014510; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Ilonen J, 2016, PEDIATR DIABETES, V17, P8, DOI 10.1111/pedi.12327; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Laine AP, 2013, TISSUE ANTIGENS, V82, P35, DOI 10.1111/tan.12143; Lee YH, 2012, INFLAMM RES, V61, P411, DOI [10.1007/s00011-012-0447-5, 10.1007/s00011-012-0455-5]; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nieminen JK, 2012, DIABETES CARE, V35, P2303, DOI 10.2337/dc11-2460; Parkkola A, 2017, PEDIAT DIABETES; Parkkola A, 2013, EUR J ENDOCRINOL, V169, P171, DOI 10.1530/EJE-13-0089; Parkkola A, 2013, DIABETES CARE, V36, P348, DOI 10.2337/dc12-0445; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Prahalad S, 2009, ARTHRITIS RHEUM-US, V60, P2124, DOI 10.1002/art.24618; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Richard-Miceli C, 2012, GENOME MED, V4, DOI 10.1186/gm305; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Somers EC, 2006, EPIDEMIOLOGY, V17, P202, DOI 10.1097/01.ede.0000193605.93416.df; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wagner AM, 2011, DIABETES-METAB RES, V27, P493, DOI 10.1002/dmrr.1189; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Zhernakova A, 2013, NAT REV ENDOCRINOL, V9, P646, DOI 10.1038/nrendo.2013.161; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	56	11	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188402	10.1371/journal.pone.0188402	http://dx.doi.org/10.1371/journal.pone.0188402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182645	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000026
J	Arppe, R; Carro-Temboury, MR; Hempel, C; Vosch, T; Sorensen, TJ				Arppe, Riikka; Carro-Temboury, Miguel R.; Hempel, Casper; Vosch, Tom; Sorensen, Thomas Just			Investigating dye performance and crosstalk in fluorescence enabled bioimaging using a model system	PLOS ONE			English	Article							LIVE-CELL MICROSCOPY; NEAR-IR EMISSION; QUANTUM DOTS; LUMINESCENCE; PROBES; BRIGHT; COMPLEXES; TOOLS; IONS	Detailed imaging of biological structures, often smaller than the diffraction limit, is possible in fluorescence microscopy due to the molecular size and photophysical properties of fluorescent probes. Advances in hardware and multiple providers of high-end bioimaging makes comparing images between studies and between research groups very difficult. Therefore, we suggest a model system to benchmark instrumentation, methods and staining procedures. The system we introduce is based on doped zeolites in stained polyvinyl alcohol (PVA) films: a highly accessible model system which has the properties needed to act as a benchmark in bioimaging experiments. Rather than comparing molecular probes and imaging methods in complicated biological systems, we demonstrate that the model system can emulate this complexity and can be used to probe the effect of concentration, brightness, and cross-talk of fluorophores on the detected fluorescence signal. The described model system comprises of lanthanide (III) ion doped Linde Type A zeolites dispersed in a PVA film stained with fluorophores. We tested: F18, MitoTracker Red and ATTO647N. This model system allowed comparing performance of the fluorophores in experimental conditions. Importantly, we here report considerable cross-talk of the dyes when exchanging excitation and emission settings. Additionally, bleaching was quantified. The proposed model makes it possible to test and benchmark staining procedures before these dyes are applied to more complex biological systems.	[Arppe, Riikka; Carro-Temboury, Miguel R.; Vosch, Tom; Sorensen, Thomas Just] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Arppe, Riikka; Carro-Temboury, Miguel R.; Vosch, Tom; Sorensen, Thomas Just] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Hempel, Casper] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark	Vosch, T; Sorensen, TJ (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.; Vosch, T; Sorensen, TJ (corresponding author), Univ Copenhagen, Dept Chem, Copenhagen, Denmark.; Hempel, C (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark.	casperhempel@gmail.com; tom@chem.ku.dk; TJS@chem.ku.dk	Arppe, Riikka/J-2249-2016; Vosch, Tom/B-4234-2015; Vosch, Tom/AAT-3852-2020; Sørensen, Thomas Just/C-2521-2013; Hempel, Casper/ABE-7065-2020	Arppe, Riikka/0000-0002-9930-1676; Vosch, Tom/0000-0001-5435-2181; Vosch, Tom/0000-0001-5435-2181; Sørensen, Thomas Just/0000-0003-1491-5116; Hempel, Casper/0000-0002-9816-4673	UNIK research initiative of the Danish Ministry of Higher Education Science [09-065274]; Danish Council of Independent Research [DFF-1323-00352, DFF-6110-00554]	UNIK research initiative of the Danish Ministry of Higher Education Science; Danish Council of Independent Research(Det Frie Forskningsrad (DFF))	We thank bio-SYNergy University of Copenhagen's Excellence Programme for Interdisciplinary Research, Villum Fonden (to TJS), the "Center for Synthetic Biology" at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Higher Education & Science (09-065274 to TV), and the Danish Council of Independent Research (DFF-1323-00352 to TV and DFF-6110-00554 to CH) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Beeby A, 2000, J PHOTOCH PHOTOBIO B, V57, P83, DOI 10.1016/S1011-1344(00)00070-1; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Bunzli JCG, 2014, LUMINESCENCE OF LANTHANIDE IONS IN COORDINATION COMPOUNDS AND NANOMATERIALS, P125; Bunzli JCG, 2006, ACCOUNTS CHEM RES, V39, P53, DOI 10.1021/ar0400894; Carnall W. T., 1979, Handbook on the Physics and Chemistry of Rare-earths, Vol.3. Non-metallic Compounds 1, P171, DOI 10.1016/S0168-1273(79)03007-5; Carter KP, 2014, CHEM REV, V114, P4564, DOI 10.1021/cr400546e; Charbonniere L, 2001, J AM CHEM SOC, V123, P2436, DOI 10.1021/ja003699h; D'Aleo A, 2012, COORDIN CHEM REV, V256, P1604, DOI 10.1016/j.ccr.2012.03.023; Dilipkumar S, 2015, RSC ADV, V5, P13175, DOI 10.1039/c4ra15225e; Faulkner S, 2005, APPL SPECTROSC REV, V40, P1, DOI 10.1081/ASR-200038308; Fountaine TJ, 2006, MODERN PATHOL, V19, P1181, DOI 10.1038/modpathol.3800628; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Gavrilovic M, 2009, J MICROSC-OXFORD, V234, P311, DOI 10.1111/j.1365-2818.2009.03170.x; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grimm JB, 2016, ANGEW CHEM INT EDIT, V55, P1723, DOI 10.1002/anie.201509649; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Grimm JB, 2013, ACS CHEM BIOL, V8, P1303, DOI 10.1021/cb4000822; Haugland RP., 2010, HDB FLUORESCENT PROB; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868; Johnsson N, 2007, ACS CHEM BIOL, V2, P31, DOI 10.1021/cb6003977; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kraus B, 2009, MODERN RES ED TOPICS, V3, P863; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Liao ZY, 2015, RSC ADV, V5, P70282, DOI 10.1039/c5ra15759e; Liao ZY, 2015, CHEM COMMUN, V51, P2372, DOI 10.1039/c4cc09618e; Montgomery CP, 2009, ACCOUNTS CHEM RES, V42, P925, DOI 10.1021/ar800174z; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Park KS, 2016, BIOMED OPT EXPRESS, V7, P2285, DOI 10.1364/BOE.7.002285; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sun WC, 1997, J ORG CHEM, V62, P6469, DOI 10.1021/jo9706178; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; Vermot J, 2008, HFSP J, V2, P143, DOI 10.2976/1.2907579; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Wegner KD, 2015, CHEM SOC REV, V44, P4792, DOI 10.1039/c4cs00532e; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wysocki LM, 2011, CURR OPIN CHEM BIOL, V15, P752, DOI 10.1016/j.cbpa.2011.10.013; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0; Zimmermann T, 2014, METHODS MOL BIOL, V1075, P129, DOI 10.1007/978-1-60761-847-8_5	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188359	10.1371/journal.pone.0188359	http://dx.doi.org/10.1371/journal.pone.0188359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176775	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900065
J	Ghio, S; Crimi, G; Pica, S; Temporelli, PL; Boffini, M; Rinaldi, M; Raineri, C; Scelsi, L; Pistono, M; Totaro, R; Guida, S; Visconti, LO				Ghio, Stefano; Crimi, Gabriele; Pica, Silvia; Temporelli, Pier Luigi; Boffini, Massimo; Rinaldi, Mauro; Raineri, Claudia; Scelsi, Laura; Pistono, Massimo; Totaro, Rossana; Guida, Stefania; Visconti, Luigi Oltrona			Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension	PLOS ONE			English	Article							PRESSURE-GRADIENT; PROGNOSTIC RELEVANCE; VASCULAR-RESISTANCE; FAILURE; CAPACITANCE; DIAGNOSIS; STIFFNESS; MORTALITY; EXERCISE	Background The hemodynamic definitions of pulmonary hypertension (PH) in left heart disease have recently been refined to better match the characteristics required to reflect the presence of pulmonary vascular disease. Accordingly, we tested the hypothesis that abnormalities in the stiffness of pulmonary circulation would persist after heart transplantation in patients with combined post-capillary and pre-capillary PH (Cpc-PH) in contrast to those with isolated post-capillary PH (Ipc-PH). Methods We retrospectively analyzed right heart hemodynamics in a cohort of 295 consecutive patients with heart failure and advanced left ventricular systolic dysfunction (LVSD) before and 1 year after heart transplantation. Results According to their baseline hemodynamic profile, patients were classified as: 75 Cpc-PH, 111 Ipc-PH, and 98 without PH (no-PH), and 11 pre-capillary PH. One year after heart transplantation, pulmonary artery pressures, pulmonary vascular resistance and cardiac index normalized in all patients regardless of the baseline hemodynamic profile. However, pulmonary arterial compliance remained lower in Cpc-PH patients (from 1.6 +/- 1.2 at baseline to 3.7 +/- 1.4 ml/mmHg at 1 year) than in Ipc-PH (from 1.2 +/- 2.0 to 4.4 +/- 2.3 ml/mmHg) and no-PH patients (from 3.7 +/- 2.0 to 4.5 +/- 1.8 ml/mmHg); (adjusted p = 0.03 Ipc-PH vs. Cpc-PH (INT)<0.001). Conclusions In heart failure patients with advanced LVSD, a hemodynamic profile characterized by Cpc-PH predicts the persistence of a stiffer pulmonary circulation at 1 year after heart transplantation.	[Ghio, Stefano; Crimi, Gabriele; Pica, Silvia; Raineri, Claudia; Scelsi, Laura; Totaro, Rossana; Guida, Stefania; Visconti, Luigi Oltrona] Fdn IRCCS, Div Cardiol, Policlin S Matteo, Pavia, Italy; [Temporelli, Pier Luigi; Pistono, Massimo] Ist Clin Sci Maugeri, Div Cardiol, Veruno, Italy; [Boffini, Massimo; Rinaldi, Mauro] Univ Turin, Surg Sci Dept, Div Cardiac Surg, Citta Salute & Sci, Turin, Italy	IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; Istituti Clinici Scientifici Maugeri IRCCS; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Ghio, S (corresponding author), Fdn IRCCS, Div Cardiol, Policlin S Matteo, Pavia, Italy.	s.ghio@smatteo.pv.it	Temporelli, Pier Luigi/AAB-9754-2020; Pica, Silvia/K-4012-2018; Crimi, Gabriele/K-4852-2016; Scelsi, Laura/AAB-9729-2019; Ghio, Stefano/ABH-1151-2021; pistono, massimo/AAO-5712-2020	Temporelli, Pier Luigi/0000-0002-6220-2471; Pica, Silvia/0000-0003-4673-3798; Crimi, Gabriele/0000-0002-2852-061X; Scelsi, Laura/0000-0001-9409-691X; Ghio, Stefano/0000-0002-1858-1152; pistono, massimo/0000-0001-7310-3690; Raineri, Claudia/0000-0001-9653-1516				Bonderman D, 2011, CHEST, V139, P122, DOI 10.1378/chest.10-0348; Delgado JF, 2005, EUR J HEART FAIL, V7, P1011, DOI 10.1016/j.ejheart.2004.10.021; Dupont M, 2012, CIRC-HEART FAIL, V5, P778, DOI 10.1161/CIRCHEARTFAILURE.112.968511; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Ghio S, 2017, INT J CARDIOL, V230, P53, DOI 10.1016/j.ijcard.2016.12.099; Ghio S, 2014, EUR RESPIR J, V43, P1403, DOI 10.1183/09031936.00195313; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Lankhaar JW, 2006, AM J PHYSIOL-HEART C, V291, pH1731, DOI 10.1152/ajpheart.00336.2006; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Masri SC, 2017, ASAIO J, V63, P139, DOI 10.1097/MAT.0000000000000467; Miller WL, 2013, JACC-HEART FAIL, V1, P290, DOI 10.1016/j.jchf.2013.05.001; NAEIJE R, 1994, AM J RESP CRIT CARE, V149, P881, DOI 10.1164/ajrccm.149.4.8143050; Naeije R, 2015, JACC-HEART FAIL, V3, P425, DOI 10.1016/j.jchf.2014.12.014; Naeije R, 2013, EUR RESPIR J, V41, P217, DOI 10.1183/09031936.00074312; Pellegrini P, 2014, CHEST, V145, P1064, DOI 10.1378/chest.13-1510; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; REUBEN SR, 1971, CIRC RES, V29, P40, DOI 10.1161/01.RES.29.1.40; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Saouti N, 2010, EUR RESPIR REV, V19, P197, DOI 10.1183/09059180.00002210; Tampakakis E, 2015, JACC-HEART FAIL, V3, P9, DOI 10.1016/j.jchf.2014.07.010; Tedford RJ, 2014, J HEART LUNG TRANSPL, V33, P289, DOI 10.1016/j.healun.2013.11.008; Tedford RJ, 2012, CIRCULATION, V125, P289, DOI 10.1161/CIRCULATIONAHA.111.051540	23	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188383	10.1371/journal.pone.0188383	http://dx.doi.org/10.1371/journal.pone.0188383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176890	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900069
J	Hasegawa, Y; Welch, JLM; Rossetti, BJ; Borisy, GG				Hasegawa, Yuko; Welch, Jessica L. Mark; Rossetti, Blair J.; Borisy, Gary G.			Preservation of three-dimensional spatial structure in the gut microbiome	PLOS ONE			English	Article							MUCUS LAYERS; BACTERIA; COLON; MUCIN; INNER; FISH	Preservation of three-dimensional structure in the gut is necessary in order to analyze the spatial organization of the gut microbiota and gut luminal contents. In this study, we evaluated preparation methods for mouse gut with the goal of preserving micron-scale spatial structure while performing fluorescence imaging assays. Our evaluation of embedding methods showed that commonly used media such as Tissue-Tek Optimal Cutting Temperature (OCT) compound, paraffin, and polyester waxes resulted in redistribution of luminal contents. By contrast, a hydrophilic methacrylate resin, Technovit H8100, preserved three-dimensional organization. Our mouse intestinal preparation protocol optimized using the Technovit H8100 embedding method was compatible with microbial fluorescence in situ hybridization (FISH) and other labeling techniques, including immunostaining and staining with both wheat germ agglutinin (WGA) and 4',6-diamidino-2-phenylindole (DAPI). Mucus could be visualized whether the sample was fixed with paraformaldehyde (PFA) or with Carnoy's fixative. The protocol optimized in this study enabled simultaneous visualization of micron-scale spatial patterns formed by microbial cells in the mouse intestines along with biogeographical landmarks such as host-derived mucus and food particles.	[Hasegawa, Yuko; Welch, Jessica L. Mark; Rossetti, Blair J.] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA 02543 USA; [Rossetti, Blair J.; Borisy, Gary G.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Hasegawa, Yuko] Okinawa Inst Sci & Technol, Okinawa Marine Sci Support Sect, Okinawa, Japan; [Rossetti, Blair J.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA	Marine Biological Laboratory - Woods Hole; Harvard University; Forsyth Institute; Okinawa Institute of Science & Technology Graduate University; Emory University	Welch, JLM (corresponding author), Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA 02543 USA.	jmarkwelch@mbl.edu		Rossetti, Blair/0000-0003-2405-4209; Hasegawa, Yuko/0000-0002-1328-276X	National Science Foundation [1650141]; National Institutes of Health National Institute of Dental and Craniofacial Research [DE022586]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding provided by National Science Foundation (www.nsf.gov) grant 1650141 to J.L. M.W. and National Institutes of Health National Institute of Dental and Craniofacial Research (ww.nidcr.nih.gov) grant DE022586 to G.G.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Cohen M, 2012, JOVE-J VIS EXP, DOI 10.3791/3928; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; De Jonge HW, 2005, MICROSC RES TECHNIQ, V66, P25, DOI 10.1002/jemt.20139; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamphuis JBJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08938-3; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Musch MW, 2013, DIGEST DIS SCI, V58, P668, DOI 10.1007/s10620-012-2509-5; RHODES JM, 1989, GUT, V30, P1660, DOI 10.1136/gut.30.12.1660; Schimak MP, 2016, APPL ENVIRON MICROB, V82, P62, DOI 10.1128/AEM.02776-15; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Welch J Mark, 2017, P NATL ACAD SCI US; Whitaker WR, 2017, CELL, V169, P538, DOI 10.1016/j.cell.2017.03.041; Yeung EC, 2015, BOTANY, V93, P1, DOI 10.1139/cjb-2014-0177; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	24	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188257	10.1371/journal.pone.0188257	http://dx.doi.org/10.1371/journal.pone.0188257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176788	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900050
J	Javadi-Paydar, M; Roscoe, RF; Denton, AR; Mactutus, CF; Booze, RM				Javadi-Paydar, Mehrak; Roscoe, Robert F., Jr.; Denton, Adam R.; Mactutus, Charles F.; Booze, Rosemarie M.			HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum	PLOS ONE			English	Article							DENDRITIC SPINES; UPTAKE INHIBITORS; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; TAT TOXICITY; PROTEIN; NEUROTOXICITY; TRANSPORTER; NEUROINFLAMMATION; SENSITIVITY	HIV-1 and addictive drugs, such as cocaine (COC), may act in combination to produce serious neurological complications. In the present experiments, striatal brain slices from HIV-1 transgenic (Tg) and F344 control female rats were studied. First, we examined dopamine (DA) reuptake in control, HIV-1, COC-treated (5 mu M) and HIV-1+COC-treated, striatal slices using fast scan cyclic voltammetry. COC-treated striatal slices from F344 control animals significantly increased DA reuptake time (T80), relative to untreated control slices. In contrast, in HIV-1 Tg striatal slices, DA reuptake time was extended by HIV-1, which was not further altered by COC treatment. Second, analysis of medium spiny neuronal populations from striatal brain slices found that controls treated with cocaine displayed increases in spine length, whereas cocaine treated HIV-1 slices displayed decreased spine length. Taken together, the current study provides evidence for dysfunction of the dopamine transporter (DAT) in mediating DA reuptake in HIV-1 Tg rats and limited responses to acute COC exposure. Collectively, dysfunction of the DAT reuptake and altered dendritic spine morphology of the MSNs, suggest a functional disruption of the dopamine system within the HIV-1 Tg rat.	[Javadi-Paydar, Mehrak; Roscoe, Robert F., Jr.; Denton, Adam R.; Mactutus, Charles F.; Booze, Rosemarie M.] Univ South Carolina, Dept Psychol, Behav Neurosci Lab, Columbia, SC 29208 USA; [Javadi-Paydar, Mehrak] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA	University of South Carolina System; University of South Carolina Columbia; Scripps Research Institute	Booze, RM (corresponding author), Univ South Carolina, Dept Psychol, Behav Neurosci Lab, Columbia, SC 29208 USA.	booze@mailbox.sc.edu		Javadi Paydar, Mehrak/0000-0003-0209-3311; Booze, Rosemarie/0000-0003-3908-8313	NIH (National Institute on Drug Abuse) [DA013137]; National Institute of Child Health and Human Development [HD043680]; National Institute of Mental Health [MH106392]; National Institute of Neurological Diseases and Stroke [NS100624]; University of South Carolina Behavioral-Biomedical Interface Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD043680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013137] Funding Source: NIH RePORTER	NIH (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of South Carolina Behavioral-Biomedical Interface Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from NIH (National Institute on Drug Abuse, DA013137 to RB; National Institute of Child Health and Human Development, HD043680 to CFM; National Institute of Mental Health, MH106392 to CFM; National Institute of Neurological Diseases and Stroke, NS100624 to CFM and the interdisciplinary research training program supported by the University of South Carolina Behavioral-Biomedical Interface Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2008, NEUROTOXICOLOGY, V29, P971, DOI 10.1016/j.neuro.2008.06.003; Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Aksenova MV, 2006, NEUROSCI LETT, V395, P235, DOI 10.1016/j.neulet.2005.10.095; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Bae J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034677; Bertrand SJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00894; Booze RM, 1999, PHARMACOL BIOCHEM BE, V64, P605, DOI 10.1016/S0091-3057(99)00154-9; Burmeister J.J., 2016, ENCY ANAL CHEM MEYER, P710; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Ferris MJ, 2009, NEUROSCIENCE, V159, P1292, DOI 10.1016/j.neuroscience.2009.01.024; Ferris MJ, 2010, J NEUROCHEM, V115, P885, DOI 10.1111/j.1471-4159.2010.06968.x; Fitting S, 2015, CURR HIV RES, V13, P21, DOI 10.2174/1570162X13666150121110731; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; Gerhardt GA, 2001, J NEUROSCI METH, V109, P13, DOI 10.1016/S0165-0270(01)00396-X; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harrod SB, 2008, PHARMACOL BIOCHEM BE, V90, P723, DOI 10.1016/j.pbb.2008.05.020; Hoffman AF, 1999, J PHARMACOL EXP THER, V289, P455; Homji NF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-3; Hu SX, 2009, J NEUROVIROL, V15, P401, DOI 10.3109/13550280903296346; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Jones SR, 1996, PSYCHOPHARMACOLOGY, V126, P331, DOI 10.1007/BF02247384; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kendall SL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-40; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; Le Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106837; Lee DE, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0390-9; Maki PM, 2009, NEUROPSYCHOL REV, V19, P204, DOI 10.1007/s11065-009-9093-2; McIntosh S, 2015, J NEUROIMMUNE PHARM, V10, P493, DOI 10.1007/s11481-015-9594-0; Meyer VJ, 2013, JAIDS-J ACQ IMM DEF, V63, P67, DOI 10.1097/QAI.0b013e318289565c; Midde NM, 2013, J NEUROIMMUNE PHARM, V8, P975, DOI 10.1007/s11481-013-9464-6; Moran LM, 2014, INT J DEV NEUROSCI, V38, P195, DOI 10.1016/j.ijdevneu.2014.09.004; Paris JJ, 2014, NEUROPSYCHOPHARMACOL, V39, P380, DOI 10.1038/npp.2013.201; Roscoe RF, 2014, J NEUROIMMUNE PHARM, V9, P642, DOI 10.1007/s11481-014-9555-z; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Schmidt H, 2009, J COMPUT NEUROSCI, V27, P229, DOI 10.1007/s10827-009-0139-5; Seabold GK, 2010, J VIS EXP; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Silvers JM, 2007, NEUROTOXICOLOGY, V28, P1184, DOI 10.1016/j.neuro.2007.07.005; Vera JH, 2016, NEUROLOGY, V86, P1425, DOI 10.1212/WNL.0000000000002485; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Will Royal, 2016, PLOS ONE, V11; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; ZAHM DS, 1992, BRAIN RES, V575, P341, DOI 10.1016/0006-8993(92)90102-F; Zhu Jia-Ying, 2011, Psyche (Cambridge), V2011, P1; Zou CY, 2016, ACTA NEUROPATHOL, V131, P235, DOI 10.1007/s00401-015-1527-8	47	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188404	10.1371/journal.pone.0188404	http://dx.doi.org/10.1371/journal.pone.0188404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176843	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900072
J	Lin, YC; Chen, CP				Lin, Yi-Chun; Chen, Chen-Peng			Characterization of small-to-medium headand-face dimensions for developing respirator fit test panels and evaluating fit of filtering facepiece respirators with different faceseal design	PLOS ONE			English	Article							ANTHROPOMETRIC SURVEY; ASSOCIATION; GENDER	A respirator fit test panel (RFTP) with facial size distribution representative of intended users is essential to the evaluation of respirator fit for new models of respirators. In this study an anthropometric survey was conducted among youths representing respirator users in mid-Taiwan to characterize head-and-face dimensions key to RFTPs for application to small-to-medium facial features. The participants were fit-tested for three N95 masks of different facepiece design and the results compared to facial size distribution specified in the RFTPs of bivariate and principal component analysis design developed in this study to realize the influence of facial characteristics to respirator fit in relation to facepiece design. Nineteen dimensions were measured for 206 participants. In fit testing the qualitative fit test (QLFT) procedures prescribed by the U. S. Occupational Safety and Health Administration were adopted. As the results show, the bizygomatic breadth of the male and female participants were 90.1 and 90.8% of their counterparts reported for the U. S. youths (P < 0.001), respectively. Compared to the bivariate distribution, the PCA design better accommodated variation in facial contours among different respirator user groups or populations, with the RFTPs reported in this study and from literature consistently covering over 92% of the participants. Overall, the facial fit of filtering facepieces increased with increasing facial dimensions. The total percentages of the tests wherein the final maneuver being completed was "Moving head up-and-down ", "Talking" or "Bending over" in bivariate and PCA RFTPs were 13.3-61.9% and 22.9-52.8%, respectively. The respirators with a three-panel flat fold structured in the facepiece provided greater fit, particularly when the users moved heads. When the facial size distribution in a bivariate RFTP did not sufficiently represent petite facial size, the fit testing was inclined to overestimate the general fit, thus for small-to-medium facial dimensions a distinct RFTP should be considered.	[Lin, Yi-Chun] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Lin, Yi-Chun; Chen, Chen-Peng] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Chen, CP (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan.	chencp@mail.cmu.edu.tw		Chen, Chen-Peng/0000-0001-9648-1942	Ministry of Science and Technology [NSC 102-2221-E-039-004-MY3, MOST 105-2221-E-039-003-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was funded by the Ministry of Science and Technology (formerly National Science Council) of Taiwan (https://www.most.gov.tw/en/public) under project numbers NSC 102-2221-E-039-004-MY3 and MOST 105-2221-E-039-003-MY3. The author CC was the recipient of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, TSI, Patent No. 6002712; Brazile W. J., 1998, APPL OCCUP ENV HYG, V13, P233, DOI DOI 10.1080/1047322X.1998.10390073; Brosseau LM, 2010, J OCCUP ENVIRON HYG, V7, P628, DOI 10.1080/15459624.2010.514782; Chen WH, 2009, ANN OCCUP HYG, V53, P297, DOI 10.1093/annhyg/men089; Coffey Christopher C, 2002, Appl Occup Environ Hyg, V17, P723, DOI 10.1080/10473220290107002; Colton C. E., 2011, OCCUPATIONAL ENV ITS, P1254; Dou HY, 2015, J FORMOS MED ASSOC, V114, P484, DOI 10.1016/j.jfma.2014.07.006; Du LL, 2008, ANN OCCUP HYG, V52, P773, DOI 10.1093/annhyg/men056; HACK AL, 1978, AM IND HYG ASSOC J, V39, P970, DOI 10.1080/0002889778507897; Han DH, 2003, AIHA J-J SCI OCCUP E, V64, P815, DOI 10.1080/15428110308984877; Hon CY, 2017, J OCCUP ENVIRON HYG, V14, P175, DOI 10.1080/15459624.2016.1237030; ISO, 2014, 169001 ISO; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kim JH, 2016, AM J INFECT CONTROL, V44, P194, DOI 10.1016/j.ajic.2015.08.027; Lee HJ, 2008, HUM BIOL, V80, P313, DOI 10.3378/1534-6617-80.3.313; Lee SA, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/8572493; NIOSH, 2005, PROC NO RCT APR STP; NIOSH, 2004, HEAD AND FAC ANTHR S; NIOSH, 2009, PROC NO RCT APR STP; Oestenstad RK, 2007, J OCCUP ENVIRON HYG, V4, P923, DOI 10.1080/15459620701709619; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; Tsai HM, 2014, JOGNN-J OBST GYN NEO, V43, P117, DOI 10.1111/1552-6909.12269; Tsai Pui-Jen, 2013, Glob J Health Sci, V5, P101, DOI 10.5539/gjhs.v5n3p101; Yang L, 2007, ANN OCCUP HYG, V51, P415, DOI 10.1093/annhyg/mem005; Yang L, 2017, J OCCUP ENVIRON HYG, V14, P9, DOI 10.1080/15459624.2016.1207778; Yeh CC, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0476-7; Yu YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085299; Zhuang ZQ, 2007, J OCCUP ENVIRON HYG, V4, P647, DOI 10.1080/15459620701497538; Zhuang ZQ, 2010, ANN OCCUP HYG, V54, P391, DOI 10.1093/annhyg/meq007; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P641, DOI 10.1080/15459620500391668; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P567, DOI 10.1080/15459620500324727	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188638	10.1371/journal.pone.0188638	http://dx.doi.org/10.1371/journal.pone.0188638			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176833	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900109
J	Paternoster, G; Martins, SB; Mattivi, A; Cagarelli, R; Angelini, P; Bellini, R; Santi, A; Galletti, G; Pupella, S; Marano, G; Copello, F; Rushton, J; Stark, KDC; Tamba, M				Paternoster, Giulia; Martins, Sara Babo; Mattivi, Andrea; Cagarelli, Roberto; Angelini, Paola; Bellini, Romeo; Santi, Annalisa; Galletti, Giorgio; Pupella, Simonetta; Marano, Giuseppe; Copello, Francesco; Rushton, Jonathan; Stark, Katharina D. C.; Tamba, Marco			Economics of One Health: Costs and benefits of integrated West Nile virus surveillance in Emilia-Romagna	PLOS ONE			English	Article								Since 2013 in Emilia-Romagna, Italy, surveillance information generated in the public health and in the animal health sectors has been shared and used to guide public health interventions to mitigate the risk of West Nile virus (WNV) transmission via blood transfusion. The objective of the current study was to identify and estimate the costs and benefits associated with this One Health surveillance approach, and to compare it to an approach that does not integrate animal health information in blood donations safety policy (uni-sectoral scenario). Costs of human, animal, and entomological surveillance, sharing of information, and triggered interventions were estimated. Benefits were quantified as the averted costs of potential human cases of WNV neuroinvasive disease associated to infected blood transfusion. In the 2009-2015 period, the One Health approach was estimated to represent a cost saving of (sic)160,921 compared to the uni-sectoral scenario. Blood donation screening was the main cost for both scenarios. The One Health approach further allowed savings of (sic)1.21 million in terms of avoided tests on blood units. Benefits of the One Health approach due to short-term costs of hospitalization and compensation for transfusion-associated disease potentially avoided, were estimated to range from (sic)0 to (sic)2.98 million according to the probability of developing WNV neuroinvasive disease after receiving an infected blood transfusion.	[Paternoster, Giulia; Santi, Annalisa; Galletti, Giorgio; Tamba, Marco] IZSLER, Brescia, Italy; [Martins, Sara Babo; Stark, Katharina D. C.] Royal Vet Coll, Dept Prod & Populat Hlth, Hatfield, Herts, England; [Martins, Sara Babo; Stark, Katharina D. C.] SAFOSO AG, Bern, Switzerland; [Mattivi, Andrea; Cagarelli, Roberto; Angelini, Paola] Reg Hlth Author Emilia Romagna, Bologna, Italy; [Bellini, Romeo] Ctr Agr Ambiente G Nicoli, Crevalcore, Italy; [Pupella, Simonetta; Marano, Giuseppe] Natl Inst Hlth, Natl Blood Ctr, ISS, Rome, Italy; [Copello, Francesco] IST Teaching Hosp, IRCCS AOU San Martino, Occupat Med Unit, Genoa, Italy; [Rushton, Jonathan] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Paternoster, Giulia] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland	IZS Lombardia e Emilia; University of London; University of London Royal Veterinary College; Istituto Superiore di Sanita (ISS); University of Liverpool; University of Zurich	Paternoster, G (corresponding author), IZSLER, Brescia, Italy.; Paternoster, G (corresponding author), Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland.	giulia.paternoster@gmail.com	pupella, simonetta/AAD-2457-2022; Marano, Giuseppe/AAC-4903-2019; Tamba, Marco/J-5495-2016; santi, annalisa/AAX-6603-2021; Paternoster, Giulia/AAC-3492-2019; Staerk, Katharina/M-4186-2013	pupella, simonetta/0000-0002-5356-6003; Tamba, Marco/0000-0002-5878-4595; santi, annalisa/0000-0002-7846-8856; Paternoster, Giulia/0000-0002-4612-1452; Marano, Giuseppe/0000-0003-0725-4583; Babo Martins, Sara/0000-0002-3466-2390; Staerk, Katharina/0000-0002-0553-5499; Galletti, Giorgio/0000-0003-4522-8976	Swiss Federal Food Safety and Veterinary Office; Royal Veterinary College	Swiss Federal Food Safety and Veterinary Office; Royal Veterinary College	The authors received no specific funding for this work The Swiss Federal Food Safety and Veterinary Office and the Royal Veterinary College funded SBM PhD project. SBM and KDCS were affiliated to SAFOSO AG during this study. The funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	Angelini P, 2010, EUROSURVEILLANCE, V15, P11; Barber LM, 2010, EMERG INFECT DIS, V16, P480, DOI 10.3201/eid1603.090667; Bellini R, 2014, EURO SURVEILL, V19; Bellini R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-323; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Canali M, 2012, CONTROLLO ZANZARA TI, P45; EC, 2014, DIRECTIVE 201489EU E; Emilia-Romagna Region, 2013, PIANO SORVEGLIANZA C; Gossner CM, 2017, EURO SURVEILL, V22; Humblet M, 2016, EUROSURVEILLANCE, V21, P17, DOI 10.2807/1560-7917.ES.2016.21.31.30309; Kolimenakis A, 2016, PUBLIC HEALTH, V131, P63, DOI 10.1016/j.puhe.2015.10.023; Korves CT, 2006, PLOS MED, V3, P211, DOI 10.1371/journal.pmed.0030021; Macini P, 2008, EURO SURVEILL, V13; Martins SB, 2016, ZOONOSES PUBLIC HLTH, V63, P386, DOI 10.1111/zph.12239; Ministero della Salute. [Italian Ministry of Health], 2014, W NIL DIS PROC OP IN; Napoli C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/643439; Niederhauser C, 2016, W NILE VIRUS PREPARE, P1; Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219; Region Emilia-Romagna, 2014, PIANO SORVEGLIANZA A; Region Emilia-Romagna, 2014, PROGETTO REALIZZAZIO; Region Emilia-Romagna, 2015, PIANO SORVEGLIANZA A; Region Emilia-Romagna, 2015, PROGETTO REALIZZAZIO; Rossini G, 2008, EURO SURVEILL, V13; Staples JE, 2014, AM J TROP MED HYG, V90, P402, DOI 10.4269/ajtmh.13-0206; Tisdell C, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P46; Zohrabian A, 2004, EMERG INFECT DIS, V10, P1736, DOI 10.3201/eid1010.030925; Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782	27	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188156	10.1371/journal.pone.0188156	http://dx.doi.org/10.1371/journal.pone.0188156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176851	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900042
J	Sturdivant, SK; Shimizu, MS				Sturdivant, S. Kersey; Shimizu, Megumi S.			In situ organism-sediment interactions: Bioturbation and biogeochemistry in a highly depositional estuary	PLOS ONE			English	Article							COASTAL MARINE BASIN; CAPE-LOOKOUT-BIGHT; HYDROGEN-SULFIDE; SEASONAL-VARIATIONS; ECOSYSTEM FUNCTION; LARVAL SETTLEMENT; COD BAY; MATTER; WATER; COMMUNITY	Organic matter (OM) production and degradation is important in coastal estuaries, and OM fate is strongly influenced by the coupled interactions of bioturbation and biogeochemistry. From April to September 2013 sediment cores and a benthic observing system, Wormcam, were used to investigate the in situ relationship of biogeochemistry and macrofauna bioturbation in Cape Lookout Bight North Carolina. Wormcam imagery provided a vivid depiction of macrofauna functioning in an environment not previously observed, and affirmed the importance of fine-scale temporal observations of the benthic environment in situ. Observation of macrofauna presence and bioturbation during the summer contradicted previous studies that found this area to be azoic during methane activity and sulfide build-up. Sulfate concentrations decreased while sulfide and dissolved inorganic carbon concentrations increased during the summer. This coincided with changes in the depth and rates of bioturbation. Summer burrow depths (similar to 0.8 cm) and rates (similar to 0.4 cm h(-1)) were significantly less than spring burrow depths (similar to 3.0 cm) and rates (similar to 1.0 cm h(-1)). While sulfate reduction and OM degradation increased with temperature at a microscopic level, macroscopic OM degradation was reduced. As a result, reduced conditions dominated and a thin aerobic sediment layer, a few millimeters in thickness, was visible at the sediment surface. Decreases in macrofauna burrow depth and rates diminishes the area of influence of bioturbators, limiting bioturbation and subsequently the important ecosystem functions these organisms provide.	[Sturdivant, S. Kersey] INSPIRE Environm, Newport, RI 02840 USA; [Sturdivant, S. Kersey] Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA; [Shimizu, Megumi S.] UNCW, Dept Biol & Marine Biol, Wilmington, NC USA	Duke University; University of North Carolina; University of North Carolina Wilmington	Sturdivant, SK (corresponding author), INSPIRE Environm, Newport, RI 02840 USA.; Sturdivant, SK (corresponding author), Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	kersey.sturdivant@duke.edu			National Science Foundation; Duke University Marine Lab; Division of Ocean Sciences [1324294]	National Science Foundation(National Science Foundation (NSF)); Duke University Marine Lab; Division of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by the National Science Foundation funded OCE-PRF to SKS, Japan Student Service Organization to MSS, and Duke University Marine Lab funded Joseph S. Ramus Endowment to SKS and MSS. The authors have declared that no competing interests exist. Author SK Sturdivant is currently also employed by a commercial company: INSPIRE Environmental. During the time of this study SKS was not employed by INSPIRE Environmental. The commercial entity INSPIRE Environmental provided support in the form of a salary for author SKS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Additional financial support from: Division of Ocean Sciences (1324294) to Dr. Samuel Kersey Sturdivant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by the National Science Foundation funded OCE-PRF to SKS, Japan Student Service Organization to MSS, and Duke University Marine Lab funded Joseph S. Ramus Endowment to SKS and MSS. We thank John Wilson for operating the RV Susan Hudson and piston corer, and Zackary Johnson for use of the DIC analyzer. We also thank D. Rittschof for a helpful critique and critical discussions.	Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Aller RC, 2001, BEL BAR LIB, P315; ALLER RC, 1978, AM J SCI, V278, P1185, DOI 10.2475/ajs.278.9.1185; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Bartlett KB, 1981, SEASONAL VARIATION S; Borowski WS, 2006, DATA REPORT DISSOLVE, P204; CANUEL EA, 1993, ORG GEOCHEM, V20, P563, DOI 10.1016/0146-6380(93)90024-6; Canuel EA, 1996, GEOCHIM COSMOCHIM AC, V60, P1793, DOI 10.1016/0016-7037(96)00045-2; CANUEL EA, 1990, GEOCHIM COSMOCHIM AC, V54, P237, DOI 10.1016/0016-7037(90)90211-3; CHANTON JP, 1983, GEOCHIM COSMOCHIM AC, V47, P1791, DOI 10.1016/0016-7037(83)90027-3; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; DAUER DM, 1981, J EXP MAR BIOL ECOL, V54, P21, DOI 10.1016/0022-0981(81)90100-3; Dauwe B, 1998, MAR ECOL PROG SER, V173, P67, DOI 10.3354/meps173067; David AA, 2014, J EXP MAR BIOL ECOL, V461, P20, DOI 10.1016/j.jembe.2014.07.012; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, BEL BAR LIB, P19; Diaz RJ, 1990, PERSPECTIVES CHESAPE; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dorgan KM, 2006, OCEANOGR MAR BIOL, V44, P85; DUNNETTE DA, 1985, WATER RES, V19, P875, DOI 10.1016/0043-1354(85)90146-0; FAGER EW, 1964, SCIENCE, V143, P356, DOI 10.1126/science.143.3604.356; FENCHEL T, 1969, Ophelia, V6, P1; FENCHEL TM, 1970, MAR BIOL, V7, P255, DOI 10.1007/BF00367496; Francois F, 2002, MAR ECOL PROG SER, V229, P127, DOI 10.3354/meps229127; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Germano JD, 2011, OCEANOGR MAR BIOL, V49, P235; Gingras M.K., 2012, TRACE FOSSILS INDICA, P837, DOI DOI 10.1016/B978-0-444-53813-0.00027-7; Graco M, 2001, LIMNOL OCEANOGR, V46, P821, DOI 10.4319/lo.2001.46.4.0821; Graf G, 1992, OCEANOGRAPHY MARINE, V16, P229; GUINASSO NL, 1975, J GEOPHYS RES-OC ATM, V80, P3032, DOI 10.1029/JC080i021p03032; Hartman Olga, 1945, DUKE UNIV MARINE STA BULL, V2, P1; Hentschel BT, 2004, J MARINE SYST, V49, P209, DOI 10.1016/j.jmarsys.2003.08.007; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; JUMARS PA, 1984, AM ZOOL, V24, P45; KEMPF SC, 1985, BIOL BULL-US, V169, P119, DOI 10.2307/1541392; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Lagauzere S, 2011, BIOGEOSCIENCES, V8, P339, DOI 10.5194/bg-8-339-2011; LEVIN LA, 1990, ECOLOGY, V71, P2191, DOI 10.2307/1938632; Levin LA, 2003, MAR ECOL PROG SER, V265, P123, DOI 10.3354/meps265123; LLANSO RJ, 1992, ESTUAR COAST SHELF S, V35, P491, DOI 10.1016/S0272-7714(05)80027-7; LLANSO RJ, 1991, J EXP MAR BIOL ECOL, V153, P165, DOI 10.1016/0022-0981(91)90223-J; Llodra ER, 2002, FECUNDITY LIFE HIST, P87; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; LYLE M, 1983, LIMNOL OCEANOGR, V28, P1026, DOI 10.4319/lo.1983.28.5.1026; MACDONALD IR, 1990, SCIENCE, V248, P1096, DOI 10.1126/science.248.4959.1096; MARTENS CS, 1984, GEOCHIM COSMOCHIM AC, V48, P1987, DOI 10.1016/0016-7037(84)90380-6; MARTENS CS, 1980, GEOCHIM COSMOCHIM AC, V44, P471, DOI 10.1016/0016-7037(80)90045-9; Meister P, 2013, GEOCHIM COSMOCHIM AC, V104, P183, DOI 10.1016/j.gca.2012.11.011; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; NICHOLLS P, 1975, BIOCHIM BIOPHYS ACTA, V396, P24, DOI 10.1016/0005-2728(75)90186-3; Oguri K, 2006, MAR CHEM, V100, P95, DOI 10.1016/j.marchem.2005.11.005; Pearson TH, 1978, OCEANOGR MAR BIOL AN, V16, P299; Petersen CG., 1913, REPORT DANISH BIOL S, V21, P1; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; POWELL EN, 1979, J EXP MAR BIOL ECOL, V37, P57, DOI 10.1016/0022-0981(79)90026-1; Preisler A, 2007, ISME J, V1, P341, DOI 10.1038/ismej.2007.50; REVSBECH NP, 1980, LIMNOL OCEANOGR, V25, P403, DOI 10.4319/lo.1980.25.3.0403; Rhoads D.C., 1974, Oceanography mar Biol, V12, P263; RHOADS DC, 1971, LIMNOL OCEANOGR, V16, P110, DOI 10.4319/lo.1971.16.1.0110; RHOADS DC, 1978, AM SCI, V66, P577; RHOADS DC, 1971, MAR BIOL, V11, P255, DOI 10.1007/BF00401273; RHOADS DC, 1982, MAR ECOL PROG SER, V8, P115, DOI 10.3354/meps008115; Rhodes D., 1982, ANIMAL SEDIMENT RELA, P3, DOI DOI 10.1007/978-1-4757-1317-6; Rosenberg R, 2001, ESTUAR COAST SHELF S, V53, P343, DOI 10.1006/ecss.2001.0810; Schaller J, 2014, CHEMOSPHERE, V107, P336, DOI 10.1016/j.chemosphere.2013.12.086; Sebesvari Z, 2006, J EXP MAR BIOL ECOL, V337, P109, DOI 10.1016/j.jembe.2006.06.007; Shumchenia EJ, 2010, ECOL INDIC, V10, P818, DOI 10.1016/j.ecolind.2010.01.003; Snelgrove P V R, 1995, OCEANOGRAPHIC LIT RE, V42, P668; Solan M, 2003, J EXP MAR BIOL ECOL, V285, P313, DOI 10.1016/S0022-0981(02)00535-X; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Solan M, 2004, MAR ECOL PROG SER, V271, P1, DOI 10.3354/meps271001; Solan M, 2002, MAR ECOL PROG SER, V228, P179, DOI 10.3354/meps228179; Sturdivant SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034539; TABATABA.MA, 1974, ENVIRON LETT, V7, P237, DOI 10.1080/00139307409437403; TAGHON GL, 1992, LIMNOL OCEANOGR, V37, P1370, DOI 10.4319/lo.1992.37.7.1370; Teal LR, 2010, MAR ECOL PROG SER, V414, P27, DOI 10.3354/meps08736; TENORE KR, 1972, ECOL MONOGR, V42, P51, DOI 10.2307/1942230; THAMDRUP B, 1994, GEOCHIM COSMOCHIM AC, V58, P5115, DOI 10.1016/0016-7037(94)90298-4; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; TORRANS EL, 1982, COMP BIOCHEM PHYS C, V71, P183, DOI 10.1016/0306-4492(82)90034-X; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Vismann B., 1990, MAR ECOL PROG SER; Volkel S, 1995, ADV COMP ENV PHYSL, P233; Volkenborn N, 2007, LIMNOL OCEANOGR, V52, P1898, DOI 10.4319/lo.2007.52.5.1898; WATZIN MC, 1986, J EXP MAR BIOL ECOL, V98, P65, DOI 10.1016/0022-0981(86)90076-6; WELLS JT, 1988, J SEDIMENT PETROL, V58, P596; WOODWICK KEITH H., 1960, PACIFIC SCI, V14, P122; YOUNG DK, 1971, MAR BIOL, V11, P242, DOI 10.1007/BF00401272; Zar JH, 1999, BIOSTATISTICAL ANAL	94	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187800	10.1371/journal.pone.0187800	http://dx.doi.org/10.1371/journal.pone.0187800			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176813	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900016
J	Zhang, JW; Burgess, JG				Zhang, Jinwei; Burgess, J. Grant			Enhanced eicosapentaenoic acid production by a new deep-sea marine bacterium Shewanella electrodiphila MAR441(T)	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SP-NOV.; PHAEODACTYLUM-TRICORNUTUM; ANTARCTIC BACTERIUM; SP. NOV.; GROWTH; BIOSYNTHESIS; PHOSPHOLIPIDS; CULTURE; OMEGA-3-FATTY-ACIDS	Omega-3 fatty acids are products of secondary metabolism, essential for growth and important for human health. Although there are numerous reports of bacterial production of omega-3 fatty acids, less information is available on the biotechnological production of these compounds from bacteria. The production of eicosapentaenoic acid (EPA, 20:5 omega 3) by a new species of marine bacteria Shewanella electrodiphila MAR441(T) was investigated under different fermentation conditions. This strain produced a high percentage (up to 26%) of total fatty acids and high yields (mg / g of biomass) of EPA at or below the optimal growth temperature. At higher growth temperatures these values decreased greatly. The amount of EPA produced was affected by the carbon source, which also influenced fatty acid composition. This strain required Na+ for growth and EPA synthesis and cells harvested at late exponential or early stationary phase had a higher EPA content. Both the highest amounts (20 mg g(-1)) and highest percent EPA content (18%) occurred with growth on L-proline and (NH4)(2)SO4. The addition of cerulenin further enhanced EPA production to 30 mg g(-1). Chemical mutagenesis using NTG allowed the isolation of mutants with improved levels of EPA content (from 9.7 to 15.8 mg g(-1)) when grown at 15 degrees C. Thus, the yields of EPA could be substantially enhanced without the need for recombinant DNA technology, often a commercial requirement for food supplement manufacture.	[Zhang, Jinwei] Univ Exeter, Med Sch, Hatherly Lab, Inst Biomed & Clin Sci, Exeter, Devon, England; [Zhang, Jinwei; Burgess, J. Grant] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Exeter; Newcastle University - UK	Burgess, JG (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	grant.burgess@ncl.ac.uk	Zhang, Jinwei/Q-7959-2019; Zhang, Jinwei/N-8584-2017	Zhang, Jinwei/0000-0001-8683-509X; Zhang, Jinwei/0000-0001-8683-509X	NERC ECOMAR program [NE/C512961/1]; BBSRC-Croda Dorothy Hodgkin Postgraduate Award (DHPA)	NERC ECOMAR program; BBSRC-Croda Dorothy Hodgkin Postgraduate Award (DHPA)	The authors acknowledge the support of the NERC ECOMAR program (NE/C512961/1) and the BBSRC-Croda Dorothy Hodgkin Postgraduate Award (DHPA) to Dr Jinwei Zhang.	AKIMOTO M, 1990, J AM OIL CHEM SOC, V67, P911, DOI 10.1007/BF02541846; Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Amiri-Jami M, 2010, J APPL MICROBIOL, V109, P1897, DOI 10.1111/j.1365-2672.2010.04817.x; Amiri-Jami M, 2006, BIOTECHNOL LETT, V28, P1187, DOI 10.1007/s10529-006-9077-8; Amiri-Jami M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv166; [Anonymous], 1946, MARINE MICROBIOLOGY; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; BAJPAI P, 1991, J AM OIL CHEM SOC, V68, P775, DOI 10.1007/BF02662171; Balogun KA, 2016, APPL PHYSL NUTR META, V1; Boswell Kimberly D. B., 1992, P274; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Chen CY, 2015, BIORESOURCE TECHNOL, V191, P407, DOI 10.1016/j.biortech.2015.03.001; Cho KW, 1999, BIOTECHNOL LETT, V21, P215, DOI 10.1023/A:1005445624918; Christie WW, 1989, GAS CHROMATOGRAPHY L, P64; Dailey FE, 2016, APPL ENVIRON MICROB, V82, P218, DOI 10.1128/AEM.02266-15; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; DOBSON SJ, 1991, ARCH MICROBIOL, V156, P56, DOI 10.1007/BF00418188; Frolova G M, 2005, Mikrobiologiia, V74, P766; Gentile G, 2003, J APPL MICROBIOL, V95, P1124, DOI 10.1046/j.1365-2672.2003.02077.x; GRIMA EM, 1994, BIOTECHNOL LETT, V16, P1035, DOI 10.1007/BF01022399; HENDERSON RJ, 1993, LIPIDS, V28, P389, DOI 10.1007/BF02535935; Hirota K, 2005, INT J SYST EVOL MICR, V55, P2355, DOI 10.1099/ijs.0.63804-0; Ivanova EP, 2003, INT J SYST EVOL MICR, V53, P577, DOI 10.1099/ijs.0.02198-0; Ivanova EP, 2001, INT J SYST EVOL MICR, V51, P1027, DOI 10.1099/00207713-51-3-1027; Jostensen JP, 1996, ARCH MICROBIOL, V165, P306, DOI 10.1007/s002030050331; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KATES M, 1986, LAB TECHNIQUES BIOCH, P1; Kato C, 2001, FEMS MICROBIOL ECOL, V35, P223, DOI 10.1016/S0168-6496(00)00100-8; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Kramkowska M, 2013, ANN AGR ENV MED, V20, P413; Kulikowski L, 2014, 5 CO GENETICALLY MOD; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; MAKEMSON JC, 1979, APPL ENVIRON MICROB, V38, P178, DOI 10.1128/AEM.38.1.178-180.1979; Meyer Hartmut, 2011, Environmental Sciences Europe, V23, P7, DOI 10.1186/2190-4715-23-7; Miron AS, 1999, J BIOTECHNOL, V70, P249; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; NICHOLS DS, 1994, MICROBIOL-UK, V140, P577, DOI 10.1099/00221287-140-3-577; Nichols DS, 1996, MICROBIOL-UK, V142, P747, DOI 10.1099/00221287-142-4-747; Nichols DS, 2002, J MICROBIOL METH, V48, P161, DOI 10.1016/S0167-7012(01)00320-7; Nichols DS, 1997, BBA-LIPID LIPID MET, V1347, P164, DOI 10.1016/S0005-2760(97)00068-4; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Opperman M, 2011, CARDIOVASC J AFR, V22, P324, DOI 10.5830/CVJA-2010-080; Peng YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162861; Rajan SR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/203093; Russell NJ, 1999, MICROBIOL-UK, V145, P767, DOI 10.1099/13500872-145-4-767; Sato S, 2008, EXTREMOPHILES, V12, P753, DOI 10.1007/s00792-008-0182-6; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; Schantz SL, 2010, ENVIRON RES, V110, P33, DOI 10.1016/j.envres.2009.09.003; Skerratt JH, 2002, INT J SYST EVOL MICR, V52, P2101, DOI [10.1099/ijs.0.02351-0, 10.1099/00207713-52-6-2101]; Uzogara SG, 2000, BIOTECHNOL ADV, V18, P179, DOI 10.1016/S0734-9750(00)00033-1; Valentine RC, 2004, PROG LIPID RES, V43, P383, DOI 10.1016/j.plipres.2004.05.004; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; Wen ZY, 2003, BIOTECHNOL ADV, V21, P273, DOI 10.1016/S0734-9750(03)00051-X; Wen ZY, 2002, PROCESS BIOCHEM, V37, P1447, DOI 10.1016/S0032-9592(02)00034-1; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wunderlich S, 2015, ADV NUTR, V6, P842, DOI 10.3945/an.115.008870; YAZAWA K, 1988, J BIOCHEM-TOKYO, V103, P5, DOI 10.1093/oxfordjournals.jbchem.a122238; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; YAZAWA K, 1988, NIPPON SUISAN GAKK, V54, P1835; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; Yumoto I, 2004, ARCH MICROBIOL, V181, P345, DOI 10.1007/s00203-004-0662-8; Zhang J, 2015, INT J SYST EVOL MICR; Zhang JW, 2007, WORLD J MICROB BIOT, V23, P1551, DOI 10.1007/s11274-007-9400-0; Zhang JW, 2015, INT J SYST EVOL MICR, V65, P2882, DOI [10.1099/ijs.0.057125-0, 10.1099/ijs.0.000345]; Zhao JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009109; Zhao JS, 2006, INT J SYST EVOL MICR, V56, P205, DOI 10.1099/ijs.0.63829-0; Zhao JS, 2005, INT J SYST EVOL MICR, V55, P1511, DOI 10.1099/ijs.0.63604-0	70	16	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188081	10.1371/journal.pone.0188081	http://dx.doi.org/10.1371/journal.pone.0188081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176835	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900034
J	Alemar, B; Gregorio, C; Herzog, J; Bittar, CM; Netto, CBO; Artigalas, O; Schwartz, IVD; Coffa, J; Camey, SA; Weitzel, J; Ashton-Prolla, P				Alemar, Baarbara; Gregorio, Cleandra; Herzog, Josef; Bittar, Camila Matzenbacher; Oliveira Netto, Cristina Brinckmann; Artigalas, Osvaldo; Schwartz, Ida Vanessa D.; Coffa, Jordy; Camey, Suzi Alves; Weitzel, Jeffrey; Ashton-Prolla, Patricia			BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?	PLOS ONE			English	Article							GERMLINE MUTATIONS; RISK-ASSESSMENT; GUIDELINES; STATEMENT; VARIANTS; FAMILIES; GENETICS; GENOMICS; SOCIETY; GENES	Background Germline pathogenic variants in BRCA1 and BRCA2 (BRCA) are the main cause of Hereditary Breast and Ovarian Cancer syndrome (HBOC). Methods In this study we evaluated the mutational profile and prevalence of BRCA pathogenic/likely pathogenic variants among probands fulfilling the NCCN HBOC testing criteria. We characterized the clinical profile of these individuals and explored the performance of international testing criteria. Results A pathogenic/likely pathogenic variant was detected in 19.1% of 418 probands, including seven novel frameshift variants. Variants of uncertain significance were found in 5.7% of individuals. We evaluated 50 testing criteria and mutation probability algorithms. There was a significant odds-ratio (OR) for mutation prediction (p <= 0.05) for 25 criteria; 14 of these had p <= 0.001. Using a cutoff point of four criteria, the sensitivity is 83.8%, and the specificity is 53.5% for being a carrier. The prevalence of pathogenic/likely pathogenic variants for each criterion ranged from 22.1% to 55.6%, and criteria with the highest ORs were those related to triple-negative breast cancer or ovarian cancer. Conclusions This is the largest study of comprehensive BRCA testing among Brazilians to date, and the first to analyze clinical criteria for genetic testing. Several criteria that are not included in the NCCN achieved a higher predictive value. Identification of the most informative criteria for each population will assist in the development of a rational approach to genetic testing, and will enable the prioritization of high-risk individuals as a first step towards offering testing in low-income countries.	[Alemar, Baarbara; Gregorio, Cleandra; Bittar, Camila Matzenbacher; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Alemar, Baarbara; Gregorio, Cleandra; Bittar, Camila Matzenbacher; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil; [Herzog, Josef; Weitzel, Jeffrey] City Hope Natl Med Ctr, Div Clin Canc Genom, Dept Populat Sci, Duarte, CA USA; [Oliveira Netto, Cristina Brinckmann; Schwartz, Ida Vanessa D.; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil; [Artigalas, Osvaldo] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [Schwartz, Ida Vanessa D.; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Coffa, Jordy] MRC Holland, Amsterdam, Netherlands; [Camey, Suzi Alves] Univ Fed Rio Grande do Sul, Dept Estat, Programa Posgrad Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; City of Hope; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	pprolla@gmail.com	Ashton-Prolla, Patricia/T-3515-2019; Ashton-Prolla, Patricia/H-2927-2012; Schwartz, Ida/M-1422-2015; Schwartz, Ida Vanessa Doederlein/ABG-5471-2020; Camey, Suzi Alves/Y-2756-2019	Schwartz, Ida/0000-0002-7933-6687; Schwartz, Ida Vanessa Doederlein/0000-0002-7933-6687; Camey, Suzi Alves/0000-0002-5564-081X; Gregorio Silva, Cleandra/0000-0002-6476-219X	Breast Cancer Research Foundation [02-2013-044]; National Institute of Health/National Cancer Institute grant [RC4 CA153828-01]; Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)	Breast Cancer Research Foundation; National Institute of Health/National Cancer Institute grant; Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by a grant from the Breast Cancer Research Foundation, Avon grant #02-2013-044 (JW), and National Institute of Health/National Cancer Institute grant #RC4 CA153828-01 (JW) for the Clinical Cancer Genomics Community Research Network. Support in part was provided by grants from Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre (PAP) and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BA). PAP is a researcher from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) and BA and CG received a grant from the same agency. Funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (Jordy Coffa) is employed by a commercial company (MRC-Holland) and we declare that "The funder provided support in the form of salaries for authors (JC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alemar B, 2016, CANCER GENET-NY, V209, P417, DOI 10.1016/j.cancergen.2016.06.008; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2015, PROTOCOL 2 BRCA1 BRC; Ashton-Prolla P, 2015, J COMMUN GENET, V6, P275, DOI 10.1007/s12687-015-0238-0; Azzollini J, 2016, EUR J INTERN MED, V32, P65, DOI 10.1016/j.ejim.2016.03.010; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581; Clinical Practice Guidelines in Oncology, 2017, GEN FAM HIGH RISK AS; Clinical Practice Guidelines in Oncology, 2014, GEN FAM HIGH RISK AS; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Felix GE, 2014, GERMLINE MUTATIONS B; Fernandes GC, 2016, ONCOTARGET; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Grana B, 2011, CLIN TRANSL ONCOL, V13, P580, DOI 10.1007/s12094-011-0701-2; Hamel N, 2011, EUR J HUM GENET, V19, P300, DOI 10.1038/ejhg.2010.203; Heidemann S, 2012, BREAST CANCER RES TR, V134, P1229, DOI 10.1007/s10549-012-2050-4; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy-Lahad E, 2007, BRIT J CANCER, V96, P11, DOI 10.1038/sj.bjc.6603535; Lu KH, 2014, J CLIN ONCOL, V32, P833, DOI 10.1200/JCO.2013.50.9257; Maistro S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2966-x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; R Core Team, 2013, R LANG ENV STAT COMP; Ready K, 2011, BREAST J, V17, P210, DOI 10.1111/j.1524-4741.2010.01055.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Silva FC, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-55; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747; Weitzel JN, 2011, CA-CANCER J CLIN, V61, P327, DOI 10.3322/caac.20128	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187630	10.1371/journal.pone.0187630	http://dx.doi.org/10.1371/journal.pone.0187630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161300	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000013
J	Contu, S; Hussain, A; Kager, S; Budhota, A; Deshmukh, VA; Kuah, CWK; Yam, LHL; Xiang, LM; Chua, KSG; Masia, L; Campolo, D				Contu, Sara; Hussain, Asif; Kager, Simone; Budhota, Aamani; Deshmukh, Vishwanath A.; Kuah, Christopher W. K.; Yam, Lester H. L.; Xiang, Liming; Chua, Karen S. G.; Masia, Lorenzo; Campolo, Domenico			Proprioceptive assessment in clinical settings: Evaluation of joint position sense in upper limb post-stroke using a robotic manipulator	PLOS ONE			English	Article							ASSISTED THERAPY; MOTOR RECOVERY; BASAL GANGLIA; ARM MOVEMENTS; STROKE; REHABILITATION; SHOULDER; PATTERNS; FINGER; ELBOW	Proprioception is a critical component for motor functions and directly affects motor learning after neurological injuries. Conventional methods for its assessment are generally ordinal in nature and hence lack sensitivity. Robotic devices designed to promote sensorimotor learning can potentially provide quantitative precise, accurate, and reliable assessments of sensory impairments. In this paper, we investigate the clinical applicability and validity of using a planar 2 degrees of freedom robot to quantitatively assess proprioceptive deficits in post-stroke participants. Nine stroke survivors and nine healthy subjects participated in the study. Participants' hand was passively moved to the target position guided by the H-Man robot (Criterion movement) and were asked to indicate during a second passive movement towards the same target (Matching movement) when they felt that they matched the target position. The assessment was carried out on a planar surface for movements in the forward and oblique directions in the contralateral and ipsilateral sides of the tested arm. The matching performance was evaluated in terms of error magnitude (absolute and signed) and its variability. Stroke patients showed higher variability in the estimation of the target position compared to the healthy participants. Further, an effect of target was found, with lower absolute errors in the contralateral side. Pairwise comparison between individual stroke participant and control participants showed significant proprioceptive deficits in two patients. The proposed assessment of passive joint position sense was inherently simple and all participants, regardless of motor impairment level, could complete it in less than 10 minutes. Therefore, the method can potentially be carried out to detect changes in proprioceptive deficits in clinical settings.	[Contu, Sara; Hussain, Asif; Budhota, Aamani; Masia, Lorenzo; Campolo, Domenico] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Robot Res Ctr, Singapore, Singapore; [Kager, Simone] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Budhota, Aamani] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore, Singapore; [Deshmukh, Vishwanath A.; Kuah, Christopher W. K.; Yam, Lester H. L.; Chua, Karen S. G.] Tan Tock Seng Hosp, Dept Rehabil Med, Ctr Adv Rehabil Therapeut, Singapore, Singapore; [Xiang, Liming] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Campolo, D (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Robot Res Ctr, Singapore, Singapore.	d.campolo@ntu.edu.sg	Campolo, Domenico/G-5648-2010; Xiang, Liming/AGF-0351-2022; Xiang, Liming/B-6966-2011	Campolo, Domenico/0000-0001-6930-0413; Xiang, Liming/0000-0003-0698-5173; Xiang, Liming/0000-0003-0698-5173; Chua, Karen/0000-0001-9809-3425	'H-Man' project, Ministry of Health, Singapore [NMRC/BnB/0006b/2013]; Interdisciplinary Graduate School, Nanyang Technological University, Singapore	'H-Man' project, Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore	Part of this work was supported by the 'H-Man' project (NMRC/BnB/0006b/2013), Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Part of this work was supported by the 'H-Man' project (NMRC/BnB/0006b/2013), Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore.	Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Balasubramanian Sivakumar, 2012, Am J Phys Med Rehabil, V91, pS255, DOI 10.1097/PHM.0b013e31826bcdc1; Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Beer RF, 1999, ARCH PHYS MED REHAB, V80, P766, DOI 10.1016/S0003-9993(99)90225-3; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; BEVAN L, 1994, J NEUROPHYSIOL, V71, P1862, DOI 10.1152/jn.1994.71.5.1862; Brewer B. R., 2014, TOP STROKE REHABIL; Campolo D, 2014, J NEUROSCI METH, V235, P285, DOI 10.1016/j.jneumeth.2014.07.003; Cappello L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00198; Carey LM, 1995, CRITICAL REV, V7; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Contu S, 2016, IEEE ENG MED BIO, P4614, DOI 10.1109/EMBC.2016.7591755; Desmurget M, 2003, EXP BRAIN RES, V153, P197, DOI 10.1007/s00221-003-1593-3; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Dewald JPA, 2001, MUSCLE NERVE, V24, P273, DOI 10.1002/1097-4598(200102)24:2<273::AID-MUS130>3.0.CO;2-Z; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Ellis MD, 2007, EXP BRAIN RES, V176, P594, DOI 10.1007/s00221-006-0637-x; Frisoli A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-36; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; GOBLE DJ, 2016, PHYS THER, V90, P1176, DOI DOI 10.2522/PTJ.20090399; Gradwell E., 2003, 8 INT C REHABILITATI, P55; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; Han J, 2011, APPL MECH MATER, V66-68, P620, DOI 10.4028/www.scientific.net/AMM.66-68.620; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Hillier S., 2015, NEUROREHAB NEURAL RE; HUANG CY, 1987, J NEUROL NEUROSUR PS, V50, P720, DOI 10.1136/jnnp.50.6.720; Hussain A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00477; Ingemanson ML, 2016, EXP BRAIN RES, V234, P83, DOI 10.1007/s00221-015-4440-4; Ishii S, 1989, Rinsho Shinkeigaku, V29, P269; Janwantanakul P, 2001, ARCH PHYS MED REHAB, V82, P840, DOI 10.1053/apmr.2001.21865; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Kosinski R.J, 2008, LIT REV REACTION TIM; Kumral Emre, 2003, J Stroke Cerebrovasc Dis, V12, P66, DOI 10.1053/jscd.2003.11; Kwakkel G., 2007, NEUROREHABILITATION; Leibowitz N, 2008, DISABIL REHABIL, V30, P1829, DOI 10.1080/09638280701640145; Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Marini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161155; Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230; MCCLATCHIE G, 1980, MED J AUSTRALIA, V1, P649, DOI 10.5694/j.1326-5377.1980.tb135209.x; Niessen MH, 2008, ARCH PHYS MED REHAB, V89, P333, DOI 10.1016/j.apmr.2007.08.157; Nordin N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-137; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; REFSHAUGE KM, 1995, J PHYSIOL-LONDON, V488, P231, DOI 10.1113/jphysiol.1995.sp020961; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Salles JI, 2011, NEUROSCI LETT, V501, P61, DOI 10.1016/j.neulet.2011.05.005; Santisteban L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154792; Schmidt RA, 1988, HUMAN KINETICS; Semrau JA, 2015, STROKE, V46, P3459, DOI 10.1161/STROKEAHA.115.010750; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Simo LS, 2011, IEEE ENG MED BIO, P8227, DOI 10.1109/IEMBS.2011.6092029; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Tyson S., 2007, NEUROREHABILITATION; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa	60	22	25	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0183257	10.1371/journal.pone.0183257	http://dx.doi.org/10.1371/journal.pone.0183257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161264	Green Published, gold			2022-12-26	WOS:000415987000002
J	Sagar, A; Dai, W; Minot, M; LeCover, R; Varner, JD				Sagar, Adithya; Dai, Wei; Minot, Mason; LeCover, Rachel; Varner, Jeffrey D.			Reduced order modeling and analysis of the human complement system	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; ACTIVATION; CASCADE; IMMUNE; IMMUNOLOGY; INHIBITOR; COMPONENT; ANTIBODY; THERAPY; ASSAYS	Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation.	[Sagar, Adithya; Dai, Wei; Minot, Mason; LeCover, Rachel; Varner, Jeffrey D.] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA	Cornell University	Varner, JD (corresponding author), Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.	jdv27@cornell.edu		Varner, Jeffrey/0000-0002-2558-7026; LeCover, Rachel/0000-0003-3044-5804; Minot, Mason/0000-0003-0225-9107	U.S. Army Research Laboratory; U.S. Army Research Office [W911NF1020114]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number W911NF1020114 to JDV.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bansal R, 2014, US Patent, Patent No. 8664362; Bassen DM, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-016-0380-2; Bergseth G, 2013, MOL IMMUNOL, V56, P232, DOI 10.1016/j.molimm.2013.05.221; Bezanson J, ARXIV14111607V4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Epstein D, 2007, US Patent App., Patent No. [12/224,708, 12224708]; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Herman J, SENSITIVITY ANAL LIB; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hirayama H, 1996, BIOSYSTEMS, V39, P173, DOI 10.1016/0303-2647(96)01617-6; Hu XZ, 2013, MOL IMMUNOL, V54, P302, DOI 10.1016/j.molimm.2012.12.018; Jamei Masoud, 2016, Curr Pharmacol Rep, V2, P161; Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Kuepfer L, 2016, CPT-PHARMACOMET SYST, V5, P516, DOI 10.1002/psp4.12134; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; Morad HOJ, 2015, J IMMUNOL METHODS, V427, P13, DOI 10.1016/j.jim.2015.09.001; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nayak S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002016; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; NUTTALL G, 1888, Z HYG, V4, P353, DOI DOI 10.1007/BF02188097; PANGBURN MK, 1984, SPRINGER SEMIN IMMUN, V7, P163, DOI 10.1007/BF01893019; Rawal N, 2008, J BIOL CHEM, V283, P7853, DOI 10.1074/jbc.M707591200; Rice NT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154127; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roguska M, 2014, INVEST OPHTH VIS SCI, V55; Rother K., 2012, COMPLEMENT SYSTEM; Sagar A, 2017, BIOTECHNOL J; Sagar A, 2015, PROCESSES, V3, P178, DOI 10.3390/pr3010178; Sager JE, 2015, DRUG METAB DISPOS, V43, P1823, DOI 10.1124/dmd.115.065920; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schwaeble HW, 2011, US Patent, Patent No. [7,919,094, 7919094]; SISSONS JGP, 1977, J CLIN INVEST, V59, P704, DOI 10.1172/JCI108689; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; SWAAK AJG, 1982, RHEUMATOL INT, V2, P161, DOI 10.1007/BF00286138; Tasseff R, 2011, INTEGR BIOL-UK, V3, P578, DOI 10.1039/c0ib00141d; Tasseff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008864; Tolson BA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004723; van Vuuren BJ, 2014, J IMMUNOL METHODS, V402, P50, DOI 10.1016/j.jim.2013.11.010; Varnerlab, JUP CONSTR MULT OPT; Vogel CW, 2004, MOL IMMUNOL, V41, P191, DOI 10.1016/j.molimm.2004.03.011; WALKER DG, 1995, BRAIN RES, V675, P75, DOI 10.1016/0006-8993(95)00041-N; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weston-Davies WH, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4280.4280; Zewde N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152337	61	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187373	10.1371/journal.pone.0187373	http://dx.doi.org/10.1371/journal.pone.0187373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155837	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700010
J	Letson, H; Dobson, G				Letson, Hayley; Dobson, Geoffrey			Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage	PLOS ONE			English	Article							7.5-PERCENT NACL ADENOSINE; RAT MODEL; TRAUMA; RESUSCITATION; EPIDEMIOLOGY; INFUSION; IMPACT; MECHANISMS; SURVIVAL; DAMPS	Background Systemic inflammation and coagulopathy are major drivers of injury progression following hemorrhagic trauma. Our aim was to examine the effect of small-volume 3% NaCl adenosine, lidocaine and Mg2+ (ALM) bolus and 0.9% NaCl/ALM 'drip' on inflammation and coagulation in a rat model of hemorrhagic shock. Methods Sprague-Dawley rats (429 +/- 4 g) were randomly assigned to: 1) shams, 2) no-treatment, 3) saline-controls, 4) ALM-therapy, and 5) Hextend (R). Hemorrhage was induced in anesthetized-ventilated animals by liver resection (60% left lateral lobe and 50% medial lobe). After 15 min, a bolus of 3% NaCl +/- ALM (0.7 ml/kg) was administered intravenously (Phase 1) followed 60 min later by 4 hour infusion of 0.9% NaCl +/- ALM (0.5 ml/kg/hour) with 1-hour monitoring (Phase 2). Plasma cytokines were measured on Magpix (R) and coagulation using Stago/Rotational Thromboelastometry. Results After Phase 1, saline-controls, no-treatment and Hextend (R) groups showed significant falls in white and red cells, hemoglobin and hematocrit (up to 30%), whereas ALM animals had similar values to shams (9-15% losses). After Phase 2, these deficits in non-ALM groups were accompanied by profound systemic inflammation. In contrast, after Phase 1 ALM-treated animals had undetectable plasma levels of IL-1 alpha and IL-1 beta, and IL-2, IL-6 and TNF-alpha were below baseline, and after Phase 2 they were less or similar to shams. Non-ALM groups (except shams) also lost their ability to aggregate platelets, had lower plasma fibrinogen levels, and were hypocoagulable. ALM-treated animals had 50-fold higher ADP-induced platelet aggregation, and 9.3-times higher collagen-induced aggregation compared to saline-controls, and had little or no coagulopathy with significantly higher fibrinogen shifting towards baseline. Hextend (R) had poor outcomes. Conclusions Small-volume ALM bolus/drip mounted a frontline defense against non-compressible traumatic hemorrhage by defending immune cell numbers, suppressing systemic inflammation, improving platelet aggregation and correcting coagulopathy. Saline-controls were equivalent to no-treatment. Possible mechanisms of ALM's immune-bolstering effect are discussed.	[Letson, Hayley; Dobson, Geoffrey] James Cook Univ, Heart Trauma & Sepsis Res Lab, Coll Med & Dent, Townsville, Qld, Australia	James Cook University	Dobson, G (corresponding author), James Cook Univ, Heart Trauma & Sepsis Res Lab, Coll Med & Dent, Townsville, Qld, Australia.	geoffrey.dobson@jcu.edu.au	Letson, Hayley Louise/V-4659-2019	Letson, Hayley Louise/0000-0003-0135-134X	USSOCOM [W81XWH-15-1-0002]; IACUC [W81XWH-15-1-0002, A2118]; USAMRMC [W81XWH-15-1-0002, S013004]	USSOCOM; IACUC; USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by USSOCOM, IACUC protocol A2118, USAMRMC proposal S013004 under Award No. W81XWH-15-1-0002. The opinions, interpretations, conclusions are those of the authors and are not necessarily endorsed by the US Department of Defense.	Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; [Anonymous], 2011, RSBO, V8, P299; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brohi K, 2010, J ROY ARMY MED CORPS, V155, P320; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Butler FK., 2014, J SPEC OPER MED, V14, P13; Bynum JA, 2017, J TRAUMA AC IN PRESS, pXX; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Davenport L, 2017, INNATE IMMUN-LONDON, V23, P482, DOI 10.1177/1753425917718921; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; Djabir Y, 2013, SHOCK, V40, P222, DOI 10.1097/SHK.0b013e3182a03566; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Dobson GP, 2016, J TRAUMA ACUTE CARE, V80, P135, DOI 10.1097/TA.0000000000000881; DOBSON GP, 2013, FRONT PHYSIOL, V4, P1, DOI DOI 10.3389/FPHYS.2013.00228; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Granfeldt A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0682-y; Granfeldt A, 2014, CRIT CARE MED, V42, pE329, DOI 10.1097/CCM.0000000000000225; Griffin MJ, 2014, J TRAUMA ACUTE CARE, V77, P471, DOI 10.1097/TA.0000000000000361; Griffin MJ, 2016, CLIN VACCINE IMMUNOL, V23, P863, DOI 10.1128/CVI.00390-16; Groeneveld KM, 2011, CURR OPIN ANESTHESIO, V24, P219, DOI 10.1097/ACO.0b013e32834401e0; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Jackman RP, 2013, CURR OPIN ANESTHESIO, V26, P196, DOI 10.1097/ACO.0b013e32835d7160; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kheirbek T, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-65; Kisat M, 2013, J SURG RES, V184, P414, DOI 10.1016/j.jss.2013.05.099; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; Letson HL, 2017, J TRAUMA ACUTE CARE, V82, P1063, DOI 10.1097/TA.0000000000001454; Letson HL, 2016, THROMB RES, V141, P58, DOI 10.1016/j.thromres.2016.03.007; Letson HL, 2015, J TRAUMA ACUTE CARE, V78, P773, DOI 10.1097/TA.0000000000000587; Letson HL, 2012, CRIT CARE MED, V40, P2417, DOI 10.1097/CCM.0b013e31825334c3; Letson HL, 2011, J TRAUMA, V71, P708, DOI 10.1097/TA.0b013e3181fa27c7; Maegele M, 2014, EUR J TRAUMA EMERG S, V40, P113, DOI 10.1007/s00068-014-0389-4; Martin SJ, 2016, FEBS J, V283, P2599, DOI 10.1111/febs.13775; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Molina PE, 2005, SHOCK, V24, P3, DOI 10.1097/01.shk.0000167112.18871.5c; Moore EE, 2005, SHOCK, V24, P71, DOI 10.1097/01.shk.0000191336.01036.fe; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pittman K, 2013, J INNATE IMMUN, V5, P315, DOI 10.1159/000347132; Sollberger G, 2014, INNATE IMMUN-LONDON, V20, P115, DOI 10.1177/1753425913484374; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Soreide K, 2014, INJURY, V45, P647, DOI 10.1016/j.injury.2012.12.027; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stannard A, 2013, J TRAUMA ACUTE CARE, V74, P830, DOI 10.1097/TA.0b013e31827a3704; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Zedler S, 2006, CURR OPIN CRIT CARE, V12, P595, DOI 10.1097/MCC.0b013e3280106806	50	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188144	10.1371/journal.pone.0188144	http://dx.doi.org/10.1371/journal.pone.0188144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145467	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800075
J	Ohba, T; Watanabe, H; Murakami, M; Iino, K; Adachi, T; Baba, Y; Kurosaki, T; Ono, K; Ito, H				Ohba, Takayoshi; Watanabe, Hiroyuki; Murakami, Manabu; Iino, Kenji; Adachi, Takeshi; Baba, Yoshihiro; Kurosaki, Tomohiro; Ono, Kyoichi; Ito, Hiroshi			Stromal interaction molecule 1 haploinsufficiency causes maladaptive response to pressure overload	PLOS ONE			English	Article							CALCIUM SENSOR STIM1; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; NUCLEAR FACTOR; HEART-FAILURE; ACTIVATION; EXPRESSION; GROWTH	Stromal interaction molecule 1 (STIM1), an endo/sarcoplasmic reticulum Ca2+ sensor, has been shown to control a Ca2+- dependent signal that promotes cardiac hypertrophy. However, whether STIM1 has adaptive role that helps to protect against cardiac overload stress remains unknown. We hypothesized that STIM1 deficiency causes a maladaptive response to pressure overload stress. We investigated STIM1 heterozygous KO (STIM1(+/)-) mice hearts, in which STIM1 protein levels decreased to 27% of wild-type (WT) with no compensatory increase in STIM2. Under stress-free conditions, no significant differences were observed in electrocardiographic and echocardiographic parameters or blood pressure between STIM1(+/)-and WT mice. However, when STIM1(+/)-mice were subjected to transverse aortic constriction (TAC), STIM1(+/-) mice had a higher mortality rate than WT mice. The TAC-induced increase in the heart weight to body weight ratio (mean mg/g +/- standard error of the mean) was significantly inhibited in STIM1(+/-) mice (WT sham, 4.12 +/- 0.14; WT TAC, 6.23 +/- 0.40; STIM1(+/-) sham, 4.53 +/- 0.16; STIM1(+/-) TAC, 4.63 +/- 0.08). Reverse transcription- polymerase chain reaction analysis of the left ventricles of TAC-treated STIM1(+/-) mice showed inhibited induction of cardiac fetal genes, including those encoding brain and atrial natriuretic proteins. Western blot analysis showed upregulated expression of transient receptor potential channel 1 (TRPC1) in TAC-treated WT mice, but suppressed expression in TAC-treated STIM1(+/-) mice. Taken together, the hearts of STIM1 haploinsufficient mice had a superficial resemblance to the WT phenotype under stress-free conditions; however, STIM1 haploinsufficient mice showed a maladaptive response to cardiac pressure overload.	[Ohba, Takayoshi; Adachi, Takeshi; Ono, Kyoichi] Akita Univ, Grad Sch Med, Dept Cell Physiol, Akita, Japan; [Watanabe, Hiroyuki; Iino, Kenji; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita, Japan; [Murakami, Manabu] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Aomori, Japan; [Baba, Yoshihiro; Kurosaki, Tomohiro] Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, Osaka, Japan	Akita University; Akita University; Hirosaki University; Osaka University	Watanabe, H (corresponding author), Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita, Japan.	hirow@doc.med.akita-u.ac.jp			JSPS KAKENHI; Saito-ho-onkai Foundation; Special Project of Three Northern Touhoku Universities; NENDOKEIKAKU research project; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Saito-ho-onkai Foundation; Special Project of Three Northern Touhoku Universities; NENDOKEIKAKU research project; Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was sponsored by Grants-in-Aid for Scientific Research from JSPS KAKENHI (H.W, T.O, K.O, M.M), the Saito-ho-onkai Foundation (T.O), Special Project of Three Northern Touhoku Universities (T.O, M.M), the NENDOKEIKAKU research project (T.O) and the Takeda Science Foundation (T.O). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar IS, 2017, CELL CALCIUM, V63, P33, DOI 10.1016/j.ceca.2016.12.009; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Collins HE, 2014, AM J PHYSIOL-HEART C, V306, pH1231, DOI 10.1152/ajpheart.00075.2014; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Faerber G, 2011, J THORAC CARDIOV SUR, V141, P492, DOI 10.1016/j.jtcvs.2010.03.029; Ferdaus MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095091; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ohba T, 2005, AKITA J MED, V32, P201; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Ohba T, 2006, BIOCHEM BIOPH RES CO, V351, P764, DOI 10.1016/j.bbrc.2006.10.107; Ohba T, 2009, BIOCHEM BIOPH RES CO, V389, P172, DOI 10.1016/j.bbrc.2009.08.117; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Schaballie H, 2015, J ALLERGY CLIN IMMUN, V136, P816, DOI 10.1016/j.jaci.2015.03.009; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187950	10.1371/journal.pone.0187950	http://dx.doi.org/10.1371/journal.pone.0187950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145451	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800042
J	Yue, YY; Jiang, MY; He, LQQ; Zhang, ZJJ; Zhang, QX; Gu, C; Liu, MJ; Li, N; Zhao, QS				Yue, Yunyun; Jiang, Mingyang; He, Luqingqing; Zhang, Zhaojunjie; Zhang, Qinxin; Gu, Chun; Liu, Meijing; Li, Nan; Zhao, Qingshun			The transcription factor Foxc1a in zebrafish directly regulates expression of nkx2.5, encoding a transcriptional regulator of cardiac progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiogenesis; Foxc1a; nkx2; 5; zebrafish	2ND HEART FIELD; AXENFELD-RIEGER-SYNDROME; CARDIOVASCULAR DEVELOPMENT; VENTRICULAR IDENTITY; BREAST-CANCER; GENE; MUTATIONS; DISEASE; CARDIOMYOGENESIS; SYSTEM	Cardiogenesis is a tightly controlled biological process required for formation of a functional heart. The transcription factor Foxc1 not only plays a crucial role in outflow tract development in mice, but is also involved in cardiac structure formation and normal function in humans. However, the molecular mechanisms by which Foxc1 controls cardiac development remain poorly understood. Previously, we reported that zebrafish embryos deficient in foxc1a, an ortholog of mammalian Foxc1, display pericardial edemas and die 9-10 days postfertilization. To further investigate Foxc1a's role in zebrafish cardiogenesis and identify its downstream target genes during early heart development, we comprehensively analyzed the cardiovascular phenotype of foxc1a-null zebrafish embryos. Our results confirmed that foxc1a-null mutants exhibit disrupted cardiac morphology, structure, and function. Performing transcriptome analysis on the foxc1a mutants, we found that the expression of the cardiac progenitor marker gene nkx2.5 was significantly decreased, but the expression of germ layer-patterning genes was unaffected. Dual-fluorescence in situ hybridization assays revealed that foxc1a and nkx2.5 are co-expressed in the anterior lateral plate mesoderm at the somite stage. Chromatin immunoprecipitation and promoter truncation assays disclosed that Foxc1a regulates nkx2.5 expression via direct binding to two noncanonical binding sites in the proximal nkx2.5 promoter. Moreover, functional rescue experiments revealed that developmental stage-specific nkx2.5 overexpression partially rescues the cardiac defects of the foxc1a-null embryos. Taken together, our results indicate that during zebrafish cardiogenesis, Foxc1a is active directly upstream of nkx2.5.	[Yue, Yunyun; Jiang, Mingyang; He, Luqingqing; Zhang, Zhaojunjie; Zhang, Qinxin; Gu, Chun; Liu, Meijing; Li, Nan; Zhao, Qingshun] Nanjing Univ, Key Lab Model Anim Dis Study, Minist Educ, Model Anim Res Ctr, 12 Xuefu Rd,Pukou Hightech Dev Zone, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Zhao, QS (corresponding author), Nanjing Univ, Key Lab Model Anim Dis Study, Minist Educ, Model Anim Res Ctr, 12 Xuefu Rd,Pukou Hightech Dev Zone, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			National Natural Science Foundation of China [31471355, 31671518]; Graduate Student Research and Innovation Program of Jiangsu Province [KYZZ15_0041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Research and Innovation Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China Grants 31471355 and 31671518 and Graduate Student Research and Innovation Program of Jiangsu Province Grant KYZZ15_0041. The authors declare that they have no conflicts of interest with the contents of this article.	Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Chang SW, 2013, HUM MUTAT, V34, P1226, DOI 10.1002/humu.22366; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; Du RF, 2016, OPHTHALMIC GENET, V37, P111, DOI 10.3109/13816810.2014.924016; George V, 2015, DEV BIOL, V400, P10, DOI 10.1016/j.ydbio.2014.12.019; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Gripp KW, 2013, AM J MED GENET A, V161A, P114, DOI 10.1002/ajmg.a.35697; Guner-Ataman B, 2013, DEVELOPMENT, V140, P1353, DOI 10.1242/dev.088351; Han BC, 2015, CELL REP, V13, P1046, DOI 10.1016/j.celrep.2015.09.063; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Honkanen RA, 2003, AM J OPHTHALMOL, V135, P368, DOI 10.1016/S0002-9394(02)02061-5; Jain R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6071; Jay P. Y., 2003, NOVART FDN SYMP, V250, P238; Jay P. Y., 2003, NOVART FDN SYMP, V250, P276; Jay Patrick Y, 2003, Novartis Found Symp, V250, P227; KAUFMANN E, 1995, J MOL BIOL, V248, P239, DOI 10.1006/jmbi.1995.0218; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Lambers E, 2016, DEV DYNAM, V245, P751, DOI [10.1002/dvdy.24397, 10.1002/DVDY.24397]; Lambers E, 2016, STEM CELLS, V34, P1487, DOI 10.1002/stem.2301; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Li JY, 2015, J BIOL CHEM, V290, P10216, DOI 10.1074/jbc.M114.612572; Li JB, 2016, ZEBRAFISH, V13, P9, DOI 10.1089/zeb.2015.1117; Li JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092728; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Nakashima Y, 2014, CIRC RES, V114, P1103, DOI 10.1161/CIRCRESAHA.114.303219; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Targoff KL, 2013, DEVELOPMENT, V140, P4203, DOI 10.1242/dev.095562; Tong YF, 2016, GENE, V588, P86, DOI 10.1016/j.gene.2016.04.061; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Yeo HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31068; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094; Zhu H, 2016, LIFE SCI, V144, P194, DOI 10.1016/j.lfs.2015.12.001	48	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					638	650		10.1074/jbc.RA117.000414	http://dx.doi.org/10.1074/jbc.RA117.000414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162723	Green Published, hybrid			2022-12-26	WOS:000419915400019
J	Trevisan, DA; Roberts, N; Lin, C; Birmingham, E				Trevisan, Dominic A.; Roberts, Nicole; Lin, Cathy; Birmingham, Elina			How do adults and teens with self-declared Autism Spectrum Disorder experience eye contact? A qualitative analysis of first-hand accounts	PLOS ONE			English	Article							ASPERGER-SYNDROME; JOINT ATTENTION; CHILDREN; GAZE; INTEGRATION; INDIVIDUALS; IMPAIRMENT; RESPONSES; AMYGDALA; INFANTS	A tendency to avoid eye contact is an early indicator of Autism Spectrum Disorder (ASD), and difficulties with eye contact often persist throughout the lifespan. Eye contact difficulties may underlie social cognitive deficits in ASD, and can create significant social and occupational barriers. Thus, this topic has received substantial research and clinical attention. In this study, we used qualitative methods to analyze self-reported experiences with eye contact as described by teens and adults with self-declared ASD. Results suggest people with a self-declared ASD diagnosis experience adverse emotional and physiological reactions, feelings of being invaded, and sensory overload while making eye contact, in addition to difficulties understanding social nuances, and difficulties receiving and sending nonverbal information. Some data support existing mindblindness frameworks, and hyperarousal or hypoarousal theories of eye contact, but we also present novel findings unaccounted for by existing frameworks. Additionally, we highlight innovative strategies people with self-declared ASD have devised to overcome or cope with their eye contact difficulties.	[Trevisan, Dominic A.; Roberts, Nicole; Birmingham, Elina] Simon Fraser Univ, Fac Educ, Burnaby, BC, Canada; [Lin, Cathy] Univ British Columbia, Sch Audiol Speech Sci, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia	Trevisan, DA (corresponding author), Simon Fraser Univ, Fac Educ, Burnaby, BC, Canada.	dtrevisa@sfu.ca		Trevisan, Dominic/0000-0003-0821-1403	National Sciences and Engineering Research Council of Canada (NSERC) [R611630]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the National Sciences and Engineering Research Council of Canada (NSERC), grant # R611630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Armstrong K., 2011, THESIS; Babbie ER, 2009, FUNDAMENTALS SOCIAL; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Bellini S., 2006, FOCUS AUTISM DEV DIS, V21, P138, DOI [DOI 10.1177/10883576060210030201, 10.1177/10883576060210030201]; BERLER ES, 1982, J APPL BEHAV ANAL, V15, P41, DOI 10.1901/jaba.1982.15-41; Birmingham E., 2012, COGNITIVE NEUROSCIEN, P251, DOI DOI 10.1093/ACPROF:OSO/9780195315455.003.0010; Birmingham E, 2009, ANN NY ACAD SCI, V1156, P118, DOI 10.1111/j.1749-6632.2009.04468.x; Brandwein AB, 2013, CEREB CORTEX, V23, P1329, DOI [10.1093/cercor/bhs109, 10.1093/cercor/bht213]; Carbone VJ, 2010, J APPL BEHAV ANAL, V43, P705, DOI 10.1901/jaba.2010.43-705; Charman T, 1997, DEV PSYCHOL, V33, P781, DOI 10.1037/0012-1649.33.5.781; Chawarska K, 2014, J AM ACAD CHILD PSY, V53, P1317, DOI 10.1016/j.jaac.2014.09.015; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Creswell J. W., 2013, QUALITATIVE INQUIRY; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; Erlandson D.A., 1993, DOING NATURALISTIC I; Ewing L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079493; Falck-Ytter T, 2015, CHILD DEV, V86, P37, DOI 10.1111/cdev.12273; Grandin T., EMERGENCE LABELED AU; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Hadjikhani N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03378-5; HELGESON DC, 1989, EDUC TRAIN MENT RET, V24, P56; Howlin P., 1999, AUTISM, V3, P299, DOI DOI 10.1177/1362361399003003007; Hwang B, 2000, J AUTISM DEV DISORD, V30, P331, DOI 10.1023/A:1005579317085; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jones RSP, 2003, J INTELLECT DEV DIS, V28, P112, DOI 10.1080/1366825031000147058; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Joseph RM, 2008, J INT NEUROPSYCH SOC, V14, P947, DOI 10.1017/S1355617708081344; KELLERMAN J, 1989, J RES PERS, V23, P145, DOI 10.1016/0092-6566(89)90020-2; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kliemann D, 2012, J NEUROSCI, V32, P9469, DOI 10.1523/JNEUROSCI.5294-11.2012; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Kylliainen A, 2012, J CHILD PSYCHOL PSYC, V53, P790, DOI 10.1111/j.1469-7610.2011.02522.x; Laugeson E. A, 2013, PEERS R CURRICULUM S; Moriuchi JM, 2017, AM J PSYCHIAT, V174, P26, DOI 10.1176/appi.ajp.2016.15091222; Muller E, 2008, AUTISM, V12, P173, DOI 10.1177/1362361307086664; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Pellicano E, 2003, BRIT J DEV PSYCHOL, V21, P33, DOI 10.1348/026151003321164609; Perlman SB, 2011, SOC NEUROSCI-UK, V6, P22, DOI 10.1080/17470911003683185; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; QSR International Pty Ltd, 2015, NVIVO QUAL DAT AN SO; ROBSON KS, 1967, J CHILD PSYCHOL PSYC, V8, P13, DOI 10.1111/j.1469-7610.1967.tb02176.x; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Sepeta L, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-17; SIGMAN M, 1986, J CHILD PSYCHOL PSYC, V27, P647, DOI 10.1111/j.1469-7610.1986.tb00189.x; Singer J., 1999, DISABILITY DISCOURSE, P59; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Strauss A., 2008, BASICS QUALITATIVE R; Szatmari P, 2016, J AM ACAD CHILD PSY, V55, P179, DOI 10.1016/j.jaac.2015.12.014; Tager-Flusberg H, 2007, CURR DIR PSYCHOL SCI, V16, P311, DOI 10.1111/j.1467-8721.2007.00527.x; Whalen C, 2003, J CHILD PSYCHOL PSYC, V44, P456, DOI 10.1111/1469-7610.00135; Williams D., 2009, NOBODY NOWHERE REMAR; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	65	34	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188446	10.1371/journal.pone.0188446	http://dx.doi.org/10.1371/journal.pone.0188446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN9ZL	29182643	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000029
J	Saldarriaga-Cordoba, M; Parkinson, CL; Daza, JM; Wuster, W; Sasa, M				Saldarriaga-Cordoba, Monica; Parkinson, Christopher L.; Daza, Juan M.; Wuster, Wolfgang; Sasa, Mahmood			Phylogeography of the Central American lancehead Bothrops asper (SERPENTES: VIPERIDAE)	PLOS ONE			English	Article							SEA-LEVEL; EVOLUTIONARY HISTORY; SPECIES DELIMITATION; PITVIPERS SERPENTES; STATISTICAL TESTS; MIDDLE PLIOCENE; PHYLOGENY; VENOM; DIVERGENCE; UPLIFT	The uplift and final connection of the Central American land bridge is considered the major event that allowed biotic exchange between vertebrate lineages of northern and southern origin in the New World. However, given the complex tectonics that shaped Middle America, there is still substantial controversy over details of this geographical reconnection, and its role in determining biogeographic patterns in the region. Here, we examine the phylogeography of Bothrops asper, a widely distributed pitviper in Middle America and northwestern South America, in an attempt to evaluate how the final Isthmian uplift and other biogeographical boundaries in the region influenced genealogical lineage divergence in this species. We examined sequence data from two mitochondrial genes (MT-CYB and MT-ND4) from 111 specimens of B. asper, representing 70 localities throughout the species' distribution. We reconstructed phylogeographic patterns using maximum likelihood and Bayesian methods and estimated divergence time using the Bayesian relaxed clock method. Within the nominal species, an early split led to two divergent lineages of B. asper: one includes five phylogroups distributed in Caribbean Middle America and southwestern Ecuador, and the other comprises five other groups scattered in the Pacific slope of Isthmian Central America and northwestern South America. Our results provide evidence of a complex transition that involves at least two dispersal events into Middle America during the final closure of the Isthmus.	[Saldarriaga-Cordoba, Monica] Univ Bernardo Higgins, Ctr Invest Recursos Nat & Sustentabilidad, Santiago, Chile; [Parkinson, Christopher L.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Daza, Juan M.] Univ Antioquia, Inst Biol, Grp Herpetol Antioquia, Medellin, Colombia; [Wuster, Wolfgang] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Sasa, Mahmood] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica; [Sasa, Mahmood] Org Trop Studies, San Jose, Costa Rica; [Sasa, Mahmood] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Parkinson, Christopher L.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Parkinson, Christopher L.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA	State University System of Florida; University of Central Florida; Universidad de Antioquia; Bangor University; Universidad Costa Rica; Universidad Costa Rica; Clemson University; Clemson University	Sasa, M (corresponding author), Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica.; Sasa, M (corresponding author), Org Trop Studies, San Jose, Costa Rica.; Sasa, M (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	msasamarin@gmail.com	Parkinson, Christopher L./AAV-9370-2021; Wuster, Wolfgang/B-2879-2008	Wuster, Wolfgang/0000-0002-4890-4311; Saldarriaga-Cordoba, Monica/0000-0002-4768-4919; Sasa, Mahmood/0000-0003-0118-5142	CONICYT [Beca AT-24060101]; Vicerrectoria de Investigacion, UCR [741-A5-050]; EU [TS3-CT91-0024, IC18-CT96-0032]; Wellcome Trust Research Career Development Fellowship; National Science Foundation [DEB-0416000, 1638879]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Vicerrectoria de Investigacion, UCR; EU(European Commission); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); National Science Foundation(National Science Foundation (NSF))	The research presented here was partially funded by a doctoral grant from CONICYT to MS-C (Proyecto Beca AT-24060101); a grant from Vicerrectoria de Investigacion, UCR 741-A5-050 to MS; EU contracts TS3-CT91-0024 and IC18-CT96-0032 and a Wellcome Trust Research Career Development Fellowship to WW; and by National Science Foundation grants DEB-0416000 and 1638879 to CLP.	Alape-Giron A, 2009, TOXICON, V54, P938, DOI 10.1016/j.toxicon.2009.06.011; Gutierrez-Garcia TA, 2013, QUATERNARY RES, V79, P311, DOI 10.1016/j.yqres.2012.12.007; [Anonymous], 2014, TRACER V1 6; ARAGON F, 1981, TOXICON, V19, P797, DOI 10.1016/0041-0101(81)90076-3; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bacon CD, 2013, BOT J LINN SOC, V171, P287, DOI 10.1111/j.1095-8339.2012.01281.x; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bolanos R, 1980, Bol Oficina Sanit Panam, V88, P189; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brito JC, 2004, AMPHIBIA-REPTILIA, V25, P459; BRUCKS JT, 1971, B MAR SCI, V21, P455; Bryson RW, 2007, MOL PHYLOGENET EVOL, V43, P674, DOI 10.1016/j.ympev.2006.11.025; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Bryson RW, 2010, EVOLUTION, V64, P2315, DOI 10.1111/j.1558-5646.2010.01014.x; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Butantan-British IBothrops/I Systematics Project, 2002, P111; Campbell JA, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P111; Campbell JA., 2004, VENOMOUS REPTILES W; Candenillas-Ordinola RE, 2010, THESIS; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Carreno Ana Luisa, 2002, P14; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Castoe TA, 2005, MOL PHYLOGENET EVOL, V37, P881, DOI 10.1016/j.ympev.2005.05.013; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Castoe TA, 2009, J BIOGEOGR, V36, P88, DOI 10.1111/j.1365-2699.2008.01991.x; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Clark RW, 2008, MOL ECOL, V17, P719; Coates Anthony G., 1996, P21; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Crawford AJ, 2007, MOL ECOL, V16, P4789, DOI 10.1111/j.1365-294X.2007.03524.x; Davidse G, 1995, FLORA MESOAMERICANA, V1; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; Daza JM, 2009, MOL PHYLOGENET EVOL, V53, P653, DOI 10.1016/j.ympev.2009.07.022; Dowsett HJ, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001133; DOWSETT HJ, 1990, GEOLOGY, V18, P435, DOI 10.1130/0091-7613(1990)018<0435:HESLDT>2.3.CO;2; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Fleming RF, 1996, MAR MICROPALEONTOL, V27, P227, DOI 10.1016/0377-8398(95)00062-3; FU YX, 1993, GENETICS, V133, P693; Graham A, 2003, LOWLAND MAYA AREA: THREE MILLENNIA AT THE HUMAN-WILDLAND INTERFACE, P31; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Gutberlet Ronald L. Jr, 2004, P634; GUTIERREZ JM, 1981, TOXICON, V19, P493, DOI 10.1016/0041-0101(81)90007-6; GUTIERREZ JM, 1980, REV BIOL TROP, V28, P341; Hafner David J., 2005, P225; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holman, 2000, FOSSIL SNAKES N AM O; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Jadin RC, 2010, J ZOOL SYST EVOL RES, V48, P360, DOI 10.1111/j.1439-0469.2009.00559.x; Johnson Jerry D., 2010, P30; Jowett T., 1986, DROSOPHILA, P275; KEIGWIN L, 1982, SCIENCE, V217, P350, DOI 10.1126/science.217.4557.350; Kirby MX, 2005, PALAEOGEOGR PALAEOCL, V228, P193, DOI 10.1016/j.palaeo.2005.06.002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laines J, 2014, TOXICON, V88, P34, DOI 10.1016/j.toxicon.2014.06.008; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Linares-Palomino R, 2010, BIODIVERS CONSERV, V19, P169, DOI 10.1007/s10531-009-9713-4; LOMONTE B, 1992, COMP BIOCHEM PHYS B, V102, P325, DOI 10.1016/0305-0491(92)90129-F; MacMillan I, 2004, TECTONOPHYSICS, V392, P325, DOI 10.1016/j.tecto.2004.04.014; Saldarriaga-Cordoba MM, 2009, TOXICON, V54, P923, DOI 10.1016/j.toxicon.2009.05.031; Marshall J. S., 2007, CENTRAL AM GEOLOGY R, P75, DOI DOI 10.1201/9780203947043.PT2; Matthee CA, 2001, SYST BIOL, V50, P367, DOI 10.1080/106351501300317987; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Morrone JJ., 2002, MONOGRAFIAS 3 MILENI, V2; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Murphy Robert W., 2002, P69; Neath AA, 2012, WIRES COMPUT STAT, V4, P199, DOI 10.1002/wics.199; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nores M, 2004, GLOBAL ECOL BIOGEOGR, V13, P149, DOI 10.1111/j.1466-882X.2004.00076.x; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Palumbi Stephen R., 1996, P205; Parkinson Christopher L., 2002, P93; Parkinson CL, 1999, COPEIA, P576, DOI 10.2307/1447591; Parkinson CL, 2000, MOL ECOL, V9, P411, DOI 10.1046/j.1365-294x.2000.00854.x; Parmley D, 2007, J HERPETOL, V41, P141, DOI 10.1670/0022-1511(2007)41[141:EFROAP]2.0.CO;2; Perlo BV, 2006, BIRDS MEXICO CENTRAL; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Ramos-Onsins SE, 2006, MOL BIOL EVOL, V23, P1642, DOI 10.1093/molbev/msl052; Rich P.V., 1983, P12; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Saravia P, 2001, TOXICON, V39, P401, DOI 10.1016/S0041-0101(00)00122-7; Sasa M, 2002, REV BIOL TROP, V50, P259; Sasa M, 2009, TOXICON, V54, P904, DOI 10.1016/j.toxicon.2009.06.024; Savage J.M., 2002, AMPHIBIANS REPTILES; SAVAGE JM, 1982, ANN MO BOT GARD, V69, P464, DOI 10.2307/2399082; Schmidt DN, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P427; Segura A, 2012, TOXICON, V59, P158, DOI 10.1016/j.toxicon.2011.11.005; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Streicher JW, 2016, EVOLUTION, V70, P1435, DOI 10.1111/evo.12967; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; VAIL PR, 1979, OCEANUS, V22, P71; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; Webb S. David, 1996, P335; WEBB SD, 1991, PALEOBIOLOGY, V17, P266, DOI 10.1017/S0094837300010605; Willows-Munro S, 2005, MOL PHYLOGENET EVOL, V35, P624, DOI 10.1016/j.ympev.2005.01.018; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Wuster W., 2002, B NAT HIST MUS LOND, V68, P101; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	120	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187969	10.1371/journal.pone.0187969	http://dx.doi.org/10.1371/journal.pone.0187969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176806	Green Published, gold			2022-12-26	WOS:000416291900026
J	Volterrani, M; Minelli, A; Gaetani, M; Grossi, N; Magni, S; Caturegli, L				Volterrani, Marco; Minelli, Alberto; Gaetani, Monica; Grossi, Nicola; Magni, Simone; Caturegli, Lisa			Reflectance, absorbance and transmittance spectra of bermudagrass and manilagrass turfgrass canopies	PLOS ONE			English	Article							ESTIMATING NITROGEN STATUS; RADIATION INTERCEPTION; MULTISPECTRAL DATA; INTERCROP CANOPY; CROP CANOPIES; WATER-CONTENT; PENETRATION; MAIZE; CULTIVARS; SATELLITE	Leaves act as a primary organ for the interception of solar radiation and their spatial arrangement determines how the plant canopy interacts with light. Many studies have been carried out on the penetration of radiation into crops however to date, few results are available on turfgrasses, mainly due to the difficulties of introducing sensors into the turf without disturbing the natural position of the leaves. In the present research two warm season turfgrasses, hybrid bermudagrass (Cynodon dactylon x transvaalensis) ' Patriot' and manilagrass (Zoysia matrella) 'Zeon', were studied. The aim was to describe their canopy architecture grown with minimal disturbance to the natural arrangement of the leaves and stems, and to determine the potential effects of canopy architecture on light penetration and reflectance. Radiometric measurements were carried out at eight different profile levels of turfgrasses that were up to 12 cm tall. A LI-COR 1800 spectroradiometer with an optical fiber cable and a 7 mm diameter sensor was used. Measurements were carried out in the 390-1100 nm region at 5 nm intervals. The LAI value was higher for the manilagrass (9.0) than for the hybrid bermudagrass (5.6). The transmitted radiation was found to be closely dependent on downward cumulative LAI. Despite a more upright habit (mean insertion angle of 22.4 degrees +/- 3.4), Zoysia matrella showed a higher NIR reflectance compared to Cdxt, which has a horizontal leaf arrangement (mean insertion angle 62.1 degrees +/- 9.6). The species studied showed substantial differences both in terms of phytometric characteristics and in the capacity to attenuate solar radiation.	[Volterrani, Marco; Gaetani, Monica; Grossi, Nicola; Magni, Simone] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Minelli, Alberto; Caturegli, Lisa] Univ Bologna, Dept Agr Sci, Bologna, Italy	University of Pisa; University of Bologna	Volterrani, M (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	marco.volterrani@unipi.it	caturegli, lisa/O-3988-2019; MINELLI, ALBERTO/ABC-8604-2020; Minelli, Alberto/O-1141-2015; GROSSI, NICOLA/K-8098-2015; MAGNI, SIMONE/M-4513-2014	caturegli, lisa/0000-0001-9749-2352; MINELLI, ALBERTO/0000-0001-5783-9091; GROSSI, NICOLA/0000-0002-6997-1599; MAGNI, SIMONE/0000-0002-8956-7235				Agati G, 2013, EUR J AGRON, V45, P39, DOI 10.1016/j.eja.2012.10.011; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Awal MA, 2006, AGR FOREST METEOROL, V139, P74, DOI 10.1016/j.agrformet.2006.06.001; Baret F, 1997, AGRONOMIE, V17, P455, DOI 10.1051/agro:19970903; Bell GE, 2004, HORTSCIENCE, V39, P1130, DOI 10.21273/HORTSCI.39.5.1130; Bell GE, 2008, BOOKS SOIL PLANT ENV, V122, P641; Bremer DJ, 2011, CROP SCI, V51, P2219, DOI 10.2135/cropsci2010.12.0729; Campbell G.S., 1990, PLANT CANOPIES THEIR, P1; Caturegli L, 2014, EUR J HORTIC SCI, V79, P97; Caturegli L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158268; Caturegli L, 2015, PRECIS AGRIC, V16, P297, DOI 10.1007/s11119-014-9376-3; Caturegli L, 2015, AGRIC AGRIC SCI PROC, V4, P59, DOI 10.1016/j.aaspro.2015.03.008; Caturegli L, 2015, INT J REMOTE SENS, V36, P2238, DOI 10.1080/01431161.2015.1035409; CLEGG MD, 1974, AGRON J, V66, P471, DOI 10.2134/agronj1974.00021962006600040001x; Darvishsefat AA, 2011, J AGR SCI TECH-IRAN, V13, P1091; Deckmyn G, 2000, J EXP BOT, V51, P1467, DOI 10.1093/jexbot/51.349.1467; Deckmyn G, 1998, PLANT ECOL, V137, P13, DOI 10.1023/A:1008004113346; Dettman-Kruse JK, 2008, CROP SCI, V48, P763, DOI 10.2135/cropsci2006.01.0040; FINKE PA, 1992, SOIL TECHNOL, V5, P257, DOI 10.1016/0933-3630(92)90026-W; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GAUSMAN HW, 1977, REMOTE SENS ENVIRON, V6, P1, DOI 10.1016/0034-4257(77)90015-3; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gitelson AA, 2014, REMOTE SENS ENVIRON, V147, P108, DOI 10.1016/j.rse.2014.02.014; GRANT L, 1987, REMOTE SENS ENVIRON, V22, P309, DOI 10.1016/0034-4257(87)90064-2; Guiducci M., 1990, Agricoltura Mediterranea, V120, P249; Hirose T, 2005, ANN BOT-LONDON, V95, P483, DOI [10.1093/aob/mci047, 10.1093/mci047]; JACKSON RD, 1986, REMOTE SENS ENVIRON, V20, P43, DOI 10.1016/0034-4257(86)90013-1; Jiang YW, 2007, CROP SCI, V47, P1611, DOI 10.2135/cropsci2006.09.0617; Kenworthy KE, 2007, HORTSCIENCE, V42, P1513, DOI 10.21273/HORTSCI.42.7.1513; KOPEC DM, 1987, CROP SCI, V27, P1298, DOI 10.2135/cropsci1987.0011183X002700060042x; Lantinga EA, 1999, AGR FOREST METEOROL, V96, P71, DOI 10.1016/S0168-1923(99)00040-4; MARANI A, 1985, CROP SCI, V25, P309, DOI 10.2135/cropsci1985.0011183X002500020024x; Monsi TM, 1953, JAP J BOT, V14, P22; MUNDEN R, 1994, INT J REMOTE SENS, V15, P705, DOI 10.1080/01431169408954110; Norman J.M, 2000, PLANT PHYSL ECOLOGY, P301; Ross J., 1981, RAD REGIME ARCHITECT, P127; SINCLAIR TR, 1974, AGRON J, V66, P201, DOI 10.2134/agronj1974.00021962006600020005x; Trenholm LE, 2000, INT J REMOTE SENS, V21, P709, DOI 10.1080/014311600210524; Tsubo M, 2002, AGR FOREST METEOROL, V110, P203, DOI 10.1016/S0168-1923(01)00287-8; WANJURA DF, 1988, INT J REMOTE SENS, V9, P249, DOI 10.1080/01431168808954849; WELLES JM, 1991, AGRON J, V83, P818, DOI 10.2134/agronj1991.00021962008300050009x; White R, 2010, CROP SCI, V50, P1066, DOI 10.2135/cropsci2009.06.0359	43	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188080	10.1371/journal.pone.0188080	http://dx.doi.org/10.1371/journal.pone.0188080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176773	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900033
J	Thomas-Meyer, M; Mytton, O; Adams, J				Thomas-Meyer, Molly; Mytton, Oliver; Adams, Jean			Public responses to proposals for a tax on sugar-sweetened beverages: A thematic analysis of online reader comments posted on major UK news websites	PLOS ONE			English	Article							HEALTH; COVERAGE; SUPPORT; POLICY; ATTITUDES; TAXATION; OBESITY; FOOD	Background Regular consumption of sugar sweetened beverages (SSBs) is associated with weight gain, type 2 diabetes, and dental caries. The UK will introduce a levy on the manufacturers of SSBs in 2018. Details will be negotiated over the next two years. How the UK public views SSB taxes is likely to be an important determinant of the content and success of the final policy. We aimed to capture the views, ideas and concerns of commenters on major UK news websites on SSB taxes. Methods and findings We conducted a qualitative analysis of reader comments to online news coverage of one proposal for an SSB tax in the UK. 1645 comments on four articles were included. Three underpinning themes influenced support or opposition to the tax: the balance between individual responsibility and autonomy, and population need; mistrust of the intention of the proposed tax and those promoting it; and variations in the perceived complexity of unhealthy diets and obesity associated with variations in what are considered appropriate interventions. Arguments under each theme were used to justify both support and opposition in different cases. Conclusions As the final form of the UK SSB tax is negotiated, effort should be made to address the concerns we identified. Our results suggest these efforts could usefully focus on emphasising the social and environmental determinants of diet and obesity, reinforcing the benefits of the tax to the NHS, and pitching the tax as playing into a variety of different conceptualisations of obesity.	[Thomas-Meyer, Molly] Essex Cty Council, Publ Hlth Dept, Chelmsford, Essex, England; [Mytton, Oliver; Adams, Jean] Univ Cambridge, MRC, Ctr Diet & Act Res CEDAR, Epidemiol Unit, Cambridge, England	University of Cambridge	Adams, J (corresponding author), Univ Cambridge, MRC, Ctr Diet & Act Res CEDAR, Epidemiol Unit, Cambridge, England.	jma79@medschl.cam.ac.uk	Adams, Jean/G-2402-2010	Adams, Jean/0000-0002-5733-7830	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; Medical Research Council [MR/K023187/1]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was undertaken by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The CEDAR grant is administered by the Medical Research Council (www.mrc.ac.uk), grant number MR/K023187/1. The funders played no role in the design of the study, data collect or interpretation, manuscript preparation or the decision to publish.	Appleby J., 2015, IS NHS PERFORMING; Barry CL, 2013, AM J PREV MED, V44, P158, DOI 10.1016/j.amepre.2012.09.065; Beeken RJ, 2013, PUBLIC HEALTH NUTR, V16, P2132, DOI 10.1017/S1368980013001821; British Psychological Society, 2014, COD HUM RES ETH; ComRes, 2015, DAIL MAIL SUG TAX PO; Curtice J, 2010, BRIT SOCIAL ATTITUDE, P131; Dahlgreen W., 2014, MOST PEOPLE DONT CHE; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Dinkelspiel F., 2014, BERKELEYSIDE; Donaldson EA, 2015, PUBLIC HEALTH NUTR, V18, P2263, DOI 10.1017/S1368980014002699; Fredheim R, 2015, ANONYMITY ONLINE COM; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gauke D, 2016, BUDGET 2016; Gershlick B, 2015, PUBLIC ATTITUDES NHS; Giles EL, 2015, FRONTIERS PUBLIC HLT, P3; Giles EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0549-5; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Hilton S, 2014, SOC SCI MED, V102, P157, DOI 10.1016/j.socscimed.2013.11.041; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Ipsos Mori Social Research Institute, 2013, GREAT BRIT WAY WE LI; Jou J, 2014, AM J PUBLIC HEALTH, V104, P847, DOI 10.2105/AJPH.2013.301679; Julia C, 2015, PUBLIC HEALTH NUTR, V18, P2679, DOI 10.1017/S1368980014003231; Kantar Media Ofcom, 2013, NEWS CONS UK; Langer R, 2005, QUAL MARK RES, V8, P189, DOI 10.1108/13522750510592454; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980; Marmot M., 2010, FAIR SOC HLTHY LIVES; Mazzocchi M, 2015, HEALTH ECON POLICY L, V10, P267, DOI 10.1017/S1744133114000346; McNaughton RJ, 2016, VACCINE; Moodie R, 2013, LANCET; Moretto N, 2014, INT J ENV RES PUB HE, V11, P2456, DOI 10.3390/ijerph110302456; Mytton OT, 2014, CURR OBES REP, V3, P432, DOI 10.1007/s13679-014-0123-x; Niederdeppe J, 2013, AM J PUBLIC HEALTH, V103, pE92, DOI 10.2105/AJPH.2012.301023; Nixon L, 2015, CRIT PUBLIC HEALTH, V25, P333, DOI 10.1080/09581596.2014.987729; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Prescott C., 2015, INTERNET ACCESS HOUS; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rivard C, 2012, PUBLIC HEALTH NUTR, V15, P1355, DOI 10.1017/S1368980011002898; Roh S, 2014, HEALTH PSYCHOL, V33, P1610, DOI 10.1037/hea0000021; Salzmann-Erikson M, 2012, APORIA, V4, P7; Salzmann-Erikson M, 2013, HEALTH SOC CARE COMM, V21, P381, DOI 10.1111/hsc.12028; Science Media Centre, 2016, EXP REACT ANN BUDG S; Simon PA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140005; Somerville C, 2015, EUROPEAN J PUBLIC HL; Sustain, 2013, SUSTAIN CHILDRENS FU; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; TIMPSON H, 2013, EXPLORING ACCEPTABIL; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UK Tax History, 2016, UK TAX HIST	50	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186750	10.1371/journal.pone.0186750	http://dx.doi.org/10.1371/journal.pone.0186750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166399	gold, Green Published, Green Submitted			2022-12-26	WOS:000416035300005
J	Kim, GE; Lee, JS; Park, MH; Yoon, JH				Kim, Ga-Eon; Lee, Ji Shin; Park, Min Ho; Yoon, Jung Han			Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma	PLOS ONE			English	Article							CANCER METASTASIS; LUNG-CANCER; TUMOR; PROTEIN; PROGRESSION; STROMA; DISEASE; COLON	Invasion and metastasis are direct causes of mortality in patients with breast cancer and require reciprocal interactions between cancer cells and the extracellular matrix (ECM). Periostin, a fasciclin-containing adhesive ECM glycoprotein, is frequently overexpressed in various types of human cancer, and its overexpression in cancer-associated stroma and/or cancer cells is usually associated with poor clinical outcomes. However, the expression of periostin in the successive steps of breast tumorigenesis and its association with outcome variables have not been well established in breast carcinoma. The present study aimed to assess the role of periostin alteration in breast tumorigenesis and evaluate the putative prognostic value of periostin as a function of its compartmentalization. Immunohistochemical staining with anti-periostin antibody was performed in a total of 300 patients (26 patients with normal breast tissues, 76 patients with ductal carcinoma in situ [DCIS], and 198 patients with invasive breast carcinoma [IBC]) using tissue microarray. Periostin immunoreactivity was assessed in both epithelial tissue and the surrounding stromal compartment. The mRNA and protein expression of periostin were analyzed in 10 paired normal/invasive cancer frozen specimens by quantitative real time-polymerase chain reaction and western blot analysis, respectively. In cancer tissues, periostin mRNA and protein expression were increased compared with adjacent normal tissues. Both epithelial and stromal periostin staining scores significantly increased in a stepwise manner with disease progression from normal breast tissue to DCIS and IBC (P = 0.000 and 0.000, respectively). High epithelial and stromal periostin expression was observed in 109/ 189 (57.7%) and 158/189 (83.6%) cases of IBC, respectively. High epithelial periostin expression was more frequently observed in the distant metastatic relapse-positive group than in the distant metastatic relapse-negative group (41/51 [80.4%] vs. 68/138 [49.3%] cases [P = 0.000]). Furthermore, high epithelial periostin expression was associated with reduced disease-free survival and overall survival in univariate and multivariate analysis. Periostin may play an important role in the progression of breast tumor, and epithelial periostin expression may serve as a new parameter for prediction of prognosis in patients with IBC. Further studies examining periostin expression and its potential as a target of IBC therapy are warranted.	[Kim, Ga-Eon; Lee, Ji Shin] Chonnam Natl Univ, Med Sch, Dept Pathol, Gwangju, South Korea; [Park, Min Ho; Yoon, Jung Han] Chonnam Natl Univ, Med Sch, Dept Surg, Gwangju, South Korea	Chonnam National University; Chonnam National University	Lee, JS (corresponding author), Chonnam Natl Univ, Med Sch, Dept Pathol, Gwangju, South Korea.	jshinlee@hanmail.net		, ji shin/0000-0003-4634-2228; Kim, Ga-Eon/0000-0001-8539-6654				Choi KU, 2011, INT J CANCER, V128, P332, DOI 10.1002/ijc.25341; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Gunia S, 2013, J CLIN PATHOL, V66, P297, DOI 10.1136/jclinpath-2012-201262; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Hong LZ, 2013, ONCOL LETT, V6, P1595, DOI 10.3892/ol.2013.1590; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; Kharaishvili G, 2011, J CLIN PATHOL, V64, P977, DOI 10.1136/jclinpath-2011-200106; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Lakhani SR, 2012, WHO CLASSIFICATION T; Li MX, 2012, CLIN EXP METASTAS, V29, P865, DOI 10.1007/s10585-012-9465-5; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lv Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0385-7; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nuzzo PV, 2014, CLIN GENITOURIN CANC, V12, P301, DOI 10.1016/j.clgc.2014.02.005; Nuzzo PV, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-625; Oda G, 2012, ONCOL REP, V28, P2003, DOI 10.3892/or.2012.2040; Puglisi F, 2008, J CLIN PATHOL, V61, P494, DOI 10.1136/jcp.2007.052506; Riener MO, 2010, HISTOPATHOLOGY, V56, P600, DOI 10.1111/j.1365-2559.2010.03527.x; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu GQ, 2013, CANCER BIOTHER RADIO, V28, P298, DOI 10.1089/cbr.2012.1374; Xu DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046670; Zhang Y, 2010, J SURG RES, V160, P102, DOI 10.1016/j.jss.2008.12.042	31	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187635	10.1371/journal.pone.0187635	http://dx.doi.org/10.1371/journal.pone.0187635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161296	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000014
J	Koeppel, F; Blanchard, S; Jovelet, C; Genin, B; Marcaillou, C; Martin, E; Rouleau, E; Solary, E; Soria, JC; Andre, F; Lacroix, L				Koeppel, Florence; Blanchard, Steven; Jovelet, Cecile; Genin, Berengsre; Marcaillou, Charles; Martin, Emmanuel; Rouleau, Etienne; Solary, Eric; Soria, Jean-Charles; Andre, Fabrice; Lacroix, Ludovic			Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients	PLOS ONE			English	Article							PD-1 BLOCKADE; LUNG-CANCER; DNA; SENSITIVITY; PROGNOSIS; BLOOD; LANDSCAPE; EVOLUTION; MELANOMA; TRIAL	Tumor mutation load (TML) has been proposed as a biomarker of patient response to immunotherapy in several studies. TML is usually determined by tumor biopsy DNA (tDNA) whole exome sequencing (WES), therefore TML evaluation is limited by informative biopsy availability. Circulating cell free DNA (cfDNA) provided by liquid biopsy is a surrogate specimen to biopsy for molecular profiling. Nevertheless performing WES on DNA from plasma is technically challenging and the ability to determine tumor mutation load from liquid biopsies remains to be demonstrated. In the current study, WES was performed on cfDNA from 32 metastatic patients of various cancer types included into MOSCATO 01 (NCT01566019) and/or MATCHR (NCT02517892) molecular triage trials. Results from targeted gene sequencing (TGS) and WES performed on cfDNA were compared to results from tumor tissue biopsy. In cfDNA samples, WES mutation detection sensitivity was 92% compared to targeted sequencing (TGS). When comparing cfDNA-WES to tDNA-WES, mutation detection sensitivity was 53%, consistent with previously published prospective study comparing cfDNA-TGS to tDNA-TGS. For samples in which presence of tumor DNA was confirmed in cfDNA, tumor mutation load from liquid biopsy was correlated with tumor biopsy. Taken together, this study demonstrated that liquid biopsy may be applied to determine tumor mutation load. Qualification of liquid biopsy for interpretation is a crucial point to use cfDNA for mutational load estimation.	[Koeppel, Florence; Jovelet, Cecile; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Genom Platform, Mol Biopathol Unit, AMMICA,INSERM,US23,CNRS,UMS3655, Villejuif, France; [Koeppel, Florence; Jovelet, Cecile; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Biol Resource Ctr, UMS3655, AMMICA,INSERM,US23,CNRS, Villejuif, France; [Blanchard, Steven; Genin, Berengsre; Marcaillou, Charles; Martin, Emmanuel] IntegraGen SA, Genopole CAMPUS 1 Bat,G8, Paris, France; [Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France; [Solary, Eric] Univ Paris Saclay, Fac Med Paris Sud, Gustave Roussy, INSERM,U1170, Villejuif, France; [Solary, Eric] Gustave Roussy, Dept Hematol, Villejuif, France; [Soria, Jean-Charles] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France; [Soria, Jean-Charles] Univ Paris Sud, Villejuif, France; [Soria, Jean-Charles; Andre, Fabrice] Gustave Roussy, Dept Med Oncol, Villejuif, France; [Soria, Jean-Charles; Andre, Fabrice] Univ Paris XI, Gustave Roussy, INSERM, U981, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Lacroix, L (corresponding author), Gustave Roussy, Genom Platform, Mol Biopathol Unit, AMMICA,INSERM,US23,CNRS,UMS3655, Villejuif, France.; Lacroix, L (corresponding author), Gustave Roussy, Biol Resource Ctr, UMS3655, AMMICA,INSERM,US23,CNRS, Villejuif, France.; Lacroix, L (corresponding author), Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France.	Ludovic.LACROIX@gustaveroussy.fr	Soria, Jean-Charles/F-3619-2014; ANDRE, Fabrice/AAL-2683-2020	ANDRE, Fabrice/0000-0001-5795-8357; koeppel, florence/0000-0003-2421-2537; Solary, Eric/0000-0002-8629-1341	INCaD-GOS-INSERM [6043]; FUI [17-ICE]	INCaD-GOS-INSERM; FUI	This work was supported by grants INCaD-GOS-INSERM 6043 and FUI 17-ICE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; Chabanon RM, 2016, CLIN CANCER RES, V22, P4309, DOI 10.1158/1078-0432.CCR-16-0903; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Danilova L, 2016, P NATL ACAD SCI USA, V113, pE7769, DOI 10.1073/pnas.1607836113; Dietz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161012; Facchinetti F, 2016, CLIN CANCER RES, V22, P5983, DOI 10.1158/1078-0432.CCR-16-0917; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomez-Roca CA, 2012, ANN ONCOL, V23, P1301, DOI 10.1093/annonc/mdr383; Johnson DB, 2016, CANCER IMMUNOL RES, V4, P959, DOI 10.1158/2326-6066.CIR-16-0143; Jovelet C, 2016, CLIN CANCER RES, V22, P2960, DOI 10.1158/1078-0432.CCR-15-2470; Klevebring D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104417; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Murtaza M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9760; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schrock A, 2017, CLIN CHEM, V63, P1288, DOI 10.1373/clinchem.2016.270207; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tacher V, 2016, EUR J CANCER, V59, P79, DOI 10.1016/j.ejca.2016.02.006; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Warton K, 2016, ENDOCR-RELAT CANCER, V23, pR157, DOI 10.1530/ERC-15-0369	23	65	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188174	10.1371/journal.pone.0188174	http://dx.doi.org/10.1371/journal.pone.0188174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161279	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000033
J	Martinez-Sernandez, V; Perteguer, MJ; Mezo, M; Gonzalez-Warleta, M; Garate, T; Valero, MA; Ubeira, FM				Martinez-Sernandez, Victoria; Perteguer, Maria J.; Mezo, Mercedes; Gonzalez-Warleta, Marta; Garate, Teresa; Adela Valero, M.; Ubeira, Florencio M.			Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins	PLOS ONE			English	Article							HEPATICA ANTIBODY-LEVELS; SERODIAGNOSIS; ADAPTATION; INFECTION; PROTEASES; CLEAVAGE; LOSSES; CATTLE; SHEEP; MILK	MF6p/FhHDM-1 is a small cationic heme-binding protein which is recognized by the monoclonal antibody (mAb) MF6, and abundantly present in parenchymal cells and secreted antigens of Fasciola hepatica. Orthologs of this protein (MF6p/HDMs) also exist in other causal agents of important foodborne trematodiasis, such as Clonorchis sinensis, Opisthorchis viverrini and Paragonimus westermani. Considering that MF6p/FhHDM-1 is relevant for heme homeostasis in Fasciola and was reported to have immunomodulatory properties, this protein is expected to be a useful target for vaccination. Thus, in this study we mapped the epitope recognized by mAb MF6 and evaluated its antigenicity in sheep. The sequence of the MF6p/FhHDM-1 ortholog from F. gigantica (MF6p/FgHDM-1) was also reported. By means of ELISA inhibitions with overlapping synthetic peptides, we determined that the epitope recognized by mAb MF6 is located within the C-terminal moiety of MF6p/FhHDM-1, which is the most conserved region of MF6p/HDMs. By immunoblotting analysis of parasite extracts and ELISA inhibitions with synthetic peptides we also determined that mAb MF6 reacted with the same intensity with F. hepatica and F. gigantica, and in decreasing order of intensity with C. sinensis, O. viverrini and P. westermani orthologs. On the contrary, mAb MF6 showed no reactivity against Dicrocoelium dendriticum and Schistosoma mansoni. The study of the recognition of peptides covering different regions of MF6p/FhHDM-1 by sera from immunized sheep revealed that the C-terminal moiety is the most antigenic, thus being of potential interest for vaccination. We also demonstrated that the production of antibodies to MF6p/FhHDM-1 in sheep infected by F. hepatica occurs relatively early and follows the same pattern as those produced against L-cathepsins.	[Martinez-Sernandez, Victoria; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela, Spain; [Perteguer, Maria J.; Garate, Teresa] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Mezo, Mercedes] INGACAL, Ctr Invest Agr Mabegondo, Lab Parasitol, Abegondo, A Coruna, Spain; [Adela Valero, M.] Univ Valencia, Fac Farm, Dept Parasitol, Valencia, Spain	Universidade de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Valencia	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela, Spain.	fm.ubeira@usc.es	PERTEGUER, MARIA J/T-1266-2018; González-Warleta, Marta/R-5124-2019; Valero, Maria Adela/AAA-1658-2020; Mezo, Mercedes/R-4703-2019; Valero, M. Adela/K-6718-2016	PERTEGUER, MARIA J/0000-0002-7533-5134; González-Warleta, Marta/0000-0003-3315-5757; Valero, Maria Adela/0000-0003-1584-8330; Mezo, Mercedes/0000-0001-8819-453X; Valero, M. Adela/0000-0003-1584-8330; Ubeira, Florencio/0000-0001-7312-2752	Ministerio de Ciencia e Innovacion, Spain [AGL2011-30563-C03-01, AGL2011-30563-C03-02, AGL2011-30563-C03-03]; Xunta de Galicia, Spain [GPC 2014/058, ED431B 2017/18]; Network of Biomedical Research on Tropical Diseases (RICET), Spain [RD12/0018/0013]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); Network of Biomedical Research on Tropical Diseases (RICET), Spain; European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	This work was funded by the Ministerio de Ciencia e Innovacion, Spain (Grants AGL2011-30563-C03-01, AGL2011-30563-C03-02 and AGL2011-30563-C03-03); Xunta de Galicia, Spain (Grants GPC 2014/058 and ED431B 2017/18); Network of Biomedical Research on Tropical Diseases (RICET), Spain (Grant RD12/0018/0013) and the European Fund for Regional Development (FEDER). VMS holds a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valero M, 2016, T ROY SOC TROP MED H, V110, P55, DOI 10.1093/trstmh/trv110; Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Aiyegbo MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170530; Alvarado R, 2017, FASEB J, V31, P85, DOI 10.1096/fj.201500093R; Ashrafi K, 2014, TRAVEL MED INFECT DI, V12, P636, DOI 10.1016/j.tmaid.2014.09.006; Charlier J, 2007, PREV VET MED, V78, P57, DOI 10.1016/j.prevetmed.2006.09.010; Charlier J, 2009, VET PARASITOL, V166, P235, DOI 10.1016/j.vetpar.2009.09.040; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Dalton JP, 1996, INFECT IMMUN, V64, P5066, DOI 10.1128/IAI.64.12.5066-5074.1996; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Martinez-Sernandez V, 2017, J BIOL CHEM; Martinez-Sernandez V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004872; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S, 2014, PARASITOLOGY, V141, P1918, DOI 10.1017/S0031182014000869; Mas-Coma S, 2014, ADV EXP MED BIOL, V766, P77, DOI 10.1007/978-1-4939-0915-5_4; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Mezo M, 2011, VET PARASITOL, V180, P237, DOI 10.1016/j.vetpar.2011.03.009; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Perteguer MJ, 2004, MOL IMMUNOL, V41, P421, DOI 10.1016/j.molimm.2004.03.032; Robinson MW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00296; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Robinson MW, 2008, TRENDS BIOCHEM SCI, V33, P601, DOI 10.1016/j.tibs.2008.09.001; Sambrook J., 2001, MOL CLONING LAB MANU; Di Maggio LS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32796; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Sivalingam GN, 2012, MOL IMMUNOL, V51, P304, DOI 10.1016/j.molimm.2012.03.030; Thivierge K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002307; Tielens AGM, 1999, FASCIOLOSIS, P277; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Zhao QP, 2004, CLIN DIAGN LAB IMMUN, V11, P814, DOI 10.1128/CDLI.11.4.814-817.2004	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188520	10.1371/journal.pone.0188520	http://dx.doi.org/10.1371/journal.pone.0188520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161330	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000063
J	Oh, J; Kim, Y; Che, L; Kim, JB; Chang, GE; Cheong, E; Kang, SG; Ha, Y				Oh, Jinsoo; Kim, Yongbo; Che, Lihua; Kim, Jeong Beom; Chang, Gyeong Eon; Cheong, Eunji; Kang, Seok-Gu; Ha, Yoon			Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma	PLOS ONE			English	Article							NEURAL STEM-CELLS; FUNCTIONAL-NEURONS; HUMAN FIBROBLASTS; MOUSE; BRAIN; GENERATION	Glioma is the most malignant type of primary central nervous system tumors, and has an extremely poor prognosis. One potential therapeutic approach is to induce the terminal differentiation of glioma through the forced expression of pro-neural factors. Our goal is to show the proof of concept of the neuronal conversion of C6 glioma through the combined action of small molecules. We investigated the various changes in gene expression, cell-specific marker expression, signaling pathways, physiological characteristics, and morphology in glioma after combination treatment with two small molecules (CHIR99021, a glycogen synthase kinase 3 [GSK3] inhibitor and forskolin, a cyclic adenosine monophosphate [cAMP] activator). Here, we show that the combined action of CHIR99021 and forskolin converted malignant glioma into fully differentiated neurons with no malignant characteristics; inhibited the proliferation of malignant glioma; and significantly down-regulated gene ontology and gene expression profiles related to cell division, gliogenesis, and angiogenesis in small molecule-induced neurons. In vivo, the combined action of CHIR99021 and forskolin markedly delayed neurological deficits and significantly reduced the tumor volume. We suggest that reprogramming technology may be a potential treatment strategy replacing the therapeutic paradigm of traditional treatment of malignant glioma, and a combination molecule comprising a GSK3 inhibitor and a cAMP inducer could be the next generation of anticancer drugs.	[Oh, Jinsoo; Kim, Yongbo; Che, Lihua; Kang, Seok-Gu; Ha, Yoon] Yonsei Univ, Dept Neurosurg, Spine & Spinal Cord Inst, Coll Med, Seoul, South Korea; [Kim, Yongbo; Che, Lihua; Ha, Yoon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Kim, Jeong Beom] Ulsan Natl Inst Sci & Technol, HSSCRC, Sch Life Sci, Ulsan, South Korea; [Kim, Jeong Beom] UNIST, MPPG, MBL, Ulsan, South Korea; [Chang, Gyeong Eon; Cheong, Eunji] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Yonsei University	Ha, Y (corresponding author), Yonsei Univ, Dept Neurosurg, Spine & Spinal Cord Inst, Coll Med, Seoul, South Korea.; Ha, Y (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	hayoon@yuhs.ac		Kim, Jeong Beom/0000-0001-6230-8826; Kang, Seok-Gu/0000-0001-5676-2037	National Research Foundation of Korea - Korean Government [NRF-2015R1A6A3A01018883]; National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A02059821, 2016R1D1A1A02937027]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2015R1A6A3A01018883). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02059821 and 2016R1D1A1A02937027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2015R1A6A3A01018883). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02059821 and 2016R1D1A1A02937027)	Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carrasco-Garcia E, 2014, CELLS-BASEL, V3, P199, DOI 10.3390/cells3020199; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Erkan EP, 2014, ONCOGENE, V33, P4778, DOI 10.1038/onc.2013.423; Guichet PO, 2013, GLIA, V61, P225, DOI 10.1002/glia.22429; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gwak SJ, 2014, SPINE, V39, pE65, DOI 10.1097/BRS.0000000000000070; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kim E, 2017, NEUROPSYCHOPHARMACOL, V42, P941, DOI 10.1038/npp.2016.258; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nakada Mitsutoshi, 2011, Cancers (Basel), V3, P3242, DOI 10.3390/cancers3033242; Nowinska K, 2016, INT J ONCOL, V48, P635, DOI 10.3892/ijo.2015.3273; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Schroder LBW, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00259; Su Z, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.425; Sukhdeo K, 2011, CELL, V146, P187, DOI 10.1016/j.cell.2011.06.047; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	27	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0178881	10.1371/journal.pone.0178881	http://dx.doi.org/10.1371/journal.pone.0178881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161257	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000001
J	Pauchard, LA; Blot, M; Bruyere, R; Barbar, SD; Croisier, D; Piroth, L; Charles, PE				Pauchard, Laure-Anne; Blot, Mathieu; Bruyere, Remi; Barbar, Saber-Davide; Croisier, Delphine; Piroth, Lionel; Charles, Pierre-Emmanuel			Linezolid and atorvastatin impact on pneumonia caused by Staphyloccocus aureus in rabbits with or without mechanical ventilation	PLOS ONE			English	Article							INDUCED LUNG INJURY; TIDAL-VOLUME; OUTCOMES; STATINS; MODEL; INFLAMMATION; MORTALITY; THERAPY; PATHWAY; SEPSIS	Pneumonia may involve methicillin-resistant Staphylococcus aureus (MRSA), with elevated rates of antibiotics failure. The present study aimed to assess the effect of statins given prior to pneumonia development. Spontaneously breathing (SB) or mechanically ventilated (MV) rabbits with pneumonia received atorvastatin alone, linezolid (LNZ) alone, or a combination of both (n = 5 in each group). Spontaneously breathing and MV untreated infected animals (n = 11 in each group), as well as uninfected animals (n = 5 in each group) were used as controls. Microbiological features and inflammation were evaluated. Data are presented as medians (interquartile range). Linezolid alone tended to reduce pulmonary MRSA load in both SB and MV rabbits, but failed to prevent bacteremia (59%) in the latter. Linezolid alone dampened TNF-alpha lung production in both SB and MV rabbits (e.g., 2226 [789] vs. 11478 [10251] pg/g; p = 0.022). Statins alone did the same in both SB and MV animals (e.g., 2040 [133]; p = 0.016), and dampened systemic inflammation in the latter, possibly through TLR2 down-regulation within the lung. However, the combination of LNZ and statin led to an increased rate of bacteremia in MV animals up to 75%. Statins provide an anti-inflammatory effect in rabbits with MRSA pneumonia, especially in MV ones. However, dampening the systemic inflammatory response with statins could impede blood defenses against MRSA.	[Pauchard, Laure-Anne; Blot, Mathieu; Bruyere, Remi; Barbar, Saber-Davide; Charles, Pierre-Emmanuel] Univ Bourgogne, Lab Lipides Nutr Canc, UMR 1231, INSERM,UFR Sci Sante, Dijon, France; [Blot, Mathieu; Piroth, Lionel] Hop F Mitterrand, Serv Malad Infect & Tropicales, Dijon, France; [Croisier, Delphine] Vivexia SARL, Gemeaux, France; [Charles, Pierre-Emmanuel] Hop F Mitterrand, Serv Reanimat Med, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Charles, PE (corresponding author), Univ Bourgogne, Lab Lipides Nutr Canc, UMR 1231, INSERM,UFR Sci Sante, Dijon, France.; Charles, PE (corresponding author), Hop F Mitterrand, Serv Reanimat Med, Dijon, France.	pierre-emmanuel.charles@chu-dijon.fr	Blot, Mathieu/D-4508-2019	Blot, Mathieu/0000-0001-6541-2434; Charles, Pierre-Emmanuel/0000-0002-0201-9544; Barbar, Saber Davide/0000-0002-5089-8088	Pfizer	Pfizer(Pfizer)	DC is an employee of the "Vivexia S.A.R. L." company and as such received a salary. This funder only provided a part of the research materials (i.e., catheter insertion in rabbits). This funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer (i.e., Aspire grant) has provided support in the form of the remaining research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbar SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158799; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Bruyere R, 2014, CRIT CARE, V18, DOI 10.1186/cc13845; Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Charles PE, 2005, CRIT CARE MED, V33, P1029, DOI 10.1097/01.CCM.0000163404.35338.72; Charles PE, 2004, INTENS CARE MED, V30, P2263, DOI 10.1007/s00134-004-2442-y; Charles PE, 2002, CRIT CARE MED, V30, P2278, DOI 10.1097/00003246-200210000-00016; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Christaki E, 2014, VIRULENCE, V5, P57, DOI 10.4161/viru.26514; Diep BA, 2013, J INFECT DIS, V208, P75, DOI 10.1093/infdis/jit129; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Jacqueline C, 2014, J INFECT DIS, V210, P814, DOI 10.1093/infdis/jiu145; Kajikawa O, 2005, GENE, V344, P193, DOI 10.1016/j.gene.2004.09.032; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Ladoire S, 2013, ANESTHESIOLOGY, V118, P1150, DOI 10.1097/ALN.0b013e31828a7016; Leung S, 2012, CRIT CARE MED, V40, P1064, DOI 10.1097/CCM.0b013e31823bc9e7; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; McAuley D, 2016, INTENSIVE CARE MED; Moriyama K, 2004, AM J PHYSIOL-LUNG C, V286, pL1114, DOI 10.1152/ajplung.00296.2003; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Siempos II, 2010, CRIT CARE MED, V38, P1321, DOI 10.1097/CCM.0b013e3181d9dad6; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Taubert M, 2016, ANTIMICROB AGENTS CH; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wang Y, 2011, AM J PHYSIOL-HEART C, V300, pH1743, DOI 10.1152/ajpheart.01335.2008; Wu BQ, 2014, CLIN EXP MED, V14, P151, DOI 10.1007/s10238-013-0231-z; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11	39	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187187	10.1371/journal.pone.0187187	http://dx.doi.org/10.1371/journal.pone.0187187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149185	gold, Green Published, Green Submitted			2022-12-26	WOS:000415646100008
J	Halboth, F; Roces, F				Halboth, Florian; Roces, Flavio			The construction of ventilation turrets in Atta vollenweideri leaf-cutting ants: Carbon dioxide levels in the nest tunnels, but not airflow or air humidity, influence turret structure	PLOS ONE			English	Article							WIND-INDUCED VENTILATION; INTERNAL STRUCTURE; 1893 HYM; FOREL; GROWTH; ARCHITECTURE; HYMENOPTERA; TEMPERATURE; PARAMETERS; PREFERENCE	Nest ventilation in the leaf-cutting ant Atta vollenweideri is driven via a wind-induced mechanism. On their nests, workers construct small turrets that are expected to facilitate nest ventilation. We hypothesized that the construction and structural features of the turrets would depend on the colony's current demands for ventilation and thus might be influenced by the prevailing environmental conditions inside the nest. Therefore, we tested whether climate-related parameters, namely airflow, air humidity and CO2 levels in the outflowing nest air influenced turret construction in Atta vollenweideri. In the laboratory, we simulated a seminatural nest arrangement with fungus chambers, a central ventilation tunnel providing outflow of air and an aboveground building arena for turret construction. In independent series, different climatic conditions inside the ventilation tunnel were experimentally generated, and after 24 hours, several features of the built turret were quantified, i.e., mass, height, number and surface area (aperture) of turret openings. Turret mass and height were similar in all experiments even when no airflow was provided in the ventilation tunnel. However, elevated CO2 levels led to the construction of a turret with several minor openings and a larger total aperture. This effect was statistically significant at higher CO2 levels of 5% and 10% but not at 1% CO2. The construction of a turret with several minor openings did not depend on the strong differences in CO2 levels between the outflowing and the outside air, since workers also built permeated turrets even when the CO2 levels inside and outside were both similarly high. We propose that the construction of turrets with several openings and larger opening surface area might facilitate the removal of CO2 from the underground nest structure and could therefore be involved in the control of nest climate in leaf-cutting ants.	[Halboth, Florian; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany	University of Wurzburg	Halboth, F (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany.	florian.halboth@uni-wuerzburg.de		Roces, Flavio/0000-0001-9258-3079	German Excellence Initiative; German Research Foundation (DFG); University of Wurzburg	German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	Florian Halboth was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bollazzi M, 2010, J ETHOL, V28, P399, DOI 10.1007/s10164-010-0207-3; Cosarinsky MI, 2007, GEODERMA, V141, P224, DOI 10.1016/j.geoderma.2007.06.006; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; CURRIE JA, 1984, J SOIL SCI, V35, P1, DOI 10.1111/j.1365-2389.1984.tb00253.x; FORSTER RE, 1957, PHYSIOL REV, V37, P391, DOI 10.1152/physrev.1957.37.4.391; Franks NR, 2004, ANIM BEHAV, V67, P965, DOI 10.1016/j.anbehav.2004.01.003; Garrett R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150111; Halboth F, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1504-2; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; Hansell M., 2005, OXF ANIMAL BIOL SER; Hasin S, 2014, ECOL EVOL, V4, P3929, DOI 10.1002/ece3.1255; HEBLING MJA, 1992, COMP BIOCHEM PHYS A, V101, P319, DOI 10.1016/0300-9629(92)90539-3; Holldobler B., 1990, pi; HOLSCHER KH, 1980, ANN ENTOMOL SOC AM, V73, P288, DOI 10.1093/aesa/73.3.288; HOWSE PE, 1966, NATURE, V210, P967, DOI 10.1038/210967b0; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; MCCOOK HC, 1877, T AM ENTOMOL SOC, V6, P253; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Pielstrom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095658; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; REARDON EJ, 1979, J HYDROL, V43, P355, DOI 10.1016/0022-1694(79)90181-1; Ribeiro PL, 2008, J INSECT BEHAV, V21, P549, DOI 10.1007/s10905-008-9150-3; ROCES F, 1989, OECOLOGIA, V81, P33, DOI 10.1007/BF00377006; Romer D, 2015, INSECT SOC, V62, P401, DOI 10.1007/s00040-015-0419-1; Romer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174597; Sousa-Souto L, 2012, SOIL BIOL BIOCHEM, V44, P21, DOI 10.1016/j.soilbio.2011.09.008; STANGE G, 1992, J COMP PHYSIOL A, V171, P317, DOI 10.1007/BF00223962; Sudd JH, 1982, SOCIAL INSECTS, P107; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; VOGEL S, 1973, J COMP PHYSIOL, V85, P1, DOI 10.1007/BF00694136; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P159, DOI 10.1016/0003-3472(62)90143-4	46	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188162	10.1371/journal.pone.0188162	http://dx.doi.org/10.1371/journal.pone.0188162			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145459	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800077
J	Ho, JC; Abdullah, LN; Pang, QY; Jha, S; Chow, EKH; Yang, H; Kato, H; Poellinger, L; Ueda, J; Lee, KL				Ho, Jolene Caifeng; Abdullah, Lissa Nurrul; Pang, Qing You; Jha, Sudhakar; Chow, Edward Kai-Hua; Yang, Henry; Kato, Hiroyuki; Poellinger, Lorenz; Ueda, Jun; Lee, Kian Leong			Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway	PLOS ONE			English	Article							HISTONE-H3 LYSINE-9 METHYLATION; PROMOTES PROLIFERATION; EPIGENETIC THERAPY; SURVIVIN GENE; GROWTH-FACTOR; CANCER; REPRESSION; CELLS; ANGIOGENESIS; METASTASIS	Epigenetic mechanisms play important roles in the regulation of tumorigenesis, and hypoxia- induced epigenetic changes may be critical for the adaptation of cancer cells to the hypoxic microenvironment of solid tumors. Previously, we showed that loss-of-function of the hypoxia-regulated H3K9 methyltransferase G9A attenuates tumor growth. However, the mechanisms by which blockade of G9A leads to a tumor suppressive effect remain poorly understood. We show that G9A is highly expressed in breast cancer and is associated with poor patient prognosis, where it may function as a potent oncogenic driver. In agreement with this, G9A inhibition by the small molecule inhibitor, BIX-01294, leads to increased cell death and impaired cell migration, cell cycle and anchorage-independent growth. Interestingly, whole transcriptome analysis revealed that genes involved in diverse cancer cell functions become hypoxia-responsive upon G9A inhibition. This was accompanied by the upregulation of the hypoxia inducible factors HIF1 alpha and HIF2 alpha during BIX-01294 treatment even in normoxia that may facilitate the tumor suppressive effects of BIX-01294. HIF inhibition was able to reverse some of the transcriptional changes induced by BIX-01294 in hypoxia, indicating that the HIFs may be important drivers of these derepressed target genes. Therefore, we show that G9A is a key mediator of oncogenic processes in breast cancer cells and G9A inhibition by BIX-01294 can successfully attenuate oncogenicity even in hypoxia.	[Ho, Jolene Caifeng; Abdullah, Lissa Nurrul; Pang, Qing You; Jha, Sudhakar; Chow, Edward Kai-Hua; Yang, Henry; Kato, Hiroyuki; Poellinger, Lorenz; Lee, Kian Leong] Natl Univ Singapore, Canc Stem Cells & Biol Program, Canc Sci Inst Singapore, Singapore, Singapore; [Poellinger, Lorenz] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Ueda, Jun] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan; [Ho, Jolene Caifeng] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Lee, Kian Leong] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	National University of Singapore; Karolinska Institutet; Asahikawa Medical College; University of Toronto; Structural Genomics Consortium; National University of Singapore	Ho, JC; Lee, KL (corresponding author), Natl Univ Singapore, Canc Stem Cells & Biol Program, Canc Sci Inst Singapore, Singapore, Singapore.; Ueda, J (corresponding author), Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan.; Ho, JC (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.; Lee, KL (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore.	jolene.ho@utoronto.ca; junueda@asahikawa-med.ac.jp; kianleong.lee@duke-nus.edu.sg	Ueda, Jun/AAX-9704-2020; LEE, Kian Leong/E-3584-2013; Jha, Sudhakar/B-2308-2009; Jha, Sudhakar/S-3550-2019	Ueda, Jun/0000-0002-9766-203X; LEE, Kian Leong/0000-0002-0443-2746; Jha, Sudhakar/0000-0002-5093-4843; Ho, Jolene/0000-0001-5908-0007	National University Cancer Institute, Singapore (NCIS) [NR13NMR1340M]; National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG) [NMRC/CIRG/1389/2014]; National Research Foundation (NRF) Singapore; Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative [R-713-005-014-271, R-713-010-189-112]; Ministry of Education, Singapore AcRF [MOE2015-T2-2-126]; Cancer Science Institute of Singapore RCE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP16K07099, JP16H01319]; Swedish Research Council	National University Cancer Institute, Singapore (NCIS); National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG)(National Medical Research Council, Singapore); National Research Foundation (NRF) Singapore(National Research Foundation, Singapore); Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative(Ministry of Education, Singapore); Ministry of Education, Singapore AcRF(Ministry of Education, Singapore); Cancer Science Institute of Singapore RCE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by National University Cancer Institute, Singapore (NCIS) Pilot Grant (NR13NMR1340M, H.K., L.P. and K.L.L.); National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG) (NMRC/CIRG/1389/2014, S.J. and L.P.); the National Research Foundation (NRF) Singapore and the Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative (R-713-005-014-271, J.C.H., Q.Y.P., H.K., L.P. and K.L.L.; R-713-010-189-112, H.Y.); Ministry of Education, Singapore AcRF Tier 2 (MOE2015-T2-2-126, L.N.A., E.K.C); Cancer Science Institute of Singapore RCE Main Grant (E.K.C.); the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grants-in-Aid for Scientific Research (JP16K07099 and JP16H01319, J.U.); the Swedish Research Council (L.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0141-5; Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Casciello F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00487; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheloni G, 2017, BLOOD, V130, P655, DOI 10.1182/blood-2016-10-745588; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Hockel M, 1996, CANCER RES, V56, P4509; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; HUA KT, 2014, MOL CANCER, V13; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ke XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106962; Kohno M, 1999, J AM SOC NEPHROL, V10, P2495; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li YD, 2015, INT J CLIN EXP PATHO, V8, P1731; Ma AN, 2010, BIOCHEM BIOPH RES CO, V393, P592, DOI 10.1016/j.bbrc.2010.02.020; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Oh SY, 2015, MOL CELLS, V38, P528, DOI 10.14348/molcells.2015.0026; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rao VK, 2016, NUCLEIC ACIDS RES, V44, P8129, DOI 10.1093/nar/gkw483; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 1996, TRENDS CARDIOVAS MED, V6, P151, DOI 10.1016/1050-1738(96)00039-4; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Ueda J, 2014, MOL CELL BIOL, V34, P3702, DOI 10.1128/MCB.00099-14; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhou RZ, 2005, CANCER RES, V65, P1839, DOI 10.1158/0008-5472.CAN-03-3755; Zhou XM, 2016, ONCOTARGET, V7, P13634, DOI 10.18632/oncotarget.7215	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188051	10.1371/journal.pone.0188051	http://dx.doi.org/10.1371/journal.pone.0188051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145444	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800056
J	Imhof, HK; Rusek, J; Thiel, M; Wolinska, J; Laforsch, C				Imhof, Hannes K.; Rusek, Jakub; Thiel, Michaela; Wolinska, Justyna; Laforsch, Christian			Do microplastic particles affect Daphnia magna at the morphological, life history and molecular level?	PLOS ONE			English	Article							COPEPOD TIGRIOPUS-JAPONICUS; MYTILUS-EDULIS L.; GENE-EXPRESSION; MARINE-ENVIRONMENT; OXIDATIVE STRESS; CARCINUS-MAENAS; DEMERSAL FISH; RESPONSES; POLLUTION; EXPOSURE	Microplastic particles are ubiquitous not only in marine but also in freshwater ecosystems. However, the impacts of microplastics, consisting of a large variety of synthetic polymers, on freshwater organisms remains poorly understood. We examined the effects of two polymer mixtures on the morphology, life history and on the molecular level of the waterflea Daphnia magna (three different clones). Microplastic particles of similar to 40 mu m were supplied at a low concentration (1% of the food particles) leading to an average of similar to 30 particles in the digestive tract which reflects a high microplastic contamination but still resembles a natural situation. Neither increased mortality nor changes on the morphological (body length, width and tail spine length) or reproductive parameters were observed for adult Daphnia. The analyses of juvenile Daphnia revealed a variety of small and rather subtle responses of morphological traits (body length, width and tail spine length). For adult Daphnia, alterations in expression of genes related to stress responses (i.e. HSP60, HSP70 & GST) as well as of other genes involved in body function and body composition (i.e. SERCA) were observed already 48h after exposure. We anticipate that the adverse effects of microplastic might be influenced by many additional factors like size, shape, type and even age of the particles and that the rather weak effects, as detected in a laboratory, may lead to reduced fitness in a natural multi-stressor environment.	[Imhof, Hannes K.; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Imhof, Hannes K.; Laforsch, Christian] Univ Bayreuth, BayCEER, Bayreuth, Germany; [Imhof, Hannes K.; Rusek, Jakub; Thiel, Michaela] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; [Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Muggelseedamm 301, Berlin, Germany; [Wolinska, Justyna] Free Univ Berlin, Inst Biol, Dept Biol Chem Pharm, Berlin, Germany	University of Bayreuth; University of Bayreuth; University of Munich; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin	Laforsch, C (corresponding author), Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany.; Laforsch, C (corresponding author), Univ Bayreuth, BayCEER, Bayreuth, Germany.	Christian.laforsch@uni-bayreuth.de	Wolinska, Justyna/N-6455-2014; Imhof, Hannes/HDN-2781-2022	Imhof, Hannes/0000-0003-4992-5357	Deutsche Forschungsgemeinschaft (DFG) [LA 2159/7-1]; Studienstiftung des deutschen Volkes; German Research Foundation (DFG); University of Bayreuth in the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth in the funding programme Open Access Publishing	We wish to thank the Deutsche Forschungsgemeinschaft (DFG; LA 2159/7-1) for funding. Generous financial support of Hannes Imhof by the "Studienstiftung des deutschen Volkes" is gratefully acknowledged. This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler I, 2015, GENOME, V58, P99, DOI 10.1139/gen-2015-0045; Altshuler I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052617; Anderson M., 2005, PERMUTATIONAL MULTIV, V24; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Barboza LGA, 2015, MAR POLLUT BULL, V97, P5, DOI 10.1016/j.marpolbul.2015.06.008; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Besseling E, 2014, ENVIRON SCI TECHNOL, V48, P12336, DOI 10.1021/es503001d; Biginagwa FJ, 2016, J GREAT LAKES RES, V42, P146, DOI 10.1016/j.jglr.2015.10.012; BLACK AR, 1990, OECOLOGIA, V83, P117, DOI 10.1007/BF00324642; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Brennecke D, 2015, MAR POLLUT BULL, V96, P491, DOI 10.1016/j.marpolbul.2015.05.001; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2015, ENVIRON SCI TECHNOL, V49, P7082, DOI 10.1021/es5060572; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Castaneda RA, 2014, CAN J FISH AQUAT SCI, V71, P1767, DOI 10.1139/cjfas-2014-0281; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Dantas DV, 2012, ENVIRON SCI POLLUT R, V19, P600, DOI 10.1007/s11356-011-0579-0; Dietrich S, 2010, CHEMOSPHERE, V79, P60, DOI 10.1016/j.chemosphere.2009.12.069; Dris R, 2015, ENVIRON CHEM, V12, P539, DOI 10.1071/EN14172; Duis K, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-015-0069-y; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Flaherty CM, 2005, CHEMOSPHERE, V61, P200, DOI 10.1016/j.chemosphere.2005.02.016; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Gall SC, 2015, MAR POLLUT BULL, V92, P170, DOI 10.1016/j.marpolbul.2014.12.041; Haap T, 2009, AQUAT TOXICOL, V94, P131, DOI 10.1016/j.aquatox.2009.06.006; Hamer J, 2014, ENVIRON SCI TECHNOL, V48, P13451, DOI 10.1021/es501385y; Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40; Heckmann LH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-175; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellemans J, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P139; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; Imhof HK, 2013, CURR BIOL, V23, pR867, DOI 10.1016/j.cub.2013.09.001; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Ki JS, 2009, AQUAT TOXICOL, V93, P177, DOI 10.1016/j.aquatox.2009.04.004; Kim J, 2009, AQUAT TOXICOL, V91, P87, DOI 10.1016/j.aquatox.2008.10.006; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Klein S, 2015, ENVIRON SCI TECHNOL, V49, P6070, DOI 10.1021/acs.est.5b00492; Koelmans AA, 2016, ENVIRON SCI TECHNOL, V50, P3315, DOI 10.1021/acs.est.5b06069; Lampert W., 2011, DAPHNIA DEVELOPMENT; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lee KW, 2013, ENVIRON SCI TECHNOL, V47, P11278, DOI 10.1021/es401932b; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Lonnstedt OM, 2016, SCIENCE, V352, P1213, DOI 10.1126/science.aad8828; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mani T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17988; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; Mintenig SM, 2017, WATER RES, V108, P365, DOI 10.1016/j.watres.2016.11.015; Motulsky H., 1995, INTUITIVE BIOSTATIST; Oliveira M, 2013, ECOL INDIC, V34, P641, DOI 10.1016/j.ecolind.2013.06.019; Otte KA, 2015, MOL ECOL, V24, P3901, DOI 10.1111/mec.13287; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Peters R. H, 1987, DAPHNIA CONSIGLIO NA; Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6257, DOI 10.1021/es800262k; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618; Rabus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067856; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; Rehse S, 2016, CHEMOSPHERE, V153, P91, DOI 10.1016/j.chemosphere.2016.02.133; Rhee JS, 2009, COMP BIOCHEM PHYS C, V149, P104, DOI 10.1016/j.cbpc.2008.07.009; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rosenkranz P, 2009, ENVIRON TOXICOL CHEM, V28, P2142, DOI 10.1897/08-559.1; Rummel CD, 2016, MAR POLLUT BULL, V102, P134, DOI 10.1016/j.marpolbul.2015.11.043; Sanchez W, 2014, ENVIRON RES, V128, P98, DOI 10.1016/j.envres.2013.11.004; Schwarzenberger A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-527; Schwenk Klaus, 1998, Aquatic Ecology, V32, P37, DOI 10.1023/A:1009939901198; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Steinberg CEW, 2010, HYDROBIOLOGIA, V652, P223, DOI 10.1007/s10750-010-0334-4; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Turner A, 2015, ENVIRON CHEM, V12, P600, DOI 10.1071/EN14143; UNEP Year Book, 2011, UNEP YB; Vandermeersch G, 2015, ENVIRON RES, V143, P46, DOI 10.1016/j.envres.2015.07.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vegter AC, 2014, ENDANGER SPECIES RES, V25, P225, DOI 10.3354/esr00623; Watts AJR, 2014, ENVIRON SCI TECHNOL, V48, P8823, DOI 10.1021/es501090e; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	92	101	104	9	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187590	10.1371/journal.pone.0187590	http://dx.doi.org/10.1371/journal.pone.0187590			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145427	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800021
J	Sawaya, AP; Pastar, I; Stojadinovic, O; Lazovic, S; Davis, SC; Gil, J; Kirsner, RS; Tomic-Canic, M				Sawaya, Andrew P.; Pastar, Irena; Stojadinovic, Olivera; Lazovic, Sonja; Davis, Stephen C.; Gil, Joel; Kirsner, Robert S.; Tomic-Canic, Marjana			Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; long noncoding RNA (long ncRNA; lncRNA); Myc (c-Myc); skin; wound healing; diabetic foot ulcers; statin; Gas5	COA REDUCTASE INHIBITORS; DIABETIC FOOT ULCERS; FARNESYL PYROPHOSPHATE; VENOUS ULCERS; GROWTH-FACTORS; STEM-CELLS; HUMAN SKIN; EXPRESSION; STATINS; EPITHELIALIZATION	Diabetic foot ulcers (DFUs), a life-threatening complication of diabetes mellitus, have limited treatment options, often resulting in amputations. HMG-CoA reductase inhibitors such as statins are cholesterol-reducing agents that may provide a new therapeutic option. Statins target the cholesterol pathway and block the synthesis of the wound-healing inhibitors farnesyl pyrophosphate (FPP) and cortisol, ligands for the glucocorticoid receptor (GR). Here we demonstrate that the naturally occurring statin mevastatin reverses FPP's effects and promotes healing by using in vitro wound healing assays, human ex vivo and porcine in vivo wound models, and DFU tissue. Moreover, we measured cortisol levels by ELISA and found that mevastatin inhibited cortisol synthesis in keratinocytes and biopsies from patients with DFU. Of note, topical mevastatin stimulated epithelialization and angiogenesis in vivo. Mevastatin also reversed FPP-mediated induction of the GR target, the transcription factor c-Myc (a biomarker of non-healing wounds), in porcine and human wound models. Importantly, mevastatin reversed c-Myc overexpression in DFUs. It induced expression of the long noncoding RNA Gas5 that blocks c-Myc expression, which was confirmed by overexpression studies. We conclude that topical mevastatin accelerates wound closure by promoting epithelialization via multiple mechanisms: modulation of GR ligands and induction of the long noncoding RNA Gas5, leading to c-Myc inhibition. In light of these findings, we propose that repurposing statin drugs for topical treatment of DFUs may offer another option for managing this serious condition.	[Sawaya, Andrew P.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Mol & Cellular Pharmacol Program, Miami, FL 33136 USA; [Sawaya, Andrew P.; Pastar, Irena; Stojadinovic, Olivera; Lazovic, Sonja; Davis, Stephen C.; Gil, Joel; Kirsner, Robert S.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Stojadinovic, Olivera] Univ Kragujevac, Fac Med Sci, Immunol Infect & Inflammat Grad Program, Kragujevac 34000, Serbia; [Kirsner, Robert S.; Tomic-Canic, Marjana] Univ Miami Hlth Syst, Univ Miami Hosp, Wound Healing Clin Res Program, Miami, FL 33136 USA	University of Miami; University of Miami; University of Kragujevac; University of Miami	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program,RMSB, 1600 NW 10th Ave,Rm 2023A, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [AR060562, NR015649, NR013881]; University of Miami SAC Award [SAC 2013-19]; New York University [PCT/U52010/062361]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013881, R01NR015649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami SAC Award; New York University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by National Institutes of Health Grants AR060562, NR015649, and NR013881 (to M. T. C.) and University of Miami SAC Award SAC 2013-19. M. T. C. is listed as the inventor of Patent PCT/U52010/062361, "Composition and Methods for Promoting Epithelialization and Wound Closure," issued to New York University based on the data presented, in part, in this study and stands to potentially gain royalties from future commercialization.	Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Asai J, 2012, AM J PATHOL, V181, P2217, DOI 10.1016/j.ajpath.2012.08.023; Banach M, 2015, EXPERT OPIN DRUG SAF, V14, P935, DOI 10.1517/14740338.2015.1039980; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bitto A, 2008, PHARMACOL RES, V57, P159, DOI 10.1016/j.phrs.2008.01.005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brem H, 2009, J INVEST DERMATOL, V129, P2275, DOI 10.1038/jid.2009.26; Corrao G, 2014, DIABETES CARE, V37, P2225, DOI 10.2337/dc13-2215; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Evangelista MTP, 2014, BRIT J DERMATOL, V170, P1151, DOI 10.1111/bjd.12883; Fox JD, 2016, WOUND REPAIR REGEN, V24, P454, DOI 10.1111/wrr.12400; Gould L, 2015, J AM GERIATR SOC, V63, P427, DOI 10.1111/jgs.13332; Haag WG, 2011, WOUND REPAIR REGEN, V19, P442, DOI 10.1111/j.1524-475X.2011.00693.x; Herskovitz I, 2017, J INVEST DERMATOL, V137, P2646, DOI 10.1016/j.jid.2017.07.837; Hu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107016; Johansen OE, 2009, J DIABETES, V1, P182, DOI 10.1111/j.1753-0407.2009.00031.x; Jozic I, 2017, J INVEST DERMATOL, V137, P1144, DOI 10.1016/j.jid.2016.11.036; Jozic I, 2014, J INVEST DERMATOL, V134, P2869, DOI 10.1038/jid.2014.363; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Laing T, 2010, J SURG RES, V161, P336, DOI 10.1016/j.jss.2009.01.024; Liang L, 2016, WOUND REPAIR REGEN, V24, P943, DOI 10.1111/wrr.12470; Lindley LE, 2016, PLAST RECONSTR SURG, V138, p18S, DOI 10.1097/PRS.0000000000002682; Liu Y, 2010, COMPARATIVE MED, V60, P142; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Mehta VB, 2008, GROWTH FACTORS, V26, P301, DOI 10.1080/08977190802393596; MENON GK, 1985, J LIPID RES, V26, P418; Olivera S, 2013, METHODS MOL BIOL, V1037, P255, DOI 10.1007/978-1-62703-505-7_14; Pastar I, 2016, J CELL PHYSIOL, V231, P2452, DOI 10.1002/jcp.25357; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O., 2010, EXPET REV DERMATOL, V5, P689, DOI [10.1586/edm.10.60, DOI 10.1586/EDM.10.60, 10.1586/edm.10.60.]; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Stojadinovic O, 2014, WOUND REPAIR REGEN, V22, P220, DOI 10.1111/wrr.12142; Stojadinovic O, 2013, EXP DERMATOL, V22, P216, DOI 10.1111/exd.12104; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; Stone RC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf8611; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Takwi AAL, 2012, EMBO MOL MED, V4, P896, DOI 10.1002/emmm.201101045; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200	54	35	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1439	1449		10.1074/jbc.M117.811240	http://dx.doi.org/10.1074/jbc.M117.811240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158265	hybrid, Green Published			2022-12-26	WOS:000423515000028
J	Hendriksen, MAH; Geleijnse, JM; van Raaij, JMA; Cappuccio, FP; Cobiac, LC; Scarborough, P; Nusselder, WJ; Jaccard, A; Boshuizen, HC				Hendriksen, Marieke A. H.; Geleijnse, Johanna M.; van Raaij, Joop M. A.; Cappuccio, Francesco P.; Cobiac, Linda C.; Scarborough, Peter; Nusselder, Wilma J.; Jaccard, Abbygail; Boshuizen, Hendriek C.			Identification of differences in health impact modelling of salt reduction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; SODIUM CONSUMPTION; DIETARY-SODIUM; RISK; INTERVENTIONS; MORTALITY	We examined whether specific input data and assumptions explain outcome differences in otherwise comparable health impact assessment models. Seven population health models estimating the impact of salt reduction on morbidity and mortality in western populations were compared on four sets of key features, their underlying assumptions and input data. Next, assumptions and input data were varied one by one in a default approach (the DYNAMO-HIA model) to examine how it influences the estimated health impact. Major differences in outcome were related to the size and shape of the dose-response relation between salt and blood pressure and blood pressure and disease. Modifying the effect sizes in the salt to health association resulted in the largest change in health impact estimates (33% lower), whereas other changes had less influence. Differences in health impact assessment model structure and input data may affect the health impact estimate. Therefore, clearly defined assumptions and transparent reporting for different models is crucial. However, the estimated impact of salt reduction was substantial in all of the models used, emphasizing the need for public health actions.	[Hendriksen, Marieke A. H.; van Raaij, Joop M. A.; Boshuizen, Hendriek C.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Geleijnse, Johanna M.; van Raaij, Joop M. A.; Boshuizen, Hendriek C.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, WHO Collaborating Ctr, Coventry, W Midlands, England; [Cappuccio, Francesco P.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Cobiac, Linda C.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Carlton, Vic, Australia; [Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England; [Nusselder, Wilma J.] Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Jaccard, Abbygail] UK Hlth Forum, London, England	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; University of Warwick; World Health Organization; University of Warwick; University of Melbourne; University of Oxford; Erasmus University Rotterdam; Erasmus MC	Hendriksen, MAH (corresponding author), Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.	marieke.hendriksen@rivm.nl	Boshuizen, Hendriek C/B-3718-2014; Scarborough, Peter/ABD-6111-2021; Geleijnse, Johanna Marianna M/B-5749-2012; Shao, Ruitai/AAU-7642-2021	Scarborough, Peter/0000-0002-2378-2944; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Jaccard, Abbygail/0000-0002-7903-5956	WHO Regional Office for Europe; National Institute for Public Health and the Environment; British Heart Foundation [FS/15/34/31656] Funding Source: researchfish	WHO Regional Office for Europe; National Institute for Public Health and the Environment; British Heart Foundation(British Heart Foundation)	The WHO Regional Office for Europe financially supported to host the workshop and the National Institute for Public Health and the Environment financially supported to perform the analyses and draft the manuscript. The funders had no role in study design, data analysis, decision to publish and preparation of the manuscript.; We would like to thank all participants of the WHO workshop on the modelling effect of salt reduction and their willingness to discuss their models during the workshop. We would like to thank WHO Regional Office for Europe for their financial support. The WHO workshop was held on 7-8 November 2013 at the National Institute for Public Health and the Environment (RIVM) in the Netherlands.	Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Cappuccio FP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007467; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gardener H, 2012, STROKE, V43, P1200, DOI 10.1161/STROKEAHA.111.641043; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; He FJ, 2008, NEPHROL DIAL TRANSPL, V23, P3382, DOI 10.1093/ndt/gfn550; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; Hendriksen MAH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118873; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; Ji C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002246; Ji C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005683; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Nghiem N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3102-1; Nghiem N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123915; RODRIGUEZFERNANDEZ, 2014, PUBLIC HEALTH NUTR, V17, P1894, DOI DOI 10.1017/S136898001300195X; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Webb M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6699; Wilson N, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0161-1; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0186760	10.1371/journal.pone.0186760	http://dx.doi.org/10.1371/journal.pone.0186760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182636	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000002
J	Han, JH; Won, JY; Hong, SK; Kim, JH; Kim, ES; Kim, HJ; Lee, HJ				Han, Ji-Hye; Won, Joong Yeon; Hong, Sung Kwang; Kim, Ja Hee; Kim, Eun Soo; Kim, Hyung-Jong; Lee, Hyo-Jeong			Objective measurement of subjective tinnitus using the acoustic change complex	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; HIDDEN HEARING-LOSS; AUDITORY-CORTEX; DETECTION DEFICITS; STARTLE PARADIGM; GAP; INHIBITION; PREVALENCE; FREQUENCY; INDEX	At present, there is no objective method for diagnosing subjective sensorineural tinnitus. Recently, the acoustic change complex (ACC) has been used to evaluate neural detection of sounds. Thus, the present study aimed to examine whether the ACC can reflect cortical detection and discrimination of sounds matched with tinnitus frequencies. We hypothesized that the ACC to change stimuli matched with tinnitus frequencies would be decreased in tinnitus patients because the tinnitus interferes with the perception of acoustic changes. To test the hypothesis, 96 ears of normal-hearing (NH) tinnitus patients and controls were tested. Among the tinnitus patients, 33 ears with a tinnitus frequency of 8 kHz constituted the tinnitus group, and the remaining 63 ears with no experience of tinnitus were allocated to the control group. For the 4 kHz non-tinnitus matched frequency, a subset of tinnitus (n = 17) and NH (n = 47) subjects was tested. The acoustic stimuli were pure tones with a total duration of 500 ms consisting of a 1 kHz tone in the first 250 ms and a second tone of either 8 kHz or 4 kHz in the latter 250 ms. The normalized amplitude of the ACC (naACC) was calculated separately for the amplitude of the N1'-P2' complex evoked by an 8 kHz or 4 kHz change stimulus and for the amplitude of the N1-P2 complex elicited by the initial 1 kHz background stimulus. Our results showed that the naACC to an 8 kHz stimulus in the tinnitus group was significantly smaller than those to 4 kHz and 8 kHz in normal controls. Additionally, in the tinnitus group, the naACC to 4 kHz was greater compared to 8 kHz. The receiver operating characteristic (ROC) curve analysis conducted for naACC to 8 kHz at UCL revealed a fair degree of diagnostic efficacy. Overall, our results indicated that the ACC to a change stimulus matched with the tinnitus frequency can provide an objective measure of frequency-specific tinnitus.	[Han, Ji-Hye; Hong, Sung Kwang; Kim, Ja Hee; Kim, Hyung-Jong; Lee, Hyo-Jeong] Hallym Univ, Coll Med, Lab Brain & Cognit Sci Convergence Med, Chunchon, South Korea; [Won, Joong Yeon; Hong, Sung Kwang; Kim, Hyung-Jong; Lee, Hyo-Jeong] Hallym Univ, Coll Med, Dept Otolaryngol, Chunchon, South Korea; [Kim, Eun Soo] Hallym Univ, Coll Med, Dept Neuroradiol, Chunchon, South Korea	Hallym University; Hallym University; Hallym University	Lee, HJ (corresponding author), Hallym Univ, Coll Med, Lab Brain & Cognit Sci Convergence Med, Chunchon, South Korea.; Lee, HJ (corresponding author), Hallym Univ, Coll Med, Dept Otolaryngol, Chunchon, South Korea.	hyojlee@hallym.ac.kr	Lee, Hyo-Jeong/AAK-7973-2020	Lee, Hyo-Jeong/0000-0003-2258-0803	Basic Science Research Program through the National Research Foundation of Korea - Korean Government [NRF-2013R1A1A3006802, NRF-2016R1A2B4016330]; Hallym University Research Fund [HURF-2016-39]	Basic Science Research Program through the National Research Foundation of Korea - Korean Government; Hallym University Research Fund	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Korean Government (NRF-2013R1A1A3006802 and NRF-2016R1A2B4016330, HJL, http://www.nrf.re.kr/nrf_eng_cms/) and the Hallym University Research Fund (HURF-2016-39, HJL and ESK, http://cms.hallym.ac.kr/user/indexMain.do?siteld=english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj HM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00026; Brown CJ, 2008, EAR HEARING, V29, P704, DOI 10.1097/AUD.0b013e31817a98af; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Gabriel D, 2004, HEARING RES, V197, P55, DOI 10.1016/j.heares.2004.07.015; Han JH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00038; HAWKINS DB, 1987, EAR HEARING, V8, P162, DOI 10.1097/00003446-198706000-00006; Hong SK, 2016, HEARING RES, V342, P86, DOI 10.1016/j.heares.2016.10.002; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kadner A, 2002, NEUROREPORT, V13, P443, DOI 10.1097/00001756-200203250-00016; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; Liu XP, 2012, BRAIN RES, V1485, P88, DOI 10.1016/j.brainres.2012.04.048; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2012, BRAIN RES, V1485, P54, DOI 10.1016/j.brainres.2012.02.067; Martin BA, 2000, J ACOUST SOC AM, V107, P2155, DOI 10.1121/1.428556; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Pantev C, 2012, ANN NY ACAD SCI, V1252, P253, DOI 10.1111/j.1749-6632.2012.06452.x; Park RJ, 2014, CLIN OTOLARYNGOL, V39, P89, DOI 10.1111/coa.12232; Paul BT, 2017, HEARING RES, V344, P170, DOI 10.1016/j.heares.2016.11.010; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Small SA, 2012, EAR HEARING, V33, pE59, DOI 10.1097/AUD.0b013e31825f29be; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Weisz N, 2005, BRAIN, V128, P2722, DOI 10.1093/brain/awh588; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013	32	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188268	10.1371/journal.pone.0188268	http://dx.doi.org/10.1371/journal.pone.0188268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176873	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900052
J	Moor, MA; Fraga, MA; Garfein, RS; Rashidi, HH; Alcaraz, J; Kritz-Silverstein, D; Elder, JP; Brodine, SK				Moor, Molly A.; Fraga, Miguel A.; Garfein, Richard S.; Rashidi, Hooman H.; Alcaraz, John; Kritz-Silverstein, Donna; Elder, John P.; Brodine, Stephanie K.			Individual and community factors contributing to anemia among women in rural Baja California, Mexico	PLOS ONE			English	Article							REPRODUCTIVE-AGE; NUTRITION SURVEY; IRON-DEFICIENCY; CHILDREN; PREVALENCE; HEALTH; FOOD; SUPPLEMENT; PROGRESA; POLICY	Introduction Anemia is a public health concern among women in rural Baja California, Mexico. The purpose of this study was to identify the individual and community factors contributing to the disproportionately high prevalence of anemia among women in this region. Methods A cross-sectional study of 118 women (15 +/- 49 years) was performed in a rural colonia (small settlement) in Baja California, Mexico in 2012. Participants completed a survey comprised of demographic, socioeconomic, health, and dietary questions and provided a capillary blood sample. A portable HemoCue was used to measure hemoglobin and diagnose anemia. Anemic participants provided a venous blood sample for laboratory testing to elucidate the etiology of anemia. Anemic participants received vitamin supplements and nutritional counseling. Assessments of six local tiendas (community grocery stores) were performed to ascertain the types of food available for purchase within the community. Results Prevalence of anemia was 22% among women; laboratory tests revealed iron deficiency was the primary etiology in 80.8% of anemia cases. Other causes of anemia in women included vitamin B-12 deficiency (11.5%) and combined iron and vitamin B-12 deficiency (7.7%). Women from low SES households and women enrolled in the government assistance program Prospera were significantly more likely to be anemic (OR = 3.48, 95% CI 1.35 +/- 8.98 and OR = 2.49, 95% CI 1.02 +/- 6.09, respectively). Vitamin supplementation was significantly more common among non-anemic women (OR = 0.12, 95% CI 0.02 +/- 0.94). Dietary assessments showed limited consumption of iron absorption enhancing foods such as fruits and vegetables. Assessments of local tiendas revealed at least one type of meat and citrus fruit available for purchase at each store; however, leafy green vegetables were only available for purchase at one store. Conclusion All cases of anemia were due to nutritional deficiencies. While vitamin supplementation is a temporary solution, improved individual nutrition knowledge and community access to iron absorption enhancing foods, particularly produce, is needed. Promoting government assistance programs like Prospera and implementing additional programs designed to improve nutrition and health literacy, in conjunction with ensuring access to nutritious foods, might reduce the high prevalence nutritional anemia within the community.	[Moor, Molly A.; Alcaraz, John; Brodine, Stephanie K.] San Diego State Univ, Grad Sch Publ Hlth, Div Epidemiol & Biostat, San Diego, CA 92182 USA; [Moor, Molly A.; Kritz-Silverstein, Donna] Univ Calif San Diego, Sch Med, Div Epidemiol, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Fraga, Miguel A.] Univ Autonoma Baja California, Sch Med, Tijuana, Mexico; [Garfein, Richard S.] Univ Calif San Diego, Sch Med, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Rashidi, Hooman H.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Elder, John P.] San Diego State Univ, Grad Sch Publ Hlth, Div Hlth Promot & Behav Sci, San Diego, CA 92182 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Universidad Autonoma de Baja California; University of California System; University of California San Diego; University of California System; University of California Davis; California State University System; San Diego State University	Moor, MA (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, Div Epidemiol & Biostat, San Diego, CA 92182 USA.; Moor, MA (corresponding author), Univ Calif San Diego, Sch Med, Div Epidemiol, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	mollymoor@hotmail.com						[Anonymous], 2008, WORLDW PREV AN 1993; Casanueva E, 2006, SALUD PUBLICA MEXICO, V48, P166, DOI 10.1590/S0036-36342006000200010; CDC, 2015, AD BLOOD LEAD EP SUR; De la Cruz-Gongora V, 2012, SALUD PUBLICA MEXICO, V54, P108, DOI 10.1590/S0036-36342012000200006; Diaz M, 2003, AM J CLIN NUTR, V78, P436, DOI 10.1093/ajcn/78.3.436; Garfein RS, 2011, J IMMIGR MINOR HEALT, V13, P940, DOI 10.1007/s10903-010-9372-2; Goodman D, 2013, J IMMIGR MINOR HEALT, V15, P93, DOI 10.1007/s10903-012-9717-0; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Levy S, 2006, PROGRESS AGAINST POVERTY: SUSTAINING MEXICO'S PROGRESA-OPORTUNIDADES PROGRAM, P1; Lopez MJ, 2015, J IMMIGR MINOR HEALT, V17, P1819, DOI 10.1007/s10903-014-9988-8; Mejia-Rodriguez F, 2008, ARCH LATINOAM NUTR, V58, P164; Moor MA, 2016, J COMMUN HEALTH, V41, P780, DOI 10.1007/s10900-016-0153-2; Pagana KD, MOSBYS MANUAL DIAGNO; Perez-Exposito AB, 2005, J NUTR, V135, P64, DOI 10.1093/jn/135.1.64; Ramirez-Silva I, 2013, J NUTR, V143, P656, DOI 10.3945/jn.112.162792; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rivera JA, 2003, SALUD PUBLICA MEXICO, V45, pS565; ROMIEU I, 1994, ENVIRON HEALTH PERSP, V102, P384, DOI 10.2307/3431627; Secretaria de Desarrollo Social (SEDESOL), CAT LOC; SEDESOL, 2010, OP PROGR RES; Shamah-Levy T, 2003, SALUD PUBLICA MEXICO, V45, pS499; Shamah-Levy T, 2013, SALUD PUBLICA MEXICO, V55, pS190; Shamah-Levy T, 2009, SALUD PUBLICA MEXICO, V51, pS515; U.S. Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, 2012, YOUR GUID AN CREATES; Villalpando S, 2009, SALUD PUBLICA MEXICO, V51, pS507; World Health Organization, 2011, SER FERR CONC ASS IR; Yip R, 2002, J NUTR, V132, p802S, DOI 10.1093/jn/132.4.802S; Yip R., 1998, IRON FORTIFICATION P; ZABIN C, 1995, INT MIGR REV, V29, P395, DOI 10.2307/2546787	29	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188590	10.1371/journal.pone.0188590	http://dx.doi.org/10.1371/journal.pone.0188590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176817	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900103
J	Negi, B; Salvi, P; Bhatt, D; Majee, M; Arora, S				Negi, Bhawana; Salvi, Prafull; Bhatt, Deepesh; Majee, Manoj; Arora, Sandeep			Molecular cloning, in-silico characterization and functional validation of monodehydroascorbate reductase gene in Eleusine coracana	PLOS ONE			English	Article							ASCORBIC-ACID; DEHYDROASCORBATE REDUCTASE; PHYSCOMITRELLA-PATENS; OXIDATIVE STRESS; SALT TOLERANCE; EXPRESSION; CHLOROPLASTS; DROUGHT; TOMATO; L.	Ascorbic acid is a ubiquitous water soluble antioxidant that plays a critical role in plant growth and environmental stress tolerance. It acts as a free radical scavenger as well as a source of reducing power for several cellular processes. Because of its pivotal role in regulating plant growth under optimal as well as sub-optimal conditions, it becomes obligatory for plants to maintain a pool of reduced ascorbic acid. Several cellular processes help in maintaining the reduced ascorbic acid pool, by regulating its synthesis and regeneration processes. Current study demonstrates that monodehydroascorbate reductase is an important enzyme responsible for maintaining the reduced ascorbate pool, by optimizing the recycling of oxidized ascorbate. Cloning and functional characterization of this important stress inducible gene is of great significance for its imperative use in plant stress management. Therefore, we have cloned and functionally validated the role of monodehydroascorbate reductase gene (mdar from a drought tolerant variety of Eleusine coracana. The cloned Ecmdar gene comprises of 1437bp CDS, encoding a 478 amino acid long polypeptide. The active site analysis showed presence of conserved Tyr348 residue, facilitating the catalytic activity in electron transfer mechanism. qPCR expression profiling of Ecmdar under stress indicated that it is an early responsive gene. The analysis of Ecmdaroverexpressing Arabidopsis transgenic lines suggests that monodehydroascorbate reductase acts as a key stress regulator by modulating the activity of antioxidant enzymes to strengthen the ROS scavenging ability and maintains ROS homeostasis. Thus, it is evident that Ecmdar is an important gene for cellular homeostasis and its over-expression could be successfully used to strengthen stress tolerance in crop plants.	[Negi, Bhawana; Bhatt, Deepesh; Arora, Sandeep] GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Coll Basic Sci & Humanities, Pantnagar, Uttarakhand, India; [Salvi, Prafull; Majee, Manoj] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India	Govind Ballabh Pant University of Agriculture Technology; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Arora, S (corresponding author), GB Pant Univ Agr & Technol, Dept Mol Biol & Genet Engn, Coll Basic Sci & Humanities, Pantnagar, Uttarakhand, India.	plantstress@gmail.com	Bhatt, Deepesh/AGU-3640-2022; Salvi, Prafull/AAP-1007-2020	Salvi, Prafull/0000-0002-7834-8803; Arora, Sandeep/0000-0002-1710-7141; Bhatt, Deepesh/0000-0003-4770-4585; Majee, Manoj/0000-0002-9156-2951				Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Agarwal S, 2011, INT J CURR RES, V3, P45; Bartwal A, 2017, IN VITRO CELL DEV-PL, V53, P41, DOI 10.1007/s11627-016-9787-0; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Begara-Morales JC, 2015, J EXP BOT, V66, P5983, DOI 10.1093/jxb/erv306; Brotman Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003221; Carvalho LC, 2011, MOL PLANT, V4, P1038, DOI 10.1093/mp/ssr027; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Drew DP, 2007, PLANTA, V225, P945, DOI 10.1007/s00425-006-0394-x; Duan GY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004049; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Eltelib HA, 2011, J PLANT PHYSIOL, V168, P619, DOI 10.1016/j.jplph.2010.09.003; Fariselli P, 2001, BIOINFORMATICS, V17, P957, DOI 10.1093/bioinformatics/17.10.957; Feng ZZ, 2010, ENVIRON POLLUT, V158, P3539, DOI 10.1016/j.envpol.2010.08.019; Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002; Gest N, 2013, PLANT BIOTECHNOL J, V11, P344, DOI 10.1111/pbi.12020; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hemavathi, 2011, MOL BREEDING, V28, P105, DOI 10.1007/s11032-010-9465-6; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Johnson JD, 2002, PHYSIOL PLANTARUM, V115, P93, DOI 10.1034/j.1399-3054.2002.1150111.x; Joshi PK, 2011, ACTA PHYSIOL PLANT, V33, P811, DOI 10.1007/s11738-010-0606-7; Kavitha K, 2010, BIOCHIMIE, V92, P1321, DOI 10.1016/j.biochi.2010.06.009; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Leterrier M, 2005, PLANT PHYSIOL, V138, P2111, DOI 10.1104/pp.105.066225; Li F, 2010, INT J BIOL MACROMOL, V46, P350, DOI 10.1016/j.ijbiomac.2010.01.007; Li W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00732; Lunde C, 2006, PLANT MOL BIOL, V60, P259, DOI 10.1007/s11103-005-3881-8; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morishita Y, 2003, PLANT CELL PHYSIOL, V44, pS136; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pandey S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00581; Pang Cai-Hong, 2008, V69, P231, DOI 10.1007/978-3-540-72954-9_9; Park AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33903; Rahman H, 2014, PLANT MOL BIOL, V85, P485, DOI 10.1007/s11103-014-0199-4; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Saxena SC, 2011, BIOLOGIA, V66, P1052, DOI 10.2478/s11756-011-0120-4; Shin SY, 2013, S AFR J BOT, V88, P388, DOI 10.1016/j.sajb.2013.08.015; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; Sudan J, 2015, PHYSIOL MOL BIOL PLA, V21, P551, DOI 10.1007/s12298-015-0327-x; Sultana S, 2012, J PLANT PHYSIOL, V169, P311, DOI 10.1016/j.jplph.2011.09.004; Szarka A, 2007, PHYSIOL PLANTARUM, V129, P225, DOI 10.1111/j.1399-3054.2006.00810.x; Talla S, 2011, J BIOSCIENCES, V36, P163, DOI 10.1007/s12038-011-9000-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Venkatesh J, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-38; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wei LT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00458; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolucka BA, 2005, J EXP BOT, V56, P2527, DOI 10.1093/jxb/eri246; Yaseen A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S13-S9; Yu LH, 2016, PLANT BIOTECHNOL J, V14, P72, DOI 10.1111/pbi.12358; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang L, 2007, CRIT REV BIOTECHNOL, V27, P173, DOI 10.1080/07388550701503626	58	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187793	10.1371/journal.pone.0187793	http://dx.doi.org/10.1371/journal.pone.0187793			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176870	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900015
J	Scrima, R; Menga, M; Pacelli, C; Agriesti, F; Cela, O; Piccoli, C; Cotoia, A; De Gregorio, A; Gefter, JV; Cinnella, G; Capitanio, N				Scrima, Rosella; Menga, Marta; Pacelli, Consiglia; Agriesti, Francesca; Cela, Olga; Piccoli, Claudia; Cotoia, Antonella; De Gregorio, Alessandra; Gefter, Julia V.; Cinnella, Gilda; Capitanio, Nazzareno			Para-hydroxyphenylpyruvate inhibits the pro-inflammatory stimulation of macrophage preventing LPS-mediated nitro-oxidative unbalance and immunometabolic shift	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY-CHAIN COMPLEXES; REACTIVE OXYGEN; INNATE IMMUNITY; ETHYL PYRUVATE; HYDROGEN-PEROXIDE; REDOX-REGULATION; GENE-EXPRESSION; IN-VITRO; MITOCHONDRIA	Targeting metabolism is emerging as a promising therapeutic strategy for modulation of the immune response in human diseases. In the presented study we used the lipopolysaccharide (LPS)-mediated activation of RAW 264.7 macrophage-like cell line as a model to investigate changes in the metabolic phenotype and to test the effect of p-hydroxyphenylpyruvate (pHPP) on it. pHPP is an intermediate of the PHE/TYR catabolic pathway, selected as analogue of the ethyl pyruvate (EP), which proved to exhibit antioxidant and anti-inflammatory activities. The results obtained show that LPS-priming of RAW 264.7 cell line to the activated M1 state resulted in up-regulation of the inducible nitric oxide synthase (iNOS) expression and consequently of NO production and in release of the pro-inflammatory cytokine IL-6. All these effects were prevented dose dependently by mM concentrations of pHPP more efficiently than EP. Respirometric and metabolic flux analysis of LPS-treated RAW 264.7 cells unveiled a marked metabolic shift consisting in downregulation of the mitochondrial oxidative phosphorylation and upregulation of aerobic glycolysis respectively. The observed respiratory failure in LPS-treated cells was accompanied with inhibition of the respiratory chain complexes I and IV and enhanced production of reactive oxygen species. Inhibition of the respiratory activity was also observed following incubation of human neonatal fibroblasts (NHDF-neo) with sera from septic patients. pHPP prevented all the observed metabolic alteration caused by LPS on RAW 264.7 or by septic sera on NHDF-neo. Moreover, we provide evidence that pHPP is an efficient reductant of cytochrome c. On the basis of the presented results a working model, linking pathogen-associated molecular patterns (PAMPs)-mediated immune response to mitochondrial oxidative metabolism, is put forward along with suggestions for its therapeutic control.	[Scrima, Rosella; Menga, Marta; Pacelli, Consiglia; Cela, Olga; Piccoli, Claudia; Capitanio, Nazzareno] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Agriesti, Francesca] IRCCS CROB, Lab Preclin & Translat Res, Potenza, Italy; [Cotoia, Antonella; De Gregorio, Alessandra; Cinnella, Gilda] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Gefter, Julia V.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA	University of Foggia; IRCCS CROB; University of Foggia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Scrima, R; Capitanio, N (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.	rosella.scrima@unifg.it; nazzareno.capitanio@unifg.it	AGRIESTI, FRANCESCA/K-7575-2016; Cinnella, Gilda/O-2987-2016; PACELLI, CONSIGLIA/J-9032-2016	AGRIESTI, FRANCESCA/0000-0001-8911-7691; Cinnella, Gilda/0000-0001-9864-2893; PACELLI, CONSIGLIA/0000-0003-4915-5823; Cotoia, Antonella/0000-0002-0154-0418	University of Foggia; Apulia Region	University of Foggia; Apulia Region	This work was supported by local funds from the University of Foggia to RS, MM, FA, OC, CPi, AD, JVG, GC, NC and funds from FIR 2015-2018 from Apulia Region to AC, CPa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; local grants from the University of Foggia; FIR 2015-2018 from Apulia Region to C.P.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; ANDRAE U, 1985, TOXICOL LETT, V28, P93, DOI 10.1016/0378-4274(85)90015-3; Atlante A, 1998, BIOCHEM BIOPH RES CO, V243, P711, DOI 10.1006/bbrc.1998.8147; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Brunori M, 2006, BBA-BIOENERGETICS, V1757, P1144, DOI 10.1016/j.bbabio.2006.05.011; CAPUANO F, 1990, FEBS LETT, V261, P39, DOI 10.1016/0014-5793(90)80631-R; Castelli GP, CRIT CARE, V8, pR234; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Chen GN, 2003, ANAL CHEM, V75, P6602, DOI 10.1021/ac034451o; Cotoia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090917; CRABB DW, 1981, METABOLISM, V30, P1024, DOI 10.1016/0026-0495(81)90105-0; Cruz RJ, 2011, J SURG RES, V165, P151, DOI 10.1016/j.jss.2009.07.008; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Deutsch JC, 1997, J CHROMATOGR B, V690, P1, DOI 10.1016/S0378-4347(96)00411-2; DIgnazio L., 2016, CELLS, V5, pE10, DOI [10.3390/cells5010010, DOI 10.3390/CELLS5010010]; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Drose S, 2014, BBA-PROTEINS PROTEOM, V1844, P1344, DOI 10.1016/j.bbapap.2014.02.006; Fink MP, 2007, J INTERN MED, V261, P349, DOI 10.1111/j.1365-2796.2007.01789.x; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Griffiths HR, 2017, REDOX BIOL, V12, P50, DOI 10.1016/j.redox.2017.01.023; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Halligan DN, 2016, SEMIN IMMUNOL, V28, P469, DOI 10.1016/j.smim.2016.09.004; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Mailloux RJ, 2015, REDOX BIOL, V4, P381, DOI 10.1016/j.redox.2015.02.001; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; McGettrick AF, 2013, J BIOL CHEM, V288, P22893, DOI 10.1074/jbc.R113.486464; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mills EL, 2016, EUR J IMMUNOL, V46, P13, DOI 10.1002/eji.201445427; Monlun M, 2017, J MOL BIOL, V429, P1, DOI 10.1016/j.jmb.2016.10.028; Movafagh S, 2015, J CELL BIOCHEM, V116, P696, DOI 10.1002/jcb.25074; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Piccoli C, 2011, J CELL MOL MED, V15, P375, DOI 10.1111/j.1582-4934.2009.00946.x; Quarato G, 2014, BIOCHEM PHARMACOL, V89, P545, DOI 10.1016/j.bcp.2014.03.018; Quarato G, 2011, BBA-BIOENERGETICS, V1807, P1114, DOI 10.1016/j.bbabio.2011.04.001; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Ruggieri V, 2015, ONCOTARGET, V6, P1217, DOI 10.18632/oncotarget.2721; Samraj RS, 2013, SHOCK, V40, P358, DOI 10.1097/SHK.0b013e3182a66bd6; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Sappington PL, 2005, BIOCHEM PHARMACOL, V70, P1579, DOI 10.1016/j.bcp.2005.08.015; Sarti P, 2012, ADV EXP MED BIOL, V942, P75, DOI 10.1007/978-94-007-2869-1_4; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Singer M, 2016, INTENS CARE MED, V42, P2027, DOI 10.1007/s00134-016-4600-4; Tweedie D, 2009, J NEUROSCI METH, V183, P182, DOI 10.1016/j.jneumeth.2009.06.034; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Yang CD, 2014, METHOD ENZYMOL, V542, P425, DOI 10.1016/B978-0-12-416618-9.00022-4; Yao C, 2015, INT J MOL MED, V35, P1443, DOI 10.3892/ijmm.2015.2146; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	71	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188683	10.1371/journal.pone.0188683	http://dx.doi.org/10.1371/journal.pone.0188683			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176872	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900117
J	Tu, HC; Lee, GH; Hsiao, TH; Kao, TT; Wang, TY; Tsai, JN; Fu, TF				Tu, Hung-Chi; Lee, Gang-Hui; Hsiao, Tsun-Hsien; Kao, Tseng-Ting; Wang, Tzu-Ya; Tsai, Jen-Ning; Fu, Tzu-Fun			One crisis, diverse impacts-Tissue-specificity of folate deficiency-induced circulation defects in zebrafish larvae	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; CONGENITAL HEART-DEFECTS; NEURAL-TUBE DEFECTS; INDUCED OXIDATIVE STRESS; CREST CELL-MIGRATION; DNA METHYLATION; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; MALIGNANT HEMATOPOIESIS; CHILDHOOD ASTHMA; PROGENITOR CELLS	Folate (vitamin B9) is an essential nutrient required for cell survival, proliferation, differentiation and therefore embryogenesis. Folate deficiency has been associated with many diseases, including congenital heart diseases and megaloblastic anemia, yet the mechanisms underlying these remains elusive. Here, we examine the impact of folate deficiency on the development of the circulation system using a zebrafish transgenic line which displays inducible folate deficiency. Impaired hematopoiesis includes decreased hemoglobin levels, decreased erythrocyte number, increased erythrocyte size and aberrant c-myb expression pattern were observed in folate deficient embryos. Cardiac defects, including smaller chamber size, aberrant cardiac function and cmIc2 expression pattern, were also apparent in folate deficient embryos. Characterization of intracellular folate content in folate deficiency revealed a differential fluctuation among the different folate derivatives that carry a single carbon group at different oxidation levels. Rescue attempts by folic acid and nucleotides resulted in differential responses among affected tissues, suggesting that different patho-mechanisms are involved in folate deficiency -induced anomalies in a tissue-specific manner. The results of the current study provide an explanation for the inconsistent outcome observed clinically in patients suffering from folate deficiency and/or receiving folate supplementation. This study also supports the use of this model for further research on the defective cardiogenesis and hematopoiesis caused by folate deficiency.	[Tu, Hung-Chi; Lee, Gang-Hui; Hsiao, Tsun-Hsien; Kao, Tseng-Ting; Fu, Tzu-Fun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Wang, Tzu-Ya; Fu, Tzu-Fun] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Tsai, Jen-Ning] Chung Shan Med Univ, Dept Med Lab & Biotechnol, Taichung, Taiwan; [Tsai, Jen-Ning] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Fu, TF (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.; Fu, TF (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.	tffu@mail.ncku.edu.tw	Tsai, Jen-Ning/AAD-4980-2019; Fu, Tzu-Fun/G-7820-2011	Lee, Gang-Hui/0000-0002-1428-1611	Ministry of Science and Technology, Taiwan [MOST 105-2321-B-006-003]; Ministry of Science and Technology (MOST, Taiwan) [105-2319-B-400-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology (MOST, Taiwan)(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology, Taiwan (www.most.gov.tw) MOST 105-2321-B-006-003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere appreciation goes to Dr. Verne Schirch, Virginia Commonwealth University, for his valuable advice and assistance in manuscript proofreading. We are also grateful for the material support from Taiwan Zebrafish Core Facility which is financially supported by the Ministry of Science and Technology (MOST, Taiwan, grant number 105-2319-B-400-001), the technical support from the Core Research Laboratory, College of Medicine, National Cheng Kung University, and the valuable advice from Dr. Ping-Yen Liu, Dr. Wen-Tai Chiu and Dr. Fu-I Lu.	Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Avwioro G., 2011, JPCS, V1, P24; Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; Barua S, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0077-z; Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553; Berndt C, 2014, REDOX BIOL, V2, P673, DOI 10.1016/j.redox.2014.04.012; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Cavanaugh AM, 2015, DEV BIOL, V404, P103, DOI 10.1016/j.ydbio.2015.06.002; Celik H, 2016, INT J HEMATOL, V103, P617, DOI 10.1007/s12185-016-1957-7; Cossins EA, 1984, FOLATES PTERINS, V1, P1; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Dai XQ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-107; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Escot S, 2013, CIRC RES, V113, P505, DOI 10.1161/CIRCRESAHA.113.301333; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Feng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08506; Field MS, 2014, J BIOL CHEM, V289, P29642, DOI 10.1074/jbc.M114.599589; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014; Gao Y, 2016, ASIA S PACIF DES AUT, P11, DOI 10.1109/ASPDAC.2016.7427977; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Gliszczynska-Swiglo A, 2007, FOOD CHEM, V101, P1480, DOI 10.1016/j.foodchem.2006.04.022; Gore AV, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006684; Gorlick R, 1999, ADV EXP MED BIOL, V457, P543; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Gut P, 2017, PHYSIOL REV, V97, P889, DOI 10.1152/physrev.00038.2016; Hobbs CA, 2005, AM J CLIN NUTR, V82, P598, DOI 10.1093/ajcn/82.3.598; Hsiao TH, 2014, MOL CELL BIOL, V34, P498, DOI 10.1128/MCB.01427-13; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Juzeniene A, 2016, J PHOTOCH PHOTOBIO B, V155, P116, DOI 10.1016/j.jphotobiol.2016.01.001; Kao TT, 2014, NEUROBIOL DIS, V71, P234, DOI 10.1016/j.nbd.2014.08.004; Kao TT, 2013, ZEBRAFISH, V10, P326, DOI 10.1089/zeb.2013.0876; Kim DW, 1996, BIOCHEMISTRY-US, V35, P15772, DOI 10.1021/bi9619684; Kirby ML, 2010, CELL ADHES MIGR, V4, P609, DOI 10.4161/cam.4.4.13489; Lee SJ, 2011, NUTR RES PRACT, V5, P520, DOI 10.4162/nrp.2011.5.6.520; Lin SH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1079; Liu SL, 2016, CIRCULATION, V134, P647, DOI 10.1161/CIRCULATIONAHA.116.022126; Ma Y, 2012, FOOD CHEM TOXICOL, V50, P2854, DOI 10.1016/j.fct.2012.04.037; McCarty MF, 2009, MED HYPOTHESES, V73, P824, DOI 10.1016/j.mehy.2008.09.058; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; O'Neill RJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00289; Piccinini F, 2016, BIOINFORMATICS, V32, P955, DOI 10.1093/bioinformatics/btv686; Pirinccioglu AG, 2012, PEDIATR INT, V54, P94, DOI 10.1111/j.1442-200X.2011.03478.x; Porcelli L, 2011, CURR DRUG METAB, V12, P975, DOI 10.2174/138920011798062274; Sarmah S, 2013, DEV DYNAM, V242, P1184, DOI 10.1002/dvdy.24015; Serra-Juhe C, 2015, EPIGENETICS-US, V10, P167, DOI 10.1080/15592294.2014.998536; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stover PJ, 2016, JAMA INTERN MED, V176, P1451, DOI 10.1001/jamainternmed.2016.4699; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; Takemura Y, 1999, ANTI-CANCER DRUG, V10, P677, DOI 10.1097/00001813-199908000-00008; THISSE C, 1993, DEVELOPMENT, V119, P1203; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tu S, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.005; Turley RS, 2015, ANN SURG, V261, P368, DOI 10.1097/SLA.0000000000000635; Veeranki SP, 2015, EPIDEMIOLOGY, V26, P934, DOI 10.1097/EDE.0000000000000380; Veeranki SP, 2014, AM J EPIDEMIOL, V179, P938, DOI 10.1093/aje/kwu019; Vermillion KL, 2014, J CELL BIOL, V204, P95, DOI 10.1083/jcb.201306071; Wang DA, 2017, CIRCULATION, V135, P1733, DOI 10.1161/CIRCULATIONAHA.116.025164; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Yalcin HC, 2017, DEV DYNAM, V246, P868, DOI 10.1002/dvdy.24497; Yamauchi M, 2011, AM J CANCER RES, V1, P823; Yu WH, 2016, CARDIOVASC TOXICOL, V16, P34, DOI 10.1007/s12012-015-9316-0; Zhang QJ, 2015, EPIGENOMICS-UK, V7, P321, DOI [10.2217/epi.14.60, 10.2217/EPI.14.60]; Zhou YG, 2011, CIRC RES, V109, P1067, DOI 10.1161/CIRCRESAHA.111.243709	72	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188585	10.1371/journal.pone.0188585	http://dx.doi.org/10.1371/journal.pone.0188585			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176804	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900100
J	Kullander, SO; Rahman, MM; Noren, M; Mollah, AR				Kullander, Sven O.; Rahman, Md. Mizanur; Noren, Michael; Mollah, Abdur Rob			Devario in Bangladesh: Species diversity, sibling species, and introgression within danionin cyprinids (Teleostei: Cyprinidae: Danioninae)	PLOS ONE			English	Article							INFERENCE; MRBAYES; GENERA; FISHES	Four species of Devario are recorded from Bangladesh: D. aequipinnatus, D. anomalus, D. coxi, new species, and D. devario. Devario aequipinnatus has a wide distribution in northern India and Bangladesh. Devario coxi, from southeastern Bangladesh near Cox's Bazar, differs from D. aequipinnatus in mtDNA (COI, p-distance 1.8%), colouration, proportional measurements, and meristics. The minor morphological differences and low frequency of overlapping meristics suggest relatively recent separation of D. coxi from other D. aequipinnatus. Devario anomalus occurs only in southeastern Bangladesh and is here reported from localities in addition to the type locality. It differs from the similar D. xyrops in adjacent Myanmar by slender body shape and by 2.3% p-distance in the COI gene. Specimens of D. anomalus from the Sangu River were found to have the mitochondrial genome of D. aequipinnatus from Bangladesh, but agree with other D. anomalus in the nuclear RAG1 gene. Devario devario has a wide distribution on the Indian Peninsula and border regions; in Bangladesh it is restricted in distribution to the Ganga, Brahmaputra, and Meghna drainages. Reports of D. assamensis and D. malabaricus from Bangladesh are misidentifications. Perilampus ostreographus M'Clelland, 1839, is tentatively synonymized with D. aequipinnatus. Phylogenetic analysis of 14 species of striped devarios based on the COI gene results in a polytomy with four unresolved clades. Devario deruptotalea from the Chindwin basin is the sister group of D. aequipinnatus+D. coxi. Devario devario is the sistergroup of D. xyrops+D. anomalus.	[Kullander, Sven O.; Noren, Michael] Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden; [Rahman, Md. Mizanur; Mollah, Abdur Rob] Univ Dhaka, Dept Zool, Dhaka, Bangladesh	Swedish Museum of Natural History; University of Dhaka	Kullander, SO (corresponding author), Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden.	sven.kullander@nrm.se		Rahman, Mohammed Mizanur/0000-0001-7576-9269; Kullander, Sven/0000-0001-6075-0266	Swedish Research Council (Vetenskapsradet: vr.se) [D0674001]	Swedish Research Council (Vetenskapsradet: vr.se)	This work was funded by the Swedish Research Council (Vetenskapsradet: vr.se), contract D0674001 to SK and ARM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Specimens were collected with the assistance of University of Dhaka research assistants. The field work was conducted for the project Genetic characterization of freshwater fishes in Bangladesh using DNA barcodes (Swedish Research Council, contract D0674001 to SK and ARM). For access to other material and information we thank past and present curators and collection staff at the California Academy of Sciences, Kansas University Biodiversity Institute and Natural History Museum, University of Michigan Museum of Zoology, The Natural History Museum and the Naturmuseum Senckenberg in Frankfurt. We thank reviewers for valuable input.	Abu Ahmed A, 2013, ZOOTAXA, V3700, P283, DOI 10.11646/zootaxa.3700.2.6; Ahmed MS, 1822, ENCY FLORA FAUNA BAN, V23, P59; Barman R.P., 1984, Bulletin of the Zoological Survey of India, V6, P163; Barman R.P., 1991, Records of the Zoological Survey of India Occasional Paper, V137, P1; Batuwita Sudesh, 2017, FishTaxa-Journal of Fish Taxonomy, V2, P156; Bhuiyan AL, 1964, FISHES OF DACCA; Bleeker P, 1860, ACTA SOC REG SCI IND, V7; Blyth E., 1858, J ASIATIC SOC BENGAL, V27, P267; Conway KW, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2136.1.4; Day F., 1877, STAT ACCOUNT BENGAL, V20; Day F, 1875, FISHES INDIA BEING N, V369-552, P79; Day F, 1875, FISHES INDIA BEING N, pi; Day F., 1878, FISHES INDIA BEING N, P553; Day F., 1875, FISHES INDIA BEING N, V1-40, P1; Day F., 1876, FISHES INDIA BEING N, P169; Day F, 1872, J ASIATIC SOC PHYS 4, V1872, P1; Drummond A.J, 2014, TRACER VERSION 1 6, DOI DOI 10.1073/pnas.1007407107; Fang F, 2003, COPEIA, P714; Fang Fang, 1998, Ichthyological Exploration of Freshwaters, V8, P273; Fang Fang, 1997, Ichthyological Exploration of Freshwaters, V7, P289; Fang F, 2009, ZOOTAXA, P33, DOI 10.11646/zootaxa.2164.1.3; Fang F, 2009, ZOOL SCR, V38, P237, DOI 10.1111/j.1463-6409.2008.00373.x; Gray JE, 1833, CHIEFLY SELECTED COL, VII; Gray JE., 1830, ILLUSTRATIONS INDIAN, V1; Griffith W., 1847, J TRAVELS ASSAM BURM, DOI DOI 10.5962/BHL.TITLE.79660; Hamilton F., 1822, ACCOUNT FISHES FOUND, VVolume 1, DOI DOI 10.5962/BHL.TITLE.59540; Heckel JJ, 1843, REISEN EUROPA ASIEN, P991, DOI DOI 10.5962/BHL.TITLE.35097; HORA SUNDER LAL, 1929, MEM INDIAN MUS, V9, P169; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Jayaram K.C., 1991, Ichthyological Exploration of Freshwaters, V2, P109; Jayaram KC, 1981, HANDBOOKCALCUTTA ZOO; Jerdon T.C., 1849, MADRAS J LIT SCI, V15, P139; Jerdon T. C., 1849, MADRAS J LIT SCI, V15, P302; Kader MA, 1839, ENCY FLORA FAUNA BAN, V23, P58; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kottelat M, 2013, RAFFLES B ZOOL, P1; Kullander F. F., 2001, THESIS; Kullander SO, 2017, ZOOTAXA, V4227, P407, DOI 10.11646/zootaxa.4227.3.7; Kullander SO, 2015, ICHTHYOL EXPLOR FRES, V25, P357; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; MCLELLAND J, 1839, INDIAN CYPRINIDAE AS, V19, P217; Menon AGK, 1963, FISHES REC ZOOL SU 2, V61, P91; Mirza M. R., 2003, Pakistan Journal of Zoology Supplementary Series, P1; Rahman AKA, 2005, FRESHWATER FISHES BA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Sen N., 1985, Journal of the Assam Science Society, V27, P60; Shrestha OM, 2012, EMPORIA STATE RES ST, V48, P14; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Systat Software, 2013, SYST VERS 13; Talwar P.K., 1991, INLAND FISHERIES IND, VI, P1; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; TILAK R, 1988, Journal of the Bombay Natural History Society, V85, P207; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x	58	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186895	10.1371/journal.pone.0186895	http://dx.doi.org/10.1371/journal.pone.0186895			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166410	gold, Green Published, Green Submitted			2022-12-26	WOS:000416035300007
J	Olsen, OE; Skjaervik, A; Stordal, BF; Sundan, A; Holien, T				Olsen, Oddrun Elise; Skjaervik, Anette; Stordal, Berit Fladvad; Sundan, Anders; Holien, Toril			TGF-beta contamination of purified recombinant GDF15	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; INTEGRIN ACTIVATION; MYELOMA CELLS; WEIGHT-LOSS; RECEPTOR; GDF-15; INHIBITOR; SURVIVAL; CANCER; MIC-1	Purified recombinant proteins for use in biomedical research are invaluable to investigate protein function. However, purity varies in protein batches made in mammalian expression systems, such as CHO-cells or HEK293-cells. This study points to caution while investigating effects of proteins related to the transforming growth factor (TGF)-beta superfamily. TGF-beta itself is a very potent cytokine and has effects on cells in the femtomolar range. Thus, even very small amounts of contaminating TGF-beta in purified protein batches may influence the experimental results given that receptors for TGF-beta are present. When we attempted to characterize possible receptors for the TGF-beta superfamily ligand GDF15, striking similarities between GDF15-induced activities and known TGF-beta activities were found. However, differences between batches of GDF15 were a concern and finally led us to the conclusion that the measured effects were caused by TGF-beta and not by GDF15. Our results emphasize that purified recombinant proteins must be used with caution and warrant proper controls. Notably, some conclusions made about GDF15 in already published papers may not be supported by the results shown. Awareness about this issue in the scientific community may prevent spreading of false positive results.	[Olsen, Oddrun Elise; Stordal, Berit Fladvad; Sundan, Anders; Holien, Toril] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Olsen, Oddrun Elise; Holien, Toril] St Olavs Univ Hosp, Clin Med, Trondheim, Norway; [Skjaervik, Anette] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway; [Sundan, Anders] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, CEMIR Ctr Mol Inflammat Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Holien, T (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway.; Holien, T (corresponding author), St Olavs Univ Hosp, Clin Med, Trondheim, Norway.	toril.holien@ntnu.no	Holien, Toril/M-6253-2018; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Holien, Toril/0000-0002-2051-5824; Olsen, Oddrun Elise/0000-0001-8922-5561	Kreftforeningen (NO) [5793765]	Kreftforeningen (NO)	The work was supported by a grant from Kreftforeningen (NO)(https://kreftforeningen.no), Project number: 5793765. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz A, 2016, BLOOD, V128, P529, DOI 10.1182/blood-2016-01-696617; Baughn LB, 2009, J IMMUNOL, V182, P1810, DOI 10.4049/jimmunol.0713726; Beatson R, 2011, BIOTECHNOL BIOENG, V108, P2759, DOI 10.1002/bit.23217; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Carthy JM, 2016, J CELL BIOCHEM, V117, P938, DOI 10.1002/jcb.25378; Corre J, 2013, STEM CELL TRANSL MED, V2, P946, DOI 10.5966/sctm.2013-0055; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Holien T, 2014, CYTOKINE GROWTH F R, V25, P343, DOI 10.1016/j.cytogfr.2014.04.009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JENNINGS JC, 1989, ENDOCRINOLOGY, V125, P404, DOI 10.1210/endo-125-1-404; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043235; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Koistinen H, 2015, MOL ENDOCRINOL, V29, P1787, DOI 10.1210/me.2015-1187; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131506; Li C, 2016, ONCOTARGET, V7, P860, DOI 10.18632/oncotarget.6205; Lu JM, 2016, BIOCHEM J, V473, P1895, DOI 10.1042/BCJ20160362; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang CY, 2014, BIOCHEM J, V460, P35, DOI 10.1042/BJ20140155; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yang L, 2017, NATURE MED	29	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187349	10.1371/journal.pone.0187349	http://dx.doi.org/10.1371/journal.pone.0187349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161287	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000008
J	Arystarkhova, E; Bouley, R; Liu, YBS; Sweadner, KJ				Arystarkhova, Elena; Bouley, Richard; Liu, Yi Bessie; Sweadner, Kathleen J.			Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport	PLOS ONE			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; RENAL COLLECTING DUCT; AQUAPORIN-2 WATER CHANNEL; RAT SKELETAL-MUSCLE; CARDIAC NA/K-ATPASE; LC-MS/MS ANALYSIS; PLASMA-MEMBRANE; DEPENDENT REGULATION; PHOSPHOLEMMAN FXYD1	The final adjustment of urine volume occurs in the inner medullary collecting duct (IMCD), chiefly mediated by the water channel aquaporin 2 (AQP2). With vasopressin stimulation, AQP2 accumulation in the apical plasma membrane of principal cells allows water reabsorption from the lumen. We report that FXYD1 (phospholemman), better known as a regulator of Na, K-ATPase, has a role in AQP2 trafficking. Daytime urine of Fxyd1 knockout mice was more dilute than WT despite similar serum vasopressin, but both genotypes could concentrate urine during water deprivation. FXYD1 was found in IMCD. In WT mice, phosphorylated FXYD1 was detected intracellularly, and vasopressin induced its dephosphorylation. We tested the hypothesis that the dilute urine in knockouts was caused by alteration of AQP2 trafficking. In WT mice at baseline, FXYD1 and AQP2 were not strongly co-localized, but elevation of vasopressin produced translocation of both FXYD1 and AQP2 to the apical plasma membrane. In kidney slices, baseline AQP2 distribution was more scattered in the Fxyd1 knockout than in WT. Apical recruitment of AQP2 occurred in vasopressin-treated Fxyd1 knockout slices, but upon vasopressin washout, there was more rapid reversal of apical AQP2 localization and more heterogeneous cytoplasmic distribution of AQP2. Notably, in sucrose gradients, AQP2 was present in a detergent-resistant membrane domain that had lower sedimentation density in the knockout than in WT, and vasopressin treatment normalized its density. We propose that FXYD1 plays a role in regulating AQP2 retention in apical membrane, and that this involves transfers between raft-like membrane domains in endosomes and plasma membranes.	[Arystarkhova, Elena; Liu, Yi Bessie; Sweadner, Kathleen J.] Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA; [Arystarkhova, Elena; Bouley, Richard; Liu, Yi Bessie; Sweadner, Kathleen J.] Harvard Med Sch, Boston, MA 02115 USA; [Bouley, Richard] Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Arystarkhova, E; Sweadner, KJ (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA.; Arystarkhova, E; Sweadner, KJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	aristarkhova@helix.mgh.harvard..edu; sweadner@helix.mgh.harvard.edu		Sweadner, Kathleen J/0000-0002-2817-5262	National Institutes of Health (BADERC, Boston Area Diabetes Endocrinology Research Center) [5P30DK057521-12]; National Institutes of Health [EY014390, NS050696, NS045083, DK096586]; Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship; NIH [S10 RR031563-01]; Boston Area Diabetes and Endocrinology Research Center [DK057521]; MGH Center for the Study of Inflammatory Bowel Disease [DK043351]	National Institutes of Health (BADERC, Boston Area Diabetes Endocrinology Research Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; MGH Center for the Study of Inflammatory Bowel Disease	The work was supported by National Institutes of Health Grants 5P30DK057521-12 (Pilot Feasibility Grant, BADERC, Boston Area Diabetes Endocrinology Research Center) (to E.A.); EY014390, NS050696 and NS045083 (to K.J.S.), DK096586 (to Dennis Brown), and a grant from Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship in memory of Carl Walters '32 (to E.A.). The Nikon A1R confocal in the PMB Microscopy Core was purchased using an NIH Shared Instrumentation Grant S10 RR031563-01 (Dennis Brown). Additional support for the Program in Membrane Biology Microscopy Core came from the Boston Area Diabetes and Endocrinology Research Center (DK057521) and the MGH Center for the Study of Inflammatory Bowel Disease (DK043351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bell JR, 2008, AM J PHYSIOL-HEART C, V294, pH613, DOI 10.1152/ajpheart.01332.2007; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; BlotChabaud M, 1996, J MEMBRANE BIOL, V153, P233, DOI 10.1007/s002329900126; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2015, BRENNER RECTORS KIDN, P281; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chassin C, 2007, J EXP MED, V204, P2837, DOI 10.1084/jem.20071032; Cheung JY, 2013, ADV EXP MED BIOL, V961, P175, DOI 10.1007/978-1-4614-4756-6_15; Cheung PW, 2017, AM J PHYSIOL-RENAL, V313, pF404, DOI 10.1152/ajprenal.00004.2017; Cheung PW, 2016, J AM SOC NEPHROL, V27, P3105, DOI 10.1681/ASN.2015080903; Choi YS, 1997, ARCH BIOCHEM BIOPHYS, V344, P165, DOI 10.1006/abbi.1997.0183; Coutry N, 1997, ANN NY ACAD SCI, V834, P545, DOI 10.1111/j.1749-6632.1997.tb52314.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; El-Armouche A, 2011, FASEB J, V25, P4467, DOI 10.1096/fj.11-184903; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Fuller W, 2013, CELL MOL LIFE SCI, V70, P1357, DOI 10.1007/s00018-012-1134-y; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hafver TL, 2016, J BIOL CHEM, V291, P4561, DOI 10.1074/jbc.M115.677898; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Han F, 2010, AM J PHYSIOL-CELL PH, V299, pC1363, DOI 10.1152/ajpcell.00027.2010; Hara M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07767-8; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; JONES LR, 1979, J BIOL CHEM, V254, P530; Jung HJ, 2016, AM J PHYSIOL-RENAL, V311, pF1318, DOI 10.1152/ajprenal.00485.2016; Katsura T, 1997, Am J Physiol, V272, pF817; Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Liu CC, 2013, FREE RADICAL BIO MED, V65, P563, DOI 10.1016/j.freeradbiomed.2013.06.040; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Moshitzky S, 2012, J BIOL CHEM, V287, P21130, DOI 10.1074/jbc.M112.347807; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Olesen ETB, 2017, AM J PHYSIOL-RENAL, V312, pF744, DOI 10.1152/ajprenal.00010.2017; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P83, DOI 10.1016/j.yjmcc.2013.05.002; Rice WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131719; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Shi HK, 2001, AM J PHYSIOL-RENAL, V280, pF505, DOI 10.1152/ajprenal.2001.280.3.F505; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2002, AM J PHYSIOL-HEART C, V283, pH576, DOI 10.1152/ajpheart.00197.2002; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; WALAAS O, 1977, FEBS LETT, V80, P417, DOI 10.1016/0014-5793(77)80489-4; Walaas O, 1999, BIOCHEM J, V343, P151, DOI 10.1042/0264-6021:3430151; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Wetzel RK, 2003, AM J PHYSIOL-RENAL, V285, pF121, DOI 10.1152/ajprenal.00241.2002; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Wypijewski KJ, 2015, MOL CELL PROTEOMICS, V14, P596, DOI 10.1074/mcp.M114.038570; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Yu MJ, 2008, AM J PHYSIOL-CELL PH, V295, pC661, DOI 10.1152/ajpcell.90650.2007; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Yui N, 2012, BIOL OPEN, V1, P101, DOI 10.1242/bio.2011042; Zhang LQ, 2007, MOL CELL BIOCHEM, V303, P231, DOI 10.1007/s11010-007-9479-5; Zhang XQ, 2015, J MOL CELL CARDIOL, V84, P104, DOI 10.1016/j.yjmcc.2015.04.017; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	77	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188006	10.1371/journal.pone.0188006	http://dx.doi.org/10.1371/journal.pone.0188006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155857	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700026
J	Ateka, E; Alicai, T; Ndunguru, J; Tairo, F; Sseruwagi, P; Kiarie, S; Makori, T; Kehoe, MA; Boykin, LM				Ateka, Elijah; Alicai, Titus; Ndunguru, Joseph; Tairo, Fred; Sseruwagi, Peter; Kiarie, Samuel; Makori, Timothy; Kehoe, Monica A.; Boykin, Laura M.			Unusual occurrence of a DAG motif in the Ipomovirus Cassava brown streak virus and implications for its vector transmission	PLOS ONE			English	Article							CUCUMBER MOSAIC-VIRUS; HELPER COMPONENT-PROTEINASE; WHITEFLY-TRANSMITTED MEMBER; AMINO-ACID SUBSTITUTIONS; VEIN-YELLOWING-VIRUS; COAT PROTEIN; APHID TRANSMISSION; EAST-AFRICA; CODING REGION; POTYVIRUS TRANSMISSION	Cassava is the main staple food for over 800 million people globally. Its production in eastern Africa is being constrained by two devastating Ipomoviruses that cause cassava brown streak disease (CBSD); Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV), with up to 100% yield loss for smallholder farmers in the region. To date, vector studies have not resulted in reproducible and highly efficient transmission of CBSV and UCBSV. Most virus transmission studies have used Bemisia tabaci (whitefly), but a maximum of 41% U/CBSV transmission efficiency has been documented for this vector. With the advent of next generation sequencing, researchers are generating whole genome sequences for both CBSV and UCBSV from throughout eastern Africa. Our initial goal for this study was to characterize U/CBSV whole genomes from CBSD symptomatic cassava plants sampled in Kenya. We have generated 8 new whole genomes (3 CBSV and 5 UCBSV) from Kenya, and in the process of analyzing these genomes together with 26 previously published sequences, we uncovered the aphid transmission associated DAG motif within coat protein genes of all CBSV whole genomes at amino acid positions 52-54, but not in UCBSV. Upon further investigation, the DAG motif was also found at the same positions in two other Ipomoviruses: Squash vein yellowing virus (SqVYV), Coccinia mottle virus (CocMoV). Until this study, the highly-conserved DAG motif, which is associated with aphid transmission was only noticed once, in SqVYV but discounted as being of minimal importance. This study represents the first comprehensive look at Ipomovirus genomes to determine the extent of DAG motif presence and significance for vector relations. The presence of this motif suggests that aphids could potentially be a vector of CBSV, SqVYV and CocMov. Further transmission and ipomoviral protein evolutionary studies are needed to confirm this hypothesis.	[Ateka, Elijah; Kiarie, Samuel; Makori, Timothy] JKUAT, Dept Hort, Nairobi, Kenya; [Alicai, Titus] Natl Crops Resources Res Inst NaCRRI, Kampala, Uganda; [Ndunguru, Joseph; Tairo, Fred; Sseruwagi, Peter] MARI, Dar Es Salaam, Tanzania; [Kehoe, Monica A.] DPIRD Diagnost Lab Serv, Dept Primary Ind & Reg Dev, S Perth, WA, Australia; [Boykin, Laura M.] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia	Jomo Kenyatta University of Agriculture & Technology; University of Western Australia	Boykin, LM (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.	laura.boykin@uwa.edu.au	Alicai, Titus/AEN-1873-2022; Boykin, Laura/H-8876-2014	Alicai, Titus/0000-0002-4489-3133; Boykin, Laura/0000-0002-6101-1921	Bill and Melinda Gates Foundation [51466]; Australian Government; Government of Western Australia	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian Government(Australian GovernmentCGIAR); Government of Western Australia	The Bill and Melinda Gates Foundation Grant no. 51466 "Regional Cassava Virus Diseases Diagnostic Project" was awarded to Mikocheni Agricultural Research Institute, Tanzania, and a sub-grant to JKUAT supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Benson Ongori for assistance with field collections in Kenya. Computational resources provided by the Pawsey Supercomputing Centre who are supported by the Australian Government and the Government of Western Australia supported this work. In addition, Prof. Alice Vrielink provided assistance with the protein structure of CBSV.	Abarshi MM, 2012, J VIROL METHODS, V179, P176, DOI 10.1016/j.jviromet.2011.10.020; Adkins S, 2007, PHYTOPATHOLOGY, V97, P145, DOI 10.1094/PHYTO-97-2-0145; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Alicai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36164; AMMAR ED, 1994, PHYTOPATHOLOGY, V84, P1054, DOI 10.1094/Phyto-84-1054; [Anonymous], 1994, POTYVIRIDAE; ATREYA CD, 1990, VIROLOGY, V178, P161, DOI 10.1016/0042-6822(90)90389-9; ATREYA PL, 1995, J GEN VIROL, V76, P265, DOI 10.1099/0022-1317-76-2-265; ATREYA PL, 1991, P NATL ACAD SCI USA, V88, P7887, DOI 10.1073/pnas.88.17.7887; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bigirimana S., 2011, New Disease Reports, V24, P26; Blanc S, 2014, ANNU REV PHYTOPATHOL, V52, P403, DOI 10.1146/annurev-phyto-102313-045920; Bock K.R., 1994, Tropical Science, V34, P134; Brunt A, 1990, VIRUS DIS TROPICAL P; Carbonell A, 2012, MOL PLANT MICROBE IN, V25, P151, DOI 10.1094/MPMI-08-11-0216; CARRINGTON JC, 1993, J VIROL, V67, P6995, DOI 10.1128/JVI.67.12.6995-7000.1993; Colvin J, 2004, P 2 EUR WHIT S 5 9 O; Congdon BS, 2017, VIRUS RES; Desbiez C, 2016, ARCH VIROL, V161, P2913, DOI 10.1007/s00705-016-2981-x; Dombrovsky A, 2005, ARCH VIROL, V150, P287, DOI 10.1007/s00705-004-0407-7; Dombrovsky A, 2013, PLANT PATHOL, V62, P750, DOI 10.1111/ppa.12004; Dombrovsky A, 2014, PEST MANAG SCI, V70, P1553, DOI 10.1002/ps.3735; Dombrovsky A, 2012, VIRUS GENES, V44, P329, DOI 10.1007/s11262-011-0686-5; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2010, GENEIOUS V5 1; Flasinski S, 1998, ARCH VIROL, V143, P2159, DOI 10.1007/s007050050449; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; GOVIER DA, 1974, VIROLOGY, V57, P285, DOI 10.1016/0042-6822(74)90129-9; Goytia E, 2006, J GEN VIROL, V87, P3413, DOI 10.1099/vir.0.82301-0; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Hillocks RJ, 1996, INT J PEST MANAGE, V42, P285, DOI 10.1080/09670879609372008; Hillocks R, 2016, J PHYTOPATHOL, V164, P86, DOI 10.1111/jph.12430; Janssen D, 2005, ARCH VIROL, V150, P1439, DOI 10.1007/s00705-005-0515-z; Jeremiah S, 2014, ROLE WHITEFLY BEMISI; Jeremiah SC, 2015, PHYTOPATHOLOGY, V105, P646, DOI 10.1094/PHYTO-05-14-0146-R; Johansen IE, 1996, J GEN VIROL, V77, P1329, DOI 10.1099/0022-1317-77-6-1329; Kalleshwaraswamy CM, 2008, PHYTOPATHOLOGY, V98, P541, DOI 10.1094/PHYTO-98-5-0541; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kinyanjui G, 2016, B ENTOMOL RES, V106, P63, DOI 10.1017/S0007485315000796; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Lennon AM, 1986, CASSAVA VIRUSES AFRI, P168; Llave C, 2002, ARCH VIROL, V147, P2365, DOI 10.1007/s00705-002-0884-5; Lopez-Moya JJ, 1999, J GEN VIROL, V80, P3281, DOI 10.1099/0022-1317-80-12-3281; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Masinde E. A., 2016, African Journal of Agricultural Research, V11, P2064; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; MURPHY JF, 1990, VIROLOGY, V178, P285, DOI 10.1016/0042-6822(90)90405-G; Mware B, 2009, JGMV, V1, P040, DOI [DOI 10.1007/S007050070078, 10.5897/JGMV.9000003, DOI 10.5897/JGMV.9000003]; Mware B. O., 2009, Journal of Applied Biosciences, V16, P864; Ndunguru J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139321; Ndunguru J, 2009, AFR J AGR RES, V4, P334; NICHOLS R. F. W., 1950, EAST AFRICAN AGRIC JOUR, V15, P154; Njoroge Moffat K., 2016, Journal of Entomology and Zoology Studies, V4, P258; Nweke FI, 1996, 14 COSCA; Ogwok E, 2016, VIRUS RES, V215, P1, DOI 10.1016/j.virusres.2016.01.015; Osogo A.K., 2014, J AGRI FOOD APPL SCI, V2, P184; Perry KL, 1998, VIROLOGY, V242, P204, DOI 10.1006/viro.1998.8991; Pirone TP, 2002, ADV BOT RES, V36, P1, DOI 10.1016/S0065-2296(02)36056-7; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; RACCAH B, 1985, ANN APPL BIOL, V106, P451, DOI 10.1111/j.1744-7348.1985.tb03135.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Revers F, 2015, ADV VIRUS RES, V92, P101, DOI 10.1016/bs.aivir.2014.11.006; RODRIGUEZCEREZO E, 1993, J GEN VIROL, V74, P1945, DOI 10.1099/0022-1317-74-9-1945; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; SHUKLA DD, 1989, ADV VIRUS RES, V36, P273, DOI 10.1016/S0065-3527(08)60588-6; SHUKLA DD, 1991, CAN J PLANT PATHOL, V13, P178, DOI 10.1080/07060669109500953; SOUMOUNOU Y, 1994, J GEN VIROL, V75, P2567, DOI 10.1099/0022-1317-75-10-2567; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Susko E, 2004, MOL BIOL EVOL, V21, P1629, DOI 10.1093/molbev/msh159; TORDO VMJ, 1995, J GEN VIROL, V76, P939, DOI 10.1099/0022-1317-76-4-939; VERCHOT J, 1991, VIROLOGY, V185, P527, DOI 10.1016/0042-6822(91)90522-D; WALKEY DGA, 1994, PLANT PATHOL, V43, P931, DOI 10.1111/j.1365-3059.1994.tb01638.x; Wikoff WR, 1997, VIROLOGY, V232, P91, DOI 10.1006/viro.1997.8543; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Wylie SJ, 2002, ARCH VIROL, V147, P1813, DOI 10.1007/s00705-002-0846-y; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yuan C, 1996, PHYTOPATHOLOGY, V86, P698, DOI 10.1094/Phyto-86-698	87	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187883	10.1371/journal.pone.0187883	http://dx.doi.org/10.1371/journal.pone.0187883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155849	gold, Green Published, Green Submitted			2022-12-26	WOS:000415756700019
J	Guendisch, U; Weiss, J; Ecoeur, F; Riker, JC; Kaupmann, K; Kallen, J; Hintermann, S; Orain, D; Dawson, J; Billich, A; Guntermann, C				Guendisch, Ulf; Weiss, Jessica; Ecoeur, Florence; Riker, Julia Christina; Kaupmann, Klemens; Kallen, Joerg; Hintermann, Samuel; Orain, David; Dawson, Janet; Billich, Andreas; Guntermann, Christine			Pharmacological inhibition of ROR gamma t suppresses the Th17 pathway and alleviates arthritis in vivo	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CYTOKINE GM-CSF; CELL-DIFFERENTIATION; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; RECEPTOR-GAMMA; T(H)17 CELLS; MICE; INFLAMMATION; INDUCTION	Retinoic acid receptor-related-orphan-receptor-C (ROR gamma t) is the key transcription factor that is driving the differentiation of IL-17 producing T-helper 17 (Th17) cells that are implicated in the pathology of various autoimmune and inflammatory diseases. Based on the importance of ROR gamma t in promoting Th17-driven pathology, there is considerable interest to develop low-molecular-weight compounds with the aim of inhibiting the transcriptional activity of this nuclear hormone receptor. In this article, we describe the in vitro and in vivo pharmacology of a potent and selective small-molecular-weight ROR gamma t inverse agonist. The compound binds to the ligand binding domain (LBD) of ROR gamma t leading to displacement of a co-activator peptide. We show for the first time that a ROR gamma t inverse agonist down-regulates permissive histone H3 acetylation and methylation at the IL17A and IL23R promoter regions, thereby providing insight into the transcriptional inhibition of ROR gamma t-dependent genes. Consistent with this, the compound effectively reduced IL-17A production by polarized human T-cells and gamma delta T-cells and attenuated transcription of ROR gamma t target genes. The inhibitor showed good in vivo efficacy in an antigen-induced arthritis model in rats and reduced the frequencies of IL-17A producing cells in ex vivo recall assays. In summary, we demonstrate that inhibiting ROR gamma t by a low-molecular-weight inhibitor results in efficient and selective blockade of the pro-inflammatory Th17/IL-17A pathway making it an attractive target for Th17-mediated disorders.	[Guendisch, Ulf; Weiss, Jessica; Ecoeur, Florence; Riker, Julia Christina; Kaupmann, Klemens; Dawson, Janet; Billich, Andreas; Guntermann, Christine] Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland; [Kallen, Joerg] Novartis Inst BioMed Res, Chem Biol & Therapeut, Basel, Switzerland; [Hintermann, Samuel; Orain, David] Novartis Inst BioMed Res, Global Discovery Chem, Basel, Switzerland	Novartis; Novartis; Novartis	Guntermann, C (corresponding author), Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland.	christine.guntermann@novartis.com		Kaupmann, Klemens/0000-0001-8903-2508; Dawson, Janet/0000-0003-4615-4091	NIBR	NIBR	NIBR provided support in the form of salaries to all authors (UG, JW, FE, JCR, KK, JK, SH, DO, JD, AB, CG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Baek SY, 2014, ACTA PHARMACOL SIN, V35, P1177, DOI 10.1038/aps.2014.58; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Banerjee D, 2016, IMMUNOLOGY, V147, P399, DOI 10.1111/imm.12570; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang MR, 2014, ARTHRITIS RHEUMATOL, V66, P579, DOI 10.1002/art.38272; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cornelissen F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2893; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cyr P, 2016, BIOORG MED CHEM LETT, V26, P4387, DOI 10.1016/j.bmcl.2016.08.012; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Hintermann S, 2016, CHEMMEDCHEM, V11, P2640, DOI 10.1002/cmdc.201600500; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kallen J, 2017, CHEMMEDCHEM, V12, P1014, DOI 10.1002/cmdc.201700278; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Liljevald M, 2016, AUTOIMMUN REV, V15, P1062, DOI 10.1016/j.autrev.2016.07.036; Luan L, 2014, CELL IMMUNOL, V290, P196, DOI 10.1016/j.cellimm.2014.06.007; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SHIMONKEVITZ R, 1993, P NATL ACAD SCI USA, V90, P923, DOI 10.1073/pnas.90.3.923; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Smith SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147979; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Ueda E, 2002, CANCER RES, V62, P901; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wang YH, 2014, BIOORGAN MED CHEM, V22, P692, DOI 10.1016/j.bmc.2013.12.021; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16355; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang LL, 2015, INT IMMUNOPHARMACOL, V25, P96, DOI 10.1016/j.intimp.2015.01.014	62	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188391	10.1371/journal.pone.0188391	http://dx.doi.org/10.1371/journal.pone.0188391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155882	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700054
J	Sotgiu, G; Falzon, D; Hollo, V; Kodmon, C; Lefebvre, N; Dadu, A; van der Werf, M				Sotgiu, Giovanni; Falzon, Dennis; Hollo, Vahur; Kodmon, Csaba; Lefebvre, Nicolas; Dadu, Andrei; van der Werf, Marieke			Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; UNITED-STATES; EPIDEMIOLOGY; REGION; UNION; RISK; ERA	Background We explored host-related factors associated with the site of tuberculosis (TB) disease using variables routinely collected by the 31 EU/EEA countries for national surveillance. Methods Logistic regression models were fitted to case-based surveillance data reported to the European Centre for Disease Prevention and Control for TB cases notified from 2003 to 2014. Missing data on HIV infection and on susceptibility to isoniazid and rifampicin for many patients precluded the inclusion of these variables in the analysis. Records from Finland, Lithuania, Spain and the United Kingdom were excluded for lack of exact details of disease localisation; other records without one or more variable (e.g. previous treatment history, geographical origin) or who had mixed pulmonary and extrapulmonary disease or more than one form of extrapulmonary disease were also removed (total exclusion = 38% of 913,637 notifications). Results 564,916 TB cases reported by 27 EU/EEA countries had exclusive pulmonary (PTB; 83%) or extrapulmonary (EPTB; 17%) disease. EPTB was associated with age <15 years (aOR: 5.50), female sex (aOR: 1.60), no previous TB treatment (aOR: 3.10), and geographic origin (aOR range: 0.52-3.74). Origin from the Indian subcontinent or Africa was most strongly associated with lymphatic, osteo-articular and peritoneal/digestive localization (aOR>3.7), and age <15 years with lymphatic (aOR: 17.96) and central nervous system disease (aOR: 11.41). Conclusions Awareness of host-related determinants of site of TB is useful for diagnosis. The predilection for EPTB among patients originating from countries outside Europe may reflect strain preferences for disease localization, geographic/ethnic differences in disease manifestation and other factors, like HIV.	[Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Med Educ & Profess Dev Unit, Dept Biomed Sci, Sassari, Italy; [Falzon, Dennis] WHO, Global TB Programme, Geneva, Switzerland; [Hollo, Vahur; Kodmon, Csaba; van der Werf, Marieke] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden; [Lefebvre, Nicolas] CHU Strasbourg, Strasbourg, France; [Dadu, Andrei] WHO, Reg Off Europe, Copenhagen, Denmark	University of Sassari; World Health Organization; European Centre for Disease Prevention & Control; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; World Health Organization	Sotgiu, G (corresponding author), Univ Sassari, Clin Epidemiol & Med Stat Unit, Med Educ & Profess Dev Unit, Dept Biomed Sci, Sassari, Italy.	gsotgiu@uniss.it	Sotgiu, Giovanni/N-1032-2017; Ködmön, Csaba/AAP-8247-2021	Sotgiu, Giovanni/0000-0002-1600-4474; Ködmön, Csaba/0000-0001-8040-6753; DADU, Andrei/0000-0002-3080-8321	USAID	USAID(United States Agency for International Development (USAID))	The study described in this paper was done in the normal course of work and did not benefit from any ad hoc financing. USAID was a principal salary supporter of the WHO co-author involved in this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada H, 2014, INT J TUBERC LUNG D, V18, P1516, DOI 10.5588/ijtld.14.0319; [Anonymous], 2016, TUB SURV MON EUR 201; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Cobat A, 2013, PUBLIC HEALTH GENOM, V16, P44, DOI 10.1159/000341499; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Fortun J, 2014, INT J TUBERC LUNG D, V18, P478, DOI 10.5588/ijtld.13.0555; Fox GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099496; Horne DJ, EXTRAPULMONARY TUBER; Kamboj M, 2006, CLIN INFECT DIS, V42, P1592, DOI 10.1086/503917; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; MEHTA JB, 1991, CHEST, V99, P1134, DOI 10.1378/chest.99.5.1134; Mokrousov I, 2015, TUBERCULOSIS, V95, pS167, DOI 10.1016/j.tube.2015.02.031; Mor Z, 2013, INT J TUBERC LUNG D, V17, P229, DOI 10.5588/ijtld.12.0375; Musellim B, 2005, INT J TUBERC LUNG D, V9, P1220; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Noertjojo K, 2002, INT J TUBERC LUNG D, V6, P879; Padberg I, 2015, INT J TUBERC LUNG D, V19, P723, DOI 10.5588/ijtld.14.0735; Perez-Guzman C, 2014, SALUD PUBLICA MEXICO, V56, P189; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Quddus M A, 2014, Mymensingh Med J, V23, P758; *R PROJ, 2013, R LANG ENV STAT COMP; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rieder HL, 1996, EUR RESPIR J, V9, P1097, DOI 10.1183/09031936.96.09051097; Sandgren A, 2013, EUROSURVEILLANCE, P183; Schwoebel V, 2000, EUR RESPIR J, V16, P364, DOI 10.1034/j.1399-3003.2000.16b28.x; Solovic I, 2013, EUROSURVEILLANCE, V18, P34; Sotgiu G, 2014, INT J TUBERC LUNG D, V18, P1389, DOI 10.5588/ijtld.14.0569; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Veen J, 2011, EUR RESPIR J, V37, P950, DOI 10.1183/09031936.00019410; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; Wilberschied L A, 1999, J Immigr Health, V1, P65, DOI 10.1023/A:1021828321167; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yang JH, 2014, TUBERCULOSIS, V94, P657, DOI 10.1016/j.tube.2014.08.014; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	39	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186499	10.1371/journal.pone.0186499	http://dx.doi.org/10.1371/journal.pone.0186499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155819	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700004
J	Xie, LJ; Jiang, L; Yang, ZG; Shi, K; Xu, HY; Li, R; Diao, KY; Guo, YK				Xie, Lin-jun; Jiang, Li; Yang, Zhi-gang; Shi, Ke; Xu, Hua-yan; Li, Rui; Diao, Kai-yue; Guo, Ying-kun			Assessment of transposition of the great arteries associated with multiple malformations using dual-source computed tomography	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SURGERY; ANGIOGRAPHY; CT	Purpose To determine the value of dual-source computed tomography (DSCT) in depicting the morphological characteristics and diagnosing the associated malformations for patients with transposition of the great arteries (TGA) before surgery. Materials and methods Twenty-five patients with TGA who underwent DSCT and transthoracic echocardiography (TTE) examination were retrospectively reviewed. The morphological types of TGA, the spatial relationship between the pulmonary artery and the aorta, as well as coronary arteryassociated abnormalities were assessed by DSCT. In contrast to TTE, the diagnostic accuracy of associated malformations on DSCT were analyzed and calculated with reference to surgical or digital subtraction angiography (DSA) findings. Effective doses (EDs) were also calculated. Results Among the 25 patients, 12 (48%) had ventricular septal defects and left ventricular outflow tract stenosis. Sixteen patients (16/25, 64%) had great arteries with an oblique spatial relationship on DSCT. In addition, we found seven patients (7/25, 28%) with coronary artery malformation, including five with an abnormal coronary origin and two with signs of a myocardial bridge. According to DSA or surgical findings, DSCT was superior to TTE in demonstrating extracardiac anomalies (sensitivity, anomalies of great vessels: 100% vs. 93.33%, other anomalies: 100% vs. 46.15%). The mean estimated ED for those aged < 10 years was < 2 mSv (1.59 +/- 0.95 mSv). Conclusions DSCT can achieve an overall assessment of patients with TGA, including any associated malformations as well as the identification of the spatial relationship of the great arteries. DSCT can therefore be considered as an alternative imaging modality for surgical decision making.	[Xie, Lin-jun; Jiang, Li; Yang, Zhi-gang; Shi, Ke; Xu, Hua-yan; Li, Rui; Diao, Kai-yue] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Xie, Lin-jun; Guo, Ying-kun] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Radiol,Key Lab Obstet & Gynecol & Pediat Dis, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Yang, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China.; Guo, YK (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Radiol,Key Lab Obstet & Gynecol & Pediat Dis, Chengdu, Sichuan, Peoples R China.	yangzg666@163.com; gykpanda@163.com			National Key Research and Development Program of China [2016YFC1300300]; Program for New Century Excellent Talents in University [NCET-13-0386]; Program for Young Scholars and Innovative Research Team in Sichuan Province of China [2017TD0005]	National Key Research and Development Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Young Scholars and Innovative Research Team in Sichuan Province of China	This work was supported by the National Key Research and Development Program of China (2016YFC1300300 to YKG), Program for New Century Excellent Talents in University (No: NCET-13-0386 to YKG), and Program for Young Scholars and Innovative Research Team in Sichuan Province (2017TD0005 to YKG) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2017, EUR RADIOL, V27, P660, DOI 10.1007/s00330-016-4411-6; Files MD, 2015, SEMIN CARDIOTHORAC V, V19, P210, DOI 10.1177/1089253215581851; Groves DW, 2017, INT J CARDIOL, V228, P180, DOI 10.1016/j.ijcard.2016.11.108; Ihlenburg S, 2014, THORAC CARDIOV SURG, V62, P203, DOI 10.1055/s-0033-1349791; Iriart X, 2012, ARCH CARDIOVASC DIS, V105, P432, DOI 10.1016/j.acvd.2012.05.005; Jaggers JJ, 2000, ANN THORAC SURG, V69, P1282; Jia QJ, 2017, EUR J RADIOL, V86, P190, DOI 10.1016/j.ejrad.2016.10.017; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Liu X, 2016, EUR J RADIOL, V85, P1601, DOI 10.1016/j.ejrad.2016.06.012; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Ou P, 2008, JACC-CARDIOVASC IMAG, V1, P331, DOI 10.1016/j.jcmg.2008.02.005; Owen M, 2011, J CHILD NEUROL, V26, P743, DOI 10.1177/0883073811402073; Schallert EK, 2013, RADIOGRAPHICS, V33, pE33, DOI 10.1148/rg.332125086; Schidlow DN, 2017, J AM COLL CARDIOL, V69, P43, DOI 10.1016/j.jacc.2016.10.051; Shi K, 2017, INT J CARDIOL, V228, P80, DOI 10.1016/j.ijcard.2016.11.169; Sithamparanathan S, 2013, JACC-CARDIOVASC IMAG, V6, P624, DOI 10.1016/j.jcmg.2012.10.027; Squarcia U, 2011, CURR OPIN PEDIATR, V23, P518, DOI 10.1097/MOP.0b013e32834aa551; Thadani SR, 2015, ECHOCARDIOGR-J CARD, V32, P157; Villafane J, 2014, J AM COLL CARDIOL, V64, P498, DOI 10.1016/j.jacc.2014.06.1150; Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352; Warnes CA, 2008, J AM COLL CARDIOL, V52, P1890, DOI 10.1016/j.jacc.2008.10.002; Yacoub M, 2017, J AM COLL CARDIOL, V69, P52, DOI 10.1016/j.jacc.2016.10.050	24	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187578	10.1371/journal.pone.0187578	http://dx.doi.org/10.1371/journal.pone.0187578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155835	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700012
J	Ghoubay-Benallaoua, D; de Sousa, C; Martos, R; Latour, G; Schanne-Klein, MC; Dupin, E; Borderie, V				Ghoubay-Benallaoua, Djida; de Sousa, Celine; Martos, Raphael; Latour, Gael; Schanne-Klein, Marie-Claire; Dupin, Elisabeth; Borderie, Vincent			Easy xeno-free and feeder-free method for isolating and growing limbal stromal and epithelial stem cells of the human cornea	PLOS ONE			English	Article							NEURAL CREST DERIVATIVES; CULTURE-CONDITIONS; PROGENITOR CELLS; TRANSPLANTATION; TISSUE; PAX6; EXPRESSION; THERAPY; NICHE	Epithelial and stromal stem cells are required to maintain corneal transparency. The aim of the study was to develop a new method to isolate and grow both corneal stromal (SSC) and epithelial limbal (LSC) stem cells from small human limbal biopsies under culture conditions in accordance with safety requirements mandatory for clinical use in humans. Superficial limbal explants were retrieved from human donor corneo-scleral rims. Human limbal cells were dissociated by digestion with collagenase A, either after epithelial scraping or with no scraping. Isolated cells were cultured with Essential 8 medium (E8), E8 supplemented with EGF (E8+) or Green's medium with 3T3 feeder-layers. Cells were characterized by immunostaining, RT-qPCR, colony forming efficiency, sphere formation, population doubling, second harmonic generation microscopy and differentiation potentials. LSC were obtained from unscraped explants in E8, E8+ and Green's media and were characterized by colony formation and expression of PAX6, Delta NP63 alpha, Bmi1, ABCG2, SOX9, CK14, CK15 and vimentin, with a few cells positive for CK3. LSC underwent 28 population doublings still forming colonies. SSC were obtained from both scraped and unscraped explants in E8 and E8+ media and were characterized by sphere formation, expression of PAX6, SOX2, BMI1, NESTIN, ABCG2, KERATOCAN, VIMENTIN, SOX9, SOX10 and HNK1, production of collagen fibrils and differentiation into keratocytes, fibroblasts, myofibroblasts, neurons, adipocytes, chondrocytes and osteocytes. SSC underwent 48 population doublings still forming spheres, Thus, this new method allows both SSC and LSC to be isolated from small superficial limbal biopsies and to be primary cultured in feeder-free and xeno-free conditions, which will be useful for clinical purposes.	[Ghoubay-Benallaoua, Djida; Martos, Raphael; Dupin, Elisabeth; Borderie, Vincent] UPMC Univ Paris 06, CNRS, UMR 7210, Inst Vis,Sorbonne Univ,INSERM, Paris, France; [Ghoubay-Benallaoua, Djida; Borderie, Vincent] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [de Sousa, Celine] Etab Francais Sang Ile France, Paris, France; [Latour, Gael] Univ Paris Saclay, Univ Paris Sud, Lab Imagerie & Modelisat Neurobiol & Cancerol, CNRS, Orsay, France; [Schanne-Klein, Marie-Claire] Univ Paris Saclay, INSERM, CNRS, Lab Opt & Biosci,U1182,Ecole Polytech, Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Ghoubay-Benallaoua, D (corresponding author), UPMC Univ Paris 06, CNRS, UMR 7210, Inst Vis,Sorbonne Univ,INSERM, Paris, France.; Ghoubay-Benallaoua, D (corresponding author), Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.	djida.ghoubay@inserm.fr	Latour, Gaël/R-6629-2017; Schanne-Klein, Marie-Claire/E-6490-2011; Borderie, Vincent/AAT-1092-2021; Ghoubay, Djida/AAE-3971-2022; Dupin, Elisabeth/X-8757-2019	Latour, Gaël/0000-0002-6244-6556; Schanne-Klein, Marie-Claire/0000-0003-3026-8932; Borderie, Vincent/0000-0002-1395-8483; MARTOS, Raphael/0000-0002-0228-9229; Ghoubay-Benallaoua, Djida/0000-0002-2282-5172	Fondation pour la Recherche Medicale [DCM20121225759]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the "Fondation pour la Recherche Medicale" No.: DCM20121225759 to Vincent Borderie. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Dr K. Grieve for the English corrections to the manuscript, S. Fouquet and D. Godefroy for the imaging facility. This work was supported by grants from the "Fondation pour la Recherche Medicale" No.: DCM20121225759	Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Behaegel J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6978253; Borderie VM, 1998, BRIT J OPHTHALMOL, V82, P382, DOI 10.1136/bjo.82.4.382; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Cheng J, 2013, OPHTHALMOLOGY, V120, P34, DOI 10.1016/j.ophtha.2012.07.037; Creuzet S, 2005, J ANAT, V207, P447, DOI 10.1111/j.1469-7580.2005.00485.x; Creuzet S, 2005, INT J DEV BIOL, V49, P161, DOI 10.1387/ijdb.041937sc; Davies SB, 2010, STEM CELLS DEV, V19, P1651, DOI 10.1089/scd.2010.0201; Di Iorio E, 2010, OCUL SURF, V8, P146, DOI 10.1016/S1542-0124(12)70225-2; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Dziasko MA, 2016, OCUL SURF, V14, P322, DOI 10.1016/j.jtos.2016.04.002; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Ghoubay-Benallaoua D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081965; Ghoubay-Benallaoua D, 2012, CURR EYE RES, V37, P644, DOI 10.3109/02713683.2012.669510; Gisoldi RAMC, 2010, CORNEA, V29, P715, DOI 10.1097/ICO.0b013e3181c91ac4; Grieve K, 2015, EXP EYE RES, V140, P75, DOI 10.1016/j.exer.2015.08.003; Gruenauer-Kloevekorn C, 2009, GRAEF ARCH CLIN EXP, V247, P93, DOI 10.1007/s00417-008-0931-3; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Kureshi AK, 2014, INVEST OPHTH VIS SCI, V55, P7583, DOI 10.1167/iovs.14-14448; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Levis HJ, 2016, CURR EYE RES, V41, P1153, DOI 10.3109/02713683.2015.1095932; Li G, 2015, J BIOL CHEM, V290, P20448, DOI 10.1074/jbc.M115.662940; Li HY, 2015, TISSUE CELL, V47, P39, DOI 10.1016/j.tice.2014.10.008; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Matthyssen S, 2017, INVEST OPHTH VIS SCI, V58, P2659, DOI 10.1167/iovs.17-21676; Na KS, 2015, OPHTHALMIC RES, V53, P217, DOI 10.1159/000375110; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nieto-Nicolau N, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3032128; Pavone F. S., 2013, 2 HARMONIC GENERATIO; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reichman S, 2017, STEM CELLS, V35, P1176, DOI 10.1002/stem.2586; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; Stasi K, 2014, INVEST OPHTH VIS SCI, V55, P375, DOI 10.1167/iovs.13-12517; Thanos M, 2010, CORNEA, V29, P462, DOI 10.1097/ICO.0b013e3181b442ea; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tidu A, 2015, ACTA BIOMATER, V22, P50, DOI 10.1016/j.actbio.2015.04.018; Uchida S, 2005, INVEST OPHTH VIS SCI, V46, P1620, DOI 10.1167/iovs.04-0288; Varghese VM, 2010, MICROSC RES TECHNIQ, V73, P1045, DOI 10.1002/jemt.20831; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; Wu J, 2014, EXP EYE RES, V120, P71, DOI 10.1016/j.exer.2014.01.005; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zakaria N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-58; Zhang JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117089; Zhao Y, 2015, CORNEA, V34, P592, DOI 10.1097/ICO.0000000000000398	57	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188398	10.1371/journal.pone.0188398	http://dx.doi.org/10.1371/journal.pone.0188398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149196	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100042
J	Kar, SK; Jansman, AJM; Benis, N; Ramiro-Garcia, J; Schokker, D; Kruijt, L; Stolte, EH; Taverne-Thiele, JJ; Smits, MA; Wells, JM				Kar, Soumya K.; Jansman, Alfons J. M.; Benis, Nirupama; Ramiro-Garcia, Javier; Schokker, Dirkjan; Kruijt, Leo; Stolte, Ellen H.; Taverne-Thiele, Johanna J.; Smits, Mari A.; Wells, Jerry M.			Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine	PLOS ONE			English	Article							CELL; RECOGNITION; ACTIVATION; PROTECTION; CYTOSCAPE; PLASMA	Dietary protein sources can have profound effects on host-microbe interactions in the gut that are critically important for immune resilience. However more knowledge is needed to assess the impact of different protein sources on gut and animal health. Thirty-six wildtype male C57BL/6J mice of 35 d age (n = 6/group; mean +/- SEM body weight 21.9 +/- 0.25 g) were randomly assigned to groups fed for four weeks with semi synthetic diets prepared with one of the following protein sources containing (300 g/kg as fed basis): soybean meal (SBM), casein, partially delactosed whey powder, spray dried plasma protein, wheat gluten meal and yellow meal worm. At the end of the experiment, mice were sacrificed to collect ileal tissue to acquire gene expression data, and mammalian (mechanistic) target of rapamycin (mTOR) activity, ileal digesta to study changes in microbiota and serum to measure cytokines and chemokines. By genome-wide transcriptome analysis, we identified fourteen high level regulatory genes that are strongly affected in SBM-fed mice compared to the other experimental groups. They mostly related to the mTOR pathway. In addition, an increased (P < 0.05) concentration of granulocyte colony-stimulating factor was observed in serum of SBM-fed mice compared to other dietary groups. Moreover, by 16S rRNA sequencing, we observed that SBM-fed mice had higher (P < 0.05) abundances of Bacteroidales family S24-7, compared to the other dietary groups. We showed that measurements of genome-wide expression and microbiota composition in the mouse ileum reveal divergent responses to diets containing different protein sources, in particular for a diet based on SBM.	[Kar, Soumya K.; Benis, Nirupama; Stolte, Ellen H.; Taverne-Thiele, Johanna J.; Smits, Mari A.; Wells, Jerry M.] Wageningen Univ & Res, Host Microbe Interact Grp, Wageningen, Netherlands; [Kar, Soumya K.; Benis, Nirupama; Schokker, Dirkjan; Kruijt, Leo; Smits, Mari A.] Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kar, Soumya K.; Jansman, Alfons J. M.; Benis, Nirupama; Schokker, Dirkjan; Kruijt, Leo; Smits, Mari A.] Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Top Inst Food & Nutr, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Smits, Mari A.] Wageningen Univ & Res, Wageningen Biovet Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kar, SK (corresponding author), Wageningen Univ & Res, Host Microbe Interact Grp, Wageningen, Netherlands.; Kar, SK (corresponding author), Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands.; Kar, SK (corresponding author), Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands.	soumya.kar@wur.nl	Ramiro-Garcia, Javier/ABA-6236-2020; Kar, Soumya/AAQ-1711-2021; Schokker, Dirkjan/AAB-2668-2020	Ramiro-Garcia, Javier/0000-0003-3896-3833; Kar, Soumya/0000-0002-7892-9034; Schokker, Dirkjan/0000-0001-6082-7227	IPOP Customized Nutrition [4417801270]; Dutch Ministry of Economic Affairs; Nutreco; Darling Ingredients Inc.	IPOP Customized Nutrition; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Nutreco; Darling Ingredients Inc.	This work was supported by Grant number: 4417801270 IPOP Customized Nutrition (http://www.wageningenur.nl/Onderzoek-Resultaten/Projecten-EZ/Expertisegebieden/Kennisbasis-onderzoeka/Afgaronde- projecten-KB/Gezond-en-veilig-voedsel-in-ketenperspectief/IPOPcustomized-nutrition-3.htm); Funding Institutes: 1. the Dutch Ministry of Economic Affairs (http://www.wageningenur.nl/nl/project/IPOP-Customized-nutrition-5.htm); 2. Nutreco (http://www.nutreco.com/); 3. Darling Ingredients Inc. (https://www.darlingii.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettini ML, 2014, J IMMUNOL, V193, P258, DOI 10.4049/jimmunol.1400322; Boding L, 2010, MOL IMMUNOL, V47, P2450, DOI 10.1016/j.molimm.2010.06.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capper J, 2013, 53 CAST; Chaimowitz NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060640; Chobert Jean-Marc, 2003, Adv Food Nutr Res, V47, P1, DOI 10.1016/S1043-4526(03)47001-0; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Funkat A, 2004, J NUTR, V134, P3264, DOI 10.1093/jn/134.12.3264; Gao YY, 2011, J ANIM SCI, V89, P150, DOI 10.2527/jas.2010-2967; Germena G, 2015, J IMMUNOL, V194, P728, DOI 10.4049/jimmunol.1401646; Ghaly A.E., 2009, American Journal of Agricultural and Biological Sciences, V4, P319; Gilbert R, 2004, WORLD ANIMAL FEED IN; Haks MC, 2002, J EXP MED, V196, P1, DOI 10.1084/jem.20020268; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Hernandez-Ledesma B, 2011, ADV COLLOID INTERFAC, V165, P23, DOI 10.1016/j.cis.2010.11.001; Heuze A V, 2016, FEEDIPEDIA PROGRAMME; Jahan-Mihan A, 2011, NUTRIENTS, V3, P574, DOI 10.3390/nu3050574; Kar SK, 2016, J ANIM SCI, V94, P30, DOI 10.2527/jas.2015-9677; Karr-Lilienthal LK, 2005, LIVEST PROD SCI, V97, P1, DOI 10.1016/j.livprodsci.2005.01.015; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Lee CY, 2013, CLIN TRANSLATIONAL G; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Madureira AR, 2007, FOOD RES INT, V40, P1197, DOI 10.1016/j.foodres.2007.07.005; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Ni Gabhann J, 2014, PLOS ONE, V9; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Pingitore A, 2015, NUTRITION, V31, P916, DOI 10.1016/j.nut.2015.02.005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RAMIROGARCIA J, 2016, F1000RESEARCH, V5; Ruth MR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-27; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siggs OM, 2015, J IMMUNOL, V194, P2587, DOI 10.4049/jimmunol.1400326; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Loeff IS, 2014, J IMMUNOL, V193, P2873, DOI 10.4049/jimmunol.1400858; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; van Neerven RJJ, 2012, J ALLERGY CLIN IMMUN, V130, P853, DOI 10.1016/j.jaci.2012.06.050; Wager CML, 2014, J IMMUNOL, V193, P4060, DOI 10.4049/jimmunol.1400318; Wang XM, 2014, J EXP MED, V211, P2351, DOI 10.1084/jem.20140646; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901	50	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188282	10.1371/journal.pone.0188282	http://dx.doi.org/10.1371/journal.pone.0188282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149221	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100035
J	Lasa, R; Tadeo, E; Toledo-Hernandez, RA; Carmona, L; Lima, I; Williams, T				Lasa, Rodrigo; Tadeo, Eduardo; Toledo-Hernandez, Ricardo A.; Carmona, Lino; Lima, Itzel; Williams, Trevor			Improved capture of Drosophila suzukii by a trap baited with two attractants in the same device	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; MATSUMURA DIPTERA DROSOPHILIDAE; UNITED-STATES; PEST-MANAGEMENT; ACETIC-ACID; PARASITOIDS; INVASION; COMBINATIONS; INFESTATION; RASPBERRIES	The improvement of trap-lure combinations is an important part of integrated pest management programs that involve monitoring pests for timely insecticide applications, or for their use in control strategies such as mass trapping or bait stations. In this study improvements in the capture of Drosophila suzukii were not observed following the inclusion of different color stimuli with respect to a red-black stripe cup trap. This red-black stripe trap with a hemispherical dome-shaped lid had a significantly improved physical retention of flies compared to traps fitted with a flat lid. Retention was further improved when an additional tube device, which could be baited with a supplemental attractant, was introduced through the dome-shaped lid. Under laboratory conditions, this trap, in which apple cider vinegar + 10% ethanol was present as the drowning solution and the additional tube device was baited with a fermenting mixture of sugar and yeast, was significantly more effective in catching D. suzukii flies than other conventional attractants or a commercial lure. The capture rate of this traplure combination remained higher than that of a commercial lure, even after 20 days of use under laboratory conditions. In a guava orchard this trap was 15-fold more effective in catching D. suzukii flies than similar traps baited with apple cider vinegar alone, 4 to 7 fold more effective than similar traps baited with a commercial lure, and 1.7-fold more effective than a fermenting mixture of yeasts and wheat flour. In commercial blackberry orchards, this trap was 6-fold more effective in trapping D. suzukii flies than the clear trap baited with apple cider vinegar used by growers. The efficacy of this trap presents a promising line of future research for monitoring and control of D. suzukii and likely other drosophilid pests.	[Lasa, Rodrigo; Tadeo, Eduardo; Carmona, Lino; Lima, Itzel; Williams, Trevor] Inst Ecol AC, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico; [Toledo-Hernandez, Ricardo A.] Driscolls, Dept Invest Aplicada, Zapopan, Jalisco, Mexico	Instituto de Ecologia - Mexico	Lasa, R (corresponding author), Inst Ecol AC, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico.	rodrilasa@gmail.com	Williams, Trevor/ABG-3961-2020; Williams, Trevor/F-1447-2011; Tadeo, Eduardo/AAG-2671-2020; Lasa, Rodrigo/Q-6288-2018	Williams, Trevor/0000-0003-3414-3440; Tadeo, Eduardo/0000-0003-4293-6731; Lasa, Rodrigo/0000-0003-1175-7538	Mexican National Science and Technology Council (CONACyT) [1028]	Mexican National Science and Technology Council (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	One of the authors (RATH) is an employee of Driscoll's, Zapopan, Mexico. Driscoll's had no part in funding this study. The study was funded by the Mexican National Science and Technology Council (CONACyT) project number 1028 (Problemas Nacionales, Convocatoria 2015) granted to RL. The funder provided support in the form of a student stipend for one author [LC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Basoalto E, 2013, J APPL ENTOMOL, V137, P561, DOI 10.1111/jen.12053; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; Burrack HJ, 2015, ENVIRON ENTOMOL, V44, P704, DOI 10.1093/ee/nvv022; Carroll J., 2016, SPOTTED WING DROSOPH; Cini A, 2012, B INSECTOL, V65, P149; Cohnstaedt LW, 2012, ANN ENTOMOL SOC AM, V105, P135, DOI 10.1603/AN11127; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; eFly SWD Working Group, 2012, SPOTT WING DROS IMP; Epsky ND, 2014, FLA ENTOMOL, V97, P85, DOI 10.1653/024.097.0111; Frewin AJ, 2017, J ECON ENTOMOL, V110, P1156, DOI 10.1093/jee/tox081; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamby KA, 2016, J PEST SCI, V89, P605, DOI 10.1007/s10340-016-0756-5; Hamby KA, 2016, J PEST SCI, V89, P621, DOI 10.1007/s10340-016-0768-1; Hamby KA, 2012, APPL ENVIRON MICROB, V78, P4869, DOI 10.1128/AEM.00841-12; Hampton E, 2014, J ECON ENTOMOL, V107, P1849, DOI 10.1603/EC14232; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; Iglesias LE, 2014, J ECON ENTOMOL, V107, P1508, DOI 10.1603/EC13538; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lasa R, 2017, ENTOMOL EXP APPL, V162, P4, DOI 10.1111/eea.12519; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lee JC, 2013, ENVIRON ENTOMOL, V48, P2; Marcus M., 2014, THESIS; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Mazzetto F, 2016, J PEST SCI, V89, P783, DOI 10.1007/s10340-016-0754-7; Mazzetto F, 2016, J PEST SCI, V89, P837, DOI 10.1007/s10340-016-0746-7; Renkema JM, 2014, J ECON ENTOMOL, V107, P2107, DOI 10.1603/EC14254; SAGARPA-SENASICA, 2014, MAN MAN FIT MOSC VIN; Santo Ramos M. de los, 2014, Journal of Food, Agriculture & Environment, V12, P349; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Wang XG, 2016, J PEST SCI, V89, P701, DOI 10.1007/s10340-016-0747-6; Wang XG, 2016, BIOL CONTROL, V96, P64, DOI 10.1016/j.biocontrol.2016.02.004; Wiman NG, 2016, J PEST SCI, V89, P653, DOI 10.1007/s10340-016-0757-4	39	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188350	10.1371/journal.pone.0188350	http://dx.doi.org/10.1371/journal.pone.0188350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149190	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100039
J	Davidson, AD; Shoemaker, KT; Weinstein, B; Costa, GC; Brooks, TM; Ceballos, G; Radeloff, VC; Rondinini, C; Graham, CH				Davidson, Ana D.; Shoemaker, Kevin T.; Weinstein, Ben; Costa, Gabriel C.; Brooks, Thomas M.; Ceballos, Gerardo; Radeloff, Volker C.; Rondinini, Carlo; Graham, Catherine H.			Geography of current and future global mammal extinction risk	PLOS ONE			English	Article							NONRANDOM EXTINCTION; RANDOM FORESTS; BODY-SIZE; CLIMATE; CONSERVATION; CLASSIFICATION; BIODIVERSITY; DECLINE; DIVERSITY; PATTERNS	Identifying which species are at greatest risk, what makes them vulnerable, and where they are distributed are central goals for conservation science. While knowledge of which factors influence extinction risk is increasingly available for some taxonomic groups, a deeper understanding of extinction correlates and the geography of risk remains lacking. Here, we develop a predictive random forest model using both geospatial and mammalian species' trait data to uncover the statistical and geographic distributions of extinction correlates. We also explore how this geography of risk may change under a rapidly warming climate. We found distinctive macroecological relationships between species-level risk and extinction correlates, including the intrinsic biological traits of geographic range size, body size and taxonomy, and extrinsic geographic settings such as seasonality, habitat type, land use and human population density. Each extinction correlate exhibited ranges of values that were especially associated with risk, and the importance of different risk factors was not geographically uniform across the globe. We also found that about 10% of mammals not currently recognized as at-risk have biological traits and occur in environments that predispose them towards extinction. Southeast Asia had the most actually and potentially threatened species, underscoring the urgent need for conservation in this region. Additionally, nearly 40% of currently threatened species were predicted to experience rapid climate change at 0.5 km/year or more. Biological and environmental correlates of mammalian extinction risk exhibit distinct statistical and geographic distributions. These results provide insight into species-level patterns and processes underlying geographic variation in extinction risk. They also offer guidance for future conservation research focused on specific geographic regions, or evaluating the degree to which species-level patterns mirror spatial variation in the pressures faced by populations within the ranges of individual species. The added impacts from climate change may increase the susceptibility of at-risk species to extinction and expand the regions where mammals are most vulnerable globally.	[Davidson, Ana D.; Weinstein, Ben; Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Davidson, Ana D.] NatureServe, Arlington, VA 22203 USA; [Shoemaker, Kevin T.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Costa, Gabriel C.] Auburn Univ, Dept Biol, Montgomery, AL 36117 USA; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr, Laguna, Philippines; [Brooks, Thomas M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Radeloff, Volker C.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Rondinini, Carlo] Sapienza Univ Rome, Dept Biol & Biotechnol, Global Mammal Assessment Program, Rome, Italy; [Graham, Catherine H.] Swiss Fed Res Inst, Unit Biodivers & Conservat, WSL, Birmensdorf, Switzerland; [Davidson, Ana D.] Colorado State Univ, Colorado Nat Heritage Program, Warner Coll Nat Resources, Ft Collins, CO 80523 USA; [Davidson, Ana D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Warner Coll Nat Resources, Ft Collins, CO 80523 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nature Conservancy; Nevada System of Higher Education (NSHE); University of Nevada Reno; Auburn University System; Auburn University; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; Universidad Nacional Autonoma de Mexico; University of Wisconsin System; University of Wisconsin Madison; Sapienza University Rome; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Colorado State University; Colorado State University	Davidson, AD (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.; Davidson, AD (corresponding author), NatureServe, Arlington, VA 22203 USA.; Davidson, AD (corresponding author), Colorado State Univ, Colorado Nat Heritage Program, Warner Coll Nat Resources, Ft Collins, CO 80523 USA.; Davidson, AD (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Warner Coll Nat Resources, Ft Collins, CO 80523 USA.	ana.davidson@colostate.edu	Graham, Catherine/A-9560-2011; Rondinini, Carlo/E-9027-2011; Radeloff, Volker C/B-6124-2016	Graham, Catherine/0000-0001-9267-7948; Radeloff, Volker C/0000-0001-9004-221X; Rondinini, Carlo/0000-0002-6617-018X; Davidson, Ana/0000-0003-4701-5923	National Science Foundation's Dimensions of Biodiversity program [DEB-1136586]; NSF [DEB-1136586, DEB-1146198]; CNPq [302776/2012-5, 563352/2010-8]; CAPES/Science without Borders grant [PVE 018/2012]; NASA Biodiversity Program	National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Science without Borders grant; NASA Biodiversity Program(National Aeronautics & Space Administration (NASA))	Our research was funded by the National Science Foundation's Dimensions of Biodiversity program (grant DEB-1136586). ADD, BW, and CHG were supported by NSF grant DEB-1136586, and KTS was supported by NSF grant DEB-1146198. GCC was supported by CNPq grants 302776/2012-5 and 563352/2010-8. GCC, CHG., and ADD were also supported by CAPES/Science without Borders grant PVE 018/2012, and VCR by the NASA Biodiversity Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bruce Young and Blair Hedges, co-PIs partly responsible for obtaining NSF DEB-1136586 grant. We thank Brody Sandel for sharing R code to produce Fig 3, and Joshua Ginsberg and an anonymous reviewer for helpful comments on a previous version of our manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Biradar CM, 2009, INT J APPL EARTH OBS, V11, P114, DOI 10.1016/j.jag.2008.11.002; Bland LM, 2014, COMP INT MULT UND IW, V28, P1; Bontemps S., 2011, GLOBCOVER 2009 PRODU; Bright E.A., 2012, LANDSCAN 2011; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cooper EJ, 2014, WARMER SHORTER WINTE; Coops NC, 2009, ECOL INDIC, V9, P948, DOI 10.1016/j.ecolind.2008.11.003; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davidson AD, 2012, DRIVERS HOTSPOTS EXT, V109; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Davies TJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0343; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Di Marco M, 2015, GLOBAL CHANGE BIOL, V21, P2169, DOI 10.1111/gcb.12834; Di Marco M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0198; Di Marco M, 2012, CONSERV LETT, V5, P134, DOI 10.1111/j.1755-263X.2011.00219.x; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Foden W., 2008, 2008 REV IUCN RED LI, P77; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; GRUMPv1, 2010, GRUMPV1 POPULATION L; Hamilton MJ, 2011, P ROY SOC B-BIOL SCI, V278, P560, DOI 10.1098/rspb.2010.1056; Hapfelmeier A, 2012, STAT COMPUT, V24; Hijmans RJ., 2016, INTRO RASTER PACKAGE, P1; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hothorn T, 1999, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2017, IUCN RED LIST SUMM T; IUCN, 2013, IUCN RED LIST OF THR; Jones KE, 2011, PHILOS T R SOC B, V366, P2451, DOI 10.1098/rstb.2011.0090; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones MJ, 2006, BIODIVERS CONSERV, V15, P1993, DOI 10.1007/s10531-005-4316-1; Jono CMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046235; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Laidre KL, 2015, ARCTIC MARINE MAMMAL, P29; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Mahlstein I, 2013, NAT CLIM CHANGE, V3, P739, DOI [10.1038/NCLIMATE1876, 10.1038/nclimate1876]; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Murray KA, 2014, GLOBAL CHANGE BIOL, V20, P483, DOI 10.1111/gcb.12366; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; NOAA, 2006, VIIRS NIGHTT LIGHTS; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rastogi A, 2012, J ENVIRON MANAGE, V113, P328, DOI 10.1016/j.jenvman.2012.10.003; Reynolds John D., 2003, P195; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Rodriguez MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P274, DOI 10.1111/j.1466-8238.2007.00363.x; Rondinini C, 2014, CONSERV LETT, V7, P126, DOI 10.1111/conl.12040; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sibly RM, 2009, AM NAT, V173, pE185, DOI 10.1086/598680; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Stanton JC, 2015, GLOBAL CHANGE BIOL, V21, P1066, DOI 10.1111/gcb.12721; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Visconti P, 2011, PHILOS T R SOC B, V366, P2693, DOI 10.1098/rstb.2011.0105	78	21	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186934	10.1371/journal.pone.0186934	http://dx.doi.org/10.1371/journal.pone.0186934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145486	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000415378800006
J	Nakayama, TJ; Rodrigues, FA; Neumaier, N; Marcolino-Gomes, J; Molinari, HBC; Santiago, TR; Formighieri, EF; Basso, MF; Farias, JRB; Emygdio, BM; de Oliveira, ACB; Campos, AD; Borem, A; Harmon, FG; Mertz-Henning, LM; Nepomuceno, AL				Nakayama, Thiago J.; Rodrigues, Fabiana A.; Neumaier, Norman; Marcolino-Gomes, Juliana; Molinari, Hugo B. C.; Santiago, Thais R.; Formighieri, Eduardo F.; Basso, Marcos F.; Farias, Jose R. B.; Emygdio, Beatriz M.; de Oliveira, Ana C. B.; Campos, Angela D.; Borem, Aluizio; Harmon, Frank G.; Mertz-Henning, Liliane M.; Nepomuceno, Alexandre L.			Insights into soybean transcriptome reconfiguration under hypoxic stress: Functional, regulatory, structural, and compositional characterization	PLOS ONE			English	Article							MEDIATOR COMPLEX SUBUNIT16; TRANSFER-RNA MODIFICATIONS; BETA-AMINOBUTYRIC ACID; GENE-EXPRESSION; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; OXYGEN DEPRIVATION; PROTEOMIC ANALYSIS; FLOODING STRESS; OSMOTIC-STRESS	Soybean (Glycine max) is one of the major crops worldwide and flooding stress affects the production and expansion of cultivated areas. Oxygen is essential for mitochondrial aerobic respiration to supply the energy demand of plant cells. Because oxygen diffusion in water is 10,000 times lower than in air, partial (hypoxic) or total (anoxic) oxygen deficiency is important component of flooding. Even when oxygen is externally available, oxygen deficiency frequently occurs in bulky, dense or metabolically active tissues such as phloem, meristems, seeds, and fruits. In this study, we analyzed conserved and divergent root transcriptional responses between flood-tolerant Embrapa 45 and flood-sensitive BR 4 soybean cultivars under hypoxic stress conditions with RNA-seq. To understand how soybean genes evolve and respond to hypoxia, stable and differentially expressed genes were characterized structurally and compositionally comparing its mechanistic relationship. Between cultivars, Embrapa 45 showed less up-and more down-regulated genes, and stronger induction of phosphoglucomutase (Glyma05g34790), unknown protein related to N-terminal protein myristoylation (Glyma06g03430), protein suppressor of phyA-105 (Glyma06g37080), and fibrillin (Glyma10g32620). RNA-seq and qRT-PCR analysis of non-symbiotic hemoglobin (Glyma11g12980) indicated divergence in gene structure between cultivars. Transcriptional changes for genes in amino acids and derivative metabolic process suggest involvement of amino acids metabolism in tRNA modifications, translation accuracy/efficiency, and endoplasmic reticulum stress in both cultivars under hypoxia. Gene groups differed in promoter TATA box, ABREs (ABA-responsive elements), and CRT/DREs (C-repeat/dehydrationresponsive elements) frequency. Gene groups also differed in structure, composition, and codon usage, indicating biological significances. Additional data suggests that cis-acting ABRE elements can mediate gene expression independent of ABA in soybean roots under hypoxia.	[Nakayama, Thiago J.; Borem, Aluizio] Univ Fed Vicosa, Dept Fitotecn, Vicosa, MG, Brazil; [Rodrigues, Fabiana A.; Neumaier, Norman; Marcolino-Gomes, Juliana; Farias, Jose R. B.; Mertz-Henning, Liliane M.; Nepomuceno, Alexandre L.] Empresa Brasileira Pesquisa Agr, Embrapa Soja, Londrina, Parana, Brazil; [Molinari, Hugo B. C.; Santiago, Thais R.; Formighieri, Eduardo F.; Basso, Marcos F.] Empresa Brasileira Pesquisa Agr, Embrapa Agroenergia, Brasilia, DF, Brazil; [Emygdio, Beatriz M.; de Oliveira, Ana C. B.; Campos, Angela D.] Empresa Brasileira Pesquisa Agr, Embrapa Clima Temperado, Pelotas, RS, Brazil; [Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of California System; University of California Berkeley	Nepomuceno, AL (corresponding author), Empresa Brasileira Pesquisa Agr, Embrapa Soja, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Mertz-Henning, Liliane Marcia/AAC-9171-2020; Formighieri, Eduardo/W-9242-2019; Formighieri, Eduardo F/F-2993-2012; Santiago, Thaís/D-3366-2018; Santiago, Thais/AAC-6911-2019	Mertz-Henning, Liliane Marcia/0000-0001-7622-0649; Santiago, Thaís/0000-0001-5740-8400; Santiago, Thais/0000-0002-5890-557X; Nakayama, Thiago/0000-0001-5033-6790; Basso, Marcos Fernando/0000-0001-8192-8959	FAPEMIG; Embrapa/Monsanto partnership	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Embrapa/Monsanto partnership	This study was funded by Embrapa/Monsanto partnership. TJN were supported by graduate fellowship from FAPEMIG.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Arbona V, 2008, J PLANT GROWTH REGUL, V27, P241, DOI 10.1007/s00344-008-9051-x; Argamasilla R, 2014, J PLANT GROWTH REGUL, V33, P169, DOI 10.1007/s00344-013-9359-z; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Bai G, 2013, PLANT MOL BIOL, V83, P651, DOI 10.1007/s11103-013-0114-4; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bonham AJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp424; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Carvalho HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086661; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Cohen YR, 2002, PLANT DIS, V86, P448, DOI 10.1094/PDIS.2002.86.5.448; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Elhaik E, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-23; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Eyboulet F, 2015, NUCLEIC ACIDS RES, V43, P9214, DOI 10.1093/nar/gkv782; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Glemin S, 2014, TRENDS GENET, V30, P263, DOI 10.1016/j.tig.2014.05.002; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Gupta KJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00369; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; HWANG SY, 1991, PLANT PHYSIOL, V97, P593, DOI 10.1104/pp.97.2.593; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Komatsu S, 2013, J PROTEOME RES, V12, P4769, DOI 10.1021/pr4001898; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Korner CJ, 2015, INT J MOL SCI, V16, P26582, DOI 10.3390/ijms161125964; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; LAANBROEK HJ, 1990, AQUAT BOT, V38, P109, DOI 10.1016/0304-3770(90)90101-P; Lamers LPM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00268; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li WX, 2011, J PLANT PHYSIOL, V168, P1837, DOI 10.1016/j.jplph.2011.05.020; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luna E, 2014, NAT CHEM BIOL, V10, P450, DOI [10.1038/nchembio.1520, 10.1038/NCHEMBIO.1520]; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; Marchetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056043; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Morot-Gaudry JF, 2001, PLANT NITROGEN, P167; Mutava RN, 2015, PLANT PHYSIOL BIOCH, V86, P109, DOI 10.1016/j.plaphy.2014.11.010; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; Oliveira HC, 2013, AMINO ACIDS, V44, P743, DOI 10.1007/s00726-012-1399-3; Paul E, 2015, MOL CELL BIOL, V35, P331, DOI 10.1128/MCB.00991-14; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; Rodrigues FA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1731-x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shabala S, 2014, PLANT CELL ENVIRON, V37, P2216, DOI 10.1111/pce.12339; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Silva PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1952-z; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Singh DK, 2010, PLANT PHYSIOL, V154, P1281, DOI 10.1104/pp.110.164095; Sorenson R, 2014, P NATL ACAD SCI USA, V111, P2373, DOI 10.1073/pnas.1314851111; Takuno S, 2013, P NATL ACAD SCI USA, V110, P1797, DOI 10.1073/pnas.1215380110; Tamang BG, 2014, PLANT CELL ENVIRON, V37, P2350, DOI 10.1111/pce.12277; Tatarinova T, 2013, GENOME BIOL EVOL, V5, P1443, DOI 10.1093/gbe/evt103; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; VanToai TT, 2001, CROP SCI, V41, P1247, DOI 10.2135/cropsci2001.4141247x; Wang CG, 2015, PLANT PHYSIOL, V169, P856, DOI 10.1104/pp.15.00351; Wang X, 2016, J PROTEOMICS, V130, P42, DOI 10.1016/j.jprot.2015.09.007; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang Y, 2016, J INTEGR PLANT BIOL, V58, P106, DOI 10.1111/jipb.12377; Yin X, 2016, PLANT MOL BIOL; Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015; Zallot R, 2014, ACS CHEM BIOL, V9, P1812, DOI 10.1021/cb500278k; Zhang XD, 2012, PLANT CELL, V24, P4294, DOI 10.1105/tpc.112.103317; Zheng Y, 2012, ANN BOT-LONDON, V110, P743, DOI 10.1093/aob/mcs133	98	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187920	10.1371/journal.pone.0187920	http://dx.doi.org/10.1371/journal.pone.0187920			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145496	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800038
J	Taurozzi, AJ; Beekharry, R; Wantoch, M; Labarthe, MC; Walker, HF; Seed, RI; Simms, M; Rodrigues, G; Bradford, J; van der Horst, G; van der Pluijm, G; Collins, AT				Taurozzi, Alberto J.; Beekharry, Ramprakash; Wantoch, Michelle; Labarthe, Marie-Christine; Walker, Hannah F.; Seed, Robert I.; Simms, Matthew; Rodrigues, Greta; Bradford, James; van der Horst, Geertje; van der Pluijm, Gabri; Collins, Anne T.			Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program	PLOS ONE			English	Article							IMMUNODEFICIENT MICE; TUMOR XENOGRAFTS; DRUG DEVELOPMENT; MODELS; CELLS; METASTASIS; SAMPLES; MOUSE	Prostate cancer research is hampered by the lack of in vivo preclinical models that accurately reflect patient tumour biology and the clinical heterogeneity of human prostate cancer. To overcome these limitations we propagated and characterised a new collection of patient-derived prostate cancer xenografts. Tumour fragments from 147 unsupervised, surgical prostate samples were implanted subcutaneously into immunodeficient Rag2(-/-)gamma C-/- mice within 24 hours of surgery. Histologic and molecular characterisation of xenografts was compared with patient characteristics, including androgen-deprivation therapy, and exome sequencing. Xenografts were established from 47 of 147 (32%) implanted primary prostate cancers. Only 14% passaged successfully resulting in 20 stable lines; derived from 20 independent patient samples. Surprisingly, only three of the 20 lines (15%) were confirmed as prostate cancer; one line comprised of mouse stroma, and 16 were verified as human donor-derived lymphoid neoplasms. PCR for Epstein-Barr Virus (EBV) nuclear antigen, together with exome sequencing revealed that the lymphomas were exclusively EBV-associated. Genomic analysis determined that 14 of the 16 EBV+ lines had unique monoclonal or oligoclonal immunoglobulin heavy chain gene rearrangements, confirming their B-cell origin. We conclude that the generation of xenografts from tumour fragments can commonly result in B-cell lymphoma from patients carrying latent EBV. We recommend routine screening, of primary outgrowths, for latent EBV to avoid this phenomenon.	[Taurozzi, Alberto J.; Walker, Hannah F.; Seed, Robert I.; Collins, Anne T.] Univ York, Canc Res Unit, Dept Biol, York, N Yorkshire, England; [Beekharry, Ramprakash] St James Univ Hosp, Dept Urol, Leeds, W Yorkshire, England; [Wantoch, Michelle] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Labarthe, Marie-Christine] Univ York, Dept Chem, York, N Yorkshire, England; [Simms, Matthew] Castle Hill Hosp, Dept Urol, Cottingham, England; [Simms, Matthew] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Rodrigues, Greta] Hull Royal Infirm, Dept Pathol, Kingston Upon Hull, N Humberside, England; [Bradford, James] Univ Sheffield, Dept Oncol & Metab, Sheffield Inst Nucle Acids, Sheffield, S Yorkshire, England; [van der Horst, Geertje; van der Pluijm, Gabri] Leiden Univ, Med Sch, Dept Urol, Leiden, Netherlands	University of York - UK; Saint James's University Hospital; University of Leeds; University of York - UK; University of Hull; University of Hull; University of York - UK; University of Hull; University of Sheffield; Leiden University; Leiden University - Excl LUMC	Collins, AT (corresponding author), Univ York, Canc Res Unit, Dept Biol, York, N Yorkshire, England.	anne.collins@york.ac.uk		Seed, Robert/0000-0002-7588-9903; van der Horst, Geertje/0000-0003-1696-160X; van der Pluijm, Gabri/0000-0002-1351-1884; Taurozzi, Alberto John/0000-0003-0378-1626; Collins, Anne/0000-0002-2991-2703; Wantoch, Michelle/0000-0001-5313-158X	Movember Foundation [GAP1 0201]; Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium) [UL2014-7058]; Prostate Cancer UK [PG12-01]; Yorkshire Cancer Research [Y257PA]	Movember Foundation; Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium); Prostate Cancer UK; Yorkshire Cancer Research	This work was supported by the Movember Foundation (grant No. GAP1 0201), (ATC), Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium) (grant No. UL2014-7058), (GvdP, GvdH, ATC), Prostate Cancer UK (grant No. PG12-01) (M-CL, ATC), and Yorkshire Cancer Research (Grant No.Y257PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, INT J UROL, V13, P47, DOI 10.1111/j.1442-2042.2006.01220.x; Chen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039294; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056903; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Craft N, 1999, CANCER RES, V59, P5030; Ellis LM, 2010, NAT MED, V16, P974, DOI 10.1038/nm0910-974; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Ichinohasama R, 1996, CANCER, V77, P2592, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2592::AID-CNCR25>3.0.CO;2-M; John T, 2012, J THORAC ONCOL, V7, P1101, DOI 10.1097/JTO.0b013e3182519d4d; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Lopez-Barcons LA, 2010, ASIAN J ANDROL, V12, P509, DOI 10.1038/aja.2010.17; McCulloch DR, 2005, PROSTATE, V65, P35, DOI 10.1002/pros.20255; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; MOSS DJ, 1988, NATURE, V331, P719, DOI 10.1038/331719a0; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Subramanian C, 2001, NAT MED, V7, P350, DOI 10.1038/85499; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; TLSTY TD, 1995, MUTAT RES-DNA REPAIR, V337, P1, DOI 10.1016/0921-8777(95)00016-D; Toivanen R, 2012, J STEROID BIOCHEM, V131, P122, DOI 10.1016/j.jsbmb.2012.01.005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; vanWeerden WM, 1996, AM J PATHOL, V149, P1055; Wetterauer C, 2015, EARLY DEV HUMAN LYMP; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188228	10.1371/journal.pone.0188228	http://dx.doi.org/10.1371/journal.pone.0188228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145505	gold, Green Accepted, Green Published			2022-12-26	WOS:000415378800094
J	Abiraman, K; Tzingounis, AV; Lykotrafitis, G				Abiraman, Krithika; Tzingounis, Anastasios V.; Lykotrafitis, George			K(Ca)2 channel localization and regulation in the axon initial segment	FASEB JOURNAL			English	Article						potassium channels; atomic force microscopy; cAMP; PKA; endocytosis	CA2+-ACTIVATED K+ CHANNEL; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; SK2 CHANNELS; APAMIN; PLASTICITY; MEMBRANE; TRAFFICKING; SUBUNITS; ISOFORM	Small conductance calcium-activated potassium (K(Ca)2) channels are expressed throughout the CNS and play a critical role in synaptic and neuronal excitability. K(Ca)2 channels have a somatodendritic distribution with their highest expression in distal dendrites. It is unclear whether K(Ca)2 channels are specifically present on the axon initial segment (AIS), the site at which action potentials are initiated in neurons. Through a powerful combination of toxin pharmacology, single-molecule atomic force microscopy, and dual-color fluorescence microscopy, we report here that K(Ca)2 channels-predominantly the K(Ca)2.3 subtype-are indeed present on the AIS. We also report that cAMP-PKA controls the axonal K(Ca)2 channel surface expression. Surprisingly, and in contrast to K(Ca)2 channels that were observed in the soma and dendrites, the inhibition of cAMP-PKA increased the surface expression of K(Ca)2 channels without promoting nanoclustering. Lastly, we found that axonal K(Ca)2 channels seem to undergo endocytosis in a dynamin-independent manner, unlike K(Ca)2 channels in the soma and dendrites. Together, these novel results demonstrate that the distribution and membrane recycling of K(Ca)2 channels differs among various neuronal subcompartments.	[Abiraman, Krithika; Tzingounis, Anastasios V.; Lykotrafitis, George] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Tzingounis, Anastasios V.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Lykotrafitis, George] Univ Connecticut, Dept Mech Engn, 191 Auditorium Rd,Unit 3139, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Lykotrafitis, G (corresponding author), Univ Connecticut, Dept Mech Engn, 191 Auditorium Rd,Unit 3139, Storrs, CT 06269 USA.; Tzingounis, AV (corresponding author), Physiol & Neurobiol, 75 North Eagleville Rd,Unit 3156, Storrs, CT 06269 USA.	anastasios.tzingounis@uconn.edu; gelyko@engr.uconn.edu			National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award [1354363]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS073981, MH110887]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH110887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073981, R56NS073981] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1351363] Funding Source: National Science Foundation	National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award (1354363; to G.L.), and the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (Grants NS073981 and MH110887; to A.V.T.). The authors declare no conflicts of interest.	Abiraman K, 2016, J MOL BIOL, V428, P2521, DOI 10.1016/j.jmb.2016.04.014; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Ballesteros-Merino C, 2014, EUR J NEUROSCI, V39, P883, DOI 10.1111/ejn.12474; Ballesteros-Merino C, 2012, HIPPOCAMPUS, V22, P1467, DOI 10.1002/hipo.20986; Bhushan B, 2004, SPRINGER HANDBOOK OF NANOTECHNOLOGY, P475; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Carrodus NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51139; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; D'hoedt D, 2004, J BIOL CHEM, V279, P12088, DOI 10.1074/jbc.C300382200; Deschaux O, 2005, NEUROSCI LETT, V386, P5, DOI 10.1016/j.neulet.2005.05.050; Deschaux O, 1997, NEUROSCI LETT, V222, P159, DOI 10.1016/S0304-3940(97)13367-5; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Leterrier C, 2015, CELL REP, V13, P2781, DOI 10.1016/j.celrep.2015.11.051; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Maciaszek JL, 2012, J NEUROSCI, V32, P11435, DOI 10.1523/JNEUROSCI.1785-12.2012; MESSIER C, 1991, BRAIN RES, V551, P322, DOI 10.1016/0006-8993(91)90950-Z; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Partola KR, 2016, J BIOMECH, V49, P1221, DOI 10.1016/j.jbiomech.2016.02.035; Rafizadeh S, 2014, P NATL ACAD SCI USA, V111, P9989, DOI 10.1073/pnas.1323541111; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Sailer CA, 2002, J NEUROSCI, V22, P9698; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Voos P, 2017, EUR BIOPHYS J BIOPHY, V46, P517, DOI 10.1007/s00249-016-1196-0; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zhang J, 2017, BIOPHYS J, V112, P143, DOI 10.1016/j.bpj.2016.11.3204; Zhang Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005567; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	37	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1794	1805		10.1096/fj.201700605R	http://dx.doi.org/10.1096/fj.201700605R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29180442	Green Published			2022-12-26	WOS:000429051400005
J	Wu, MR; Liu, HM; Lu, CW; Shen, WH; Lin, IJ; Liao, LW; Huang, YY; Shieh, MJ; Hsiao, JK				Wu, Menq-Rong; Liu, Hon-Man; Lu, Chen-Wen; Shen, Way-Hone; Lin, I-Jou; Liao, Li-Wen; Huang, Yi-You; Shieh, Ming-Jium; Hsiao, Jong-Kai			Organic anion-transporting polypeptide 1B3 as a dual reporter gene for fluorescence and magnetic resonance imaging	FASEB JOURNAL			English	Article						IVIS; cell tracking; ICG; Gd-EOB-DTPA; near-infrared	GD-EOB-DTPA; HEPATIC-UPTAKE; CONTRAST; MRI; AGENT; RECEPTOR; LIGHT; OATPS	Reporter proteins have broad applications in visualizing molecular events at the cellular, tissue and whole-body levels. Transmembrane transporters recognizing specific molecular domains are of particular interest because they enable the migration of signal-source molecules from the extracellular space to the cytoplasm for subsequent application in multimodality imaging. Organic anion-transporting polypeptides (OATPs) have demonstrated their MRI reporter efficacy. We further expanded their use as a dual-modality reporter in MRI and noninvasive in vivo imaging system (IVIS). We overexpressed OATP1B3 in the HT-1080 sarcoma cell line. Both Gd-EOB-DTPA, an MRI contrast agent, and indocyanine green (ICG), a near-infrared fluorescent dye that provides better deep-tissue detection because of its long wave length, could be delivered to the intracellular space and imaged in a tumor-bearing nude mouse model. Our in vivo dual-imaging reporter system achieved high sensitivity in MRI and observation periods lasting as long as 96 h in IVIS. Because of the superior temporal and spatial resolutions and the clinical availability of both ICG and Gd-EOB-DTPA, this dual-imaging OATP1B3 system will find biomedical use in tumor biology, stem cell trafficking, and tissue engineering.	[Wu, Menq-Rong; Huang, Yi-You; Shieh, Ming-Jium] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Liu, Hon-Man] Natl Taiwan Univ, Dept Med Imaging, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Hon-Man] Natl Taiwan Univ, Dept Radiol, Coll Med, Taipei, Taiwan; [Wu, Menq-Rong; Lu, Chen-Wen; Shen, Way-Hone; Lin, I-Jou; Liao, Li-Wen; Hsiao, Jong-Kai] Taipei TzuChi Gen Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Imaging, New Taipei, Taiwan; [Liu, Hon-Man] Fu Jen Catholic Univ & Hosp, Dept Radiol & Med Imaging, New Taipei, Taiwan; [Lu, Chen-Wen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Hsiao, Jong-Kai] Tzu Chi Univ, Sch Med, Hualien, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan Normal University; Tzu Chi University	Hsiao, JK (corresponding author), Taipei Tzu Chi Hosp, Dept Med Imaging, 289 Jianguo Rd, New Taipei 23142, Taiwan.	jongkai@gmail.com		LIU, HON-MAN/0000-0001-6715-6366; Wu, Menq-Rong/0000-0002-6139-8062	National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan) [MOST 105-2325-B-001-010]; Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); National Science Council [NSC 99-2314-B-303-012-MY3, 102-2628-B-303-001-MY3, 103-2314-B-303-001-MY3]; Taiwan Ministry of Science and Technology	National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan); Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Science and Technology	The authors thank the 7-T Animal MRI Core Lab of the Molecular Imaging Center (National Taiwan University) for providing technical and facility support; the Taiwan Mouse Clinic, which is funded by the National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan; Grant MOST 105-2325-B-001-010) for providing technical support for the IVIS experiment, and the staff of the Core Labs Department of Medical Research (National Taiwan University Hospital) for providing technical support. Financial support was provided by The Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); and by Grant NSC 99-2314-B-303-012-MY3, 102-2628-B-303-001-MY3 and 103-2314-B-303-001-MY3 from the National Science Council, and the Taiwan Ministry of Science and Technology to J.H. The authors declare no conflicts of interest.	Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; de Graaf W, 2011, J HEPATOL, V54, P738, DOI 10.1016/j.jhep.2010.07.047; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; Gilad AA, 2008, J NUCL MED, V49, P1905, DOI 10.2967/jnumed.108.053520; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Hoogstins CES, 2016, CLIN CANCER RES, V22, P2929, DOI 10.1158/1078-0432.CCR-15-2640; Ito A, 2014, GASTRIC CANCER, V17, P497, DOI 10.1007/s10120-013-0316-0; Judy RP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16208; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Laufer J, 2013, BIOMED OPT EXPRESS, V4, P2477, DOI 10.1364/BOE.4.002477; Laufer J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056016; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Maruyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122849; Muhler A., 1993, MAGMA MAGN RESON MAT, V1, P134; Murata M, 2014, EUR J PHARM BIOPHARM, V86, P115, DOI 10.1016/j.ejpb.2013.09.006; Patrick PS, 2014, MOL IMAGING BIOL, V16, P626, DOI 10.1007/s11307-014-0741-4; Patrick PS, 2014, P NATL ACAD SCI USA, V111, P415, DOI 10.1073/pnas.1319000111; Qin CX, 2013, SCI REP-UK, V3, DOI 10.1038/srep01490; Sabapathy V, 2015, STEM CELLS INT, V2015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonitzer V, 2014, J NUCL MED, V55, P1342, DOI 10.2967/jnumed.113.134775; Serganova I, 2012, NUCL MED REV, V15, pC20; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Thakkar N, 2015, AAPS J, V17, P535, DOI 10.1208/s12248-015-9740-x; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Vandsburger MH, 2013, NMR BIOMED, V26, P872, DOI 10.1002/nbm.2869; Weber J, 2016, NAT METHODS, V13, P639, DOI [10.1038/NMETH.3929, 10.1038/nmeth.3929]; Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	35	23	24	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1705	1715		10.1096/fj.201700767R	http://dx.doi.org/10.1096/fj.201700767R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146731	Green Published, hybrid			2022-12-26	WOS:000427246000046
J	Lv, B; Sun, HL; Huang, S; Feng, XD; Jiang, T; Li, C				Lv, Bo; Sun, Hanli; Huang, Shen; Feng, Xudong; Jiang, Tao; Li, Chun			Structure-guided engineering of the substrate specificity of a fungal -glucuronidase toward triterpenoid saponins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mutation; glycoside hydrolase; protein engineering; substrate specificity; fungal -glucuronidase; triterpenoid saponins	GLYCYRRHETIC ACID MONOGLUCURONIDE; CODE SATURATION MUTAGENESIS; MAIZE BETA-GLUCOSIDASE; HUMAN INTESTINAL FLORA; CANCER DRUG TOXICITY; AGLYCONE SPECIFICITY; CRYSTAL-STRUCTURES; HYDROLASE; INSIGHTS; COMPLEX	Glycoside hydrolases (GHs) have attracted special attention in research aimed at modifying natural products by partial removal of sugar moieties to manipulate their solubility and efficacy. However, these modifications are challenging to control because the low substrate specificity of most GHs often generates undesired by-products. We previously identified a GH2-type fungal -glucuronidase from Aspergillus oryzae (PGUS) exhibiting promiscuous substrate specificity in hydrolysis of triterpenoid saponins. Here, we present the PGUS structure, representing the first structure of a fungal -glucuronidase, and that of an inactive PGUS mutant in complex with the native substrate glycyrrhetic acid 3-O-mono--glucuronide (GAMG). PGUS displayed a homotetramer structure with each monomer comprising three distinct domains: a sugar-binding, an immunoglobulin-like -sandwich, and a TIM barrel domain. Two catalytic residues, Glu(414) and Glu(505), acted as acid/base and nucleophile, respectively. Structural and mutational analyses indicated that the GAMG glycan moiety is recognized by polar interactions with nine residues (Asp(162), His(332), Asp(414), Tyr(469), Tyr(473), Asp(505), Arg(563), Asn(567), and Lys(569)) and that the aglycone moiety is recognized by aromatic stacking and by a interaction with the four aromatic residues Tyr(469), Phe(470), Trp(472), and Tyr(473). Finally, structure-guided mutagenesis to precisely manipulate PGUS substrate specificity in the biotransformation of glycyrrhizin into GAMG revealed that two amino acids, Ala(365) and Arg(563), are critical for substrate specificity. Moreover, we obtained several mutants with dramatically improved GAMG yield (>95%). Structural analysis suggested that modulating the interaction of -glucuronidase simultaneously toward glycan and aglycone moieties is critical for tuning its substrate specificity toward triterpenoid saponins.	[Lv, Bo; Huang, Shen; Feng, Xudong; Li, Chun] Beijing Inst Technol, Sch Chem & Chem Engn, Inst Biotransformat & Synthet Biosyst, Dept Biochem Engn, Beijing 100081, Peoples R China; [Sun, Hanli; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, C (corresponding author), Beijing Inst Technol, Sch Chem & Chem Engn, Inst Biotransformat & Synthet Biosyst, Dept Biochem Engn, Beijing 100081, Peoples R China.	lichun@bit.edu.cn			National Natural Science Foundation of China [21606019, 21506011]; National Natural Science Fund for Distinguished Young Scholars of China [21425624]; Basic Research Foundation of Beijing Institute of Technology [20151642001]; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education [2015202]; Strategic Priority Research Program [XDB08010301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Basic Research Foundation of Beijing Institute of Technology; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education; Strategic Priority Research Program(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 21606019 and 21506011; National Natural Science Fund for Distinguished Young Scholars of China Grant 21425624; Basic Research Foundation of Beijing Institute of Technology Grant 20151642001; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education Grant 2015202; and The Strategic Priority Research Program Grant XDB08010301. The authors declare that they have no conflicts of interest with the contents of this article.	Akao T, 2000, BIOL PHARM BULL, V23, P1418, DOI 10.1248/bpb.23.1418; Akao T, 2001, BIOL PHARM BULL, V24, P1108, DOI 10.1248/bpb.24.1108; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito-Arias Marco, 2007, P1; Chouiter R, 2008, J MOL CATAL B-ENZYM, V50, P114, DOI 10.1016/j.molcatb.2007.09.015; Cicek M, 2000, J BIOL CHEM, V275, P20002, DOI 10.1074/jbc.M001609200; Czjzek M, 2001, BIOCHEM J, V354, P37, DOI 10.1042/0264-6021:3540037; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Iglesias-Fernandez J, 2015, CHEM SCI, V6, P1167, DOI 10.1039/c4sc02240h; Ikram NKBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00129; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Jensen M, 2011, BIOORGAN MED CHEM, V19, P2407, DOI 10.1016/j.bmc.2011.02.016; Karmazyn M, 2011, DRUGS, V71, P1989, DOI 10.2165/11594300-000000000-00000; Koleva II, 2012, MOL NUTR FOOD RES, V56, P30, DOI 10.1002/mnfr.201100165; Krahulec J, 2007, APPL MICROBIOL BIOT, V74, P1016, DOI 10.1007/s00253-006-0745-3; Luan ZJ, 2015, CATAL SCI TECHNOL, V5, P2622, DOI 10.1039/c5cy00085h; Madeira JV, 2015, CRIT REV BIOTECHNOL, V35, P75, DOI 10.3109/07388551.2013.803020; Maeda Y, 2008, INTERNAL MED, V47, P1345, DOI 10.2169/internalmedicine.47.1080; Michikawa M, 2012, J BIOL CHEM, V287, P14069, DOI 10.1074/jbc.M112.346288; MIZUTANI K, 1994, BIOSCI BIOTECH BIOCH, V58, P554, DOI 10.1271/bbb.58.554; Naz H, 2013, REJUV RES, V16, P352, DOI 10.1089/rej.2013.1407; Nishizawa K, 2014, J VIROL, V88, P4083, DOI 10.1128/JVI.03775-13; Pentzold S, 2014, BIOL REV, V89, P531, DOI 10.1111/brv.12066; Poo H, 2002, BIOTECHNOL LETT, V24, P1185, DOI 10.1023/A:1016107230825; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Saino H, 2014, J BIOL CHEM, V289, P16826, DOI 10.1074/jbc.M114.553271; Sakurama H, 2014, APPL MICROBIOL BIOT, V98, P4021, DOI 10.1007/s00253-013-5325-8; Seki H, 2015, PLANT CELL PHYSIOL, V56, P1463, DOI 10.1093/pcp/pcv062; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Sun ZT, 2016, ACS CATAL, V6, P1590, DOI 10.1021/acscatal.5b02751; Sun ZT, 2016, ACS CATAL, V6, P1598, DOI 10.1021/acscatal.5b02752; Tankrathok A, 2013, ACTA CRYSTALLOGR D, V69, P2124, DOI 10.1107/S0907444913020568; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Xu LH, 2006, BIOTECHNIQUES, V41, P319, DOI 10.2144/000112219	40	18	22	4	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					433	443		10.1074/jbc.M117.801910	http://dx.doi.org/10.1074/jbc.M117.801910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29146597	Green Published, hybrid			2022-12-26	WOS:000419915400003
J	Watts, JS; Morton, DG; Kemphues, KJ; Watts, JL				Watts, Jason S.; Morton, Diane G.; Kemphues, Kenneth J.; Watts, Jennifer L.			The biotin-ligating protein BPL-1 is critical for lipid biosynthesis and polarization of the Caenorhabditis elegans embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotin; Caenorhabditis elegans (C; elegans); cell polarity; development; embryo; polyunsaturated fatty acid (PUFA)	MULTIPLE CARBOXYLASE DEFICIENCY; HUMAN HOLOCARBOXYLASE SYNTHETASE; FATTY-ACID OXIDATION; C-ELEGANS; MALONYL-COA; INTERMEDIARY METABOLISM; GENE; BIOTINYLATION; TEMPERATURE; DESATURASE	Biotin is an essential cofactor for multiple metabolic reactions catalyzed by carboxylases. Biotin is covalently linked to apoproteins by holocarboxylase synthetase (HCS). Accordingly, some mutations in HCS cause holocarboxylase deficiency, a rare metabolic disorder that can be life-threatening if left untreated. However, the long-term effects of HCS deficiency are poorly understood. Here, we report our investigations of bpl-1, which encodes the Caenorhabditis elegans ortholog of HCS. We found that mutations in the biotin-binding region of bpl-1 are maternal-effect lethal and cause defects in embryonic polarity establishment, meiosis, and the integrity of the eggshell permeability barrier. We confirmed that BPL-1 biotinylates four carboxylase enzymes, and we demonstrate that BPL-1 is required for efficient de novo fatty acid biosynthesis. We also show that the lack of larval growth defects as well as nearly normal fatty acid composition in young adult worms is due to sufficient fatty acid precursors provided by dietary bacteria. However, BPL-1 disruption strongly decreased levels of polyunsaturated fatty acids in embryos produced by bpl-1 mutant hermaphrodites, revealing a critical role for BPL-1 in lipid biosynthesis during embryogenesis and demonstrating that dietary fatty acids and lipid precursors are not adequate to support early embryogenesis in the absence of BPL-1. Our findings highlight that studying BPL-1 function in C. elegans could help dissect the roles of this important metabolic enzyme under different environmental and dietary conditions.	[Watts, Jason S.; Watts, Jennifer L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Watts, Jason S.; Watts, Jennifer L.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Morton, Diane G.; Kemphues, Kenneth J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Washington State University; Washington State University; Cornell University	Watts, JL (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@vetmed.wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639	National Science Foundation/Biological Infrastructure/Living Collections program [DBI-0742708]; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079112, T32GM083864] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Science Foundation/Biological Infrastructure/Living Collections program; National Institutes of Health Office of Research Infrastructure Programs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Bacterial strains were provided by the Coli Genetic Stock Center, supported by National Science Foundation/Biological Infrastructure/Living Collections program Grant DBI-0742708. Nematode strains were provided by the Caenorhabditis Genetics Center, funded by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440. We thank Liam Coyne for assistance with early bpl-1 RNAi experiments.	Bao BL, 2011, BIOCHEM BIOPH RES CO, V412, P115, DOI 10.1016/j.bbrc.2011.07.055; Benenati G, 2009, MECH DEVELOP, V126, P382, DOI 10.1016/j.mod.2009.02.001; Boyd L, 1996, DEVELOPMENT, V122, P3075; Brennan LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075712; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; Dancy BCR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141850; Deline ML, 2013, JOVE-J VIS EXP, DOI 10.3791/50879; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gurvitz A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007791; HARDER ME, 1972, P NATL ACAD SCI USA, V69, P3105, DOI 10.1073/pnas.69.11.3105; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; KEMPHUES KJ, 1988, GENETICS, V120, P977; Lin CCJ, 2017, NAT CELL BIOL, V19, P550, DOI 10.1038/ncb3515; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mock DM, 2009, J NUTR, V139, P154, DOI 10.3945/jn.108.095273; MOORE J H, 1979, Progress in Lipid Research, V17, P347, DOI 10.1016/0079-6832(79)90012-0; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; POSTBEITTENMILLER D, 1992, PLANT PHYSIOL, V100, P923, DOI 10.1104/pp.100.2.923; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Reche PA, 2000, PROTEIN SCI, V9, P1922, DOI 10.1110/ps.9.10.1922; Rios-Avila L, 2011, CLIN CHIM ACTA, V412, P735, DOI 10.1016/j.cca.2010.12.031; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rose Lesilee, 2014, WormBook, P1, DOI 10.1895/wormbook.1.30.2; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; Sternicki LM, 2017, TRENDS BIOCHEM SCI, V42, P383, DOI 10.1016/j.tibs.2017.02.001; Stiernagle T., 2006, WORMBOOK, DOI [10.1895/wormbook.1.1010.1, DOI 10.1895/W0RMB00K.1.1010.1]; Suzuki Y, 2005, HUM MUTAT, V26, P285, DOI 10.1002/humu.20204; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; TAKAMURA Y, 1988, J GEN MICROBIOL, V134, P2249; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tang HY, 2017, CELL, V169, P457, DOI 10.1016/j.cell.2017.03.049; Trujillo-Gonzalez I, 2014, MOL GENET METAB, V111, P321, DOI 10.1016/j.ymgme.2013.10.016; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Verbrugghe KJC, 2011, JOVE-J VIS EXP, DOI 10.3791/2625; Watson E, 2016, ELIFE, V5, DOI 10.7554/eLife.17670; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; WOLF B, 1981, PEDIATRICS, V68, P113; Yang X, 2001, HUM GENET, V109, P526, DOI 10.1007/s004390100603; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zempleni J, 2014, NUTR REV, V72, P369, DOI 10.1111/nure.12103; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429	55	12	12	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					610	622		10.1074/jbc.M117.798553	http://dx.doi.org/10.1074/jbc.M117.798553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158261	Green Published, hybrid			2022-12-26	WOS:000419915400017
J	Dalton, CM; El-Sabaawi, RW; Honeyfield, DC; Auer, SK; Reznick, DN; Flecker, AS				Dalton, Christopher M.; El-Sabaawi, Rana W.; Honeyfield, Dale C.; Auer, Sonya K.; Reznick, David N.; Flecker, Alexander S.			The influence of dietary and whole-body nutrient content on the excretion of a vertebrate consumer	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; GUPPIES POECILIA-RETICULATA; TRINIDADIAN GUPPIES; ORGANISMAL STOICHIOMETRY; ECOLOGICAL STOICHIOMETRY; PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; METABOLIC THEORY; FISH; GROWTH	In many contexts, nutrient excretion by consumers can impact ecosystems by altering the availability of limiting nutrients. Variation in nutrient excretion can be predicted by mass balance models, most of which are premised on two key ideas: (1) consumers maintain fixed whole-body nutrient content (i. e., % N and % P), so-called fixed homeostasis; (2) if dietary nutrients are not matched to whole-body nutrients, excesses of any nutrient are released as excretion to maintain fixed homeostasis. Mass balance models thus predict that consumer excretion should be positively correlated with diet nutrients and negatively correlated with whole-body nutrients. Recent meta-analyses and field studies, however, have often failed to find these expected patterns, potentially because of a confounding influence-flexibility in whole-body nutrient content with diet quality (flexible homeostasis). Here, we explore the impact of flexible homeostasis on nutrient excretion by comparing the N and P excretion of four genetically diverged Trinidadian guppy (Poecilia reticulata) populations when reared on diets of variable P content. As predicted by mass balance, P excretion increased on the high-P diet, but, contrary to the notion of fixed homeostasis, guppy whole-body % P also increased on the high-P diet. While there was no overall correlation between excretion nutrients and whole-body nutrients, when the effect of diet on both whole-body and excretion nutrients was included, we detected the expected negative correlation between whole-body N: P and excretion N: P. This last result suggests that mass balance can predict excretion rates within species, but only if dietary effects on whole-body nutrient content are controlled. Flexible homeostasis can obscure patterns predicted by mass balance, creating an imperative to accurately capture an organism's diet quality in predicting its excretion rate.	[Dalton, Christopher M.; Flecker, Alexander S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [El-Sabaawi, Rana W.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Honeyfield, Dale C.] US Geol Survey, Northern Appalachian Res Lab, Wellsboro, PA USA; [Auer, Sonya K.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Cornell University; University of Victoria; United States Department of the Interior; United States Geological Survey; University of Glasgow; University of California System; University of California Riverside	Dalton, CM (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA.	cmd273@cornell.edu		reznick, david/0000-0002-1144-0568	US National Science Foundation Frontiers in Integrative Biological Research Grant [DEB 0623632]; Cornell University Program in Biogeochemistry and Environmental Biocomplexity Small Grant; Cornell University Andrew W. Mellon Foundation Grant for Student Research	US National Science Foundation Frontiers in Integrative Biological Research Grant; Cornell University Program in Biogeochemistry and Environmental Biocomplexity Small Grant; Cornell University Andrew W. Mellon Foundation Grant for Student Research	Funding for this research was provided by a US National Science Foundation Frontiers in Integrative Biological Research Grant (DEB 0623632), the Cornell University Program in Biogeochemistry and Environmental Biocomplexity Small Grant, and the Cornell University Andrew W. Mellon Foundation Grant for Student Research.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allgeier JE, 2015, P NATL ACAD SCI USA, V112, pE2640, DOI 10.1073/pnas.1420819112; Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benstead JP, 2014, ECOLOGY, V95, P2768, DOI 10.1890/13-1859.1; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Dalton CM, 2014, METABOLIC STOICHIOME, P691; De Silva S.G., 1995, FISH NUTR AQUACULTUR, P319; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; Durston DJ, 2017, FUNCT ECOL, V31, P2128, DOI 10.1111/1365-2435.12919; El-Sabaawi RW, 2016, OECOLOGIA, V181, P1209, DOI 10.1007/s00442-016-3599-0; El-Sabaawi RW, 2015, FRESHWATER BIOL, V60, P590, DOI 10.1111/fwb.12507; El-Sabaawi RW, 2012, FUNCT ECOL, V26, P666, DOI 10.1111/j.1365-2435.2012.01974.x; El-Sabaawi RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032713; FRASER DF, 1987, BEHAV ECOL SOCIOBIOL, V21, P203, DOI 10.1007/BF00292500; GILLIAM JF, 1993, ECOLOGY, V74, P1856, DOI 10.2307/1939943; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Halvorson HM, 2016, FRESHW SCI, V35, P1103, DOI 10.1086/689212; Handelsman CA, 2013, INTEGR COMP BIOL, V53, P975, DOI 10.1093/icb/ict057; Hendrixson HA, 2007, J FISH BIOL, V70, P121, DOI 10.1111/j.1095-8649.2006.01280.x; Higgins KA, 2006, OIKOS, V114, P419; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Kajimura M, 2004, J EXP BIOL, V207, P1993, DOI 10.1242/jeb.00901; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Layman CA, 2013, ECOLOGY, V94, P530, DOI 10.1890/12-0705.1; Leal MC, 2017, ECOL EVOL, V7, P2617, DOI 10.1002/ece3.2802; McIntyre PB, 2010, AM FISH S S, V73, P539; McManamay RA, 2011, J N AM BENTHOL SOC, V30, P84, DOI 10.1899/09-152.1; Mitra A, 2007, AM NAT, V169, P632, DOI 10.1086/513187; MOMMSEN TP, 1992, EXPERIENTIA, V48, P583, DOI 10.1007/BF01920243; Moody EK, 2015, FRESHWATER BIOL, V60, P456, DOI 10.1111/fwb.12500; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Pilati A, 2007, OIKOS, V116, P1663, DOI 10.1111/j.2007.0030-1299.15970.x; R-Team DC, 2010, R LANG ENV STAT COMP; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; REZNICK D, 1983, ECOLOGY, V64, P862, DOI 10.2307/1937209; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Rodehutscord M, 2000, AQUACULTURE, V188, P383, DOI 10.1016/S0044-8486(00)00341-0; Saba GK, 2009, MAR ECOL PROG SER, V386, P147, DOI 10.3354/meps08070; Schindler DE, 1997, ECOLOGY, V78, P1816; SHIM KF, 1989, NIPPON SUISAN GAKK, V55, P1947; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Song ZB, 2011, ETHOLOGY, V117, P1009, DOI 10.1111/j.1439-0310.2011.01952.x; Stainton MP, 1977, FISH MAR SERV MISC S, V2, P25; Sterner RW, 2000, ECOLOGY, V81, P127, DOI 10.1890/0012-9658(2000)081[0127:CNAPSO]2.0.CO;2; STERNER RW, 1990, AM NAT, V136, P209, DOI 10.1086/285092; STERNER RW, 1992, BIOGEOCHEMISTRY, V17, P49; Sullam KE, 2015, OECOLOGIA, V177, P245, DOI 10.1007/s00442-014-3158-5; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Torres LE, 2007, OIKOS, V116, P259, DOI 10.1111/j.2006.0030-1299.15268.x; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; Vanni MJ, 2016, ECOLOGY, V97, P3460, DOI 10.1002/ecy.1582; Vanni MJ, 2013, ECOLOGY, V94, P2195, DOI 10.1890/12-1559.1; Villeger S, 2012, FRESHWATER BIOL, V57, P2330, DOI 10.1111/fwb.12009; Vrede T, 2011, OIKOS, V120, P886, DOI 10.1111/j.1600-0706.2010.18939.x; Whiles MR, 2009, LIMNOL OCEANOGR-METH, V7, P1; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Zandona E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136079; Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x	65	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187931	10.1371/journal.pone.0187931	http://dx.doi.org/10.1371/journal.pone.0187931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176898	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000416291900023
J	Koschmieder, J; Fehling-Kaschek, M; Schaub, P; Ghisla, S; Brausemann, A; Timmer, J; Beyer, P				Koschmieder, Julian; Fehling-Kaschek, Mirjam; Schaub, Patrick; Ghisla, Sandro; Brausemann, Anton; Timmer, Jens; Beyer, Peter			Plant-type phytoene desaturase: Functional evaluation of structural implications	PLOS ONE			English	Article							PLASTID TERMINAL OXIDASE; CAROTENOID BIOSYNTHESIS; MOLECULAR-OXYGEN; ZETA-CAROTENE; GENE; CHROMOPLASTS; TANGERINE; LYCOPENE; REVEALS; PATHWAY	Phytoene desaturase (PDS) is an essential plant carotenoid biosynthetic enzyme and a prominent target of certain inhibitors, such as norflurazon, acting as bleaching herbicides. PDS catalyzes the introduction of two double bonds into 15-cis-phytoene, yielding 9,15,9'tri- cis-.-carotene via the intermediate 9,15-di-cis-phytofluene. We present the necessary data to scrutinize functional implications inferred from the recently resolved crystal structure of Oryza sativa PDS in a complex with norflurazon. Using dynamic mathematical modeling of reaction time courses, we support the relevance of homotetrameric assembly of the enzyme observed in crystallo by providing evidence for substrate channeling of the intermediate phytofluene between individual subunits at membrane surfaces. Kinetic investigations are compatible with an ordered ping-pong bi-bi kinetic mechanism in which the carotene and the quinone electron acceptor successively occupy the same catalytic site. The mutagenesis of a conserved arginine that forms a hydrogen bond with norflurazon, the latter competing with plastoquinone, corroborates the possibility of engineering herbicide resistance, however, at the expense of diminished catalytic activity. This mutagenesis also supports a "flavin only" mechanism of carotene desaturation not requiring charged residues in the active site. Evidence for the role of the central 15-cis double bond of phytoene in determining regio-specificity of carotene desaturation is presented.	[Koschmieder, Julian; Schaub, Patrick; Beyer, Peter] Univ Freiburg, Fac Biol, Freiburg, Germany; [Fehling-Kaschek, Mirjam; Timmer, Jens] Univ Freiburg, Dept Phys, Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, Constance, Germany; [Brausemann, Anton] Univ Freiburg, Inst Biochem, Freiburg, Germany; [Timmer, Jens; Beyer, Peter] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Konstanz; University of Freiburg; University of Freiburg	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Freiburg, Germany.; Timmer, J (corresponding author), Univ Freiburg, Dept Phys, Freiburg, Germany.; Timmer, J; Beyer, P (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany.	jeti@fdm.uni-freiburg.de; peter.beyer@biologie.uni-freiburg.de	Schaub, Patrick/C-8358-2018		BMBF [Her2Low, 031A429B]; European Union Program 7 METAPRO [244348]; HarvestPlus Research consortium [2014H6320.FRE]; Ministry of Science, Research and the Arts Baden-Wuerttemberg within the Brigitte-Schlieben-Lange program; Joachim Herz Foundation; LGFG of the federal state Baden-Wuerttemberg	BMBF(Federal Ministry of Education & Research (BMBF)); European Union Program 7 METAPRO; HarvestPlus Research consortium; Ministry of Science, Research and the Arts Baden-Wuerttemberg within the Brigitte-Schlieben-Lange program; Joachim Herz Foundation; LGFG of the federal state Baden-Wuerttemberg	This work was supported by the BMBF (Her2Low, No. 031A429B, to JT), by the European Union Program 7 METAPRO (No. 244348, to PB), the HarvestPlus Research consortium (2014H6320.FRE, to PB), the Ministry of Science, Research and the Arts Baden-Wuerttemberg within the Brigitte-Schlieben-Lange program and by the Joachim Herz Foundation (to MFK) and the LGFG of the federal state Baden-Wuerttemberg (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Arias RS, 2006, PLANT BIOTECHNOL J, V4, P263, DOI 10.1111/j.1467-7652.2006.00179.x; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Brausemann A, 2017, STRUCTURE, V25, P1222, DOI 10.1016/j.str.2017.06.002; Bruno M, 2016, J EXP BOT, V67, P5993, DOI 10.1093/jxb/erw356; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; CLOUGH JM, 1979, J CHEM SOC CHEM COMM, P616, DOI 10.1039/c39790000616; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; EBENEZER WJ, 1993, J CHEM SOC PERK T 1, P1869, DOI 10.1039/p19930001869; ESPOSTI MD, 1981, ARCH BIOCHEM BIOPHYS, V210, P21, DOI 10.1016/0003-9861(81)90159-4; Gemmecker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131717; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; HAMILTON RL, 1980, J LIPID RES, V21, P981; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huang JC, 2008, J PHYCOL, V44, P684, DOI 10.1111/j.1529-8817.2008.00511.x; HUGUENEY P, 1992, EUR J BIOCHEM, V209, P399, DOI 10.1111/j.1432-1033.1992.tb17302.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Kaschek D, 2016, DYNAMIC MODELING PAR; Laber B, 1999, PESTIC BIOCH PHYSL; Liu J, 2013, PROCESS BIOCHEM, V48, P788, DOI 10.1016/j.procbio.2013.04.020; Liu J, 2010, PLANTA, V232, P61, DOI 10.1007/s00425-010-1132-y; MARTINEZFEREZ I, 1994, PESTIC BIOCHEM PHYS, V48, P185, DOI 10.1006/pest.1994.1019; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Rodriguez-Concepcion M, CAROTENOID BIOSYNTHE; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i03; Vazquez A-O, 2014, PLANT CELL, V26, P2524; Yu QJ, 2014, BBA-BIOENERGETICS, V1837, P1284, DOI 10.1016/j.bbabio.2014.04.007; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843	41	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187628	10.1371/journal.pone.0187628	http://dx.doi.org/10.1371/journal.pone.0187628			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176862	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900012
J	Pan, JH; Lim, Y; Kim, JH; Heo, W; Lee, KY; Shin, HJ; Kim, JK; Lee, JH; Kim, YJ				Pan, Jeong Hoon; Lim, Yejin; Kim, Jun Ho; Heo, Wan; Lee, Ki Yong; Shin, Hye Ji; Kim, Jae Kyeom; Lee, Jin Hyup; Kim, Young Jun			Root bark of Ulmus davidiana var. japonica restrains acute alcohol-induced hepatic steatosis onset in mice by inhibiting ROS accumulation	PLOS ONE			English	Article							INDUCED LIVER-INJURY; SYNTHESIZED FATTY-ACIDS; NF-KAPPA-B; OXIDATIVE STRESS; ANTIINFLAMMATORY ACTIVITY; LIPID-METABOLISM; DIETARY ADIPOSE; KUPFFER CELLS; ETHANOL; DISEASE	Alcohol-induced hepatic steatosis and inflammation are key drivers of alcohol-induced liver injury, mainly caused by oxidative stress. The roots bark of Ulmus davidiana var. japonica is well known for its substantial antioxidative and antitumorigenic potency. In this study, we examined whether this plant can ameliorate alcohol -induced liver injuries characterized by hepatic steatosis and inflammation through its antioxidative activity. C57BL/6J mice were treated with the root bark extract of Ulmus davidiana var. japonica (RUE; 100 mg of extract/kg bodyweight; oral gavage) and alcohol (1 g/kg of bodyweight; oral gavage) for 5 days. Markers of acute alcohol -induced hepatic steatosis were determined and putative molecular mechanisms responsible for the protection of RUE were investigated. RUE noticeably protected against alcohol -induced hepatic steatosis and inflammation. Reactive oxygen species (ROS), over-produced by alcohol, negatively orchestrated various signaling pathways involved in the lipid metabolism and inflammation. These pathways were restored through the ROS scavenging activity of RUE in the liver. In particular, the expression of lipogenic genes (e.g., SREBP-1, ACC, and FAS) and inflammatory cytokines (e.g., IL-1(3, and NF-kappa B p65) significantly decreased with RUE treatment. Conversely, the expression of fatty acid oxidation-related genes (e.g., SI RT1, AMPK alpha, and PGC1 alpha) were increased in mice treated with RUE. Thus, the results indicate that RUE counteracts and thus attenuates alcoholic hepatic steatosis onset in mice, possibly by suppressing ROS-mediated steatosis and inflammation.	[Pan, Jeong Hoon; Lim, Yejin; Kim, Jun Ho; Heo, Wan; Lee, Jin Hyup; Kim, Young Jun] Korea Univ, Dept Food & Biotechnol, Sejong, South Korea; [Pan, Jeong Hoon; Kim, Jae Kyeom] Univ Arkansas, Sch Human Environm Sci, Fayetteville, AR 72701 USA; [Lee, Ki Yong; Shin, Hye Ji] Korea Univ, Coll Pharm, Sejong, South Korea	Korea University; University of Arkansas System; University of Arkansas Fayetteville; Korea University	Lee, JH; Kim, YJ (corresponding author), Korea Univ, Dept Food & Biotechnol, Sejong, South Korea.; Kim, JK (corresponding author), Univ Arkansas, Sch Human Environm Sci, Fayetteville, AR 72701 USA.	jkk003@uark.edu; jinhyuplee@korea.ac.kr; yk46@korea.ac.kr			International Science and Business Belt Program through the Ministry of Science, ICT and Future Planning [2015K000388]	International Science and Business Belt Program through the Ministry of Science, ICT and Future Planning	The research was supported by the International Science and Business Belt Program through the Ministry of Science, ICT and Future Planning (Grant Number: 2015K000388).	Bharrhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020635; Cao Q, 2002, BIOCHEM BIOPH RES CO, V294, P849, DOI 10.1016/S0006-291X(02)00586-7; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Choi SY, 2010, J MED FOOD, V13, P1019, DOI 10.1089/jmf.2009.1207; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Gobejishvili L, 2006, AM J PHYSIOL-GASTR L, V291, pG681, DOI 10.1152/ajpgi.00098.2006; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hou ZH, 2010, J AGR FOOD CHEM, V58, P3191, DOI 10.1021/jf904407x; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jung HJ, 2008, BIOMOL THER, V16, P9, DOI 10.4062/biomolther.2008.16.1.009; Jung MJ, 2008, FOOD CHEM, V108, P482, DOI 10.1016/j.foodchem.2007.10.081; Jung MJ, 2010, FOOD CHEM, V120, P313, DOI 10.1016/j.foodchem.2009.09.085; Kim YC, 2007, FITOTERAPIA, V78, P196, DOI 10.1016/j.fitote.2006.11.013; Koch Osvaldo R., 2004, Molecular Aspects of Medicine, V25, P191, DOI 10.1016/j.mam.2004.02.019; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; LIEBER CS, 1966, J CLIN INVEST, V45, P1400, DOI 10.1172/JCI105448; LIEBER CS, 1966, J CLIN INVEST, V45, P51, DOI 10.1172/JCI105323; Lluis JM, 2003, GASTROENTEROLOGY, V124, P708, DOI 10.1053/gast.2003.50089; Mendez-Sanchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Pan JH, 2016, J FUNCT FOODS, V25, P135, DOI 10.1016/j.jff.2016.04.024; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shivashankara AR, 2012, FOOD FUNCT, V3, P101, DOI 10.1039/c1fo10170f; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Song YX, 2016, J DAIRY SCI, V99, P9184, DOI 10.3168/jds.2016-11219; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Sun Q, 2016, ALCOHOL CLIN EXP RES, V40, P2076, DOI 10.1111/acer.13172; Tang CC, 2013, FOOD CHEM TOXICOL, V62, P786, DOI 10.1016/j.fct.2013.10.011; Tang YH, 2012, FOOD CHEM TOXICOL, V50, P1194, DOI 10.1016/j.fct.2012.02.008; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang SG, 2016, ALCOHOL CLIN EXP RES, V40, P1215, DOI 10.1111/acer.13078; Xiong SG, 2003, ALCOHOL, V30, P107, DOI 10.1016/S0741-8329(03)00100-9; Yang LL, 2012, FREE RADICAL BIO MED, V53, P1170, DOI 10.1016/j.freeradbiomed.2012.06.029; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2015, HEPATOBIL SURG NUTR, V4, P88, DOI 10.3978/j.issn.2304-3881.2014.12.06; Zheng MS, 2011, ARCH PHARM RES, V34, P1443, DOI 10.1007/s12272-011-0905-6; Zheng MS, 2010, BIOMOL THER, V18, P321, DOI 10.4062/biomolther.2010.18.3.321	44	19	20	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188381	10.1371/journal.pone.0188381	http://dx.doi.org/10.1371/journal.pone.0188381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176803	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900068
J	Pan, S; Liu, Y; Si, Y; Zhang, Q; Wang, L; Liu, JW; Wang, CL; Xiao, SQ				Pan, Shuang; Liu, Yi; Si, Yi; Zhang, Qiang; Wang, Lin; Liu, Jianwei; Wang, Chunling; Xiao, Shuiqing			Prevalence of fimA genotypes of Porphyromonas gingivalis in adolescent orthodontic patients	PLOS ONE			English	Article							PERIODONTAL PATHOGENS; STRAINS; GENE; ACTINOMYCETEMCOMITANS; QUANTIFICATION; IDENTIFICATION; GINGIVITIS; BINDING; ADULTS	Background The placement of fixed orthodontic appliances may alter the composition of oral microbiota and has the potential risk of periodontal complication. Porphyromonas gingivalis fimbriae play a critical role in colonization of P. gingivalis in subgingival regions. In this study, we investigated the association between the prevalence of P. gingivalis-specific fimA genotypes and periodontal health status in adolescent orthodontic patients, to identify the pathogencity of P. gingivalis during orthodontic therapy. Methods Sixty-one adolescent orthodontic patients were enrolled in the case group, while the control group consisted of 56 periodontally healthy adolescents. At baseline (TO), clinical parameter (gingival index) was tested, and subgingival plaque samples were obtained from the lower incisors. The incidences of P. gingivalis and fimA genotypes were detected by polymerase chain reaction. All parameters were reassessed after 1 month (T1), 2 months (T2), 3 months (T3), and 6 months (T4) in the case group and then compared with those of the controls. Results Both microbiological and clinical parameters from orthodontic patients started to increase after placement of fixed appliances. Maximum values were reached at 3 months after placement and followed by their decreases at six months. However, the microbiological and clinical parameters in the case group were significantly higher than those of the control group. The GI of fimA II, IV-positive samples was significantly higher than that of negative samples. Conclusion P. gingivalis carrying fimA II or IV was closely related to orthodontic gingivitis. In addition, proper oral hygiene control could lead to little increase in dental plaque accumulation, and exert a beneficial effect to periodontal tissues.	[Pan, Shuang; Wang, Chunling] Shandong Univ, Sch Stomatol, Dept Orthodont, Jinan, Shandong, Peoples R China; [Pan, Shuang; Liu, Jianwei] Jinan Stomatol Hosp, Dept Orthodont, Jinan, Shandong, Peoples R China; [Liu, Yi] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan, Shandong, Peoples R China; [Si, Yi; Xiao, Shuiqing] Shandong Med Coll, Dept Oral Med, Jinan, Shandong, Peoples R China; [Zhang, Qiang; Xiao, Shuiqing] Jinan Stomatol Hosp, Dept Implantol, Jinan, Shandong, Peoples R China; [Wang, Lin] First Hosp Jinan, Dept Stomatol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Wang, CL (corresponding author), Shandong Univ, Sch Stomatol, Dept Orthodont, Jinan, Shandong, Peoples R China.; Xiao, SQ (corresponding author), Shandong Med Coll, Dept Oral Med, Jinan, Shandong, Peoples R China.; Xiao, SQ (corresponding author), Jinan Stomatol Hosp, Dept Implantol, Jinan, Shandong, Peoples R China.	wangchl@sdu.edu.cn; shqxiao@126.com			Enterprise Innovation program of Jinan Science and Technology Bureau [201201057]	Enterprise Innovation program of Jinan Science and Technology Bureau	This work was supported by the Enterprise Innovation program of Jinan Science and Technology Bureau (no. 201201057) to Shuiqing Xiao. http://www.insti.gov.cn/jnsti/technet. This funding provided financial support to purchase materials in the work.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2000, J DENT RES, V79, P1664, DOI 10.1177/00220345000790090501; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Decaillet Fabien, 2012, Schweiz Monatsschr Zahnmed, V122, P198; DICKINSON DP, 1988, J BACTERIOL, V170, P1658, DOI 10.1128/jb.170.4.1658-1665.1988; Elamin A, 2011, J PERIODONTAL RES, V46, P285, DOI 10.1111/j.1600-0765.2010.01337.x; Enersen M, J ORAL MICROBIOLOGY; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; Faveri M, 2009, J CLIN PERIODONTOL, V36, P739, DOI 10.1111/j.1600-051X.2009.01449.x; Feng XH, 2014, J PERIODONTOL, V85, P150, DOI 10.1902/jop.2013.120677; Freitas Amanda Osório Ayres de, 2014, Dental Press J. Orthod., V19, P46, DOI 10.1590/2176-9451.19.2.046-055.oar; FUJIWARA T, 1994, FEMS MICROBIOL LETT, V124, P333, DOI 10.1016/0378-1097(94)00451-X; Gao L, 2012, DNA CELL BIOL, V31, P1027, DOI 10.1089/dna.2011.1487; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Guglielmetti MR, 2014, J PERIODONTOL, V85, P1450, DOI 10.1902/jop.2014.140048; Guo L, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0308-7; Hayashi F, 2012, J ORAL SCI, V54, P77, DOI 10.2334/josnusd.54.77; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; KINDER SA, 1989, INFECT IMMUN, V57, P3425, DOI 10.1128/IAI.57.11.3425-3433.1989; LAMONT RJ, 1992, ORAL MICROBIOL IMMUN, V7, P193, DOI 10.1111/j.1399-302X.1992.tb00024.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lee SM, 2005, J MICROBIOL, V43, P260; LINDHE J, 1975, J PERIODONTAL RES, V10, P243, DOI 10.1111/j.1600-0765.1975.tb00031.x; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085280; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Missailidis CG, 2004, ORAL MICROBIOL IMMUN, V19, P224, DOI 10.1111/j.1399-302X.2004.00140.x; Morinushi T, 2000, J PERIODONTOL, V71, P403, DOI 10.1902/jop.2000.71.3.403; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909, DOI 10.1128/JCM.38.5.1909-1914.2000; Nakagawa I, 2002, J PERIODONTAL RES, V37, P425, DOI 10.1034/j.1600-0765.2002.01637.x; Nakano K, 2004, ORAL MICROBIOL IMMUN, V19, P205, DOI 10.1111/j.0902-0055.2004.00133.x; Pan Shuang, 2017, PLoS One, V12, pe0171550, DOI 10.1371/journal.pone.0171550; Ristic M, 2007, ORTHOD CRANIOFAC RES, V10, P187, DOI 10.1111/j.1601-6343.2007.00396.x; SAXE SR, 1967, PERIODONTICS, V5, P217; SCHWARZ S, 1987, INFECT IMMUN, V55, P2391, DOI 10.1128/IAI.55.10.2391-2397.1987; Thornberg MJ, 2009, AM J ORTHOD DENTOFAC, V135, P95, DOI 10.1016/j.ajodo.2007.02.057; Yang Gang-Ling, 2015, Shanghai Kou Qiang Yi Xue, V24, P102; Yang NY, 2014, INT J PAEDIATR DENT, V24, P226, DOI 10.1111/ipd.12065; Yao ES, 1996, ORAL MICROBIOL IMMUN, V11, P35, DOI 10.1111/j.1399-302X.1996.tb00334.x; Zanatta Fabricio Batistin, 2014, Dental Press J. Orthod., V19, P59, DOI 10.1590/2176-9451.19.3.059-066.oar; Zhao L, 2007, J PERIODONTAL RES, V42, P511, DOI 10.1111/j.1600-0765.2007.00975.x; Zhou XD, 2015, CLIN ORAL INVEST, V19, P937, DOI 10.1007/s00784-014-1316-0	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188420	10.1371/journal.pone.0188420	http://dx.doi.org/10.1371/journal.pone.0188420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176857	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900074
J	Pedro, JM; Brito, M; Barros, H				Pedro, Joao M.; Brito, Miguel; Barros, Henrique			Tobacco consumption and nicotine dependence in Bengo Province, Angola: A community-based survey	PLOS ONE			English	Article							SMOKING PREVALENCE; COUNTRIES; EPIDEMIOLOGY; POLICY	There is concern about the potentially increasing use of tobacco in Angola. However, information on the frequency and determinants of this use is not systematised. This study aimed to estimate the prevalence of tobacco consumption and nicotine dependence among smokers in an Angolan population and considering individual socio-demographic and behavioural characteristics. A community-based survey with 2,472 respondents (age range: 15-64 years) was conducted in 2013-2014 in the country's Bengo Province. The collection methodology for assessing each type of tobacco consumption and its daily quantification followed the World Health Organization STEPwise approach to chronic disease risk factor surveillance. The Fagerstro E m Test for Nicotine Dependence was also used to assess smokers. Mean values for prevalence of tobacco use and nicotine dependence were estimated by sex and by previously defined variables. Daily smoking (6.1%) was found to be higher for males (10.0%) them among females (2.6%), and the amount of ex-smokers (7.5%) was higher them smokers. Only 0.2% of those surveyed reported use of smokeless (chewing) tobacco. One-third of ever-smokers reported having started smoking daily before age 18. Nicotine dependence levels were classified as very low or low in 83.6% of the smokers. Daily smoking prevalence increased with age, and was higher in rural areas and among individuals with no formal education, lower incomes, and alcohol consumption. This population presented a low smoking prevalence, along with a low number of daily smoked cigarettes and low levels of nicotine dependency, despite the low prices of, and easy access to, manufactured cigarettes. These two factors conjugated with the current absence of an Angolan policy for tobacco control, enhance the susceptibility for rising overall tobacco use in the near future.	[Pedro, Joao M.; Brito, Miguel] CISA, Caxito, Angola; [Pedro, Joao M.; Barros, Henrique] Univ Porto, Inst Saude Publ, EPI Unit, Rua Taipas 135, Oporto, Portugal; [Brito, Miguel] Inst Politecn Lisboa, Escola Super Tecnol Saude Lisboa, Av D Joan 2,Lote 4-69-01, Lisbon, Portugal; [Barros, Henrique] Univ Porto, Fac Med, Oporto, Portugal	Universidade do Porto; Polytechnic Institute of Lisbon; Universidade de Lisboa; Universidade do Porto	Pedro, JM (corresponding author), CISA, Caxito, Angola.; Pedro, JM (corresponding author), Univ Porto, Inst Saude Publ, EPI Unit, Rua Taipas 135, Oporto, Portugal.	joao.almeidapedro@cisacaxito.org	Pedro, Joao M/A-6556-2013; Barros, Henrique/A-5488-2008; Brito, Miguel/A-7970-2016; Barros, Henrique/Q-8609-2019	Pedro, Joao M/0000-0003-2405-521X; Brito, Miguel/0000-0001-6394-658X; Barros, Henrique/0000-0003-4699-6571	Camoes, Institute of Cooperation and Language, Portugal; Calouste Gulbenkian Foundation, Portugal; Government of Bengo Province; Angolan Ministry of Health; Eduardo dos Santos Foundation, Angola; EPIUnit, Institute of Public Health, University of Porto, Portugal [UID/DTP/04750/2013]	Camoes, Institute of Cooperation and Language, Portugal; Calouste Gulbenkian Foundation, Portugal; Government of Bengo Province; Angolan Ministry of Health; Eduardo dos Santos Foundation, Angola; EPIUnit, Institute of Public Health, University of Porto, Portugal	This work was supported by the promoters of the CISA as follows: Camoes, Institute of Cooperation and Language, Portugal (www.instituto-camoesptien/); Calouste Gulbenkian Foundation, Portugal (https//gulbenkian.pt/en/);Government of Bengo Province; Angolan Ministry of Health (www.minsa.gov.ao), and also the Eduardo dos Santos Foundation, Angola(www.fesa.og.ao/) and the EPIUnit, Institute of Public Health, University of Porto, Portugal (http://ispup.up.pt; ref UID/DTP/04750/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achia TNO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117219; Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; [Anonymous], 1999, CURBING EPIDEMIC GOV; [Anonymous], 2013, STEPS INSTR SUPP MAT; Boas Morten, 2005, ALCOHOL DRUG CONSUMP; Brathwaite R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132401; Capingana DP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-732; Costa MJ, 2012, AFR POPUL STUD J, V26, P2; Eriksen M, 2015, TOBACCO ATLAS; Ferreira PL, 2009, REV PORTUGUESA SAUDE, V27, P2; Institute for Health Metrics and Evaluation, GBD COMP VIZ HUB; Instituto Nacional de Estatistica, 2016, REC GER POP VOS CENS; Instituto Nacional de Luta Anti-Droga, PROD TAB EM ANG; Jha P., 2000, TOBACCO CONTROL DEV; Mamudu HM, 2008, AM J PUBLIC HEALTH, V98, P1630, DOI 10.2105/AJPH.2007.129478; Mensah GA, 2013, PROG CARDIOVASC DIS, V56, P240, DOI 10.1016/j.pcad.2013.10.014; Ministerio da Saude da Republica de Angola, 2014, PLAN NACL DES SAN 20; Nturibi EM, 2009, INT J TUBERC LUNG D, V13, P165; Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341; Padrao P, 2013, NICOTINE TOB RES, V15, P199, DOI 10.1093/ntr/nts111; Pampel Fred C, 2006, Int J Comp Sociol, V47, P466, DOI 10.1177/0020715206070267; Patel Preeti, 2007, Tob Control, V16, pe1, DOI 10.1136/tc.2006.016071; Pedro JM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2759-9; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Saleheen D, 2014, ARTERIOSCL THROM VAS, V34, P1811, DOI 10.1161/ATVBAHA.114.303826; Simao M, 2008, REV LAT-AM ENFERM, V16, P672, DOI 10.1590/S0104-11692008000400004; Sreeramareddy CT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0243-x; Tanihara S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006658; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2015, WHO REP GLOB TOB EPI; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2015, REP GLOB TOB EPID 20; World Health Organization, 2012, WHO GLOB REP MORT AT	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188586	10.1371/journal.pone.0188586	http://dx.doi.org/10.1371/journal.pone.0188586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176892	Green Published, gold			2022-12-26	WOS:000416291900101
J	Yu, N; Shu, S; Lin, Y; She, JW; Ip, HSS; Qiu, XH; Zhu, YF				Yu, Nu; Shu, Shi; Lin, Yan; She, Jianwen; Ip, Ho Sai Simon; Qiu, Xinghua; Zhu, Yifang			High efficiency cabin air filter in vehicles reduces drivers' roadway particulate matter exposures and associated lipid peroxidation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; LOS-ANGELES FREEWAYS; LONG-TERM EXPOSURE; OXIDATIVE STRESS; URINARY 1-HYDROXYPYRENE; MYOCARDIAL-INFARCTION; ULTRAFINE PARTICLES; NORTH CHINA; POLLUTION; FINE	Commuters who spend long hours on roads are exposed to high levels of traffic related air pollutants (TRAPs). Despite some well-known multiple adverse effects of TRAPs on human health, limited studies have focused on mitigation strategies to reduce these effects. In this study, we measured fine particulate matter (PM2.5) and ultrafine particle (UFP) concentrations inside and outside 17 taxis simultaneously while they were driven on roadways. The drivers' urinary monohydroxylated polycyclic aromatic hydrocarbons (OH-PAHs) and malondialdehyde (MDA) concentrations just before and right after the driving tests were also determined. Data were collected under three driving conditions (i.e. no mitigation (NM), window closed (WC), and window closed plus using high efficiency cabin air filters (WC + HECA)) for each taxi and driver. The results show that, compared to NM, the WC + HECA reduced in-cabin PM2.5 and UFP concentrations, by 37% and 47% respectively (p < 0.05), whereas the reductions on PAH exposures were insignificant. Although nonsignificant, a reduction of 17% was also observed in the drivers' urinary MDA under WC+ HECA. The MDA concentrations were found to be significantly associated with the in-cabin PM2.5 and UFP concentrations, suggesting the reduction of the drivers' lipid peroxidation can be at least partially attributed to the PM2.5 and UFP reduction by WC+ HECA. Overall, these results suggest HECA filters have potential to reduce particle levels inside taxis and protect drivers' health.	[Yu, Nu; Shu, Shi; Lin, Yan; Zhu, Yifang] Univ Calif Los Angeles, Dept Environm Hlth Sci, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [She, Jianwen; Ip, Ho Sai Simon] Calif Dept Publ Hlth, 850 Marina Bay Pkwy, Richmond, CA USA; [Qiu, Xinghua] Peking Univ, State Key Joint Lab Environm Simulat & Pollut Con, Coll Environm Sci & Engn, Beijing, Peoples R China; [Qiu, Xinghua] Peking Univ, Ctr Environm & Hlth, Beijing, Peoples R China	University of California System; University of California Los Angeles; California Department of Public Health; Peking University; Peking University	Zhu, YF (corresponding author), Univ Calif Los Angeles, Dept Environm Hlth Sci, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	yifang@ucla.edu	Qiu, Xinghua/B-9951-2013; Lin, Yan/N-7882-2014	Lin, Yan/0000-0003-4384-8354	National Institute of Occupational Safety and Health (NIOSH) [1R21OH0010196-01A1]; Southern California NIOSH Education and Research Center (SCERC); Centers for Disease Control and Prevention (CDC) [T42 OH008412]	National Institute of Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Southern California NIOSH Education and Research Center (SCERC); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the National Institute of Occupational Safety and Health (NIOSH, 1R21OH0010196-01A1 to YZ), and targeted research training program of the Southern California NIOSH Education and Research Center (SCERC), with grant agreement number T42 OH008412 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Occupational Safety and Health (NIOSH, 1R21OH0010196-01A1), and targeted research training program of the Southern California NIOSH Education and Research Center (SCERC), with Grant Agreement Number T42 OH008412 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of CDC. The authors want to thank California Department of Public Health (CDPH) for analyzing the urine samples for PAH metabolites. We thank the taxi drivers who contributed to this study.	Ahmed T. A., 2015, PHARMACOKINETICS DRU; Allen JO, 1996, ENVIRON SCI TECHNOL, V30, P1023, DOI 10.1021/es950517o; Araujo JA, 2011, AIR QUAL ATMOS HLTH, V4, P79, DOI 10.1007/s11869-010-0101-8; Bae S, 2010, ENVIRON HEALTH PERSP, V118, P579, DOI 10.1289/ehp.0901077; Blasi G, 2006, DRIVING POOR TAXI DR; Chetiyanukornkul T, 2006, ANAL BIOANAL CHEM, V386, P712, DOI 10.1007/s00216-006-0628-6; Cohen G, 2017, EUR J PREV CARDIOL, V24, P92, DOI 10.1177/2047487316669415; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2; Fruin S, 2008, ATMOS ENVIRON, V42, P207, DOI 10.1016/j.atmosenv.2007.09.057; Garde AH, 2003, SCAND J CLIN LAB INV, V63, P521, DOI 10.1080/00365510310000501; Guo CX, 2015, INT J NANOMED, V10, P1463, DOI 10.2147/IJN.S76114; Hou L, 2010, ENV HLTH, V9; Hudda N, 2011, ENVIRON SCI TECHNOL, V45, P8691, DOI 10.1021/es202025m; JONGENEELEN FJ, 1988, ANN OCCUP HYG, V32, P35, DOI 10.1093/annhyg/32.1.35; JONGENEELEN FJ, 1994, TOXICOL LETT, V72, P205, DOI 10.1016/0378-4274(94)90030-2; Jongeneelen FJ, 2001, ANN OCCUP HYG, V45, P3, DOI 10.1016/S0003-4878(00)00009-0; Karottki DG, 2015, INT J ENV RES PUB HE, V12, P1667, DOI 10.3390/ijerph120201667; Kearney E, 2013, METHODS MOL BIOL, V1065, P277, DOI 10.1007/978-1-62703-616-0_18; Lee ES, 2014, ENVIRON SCI TECHNOL, V48, P2328, DOI 10.1021/es404952q; Li RJ, 2015, ENVIRON SCI POLLUT R, V22, P20167, DOI 10.1007/s11356-015-5222-z; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2012, CHEM RES TOXICOL, V25, P1452, DOI 10.1021/tx300108e; Li Z, 2006, ABSTR PAP AM CHEM S, V232, P606; Lin Y, 2016, ENVIRON SCI TECHNOL, V50, P3738, DOI 10.1021/acs.est.5b04629; Lin Y, 2015, J GEOPHYS RES-ATMOS, V120, P7219, DOI 10.1002/2015JD023628; Lin Y, 2015, ENVIRON POLLUT, V196, P164, DOI 10.1016/j.envpol.2014.10.005; Liu XL, 2005, INHAL TOXICOL, V17, P467, DOI 10.1080/08958370590964467; Magnani ND, 2011, BIOCHEM BIOPH RES CO, V412, P667, DOI 10.1016/j.bbrc.2011.08.021; Le NA, 2015, INT J MOL SCI, V16, P401, DOI 10.3390/ijms16010401; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Saffari A, 2013, ENVIRON POLLUT, V181, P14, DOI 10.1016/j.envpol.2013.06.001; Shu S, 2015, ATMOS ENVIRON, V122, P628, DOI 10.1016/j.atmosenv.2015.10.030; Sorensen M, 2003, MUTAT RES-REV MUTAT, V544, P255, DOI 10.1016/j.mrrev.2003.06.010; Su JG, 2015, ENVIRON INT, V78, P82, DOI 10.1016/j.envint.2014.12.007; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Tartakovsky L, 2013, ATMOS ENVIRON, V64, P320, DOI 10.1016/j.atmosenv.2012.10.003; United Nations, 1989, 57 UN; VANSTADEN JF, 1983, FRESEN Z ANAL CHEM, V315, P141, DOI 10.1007/BF00488885; Westgard JO, 2016, ANN CLIN BIOCHEM, V53, P32, DOI 10.1177/0004563215597248; Wu J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-47; Wu J, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-101; Xie MJ, 2014, ATMOS ENVIRON, V95, P355, DOI 10.1016/j.atmosenv.2014.06.056; Yamano Y, 2014, INT ARCH OCC ENV HEA, V87, P705, DOI 10.1007/s00420-013-0913-6; Yang QY, 2015, ENVIRON SCI POLLUT R, V22, P1760, DOI 10.1007/s11356-014-3284-y; Yanosky JD, 2002, ATMOS ENVIRON, V36, P107, DOI 10.1016/S1352-2310(01)00422-8; Zeng Q, 2017, ENVIRON POLLUT, V220, P713, DOI 10.1016/j.envpol.2016.10.036; Zhang QF, 2010, ATMOS ENVIRON, V44, P253, DOI 10.1016/j.atmosenv.2009.09.044; Zhang X, 2016, ENVIRON RES, V150, P306, DOI 10.1016/j.envres.2016.06.019; Zhu YF, 2008, J AIR WASTE MANAGE, V58, P424, DOI 10.3155/1047-3289.58.3.424; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797	51	22	24	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188498	10.1371/journal.pone.0188498	http://dx.doi.org/10.1371/journal.pone.0188498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176859	Green Published, gold			2022-12-26	WOS:000416291900086
J	Enea-Drapeau, C; Carlier, M; Huguet, P				Enea-Drapeau, Claire; Carlier, Michele; Huguet, Pascal			Implicit theories concerning the intelligence of individuals with Down syndrome	PLOS ONE			English	Article							ASSOCIATION TEST; STEREOTYPE FORMATION; INTERVENTION; CHILDREN; ACHIEVEMENT; PERSONALITY; PEOPLE; SCHOOL; PERSPECTIVES; DISABILITIES	Studies over the past three decades have shown that learning difficulties are not only determined by neurological disorders, but also by motivational and/or socio-cognitive factors Among these factors, implicit theories of intelligence (also referred to as conceptions, mindsets or beliefs about intelligence) are key elements. The belief that intelligence is fixed (entity theory), as opposed to malleable (incremental theory), is generally associated with negative teaching practices and poorer student outcomes, yet beliefs about the intelligence of individuals with intellectual disabilities have not received much attention. We propose the first study on conceptions of intelligence of persons with intellectual disabilities, here people with Down syndrome. Participants were 55 professionally qualified people working with individuals with intellectual disabilities and 81 adults from the community. We compared what both groups of participants believe about intelligence of typical people and what they believe about the intelligence of individuals with Down syndrome. We also investigated implicit theories of intelligence as predictors of explicit judgments about intelligence and implicit attitudes toward people with Down syndrome. Whatever the work experience in the field of intellectual disability, implicit theories of intelligence were found to be less incremental when considering people with Down syndrome than when considering typical people; and the stronger the belief in entity theory, the more negative (and less positive) the judgments expressed explicitly. Implicit theories of intelligence were also found to be predictors of negative implicit attitude but only in adults from the community. These findings offer prospects for improving practices by people working in the field of intellectual disability. They might interest a wide range of people caring for people with intellectual disabilities, such as teachers, but also other professional caregivers, and other scientists focusing on intellectual disabilities or social cognition.	[Enea-Drapeau, Claire] Aix Marseille Univ, PSYCLE, Aix En Provence, France; [Carlier, Michele] Aix Marseille Univ, CNRS, LPC, Marseille, France; [Huguet, Pascal] Univ Clermont Auvergne, Clermont Ferrand, France; [Huguet, Pascal] CNRS, LAPSCO, Clermont Ferrand, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Enea-Drapeau, C (corresponding author), Aix Marseille Univ, PSYCLE, Aix En Provence, France.	claire.enea-drapeau@univ-amu.fr		Huguet, Pascal/0000-0002-0707-7655	Fondation Jerome Lejeune	Fondation Jerome Lejeune	Michele Carlier received a grant from Fondation Jerome Lejeune (https://www.fondationlejeune.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Butler R, 2000, J PERS SOC PSYCHOL, V78, P965, DOI 10.1037/0022-3514.78.5.965; Carlier M., 2007, DEFICIENCES INTELLEC; Carr J., 1995, DOWNS SYNDROME CHILD; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19; Cimpian A, 2007, PSYCHOL SCI, V18, P314, DOI 10.1111/j.1467-9280.2007.01896.x; Cvencek D, 2016, J EXP SOC PSYCHOL, V62, P50, DOI 10.1016/j.jesp.2015.09.015; Da Fonseca D, 2008, BEHAV RES THER, V46, P529, DOI 10.1016/j.brat.2008.01.006; Da Fonseca D, 2004, LENCEPHALE, V30, P456; Davis AS, 2008, SCHOOL PSYCHOL QUART, V23, P271, DOI 10.1037/1045-3830.23.2.271; Dweck CS, 2007, EDUC LEADERSHIP, V65, P34; DWECK CS, 1995, PSYCHOL INQ, V6, P322, DOI 10.1207/s15327965pli0604_12; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; Enea-Drapeau C, 2014, RES DEV DISABIL, V35, P3598, DOI 10.1016/j.ridd.2014.09.003; Enea-Drapeau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034369; Fidler DJ, 2007, MENT RETARD DEV D R, V13, P262, DOI 10.1002/mrdd.20166; Gibson D., 1978, DOWNS SYNDROME PSYCH; Gonida E, 2006, AM J PSYCHOL, V119, P223, DOI 10.2307/20445336; GREENSPAN S, 1983, AM J MENT DEF, V88, P218; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grieco J, 2015, AM J MED GENET C, V169, P135, DOI 10.1002/ajmg.c.31439; Gunderson EA, 2013, CHILD DEV, V84, P1526, DOI 10.1111/cdev.12064; Gutshall CA, 2013, PSYCHOL SCHOOLS, V50, P1073, DOI 10.1002/pits.21725; Jonsson AC., 2012, EDUC INQ, V3, P259, DOI [10.3402/edui.v3i2.22033, DOI 10.3402/EDUI.V3I2.22033]; Jonsson AC, 2010, J CRIT EDUC POLICY S, V8, P1; KOESTNER R, 1995, J INTELL DISABIL RES, V39, P57, DOI 10.1111/j.1365-2788.1995.tb00914.x; Kozulin A, 2010, RES DEV DISABIL, V31, P551, DOI 10.1016/j.ridd.2009.12.001; Leroy N, 2007, EUR J PSYCHOL EDUC, V22, P529, DOI 10.1007/BF03173470; LEVINE JM, 1993, ANNU REV PSYCHOL, V44, P585, DOI 10.1146/annurev.psych.44.1.585; Levy SR, 1998, J PERS SOC PSYCHOL, V74, P1421, DOI 10.1037//0022-3514.74.6.1421; Levy SR, 1999, CHILD DEV, V70, P1163, DOI 10.1111/1467-8624.00085; Lynott Donna-Jean., 1994, J RES DEV EDUC, V4, P253; Mascret N, 2015, EUR J PSYCHOL EDUC, V30, P269, DOI 10.1007/s10212-015-0249-6; Molina S., 2004, J COGN ED PSYCHOL, V4, P65; Monteil J.-M., 1999, EUROPEAN MONOGRAPHS; Paunesku D, 2015, PSYCHOL SCI, V26, P784, DOI 10.1177/0956797615571017; Pishghadam R, 2015, AUST J TEACH ED, V40; Plaks JE, 2001, J PERS SOC PSYCHOL, V80, P876, DOI 10.1037/0022-3514.80.6.876; Pretzlik U, 2003, COGNITIVE DEV, V18, P579, DOI 10.1016/j.cogdev.2003.09.008; Rattan A, 2012, J EXP SOC PSYCHOL, V48, P731, DOI 10.1016/j.jesp.2011.12.012; Roubertoux PL, 2007, EMBO REP, V8, pS7, DOI 10.1038/sj.embor.7400991; Rydell RJ, 2007, PERS SOC PSYCHOL B, V33, P549, DOI 10.1177/0146167206296956; Watanabe M, 2006, THEOR PRACT, V45, P24, DOI 10.1207/s15430421tip4501_4; World Health Organization, 2016, GEN HUM DIS; Yeager DS, 2013, CHILD DEV, V84, P1651, DOI 10.1111/cdev.12062; Yeager DS, 2014, J PERS SOC PSYCHOL, V106, P867, DOI 10.1037/a0036335	48	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188513	10.1371/journal.pone.0188513	http://dx.doi.org/10.1371/journal.pone.0188513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166393	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300043
J	Kodihalli, S; Emanuel, A; Takla, T; Hua, Y; Hobbs, C; LeClaire, R; O'Donnell, DC				Kodihalli, Shantha; Emanuel, Andrew; Takla, Teresa; Hua, Yi; Hobbs, Charles; LeClaire, Ross; O'Donnell, Denise C.			Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques	PLOS ONE			English	Article							BLACK TAR HEROIN; WOUND BOTULISM; UNITED-STATES; INTRAMUSCULAR INJECTION; NEUROTOXIN; TOXIN; SEROTYPES; RECOVERY; PROTEIN; IDENTIFICATION	Background There are currently no licensed vaccines available for prevention of botulism in humans. The vaccination is not desirable due to expanding therapeutic indications of botulinum toxins. The only available specific treatment for botulism is antitoxin to remove circulating toxin, thus, preventing further neuronal damage. BAT (R) (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)) has been developed and its therapeutic efficacy evaluated against botulinum neurotoxin serotype A (BoNT/A) in Rhesus macaques. Methods and findings In a post-exposure prophylaxis (PEP) study, animals were exposed to 4xLD(50)/kg of BoNT/A and administered intravenously with either BAT (1x or 0.1x scaled human dose), or placebo at 4 hours post-exposure. The animals were monitored for 14 days. For the therapeutic intervention studies, animals were exposed to a 1.7x LD50/kg of BoNT/A and treated intravenously with either placebo or BAT at a 1x scaled human dose at the onset of clinical signs. Animals were monitored on an hourly basis for 14 or 21 days. In the PEP study, all animals tolerated equine based antitoxin without any adverse clinical signs. A 100% survival was observed in groups treated with the BAT compared to 0% survival in those treated with the placebo (p<0.001, Fisher's exact test). BAT antitoxin prevented the development of signs of neurotoxicity of botulinum toxin. In a therapeutic study, treatment with the BAT at scaled 1x human dose after the onset of clinical signs significantly enhanced survival compared to the placebo (46.6% vs. 0%, p<0.0001, Fisher's exact test). Additionally, treatment with the BAT delayed the progression of signs (muscular weakness, respiratory distress, oral/nasal discharge) of toxin intoxication and reduced the severity of the disease. Conclusions A single dose of BAT, when administered to symptomatic monkeys, resulted in a statistically significant survival benefit compared to the placebo. Additionally, BAT completely protected monkeys from the clinical signs of intoxication and subsequent death when administered as PEP treatment. These data in part supported the licensure of BAT under the Animal Rule in the United States by the Food and Drug Administration.	[Kodihalli, Shantha; Emanuel, Andrew; Takla, Teresa] Emergent BioSolut, Res & Dev, Winnipeg, MB, Canada; [Hua, Yi] Emergent BioSolut, Clin Res, Winnipeg, MB, Canada; [Hobbs, Charles; LeClaire, Ross; O'Donnell, Denise C.] Lovelace Resp Res Inst, Albuquerque, NM USA	Lovelace Respiratory Research Institute	Kodihalli, S (corresponding author), Emergent BioSolut, Res & Dev, Winnipeg, MB, Canada.	skodihalli@ebsi.com			Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHS0100200600017C]	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	This work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHS0100200600017C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1992, DIBARTOLA FLUID THER, P35; [Anonymous], 2004, TXB PEDIAT INFECT DI; [Anonymous], 2011, GUIDE CARE USE LAB A; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219; Avril A, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0206-0; BALL AP, 1979, Q J MED, V48, P473; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Barash JR, 2005, J CLIN MICROBIOL, V43, P4280, DOI 10.1128/JCM.43.8.4280-4282.2005; Berger Tamar, 2016, Disaster Mil Med, V2, P7, DOI 10.1186/s40696-016-0017-4; Brett MM, 2004, J MED MICROBIOL, V53, P555, DOI 10.1099/jmm.0.05379-0; Cardella MA, 1964, BOTULISM P S, P113; CDC, 2011, NAT ENT DIS SURV BOT; Cheng LW, 2011, TOXICON, V58, P62, DOI 10.1016/j.toxicon.2011.05.003; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Chertow DS, 2006, JAMA-J AM MED ASSOC, V296, P2476, DOI 10.1001/jama.296.20.2476; COLEBATCH JG, 1989, LANCET, V2, P1216; DEMARCHI J, 1958, Bull Acad Natl Med, V142, P580; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; Fortman JD, 2002, LAB NONHUMAN PRIMATE, P96; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Galldiks N, 2007, NEUROCRIT CARE, V6, P30, DOI 10.1385/NCC:6:1:30; GANGAROSA EJ, 1971, AM J EPIDEMIOL, V93, P93, DOI 10.1093/oxfordjournals.aje.a121239; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; HOLZER E, 1962, Med Klin, V57, P1735; Hope VD, 2012, AM J PUBLIC HEALTH, V102, P122, DOI 10.2105/AJPH.2011.300314; HUGHES JM, 1981, ANN INTERN MED, V95, P442, DOI 10.7326/0003-4819-95-4-442; Kalb SR, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0567-5; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; Koenig MG, 1974, HARRISONS PRINCIPLES, P849; Kongsaengdao S, 2006, CLIN INFECT DIS, V43, P1247, DOI 10.1086/508176; Maslanka SE, 2016, J INFECT DIS, V213, P379, DOI 10.1093/infdis/jiv327; McCarty CL, 2015, MMWR-MORBID MORTAL W, V64, P802, DOI 10.15585/mmwr.mm6429a6; MERSON MH, 1973, NEW ENGL J MED, V289, P1005, DOI 10.1056/NEJM197311082891904; Miethe S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161446; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; OBERST FW, 1968, CLIN PHARMACOL THER, V9, P209; Offerman SR, 2009, WEST J EMERG MED, V10, P251; Palmateer NE, 2013, EMERG INFECT DIS, V19, P29, DOI 10.3201/eid1901.120044; Passaro DJ, 1998, JAMA-J AM MED ASSOC, V279, P859, DOI 10.1001/jama.279.11.859; Raciborska DA, 1999, CAN J PHYSIOL PHARM, V77, P679, DOI 10.1139/cjpp-77-9-679; Rasetti-Escargueil C, 2015, MABS-AUSTIN, V7, P1161, DOI 10.1080/19420862.2015.1082016; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Remillard R., 2000, SMALL ANIMAL CLIN NU, P351; ROBLOT P, 1994, J MED MICROBIOL, V40, P379, DOI 10.1099/00222615-40-6-379; Rosow LK, 2015, PEDIATR NEUROL, V52, P487, DOI 10.1016/j.pediatrneurol.2015.01.006; Sandrock CE, 2001, CHEST, V120, P562, DOI 10.1378/chest.120.2.562; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Simpson L, 2013, TOXICON, V68, P40, DOI 10.1016/j.toxicon.2013.02.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sobel J, 2009, EMERG INFECT DIS, V15, P969, DOI 10.3201/eid1506.070571; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Varma JK, 2004, CLIN INFECT DIS, V39, P357, DOI 10.1086/422318; Watson AK, 2017, BIRTH DEFECTS RES, V109, P391, DOI 10.1002/bdr2.1016; WOODRUFF BA, 1992, J INFECT DIS, V166, P1281, DOI 10.1093/infdis/166.6.1281	63	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186892	10.1371/journal.pone.0186892	http://dx.doi.org/10.1371/journal.pone.0186892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166654	Green Submitted, gold, Green Published			2022-12-26	WOS:000416035300006
J	Jain, V; Das, B				Jain, Vinay; Das, Birajalaxmi			Global transcriptome profile reveals abundance of DNA damage response and repair genes in individuals from high level natural radiation areas of Kerala coast	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; EXPRESSION PROFILES; SOUTHWEST COAST; RADIOADAPTIVE RESPONSE; BACKGROUND-RADIATION; HUMAN-POPULATION; EXPOSURE	The high level natural radiation areas (HLNRA) of Kerala coast in south west India is unique for its wide variation in the background radiation dose (<1.0mGy to 45mGy/year) and vast population size. Several biological studies conducted in this area did not reveal any adverse effects of chronic low dose and low dose rate radiation on human population. In the present study, global transcriptome analysis was carried out in peripheral blood mono-nuclear cells of 36 individuals belonging to different background dose groups [NLNRA, (Group I, <= 1.50 mGy/year) and three groups of HLNRA; Group II, 1.51-5.0 mGy/year), Group III, 5.01-15mGy/year and Group IV, >15.0 mGy/year] to find out differentially expressed genes and their biological significance in response to chronic low dose radiation exposure. Our results revealed a dose dependent increase in the number of differentially expressed genes with respect to different background dose levels. Gene ontology analysis revealed majority of these differentially expressed genes are involved in DNA damage response (DDR) signaling, DNA repair, cell cycle arrest, apoptosis, histone/chromatin modification and immune response. In the present study, 64 background dose responsive genes have been identified as possible chronic low dose radiation signatures. Validation of 30 differentially expressed genes was carried out using fluorescent based universal probe library. Abundance of DDR and DNA repair genes along with pathways such as MAPK, p53 and JNK in higher background dose groups (>5.0mGy/year) indicated a possible threshold dose for DDR signaling and are plausible reason of observing in vivo radio-adaptive response and non-carcinogenesis in HLNRA population. To our knowledge, this is the first study on molecular effect of chronic low dose radiation exposure on human population from high background radiation areas at transcriptome level using high throughput approach. These findings have tremendous implications in understanding low dose radiation biology especially, the effect of low dose radiation exposure in humans.	[Jain, Vinay; Das, Birajalaxmi] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Low Level Radiat Res Sect, Biosci Grp, Bombay, Maharashtra, India; [Jain, Vinay; Das, Birajalaxmi] Homi Bhabha Natl Inst, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Das, B (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Low Level Radiat Res Sect, Biosci Grp, Bombay, Maharashtra, India.; Das, B (corresponding author), Homi Bhabha Natl Inst, Bombay, Maharashtra, India.	biraj@barc.gov.in		Jain, Vinay/0000-0002-9172-0067				Albanese J, 2007, EXP HEMATOL, V35, P47, DOI 10.1016/j.exphem.2007.01.012; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; Amundson SA, 2003, MOL CANCER RES, V1, P445; Amundson SA, 2001, RADIAT PROT DOSIM, V97, P11, DOI 10.1093/oxfordjournals.rpd.a006632; Amundson Sally A, 2003, Methods Mol Biol, V223, P141; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; Das B, 2012, INT J RADIAT BIOL, V88, P642, DOI 10.3109/09553002.2012.699135; Das B, 2009, INT J RADIAT BIOL, V85, P272, DOI 10.1080/09553000902751462; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Fachin AL, 2007, RADIAT RES, V168, P650, DOI 10.1667/RR0487.1; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Falk M, 2007, BBA-MOL CELL RES, V1773, P1534, DOI 10.1016/j.bbamcr.2007.07.002; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fornace Albert J Jr, 2002, Mil Med, V167, P13; Franco N, 2005, RADIAT RES, V163, P623, DOI 10.1667/RR3391; Fujimori A, 2005, CANCER RES, V65, P10159, DOI 10.1158/0008-5472.CAN-05-2015; Ghandhi SA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0097-x; Gopal-Ayengar A.R., 1971, P 4 INT C PEAC US AT, V2, P31; GOPALAYEAR, 1970, INDIAN J EXP BIOL, V8, P313; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; GRUNEBERG H, 1964, NATURE, V204, P222, DOI 10.1038/204222a0; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Jagirdar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078075; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jaikrishan G, 2013, J COMMUN GENET, V4, P21, DOI 10.1007/s12687-012-0113-1; Jain V, 2017, MUTAT RES-FUND MOL M, V806, P39, DOI 10.1016/j.mrfmmm.2017.09.003; Jain V, 2016, MUTAT RES-FUND MOL M, V788, P50, DOI 10.1016/j.mrfmmm.2016.03.002; Jain V, 2014, INT J RADIAT BIOL, V90, P1143, DOI 10.3109/09553002.2014.925605; Jain Vinay, 2011, International Journal of Low Radiation, V8, P55; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Karuppasamy CV, 2016, MUTAT RES-GEN TOX EN, V800, P40, DOI 10.1016/j.mrgentox.2016.03.005; Koya PKM, 2015, RADIAT ENVIRON BIOPH, V54, P453, DOI 10.1007/s00411-015-0615-4; Koya PKM, 2012, RADIAT RES, V177, P109, DOI 10.1667/RR2699.1; Kumar PRV, 2015, MUTAT RES-FUND MOL M, V775, P59, DOI 10.1016/j.mrfmmm.2015.03.011; Kumar PRV, 2012, RADIAT RES, V177, P643, DOI 10.1667/RR2681.1; Lanza V, 2005, J RADIAT RES, V46, P265, DOI 10.1269/jrr.46.265; Long XH, 2007, INT J MOL MED, V19, P607; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Morandi E, 2009, RADIAT RES, V172, P500, DOI 10.1667/RR1545.1; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Nair KRR, 2005, INT CONGR SER, V1276, P41, DOI 10.1016/j.ics.2004.10.030; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; NAYAR GG, 1970, RADIAT BOT, V10, P287, DOI 10.1016/S0033-7560(70)80023-0; Nenoi M, 2015, HUM EXP TOXICOL, V34, P272, DOI 10.1177/0960327114537537; Nylund R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-52; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Pernot E, 2012, MUTAT RES-REV MUTAT, V751, P258, DOI 10.1016/j.mrrev.2012.05.003; Ramachandran EN, 2017, MUTAGENESIS, V32, P267, DOI 10.1093/mutage/gew057; Ramachandran EN, 2013, INT J RADIAT BIOL, V89, P259, DOI 10.3109/09553002.2013.747014; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Saini D, 2012, MOL CELL BIOCHEM, V364, P271, DOI 10.1007/s11010-012-1227-9; Shelke S, 2015, MUTAGENESIS, V30, P365, DOI 10.1093/mutage/geu081; Shimizu T, 1999, EXP CELL RES, V251, P424, DOI 10.1006/excr.1999.4582; Sokolov M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010055; Sokolov M, 2014, INT J MOL SCI, V15, P588, DOI 10.3390/ijms15010588; Takahashi A, 2010, INT J RADIAT ONCOL, V78, P1171, DOI 10.1016/j.ijrobp.2010.04.062; Tang FR, 2015, INT J RADIAT BIOL, V91, P13, DOI 10.3109/09553002.2014.937510; Toprani S.M., 2015, MUTAGENESIS; Toprani SM, 2015, MUTAGENESIS, V30, P247, DOI 10.1093/mutage/geu065; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; Vaiserman AM, 2010, DOSE-RESPONSE, V8, P172, DOI 10.2203/dose-response.09-037.Vaiserman; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Warters RL, 2009, RADIAT RES, V172, P82, DOI 10.1667/RR1677.1; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002	71	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187274	10.1371/journal.pone.0187274	http://dx.doi.org/10.1371/journal.pone.0187274			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161272	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000006
J	Olinger, LK; Heidmann, SL; Durdall, AN; Howe, C; Ramseyer, T; Thomas, SG; Lasseigne, DN; Brown, EJ; Cassell, JS; Donihe, MM; Romero, MDD; Duke, MA; Green, D; Hillbrand, P; Grimes, KRW; Nemeth, RS; Smith, TB; Brandt, M				Olinger, Lauren K.; Heidmann, Sarah L.; Durdall, Allie N.; Howe, Colin; Ramseyer, Tanya; Thomas, Sara G.; Lasseigne, Danielle N.; Brown, Elizabeth J.; Cassell, John S.; Donihe, Michele M.; Romero, Mareike D. Duffing; Duke, Mara A.; Green, Damon; Hillbrand, Paul; Grimes, Kristin R. Wilson; Nemeth, Richard S.; Smith, Tyler B.; Brandt, Marilyn			Altered juvenile fish communities associated with invasive Halophila stipulacea seagrass habitats in the US Virgin Islands	PLOS ONE			English	Article							CORAL-REEF FISH; SYRINGODIUM-FILIFORME; CAULERPA-TAXIFOLIA; CARIBBEAN ISLAND; ASSEMBLAGES; BEDS; DIVERSITY; MANGROVES; PATTERNS; HAEMULIDAE	Caribbean seagrass habitats provide food and protection for reef-associated juvenile fish. The invasive seagrass Halophila stipulacea is rapidly altering these seascapes. Since its arrival in the Caribbean in 2002, H. stipulacea has colonized and displaced native sea-grasses, but the function of this invasive seagrass as a juvenile fish habitat remains unknown. To compare diversity, community structure, and abundance of juvenile fish between H. stipulacea and native seagrass beds, fish traps were deployed in four nearshore bays around St. Thomas, U.S. Virgin Islands. Traps were deployed in Frenchman, Lindbergh, and Sprat Bays for 24 h intervals in patches of bare sand, patches of H. stipulacea and patches of the native Caribbean seagrasses Thalassia testudinum and Syringodium filiforme. Traps were then deployed in Brewers Bay for 12 h intervals in stands of H. stipulacea and S. filiforme. Relative and total abundances of juvenile fish, identified at least to family, were compared across treatment habitats for each trap deployment period. The catch from H. stipulacea, compared to native seagrasses, comprised a greater abundance of nocturnal carnivores Lutjanus synagris (family Lutjanidae) and Haemulon flavolineatum (family Haemulidae). Additionally, the herbivore species Sparisoma aurofrenatum (family Labridae) and Acanthurus bahianus (family Acanthuridae) and the diurnal carnivore species Pseudopeneus maculatus (family Mullidae) were relatively scarce in H. stipulacea. The catch from sand was much smaller, compared to vegetated habitats, and comprised only L. synagris, H. flavolineatum, and H. aurolineatum. These results provide evidence of reduced family diversity and altered juvenile fish assemblages in H. stipulacea, driven by an abundance of some nocturnal carnivores and scarcity of herbivores and diurnal carnivores. The findings from the present work underpin the need for further investigation and mitigation of this invasion, particularly where H. stipulacea is driving seascape-alterations of key juvenile fish habitats.	[Olinger, Lauren K.; Heidmann, Sarah L.; Durdall, Allie N.; Howe, Colin; Ramseyer, Tanya; Thomas, Sara G.; Lasseigne, Danielle N.; Brown, Elizabeth J.; Cassell, John S.; Donihe, Michele M.; Romero, Mareike D. Duffing; Duke, Mara A.; Green, Damon; Hillbrand, Paul; Grimes, Kristin R. Wilson; Nemeth, Richard S.; Smith, Tyler B.; Brandt, Marilyn] Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI 00802 USA	University of the Virgin Islands	Olinger, LK (corresponding author), Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI 00802 USA.	lauren.olinger@students.uvi.edu	Olinger, Lauren/AAW-2387-2020; Ramseyer, Tanya/GZG-4008-2022	Olinger, Lauren/0000-0003-1078-522X; Heidmann, Sarah/0000-0002-0729-0229; Howe, Colin/0000-0002-4124-7910	Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation) [1355437]; University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES)	Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation); University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES)	Funding was provided by the Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation #1355437). No funding agency participated in the design or interpretation of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Teresa Turner, Sennai Habtes, and Renata Platenberg for helpful comments on earlier drafts of this manuscript. We also thank the University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES) for programmatic and research support. Finally, we thank the US National Science Foundation, through the VI Experimental Program to Stimulate Competitive Research (VI-EPSCoR), which contributed valuable infrastructure support and research equipment. This is contribution #170 from the Center for Marine and Environmental Studies, University of the Virgin Islands.	Able KW, 2000, ESTUARIES, V23, P633, DOI 10.2307/1352890; Allen G., 1985, FAO FISH SYNOP, V125, P1; [Anonymous], 2021, LANG ENV STAT COMP; BELL JD, 1989, BIOL SEAGRASSES; Bervoets T, 2013, RESULTS NATURE FDN R; Bohlke J.E., 1993, FISHES BAHAMAS ADJAC; Bohnsack JA, 1987, RESOURCE SURVEY FISH; Caldwell ZR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153066; Cappo MM, 1996, 6 CRC REEF; Castillo-Rivera M, 2002, REV FISH BIOL FISHER, V12, P167, DOI 10.1023/A:1025051027676; Cervigon F., 1993, PECES MARINOS VENEZU, V2; Courtenay WE, 1995, FAO SPECIES IDENTIFI; Crowder LB, 1991, HABITAT STRUCTURE; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; de la Moriniere EC, 2003, ESTUAR COAST SHELF S, V57, P1079, DOI 10.1016/S0272-7714(03)00011-8; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2005, MAR ECOL PROG SER, V299, P277, DOI 10.3354/meps299277; Ellis S., 2016, POTENTIALLY INVASIVE; Fischer W, 1995, FAO GUIDE IDENTIFICA, VI; Franco A, 2006, ESTUAR COAST SHELF S, V66, P67, DOI 10.1016/j.ecss.2005.07.020; Franks James S., 2000, Gulf and Caribbean Research, V12, P11; FROESE R., 2022, US; GARDNER SM, 1995, J VEG SCI, V6, P349, DOI 10.2307/3236234; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; HIGH WL, 1970, COMMER FISH REV, V32, P31; Hitt S, 2011, MAR ECOL PROG SER, V427, P275, DOI 10.3354/meps09093; Hori M, 2009, MAR BIOL, V156, P1447, DOI 10.1007/s00227-009-1184-3; Huijbers CM, 2015, HYDROBIOLOGIA, V750, P89, DOI 10.1007/s10750-014-2162-4; Hylkema A, 2015, ESTUAR COAST, V38, P1448, DOI 10.1007/s12237-014-9907-1; Island Resources Foundation (US), 1977, MAR ENV VIRG ISL TEC; Kadison E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180063; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kingsford M, 1996, STUDYING TEMPERATE M; Kopp D, 2007, AQUAT BOT, V87, P31, DOI 10.1016/j.aquabot.2007.01.008; Kopp D, 2010, J COASTAL RES, V26, P1133, DOI 10.2112/JCOASTRES-D-09-00063.1; Longepierre S, 2005, BIODIVERS CONSERV, V14, P365, DOI [10.1007/s10531-004-5356-7, 10.1007/s10531-004-5056-7]; Lugendo BR, 2007, HYDROBIOLOGIA, V586, P1, DOI 10.1007/s10750-006-0398-3; Macia S, 2005, MAR ECOL PROG SER, V303, P113, DOI 10.3354/meps303113; Mellin C, 2007, CORAL REEFS, V26, P895, DOI 10.1007/s00338-007-0281-3; Nagelkerken I, 2000, MAR ECOL PROG SER, V194, P55, DOI 10.3354/meps194055; Nagelkerken I, 2004, J SEA RES, V52, P127, DOI 10.1016/j.seares.2003.11.002; Nagelkerken I., 2001, Aquatic Ecology, V35, P73, DOI 10.1023/A:1011416902370; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Overholtzer KL, 1999, MAR ECOL PROG SER, V177, P177, DOI 10.3354/meps177177; Pillans RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105507; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Platenberg RJ, 2006, WETLANDS CONSERVATIO; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; Renchen FL, 2012, J FISH BIO, V81, P1; Rindi F, 1999, OCEANOL ACTA, V22, P421, DOI 10.1016/S0399-1784(00)88725-3; Robins C.R., 1986, PETERSON FIELD GUIDE; Rogers CS, 2014, FRONT ECOL ENVIRON, V12, P546, DOI 10.1890/14.WB.016; Rogers CS, 1982, MARINE ENV BREWERS B; Rojas PM, 2014, LAT AM J AQUAT RES, V42, P989, DOI 10.3856/vol42-issue5-fulltext-6; Ruiz H, 2004, B MAR SCI, V75, P131; Silvano RAM, 2001, ENVIRON BIOL FISH, V60, P465, DOI 10.1023/A:1011064923544; Smith T.B., 2015, US VIRGIN ISLANDS TE; Smith TM, 2008, MAR ECOL PROG SER, V359, P203, DOI 10.3354/meps07348; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Spotte S, 1996, OCEANOGR LIT REV, V12, P1263; Steiner S.C.C., 2015, REEF ENCOUNTER, V30, P43; Steiner SC, 2013, 32 I TROP MAR EC; Thompson M, 1969, ZOOL DEP U W INDIES, V3, P1; TRIBBLE GW, 1981, MAR BIOL, V65, P277, DOI 10.1007/BF00397122; Uiblein F, 2007, MAR BIOL RES, V3, P275, DOI 10.1080/17451000701687129; van der Loos LM, 2017, MAR BIODIVERS, V47, P123, DOI 10.1007/s12526-016-0608-9; van Tussenbroek BI, 2016, J SEA RES, V115, P1, DOI 10.1016/j.seares.2016.05.005; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Whitfield A. K, 2017, REV FISH BIOL FISHER, P1; Willette DA, 2014, AQUAT BOT, V112, P98, DOI 10.1016/j.aquabot.2013.10.001; Willette DA, 2012, AQUAT BOT, V103, P74, DOI 10.1016/j.aquabot.2012.06.007; York PH, 2006, MAR ECOL PROG SER, V312, P223, DOI 10.3354/meps312223	78	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188386	10.1371/journal.pone.0188386	http://dx.doi.org/10.1371/journal.pone.0188386			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161322	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000046
J	Bakker, JT; Kuperus, JS; Kuijf, HJ; Oner, FC; de Jong, PA; Verlaan, JJ				Bakker, Jessica T.; Kuperus, Jonneke S.; Kuijf, Hugo J.; Oner, F. Cumhur; de Jong, Pim A.; Verlaan, Jorrit-Jan			Morphological characteristics of diffuse idiopathic skeletal hyperostosis in the cervical spine	PLOS ONE			English	Article							FORESTIER-DISEASE; INTUBATION; DYSPHAGIA; OSSIFICATION; FEATURES	Objectives Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by anterior ossification of the spine and can lead to dysphagia and airway obstruction. The morphology of the newly formed bone in the cervical spine is different compared to the thoracic spine, possibly due to dissimilarities in local vascular anatomy. In this study the spatial relationship of the new bone with the arterial system, trachea and esophagus was analyzed and compared between subjects with and without DISH. Methods Cervical computed tomography (CT) scans were obtained from five patients with dysphagia and DISH and ten control subjects. The location of the vertebral and carotid arteries, surface area of the hyperostosis and distance between the vertebral body and the trachea and esophagus was assessed in the axial view. Results The surface area of the newly formed bone was located symmetrically anterior to the vertebral body. The ossifications were non-flowing in the sagittal view and no segmental vessels were observed. Substantial displacement of the trachea/esophagus was present in the group with DISH compared to the controls. Conclusions The hyperostosis at the cervical level was symmetrically distributed anterior to the vertebral bodies without a flowing pattern, in contrast to the asymmetrical flowing pattern typically found in the thoracic spine. The hypothesis that the vascular system acts as a natural barrier against new bone formation in DISH could be further supported with these findings. The significant ventral displacement of the trachea and esophagus may explain the mechanism of dysphagia and airway obstruction in DISH.	[Bakker, Jessica T.; Kuperus, Jonneke S.; Oner, F. Cumhur; Verlaan, Jorrit-Jan] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Kuijf, Hugo J.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Verlaan, JJ (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.j.verlaan@umcutrecht.nl	Kuijf, Hugo J/G-2711-2013	Kuijf, Hugo J/0000-0001-6997-9059				Bougaki M, 2004, ANAESTHESIA, V59, P303, DOI 10.1111/j.1365-2044.2004.03690.x; CARILE L, 1989, J RHEUMATOL, V16, P1120; CROSBY ET, 1993, CAN J ANAESTH, V40, P54, DOI 10.1007/BF03009319; Eskander MS, 2010, SPINE, V35, P2035, DOI 10.1097/BRS.0b013e3181c9f3d4; FORESTIER J, 1950, ANN RHEUM DIS, V9, P321, DOI 10.1136/ard.9.4.321; Kuijf HJ, 2013, IMAGE PROCESSING TEC; Le AQ, 2014, J NEUROSURG-SPINE, V21, P565, DOI 10.3171/2014.6.SPINE13908; Mader R, 2009, OSTEOARTHR CARTILAGE, V17, P825, DOI 10.1016/j.joca.2008.12.004; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; MCCAFFERTY RR, 1995, J NEUROSURG, V83, P13, DOI 10.3171/jns.1995.83.1.0013; Naik B, 2004, ANESTHESIOLOGY, V100, P1311, DOI 10.1097/00000542-200405000-00039; Oppenlander ME, 2009, SURG NEUROL, V72, P266, DOI 10.1016/j.surneu.2008.08.081; Ozkalkanli Murat Y, 2006, J Anesth, V20, P304, DOI 10.1007/s00540-006-0418-5; Palmer JHM, 2000, ANAESTHESIA, V55, P70, DOI 10.1046/j.1365-2044.2000.01121.x; Presutti L, 2010, ANN OTO RHINOL LARYN, V119, P602, DOI 10.1177/000348941011900906; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Thompson C, 2010, CAN J ANAESTH, V57, P679, DOI 10.1007/s12630-010-9313-5; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Verlaan JJ, 2011, EUR SPINE J, V20, P1474, DOI 10.1007/s00586-011-1719-4; Verlaan JJ, 2011, SPINE J, V11, P1058, DOI 10.1016/j.spinee.2011.09.014; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Westerveld LA, 2008, J RHEUMATOL, V35, P1635	23	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188414	10.1371/journal.pone.0188414	http://dx.doi.org/10.1371/journal.pone.0188414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155874	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700057
J	Taylor, AW; Bewick, BM; Makanjuola, AB; Qian, L; Kirzhanova, VV; Alterwain, P				Taylor, Anne W.; Bewick, Bridgette M.; Makanjuola, Alfred B.; Qian, Ling; Kirzhanova, Valentina V.; Alterwain, Paulo			Context and culture associated with alcohol use amongst youth in major urban cities: A cross-country population based survey	PLOS ONE			English	Article							EARLY-ADULTHOOD; SUBSTANCE USE; GLOBAL HEALTH; DRINKING; ADOLESCENCE; GENDER; CONSEQUENCES; TRAJECTORIES; CONSUMPTION; CHINA	Background Alcohol consumption patterns are dependent upon culture and context. The aim of this study was to interview people aged 18 - 34 year old living in four cities in different regions of the world to explore differences in a range of alcohol measures to assist in determining culturally appropriate alcohol initiatives for this age group. Method Multistage random sampling was consistent across the four cities (Ilorin (Nigeria), Wuhan (China), Montevideo (Uruguay) and Moscow (Russia)). The questionnaire was forward and back translated into relevant languages and face-to-face interviewing undertaken. The data were weighted to the population of each city. Uni-variable analysis (ever consumed, first time consumed, age when drunk for first time, number of days consumed, type consumed) and logistic regression modeling were undertaken. The final model for each city was adjusted for age, sex, marital status, highest education and employment status. In total 6235 interviews were undertaken (1391 in Ilorin, 1600 in Montevideo, 1604 in Moscow and 1640 in Wuhan). Results Alcohol was consumed by 96.4% in Montevideo, 86.1% in Moscow, 53.4% in Wuhan and 33.3% in Ilorin. There was very little difference by gender except Ilorin males were more likely to consume alcohol than females. Alcohol was consumed on more days for Ilorin males; Wuhan females consumed alcohol on the least number of days; Ilorin had the most abstainers; Montevideo and Moscow the highest proportion of light drinkers; Ilorin and Montevideo the highest proportion of heavy drinkers. Differences by type of alcohol were also apparent. The final logistic regression model provided different models including higher alcohol consumption rates for males, 25 - 34 years of age, divorced/separated marital status and employed part time for Ilorin respondents; males and higher educated for Montevideo; males, 25 to 29 years of age and higher educated for Moscow; and 25 - 29 years of age, non-married and vocationally trained for those in Wuhan. Conclusion Alcohol consumption in these four cities does not increase with age as found in most high income countries. The alcohol consumption patterns during this stage of the life cycle are important to assess so that high level, as well as country-specific, planning and interventions can be implemented.	[Taylor, Anne W.] Univ Adelaide, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Bewick, Bridgette M.] Univ Leeds, Leeds Inst Hlth Sci, Sch Med, Leeds, W Yorkshire, England; [Makanjuola, Alfred B.] Univ Ilorin, Dept Behav Sci, Teaching Hosp, Ilorin, Nigeria; [Qian, Ling] PR Minist Hlth, Ctr Hlth Educ, Beijing, Peoples R China; [Kirzhanova, Valentina V.] Minist Hlth Russian Federat, Fed Med Res Ctr Psychiat & Narcol, Dept Epidemiol, Moscow, Russia; [Alterwain, Paulo] ProHumanitas Fdn, Montevideo, Uruguay	University of Adelaide; University of Leeds; University of Ilorin; Ministry of Health of the Russian Federation	Taylor, AW (corresponding author), Univ Adelaide, Populat Res & Outcome Studies, Adelaide, SA, Australia.	anne.taylor@adelaide.edu.au	Kirzhanova, Valentina/AAI-3529-2020; Taylor, Anne/F-5708-2010	Bewick, Bridgette/0000-0001-5752-5623; Kirzhanova, Valentina V./0000-0002-3243-1409; Taylor, Anne/0000-0002-4422-7974	International Alliance for Responsible Drinking	International Alliance for Responsible Drinking	Funding to support the work for this manuscript including travel and reasonable expenses was provided by International Alliance for Responsible Drinking. The funders had no role in the analysis, data interpretation and writing of this manuscript. The corresponding author was the only one to have full access to all the data and had final responsibility for the decision to submit for publication.	Adelekan M L, 2001, West Afr J Med, V20, P28; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Colder CR, 2014, PSYCHOL ADDICT BEHAV, V28, P659, DOI 10.1037/a0035271; Costanzo PR, 2007, J STUD ALCOHOL DRUGS, V68, P727, DOI 10.15288/jsad.2007.68.727; Degenhardt L, 2016, LANCET PSYCHIAT, V3, P251, DOI 10.1016/S2215-0366(15)00508-8; Degenhardt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003015; Dumbili EW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1499-6; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; Esan O, 2013, ALCOHOL, V47, P249, DOI 10.1016/j.alcohol.2012.12.011; Graham K, 2011, ADDICTION, V106, P1391, DOI 10.1111/j.1360-0443.2011.03425.x; Guttmannova K, 2011, J STUD ALCOHOL DRUGS, V72, P221, DOI 10.15288/jsad.2011.72.221; Hall WD, 2016, LANCET PSYCHIAT, V3, P265, DOI 10.1016/S2215-0366(16)00013-4; Ibanga Akanidomo K J, 2009, Contemp Drug Probl, V36, P111; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Kuendig H, 2008, EUR J PUBLIC HEALTH, V18, P386, DOI 10.1093/eurpub/ckn007; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; Mistry R, 2015, J YOUTH ADOLESCENCE, V44, P1871, DOI 10.1007/s10964-015-0309-x; Nelson DE, 2009, AM J PREV MED, V36, P218, DOI 10.1016/j.amepre.2008.10.018; Norstrom T, 2012, J STUD ALCOHOL DRUGS, V73, P542, DOI 10.15288/jsad.2012.73.542; Oesterle S, 2004, J STUD ALCOHOL, V65, P204, DOI 10.15288/jsa.2004.65.204; Van Gundy K, 2002, SUBST USE MISUSE, V37, P65, DOI 10.1081/JA-120001497; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5; Zhang JF, 2004, ADDICTION, V99, P1103, DOI 10.1111/j.1360-0443.2004.00799.x	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187812	10.1371/journal.pone.0187812	http://dx.doi.org/10.1371/journal.pone.0187812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155847	Green Published, gold			2022-12-26	WOS:000415756700018
J	Garbett, NC; Brock, GN; Chaires, JB; Mekmaysy, CS; DeLeeuw, L; Sivils, KL; Harley, JB; Rovin, BH; Kulasekera, KB; Jarjour, WN				Garbett, Nichola C.; Brock, Guy N.; Chaires, Jonathan B.; Mekmaysy, Chongkham S.; DeLeeuw, Lynn; Sivils, Kathy L.; Harley, John B.; Rovin, Brad H.; Kulasekera, K. B.; Jarjour, Wael N.			Characterization and classification of lupus patients based on plasma thermograms	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; DSC ANALYSIS; REVISED CRITERIA; DISEASE-ACTIVITY; CANCER PATIENTS; BLOOD-PLASMA; ERYTHEMATOSUS; PROTEOME; BIOMARKERS; DIAGNOSIS	Objective Plasma thermograms (thermal stability profiles of blood plasma) are being utilized as a new diagnostic approach for clinical assessment. In this study, we investigated the ability of plasma thermograms to classify systemic lupus erythematosus (SLE) patients versus non SLE controls using a sample of 300 SLE and 300 control subjects from the Lupus Family Registry and Repository. Additionally, we evaluated the heterogeneity of thermograms along age, sex, ethnicity, concurrent health conditions and SLE diagnostic criteria. Methods Thermograms were visualized graphically for important differences between covariates and summarized using various measures. A modified linear discriminant analysis was used to segregate SLE versus control subjects on the basis of the thermograms. Classification accuracy was measured based on multiple training/test splits of the data and compared to classification based on SLE serological markers. Results Median sensitivity, specificity, and overall accuracy based on classification using plasma thermograms was 86%, 83%, and 84% compared to 78%, 95%, and 86% based on a combination of five antibody tests. Combining thermogram and serology information together improved sensitivity from 78% to 86% and overall accuracy from 86% to 89% relative to serology alone. Predictive accuracy of thermograms for distinguishing SLE and osteoarthritis/rheumatoid arthritis patients was comparable. Both gender and anemia significantly interacted with disease status for plasma thermograms (p<0.001), with greater separation between SLE and control thermograms for females relative to males and for patients with anemia relative to patients without anemia. Conclusion Plasma thermograms constitute an additional biomarker which may help improve diagnosis of SLE patients, particularly when coupled with standard diagnostic testing. Differences in thermograms according to patient sex, ethnicity, clinical and environmental factors are important considerations for application of thermograms in a clinical setting.	[Garbett, Nichola C.; Chaires, Jonathan B.; Mekmaysy, Chongkham S.; DeLeeuw, Lynn] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Brock, Guy N.; Kulasekera, K. B.] Univ Louisville, Dept Bioinformat & Biostat, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Sivils, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Dept Pediat, Cincinnati, OH 45229 USA; [Harley, John B.] Univ Cincinnati, Cincinnati, OH USA; [Rovin, Brad H.] Ohio State Univ, Wexner Med Ctr, Nephrol Div, Columbus, OH 43210 USA; [Jarjour, Wael N.] Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Dept Internal Med, Columbus, OH 43210 USA; [Brock, Guy N.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA	University of Louisville; University of Louisville; Oklahoma Medical Research Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Garbett, NC (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	nichola.garbett@louisville.edu		brock, guy/0000-0001-5317-079X	National Institutes of Health [P20 RR018733, GM103482, UL1TR001070, N01AR62277, N01AR52221]; National Cancer Institute of the National Institutes of Health [R21CA187345]; Kentucky Science and Technology Corporation [COMMFUND-1517-RFP-017]; Office of the Executive Vice President for Research and Innovation at the University of Louisville; Elsa U. Pardee foundation; U.S. Department of Veterans Affairs [A124717, HG006828]; NATIONAL CANCER INSTITUTE [R21CA187345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kentucky Science and Technology Corporation; Office of the Executive Vice President for Research and Innovation at the University of Louisville; Elsa U. Pardee foundation; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Collection of plasma thermogram data was supported by use of the Biophysical Core Facility at the James Graham Brown Cancer Center and by grants P20 RR018733 and P20 GM103482 from the National Institutes of Health (www.nih.gov). Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (www.cancer.gov) under Award Number R21CA187345 (NCG), by the Kentucky Science and Technology Corporation (www.kstc.com) under Award Number COMMFUND-1517-RFP-017 (NCG), by a Competitive Enhancement Grant from the Office of the Executive Vice President for Research and Innovation at the University of Louisville (www. louisville.edu/research) (NCG) and by a grant from the Elsa U. Pardee foundation (www. pardeefoundation.org) (JBC). GNB was supported in part by the National Institutes of Health grant UL1TR001070. JBH was supported by the U.S. Department of Veterans Affairs (www.va.gov) and grants A124717 and HG006828. The Lupus Family Registry and Repository was supported by National Institutes of Health under Award Numbers N01AR62277 and N01AR52221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the immensely valuable resource of the Lupus Family Registry and Repository for lupus research and for generously providing access to patient samples and data for this study. We thank the James Graham Brown Cancer Center for support of the plasma thermogram research.	Ahearn JM, 2012, TRANSL RES, V159, P326, DOI 10.1016/j.trsl.2012.01.021; Anic F, 2014, CROAT MED J, V55, P514, DOI 10.3325/cmj.2014.55.514; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cerovec M, 2012, CROAT MED J, V53, P149, DOI 10.3325/cmj.2012.53.149; Chagovetz AA, 2013, NEUROSURGERY, V73, P289, DOI 10.1227/01.neu.0000430296.23799.cd; Chagovetz AA, 2011, J NEURO-ONCOL, V105, P499, DOI 10.1007/s11060-011-0630-5; Fekecs T, 2012, J THERM ANAL CALORIM, V108, P149, DOI 10.1007/s10973-011-1800-6; Fish DJ, 2010, BIOPHYS CHEM, V152, P184, DOI 10.1016/j.bpc.2010.09.007; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2016, BBA-GEN SUBJECTS, V1860, P981, DOI 10.1016/j.bbagen.2015.10.004; Garbett NC, 2015, METHODS, V76, P41, DOI 10.1016/j.ymeth.2014.10.030; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2013, BBA-GEN SUBJECTS, V1830, P4675, DOI 10.1016/j.bbagen.2013.05.007; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Illei GG, 2004, ARTHRITIS RHEUM, V50, P2048, DOI 10.1002/art.20345; Kalunian KC, 2012, ARTHRITIS RHEUM-US, V64, P4040, DOI 10.1002/art.34669; Krumova S, 2013, THERMOCHIM ACTA, V572, P59, DOI 10.1016/j.tca.2013.09.015; Liu CC, 2010, RHEUM DIS CLIN N AM, V36, P161, DOI 10.1016/j.rdc.2009.12.003; Mehdi M, 2013, J THERM ANAL CALORIM, V111, P1801, DOI 10.1007/s10973-012-2468-2; Michnik A, 2010, J THERM ANAL CALORIM, P102; Michnik A, 2011, THERMAL ANAL MED APP, P171; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Romero-Diaz J, 2011, ARTHRIT CARE RES, V63, pS37, DOI 10.1002/acr.20572; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; The Autoimmune Diseases Coordinating Committee, 2005, NIH PUBL; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; XI Y, 2011, SKIN CANC OVERVIEW; Xu P, 2009, COMPUT STAT DATA AN, V53, P1674, DOI 10.1016/j.csda.2008.02.005; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019	33	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0186398	10.1371/journal.pone.0186398	http://dx.doi.org/10.1371/journal.pone.0186398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149219	gold, Green Submitted, Green Published			2022-12-26	WOS:000415646100003
J	Gogna, N; Sharma, R; Gupta, V; Dorai, K; Prasad, NG				Gogna, Navdeep; Sharma, Rakesh; Gupta, Vanika; Dorai, Kavita; Prasad, N. G.			Evolution of the metabolome in response to selection for increased immunity in populations of Drosophila melanogaster	PLOS ONE			English	Article							STRESS; NMR; TEMPERATURE; MYOINOSITOL; HEMOLYMPH; NETWORKS; DIAPAUSE; MODELS; COST	We used NMR-based metabolomics to test two hypotheses-(i) there will be evolved differences in the metabolome of selected and control populations even under un-infected conditions and (ii) post infection, the metabolomes of the selected and control populations will respond differently. We selected replicate populations of Drosophila melanogaster for increased survivorship (I) against a gram-negative pathogen. We subjected the selected (I) and their control populations (S) to three different treatments: (1) infected with heat-killed bacteria (i), (2) sham infected (s), and (3) untreated (u). We performed 1D and 2D NMR experiments to identify the metabolic differences. Multivariate analysis of the metabolic profiles of the untreated (Iu and Su) flies yielded higher concentrations of lipids, organic acids, sugars, amino acids, NAD and AMP in the Iu treatment as compared to the Su treatment, showing that even in the absence of infection, the metabolome of the I and S regimes was different. In the S and I regimes, post infection/injury, concentration of metabolites directly or indirectly associated with energy related pathways (lipids, organic acids, sugars) declined while the concentration of metabolites that are probably associated with immune response (amino acids) increased. However, in most cases, the I regime flies had a higher concentration of such metabolites even under un-infected conditions. The change in the metabolite concentration upon infection/injury was not always comparable between I and S regimes (in case of lactate, alanine, leucine, lysine, threonine) indicating that the I and S regimes had evolved to respond differentially to infection and to injury.	[Gogna, Navdeep; Sharma, Rakesh; Dorai, Kavita] Indian Inst Sci Educ & Res, Dept Phys Sci, Mohali, Punjab, India; [Gupta, Vanika; Prasad, N. G.] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India; [Gupta, Vanika] Cornell Univ, Dept Entomol, Lazzaro Lab, Constock Hall, Ithaca, NY 14853 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Cornell University	Prasad, NG (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India.	prasad@iisermohali.ac.in	Gupta, Vanika/AAX-7429-2021	Gogna, Navdeep/0000-0003-4918-0850; Gupta, Vanika/0000-0002-5636-1337	Indian Institute of Science Education and Research Mohali	Indian Institute of Science Education and Research Mohali	The study was funded by Indian Institute of Science Education and Research Mohali through internal grants to KD and NGP. IISER Mohali had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bervoets L, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0246-9; Blomkalns A., 2006, EMERGENCY MED CARDIA, V2, P43; Brereton RG, 2007, APPL CHEMOMETRICS SC, DOI [10.1002/0470863242, DOI 10.1002/9780470057780.CH1, 10.1002/9780470057780.ch1]; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679; Chippindale AK, 1997, J EVOLUTION BIOL, V10, P269, DOI 10.1007/s000360050023; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dionne MS, 2014, FLY, V8, P75, DOI 10.4161/fly.28113; Dossey AT, 2006, ACS CHEM BIOL, V1, P511, DOI 10.1021/cb600318u; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Feala JD, 2008, PROG BIOPHYS MOL BIO, V96, P209, DOI 10.1016/j.pbiomolbio.2007.07.014; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Gogna N, 2015, MOL BIOSYST, V11, P3305, DOI 10.1039/c5mb00386e; Gupta V, 2016, EVOLUTION, V70, P934, DOI 10.1111/evo.12896; Gupta V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-185; Hang SY, 2014, CELL HOST MICROBE, V16, P592, DOI 10.1016/j.chom.2014.10.006; Klepsatel P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33667; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kristensen TN, 2012, EVOL ECOL RES, V14, P821; Lenz EM, 2001, INSECT BIOCHEM MOLEC, V32, P51, DOI 10.1016/S0965-1748(01)00078-9; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Malmendal A, 2013, NATURWISSENSCHAFTEN, V100, P417, DOI 10.1007/s00114-013-1040-7; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Park D, 2000, BBA-GENE STRUCT EXPR, V1494, P277, DOI 10.1016/S0167-4781(00)00085-3; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Phalaraksh C, 2008, SCIENCEASIA, V34, P279, DOI 10.2306/scienceasia1513-1874.2008.34.279; An PNT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099519; Sarup P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047461; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Snart CJP, 2015, ENTOMOL EXP APPL, V155, P1, DOI 10.1111/eea.12281; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Vigoder FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165724; Wang YL, 2010, J PROTEOME RES, V9, P1257, DOI 10.1021/pr9007392; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Williams CM, 2014, EVOLUTION, V68, P3505, DOI 10.1111/evo.12541; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	46	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188089	10.1371/journal.pone.0188089	http://dx.doi.org/10.1371/journal.pone.0188089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149207	Green Submitted, Green Published, gold			2022-12-26	WOS:000415646100024
J	Mao, BH; Qiu, J; Zhao, N; Shao, YW; Dai, W; He, XC; Cui, HM; Lin, XJ; Lv, L; Tang, ZF; Xu, SJ; Huang, H; Zhou, M; Xu, XY; Qiu, WT; Liu, Q; Zhang, YW				Mao, Baohong; Qiu, Jie; Zhao, Nan; Shao, Yawen; Dai, Wei; He, Xiaochun; Cui, Hongmei; Lin, Xiaojuan; Lv, Ling; Tang, Zhongfeng; Xu, Sijuan; Huang, Huang; Zhou, Min; Xu, Xiaoying; Qiu, Weitao; Liu, Qing; Zhang, Yawei			Maternal folic acid supplementation and dietary folate intake and congenital heart defects	PLOS ONE			English	Article							MULTIVITAMIN SUPPLEMENTATION; PRETERM BIRTH; RISK-FACTORS; POPULATION; PREVALENCE; SURVEILLANCE; ASSOCIATION; DISEASES; SMOKING; ORIGIN	Background It has been reported that folic acid supplementation before and/or during pregnancy could reduce the risk of congenital heart defects (CHDs). However, the results from limited epidemiologic studies have been inconclusive. We investigated the associations between maternal folic acid supplementation, dietary folate intake, and the risk of CHDs. Methods A birth cohort study was conducted in 2010-2012 at the Gansu Provincial Maternity & Child Care Hospital in Lanzhou, China. After exclusion of stillbirths and multiple births, a total of 94 births were identified with congenital heart defects, and 9,993 births without any birth defects. Unconditional logistic regression was used to estimate the associations. Results Compared to non-users, folic acid supplement users before pregnancy had a reduced risk of overall CHDs (OR: 0.42, 95% CI: 0.21-0.86, P-trend = 0.025) after adjusted for potential confounders. A protective effect was observed for certain subtypes of CHDs (OR: 0.37, 95% CI: 0.16-0.85 for malformation of great arteries; 0.26, 0.10-0.68 for malformation of cardiac septa; 0.34, 0.13-0.93 for Atrial septal defect). A similar protective effect was also seen for multiple CHDs (OR: 0.49, 95% CI: 0.26-0.93, P-trend = 0.004). Compared with the middle quartiles of dietary folate intake, lower dietary folate intake (< 149.88 mu g/day) during pregnancy were associated with increased risk of overall CHDs (OR: 1.63, 95% CI: 1.01-2.62) and patent ductus arteriosus (OR: 1.85, 95% CI: 1.03-3.32). Women who were non-user folic acid supplement and lower dietary folate intake have almost 2-fold increased CHDs risk in their offspring. Conclusions Our study suggested that folic acid supplementation before pregnancy was associated with a reduced risk of CHDs, lower dietary folate intake during pregnancy was associated with increased risk. The observed associations varied by CHD subtypes. A synergistic effect of dietary folate intake and folic acid supplementation was also observed.	[Mao, Baohong; Qiu, Jie; Shao, Yawen; Dai, Wei; He, Xiaochun; Cui, Hongmei; Lin, Xiaojuan; Lv, Ling; Tang, Zhongfeng; Xu, Sijuan; Zhou, Min; Xu, Xiaoying; Qiu, Weitao; Liu, Qing] Gansu Prov Matern & Child Care Hosp, Lanzhou, Gansu, Peoples R China; [Zhao, Nan; Huang, Huang; Zhang, Yawei] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	Yale University	Liu, Q (corresponding author), Gansu Prov Matern & Child Care Hosp, Lanzhou, Gansu, Peoples R China.; Zhang, YW (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	2305470816@qq.com; yawei.zhang@yale.edu	Huang, Huang/AAN-5671-2020; Zhao, Nan/GQH-3848-2022; Huang, Huang/GPC-6042-2022	Zhao, Nan/0000-0001-5358-866X; Huang, Huang/0000-0003-0147-9650	Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant [1204WCGA021]; National Institutes of Health [K02HD70324]	Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by internal funding from the Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant (1204WCGA021), and the National Institutes of Health Grants (K02HD70324).	Bean LJH, 2011, BIRTH DEFECTS RES A, V91, P885, DOI 10.1002/bdra.22848; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Correa A, 2003, PEDIATRICS, V111, P1146; Csaky-Szunyogh M, 2014, PEDIATR CARDIOL, V35, P108, DOI 10.1007/s00246-013-0749-6; Csaky-Szunyogh M, 2013, AM J MED GENET A, V161, P2444, DOI 10.1002/ajmg.a.36118; Csaky-Szunyogh M, 2013, J MATERN-FETAL NEO M, V26, P738, DOI 10.3109/14767058.2012.755170; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Czeizel AE, 1998, EUR J OBSTET GYN R B, V78, P151, DOI 10.1016/S0301-2115(98)00061-X; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Fekete K, 2010, MATERN CHILD NUTR, V6, P23, DOI 10.1111/j.1740-8709.2010.00261.x; Hobbs CA, 2011, BIRTH DEFECTS RES A, V91, P195, DOI 10.1002/bdra.20784; Institute of Nutrition and Food Hygiene Chinese Academy of Preventive Medicine, 1999, TABLE OF FOOD COMPON; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Leirgul E, 2015, PAEDIATR PERINAT EP, V29, P391, DOI 10.1111/ppe.12212; Li H, 2015, IJC HEART VASC, V6, P25, DOI 10.1016/j.ijcha.2014.10.002; Li XH, 2013, PREV MED, V56, P385, DOI 10.1016/j.ypmed.2013.02.019; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133961; Liu XH, 2016, EUR J NUTR, V55, P1411, DOI 10.1007/s00394-015-0959-1; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Obermann-Borst SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.911; Oyen N, 2009, AM HEART J, V157, P467, DOI 10.1016/j.ahj.2008.10.017; Qiu J, 2014, AM J EPIDEMIOL, V180, P94, DOI 10.1093/aje/kwu092; Rosenquist TH, 2013, DEV DYNAM, V242, P201, DOI 10.1002/dvdy.23922; Scanlon KS, 1998, EPIDEMIOLOGY, V9, P95, DOI 10.1097/00001648-199801000-00019; Shaw GM, 2010, BIRTH DEFECTS RES A, V88, P144, DOI 10.1002/bdra.20648; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Smedts HPM, 2008, EUR J NUTR, V47, P357, DOI 10.1007/s00394-008-0735-6; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; van Beynum IM, 2010, EUR HEART J, V31, P464, DOI 10.1093/eurheartj/ehp479; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vereczkey A, 2013, BIRTH DEFECTS RES A, V97, P217, DOI 10.1002/bdra.23124; Verkleij-Hagoort AC, 2006, EUR J NUTR, V45, P478, DOI 10.1007/s00394-006-0622-y; Wang Y, 2015, EUR J CLIN NUTR, V69, P1145, DOI 10.1038/ejcn.2014.295; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070; Williams LJ, 2004, BIRTH DEFECTS RES A, V70, P59, DOI 10.1002/bdra.10145; Xie DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147280; Zhang YL, 2011, J ULTRAS MED, V30, P989, DOI 10.7863/jum.2011.30.7.989	40	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187996	10.1371/journal.pone.0187996	http://dx.doi.org/10.1371/journal.pone.0187996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145433	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800047
J	Santasalo-Aarnio, A; Galfi, I; Virtanen, J; Gasik, MM				Santasalo-Aarnio, Annukka; Galfi, Istvan; Virtanen, Jorma; Gasik, Michael M.			New analytical methodology for analysing S (IV) species at low pH solutions by one stage titration method (bichromatometry) with a clear colour change. Could potentially replace the state-of-art-method iodometry at low pH analysis due higher accuracy	PLOS ONE			English	Article							SCREEN-PRINTED ELECTRODES; SULFUR-DIOXIDE; SO2-DEPOLARIZED ELECTROLYZER; AQUEOUS-SOLUTIONS; SOLUBILITY; ABSORPTION; ACID	A new, faster and more reliable analytical methodology for S(IV) species analysis at low pH solutions by bichromatometry is proposed. For decades the state of the art methodology has been iodometry that is still well justified method for neutral solutions, thus at low pH media possess various side reactions increasing inaccuracy. In contrast, the new methodology has no side reactions at low pH media, requires only one titration step and provides a clear color change if S(IV) species are present in the solution. The method is validated using model solutions with known concentrations and applied to analyses of gaseous SO2 from purged solution in low pH media samples. The results indicate that bichromatometry can accurately analyze SO2 from liquid samples having pH even below 0 relevant to metallurgical industrial processes.	[Santasalo-Aarnio, Annukka; Galfi, Istvan; Virtanen, Jorma; Gasik, Michael M.] Aalto Univ, Dept Chem & Met Engn, Sch Chem Engn, Aalto, Finland	Aalto University	Santasalo-Aarnio, A (corresponding author), Aalto Univ, Dept Chem & Met Engn, Sch Chem Engn, Aalto, Finland.	annukka.santasalo@aalto.fi	Gasik, Michael/G-2224-2013; Santasalo-Aarnio, Annukka/E-2879-2013	Gasik, Michael/0000-0002-5782-7987; Santasalo-Aarnio, Annukka/0000-0003-0077-966X	European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking of the SOL2HY2 project [325320]	European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking of the SOL2HY2 project	The European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking, under grant agreement no 325320 of the SOL2HY2 project. The funding was received by prof. M.M. Gasik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devaramani S, 2012, ELECTROCHIM ACTA, V85, P579, DOI 10.1016/j.electacta.2012.08.105; Gasik MM, 2017, INT J HYDROGEN ENERG, V42, P13407, DOI 10.1016/j.ijhydene.2017.03.003; Ghoseyri A, 2013, ADV MATER RES-SWITZ, V605-607, P1387, DOI 10.4028/www.scientific.net/AMR.605-607.1387; GOVINDARAO VMH, 1993, IND ENG CHEM RES, V32, P2111, DOI 10.1021/ie00021a037; Hart JP, 2002, BIOSENS BIOELECTRON, V17, P389, DOI 10.1016/S0956-5663(01)00308-6; HAYDUK W, 1988, J CHEM ENG DATA, V33, P506, DOI 10.1021/je00054a033; HUNGER T, 1990, J CHEM ENG DATA, V35, P453, DOI 10.1021/je00062a024; Jeffry G.H., 1989, VOGELS TXB QUANTITAT, V5th, P398; JUDA W, 1967, CHEM ENG PROG, V63, P59; Maass CE, 1928, J AM CHEM SOC, V50, P1352, DOI 10.1021/ja01392a016; Molinero-Abad B, 2013, MICROCHIM ACTA, V180, P1351, DOI 10.1007/s00604-013-1074-8; Mondal MK, 2007, FLUID PHASE EQUILIBR, V253, P98, DOI 10.1016/j.fluid.2007.01.015; Rabe A.E., 1963, J CHEM ENG DATA, V8, P333, DOI [10.1021/je60018a017, DOI 10.1021/JE60018A017]; Ramos RM, 2016, ELECTROCHEM COMMUN, V63, P52, DOI 10.1016/j.elecom.2015.12.010; Santasalo-Aarnio A, 2016, J SOLID STATE ELECTR, V20, P1655, DOI 10.1007/s10008-016-3169-8; Santasalo-Aarnio A, 2016, J POWER SOURCES, V306, P1, DOI 10.1016/j.jpowsour.2015.11.104; Shaw AC, 2011, INT J HYDROGEN ENERG, V36, P4749, DOI 10.1016/j.ijhydene.2011.01.105; Sivasubramanian P, 2007, INT J HYDROGEN ENERG, V32, P463, DOI 10.1016/j.ijhydene.2006.06.056; Steimke JL, 2015, INT J HYDROGEN ENERG, V40, P13281, DOI 10.1016/j.ijhydene.2015.08.041; Streeter I, 2005, J PHYS CHEM B, V109, P18500, DOI 10.1021/jp058119n; WEST PW, 1956, ANAL CHEM, V28, P1816, DOI 10.1021/ac60120a005; Xiang CX, 2016, MATER HORIZ, V3, P169, DOI 10.1039/c6mh00016a; Xue LL, 2013, INT J HYDROGEN ENERG, V38, P11017, DOI 10.1016/j.ijhydene.2012.12.120; Zhang QL, 1998, IND ENG CHEM RES, V37, P1167, DOI 10.1021/ie9706119	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188227	10.1371/journal.pone.0188227	http://dx.doi.org/10.1371/journal.pone.0188227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145479	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800093
J	Schembri, R; Spong, J; Peters, A; Rochford, P; Wilksch, P; O'Donoghue, FJ; Greenwood, KM; Barnes, M; Kennedy, GA; Berlowitz, DJ				Schembri, Rachel; Spong, Jo; Peters, Allison; Rochford, Peter; Wilksch, Philip; O'Donoghue, Fergal J.; Greenwood, Kenneth M.; Barnes, Maree; Kennedy, Gerard A.; Berlowitz, David J.			Light sensors for objective light measurement in ambulatory polysomnography	PLOS ONE			English	Article							SLEEP-APNEA; DIAGNOSIS; DEVICE	Ambulatory polysomnography (PSG) does not commonly include an objective measure of light to determine the time of lights off (Loff), and thus cannot be used to calculate important indices such as sleep onset latency and sleep efficiency. This study examined the technical specifications and appropriateness of a prototype light sensor (LS) for use in ambulatory Compumedics Somte PSG. Two studies were conducted. The first examined the light measurement characteristics of the LS when used with a portable PSG device, specifically recording trace range, linearity, sensitivity, and stability. This involved the LS being exposed to varying incandescent and fluorescent light levels in a light controlled room. Secondly, the LS was trialled in 24 home and 12 hospital ambulatory PSGs to investigate whether light levels in home and hospital settings were within the recording range of the LS, and to quantify the typical light intensity reduction at the time of Loff. A preliminary exploration of clinical utility was also conducted. Linearity between LS voltage and lux was demonstrated, and the LS trace was stable over 14 hours of recording. The observed maximum voltage output of the LS/PSG device was 250 mV, corresponding to a maximum recording range of 350 lux and 523 lux for incandescent and fluorescent light respectively. At the time of Loff, light levels were within the recording range of the LS, and on average dropped by 72 lux (9-245) in the home and 76 lux (4-348) in the hospital setting. Results suggest that clinical utility was greatest in hospital settings where patients are less mobile. The LS was a simple and effective objective marker of light level in portable PSG, which can be used to identify Loff in ambulatory PSG. This allows measurement of additional sleep indices and support with clinical decisions.	[Schembri, Rachel; Spong, Jo; Rochford, Peter; O'Donoghue, Fergal J.; Barnes, Maree; Kennedy, Gerard A.; Berlowitz, David J.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia; [Schembri, Rachel; O'Donoghue, Fergal J.; Barnes, Maree; Berlowitz, David J.] Univ Melbourne, Dept Med Dent & Hlth Sci, Parkville, Vic, Australia; [Spong, Jo] La Trobe Univ, La Trobe Rural Hlth Sch, Coll Sci Hlth & Engn, Bendigo, Vic, Australia; [Peters, Allison] Melbourne Sleep Disorders Ctr, Melbourne, Vic, Australia; [Wilksch, Philip] RMIT Univ, Sch Sci, Melbourne, Vic, Australia; [Greenwood, Kenneth M.] James Cook Univ, Singapore, Singapore; [Kennedy, Gerard A.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; La Trobe University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Schembri, R (corresponding author), Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia.; Schembri, R (corresponding author), Univ Melbourne, Dept Med Dent & Hlth Sci, Parkville, Vic, Australia.	rachel.schembri@austin.org.au	Spong, Jo/AAC-7745-2019; Wilksch, Philip/I-3888-2019; Spong, Jo/D-1941-2018; Berlowitz, David/D-4939-2011	Wilksch, Philip/0000-0003-1552-0263; Spong, Jo/0000-0001-7066-1996; Berlowitz, David/0000-0003-2543-8722	National Health and Medical Research Council postgraduate stipend [616605, 1080020]; Transport Accident Commission, Victoria, Australia	National Health and Medical Research Council postgraduate stipend; Transport Accident Commission, Victoria, Australia	This study was supported by National Health and Medical Research Council postgraduate stipend (Rachel Schembri, #616605) and project grant (#1080020 to David J Berlowitr); The COSAQ study is proudly supported by the Transport Accident Commission, Victoria, Australia. This study was led from the Institute for Breathing and Sleep with data collection undertaken across multiple sites. The technical sensor testing was performed at the Institute for Breathing and Sleep, and RMIT University. Overnight polysomnography was performed in participants' homes, or in hospital beds of the centres participating in the COSAQ study.	Berlowitz DJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-181; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bruyneel M, 2011, J SLEEP RES, V20, P201, DOI 10.1111/j.1365-2869.2010.00859.x; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Kingshott RN, 2000, SLEEP, V23, P1109, DOI 10.1093/sleep/23.8.1j; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; Schembri R, 2010, AUSTR SLEEP ASS ANN; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	10	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188124	10.1371/journal.pone.0188124	http://dx.doi.org/10.1371/journal.pone.0188124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145507	Green Published, Green Accepted, gold			2022-12-26	WOS:000415378800070
J	Whitmire, LE; Ling, L; Bugay, V; Carver, CM; Timilsina, S; Chuang, HH; Jaffe, DB; Shapiro, MS; Cavazos, JE; Brenner, R				Whitmire, Luke E.; Ling, Ling; Bugay, Vladslav; Carver, Chase M.; Timilsina, Santosh; Chuang, Hui-Hsiu; Jaffe, David B.; Shapiro, Mark S.; Cavazos, Jose E.; Brenner, Robert			Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; DEPENDENT POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; BETA-SUBUNIT; PYRAMIDAL NEURONS; UP-REGULATION; CELLS; RAT; EXCITABILITY	A major challenge is to understand maladaptive changes in ion channels that sets neurons on a course towards epilepsy development. Voltage-and calcium-activated K+ (BK) channels contribute to early spike timing in neurons, and studies indicate that the BK channel plays a pathological role in increasing excitability early after a seizure. Here, we have investigated changes in BK channels and their accessory beta 4 subunit (KCNMB4) in dentate gyrus (DG) granule neurons of the hippocampus, key neurons that regulate excitability of the hippocampus circuit. Two days after pilocarpine-induced seizures, we found that the predominant effect is a downregulation of the beta 4 accessory subunit mRNA. Consistent with reduced expression, single channel recording and pharmacology indicate a switch in the subtype of channels expressed; from iberiotoxin-resistant, type II BK channels (BK alpha/beta 4) that have higher channel open probability and slow gating, to iberiotoxin-sensitive type I channels (BK a alone) with low open probability and faster gating. The switch to a majority of type I channel expression following seizure activity is correlated with a loss of BK channel function on spike threshold while maintaining the channel's contribution to increased early spike frequency. Using heterozygous beta 4 knockout mice, we find reduced expression is sufficient to increase seizure sensitivity. We conclude that seizure-induced downregulation of KCNMB4 is an activity dependent mechanism that increases the excitability of DG neurons. These novel findings indicate that BK channel subtypes are not only defined by cell-specific expression, but can also be plastic depending on the recent history of neuronal excitability.	[Whitmire, Luke E.; Ling, Ling; Bugay, Vladslav; Carver, Chase M.; Timilsina, Santosh; Chuang, Hui-Hsiu; Shapiro, Mark S.; Brenner, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Jaffe, David B.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Cavazos, Jose E.] Univ Texas Hlth Sci Ctr San Antonio, Neurol, San Antonio, TX 78229 USA; [Whitmire, Luke E.] Brain Sentinel, San Antonio, TX USA; [Ling, Ling] Cent S Univ, Xiangya Sch Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Central South University	Brenner, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu	Cavazos, Jose/J-4122-2016	Cavazos, Jose/0000-0001-5777-2608; Brenner, Robert/0000-0002-1036-8031	National Institute of Health [NS052574, NS043394]; National Science Foundation [1456862]; Xiangya Medical Student Research Program; Institute for Integration of Medicine and Science, at UT Health San Antonio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Xiangya Medical Student Research Program; Institute for Integration of Medicine and Science, at UT Health San Antonio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institute of Health NS052574 and NS043394, National Science Foundation 1456862, the Xiangya Medical Student Research Program, the Institute for Integration of Medicine and Science, at UT Health San Antonio.	Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; Balzekas I, 2016, NEUROSCI LETT, V622, P30, DOI 10.1016/j.neulet.2016.04.033; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; DiFrancesco JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00071; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Ermolinsky BS, 2011, NEUROSCI RES, V69, P73, DOI 10.1016/j.neures.2010.09.011; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; IKEMOTO Y, 1989, BIOPHYS J, V56, P207, DOI 10.1016/S0006-3495(89)82665-7; Jaffe DB, 2011, NEUROSCIENCE, V192, P205, DOI 10.1016/j.neuroscience.2011.06.028; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; Khan SA, 1998, J PHARMACOL EXP THER, V284, P838; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Mehranfard N, 2014, IRAN J PHARM RES, V13, P125; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Montgomery JR, 2013, AM J PHYSIOL-CELL PH, V304, pC299, DOI 10.1152/ajpcell.00302.2012; Montgomery JR, 2012, P NATL ACAD SCI USA, V109, P18997, DOI 10.1073/pnas.1205573109; Nguyen Nguyen V, 2013, Methods Mol Biol, V998, P133, DOI 10.1007/978-1-62703-351-0_10; Peng BW, 2013, EPILEPSIA, V54, P1223, DOI 10.1111/epi.12150; Petrik D, 2011, EUR J NEUROSCI, V34, P695, DOI 10.1111/j.1460-9568.2011.07799.x; Powell KL, 2014, EPILEPSIA, V55, P609, DOI 10.1111/epi.12563; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rehak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061844; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Stegen M, 2009, EPILEPSIA, V50, P646, DOI 10.1111/j.1528-1167.2009.02025.x; Van Goor F, 2001, J NEUROSCI, V21, P5902, DOI 10.1523/JNEUROSCI.21-16-05902.2001; Wang B, 2009, J GEN PHYSIOL, V133, P283, DOI 10.1085/jgp.200810141; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746	44	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188064	10.1371/journal.pone.0188064	http://dx.doi.org/10.1371/journal.pone.0188064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145442	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800059
J	Yang, AL; Guo, ZY; Ren, QQ; Wu, LW; Ma, Y; Hu, AB; Wang, DP; Ye, HD; Zhu, XF; Ju, WQ; He, XS				Yang, Anli; Guo, Zhiyong; Ren, Qingqi; Wu, Linwei; Ma, Yi; Hu, Anbin; Wang, Dongping; Ye, Haidan; Zhu, Xiaofeng; Ju, Weiqiang; He, Xiaoshun			Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study	PLOS ONE			English	Article							RECEIVING LAMIVUDINE PROPHYLAXIS; HBV VACCINE; RECURRENCE; RECIPIENTS; ANTIBODY; IMMUNOGLOBULIN; EOSINOPHIL; FAILURE	Introduction Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT). Since lifelong use of HBIG is expensive and inconvenient and the antibodies level in anti-hepatitis B surface (HBs) is not sustainable and stable, an alternative strategy is to produce anti-HBs antibodies by active immunization. Our present study aimed to prospectively investigate the efficacy and safety of procedural HBV vaccination in transplanted patients. Methods Recipients who had undergone LT for hepatitis B related liver diseases more than one year before, with no evidence of HBV recurrence or rejection and normal liver function were enrolled. All subjects received the hepatitis B vaccine (40 mu g) by intramuscular injection at months 0, 1, 2, 6 and 12 after enrollment with continuous administration of NAs. The liver function and anti-HBs titers were measured before each vaccination and HBIG (400U) was administrated intramuscularly when anti-HBs titer was lower than 30 IU/L during the course. The results of routine blood tests, liver function, concentration of immunosuppressant, and HBV-DNA copies were monitored during the research. After completion of the vaccination procedure, recipients were regarded as responders if their anti-HBs greater than 30 IU/L were maintained for up to six months without using HBIG and vaccine. Results Twenty-seven patients were enrolled in this study and the average anti-HBs titer before vaccination was 19.86 +/- 14.80 IU/L. The average anti-HBs titer of the nine responders at the end of the follow-up was 57.14 +/- 22.75 IU/L, giving an overall response rate of 33.3% (9/27). There were no reports of reactivation of HBV, rejection, severe anaphylaxis or other adverse events. Responders and non-responders showed their significant difference in anti-HBs titers after the fourth vaccination (P<0.01). Moreover, the majority of non-responders (11/18, 63.64%) had high LY/EO rates (lymphocyte number/eosinophil number>15) while most responders (8/9, 88.89%) had low LY/EO rates at the beginning of vaccination (P = 0.019). Conclusions Active immunization is an effective, cost-saving, and safe method for the prevention of HBV reactivation in patients transplanted for hepatitis B virus related liver diseases. The LY/EO rate may be a valuable indicator in selecting potential recipients for vaccination.	[Yang, Anli; Guo, Zhiyong; Ren, Qingqi; Wu, Linwei; Ma, Yi; Hu, Anbin; Wang, Dongping; Ye, Haidan; Zhu, Xiaofeng; Ju, Weiqiang; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou, Guangdong, Peoples R China; [Yang, Anli; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Organ Donat & Transplant Im, Guangzhou, Guangdong, Peoples R China; [Yang, Anli; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Int Cooperat Base Sci & Technol Org, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ju, WQ; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou, Guangdong, Peoples R China.; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Organ Donat & Transplant Im, Guangzhou, Guangdong, Peoples R China.; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Int Cooperat Base Sci & Technol Org, Guangzhou, Guangdong, Peoples R China.	weiqiangju@163.com; gdtrc@163.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation) [2015B050501002]; Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology [2013A061401007]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation); Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology	This study was supported by grants from National High Technology Research and Development Program of China (863 Program; 2012AA021008), Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation) (2015B050501002) and Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology (2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelico M, 2002, HEPATOLOGY, V35, P176, DOI 10.1053/jhep.2002.30278; Bosse M, 1996, IMMUNOLOGY, V87, P149; Brescia G, 2016, AM J OTOLARYNG, V37, P339, DOI 10.1016/j.amjoto.2016.02.002; Huprikar S, 2015, AM J TRANSPLANT, V15, P1162, DOI 10.1111/ajt.13187; Ishigami M, 2015, WORLD J GASTROENTERO, V21, P10290, DOI 10.3748/wjg.v21.i36.10290; Ishigami M, 2011, J GASTROENTEROL, V46, P367, DOI 10.1007/s00535-010-0313-6; Lee S, 2016, LIVER TRANSPLANT, V22, P247, DOI 10.1002/lt.24372; Lo CM, 2007, AM J TRANSPLANT, V7, P434, DOI 10.1111/j.1600-6143.2006.01636.x; Lo CM, 2003, HEPATOLOGY, V37, P36, DOI 10.1053/jhep.2003.50035; Lo CM, 2005, J HEPATOL, V43, P283, DOI 10.1016/j.jhep.2005.03.013; Lu SC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/764234; Matsunaga J, 2000, BRIT J PHARMACOL, V130, P1539, DOI 10.1038/sj.bjp.0703473; Meireles LC, 2015, WORLD J HEPATOL, V7, P2127, DOI 10.4254/wjh.v7.i18.2127; Millan O, 2010, CLIN IMMUNOL, V137, P337, DOI 10.1016/j.clim.2010.08.004; Ohno Y, 2014, TRANSPL P, V46, P721, DOI 10.1016/j.transproceed.2013.12.005; Orlando R, 2015, EUR J CLIN MICROBIOL, V34, P1059, DOI 10.1007/s10096-015-2341-x; Patel SS, 2016, CURR OPIN PEDIATR, V28, P653, DOI 10.1097/MOP.0000000000000391; Shouval D, 2015, MED MICROBIOL IMMUN, V204, P57, DOI 10.1007/s00430-014-0374-x; Starkel P, 2005, LIVER TRANSPLANT, V11, P1228, DOI 10.1002/lt.20464; Sundaram V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4263; Tahara H, 2009, TRANSPL INT, V22, P805, DOI 10.1111/j.1432-2277.2009.00864.x; Takaki A, 2015, HEPATOL RES, V45, P38, DOI 10.1111/hepr.12368; Takaki A, 2013, J GASTROENTEROL, V48, P1373, DOI 10.1007/s00535-013-0763-8; Togashi J, 2016, HEPATOL RES, V46, pE51, DOI 10.1111/hepr.12526; Usui M, 2016, TRANSPL P, V48, P1179, DOI 10.1016/j.transproceed.2015.12.110; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wong TW, 2014, J IMMUNOL, V192, P3548, DOI 10.4049/jimmunol.1302241; Yenigun A, 2016, AM J RHINOL ALLERGY, V30, pE21, DOI 10.2500/ajra.2016.30.4296; Yenigun Alper, 2015, Kulak Burun Bogaz Ihtis Derg, V25, P193, DOI 10.5606/kbbihtisas.2015.10734; Yoshizawa A, 2016, HEPATOL RES, V46, P541, DOI 10.1111/hepr.12586; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345	31	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188190	10.1371/journal.pone.0188190	http://dx.doi.org/10.1371/journal.pone.0188190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145470	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800084
J	Takemoto, Y; Slough, DP; Meinke, G; Katnik, C; Graziano, ZA; Chidipi, B; Reiser, M; Alhadidy, MM; Ramirez, R; Salvador-Montanes, O; Ennis, S; Guerrero-Serna, G; Haburcak, M; Diehl, C; Cuevas, J; Jalife, J; Bohm, A; Lin, YS; Noujaim, SF				Takemoto, Yoshio; Slough, Diana P.; Meinke, Gretchen; Katnik, Christopher; Graziano, Zachary A.; Chidipi, Bojjibabu; Reiser, Michelle; Alhadidy, Mohammed M.; Ramirez, Rafael; Salvador-Montanes, Oscar; Ennis, Steven; Guerrero-Serna, Guadalupe; Haburcak, Marian; Diehl, Carl; Cuevas, Javier; Jalife, Jose; Bohm, Andrew; Lin, Yu-Shan; Noujaim, Sami F.			Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule	FASEB JOURNAL			English	Article						potassium inward rectifier; atrial fibrillation; I-KACh	ATRIAL-FIBRILLATION; CRYSTAL-STRUCTURE; PROTEIN; CHLOROQUINE; PATHOPHYSIOLOGY; INHIBITION; PREDICTION; RESIDUES; BINDING; SYSTEM	The acetylcholine-activated inward rectifier potassium current (I-KACh) is constitutively active in persistent atrial fibrillation (AF). We tested the hypothesis that the blocking of I-KACh with the small molecule chloroquine terminates persistent AF. We used a sheep model of tachypacing-induced, persistent AF, molecular modeling, electrophysiology, and structural biology approaches. The 50% inhibition/inhibitory concentration of I-KACh block with chloroquine, measured by patch clamp, was 1 mu M. In optical mapping of sheep hearts with persistent AF, 1 mu M chloroquine restored sinus rhythm. Molecular modeling suggested that chloroquine blocked the passage of a hydrated potassium ion through the intracellular domain of Kir3.1 (a molecular correlate of I-KACh) by interacting with residues D260 and F255, in proximity to I228, Q227, and L299. H-1 N-15 heteronuclear single-quantum correlation of purified Kir3.1 intracellular domain confirmed the modeling results. F255, I228, Q227, and L299 underwent significant chemical-shift perturbations upon drug binding. We then crystallized and solved a 2.5 angstrom X-ray structure of Kir3.1 with F255A mutation. Modeling of chloroquine binding to the mutant channel suggested that the drug's binding to the pore becomes off centered, reducing its ability to block a hydrated potassium ion. Patch clamp validated the structural and modeling data, where the F255A and D260A mutations significantly reduced I-KACh block by chloroquine. With the use of numerical and structural biology approaches, we elucidated the details of how a small molecule could block an ion channel and exert antiarrhythmic effects. Chloroquine binds the I-KACh channel at a site formed by specific amino acids in the ion-permeation pathway, leading to decreased I-KACh and the subsequent termination of AF.	[Takemoto, Yoshio] Nagoya Univ, Res Inst Environm Med, Dept Cardiovasc Res, Nagoya, Aichi, Japan; [Takemoto, Yoshio; Ramirez, Rafael; Salvador-Montanes, Oscar; Ennis, Steven; Guerrero-Serna, Guadalupe; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Slough, Diana P.; Graziano, Zachary A.; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA USA; [Meinke, Gretchen; Bohm, Andrew] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Katnik, Christopher; Chidipi, Bojjibabu; Reiser, Michelle; Alhadidy, Mohammed M.; Cuevas, Javier; Noujaim, Sami F.] Univ S Florida, Mol Pharmacol & Physiol Dept, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Haburcak, Marian] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Diehl, Carl] Sarom Biostruct, Copenhagen, Denmark; [Jalife, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Jalife, Jose] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain	Nagoya University; University of Michigan System; University of Michigan; Tufts University; Tufts University; State University System of Florida; University of South Florida; Brandeis University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Noujaim, SF (corresponding author), Univ S Florida, Mol Pharmacol & Physiol Dept, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	snoujaim@health.usf.edu	Ramirez, Rafael J./AAI-7712-2020; Jalife, Jose/A-8781-2019; Jalife, Jose/AAJ-9156-2021; CHIDIPI, BOJJI BABU/AAZ-8681-2021; Jalife, Jose/L-4833-2015; Salvador Montanes, Oscar/GQZ-7546-2022	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500; CHIDIPI, BOJJI BABU/0000-0003-4107-1668; Jalife, Jose/0000-0003-0080-3500; Salvador Montanes, Oscar/0000-0002-3201-1316; Sanford, Diana/0000-0002-3777-8292; Haburcak, Marian/0000-0003-0662-0756	American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R21 HL138064, R01HL129136]; Tufts start-up Fund; Knez Family Investment Fund; NIH NHLBI [R01HL122352]; Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium; Substrate for Cardiac Fibrillation; University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research [HEK293]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL138064, R01HL122352, R01HL129136] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Tufts start-up Fund; Knez Family Investment Fund; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium(Leducq Foundation); Substrate for Cardiac Fibrillation; University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Kevin Nash (University of South Florida) for his help with creation of mutant constructs. This work was supported, in part, by an American Heart Association postdoctoral fellowship to Y.T.; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), R21 HL138064 and R01HL129136 to S.F.N.; Tufts start-up and the Knez Family Investment Funds for Y-S.L.; and NIH NHLBI R01HL122352, the Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium and the Substrate for Cardiac Fibrillation, and University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research to J.J. HEK293 cells, stably transfected with Kir3.1 and Kir3.4, were a kind gift from the laboratory of Dr. Douglas Bayliss (University of Virginia Charlottesville, VA, USA). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; BURRELL ZL, 1958, NEW ENGL J MED, V258, P798, DOI 10.1056/NEJM195804172581608; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Dobrev D, 2011, CARDIOVASC RES, V89, P689, DOI 10.1093/cvr/cvr021; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari R, 2016, INT J CARDIOL, V203, P22, DOI 10.1016/j.ijcard.2015.10.089; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IIJIMA H, 1987, PROTEINS, V2, P330, DOI 10.1002/prot.340020408; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurachi Y, 2004, J PHYSIOL-LONDON, V554, P285, DOI 10.1113/jphysiol.2003.048439; Li DX, 2016, BIOPHYS CHEM, V219, P43, DOI 10.1016/j.bpc.2016.09.010; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; Martins RP, 2014, CIRCULATION, V129, P1472, DOI 10.1161/CIRCULATIONAHA.113.004742; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nattel S, 2016, NAT REV CARDIOL, V13, P575, DOI 10.1038/nrcardio.2016.118; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Noujaim SF, 2011, CARDIOVASC RES, V89, P862, DOI 10.1093/cvr/cvr008; Noujaim SF, 2010, FASEB J, V24, P4302, DOI 10.1096/fj.10-163246; Olshansky B, 2004, J AM COLL CARDIOL, V43, P2063, DOI 10.1016/j.jacc.2004.03.020; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Podd SJ, 2016, EUROPACE, V18, P340, DOI 10.1093/europace/euv263; Ramu Y, 2004, BIOCHEMISTRY-US, V43, P10701, DOI 10.1021/bi049125x; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; Sanchez-Capula JA, 2001, J PHARMACOL EXP THER, V297, P437; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Takemoto Yoshio, 2016, JACC Basic Transl Sci, V1, P143; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; Voigt N, 2010, N-S ARCH PHARMACOL, V381, P251, DOI 10.1007/s00210-009-0452-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Walfridsson H, 2015, EUROPACE, V17, P473, DOI 10.1093/europace/euu192; WALKER O, 1983, BRIT J CLIN PHARMACO, V16, P701, DOI 10.1111/j.1365-2125.1983.tb02244.x; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	54	15	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1778	1793		10.1096/fj.201700349R	http://dx.doi.org/10.1096/fj.201700349R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162702	Green Published, Green Submitted			2022-12-26	WOS:000429051400004
J	Woodcock, CSC; Huang, Y; Woodcock, SR; Salvatore, SR; Singh, B; Golin-Bisello, F; Davidson, NE; Neumann, CA; Freeman, BA; Wendell, SG				Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R.; Salvatore, Sonia R.; Singh, Bhupinder; Golin-Bisello, Franca; Davidson, Nancy E.; Neumann, Carola A.; Freeman, Bruce A.; Wendell, Stacy G.			Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer chemoprevention; drug action; NF-kappaB; proliferation; reactive nitrogen species (RNS); reactive oxygen species (ROS); signaling; tumor immunology; tumor necrosis factor (TNF)	NF-KAPPA-B; CONJUGATED LINOLEIC-ACID; TRITERPENOID CDDO-ME; CONSTITUTIVE ACTIVATION; COVALENT MODIFICATION; PPAR-GAMMA; DEGRADATION; GLUTATHIONE; RESISTANCE; EXPRESSION	Triple-negative breast cancer (TNBC) comprises approximate to 20% of all breast cancers and is the most aggressive mammary cancer subtype. Devoid of the estrogen and progesterone receptors, along with the receptor tyrosine kinase ERB2 (HER2), that define most mammary cancers, there are no targeted therapies for patients with TNBC. This, combined with a high metastatic rate and a lower 5-year survival rate than for other breast cancer phenotypes, means there is significant unmet need for new therapeutic strategies. Herein, the anti-neoplastic effects of the electrophilic fatty acid nitroalkene derivative, 10-nitro-octadec-9-enoic acid (nitro-oleic acid, NO2-OA), were investigated in multiple preclinical models of TNBC. NO2-OA reduced TNBC cell growth and viability in vitro, attenuated TNF-induced TNBC cell migration and invasion, and inhibited the tumor growth of MDA-MB-231 TNBC cell xenografts in the mammary fat pads of female nude mice. The up-regulation of these aggressive tumor cell growth, migration, and invasion phenotypes is mediated in part by the constitutive activation of pro-inflammatory nuclear factor B (NF-B) signaling in TNBC. NO2-OA inhibited TNF-induced NF-B transcriptional activity in human TNBC cells and suppressed downstream NF-B target gene expression, including the metastasis-related proteins intercellular adhesion molecule-1 and urokinase-type plasminogen activator. The mechanisms accounting for NF-B signaling inhibition by NO2-OA in TNBC cells were multifaceted, as NO2-OA (a) inhibited the inhibitor of NF-B subunit kinase phosphorylation and downstream inhibitor of NF-B degradation, (b) alkylated the NF-B RelA protein to prevent DNA binding, and (c) promoted RelA polyubiquitination and proteasomal degradation. Comparisons with non-tumorigenic human breast epithelial MCF-10A and MCF7 cells revealed that NO2-OA more selectively inhibited TNBC function. This was attributed to more facile mechanisms for maintaining redox homeostasis in normal breast epithelium, including a more favorable thiol/disulfide balance, greater extents of multidrug resistance protein-1 (MRP1) expression, and greater MRP1-mediated efflux of NO2-OA-glutathione conjugates. These observations reveal that electrophilic fatty acid nitroalkenes react with more alkylation-sensitive targets in TNBC cells to inhibit growth and viability.	[Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R.; Salvatore, Sonia R.; Singh, Bhupinder; Golin-Bisello, Franca; Neumann, Carola A.; Freeman, Bruce A.; Wendell, Stacy G.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Huang, Yi; Neumann, Carola A.] UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15232 USA; [Davidson, Nancy E.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Davidson, Nancy E.] Univ Washington, Dept Med, Seattle, WA 98109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Freeman, BA; Wendell, SG (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; gstacy@pitt.edu	Gelhaus, Stacy/AAF-2570-2019; Woodcock, Steven/AAE-9199-2020; Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Singh, Bhupinder/0000-0002-4241-4610; Neumann, Carola/0000-0003-2801-9531; Salvatore, Sonia/0000-0002-9942-3905	United States Army Breast Cancer Research Breakthrough Awards [W81XWH-14-1-0237, W81XWH-14-1-0238]; National Institutes of Health [R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455, R21AI122071-01A1, 5P30-CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, P01HL103455, R01HL064937, R01HL132550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	United States Army Breast Cancer Research Breakthrough Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by United States Army Breast Cancer Research Breakthrough Awards W81XWH-14-1-0237 (to Y.H.) and W81XWH-14-1-0238 (to N. E. D.) and National Institutes of Health Grants R01-HL058115, R01-HL64937, P30-DK072506, and P01-HL103455 (to B. A. F.), R21AI122071-01A1 (to S. G. W.), and 5P30-CA047904 (to N. E. D.). B. A. F., S. G. W., S. R. W., and C. C. W. acknowledge interest in Complexa, Inc. No potential conflicts of interest were disclosed by other authors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Ambrozova G, 2016, FREE RADICAL BIO MED, V90, P252, DOI 10.1016/j.freeradbiomed.2015.11.026; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Codreanu SG, 2014, MOL CELL PROTEOMICS, V13, P849, DOI 10.1074/mcp.M113.032953; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Delmastro-Greenwood M, 2015, FREE RADICAL BIO MED, V89, P333, DOI 10.1016/j.freeradbiomed.2015.07.149; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Fazzari M, 2017, J LIPID RES, V58, P375, DOI 10.1194/jlr.M072058; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Heitz F, 2009, EUR J CANCER, V45, P2792, DOI 10.1016/j.ejca.2009.06.027; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hughan KS, 2017, HYPERTENSION, V70, P634, DOI 10.1161/HYPERTENSIONAHA.117.09016; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kastrati I, 2016, J BIOL CHEM, V291, P3639, DOI 10.1074/jbc.M115.679704; Kelley EE, 2014, CARDIOVASC RES, V101, P352, DOI 10.1093/cvr/cvt341; Klinke A, 2014, AM J RESP CELL MOL, V51, P155, DOI 10.1165/rcmb.2013-0063OC; Koenitzer JR, 2016, REDOX BIOL, V8, P1, DOI 10.1016/j.redox.2015.11.002; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Levonen AL, 2014, FREE RADICAL BIO MED, V71, P196, DOI 10.1016/j.freeradbiomed.2014.03.025; Li HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10244; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Moody WE, 2016, HYPERTENSION, V67, P368, DOI 10.1161/HYPERTENSIONAHA.115.06608; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Paranjpe A, 2013, CARCINOGENESIS, V34, P990, DOI 10.1093/carcin/bgt032; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Qiao YC, 2016, J BIOL CHEM, V291, P5068, DOI 10.1074/jbc.M115.702571; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rudnicki M, 2011, ARTERIOSCL THROM VAS, V31, P1360, DOI 10.1161/ATVBAHA.111.224626; Rudolph TK, 2016, CARDIOVASC RES, V109, P174, DOI 10.1093/cvr/cvv254; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Sibhatu MB, 2008, CARCINOGENESIS, V29, P807, DOI 10.1093/carcin/bgn013; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Snyder NW, 2015, CHEM-BIOL INTERACT, V234, P144, DOI 10.1016/j.cbi.2014.10.029; So JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107616; Song NY, 2011, CHEM RES TOXICOL, V24, P1231, DOI 10.1021/tx200090n; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Verescakova H, 2017, FREE RADICAL BIO MED, V104, P10, DOI 10.1016/j.freeradbiomed.2017.01.003; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wang HP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293474; Wang WD, 2016, AM J PHYSIOL-RENAL, V310, pF697, DOI 10.1152/ajprenal.00321.2015; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Zalba G, 2007, ARTERIOSCL THROM VAS, V27, P587, DOI 10.1161/01.ATV.0000256467.25384.c6	71	36	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1120	1137		10.1074/jbc.M117.814368	http://dx.doi.org/10.1074/jbc.M117.814368			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158255	hybrid, Green Published			2022-12-26	WOS:000423515000002
J	Huang, HT; Bobst, CE; Iwig, JS; Chivers, PT; Kaltashov, IA; Maroney, MJ				Huang, Hsin-Ting; Bobst, Cedric E.; Iwig, Jeffrey S.; Chivers, Peter T.; Kaltashov, Igor A.; Maroney, Michael J.			Co(II) and Ni(II) binding of the Escherichia coli transcriptional repressor RcnR orders its N terminus, alters helix dynamics, and reduces DNA affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal homeostasis; metal ion-protein interaction; metalloprotein; transcription regulation; hydrogen exchange mass spectrometry	CONTROLLING ZINC HOMEOSTASIS; HYDROGENASE MATURATION; PROTEIN NIKA; NICKEL; REGULATOR; RECOGNITION; PATHWAY; HYPB; SLYD; CSOR	RcnR, a transcriptional regulator in Escherichia coli, derepresses the expression of the export proteins RcnAB upon binding Ni(II) or Co(II). Lack of structural information has precluded elucidation of the allosteric basis for the decreased DNA affinity in RcnR's metal-bound states. Here, using hydrogen-deuterium exchange coupled with MS (HDX-MS), we probed the RcnR structure in the presence of DNA, the cognate metal ions Ni(II) and Co(II), or the noncognate metal ion Zn(II). We found that cognate metal binding altered flexibility from the N terminus through helix 1 and modulated the RcnR-DNA interaction. Apo-RcnR and RcnR-DNA complexes and the Zn(II)-RcnR complex exhibited similar H-2 uptake kinetics, with fast-exchanging segments located in the N terminus, in helix 1 (residues 14-24), and at the C terminus. The largest difference in H-2 incorporation between apo- and Ni(II)- and Co(II)-bound RcnR was observed in helix 1, which contains the N terminus and His-3, and has been associated with cognate metal binding. H-2 uptake in helix 1 was suppressed in the Ni(II)- and Co(II)-bound RcnR complexes, in particular in the peptide corresponding to residues 14-24, containing Arg-14 and Lys-17. Substitution of these two residues drastically affected DNA-binding affinity, resulting in rcnA expression in the absence of metal. Our results suggest that cognate metal binding to RcnR orders its N terminus, decreases helix 1 flexibility, and induces conformational changes that restrict DNA interactions with the positively charged residues Arg-14 and Lys-17. These metal-induced alterations decrease RcnR-DNA binding affinity, leading to rcnAB expression.	[Huang, Hsin-Ting; Bobst, Cedric E.; Kaltashov, Igor A.; Maroney, Michael J.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Iwig, Jeffrey S.] Carmot Therapeut Inc, San Francisco, CA 94158 USA; [Chivers, Peter T.] Univ Durham, Dept Biosci, Durham DH1 3LE, England; [Chivers, Peter T.] Univ Durham, Dept Chem, Durham DH1 3LE, England	University of Massachusetts System; University of Massachusetts Amherst; Durham University; Durham University	Maroney, MJ (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	mmaroney@chem.umass.edu		Chivers, Peter/0000-0002-8779-1452; Maroney, Michael/0000-0002-5598-3038	National Institutes of Health [R01-GM069696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM069696 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blaha D, 2011, BIOCHIMIE, V93, P434, DOI 10.1016/j.biochi.2010.10.016; Bleriot C, 2011, J BACTERIOL, V193, P3785, DOI 10.1128/JB.05032-11; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Carr CE, 2017, INORG CHEM, V56, P6459, DOI 10.1021/acs.inorgchem.7b00527; Chang FMJ, 2015, BIOCHEMISTRY-US, V54, P2463, DOI 10.1021/acs.biochem.5b00154; Chang FMJ, 2014, J BIOL CHEM, V289, P19204, DOI 10.1074/jbc.M114.556704; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Chung KCC, 2011, J BIOL CHEM, V286, P43081, DOI 10.1074/jbc.M111.290726; Denby KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38879; DEPINA K, 1995, EUR J BIOCHEM, V227, P857; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Heddle J, 2003, J BIOL CHEM, V278, P50322, DOI 10.1074/jbc.M307941200; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Hud NV, 2003, BIOPOLYMERS, V69, P144, DOI 10.1002/bip.10364; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; Kaltashov IA, 2013, PROTEIN SCI, V22, P530, DOI 10.1002/pro.2238; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Musiani F, 2015, METALLOMICS, V7, P1305, DOI 10.1039/c5mt00072f; Nevin P, 2015, FEBS J, V282, P2646, DOI 10.1111/febs.13304; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	35	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					324	332		10.1074/jbc.RA117.000398	http://dx.doi.org/10.1074/jbc.RA117.000398			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29150441	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000419453200027
J	Weng, ZF; Shang, Y; Yao, DQ; Zhu, JW; Zhang, RG				Weng, Zhuangfeng; Shang, Yuan; Yao, Deqiang; Zhu, Jinwei; Zhang, Rongguang			Structural analyses of key features in the KANK1 center dot KIF21A complex yield mechanistic insights into the cross-talk between microtubules and the cell cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL FIBROSIS; KINESIN KIF21A; KANK PROTEINS; ADHESION; MIGRATION; ENDS; MUTATIONS; DYNAMICS; ACTIN; STABILIZATION	The cross-talk between dynamic microtubules and the cell cortex plays important roles in cell division, polarity, and migration. A critical adaptor that links the plus ends of microtubules with the cell cortex is the KANK N-terminal motif and ankyrin repeat domains 1 (KANK1)/kinesin family member 21A (KIF21A) complex. Genetic defects in these two proteins are associated with various cancers and developmental diseases, such as congenital fibrosis of the extraocular muscles type 1. However, the molecular mechanism governing the KANK1/KIF21A interaction and the role of the conserved ankyrin (ANK) repeats in this interaction are still unclear. In this study, we present the crystal structure of the KANK1 center dot KIF21A complex at 2.1 angstrom resolution. The structure, together with biochemical studies, revealed that a five-helix-bundle-capping domain immediately preceding the ANK repeats of KANK1 forms a structural and functional supramodule with its ANK repeats in binding to an evolutionarily conserved peptide located in the middle of KIF21A. We also show that several missense mutations present in cancer patients are located at the interface of the KANK1 center dot KIF21A complex and destabilize its formation. In conclusion, our study elucidates the molecular basis underlying the KANK1/KIF21A interaction and also provides possible mechanistic explanations for the diseases caused by mutations in KANK1 and KIF21A.	[Weng, Zhuangfeng; Yao, Deqiang; Zhu, Jinwei; Zhang, Rongguang] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, Natl Ctr Prot Sci Shanghai,Univ Chinese Acad Sci, 333 Haike Rd, Shanghai 201203, Peoples R China; [Weng, Zhuangfeng; Zhang, Rongguang] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Shang, Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Rongguang] Chinese Acad Sci, Shanghai Res Ctr, Shanghai 200031, Peoples R China; [Shang, Yuan] Univ Arizona, Ctr Biomed Informat & Biostat, Tucson, AZ 85721 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Hong Kong University of Science & Technology; Chinese Academy of Sciences; University of Arizona	Zhu, JW; Zhang, RG (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, Natl Ctr Prot Sci Shanghai,Univ Chinese Acad Sci, 333 Haike Rd, Shanghai 201203, Peoples R China.; Zhang, RG (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.; Zhang, RG (corresponding author), Chinese Acad Sci, Shanghai Res Ctr, Shanghai 200031, Peoples R China.	jinwei.zhu@sibcb.ac.cn; rgzhang@sibcb.ac.cn	SHANG, Raymond Yuan/AAV-3446-2020	SHANG, Yuan/0000-0002-7093-4234	National Natural Science Foundation of China [31470733, U1532121]; Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant [14YF1406700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08030104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31470733 and U1532121, Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant 14YF1406700 (to J. Z.), and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08030104 (to R. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Astro V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3312; Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; de Curtis I, 2012, J CELL SCI, V125, P4435, DOI 10.1242/jcs.108266; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Heidary Gena, 2008, Semin Ophthalmol, V23, P3, DOI 10.1080/08820530701745181; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kakinuma N, 2009, BIOCHEM BIOPH RES CO, V386, P639, DOI 10.1016/j.bbrc.2009.06.109; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; Luo M, 2016, EXP DERMATOL, V25, P321, DOI 10.1111/exd.12933; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; Sveen A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0434-0; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; Tuncay H, 2016, CELL MOL LIFE SCI, V73, P1195, DOI 10.1007/s00018-015-2116-7; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Willour VL, 2004, AM J HUM GENET, V75, P508, DOI 10.1086/423899; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					215	225		10.1074/jbc.M117.816017	http://dx.doi.org/10.1074/jbc.M117.816017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158259	hybrid, Green Published			2022-12-26	WOS:000419453200019
J	Akgul, F; Sercelik, A; Cetin, H; Erten, T				Akgul, Ferit; Sercelik, Alper; Cetin, Hakan; Erten, Turgay			Association of parathyroid hormone and vitamin D with untreated hypertension: Is it different in white-coat or sustained hypertension?	PLOS ONE			English	Article							BLOOD-PRESSURE; INCIDENT HYPERTENSION; CARDIOVASCULAR RISK; 25-HYDROXYVITAMIN D; PRIMARY HYPERPARATHYROIDISM; INDEPENDENT ASSOCIATIONS; MASKED HYPERTENSION; GENERAL-POPULATION; EUROPEAN-SOCIETY; ATHEROSCLEROSIS	Background Previous reports about the relationship between a high parathyroid hormone (PTH) and low vitamin D levels with blood pressure in different hypertension groups are conflicting. Objective We studied serum PTH and vitamin D levels in white-coat (WCHT) and sustained hypertension (SHT) patients who had not been on antihypertensive treatment. We also investigated the association between serum PTH and vitamin D levels with respect to blood pressure in SHT and WCHT patients. Methods We included 52 SHT patients (54.06 +/- 9.2 years, 32 newly diagnosed and 20 previously diagnosed with SHT who had not been treated with antihypertensive medication for 3 months or more), 48 WCHT patients (53.64 +/- 9.5 years), and 50 normotensive (NT) healthy controls (53.44 +/- 8.4 years) in our study. In addition to routine tests, PTH and vitamin D levels were measured. Results Serum PTH levels were significantly higher in SHT patients not taking antihypertensive medications than in WCHT patients and NT controls (p = 0.004). Although PTH levels were higher in WCHT than in NT groups, the difference was not statistically significant. In SHT patients, PTH levels showed a positive correlation with office systolic (r = 0.363, p = 0.008), office diastolic (r = 0.282, p = 0.038), home systolic (r = 0.390, p = 0.004), and home diastolic blood pressures (r = 0.397, p = 0.003). Serum vitamin D levels were similar in SHT, WCHT and NT groups. Vitamin D levels were not associated with blood pressures in the entire study group. Furthermore, no significant relation was found between vitamin D and PTH levels in SHT and WCHT groups. Conclusion PTH levels are significantly higher in untreated SHT patients than WCHT patients and NT subjects. However, vitamin D levels are similar in SHT, WCHT and NT groups. There is a significant association between PTH levels and blood pressures suggesting PTH has a role in increase of blood pressure in SHT.	[Akgul, Ferit; Erten, Turgay] Bulent Ecevit Univ, Dept Cardiol, Zonguldak, Turkey; [Sercelik, Alper] Sanko Univ, Dept Cardiol, Gaziantep, Turkey; [Cetin, Hakan] Van Yuzuncu Yil Univ, Dept Mol Biol & Genet, Van, Turkey	Bulent Ecevit University; Gaziantep University; Sanko University; Yuzuncu Yil University	Akgul, F (corresponding author), Bulent Ecevit Univ, Dept Cardiol, Zonguldak, Turkey.	ferit326@gmail.com		Akgul, Ferit/0000-0002-1383-1001				Alkhatatbeh MJ, 2017, METAB SYNDR RELAT D, V15, P213, DOI 10.1089/met.2017.0003; Alpsoy S, 2016, BLOOD PRESS MONIT, V21, P131, DOI 10.1097/MBP.0000000000000171; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Broulik PD, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/309068; Brown J, 2015, J CLIN ENDOCR METAB, V100, P490, DOI 10.1210/jc.2014-3949; CALVO MS, 1988, J CLIN ENDOCR METAB, V66, P823, DOI 10.1210/jcem-66-4-823; Chan R, 2012, J HUM HYPERTENS, V26, P20, DOI 10.1038/jhh.2010.126; Cuckson AC, 2002, BLOOD PRESS MONIT, V7, P319, DOI 10.1097/00126097-200212000-00005; Cuspidi C, 2015, J HYPERTENS, V33, P24, DOI 10.1097/HJH.0000000000000416; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Fukuhara M, 2013, STROKE, V44, P1512, DOI 10.1161/STROKEAHA.111.000704; GENNARI C, 1995, MINER ELECTROL METAB, V21, P77; Hassan M, 2014, J RENIN-ANGIO-ALDO S, V15, P278, DOI 10.1177/1470320314539180; Huang YL, 2017, J HYPERTENS, V35, P677, DOI 10.1097/HJH.0000000000001226; Khattar RS, 1998, CIRCULATION, V98, P1892, DOI 10.1161/01.CIR.98.18.1892; Kim H, 2013, CALCIFIED TISSUE INT, V93, P549, DOI 10.1007/s00223-013-9789-4; Kosch M, 2000, CARDIOVASC RES, V47, P813, DOI 10.1016/S0008-6363(00)00130-9; Li LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043344; Lila Anurag Ranjan, 2012, Indian J Endocrinol Metab, V16, P258, DOI 10.4103/2230-8210.93745; Lu M, 2013, J CLIN ENDOCR METAB, V98, pE1345, DOI 10.1210/jc.2013-1466; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Nielsen PK, 1996, NEPHROL DIAL TRANSPL, V11, P1762; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Peng M, 2016, INTERNAL MED, V55, P1255, DOI 10.2169/internalmedicine.55.5898; Perkovic V, 2003, KIDNEY BLOOD PRESS R, V26, P27, DOI 10.1159/000069761; Pierdomenico SD, 2008, J HUM HYPERTENS, V22, P408, DOI 10.1038/jhh.2008.6; ROSSI E, 1995, AM J HYPERTENS, V8, P884, DOI 10.1016/0895-7061(95)00182-O; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P3245, DOI 10.1097/01.ASN.0000101240.47747.7F; Siven SSE, 2016, J HYPERTENS, V34, P54, DOI 10.1097/HJH.0000000000000750; Skaaby T, 2012, CARDIOLOGY, V123, P62, DOI 10.1159/000341277; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Ulu SM, 2014, CLIN EXP HYPERTENS, V36, P52, DOI 10.3109/10641963.2013.783054; van Ballegooijen AJ, 2014, J AM COLL CARDIOL, V63, P1214, DOI 10.1016/j.jacc.2014.01.012; Wimalawansa S. J., 2016, J STEROID BIOCHEM; Yagi S, 2014, ENDOCR J, V61, P727, DOI 10.1507/endocrj.EJ14-0004; Zaheer S, 2016, J BONE MINER RES, V31, P1137, DOI 10.1002/jbmr.2779; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188669	10.1371/journal.pone.0188669	http://dx.doi.org/10.1371/journal.pone.0188669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176783	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900113
J	Andersen, GE; Johnson, CN; Barmuta, LA; Jones, ME				Andersen, Georgina E.; Johnson, Christopher N.; Barmuta, Leon A.; Jones, Menna E.			Dietary partitioning of Australia's two marsupial hypercarnivores, the Tasmanian devil and the spotted-tailed quoll, across their shared distributional range	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; DISEASE-INDUCED DECLINE; FACIAL TUMOR DISEASE; DASYURUS-MACULATUS; INTRAGUILD PREDATION; RAIN-FOREST; SARCOPHILUS-HARRISII; SYMPATRIC CARNIVORES; MAMMALIAN CARNIVORES; APEX PREDATOR	Australia's native marsupial fauna has just two primarily flesh-eating 'hypercarnivores', the Tasmanian devil (Sarcophilus harrisii) and the spotted-tailed quoll (Dasyurus maculatus) which coexist only on the island of Tasmania. Devil populations are currently declining due to a fatal transmissible cancer. Our aim was to analyse the diet of both species across their range in Tasmania, as a basis for understanding how devil decline might affect the abundance and distribution of quolls through release from competition. We used faecal analysis to describe diets of one or both species at 13 sites across Tasmania. We compared diet composition and breadth between the two species, and tested for geographic patterns in diets related to rainfall and devil population decline. Dietary items were classified into 6 broad categories: large mammals (>= 7.0kg), medium-sized mammals (0.5-6.9kg), small mammals (<0.5kg), birds, reptiles and invertebrates. Diet overlap based on prey-size category was high. Quoll diets were broader than devils at all but one site. Devils consumed more large and medium-sized mammals and quolls more small mammals, reptiles and invertebrates. Medium-sized mammals (mainly Tasmanian pademelon Thylogale billardierii), followed by large mammals (mainly Bennett's wallaby Macropus rufogriseus) and birds, were the most important prey groups for both species. Diet composition varied across sites, suggesting that both species are flexible and opportunistic foragers, but was not related to rainfall for devils. Quolls included more large mammals but fewer small mammals and invertebrates in their diet in the eastern drier parts of Tasmania where devils have declined. This suggests that a competitive release of quolls may have occurred and the substantial decline of devils has provided more food in the large-mammal category for quolls, perhaps as increased scavenging opportunities. The high diet overlap suggests that if resources become limited in areas of high devil density, interspecific competition could occur.	[Andersen, Georgina E.; Johnson, Christopher N.; Barmuta, Leon A.; Jones, Menna E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Johnson, Christopher N.] Univ Tasmania, Australian Res Council, Ctr Australian Biodivers & Heritage, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Andersen, GE (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	georgina.andersen@utas.edu.au	Barmuta, Leon/J-2413-2013; CABAH, ARC/T-6419-2019; Johnson, Christopher/J-7894-2014	Barmuta, Leon/0000-0002-8946-3727; Johnson, Christopher/0000-0002-9719-3771; Andersen, Georgina/0000-0001-9425-8296; Jones, Menna/0000-0001-7558-9022	Australian Research Council Discovery Scheme grant [DP110103069]; Holsworth Wildlife Research Endowment; Save the Tasmanian Devil Appeal [F3F98304778C800ECA2576CB007D1E6B]	Australian Research Council Discovery Scheme grant; Holsworth Wildlife Research Endowment; Save the Tasmanian Devil Appeal	This research was funded by grants from the Australian Research Council Discovery Scheme grant (DP110103069) to MEJ and CNJ, the Holsworth Wildlife Research Endowment (http://www.ecolsoc.org.au/endowments) and a Dr Eric Guiler Tasmanian Devil Research grant from the Save the Tasmanian Devil Appeal (http://www.tassiedevil.com.au/tasdevil.nsf/Grants-&-scholarships/F3F98304778C800ECA2576CB007D1E6B) to GEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 2008, Conservation Science Western Australia, V7, P1; Andersen GE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11454-z; Andersen GE, 2016, BEHAV ECOL SOCIOBIOL, V70, P1831, DOI 10.1007/s00265-016-2189-9; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Belcher C, 2008, MAM MALS AUSTR; Belcher CA, 2007, AUST J ZOOL, V55, P117, DOI 10.1071/ZO06102; Belcher CA, 2006, J ZOOL, V269, P183, DOI 10.1111/j.1469-7998.2006.00056.x; BELCHER CA, 1995, WILDLIFE RES, V22, P341, DOI 10.1071/WR9950341; Brillouin L., 1956, SCI INFORM THEORY; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; Brunner H, 2002, INTERACTIVE TOOL IDE; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Cirovic D, 2016, BIOL CONSERV, V199, P51, DOI 10.1016/j.biocon.2016.04.027; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cypher BL, 1998, J MAMMAL, V79, P204, DOI 10.2307/1382855; Davis NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120975; Dawson JP, 2007, WILDLIFE RES, V34, P342, DOI 10.1071/WR05101; Dickman C., 1996, OVERVIEW IMPACTS FER; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; EMMONS LH, 1980, ECOL MONOGR, V50, P31, DOI 10.2307/2937245; ESTRADA A, 1985, AM J PRIMATOL, V9, P27, DOI 10.1002/ajp.1350090104; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Gause G. F., 1934, STRUGGLE EXISTENCE; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2006, J ZOOL, V269, P241, DOI 10.1111/j.1469-7998.2006.00046.x; Glen AS, 2011, AUSTRAL ECOL, V36, P290, DOI 10.1111/j.1442-9993.2010.02149.x; Guiler ER, 1985, THYLACINE TRAGEDY TA; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hobday AJ, 2008, WILDLIFE RES, V35, P712, DOI 10.1071/WR08067; Hollings T, 2016, ECOLOGY, V97, P394, DOI 10.1890/15-0204.1; Hollings T, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0124; Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Hovenden M., 1999, VEGETATION TASMANIA; Janssen A, 2007, ECOLOGY, V88, P2713, DOI 10.1890/06-1408.1; Jarnemo A, 2004, CAN J ZOOL, V82, P416, DOI 10.1139/z04-011; Jones M, 1997, ECOLOGY, V78, P2569; Jones M, 1996, NATURE AUSTR, V25, P46; Jones M.E., 2003, PREDATORS POUCHES BI, P281; Jones M. E., 2008, MAMMALS AUSTR, P78; Jones M.E., 1995, THESIS; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; Kamler JF, 2004, WEST N AM NATURALIST, V64, P53; Keast A., 1981, ECOLOGICAL BIOGEOGRA, P1891; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Le Mar K, 2005, AUSTRAL ECOL, V30, P674, DOI 10.1111/j.1442-9993.2005.01510.x; LEVINS RICHARD, 1968; Lobert B, 2001, WILDLIFE RES, V28, P637, DOI 10.1071/WR00124; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; McDonald JE, 2005, J MAMMAL, V86, P1022, DOI 10.1644/1545-1542(2005)86[1022:EOSAAO]2.0.CO;2; Menkhorst P.W., 2011, FIELD GUIDE MAMMALS, V3rd; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Peacock D, 2014, AUST J ZOOL, V62, P294, DOI 10.1071/ZO14029; Pemberton D., 1990, THESIS; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Prigioni C, 2008, ITAL J ZOOL, V75, P173, DOI 10.1080/11250000701885521; R Core Team, 2013, R LANG ENV STAT COMP; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Schoener T.W., 1986, P91; TAYLOR R J, 1985, Papers and Proceedings of the Royal Society of Tasmania, V119, P69; Troy S. N., 2014, THESIS; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Wiggins NL, 2011, WILDLIFE RES, V38, P103, DOI 10.1071/WR10116; Yarnell RW, 2013, S AFR J WILDL RES, V43, P155, DOI 10.3957/056.043.0206	78	22	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188529	10.1371/journal.pone.0188529	http://dx.doi.org/10.1371/journal.pone.0188529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176811	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000416291900090
J	Liu, LQ; Rosjat, N; Popovych, S; Wang, BA; Yeldesbay, A; Toth, TI; Viswanathan, S; Grefkes, CB; Fink, GR; Daun, S				Liu, Liqing; Rosjat, Nils; Popovych, Svitlana; Wang, Bin A.; Yeldesbay, Azamat; Toth, Tibor I.; Viswanathan, Shivakumar; Grefkes, Christian B.; Fink, Gereon R.; Daun, Silvia			Age-related changes in oscillatory power affect motor action	PLOS ONE			English	Article							LIFE-SPAN; WORKING-MEMORY; PHASE-LOCKING; OLDER-ADULTS; AMPLITUDE MODULATIONS; SENSORIMOTOR CORTEX; COGNITIVE CONTROL; BRAIN ACTIVITY; MOVEMENT; DYNAMICS	With increasing age cognitive performance slows down. This includes cognitive processes essential for motor performance. Additionally, performance of motor tasks becomes less accurate. The objective of the present study was to identify general neural correlates underlying age-related behavioral slowing and the reduction in motor task accuracy. To this end, we continuously recorded EEG activity from 18 younger and 24 older right-handed healthy participants while they were performing a simple finger tapping task. We analyzed the EEG records with respect to local changes in amplitude (power spectrum) as well as phase locking between the two age groups. We found differences between younger and older subjects in the amplitude of post-movement synchronization in the beta band of the sensory- motor and medial prefrontal cortex (mPFC). This post-movement beta amplitude was significantly reduced in older subjects. Moreover, it positively correlated with the accuracy with which subjects performed the motor task at the electrode FCz, which detects activity of the mPFC and the supplementary motor area. In contrast, we found no correlation between the accurate timing of local neural activity, i. e. phase locking in the delta-theta frequency band, with the reaction and movement time or the accuracy with which the motor task was performed. Our results show that only post-movement beta amplitude and not delta-theta phase locking is involved in the control of movement accuracy. The decreased post-movement beta amplitude in the mPFC of older subjects hints at an impaired deactivation of this area, which may affect the cognitive control of stimulus-induced motor tasks and thereby motor output.	[Liu, Liqing; Rosjat, Nils; Popovych, Svitlana; Yeldesbay, Azamat; Toth, Tibor I.; Daun, Silvia] Univ Cologne, Inst Zool, Dept Anim Physiol, Heisenberg Res Grp Computat Neurosci,Modeling Neu, Cologne, Germany; [Liu, Liqing; Rosjat, Nils; Popovych, Svitlana; Wang, Bin A.; Yeldesbay, Azamat; Viswanathan, Shivakumar; Grefkes, Christian B.; Fink, Gereon R.; Daun, Silvia] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Viswanathan, Shivakumar; Grefkes, Christian B.; Fink, Gereon R.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany	University of Cologne; Helmholtz Association; Research Center Julich; University of Cologne	Daun, S (corresponding author), Univ Cologne, Inst Zool, Dept Anim Physiol, Heisenberg Res Grp Computat Neurosci,Modeling Neu, Cologne, Germany.; Daun, S (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany.	s.daun@fz-juelich.de	Grefkes, Christian/H-3972-2013; Wang, Bin/AAX-2956-2020; Viswanathan, Shivakumar/AAB-9426-2020; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012	Grefkes, Christian/0000-0002-1656-720X; Wang, Bin/0000-0001-9388-6119; Viswanathan, Shivakumar/0000-0002-7513-3778; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Daun, Silvia/0000-0001-7342-1015; Yeldesbay, Azamat/0000-0003-0800-7197; Rosjat, Nils/0000-0002-1977-4642	University of Cologne Emerging Groups Initiative (CONNECT group); German Excellence Initiative; German Research Foundation (DFG) [GR3690/2-1, GR3690/4-1, DA 1953/5-2]; DFG [GR 3285/5-1]; Marga and Walter Boll Foundation	University of Cologne Emerging Groups Initiative (CONNECT group); German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Marga and Walter Boll Foundation	This work was funded by the University of Cologne Emerging Groups Initiative (CONNECT group) within the framework of the Institutional Strategy of the University of Cologne and the German Excellence Initiative (http://exzellenz.koeln.de/11509.html?uzk15_quicknav=11498.html). SD gratefully acknowledges additional support from the German Research Foundation (DFG; GR3690/2-1, GR3690/4-1, DA 1953/5-2) (http://www.dfg.de/gefoerderte_projekte/). CG also acknowledges funding from the DFG (GR 3285/5-1) (http.//www.dfg.de/gefoerderte_projekte/). GRF gratefully acknowledges additional support by the Marga and Walter Boll Foundation (http:w//www. bollstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Christou EA, 2011, AGE, V33, P393, DOI 10.1007/s11357-010-9190-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Gaetz W, 2010, NEUROIMAGE, V51, P792, DOI 10.1016/j.neuroimage.2010.01.077; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Handy TC, 2005, EVENT RELATED POTENT; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Homan R W, 1987, CLIN NEUROPHYSIOL, V66, P376, DOI DOI 10.1016/0013-4694(87)90206-9; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Igarashi J, 2013, J NEUROSCI, V33, P18515, DOI 10.1523/JNEUROSCI.2126-13.2013; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Labyt E, 2003, CLIN NEUROPHYSIOL, V114, P1153, DOI 10.1016/S1388-2457(03)00058-0; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; MacDonald SWS, 2006, J CLIN EXP NEUROPSYC, V28, P655, DOI 10.1080/13803390590954245; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Min BK, 2007, INT J PSYCHOPHYSIOL, V65, P58, DOI 10.1016/j.ijpsycho.2007.03.002; Muller V, 2009, DEVELOPMENTAL SCI, V12, P839, DOI 10.1111/j.1467-7687.2009.00834.x; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Papegaaij S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00126; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Popovych S, 2016, NEUROIMAGE, V139, P439, DOI 10.1016/j.neuroimage.2016.06.052; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Sander MC, 2012, NEUROIMAGE, V59, P646, DOI 10.1016/j.neuroimage.2011.06.092; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stelmach GE, 2012, SENSORIMOTOR IMPAIRM; Tan HL, 2016, J NEUROSCI, V36, P1516, DOI 10.1523/JNEUROSCI.3204-15.2016; Tass P., 2007, PHASE RESETTING MED; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Toledo DR, 2016, CLIN NEUROPHYSIOL, V127, P655, DOI 10.1016/j.clinph.2015.05.003; van Wijk BCM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00252; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Wang BA, 2017, NEUROIMAGE, V159, P248, DOI 10.1016/j.neuroimage.2017.07.054; Werkle-Bergner M, 2012, NEUROIMAGE, V60, P71, DOI 10.1016/j.neuroimage.2011.11.071; Werkle-Bergner M, 2009, CLIN NEUROPHYSIOL, V120, P1291, DOI 10.1016/j.clinph.2009.04.012; Wu T, 2005, J PHYSIOL-LONDON, V562, P605, DOI 10.1113/jphysiol.2004.076042; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042	44	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187911	10.1371/journal.pone.0187911	http://dx.doi.org/10.1371/journal.pone.0187911			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176853	Green Published, gold			2022-12-26	WOS:000416291900022
J	Stifter, J; Ulbrich, F; Goebel, U; Bohringer, D; Lagreze, WA; Biermann, J				Stifter, Julia; Ulbrich, Felix; Goebel, Ulrich; Boehringer, Daniel; Lagreze, Wolf Alexander; Biermann, Julia			Neuroprotection and neuroregeneration of retinal ganglion cells after intravitreal carbon monoxide release	PLOS ONE			English	Article							III BETA-TUBULIN; ISCHEMIA-REPERFUSION INJURY; FIBRILLARY ACIDIC PROTEIN; CULTURED MULLER CELLS; RAT RETINA; ADULT-RAT; GENE-EXPRESSION; NEUROTROPHIC FACTOR; HEME OXYGENASE-1; RADIAL GLIA	Purpose Retinal ischemia induces apoptosis leading to neurodegeneration and vision impairment. Carbon monoxide (CO) in gaseous form showed cell-protective and anti-inflammatory effects after retinal ischemia-reperfusion-injury (IRI). These effects were also demonstrated for the intravenously administered CO-releasing molecule (CORM) ALF-186. This article summarizes the results of intravitreally released CO to assess its suitability as a neuroprotective and neuroregenerative agent. Methods Water-soluble CORM ALF-186 (25 mu g), PBS, or inactivated ALF (iALF) (all 5 mu l) were intravitreally applied into the left eyes of rats directly after retinal IRI for 1 h. Their right eyes remained unaffected and were used for comparison. Retinal tissue was harvested 24 h after intervention to analyze mRNA or protein expression of Caspase-3, pERK1/2, p38, HSP70/90, NF-kappaB, AIF-1 (allograft inflammatory factor), TNF-alpha, and GAP-43. Densities of fluorogold-prelabeled retinal ganglion cells (RGC) were examined in flat-mounted retinae seven days after IRI and were expressed as mean/mm(2). The ability of RGC to regenerate their axon was evaluated two and seven days after IRI using retinal explants in laminin-1-coated cultures. Immunohistochemistry was used to analyze the different cell types growing out of the retinal explants. Results Compared to the RGC-density in the contralateral right eyes (2804 +/- 214 RGC/mm(2); data are mean +/- SD), IRI+PBS injection resulted in a remarkable loss of RGC (1554 +/- 159 RGC/mm(2)), p<0.001. Intravitreally injected ALF-186 immediately after IRI provided RGC protection and reduced the extent of RGC-damage (IRI+PBS 1554 +/- 159 vs. IRI+ALF 2179 +/- 286, p<0.001). ALF-186 increased the IRI-mediated phosphorylation of MAP-kinase p38. Anti-apoptotic and anti-inflammatory effects were detectable as Caspase-3, NF-kappaB, TNF-alpha, and AIF-1 expression were significantly reduced after IRI+ALF in comparison to IRI+PBS or IRI+iALF. Gap-43 expression was significantly increased after IRI+ALF. iALF showed effects similar to PBS. The intrinsic regenerative potential of RGC-axons was induced to nearly identical levels after IRI and ALF or iALF-treatment under growth-permissive conditions, although RGC viability differed significantly in both groups. Intravitreal CO further increased the IRI-induced migration of GFAP-positive cells out of retinal explants and their transdifferentiation, which was detected by re-expression of beta-III tubulin and nestin. Conclusion Intravitreal CORM ALF-186 protected RGC after IRI and stimulated their axons to regenerate in vitro. ALF conveyed anti-apoptotic, anti-inflammatory, and growth-associated signaling after IRI. COs role in neuroregeneration and its effect on retinal glial cells needs further investigation	[Stifter, Julia; Boehringer, Daniel; Lagreze, Wolf Alexander; Biermann, Julia] Univ Freiburg, Med Ctr, Eye Ctr, Killianstr 5, Freiburg, Germany; [Stifter, Julia; Ulbrich, Felix; Goebel, Ulrich; Boehringer, Daniel; Lagreze, Wolf Alexander; Biermann, Julia] Univ Freiburg, Fac Med, Freiburg, Germany; [Ulbrich, Felix; Goebel, Ulrich] Univ Freiburg, Med Ctr, Dept Anesthesiol & Intens Care, Hugstetter Str 55, Freiburg, Germany; [Biermann, Julia] Univ Munster, Med Ctr, Dept Ophthalmol, Domagkstr 15, Munster, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Munster	Biermann, J (corresponding author), Univ Freiburg, Med Ctr, Eye Ctr, Killianstr 5, Freiburg, Germany.; Biermann, J (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Biermann, J (corresponding author), Univ Munster, Med Ctr, Dept Ophthalmol, Domagkstr 15, Munster, Germany.	juliabiermann2017@gmail.com	Goebel, Ulrich M./AGG-1495-2022; Goebel, Ulrich/Q-7613-2016	Goebel, Ulrich/0000-0002-9991-3226	German Research Foundation (DFG) [BI 1567/2-1, GO 2158/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was conducted at the Eye Center, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany, and granted by The German Research Foundation (DFG, Grants: BI 1567/2-1 and GO 2158/3-1). The funder (DFG) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Biermann J, 2012, EVALUATION INTRAOCUL; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; BIGNAMI A, 1979, EXP EYE RES, V28, P63; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chen JJ, 2014, REV NEUROSCIENCE, V25, P269, DOI 10.1515/revneuro-2013-0046; Chen ZL, 2016, BIOCHEM BIOPH RES CO, V469, P809, DOI 10.1016/j.bbrc.2015.12.064; Choi YK, 2016, BIOCHEM BIOPH RES CO, V479, P297, DOI 10.1016/j.bbrc.2016.09.063; DABIN I, 1995, GLIA, V14, P23, DOI 10.1002/glia.440140105; Dijk F, 2007, EXP EYE RES, V84, P858, DOI 10.1016/j.exer.2007.01.006; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Duan CL, 2015, GLIA, V63, P1660, DOI 10.1002/glia.22837; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Estes S, 2016, DEV NEUROBIOL; Fischer AJ, 2002, DEV BIOL, V251, P367, DOI 10.1006/dbio.2002.0813; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fournier AE, 1997, J NEUROSCI RES, V47, P561, DOI 10.1002/(SICI)1097-4547(19970315)47:6<561::AID-JNR1>3.3.CO;2-Q; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Fu QL, 2008, CELL MOL NEUROBIOL, V28, P317, DOI 10.1007/s10571-007-9155-z; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hanafy KA, 2013, CURR PHARM DESIGN, V19, P2771; Hettiarachchi NT, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.529; Hirsch S, 2000, RESTOR NEUROL NEUROS, V17, P125; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; Katsetos CD, 2007, NEUROCHEM RES, V32, P1387, DOI 10.1007/s11064-007-9321-1; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Kubrusly RCC, 2005, BRAIN RES, V1038, P141, DOI 10.1016/j.brainres.2005.01.031; Kubrusly RCC, 2008, NEUROCHEM INT, V53, P63, DOI 10.1016/j.neuint.2008.05.002; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P967; Larsen AK, 1996, INVEST OPHTH VIS SCI, V37, P2603; Lasseck J, 2007, EXP EYE RES, V85, P90, DOI 10.1016/j.exer.2007.03.005; Lawrence JM, 2007, STEM CELLS, V25, P2033, DOI 10.1634/stemcells.2006-0724; Lorber B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115996; Lorber B, 2012, NEUROBIOL DIS, V45, P243, DOI 10.1016/j.nbd.2011.08.008; Mahan VL, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-32; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; NEEDHAM LK, 1987, J NEUROSCI, V7, P1; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Nowicki M, 2009, EUR J CELL BIOL, V88, P551, DOI 10.1016/j.ejcb.2009.05.003; Prasad SS, 2010, INVEST OPHTH VIS SCI, V51, P6207, DOI 10.1167/iovs.10-5632; Queiroga CSF, 2016, J CELL SCI, V129, P3178, DOI 10.1242/jcs.187260; Reichenbach Andreas, 1995, P395; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROBINSON GA, 1994, MOL BRAIN RES, V24, P43, DOI 10.1016/0169-328X(94)90116-3; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Ryter SW, 2016, TRANSL RES, V167, P7, DOI 10.1016/j.trsl.2015.06.011; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Schallner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046479; Scheiblich H, 2015, DEV NEUROBIOL, V75, P854, DOI 10.1002/dneu.22253; SCHWARTZ M, 1987, J PHYSIOL-PARIS, V82, P314; Seixas JD, 2013, DALTON T, V42, P5985, DOI 10.1039/c2dt32174b; Sild M, 2011, NEUROSCIENTIST, V17, P288, DOI 10.1177/1073858410385870; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; Ulbrich F, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0905-7; Ulbrich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165182; Ulbrich F, 2016, GRAEF ARCH CLIN EXP, V254, P1967, DOI 10.1007/s00417-016-3435-6; VINORES SA, 1995, EXP EYE RES, V60, P385, DOI 10.1016/S0014-4835(05)80095-8; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; WEN R, 1995, J NEUROSCI, V15, P7377; Xue LP, 2006, NEUROSCIENCE, V139, P723, DOI 10.1016/j.neuroscience.2005.12.032; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172	75	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188444	10.1371/journal.pone.0188444	http://dx.doi.org/10.1371/journal.pone.0188444			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176876	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900079
J	Bick, D; Howard, LM; Oram, S; Zimmerman, C				Bick, Debra; Howard, Louise M.; Oram, Sian; Zimmerman, Cathy			Maternity care for trafficked women: Survivor experiences and clinicians' perspectives in the United Kingdom's National Health Service	PLOS ONE			English	Review							ACCESS	Background Although trafficked women and adolescents are at risk of unprotected or forced sex, there is little research on maternity care among trafficking survivors. We explored health care needs, service use and challenges among women who became pregnant while in the trafficking situation in the United Kingdom (UK) and clinicians' perspectives of maternity care for trafficked persons. Methods Cross-sectional survey and qualitative interviews with trafficking survivors recruited from statutory and voluntary sector organisations in England and qualitative interviews with maternity clinicians and family doctors undertaken to offer further insight into experiences reported by these women. Findings Twenty-eight (29%) of 98 women who took part in a large study of trafficking survivors reported one or more pregnancies while trafficked, whose data are reported here. Twelve (42.8%) of these women reported at least one termination of pregnancy while in the trafficking situation and 25 (89.3%) experienced some form of mental health disorder. Nineteen (67.9%) women experienced pre-trafficking physical abuse and 9 (32.%) sexual abuse. A quarter of women were trafficked for sexual exploitation, six for domestic servitude and two for manual labour. Survivors and clinicians described service challenges, including restrictions placed on women's movements by traffickers, poor knowledge on how to access maternity care, poor understanding of healthcare entitlements and concerns about confidentiality. Maternity care clinicians recognised potential indicators of trafficking, but considered training would help them identify and respond to victims. Main limitations include that findings reflect women who had exited the trafficking situation, however as some had only recently exited the trafficking situation, difficulties with recall were likely to be low. Conclusions More than one in four women became pregnant while trafficked, indicating that maternity services offer an important contact point for identification and care. Given the prevalence of sexual exploitation and abuse among trafficking survivors, clinicians should ensure antenatal care and screening for sexually transmitted infections can be readily accessed by women. Clinicians require specialised training alongside designated pathways and protocols with clear referral options to ensure confidential maternity care tailored to each woman's needs.	[Bick, Debra] Kings Coll London, St Thomas Hosp London, Dept Women & Childrens Hlth, Sch Life Course Sci, London, England; [Howard, Louise M.; Oram, Sian] Kings Coll London, David Goldberg Ctr, Inst Psychiat & Neurosci, Sect Womens Mental Hlth, De Crespigny Pk, London, England; [Zimmerman, Cathy] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Gender Violence & Hlth Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Bick, D (corresponding author), Kings Coll London, St Thomas Hosp London, Dept Women & Childrens Hlth, Sch Life Course Sci, London, England.	debra.bick@kcl.ac.uk	Oram, Sian/G-3342-2013; Bick, Debra/P-9575-2018	Bick, Debra/0000-0002-8557-7276; Oram, Sian/0000-0001-8704-0379; Howard, Louise/0000-0001-9942-744X	Department of Health Policy Research Programme (Optimising Identification, Referral and Care of Trafficked People) [NHS 115/0006]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Department of Health Policy Research Programme [115/0006]; NIHR South London and Maudsley NHS Foundation Trust Biomedical Research Centre-Mental Health; NIHR Research Professorship [NIHR-RP-R3-12-011]; NIHR CLAHRC South London; King's College London; National Institute for Health Research [NIHR-RP-R3-12-011] Funding Source: researchfish	Department of Health Policy Research Programme (Optimising Identification, Referral and Care of Trafficked People); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Department of Health Policy Research Programme; NIHR South London and Maudsley NHS Foundation Trust Biomedical Research Centre-Mental Health; NIHR Research Professorship; NIHR CLAHRC South London; King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	This independent research was commissioned and funded by the Department of Health Policy Research Programme (Optimising Identification, Referral and Care of Trafficked People within the NHS 115/0006). The authors acknowledge the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. LMH, SO and CZ were supported by the Department of Health Policy Research Programme (115/0006). LMH is supported by the NIHR South London and Maudsley NHS Foundation Trust Biomedical Research Centre-Mental Health and an NIHR Research Professorship (NIHR-RP-R3-12-011). DB is part funded by the NIHR CLAHRC South London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Open access for this article was funded by King's College London.	American College of Obstetrics and Gynecology, INT PARTN VIOL COMM; Bick D, 2015, POSTPREGNANCY CARE M; Campbell OMR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001972; Cuadra CB, 2012, EUR J PUBLIC HEALTH, V22, P267, DOI 10.1093/eurpub/ckr049; Department of Health England, 2015, GUID IMPL OV VIS HOS; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hegarty K, 2011, AUST FAM PHYSICIAN, V40, P852; International Labour Office Global Estimate of Forced Labour, 2012, RES METH; Knight MTD, 2015, BEHALF MBRRACE UK SA; Konstantopoulos WM, 2013, J URBAN HEALTH, V90, P1194, DOI 10.1007/s11524-013-9837-4; Lederer L, 2014, ANN HLTH LAW, V23, P16; McCauley HL, 2010, INT J GYNECOL OBSTET, V110, P266, DOI 10.1016/j.ijgo.2010.04.016; National Institute for Health and Care Excellence, 2014, INTR CAR HLTH WOM TH, V190; National Institute for Health and Care Excellence, 2015, ANT CAR UNC PREGN, V62; National Institute of Clinical Excellence (NICE), 2010, PREGN COMPL SOC FACT; Oram S, 2016, AM J PUBLIC HEALTH, V106, P1073, DOI 10.2105/AJPH.2016.303095; Oram S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001224; Ottisova L., 2016, EPIDEMIOLOGY PSYCHIA; Provider Responses Treatment and Care for Trafficked People, 2015, OPT ID REF CAR TRAFF; Ross C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008682; Sandall J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub4; Small R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-152; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stewart E., 2011, J REFUG STUD, V25, P1; Tamara Windau-Melmer, 2013, GUIDE ADVOCATING RES; The Anti Trafficking Monitoring Group, 2013, DOCK EX UKS CRIM JUS; UK National Crime Agency, 2016, NAT REF MECH STAT EN; UK Visas and Immigration, 2016, HEALTHC NEEDS PREGN; United Nations Office on Drugs and Crime, 2014, GLOB REP TRAFF PERS; Westwood J, 2016, BRIT J GEN PRACT, V66, pE794, DOI 10.3399/bjgp16X687073; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; WHO, 2013, RESPONDING INTIMATE; Zimmerman, 2003, WHO ETHICAL SAFETY R; Zimmerman C, 2003, FINDINGS EUROPEAN ST; Zimmerman C., 2006, STOLEN SMILES SUMMAR; Zimmerman C, 2014, STUDY TRAFFICKING EX; Zimmerman C, 2008, AM J PUBLIC HEALTH, V98, P55, DOI 10.2105/AJPH.2006.108357; Zimmerman Z, 2009, CARING TRAFFICKED PE	38	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187856	10.1371/journal.pone.0187856	http://dx.doi.org/10.1371/journal.pone.0187856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166394	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000416035300020
J	Hu, RJ; Li, J; Soomro, RN; Wang, F; Feng, Y; Yang, XJ; Yao, JH				Hu, Rujiu; Li, Jing; Soomro, Rab Nawaz; Wang, Fei; Feng, Yan; Yang, Xiaojun; Yao, Junhu			The N-15-leucine single-injection method allows for determining endogenous losses and true digestibility of amino acids in cecectomized roosters	PLOS ONE			English	Article							N-15-ISOTOPE DILUTION TECHNIQUE; ILEAL DIGESTA; GROWING PIGS; NITROGEN-EXCRETION; CRUDE PROTEIN; DISTAL ILEUM; RECOVERY; CHICKENS; FLOW; FEEDSTUFFS	This study was conducted to assess the influence of dietary protein content in poultry when using the N-15-leucine single-injection method to determine endogenous amino acid losses (EAALs) in poultry. Forty-eight cecectomized roosters (2.39 +/- 0.23 kg) were randomly allocated to eight dietary treatments containing protein levels of 0, 3%, 6%, 9%, 12%, 15%, 18% and 21%. Each bird was precisely fed an experimental diet of 25 g/kg of body weight. After feeding, all roosters were subcutaneously injected with a N-15-leucine solution at a dose of 20 mg/kg of body weight. Blood was sampled 23 h after the injection, and excreta samples were continuously collected during the course of the 48-h experiment. The ratio of N-15-enrichment of leucine in crude mucin to free leucine in plasma ranged from 0.664 to 0.763 and remained relatively consistent (P > 0.05) across all treatments. The amino acid (AA) profiles of total endogenous AAs, except isoleucine, alanine, aspartic acid, cysteine, proline and serine, were not influenced (P > 0.05) by dietary protein contents. The predominant endogenous AAs in the excreta were glutamic acid, aspartic acid, threonine, serine and proline. The order of the relative proportions of these predominant AAs also remained relatively constant (P > 0.05). The endogenous losses of total AAs determined with the N-15-leucine single-injection method increased curvilinearly with the dietary protein contents. The true digestibility of most AAs and total AAs was independent of their respective dietary protein levels. Collectively, the N-15-leucine single-injection method is appropriate for determining EAALs and the true digestibility of AAs in poultry fed varying levels of protein-containing ingredients.	[Hu, Rujiu; Li, Jing; Soomro, Rab Nawaz; Wang, Fei; Yang, Xiaojun; Yao, Junhu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Feng, Yan] Shanxi Agr Univ, Coll Life Sci, Jinzhong, Shanxi, Peoples R China	Northwest A&F University - China; Shanxi Agricultural University	Yao, JH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	yaojunhu2004@sohu.com	WANG, Fei/J-8497-2013	WANG, Fei/0000-0002-5213-4399; Hu, Rujiu/0000-0002-6090-0209				Adedokun SA, 2011, POULTRY SCI, V90, P1737, DOI 10.3382/ps.2010-01245; [Anonymous], 2007, 200704 AOAC; Boisen S, 1996, ACTA AGR SCAND A-AN, V46, P154, DOI 10.1080/09064709609415866; DELANGE CFM, 1989, J ANIM SCI, V67, P755; DELANGE CFM, 1990, J ANIM SCI, V68, P409; Eklund M, 2008, J ANIM PHYSIOL AN N, V92, P578, DOI 10.1111/j.1439-0396.2007.00751.x; FAN MZ, 1995, J ANIM SCI, V73, P2319; Hess V, 1998, J NUTR, V128, P1969, DOI 10.1093/jn/128.11.1969; Hodgkinson SM, 2007, J SCI FOOD AGR, V87, P233, DOI 10.1002/jsfa.2701; Kim EJ, 2011, POULTRY SCI, V90, P396, DOI 10.3382/ps.2010-01088; Leterme P, 1998, J NUTR, V128, P1961, DOI 10.1093/jn/128.11.1961; Lien KA, 1997, J ANIM SCI, V75, P159; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; Miner-Williams W, 2014, EUR J CLIN NUTR, V68, P363, DOI 10.1038/ejcn.2013.270; Miner-Williams W, 2012, AM J CLIN NUTR, V96, P508, DOI 10.3945/ajcn.111.033472; Moughan PJ, 2012, BRIT J NUTR, V108, pS258, DOI 10.1017/S0007114512002474; MOUGHAN PJ, 1992, J SCI FOOD AGR, V58, P165, DOI 10.1002/jsfa.2740580202; NRC, 1994, NUTR REQ POULTR; Nyachoti CM, 1997, CAN J ANIM SCI, V77, P149, DOI 10.4141/A96-044; PAYNE WL, 1971, POULTRY SCI, V50, P143, DOI 10.3382/ps.0500143; Pedersen C, 2002, ACTA AGR SCAND A-AN, V52, P121, DOI 10.1080/090647002320229374; Ravindran V, 2004, BRIT J NUTR, V92, P217, DOI 10.1079/BJN20041202; Ravindran V, 2004, AUST J AGR RES, V55, P705, DOI 10.1071/AR04008; Ravindran V, 2009, BRIT J NUTR, V101, P822, DOI 10.1017/S0007114508039974; SCHULZE H, 1995, J SCI FOOD AGR, V69, P41, DOI 10.1002/jsfa.2740690108; Selle PH, 2012, NUTR RES REV, V25, P1, DOI 10.1017/S0954422411000151; SOUFFRANT WB, 1986, ARCH TIERERNAHR, V36, P269, DOI 10.1080/17450398609425271; Steendam CA, 2004, J NUTR, V134, P3068, DOI 10.1093/jn/134.11.3068; Stein HH, 2007, J ANIM SCI, V85, P172, DOI 10.2527/jas.2005-742; Wolfe RR, 2004, ISOTOPE TRACERS META; Xu M, 2011, NUTRITION, V27, P829, DOI 10.1016/j.nut.2010.08.014; Zhang HL, 2005, ANIM SCI, V81, P257, DOI 10.1079/ASC50240257	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188525	10.1371/journal.pone.0188525	http://dx.doi.org/10.1371/journal.pone.0188525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166671	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300045
J	Jaiswal, D; Cowley, N; Bian, ZC; Zheng, GA; Claffey, KP; Hoshino, K				Jaiswal, Devina; Cowley, Norah; Bian, Zichao; Zheng, Guoan; Claffey, Kevin P.; Hoshino, Kazunori			Stiffness analysis of 3D spheroids using microtweezers	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BREAST-CANCER CELLS; OPTICAL TWEEZERS; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; MAGNETIC TWEEZERS; TISSUES; MODEL; DEFORMABILITY; INDENTATION	We describe a novel mechanical characterization method that has directly measured the stiffness of cancer spheroids for the first time to our knowledge. Stiffness is known to be a key parameter that characterizes cancerous and normal cells. Atomic force microscopy or optical tweezers have been typically used for characterization of single cells with the measurable forces ranging from sub pN to a few hundred nN, which are not suitable for measurement of larger 3D cellular structures such as spheroids, whose mechanical characteristics have not been fully studied. Here, we developed microtweezers that measure forces from sub hundred nN to mN. The wide force range was achieved by the use of replaceable cantilevers fabricated from SU8, and brass. The chopstick-like motion of the two cantilevers facilitates easy handling of samples and microscopic observation for mechanical characterization. The cantilever bending was optically tracked to find the applied force and sample stiffness. The efficacy of the method was demonstrated through stiffness measurement of agarose pillars with known concentrations. Following the initial system evaluation with agarose, two cancerous (T47D and BT474) and one normal epithelial (MCF 10A) breast cell lines were used to conduct multi-cellular spheroid measurements to find Young's moduli of 230, 420 and 1250 Pa for BT474, T47D, and MCF 10A, respectively. The results showed that BT474 and T47D spheroids are six and three times softer than epithelial MCF10A spheroids, respectively. Our method successfully characterized samples with wide range of Young's modulus including agarose (25-100 kPa), spheroids of cancerous and non-malignant cells (190-200 mu m, 230-1250 Pa) and collagenase-treated spheroids (215 mu m, 130 Pa).	[Jaiswal, Devina; Cowley, Norah; Bian, Zichao; Zheng, Guoan; Hoshino, Kazunori] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Claffey, Kevin P.] Univ Connecticut, Hlth Ctr, Dept Cell Biol, Farmington, CT USA	University of Connecticut; University of Connecticut	Hoshino, K (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.	hoshino@engr.uconn.edu	Hoshino, Kazunori/C-3988-2014	Hoshino, Kazunori/0000-0002-7080-7825; Bian, Zichao/0000-0001-5757-2112; Zheng, Guoan/0000-0002-4268-2690	NSFIDBR [1555986]	NSFIDBR(National Science Foundation (NSF))	This work was supported by NSFIDBR: 1555986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the National Science Foundation (NSFIDBR: 1555986) for financial support.	Adamo A, 2012, ANAL CHEM, V84, P6438, DOI 10.1021/ac300264v; Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065; Ahearne M, 2008, TOP TISSUE ENG, V4, P1; [Anonymous], 2008, ROB AUT 2008 ICRA 20; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Blanchette N, 2016, FASEB J 2016 S, V30; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Cross SE, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384003; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Darling EM, 2007, BIOPHYS J, V92, P1784, DOI 10.1529/biophysj.106.083097; Duc TC, 2007, IEEE SENS J, V7, P96, DOI 10.1109/JSEN.2006.886992; Eikenes L, 2010, ANTICANCER RES, V30, P359; Faria EC, 2008, ANALYST, V133, P1498, DOI 10.1039/b803355b; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Fung Y.C., 2013, BIOMECHANICS MECH PR; Goodman TT, 2007, INT J NANOMED, V2, P265; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hafizovic S, 2004, P NATL ACAD SCI USA, V101, P17011, DOI 10.1073/pnas.0405725101; Haga H, 2000, ULTRAMICROSCOPY, V82, P253, DOI 10.1016/S0304-3991(99)00157-6; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Hsiao AY, 2009, BIOMATERIALS, V30, P3020, DOI 10.1016/j.biomaterials.2009.02.047; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Hwang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27238; Iatridis JC, 2003, CONNECT TISSUE RES, V44, P208, DOI 10.1080/03008200390244069; Ivascu A, 2007, INT J ONCOL, V31, P1403; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jacot JG, 2006, J BIOMED MATER RES A, V79A, P485, DOI 10.1002/jbm.a.30812; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jin HJ, 2011, LAB CHIP, V11, P115, DOI [10.1039/c0lc00134a, 10.1039/c01c00134a]; Johnson KL, 2005, CONTACT MECH; Kilani RT, 2003, VIRUS RES, V93, P1, DOI 10.1016/S0168-1702(03)00045-5; Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313; Lam RHW, 2012, INTEGR BIOL-UK, V4, P1289, DOI 10.1039/c2ib20134h; Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570; Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Li M, 2007, NAT NANOTECHNOL, V2, P114, DOI 10.1038/nnano.2006.208; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lulevich V, 2006, LANGMUIR, V22, P8151, DOI 10.1021/la060561p; Masuzaki R, 2007, HEPATOL INT, V1, P394, DOI 10.1007/s12072-007-9012-7; Mattei G, 2016, ACTA BIOMATER, V45, P60, DOI 10.1016/j.actbio.2016.08.055; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Sharma R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/236147; Shkumatov A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094764; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Tang B, 2006, PHILOS MAG, V86, P5653, DOI 10.1080/14786430600728646; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Tanikawa T, 1999, IEEE T ROBOTIC AUTOM, V15, P152, DOI 10.1109/70.744610; Thaysen J, 2000, SENSOR ACTUAT A-PHYS, V83, P47, DOI 10.1016/S0924-4247(00)00299-5; Thoumine O, 1997, J CELL SCI, V110, P2109; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Yamahata C, 2008, J MICROELECTROMECH S, V17, P623, DOI 10.1109/JMEMS.2008.922080; Yang Y, 2007, J R SOC INTERFACE, V4, P1169, DOI 10.1098/rsif.2007.1044; Zhang JXJ., 2013, MOL SENSORS NANODEVI; Zhang W, 2007, BIOMATERIALS, V28, P3579, DOI 10.1016/j.biomaterials.2007.04.040; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109	74	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188346	10.1371/journal.pone.0188346	http://dx.doi.org/10.1371/journal.pone.0188346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166651	gold, Green Submitted, Green Published			2022-12-26	WOS:000416035300032
J	Ralli, M; Salvi, RJ; Greco, A; Turchetta, R; De Virgilio, A; Altissimi, G; Attanasio, G; Cianfrone, G; de Vincentiis, M				Ralli, Massimo; Salvi, Richard J.; Greco, Antonio; Turchetta, Rosaria; De Virgilio, Armando; Altissimi, Giancarlo; Attanasio, Giuseppe; Cianfrone, Giancarlo; de Vincentiis, Marco			Characteristics of somatic tinnitus patients with and without hyperacusis	PLOS ONE			English	Article							TEMPOROMANDIBULAR DISORDERS; PSYCHIATRIC COMORBIDITY; HEARING SENSITIVITY; PERSONALITY-TRAITS; MODULATE TINNITUS; COCHLEAR NUCLEUS; SOUND; HEALTH; QUESTIONNAIRE; PITCH	Objective Determine if somatic tinnitus patients with hyperacusis have different characteristics from those without hyperacusis. Patients and methods 172 somatic tinnitus patients with (n = 82) and without (n = 90) hyperacusis referred to the Tinnitus Unit of Sapienza University of Rome between June 2012 and June 2016 were compared for demographic characteristics, tinnitus features, self-administered questionnaire scores, nature of somatic modulation and history. Results Compared to those without hyperacusis, patients with somatic tinnitus and hyperacusis: (a) were older (43.38 vs 39.12 years, p = 0.05), (b) were more likely to have bilateral tinnitus (67.08% vs 55.56%, p = 0.04), (c) had a higher prevalence of somatic modulation of tinnitus (53.65% vs 36.66%, p = 0.02) and (d) scored significantly worse on tinnitus annoyance (39.34 vs 22.81, p<0.001) and subjective hearing level (8.04 vs 1.83, p<0.001). Conclusion Our study shows significantly higher tinnitus modulation and worse self-rating of tinnitus and hearing ability in somatic tinnitus patients with hyperacusis versus somatic tinnitus patients without hyperacusis. These differences could prove useful in developing a better understanding of the pathophysiology and establishing a course of treatment for these two groups of patients.	[Ralli, Massimo] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy; [Salvi, Richard J.] Univ Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA; [Salvi, Richard J.] Asia Univ, Dept Audiol & Speech Language Pathol, Taichung, Taiwan; [Greco, Antonio; Turchetta, Rosaria; De Virgilio, Armando; Altissimi, Giancarlo; Attanasio, Giuseppe; Cianfrone, Giancarlo; de Vincentiis, Marco] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy	Sapienza University Rome; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Asia University Taiwan; Sapienza University Rome	Ralli, M (corresponding author), Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy.	massimo.ralli@uniroma1.it	Ralli, Massimo/E-1780-2018; De Virgilio, Armando/G-8710-2012	De Virgilio, Armando/0000-0003-0738-8223; Ralli, Massimo/0000-0001-8776-0421; greco, antonio/0000-0002-4824-9871	National Institute on Deafness and Other Communication Disorders [R01DC014452]; Italian Association for Research on Deafness (AIRS Onlus)	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Italian Association for Research on Deafness (AIRS Onlus)	Prof Richard J Salvi was supported by National Institute on Deafness and Other Communication Disorders, R01DC014452.r We thank Italian Association for Research on Deafness (AIRS Onlus) for support in the management of patients.	Aazh H, 2017, INT J AUDIOL, V56, P793, DOI 10.1080/14992027.2017.1335888; Aazh H, 2017, INT J AUDIOL, V56, P677, DOI 10.1080/14992027.2017.1335887; Aazh H, 2016, INT J AUDIOL, V55, P514, DOI 10.1080/14992027.2016.1178400; Ambrosini Anna, 2006, J Headache Pain, V7, P377, DOI 10.1007/s10194-006-0343-x; Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; Andersson G, 2005, INT J AUDIOL, V44, P671, DOI 10.1080/14992020500266720; [Anonymous], 1979, JAMA-J AM MED ASSOC, V241, P2055; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Baguley DM, 2006, OTOL NEUROTOL, V27, P220, DOI 10.1097/01.mao.0000172412.87778.28; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bernhardt O, 2011, J ORAL REHABIL, V38, P891, DOI 10.1111/j.1365-2842.2011.02224.x; Bernhardt O, 2004, J ORAL REHABIL, V31, P311, DOI 10.1046/j.1365-2842.2003.01249.x; Brotherton H, 2015, AUDIOL NEURO-OTOL, V20, P273, DOI 10.1159/000430459; Buergers R, 2014, J PROSTHET DENT, V111, P222, DOI 10.1016/j.prosdent.2013.10.001; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Chen YC, 2017, HEAR RES; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; Cook DB, 2004, J RHEUMATOL, V31, P364; Dehmel S, 2008, AM J AUDIOL, V17, pS193, DOI 10.1044/1059-0889(2008/07-0045); Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; ERLANDSSON SI, 1992, AUDIOLOGY, V31, P168; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Ferendiuk E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/824684; Fioretti A, 2015, ACTA OTORHINOLARYNGO, V35, P110; Fioretti AB, 2013, NOISE HEALTH, V15, P91, DOI 10.4103/1463-1741.110287; Gilles A, 2014, OTOL NEUROTOL, V35, P401, DOI 10.1097/MAO.0000000000000248; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Haider HF, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00207; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Hilgenberg PB, 2012, J ORAL REHABIL, V39, P239, DOI 10.1111/j.1365-2842.2011.02266.x; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Kumar P, 2017, AM J OTOLARYNG, V38, P163, DOI 10.1016/j.amjoto.2016.12.002; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee CF, 2016, EUR ARCH OTO-RHINO-L, V273, P203, DOI 10.1007/s00405-015-3491-2; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Manfredini Daniele, 2015, Int Tinnitus J, V19, P47, DOI 10.5935/0946-5448.20150008; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus OM, 2010, INT J AUDIOL, V49, P7, DOI 10.3109/14992020903160868; Middleton JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00035; Moller AR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/608437; Mols F, 2012, J AFFECT DISORDERS, V136, P26, DOI 10.1016/j.jad.2011.08.034; Monzani D, 2007, Acta Otorhinolaryngol Ital, V27, P186; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Nelting M, 2002, LARYNGO RHINO OTOL, V81, P327, DOI 10.1055/s-2002-28342; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Passi Stefania, 2008, Int Tinnitus J, V14, P26; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Ralli M, 2017, J INT MED RES; Ralli M, 2016, AUDIOL NEURO-OTOL, V21, P372, DOI 10.1159/000452472; Ralli M, 2010, OTOL NEUROTOL, V31, P823, DOI 10.1097/MAO.0b013e3181de4662; RUBINSTEIN B, 1990, Journal of Craniomandibular Disorders, V4, P186; Salviati M, 2013, PSYCHOSOMATICS, V54, P248, DOI 10.1016/j.psym.2012.05.007; Sanchez TG, 2011, CLINICS, V66, P1089, DOI 10.1590/S1807-59322011000600028; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schecklmann M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/191479; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shekhawat GS, 2014, EUR ARCH OTO-RHINO-L, V271, P41, DOI 10.1007/s00405-013-2375-6; Sheppard A, 2014, ACTA OTORHINOLARYNGO, V34, P79; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Simmons Richard, 2008, Seminars in Hearing, V29, P361, DOI 10.1055/s-0028-1095895; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Tyler RS, 2014, AM J AUDIOL, V23, P402, DOI 10.1044/2014_AJA-14-0010; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Villaume K, 2017, SCAND J PSYCHOL, V58, P158, DOI 10.1111/sjop.12350; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright, 1997, Int Tinnitus J, V3, P55	77	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188255	10.1371/journal.pone.0188255	http://dx.doi.org/10.1371/journal.pone.0188255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161302	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000037
J	Begum, T; Rahman, A; Nababan, H; Hoque, DME; Khan, A; Ali, T; Anwar, I				Begum, Tahmina; Rahman, Aminur; Nababan, Herfina; Hoque, Dewan Md. Emdadul; Khan, Al Fazal; Ali, Taslim; Anwar, Iqbal			Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh	PLOS ONE			English	Article							MATERNAL AGE; DEVELOPING-COUNTRIES; RATES; HEALTH; BIRTH; WOMEN; LABOR; RISK; COMPLICATIONS; METAANALYSIS	Background and methods Caesarean section (C-section) is a major obstetric intervention for saving lives of women and their newborns from pregnancy and childbirth related complications. Un-necessary C-sections may have adverse impact upon maternal and neonatal outcomes. In Bangladesh there is paucity of data on clinical indication of C-section at population level. We conducted a retrospective study in icddr, b Health and Demographic Surveillance System (HDSS) area of Matlab to look into the indications and determinants of C-sections. All resident women in HDSS service area who gave birth in 2013 with a known birth outcome, were included in the study. Women who underwent C-section were identified from birth and pregnancy files of HDSS and their indication for C-section were collected reviewing health facility records where the procedure took place, supplemented by face-to-face interview of mothers where data were missing. Indications of C-section were presented as frequency distribution and further divided into different groups following 3 distinct classification systems. Socio-demographic predictors were explored following statistical method of binary logistic regression. Findings During 2013, facility delivery rate was 84% and population based C-section rate was 35% of all deliveries in icddr, b service area. Of all C-sections, only 1.4% was conducted for Absolute Maternal Indications (AMIs). Major indications of C-sections included: repeat C-section (24%), foetal distress (21%), prolonged labour (16%), oligohydramnios (14%) and postmaturity (13%). More than 80% C-sections were performed in for-profit private facilities. Probability of C-section delivery increased with improved socio-economic status, higher education, lower birth order, higher age, and with more number of Antenatal Care use and presence of bad obstetric history. Eight maternal deaths occurred, of which five were delivered by C-section. Conclusions C-section rate in this area was much higher than national average as well as global recommendations. Very few of C-sections were undertaken for AMIs. Routine monitoring of clinical indication of C-section in public and private facilities is needed to ensure rational use of the procedure.	[Begum, Tahmina; Ali, Taslim; Anwar, Iqbal] Icddr, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Rahman, Aminur; Hoque, Dewan Md. Emdadul] Icddr, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Nababan, Herfina] Univ Melbourne, Nossal Inst Global Hlth, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Khan, Al Fazal] Icddr, Nutr & Clin Serv Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; International Centre for Diarrhoeal Disease Research (ICDDR)	Rahman, A (corresponding author), Icddr, Maternal & Child Hlth Div, Dhaka, Bangladesh.	draminur@icddrb.org	Hoque, Dewan/O-3606-2015; Hoque, Dewan Md. Emdadul/J-1999-2019; Rahman, Aminur/AAG-5391-2020	Hoque, Dewan/0000-0001-8219-9196; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Rahman, Aminur/0000-0003-1434-3883; Nababan, Herfina/0000-0002-7818-4132; Khan, Md Alfazal/0000-0002-7916-482X	School of Public health study at Dhaka, Bangladesh; European Union; Fogarty Fellowship	School of Public health study at Dhaka, Bangladesh; European Union(European Commission); Fogarty Fellowship	The first author, Tahmina Begum, received a student Fogarty grant during her MPH program at James P Grant of School of Public health study at Dhaka, Bangladesh. The authors also kindly acknowledge the European Union funded SHARE project at icddr,b to provide the publication charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aleem H, 2005, INT J GYNECOL OBSTET, V90, P94, DOI 10.1016/j.ijgo.2005.03.027; Ahmad Hina, 2009, JPMA Journal of the Pakistan Medical Association, V59, P691; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Aminu M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-130; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2010, Obstet Gynecol, V116, P450, DOI 10.1097/AOG.0b013e3181eeb251; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Betran A, 2015, BJOG INT J OBSTET GY; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98; Biswas A, 2014, MPDR NEWSLETTER; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chowdhury LR, 2014, NEEDS ASSESSMENT STU; Cockcroft A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S8; Collin Simon M, 2007, Int J Equity Health, V6, P9, DOI 10.1186/1475-9276-6-9; DUBOURG D, 2007, UON NETWORK TACKLING; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Ecker JL, 2001, AM J OBSTET GYNECOL, V185, P883, DOI 10.1067/mob.2001.117364; Festin MR, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-17; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gamble JA, 2001, BIRTH-ISS PERINAT C, V28, P101, DOI 10.1046/j.1523-536X.2001.00101.x; Gholitabar M, 2011, BMJ-BRIT MED J, P343; Gibbons L, 2010, GLOBAL NUMBERS COSTS; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Heffner LJ, 2003, OBSTET GYNECOL, V102, P287, DOI 10.1016/S0029-7844(03)00531-3; Hofmeyr GJ, 2014, COCHRANE LIB; HPNSDP, 2012, BANGL HLTH FAC SURV; Huda FA, 2012, J HEALTH POPUL NUTR, V30, P131, DOI 10.3329/jhpn.v30i2.11295; icddr b, 2015, REG MATL HLTH DEM EV, P126; Khawaja M, 2004, HEALTH POLICY, V69, P273, DOI 10.1016/j.healthpol.2004.05.006; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; Mansur Ahmed M S A, 2014, J Family Reprod Health, V8, P175; MDSR action network B, 2016, BANGL ROLL OUT MPDSR; Morris RK, 2014, BJOG-INT J OBSTET GY, V121, P686, DOI 10.1111/1471-0528.12589; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Nazneen R, 2011, JBCPS, V29, P126; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Penn Z, 2001, BEST PRACT RES CL OB, V15, P1, DOI 10.1053/beog.2000.0146; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Program EHC, 2012, STRATEGIES REDUCE CE; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Rahman A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-914; Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044; Roberts CL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001725; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Sakae Thiago Mamôru, 2009, Rev. Saúde Pública, V43, P472, DOI 10.1590/S0034-89102009000300011; Sanavi Fariba Shahraki, 2012, J Reprod Infertil, V13, P237; Satyanarayana P, 2015, J INFECT DIS THERAPY; Stanton C, 2008, BIRTH-ISS PERINAT C, V35, P204, DOI 10.1111/j.1523-536X.2008.00241.x; Taspinar A, 2014, CUMHURIYET TIP DERGI, V36, P442; Teguete I., 2012, DETERMINING FACTORS; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x; WHO H, 2015, WHO STAT CAES SECT R; World Health Organization, 1994, IND MON MAT HLTH GOA; World Health Organization, 2004, INT STAT CLASS DIS R	64	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188074	10.1371/journal.pone.0188074	http://dx.doi.org/10.1371/journal.pone.0188074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155840	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700029
J	Chen, YM; Chen, HH; Huang, WN; Liao, TL; Chen, JP; Chao, WC; Lin, CT; Hung, WT; Hsieh, CW; Hsieh, TY; Chen, YH; Chen, DY				Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Liao, Tsai-Ling; Chen, Jun-Peng; Chao, Wen-Cheng; Lin, Ching-Tsai; Hung, Wei-Ting; Hsieh, Chia-Wei; Hsieh, Tsu-Yi; Chen, Yi-Hsing; Chen, Der-Yuan			Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis	PLOS ONE			English	Article							MINERAL DENSITY; DISEASE-ACTIVITY; INADEQUATE RESPONSE; FRACTURE RISK; METHOTREXATE; THERAPY; COHORT; INTERLEUKIN-6; OSTEOPOROSIS; PROGRESSION	Rheumatoid arthritis (RA) is associated with a high risk of osteoporosis and fracture. Interleukin (IL)-6 inhibitors may suppress osteoclast activation. Anticitrullinated protein antibody (ACPA) titers are inversely associated with bone mineral density (BMD). However, the differential effect of ACPA on bone turnover marker (BTM) and BMD changes after IL-6 inhibition remains unclear. This prospective study recruited patients with active RA with inadequate response to methotrexate or biologics. BMD was measured before and after 2-year tocilizumab (TCZ) treatment. Serum osteocalcin, N-terminal propeptide of type I collagen (P1NP), and C-terminal cross-linking telopeptide of type I collagen (CTX) levels were assessed at the baseline and after treatment. We enrolled 76 patients with RA (89.5% women, age: 57.2 +/- 13.3 years) receiving TCZ. The 28-joint disease activity score was negatively correlated with BMD and T-scores of the lumbar spine and bilateral femoral neck. ACPA-positive patients had lower lumbar spine and femoral neck T-scores. After 2-year TCZ treatment, CTX levels significantly decreased (0.32 +/- 0.21 vs. 0.26 +/- 0.17, p = 0.038). Femoral neck BMD increased significantly (0.71 +/- 0.22 vs. 0.69 +/- 0.55, p = 0.008). Decreased CTX levels and improved BMD were observed only in ACPA-positive patients. After treatment, femoral neck BMD significantly increased only in patients receiving a glucocorticoid dose of >= 5 mg/day. Two-year TCZ treatment reduced bone resorption and increased femoral BMD in ACPA-positive patients. The net effects of glucocorticoids and IL-6 inhibition on BMD imply that strict inflammation control might affect bone metabolism.	[Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Chao, Wen-Cheng; Lin, Ching-Tsai; Hung, Wei-Ting; Hsieh, Chia-Wei; Hsieh, Tsu-Yi; Chen, Yi-Hsing; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Chen, Yi-Hsing; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Hsieh, Chia-Wei; Chen, Der-Yuan] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Jun-Peng] Biostat Task Force Taichung Vet Gen Hosp, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Div Chest Med, Taichung, Taiwan; [Hung, Wei-Ting; Hsieh, Tsu-Yi; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Hsieh, Chia-Wei] Feng Chia Univ, PhD Program Business, Taichung, Taiwan; [Chen, Der-Yuan] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Feng Chia University; National Chung Hsing University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.	dychen@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Hsieh, Tsu-Yi/0000-0001-9897-6957	Taichung Veterans General Hospital, Taiwan [TCVGH-1067308C, 1067326D]	Taichung Veterans General Hospital, Taiwan	This study was supported by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1067308C & 1067326D).	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Balasubramanian A, 2016, OSTEOPOROSIS INT, V27, P3239, DOI 10.1007/s00198-016-3646-z; Book C, 2008, SCAND J RHEUMATOL, V37, P248, DOI 10.1080/03009740801998747; Briot K, 2015, JOINT BONE SPINE, V82, P109, DOI 10.1016/j.jbspin.2014.10.015; Bugatti S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1116-9; Burmester GR, 2017, ANN RHEUM DIS, V76, P1279, DOI 10.1136/annrheumdis-2016-210561; Edwards CJ, 2010, OSTEOPOROSIS INT, V21, P1287, DOI 10.1007/s00198-010-1192-7; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Garnero P, 2010, ARTHRITIS RHEUM-US, V62, P33, DOI 10.1002/art.25053; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hashimoto J, 2011, MOD RHEUMATOL, V21, P10, DOI 10.1007/s10165-010-0325-3; Karsdal MA, 2012, SEMIN ARTHRITIS RHEU, V42, P131, DOI 10.1016/j.semarthrit.2012.01.004; Kawai VK, 2013, ARTHRIT CARE RES, V65, P1085, DOI 10.1002/acr.21937; Kim SY, 2012, J BONE MINER RES, V27, P789, DOI 10.1002/jbmr.1489; Krieckaert CLM, 2013, RHEUMATOLOGY, V52, P547, DOI 10.1093/rheumatology/kes320; Kume K, 2014, RHEUMATOLOGY, V53, P900, DOI 10.1093/rheumatology/ket468; Lin YC, 2015, OSTEOPOROSIS INT, V26, P811, DOI 10.1007/s00198-014-2968-y; Llorente I, 2017, RHEUMATOL INT, V37, P799, DOI 10.1007/s00296-017-3674-9; Martin-Mola E, 2016, RHEUMATOL INT, V36, P1043, DOI 10.1007/s00296-016-3506-3; Meguid MHA, 2013, RHEUMATOL INT, V33, P697, DOI 10.1007/s00296-012-2375-7; Meng J, 2017, MEDICINE, V96, P6677; Mohammad A, 2014, RHEUMATOLOGY, V53, P821, DOI 10.1093/rheumatology/ket353; Mori Y, 2017, J BONE MINER METAB, V35, P52, DOI 10.1007/s00774-015-0716-9; Orsolini G, 2017, CALCIFIED TISSUE INT, V101, P17, DOI 10.1007/s00223-017-0253-8; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Siu S, 2015, ARTHRIT CARE RES, V67, P754, DOI 10.1002/acr.22519; Straub RH, 2015, SEMIN ARTHRITIS RHEU, V45, P220, DOI 10.1016/j.semarthrit.2015.04.014; Szulc P, 2017, OSTEOPOROS INT; Tanaka K, 2014, CLIN EXP IMMUNOL, V175, P172, DOI 10.1111/cei.12201; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; van der Goes MC, 2013, OSTEOPOROSIS INT, V24, P1429, DOI 10.1007/s00198-012-2073-z; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; Wijbrandts CA, 2009, ANN RHEUM DIS, V68, P373, DOI 10.1136/ard.2008.091611; Zerbini CAF, 2017, OSTEOPOROSIS INT, V28, P429, DOI 10.1007/s00198-016-3769-2	36	22	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188454	10.1371/journal.pone.0188454	http://dx.doi.org/10.1371/journal.pone.0188454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155868	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700061
J	Durbeej, N; Elgan, TH; Jalling, C; Gripenberg, J				Durbeej, Natalie; Elgan, Tobias H.; Jalling, Camilla; Gripenberg, Johanna			Alcohol intoxication at Swedish football matches: A study using biological sampling to assess blood alcohol concentration levels among spectators	PLOS ONE			English	Article							TARGETING LICENSED PREMISES; SPORTING EVENTS; BINGE DRINKING; BEER; PREVENTION; STOCKHOLM; VIOLENCE; IMPLEMENTATION; CONSUMPTION; MANAGEMENT	Alcohol use and alcohol-related problems, including accidents, vandalism and violence, at sporting events are of increased concern in Sweden and other countries. The relationship between alcohol use and violence has been established and can be explained by the level of intoxication. Given the occurrence of alcohol use and alcohol-related problems at sporting events, research has assessed intoxication levels measured through biological sampling among spectators. This cross-sectional study aimed to assess the level of alcohol intoxication among spectators at football matches in the Swedish Premier Football League. Spectators were randomly selected and invited to participate in the study. Alcohol intoxication was measured with a breath analyser for Blood Alcohol Concentration levels, and data on gender, age, and recent alcohol use were gathered through a face-to-face interview. Blood Alcohol Concentration samples from 4420 spectators were collected. Almost half (46.8%) had a positive Blood Alcohol Concentration level, with a mean value of 0.063%, while 8.9% had a Blood Alcohol Concentration level >= 0.1%, with a mean value of 0.135%. Factors that predicted a higher Blood Alcohol Concentration level included male gender (p = 0.005), lower age (p < 0.001), attending a local derby (p < 0.001), alcohol use prior to having entered the arena (p < 0.001), attending a weekend match (p < 0.001), and being a spectator at supporter sections (p < 0.001). About half of all spectators at football matches in the Swedish Premier Football League drink alcohol in conjunction with the match. Approximately one tenth have a high level of alcohol intoxication.	[Durbeej, Natalie] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, STAD, Stockholm, Sweden; Stockholm Hlth Care Serv, Stockholm Cty Council, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council	Durbeej, N (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, STAD, Stockholm, Sweden.	Natalie.Durbeej@ki.se	Elgan, Tobias/AAD-5281-2019; Gripenberg, Johanna/AAD-3611-2022; Elgan, Tobias H/B-8573-2017	Elgan, Tobias/0000-0001-6406-4685; Elgan, Tobias H/0000-0001-6406-4685; Jalling, Camilla/0000-0001-5905-2110	Public Health Agency of Sweden [05603-2014-6.2]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly [2014-0027]	Public Health Agency of Sweden; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly	The study was funded by the Public Health Agency of Sweden (grant no. 05603-2014-6.2, URL: www.folkhalsomyndigheten.se/) and the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (grant no. 2014-0027, URL: www.can.se/sra). THE and JG received the funding. The study funders had no role in the design, collection, analysis, or interpretation of the data, or in the preparation of the manuscript or decision to submit the manuscript for publication.	Barrocas A, 2014, J ABNORM CHILD PSYCH, P1; Baumberg B, 2006, DRUG ALCOHOL REV, V25, P537, DOI 10.1080/09595230600944479; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; Bormann CA, 2001, J AM COLL HEALTH, V50, P81, DOI 10.1080/07448480109596011; Casswell S, 2011, ADDICTION, V106, P1087, DOI 10.1111/j.1360-0443.2011.03361.x; Champion Heather, 2009, Int J Adolesc Med Health, V21, P249, DOI 10.1515/IJAMH.2009.21.2.249; Durbeej N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3145-3; Erickson DJ, 2011, ALCOHOL CLIN EXP RES, V35, P689, DOI 10.1111/j.1530-0277.2010.01386.x; Farrington D. P., 1994, AGGRESSIVE BEHAV CUR, P215, DOI DOI 10.1007/978-1-4757-9116-7_9; Felson RB, 2010, CRIM JUSTICE BEHAV, V37, P1343, DOI 10.1177/0093854810382003; Glassman T., 2011, J ALCOHOL DRUG EDUC, V55, P55; Gripenberg-Abdon J, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-7; Holder HD, 2000, ADDICT BEHAV, V25, P843, DOI 10.1016/S0306-4603(00)00121-0; Jones L, 2011, HEALTH PLACE, V17, P508, DOI 10.1016/j.healthplace.2010.12.006; Kingsland M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0183-y; Kingsland M, 2015, DRUG ALCOHOL REV, V34, P447, DOI 10.1111/dar.12252; Lenk KM, 2009, DRUG-EDUC PREV POLIC, V16, P451, DOI 10.1080/09687630802278478; Lloyd B, 2013, ADDICTION, V108, P701, DOI 10.1111/add.12041; Lundholm L, 2013, DRUG ALCOHOL DEPEN, V129, P110, DOI 10.1016/j.drugalcdep.2012.09.019; Lyne M, 2012, AUST NZ J PUBL HEAL, V36, P55, DOI 10.1111/j.1753-6405.2011.00813.x; Mansdotter AM, 2007, EUR J PUBLIC HEALTH, V17, P618, DOI 10.1093/eurpub/ckm017; Muller D, 2014, VARNING STAN STUDIE; Neal DJ, 2007, ADDICT BEHAV, V32, P2681, DOI 10.1016/j.addbeh.2007.06.020; Peitersen B., 2009, Soccer and Society, V10, P374, DOI 10.1080/14660970902771431; Ramstedt M, 2013, DRUG ALCOHOL REV, V32, P561, DOI 10.1111/dar.12069; Rees DI, 2009, J SPORT ECON, V10, P68, DOI 10.1177/1527002508327389; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Roiu I, 2013, FORENSIC SCI INT, V232, P125, DOI 10.1016/j.forsciint.2013.07.002; Room R, 2001, J SUBST USE, V4, P218, DOI DOI 10.1080/146598901753325048; Rowland BC, 2015, AUST NZ J PUBL HEAL, V39, P210, DOI 10.1111/1753-6405.12280; Tabachnick BG., USING MULTIVARIATE S; The National Council For Crime Prevention, 2008, STRAT MOT FOTB ORD; Toomey TL, 2008, ALCOHOL CLIN EXP RES, V32, P1859, DOI 10.1111/j.1530-0277.2008.00770.x; Trolldal B, 2013, ADDICTION, V108, P89, DOI 10.1111/j.1360-0443.2012.04004.x; Voas RB, 2006, EVALUATION REV, V30, P44, DOI 10.1177/0193841X05277285; Wallin E, 2004, PREV SCI, V5, P221, DOI 10.1023/B:PREV.0000045356.37507.86; Wallin E, 2003, J STUD ALCOHOL, V64, P270, DOI 10.15288/jsa.2003.64.270; Wallin E, 2002, ADDICTION, V97, P901, DOI 10.1046/j.1360-0443.2002.00160.x; WHO, 2007, DRINK DRIV ROAD SAF; Wolfe J, 1998, ANN EMERG MED, V31, P629, DOI 10.1016/S0196-0644(98)70209-4; Wright NR, 2006, ADDICT RES THEORY, V14, P133, DOI 10.1080/16066350500505850	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188284	10.1371/journal.pone.0188284	http://dx.doi.org/10.1371/journal.pone.0188284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155885	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700042
J	Najafi, H; Yarijani, ZM; Changizi-Ashtiyani, S; Mansouri, K; Modarresi, M; Madani, SH; Bastani, B				Najafi, Houshang; Yarijani, Zeynab Mohamadi; Changizi-Ashtiyani, Saeed; Mansouri, Kamran; Modarresi, Masoud; Madani, Seyed Hamid; Bastani, Bahar			Protective effect of Malva sylvestris L. extract in ischemia-reperfusion induced acute kidney and remote liver injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INDUCED HEPATOTOXICITY; ANTIOXIDANT ACTIVITY; RATS; INFLAMMATION; DYSFUNCTION; TARGETS; DAMAGE; PATHOPHYSIOLOGY; POLYSACCHARIDE	Mallow (Malva sylvestris L.) has had medicinal and therapeutic uses in addition to its oral consumption. The present study was conducted to examine the protective effect of Malva sylvestris L. extract on ischemia-reperfusion-induced kidney injury and remote organ injuries in the liver. Before ischemia-reperfusion, rats in the different groups received intraperitoneal normal saline or mallow extract at the doses of 200, 400 or 600 mg/kg of body weight. After 30-minutes of bilateral renal ischemia followed by 24-hours of reperfusion, tissue damage in the kidney and liver samples were determined through studying H&E-stained slides under a light microscope. The degree of leukocyte infiltration and tissue mRNA expressions of TNF- and ICAM-1 were then measured to examine the degree of renal inflammation. The renal tissue MDA and FRAP levels were measured for determining the amount of oxidative stress. Plasma concentrations of creatinine, urea, ALT and ALP were also measured. Ischemia- reperfusion led to a significant increase in plasma concentrations of creatinine, urea, ALT and ALP, and renal tissue MDA, and a significant decrease in renal tissue FRAP. The expression of pro-inflammatory factors in the kidney tissue, the level of leukocyte infiltration and the amount of tissue damage in the kidney and liver also increased. Pretreatment by mallow extract led to a significant improvement in all the variables measured. The 200- and 400-mg doses yielded better results in most parameters compared to the 600-mg dose. The findings showed that mallow extract protects the kidney against ischemia-reperfusion and reduces remote organ injury in the liver.	[Najafi, Houshang; Yarijani, Zeynab Mohamadi; Mansouri, Kamran] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran; [Changizi-Ashtiyani, Saeed] Arak Univ Med Sci, Sch Paramed Sci, Dept Physiol, Arak, Iran; [Modarresi, Masoud] Kermanshah Univ Med Sci, Fac Pharm, Sch Paramed Sci, Dept Physiol, Kermanshah, Iran; [Madani, Seyed Hamid] Kermanshah Univ Med Sci, Sch Med, Dept Pathol, Kermanshah, Iran; [Bastani, Bahar] St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63103 USA	Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Saint Louis University	Bastani, B (corresponding author), St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63103 USA.	bastanib@slu.edu	Najafi, Houshang/K-1597-2017; yarijani, zeynab mohamadi/AAY-4850-2020; SaberiNajafi, Hashem/AFS-6719-2022	Mohamadi Yarijani, Zeynab/0000-0002-0693-6788; Bastani, Bahar/0000-0002-2138-4248; Najafi, Houshang/0000-0001-9642-9124	Kermanshah University of Medical Sciences [93422]	Kermanshah University of Medical Sciences	This work was funded by grant # 93422, research deputy of Kermanshah University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the research deputy of Kermanshah University of medical sciences for financial support (research project 93422 to HN).	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Anders HJ, 2014, J AM SOC NEPHROL, V25, P1387, DOI 10.1681/ASN.2014010117; Arabaci G, J CHEM, V2013; Ashtiyani SC, 2012, IRAN J KIDNEY DIS, V6, P275; Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; Benso B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162728; Benso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140331; BILLETER M, 1991, PHYTOCHEMISTRY, V30, P987, DOI 10.1016/0031-9422(91)85292-8; Blunden G, 2001, PHYTOCHEMISTRY, V58, P451, DOI 10.1016/S0031-9422(01)00263-1; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Changizi-Ashtiyani S, 2016, CANCER GENE THER, V23, P235, DOI 10.1038/cgt.2016.24; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chiclana CF, 2009, LAT AM J PHARM, V28, P275; Choi KS, 2014, ARCH BIOCHEM BIOPHYS, V559, P38, DOI 10.1016/j.abb.2014.05.016; Classen B, 2002, PLANTA MED, V68, P232, DOI 10.1055/s-2002-23127; Conforti F, 2008, J ETHNOPHARMACOL, V116, P144, DOI 10.1016/j.jep.2007.11.015; Cutillo F, 2006, PHYTOCHEMISTRY, V67, P481, DOI 10.1016/j.phytochem.2005.11.023; Dagher PC, 2003, J AM SOC NEPHROL, V14, P2188, DOI 10.1097/01.ASN.0000079790.91292.4A; Doi K, 2016, KIDNEY INT, V89, P555, DOI 10.1016/j.kint.2015.11.019; Donnahoo KK, 1999, J UROLOGY, V162, P196, DOI 10.1097/00005392-199907000-00068; Elsagh M, 2015, COMPLEMENT THER CLIN, V21, P105, DOI 10.1016/j.ctcp.2015.02.003; Fadillioglu E, 2008, ARCH PHARM RES, V31, P705, DOI 10.1007/s12272-001-1216-3; Martins CAF, 2014, BIOMED CHROMATOGR, V28, P986, DOI 10.1002/bmc.3106; Ganai BA, 1997, PHYTOCHEMISTRY, V45, P879, DOI 10.1016/S0031-9422(97)82709-4; Ganai BA, 2006, J IND POLLUT CONTR, V22, P77; Gardner DS, 2016, AM J PHYSIOL-RENAL, V310, pF259, DOI 10.1152/ajprenal.00389.2015; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; GONDA R, 1990, CARBOHYD RES, V198, P323, DOI 10.1016/0008-6215(90)84302-B; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Guarrera PM, 2005, FITOTERAPIA, V76, P1, DOI 10.1016/j.fitote.2004.09.006; Guil JL, 1996, J CHROMATOGR A, V719, P229, DOI 10.1016/0021-9673(95)00414-9; Hamedi A, 2016, J EVID-BASED INTEGR, V21, P14, DOI 10.1177/2156587215589184; Hicsonmez U, 2009, BIOL TRACE ELEM RES, V128, P248, DOI 10.1007/s12011-008-8270-0; Hussain L, 2014, TURK J BIOL, V38, P396, DOI 10.3906/biy-1312-32; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; Kauss T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2372; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee CG, 2014, KIDNEY INT, V86, P943, DOI 10.1038/ki.2014.117; Mahmoudzadeh L, 2017, NEPHROLOGY, V22, P748, DOI 10.1111/nep.12849; Marouane W, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-65; Matejovic M, 2016, J AM SOC NEPHROL, V27, P49, DOI 10.1681/ASN.2015030234; Najafi H, 2016, EXP PHYSIOL, V101, P913, DOI 10.1113/EP085583; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Samavati V, 2013, INT J BIOL MACROMOL, V60, P427, DOI 10.1016/j.ijbiomac.2013.04.050; Sleiman NH, 2009, PLANTA MED, V75, P1010; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Yarijani ZM, 2016, IRAN J BASIC MED SCI, V19, P337	56	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188270	10.1371/journal.pone.0188270	http://dx.doi.org/10.1371/journal.pone.0188270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155898	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700040
J	DeCamp, AC; Rolland, M; Edlefsen, PT; Sanders-Buell, E; Hall, B; Magaret, CA; Fiore-Gartland, AJ; Juraska, M; Carpp, LN; Karuna, ST; Bose, M; LePore, S; Miller, S; O'Sullivan, A; Poltavee, K; Bai, HJ; Dommaraju, K; Zhao, H; Wong, K; Chen, LN; Ahmed, H; Goodman, D; Tay, MZ; Gottardo, R; Koup, RA; Bailer, R; Mascola, JR; Graham, BS; Roederer, M; O'Connell, RJ; Michael, NL; Robb, ML; Adams, E; D'Souza, P; Kublin, J; Corey, L; Geraghty, DE; Frahm, N; Tomaras, GD; McElrath, MJ; Frenkel, L; Styrchak, S; Tovanabutra, S; Sobieszczyk, ME; Hammer, SM; Kim, JH; Mullins, JI; Gilbert, PB				DeCamp, Allan C.; Rolland, Morgane; Edlefsen, Paul T.; Sanders-Buell, Eric; Hall, Breana; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; Zhao, Hong; Wong, Kim; Chen, Lennie; Ahmed, Hasan; Goodman, Derrick; Tay, Matthew Z.; Gottardo, Raphael; Koup, Richard A.; Bailer, Robert; Mascola, John R.; Graham, Barney S.; Roederer, Mario; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Adams, Elizabeth; D'Souza, Patricia; Kublin, James; Corey, Lawrence; Geraghty, Daniel E.; Frahm, Nicole; Tomaras, Georgia D.; McElrath, M. Juliana; Frenkel, Lisa; Styrchak, Sheila; Tovanabutra, Sodsai; Sobieszczyk, Magdalena E.; Hammer, Scott M.; Kim, Jerome H.; Mullins, James I.; Gilbert, Peter B.			Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120	PLOS ONE			English	Article							PROPORTIONAL HAZARDS MODELS; DNA CANDIDATE VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; IMMUNOGENICITY EVALUATION; ENVELOPE GLYCOPROTEIN; CONTINUOUS MARKS; IMMUNE PRESSURE; PHASE-1 SAFETY; T-CELLS	Although the HVTN 505 DNA/recombinant adenovirus type 5 vector HIV-1 vaccine trial showed no overall efficacy, analysis of breakthrough HIV-1 sequences in participants can help determine whether vaccine-induced immune responses impacted viruses that caused infection. We analyzed 480 HIV-1 genomes sampled from 27 vaccine and 20 placebo recipients and found that intra-host HIV-1 diversity was significantly lower in vaccine recipients (P <= 0.04, Q-values <= 0.09) in Gag, Pol, Vif and envelope glycoprotein gp120 (Env-gp120). Furthermore, Env-gp120 sequences from vaccine recipients were significantly more distant from the subtype B vaccine insert than sequences from placebo recipients (P = 0.01, Q-value = 0.12). These vaccine effects were associated with signatures mapping to CD4 binding site and CD4-induced monoclonal antibody footprints. These results suggest either (i) no vaccine efficacy to block acquisition of any viral genotype but vaccine-accelerated Env evolution post-acquisition; or (ii) vaccine efficacy against HIV-1s with Env sequences closest to the vaccine insert combined with increased acquisition due to other factors, potentially including the vaccine vector.	[DeCamp, Allan C.; Edlefsen, Paul T.; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Gottardo, Raphael; Kublin, James; Corey, Lawrence; Frahm, Nicole; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [DeCamp, Allan C.; Edlefsen, Paul T.; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Gottardo, Raphael; Kublin, James; Corey, Lawrence; Frahm, Nicole; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Rolland, Morgane; Sanders-Buell, Eric; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Tovanabutra, Sodsai] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Rolland, Morgane; Sanders-Buell, Eric; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Adams, Elizabeth; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Edlefsen, Paul T.; Gottardo, Raphael; Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hall, Breana; Zhao, Hong; Wong, Kim; Chen, Lennie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ahmed, Hasan] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Goodman, Derrick; Tay, Matthew Z.; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Koup, Richard A.; Bailer, Robert; Mascola, John R.; Graham, Barney S.; Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Adams, Elizabeth; D'Souza, Patricia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Frahm, Nicole; Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Med, Seattle, WA USA; [Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa; Styrchak, Sheila] Seattle Childrens Res Inst, Seattle, WA USA; [Frenkel, Lisa] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sobieszczyk, Magdalena E.; Hammer, Scott M.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Columbia University; International Vaccine Institute	DeCamp, AC; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA.; DeCamp, AC; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA.; Rolland, M (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.; Rolland, M (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA.; Gilbert, PB (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	adecamp@scharp.org; mrolland@hivresearch.org; pgilbert@scharp.org	Carpp, Lindsay/AAM-1148-2021; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; Roederer, Mario/G-1887-2011; Gottardo, Raphael/HCH-3169-2022; Corey, Lawrence/AAE-1796-2020; Tay, Matthew/GYQ-6959-2022	Graham, Barney S./0000-0001-8112-0853; Corey, Lawrence/0000-0002-2179-2436; deCamp, Allan/0000-0003-1404-4322; Gottardo, Raphael/0000-0002-3867-0232; Bai, Hongjun/0000-0002-3501-3974; Tay, Matthew Zirui/0000-0002-1763-913X	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [R37AI054165, UM1AI068635]; HVTN 505 trial; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054165, UM1AI068635, UM1AI068614, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HVTN 505 trial; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under award numbers R37AI054165 and UM1AI068635. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the participants, investigators, and sponsors of the HVTN 505 trial.; The authors thank the participants, investigators, and sponsors of the HVTN 505 trial. The authors also thank the HVTN Core staff; the Statistical Center for HIV/AIDS Research and Prevention; the HVTN laboratories; Susan Zolla-Pazner for help in identifying V3 and gp41 immunodominant hotspots; Adi Ferrara for assistance with technical writing; and R. Glenn Overman, Pinghuang Liu, Vicki Ashley, Kristy Long, Sheetal Sawant, Judith Lucas, Michael Archibald, Sarah Thiebaud, and April Randhawa for help with the ADCP assay.	[Anonymous], 2014, TOD HIV AIDS EP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Day TA, 2013, CURR HIV RES, V11, P441, DOI 10.2174/1570162X113116660051; Dommaraju K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111334; Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Fiore-Gartland A, 2017, BIOINFORMATICS; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Gilbert PB, 2015, J R STAT SOC C-APPL, V64, P49, DOI 10.1111/rssc.12067; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Hertz T, 2016, VACCINE, V34, P5792, DOI 10.1016/j.vaccine.2016.09.054; HOLM S, 1979, SCAND J STAT, V6, P65; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Iyer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135903; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Janes HE, 2017, J INFECT DIS, V215, P1376, DOI 10.1093/infdis/jix086; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Juraska M, 2013, BIOMETRICS, V69, P328, DOI 10.1111/biom.12016; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Mancl LA, 2001, BIOMETRICS, V57, P126, DOI 10.1111/j.0006-341X.2001.00126.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137666; Mullins Lab, WEB PSSM 2007 2009; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pharris A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.47.20968; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, 19 C RETR OPP INF SE; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sterrett S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu056; Sun YQ, 2009, ANN STAT, V37, P394, DOI 10.1214/07-AOS554; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; UNAIDS, 2014, THE GAP REP; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Yang X, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S77099; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022	59	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0185959	10.1371/journal.pone.0185959	http://dx.doi.org/10.1371/journal.pone.0185959			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149197	Green Submitted, Green Published, gold			2022-12-26	WOS:000415646100002
J	Huynh, MP; Meihls, LN; Hibbard, BE; Lapointe, SL; Niedz, RP; Ludwick, DC; Coudron, TA				Huynh, Man P.; Meihls, Lisa N.; Hibbard, Bruce E.; Lapointe, Stephen L.; Niedz, Randall P.; Ludwick, Dalton C.; Coudron, Thomas A.			Diet improvement for western corn rootworm (Coleoptera: Chrysomelidae) larvae	PLOS ONE			English	Article							ARTIFICIAL DIET; RESISTANCE; SUSCEPTIBILITY; CURCULIONIDAE; INSECTICIDES; OPTIMIZATION; VARIABLES; SURVIVAL; NEBRASKA; CRY3BB1	The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte, is the most serious insect pest of corn (Zea mays L.) in the United States and parts of Europe, and arguably one of the world's most expensive pests to control. Several diet formulations are currently used by industry and public researchers to evaluate WCR larvae in diet-toxicity bioassays. However, a publicly available diet that produces normative insects that are physiologically similar to WCR larvae reared on corn roots will accelerate development of management technologies. We report a new diet formulation that supports improved weight gain, larval development and survival compared with the only public diet for WCR that is currently available in the refereed literature. The formulation was created by using response surface methods combined with n-dimensional mixture designs to identify and improve the formulation of key ingredients. Weight gain increased two-fold, and survival and molting rates increased from 93% and 90%, respectively when reared on the public diet, to approximately 99% for both survival and molting at 11 days when reared on our new formulation. This new formulation provides a standardized growth medium for WCR larvae that will facilitate comparison of research results from various working groups and compliance with regulatory requirements.	[Huynh, Man P.; Ludwick, Dalton C.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Huynh, Man P.] Can Tho Univ, Dept Plant Protect, Can Tho, Vietnam; [Meihls, Lisa N.; Hibbard, Bruce E.] USDA ARS, Plant Genet Res Unit, Columbia, MO USA; [Lapointe, Stephen L.; Niedz, Randall P.] USDA ARS, Hort Res Lab, Ft Pierce, FL USA; [Coudron, Thomas A.] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	University of Missouri System; University of Missouri Columbia; Can Tho University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Coudron, TA (corresponding author), USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA.	tom.coudron@ars.usda.gov		Huynh, Man/0000-0002-7736-3809; Hibbard, Bruce/0000-0001-8067-4416	Monsanto Corn Rootworm Knowledge Research Grant Program; USDA-Agricultural Research Service [5070-22000-037-00-D, 5070-21000-038-00-D, 6034-21000-014-00-D, 6034-22320-004-00-D]	Monsanto Corn Rootworm Knowledge Research Grant Program; USDA-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research for this study was funded, in part, by the Monsanto Corn Rootworm Knowledge Research Grant Program [https://monsanto.com/products/product-stewardship/corn-rootworm-managernent/corn-rootworm-knowledge-research-program/] to BEH which was not involved in the research design, data collection and analysis, decision to publish, or reparation of the manuscript. Funding was also provided by the USDA-Agricultural Research Service through projects numbered 5070-22000-037-00-D (to TAC), 5070-21000-038-00-D (to BEH), 6034-21000-014-00-D (to RPN) and 6034-22320-004-00-D (to SLL).	ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; Anderson M. J., 2007, Quality Engineering, V19, P111, DOI 10.1080/08982110701241434; BALL HJ, 1963, J ECON ENTOMOL, V56, P553, DOI 10.1093/jee/56.5.553; Cohen A. C., 2015, INSECT DIETS SCI TEC; Cornell J.A., 2002, EXPT MIXTURES DESIGN, Vthird, DOI DOI 10.1198/004017002320256620; CULY MD, 1992, J ECON ENTOMOL, V85, P2440, DOI 10.1093/jee/85.6.2440; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; [E.P.A Agency USEP], 2014, EPA PROP IMPR CORN R; [E.P.A Agency USEP], 2016, EPA NEEDS BETT DAT P; [E.P.A Agency USEP], 2016, EPA DOCK CORN ROOTW; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2010, FLA ENTOMOL, V93, P56, DOI 10.1653/024.093.0108; Levine Eli, 2002, American Entomologist, V48, P94; Ludwick D, 2016, CAB REV; Ludwick DC, 2017, J APPL ENTOMOL, V141, P28, DOI 10.1111/jen.12377; MARRONE PG, 1985, J ECON ENTOMOL, V78, P290, DOI 10.1093/jee/78.1.290; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Mitchell P., 2011, 24 IWGO C 3 INT C DI; Myers R.H., 2016, RESPONSE SURFACE MET; Myers RH., 2016, RESPONSE SURFACE MET; Niedz RP, 2016, IN VITRO CELL DEV-PL, V52, P547, DOI 10.1007/s11627-016-9786-1; Pascacio-Villafan C, 2014, J CHEM ECOL, V40, P297, DOI 10.1007/s10886-014-0404-6; Pereira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142299; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; ROSE RI, 1973, J ECON ENTOMOL, V66, P398, DOI 10.1093/jee/66.2.398; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; SCHEFFE H, 1958, J ROY STAT SOC B, V20, P344; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Smith W.F., 2005, EXPT DESIGN FORMULAT; SUTTER GR, 1971, J ECON ENTOMOL, V64, P65, DOI 10.1093/jee/64.1.65; Swaisgood H., 2008, FENNEMAS FOOD CHEM; The SAS Institute, 2013, SAS VERS 9 4; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Weisberg S., 1985, APPL LINEAR REGRESSI; Whitcomb P.J., 2004, RSM SIMPLIFIED OPTIM, DOI [DOI 10.1201/9781315382326, 10.1201/9781315382326]; Wilson TA, 2004, ENVIRON ENTOMOL, V33, P1102, DOI 10.1603/0046-225X-33.4.1102; Zukoff SN, 2016, J EC ENTOMOL	41	12	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187997	10.1371/journal.pone.0187997	http://dx.doi.org/10.1371/journal.pone.0187997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149192	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100022
J	Padovan, MG; Whitehouse, A; Gouveia, N; Habermann, M; Grigg, J				Padovan, Michele Galhardoni; Whitehouse, Abigail; Gouveia, Nelson; Habermann, Mateus; Grigg, Jonathan			Carbonaceous particulate matter on the lung surface from adults living in Sao Paulo, Brazil	PLOS ONE			English	Article							AIRWAY MACROPHAGES; PARTICLES; POLLUTION; EXPOSURE; CHILDREN; SMOKERS	Accumulation of carbonaceous particulate matter (PM) in the lung is associated with chronic disease. The amount of carbonaceous PM in airway macrophages is reported to be associated with exposure to both fossil fuel PM and cigarette smoke. However, the contribution of these exposures to carbonaceous PM at the lung surface is unclear. Objectives We therefore sought to identify the exposures associated with lung surface in long-term residents of Sao Paulo, Brazil. Methods Lung surface carbon were analyzed in 72 autopsy specimens by image analysis. Smoking history, measured PM10 nearest to the home, distance to main road, and distance-weighted traffic density were used as exposure variables. Data are summarized as median (IQR), and compared by Mann Whitney Test, with correlations done by Spearman's correlation. Results There was no association between lung surface and age or gender. There was no statistically significant association in lung surface between smokers and non-smokers 6.74 cm(2) (3.47 to 10.02) versus 5.20cm(2) (2.29 to 7.54), and there was no significant association between lung surface carbon and exposure to environmental PM and markers of traffic exposure. Conclusion We did not find a statistically significant association between lung surface and smokers and non-smokers, and no statistically significant association between lung surface carbon and environmental exposure variables. These results suggest that lung surface carbon in long-term residents of Sao Paulo may predominately be from environmental PM, but the most appropriate environmental exposure marker remains unclear.	[Padovan, Michele Galhardoni; Whitehouse, Abigail; Grigg, Jonathan] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England; [Padovan, Michele Galhardoni] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil; [Gouveia, Nelson; Habermann, Mateus] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil	University of London; Queen Mary University London; Universidade de Sao Paulo; Universidade de Sao Paulo	Padovan, MG (corresponding author), Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England.; Padovan, MG (corresponding author), Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil.	m.padovan@qmul.ac.uk	Gouveia, Nelson C/C-4580-2013; Whitehouse, Abigail/V-3731-2019	Gouveia, Nelson C/0000-0003-0625-0265; Whitehouse, Abigail/0000-0003-1695-7141; Grigg, Jonathan/0000-0003-3109-6028	CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil [99999.010610/2014-06]	CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil	This study was supported by CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil, grant number: 99999.010610/2014-06, http://www.capes.gov.br/, to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EVIDENCE SUBMITTED R; Arnold C., 2015, ENV HLTH PERSPECT, V124, pA13; Bai Y, 2015, ENVIRON INT, V74, P32, DOI 10.1016/j.envint.2014.09.010; Belli AJ, 2016, ENVIRON RES, V150, P398, DOI 10.1016/j.envres.2016.06.025; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615; Brauer M, 2001, ENVIRON HEALTH PERSP, V109, P1039, DOI 10.2307/3454959; Bunn HJ, 2001, THORAX, V56, P932, DOI 10.1136/thorax.56.12.932; CETESB, 2015, QUALIDADE AR ESTADO; Finch GL, 2002, INHAL TOXICOL, V14, P1017, DOI 10.1080/08958370290084764; Gerber A, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0047-8; Habermann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113900; Jacobs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016200; Kato A, 2003, INHAL TOXICOL, V15, P799, DOI 10.1080/08958370390217855; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Nwokoro C, 2012, EUR RESPIR J, V40, P1091, DOI 10.1183/09031936.00195711; Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998; PEPELKO WE, 1980, J ENVIRON PATHOL TOX, V4, P449; Pinkerton K. E., 2000, ENV HLTH PERSPECTIVE; Pratt P C, 1971, CHEST, V59, pS39; Saxena RK, 2011, J TOXICOL ENV HEAL A, V74, P706, DOI 10.1080/15287394.2011.556059; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; WHO, 2006, INDIAN J MED RES; You R, 2015, ELIFE, V4, DOI 10.7554/eLife.09623	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188237	10.1371/journal.pone.0188237	http://dx.doi.org/10.1371/journal.pone.0188237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149218	Green Submitted, gold, Green Published			2022-12-26	WOS:000415646100031
J	Candeo, LC; Rigonato-Oliveira, NC; Brito, AA; Marcos, RL; Franca, CM; Fernandes, KPS; Mesquita-Ferrari, RA; Bussadori, SK; Vieira, RP; Lino-dos-Santos-Franco, A; Ligeiro-Oliveira, AP; Horliana, ACRT				Candeo, Larissa Carbonera; Rigonato-Oliveira, Nicole Cristine; Brito, Aurileia Aparecida; Marcos, Rodrigo Labat; Franca, Cristiane Miranda; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil; Vieira, Rodolfo Paula; Lino-dos-Santos-Franco, Adriana; Ligeiro-Oliveira, Ana Paula; Ratto Tempestini Horliana, Anna Carolina			Effects of periodontitis on the development of asthma: The role of photodynamic therapy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DIABETES-MELLITUS; METHYLENE-BLUE; ASSOCIATION; HEALTH; MODEL; INFECTIONS; MECHANISMS; RESISTANCE; REDUCTION	To evaluate whether periodontitis modulates lung inflammation in an experimental model of asthma as well as the photodynamic therapy (PDT) is associated with a reduction of lung inflammation. Seventy-two BALB/c male mice (similar to 2 months) were randomly divided into 8 groups (n = 9): Basal, Periodontitis (P), P+PT, P+PT+PDT, Asthma (A), A+P, A+P+PT, and A+P+PT+PDT. Periodontitis was induced by using the ligature technique and asthma was induced by ovalbumin (OVA). PT was performed with curettes and PDT with methylene blue (0.005%), lambda = 660nm, with a radiant exposure of 318J/cm(2). After 43 days, euthanasia was carried out prior to lung and mandible morphological analyzes. All of the manipulations of the animals were performed by only one operator. The total and differential cell counts and cytokines IL-4, IL-5, IL-10, IFN-gamma, TNF-alpha, IL-1 beta, and IL-6 were evaluated in the bronchoalveolar lavage (BAL) and in the serum. Mucus and alkaline phosphatase were also quantified. Statistical analyzes were performed by a blinded statistician. One-way analysis of variance (ANOVA) was employed, followed by the Student-Newman-Keuls test. Periodontitis group (P) increased alkaline phosphatase and bone resorption (p<0.05), validating the experimental model of periodontitis. The A group and the P group increased the total amount of cells (p<0.05) in the BAL. However, in the A+P group, there was a decrease in these cells, except for in the A+P+PT+PDT group (p< 0.05). The asthma group increased the Th2 cytokines and P group increased the Th1 cytokine profile, and A+P+PT+PDT group increased IL-10 cytokine. Mucus was increased for the A and P groups. In conclusion, periodontitis in the asthmatic mice reduced the inflammatory migrated cells in the BAL (eosinophils, lymphocytes, macrophages). In addition, it reduced the levels of the IL-4 and TNF-alpha cytokines, which was also accompanied by a decreased mucus production. After PDT treatment the total cell count increased however, this increase was not accompanied by a pro-inflammatory cytokines release. Only in PDT group the anti-inflammatory IL-10 was increased. Further studies are needed to understand this mechanism of action.	[Candeo, Larissa Carbonera; Rigonato-Oliveira, Nicole Cristine; Brito, Aurileia Aparecida; Marcos, Rodrigo Labat; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil; Lino-dos-Santos-Franco, Adriana; Ligeiro-Oliveira, Ana Paula; Ratto Tempestini Horliana, Anna Carolina] Univ Nove Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Franca, Cristiane Miranda] OHSU Sch Dent, Dept Restorat Dent, Div Biomat & Biomech, Portland, OR USA; [Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil] Univ Nove Julho, UNINOVE, Post Grad Program Rehabil Sci, Sao Paulo, Brazil; [Vieira, Rodolfo Paula] Inst Brasileiro Ensino Pesquisa Imunol Pulm & Exer, Sao Jose Dos Campos, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho	Horliana, ACRT (corresponding author), Univ Nove Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil.	annacrth@gmail.com	Fernandes, Kristianne Porta Santos/I-4417-2016; Ferrari, Raquel/I-4419-2016; Franco, Adriana Lino dos Santos/AAA-7081-2019; Marcos, Rodrigo Labat/F-3524-2015; Lino-dos-Santos-Franco, Adriana/F-6336-2012; Bussadori, Sandra/J-5458-2014; Horliana, Anna Carolina Ratto Tempestini/J-3257-2015; Horliana, Anna/ABH-9640-2020; Franca, Cristiane/B-2563-2014; de Paula Vieira, Rodolfo/E-9315-2011	Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Ferrari, Raquel/0000-0001-5142-9526; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; Marcos, Rodrigo Labat/0000-0002-9750-6491; Bussadori, Sandra/0000-0002-9853-1138; Horliana, Anna Carolina Ratto Tempestini/0000-0003-3476-9064; Franca, Cristiane/0000-0002-9285-4622; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Brito, Aurileia/0000-0001-9683-4410; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2015/20535-1, 2012/16498-5, 2015/00830-9]; FAPESP [2015/23152-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP: Process Number #2015/20535-1 (Dr. Anna Carolina Ratto Tempestini Horliana), Process Number #2012/16498-5 (Dr. Ana Paula Ligeiro-Oliveira), Process Number #2015/00830-9 (Dr. Adriana Lino-dos-Santos-Franco) and a Grant from FAPESP # 2015/23152-6 (Nicole Cristine Rigonato-Oliveira- PhD student). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Alvarenga LH, 2015, PHOTODIAGN PHOTODYN, V12, P131, DOI 10.1016/j.pdpdt.2014.10.002; Arbes SJ, 2011, J ALLERGY CLIN IMMUN, V127, P1119, DOI 10.1016/j.jaci.2011.03.023; Armitage GC, 2003, J PERIODONTOL, V74, P1237, DOI 10.1902/jop.2003.74.8.1237; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Betsy J, 2014, J CLIN PERIODONTOL, V41, P573, DOI 10.1111/jcpe.12249; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Cai JL, 2007, DEV BIOL, V304, P499, DOI 10.1016/j.ydbio.2007.01.002; Card JW, 2010, INFECT IMMUN, V78, P2488, DOI 10.1128/IAI.01270-09; Carvalho VF, 2015, J CLIN PERIODONTOL, V42, P440, DOI 10.1111/jcpe.12393; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; CHEN AC, 1995, SCAND J INFECT DIS, V27, P289, DOI 10.3109/00365549509019023; da Silva MD, 2015, MOL NEUROBIOL, V51, P19, DOI 10.1007/s12035-014-8790-x; dos Santos JD, 2017, MICROB PATHOGENESIS, V110, P507, DOI 10.1016/j.micpath.2017.07.045; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Evangelista EE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0757-3; Friedrich N, 2006, CLIN EXP ALLERGY, V36, P495, DOI 10.1111/j.1365-2222.2006.02455.x; Gemmell E, 2004, PERIODONTOL 2000, V35, P21, DOI 10.1111/j.0906-6713.2004.003557.x; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Gomes-Filho IS, 2014, J PERIODONTOL, V85, pE82, DOI [10.1902/jop.2013.130369, 10.1902/jop.2013.130509]; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hujoel PP, 2008, J PERIODONTOL, V79, P1330, DOI [10.1902/jop.2008.070648, 10.1902/jop.2008.070648 ]; HYYPPA T, 1981, J CLIN PERIODONTOL, V8, P500, DOI 10.1111/j.1600-051X.1981.tb00899.x; Irwin C R, 1998, Oral Dis, V4, P43; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kim JH, 2015, J PERIODONTOL, V86, P1005, DOI 10.1902/jop.2015.150083; Komerik N, 2003, ANTIMICROB AGENTS CH, V47, P932, DOI 10.1128/AAC.47.3.932-940.2003; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kubota M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155594; Kunna R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0578-y; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lee SW, 2017, J PERIODONTOL, V88, P575, DOI 10.1902/jop.2017.160706; Lenander-Lumikari M, 1998, ARCH ORAL BIOL, V43, P151, DOI 10.1016/S0003-9969(97)00110-6; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; de Oliveira APL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-115; McDevitt MJ, 2000, J PERIODONTOL, V71, P156, DOI 10.1902/jop.2000.71.2.156; Mistry A, 2016, J LASERS MED SCI, V7, P250, DOI 10.15171/jlms.2016.44; NAKASHIMA K, 1994, J CLIN PERIODONTOL, V21, P327, DOI 10.1111/j.1600-051X.1994.tb00721.x; Nibali L, 2013, CURR PHARM DESIGN, V19, P2687, DOI 10.2174/1381612811319150003; Peron JP, 2015, PLOS ONE, V31; Prates RA, 2011, PHOTOMED LASER SURG, V29, P835, DOI 10.1089/pho.2010.2984; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rai M, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/4/046009; Rams TE, 2014, J PERIODONTOL, V85, P160, DOI 10.1902/jop.2013.130142; Rivera R, 2016, J CLIN PERIODONTOL, V43, P566, DOI 10.1111/jcpe.12553; Rocha JA, 2016, AM J PHYSIOL-REG I, V310, pR697, DOI 10.1152/ajpregu.00328.2015; Sabino CP, 2016, J PHOTOCH PHOTOBIO B, V160, P72, DOI 10.1016/j.jphotobiol.2016.03.047; Santana CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122042; Segarra-Vidal M, 2017, J CLIN PERIODONTOL, V44, P915, DOI 10.1111/jcpe.12768; Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Stensson M, 2010, CARIES RES, V44, P540, DOI 10.1159/000321566; Sullivan PW, 2018, J ASTHMA, V55, P659, DOI 10.1080/02770903.2017.1350972; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; Thomas MS, 2010, AUST DENT J, V55, P128, DOI 10.1111/j.1834-7819.2010.01226.x; Tillie-Leblond I, 2005, ALLERGY, V60, P23, DOI 10.1111/j.1398-9995.2005.00632.x; Umeda M, 2011, J INVESTIG CLIN DENT, V2, P268, DOI 10.1111/j.2041-1626.2011.00071.x; Vargas MH, 2015, J ASTHMA, V52, P376, DOI 10.3109/02770903.2014.974816; Vieira RP, 2014, INT J SPORTS MED, V35, P629, DOI 10.1055/s-0033-1358477; von Hertzen L, 2006, J ALLERGY CLIN IMMUN, V117, P334, DOI 10.1016/j.jaci.2005.11.013; Yaghobee S., 2008, Journal of Dentistry of Tehran University of Medical Sciences, V5, P47; Zeng XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046508	69	9	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187945	10.1371/journal.pone.0187945	http://dx.doi.org/10.1371/journal.pone.0187945			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145431	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800041
J	Fuller, TL; Calvet, G; Estevam, CG; Angelo, JR; Abiodun, GJ; Halai, UA; De Santis, B; Sequeira, PC; Araujo, EM; Sampaio, SA; de Mendonca, MCL; Fabri, A; Ribeiro, RM; Harrigan, R; Smith, TB; Gabaglia, CR; Brasil, P; de Filippis, AMB; Nielsen-Saines, K				Fuller, Trevon L.; Calvet, Guilherme; Estevam, Camila Genaro; Angelo, Jussara Rafael; Abiodun, Gbenga J.; Halai, Umme-Aiman; De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Harrigan, Ryan; Smith, Thomas B.; Gabaglia, Claudia Raja; Brasil, Patricia; Bispo de Filippis, Ana Maria; Nielsen-Saines, Karin			Behavioral, climatic, and environmental risk factors for Zika and Chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16	PLOS ONE			English	Article							GLOBAL BURDEN; DENGUE; TRANSMISSION; OUTBREAK; DISEASES; STATES	The burden of arboviruses in the Americas is high and may result in long-term sequelae with infants disabled by Zika virus infection (ZIKV) and arthritis caused by infection with Chikungunya virus (CHIKV). We aimed to identify environmental drivers of arbovirus epidemics to predict where the next epidemics will occur and prioritize municipalities for vector control and eventual vaccination. We screened sera and urine samples (n = 10,459) from residents of 48 municipalities in the state of Rio de Janeiro for CHIKV, dengue virus (DENV), and ZIKV by molecular PCR diagnostics. Further, we assessed the spatial pattern of arbovirus incidence at the municipal and neighborhood scales and the timing of epidemics and major rainfall events. Lab-confirmed cases included 1,717 infections with ZIKV (43.8%) and 2,170 with CHIKV (55.4%) and only 29 (< 1%) with DENV. ZIKV incidence was greater in neighbor-hoods with little access to municipal water infrastructure (r = -0.47, p = 1.2x10(-8)). CHIKV incidence was weakly correlated with urbanization (r = 0.2, p = 0.02). Rains began in October 2015 and were followed one month later by the largest wave of ZIKV epidemic. ZIKV cases markedly declined in February 2016, which coincided with the start of a CHIKV outbreak. Rainfall predicted ZIKV and CHIKV with a lead time of 3 weeks each time. The association between rainfall and epidemics reflects vector ecology as the larval stages of Aedes aegypti require pools of water to develop. The temporal dynamics of ZIKV and CHIKV may be explained by the shorter incubation period of the viruses in the mosquito vector; 2 days for CHIKV versus 10 days for ZIKV.	[Fuller, Trevon L.; Harrigan, Ryan; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Estevam, Camila Genaro] Univ Estadual Sao Paulo, Rio Claro, SP, Brazil; [Angelo, Jussara Rafael] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Abiodun, Gbenga J.] Fdn Profess Dev, Pretoria, Gauteng, South Africa; [Halai, Umme-Aiman; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA; [De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gabaglia, Claudia Raja] Cty Biomed Res Inst Southern Calif, Oceanside, CA USA; [Halai, Umme-Aiman] Cty Los Angeles Dept Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; Los Angeles County Department of Public Health	Fuller, TL (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.	fullertl@ucla.edu	Brasil, Patricia/P-3536-2014; Sequeira, Patricia/AAK-3739-2021; Calvet, GA/G-6959-2013; Fuller, Trevon/B-8087-2014	Calvet, GA/0000-0002-3545-5238; Fuller, Trevon/0000-0001-9954-4267; Genaro Estevam, Camila/0000-0001-6971-9580; Abiodun, Gbenga/0000-0002-6805-2128; Brasil, Patricia/0000-0001-9555-7976	European Union's Horizon research and innovation program (Zika action) [734857]; European Union's Horizon research and innovation program (Zika plan) [734584]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-18/2015TXB]; National Council for Scientific and Technological Development of Brazil; Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health; National Science Foundation [1243524, AI28697, 1R21AI129534-01, D43TW009343]; University of California Global Health Institute; Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129534] Funding Source: NIH RePORTER	European Union's Horizon research and innovation program (Zika action); European Union's Horizon research and innovation program (Zika plan); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health; National Science Foundation(National Science Foundation (NSF)); University of California Global Health Institute; Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by: the European Union's Horizon 2020 research and innovation program (Zika action grant agreement no. 734857 and Zika plan grant agreement no. 734584), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro grant no. E-18/2015TXB, National Council for Scientific and Technological Development of Brazil, Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health, National Science Foundation grant number 1243524, a University of California Global Health Institute grant, National Institutes of Health grants AI28697, 1R21AI129534-01, and D43TW009343, and by the Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas.	de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Battiston D, 2013, SOC INDIC RES, V112, P291, DOI 10.1007/s11205-013-0249-3; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; City Health Department of Rio de Janeiro, 2015, CAS CHIK MONTH SYMPT; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; de Lima-Camara TN, 2017, CABI CLIM CHANGE SER, P127, DOI 10.1079/9781780645377.0127; de Oliveira AF, 2015, CIENC SAUDE COLETIVA, V20, P1027, DOI 10.1590/1413-81232015204.00372014; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Flauzino RF, 2011, SAUDE SOC-SAO PAULO, V20, P225, DOI 10.1590/S0104-12902011000100023; Flauzino Regina Fernandes, 2009, Rev. Saúde Pública, V43, P1035, DOI 10.1590/S0034-89102009005000064; Flauzino RF, 2009, REV PANAM SALUD PUBL, V25, P456, DOI 10.1590/S1020-49892009000500012; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; INMET, 2017, BANC DAD MET GIC ENS; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203; LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004; Ministerio da Saude, 2013, LEV RAPIND AED AEG L; Ministerio da Saude, 2017, MON INT ALT CRESC DE; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X; Rodriguez-Morales AJ, 2017, RHEUMATOL INT, V37, P1757, DOI 10.1007/s00296-017-3795-1; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65; van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, P18; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358; Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; *WHO, 2016, ZIK STRAT RESP PLAN, DOI DOI 10.1128/CMR.00072-15; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	51	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188002	10.1371/journal.pone.0188002	http://dx.doi.org/10.1371/journal.pone.0188002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145452	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800048
J	Koesema, E; Kodadek, T				Koesema, Eric; Kodadek, Thomas			Global analysis of gene expression mediated by OX1 orexin receptor signaling in a hypothalamic cell line	PLOS ONE			English	Article							H295R ADRENOCORTICAL-CELLS; EPITHELIAL NA+ CHANNEL; SYNAPTIC PLASTICITY; HYPOCRETIN NEURONS; SLEEP-DEPRIVATION; REGULATED KINASE; RESPONSE ELEMENT; PHOSPHOLIPASE-C; ADIPOSE-TISSUE; CA2+ INFLUX	The orexins and their cognate G-protein coupled receptors have been widely studied due to their associations with various behaviors and cellular processes. However, the detailed downstream signaling cascades that mediate these effects are not completely understood. We report the generation of a neuronal model cell line that stably expresses the OX1 orexin receptor (OX1) and an RNA-Seq analysis of changes in gene expression seen upon receptor activation. Upon treatment with orexin, several families of related transcription factors are transcriptionally regulated, including the early growth response genes (Egr), the Kruppel- like factors (Klf), and the Nr4a subgroup of nuclear hormone receptors. Furthermore, some of the transcriptional effects observed have also been seen in data from in vivo sleep deprivation microarray studies, supporting the physiological relevance of the data set. Additionally, inhibition of one of the most highly regulated genes, serum and glucocorticoid-regulated kinase 1 (Sgk1), resulted in the diminished orexin-dependent induction of a subset of genes. These results provide new insight into the molecular signaling events that occur during OX1 signaling and support a role for orexin signaling in the stimulation of wakefulness during sleep deprivation studies.	[Koesema, Eric; Kodadek, Thomas] Scripps Florida, Dept Chem, Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Kodadek, T (corresponding author), Scripps Florida, Dept Chem, Scripps Res Inst, Jupiter, FL 33458 USA.	kodadek@scripps.edu		Kodadek, Thomas/0000-0003-1930-4795; Koesema, Eric/0000-0002-7743-0127				Allard JS, 2007, NEUROPEPTIDES, V41, P329, DOI 10.1016/j.npep.2007.04.006; Amato R, 2013, ONCOGENE, V32, P4572, DOI 10.1038/onc.2012.470; Ammoun S, 2006, J BIOL CHEM, V281, P834, DOI 10.1074/jbc.M508603200; Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; ANDERS S, 2010, GENOME BIOL, V11; Appelbaum L, 2009, P NATL ACAD SCI USA, V106, P21942, DOI 10.1073/pnas.906637106; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Bridi MS, 2013, NEUROBIOL LEARN MEM, V105, P151, DOI 10.1016/j.nlm.2013.06.020; Broberger C, 1998, J COMP NEUROL, V402, P460; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chang XC, 2015, MOL MED REP, V12, P7582, DOI 10.3892/mmr.2015.4381; Chen J, 2015, CELL SIGNAL, V27, P1426, DOI 10.1016/j.cellsig.2015.03.027; Cheng MC, 2015, BRAIN RES, V1629, P126, DOI 10.1016/j.brainres.2015.10.021; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; dela Pena I, 2013, PSYCHOPHARMACOLOGY, V230, P399, DOI 10.1007/s00213-013-3168-8; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekholm ME, 2007, BIOCHEM BIOPH RES CO, V353, P475, DOI 10.1016/j.bbrc.2006.12.045; Elbaz I, 2012, J NEUROSCI, V32, P12961, DOI 10.1523/JNEUROSCI.1284-12.2012; Esmaeili-Mahani S, 2013, NEUROCHEM INT, V63, P719, DOI 10.1016/j.neuint.2013.09.022; Feng Y, 2014, NEUROSCI LETT, V579, P35, DOI 10.1016/j.neulet.2014.07.014; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hamuro J, 2011, BIOCHEM BIOPH RES CO, V408, P293, DOI 10.1016/j.bbrc.2011.04.020; Harris DM, 2002, PANCREAS, V25, P405, DOI 10.1097/00006676-200211000-00014; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harris GC, 2007, BEHAV BRAIN RES, V183, P43, DOI 10.1016/j.bbr.2007.05.025; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Heller EA, 2015, J NEUROCHEM, V132, P243, DOI 10.1111/jnc.12925; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Hollander JA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00047; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; Holmqvist T, 2002, FEBS LETT, V526, P11, DOI 10.1016/S0014-5793(02)03101-0; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082563; Jaeger LB, 2002, PEPTIDES, V23, P1683, DOI 10.1016/S0196-9781(02)00110-9; Jantti MH, 2012, BRIT J PHARMACOL, V165, P1109, DOI 10.1111/j.1476-5381.2011.01565.x; Johansson L, 2007, BRIT J PHARMACOL, V150, P97, DOI 10.1038/sj.bjp.0706959; Johnson LA, 2014, NEUROBIOL DIS, V64, P150, DOI 10.1016/j.nbd.2013.12.016; Karteris E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1089, DOI 10.1152/ajpendo.00351.2004; Karteris E, 2001, J CLIN ENDOCR METAB, V86, P4512, DOI 10.1210/jc.86.9.4512; Korotkova TM, 2003, J NEUROSCI, V23, P7; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Kukkonen JP, 2016, CELL SIGNAL, V28, P51, DOI 10.1016/j.cellsig.2015.11.009; Kukkonen JP, 2014, BIOCHIMIE, V96, P158, DOI 10.1016/j.biochi.2013.06.015; Lang F, 2016, NEPHROL DIAL TRANSPL, V31, P200, DOI 10.1093/ndt/gfv270; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Galvao MDL, 2009, PSYCHONEUROENDOCRINO, V34, P1176, DOI 10.1016/j.psyneuen.2009.03.003; Larsson KP, 2003, BIOCHEM BIOPH RES CO, V309, P209, DOI 10.1016/S0006-291X(03)01563-8; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Leonard CS, 2014, BRIT J PHARMACOL, V171, P294, DOI 10.1111/bph.12296; Li JY, 2005, J NEUROENDOCRINOL, V17, P394, DOI 10.1111/j.1365-2826.2005.01317.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Malendowicz LK, 1999, J STEROID BIOCHEM, V70, P185, DOI 10.1016/S0960-0760(99)00110-7; Mehta R, 2015, NEUROSCI LETT, V590, P62, DOI 10.1016/j.neulet.2015.01.067; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Miranda P, 2013, J NEUROSCI, V33, P2684, DOI 10.1523/JNEUROSCI.3442-12.2013; Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; Nanmoku T, 2002, REGUL PEPTIDES, V104, P125, DOI 10.1016/S0167-0115(01)00356-1; Nanmoku T, 2000, BIOCHEM BIOPH RES CO, V274, P310, DOI 10.1006/bbrc.2000.3137; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Noda S, 2013, MOL NUTR FOOD RES, V57, P2019, DOI 10.1002/mnfr.201300045; Nonogaki K, 2006, BIOCHEM BIOPH RES CO, V344, P696, DOI 10.1016/j.bbrc.2006.03.196; Putula J, 2011, NEUROSCI LETT, V494, P57, DOI 10.1016/j.neulet.2011.02.055; Ramanjaneya M, 2008, ENDOCRINOLOGY, V149, P4106, DOI 10.1210/en.2007-1739; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; RISHI AK, 1995, CANCER RES, V55, P4999; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Saint-Preux F, 2013, NEUROSCIENCE, V243, P89, DOI 10.1016/j.neuroscience.2013.03.052; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Segal JP, 2005, J NEUROSCI, V25, P4181, DOI 10.1523/JNEUROSCI.0158-05.2005; Selbach O, 2004, NEUROSCIENCE, V127, P519, DOI 10.1016/j.neuroscience.2004.05.012; Selbach O, 2010, ACTA PHYSIOL, V198, P277, DOI 10.1111/j.1748-1716.2009.02021.x; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tang JY, 2008, CELL SIGNAL, V20, P1651, DOI 10.1016/j.cellsig.2008.05.010; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Turunen PM, 2012, MOL PHARMACOL, V82, P156, DOI 10.1124/mol.112.078063; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Wang CM, 2014, BBA-MOL CELL RES, V1843, P652, DOI 10.1016/j.bbamcr.2013.12.010; Wang HF, 2010, PHYSIOL GENOMICS, V42, P427, DOI 10.1152/physiolgenomics.00205.2009; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; Wesch D, 2010, AM J PHYSIOL-CELL PH, V299, pC779, DOI 10.1152/ajpcell.00184.2010; Wieland HA, 2002, EUR J BIOCHEM, V269, P1128, DOI 10.1046/j.0014-2956.2001.02739.x; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Xu A, 2010, J PHARMACOL SCI, V114, P444, DOI 10.1254/jphs.10177FP; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	109	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188082	10.1371/journal.pone.0188082	http://dx.doi.org/10.1371/journal.pone.0188082			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145494	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800062
J	Bohrer, RC; Dicks, N; Gutierrez, K; Duggavathi, R; Bordignon, V				Bohrer, Rodrigo C.; Dicks, Naomi; Gutierrez, Karina; Duggavathi, Raj; Bordignon, Vilceu			Double-strand DNA breaks are mainly repaired by the homologous recombination pathway in early developing swine embryos	FASEB JOURNAL			English	Article						DNA damage; DNA repair; ATM; ATR; DNA-PK	DEPENDENT PROTEIN-KINASE; CELL-CYCLE; GENOME STABILITY; MAMMALIAN-CELLS; DAMAGE RESPONSE; HISTONE H2AX; IN-VIVO; ATM; MOUSE; INTEGRITY	DNA double-strand breaks (DSBs) are less frequent than single-strand breaks but have more harmful consequences on cell survival and physiology. Homologous recombination (HR) and nonhomologous end-joining (NHEJ) are the two main pathways that are responsible for DSB repair in eukaryotic cells, but their importance for the preservation of genome stability in totipotent blastomeres of early developing embryos has not been determined. In this study, we observed that the chemical inhibition of HR or both pathways, but not NHEJ alone, increased the number of DSBs, reduced embryo development to the blastocyst stage, and resulted in embryos with higher proportions of apoptotic cells. Targeted knockdown of ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related; HR regulators) and DNA-dependent protein kinase (NHEJ regulator) mRNAs revealed that the attenuation of HR or both HR and NHEJ regulators severely impaired blastocyst formation and quality. Attenuation of ATM alone resulted in a higher incidence of DSBs, lower development and embryo quality, and increased mRNA abundance of genes that are involved in either repair pathway. These findings indicate that HR is the main pathway responsible for the promotion of DSB repair in early developing embryos, and that ATM seems to be more important than ATR in the regulation of the HR pathway in mammalian embryos.	[Bohrer, Rodrigo C.; Dicks, Naomi; Gutierrez, Karina; Duggavathi, Raj; Bordignon, Vilceu] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada	McGill University	Bordignon, V (corresponding author), McGill Univ, Dept Anim Sci, MS1-089,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	vilceu.bordignon@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022; Bohrer, Rodrigo/I-7725-2013	Bohrer, Rodrigo/0000-0002-0726-7643; Gutierrez, Karina/0000-0001-9112-1542; Bordignon, Vilceu/0000-0001-7076-7707	Natural Sciences and Engineering Research Council (NSERC) of Canada [2016-04910]; Science Without Borders Program of the Brazilian Council of Scientific and Technological Development; NSERC Alexander Graham Bell Canada Graduate Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science Without Borders Program of the Brazilian Council of Scientific and Technological Development; NSERC Alexander Graham Bell Canada Graduate Scholarship	The authors thank Olymel S.E.C./L.P. (Saint Esprit, QC, Canada) for providing porcine ovaries for use in these experiments. This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant 2016-04910; to V.B.). R.C.B. and K.G. were supported by scholarships from the Science Without Borders Program of the Brazilian Council of Scientific and Technological Development. N.D. is supported by an NSERC Alexander Graham Bell Canada Graduate Scholarship. The authors declare no conflicts of interest.	Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Barreta MH, 2012, EXP CELL RES, V318, P2049, DOI 10.1016/j.yexcr.2012.06.003; Bohrer RC, 2013, REPRODUCTION, V146, P325, DOI 10.1530/REP-13-0271; Bohrer RC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130542; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Grigaravicius P, 2009, MUTAGENESIS, V24, P191, DOI 10.1093/mutage/gen071; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Juan HC, 2016, CELL DEATH DIFFER, V23, P1038, DOI 10.1038/cdd.2015.157; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kujjo LL, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092064; Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; MUKHERJEE AB, 1976, P NATL ACAD SCI USA, V73, P1608, DOI 10.1073/pnas.73.5.1608; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; PAPAIOANNOU VE, 1982, J EMBRYOL EXP MORPH, V68, P199; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHOENBECK RA, 1992, BIOL REPROD, V47, P1118, DOI 10.1095/biolreprod47.6.1118; Simon L, 2014, HUM REPROD, V29, P2402, DOI 10.1093/humrep/deu228; SMITH RKW, 1986, J REPROD FERTIL, V76, P393, DOI 10.1530/jrf.0.0760393; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Wang B, 2013, SCI WORLD J, DOI 10.1155/2013/405645; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142561; Wang ZW, 2013, CELL CYCLE, V12, P3336, DOI 10.4161/cc.26327; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	56	10	10	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1818	1829		10.1096/fj.201700800R	http://dx.doi.org/10.1096/fj.201700800R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162700				2022-12-26	WOS:000429051400007
J	O'Donnell, JP; Byrnes, LJ; Cooley, RB; Sondermann, H				O'Donnell, John P.; Byrnes, Laura J.; Cooley, Richard B.; Sondermann, Holger			A hereditary spastic paraplegia-associated atlastin variant exhibits defective allosteric coupling in the catalytic core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynamin-related proteins; GTPase; membrane fusion; allosteric regulation; enzyme structure; axonopathy; hereditary spastic paraplegia	CRYSTAL-STRUCTURE; GTP HYDROLYSIS; STRUCTURAL INSIGHTS; HOMOTYPIC FUSION; MEMBRANE-FUSION; PROVIDE INSIGHT; G DOMAIN; DYNAMIN; DIMERIZATION; NETWORK	The dynamin-related GTPase atlastin (ATL) catalyzes membrane fusion of the endoplasmic reticulum and thus establishes a network of branched membrane tubules. When ATL function is compromised, the morphology of the endoplasmic reticulum deteriorates, and these defects can result in neurological disorders such as hereditary spastic paraplegia and hereditary sensory neuropathy. ATLs harness the energy of GTP hydrolysis to initiate a series of conformational changes that enable homodimerization and subsequent membrane fusion. Disease-associated amino acid substitutions cluster in regions adjacent to ATL's catalytic site, but the consequences for the GTPase's molecular mechanism are often poorly understood. Here, we elucidate structural and functional defects of an atypical hereditary spastic paraplegia mutant, ATL1-F151S, that is impaired in its nucleotide-hydrolysis cycle but can still adopt a high-affinity homodimer when bound to a transition-state analog. Crystal structures of mutant proteins yielded models of the monomeric pre- and post-hydrolysis states of ATL. Together, these findings define a mechanism for allosteric coupling in which Phe(151) is the central residue in a hydrophobic interaction network connecting the active site to an interdomain interface responsible for nucleotide loading.	[O'Donnell, John P.; Byrnes, Laura J.; Cooley, Richard B.; Sondermann, Holger] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Byrnes, Laura J.] Pfizer, Worldwide Med Chem, Eastern Point Rd, Groton, CT 06340 USA; [Cooley, Richard B.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Cornell University; Pfizer; Oregon State University	Sondermann, H (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	hs293@cornell.edu		O'Donnell, John/0000-0002-0571-3603; Cooley, Richard/0000-0003-3928-2757	National Science Foundation [DMR1332208]; National Institutes of Health [GM103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267, P41GM103485, T32GM008500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077650] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CHESS is supported by National Science Foundation Grant DMR1332208. The macromolecular diffraction at the CHESS facility is supported by National Institutes of Health Grant GM103485.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand R, 2016, BIOCHEM BIOPH RES CO, V469, P76, DOI 10.1016/j.bbrc.2015.11.074; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Daumke O, 2016, BIOPOLYMERS, V105, P580, DOI 10.1002/bip.22855; De N, 2010, METHOD ENZYMOL, V471, P161, DOI 10.1016/S0076-6879(10)71010-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fischer D, 2014, BRAIN, V137, DOI 10.1093/brain/awu091; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hu XY, 2015, PROTEIN CELL, V6, P307, DOI 10.1007/s13238-015-0139-3; Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287; Ivanova N, 2007, ARCH NEUROL-CHICAGO, V64, P706, DOI 10.1001/archneur.64.5.706; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khan TN, 2014, EUR J HUM GENET, V22, P1180, DOI 10.1038/ejhg.2014.5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Li J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43490; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; O'Donnell JP, 2017, STRUCTURE, V25, P997, DOI 10.1016/j.str.2017.05.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pendin D, 2011, P NATL ACAD SCI USA, V108, P16283, DOI 10.1073/pnas.1106421108; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Saini SG, 2014, MOL BIOL CELL, V25, P3942, DOI 10.1091/mbc.E14-08-1284; Smith BN, 2009, CLIN GENET, V75, P485, DOI 10.1111/j.1399-0004.2009.01184.x; Ulengin I, 2015, MOL BIOL CELL, V26, P1616, DOI 10.1091/mbc.E14-10-1447; Vetter IR, 2014, RAS SUPERFAMILY SMAL, V1, P25; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang SY, 2013, J CELL BIOL, V203, P801, DOI 10.1083/jcb.201308001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor J, 2017, J CELL BIOL, V216, P1321, DOI 10.1083/jcb.201609071; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wu FY, 2015, PROTEIN CELL, V6, P139, DOI 10.1007/s13238-014-0118-0; Yan LM, 2015, J CELL BIOL, V210, P961, DOI 10.1083/jcb.201502078; Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	62	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					687	700		10.1074/jbc.RA117.000380	http://dx.doi.org/10.1074/jbc.RA117.000380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29180453	Green Published, hybrid			2022-12-26	WOS:000419915400023
J	Moon, SH; Liu, XP; Cedars, AM; Yang, K; Kiebish, MA; Joseph, SM; Kelley, J; Jenkins, CM; Gross, RW				Moon, Sung Ho; Liu, Xinping; Cedars, Ari M.; Yang, Kui; Kiebish, Michael A.; Joseph, Susan M.; Kelley, John; Jenkins, Christopher M.; Gross, Richard W.			Heart failure-induced activation of phospholipase iPLA(2)gamma generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE EPOXIDE HYDROLASE; MYOCARDIAL ISCHEMIA-REPERFUSION; FAILING HUMAN HEARTS; CELL-DEATH; A(2)GAMMA IPLA(2)GAMMA; SARCOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY; INFARCT SIZE; NITRIC-OXIDE; CALCIUM	Congestive heart failure typically arises from cardiac myocyte necrosis/apoptosis, associated with the pathological opening of the mitochondrial permeability transition pore (mPTP). mPTP opening decreases the mitochondrial membrane potential leading to the activation of Ca2+-independent phospholipase A(2)gamma (iPLA(2)gamma) and the production of downstream toxic metabolites. However, the array of enzymatic mediators and the exact chemical mechanisms responsible for modulating myocardial mPTP opening remain unclear. Herein, we demonstrate that human heart failure activates specific myocardial mitochondrial phospholipases that increase Ca2+-dependent production of toxic hydroxyeicosatetraenoic acids (HETEs) and attenuate the activity of phospholipases that promote the synthesis of protective epoxyeicosatrienoic acids (EETs). Mechanistically, HETEs activated the Ca2+-induced opening of the mPTP in failing human myocardium, and the highly selective pharmacological blockade of either iPLA(2)gamma or lipoxygenases attenuated mPTP opening in failing hearts. In contrast, pharmacological inhibition of cytochrome P450 epoxygenases opened the myocardial mPTP in human heart mitochondria. Remarkably, the major mitochondrial phospholipase responsible for Ca2+-activated release of arachidonic acid (AA) in mitochondria from non-failing hearts was calcium-dependent phospholipase A(2)zeta (cPLA(2)zeta) identified by sequential column chromatographies and activity-based protein profiling. In contrast, iPLA(2)gamma predominated in failing human myocardium. Stable isotope kinetics revealed that in non-failing human hearts, cPLA(2)zeta metabolically channels arachidonic acid into EETs, whereas in failing hearts, increased iPLA(2)gamma activity channels AA into toxic HETEs. These results mechanistically identify the sequelae of pathological remodeling of human mitochondrial phospholipases in failing myocardium. This remodeling metabolically channels AA into toxic HETEs promoting mPTP opening, which induces necrosis/apoptosis leading to further progression of heart failure.	[Moon, Sung Ho; Liu, Xinping; Cedars, Ari M.; Yang, Kui; Kiebish, Michael A.; Kelley, John; Jenkins, Christopher M.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Joseph, Susan M.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Cedars, Ari M.] Baylor Heart & Vasc Hosp, Ctr Adult Congenital Heart Dis, 621 North Hall St,Ste 120, Dallas, TX 75226 USA; [Yang, Kui] US FDA, St Louis, MO 63110 USA; [Kiebish, Michael A.] BERG Hlth, 500 Old Connecticut Path, Framingham, MA 01701 USA; [Joseph, Susan M.] Baylor Heart & Vasc Hosp, Ctr Adv Heart & Lung Dis, 3410 Worth St,Suite 250, Dallas, TX 75246 USA; [Kelley, John] BJC HealthCare, 425 S Euclid Ave,Mailstop 90-09-340, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); US Food & Drug Administration (FDA)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	aricedars1@baylorhealth.edu; Michael.Kiebish@BergHealth.com; susanjoseph@baylorhealth.edu; John.Kelley@bjc.org; rgross@wustl.edu			National Institutes of Health [RO1HL133178, RO1HL118639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639, R01HL133178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1HL133178 and RO1HL118639. R. W. G. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gross GJ, 2013, J MOL CELL CARDIOL, V59, P20, DOI 10.1016/j.yjmcc.2013.02.003; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; HAZEN SL, 1993, J CLIN INVEST, V91, P2513, DOI 10.1172/JCI116487; HAZEN SL, 1992, CIRC RES, V70, P486, DOI 10.1161/01.RES.70.3.486; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Holzem KM, 2016, FASEB J, V30, P2698, DOI 10.1096/fj.201500118R; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; Liu XP, 2013, ANAL BIOCHEM, V442, P40, DOI 10.1016/j.ab.2013.06.014; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lopez-Crisosto C, 2017, NAT REV CARDIOL, V14, P342, DOI 10.1038/nrcardio.2017.23; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161629; Lv XJ, 2008, EUR J PHARMACOL, V596, P118, DOI 10.1016/j.ejphar.2008.08.008; Merabet N, 2012, J MOL CELL CARDIOL, V52, P660, DOI 10.1016/j.yjmcc.2011.11.015; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Moon SH, 2016, J BIOL CHEM, V291, P19687, DOI 10.1074/jbc.M116.740597; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nazarewicz RR, 2007, ARCH BIOCHEM BIOPHYS, V468, P114, DOI 10.1016/j.abb.2007.09.018; Nithipatikom K, 2004, CIRC RES, V95, pE65, DOI 10.1161/01.RES.0000146277.62128.6f; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Rauckhorst AJ, 2015, FEBS LETT, V589, P2367, DOI 10.1016/j.febslet.2015.07.016; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Shinmura K, 2005, AM J PHYSIOL-HEART C, V288, pH2093, DOI 10.1152/ajpheart.01003.2004; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Suzuki H, 2015, DIABETES, V64, P618, DOI 10.2337/db13-1896; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thiemermann C, 2000, PHARMACOL THERAPEUT, V87, P61, DOI 10.1016/S0163-7258(00)00069-3; Wen YS, 2003, TRENDS CARDIOVAS MED, V13, P129, DOI 10.1016/S1050-1738(03)00027-6; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200	50	25	28	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					115	129		10.1074/jbc.RA117.000405	http://dx.doi.org/10.1074/jbc.RA117.000405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158256	hybrid, Green Published			2022-12-26	WOS:000419453200011
J	Dharmawardena, P; Rodrigo, C; Mendis, K; Gunasekera, WMKTDW; Premaratne, R; Ringwald, P; Fernando, D				Dharmawardena, Priyani; Rodrigo, Chaturaka; Mendis, Kamini; Gunasekera, W. M. Kumudu T. de A. W.; Premaratne, Risintha; Ringwald, Pascal; Fernando, Deepika			Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination	PLOS ONE			English	Article							RESISTANT PLASMODIUM-VIVAX; ARTEMISININ RESISTANCE; FALCIPARUM-MALARIA; EMERGENCE	After eliminating local malaria transmission and being certified as a malaria-free country, Sri Lanka is facing the challenge of imported malaria. At the same time, the country has the unique opportunity to be a case study for other countries in a similar situation by approaching this issue systematically, guided by evidence. This study demonstrates the importance of developing a mechanism to detect imported malaria and adopting an evidence-based approach to study the resistance of imported malaria to anti-malarial medicines. This is a prospective study of patients diagnosed with imported malaria in Sri Lanka and treated according to the national treatment guidelines, over 24 months (2015 2016). The clinical features, time to diagnosis, origin of the infection, infecting species, parasite density and the treatment given were recorded. All patients were followed up for 28 days, and in the case of Plasmodium vivax and P. ovale infections, the follow up period was extended to 12 months to establish treatment failures and relapses. Fifty nine uncomplicated and 15 severe imported malaria cases were reported in Sri Lanka during the study period. Most of these infections originated in either Sub-Saharan Africa or South and Southeast Asia. Having a P. vivax infection and low parasitic counts were significantly associated with relative diagnostic delay. One of the 14 uncomplicated P. falciparum patients and two of the 12 severe P. falciparum malaria patients who were followed up till day 28 had a late clinical failure. The others responded adequately to treatment both clinically and parasitologically. There was no treatment failure reported amongst any other species. This study, which is the first to assess the therapeutic response of imported malaria in Sri Lanka after elimination, demonstrates that the current antimalarial treatment policies and strategies in Sri Lanka have been effective against infections acquired overseas up until the end of year 2016.	[Dharmawardena, Priyani; Gunasekera, W. M. Kumudu T. de A. W.; Premaratne, Risintha] Anti Malaria Campaign, Narahenpita, Colombo, Sri Lanka; [Rodrigo, Chaturaka] Univ New South Wales, Sch Med Sci, Dept Pathol, Sydney, NSW, Australia; [Rodrigo, Chaturaka] Univ Colombo, Dept Clin Med, Fac Med, Colombo, Sri Lanka; [Mendis, Kamini] WHO, Global Malaria Program, Colombo, Sri Lanka; [Ringwald, Pascal] WHO, Geneva, Switzerland; [Fernando, Deepika] Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka; [Premaratne, Risintha] WHO, South East Asian Reg Off, New Delhi, India	University of New South Wales Sydney; University of Colombo; World Health Organization; World Health Organization; University of Colombo; World Health Organization	Fernando, D (corresponding author), Univ Colombo, Dept Parasitol, Fac Med, Colombo, Sri Lanka.	ferndeep@gmail.com	; Rodrigo, Chaturaka/A-8400-2011	Gunasekera, Kumudunayana/0000-0003-3979-2191; Rodrigo, Chaturaka/0000-0003-2189-9177	National Science Foundation, Sri Lanka [RG/2014/HS/03]	National Science Foundation, Sri Lanka(National Science Foundation (NSF))	Financial assistance from National Science Foundation, Sri Lanka (Grant No. RG/2014/HS/03 is gratefully acknowledged. Website: http://www.nsf.ac.lk.	Anti Malaria Campaign of Sri Lanka, 2013, GUID MAL CHEM MAN PA; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Cullen KA, 2014, MMWR-MORBID MORTAL W, V63, P1; Department of Census and Statistics of Sri Lanka, 2012, SRI LANK CENS POP HO; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Duru V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0539-5; Fernando SD, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0128-3; Fernando SD, 2015, INT HEALTH, V7, P317, DOI 10.1093/inthealth/ihv046; Fernando SD, 2014, INT HEALTH, V6, P196, DOI 10.1093/inthealth/ihu044; Fernandopulle B M R, 2003, Ceylon Med J, V48, P32; Firdous N, 2011, J COMMUN GENET, V2, P173, DOI 10.1007/s12687-011-0054-0; Garg M, 1995, T ROY SOC TROP MED H, V89, P656, DOI 10.1016/0035-9203(95)90432-8; Gunathilaka Nayana, 2015, Malar Res Treat, V2015, P367635, DOI 10.1155/2015/367635; Khan A, 2016, LANCET GLOB HEALTH, V4, pE790, DOI 10.1016/S2214-109X(16)30251-0; Kshirsagar NA, 2000, ANN TROP MED PARASIT, V94, P189, DOI 10.1080/00034980057536; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; Ministry of Health Sri Lanka, 2016, NAT REP WHO CERT; Mornand P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180758; Nandy A, 2003, ANN TROP MED PARASIT, V97, P215, DOI 10.1179/000349803235001868; Premaratna R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-302; Ranaweera AD, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1776-1; Rasmussen C, 2017, NEW ENGL J MED, V377, P305, DOI 10.1056/NEJMc1705789; Salvador C, 2017, ACTA TROP, V171, P146, DOI 10.1016/j.actatropica.2017.03.032; Singh RK, 2000, T ROY SOC TROP MED H, V94, P327, DOI 10.1016/S0035-9203(00)90305-5; Sonkong K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-3; Sri Lanka Tourism Development Authority, 2016, ANN STAT REP SRI LAN; WHO, 2010, GUID TREATM MAL, V2nd; Wickremasinghe AR, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1763-6; Wilairatana Polrat, 2013, Asian Pac J Trop Biomed, V3, P586, DOI 10.1016/S2221-1691(13)60119-7; World Health Organization, 2015, WORLD MAL REP COUNTR; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2003, ASS MON ANTM DRUG EF; World Health Organization, 2015, STAT REP ART ACT RES	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188613	10.1371/journal.pone.0188613	http://dx.doi.org/10.1371/journal.pone.0188613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182619	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000043
J	Hanigan, IC; Cochrane, T; Davey, R				Hanigan, Ivan C.; Cochrane, Thomas; Davey, Rachel			Impact of scale of aggregation on associations of cardiovascular hospitalization and socioeconomic disadvantage	PLOS ONE			English	Article							DISEASE; INEQUALITIES; MORTALITY	Background There are numerous studies that show an increased incidence of cardiovascular disease with increasing levels of socio-economic disadvantage. Exposures that might influence the relationship include elements of the built environment and social systems that shape lifestyle risk behaviors. In Canberra (the Australian capital city) there has been a particular housing policy to create 'mixed-tenure' neighborhoods so that small pockets of disadvantage are surrounded by more affluent residences (known as a 'salt-and-pepper' pattern). This may contribute to a scatter of higher incidence rates in very small areas in this population that may be obscured if aggregated data are used. This study explored the effect of changing the scale of the spatial units used in small area disease modelling, aiming to understand the impact of this issue and the implications for local public health surveillance. Methods The residence location of hospitalized individuals were aggregated to two differently scaled area units. First, the Australian Bureau of Statistics Statistical Area 2 (SA2) which is normally used as the basis for deidentification and release of health data. Second, these data were aggregated to a smaller level: the Statistical Area 1 (SA1). Generalized Additive Models with penalized regression splines were used to assess the association of age-sex-standardized rates for cardiovascular disease hospital admissions with disadvantage. Results The relationships observed were different between the two types of spatial units. The SA1 level exposure-response curve for rates against the disadvantage index extended in a linear fashion above the midrange level, while that found at SA2-level suggested a curvilinear form with no evidence that rates increased with higher disadvantage beyond the midrange. Conclusion Our result supports findings of other work that has found disadvantage increases risk of cardiovascular disease. The shape of the curves suggest a difference in associations of cardiovascular disease rates with disadvantage scores between SA1 versus SA2. From these results it can be concluded that scale of analysis does influence the understanding of geographical patterns of socio-economic disadvantage and cardiovascular disease morbidity. Health surveillance and interventions in Canberra should take into account the impact of the scale of aggregation on the association between disadvantage and cardiovascular disease observed.	[Hanigan, Ivan C.; Cochrane, Thomas; Davey, Rachel] Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Spatial Epidemiol Grp, Canberra, ACT, Australia; [Hanigan, Ivan C.] Univ Sydney, Sydney Med Sch, Univ Ctr Rural Hlth, Sydney, NSW, Australia	University of Canberra; University of Sydney	Hanigan, IC (corresponding author), Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Spatial Epidemiol Grp, Canberra, ACT, Australia.; Hanigan, IC (corresponding author), Univ Sydney, Sydney Med Sch, Univ Ctr Rural Hlth, Sydney, NSW, Australia.	ivan.hanigan@canberra.edu.au	Cochrane, Tom/M-8588-2015	Cochrane, Tom/0000-0002-6391-2109; Hanigan, Ivan/0000-0002-6360-6793				[Anonymous], 2013, SOC IND AR SEIFA; Australian Bureau of Statistics, 2015, AUSTR BUR STAT 3101; Australian Bureau of Statistics, 2011, CENS 2011 TABLEBUILD; Australian Bureau of Statistics, 2018, AUSTR STAT GEOGR STA; Australian Institute for Health and Welfare, 2011, AUSTR I HLTH WELF HL, V39; Bivand RS, 2008, USE R, P1; Bynum JPW, 2011, HEALTH AFFAIR, V30, P975, DOI 10.1377/hlthaff.2010.1102; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Eagleson S, 1999, P 6 S E AS SURV C FR; Fotheringham A, 1991, ENV PLANNING A, V23; Goldie X, 2014, AUST GEOGR, V45, P521, DOI 10.1080/00049182.2014.953737; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Institute of Health Metrics and Evaluation, 2015, GBD PROF AUSTR 2015; Kang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075957; Kawachi I, 2010, EXPLORATION HLTH DIS; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Matisziw TC, 2008, COMPUT ENVIRON URBAN, V32, P81, DOI 10.1016/j.compenvurbsys.2007.06.002; Mazumdar S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012548; Meade M., 2000, MED GEOGRAPHY; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Openshaw S., 1984, MODIFIABLE AREAL UNI; Pink B, 2013, SOCIO EC INDEXES ARE; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Reynolds L, 2012, J ROY SOC MED, V105, P7, DOI 10.1258/jrsm.2011.110195; Stallings-Smith S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062063; Stephens AS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013227; Tanton R, 2015, POLICY STUD-UK, V36, P92, DOI 10.1080/01442872.2014.981062; Te Grotenhuis M, 2011, INT J EPIDEMIOL, V40, P1123, DOI 10.1093/ije/dyr081; Turrell G, 2001, INT J EPIDEMIOL, V30, P231, DOI 10.1093/ije/30.2.231; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wrigley N, 1996, SPATIAL ANAL MODELLI, P23; Yu Y, 2017, PREV MED, V99, P134, DOI 10.1016/j.ypmed.2017.02.008	37	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188161	10.1371/journal.pone.0188161	http://dx.doi.org/10.1371/journal.pone.0188161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN9ZL	29182618	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000011
J	Kim, HJ; Kim, N; Kim, YS; Nam, RH; Lee, SM; Park, JH; Choi, D; Hwang, YJ; Lee, J; Lee, HS; Kim, MS; Lee, MY; Lee, DH				Kim, Hee Jin; Kim, Nayoung; Kim, Yong Sung; Nam, Ryoung Hee; Lee, Sun Min; Park, Ji Hyun; Choi, Daeun; Hwang, Young-Jae; Lee, Jongchan; Lee, Hye Seung; Kim, Min-Seob; Lee, Moon Young; Lee, Dong Ho			Changes in the interstitial cells of Cajal and neuronal nitric oxide synthase positive neuronal cells with aging in the esophagus of F344 rats	PLOS ONE			English	Article							ENTERIC CO-INNERVATION; MYENTERIC PLEXUS; SMOOTH-MUSCLE; IMPEDANCE MANOMETRY; AGE; COLON; SPHINCTER; ACHALASIA; PATHOPHYSIOLOGY; RELAXATION	The aging-associated cellular and molecular changes in esophagus have not been established, yet. Thus we evaluated histological structure, interstitial cells of Cajal (ICCs), neuronal nitric oxide synthase (nNOS)-positive cells, and contractility in the esophagus of Fischer 344 rat at different ages (6-, 31-, 74-weeks, and 2-years). The lamina propria thickness and endomysial area were calculated. The immunoreactivity of c-Kit, nNOS and protein gene product (PGP) 9.5 was counted after immunohistochemistry. Expression of c-Kit, stem cell factor (SCF), nNOS and PGP 9.5 mRNA was measured by real-time PCR, and expression of c-Kit and nNOS protein was detected by Western blot. Isovolumetric contractile force measurement and electrical field stimulation (EFS) were conducted. The lamina propria thickness increased (6 week vs 2 year, P = 0.005) and the endomysial area of longitudinal muscle decreased with aging (6 week vs 2 year, P<0.001), while endomysial area of circular muscle did not significantly decrease. The proportions of NOS-immunoreactive cells and c-Kit-immunoreactive areas declined with aging (6 week vs 2 year; P<0.001 and P = 0.004, respectively), but there was no significant change of PGP 9.5-immunopositiviy. The expressions of nNOS, c-Kit and SCF mRNA also reduced with aging (6 week vs 2 year; P = 0.006, P = 0.001 and P = 0.006, respectively), while the change of PGP 9.5 mRNA expression was not significant. Western blot showed the significant decreases of nNOS and c-Kit protein expression with aging (6 week vs 2 year; P = 0.008 and P = 0.012, respectively). The EFSinduced esophageal contractions significantly decreased in 2-yr-old rat compared with 6wk- old rats, however, L-NG-Nitroarginine methylester did not significantly increase the spontaneous and EFS-induced contractions in the 6-wk- and 2-yr-old rat esophagus. In conclusion, an increase of lamina propria thickness, a decrease of endomysial area, c-Kit, SCF and NOS expression with preserved total enteric neurons, and contractility in aged rat esophagus may explain the aging-associated esophageal dysmotility.	[Kim, Hee Jin; Kim, Nayoung; Nam, Ryoung Hee; Lee, Sun Min; Park, Ji Hyun; Choi, Daeun; Hwang, Young-Jae; Lee, Jongchan; Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Hee Jin] Myongji Hosp, Dept Internal Med, Goyang, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Dept Gastroenterol, Iksan, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sch Med, Digest Dis Res Inst, Iksan, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Seongnam, South Korea; [Kim, Min-Seob; Lee, Moon Young] Wonkwang Univ, Coll Med, Dept Physiol, Iksan, South Korea; [Kim, Min-Seob; Lee, Moon Young] Wonkwang Univ, Coll Med, Inst Wonkwang Med Sci, Iksan, South Korea	Seoul National University (SNU); Myongji Hospital; Seoul National University (SNU); Seoul National University (SNU); Wonkwang University; Wonkwang University; Seoul National University (SNU); Wonkwang University; Wonkwang University	Kim, N (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	nayoungkim49@empas.com	Lee, Hye Seung/G-6419-2011; Kim, Yong Sung/GMW-8652-2022	Lee, Hye Seung/0000-0002-1667-7986; Kim, Yong Sung/0000-0001-8836-4818; Kim, Nayoung/0000-0002-9397-0406; Lee, Darrall/0000-0002-6990-4441	National Research Foundation (NRF) of Korea grant for the Global Core Research Center (GCRC) - Korea government (MSIP) [2011-0030001]	National Research Foundation (NRF) of Korea grant for the Global Core Research Center (GCRC) - Korea government (MSIP)	This work was supported by a National Research Foundation (NRF) of Korea grant for the Global Core Research Center (GCRC) funded by the Korea government (MSIP) (No. 2011-0030001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard CE, 2009, NEUROGASTROENT MOTIL, V21, P746, DOI 10.1111/j.1365-2982.2008.01245.x; Besanko LK, 2011, WORLD J GASTROENTERO, V17, P1326, DOI 10.3748/wjg.v17.i10.1326; Bitar K, 2011, NEUROGASTROENT MOTIL, V23, P490, DOI 10.1111/j.1365-2982.2011.01678.x; Bitar KN, 2004, MECH AGEING DEV, V125, P907, DOI 10.1016/j.mad.2004.05.010; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Camilleri M, 2008, NEUROGASTROENT MOTIL, V20, P185, DOI 10.1111/j.1365-2982.2007.01072.x; Cock C, 2016, NEUROGASTROENT MOTIL, V28, P1890, DOI 10.1111/nmo.12892; Cook IJ, 2009, GASTROENTEROL CLIN N, V38, P411, DOI 10.1016/j.gtc.2009.06.003; Cowen T, 2000, GUT, V47, P653, DOI 10.1136/gut.47.5.653; D'allard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060961; Dantas DAD, 2012, SLEEP, V35, P483, DOI 10.5665/sleep.1730; FAUSSONEPELLEGRINI MS, 1986, HISTOL HISTOPATHOL, V1, P119; Franceschi M, 2009, BEST PRACT RES CL GA, V23, P839, DOI 10.1016/j.bpg.2009.10.004; Gamage P P K M, 2013, Neurogastroenterol Motil, V25, pe495; Gockel I, 2008, AM J GASTROENTEROL, V103, P856, DOI 10.1111/j.1572-0241.2007.01667.x; Gomez-Pinilla PJ, 2011, NEUROGASTROENT MOTIL, V23, P36, DOI 10.1111/j.1365-2982.2010.01590.x; Gregersen H, 2008, DIGEST DIS SCI, V53, P3065, DOI 10.1007/s10620-008-0278-y; Groneberg D, 2015, J PHYSIOL-LONDON, V593, P403, DOI 10.1113/jphysiol.2014.273540; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; Groneberg D, 2011, GASTROENTEROLOGY, V140, P1608, DOI 10.1053/j.gastro.2011.01.038; Hoshino M, 2013, DIS ESOPHAGUS, V26, P14, DOI 10.1111/j.1442-2050.2011.01318.x; Jo HJ, 2014, AM J PHYSIOL-GASTR L, V306, pG659, DOI 10.1152/ajpgi.00304.2012; Kallmuenzer B, 2008, NEUROGASTROENT MOTIL, V20, P597, DOI 10.1111/j.1365-2982.2007.01075.x; Kang JM, 2010, AM J PHYSIOL-GASTR L, V299, pG1147, DOI 10.1152/ajpgi.00218.2010; Kwon YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169113; LEESE G, 1986, ACTA ANAT, V127, P77; MECIANO J, 1995, GERONTOLOGY, V41, P18; MURRAY J, 1991, AM J PHYSIOL, V261, pG401, DOI 10.1152/ajpgi.1991.261.3.G401; Nakahara M, 2002, J GASTROEN HEPATOL, V17, P666, DOI 10.1046/j.1440-1746.2002.02756.x; PATAPOUTIAN A, 1995, SCIENCE, V270, P1818, DOI 10.1126/science.270.5243.1818; Phillips RJ, 2003, AUTON NEUROSCI-BASIC, V106, P69, DOI 10.1016/S1566-0702(03)00072-9; Phillips RJ, 2007, NEUROBIOL AGING, V28, P1124, DOI 10.1016/j.neurobiolaging.2006.05.019; Rumessen JJ, 2001, CELL TISSUE RES, V306, P1, DOI 10.1007/s004410100418; Saffrey MJ, 2014, AGE, V36, P1019, DOI 10.1007/s11357-013-9603-2; Salles N, 2009, BEST PRACT RES CL GA, V23, P805, DOI 10.1016/j.bpg.2009.09.002; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Shim YK, 2017, J NEUROGASTROENTEROL, V23, P229, DOI 10.5056/jnm16104; Sivarao DV, 2001, GASTROENTEROLOGY, V121, P34, DOI 10.1053/gast.2001.25541; Takahashi T, 2000, BRAIN RES, V883, P15, DOI 10.1016/S0006-8993(00)02867-5; Takaki Miyako, 2003, Journal of Smooth Muscle Research, V39, P137, DOI 10.1540/jsmr.39.137; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196; van Hoeij FB, 2016, J NEUROGASTROENTEROL, V22, P6, DOI 10.5056/jnm15177; Villanacci V, 2010, J CLIN GASTROENTEROL, V44, P407, DOI 10.1097/MCG.0b013e3181bc9ebf; Wade PR, 2004, NEUROGASTROENT MOTIL, V16, P19, DOI 10.1111/j.1743-3150.2004.00469.x; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Wiskur Brandt, 2010, Curr Gastroenterol Rep, V12, P507, DOI 10.1007/s11894-010-0139-7; Worl J, 2005, HISTOCHEM CELL BIOL, V123, P117, DOI 10.1007/s00418-005-0764-7; Wu M, 2003, HISTOCHEM CELL BIOL, V119, P395, DOI 10.1007/s00418-003-0526-3; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	50	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0186322	10.1371/journal.pone.0186322	http://dx.doi.org/10.1371/journal.pone.0186322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182640	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000001
J	Sekulic-Jablanovic, M; Petkovic, V; Wright, MB; Kucharava, K; Huerzeler, N; Levano, S; Brand, Y; Leitmeyer, K; Glutz, A; Bausch, A; Bodmer, D				Sekulic-Jablanovic, Marijana; Petkovic, Vesna; Wright, Matthew B.; Kucharava, Krystsina; Huerzeler, Nathan; Levano, Soledad; Brand, Yves; Leitmeyer, Katharina; Glutz, Andrea; Bausch, Alexander; Bodmer, Daniel			Effects of peroxisome proliferator activated receptors (PPAR)-gamma and -alpha agonists on cochlear protection from oxidative stress	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INDUCED HEARING-LOSS; PPAR-GAMMA; PARKINSONS-DISEASE; DEATH PATHWAY; MOUSE MODEL; PIOGLITAZONE; MICE; GENTAMICIN; MECHANISMS	Various insults cause ototoxicity in mammals by increasing oxidative stress leading to apoptosis of auditory hair cells (HCs). The thiazolidinediones (TZDs; e.g., pioglitazone) and fibrate (e.g., fenofibrate) drugs are used for the treatment of diabetes and dyslipidemia. These agents target the peroxisome proliferator-activated receptors, PPAR gamma and PPAR alpha, which are transcription factors that influence glucose and lipid metabolism, inflammation, and organ protection. In this study, we explored the effects of pioglitazone and other PPAR agonists to prevent gentamicin-induced oxidative stress and apoptosis in mouse organ of Corti (OC) explants. Western blots showed high levels of PPAR gamma and PPAR alpha proteins in mouse OC lysates. Immunofluorescence assays indicated that PPAR gamma and PPAR alpha proteins are present in auditory HCs and other cell types in the mouse cochlea. Gentamicin treatment induced production of reactive oxygen species (ROS), lipid peroxidation, caspase activation, PARP-1 cleavage, and HC apoptosis in cultured OCs. Pioglitazone mediated its antiapoptotic effects by opposing the increase in ROS induced by gentamicin, which inhibited the subsequent formation of 4-hydroxy-2-nonenal (4-HNE) and activation of pro-apoptotic mediators. Pioglitazone mediated its effects by upregulating genes that control ROS production and detoxification pathways leading to restoration of the reduced: oxidized glutathione ratio. Structurally diverse PPAR agonists were protective of HCs. Pioglitazone (PPAR gamma-specific), tesaglitazar (PPAR gamma/alpha-specific), and fenofibric acid (PPAR alpha-specific) all provided >90% protection from gentamicin toxicity by regulation of overlapping subsets of genes controlling ROS detoxification. This study revealed that PPARs play important roles in the cochlea, and that PPAR-targeting drugs possess therapeutic potential as treatment for hearing loss.	[Sekulic-Jablanovic, Marijana; Petkovic, Vesna; Kucharava, Krystsina; Huerzeler, Nathan; Levano, Soledad; Brand, Yves; Leitmeyer, Katharina; Glutz, Andrea; Bodmer, Daniel] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Brand, Yves; Bodmer, Daniel] Univ Hosp Basel, Clin Otolaryngol Head & Neck Surg, Basel, Switzerland; [Wright, Matthew B.; Bausch, Alexander] Strekin AG, Basel, Switzerland	University of Basel; University of Basel	Sekulic-Jablanovic, M (corresponding author), Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland.	marijana.sekulic@unibas.ch		Petkovic, Vesna/0000-0002-0741-9774; Wright, matthewwright/0000-0002-0532-3381; Levano, Soledad/0000-0002-0963-7951	Swiss Commission for Technology Innovation (CTI) [18117.1 PFLS-LS]	Swiss Commission for Technology Innovation (CTI)	This work was supported by a grant from the Swiss Commission for Technology Innovation (CTI) Nr. 18117.1 PFLS-LS to Prof Bodmer and Dr Petkovic with a 10% matching cash contribution from Strekin AG. The Swiss Commission for Technology Innovation (CTI) had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication, https://www.kti.admin.ch/kti/en/home.html. Strekin AG through Dr. Wright participated in study design; interpretation of data; writing of the paper; and decision to submit for publication.; The authors would like to acknowledge the grant support provided by the Swiss Commission for Technology Innovation (CTI) Nr. 18117.1 PFLS-LS. We would like to thank Eliane Ebnoether and Alessia Ramseier for their support with the initial experiments.	Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Cabrera JA, 2012, TRANSL RES, V159, P383, DOI 10.1016/j.trsl.2011.11.001; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Dietz M, 2012, CHEMMEDCHEM, V7, P1101, DOI 10.1002/cmdc.201100598; Esposito E, 2011, EXPERT OPIN THER TAR, V15, P943, DOI 10.1517/14728222.2011.581231; Fetoni AR, 2010, NEUROSCIENCE, V169, P1575, DOI 10.1016/j.neuroscience.2010.06.022; Fetoni AR, 2009, ACTA OTORHINOLARYNGO, V29, P70; Fetoni AR, 2004, ACTA OTO-LARYNGOL, V124, P421, DOI 10.1080/00016480410016559; Grommes C, 2013, CANCER CHEMOTH PHARM, V71, P929, DOI 10.1007/s00280-013-2084-2; Hanefeld M, 2001, INT J CLIN PRACT, P27; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim T, 2013, WORLD J CARDIOL, V5, P164, DOI 10.4330/wjc.v5.i6.164; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Moller DE, 2001, ADV PROTEIN CHEM, V56, P181; Muller U, 2015, NAT REV DRUG DISCOV, V14, P346, DOI 10.1038/nrd4533; Nakamura T, 2007, STROKE, V38, P3016, DOI 10.1161/STROKEAHA.107.486522; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Okada K, 2006, BRAIN RES, V1102, P175, DOI 10.1016/j.brainres.2006.04.108; Park C, 2017, INT J MOL MED, V39, P960, DOI 10.3892/ijmm.2017.2916; Priuska EM, 1995, BIOCHEM PHARMACOL, V50, P1749, DOI 10.1016/0006-2952(95)02160-4; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Sha SH, 1999, HEARING RES, V128, P112, DOI 10.1016/S0378-5955(98)00200-7; Shi XR, 2003, BRAIN RES, V967, P1, DOI 10.1016/S0006-8993(02)04090-8; SOBKOWICZ HM, 1993, ACTA OTO-LARYNGOL, P3; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Wang J, 2007, MOL PHARMACOL, V71, P654, DOI 10.1124/mol.106.028936; Wang PJ, 2014, J CARDIOVASC PHARM, V64, P497, DOI 10.1097/FJC.0000000000000143; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; YAMANE H, 1995, ACTA OTO-LARYNGOL, P87; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061	42	37	39	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188596	10.1371/journal.pone.0188596	http://dx.doi.org/10.1371/journal.pone.0188596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182629	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000042
J	Ottas, A; Fishman, D; Okas, TL; Pussa, T; Toomik, P; Martson, A; Kingo, K; Soomets, U				Ottas, Aigar; Fishman, Dmytro; Okas, Tiia-Linda; Pussa, Tonu; Toomik, Peeter; Martson, Aare; Kingo, Kulli; Soomets, Ursel			Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; COMORBIDITIES; FILAGGRIN; DISEASE; CHILDHOOD; PROFILES; DATABASE; ECZEMA; LIVER; SKIN	Atopic dermatitis is a chronic inflammatory disease which usually starts in the early childhood and ends before adulthood. However up to 3% of adults remain affected by the disease. The onset and course of the disease is influenced by various genetic and environmental factors. Although the immune system has a great effect on the outcome of the disease, metabolic markers can also try to explain the background of atopic dermatitis. In this study we analyzed the serum of patients with atopic dermatitis using both targeted and untargeted metabolomics approaches. We found the most significant changes to be related to phosphatidylcholines, acylcarnitines and their ratios and a cleavage peptide of Fibrinogen A-alpha. These findings that have not been reported before will further help to understand this complex disease.	[Ottas, Aigar; Soomets, Ursel] Univ Tartu, Inst Biomed & Translat Med, Dept Biochem, Tartu, Estonia; [Fishman, Dmytro] Univ Tartu, Inst Comp Sci, Fac Sci & Technol, Tartu, Estonia; [Fishman, Dmytro] Quretec OU, Tartu, Estonia; [Okas, Tiia-Linda] Univ Tartu, Tartu, Estonia; [Pussa, Tonu; Toomik, Peeter] Estonian Univ Life Sci, Dept Food Hyg, Tartu, Estonia; [Martson, Aare] Tartu Univ Hosp, Clin Traumatol & Orthoped, Tartu, Estonia; [Kingo, Kulli] Univ Tartu, Dept Dermatol, Tartu, Estonia; [Kingo, Kulli] Tartu Univ Hosp, Clin Dermatol, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu; Estonian University of Life Sciences; University of Tartu	Ottas, A (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Biochem, Tartu, Estonia.	aigar.ottas@ut.ee	Martson, Aare/AAQ-8714-2020; Kingo, Külli/H-3603-2012; Soomets, Ursel/H-5919-2015	Martson, Aare/0000-0003-4857-484X; Kingo, Kulli/0000-0001-6301-9612; Soomets, Ursel/0000-0002-3681-188X	Estonian Research Council [IUT20-42]; University of Tartu [SP1GVARENG, PUT177, PUT1465]; European Union through the European Regional Development Fund	Estonian Research Council(Estonian Research Council); University of Tartu; European Union through the European Regional Development Fund(European Commission)	This study was made possible by the funding from grant IUT20-42 from the Estonian Research Council, SP1GVARENG from the University of Tartu, personal research grant PUT177, PUT1465 and by the European Union through the European Regional Development Fund.	Assfalg M, 2012, BRIT J DERMATOL, V166, P1123, DOI 10.1111/j.1365-2133.2011.10711.x; Blum A, 2015, OPEN MED-WARSAW, V10, P318, DOI 10.1515/med-2015-0045; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Brunner PM, 2017, J INVEST DERMATOL, V137, P18, DOI 10.1016/j.jid.2016.08.022; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Deckert S, 2014, ALLERGY, V69, P37, DOI 10.1111/all.12246; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Famularo G, 1997, CARNITINE TODAY, P119; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Geisser S., PREDICTIVE INFERENCE; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Hotze M, 2014, ALLERGY, V69, P132, DOI 10.1111/all.12234; Huang Y, 2014, J PROTEOME RES, V13, P5715, DOI 10.1021/pr5007069; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; LOTTI T, 1989, INT J DERMATOL, V28, P457, DOI 10.1111/j.1365-4362.1989.tb02506.x; Mannaerts GP, 2000, CELL BIOCHEM BIOPHYS, V32, P73, DOI 10.1385/CBB:32:1-3:73; Nastalek M, 2010, J THROMB THROMBOLYS, V30, P121, DOI 10.1007/s11239-010-0478-0; Ng A. Y., 1997, P 14 INT C MACH LEAR, P245; Niang F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17693; Nijsten T, 2017, J INVEST DERMATOL, V137, P1009, DOI 10.1016/j.jid.2017.02.003; Okeke NL, 2016, OPEN FORUM INFECT DI, V3, P2138; Peiser M, 2007, J INVEST DERMATOL, V127, P973, DOI 10.1038/sj.jid.5700623; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Seino S, 2012, J CLIN BIOCHEM NUTR, V50, P152, DOI 10.3164/jcbn.11-29; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Team RC, 2014, R LANG ENV STAT COMP; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Want EJ, 2010, ANAL CHEM, V82, P5282, DOI 10.1021/ac1007078; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xu G, 2016, J CLIN ENDOCR METAB, V101, P5044, DOI 10.1210/jc.2016-1859	40	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188580	10.1371/journal.pone.0188580	http://dx.doi.org/10.1371/journal.pone.0188580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176763	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900099
J	Ramirez, JC; Parrado, R; Sulleiro, E; de la Barra, A; Rodriguez, M; Villarroel, S; Irazu, L; Alonso-Vega, C; Alves, F; Curto, MA; Garcia, L; Ortiz, L; Torrico, F; Gascon, J; Flevaud, L; Molina, I; Ribeiro, I; Schijman, AG				Ramirez, Juan C.; Parrado, Rudy; Sulleiro, Elena; de la Barra, Anabelle; Rodriguez, Marcelo; Villarroel, Sandro; Irazu, Lucia; Alonso-Vega, Cristina; Alves, Fabiana; Curto, Maria A.; Garcia, Lineth; Ortiz, Lourdes; Torrico, Faustino; Gascon, Joaquim; Flevaud, Laurence; Molina, Israel; Ribeiro, Isabela; Schijman, Alejandro G.			First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VIRUS TYPE-1 RNA; TRYPANOSOMA-CRUZI; MOLECULAR-DETECTION; DNA; AMPLIFICATION; LABORATORIES; MULTICENTER; ASSAYS; STANDARDIZATION	Real-Time PCR (qPCR) testing is recommended as both a diagnostic and outcome measurement of etiological treatment in clinical practice and clinical trials of Chagas disease (CD), but no external quality assurance (EQA) program provides performance assessment of the assays in use. We implemented an EQA system to evaluate the performance of molecular biology laboratories involved in qPCR based follow-up in clinical trials of CD. An EQA program was devised for three clinical trials of CD: the E1224 (NCT01489228), a pro drug of ravuconazole; the Sampling Study (NCT01678599), that used benznidazole, both conducted in Bolivia; and the CHAGASAZOL (NCT01162967), that tested posaconazole, conducted in Spain. Four proficiency testing panels containing negative controls and seronegative blood samples spiked with 1, 10 and 100 parasite equivalents (par. eq.)/mL of four Trypanosoma cruzistocks, were sent from the Core Lab in Argentina to the participating laboratories located in Bolivia and Spain. Panels were analyzed simultaneously, blinded to sample allocation, at 4-month intervals. In addition, 302 random blood samples from both trials carried out in Bolivia were sent to Core Lab for retesting analysis. The analysis of proficiency testing panels gave 100% of accordance (within laboratory agreement) and concordance (between laboratory agreement) for all T. cruzistocks at 100 par. eq./mL; whereas their values ranged from 71 to 100% and from 62 to 100% at 1 and 10 par. eq./mL, respectively, depending on the T. cruzi stock. The results obtained after twelve months of preparation confirmed the stability of blood samples in guanidine-EDTA buffer. No significant differences were found between qPCR results from Bolivian laboratory and Core Lab for retested clinical samples. This EQA program for qPCR analysis of CD patient samples may significantly contribute to ensuring the quality of laboratory data generated in clinical trials and molecular diagnostics laboratories of CD.	[Ramirez, Juan C.; Curto, Maria A.; Schijman, Alejandro G.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, Buenos Aires, DF, Argentina; [Parrado, Rudy; de la Barra, Anabelle; Villarroel, Sandro; Garcia, Lineth] Univ Mayor de San Simon, Inst Invest Biomed IIBISMED, Cochabamba, Bolivia; [Sulleiro, Elena; Molina, Israel] Univ Autonoma Barcelona, PROSICS Barcelona, Hosp Univ Vall dHebron, Barcelona, Spain; [Rodriguez, Marcelo; Irazu, Lucia] ANLIS Dr Carlos G Malbran, Inst Nacl Enfermedades Infecciosas INEI, Buenos Aires, DF, Argentina; [Alonso-Vega, Cristina; Alves, Fabiana; Ribeiro, Isabela] DNDi, Geneva, Switzerland; [Ortiz, Lourdes] Univ Autonoma Juan Misael Saracho, Tarija, Bolivia; [Torrico, Faustino] Fdn CEADES, Cochabamba, Bolivia; [Gascon, Joaquim] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Flevaud, Laurence] Med Sans Frontieres Operat Ctr Barcelona Athens O, Barcelona, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Schijman, AG (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, Buenos Aires, DF, Argentina.	schijman@dna.uba.ar	Gascon, Joaquim/M-3598-2015	Gascon, Joaquim/0000-0002-5045-1585; Alonso-Vega, Cristina/0000-0003-3399-3021; Sulleiro, Elena/0000-0002-9783-6060; Molina Romero, Israel/0000-0001-6642-7515	Drugs for Neglected Diseases initiative; National Agency of Science, Technology and Productive Innovation [PICT 2011-0207, PICT 2014-0267]; Wellcome Trust [095422 - E1224, NCT01489228]; Medecins Sans Frontieres (Doctors without Borders), International; Ministry of Foreign Affairs, Spain; Department for International Development (DFID), UK; Dutch Ministry of Foreign Affairs (DGIS), The Netherlands; Rockefeller Foundation, USA	Drugs for Neglected Diseases initiative; National Agency of Science, Technology and Productive Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres (Doctors without Borders), International; Ministry of Foreign Affairs, Spain; Department for International Development (DFID), UK; Dutch Ministry of Foreign Affairs (DGIS), The Netherlands; Rockefeller Foundation, USA	This work was supported by Drugs for Neglected Diseases initiative and by the National Agency of Science, Technology and Productive Innovation grants PICT 2011-0207 and PICT 2014-0267. The EQA evaluation for the two DNDi-sponsored clinical trials was funded through DNDi by the following donors: Strategic Translation Award from the Wellcome Trust grant 095422 - E1224 trial (NCT01489228); Medecins Sans Frontieres (Doctors without Borders), International; Ministry of Foreign Affairs, Spain; Department for International Development (DFID), UK; Dutch Ministry of Foreign Affairs (DGIS), The Netherlands; Rockefeller Foundation, USA; and anonymous donors.	Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010; Cruz I, 2013, EXP PARASITOL, V134, P281, DOI 10.1016/j.exppara.2013.03.026; Domingo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036291; Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15; Grundy JE, 1996, J CLIN MICROBIOL, V34, P1166, DOI 10.1128/JCM.34.5.1166-1170.1996; Hirsch HH, 1999, J MED VIROL, V57, P31, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;31::AID-JMV5&gt;3.0.CO;2-J; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langton SD, 2002, INT J FOOD MICROBIOL, V79, P175, DOI 10.1016/S0168-1605(02)00107-1; Lefrere JJ, 2000, J VIROL METHODS, V85, P117, DOI 10.1016/S0166-0934(99)00160-3; Martinez-Perez A, 2016, ACTA TROP, V157, P145, DOI 10.1016/j.actatropica.2016.01.032; Murphy SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097398; Muyldermans G, 2005, J CLIN MICROBIOL, V43, P30, DOI 10.1128/JCM.43.1.30-35.2005; Noordhoek GT, 1996, J CLIN MICROBIOL, V34, P2522, DOI 10.1128/JCM.34.10.2522-2525.1996; Nowicki MJ, 2001, J CLIN MICROBIOL, V39, P3760, DOI 10.1128/JCM.39.10.3760-3763.2001; Pelloux H, 1998, FEMS MICROBIOL LETT, V165, P231, DOI 10.1111/j.1574-6968.1998.tb13151.x; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Porras AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003697; Robertson JS, 1998, BIOLOGICALS, V26, P111, DOI 10.1006/biol.1998.0136; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Schweiger B, 1997, J VIROL METHODS, V67, P45, DOI 10.1016/S0166-0934(97)00075-X; TDR/WHO, 2012, WHO TECHN REP SER, P975; Torrico F, 2017, LANCET INFECT DIS; Valentine-Thon E, 2001, J CLIN MICROBIOL, V39, P4407, DOI 10.1128/JCM.39.12.4407-4412.2001; van Loon AM, 1999, B WORLD HEALTH ORGAN, V77, P217; Weber T, 1997, J VIROL METHODS, V69, P231, DOI 10.1016/S0166-0934(97)00152-3; WHO/CDC/CLSI, 2009, CURR LAB PRACT SER; YenLieberman B, 1996, J CLIN MICROBIOL, V34, P2695, DOI 10.1128/JCM.34.11.2695-2701.1996; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188550	10.1371/journal.pone.0188550	http://dx.doi.org/10.1371/journal.pone.0188550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176887	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900096
J	Smith, LJ; Macleod, KA; Collier, GJ; Horn, FC; Sheridan, H; Aldag, I; Taylor, CJ; Cunningham, S; Wild, JM; Horsley, A				Smith, Laurie J.; Macleod, Kenneth A.; Collier, Guilhem J.; Horn, Felix C.; Sheridan, Helen; Aldag, Ina; Taylor, Chris J.; Cunningham, Steve; Wild, Jim M.; Horsley, Alex			Supine posture changes lung volumes and increases ventilation heterogeneity in cystic fibrosis	PLOS ONE			English	Article							INERT-GAS WASHOUT; CLEARANCE INDEX; COMPUTED-TOMOGRAPHY; TIDAL VOLUME; MULTIPLE; CHILDREN; DISEASE; AIRWAYS; HEIGHT; ADULTS	Introduction Lung Clearance Index (LCI) is recognised as an early marker of cystic fibrosis (CF) lung disease. The effect of posture on LCI however is important when considering longitudinal measurements from infancy and when comparing LCI to imaging studies. Methods 35 children with CF and 28 healthy controls (HC) were assessed. Multiple breath washout (MBW) was performed both sitting and supine in triplicate and analysed for LCI, S-cond, S-acin, and lung volumes. These values were also corrected for the Fowler dead-space to create 'alveolar' indices. Results From sitting to supine there was a significant increase in LCI and a significant decrease in FRC for both CF and HC (p<0.01). LCI, when adjusted to estimate 'alveolar' LCI (LCIalv), increased the magnitude of change with posture for both LCIalv and FRCalv in both groups, with a greater effect of change in lung volume in HC compared with children with CF. The% change in LCIalv for all subjects correlated significantly with lung volume % changes, most notably tidal volume/functional residual capacity (Vt(alv)/FRCalv (r = 0.54, p<0.001)). Conclusion There is a significant increase in LCI from sitting to supine, which we believe to be in part due to changes in lung volume and also increasing ventilation heterogeneity related to posture. This may have implications in longitudinal measurements from infancy to older childhood and for studies comparing supine imaging methods to LCI.	[Smith, Laurie J.; Collier, Guilhem J.; Horn, Felix C.; Wild, Jim M.] Univ Sheffield, Acad Radiol, POLARIS, Sheffield, S Yorkshire, England; [Smith, Laurie J.; Aldag, Ina; Taylor, Chris J.] Sheffield Childrens Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Macleod, Kenneth A.; Sheridan, Helen; Cunningham, Steve] Royal Hosp Sick Children, Edinburgh, Midlothian, Scotland; [Horsley, Alex] Univ Manchester, Resp Res Grp, Div Infect Immun & Resp Med, Manchester, Lancs, England	University of Sheffield; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Manchester	Horsley, A (corresponding author), Univ Manchester, Resp Res Grp, Div Infect Immun & Resp Med, Manchester, Lancs, England.	alexander.horsley@manchester.ac.uk	MacLeod, Kenneth/GWU-8940-2022	Cunningham, Steve/0000-0001-7342-251X; Wild, Jim/0000-0002-7246-8660; Collier, Guilhem/0000-0002-1874-4775; Horsley, Alex/0000-0003-1828-0058	NIHR; Cystic Fibrosis Trust; UK Cystic Fibrosis Gene Therapy Consortium; National Institute for Health Research (NIHR); HEE/NIHR clinical doctoral research fellowship; NIHR Clinician Scientist award; NIHR Professorship award; MRC [MR/M008894/1] Funding Source: UKRI; British Heart Foundation [SP/14/6/31350] Funding Source: researchfish; Medical Research Council [MR/M008894/1] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-012-013, ICA-CDRF-2015-01-027, NIHR-RP-R3-12-027] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Cystic Fibrosis Trust; UK Cystic Fibrosis Gene Therapy Consortium; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); HEE/NIHR clinical doctoral research fellowship; NIHR Clinician Scientist award; NIHR Professorship award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the NIHR; Cystic Fibrosis Trust; UK Cystic Fibrosis Gene Therapy Consortium. LS, AH and JW were supported by the National Institute for Health Research (NIHR), LS was supported by an HEE/NIHR clinical doctoral research fellowship, AH was supported by an NIHR Clinician Scientist award and JW was supported by an NIHR Professorship award. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; de Jong PA, 2006, THORAX, V61, P80, DOI 10.1136/thx.2005.045146; FOWLER WS, 1948, AM J PHYSIOL, V154, P405, DOI 10.1152/ajplegacy.1948.154.3.405; Gronkvist M, 2002, J APPL PHYSIOL, V92, P634, DOI 10.1152/japplphysiol.00161.2001; Gustafsson PM, 2003, PEDIATR PULM, V36, P34, DOI 10.1002/ppul.10310; Haidopoulou K, 2012, RESP PHYSIOL NEUROBI, V180, P247, DOI 10.1016/j.resp.2011.11.016; Hannon D, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000031; Horn FC, 2014, J APPL PHYSIOL, V116, P129, DOI 10.1152/japplphysiol.00378.2013; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley A, 2015, PAEDIATR RESPIR REV, V16, P15, DOI 10.1016/j.prrv.2015.07.010; Horsley A, 2015, RESPIROLOGY, V20, P33, DOI 10.1111/resp.12382; Kee K, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12590; Lum S, 2013, EUR RESPIR J, V41, P1371, DOI 10.1183/09031936.00005512; Marshall H, 2017, THORAX, V72, P760, DOI 10.1136/thoraxjnl-2016-208948; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Poncin W, 2016, J CYSTIC FIBROSIS OF; Prisk GK, 1995, J APPL PHYSL 1985, V78, P597; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raaijmakers L, 2017, J CYSTIC FIBROSIS; Ramsey KA, 2017, J CYSTIC FIBROSIS OF; Ramsey KA, 2016, AM J RESP CRIT CARE, V193, P60, DOI 10.1164/rccm.201507-1409OC; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schmalisch G, 2015, PHYSIOL MEAS, V36, P1601, DOI 10.1088/0967-3334/36/7/1601; Stahl M, 2016, AM J RESP CRITICAL C; Svenningsen S, 2016, EUR RESPIR J, V48, P370, DOI 10.1183/13993003.00393-2016; Theilmann RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157177; Verbanck S, 2011, COMPR PHYSIOL, V1, P809, DOI 10.1002/cphy.c100018; West J.B., 2012, RESP PHYSL ESSENTIAL; Yammine S, 2014, J CYST FIBROS, V13, P190, DOI 10.1016/j.jcf.2013.08.010	31	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188275	10.1371/journal.pone.0188275	http://dx.doi.org/10.1371/journal.pone.0188275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176899	Green Published, gold, Green Accepted			2022-12-26	WOS:000416291900055
J	Legramante, JM; Mastropasqua, M; Susi, B; Porzio, O; Mazza, M; Agrippino, GM; D'Agostini, C; Brandi, A; Giovagnoli, G; Di Lecce, VN; Bernardini, S; Minieri, M				Legramante, Jacopo Maria; Mastropasqua, Maria; Susi, Beniamino; Porzio, Ottavia; Mazza, Marta; Agrippino, Grazia Miranda; D'Agostini, Cartesio; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito Nicola; Bernardini, Sergio; Minieri, Marilena			Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB	PLOS ONE			English	Article							MORTALITY; PROADRENOMEDULLIN; DERIVATION; ADMISSION; PEPTIDE; MARKER; INDEX; TOOL	Aim (i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65. Methods Observational prospective, single-center study in patients with suspected community acquired pneumonia (CAP). Eighty one patients underwent full clinical and laboratory assessment as by protocol, and were followed up a 28 days. Primary endpoints measured were: death, death at 14 days, non-invasive mechanical ventilation (NIMV), endotracheal intubation (EI), ICU admission, overall hospital stay > 10 days, emergency department stay > 4 days. The discriminative performance of MR-pro-ADM and clinical scores was assessed by AUROC analysis. Results The distribution for MR-pro-ADM followed an upward trend, increasing with the increase of both PSI (p<0.001) and CURB65 (p<0.001) classes. However, the difference between MRproADM values and score classes was significant only in the case of CURB65 classes 0 and 1 (p = 0.046), 2 (p = 0.013), and 3 (p = 0.011); and with PSI classes 5, 3 (p = 0.044), and 1 (p = 0.020). As to the differences among variables for the six end-points, MR-pro-ADM values in the two groups selected for each considered end-point differed in a statistically significant manner for all endpoints. Both PSI and CURB65 differed significantly for all end-points, except for stay in the ED longer than 4 days and the hospital stay longer than 10 days and endotracheal intubation (only PSI classes differed with statistical significance). ROC analyses evidenced that MR-pro-ADM values gave the greatest AUC for the prediction of death, endotracheal intubation, hospital stay >10 days and DE stay >4 days, compared to the PSI and CURB (though difference not statistically significant). For each endpoint measured, the best thresholds values for Mr-pro-ADM were: 1.6 (specificity 76.5%; sensitivity 77.8%) for death; 2.5 (specificity 88.9%; sensitivity 80.0%) for death at 14 days; 1.5 (specificity 77.0%; sensitivity 87.5%) for NIMV; 2.4 (specificity 88.7%; sensitivity 83.3%) for endotracheal intubation; 0.9 (specificity 53.5%; sensitivity 70.6%) for DE stay greater than 4 days; 1.9 (specificity 82.1%; sensitivity 55.3%) for hospital stay greater than 10 days. The AUC for the combination of MR-pro-ADM and PSI was 81.29% [63.41%-99.17%], but not in a statistically significant manner compared to the AUCs of the single predictors. Conversely, the AUC for the combination of MR-pro-ADM and CURB65 was 87.58% [75.54%-99.62%], which was significantly greater than the AUC of CURB65 (p = 0.047) or PSI (p = 0.017) alone. Conclusions The present study confirms that assessment of MR-pro-ADM levels in CAP patients in addition to CURB scores increases the prognostic accuracy of CURB alone and may help rule out discrepancies arising from flawed clinical severity classification. With particular reference to patients scoring in the upper classes of CURB and PSI, MR-pro-ADM values provided additional information towards a better risk stratification of those patients. In particular, our results pointed towards two MR-pro-ADM threshold values that appear to predict with a good degree of accuracy the patient's need for non-invasive mechanical ventilation, endotracheal intubation, or intensive care. This aspect, however, deserves further investigation.	[Legramante, Jacopo Maria; Mastropasqua, Maria; Susi, Beniamino; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito Nicola] Policlin Tor Vergata, Emergency Dept, Rome, Italy; [Legramante, Jacopo Maria] Univ Tor Vergata, Dept Med Syst, Rome, Italy; [Porzio, Ottavia] Osped Pediat Bambino Gesu, IRCCS, Clin Lab, Rome, Italy; [Porzio, Ottavia; Bernardini, Sergio; Minieri, Marilena] Univ Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Mazza, Marta] Osped Maria Vittoria, Med & Chirurg Accettaz & Urgenza, Turin, Italy; [Agrippino, Grazia Miranda] AOU Careggi, Med Alta Complessita Assistenziale 3, Florence, Italy; [D'Agostini, Cartesio] Policlin Tor Vergata, Lab Clin Microbiol, Rome, Italy; [Bernardini, Sergio; Minieri, Marilena] Policlin Tor Vergata, Dept Lab Med, Lab Clin Biochem, Rome, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; IRCCS Bambino Gesu; University of Rome Tor Vergata; Maria Vittoria Hospital; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Legramante, JM (corresponding author), Policlin Tor Vergata, Emergency Dept, Rome, Italy.; Legramante, JM (corresponding author), Univ Tor Vergata, Dept Med Syst, Rome, Italy.	legraman@uniroma2.it	Minieri, Marilena/AAD-1763-2020; Minieri, Marilena/ABC-4897-2021	MINIERI, MARILENA/0000-0002-2512-4793; PORZIO, OTTAVIA/0000-0001-5931-8679				Albrich WC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-112; Alcoba G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1095-5; Aujesky D, 2008, CLIN INFECT DIS, V47, pS133, DOI 10.1086/591394; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; Blasi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-44; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Courtais C, 2013, AM J EMERG MED, V31, P215, DOI 10.1016/j.ajem.2012.07.017; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng JC, 2005, CLIN CHEST MED, V26, P1, DOI 10.1016/j.ccm.2004.10.009; Espana P, 2014, J INFECT; Fine M, 1997, NEW ENGL J MED, V336, P240; Heron M., 2009, NATL VITAL STAT REPO, V57, P1; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hirata Y, 1996, J CLIN ENDOCR METAB, V81, P1449, DOI 10.1210/jc.81.4.1449; Huang DT, 2009, CHEST, V136, P823, DOI 10.1378/chest.08-1981; Ioachimescu OC, 2004, INT J ANTIMICROB AG, V24, P485, DOI 10.1016/j.ijantimicag.2004.05.006; Jain Saransh, 2014, BMC Res Notes, V7, P458, DOI 10.1186/1756-0500-7-458; KELLY BJ, 1993, CHEST, V104, P1818, DOI 10.1378/chest.104.6.1818; Khan F, 2016, COMMUNITY ACQUIR INF, V3, P36; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Koutroulis I, 2014, INT SCHOLARLY RES NO; Kutz A, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-102; Lamy Olivier, 2004, Eur J Intern Med, V15, P28, DOI 10.1016/j.ejim.2003.11.003; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Magrini L, 2013, EUR REV MED PHARMACO, V17, P133; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pieralli Filippo, 2015, J Clin Med Res, V7, P706, DOI 10.14740/jocmr2251w; Rodriguez A, 2009, INTENS CARE MED, V35, P430, DOI 10.1007/s00134-008-1363-6; Roson B, 2001, CLIN INFECT DIS, V33, P158, DOI 10.1086/321808; Suberviola B, 2012, SWISS MED WEEKLY, P142; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; Tanenao E, 2001, PEPTIDES, V22, P1693; Travaglino F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-184; Valenzuela-Sanchez F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.65	39	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187702	10.1371/journal.pone.0187702	http://dx.doi.org/10.1371/journal.pone.0187702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161297	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000018
J	Sobhkhez, M; Krasnov, A; Chang, CJ; Robertsen, B				Sobhkhez, Mehrdad; Krasnov, Aleksej; Chang, Chia Jung; Robertsen, Borre			Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus	PLOS ONE			English	Article							HEMATOPOIETIC NECROSIS VIRUS; ATLANTIC SALMON; RAINBOW-TROUT; CHEMOKINE RECEPTORS; B-CELLS; IMMUNE-RESPONSES; MX1 PROMOTER; T-CELLS; INTERFERON; EXPRESSION	A previous study showed that a plasmid expressing IFNa (pIFNa) strongly enhanced protection and antibody production of a DNA vaccine against infectious salmon anemia virus (ISAV) in Atlantic salmon. The vaccine consisted of a plasmid (pHE) expressing the virus hemagglutinin-esterase as an antigen. To increase the understanding of the adjuvant effect of pIFNa, we here compared transcriptome responses in salmon muscle at the injection site at week 1 and 2 after injection of pIFNa, pHE, plasmid control (pcDNA3.3) and PBS, respectively. The results showed that the IFNa plasmid mediates an increase in gene transcripts of at least three major types in the muscle; typical IFN-I induced genes (ISGs), certain chemokines and markers of B-cells, T-cells and antigen-presenting cells. The latter suggests recruitment of cells to the plasmid injection site. Attraction of lymphocytes was likely caused by the induction of chemokines homologous to mammalian CCL5, CCL8, CCL19 and CXCL10. IFN may possibly also co-stimulate activation of lymphocytes as suggested by studies in mammals. A major finding was that both pcDNA3.3 and pHE caused responses similar to pIFNa, but at lower magnitude. Plasmid DNA may thus by itself have adjuvant activity as observed in mammalian models. Notably, pHE had a lower effect on many immune genes including ISGs and chemokines than pcDNA3.3, which suggests an inhibitory effect of HE expression on the immune genes. This hypothesis was supported by an Mx-reporter assay. The present study thus suggests that a main role for pIFNa as adjuvant in the DNA vaccine against ISAV may be to overcome the inhibitory effect of HE-expression on plasmid-induced ISGs and chemokines.	[Sobhkhez, Mehrdad; Chang, Chia Jung; Robertsen, Borre] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Krasnov, Aleksej] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway	UiT The Arctic University of Tromso; Nofima	Robertsen, B (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway.	borre.robertsen@uit.no	Chang, Chia-Jung/AAX-2264-2020	Chang, Chia-Jung/0000-0002-4945-5802	Aquaculture programme of the Research Council of Norway [237315/E40, 254907/E40]; Research Council of Norway; Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Aquaculture programme of the Research Council of Norway; Research Council of Norway(Research Council of Norway); Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Borre Robertsen received funding from the Aquaculture programme of the Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906), grants no. 237315/E40 and 254907/E40. NOFIMA AS (https://nofima.no/en/research/) provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NOFIMA AS is a non-profit research institution supported by grants from the following sources: The Research Council of Norway; The Ministry of Trade, Industry and Fisheries; The Norwegian Seafood Research Fund (FHF).; This work was funded by the Aquaculture Programme of the Research Council of Norway, grants no. 237315/E40 and 254907/E40.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Chang CJ, 2016, FISH SHELLFISH IMMUN, V57, P35, DOI 10.1016/j.fsi.2016.08.020; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Coban C, 2013, HUM VACC IMMUNOTHER, V9, P2216, DOI 10.4161/hv.25893; Collet B, 2004, DEV COMP IMMUNOL, V28, P793, DOI 10.1016/j.dci.2003.12.005; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683; Grimholt U, 2015, DEV COMP IMMUNOL, V49, P79, DOI 10.1016/j.dci.2014.11.009; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Jorgensen SM, 2006, FISH SHELLFISH IMMUN, V21, P548, DOI 10.1016/j.fsi.2006.03.004; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Krasnov A, 2011, MOL IMMUNOL, V49, P163, DOI 10.1016/j.molimm.2011.08.007; Krasnov A, 2011, COMP BIOCHEM PHYS D, V6, P31, DOI 10.1016/j.cbd.2010.04.006; Kurath G, 2008, REV SCI TECH OIE, V27, P175, DOI 10.20506/rst.27.1.1793; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Liu Y, 2008, DEV COMP IMMUNOL, V32, P26, DOI 10.1016/j.dci.2007.03.015; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Seppola M, 2007, DEV COMP IMMUNOL, V31, P156, DOI 10.1016/j.dci.2006.05.009; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shirota H, 2007, J IMMUNOL, V179, P329, DOI 10.4049/jimmunol.179.1.329; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Syed M, 2003, MAR BIOTECHNOL, V5, P253, DOI 10.1007/s10126-002-0063-4; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; van Hateren Andy, 2017, F1000Res, V6, P158, DOI 10.12688/f1000research.10474.1; Xu C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1302-1	42	14	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188456	10.1371/journal.pone.0188456	http://dx.doi.org/10.1371/journal.pone.0188456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161315	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000057
J	Trewin, AJ; Levinger, I; Parker, L; Shaw, CS; Serpiello, FR; Anderson, MJ; McConell, GK; Hare, DL; Stepto, NK				Trewin, Adam J.; Levinger, Itamar; Parker, Lewan; Shaw, Christopher S.; Serpiello, Fabio R.; Anderson, Mitchell J.; McConell, Glenn K.; Hare, David L.; Stepto, Nigel K.			Acute exercise alters skeletal muscle mitochondrial respiration and H2O2 emission in response to hyperinsulinemic-euglycemic clamp in middle-aged obese men	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; INSULIN SENSITIVITY; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; TBC1D1 PHOSPHORYLATION; AS160 PHOSPHORYLATION; SIGNALING PATHWAYS; PROTEIN-SYNTHESIS; ATP PRODUCTION; IN-VIVO	Obesity, sedentary lifestyle and aging are associated with mitochondrial dysfunction and impaired insulin sensitivity. Acute exercise increases insulin sensitivity in skeletal muscle; however, whether mitochondria are involved in these processes remains unclear. The aim of this study was to investigate the effects of insulin stimulation at rest and after acute exercise on skeletal muscle mitochondrial respiratory function (JO(2)) and hydrogen peroxide emission (JH(2)O(2)), and the associations with insulin sensitivity in obese, sedentary men. Nine men (means +/- SD: 57 +/- 6 years; BMI 33 +/- 5 kg. m(2)) underwent hyperinsulinemic-euglycemic clamps in two separate trials 1-3 weeks apart: one under resting conditions, and another 1 hour after high-intensity exercise (4x4 min cycling at 95% HRpeak). Muscle biopsies were obtained at baseline, and pre/post clamp to measure JO(2) with high-resolution respirometry and JH(2)O(2) via Amplex UltraRed from permeabilized fibers. Post-exercise, both JO(2) and JH(2)O(2) during ADP stimulated state-3/OXPHOS respiration were lower compared to baseline (P<0.05), but not after subsequent insulin stimulation. JH(2)O(2) was lower post-exercise and after subsequent insulin stimulation compared to insulin stimulation in the rest trial during succinate supported state-4/leak respiration (P<0.05). In contrast, JH(2)O(2) increased during complex-I supported leak respiration with insulin after exercise compared with resting conditions (P<0.05). Resting insulin sensitivity and JH(2)O(2) during complex-I leak respiration were positively correlated (r = 0.77, P<0.05). We conclude that in obese, older and sedentary men, acute exercise modifies skeletal muscle mitochondrial respiration and H2O2 emission responses to hyperinsulinemia in a respiratory state-specific manner, which may have implications for metabolic diseases involving insulin resistance.	[Trewin, Adam J.; Levinger, Itamar; Parker, Lewan; Shaw, Christopher S.; Serpiello, Fabio R.; Anderson, Mitchell J.; McConell, Glenn K.; Stepto, Nigel K.] Victoria Univ, ISEAL, Melbourne, Vic, Australia; [Levinger, Itamar; Stepto, Nigel K.] Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Australia; [Parker, Lewan; Shaw, Christopher S.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Hare, David L.] Univ Melbourne, Melbourne, Vic, Australia; [Hare, David L.] Austin Hlth, Dept Cardiol, Melbourne, Vic, Australia; [Stepto, Nigel K.] Monash Univ, MCHRI, Clayton, Vic, Australia; [Stepto, Nigel K.] Monash Hlth, Clayton, Vic, Australia; [Trewin, Adam J.] Univ Rochester, Med Ctr, Dept Anesthesiol & Perioperat Med, Rochester, NY 14642 USA	Victoria University; Victoria University; Deakin University; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Rochester	Stepto, NK (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic, Australia.; Stepto, NK (corresponding author), Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Australia.; Stepto, NK (corresponding author), Monash Univ, MCHRI, Clayton, Vic, Australia.; Stepto, NK (corresponding author), Monash Hlth, Clayton, Vic, Australia.	Nigel.Stepto@vu.edu.au	Trewin, Adam/M-1584-2019	Trewin, Adam/0000-0001-7322-4054; McConell, Glenn/0000-0002-8572-9065; Levinger, Itamar/0000-0001-9194-2033; Stepto, Nigel/0000-0002-0875-6836; Parker, Lewan/0000-0002-5372-1851	Victoria University Research Development Grant Scheme; Australian Government through the National Collaborative Research Network Grant Scheme	Victoria University Research Development Grant Scheme; Australian Government through the National Collaborative Research Network Grant Scheme	This research was funded by the Victoria University Research Development Grant Scheme (I.L., D.L.H. and G.K.M.) This funding was from the authors institution and they had no input into study design and data analysis. They have no embargo on publication of results. Two authors received funding to support their salaries to undertake this investigator initiated research. I.L. is a Heart Foundation Future Leader Fellow (ID No.100040). N.K.S. was supported by the Australian Government through the National Collaborative Research Network Grant Scheme.	Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Barazzoni R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1117, DOI 10.1152/ajpendo.00067.2012; Brand MD, 2016, CELL METABOLISM; Campbell PT, 2010, MED SCI SPORT EXER, V42, P1448, DOI 10.1249/MSS.0b013e3181cfc908; Chow LS, 2016, DIABETOLOGIA, P1; ConstantinTeodosiu D, 1996, EUR J APPL PHYSIOL, V73, P186, DOI 10.1007/BF00262830; COSTILL DL, 1988, J APPL PHYSIOL, V64, P2245, DOI 10.1152/jappl.1988.64.5.2245; Fabbri E, 2016, DIABETES; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fisher-Wellman KH, 2014, DIABETES, V63, P132, DOI 10.2337/db13-0940; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GOLLNICK PD, 1990, PFLUG ARCH EUR J PHY, V415, P407, DOI 10.1007/BF00373617; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Green HJ, 2008, J APPL PHYSIOL, V104, P931, DOI 10.1152/japplphysiol.01151.2007; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hickey AJR, 2012, J COMP PHYSIOL B, V182, P91, DOI 10.1007/s00360-011-0599-6; Hordern MD, 2012, J SCI MED SPORT, V15, P25, DOI 10.1016/j.jsams.2011.04.005; Howlett KF, 2008, AM J PHYSIOL-ENDOC M, V294, pE401, DOI 10.1152/ajpendo.00542.2007; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Kramer PA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00347; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Levinger I, 2007, DIABETES CARE, V30, P2205, DOI 10.2337/dc07-0841; Levinger I, 2014, J BONE MINER RES, V29, P2571, DOI 10.1002/jbmr.2285; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Makrecka-Kuka M, 2015, BIOMOLECULES, V5, P1319, DOI 10.3390/biom5031319; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Parker L, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00087; Parker L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171613; Parker L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00411; Perry CGR, 2012, J PHYSIOL-LONDON, V590, P5475, DOI 10.1113/jphysiol.2012.234682; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stephenson EJ, 2012, J APPL PHYSIOL, V113, P1403, DOI 10.1152/japplphysiol.00788.2012; Stephenson EJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1541, DOI 10.1152/ajpendo.00590.2011; Stepto NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053080; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Timpani C. A., 2016, NEUROTHERAPEUTICS, P1; Tonkonogi M, 1998, J PHYSIOL-LONDON, V510, P279, DOI 10.1111/j.1469-7793.1998.279bz.x; Tonkonogi M, 1999, PFLUG ARCH EUR J PHY, V437, P562, DOI 10.1007/s004240050818; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Trewin AJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE388, DOI 10.1152/ajpendo.00605.2014; Votion DM, 2010, EQUINE VET J, V42, P268, DOI 10.1111/j.2042-3306.2010.00271.x; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Zhao XL, 2014, J PROTEOME RES, V13, P2359, DOI 10.1021/pr401163t; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	67	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188421	10.1371/journal.pone.0188421	http://dx.doi.org/10.1371/journal.pone.0188421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161316	Green Published, gold, Green Accepted			2022-12-26	WOS:000415987000053
J	Hoermann, R; Midgley, JEM; Larisch, R; Wolfgang, J; Dietrich, C				Hoermann, Rudolf; Midgley, John Edward Maurice; Larisch, Rolf; Wolfgang, Johannes; Dietrich, Christian			Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxine	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; FREE T4 RELATIONSHIP; FEEDBACK-CONTROL; MATHEMATICAL-MODEL; REFERENCE RANGE; TSH; HORMONE; AGE; ASSOCIATION; GUIDELINES	Introduction The relationship between pituitary TSH and thyroid hormones is central to our understanding of thyroid physiology and thyroid function testing. Here, we generated distribution patterns by using validated tools of thyroid modelling. Methods We simulated patterns of individual set points under various conditions, based on a homeostatic model of thyroid feedback control. These were compared with observed data points derived from clinical trials. Results A random mix of individual set points was reconstructed by simulative modelling with defined structural parameters. The pattern displayed by the cluster of hypothetical points resembled that observed in a natural control group. Moderate variation of the TSH-FT4 gradient over the functional range introduced further flexibility, implementing a scenario of adaptive set points. Such a scenario may be a realistic possibility for instance in treatment where relationships and equilibria between thyroid parameters are altered by various influences such as LT4 dose and conversion efficiency. Conclusions We validated a physiologically based homeostatic model that permits simulative reconstruction of individual set points. This produced a pattern resembling the observed data under various conditions. Applied modelling, although still experimental at this stage, shows a potential to aid our physiological understanding of the interplay between TSH and thyroid hormones. It should eventually benefit personalised clinical decision making.	[Hoermann, Rudolf; Larisch, Rolf] Klinikum Ludenscheid, Dept Nucl Med, Paulmannshoherstr, Ludenscheid, Germany; [Midgley, John Edward Maurice] North Lakes Clin, 20 Wheatley Ave, Ilkley, England; [Dietrich, Christian] Ruhr Univ Bochum, Med Dept 1, Endocrinol & Diabetol, Bergmannsheil Univ Hosp, Bochum, Germany; [Dietrich, Christian] Ruhr Univ Bochum, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany; [Dietrich, Christian] Witten Herdecke Univ, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Dietrich, C (corresponding author), Ruhr Univ Bochum, Med Dept 1, Endocrinol & Diabetol, Bergmannsheil Univ Hosp, Bochum, Germany.; Dietrich, C (corresponding author), Ruhr Univ Bochum, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany.; Dietrich, C (corresponding author), Witten Herdecke Univ, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany.	johannes.dietrich@ruhr-uni-bochum.de	Dietrich, Johannes W./C-3498-2009	Dietrich, Johannes W./0000-0002-1185-3549; Hoermann, Rudolf/0000-0002-1326-4270	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sanofi-Henning; Hexal AG; Bristol-Myers Squibb; Pfizer	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sanofi-Henning; Hexal AG; Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. JWD received funding and personal fees by Sanofi-Henning, Hexal AG, Bristol-Myers Squibb and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2003, THYROID, V13, P1069, DOI 10.1089/105072503770867237; [Anonymous], 2021, LANG ENV STAT COMP; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Benhadi N, 2010, EUR J ENDOCRINOL, V162, P323, DOI 10.1530/EJE-09-0655; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Chatzitomaris A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00163; Clark PM, 2012, J CLIN PATHOL, V65, P463, DOI 10.1136/jclinpath-2011-200433; De Grande LAC, 2015, EUR THYROID J, V4, P69, DOI 10.1159/000369796; Dietrich JW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00057; Dietrich JW, 2015, LANCET DIABETES ENDO, V3, P932, DOI 10.1016/S2213-8587(15)00421-0; Dietrich JW, 2012, J THROID RES, V2012, DOI 10.1155/2012/351864; Dietrich Johannes W, 2008, BMC Endocr Disord, V8, P13, DOI 10.1186/1472-6823-8-13; Dietrich JW, 2004, CYBERNET SYST, V35, P315, DOI 10.1080/01969720490443354; Dietrich JW, 2016, SCHILDDRUSE 2015, P107; Dietrich JW., 2006, CYBERNET SYST, V2006, P269; Dietrich JW., 2001, HYPOPHYSEN SCHILDDR, V2, DOI [10.13140/RG.2.1.4845.9368, DOI 10.13140/RG.2.1.4845.9368]; Eisenberg M, 2008, THYROID, V18, P1071, DOI 10.1089/thy.2007.0388; Fitzgerald SP, 2016, J THROID RES, V2016, DOI 10.1155/2016/6351473; Fliers E, 2014, EUR J ENDOCRINOL, V171, pR197, DOI 10.1530/EJE-14-0285; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Goede SL, 2014, B MATH BIOL, V76, P1270, DOI 10.1007/s11538-014-9955-5; Goede SL, 2014, MATH BIOSCI, V249, P1, DOI 10.1016/j.mbs.2014.01.001; Goede SL, 2013, WIPO number WO/2014/088516, Patent No. 2014088516; Goede SL, 2016, J CLIN ENDOCR METAB, V101, pL56; Hadlow NC, 2013, J CLIN ENDOCR METAB, V98, P2936, DOI 10.1210/jc.2012-4223; Hoermann R, 2015, HORM METAB RES, V47, P674, DOI 10.1055/s-0034-1398616; Hoermann R, 2012, J THYROID RES, V2012, P1, DOI [10.1089/thy.2008.0155, DOI 10.1089/THY.2008.0155]; Hoermann R, 2017, J ENDOCR SOC, V1, P874, DOI 10.1210/js.2017-00057; Hoermann R, 2017, THER ADV ENDOCRINOL, V8, P83, DOI 10.1177/2042018817716401; Hoermann R, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00142; Hoermann R, 2016, EUR THYROID J, V5, P171, DOI 10.1159/000447967; Hoermann R, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00177; Hoermann R, 2016, EUR J ENDOCRINOL, V174, P735, DOI 10.1530/EJE-16-0031; Hoermann R, 2014, CLIN ENDOCRINOL, V81, P907, DOI 10.1111/cen.12527; Hoermann R, 2013, EUR J ENDOCRINOL, V168, P271, DOI 10.1530/EJE-12-0819; Hoermann R, 2010, EUR J ENDOCRINOL, V162, P1123, DOI 10.1530/EJE-10-0106; Ito M, 2017, THYROID, V27, P484, DOI 10.1089/thy.2016.0426; Ito M, 2015, EUR J ENDOCRINOL, V173, P333, DOI 10.1530/EJE-15-0138; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Larisch R, 2015, NUKLEARMED-NUCL MED, V54, P112, DOI 10.3413/Nukmed-0671-14-06; Laurberg P, 2011, NAT REV ENDOCRINOL, V7, P232, DOI 10.1038/nrendo.2011.13; Leow MKS, 2007, J THEOR BIOL, V248, P275, DOI 10.1016/j.jtbi.2007.05.016; Leow MKS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00064; Leow MKS, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-35; Mariotti S, 2011, NORMAL PHYSL HYPOTHA, P1; McAninch EA, 2015, LANCET DIABETES ENDO, V3, P756, DOI 10.1016/S2213-8587(15)00325-3; Midgley John E M, 2016, J Clin Endocrinol Metab, V101, pL40, DOI 10.1210/jc.2016-1115; Midgley JEM, 2015, ENDOCR CONNECT, V4, P196, DOI [10.1530/EC-150056, 10.1530/EC-15-0056]; Midgley JEM, 2013, J CLIN PATHOL, V66, P335, DOI 10.1136/jclinpath-2012-201213; REICHLIN S, 1967, J CLIN ENDOCR METAB, V27, P251, DOI 10.1210/jcem-27-2-251; Rothacker KM, 2016, J CLIN ENDOCR METAB, V101, P1151, DOI 10.1210/jc.2015-4011; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Soetaert K, 2009, PRACTICAL GUIDE ECOL, P1; Strich D, 2016, EUR J ENDOCRINOL, V175, P49, DOI 10.1530/EJE-16-0007; van Deventer HE, 2011, CLIN CHEM, V57, P122, DOI 10.1373/clinchem.2010.154088; Winther KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156925	56	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187232	10.1371/journal.pone.0187232	http://dx.doi.org/10.1371/journal.pone.0187232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155897	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700008
J	Schumacher, MM; Jun, DJ; Johnson, BM; DeBose-Boyd, RA				Schumacher, Marc M.; Jun, Dong-Jae; Johnson, Brittany M.; DeBose-Boyd, Russell A.			UbiA prenyltransferase domain-containing protein-1 modulates HMG-CoA reductase degradation to coordinate synthesis of sterol and nonsterol isoprenoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic reticulum-associated protein degradation (ERAD); Golgi; cholesterol metabolism; isoprenoid	COENZYME-A REDUCTASE; CRYSTALLINE CORNEAL-DYSTROPHY; ENDOPLASMIC-RETICULUM; ACCELERATED DEGRADATION; FEEDBACK-REGULATION; HUMAN FIBROBLASTS; MESSENGER-RNA; TARGET GENES; CHOLESTEROL; CELLS	UBIAD1 (UbiA prenyltransferase domain-containing protein-1) utilizes geranylgeranyl pyrophosphate (GGpp) to synthesize vitamin K-2. We previously reported that sterols stimulate binding of UBIAD1 to endoplasmic reticulum (ER)-localized 3-hydroxy-3-methylglutaryl (HMG) CoA reductase. UBIAD1 binding inhibits sterol-accelerated, ER-associated degradation (ERAD) of reductase, one of several mechanisms for feedback control of this rate-limiting enzyme in the branched pathway that produces cholesterol and nonsterol isoprenoids such as GGpp. Accumulation of GGpp in ER membranes triggers release of UBIAD1 from reductase, permitting its maximal ERAD and ER-to-Golgi transport of UBIAD1. Mutant UBIAD1 variants associated with Schnyder corneal dystrophy (SCD), a human disorder characterized by corneal accumulation of cholesterol, resist GGpp-induced release from reductase and remain sequestered in the ER to block reductase ERAD. Using lines of genetically manipulated cells, we now examine consequences of UBIAD1 deficiency and SCD-associated UBIAD1 on reductase ERAD and cholesterol synthesis. Our results indicated that reductase becomes destabilized in the absence of UBIAD1, resulting in reduced cholesterol synthesis and intracellular accumulation. In contrast, an SCD-associated UBIAD1 variant inhibited reductase ERAD, thereby stabilizing the enzyme and contributing to enhanced synthesis and intracellular accumulation of cholesterol. Finally, we present evidence that GGpp-regulated, ER-to-Golgi transport enables UBIAD1 to modulate reductase ERAD such that synthesis of nonsterol isoprenoids is maintained in sterol-replete cells. These findings further establish UBIAD1 as a central player in the reductase ERAD pathway and regulation of isoprenoid synthesis. They also indicate that UBIAD1-mediated inhibition of reductase ERAD underlies cholesterol accumulation associated with SCD.	[Schumacher, Marc M.; Jun, Dong-Jae; Johnson, Brittany M.; DeBose-Boyd, Russell A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Schumacher, Marc/0000-0002-5527-4215	National Institutes of Health [HL020948, GM112409]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL020948 and GM112409 (to R. D. B.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1980, J LIPID RES, V21, P505; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang S, 2017, J BIOL CHEM, V292, P9382, DOI 10.1074/jbc.M117.788562; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Liu SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147306; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Schumacher MM, 2016, J LIPID RES, V57, P1286, DOI 10.1194/jlr.M068759; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	33	16	16	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					312	323		10.1074/jbc.RA117.000423	http://dx.doi.org/10.1074/jbc.RA117.000423			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29167270	Green Published, hybrid			2022-12-26	WOS:000419453200026
J	Arnold, JC; Cantu, MA; Kasanga, EA; Nejtek, VA; Papa, EV; Bugnariu, N; Salvatore, MF				Arnold, Jennifer C.; Cantu, Mark A.; Kasanga, Ella A.; Nejtek, Vicki A.; Papa, Evan V.; Bugnariu, Nicoleta; Salvatore, Michael F.			Aging-related limit of exercise efficacy on motor decline	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE PHOSPHORYLATION; QUALITY-OF-LIFE; PARKINSONS-DISEASE; PHYSICAL-ACTIVITY; OLDER-ADULTS; COMMUNITY POPULATION; NIGRAL GFR-ALPHA-1; GAIT PERFORMANCE; DOPAMINE; MIDLIFE	Identifying lifestyle strategies and allied neurobiological mechanisms that reduce aging related motor impairment is imperative, given the accelerating number of retirees and increased life expectancy. A physically active lifestyle prior to old age can reduce risk of debilitating motor decline. However, if exercise is initiated after motor decline has begun in the lifespan, it is unknown if aging itself may impose a limit on exercise efficacy to decelerate further aging-related motor decline. In Brown-Norway/Fischer 344 F-1 hybrid (BNF) rats, locomotor activity begins to decrease in middle age (12-18 months). One mechanism of aging-related motor decline may be decreased expression of GDNF family receptor, GFR alpha-1, which is decreased in substantia nigra (SN) between 12 and 30 months old. Moderate exercise, beginning at 18 months old, increases nigral GFR alpha-1 and tyrosine hydroxylase (TH) expression within 2 months. In aged rats, replenishing aging-related loss of GFR alpha-1 in SN increases TH in SN alone and locomotor activity. A moderate exercise regimen was initiated in sedentary male BNF rats in a longitudinal study to evaluate if exercise could attenuate aging-related motor decline when initiated at two different ages in the latter half of the lifespan (18 or 24 months old). Motor decline was reversed in the 18-, but not 24-month-old, cohort. However, exercise efficacy in the 18-month-old group was reduced as the rats reached 27 months old. GFR alpha-1 expression was not increased in either cohort. These studies suggest exercise can decelerate motor decline when begun in the latter half of the life span, but its efficacy may be limited by age of initiation. Decreased plasticity of GFR alpha-1 expression following exercise may limit its efficacy to reverse motor decline.	[Arnold, Jennifer C.; Salvatore, Michael F.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Arnold, Jennifer C.] NYU, Sch Med, Dept Neurosurg, New York, NY USA; [Cantu, Mark A.; Kasanga, Ella A.; Nejtek, Vicki A.; Salvatore, Michael F.] Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Ft Worth, TX 76203 USA; [Cantu, Mark A.; Kasanga, Ella A.; Salvatore, Michael F.] Univ North Texas, Hlth Sci Ctr, Ctr Neurosci Discovery, Ft Worth, TX 76203 USA; [Nejtek, Vicki A.] Univ North Texas, Hlth Sci Ctr, Ctr Alzheimers & Neurodegenerat Dis Res, Ft Worth, TX USA; [Papa, Evan V.] Idaho State Univ, Meridian Hlth Sci Ctr, Dept Phys & Occupat Therapy, Meridian, ID USA; [Bugnariu, Nicoleta] Univ North Texas, Hlth Sci Ctr, Sch Hlth Profess, Ft Worth, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; New York University; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Idaho; Idaho State University; University of North Texas System; University of North Texas Denton	Salvatore, MF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.; Salvatore, MF (corresponding author), Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Ft Worth, TX 76203 USA.; Salvatore, MF (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Neurosci Discovery, Ft Worth, TX 76203 USA.	Michael.Salvatore@unthsc.edu	Salvatore, Michael/ABC-8926-2021	Papa, Evan/0000-0002-5013-3018	National Institute on Aging [AG040261]; NATIONAL INSTITUTE ON AGING [R01AG040261] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was fully funded by a grant award (AG040261) by the National Institute on Aging to MF Salvatore. The funder had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Abercrombie E. D., 1995, PSYCHOPHARMACOLOGY 4, P355; Arnold JC, 2014, JOVE-J VIS EXP, DOI 10.3791/51827; Arnold JC, 2016, ACS CHEM NEUROSCI, V7, P227, DOI 10.1021/acschemneuro.5b00282; Batra A, 2016, J AGING PHYS ACTIV, V24, P649, DOI 10.1123/japa.2015-0281; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Buchman AS, 2007, J AM GERIATR SOC, V55, P11, DOI 10.1111/j.1532-5415.2006.01032.x; Buchman AS, 2016, NEUROLOGY, V87, P1036, DOI 10.1212/WNL.0000000000003059; Buchman AS, 2012, ANN NEUROL, V71, P258, DOI 10.1002/ana.22588; Carvalho A, 2015, CLIN INTERV AGING, V10, P183, DOI 10.2147/CIA.S68779; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; Denison HJ, 2013, J AM GERIATR SOC, V61, P1034, DOI 10.1111/jgs.12286; Egerton T, 2016, J GERONTOL A-BIOL, V71, P670, DOI 10.1093/gerona/glv150; Emborg ME, 1998, J COMP NEUROL, V401, P253; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fleischman DA, 2007, EXP AGING RES, V33, P59, DOI 10.1080/03610730601006370; Grondin R, 2003, J NEUROSCI, V23, P1974; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Hawley-Hague H, 2016, J AGING PHY ACT, V24, P649; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; Herman T, 2007, ARCH PHYS MED REHAB, V88, P1154, DOI 10.1016/j.apmr.2007.05.015; Hillsdon MM, 2005, AM J PREV MED, V28, P245, DOI 10.1016/j.amepre.2004.12.008; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Keysor JJ, 2001, J GERONTOL A-BIOL, V56, pM412, DOI 10.1093/gerona/56.7.M412; Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921; Manini TM, 2016, BRIT J SPORT MED, V43, P28; Manty M, 2015, PSYCHOSOM MED, V77, P823, DOI 10.1097/PSY.0000000000000214; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; Matsuo A, 2000, BRAIN RES, V859, P57, DOI 10.1016/S0006-8993(99)02442-7; McCullough MJ, 2013, NEUROSCIENCE, V240, P258, DOI 10.1016/j.neuroscience.2013.02.063; Murray AM, 2004, J GERONTOL A-BIOL, V59, P864; Musich S, 2017, POPUL HEALTH MANAG, V20, P199, DOI 10.1089/pop.2016.0071; Nadeau A, 2014, MED SCI SPORT EXER, V46, P645, DOI 10.1249/MSS.0000000000000144; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Patel KV, 2006, AM J PREV MED, V31, P217, DOI 10.1016/j.amepre.2006.05.005; Peacock CA, 2014, AGING CLIN EXP RES, V26, P403, DOI 10.1007/s40520-013-0189-4; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Pruett BS, 2013, MOL NEUROBIOL, V47, P988, DOI 10.1007/s12035-013-8397-7; Pruett BS, 2010, J NEUROCHEM, V115, P707, DOI 10.1111/j.1471-4159.2010.06963.x; Ridgel AL, 2009, NEUROREHAB NEURAL RE, V23, P600, DOI 10.1177/1545968308328726; Rosano C, 2012, J GERONTOL A-BIOL, V67, P957, DOI 10.1093/gerona/glr262; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Salvatore MF, 2004, J NEUROCHEM, V90, P245, DOI 10.1111/j.1471-4159.2004.02496.x; Salvatore MF, 2017, J GERONTOL BIOL SCI; Salvatore MF, 2016, NEUROBIOL AGING, V37, P192, DOI 10.1016/j.neurobiolaging.2015.10.006; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Santos D, 2017, J GERONTOL BIOL SCI; Savela SL, 2010, ARCH INTERN MED, V170, P1171, DOI 10.1001/archinternmed.2010.187; Seldeen KL, 2017, J GERONTOL BIOL SCI; Shen X, 2016, NEUROREHAB NEURAL RE, V30, P512, DOI 10.1177/1545968315613447; Skalicky M, 1996, MECH AGEING DEV, V87, P127, DOI 10.1016/0047-6374(96)01707-1; Smith AD, 2003, EXP NEUROL, V184, P31, DOI 10.1016/j.expneurol.2003.08.017; Smith BA, 2011, BRAIN RES, V1386, P70, DOI 10.1016/j.brainres.2011.02.003; Stenholm S, 2016, J GERONTOL A; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; U.S. Department of Health and Human Services National Heart Lung and Blood Institute, 2007, NIH PUBLICATION; VanSwearingen JM, 2011, PHYS THER, V91, P1740, DOI 10.2522/ptj.20100391; Viidik A, 1997, AGING-CLIN EXP RES, V9, P64, DOI 10.1007/BF03340129; WOLF ME, 1991, J NEUROCHEM, V56, P1191, DOI 10.1111/j.1471-4159.1991.tb11410.x; Wong-Yu ISK, 2015, PARKINSONISM RELAT D, V21, P615, DOI 10.1016/j.parkreldis.2015.03.022; Yurek DM, 1998, BRAIN RES, V791, P246, DOI 10.1016/S0006-8993(98)00110-3	63	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188538	10.1371/journal.pone.0188538	http://dx.doi.org/10.1371/journal.pone.0188538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176896	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900093
J	Pecanha, WT; Althoff, SL; Galiano, D; Quintela, FM; Maestri, R; Goncalves, GL; Freitas, TRO				Pecanha, Willian T.; Althoff, Sergio L.; Galiano, Daniel; Quintela, Fernando M.; Maestri, Renan; Goncalves, Gislene L.; Freitas, Thales R. O.			Pleistocene climatic oscillations in Neotropical open areas: Refuge isolation in the rodent Oxymycterus nasutus endemic to grasslands	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; GENUS AKODON RODENTIA; HAPLOTYPE RECONSTRUCTION; GEOGRAPHIC-DISTRIBUTION; GENETIC CONSEQUENCES; STATISTICAL-METHOD; ARAUCARIA FOREST; COASTAL-PLAIN; SOUTH-AMERICA; SWAMP RAT	Pleistocene climatic oscillations favoured the expansion of grassland ecosystems and open vegetation landscapes throughout the Neotropics, and influenced the evolutionary history of species adapted to such environments. In this study, we sampled populations of the rodent Oxymycterus nasutus endemic to open areas in the Pampas and Atlantic Forest biomes to assess the tempo and mode of population divergence using an integrative approach, including coalescence theory, ecological niche models, and morphometry. Our results indicated that these O. nasutus populations exhibited high levels of genetic structure. Six major mtDNA clades were found, structuring these biomes into distinct groups. Estimates of their divergence times was indicated to be 0.571 myr. The high degree of genetic structure is reflected in the analyses of geometric morphometric; skull differences between lineages in the two ecoregions were detected. During the last glacial maximum, there was a strong increase in suitable abiotic conditions for O. nasutus. Distinct molecular markers revealed a population expansion over time, with a possible demographic retraction during the post-glacial period. Considering that all clades coalesce with the last interglacial maximum, our results indicated that reduction in suitable conditions during this period may have resulted in a possible vicariance associated with refuge isolation.	[Pecanha, Willian T.; Goncalves, Gislene L.; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Althoff, Sergio L.] Univ Reg Blumenau, Dept Ciencias Nat, Lab Biol Anim, Blumenau, SC, Brazil; [Galiano, Daniel] Unochapeco, Area Ciencias Exatas & Ambientais, Posgrad Ciencias Ambientais, Florianopolis, SC, Brazil; [Quintela, Fernando M.] Univ Fed Rio Grande, Inst Ciencias Biol, Programa Posgrad Biol Ambientes Aquat Continentai, Porto Alegre, RS, Brazil; [Maestri, Renan] Univ Fed Rio Grande do Sul, Dept Zool, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Goncalves, Gislene L.] Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile	Universidade Federal do Rio Grande do Sul; Universidade Regional de Blumenau (FURB); Universidade Comunitaria Regional de Chapeco; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidad de Tarapaca	Goncalves, GL (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Goncalves, GL (corresponding author), Univ Tarapaca, Fac Ciencias Agron, Dept Recursos Ambientales, Arica, Chile.	lopes.goncalves@ufrgs.br	Freitas, Thales Renato Ochotorena de/G-1160-2012; Maestri, Renan/L-2637-2015; Galiano, Daniel/ABV-4574-2022; Galiano, Daniel/O-1671-2013; Goncalves, Gislene Lopes/D-3567-2013; Althoff, Sérgio Luiz/AAE-5820-2020	Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Maestri, Renan/0000-0001-9134-2943; Galiano, Daniel/0000-0003-1428-8634; Goncalves, Gislene Lopes/0000-0002-1459-4888; Althoff, Sergio Luiz/0000-0002-0877-5156	Coordenadoria de Aperfeigoamento Pessoal (CAPES); Fundagao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPERGS [16/2551-0000485-4]; CNPq [150391/2017-0]	Coordenadoria de Aperfeigoamento Pessoal (CAPES); Fundagao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Coordenadoria de Aperfeigoamento Pessoal (CAPES), Fundagao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). G.L. Gongalves and R. Maestri received fellowship from FAPERGS (16/2551-0000485-4) and CNPq (150391/2017-0), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Enrique M. Gonzalez (Museo Nacional de Historia Natural, MNHN), Enrique P. Lessa (Universidad de la Republica), Alexandre U. Christoff (Museu de Ciencias Naturais da Universidade de Luterana do Brasil, MCNU), Andre L. Luza (UFRGS), Iris Hass (UFPR), Ives J. Sbalqueiro (UFPR), Antenor Silva and Sebastiao Pereira (Museu de Historia Natural "Capao da Imbuia", MHNCI) for loan tissue/skull samples. Thanks also to Andres Parada (Universidade Austral de Chile) for helping with the substitution rate for time-tree estimates and Elizabeth Rachenberg (FURB) for helping with the curatorial work of the material. Geraldo Mader, Andrea Turchetto-Zolet (PPGBM-UFRGS) and two anonymous reviewers made suggestions on earlier drafts of the manuscript that helped improve and clarify the text. This research was supported by the Coordenadoria de Aperfeicoamento Pessoal (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). G.L. Goncalves and R. Maestri received fellowships from FAPERGS (16/2551-0000485-4) and CNPq (150391/2017-0), respectively.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; [Anonymous], 2014, R LANG ENV STAT COMP; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow J.C., 1969, LIFE SCI CONTRIBUTIO, V75, P1, DOI [10.5962/bhl.title.52067, DOI 10.5962/BHL.TITLE.52067]; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Behling H, 2001, J S AM EARTH SCI, V14, P631, DOI 10.1016/S0895-9811(01)00040-2; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Behling H, 2009, CAMPOS SULINOS CONSE; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; BILENCA D, 2004, IDENTIFICACION AREAS; Bonvicino CR., 2008, GUIA ROEDORES BRASIL, V2008, p120p; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Cristiano MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146734; D'Elia G, 2004, J MAMMAL, V85, P897, DOI 10.1644/BRB-201; D'Elia G, 2015, J MAMMAL, V96, P1081, DOI 10.1093/jmammal/gyv115; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira Joao A., 2015, P247; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felappi JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118162; Fregonezi JN, 2013, BOT J LINN SOC, V171, P140, DOI 10.1111/j.1095-8339.2012.01292.x; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Geise L, 2001, J MAMMAL, V82, P92, DOI 10.1644/1545-1542(2001)082<0092:DITGAR>2.0.CO;2; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Goncalves PR, 2014, ZOOTAXA, V 3760, P1, DOI 10.11646/zootaxa.3760.1.1; Goncalves Pablo Rodrigues, 2007, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Gonzalez E.M., 2001, GUIA CAMPO MAMIFEROS; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoffmann FG, 2002, J MAMMAL, V83, P408, DOI 10.1644/1545-1542(2002)083<0408:SOOWDO>2.0.CO;2; Martinez JJ, 2011, ZOOL ANZ, V250, P175, DOI 10.1016/j.jcz.2011.03.001; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisiecki LE, 2007, QUATERNARY SCI REV, V26, P56, DOI 10.1016/j.quascirev.2006.09.005; Maestri R, 2016, J BIOGEOGR, V43, P2160, DOI 10.1111/jbi.12815; Maestri R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122412; Mapelli FJ, 2012, J ZOOL, V286, P48, DOI 10.1111/j.1469-7998.2011.00849.x; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Montes MA, 2008, J EVOLUTION BIOL, V21, P1823, DOI 10.1111/j.1420-9101.2008.01586.x; Mora MS, 2013, J MAMMAL, V94, P459, DOI 10.1644/11-MAMM-A-242.1; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Paise G, 2006, J MAMMAL, V87, P733, DOI 10.1644/05-MAMM-A-158R5.1; Parada A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0440-z; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Platt RN, 2015, J MAMMAL, V96, P708, DOI 10.1093/jmammal/gyv067; Quintela FM, 2016, AN ACAD BRAS CIENC, V88, P451, DOI 10.1590/0001-3765201620140631; Quintela FM, 2015, MAMM BIOL, V80, P510, DOI 10.1016/j.mambio.2015.08.003; Quintela FM, 2017, ZOOTAXA, V4294, P71, DOI 10.11646/zootaxa.4294.1.3; Quintela FM, 2014, ZOOTAXA, V3811, P207, DOI 10.11646/zootaxa.3811.2.3; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rambaut A., 2009, TRACER VERSION 1 5; REIG OA, 1984, REV BRAS GENET, V7, P333; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAJIMA F, 1989, GENETICS, V123, P585; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tomazelli L.J., 2005, GRAVEL, V3, P110; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Weschenfelder J, 2010, BRAZ J OCEANOGR, V58, P35, DOI 10.1590/S1679-87592010000600005; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; [No title captured]	82	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187329	10.1371/journal.pone.0187329	http://dx.doi.org/10.1371/journal.pone.0187329			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176839	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900008
J	Hot'ka, M; Zahradnik, I				Hot'ka, Matej; Zahradnik, Ivan			Reconstruction of membrane current by deconvolution and its application to membrane capacitance measurements in cardiac myocytes	PLOS ONE			English	Article							SQUARE-WAVE STIMULATION; HIGH-RESOLUTION; CELL CAPACITANCE; SINGLE CELLS; CLAMP; CONFIGURATION	Correct detection of membrane currents under whole-cell patch-clamp conditions is limited by the transfer function of a recording system. The low-pass output filter of a recording amplifier alters the time course of membrane current and causes errors in relevant descriptors. To solve these problems, we developed a practical procedure for reconstruction of the time course of membrane currents based on deconvolution of recorded currents in frequency domain. The procedure was tested on membrane capacitance estimates from current responses to step voltage pulses. The reconstructed current responses, in contrast to original current records, could be described exactly by an adequate impedance model of a recorded cell. The reconstruction allowed to increase the accuracy and reliability of membrane capacitance measurements in wide range of cell sizes and to suppress the cross-talk errors well below the noise. Moreover, it allowed resolving the instabilities in recording conditions arising from parasitic capacitance and seal resistance variation. Complex tests on hardware models, on simulated data sets, and on living cells confirmed robustness and reliability of the deconvolution procedure. The aptitude of the method was demonstrated in isolated rat cardiac myocytes by recording of spontaneous vesicular events, by discerning the formation of a fusion pore, and by revealing artefacts due to unstable seal resistance.	[Hot'ka, Matej; Zahradnik, Ivan] Slovak Acad Sci, Inst Mol Physiol & Genet, Dept Muscle Cell Res, Ctr Biosci, Bratislava, Slovakia; [Hot'ka, Matej] Pavol Jozef Safarik Univ, Dept Biophys, Fac Sci, Kosice, Slovakia	Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice	Zahradnik, I (corresponding author), Slovak Acad Sci, Inst Mol Physiol & Genet, Dept Muscle Cell Res, Ctr Biosci, Bratislava, Slovakia.	ivan.zahradnik@savba.sk		Zahradnik, Ivan/0000-0001-5125-9467; Hotka, Matej/0000-0002-0482-9401	Slovak Research and Development Agency (SRDA) [0721-10, 15-0302]; Vedecka grantova agentura Ministerstva skolstva, vedy, vjskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA) [2/0147/14]	Slovak Research and Development Agency (SRDA)(Slovak Research and Development Agency); Vedecka grantova agentura Ministerstva skolstva, vedy, vjskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA)	This work was supported by Slovak Research and Development Agency (SRDA, APW), 0721-10 (A. Zahradnikova), http://www.apvv.sk/agentura.html?lang=en; Slovak Research and Development Agency (SRDA, APVV), 15-0302 (A. Zahradnikova), http://www.apvv.sk/agentura.html?lang=en; Vedecka grantova agentura Ministerstva skolstva, vedy, vjskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA), 2/0147/14 (IZ), http://vega.sav.sk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2000, BIOPHYS J, V79, P2162, DOI 10.1016/S0006-3495(00)76464-2; FISCHMEISTER R, 1986, PFLUG ARCH EUR J PHY, V406, P73, DOI 10.1007/BF00582957; Gillis K. D., 1995, SINGLE CHANNEL RECOR; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Hotka M, 2016, ACTA PHYSIOL, V217, P44; Hotka M, 2016, BIOPHYS J, V110, p429A, DOI 10.1016/j.bpj.2015.11.2315; Hotka M, 2014, BIOPHYS J, V106, p121A, DOI 10.1016/j.bpj.2013.11.726; Janicek R, 2012, J PHYSIOL-LONDON, V590, P5091, DOI 10.1113/jphysiol.2012.234823; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lindau M, 2012, BBA-GEN SUBJECTS, V1820, P1234, DOI 10.1016/j.bbagen.2011.12.011; Mackova A K, 2017, EUR BIOPHYS J; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; Novak P, 2006, ANN BIOMED ENG, V34, P1201, DOI 10.1007/s10439-006-9140-6; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; ROHLICEK V, 1994, PFLUG ARCH EUR J PHY, V428, P30, DOI 10.1007/BF00374749; Ryu SY, 2002, PFLUG ARCH EUR J PHY, V444, P568, DOI 10.1007/s00424-002-0852-7; SAKMANN B, 1983, SINGLE CHANNEL RECOR; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; Sigworth FJ, 1983, SINGLE CHANNEL RECOR; Smith SW, 1997, SCI ENG GUIDE DIGITA; Thompson RE, 2001, BIOPHYS J, V81, P937, DOI 10.1016/S0006-3495(01)75752-9	21	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188452	10.1371/journal.pone.0188452	http://dx.doi.org/10.1371/journal.pone.0188452			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166646	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300039
J	Zierath, S; Hughes, AM; Fretwell, N; Dibley, M; Ekenstedt, KJ				Zierath, Sharon; Hughes, Angela M.; Fretwell, Neale; Dibley, Mark; Ekenstedt, Kari J.			Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012)	PLOS ONE			English	Article							FACTOR-VII DEFICIENCY; PHOSPHOFRUCTOKINASE DEFICIENCY; MYOTONIA-CONGENITA; CANINE CYSTINURIA; MISSENSE MUTATION; MOLECULAR-BASIS; GENOME; SLC3A1	Background A large and growing number of inherited genetic disease mutations are now known in the dog. Frequencies of these mutations are typically examined within the breed of discovery, possibly in related breeds, but nearly always in purebred dogs. No report to date has examined the frequencies of specific genetic disease mutations in a large population of mixed-breed dogs. Further, veterinarians and dog owners typically dismiss inherited/genetic diseases as possibilities for health problems in mixed-breed dogs, assuming hybrid vigor will guarantee that single-gene disease mutations are not a cause for concern. Therefore, the objective of this study was to screen a large mixed-breed canine population for the presence of mutant alleles associated with five autosomal recessive disorders: hyperuricosuria and hyperuricemia (HUU), cystinuria (CYST), factor VII deficiency (FVIID), myotonia congenita (MYC) and phosphofructokinase deficiency (PKFD). Genetic testing was performed in conjunction with breed determination via the commercially-available Wisdom Panel (TM) test. Results From a population of nearly 35,000 dogs, homozygous mutant dogs were identified for HUU (n = 57) and FVIID (n = 65). Homozygotes for HUU and FVIID were identified even among dogs with highly mixed breed ancestry. Carriers were identified for all disorders except MYC. HUU and FVIID were of high enough frequency to merit consideration in any mixed-breed dog, while CYST, MYC, and PKFD are vanishingly rare. Conclusions The assumption that mixed-breed dogs do not suffer from single-gene genetic disorders is shown here to be false. Within the diseases examined, HUU and FVIID should remain on any practitioner's rule-out list, when clinically appropriate, for all mixed-breed dogs, and judicious genetic testing should be performed for diagnosis or screening. Future testing of large mixed-breed dog populations that include additional known canine genetic mutations will refine our knowledge of which genetic diseases can strike mixed-breed dogs.	[Zierath, Sharon] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci Dept, St Paul, MN 55108 USA; [Hughes, Angela M.; Fretwell, Neale; Dibley, Mark] Mars Vet, Vancouver, WA USA; [Ekenstedt, Kari J.] Purdue Univ, Dept Basic Med Sci, Coll Vet Med, W Lafayette, IN 47907 USA	University of Minnesota System; University of Minnesota Twin Cities; Mars; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ekenstedt, KJ (corresponding author), Purdue Univ, Dept Basic Med Sci, Coll Vet Med, W Lafayette, IN 47907 USA.	kje0003@purdue.edu			University of Wisconsin - River Falls Summer Scholars Program	University of Wisconsin - River Falls Summer Scholars Program	This study was supported by the University of Wisconsin - River Falls Summer Scholars Program (awarded to KJE and SZ), www.uwrf.edu/URSCA/SuglmerScholarsProgram.cfm. Data were generated via the commercially available Wisdom Panel test, www.wisdompanel.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Beck CL, 1996, P NATL ACAD SCI USA, V93, P11248, DOI 10.1073/pnas.93.20.11248; Broeckx BJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074811; Brons AK, 2013, J VET INTERN MED, V27, P1400, DOI 10.1111/jvim.12176; Callan MB, 2006, J THROMB HAEMOST, V4, P2616, DOI 10.1111/j.1538-7836.2006.02203.x; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cosgrove L, 2015, CAN VET J, V56, P1153; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Dreger DL, 2016, GENETICS, V204, P737, DOI 10.1534/genetics.116.192427; Finnigan DF, 2007, J VET INTERN MED, V21, P458, DOI 10.1892/0891-6640(2007)21[458:ANMOTC]2.0.CO;2; Fogle B., 2010, DOG DEFINITIVE GUIDE; Gerber K, 2009, VET CLIN PATH, V38, P46, DOI 10.1111/j.1939-165X.2008.00089.x; GIGER U, 1992, J AM VET MED ASSOC, V201, P1569; Gultekin GI, 2012, MOL CELL PROBE, V26, P243, DOI 10.1016/j.mcp.2012.02.004; Henthorn PS, 2000, HUM GENET, V107, P295; Kaae JA, 2007, J VET INTERN MED, V21, P976, DOI 10.1892/0891-6640(2007)21[976:HFVDIT]2.0.CO;2; Karmi N, 2010, J VET INTERN MED, V24, P1337, DOI 10.1111/j.1939-1676.2010.0631.x; Lobetti RG, 2009, J S AFR VET ASSOC, V80, P106; McGreevy PD, 1999, ANIM WELFARE, V8, P329; Nicholas FW, 2011, VET J, V189, P132, DOI 10.1016/j.tvjl.2011.06.009; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; R Core Team, 2013, R LANG ENV STAT COMP; Rhodes TH, 1999, FEBS LETT, V456, P54, DOI 10.1016/S0014-5793(99)00926-6; Sargan DR, 2004, MAMM GENOME, V15, P503, DOI 10.1007/s00335-004-3047-z; SCHAIBLE RH, 1976, GENETICS, V83, pS68; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Skibild E, 2001, J SMALL ANIM PRACT, V42, P298, DOI 10.1111/j.1748-5827.2001.tb02043.x; Slutsky J, 2013, VET J, V197, P182, DOI 10.1016/j.tvjl.2013.02.021; Smith BF, 1996, J BIOL CHEM, V271, P20070, DOI 10.1074/jbc.271.33.20070; Zouganelis GD, 2014, FORENSIC SCI INT, V245, P51, DOI 10.1016/j.forsciint.2014.10.001	30	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188543	10.1371/journal.pone.0188543	http://dx.doi.org/10.1371/journal.pone.0188543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166669	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300049
J	Freire, PP; Cury, SS; de Oliveira, G; Fernandez, GJ; Moraes, LN; Duran, BOD; Ferreira, JH; Fuziwara, CS; Kimura, ET; Dal-Pai-Silva, M; Carvalho, RF				Freire, Paula Paccielli; Cury, Sarah Santiloni; de Oliveira, Grasieli; Fernandez, Geysson Javier; Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; Ferreira, Juarez Henrique; Fuziwara, Cesar Seigi; Kimura, Edna Teruko; Dal-Pai-Silva, Maeli; Carvalho, Robson Francisco			Osteoglycin inhibition by microRNA miR-155 impairs myogenesis	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; CELL-DIFFERENTIATION; MOUSE; MIMECAN; IDENTIFICATION; PROLIFERATION; HYPERTROPHY; MIGRATION; ATROPHY	Skeletal myogenesis is a regulated process in which mononucleated cells, the myoblasts, undergo proliferation and differentiation. Upon differentiation, the cells align with each other, and subsequently fuse to form terminally differentiated multinucleated myotubes. Previous reports have identified the protein osteoglycin (Ogn) as an important component of the skeletal muscle secretome, which is expressed differentially during muscle development. However, the posttranscriptional regulation of Ogn by microRNAs during myogenesis is unknown. Bioinformatic analysis showed that miR-155 potentially targeted the Ogn transcript at the 3'-untranslated region (3' UTR). In this study, we tested the hypothesis that miR-155 inhibits the expression of the Ogn to regulate skeletal myogenesis. C2C12 myoblast cells were cultured and miR-155 overexpression or Ogn knockdown was induced by transfection with miR-155 mimic, siRNA-Ogn, and negative controls with lipofectamine for 15 hours. Near confluence (80-90%), myoblasts were induced to differentiate myotubes in a differentiation medium. Luciferase assay was used to confirm the interaction between miR-155 and Ogn 3' UTR. RT-qPCR and Western blot analyses were used to confirm that the differential expression of miR-155 correlates with the differential expression of myogenic molecular markers (Myh2, MyoD, and MyoG) and inhibits Ogn protein and gene expression in myoblasts and myotubes. Myoblast migration and proliferation were assessed using Wound Healing and MTT assays. Our results show that miR-155 interacts with the 3' UTR Ogn region and decrease the levels of Ogn in myotubes. The overexpression of miR-155 increased MyoG expression, decreased myoblasts wound closure rate, and decreased Myh2 expression in myotubes. Moreover, Ogn knockdown reduced the expression levels of MyoD, MyoG, and Myh2 in myotubes. These results reveal a novel pathway in which miR-155 inhibits Ogn expression to regulate proliferation and differentiation of C2C12 myoblast cells.	[Freire, Paula Paccielli; Cury, Sarah Santiloni; de Oliveira, Grasieli; Fernandez, Geysson Javier; Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; Ferreira, Juarez Henrique; Dal-Pai-Silva, Maeli; Carvalho, Robson Francisco] Sao Paulo State Univ, Inst Biosci, Dept Morphol, Sao Paulo, Brazil; [Fuziwara, Cesar Seigi; Kimura, Edna Teruko] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo	Carvalho, RF (corresponding author), Sao Paulo State Univ, Inst Biosci, Dept Morphol, Sao Paulo, Brazil.	rcarvalho@ibb.unesp.br	Carvalho, Robson Francisco/AAE-4134-2020; Fernandez, geysson javier/O-2783-2017; Fuziwara, Cesar S/G-6149-2011; Fernandez, Geysson/AAT-9495-2021; Dal-Pai-Silva, Maeli/GLR-1413-2022; Duran, Bruno/AAA-9977-2020; Cury, Sarah Santiloni/AAJ-2519-2020; Freire, Paula Paccielli/D-6504-2018; de Moraes, Leonardo Nazario/F-8621-2012; Carvalho, Robson Francisco/E-1161-2012; Kimura, Edna/D-7334-2012	Carvalho, Robson Francisco/0000-0002-4901-7714; Fernandez, geysson javier/0000-0002-7982-9940; Fuziwara, Cesar S/0000-0002-0567-5432; Duran, Bruno/0000-0002-7920-8175; Freire, Paula Paccielli/0000-0003-0649-8279; Carvalho, Robson Francisco/0000-0002-4901-7714; Kimura, Edna/0000-0001-8403-4459; Dal Pai, Maeli/0000-0001-7269-9197; Moraes, Leonardo/0000-0003-4515-4137; Fernandez, Geysson Javier/0000-0002-8493-1587	Sao Paulo Research Foundation [2012/13961-6]; MSc. FAPESP fellowship [2014/13783-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MSc. FAPESP fellowship	This study was supported by Sao Paulo Research Foundation (grant #2012/13961-6 to RFC). PPF was funded by a MSc. FAPESP fellowship # 2014/13783-6. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Antoniou A, 2014, J BIOL CHEM, V289, P3923, DOI 10.1074/jbc.M113.507343; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentzinger CF, 2012, COLD SPRING HARB PER, V4; Betel D, 2008, NUCLEIC ACIDS RES, P36; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan CYX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004804; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cui XN, 2008, ACTA BIOCH BIOPH SIN, V40, P349, DOI 10.1111/j.1745-7270.2008.00392.x; Dimchev GA, 2013, J MUSCLE RES CELL M, V34, P125, DOI 10.1007/s10974-013-9340-2; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Grzelkowska-Kowalczyk K, 2015, J INTERF CYTOK RES, V35, P89, DOI 10.1089/jir.2014.0018; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hitachi K, 2014, INT J BIOCHEM CELL B, V47, P93, DOI 10.1016/j.biocel.2013.12.003; Hu SM, 2005, J CLIN ENDOCR METAB, V90, P6657, DOI 10.1210/jc.2005-0322; Huang C, 2013, ONCOL REP, V30, P1223, DOI 10.3892/or.2013.2576; Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9; Liu J, 2012, J CELL MOL MED, V16, P2379, DOI 10.1111/j.1582-4934.2012.01551.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Meyer SU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135284; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nie M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.165; Owens DJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE1019, DOI 10.1152/ajpendo.00375.2015; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Tasheva ES, 2002, MOL VIS, V8, P407; Tasheva ES, 2000, CYTOGENET CELL GENET, V88, P326, DOI 10.1159/000015521; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35	52	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188464	10.1371/journal.pone.0188464	http://dx.doi.org/10.1371/journal.pone.0188464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161332	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000061
J	Wang, SH; Lin, HJ; Lin, YY; Chen, YJ; Pan, YH; Tung, CT; Mersmann, HJ; Ding, ST				Wang, Siou-Huei; Lin, Han-Jen; Lin, Yuan-Yu; Chen, Yu-Jen; Pan, Yu-Hui; Tung, Cheng-Ting; Mersmann, Harry John; Ding, Shih-Torng			Embryonic cholesterol esterification is regulated by a cyclic AMP-dependent pathway in yolk sac membrane-derived endodermal epithelial cells	PLOS ONE			English	Article							HMG-COA REDUCTASE; ACYL-COENZYME-A; CHICK-EMBRYO; GALLUS-DOMESTICUS; LIPID-METABOLISM; FATTY-ACIDS; ACYLTRANSFERASE; GROWTH; LIVER; RAT	During avian embryonic development, endodermal epithelial cells (EECs) absorb yolk through the yolk sac membrane. Sterol O-acyltransferase (SOAT) is important for esterification and yolk lipid utilization during development. Because the major enzyme for yolk sac membrane cholesteryl ester synthesis is SOAT1, we cloned the avian SOAT1 promoter and elucidated the cellular functions of SOAT1. Treatments with either glucagon, isobutylmethyl-xanthine (IBMX), an adenylate cyclase activator (forskolin), a cAMP analog (dibutyryl-cAMP), or a low glucose concentration all increased SOAT1 mRNA accumulation in EECs from Japanese quail, suggesting that SOAT1 is regulated by nutrients and hormones through a cAMP-dependent pathway. Activity of protein kinase A (PKA) was increased by IBMX, whereas co-treatment with the PKA inhibitor, H89 negated the increase in PKA activity. Cyclic AMP-induced EECs had greater cholesterol esterification than untreated EECs. By promoter deletion and point-mutation, the cAMP-response element (-349 to -341 bp) was identified as critical in mediating transcription of SOAT1. In conclusion, expression of SOAT1 was regulated by a cAMP-dependent pathway and factors that increase PKA will increase SOAT1 to improve the utilization of lipids in the EECs and potentially modify embryonic growth.	[Wang, Siou-Huei; Lin, Han-Jen; Pan, Yu-Hui; Tung, Cheng-Ting; Mersmann, Harry John; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Lin, Yuan-Yu] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung, Taiwan; [Chen, Yu-Jen; Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan	National Taiwan University; Tunghai University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.	sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Ding, Shih-Torng/0000-0002-9866-1776; Lin, Yuan-Yu/0000-0002-3397-3218	Ministry of Science and Technology in Taiwan [104-2313-B-002-039-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, under Grant 104-2313-B-002-039-MY3 in Taiwan to Shih-Torng Ding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, under Grant 104-2313-B-002-039-MY3 in Taiwan. We declare that the experiments comply with the current Taiwan laws, the place in which the experiments were performed. There is no conflict of interest.	Banner K H, 1995, Monaldi Arch Chest Dis, V50, P286; Bauer R, 2013, J BIOL CHEM, V288, P1088, DOI 10.1074/jbc.M112.393090; BEINS DM, 1982, BIOCHEM J, V202, P631, DOI 10.1042/bj2020631; BOTHAM KM, 1992, BIOCHEM SOC T, V20, P454, DOI 10.1042/bst0200454; Cheng DH, 1999, LIPIDS, V34, P261, DOI 10.1007/s11745-999-0362-z; De Groef B, 2008, MOL CELL ENDOCRINOL, V293, P17, DOI 10.1016/j.mce.2008.06.002; Ding ST, 2000, POULTRY SCI, V79, P1460, DOI 10.1093/ps/79.10.1460; ERICKSON SK, 1980, J LIPID RES, V21, P930; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; FIELD FJ, 1987, J LIPID RES, V28, P50; GARCIAGONZALEZ M, 1992, MOL CELL BIOCHEM, V115, P173; Ge J, 2013, J CELL BIOCHEM, V114, P2188, DOI 10.1002/jcb.24568; Geng F, 2016, CLIN CANCER RES, V22, P5337, DOI 10.1158/1078-0432.CCR-15-2973; Gopalakrishnan S, 2011, JOVE-J VIS EXP, DOI 10.3791/3138; GREER JL, 1992, COMP BIOCHEM PHYS B, V103, P9, DOI 10.1016/0305-0491(92)90405-G; HEIDER JG, 1983, J LIPID RES, V24, P1127; Hussein A, 2005, INT J ONCOL, V27, P155; Kim JW, 2010, ASIAN AUSTRAL J ANIM, V23, P1668, DOI 10.5713/ajas.2010.10329; Lee SML, 2013, JOVE-J VIS EXP, DOI 10.3791/50615; Lin HJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53624; Lin HJ, 2017, J BIOMED SCI ENG, V10, P37; Lu JW, 2007, POULTRY SCI, V86, P673, DOI 10.1093/ps/86.4.673; NOBLE RC, 1986, P NUTR SOC, V45, P17, DOI 10.1079/PNS19860030; NOBLE RC, 1984, WORLD POULTRY SCI J, V40, P114, DOI 10.1079/WPS19840009; NOBLE RC, 1984, POULTRY SCI, V63, P558, DOI 10.3382/ps.0630558; Pereira MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128949; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell KA, 2004, J COMP PHYSIOL B, V174, P163, DOI 10.1007/s00360-003-0401-5; Rogers MA, 2015, J STEROID BIOCHEM, V151, P102, DOI 10.1016/j.jsbmb.2014.09.008; Sahan U, 2014, POULTRY SCI, V93, P2069, DOI 10.3382/ps.2013-03850; SHAND JH, 1993, LIPIDS, V28, P621, DOI 10.1007/BF02536056; STONE BG, 1989, J LIPID RES, V30, P1681; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Tokusoglu O, 2006, INT J FOOD SCI NUTR, V57, P537, DOI 10.1080/09637480601049725; Vieira SL, 2007, BRAZ J POULTRY SCI, V9, P1, DOI 10.1590/S1516-635X2007000100001; Yadgary L, 2010, POULTRY SCI, V89, P2441, DOI 10.3382/ps.2010-00681	36	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187560	10.1371/journal.pone.0187560	http://dx.doi.org/10.1371/journal.pone.0187560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161294	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000011
J	Wu, CP; Vellend, M; Yuan, WG; Jiang, B; Liu, JJ; Shen, AH; Liu, JL; Zhu, JR; Yu, MJ				Wu, Chuping; Vellend, Mark; Yuan, Weigao; Jiang, Bo; Liu, Jiajia; Shen, Aihua; Liu, Jinliang; Zhu, Jinru; Yu, Mingjian			Patterns and determinants of plant biodiversity in non-commercial forests of eastern China	PLOS ONE			English	Article							SPECIES COMPOSITION; TROPICAL FOREST; BETA-DIVERSITY; TREE DIVERSITY; RAIN-FOREST; HABITAT HETEROGENEITY; SECONDARY SUCCESSION; SUBTROPICAL FORESTS; TOPOGRAPHY; MANAGEMENT	Non-commercial forests represent important habitats for the maintenance of biodiversity and ecosystem function in China, yet no studies have explored the patterns and determinants of plant biodiversity in these human dominated landscapes. Here we test the influence of (1) forest type (pine, mixed, and broad-leaved), (2) disturbance history, and (3) environmental factors, on tree species richness and composition in 600 study plots in eastern China. In total, we found 143 species in 53 families of woody plants, with a number of species rare and endemic in the study region. Species richness in mixed forest and broad-leaved forest was higher than that in pine forest, and was higher in forests with less disturbance. Species composition was influenced by environment factors in different ways in different forest types, with important variables including elevation, soil depth and aspect. Surprisingly, we found little effect of forest age after disturbance on species composition. Most non-commercial forests in this region are dominated by species poor pine forests and mixed young forests. As such, our results highlight the importance of broad-leaved forests for regional plant biodiversity conservation. To increase the representation of broad-leaved non-commercial forests, specific management practices such as thinning of pine trees could be undertaken.	[Wu, Chuping; Liu, Jiajia; Liu, Jinliang; Yu, Mingjian] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wu, Chuping; Yuan, Weigao; Jiang, Bo; Shen, Aihua; Zhu, Jinru] Zhejiang Acad Forestry, Hangzhou, Zhejiang, Peoples R China; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	Zhejiang University; University of Sherbrooke	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Liu, Jiajia/I-5253-2019; Liu, Jinliang/B-1716-2015	Liu, Jiajia/0000-0002-1923-5964; Liu, Jinliang/0000-0002-2476-1803; Chuping, Wu/0000-0002-7372-9332; yu, ming jian/0000-0001-8060-8427	Major Cooperation Project of Zhejiang Province; Chinese Academy of Forestry [2014SY01]; Science and Technology Project of Zhejiang Province [2015C02016]; Zhejiang Provincial Natural Science Foundation [LY16C160003]	Major Cooperation Project of Zhejiang Province; Chinese Academy of Forestry; Science and Technology Project of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This research was funded by Major Cooperation Project of Zhejiang Province and Chinese Academy of Forestry (No. 2014SY01), http://www.caf.ac.cn; Science and Technology Project of Zhejiang Province (No. 2015C02016), http://www.zjinfo.gov.cn; Zhejiang Provincial Natural Science Foundation (No. LY16C160003), http://www.zjinfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, VEGETATION CHINA; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Arroyo-Rodriguez V., 2015, BIOL REV; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Barwell LJ, 2015, J ANIM ECOL, V84, P1112, DOI 10.1111/1365-2656.12362; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Chai SL, 2011, J ECOL, V99, P113, DOI 10.1111/j.1365-2745.2010.01742.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cramer MJ, 2002, J MAMMAL, V83, P743, DOI 10.1644/1545-1542(2002)083&lt;0743:HHHAAR&gt;2.0.CO;2; Cubbage F, 2007, FOREST POLICY ECON, V9, P833, DOI 10.1016/j.forpol.2006.03.010; Davies RG, 2007, GLOBAL ECOL BIOGEOGR, V16, P220, DOI 10.1111/j.1466-8238.2007.00282.x; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; FAO, 2015, CHIN GLOB FOR RES AS; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Feng G, 2016, BIOL CONSERVATION; Forestry Department of Zhejiang Province, 2011, ZHEJ EC NONC FOR REP; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Goosem M, 2016, J VEG SCI, V27, P504, DOI 10.1111/jvs.12376; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; Hua F, 2016, NATURE COMMUNICATION; Jones ET, 2007, FOREST ECOL MANAG, V246, P29, DOI 10.1016/j.foreco.2007.03.048; Kaboli M, 2006, J BIOGEOGR, V33, P133, DOI 10.1111/j.1365-2699.2005.01379.x; Katovai E, 2016, FOREST ECOL MANAG, V372, P53, DOI 10.1016/j.foreco.2016.03.052; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Li MS, 2012, ADV MATER RES-SWITZ, V433-440, P1286, DOI 10.4028/www.scientific.net/AMR.433-440.1286; Liebsch D, 2008, BIOL CONSERV, V141, P1717, DOI 10.1016/j.biocon.2008.04.013; Lin D, 2012, PLOS ONE; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Liu JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35926; [刘世荣 Liu Shirong], 2015, [生态学报, Acta Ecologica Sinica], V35, P1; Liu YN, 2015, APPL VEG SCI, V18, P34, DOI 10.1111/avsc.12101; Lu Pin, 2013, Biodiversity Science, V21, P554, DOI 10.3724/SP.J.1003.2013.10049; Maeshiro R, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00125.1; Marcelo T, 2004, BIODIVERS CONSERV, V13, P1419; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Matthews JW, 2010, J APPL ECOL, V47, P1128, DOI 10.1111/j.1365-2664.2010.01862.x; Meng JH, 2014, FORESTS, V5, P3199, DOI 10.3390/f5123199; Minden V, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0284; Mo XX, 2011, BIOL CONSERV, V144, P1832, DOI 10.1016/j.biocon.2011.03.019; Osazuwa-Peters OL, 2015, FOREST ECOL MANAG, V357, P10, DOI 10.1016/j.foreco.2015.08.002; Qian H, 2013, PLOS ONE; Qian H, 2009, ACTA OECOL, V35, P819, DOI 10.1016/j.actao.2009.08.009; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; [沈琪 Shen Qi], 2005, [生态学报, Acta Ecologica Sinica], V25, P2131; Slik J, 2008, OECOLOGIA, V158, P579, DOI 10.1007/s00442-008-1163-2; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Song C, 2009, REFORESTING LANDSCAP, P10; Swinfield T, 2016, FOREST ECOL MANAG, V381, P209, DOI 10.1016/j.foreco.2016.09.020; Ticktin T, 2002, CONSERV BIOL, V16, P691, DOI 10.1046/j.1523-1739.2002.00372.x; Wang DP, 2006, FOREST ECOL MANAG, V222, P384, DOI 10.1016/j.foreco.2005.10.053; Wang QG, 2014, CHINESE SCI BULL, V59, P5113, DOI 10.1007/s11434-014-0453-9; Wang SP, 2012, ECOGRAPHY, V35, P1168, DOI 10.1111/j.1600-0587.2012.00045.x; Warren-Thomas E, 2014, FOREST ECOL MANAG, V334, P369, DOI 10.1016/j.foreco.2014.09.022; Xu CG, 2012, CLIMATIC CHANGE, V110, P53, DOI 10.1007/s10584-011-0098-5; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Yuan Jin-Feng, 2011, Bulletin of Botanical Research, V31, P61; Zeng De-hui, 2004, Journal of Forestry Research (Harbin), V15, P127, DOI 10.1007/BF02856747; Zhang ZJ, 2011, BIOL LETTERS, V7, P403, DOI 10.1098/rsbl.2010.1081; Zhou Zhi-chun, 2004, Forest Research, V17, P420	70	10	14	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188409	10.1371/journal.pone.0188409	http://dx.doi.org/10.1371/journal.pone.0188409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161324	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000050
J	Maina, AN; Klein, TA; Kim, HC; Chong, ST; Yang, Y; Mullins, K; Jiang, J; St John, H; Jarman, RG; Hang, J; Richards, AL				Maina, Alice N.; Klein, Terry A.; Kim, Heung-Chul; Chong, Sung-Tae; Yang, Yu; Mullins, Kristin; Jiang, Ju; St John, Heidi; Jarman, Richard G.; Hang, Jun; Richards, Allen L.			Molecular characterization of novel mosquitoborne Rickettsia spp. from mosquitoes collected at the Demilitarized Zone of the Republic of Korea	PLOS ONE			English	Article							SPOTTED-FEVER GROUP; SOUTH-KOREA; PHYLOGENETIC ANALYSIS; FELIS INFECTION; TICKS; GYEONGGI; HUMANS; IDENTIFICATION; MONACENSIS; PROVINCES	Rickettsiae are associated with a diverse range of invertebrate hosts. Of these, mosquitoes could emerge as one of the most important vectors because of their ability to transmit significant numbers of pathogens and parasites throughout the world. Recent studies have implicated Anopheles gambiae as a potential vector of Rickettsia felis. Herein we report that a metagenome sequencing study identified rickettsial sequence reads in culicine mosquitoes from the Republic of Korea. The detected rickettsiae were characterized by a genus-specific quantitative real-time PCR assay and sequencing of rrs, gltA, 17kDa, ompB, and sca4 genes. Three novel rickettsial genotypes were detected (Rickettsia sp. A12.2646, Rickettsia sp. A12.2638 and Rickettsia sp. A12.3271), from Mansonia uniformis, Culex pipiens, and Aedes esoensis, respectively. The results underscore the need to determine the Rickettsia species diversity associated with mosquitoes, their evolution, distribution and pathogenic potential.	[Maina, Alice N.; Mullins, Kristin; Jiang, Ju; St John, Heidi; Richards, Allen L.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Klein, Terry A.] 65th Med Brigade, Med Dept Act Korea, Unit 15281, Seoul, South Korea; [Kim, Heung-Chul; Chong, Sung-Tae] 65th Med Brigade, Med Dept Act Korea, Unit 15247, Seoul, South Korea; [Yang, Yu; Jarman, Richard G.; Hang, Jun] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Mullins, Kristin] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore	Maina, AN (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	alice.n.maina.ctr@mail.mil			Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS) [188M.0931.001-A0074, P0015-17-ME, 17-WR-1.2.1]	Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS)	This research was funded by the Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Work Unit Numbers: 188M.0931.001-A0074, P0015-17-ME and 17-WR-1.2.1. The grant(s) were awarded to ALR, TAK and RGJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae JS, 2008, J VET SCI, V9, P285, DOI 10.4142/jvs.2008.9.3.285; Chung MH, 2006, EMERG INFECT DIS, V12, P1122, DOI 10.3201/eid1207.051372; Dieme C, 2015, P NATL ACAD SCI USA, V112, P8088, DOI 10.1073/pnas.1413835112; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Guo WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep38770; Hang J, 2016, GENE ANNOUNC, V4; Hechemy KE, ANN NY ACAD SCI, V990, P17; Hertig M, 1924, J MED RES, V44, P329; Jang WJ, 2005, MICROBIOL IMMUNOL, V49, P17, DOI 10.1111/j.1348-0421.2005.tb03635.x; Jang WJ, 2004, J CLIN MICROBIOL, V42, P2310, DOI 10.1128/JCM.42.5.2310-2313.2004; Jiang J, 2005, ANN NY ACAD SCI, V1063, P337, DOI 10.1196/annals.1355.054; Jiang J, 2015, EMERG INFECT DIS, V21, P1073, DOI 10.3201/eid2106.141487; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Kang SW, 2013, PARASITOL INT, V62, P276, DOI 10.1016/j.parint.2013.02.002; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kilianski A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0840-5; Ko S, 2011, VECTOR-BORNE ZOONOT, V11, P1243, DOI 10.1089/vbz.2010.0261; Korkusol A, 2017, J GEN VIROL, V98, P1122, DOI 10.1099/jgv.0.000746; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JH, 2003, MICROBIOL IMMUNOL, V47, P301, DOI 10.1111/j.1348-0421.2003.tb03399.x; Lee K. W., 1998, REVISION ILLUSTRATED; Lee KM, 2013, MICROBIOL IMMUNOL, V57, P487, DOI 10.1111/1348-0421.12062; Liu D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1885-7; Ma JS, 2006, EMERG INFECT DIS, V12, P531, DOI 10.3201/eid1203.050957; Maina AN, 2012, EMERG INFECT DIS, V18, P328, DOI 10.3201/eid1802.111372; Mediannikov O, 2013, EMERG INFECT DIS, V19, P1775, DOI 10.3201/eid1911.130361; Noh Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1955-x; Parola P, 2016, LANCET INFECT DIS, V16, P1112, DOI 10.1016/S1473-3099(16)30331-0; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sakamoto JM, 2007, APPL ENVIRON MICROB, V73, P6637, DOI 10.1128/AEM.00923-07; Shin SH, 2013, EXP APPL ACAROL, V61, P337, DOI 10.1007/s10493-013-9699-1; Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanaka K., 1979, CONTRIB AM ENTOMOL I, V16, P43; Vayssier-Taussat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081439; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Xiang L, 2017, ANTON LEEUW INT J G, V110, P105, DOI 10.1007/s10482-016-0780-8; Zhang JL, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.107; Zhang JL, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0682-1	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188327	10.1371/journal.pone.0188327	http://dx.doi.org/10.1371/journal.pone.0188327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155880	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700047
J	Li, JW; Zhang, WM; Zeng, WQ; Chen, GL; Qiu, ZC; Cao, XY; Gao, XY				Li, Jianwei; Zhang, Weimin; Zeng, Weiqin; Chen, Guolong; Qiu, Zhongchao; Cao, Xinyuan; Gao, Xuanyi			Estimation of stress distribution in ferromagnetic tensile specimens using low cost eddy current stress measurement system and BP neural network	PLOS ONE			English	Article							X-RAY; RESIDUAL-STRESSES; METALS	Estimation of the stress distribution in ferromagnetic components is very important for evaluating the working status of mechanical equipment and implementing preventive maintenance. Eddy current testing technology is a promising method in this field because of its advantages of safety, no need of coupling agent, etc. In order to reduce the cost of eddy current stress measurement system, and obtain the stress distribution in ferromagnetic materials without scanning, a low cost eddy current stress measurement system based on Archimedes spiral planar coil was established, and a method based on BP neural network to obtain the stress distribution using the stress of several discrete test points was proposed. To verify the performance of the developed test system and the validity of the proposed method, experiment was implemented using structural steel (Q235) specimens. Standard curves of sensors at each test point were achieved, the calibrated data were used to establish the BP neural network model for approximating the stress variation on the specimen surface, and the stress distribution curve of the specimen was obtained by interpolating with the established model. The results show that there is a good linear relationship between the change of signal modulus and the stress in most elastic range of the specimen, and the established system can detect the change in stress with a theoretical average sensitivity of -0.4228 mV/MPa. The obtained stress distribution curve is well consonant with the theoretical analysis result. At last, possible causes and improving methods of problems appeared in the results were discussed. This research has important significance for reducing the cost of eddy current stress measurement system, and advancing the engineering application of eddy current stress testing.	[Li, Jianwei; Zhang, Weimin; Zeng, Weiqin; Chen, Guolong; Cao, Xinyuan] Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China; [Li, Jianwei] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China; [Zeng, Weiqin] Beijing Carduo Informat Technol Co Ltd, Beijing, Peoples R China; [Qiu, Zhongchao] Shandong Management Univ, Sch Mech & Elect Engn, Jinan, Shandong, Peoples R China; [Gao, Xuanyi] Beijing Inst Technol, Sch Informat & Elect, Beijing, Peoples R China	Beijing Institute of Technology; Henan Agricultural University; Shandong Management University; Beijing Institute of Technology	Zhang, WM (corresponding author), Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China.	zhangwm@bit.edu.cn	li, jian/GSE-0245-2022; Chen, Guolong/HDM-8516-2022; LI, JIAN/GRY-2197-2022	Chen, Guolong/0000-0001-6070-3881; 	National Natural Science Foundation of China [51275048]; Beijing Carduo Information Technology Company Limited	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Carduo Information Technology Company Limited	This research was supported by the National Natural Science Foundation of China (Grant No.51275048). The website of the funder is http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beijing Carduo Information Technology Company Limited provided support in the form of salaries for author [Weiqin Zeng], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Abrantes RF, 2016, MEASUREMENT, V77, P351, DOI 10.1016/j.measurement.2015.09.026; Abu-Nabah BA, 2007, NDT&E INT, V40, P405, DOI 10.1016/j.ndteint.2007.01.003; BROWN WF, 1949, PHYS REV, V75, P147, DOI 10.1103/PhysRev.75.147; Chelabi M, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/15/155303; Dahia A, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/19/195002; Dobrocka E, 2017, APPL SURF SCI, V395, P16, DOI 10.1016/j.apsusc.2016.06.060; Garcia-Martin J, 2011, SENSORS-BASEL, V11, P2525, DOI 10.3390/s110302525; Habibalahi A, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055601; Harati E, 2017, MATERIALS, V10, DOI 10.3390/ma10060593; Hatafuku H, 2002, IEEE T MAGN, V38, P3309, DOI 10.1109/TMAG.2002.802299; Hecht-Nielsen R, 1989, IJCNN INT JOINT C NE; JILES DC, 1984, J APPL PHYS, V55, P2115, DOI 10.1063/1.333582; JILES DC, 1995, J PHYS D APPL PHYS, V28, P1537, DOI 10.1088/0022-3727/28/8/001; Kim JM, 2017, NDT&E INT, V87, P93, DOI 10.1016/j.ndteint.2017.02.002; KITTEL C, 1956, SOLID STATE PHYS, V3, P437; Lera G, 2002, IEEE T NEURAL NETWOR, V13, P1200, DOI 10.1109/TNN.2002.1031951; Li ZB, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2701773; Mahmoodi M, 2012, MATER DESIGN, V40, P516, DOI 10.1016/j.matdes.2012.03.029; Martinez-Perez ML, 2004, ACTA MATER, V52, P5303, DOI 10.1016/j.actamat.2004.07.036; Rosado LS, 2015, NDT&E INT, V70, P29, DOI 10.1016/j.ndteint.2014.09.009; Schoenekess HC, 2007, IEEE SENS J, V7, P1200, DOI 10.1109/JSEN.2007.900961; Sekine Y, 2012, J NONDESTRUCT EVAL, V31, P99, DOI 10.1007/s10921-011-0125-5; Shu D, 2015, J MAGN MAGN MATER, V394, P195, DOI 10.1016/j.jmmm.2015.06.059; Singhal D, 2011, INT J ELEC POWER, V33, P550, DOI 10.1016/j.ijepes.2010.12.009; Sutherland J, 1997, MATER EVAL, V55, P85; Wang ZD, 2010, NDT&E INT, V43, P513, DOI 10.1016/j.ndteint.2010.05.007; Withers PJ, 2007, CR PHYS, V8, P806, DOI 10.1016/j.crhy.2007.09.015; Wu B, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/904826; Xiu CZ, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060538; Xiu CZ, 2017, SENSOR REV, V37, P43, DOI 10.1108/SR-08-2016-0145; Yu F, 2005, J NONDESTRUCT EVAL, V24, P143, DOI 10.1007/s10921-005-8783-9; Zhan Y, 2017, ULTRASONICS, V73, P271, DOI 10.1016/j.ultras.2016.08.013; Zhang WM, 2017, NONDESTRUCT TEST EVA, V32, P152, DOI 10.1080/10589759.2016.1184266; Zhou DQ, 2017, MEASUREMENT, V105, P136, DOI 10.1016/j.measurement.2017.04.001; Zilberstein V, 2002, J PRESS VESS-T ASME, V124, P375, DOI 10.1115/1.1491273	35	4	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188197	10.1371/journal.pone.0188197	http://dx.doi.org/10.1371/journal.pone.0188197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145500	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800087
J	Onyango, DO; Yuen, CM; Cain, KP; Ngari, F; Masini, EO; Borgdorff, MW				Onyango, Dickens O.; Yuen, Courtney M.; Cain, Kevin P.; Ngari, Faith; Masini, Enos O.; Borgdorff, Martien W.			Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya	PLOS ONE			English	Article							RISK-FACTORS; SOUTH-AFRICA; INFECTED ADULTS; THERAPY; DEATH; COHORT; PREVALENCE; PROGRAM; INDIA	Background Mortality from TB continues to be a global public health challenge. TB ranks alongside Human Immunodeficiency Virus (HIV) as the leading infectious causes of death globally. HIV is a major driver of TB related morbidity and mortality while TB is the leading cause of mortality among people living with HIV/AIDS. We sought to determine excess mortality associated with HIV and the effect of antiretroviral therapy on reducing mortality among tuberculosis patients in Kenya. Methods We conducted a retrospective analysis of Kenya national tuberculosis program data of patients enrolled from 2013 through 2014. We used direct standardization to obtain standardized mortality ratios for tuberculosis patients compared with the general population. We calculated the population attributable fraction of tuberculosis deaths due to HIV based on the standardized mortality ratio for deaths among TB patients with HIV compared to TB patients without HIV. We used Cox proportional hazards regression for assessing risk factors for mortality. Results Of 162,014 patients included in the analysis, 6% died. Mortality was 10.6 (95% CI: 10.4-10.8) times higher among TB patients than the general population; 42% of deaths were attributable to HIV infection. Patients with HIV who were not receiving ART had an over four-fold risk of death compared to patients without HIV (aHR = 4.2, 95% CI 3.9-4.6). In contrast, patients with HIV who were receiving ART had only 2.6 times the risk of death (aHR = 2.6, 95% CI 2.5-2.7). Conclusion HIV was a significant contributor to TB-associated deaths in Kenya. Mortality among HIV-infected individuals was higher among those not on ART than those on ART. Early initiation of ART among HIV infected people (a "test and treat" approach) should further reduce TB-associated deaths.	[Onyango, Dickens O.] Kisumu Cty Dept Hlth, Kisumu, Kenya; [Yuen, Courtney M.] Harvard Med Sch, Boston, MA USA; [Cain, Kevin P.; Borgdorff, Martien W.] US Ctr Dis Control & Prevent Kenya, Kisumu, Kenya; [Ngari, Faith; Masini, Enos O.] Natl TB Leprosy & Lung Dis Program, Nairobi, Kenya	Harvard University; Harvard Medical School	Onyango, DO (corresponding author), Kisumu Cty Dept Hlth, Kisumu, Kenya.	macdickens2002@gmail.com	Onyango, Dickens/AAF-9545-2020	Onyango, Dickens/0000-0002-1634-0531; Yuen, Courtney/0000-0002-5219-2599	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	A portion of the staffing support for this project was funded by U.S. President's Emergency Plan for AIDS Relief (PEPFAR).	Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; [Anonymous], 2010, TREATM TUB GUID; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; COLOMBIA. MINISTERIO DE SALUD. CINETS, 2013, GUID MAN TUB LEPR KE, P21; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Field N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0679-9; Fox GJ, 2016, INT J INFECT DIS; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Harries AD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17396; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kenya National Bureau of Statistics, 2012, 2009 KEN POP HOUS CE; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Kipruto H., 2013, ASSESSMENT PERFORMAN; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kolappan C, 2006, B WORLD HEALTH ORGAN, V84, P555, DOI 10.2471/BLT.05.022087; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lesko CR, 2016, INT J EPIDEMIOL, V45, P140, DOI 10.1093/ije/dyv352; Lighter Jennifer, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P61, DOI 10.1016/j.cppeds.2008.12.003; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Measure DHS, 2006, METH DHS MORT RAT ES; Mendelson M, 2007, BRIT MED BULL, V81-82, P149, DOI 10.1093/bmb/ldm009; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moosazadeh M, 2015, E MEDITERR HEALTH J, V21, P287, DOI 10.26719/2015.21.4.287; Nakiyingi L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0812-4; Nyang'au LO, 2016, 1 LINE ANTITB DRUG R; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Pina JM, 2006, REV CLIN ESP, V206, P560, DOI 10.1016/S0014-2565(06)72897-1; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Schreiber YS, 2009, INT J TUBERC LUNG D, V13, P1274; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; UNAIDS, FACT SHEET LAT STAT; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Wang WB, 2015, B WORLD HEALTH ORGAN, V93, P826, DOI 10.2471/BLT.15.154161; WHO, 2014, GLOB TUB REP 2014; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2012, POL COLL IB HIV ACT; World Health Organization, 2015, GUID START ANT THER; World Health Organization (WHO), 2016, END TB STRAT; Yan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160481; Yuen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099880	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188235	10.1371/journal.pone.0188235	http://dx.doi.org/10.1371/journal.pone.0188235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145454	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800097
J	Parajuli, A; Gronroos, M; Kauppi, S; Plociniczak, T; Roslund, MI; Galitskaya, P; Laitinen, OH; Hyoty, H; Jumpponen, A; Strommer, R; Romantschuk, M; Hui, N; Sinkkonen, A				Parajuli, Anirudra; Gronroos, Mira; Kauppi, Sari; Plociniczak, Tomasz; Roslund, Marja I.; Galitskaya, Polina; Laitinen, Olli H.; Hyoty, Heikki; Jumpponen, Ari; Strommer, Rauni; Romantschuk, Martin; Hui, Nan; Sinkkonen, Aki			The abundance of health-associated bacteria is altered in PAH polluted soils-Implications for health in urban areas?	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; MICROBIAL COMMUNITY STRUCTURE; GUT MICROBIOTA; OCCUPATIONAL-EXPOSURE; CONTAMINATED SOIL; CANCER-RISK; DEGRADATION; DIVERSITY; BIODEGRADATION; BIOREMEDIATION	Long-term exposure to polyaromatic hydrocarbons (PAHs) has been connected to chronic human health disorders. It is also well-known that i) PAH contamination alters soil bacterial communities, ii) human microbiome is associated with environmental microbiome, and iii) alteration in the abundance of members in several bacterial phyla is associated with adverse or beneficial human health effects. We hypothesized that soil pollution by PAHs altered soil bacterial communities that had known associations with human health. The rationale behind our study was to increase understanding and potentially facilitate reconsidering factors that lead to health disorders in areas characterized by PAH contamination. Large containers filled with either spruce forest soil, pine forest soil, peat, or glacial sand were left to incubate or contaminated with creosote. Biological degradation of PAHs was monitored using GC-MS, and the bacterial community composition was analyzed using 454 pyrosequencing. Proteobacteria had higher and Actinobacteria and Bacteroidetes had lower relative abundance in creosote contaminated soils than in non-contaminated soils. Earlier studies have demonstrated that an increase in the abundance of Proteobacteria and decreased abundance of the phyla Actinobacteria and Bacteroidetes are particularly associated with adverse health outcomes and immunological disorders. Therefore, we propose that pollution-induced shifts in natural soil bacterial community, like in PAH-polluted areas, can contribute to the prevalence of chronic diseases. We encourage studies that simultaneously address the classic "adverse toxin effect" paradigm and our novel "altered environmental microbiome" hypothesis.	[Parajuli, Anirudra; Gronroos, Mira; Roslund, Marja I.; Strommer, Rauni; Romantschuk, Martin; Hui, Nan; Sinkkonen, Aki] Univ Helsinki, Sect Environm Ecol, Dept Environm Sci, Lahti, Finland; [Kauppi, Sari] SYKE, Finnish Environm Inst, Ctr Sustainable Consumpt & Prod Contaminants, Helsinki, Finland; [Plociniczak, Tomasz] Univ Silesia, Dept Microbiol, Katowice, Poland; [Galitskaya, Polina; Romantschuk, Martin; Sinkkonen, Aki] Kazan Fed Univ, Kazan, Russia; [Laitinen, Olli H.; Hyoty, Heikki] Univ Tampere, Sch Med, Dept Virol, Tampere, Finland; [Hyoty, Heikki] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Hyoty, Heikki] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS USA	University of Helsinki; Finnish Environment Institute; University of Silesia in Katowice; Kazan Federal University; Tampere University; Pirkanmaa Hospital District; Kansas State University	Hui, N; Sinkkonen, A (corresponding author), Univ Helsinki, Sect Environm Ecol, Dept Environm Sci, Lahti, Finland.; Sinkkonen, A (corresponding author), Kazan Fed Univ, Kazan, Russia.	nan.hui@helsinki.fi; aki.sinkkonen@helsinki.fi	Romantschuk, Martin/A-6405-2008; Roslund, M.I./ABH-9506-2020; Laitinen, Olli H/A-6618-2016; Hui, Nan/H-3560-2018; Galitskaya, Polina/AAR-3186-2021	Roslund, M.I./0000-0002-3153-7375; Laitinen, Olli H/0000-0002-3751-9952; Hui, Nan/0000-0001-8517-8454; Galitskaya, Polina/0000-0002-5070-786X; Gronroos, Mira/0000-0002-8210-8837; sinkkonen, aki/0000-0002-6821-553X; Plociniczak, Tomasz/0000-0001-9594-4378; Kauppi, Sari/0000-0001-7641-200X; Hyoty, Heikki/0000-0003-0370-4145	Finnish Funding Agency for Technology and InnovationTekes [40333/14]; Tekes [40333/14]	Finnish Funding Agency for Technology and InnovationTekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES))	The research was funded by Finnish Funding Agency for Technology and InnovationTekes (decision number 40333/14), https://www.tekes.fiien/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Heidi Jaaskelainen provided chemical analytical assistance. The research was funded by Tekes (decision number 40333/14). We thank the reviewers for their constructive feedbacks on the manuscript.	Abdel-Shafy Hussein I., 2016, Egyptian Journal of Petroleum, V25, P107, DOI 10.1016/j.ejpe.2015.03.011; Antizar-Ladislao B, 2008, INT BIODETER BIODEGR, V61, P357, DOI 10.1016/j.ibiod.2007.10.002; Belz RG, 2016, SCI TOTAL ENVIRON, V566, P1205, DOI 10.1016/j.scitotenv.2016.05.176; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Cachada A, 2012, SCI TOTAL ENVIRON, V430, P184, DOI 10.1016/j.scitotenv.2012.04.075; Cerniglia Carl E., 1993, Current Opinion in Biotechnology, V4, P331, DOI [10.1016/0958-1669(93)90104-5, 10.1007/BF00129093]; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ciaccio CE, 2015, J ASTHMA, V52, P873, DOI 10.3109/02770903.2015.1028076; Cousins IT, 1999, SCI TOTAL ENVIRON, V228, P5, DOI 10.1016/S0048-9697(99)00015-7; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Diggs DL, 2011, J ENVIRON SCI HEAL C, V29, P324, DOI 10.1080/10590501.2011.629974; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrarese E, 2008, J HAZARD MATER, V152, P128, DOI 10.1016/j.jhazmat.2007.06.080; Garrels W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21953; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Hansi M, 2014, ENVIRON POLLUT, V184, P443, DOI 10.1016/j.envpol.2013.09.027; Hanski I., 2014, Ethics in Science and Environmental Politics (ESEP), V14, P19, DOI 10.3354/esep00150; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Honkonen O, 2013, ENVIRON MONIT ASSESS, V185, P1437, DOI 10.1007/s10661-012-2643-8; Hui N, 2012, BOREAL ENV RES; Jacobson MC, 2000, REV GEOPHYS, V38, P267, DOI 10.1029/1998RG000045; Jensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056418; Johnsen AR, 2007, APPL ENVIRON MICROB, V73, P1474, DOI 10.1128/AEM.02236-06; JUHASZ A. L., 2000, INT BIODETERIOR, V45, P88; Karstensen KH, 1996, NORDIC GUIDELINES CH; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kauppi S, 2012, ENVIRON SCI POLLUT R, V19, P53, DOI 10.1007/s11356-011-0528-y; Kaushik CP, 2012, POLYCYCL AROMAT COMP, V32, P626, DOI 10.1080/10406638.2012.695318; Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kulik N, 2006, J ENVIRON MANAGE, V78, P382, DOI 10.1016/j.jenvman.2005.05.005; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Llado S, 2015, J HAZARD MATER, V283, P35, DOI 10.1016/j.jhazmat.2014.08.065; Lors C, 2010, CHEMOSPHERE, V81, P1263, DOI 10.1016/j.chemosphere.2010.09.021; Lotfabad SK, 2002, APPL MICROBIOL BIOT, V60, P361, DOI 10.1007/s00253-002-1104-7; Mah Ka Weng, 2008, Allergol Int, V57, P65, DOI 10.2332/allergolint.O-07-501; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Masih A, 2006, CHEMOSPHERE, V65, P449, DOI 10.1016/j.chemosphere.2006.01.062; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mcgenity T.J., 2010, HDB HYDROCARBON LIPI, P3847, DOI [10.1007/978-3-540-77587-4_301, DOI 10.1007/978-3-540-77587-4_301]; Mehta CM, 2016, COMPOST SCI UTIL, V24, P105, DOI 10.1080/1065657X.2015.1087894; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; MUELLER JG, 1989, ENVIRON SCI TECHNOL, V23, P1197, DOI 10.1021/es00068a003; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsson AC, 2010, OCCUP ENVIRON MED, V67, P98, DOI 10.1136/oem.2009.046680; Panzer AR, 2015, CURR OPIN RHEUMATOL, V27, P373, DOI 10.1097/BOR.0000000000000191; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Peng JJ, 2013, BIORESOURCE TECHNOL, V143, P608, DOI 10.1016/j.biortech.2013.06.039; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; Plociniczak T, 2013, APPL SOIL ECOL, V63, P1, DOI 10.1016/j.apsoil.2012.09.009; Plociniczak T, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpla.2016.00101, 10.3389/fpls.2016.00101]; Rantalainen ML, 2006, SCI TOTAL ENVIRON, V369, P99, DOI 10.1016/j.scitotenv.2006.05.005; Rivas FJ, 2006, J HAZARD MATER, V138, P234, DOI 10.1016/j.jhazmat.2006.07.048; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Sawulski P, 2014, BIODEGRADATION, V25, P835, DOI 10.1007/s10532-014-9703-4; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Singleton DR, 2006, ENVIRON MICROBIOL, V8, P1736, DOI 10.1111/j.1462-2920.2006.01112.x; Sinkkonen A, 2014, J ENVIRON SCI HEAL B, V49, P756, DOI 10.1080/03601234.2014.929865; Sinkkonen A, 2013, J SOIL SEDIMENT, V13, P1430, DOI 10.1007/s11368-013-0742-y; Sinkkonen A, 2013, ENVIRON SCI POLLUT R, V20, P1737, DOI 10.1007/s11356-012-1047-1; Sun JH, 2009, ECOTOX ENVIRON SAFE, V72, P1614, DOI 10.1016/j.ecoenv.2008.05.010; Tejeda-Agredano MC, 2013, SOIL BIOL BIOCHEM, V57, P830, DOI 10.1016/j.soilbio.2012.08.008; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Torneman N, 2008, ENVIRON TOXICOL CHEM, V27, P1039, DOI 10.1897/07-440.1; Unwin J, 2006, ANN OCCUP HYG, V50, P395, DOI [10.1093/annhyg/mel010, 10.1093/annhyg/mei010]; Valderrama C, 2008, J HAZARD MATER, V157, P386, DOI 10.1016/j.jhazmat.2007.12.119; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y., 2016, FRONTIERS MICROBIOLO, V7; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012; WILD SR, 1995, ENVIRON POLLUT, V88, P91, DOI 10.1016/0269-7491(95)91052-M; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ying S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141842; Yu D, 2015, APPL SOIL ECOL, V92, P47, DOI 10.1016/j.apsoil.2015.03.005; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	85	33	36	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187852	10.1371/journal.pone.0187852	http://dx.doi.org/10.1371/journal.pone.0187852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145477	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800035
J	Lee, NS; Chang, HR; Kim, S; Ji, JH; Lee, J; Lee, HJ; Seo, Y; Kang, M; Han, JS; Myung, K; Kim, Y; Kim, H				Lee, Nam Soo; Chang, Hae Ryung; Kim, Soomi; Ji, Jae-Hoon; Lee, Joorak; Lee, Hyun Ji; Seo, Yoojeong; Kang, Misun; Han, Joo Seok; Myung, Kyungjae; Kim, Yonghwan; Kim, Hongtae			Ring finger protein 126 (RNF126) suppresses ionizing radiation-induced p53-binding protein 1 (53BP1) focus formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; histone modification; signal transduction; ubiquitylation (ubiquitination)	DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; BINDING DOMAINS; REPAIR PROTEINS; UBIQUITIN; ATM; BRCA1; RNF8; UBIQUITYLATION	Cells have evolved sophisticated mechanisms to maintain genomic integrity in response to DNA damage. Ionizing radiation (IR)-induced DNA damage results in the formation of IR-induced foci (iRIF) in the nucleus. The iRIF formation is part of the DNA damage response (DDR), which is an essential signaling cascade that must be strictly regulated because either the loss of or an augmented DDR leads to loss of genome integrity. Accordingly, negative regulation of the DDR is as critical as its activation. In this study, we have identified ring finger protein 126 (RNF126) as a negative regulator of the DDR from a screen of iRIF containing 53BP1. RNF126 overexpression abolishes not only the formation of 53BP1 iRIF but also of RNF168, FK2, RAP80, and BRCA1. However, the iRIF formation of H2AX, MDC1, and RNF8 is maintained, indicating that RNF126 acts between RNF8 and RNF168 during the DDR. In addition, RNF126 overexpression consistently results in the loss of RNF168-mediated H2A monoubiquitination at lysine 13/15 and inhibition of the non-homologous end joining capability. Taken together, our findings reveal that RNF126 is a novel factor involved in the negative regulation of DDR, which is important for sustaining genomic integrity.	[Lee, Nam Soo; Kim, Soomi; Lee, Joorak; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea; [Chang, Hae Ryung; Lee, Hyun Ji; Seo, Yoojeong; Kim, Yonghwan] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea; [Ji, Jae-Hoon] Ajou Univ, Sch Med, Genom Instabil Res Ctr, Suwon 16499, South Korea; [Kang, Misun; Han, Joo Seok; Myung, Kyungjae] Ulsan Natl Inst Sci & Technol, Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Kim, Hongtae] Sungkyunkwan Univ, Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon 16419, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University; Ajou University; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU)	Kim, Y (corresponding author), 100 Cheongpa Ro,47 Gil, Seoul 04310, South Korea.; Kim, H (corresponding author), 300 Cheoncheon Dong, Suwon 16473, South Korea.	yhkim@sookmyung.ac.kr; khtcat@skku.edu		Kim, Soomi/0000-0003-2171-4398; Lee, Hyunji/0000-0001-8092-6273	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A2A01003975, NRF-2016R1A5A1011974]; Genome Technology to Business Translation Program [2014M3C9A2064688]; Korean government (MSIP) [2011-0030043]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Genome Technology to Business Translation Program; Korean government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (NRF-2015R1A2A2A01003975 and NRF-2016R1A5A1011974), the Genome Technology to Business Translation Program (2014M3C9A2064688), and the Korean government (MSIP) (2011-0030043). The authors declare that they have no conflicts of interest with the contents of this article.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ishida N, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00347-16; Jungmichel S, 2012, NUCLEIC ACIDS RES, V40, P3913, DOI 10.1093/nar/gkr1300; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Min S, 2014, CELL CYCLE, V13, P666, DOI 10.4161/cc.27548; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang Y, 2016, ONCOGENE, V35, P1363, DOI 10.1038/onc.2015.198	33	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					588	598		10.1074/jbc.M116.765602	http://dx.doi.org/10.1074/jbc.M116.765602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29167269	Green Published, hybrid			2022-12-26	WOS:000419915400015
J	Conlan, JA; Humphrey, CA; Severati, A; Francis, DS				Conlan, Jessica A.; Humphrey, Craig A.; Severati, Andrea; Francis, David S.			Influence of different feeding regimes on the survival, growth, and biochemical composition of Acropora coral recruits	PLOS ONE			English	Article							SCLERACTINIAN CORAL; MARINE FISH; FATTY-ACID; POSTSETTLEMENT SURVIVAL; STYLOPHORA-PISTILLATA; PORITES-COMPRESSA; THERMAL-STRESS; HETEROTROPHY; ZOOXANTHELLAE; SETTLEMENT	Heterotrophic feeding in newly-settled coral planulae can potentially improve survivorship and accelerate early development in some species; however, an optimal diet to facilitate this does not currently exist. This study evaluated the efficacy of three heterotrophic feeding regimes (enriched rotifers, unfiltered seawater, and a novel, particulate diet), against a wholly-phototrophic treatment on Acropora hyacinthus, A. loripes, A. millepora, and A. tenuis recruits, over 93 days post-settlement. The unfiltered seawater treatment recorded maximum survival for all species (A. hyacinthus 95.9 +/- 8.0%, A. loripes: 74.3 +/- 11.5%, A. millepora: 67 +/- 12.7%, A. tenuis: 53.2 +/- 11.3%), although not significant. Growth (% surface area gain) was also greatest in the unfiltered seawater, and this was significant for A. millepora (870 +/- 307%) and A. tenuis (693 +/- 91.8%) (p< 0.05). Although total lipid concentration was relatively stable across treatments, the lipid class composition exhibited species-specific responses to each treatment. Lower saturated and higher polyunsaturated fatty acids appeared beneficial to recruit performance, particularly in the unfiltered seawater, which generally contained the highest levels of 20: 5n-3 (EPA), 22:6n-3 (DHA), and 20:4n-6 (ARA). The present study demonstrates the capacity of a nutritionally adequate and readily accepted heterotrophic feeding regime to increase coral recruit survival, growth, and health, which can greatly reduce the time required in cost-and labour-intensive culture.	[Conlan, Jessica A.; Francis, David S.] Deakin Univ, Geelong, Vic, Australia; [Conlan, Jessica A.; Francis, David S.] Sch Life & Environm Sci, Warrnambool Campus, Warrnambool, Vic, Australia; [Conlan, Jessica A.; Humphrey, Craig A.; Severati, Andrea] Australian Inst Marine Sci, Natl Sea Simulator, Townsville, Qld, Australia	Deakin University; Australian Institute of Marine Science	Conlan, JA (corresponding author), Deakin Univ, Geelong, Vic, Australia.; Conlan, JA (corresponding author), Sch Life & Environm Sci, Warrnambool Campus, Warrnambool, Vic, Australia.; Conlan, JA (corresponding author), Australian Inst Marine Sci, Natl Sea Simulator, Townsville, Qld, Australia.	jessconlan@live.com.au		Humphrey, Craig/0000-0002-1303-036X; Conlan, Jessica/0000-0003-0908-0345; Francis, David/0000-0002-4829-6926				Amar KO, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-126; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ARAI T, 1993, CORAL REEFS, V12, P71; Barclay W, 1996, J WORLD AQUACULT SOC, V27, P314, DOI 10.1111/j.1749-7345.1996.tb00614.x; Chamberland VF, 2016, B MAR SCI, V92, P263, DOI 10.5343/bms.2015.1074; Conceicao LEC, 2010, AQUAC RES, V41, P613, DOI 10.1111/j.1365-2109.2009.02242.x; Conlan JA, 2014, AQUACULTURE, V434, P159, DOI 10.1016/j.aquaculture.2014.07.030; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; Denstadli V, 2011, J NUTR, V141, P1618, DOI 10.3945/jn.111.141820; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Dunn JG, 2012, J EXP MAR BIOL ECOL, V411, P34, DOI 10.1016/j.jembe.2011.10.013; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Figueiredo J, 2012, CORAL REEFS, V31, P613, DOI 10.1007/s00338-012-0874-3; Furnas MJ, 1996, CONT SHELF RES, V16, P1127, DOI 10.1016/0278-4343(95)00060-7; Godinot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025024; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Guest JR, 2014, CORAL REEFS, V33, P45, DOI 10.1007/s00338-013-1114-1; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harrison Peter L., 2007, P316; Hauville MR, 2016, AQUAC RES, V47, P1443, DOI 10.1111/are.12602; Hii YS, 2009, AQUACULT INT, V17, P363, DOI 10.1007/s10499-008-9208-4; Hillyer KE, 2016, J EXP BIOL, V219, P516, DOI 10.1242/jeb.128660; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Imbs AB, 2010, RUSS J MAR BIOL+, V36, P452, DOI 10.1134/S1063074010060076; Izquierdo MS, 2000, FISH PHYSIOL BIOCHEM, V22, P97, DOI 10.1023/A:1007810506259; Jung RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028373; Kindt R., 2005, WORLD; Kuhn M., 2016, R PACKAGE VERSION 6; Leal MC, 2016, REV AQUACULT, V8, P136, DOI 10.1111/raq.12087; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Lund I., 2007, THESIS, P1; Mejri S, 2014, AQUACULTURE, V431, P99, DOI 10.1016/j.aquaculture.2014.03.022; Mendiburu F., 2015, AGRICOLAE STAT PROCE; Morais S, 2007, AQUACULTURE, V268, P106, DOI 10.1016/j.aquaculture.2007.04.033; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; Nitschke MR, 2016, CORAL REEFS, V35, P335, DOI 10.1007/s00338-015-1349-0; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; Parrish C. C., 1996, Journal of Chromatography A, V741, P91, DOI 10.1016/0021-9673(96)00147-1; Penin L, 2011, HYDROBIOLOGIA, V663, P259, DOI 10.1007/s10750-010-0569-0; Petersen D., 2005, THESIS U DUISBURG ES, P165; Petersen D, 2008, AQUACULTURE, V277, P174, DOI 10.1016/j.aquaculture.2008.02.034; R Development Core Team, 2016, R LANG ENV STAT COMP; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Regnier T, 2012, J EXP ZOOL PART A, V317A, P347, DOI 10.1002/jez.1728; Rodrigues LJ, 2008, J EXP MAR BIOL ECOL, V358, P136, DOI 10.1016/j.jembe.2008.02.004; RStudio Team, 2015, RSTUDIO INT DEV ENV; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sebens KP, 1998, MAR BIOL, V131, P347, DOI 10.1007/s002270050328; Sorgeloos P, 2001, AQUACULTURE, V200, P147, DOI 10.1016/S0044-8486(01)00698-6; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Toh TC, 2013, AQUACULTURE, V414, P288, DOI 10.1016/j.aquaculture.2013.08.025; Toh TC, 2013, MAR FRESHW BEHAV PHY, V46, P313, DOI 10.1080/10236244.2013.832890; Toh TC, 2014, PLOS ONE, P9; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tremblay P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38112; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	66	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188568	10.1371/journal.pone.0188568	http://dx.doi.org/10.1371/journal.pone.0188568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182647	Green Submitted, gold, Green Published			2022-12-26	WOS:000416402000037
J	Neumann, AM; Abele, J; Kirschstein, T; Engelmann, R; Sellmann, T; Kohling, R; Muller-Hilke, B				Neumann, Anne-Marie; Abele, Julia; Kirschstein, Timo; Engelmann, Robby; Sellmann, Tina; Koehling, Ruediger; Mueller-Hilke, Brigitte			Mycophenolate mofetil prevents the delayed T cell response after pilocarpine-induced status epilepticus in mice	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; BLOOD-BRAIN-BARRIER; RASMUSSENS ENCEPHALITIS; HIPPOCAMPAL SCLEROSIS; SPONTANEOUS SEIZURES; DENTATE GYRUS; C57BL/6 MICE; MODEL; INFLAMMATION; EPILEPTOGENESIS	Growing clinical and laboratory evidence corroborates a role for the immune system in the pathophysiology of epilepsy. In order to delineate the immune response following pilocarpine- induced status epilepticus (SE) in the mouse, we monitored the kinetics of leukocyte presence in the hippocampus over the period of four weeks. SE was induced following a ramping protocol of pilocarpine injection into 4 -5 weeks old C57BL/6 mice. Brains were removed at days 1-4, 14 or 28 after SE, and the hippocampi were analyzed via flow cytometry, via quantitative reverse transcriptase PCR (qRT-PCR) and via immunohistochemistry. Epileptogenesis was confirmed by Timm staining of mossy fiber sprouting in the inner molecular layer of the dentate gyrus. The flow cytometry data revealed a biphasic immune response following pilocarpine-induced SE with a transient increase in activated CD11b(+) and F4/80(+) macrophages within the first four days replaced by an increase in CD3(+) T-lymphocytes around day 28. This delayed T cell response was confirmed via qRT-PCR and via immunohistochemistry. In addition, qRT-PCR data could show that the delayed T cell response was associated with an increased CD8/CD4 ratio indicating a cytotoxic T cell response after SE. Intriguingly, early intervention with mycophenolate mofetil administration on days 0-3 after SE prevented this delayed T cell response. These results show an orchestrated immunological sequela and provide evidence that the delayed T cell response is sensitive to early immunomodulatory intervention.	[Neumann, Anne-Marie; Abele, Julia; Engelmann, Robby; Mueller-Hilke, Brigitte] Univ Rostock, Inst Immunol, Rostock, Germany; [Neumann, Anne-Marie; Abele, Julia; Kirschstein, Timo; Sellmann, Tina; Koehling, Ruediger] Univ Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany	University of Rostock; University of Rostock	Muller-Hilke, B (corresponding author), Univ Rostock, Inst Immunol, Rostock, Germany.	brigitte.mueller-hilke@med.uni-rostock.de	Köhling, Rüdiger/K-8647-2013	Köhling, Rüdiger/0000-0003-3330-4898; Neumann, Anne-Marie/0000-0001-5831-0608	Medical Faculty of the University of Rostock (FORUN grants) [889026/2011, 889026/2012]	Medical Faculty of the University of Rostock (FORUN grants)	This study was funded by grants from Medical Faculty of the University of Rostock (FORUN grants no. 889026/2011 and 889026/2012 to TK and BMH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by grants from Medical Faculty of the University of Rostock (FORUN grants no. 889026/2011 and 889026/2012 to TK and BMH). The authors gratefully acknowledge Katrin Porath and Hanka Schmidt for their excellent technical assistance. The authors have declared that no competing interests exist.	Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Aronica E, 2007, NEUROSCIENTIST, V13, P100, DOI 10.1177/1073858406295832; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; Bauer J, 2007, ANN NEUROL, V62, P67, DOI 10.1002/ana.21148; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Borges K, 2006, EXP NEUROL, V201, P416, DOI 10.1016/j.expneurol.2006.04.031; Cavalheiro EA, 1996, EPILEPSIA, V37, P1015, DOI 10.1111/j.1528-1157.1996.tb00541.x; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; Cusick MF, 2017, J NEUROVIROL, V23, P696, DOI 10.1007/s13365-017-0554-8; Cusick MF, 2013, J VIROL, V87, P1849, DOI 10.1128/JVI.02747-12; Deprez F, 2011, NEUROBIOL DIS, V44, P174, DOI 10.1016/j.nbd.2011.06.011; Golombeck KS, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000232; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Libbey JE, 2011, J VIROL, V85, P6913, DOI 10.1128/JVI.00458-11; Lu JQ, 2017, J NEUROPATH EXP NEUR, V76, P206, DOI 10.1093/jnen/nlx001; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Muller CJ, 2009, GENES BRAIN BEHAV, V8, P481, DOI 10.1111/j.1601-183X.2009.00490.x; RACINE RJ, 1973, ELECTROEN CLIN NEURO, V35, P553, DOI 10.1016/0013-4694(73)90033-3; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Schauwecker PE, 2012, NEUROBIOL DIS, V45, P297, DOI 10.1016/j.nbd.2011.08.013; Schulz R, 2012, NEUROBIOL DIS, V45, P337, DOI 10.1016/j.nbd.2011.08.019; Schwab N, 2009, BRAIN, V132, P1236, DOI 10.1093/brain/awp003; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; TIMM F, 1958, Dtsch Z Gesamte Gerichtl Med, V46, P706, DOI 10.1007/BF00665092; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Vezzani A, 2011, BRAIN BEHAV IMMUN, V25, P1281, DOI 10.1016/j.bbi.2011.03.018; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vinet J, 2016, GLIA, V64, P1350, DOI 10.1002/glia.23008; Winokur RS, 2004, EPILEPSY RES, V58, P93, DOI 10.1016/j.eplepsyres.2004.01.002; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0187330	10.1371/journal.pone.0187330	http://dx.doi.org/10.1371/journal.pone.0187330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182639	gold, Green Published, Green Submitted			2022-12-26	WOS:000416402000003
J	Roth, M; Pasquali, C; Stolz, D; Tamm, M				Roth, Michael; Pasquali, Christian; Stolz, Daiana; Tamm, Michael			Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; BACTERIAL EXTRACT; T-CELLS; BV; EXPRESSION; RESPONSES; IMMUNOSTIMULANT; CALRETICULIN; INTERFERON; CHILDREN	Background Bronchial epithelial cells (BEC) are primary target for Rhinovirus infection through attaching to cell membrane proteins. OM-85, a bacterial extract, improves recovery of asthma and COPD patients after viral infections, but only part of the mechanism was addressed, by focusing on defined immune cells. Objective We therefore determined the effect of OM-85 on isolated primary human BEC of controls (n = 8), asthma patients (n = 10) and COPD patients (n = 9). Methods BEC were treated with OM-85 alone (24 hours) or infected with Rhinovirus. BEC survival was monitored by manual cell counting and Rhinovirus replication by lytic activity. Immunoblotting and ELISA were used to determine the expression of Rhinovirus interacting proteins: intracellular adhesion molecule (ICAM), major histocompatibility complex class II (MHC-2), complement component C1q receptor (C1q-R), inducible T-Cell co-stimulator (ICOS), its ligand ICOSL, and myeloid differentiation primary response gene 88 (Myd88); as well as for signal transducers Erk1/2, p38, JNK mitogen activated protein kinases MAPK), and cAMP. Results OM-85 significantly reduced Rhinovirus-induced BEC death and virus replication. OM-85 significantly increased the expression of virus interacting proteins C1q-R and beta-defensin in all 3 probes and groups, which was prevented by either Erk1/2 MAPK or cAMP inhibition. In addition, OM-85 significantly reduced Rhinovirus induced expression of ICAM1 involving p38 MAPK. In BEC OM-85 had no significant effect on the expression of ICOS, ICOSL and MHC-2 membrane proteins nor on the adaptor protein MyD88. Conclusion The OM-85-induced increased of C1q-R and beta-defensin, both important for antigen presentation and phagocytosis, supports its activity in host cell's defence against Rhinovirus infection.	[Roth, Michael; Stolz, Daiana; Tamm, Michael] DBM Univ Basel, Pulm Cell Res, Basel, Switzerland; [Roth, Michael; Stolz, Daiana; Tamm, Michael] Univ Hosp Basel, Pneumol Clin, Basel, Switzerland; [Pasquali, Christian] OM Pharma SA, Geneva, Switzerland	University of Basel	Roth, M (corresponding author), DBM Univ Basel, Pulm Cell Res, Basel, Switzerland.; Roth, M (corresponding author), Univ Hosp Basel, Pneumol Clin, Basel, Switzerland.	Michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821; Stolz, Daiana/0000-0003-0099-882X	OM Pharma	OM Pharma	MT received funding for this work from OM Pharma, which was in part used to cover the salary of a post-doc who was partly involved in this work. CP received financial support in the form of a salary from OM Pharma, a member of the Vifor Pharma Group. Vifor provided support in the form of cost reimbursement of all biologicals and chemicals used to perform this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahrens B, 2011, INT ARCH ALLERGY IMM, V156, P196, DOI 10.1159/000322352; Anthonisen NR, 1997, AM J RESP CRIT CARE, V156, P1713, DOI 10.1164/ajrccm.156.6.ed15-97; Antonova L P, 2008, Probl Tuberk Bolezn Legk, P8; Baruah P, 2009, BLOOD, V113, P3485, DOI 10.1182/blood-2008-06-164392; Bessler WG, 2010, INT IMMUNOPHARMACOL, V10, P1086, DOI 10.1016/j.intimp.2010.06.009; Blaas Dieter, 2016, Mol Cell Pediatr, V3, P21, DOI 10.1186/s40348-016-0049-3; Bochkov YA, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0608-7; Bowman LM, 2001, INFECT IMMUN, V69, P3719, DOI 10.1128/IAI.69.6.3719-3727.2001; Capetti A, 2013, HUM VACC IMMUNOTHER, V9, P1849, DOI 10.4161/hv.25104; Cazzola Mario, 2009, Ther Adv Respir Dis, V3, P59, DOI 10.1177/1753465809104677; CONWAY EM, 1995, J BIOL CHEM, V270, P17011, DOI 10.1074/jbc.270.28.17011; Coviello S, 2014, HUM VACC IMMUNOTHER, V10, P2896, DOI 10.4161/hv.29784; Dang AT, 2017, SCI REP-UK, V7, DOI 10.1038/srep43844; DUCHOW J, 1992, INT J IMMUNOPHARMACO, V14, P761, DOI 10.1016/0192-0561(92)90073-T; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; EMMERICH B, 1990, RESPIRATION, V57, P90; Esposito S, 2014, VACCINE, V32, P2546, DOI 10.1016/j.vaccine.2014.03.055; Graham LM, 2015, CURR MED RES OPIN, V9, P1; Grainge CL, 2013, CHEST, V144, P1906, DOI 10.1378/chest.12-1944; Han L, 2014, AM J RHINOL ALLERGY, V28, P110, DOI 10.2500/ajra.2013.27.4021; Hong C, 2013, MOL IMMUNOL, V55, P237, DOI 10.1016/j.molimm.2013.02.003; Hostettler KE, 2008, CLIN EXP ALLERGY, V38, P1309, DOI 10.1111/j.1365-2222.2008.03017.x; Huber M, 2005, EUR J MED RES, V10, P209; Kearney SC, 2015, ANN ALLERG ASTHMA IM, V114, P364, DOI 10.1016/j.anai.2015.02.008; Kim SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.165; Lambers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073399; Liao Jia-Yi, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P508; Luan H, 2014, J INTERF CYTOK RES, V34, P526, DOI 10.1089/jir.2013.0077; Mukhopadhyay S, 2014, RESPIROLOGY, V19, P508, DOI 10.1111/resp.12285; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Nazzal D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.377; Oliver BGG, 2008, THORAX, V63, P519, DOI 10.1136/thx.2007.081752; Parola C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082867; Pasquali C, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00041; Powell JJ, 2010, J AUTOIMMUN, V34, pJ226, DOI 10.1016/j.jaut.2009.11.006; Qian XS, 2006, EUR J IMMUNOL, V36, P906, DOI 10.1002/eji.200535253; Quezada A, 1999, J INVEST ALLERG CLIN, V9, P178; Razi CH, 2010, J ALLERGY CLIN IMMUN, V126, P763, DOI 10.1016/j.jaci.2010.07.038; Schaad UB, 2010, WORLD J PEDIATR, V6, P5, DOI 10.1007/s12519-010-0001-x; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Traub S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003520; Verneret M, 2014, J INNATE IMMUN, V6, P426, DOI 10.1159/000358834; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Zelle-Rieser C, 2001, IMMUNOL LETT, V76, P63, DOI 10.1016/S0165-2478(00)00326-6	45	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188010	10.1371/journal.pone.0188010	http://dx.doi.org/10.1371/journal.pone.0188010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182620	Green Submitted, gold, Green Published			2022-12-26	WOS:000416402000008
J	Tai, PWL; Wu, H; van Wijnen, AAJ; Stein, GS; Stein, JL; Lian, JB				Tai, Phillip W. L.; Wu, Hai; van Wijnen, Andre A. J.; Stein, Gary S.; Stein, Janet L.; Lian, Jane B.			Genome-wide DNase hypersensitivity, and occupancy of RUNX2 and CTCF reveal a highly dynamic gene regulome during MC3T3 pre-osteoblast differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; OSTEOCALCIN PROMOTER; CHROMATIN-STRUCTURE; PROTEIN EXPRESSION; PIONEER FACTORS; IN-VIVO; BONE; ORGANIZATION; SITES; LANDSCAPE	The ability to discover regulatory sequences that control bone-related genes during development has been greatly improved by massively parallel sequencing methodologies. To expand our understanding of cis-regulatory regions critical to the control of gene expression during osteoblastogenesis, we probed the presence of open chromatin states across the osteoblast genome using global DNase hypersensitivity (DHS) mapping. Our profiling of MC3T3 mouse pre-osteoblasts during differentiation has identified more than 224,000 unique DHS sites. Approximately 65% of these sites are dynamic during temporal stages of osteoblastogenesis, and a majority of them are located within non-promoter (intergenic and intronic) regions. Nearly half of all DHS sites (both constitutive and dynamic) overlap binding events of the bone-essential RUNX2 and/or the chromatin-related CTCF transcription factors. This finding reinforces the role of these regulatory proteins as essential components of the bone gene regulome. We observe a reduction in chromatin accessibility throughout the genome between pre-osteoblast and early osteoblasts. Our analysis also defined a class of differentially expressed genes that harbor DHS peaks centered within 1 kb downstream of transcriptional end sites (TES). These DHSs at the 3'-flanks of genes exhibit dynamic changes during differentiation that may impact regulation of the osteoblast genome. Taken together, the distribution of DHS regions within non-promoter locations harboring osteoblast and chromatin related transcription factor binding motifs, reflect novel cis-regulatory requirements to support temporal gene expression in differentiating osteoblasts.	[Tai, Phillip W. L.; Wu, Hai; Stein, Gary S.; Stein, Janet L.; Lian, Jane B.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [van Wijnen, Andre A. J.] Mayo Clin, Rochester, MN USA; [Tai, Phillip W. L.] Univ Massachusetts, Sch Med, Horae Gene Therapy Ctr, Worcester, MA USA	University of Vermont; Mayo Clinic; University of Massachusetts System; University of Massachusetts Worcester	Stein, JL; Lian, JB (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA.	janet.stein@uvm.edu; jane.lian@uvm.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Tai, Phillip/0000-0001-7409-8344	National Institutes of Health [P01CA082834, P01AR48818, R01 AR039588, R37DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants P01CA082834 and P01AR48818 (to G.S.S.); R01 AR039588 (to G.S. S. and J.B.L.); and R37DE012528 (to J.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Barutcu AR, 2014, NUCLEIC ACIDS RES, V42, P10360, DOI 10.1093/nar/gku712; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Gao B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099137; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gutierrez S, 2004, J BIOL CHEM, V279, P43581, DOI 10.1074/jbc.M408335200; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Isaac J, 2014, CELL DEATH DIFFER, V21, P1365, DOI 10.1038/cdd.2014.82; Iyer S, 2013, ANN NY ACAD SCI, V1280, P11, DOI 10.1111/nyas.12091; Javed A, 1999, MOL CELL BIOL, V19, P7491; Junier I, 2012, NUCLEIC ACIDS RES, V40, P7718, DOI 10.1093/nar/gks536; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KERR JM, 1993, GENOMICS, V17, P408, DOI 10.1006/geno.1993.1340; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Komori T, 2017, ADV EXP MED BIOL, V962, P83, DOI 10.1007/978-981-10-3233-2_6; Krivega I, 2012, CURR OPIN GENET DEV, V22, P79, DOI 10.1016/j.gde.2011.11.001; Kuhnisch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086115; Lee BK, 2012, J BIOL CHEM, V287, P30906, DOI 10.1074/jbc.R111.324962; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Lian JB, 2013, J BONE MINER RES, V28, P2060, DOI 10.1002/jbmr.2076; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Liu PY, 2004, J MED GENET, V41, P752, DOI 10.1136/jmg.2004.019851; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Medina R, 2012, MOL CELL BIOL, V32, P3860, DOI 10.1128/MCB.00736-12; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Montavon T, 2012, TRENDS CELL BIOL, V22, P347, DOI 10.1016/j.tcb.2012.04.003; MONTECINO M, 1994, BIOCHEMISTRY-US, V33, P348, DOI 10.1021/bi00167a045; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Reumann MK, 2011, BONE, V49, P743, DOI 10.1016/j.bone.2011.06.023; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Seo KW, 2013, CELL TRANSPLANT, V22, P29, DOI 10.3727/096368912X654948; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shows KH, 2008, DNA CELL BIOL, V27, P589, DOI 10.1089/dna.2008.0766; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Stavreva DA, 2015, GENOME RES, V25, P845, DOI 10.1101/gr.184168.114; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Tai PWL, 2014, GENE, V550, P1, DOI 10.1016/j.gene.2014.05.044; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tanaka K, 2016, BRIT J PHARMACOL, V173, P1058, DOI 10.1111/bph.13418; Tang Y, 2016, NAT CELL BIOL, V18, P917, DOI 10.1038/ncb3394; Thompson B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148619; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Xu FH, 2012, J BIOL CHEM, V287, P5033, DOI 10.1074/jbc.M111.279968; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040	70	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188056	10.1371/journal.pone.0188056	http://dx.doi.org/10.1371/journal.pone.0188056			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176792	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900031
J	Christ, P; Reifenrath, A; Kahnt, J; Hauser, F; Hill, SR; Schachtner, J; Ignell, R				Christ, Peter; Reifenrath, Anna; Kahnt, Joerg; Hauser, Frank; Hill, Sharon Rose; Schachtner, Joachim; Ignell, Rickard			Feeding-induced changes in allatostatin-A and short neuropeptide F in the antennal lobes affect odor-mediated host seeking in the yellow fever mosquito, Aedes aegypti	PLOS ONE			English	Article							MALARIA MOSQUITO; OLFACTORY SENSITIVITY; GENE-EXPRESSION; DESERT LOCUST; BEHAVIOR; BLOOD; DIPTERA; SUGAR; CULICIDAE; NEURONS	Aedes aegypti is a model species in which the endogenous regulation of odor-mediated host seeking behavior has received some attention. Sugar feeding and host seeking in female A. aegypti are transiently inhibited following a blood meal. This inhibition is partially mediated by short neuropeptide F (sNPF). The paired antennal lobes (ALs), as the first processing centers for olfactory information, has been shown to play a significant role in the neuropeptidergic regulation of odor-mediated behaviors in insects. The expression of sNPF, along with other peptides in the ALs of A. aegypti, indicate parallel neuromodulatory systems that may affect olfactory processing. To identify neuropeptides involved in regulating the odor-mediated host seeking behavior in A. aegypti, we use a semi-quantitative neuropeptidomic analysis of single ALs to analyze changes in the levels of five individual neuropeptides in response to different feeding regimes. Our results show that the level of sNPF-2, allatostatin-A-5 (AstA-5) and neuropeptide-like precursor-1-5 (NPLP-1-5), but not of tachykinin- related-peptides and SIFamide (SIFa), in the AL of female mosquitoes, changes 24 h and 48 h post-blood meal, and are dependent on prior access to sugar. To assess the role of these neuropeptides in modulating host seeking behavior, when systemically injected individually, sNPF-2 and AstA-5 significantly reduced host seeking behavior. However, only the injection of the binary mixture of the two neuropeptides lead to a host seeking inhibition similar to that observed in blood fed females. We conclude that modulation of the odor mediated host seeking behavior of A. aegypti is likely regulated by a dual neuropeptidergic pathway acting in concert in the ALs.	[Christ, Peter; Hill, Sharon Rose; Ignell, Rickard] Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, Alnarp, Sweden; [Reifenrath, Anna; Schachtner, Joachim] Philipps Univ Marburg, Dept Biol, Neurobiol Ethol, Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Marburg, Germany; [Hauser, Frank] Univ Copenhagen, Dept Biol, Ctr Funct & Comparat Insect Genom, Copenhagen, Denmark	Swedish University of Agricultural Sciences; Philipps University Marburg; Max Planck Society; University of Copenhagen	Ignell, R (corresponding author), Swedish Univ Agr Sci, Dept Plant Protect Biol, Unit Chem Ecol, Alnarp, Sweden.	rickard.ignell@slu.se	Hauser, Frank/M-2952-2014; Schachtner, Joachim/AAG-1101-2020; Hill, Sharon R/A-5121-2008; Christ, Peter/U-1011-2017	Hauser, Frank/0000-0001-5563-2345; Schachtner, Joachim/0000-0001-7268-0699; Hill, Sharon R/0000-0002-6474-0214; Christ, Peter/0000-0003-3583-8690	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was founded by the Swedish Research Council. The funder had no role in study design, data collectionan danalysis, decisionto publish, or preparation of the manuscript.	Aguilar R, 2003, REGUL PEPTIDES, V115, P171, DOI 10.1016/S0167-0115(03)00165-4; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; [Anonymous], 1992, BIOL MOSQUITOES DEV; Bodin A, 2009, J EXP BIOL, V212, P2386, DOI 10.1242/jeb.030668; BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035; BRIEGEL H, 1973, GERONTOLOGY, V19, P240, DOI 10.1159/000211976; BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P179, DOI 10.1016/0022-1910(84)90124-0; DESIDERIO DM, 1983, BIOMED MASS SPECTROM, V10, P471, DOI 10.1002/bms.1200100806; Dillen S, 2016, INSECT BIOCHEM MOLEC, V68, P64, DOI 10.1016/j.ibmb.2015.11.007; Dillen S, 2014, PEPTIDES, V53, P134, DOI 10.1016/j.peptides.2013.09.018; Dillen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053604; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; HAYES RO, 1953, J ECON ENTOMOL, V46, P624, DOI 10.1093/jee/46.4.624; Hentze JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11680; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Jiang HB, 2017, J INSECT PHYSIOL, V99, P78, DOI 10.1016/j.jinsphys.2017.03.012; JONES MDR, 1981, PHYSIOL ENTOMOL, V6, P307, DOI 10.1111/j.1365-3032.1981.tb00275.x; JUDSON CL, 1967, BIOL BULL-US, V133, P369, DOI 10.2307/1539832; Kim SM, 2017, ANN REV NEUROSCI, V40; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P231, DOI 10.1016/0022-1910(79)90048-9; KLOWDEN MJ, 1987, J INSECT PHYSIOL, V33, P689, DOI 10.1016/0022-1910(87)90052-7; KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P583, DOI 10.1016/0022-1910(79)90073-8; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; KLOWDEN MJ, 1986, J INSECT PHYSIOL, V32, P479, DOI 10.1016/0022-1910(86)90009-0; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486; Majeed S, 2014, J EXP BIOL, V217, P598, DOI 10.1242/jeb.092718; Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0; Mikani A, 2012, PEPTIDES, V34, P135, DOI 10.1016/j.peptides.2011.10.028; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Naksathit AT, 1999, J MED ENTOMOL, V36, P13, DOI 10.1093/jmedent/36.1.13; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; NAYAR JK, 1975, J MED ENTOMOL, V12, P92, DOI 10.1093/jmedent/12.1.92; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Qiu YT, 2013, J INSECT PHYSIOL, V59, P1111, DOI 10.1016/j.jinsphys.2013.09.001; Riabinina O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13010; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sachse S., 2011, E NEUROFORUM, V2, P49, DOI [10.1007/s13295-011-0020-7, DOI 10.1007/S13295-011-0020-7]; Schachtner J, 2010, METHODS MOL BIOL, V615, P129, DOI 10.1007/978-1-60761-535-4_10; Schoofs L, 2017, ANNU REV ENTOMOL, V62, P35, DOI 10.1146/annurev-ento-031616-035500; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Siju KP, 2014, J COMP NEUROL, V522, P592, DOI 10.1002/cne.23434; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Sterkel M, 2011, J PROTEOME RES, V10, P3363, DOI 10.1021/pr2001012; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; VARGO AM, 1982, J MED ENTOMOL, V19, P710, DOI 10.1093/jmedent/19.6.710; VARGO AM, 1984, MOSQ NEWS, V44, P6; Wang JW, 2012, DEV NEUROBIOL, V72, P87, DOI 10.1002/dneu.20936; Winther AME, 2010, FLY, V4, P167, DOI 10.4161/fly.4.2.11467; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P10, DOI 10.1016/j.ibmb.2011.10.002	60	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188243	10.1371/journal.pone.0188243	http://dx.doi.org/10.1371/journal.pone.0188243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166650	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300030
J	Farooq, A; Waheed, U; Zaheer, HA; Aldakheel, F; Alduraywish, S; Arshad, M				Farooq, Ahmad; Waheed, Usman; Zaheer, Hasan Abbas; Aldakheel, Fahad; Alduraywish, Shatha; Arshad, Muhammad			Detection of HBsAg mutants in the blood donor population of Pakistan	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SURFACE-ANTIGEN; CYSTEINE RESIDUES; C VIRUS; PREVALENCE; TRANSMISSION; PERFORMANCE; INFECTION; VARIANTS; ASSAYS	Background Infection with the Hepatitis B virus (HBV) continues to be one of the leading healthcare issues in Pakistan, affecting over 6 million people. The existence of HBsAg mutants is well documented in many countries. In Pakistan, HBV screening in the majority of the blood banks is performed by Rapid Detection Devices or ELISA tests. These tests are designed to detect HBsAg, but may not detect the mutant HBsAg. Failure to detect the HBsAg mutant may result in the transmission of HBV infection from donor to recipient. Hence, there is a need to identify a HBsAg assay which can detect mutants in a country where simple and conventional HBsAg assays with varying sensitivity and specificity are used to detect HBV infections. Material and methods Three routinely used diagnostic tests (Rapid Detection Devices, ELISA and CLIA) for HBsAg were compared with the LIAISON (R) XL Murex HBsAg Quant Assay to determine the prevalence of HBV mutants in the Pakistani blood donor population. The samples of blood donors from different cities of Pakistan were collected. The testing was performed using SD Bioline rapid assay (n = 1500), ELISA (n = 1500), and Abbott ARCHITECT (R) CLIA system (n = 1500) at the centers where the donations were collected. All samples (n = 4500) were re-tested for comparative analysis on the LIAISON (R) XL Murex HBsAg Quant assay (DiaSorin S.p.A.). PCR testing was performed as a gold standard on all discordant samples. Results 119/4500 (2.64%) of the samples were positive for antibodies against HBsAg. The sensitivity of SD Bioline Rapid, GB HBsAg ELISA, Abbott ARCHITECT (R) and LIAISON (R) XL Murex HBsAg Quant assay was 17.24%, 43.75%, 90.91% and 100% respectively. The specificity of SD Bioline Rapid, GB HBsAg ELISA, Abbott ARCHITECT (R) and LIAISON (R) XL Murex HBsAg Quant Assay was 98.82%, 99.59%, 100% and 100%, respectively. Conclusion LIAISON (R) XL Murex HBsAg Quant assay is a highly sensitive, specific and accurate screening assay for detecting wild type as well as mutant HBsAg.	[Farooq, Ahmad; Arshad, Muhammad] Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan; [Waheed, Usman; Zaheer, Hasan Abbas] Shaheed Zulfiqar Ali Bhutto Med Univ, Dept Pathol, Islamabad, Pakistan; [Waheed, Usman; Zaheer, Hasan Abbas] Shaheed Zulfiqar Ali Bhutto Med Univ, Blood Bank, Islamabad, Pakistan; [Zaheer, Hasan Abbas] Govt Pakistan, Minist Natl Hlth Serv, Safe Blood Transfus Programme, Islamabad, Pakistan; [Aldakheel, Fahad] King Saud Univ, Dept Clin Lab Med, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Alduraywish, Shatha] King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia	International Islamic University, Pakistan; King Saud University; King Saud University	Arshad, M (corresponding author), Int Islamic Univ, Dept Bioinformat & Biotechnol, Islamabad, Pakistan.	m.arshad@iiu.edu.pk	Alduraywish, Shatha A./U-7874-2017; Aldakheel, Fahad/F-6406-2017	Alduraywish, Shatha A./0000-0003-4895-1553; Aldakheel, Fahad/0000-0001-8047-8650; Arshad, Muhammad/0000-0002-6381-1746; farooq, ahmad/0000-0002-1926-3279	Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan; DiaSorin, S.p.A	Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan; DiaSorin, S.p.A	This research project was supported by Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan. The part of study related to LIAISON (R) XL Murex HBsAg Quant assay was funded by DiaSorin, S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Akhtar S, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-26; Akhtar Tanveer, 2008, Journal of Agricultural and Biological Science, V3, P30; Alam MM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-115; ANTONI BA, 1994, EUR J BIOCHEM, V222, P121, DOI 10.1111/j.1432-1033.1994.tb18849.x; Bosan A, 2010, J PAK MED ASSOC, V60, P1045; Burdino E, 2014, J CLIN VIROL, V60, P341, DOI 10.1016/j.jcv.2014.05.013; Chattopadhyay Saket, 2005, Hemodial Int, V9, P362, DOI 10.1111/j.1542-4758.2005.01154.x; Farhat M, 2014, INT J MICROBIOL ALLI, V1, P98; FAROOQ MA, 2005, PAK J PATHOL, V16, P42; Gerlich W H, 2004, Intervirology, V47, P310; Hashimi ZY, 1996, HEPATITIS B VIRUSANT, V6, P547; He C, 2001, J GASTROEN HEPATOL, V16, P1373, DOI 10.1046/j.1440-1746.2001.02654.x; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Hussain WZ, 1998, PAK ARMED FORCES MED, V48, P102; Khan N, 2004, J VIROL, V78, P3262, DOI 10.1128/JVI.78.7.3262-3270.2004; Khattak M F, 2002, J Pak Med Assoc, V52, P398; KHICHI GQK, 2000, PAK J MED SCI, V16, P238; Koyanagi T, 2000, Med Sci Monit, V6, P1165; Krawczyk A, 2014, J CLIN VIROL, V59, P44, DOI 10.1016/j.jcv.2013.10.009; Malm K, 2015, TRANSFUSION MED, V25, P101, DOI 10.1111/tme.12181; MANGOLD CMT, 1993, J VIROL, V67, P4588, DOI 10.1128/JVI.67.8.4588-4597.1993; Ngui SL, 1999, REV MED VIROL, V9, P183, DOI 10.1002/(SICI)1099-1654(199907/09)9:3&lt;183::AID-RMV248&gt;3.0.CO;2-P; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Paul FC, 2006, EMERG INFECT DIS, V12, P2; Perazzo P., 2015, J HUMAN VIROL RETROV, V2, P46, DOI 10.15406/jhvrv.2015.02.00046; Sato K, 1996, J CLIN MICROBIOL, V34, P1420, DOI 10.1128/JCM.34.6.1420-1422.1996; Sticchi L, 2013, HUM VACC IMMUNOTHER, V9, P568, DOI 10.4161/hv.23236; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; Thakur V, 2005, J MED VIROL, V76, P40, DOI 10.1002/jmv.20321; Waheed Y, 2009, WORLD J GASTROENTERO, V15, P5647, DOI 10.3748/wjg.15.5647; WHO, 2015, HEP B; WHO (World Health Organization), 2001, INTR HEP B VACC CHIL; World Health Organization, 2015, 1 HEP B TREATM GUID; Yakaryilmaz F, 2006, RENAL FAILURE, V28, P729, DOI 10.1080/08860220600925602; Zaheer HA, 2014, J BLOOD DISORDERS TR, V5, P10; ZANETTI AR, 1988, LANCET, V2, P1132; Zhu R, 2008, PATHOL RES PRACT, V204, P731, DOI 10.1016/j.prp.2008.05.001; Zuberi S J, 1978, J Pak Med Assoc, V28, P2	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188066	10.1371/journal.pone.0188066	http://dx.doi.org/10.1371/journal.pone.0188066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166662	Green Submitted, Green Published, gold			2022-12-26	WOS:000416035300023
J	Miyazawa, M; Takatori, H; Shimakami, T; Kawaguchi, K; Kitamura, K; Arai, K; Matsuda, K; Sanada, T; Urabe, T; Inamura, K; Kagaya, T; Mizuno, H; Fuchizaki, U; Yamashita, T; Sakai, Y; Yamashita, T; Mizukoshi, E; Honda, M; Kaneko, S				Miyazawa, Masaki; Takatori, Hajime; Shimakami, Tetsuro; Kawaguchi, Kazunori; Kitamura, Kazuya; Arai, Kuniaki; Matsuda, Koichiro; Sanada, Taku; Urabe, Takeshi; Inamura, Katsuhisa; Kagaya, Takashi; Mizuno, Hideki; Fuchizaki, Uichiro; Yamashita, Taro; Sakai, Yoshio; Yamashita, Tatsuya; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi			Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus	PLOS ONE			English	Article							STEROID-THERAPY; SCLEROSING CHOLANGITIS; DIAGNOSTIC-CRITERIA; CONSENSUS; JAPAN; MULTICENTER; MALIGNANCY; GUIDELINES; ENDOCRINE; EXOCRINE	Background and aim Relapse and diabetes mellitus (DM) are major problems for the prognosis of autoimmune pancreatitis (AIP). We examined the prognosis of type 1 AIP after corticosteroid therapy (CST)-induced remission in terms of relapse and DM. Methods The study enrolled 82 patients diagnosed with type 1 AIP who achieved remission with CST. We retrospectively evaluated the relapse rate in terms of the administration period of CST, clinical factors associated with relapse, and the temporal change in glucose tolerance. Results During follow-up, 32 patients (39.0%) experienced relapse. There was no significant clinical factor that could predict relapse before beginning CST. AIP patients who ceased CST within 2 or 3 years experienced significantly earlier relapse than those who had the continuance of CST (p = 0.050 or p = 0.020). Of the 37 DM patients, 15 patients (40.5%) had pre-existing DM, 17 (45.9%) showed new-onset DM, and 5 (13.5%) developed CST-induced DM. Patients with new-onset DM were significantly more likely to show improvement (p = 0.008) than those with pre-existing DM. Conclusions It was difficult to predict relapse of AIP based on clinical parameters before beginning CST. Relapse was likely to occur within 3 years after the beginning of CST and maintenance of CST for at least 3 years reduced the risk of relapse. The early initiation of CST for AIP with impaired glucose tolerance is desirable because pre-existing DM is refractory to CST.	[Miyazawa, Masaki; Takatori, Hajime; Shimakami, Tetsuro; Kawaguchi, Kazunori; Kitamura, Kazuya; Arai, Kuniaki; Yamashita, Taro; Sakai, Yoshio; Yamashita, Tatsuya; Mizukoshi, Eishiro; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Miyazawa, Masaki; Fuchizaki, Uichiro] Keiju Med Ctr, Dept Gastroenterol, Nanao, Japan; [Matsuda, Koichiro] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan; [Sanada, Taku] Fukui Ken Saiseikai Hosp, Dept Internal Med, Fukui, Japan; [Urabe, Takeshi] Publ Cent Hosp Matto Ishikawa, Dept Gastroenterol, Haku San, Japan; [Inamura, Katsuhisa] Tonami Gen Hosp, Dept Internal Med, Tonami, Toyama, Japan; [Kagaya, Takashi] Natl Hosp Org, Dept Gastroenterol, Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan; [Mizuno, Hideki] Toyama City Hosp, Dept Gastroenterol, Toyama, Japan	Kanazawa University	Miyazawa, M (corresponding author), Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.; Miyazawa, M (corresponding author), Keiju Med Ctr, Dept Gastroenterol, Nanao, Japan.	miyacchi_1985@yahoo.co.jp	Miyazawa, Masaki/AAD-4425-2021	Miyazawa, Masaki/0000-0003-0341-1123; Kawaguchi, Kazunori/0000-0002-4927-1704	Grants-in-Aid for Scientific Research [17K09413] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Frulloni L, 2010, PANCREATOLOGY, V10, P129, DOI 10.1159/000265945; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hirano K, 2007, GUT, V56, P1719, DOI 10.1136/gut.2006.115246; Hirano K, 2016, J CLIN GASTROENTEROL, V50, P331, DOI 10.1097/MCG.0000000000000440; Hirano K, 2012, PANCREAS, V41, P691, DOI 10.1097/MPA.0b013e31823bcdee; Huggett MT, 2014, AM J GASTROENTEROL, V109, P1675, DOI 10.1038/ajg.2014.223; Ito T, 2007, J GASTROENTEROL, V42, P50, DOI 10.1007/s00535-007-2051-y; Kamisawa T, 2003, PANCREAS, V27, P235, DOI 10.1097/00006676-200310000-00007; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Kim HM, 2010, PANCREAS, V39, P555, DOI 10.1097/MPA.0b013e3181c8b4a5; Kubota K, 2007, GASTROINTEST ENDOSC, V66, P1142, DOI 10.1016/j.gie.2007.06.059; Kubota K, 2011, J GASTROENTEROL, V46, P834, DOI 10.1007/s00535-011-0393-y; Liu B, 2013, WORLD J GASTROENTERO, V19, P569, DOI 10.3748/wjg.v19.i4.569; Maire F, 2011, AM J GASTROENTEROL, V106, P151, DOI 10.1038/ajg.2010.314; Masamune A, 2016, GUT; *MEMB CRIT COMM AU, 2002, J JPN PAN SOC, V17, P585; Miyamoto Y, 2012, GUT LIVER, V6, P501, DOI 10.5009/gnl.2012.6.4.501; Naitoh I, 2010, PANCREAS, V39, pE1, DOI 10.1097/MPA.0b013e3181bd64a1; Nakazawa T, 2009, HEPATO-GASTROENTEROL, V56, P584; Nishimori I, 2006, PANCREAS, V32, P244, DOI 10.1097/01.mpa.0000202950.02988.07; Notohara K, 2015, PANCREAS, V44, P1072, DOI 10.1097/MPA.0000000000000438; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; Raina A, 2009, AM J GASTROENTEROL, V104, P2295, DOI 10.1038/ajg.2009.325; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shimizu S, 2015, SCAND J GASTROENTERO, V50, P1411, DOI 10.3109/00365521.2015.1054424; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	32	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188549	10.1371/journal.pone.0188549	http://dx.doi.org/10.1371/journal.pone.0188549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166415	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300050
J	Park, H; Cho, S; Woo, H; Park, SK; Shin, HR; Chang, SH; Yoo, KY; Shin, A				Park, Hyeree; Cho, Sooyoung; Woo, Hyeongtaek; Park, Sue K.; Shin, Hai-Rim; Chang, Soung-Hoon; Yoo, Keun-Young; Shin, Aesun			Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort	PLOS ONE			English	Article							DIABETES-MELLITUS; EPIDEMIOLOGY	Previous cohort studies have demonstrated a positive association between diabetes mellitus (DM) and colorectal cancer (CRC). However, there are few comparisons between DM groups categorized by fasting glucose level. This study examined associations between diabetes as defined by fasting glucose level and self-reported history of DM and CRC risk among Korean adults. Data from the Korean Multi-center Cancer Cohort between 1993 and 2005 were analyzed. The study population comprised 14,570 participants aged 20 years or older. Participants were followed until December 31, 2012 (median follow-up: 11.9 years). Among participants with high fasting glucose (>= 126mg/dL), the risk of developing CRC was significantly higher (HR: 1.51 [1.02-2.25]) than among participants with low fasting glucose (<126mg/dL). Risk was not significantly higher among participants with self-reported history of DM (HR: 1.34 [0.78-2.31]). When both fasting glucose and history of DM were considered together, the risk of CRC among participants with both high fasting glucose and history of DM was 54% (HR: 1.54 [0.97-2.43]), and the risk of CRC among participants with high fasting glucose and no history of DM was 50% (HR: 1.50 [0.73-3.05]). When the first 5 years of follow-up were excluded, among participants with high fasting glucose, the risk of developing CRC was significantly higher (HR: 1.61 [1.02-2.56]) than among participants with low fasting glucose. Risk of CRC was also significantly higher among participants with high fasting glucose and no history of DM (HR: 1.69 [1.01-2.84]). High fasting glucose and self-reported history of DM were associated with increased risk of CRC in this Korean population.	[Park, Hyeree] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Cho, Sooyoung; Woo, Hyeongtaek; Park, Sue K.; Yoo, Keun-Young; Shin, Aesun] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sue K.; Shin, Aesun] Seoul Natl Univ, Coll Med, Canc Res Ctr, Seoul, South Korea; [Shin, Hai-Rim] WHO, Reg Off Western Pacific, Manila, Philippines; [Chang, Soung-Hoon] Konkuk Univ, Sch Med, Dept Prevent Med, Chungju, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); WHO Western Pacific Regional Office; World Health Organization; Konkuk University; Konkuk University Medical Center	Shin, A (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Shin, A (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Ctr, Seoul, South Korea.	shinaesun@snu.ac.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969; Park, Hyeree/0000-0003-1551-260X	Seoul National University Hospital	Seoul National University Hospital	This research was funded by the Seoul National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2014, 6 KOR NAT HLTH NUTR; [Anonymous], 2007, KOR NAT HLTH NUTR EX; [Anonymous], 2015, 2014 STAT RES CAUS D; [Anonymous], 2013, ANN REP CANC INC; Caiazza F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00019; Cho Sooyoung, 2015, J Cancer Prev, V20, P147, DOI 10.15430/JCP.2015.20.2.147; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Frank EA, 2012, J CLIN LAB ANAL, V26, P317, DOI 10.1002/jcla.21524; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Guraya SY, 2015, WORLD J GASTROENTERO, V21, P6026, DOI 10.3748/wjg.v21.i19.6026; Gwack Jin, 2007, J Prev Med Public Health, V40, P23; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Kim SG, 2008, J KOREAN MED ASSOC, V51, P791, DOI 10.5124/jkma.2008.51.9.791; Kiunga GA, 2004, CANCER LETT, V211, P145, DOI 10.1016/j.canlet.2004.02.015; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Luo S, 2016, CLIN RES HEPATOL GAS, V40, P110, DOI 10.1016/j.clinre.2015.05.021; Song SO, 2016, DIABETES METAB J, V40, P35, DOI 10.4093/dmj.2016.40.1.35; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85	25	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188465	10.1371/journal.pone.0188465	http://dx.doi.org/10.1371/journal.pone.0188465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161326	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000062
J	Xu, H; Chen, XY; Ying, NJ; Wang, MX; Xu, XL; Shi, RY; Hua, YJ				Xu, Hong; Chen, Xuanyi; Ying, Nanjiao; Wang, Meixia; Xu, Xiaoli; Shi, Rongyi; Hua, Yuejin			Mass spectrometry-based quantification of the cellular response to ultraviolet radiation in HeLa cells	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BIOLOGICAL FUNCTIONS; PHOSPHORYLATION; DIVISION; DIFFERENTIATION; INITIATION; PROTEINS; DYNAMICS; REPAIR; CYCLE	Ultraviolet (UV) irradiation is a common form of DNA damage that can cause pyrimidine dimers between DNA, which can cause gene mutations, even double-strand breaks and threaten genome stability. If DNA repair systems default their roles at this stage, the organism can be damaged and result in disease, especially cancer. To better understand the cellular response to this form of damage, we applied highly sensitive mass spectrometry to perform comparative proteomics of phosphorylation in HeLa cells. A total of 4367 phosphorylation sites in 2100 proteins were identified, many of which had not been reported previously. Comprehensive bioinformatics analysis revealed that these proteins were involved in many important biological processes, including signaling, localization and cell cycle regulation. The nuclear pore complex, which is very important for RNA transport, was changed significantly at phosphorylation level, indicating its important role in response to UV-induced cellular stress. Protein-protein interaction network analysis and DNA repair pathways crosstalk were also examined in this study. Proteins involved in base excision repair, nucleotide repair and mismatch repair changed their phosphorylation pattern in response to UV treatment, indicating the complexity of cellular events and the coordination of these pathways. These systematic analyses provided new clues of protein phosphorylation in response to specific DNA damage, which is very important for further investigation. And give macroscopic view on an overall phosphorylation situation under UV radiation.	[Xu, Hong; Chen, Xuanyi; Xu, Xiaoli; Shi, Rongyi; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Ying, Nanjiao] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Zhejiang, Peoples R China; [Wang, Meixia] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Dianzi University	Hua, YJ (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China.	yjhua@zju.edu.cn		Chen, Xuanyi/0000-0001-7406-4806	National Basic Research Program of China [2015CB910600]; National Natural Science Foundation of China [31210103904]; Natural Science Foundation of Zhejiang Province [LY16C050003]; National Key R&D Program of China [2017YFA0503900]; Science Technology Department, Zhejiang Province [KN20160607]; PTM Biolabs	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Science Technology Department, Zhejiang Province; PTM Biolabs	The work was supported by the following: National Basic Research Program of China (2015CB910600 to YH); National Natural Science Foundation of China (31210103904 to YH), Natural Science Foundation of Zhejiang Province (LY16C050003 to HX), National Key R&D Program of China (2017YFA0503900 to YH), and The Science Technology Department, Zhejiang Province (KN20160607 to HX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MS analysis in our research is supported by PTM Biolabs.	Aslanian A, 2014, DNA REPAIR, V15, P29, DOI 10.1016/j.dnarep.2013.12.007; Awad S, 2015, J PATHOL, V235, P606, DOI 10.1002/path.4489; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Black WP, 2010, J BACTERIOL, V192, P4267, DOI 10.1128/JB.00403-10; Borgal L, 2016, CELL CYCLE, V15, P1034, DOI 10.1080/15384101.2016.1152429; Britt AB, 2004, PHOTOSYNTH RES, V81, P105, DOI 10.1023/B:PRES.0000035035.12340.58; Bukata L, 2013, CURR OPIN CELL BIOL, V25, P378, DOI 10.1016/j.ceb.2013.03.002; Chatterjee J, 2013, ANGEW CHEM INT EDIT, V52, P254, DOI 10.1002/anie.201205674; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Fukukawa C, 2010, GENE CHROMOSOME CANC, V49, P861, DOI 10.1002/gcc.20795; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Li F, 2016, DNA REPAIR, V38, P68, DOI 10.1016/j.dnarep.2015.11.021; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Rona G, 2014, CELL CYCLE, V13, P3551, DOI 10.4161/15384101.2014.960740; Tan L, 2011, P NATL ACAD SCI USA, V108, P16675, DOI 10.1073/pnas.1106748108; Teixeira FK, 2015, NAT CELL BIOL, V17, P689, DOI 10.1038/ncb3165; van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Wang AX, 2010, FASEB J, V24, P833, DOI 10.1096/fj.09-142976; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Wu LH, 2014, SCI CHINA LIFE SCI, V57, P482, DOI 10.1007/s11427-014-4631-4; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Yuan CF, 2014, CELL CYCLE, V13, P807, DOI 10.4161/cc.27727	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186806	10.1371/journal.pone.0186806	http://dx.doi.org/10.1371/journal.pone.0186806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155820	gold, Green Submitted, Green Published			2022-12-26	WOS:000415756700005
J	Hutchinson, NX; Gibbs, A; Tonks, A; Hope-Gill, BD				Hutchinson, Nicola-xan; Gibbs, Allen; Tonks, Amanda; Hope-Gill, Benjamin D.			Airway expression of Transient Receptor Potential (TRP) Vanniloid-1 and Ankyrin-1 channels is not increased in patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; CHRONIC COUGH; SENSORY NEURONS; ALVEOLITIS; GUIDELINES; SELECTION; REFLEX; SYSTEM; NERVES; NGF	Dry cough is a common symptom described in patients with Idiopathic Pulmonary Fibrosis (IPF) and impairs quality of life. The exact mechanisms causing cough in IPF remain unclear, however evidence suggests altered cough neurophysiology and sensitisation plays a role; IPF patients have an enhanced cough reflex sensitivity to inhaled capsaicin. The Transient Receptor Potential Vanniloid-1 channel (TRPV-1) has a role in the cough reflex and airway expression is increased in patients with chronic cough. The Ankyrin-1 receptor (TRPA-1) is often co-expressed. It was hypothesised that, like chronic cough patients, IPF patients have increased airway TRP receptor expression. Bronchial biopsies were obtained from 16 patients with IPF, 11 patients with idiopathic chronic cough and 8 controls without cough. All other causes of cough were rigorously excluded. Real-time quantitative Polymerase Chain Reaction was used to detect TRPV-1 and TRPA-1 mRNA expression with Immunohistochemistry demonstrating protein expression. Mean TRPV-1 and TRPA-1 gene expression was higher in IPF patients compared with controls, but the difference did not reach statistical significance. Immunostaining supported these findings. This study suggests that structural up-regulation of central airway TRP receptors is not the key mechanism for cough in IPF patients. It is probable that IPF cough results from altered neuronal sensitivity at multiple levels of the cough pathway.	[Hutchinson, Nicola-xan] Princess Wales Hosp, Dept Resp Med, Bridgend, Wales; [Gibbs, Allen] Cardiff & Vale Univ Hlth Board, Dept Histopathol, Cardiff, S Glam, Wales; [Tonks, Amanda] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Hope-Gill, Benjamin D.] Cardiff & Vale Univ Hlth Board, Dept Resp Med, Cardiff, S Glam, Wales	Cardiff University	Hutchinson, NX (corresponding author), Princess Wales Hosp, Dept Resp Med, Bridgend, Wales.	nxhutch1@doctors.org.uk			Institutional Lung Research Endowment funds	Institutional Lung Research Endowment funds	The funding was entirely from Institutional Lung Research Endowment funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Allen D, 2008, J DERMATOL SCI, V49, P217, DOI 10.1016/j.jdermsci.2007.10.001; Ando A, 2016, THORAX, V71, P323, DOI 10.1136/thoraxjnl-2015-207425; [Anonymous], 1994, Respir Med, V88, P165; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Bonvini SJ, 2015, N-S ARCH PHARMACOL, V388, P401, DOI 10.1007/s00210-014-1082-1; Bradley B, 2008, THORAX, V63, P1029; Buch TRH, 2013, CHEM-BIOL INTERACT, V206, P462, DOI 10.1016/j.cbi.2013.08.012; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Doherty MJ, 2000, THORAX, V55, P1028, DOI 10.1136/thorax.55.12.1028; Grace MS, 2014, BRIT J PHARMACOL, V171, P2593, DOI 10.1111/bph.12538; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Gu QH, 2003, J NEUROPHYSIOL, V89, P1985, DOI 10.1152/jn.00748.2002; Harrison Nicholas Kim, 2013, Cough, V9, P9, DOI 10.1186/1745-9974-9-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hope-Gill BDM, 2003, AM J RESP CRIT CARE, V168, P995, DOI 10.1164/rccm.200304-597OC; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jie Shu, 2013, 2013 Seventh International Conference on Image and Graphics (ICIG), P937, DOI 10.1109/ICIG.2013.197; Key Angela L, 2010, Cough, V6, P4, DOI 10.1186/1745-9974-6-4; Mazzone SB, 2005, J PHYSIOL-LONDON, V569, P559, DOI 10.1113/jphysiol.2005.093153; Minner F, 2009, J INVEST DERMATOL, V129, P770, DOI 10.1038/jid.2008.247; Mitchell JE, 2005, EXP LUNG RES, V31, P295, DOI 10.1080/01902140590918803; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; OCONNELL F, 1995, AM J RESP CRIT CARE, V152, P2068, DOI 10.1164/ajrccm.152.6.8520777; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sawynok J, 2005, CURR PHARM DESIGN, V11, P2995, DOI 10.2174/1381612054865019; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sparrow MP, 1999, AM J RESP CELL MOL, V20, P550, DOI 10.1165/ajrcmb.20.4.3385; SUROWY CS, 2010, VANILLOID RECEPTOR T, P101; Swigris Jeffrey J, 2005, Health Qual Life Outcomes, V3, P61, DOI 10.1186/1477-7525-3-61; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takemura M, 2008, PULM PHARMACOL THER, V21, P833, DOI 10.1016/j.pupt.2008.09.005; Taylor-Clark TE, 2009, PULM PHARMACOL THER, V22, P71, DOI 10.1016/j.pupt.2008.12.019; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Watanabe N, 2005, PULM PHARMACOL THER, V18, P187, DOI 10.1016/j.pupt.2004.12.002; Wick MR, 2000, SEMIN DIAGN PATHOL, V17, P194; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187847	10.1371/journal.pone.0187847	http://dx.doi.org/10.1371/journal.pone.0187847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149168	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000415646100015
J	Lin, TH; Hu, HT; Wang, HC; Wu, MC; Wu, SW; Yeh, ML				Lin, Tzu-Hsiang; Hu, Hsin-Tai; Wang, Hsueh-Chun; Wu, Meng-Chian; Wu, Shu-Wei; Yeh, Ming-Long			Evaluation of osseous integration of titanium orthopedic screws with novel SLA treatment in porcine model	PLOS ONE			English	Article							TREATED MINI-IMPLANTS; SURFACE-TREATMENT; PEDICLE SCREWS; BONE RESPONSE; TORQUE; OSTEOPOROSIS; PREVALENCE; FRACTURES; ROUGHNESS; REMOVAL	The success of many endosseous implants in orthopaedic and dental applications depends on the surface characteristics, as they affect osseous integration. Previous investigations indicated that a novel large-grit sand-blasted and acid-etched (SLA) titanium (denoted as SLAffinity-Ti) implant had better bone integration than that of a comparably shaped implant with a plasma-sprayed titanium surface. The purpose of the present investigation was to create a SLAffinity surface on pedicle screws and trauma screws and to compare it with the surfaces of a sand-blasted-only implant and commercial implants in terms of bone integration. The cortical bone and spine of twelve minipigs were implanted with 3 and 4 implants, respectively, and the bone integration was evaluated using micro-computed tomography (micro-CT), mechanical tests (pull-out strength and stripping torque), and histological analysis (toluidine blue and hematoxylin and eosin staining) one and three months after implantation. The micro-CT images showed that the gap between the bone and implant was consistently higher in the sand-blasted-only and commercial groups compared to that in the SLAffinity group 1 and 3 months after implantation. Moreover, the bone volume of implant inserted into bone and the percentage of implant inside bone tissue were greater in the SLAffinity screws 1 and 3 months after implantation, as compared to the sand-blasted and commercial screws. In the mechanical tests, the removal torque and pull-out strength (p < 0.05) were higher in the SLAffinity group at 1 and 3 months. The histological results were consistent with mechanical testing, showing that the SLAffinity group had the most mineralized matrix, the most bone formation around the screws, and the most bone cells in bone tissue. These findings indicate that a SLAffinity surface can effectively enhance the holding strength and integration of pedicle screws and cortical screws, promoting early healing and improving outcomes, compared to sand-blasted-only and commercial implants.	[Lin, Tzu-Hsiang; Wang, Hsueh-Chun; Wu, Meng-Chian; Wu, Shu-Wei; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Hu, Hsin-Tai] Hung Chun Bio Sci Co, Dept Technol Dev, Kaohsiung Sci Pk, Kaohsiung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Yeh, ML (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	mlyeh@mail.ncku.edu.tw			Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C [102-EG-17-A-19-H-0092]	Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C	This work was supported by the Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C. Grant number is 102-EG-17-A-19-H-0092. The URL is https://www.moea.gov.tw/MNS/doit/content/Content.aspx?menu id=13394. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ABRASION DENT IMPLAN; Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f; Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P1652, DOI 10.2106/JBJS.I.01111; Buser D, 1991, Int J Oral Maxillofac Implants, V6, P405; BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708; Buser D, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P88; Chang CS, 2009, CLIN ORAL IMPLAN RES, V20, P1178, DOI 10.1111/j.1600-0501.2009.01728.x; Chiang HJ, 2016, J BIOMED MATER RES A, V104, P397, DOI 10.1002/jbm.a.35577; Chiang HJ, 2014, IMPLANT DENT, V23, P659, DOI 10.1097/ID.0000000000000181; Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x; Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q; Davies John E, 2003, J Dent Educ, V67, P932; Esses SI, 1993, SPINE, V18, P8; Jeon MS, 2008, KOREAN J ORTHOD, V38, P328, DOI 10.4041/kjod.2008.38.5.328; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kim SH, 2008, AM J ORTHOD DENTOFAC, V134, P36, DOI 10.1016/j.ajodo.2006.07.038; Kim SH, 2009, ANGLE ORTHOD, V79, P899, DOI 10.2319/090608-466.1; Klokkevold PR, 2001, CLIN ORAL IMPLAN RES, V12, P350, DOI 10.1034/j.1600-0501.2001.012004350.x; Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df; Lee WF., 2013, J EXPE CLIN MEDI, V5, P92, DOI [10.1016/j.jecm.2013.04.002, DOI 10.1016/J.JECM.2013.04.002]; Lin YH, 2012, IMPLANT DENT, V21, P344, DOI 10.1097/ID.0b013e31825fed00; Mandelbaum BR, 1998, AM J SPORT MED, V26, P853, DOI 10.1177/03635465980260062201; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Okuyama K, 2001, Spine J, V1, P402, DOI 10.1016/S1529-9430(01)00078-X; Ou K-L, 2016, J STEM CELL RES THE, V06; Patel SS, 2016, J CLIN NEUROSCI, V24, P63, DOI 10.1016/j.jocn.2015.07.018; Pazianas M, 2007, CLIN THER, V29, P1548, DOI 10.1016/j.clinthera.2007.08.008; Pfeiffer M, 1996, SPINE, V21, P1037, DOI 10.1097/00007632-199605010-00009; PIATTELLI A, 1995, BIOMATERIALS, V16, P917, DOI 10.1016/0142-9612(95)93116-U; Plachokova AS, 2008, CLIN ORAL IMPLAN RES, V19, P539, DOI 10.1111/j.1600-0501.2008.01525.x; Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499; Sirisa-Ard A, 2015, EUROPEAN J ORTHODONT; Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340; WILKE HJ, 1990, ADV BIOMAT, V9, P309; ZDEBLICK TA, 1993, SPINE, V18, P1673, DOI 10.1097/00007632-199309000-00016; 오남희, 2006, [The Korean Journal of Orthodontics, 대한치과교정학회지], V36, P324	39	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188364	10.1371/journal.pone.0188364	http://dx.doi.org/10.1371/journal.pone.0188364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149204	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100040
J	Xiong, AL; Haithcock, J; Liu, YY; Eusner, L; McConnell, M; White, HD; Belknap, B; Forgacs, E				Xiong, Ailian; Haithcock, Jessica; Liu, Yingying; Eusner, Lauren; McConnell, Matthew; White, Howard D.; Belknap, Betty; Forgacs, Eva			The shaker-1 mouse myosin VIIa deafness mutation results in a severely reduced rate of the ATP hydrolysis step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER-SYNDROME; MUSCLE-CONTRACTION; CELLULAR FUNCTIONS; FLUORESCENT-PROBE; FERM DOMAIN; ACTOMYOSIN; COMPLEX; GENE; STEREOCILIA; CELLS	Mutations in the MYO7A gene, encoding the motor protein myosin VIIa, can cause Usher 1B, a deafness/blindness syndrome in humans, and the shaker-1 phenotype, characterized by deafness, head tossing, and circling behavior, in mice. Myosin VIIa is responsible for tension bearing and the transduction mechanism in the stereocilia and for melanosome transport in the retina, in line with the phenotypic outcomes observed in mice. However, the effect of the shaker-1 mutation, a R502P amino acid substitution, on the motor function is unclear. To explore this question, we determined the kinetic properties and the effect on the filopodial tip localization of the recombinant mouse myosin VIIa-5IQ-SAH R502P (myoVIIa-sh1) construct. Interestingly, although residue 502 is localized to a region thought to be involved in interacting with actin, the kinetic parameters for actin binding changed only slightly for the mutant construct. However, the rate constant for ATP hydrolysis (k(+H)+k(-H)) was reduced by similar to 200-fold from 12 s(-1) to 0.05 s(-1), making the hydrolysis step the rate-limiting step of the ATPase cycle in the presence and absence of actin. Given that wild-type mouse myosin VIIa is a slow, high-duty ratio, monomeric motor, this altered hydrolysis rate would reduce activity to extremely low levels. Indeed, the translocation to the filopodial tips was hampered by the diminished motor function of a dimeric construct of the shaker-1 mutant. We conclude that the diminished motor activity of this mutant is most likely responsible for impaired hearing in the shaker-1 mice.	[Xiong, Ailian; Haithcock, Jessica; Liu, Yingying; Eusner, Lauren; McConnell, Matthew; White, Howard D.; Belknap, Betty; Forgacs, Eva] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	Eastern Virginia Medical School	Forgacs, E (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	forgace@evms.edu	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022		NIDCD, National Institutes of Health [R03DC009335, 3RO3DC009335-02S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009335] Funding Source: NIH RePORTER	NIDCD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD, National Institutes of Health RO3 Grants R03DC009335 and 3RO3DC009335-02S1 (to E.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Black DJ, 2000, BIOCHEMISTRY-US, V39, P13831, DOI 10.1021/bi001106+; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chavrier P, 2002, NAT CELL BIOL, V4, pE169, DOI 10.1038/ncb0702-e169; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Ebrahim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10833; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Gibbs D, 2010, INVEST OPHTH VIS SCI, V51, P1130, DOI 10.1167/iovs.09-4032; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; Li JC, 2017, STRUCTURE, V25, P579, DOI 10.1016/j.str.2017.02.002; Li JC, 2016, TRAFFIC, V17, P822, DOI 10.1111/tra.12383; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Maniak M, 2001, CURR BIOL, V11, pR315, DOI 10.1016/S0960-9822(01)00173-7; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Self T, 1998, DEVELOPMENT, V125, P557; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; Walklate J, 2016, J EXP BIOL, V219, P168, DOI 10.1242/jeb.124594; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	50	3	3	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					819	829		10.1074/jbc.M117.810119	http://dx.doi.org/10.1074/jbc.M117.810119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29167268	hybrid, Green Published			2022-12-26	WOS:000422864500006
J	Ramos, CJ; Lin, CM; Liu, XW; Antonetti, DA				Ramos, Carla J.; Lin, Chengmao; Liu, Xuwen; Antonetti, David A.			The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras-related protein 1 (Rap1); small GTPase; tight junction; tumor necrosis factor (TNF); vascular endothelial growth factor (VEGF); EPAC; blood-retinal barrier	ENDOTHELIAL BARRIER FUNCTION; TIGHT JUNCTION TRAFFICKING; EXCHANGE FACTOR; OCCLUDIN PHOSPHORYLATION; CELL JUNCTIONS; CYCLIC-AMP; CAMP; RAP1; EPAC; PROTEIN	Increased retinal vascular permeability contributes to macular edema, a leading cause of vision loss in eye pathologies such as diabetic retinopathy, age-related macular degeneration, and central retinal vein occlusions. Pathological changes in vascular permeability are driven by growth factors such as VEGF and pro-inflammatory cytokines such as TNF-. Identifying the pro-barrier mechanisms that block vascular permeability and restore the blood-retinal barrier (BRB) may lead to new therapies. The cAMP-dependent guanine nucleotide exchange factor (EPAC) exchange-protein directly activated by cAMP promotes exchange of GTP in the small GTPase Rap1. Rap1 enhances barrier properties in human umbilical endothelial cells by promoting adherens junction assembly. We hypothesized that the EPAC-Rap1 signaling pathway may regulate the tight junction complex of the BRB and may restore barrier properties after cytokine-induced permeability. Here, we show that stimulating EPAC or Rap1 activation can prevent or reverse VEGF- or TNF--induced permeability in cell culture and in vivo. Moreover, EPAC activation inhibited VEGF receptor (VEGFR) signaling through the Ras/MEK/ERK pathway. We also found that Rap1B knockdown or an EPAC antagonist increases endothelial permeability and that VEGF has no additive effect, suggesting a common pathway. Furthermore, GTP-bound Rap1 promoted tight junction assembly, and loss of Rap1B led to loss of junctional border organization. Collectively, our results indicate that the EPAC-Rap1 pathway helps maintain basal barrier properties in the retinal vascular endothelium and activation of the EPAC-Rap1 pathway may therefore represent a potential therapeutic strategy to restore the BRB.	[Ramos, Carla J.; Lin, Chengmao; Liu, Xuwen; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan	Antonetti, DA (corresponding author), Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	dantonet@med.umich.edu	LIU, XUWEN/AAR-9250-2020	Lin, Cheng-mao/0000-0003-2409-9423; Ramos, Carla Jhoana/0000-0001-5041-6758; antonetti, david/0000-0003-1130-6577	National Institutes of Health [EY012021, P30EY007003]; Research to Prevent Blindness; Kellogg Eye Center Core Center for Vision Research; Michigan Diabetes Research and Training Center [DK020572]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY012021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Kellogg Eye Center Core Center for Vision Research; Michigan Diabetes Research and Training Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant EY012021 (to D. A. A.), grants from the Research to Prevent Blindness (to D. A. A.) and Kellogg Eye Center Core Center for Vision Research, National Institutes of Health Grant P30EY007003, and Michigan Diabetes Research and Training Center Grant DK020572. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 1998, AM J PHYSIOL-HEART C, V274, pH1885, DOI 10.1152/ajpheart.1998.274.6.H1885; Antonetti David A, 2003, Methods Mol Med, V89, P365; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145689; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; D'Atri F, 2002, MOL MEMBR BIOL, V19, P103, DOI 10.1080/09687680210129236; de Kreuk BJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11394; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeMaio L, 2004, MICROVASC RES, V68, P295, DOI 10.1016/j.mvr.2004.06.007; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; He P, 2000, AM J PHYSIOL-HEART C, V278, pH1124, DOI 10.1152/ajpheart.2000.278.4.H1124; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liu J, 2015, SCI CHINA LIFE SCI, V58, P521, DOI 10.1007/s11427-015-4860-1; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Penzes P, 2011, MOL CELL NEUROSCI, V46, P368, DOI 10.1016/j.mcn.2010.11.008; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Ramos CJ, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1339768; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; ROUSSEAUMERCK MF, 1990, CYTOGENET CELL GENET, V53, P2, DOI 10.1159/000132883; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377; Titchenell PM, 2012, BIOCHEM J, V446, P455, DOI 10.1042/BJ20111961; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; van Dam Teunis J P, 2011, Small GTPases, V2, P4; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; Wang HB, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.56; Whitaker CM, 2010, NEUROSCIENCE, V165, P955, DOI 10.1016/j.neuroscience.2009.10.054; Wilson CW, 2014, CELL ADHES MIGR, V8, P76, DOI 10.4161/cam.28115; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Wittchen ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073070; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; Yuan ZG, 2013, INT J MOL SCI, V14, P13377, DOI 10.3390/ijms140713377	62	34	35	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					717	730		10.1074/jbc.M117.815381	http://dx.doi.org/10.1074/jbc.M117.815381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158262	Green Published, hybrid			2022-12-26	WOS:000419915400025
J	Mehlhorn, J; Rehkaemper, G				Mehlhorn, Julia; Rehkaemper, Gerd			The orientation of homing pigeons (Columba livia f.d.) with and without navigational experience in a two-dimensional environment	PLOS ONE			English	Article							SPATIAL REORIENTATION; TOUCH-SCREEN; SPONTANEOUSLY REORIENT; VISUAL-DISCRIMINATION; LANDMARK INFORMATION; GEOMETRIC MODULE; BRAIN; LATERALIZATION; ASYMMETRIES; CHICKS	Homing pigeons are known for their excellent homing ability, and their brains seem to be functionally adapted to homing. It is known that pigeons with navigational experience show a larger hippocampus and also a more lateralised brain than pigeons without navigational experience. So we hypothesized that experience may have an influence also on orientation ability. We examined two groups of pigeons (11 with navigational experience and 17 without) in a standard operant chamber with a touch screen monitor showing a 2-D schematic of a rectangular environment (as "geometric" information) and one uniquely shaped and colored feature in each corner (as "landmark" information). Pigeons were trained first for pecking on one of these features and then we examined their ability to encode geometric and landmark information in four tests by modifying the rectangular environment. All tests were done under binocular and monocular viewing to test hemispheric dominance. The number of pecks was counted for analysis. Results show that generally both groups orientate on the basis of landmarks and the geometry of environment, but landmark information was preferred. Pigeons with navigational experience did not perform better on the tests but showed a better conjunction of the different kinds of information. Significant differences between monocular and binocular viewing were detected particularly in pigeons without navigational experience on two tests with reduced information. Our data suggest that the conjunction of geometric and landmark information might be integrated after processing separately in each hemisphere and that this process is influenced by experience.	[Mehlhorn, Julia; Rehkaemper, Gerd] Univ Dusseldorf, Res Grp Comparat Neurobiol & Evolutionary Res, Inst Anat 1, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Mehlhorn, J (corresponding author), Univ Dusseldorf, Res Grp Comparat Neurobiol & Evolutionary Res, Inst Anat 1, Dusseldorf, Germany.	julia.mehlhorn@uni-duesseldorf.de						Bingman VP, 2003, BRAIN BEHAV EVOLUT, V62, P117, DOI 10.1159/000072442; Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Brown AA, 2007, PSYCHOL SCI, V18, P569, DOI 10.1111/j.1467-9280.2007.01941.x; Cheng K, 2006, BEHAV PROCESS, V72, P115, DOI 10.1016/j.beproc.2005.11.018; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chiandetti C, 2015, DEVELOPMENTAL SCI, V18, P972, DOI 10.1111/desc.12277; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; CLAYTON NS, 1994, P NATL ACAD SCI USA, V91, P7410, DOI 10.1073/pnas.91.16.7410; Diekamp B, 2002, BEHAV BRAIN RES, V136, P103, DOI 10.1016/S0166-4328(02)00106-7; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2001, EUR J NEUROSCI, V13, P1617, DOI 10.1046/j.0953-816x.2001.01522.x; Gagliardo A, 2007, J EXP BIOL, V210, P1132, DOI 10.1242/jeb.003244; Gunturkun O, 1997, EXP BRAIN RES, V116, P561, DOI 10.1007/PL00005785; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; Gunturkun O, 1991, NEURAL BEHAV PLAST; Kahn MC, 2004, BEHAV NEUROSCI, V118, P333, DOI 10.1037/0735-7044.118.2.333; Kelly DM, 1998, J COMP PSYCHOL, V112, P259, DOI 10.1037/0735-7036.112.3.259; Kelly DM, 2004, J COMP PSYCHOL, V118, P384, DOI 10.1037/0735-7036.118.4.384; Lee SA, 2013, J EXP BIOL, V216, P3693, DOI 10.1242/jeb.088625; Lee SA, 2012, ANIM COGN, V15, P861, DOI 10.1007/s10071-012-0512-z; Lee SA, 2012, BIOL LETTERS, V8, P492, DOI 10.1098/rsbl.2012.0067; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Manns M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00206; Martinho A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1957; Mayer U, 2016, HIPPOCAMPUS, V26, P27, DOI 10.1002/hipo.22486; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Mehlhorn J, 2010, J EXP BIOL, V213, P2219, DOI 10.1242/jeb.043208; Mehlhorn J, 2009, NATURWISSENSCHAFTEN, V96, P1011, DOI 10.1007/s00114-009-0560-7; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Pecchia T, 2012, BEHAV LATERALIZATION; Pecchia T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022657; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; RASHID N, 1989, NEUROPSYCHOLOGIA, V27, P937, DOI 10.1016/0028-3932(89)90069-9; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; REHKAMPER G, 1988, BRAIN BEHAV EVOLUT, V31, P141, DOI 10.1159/000116581; Rogers L, 1996, NEUROSCI BIOBEHAV R, V20, P487, DOI 10.1016/0149-7634(95)00024-0; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers LJ, 1999, BEHAV BRAIN RES, V98, P277, DOI 10.1016/S0166-4328(98)00094-1; Sherry D, 1998, SPATIAL REPRESENTATION IN ANIMALS, P133; Sovrano VA, 2003, J EXP PSYCHOL ANIM B, V29, P199, DOI 10.1037/0097-7403.29.3.199; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Spetch ML, 1997, J COMP PSYCHOL, V111, P14, DOI 10.1037/0735-7036.111.1.14; Spetch ML, 1996, J COMP PSYCHOL, V110, P55, DOI 10.1037/0735-7036.110.1.55; SPETCH ML, 1995, J EXP PSYCHOL-ANIM B, V21, P166, DOI 10.1037/0097-7403.21.2.166; SPETCH ML, 1988, ANIM BEHAV, V36, P293, DOI 10.1016/S0003-3472(88)80274-4; Tommasi L, 2001, BEHAV NEUROSCI, V115, P602, DOI 10.1037//0735-7044.115.3.602; Tommasi L, 2012, NEUROSCI BIOBEHAV R, V36, P799, DOI 10.1016/j.neubiorev.2011.12.007; Ulrich C, 1999, BEHAV BRAIN RES, V104, P169, DOI 10.1016/S0166-4328(99)00062-5; Ushitani T, 2011, J COMP PSYCHOL, V125, P317, DOI 10.1037/a0023044; VALLORTIGARA G, 1990, J COMP PSYCHOL, V104, P248, DOI 10.1037/0735-7036.104.3.248; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Vargas JP, 2004, EUR J NEUROSCI, V20, P1937, DOI 10.1111/j.1460-9568.2004.03654.x; Verhaal J, 2012, EUR J NEUROSCI, V35, P1337, DOI 10.1111/j.1460-9568.2012.08049.x; Walcott C, 2005, INTEGR COMP BIOL, V45, P574, DOI 10.1093/icb/45.3.574; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028; Wilzeck C, 2009, EUR J NEUROSCI, V29, P813, DOI 10.1111/j.1460-9568.2009.06626.x	62	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188483	10.1371/journal.pone.0188483	http://dx.doi.org/10.1371/journal.pone.0188483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176875	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900084
J	Ahmadi, H				Ahmadi, Hamed			A mathematical function for the description of nutrient-response curve	PLOS ONE			English	Article							NUTRITIONAL-REQUIREMENTS; GROWING RATS; REGRESSION	Several mathematical equations have been proposed to modeling nutrient-response curve for animal and human justified on the goodness of fit and/or on the biological mechanism. In this paper, a functional form of a generalized quantitative model based on Rayleigh distribution principle for description of nutrient-response phenomena is derived. The three parameters governing the curve a) has biological interpretation, b) may be used to calculate reliable estimates of nutrient response relationships, and c) provide the basis for deriving relationships between nutrient and physiological responses. The new function was successfully applied to fit the nutritional data obtained from 6 experiments including a wide range of nutrients and responses. An evaluation and comparison were also done based simulated data sets to check the suitability of new model and four-parameter logistic model for describing nutrient responses. This study indicates the usefulness and wide applicability of the new introduced, simple and flexible model when applied as a quantitative approach to characterizing nutrient-response curve. This new mathematical way to describe nutritional-response data, with some useful biological interpretations, has potential to be used as an alternative approach in modeling nutritional responses curve to estimate nutrient efficiency and requirements.	[Ahmadi, Hamed] Tarbiat Modares Univ, Dept Poultry Sci, Biosci & Agr Modeling Res Unit, Tehran, Iran	Tarbiat Modares University	Ahmadi, H (corresponding author), Tarbiat Modares Univ, Dept Poultry Sci, Biosci & Agr Modeling Res Unit, Tehran, Iran.	hamed.ahmadi@modares.ac.ir		Ahmadi, Hamed/0000-0002-7445-3139	Research & Technology affair at the Tarbiat Modares University	Research & Technology affair at the Tarbiat Modares University	Financial support was provided by the Research & Technology affair at the Tarbiat Modares University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du FY, 2000, J NUTR, V130, P514, DOI 10.1093/jn/130.3.514; GAHL MJ, 1991, J NUTR, V121, P1720, DOI 10.1093/jn/121.11.1720; Hunt JR, 2008, J NUTR, V138, P1462, DOI 10.1093/jn/138.8.1462; Institute S, 2008, SAS STAT 9 2 US GUID; Krishnamoorthy K, 2006, STAT TEXTB MONOGR, P1; Lamberson WR, 2002, POULTRY SCI, V81, P481, DOI 10.1093/ps/81.4.481; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; MERCER LP, 1992, J NUTR, V122, P706, DOI 10.1093/jn/122.suppl_3.706; MERCER LP, 1978, J NUTR, V108, P1244, DOI 10.1093/jn/108.8.1244; MERCER LP, 1993, J NUTR, V123, P964, DOI 10.1093/jn/123.5.964; MERCER LP, 1982, J NUTR, V112, P560, DOI 10.1093/jn/112.3.560; MORGAN PH, 1975, P NATL ACAD SCI USA, V72, P4327, DOI 10.1073/pnas.72.11.4327; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Passlack N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149190; Pesti GM, 2009, BRIT POULTRY SCI, V50, P16, DOI 10.1080/00071660802530639; Rayleigh, 1919, PHILOS MAG, V37, P321, DOI 10.1080/14786440408635894; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; Shan AS, 2003, POULTRY SCI, V82, P1154, DOI 10.1093/ps/82.7.1154; Strathe AB, 2011, POULTRY SCI, V90, P1496, DOI 10.3382/ps.2011-01345; Wen LM, 2015, FISH SHELLFISH IMMUN, V46, P501, DOI 10.1016/j.fsi.2015.07.001	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187292	10.1371/journal.pone.0187292	http://dx.doi.org/10.1371/journal.pone.0187292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161271	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000007
J	Nateghi, R; Mukherjee, S				Nateghi, Roshanak; Mukherjee, Sayanti			A multi-paradigm framework to assess the impacts of climate change on end-use energy demand	PLOS ONE			English	Article							ELECTRICITY; CONSUMPTION; OPTIMIZATION; SENSITIVITY; METHODOLOGY; MODELS; STATE	Projecting the long-term trends in energy demand is an increasingly complex endeavor due to the uncertain emerging changes in factors such as climate and policy. The existing energy-economy paradigms used to characterize the long-term trends in the energy sector do not adequately account for climate variability and change. In this paper, we propose a multi-paradigm framework for estimating the climate sensitivity of end-use energy demand that can easily be integrated with the existing energy-economy models. To illustrate the applicability of our proposed framework, we used the energy demand and climate data in the state of Indiana to train a Bayesian predictive model. We then leveraged the end-use demand trends as well as downscaled future climate scenarios to generate probabilistic estimates of the future end-use demand for space cooling, space heating and water heating, at the individual household and building level, in the residential and commercial sectors. Our results indicated that the residential load is much more sensitive to climate variability and change than the commercial load. Moreover, since the largest fraction of the residential energy demand in Indiana is attributed to heating, future warming scenarios could lead to reduced end-use demand due to lower space heating and water heating needs. In the commercial sector, the overall energy demand is expected to increase under the future warming scenarios. This is because the increased cooling load during hotter summer months will likely outpace the reduced heating load during the more temperate winter months.	[Nateghi, Roshanak; Mukherjee, Sayanti] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Nateghi, Roshanak] Purdue Univ, Div Environm & Ecol Engn, W Lafayette, IN 47907 USA; [Mukherjee, Sayanti] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mukherjee, S (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.; Mukherjee, S (corresponding author), Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA.	sayanti.purdue@gmail.com	Mukherjee, Sayanti/AAG-6266-2021; Nateghi, Roshanak/AAQ-2425-2020	Mukherjee, Sayanti/0000-0002-5833-1617	Purdue EEE-SER; NSF SEES [1555582]	Purdue EEE-SER; NSF SEES(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for this project was provided by Purdue EEE-SER seed grant, and the NSF SEES #1555582, entitled "Sustainable Energy Infrastructure Planning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpanda S, 2008, OIL CRISIS ENERGY SA; Amato AD, 2005, CLIMATIC CHANGE, V71, P175, DOI 10.1007/s10584-005-5931-2; Blum H, 2010, QUANTITATIVE ANAL PR; Chandramowli SN, 2014, SUSTAIN ENERGY TECHN, V5, P62, DOI 10.1016/j.seta.2013.11.003; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Davis LW, 2012, NBER CONF R, P301; Derrible S, 2015, ENERG BUILDINGS, V108, P304, DOI 10.1016/j.enbuild.2015.09.022; DOE, 2015, CLIM CHANG US EN SEC; EIA, 2017, IND PROF AN; EIA, 2014, INDEPENDENT STAT ANA; Energy Information Administration 2014, 2000, EN REL CARB DIOX EM; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Griffith B., 2006, ASSESSMENT TECHNICAL; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Howard B, 2012, ENERG BUILDINGS, V45, P141, DOI 10.1016/j.enbuild.2011.10.061; Ilie L, 2006, EC CONSIDERATIONS RE; Kapelner A., 2013, ARXIV13122171; Kaza N, 2010, ENERG POLICY, V38, P6574, DOI 10.1016/j.enpol.2010.06.028; Kiran MS, 2012, ENERG CONVERS MANAGE, V53, P75, DOI 10.1016/j.enconman.2011.08.004; Krishnan V, 2016, ENERGY SYST, V7, P297, DOI 10.1007/s12667-015-0158-4; Levinson A, 2004, RESOUR ENERGY ECON, V26, P51, DOI [10.1016/S0928-7655(03)00047-2, 10.1016/50928-7655(03)00047-2]; Loulou R., 2005, DOCUMENTATION TIME 2, P1; Loulou R., DOCUMENTATION MARKAL; Min J, 2010, J IND ECOL, V14, P791, DOI 10.1111/j.1530-9290.2010.00279.x; Moss Richard, 2008, NEW SCENARIOS ANAL E; Mukherjee S, RISK ANAL; Mukherjee S, 2017, IEEE XPLORE; Mukhopadhyay S, 2017, ENERGY, V128, P688, DOI 10.1016/j.energy.2017.04.034; NOAA, 2017, CLIM DAT ONL DAT DIS; Sailor DJ, 2001, ENERGY, V26, P645, DOI 10.1016/S0360-5442(01)00023-8; Sailor DJ, 1997, ENERGY, V22, P987, DOI 10.1016/S0360-5442(97)00034-0; Sathaye J, 1989, END USE APPROACH DEV; SEDS, 2016, STAT DAT SYST SEDS 1; Steemers K, 2009, BUILD RES INF, V37, P625, DOI 10.1080/09613210903186661; Suganthi L, 2012, RENEW SUST ENERG REV, V16, P1223, DOI 10.1016/j.rser.2011.08.014; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Tohver IM, 2014, J AM WATER RESOUR AS, V50, P1461, DOI 10.1111/jawr.12199; Torcellini P., 2008, DOE COMMERCIAL BUILD, P17; United States Energy Information Administration, 2009, RECS RES EN CONS SUR; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Voit J., 2005, STAT MECH FINANCIAL; Winiarski DW, 2006, PNNL20346; Yalcintas M, 2006, INT J ENERG RES, V30, P1158, DOI 10.1002/er.1212; Yun GY, 2011, APPL ENERG, V88, P2191, DOI 10.1016/j.apenergy.2011.01.010	45	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188033	10.1371/journal.pone.0188033	http://dx.doi.org/10.1371/journal.pone.0188033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155862	gold, Green Published, Green Submitted			2022-12-26	WOS:000415756700027
J	Su, K; Liu, S; Wu, T; Yin, YC; Zhang, RP; Li, SL; Zhang, YZ				Su, Ke; Liu, Song; Wu, Tao; Yin, Yingchao; Zhang, Ruipeng; Li, Shilun; Zhang, Yingze			Posterior column acetabular fracture fixation using a W-shaped angular plate: A biomechanical analysis	PLOS ONE			English	Article							OPERATIVE TREATMENT; SCREW FIXATION; WALL	Objective The purpose of this study was to compare the stability and feasibility of four fixation constructs in a posterior column acetabular fracture: one reconstruction plate, one reconstruction plate and lag screw, two reconstruction plates, and a W-shaped acetabular angular plate. Methods Twenty embalmed cadaveric pelvises with a posterior column acetabular fractures were allocated to one of four groups: 1) a reconstruction plate, 2) a reconstruction plate with a posterior column lag screw, 3) double reconstruction plates, and 4) a W-shaped acetabular angular plate. These constructs were mechanically loaded on a testing machine, and construct stiffness values were measured. Strain gauges were utilized to measure the mechanical behavior in the condition of compressive force. Results Final stiffness was not different between the two reconstruction plates (445.81 +/- 98.30 N/mm) and the W-shaped acetabular angular plate (447.43 +/- 98.45 N/mm, p = 0.524), both of which were superior to a single reconstruction plate (248.90 +/- 61.95 N/mm) and a combined plate and lag screw (326.41 +/- 94.34 N/mm). Following the fixation of the W-shaped acetabular angular plate, the strain distribution was similar to the intact condition around the acetabulum. The parameters of the W-shaped acetabular angular plate that were observed at the superior region of the acetabulum were less than those of a single reconstruction plate (p<0.05), a single reconstruction plate with lag screw (p<0.05), and two reconstruction plates (p<0.05). Conclusions The novel W-shaped acetabular angular plate fixation technique was able to provide the biomechanically stiffest construct for stabilization of a posterior column acetabular fracture; it also resulted in a partial restoration of joint loading parameters toward the intact state.	[Su, Ke] Cangzhou Cent Hosp, Dept Orthopaed Surg, Cangzhou, Hebei, Peoples R China; [Liu, Song; Wu, Tao; Yin, Yingchao; Zhang, Ruipeng; Li, Shilun; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.	yzzhangdr@126.com		Zhang, Yingze/0000-0003-1923-3659; Zhang, Ruipeng/0000-0002-1702-8988; Yin, Yingchao/0000-0002-0989-9556; Zhang, YIngze/0000-0001-8042-6105	Natural Science Foundation of China [81572125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Natural Science Foundation of China, Approval number: 81572125, http://www.nsfc.gov.cn/. The funders provided financial support, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JK, 2001, CLIN ORTHOP RELAT R, P433; DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N; Ebraheim N A, 1989, J Orthop Trauma, V3, P196, DOI 10.1097/00005131-198909000-00003; Feng XR, 2016, INJURY, V47, P702, DOI 10.1016/j.injury.2016.01.026; Fulkerson E, 2006, J TRAUMA, V60, P830, DOI 10.1097/01.ta.0000195462.53525.0c; Giordano V, 2009, INT J MED SCI, V6, P192; KNIGHT RA, 1958, J BONE JOINT SURG AM, V40, P1; Liu XW, 2010, CLIN BIOMECH, V25, P312, DOI 10.1016/j.clinbiomech.2010.01.008; MATTA JM, 1986, CLIN ORTHOP RELAT R, P230; Mehin R, 2009, CAN J SURG, V52, P221; OLSON SA, 1995, J BONE JOINT SURG AM, V77A, P1184, DOI 10.2106/00004623-199508000-00007; Ramos AMdT, 2017, CLIM DYNAM, P1; Russell GV, 2001, J TRAUMA, V51, P1098, DOI 10.1097/00005373-200112000-00014; SAWAGUCHI T, 1984, ACTA ORTHOP SCAND, V55, P601, DOI 10.3109/17453678408992404; SCHOPFER A, 1994, INT ORTHOP, V18, P96, DOI 10.1007/BF02484418; Schutz Michael, 2003, J Orthop Sci, V8, P252, DOI 10.1007/s007760300044; Shazar N, 1998, CLIN ORTHOP RELAT R, P215; Suzuki T, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-7; Uchida Kenzo, 2013, Eur J Orthop Surg Traumatol, V23, P155, DOI 10.1007/s00590-012-0938-7; Wu XB, 2010, J TRAUMA, V69, P423, DOI 10.1097/TA.0b013e3181ca05f6; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092210; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076464	22	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187886	10.1371/journal.pone.0187886	http://dx.doi.org/10.1371/journal.pone.0187886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155842	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700020
J	Xia, TT; Chai, XC; Shen, JQ				Xia, Tingting; Chai, Xichen; Shen, Jiaqing			Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss	PLOS ONE			English	Article							FECAL ELASTASE-1; CANCER ANOREXIA; OLDER-ADULTS; INFLAMMATION; GUIDELINES; DIAGNOSIS; PEPTIDES; CACHEXIA; DISEASE	Background Appetite loss is one complication of chronic heart failure (CHF), and its association with pancreatic exocrine insufficiency (PEI) is not well investigated in CHF. Aim We attempted to detect the association between PEI and CHF-induced appetite. Methods Patients with CHF were enrolled, and body mass index (BMI), left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) cardiac function grading, B-type natriuretic peptide (BNP), serum albumin, pro-albumin and hemoglobin were evaluated. The pancreatic exocrine function was measured by fecal elastase-1 (FE-1) levels in the enrolled patients. Appetite assessment was tested by completing the simplified nutritional appetite questionnaire (SNAQ). The improvement of appetite loss by supplemented pancreatic enzymes was also researched in this study. Results The decrease of FE-1 levels was found in patients with CHF, as well as SNAQ scores. A positive correlation was observed between SNAQ scores and FE-1 levels (r = 0.694, p < 0.001). Pancreatic enzymes supplement could attenuate the decrease of SNAQ scores in CHF patients with FE-1 levels < 200 mu g/g stool and SNAQ < 14. Conclusions Appetite loss is commonly seen in CHF, and is partially associated with pancreatic exocrine insufficiency. Oral pancreatic enzyme replacement therapy attenuates the chronic heart failure-induced appetite loss. These results suggest a possible pancreatic-cardiac relationship in chronic heart failure, and further experiment is needed for clarifying the possible mechanisms.	[Xia, Tingting; Shen, Jiaqing] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Chai, Xichen] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, JQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China.	sjqsz@126.com			National Natrual Science Foundation of China [81300357]; Suzhou Municipal Science and Technology Development Program [SYS201333]	National Natrual Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Municipal Science and Technology Development Program	This work was supported by National Natrual Science Foundation of China (No. 81300357) and Suzhou Municipal Science and Technology Development Program (SYS201333).	Aguilera A, 2003, AM J KIDNEY DIS, V42, P787, DOI 10.1016/S0272-6386(03)00920-X; Barrett GL, 2011, REGUL PEPTIDES, V170, P24, DOI 10.1016/j.regpep.2011.05.004; Chronic Heart Failure, 2010, NAT CLIN GUID DIAGN, P38; Cubbon RM, 2011, CIRC-HEART FAIL, V4, P396, DOI 10.1161/CIRCHEARTFAILURE.110.959882; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dominguez-Munoz JE, 2011, ADV MED SCI-POLAND, V56, P1, DOI 10.2478/v10039-011-0005-3; Dominici R, 2002, CLIN CHEM LAB MED, V40, P325, DOI 10.1515/CCLM.2002.051; Gandhi PU, 2014, ANN GLOB HEALTH, V80, P46, DOI 10.1016/j.aogh.2013.12.005; Haug U, 2007, CLIN CHEM, V53, P787, DOI 10.1373/clinchem.2006.078188; Hubbard RE, 2008, J AM GERIATR SOC, V56, P279, DOI 10.1111/j.1532-5415.2007.01548.x; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Irving G, 2013, INT J CARDIOL, V168, P2304, DOI 10.1016/j.ijcard.2013.01.189; Kaur S, 2008, ASIA PAC J CLIN NUTR, V17, P199; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Landi F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020069; Leeds JS, 2011, NAT REV GASTRO HEPAT, V8, P405, DOI 10.1038/nrgastro.2011.91; Lindkvist B, 2013, WORLD J GASTROENTERO, V19, P7258, DOI 10.3748/wjg.v19.i42.7258; Loncar G, 2015, INT J CARDIOL, V201, pE1, DOI 10.1016/j.ijcard.2015.10.115; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Meijers WC, 2014, AM HEART J, V167, P853, DOI 10.1016/j.ahj.2014.02.011; Molfino A, 2017, J CACHEXIA SARCOPENI, V8, P40, DOI 10.1002/jcsm.12156; Ozcan M, 2015, TURK KARDIYOL DERN A, V43, P131, DOI 10.5543/tkda.2015.06606; Phillips MB, 2010, ASIA PAC J CLIN NUTR, V19, P440; Pongprasobchai S, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12406; Rahman A, 2016, JPEN-PARENTER ENTER, V40, P475, DOI 10.1177/0148607114566854; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Gracia JR, 2017, REV CLIN ESP, V217, P161, DOI 10.1016/j.rce.2016.10.012; Saitoh M, 2016, WIEN KLIN WOCHENSCHR, V128, P455, DOI 10.1007/s00508-016-1100-z; Scheede-Bergdahl C, 2012, CLIN NUTR, V31, P85, DOI 10.1016/j.clnu.2011.07.010; Smiechowska J, 2010, J INVEST MED, V58, P554, DOI 10.231/JIM.0b013e3181cf91ca; Stevenson LW, 2011, CIRC-HEART FAIL, V4, P390, DOI 10.1161/CIRCHEARTFAILURE.111.963066; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Turrin NP, 2004, CURR OPIN CLIN NUTR, V7, P419, DOI 10.1097/01.mco.0000134373.16557.92; Visvanathan R, 2009, GASTROENTEROL CLIN N, V38, P393, DOI 10.1016/j.gtc.2009.06.009; Whitcomb DC, 2016, PANCREAS, V45, P679, DOI 10.1097/MPA.0000000000000514; Wilson Margaret-Mary G, 2007, Mo Med, V104, P46; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; Xu YP, 2012, PANCREAS, V41, P922, DOI 10.1097/MPA.0b013e31823d7f2d	38	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187804	10.1371/journal.pone.0187804	http://dx.doi.org/10.1371/journal.pone.0187804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155861	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700016
J	Core, JQ; Mehrabi, M; Robinson, ZR; Ochs, AR; McCarthy, LA; Zaragoza, MV; Grosberg, A				Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Zaragoza, Michael V.; Grosberg, Anna			Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations	PLOS ONE			English	Article							GILFORD PROGERIA SYNDROME; ENVELOPE ALTERATIONS; IMAGE-ANALYSIS; SHAPE; CARDIOMYOPATHY; FIBROBLASTS; LAMINA; INVAGINATIONS; DEFORMATION; FAMILY	Nuclear shape defects are a distinguishing characteristic in laminopathies, cancers, and other pathologies. Correlating these defects to the symptoms, mechanisms, and progression of disease requires unbiased, quantitative, and high-throughput means of quantifying nuclear morphology. To accomplish this, we developed a method of automatically segmenting fluorescently stained nuclei in 2D microscopy images and then classifying them as normal or dysmorphic based on three geometric features of the nucleus using a package of Matlab codes. As a test case, cultured skin-fibroblast nuclei of individuals possessing LMNA splice-site mutation (c.357-2A>G), LMNA nonsense mutation (c. 736 C>T, pQ246X) in exon 4, LMNA missense mutation (c.1003C>T, pR335W) in exon 6, Hutchinson-Gilford Progeria Syndrome, and no LMNA mutations were analyzed. For each cell type, the percentage of dysmorphic nuclei, and other morphological features such as average nuclear area and average eccentricity were obtained. Compared to blind observers, our procedure implemented in Matlab codes possessed similar accuracy to manual counting of dysmorphic nuclei while being significantly more consistent. The automatic quantification of nuclear defects revealed a correlation between in vitro results and age of patients for initial symptom onset. Our results demonstrate the method's utility in experimental studies of diseases affecting nuclear shape through automated, unbiased, and accurate identification of dysmorphic nuclei.	[Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Grosberg, Anna] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Grosberg, Anna] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Techn, Irvine, CA 92697 USA; [Zaragoza, Michael V.] Univ Calif Irvine, Sch Med, Pediat Genet & Gen Div, Irvine, CA 92717 USA; [Zaragoza, Michael V.] Univ Calif Irvine, Biol Chem Sch Med, Irvine, CA USA; [Grosberg, Anna] Univ Calif Irvine, Chem Engn & Mat Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Grosberg, A (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Grosberg, A (corresponding author), Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Techn, Irvine, CA 92697 USA.; Grosberg, A (corresponding author), Univ Calif Irvine, Chem Engn & Mat Sci, Irvine, CA 92697 USA.	grosberg@uci.edu		Grosberg, Anna/0000-0002-8878-0843	National Institutes of Health [NIHR01 HL129008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116270, R01HL129008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [grant number: NIHR01 HL129008 2015-2020 (PIs: Grosberg, Zaragoza)]. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Booth-Gauthier EA, 2013, INTEGR BIOL-UK, V5, P569, DOI 10.1039/c3ib20231c; BOURGEOIS CA, 1979, J ULTRA MOL STRUCT R, V68, P328, DOI 10.1016/S0022-5320(79)90165-5; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cardillo G, 2009, COHENS KAPPA MATLAB; Chernov N., 2009, ELLIPSE FIT DIRECT M; Choi S, 2011, NUCLEUS-PHILA, V2, P570, DOI 10.4161/nucl.2.6.17798; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Clubb BH, 1998, TISSUE CELL, V30, P684, DOI 10.1016/S0040-8166(98)80087-6; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Drew NK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004190; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Georgatos SD, 1997, J CELL SCI, V110, P2129; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupta P, 2010, BASIC RES CARDIOL, V105, P365, DOI 10.1007/s00395-010-0085-4; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hoshiba T, 2008, BIOCHEM BIOPH RES CO, V374, P688, DOI 10.1016/j.bbrc.2008.07.112; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Kim HK, 2011, J KOREAN MED SCI, V26, P1642, DOI 10.3346/jkms.2011.26.12.1642; Kroon DJ, 2010, SNAKE ACTIVE CONTOUR; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langevin HM, 2010, HISTOCHEM CELL BIOL, V133, P405, DOI 10.1007/s00418-010-0680-3; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lu JT, 2011, DIS MODEL MECH, V4, P562, DOI 10.1242/dmm.006346; MAKOUS N, 1962, AM HEART J, V64, P334, DOI 10.1016/0002-8703(62)90148-5; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Nikonenko AG, 2015, CYTOM PART A, V87A, P309, DOI 10.1002/cyto.a.22612; Ogura M, 2016, MED MOL MORPHOL, V49, P76, DOI 10.1007/s00795-015-0121-4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Park WB, 2017, IUCRJ, V4, P486, DOI 10.1107/S205225251700714X; Ropers Hans-Hilger, 2010, Dialogues Clin Neurosci, V12, P95; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Sommer H. J, 1998, POLYGEOM; Wang P, 2016, SIGNAL PROCESS, V122, P1, DOI 10.1016/j.sigpro.2015.11.011; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wiggan O, 2017, SCI REP-UK, V7, DOI 10.1038/srep40953; Yap M. H., 2017, IEEE J BIOMEDICAL HL; Zaragoza MV, 2017, CLIN GENET, V91, P499, DOI 10.1111/cge.12870; Zaragoza MV, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040040; Zaragoza MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155421; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	52	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188256	10.1371/journal.pone.0188256	http://dx.doi.org/10.1371/journal.pone.0188256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149195	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100032
J	Grimston, SK; Fontana, F; Watkins, M; Civitelli, R				Grimston, Susan K.; Fontana, Francesca; Watkins, Marcus; Civitelli, Roberto			Heterozygous deletion of both sclerostin (Sost) and connexin43 (Gja1) genes in mice is not sufficient to impair cortical bone modeling	PLOS ONE			English	Article							OSTEOBLAST; MECHANISMS; INCREASES; STRENGTH; SKELETON; MASS; LOAD	Connexin43 (Cx43) is the main gap junction protein expressed in bone forming cells, where it modulates peak bone mass acquisition and cortical modeling. Genetic ablation of the Cx43 gene (Gja1) results in cortical expansion with accentuated periosteal bone formation associated with decreased expression of the Wnt inhibitor sclerostin. To determine whether sclerostin (Sost) down-regulation might contribute to periosteal expansion in Gja1 deficient bones, we took a gene interaction approach and crossed mice harboring germline null alleles for Gja1 or Sost to generate single Gja1(+/-) and Sost(+/-) and double Gja1(+/-); Sost(+/-) heterozygous mice. In vivo mu CT analysis of cortical bone at age 1 and 3 months confirmed increased thickness in Sost(-/-) mice, but revealed no cortical abnormalities in single Gja1(+/-) or Sost(+/-) mice. Double heterozygous Gja1(+/-) Sost(+/-) also showed no differences in mineral density, cortical thickness, width or geometry relative to wild type control mice. Likewise, 3-point bending measurement of bone strength revealed no significant differences between double Gja1(+/-); Sost(+/-) or single heterozygous and wild type mice. Although these data do not exclude a contribution of reduced sclerostin in the cortical expansion seen in Gja1 deficient bones, they are not consistent with a strong genetic interaction between Sost and Gja1 dictating cortical modeling.	[Grimston, Susan K.; Fontana, Francesca; Watkins, Marcus; Civitelli, Roberto] Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis,Musculoskeletal Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Fontana, F (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis,Musculoskeletal Res Ctr, St Louis, MO 63110 USA.	francesca.fontana@wustl.edu	Civitelli, Roberto/AAA-8260-2019; Watkins, Marcus/V-8817-2019	Civitelli, Roberto/0000-0003-4076-4315; Watkins, Marcus/0000-0002-1224-3478; Fontana, Francesca/0000-0002-5889-9413	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR041255, P30-R057235]; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR041255] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (www.niams.nih.gov) R01-AR041255 (RC), P30-R057235 (Core Center for Musculoskeletal Biology and Medicine), and funds from the Barnes Jewish Hospital Foundation (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivi N, 2013, J ORTHOP RES; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Florio M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11505; Grimston SK, 2006, ANN NY ACAD SCI, V1068, P214, DOI 10.1196/annals.1346.023; Grimston SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044222; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Kelly JJ, 2015, CELL TISSUE RES, V360, P701, DOI 10.1007/s00441-014-2024-4; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; Plotkin LI, 2015, CELL MOL LIFE SCI, V72, P2853, DOI 10.1007/s00018-015-1963-6; Portney LG, 1993, FDN CLIN RES APPL PR, P525; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Silva MJ, 2000, J BIOMECH, V33, P231, DOI 10.1016/S0021-9290(99)00158-X; Stains JP, 2016, SEMIN CELL DEV BIOL, V50, P31, DOI 10.1016/j.semcdb.2015.12.017; Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6; Stolina M, 2014, BONE, V67, P305, DOI 10.1016/j.bone.2014.07.031; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Watkins MP, 2012, BONE, V51, P787, DOI 10.1016/j.bone.2012.06.018	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187980	10.1371/journal.pone.0187980	http://dx.doi.org/10.1371/journal.pone.0187980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149200	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100020
J	Manabe, S; Morimoto, C; Hamano, Y; Fujimoto, S; Tamaki, K				Manabe, Sho; Morimoto, Chie; Hamano, Yuya; Fujimoto, Shuntaro; Tamaki, Keiji			Development and validation of open-source software for DNA mixture interpretation based on a quantitative continuous model	PLOS ONE			English	Article							LOW-TEMPLATE; INTERNATIONAL SOCIETY; FORENSIC GENETICS; PROFILES; CASEWORK; RECOMMENDATIONS; POPULATION; COMMISSION; LOCI	In criminal investigations, forensic scientists need to evaluate DNA mixtures. The estimation of the number of contributors and evaluation of the contribution of a person of interest (POI) from these samples are challenging. In this study, we developed a new open-source software "Kongoh" for interpreting DNA mixture based on a quantitative continuous model. The model uses quantitative information of peak heights in the DNA profile and considers the effect of artifacts and allelic drop-out. By using this software, the likelihoods of 1-4 persons' contributions are calculated, and the most optimal number of contributors is automatically determined; this differs from other open-source software. Therefore, we can eliminate the need to manually determine the number of contributors before the analysis. Kongoh also considers allele-or locus-specific effects of biological parameters based on the experimental data. We then validated Kongoh by calculating the likelihood ratio (LR) of a POI's contribution in true contributors and non-contributors by using 2-4 person mixtures analyzed through a 15 short tandem repeat typing system. Most LR values obtained from Kongoh during true-contributor testing strongly supported the POI's contribution even for small amounts or degraded DNA samples. Kongoh correctly rejected a false hypothesis in the non-contributor testing, generated reproducible LR values, and demonstrated higher accuracy of the estimated number of contributors than another software based on the quantitative continuous model. Therefore, Kongoh is useful in accurately interpreting DNA evidence like mixtures and small amounts or degraded DNA samples.	[Manabe, Sho; Morimoto, Chie; Hamano, Yuya; Fujimoto, Shuntaro; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan; [Hamano, Yuya] Kyoto Prefectural Police Headquarters, Forens Sci Lab, Kyoto, Japan	Kyoto University	Tamaki, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan.	ktamaki@fp.med.kyoto-u.ac.jp		Tamaki, Keiji/0000-0003-2664-0471	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05273, 14J03372]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 16H05273 and 14J03372.; We are very grateful to Ryo Yamada for his critique and insightful discussion on the manuscript. This work was supported by JSPS KAKENHI Grant Number 16H05273 and 14J03372.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2011, QUALITY ASSURANCE ST; Bleka O, 2016, FORENSIC SCI INT-GEN, V25, P85, DOI 10.1016/j.fsigen.2016.07.016; Bleka O, 2016, FORENSIC SCI INT-GEN, V21, P35, DOI 10.1016/j.fsigen.2015.11.008; Bright JA, 2016, FORENSIC SCI INT-GEN, V23, P226, DOI 10.1016/j.fsigen.2016.05.007; Bright JA, 2013, AUST J FORENSIC SCI, V45, P445, DOI 10.1080/00450618.2013.772235; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Clayton TM, 1998, FORENSIC SCI INT, V91, P55, DOI 10.1016/S0379-0738(97)00175-8; Cowell RG, 2015, J R STAT SOC C-APPL, V64, P1, DOI 10.1111/rssc.12071; Evett I, 2000, SCI JUSTICE, V40, P233, DOI 10.1016/S1355-0306(00)71993-9; Gibb AJ, 2009, SCI JUSTICE, V49, P24, DOI 10.1016/j.scijus.2008.05.002; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2012, FORENSIC SCI INT-GEN, V6, P679, DOI 10.1016/j.fsigen.2012.06.002; Gill P, 2015, FORENSIC SCI INT-GEN, V18, P100, DOI 10.1016/j.fsigen.2015.03.014; Haned H, 2012, FORENSIC SCI INT-GEN, V6, P762, DOI 10.1016/j.fsigen.2012.08.008; Haned H, 2016, SCI JUSTICE, V56, P104, DOI 10.1016/j.scijus.2015.11.007; Hill CR, 2013, FORENSIC SCI INT-GEN, V7, pE82, DOI 10.1016/j.fsigen.2012.12.004; Kelly H, 2014, SCI JUSTICE, V54, P66, DOI 10.1016/j.scijus.2013.07.003; Lohmueller KE, 2013, J FORENSIC SCI, V58, pS243, DOI 10.1111/1556-4029.12017; Manabe S, 2016, LEGAL MED-TOKYO, V19, P16, DOI 10.1016/j.legalmed.2016.01.007; Manabe S, 2015, FORENS SCI INT-GEN S, V5, pE104, DOI 10.1016/j.fsigss.2015.09.042; Perlin MW, 2011, J FORENSIC SCI, V56, P1430, DOI 10.1111/j.1556-4029.2011.01859.x; Petricevic S, 2010, FORENSIC SCI INT-GEN, V4, P305, DOI 10.1016/j.fsigen.2009.11.003; Presciuttini S, 2016, FORENSIC SCI INT-GEN, V25, pE18, DOI 10.1016/j.fsigen.2016.08.005; Puch-Solis R, 2013, FORENSIC SCI INT-GEN, V7, P555, DOI 10.1016/j.fsigen.2013.05.009; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2015, GUID VAL PROB GEN SY; Steele CD, 2016, STAT APPL GENET MOL, V15, P431, DOI 10.1515/sagmb-2016-0038; Steele CD, 2014, FORENSIC SCI INT-GEN, V13, P82, DOI 10.1016/j.fsigen.2014.06.018; Swaminathan H, 2016, FORENSIC SCI INT-GEN, V22, P149, DOI 10.1016/j.fsigen.2016.02.005; Taylor D, 2013, FORENSIC SCI INT-GEN, V7, P516, DOI 10.1016/j.fsigen.2013.05.011; Yoshida K, 2005, J FORENSIC SCI, V50, P718	31	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188183	10.1371/journal.pone.0188183	http://dx.doi.org/10.1371/journal.pone.0188183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149210	Green Submitted, Green Published, gold			2022-12-26	WOS:000415646100026
J	Kim, Y; Kim, BK; Choi, HJ; Ryu, SW; Kim, ES; Chang, YS; Kim, HJ; Cha, JH; Kim, JH; Shin, C; Lee, SH				Kim, Young; Kim, Byeong Ki; Choi, Hong Jo; Ryu, Sung Weon; Kim, Eui Sook; Chang, Yoon Soo; Kim, Hee Jin; Cha, Jae Hyung; Kim, Je Hyeong; Shin, Chol; Lee, Seung Heon			Lessons learned from continued TB outbreaks in a high school	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; TUBERCULOSIS INFECTION; GUIDELINES; DISEASE; COUNTRIES	We investigated the aftereffects of confirmatory QuantiFERON testing (QFT) added to a positive tuberculin skin test (TST). We reviewed the pre and post course of sequential tuberculosis (TB) outbreaks in a high school where massive 43 active TB cases had been found within one year before delayed contact investigation. And we investigated the TB development in relation to initial TST and QFT during mean follow-up of 3.9 +/- 0.9 years. After delayed contact investigation for two subsequent TB outbreaks, 925 contacts were divided into the following 3 groups: TST-(n = 632), TST+/QFT+(n = 24), TST+/QFT-(n = 258). QFT-was more prevalent than QFT + in contacts with 10mm <= TST < 15mm (158, 61.2%) compared with TST >= 15mm (100, 38.8%) among the TST + reactors (P < 0.001). Among the 258 TST+/QFT-subjects, 256 received no latent TB infection (LTBI) treatment, but 7 contacts developed TB during follow-up. Among these 7 patients, 4 had initial TST >= 15mm and 3 had 10mm <= TST < 15mm. In conclusion, the delayed contact investigation for LTBI in a high school resulted in continued TB developments. False-negative QFT performed late among the TST + reactors should not be considered criteria for LTBI treatment. Additionally, the contacts only with TST >= 15mm should be considered for LTBI treatment in congregate settings of intermediate-burden countries.	[Kim, Young; Kim, Byeong Ki; Kim, Je Hyeong; Shin, Chol; Lee, Seung Heon] Korea Univ, Coll Med, Ansan Hosp, Div Pulm Sleep & Crit Care Med,Dept Internal Med, Ansan, South Korea; [Kim, Young; Chang, Yoon Soo] Yonsei Univ, Coll Med, Seoul, South Korea; [Choi, Hong Jo; Ryu, Sung Weon; Kim, Hee Jin] Korea Inst TB, Osong, South Korea; [Kim, Eui Sook] Publ Healthcare Ctr, Ansan, South Korea; [Cha, Jae Hyung] Korea Univ, Coll Med, Ansan Hosp, Med Sci Res Ctr, Ansan, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Korea Univ, Coll Med, Ansan Hosp, Div Pulm Sleep & Crit Care Med,Dept Internal Med, Ansan, South Korea.	lee-sh@korea.ac.kr	Lee, Seungheon/F-3246-2019	Lee, Seungheon/0000-0002-7180-3877; Kim, Je Hyeong/0000-0002-8995-7460; Ryoo, Sungweon/0000-0002-5085-0068; Chang, Yoon Soo/0000-0003-3340-4223				Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Gaur RL, 2013, J CLIN MICROBIOL, V51, P3521, DOI 10.1128/JCM.01627-13; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Lee SH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1117-3; Lee SH, 2010, RESP MED, V104, P448, DOI 10.1016/j.rmed.2009.10.006; Lee YK, 2015, PUBLIC HLTH WKLY REP, V8, P651; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; National Tuberculosis Controllers Association, GUID INV CONT PERS I; NICE (National Institute of Clinical Excellence), 2016, TUB NICE GUID NG33 TUB NICE GUID NG33; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; WHO, 2014, GLOB TUB REP 2014; WHO Tuberculosis Programme, 1994, WHO TUB PROGR FRAM E; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188076	10.1371/journal.pone.0188076	http://dx.doi.org/10.1371/journal.pone.0188076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145443	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800061
J	Kroh, HK; Chandrasekaran, R; Zhang, ZF; Rosenthal, K; Woods, R; Jin, XF; Nyborg, AC; Rainey, GJ; Warrener, P; Melnyk, RA; Spiller, BW; Lacy, DB				Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Zhang, Zhifen; Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul; Melnyk, Roman A.; Spiller, Benjamin W.; Lacy, D. Borden			A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE FORMATION; STRUCTURAL DETERMINANTS; TRANSLOCATION; MECHANISM; INFECTION; RECEPTOR; BINDING; DOMAIN; SOFTWARE; IDENTIFY	Clostridium difficile infection is the leading cause of hospital-acquired diarrhea and is mediated by the actions of two toxins, TcdA and TcdB. The toxins perturb host cell function through a multistep process of receptor binding, endocytosis, low pH-induced pore formation, and the translocation and delivery of an N-terminal glucosyltransferase domain that inactivates host GTPases. Infection studies with isogenic strains having defined toxin deletions have established TcdB as an important target for therapeutic development. Monoclonal antibodies that neutralize TcdB function have been shown to protect against C. difficile infection in animal models and reduce recurrence in humans. Here, we report the mechanism of TcdB neutralization by PA41, a humanized monoclonal antibody capable of neutralizing TcdB from a diverse array of C. difficile strains. Through a combination of structural, biochemical, and cell functional studies, involving X-ray crystallography and EM, we show that PA41 recognizes a single, highly conserved epitope on the TcdB glucosyltransferase domain and blocks productive translocation and delivery of the enzymatic cargo into the host cell. Our study reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, which involves targeting a process that is conserved across the large clostridial glucosylating toxins. The PA41 antibody described here provides a valuable tool for dissecting the mechanism of toxin pore formation and translocation across the endosomal membrane.	[Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Spiller, Benjamin W.; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Zhang, Zhifen; Melnyk, Roman A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhang, Zhifen; Melnyk, Roman A.] Hosp Sick Children, Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul] MedImmune LLC, Gaithersburg, MD 20878 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Lacy, D. Borden] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Rainey, G. Jonah] MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA	Vanderbilt University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); AstraZeneca; Medimmune; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Lacy, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, A5301 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022; Melnyk, Roman/GQA-9908-2022		National Institutes of Health [S10 RR026915]; Vanderbilt Center for Structural Biology; DOE Office of Science [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; Vanderbilt Structural Electron Microscopy Facility; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108778, R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Center for Structural Biology; DOE Office of Science(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; Vanderbilt Structural Electron Microscopy Facility; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Jimmy Ballard (University of Oklahoma Medical Center) for the TcdB sequences from ribotypes 027 and 078 and the B. megaterium pHis1622 expression plasmid containing TcdB holotoxin from C. difficile 027/BI/NAP1 R20291. A portion of the experiments described here used the Vanderbilt robotic crystallization facility, which was supported by National Institutes of Health Grant S10 RR026915, and the Vanderbilt Structural Electron Microscopy Facility, which is supported in part by the Vanderbilt Center for Structural Biology. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Chandrasekaran R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006070; Chen S, 2016, TOXINS, V8, pE241; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Diep BA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02456-16; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gupta P, 2017, J BIOL CHEM, V292, P17290, DOI 10.1074/jbc.M117.806687; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Juris SJ, 2007, INFECT IMMUN, V75, P5052, DOI 10.1128/IAI.00490-07; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klingenberg O, 1996, BIOCHEM J, V313, P647, DOI 10.1042/bj3130647; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kroh HK, 2017, J BIOL CHEM, V292, P14401, DOI 10.1074/jbc.M117.781112; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Lanis JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003523; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Legler PM, 2017, MABS-AUSTIN, V9, P43, DOI 10.1080/19420862.2016.1236882; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechaly A, 2012, J BIOL CHEM, V287, P32665, DOI 10.1074/jbc.M112.400473; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morrison C, 2015, NAT REV DRUG DISCOV, V14, P737, DOI 10.1038/nrd4770; MULLARD A, 2016, NAT REV DRUG DISCOV, V15, P811; Oganesyan V, 2014, J BIOL CHEM, V289, P29874, DOI 10.1074/jbc.M114.601328; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qiu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157970; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang ZY, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw078; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	74	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					941	952		10.1074/jbc.M117.813428	http://dx.doi.org/10.1074/jbc.M117.813428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180448	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000422864500015
J	Goulet, DR; Orcutt, SJ; Zwolak, A; Rispens, T; Labrijn, AF; de Jong, RN; Atkins, WM; Chiu, ML				Goulet, Dennis R.; Orcutt, Steven J.; Zwolak, Adam; Rispens, Theo; Labrijn, Aran F.; de Jong, Rob N.; Atkins, William M.; Chiu, Mark L.			Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bispecific antibodies; antibody; cancer therapy; controlled Fab-arm exchange; fluorescence correlation spectroscopy (FCS); fluorescence resonance energy transfer (FRET); kinetics; reaction mechanism	BINDING; IGG4; POTENT; DOMAIN; DETERMINANTS; DISSOCIATION; GENERATION; ANTITUMOR; CHAINS	Bispecific antibodies (bsAbs) combine the antigen specificities of two distinct Abs and demonstrate therapeutic promise based on novel mechanisms of action. Among the many platforms for creating bsAbs, controlled Fab-arm exchange (cFAE) has proven useful based on minimal changes to native Ab structure and the simplicity with which bsAbs can be formed from two parental Abs. Despite a published protocol for cFAE and its widespread use in the pharmaceutical industry, the reaction mechanism has not been determined. Knowledge of the mechanism could lead to improved yields of bsAb at faster rates as well as foster adoption of process control. In this work, a combination of Forster resonance energy transfer (FRET), nonreducing SDS-PAGE, and strategic mutation of the Ab hinge region was employed to identify and characterize the individual steps of cFAE. Fluorescence correlation spectroscopy (FCS) was used to determine the affinity of parental (homodimer) and bispecific (heterodimer) interactions within the C(H)3 domain, further clarifying the thermodynamic basis for bsAb formation. The result is a clear sequence of events with rate constants that vary with experimental conditions, where dissociation of the K409R parental Ab into half-Ab controls the rate of the reaction.	[Goulet, Dennis R.; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Orcutt, Steven J.; Zwolak, Adam; Chiu, Mark L.] Janssen Res & Dev LLC, Biol Discovery, Spring House, PA 19477 USA; [Rispens, Theo] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Labrijn, Aran F.; de Jong, Rob N.] Genmab, Yalelaan 60, NL-3584 CM Utrecht, Netherlands	University of Washington; University of Washington Seattle; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of Amsterdam; Genmab	Chiu, ML (corresponding author), 200 Great Valley Pkwy, Malvern, PA 19355 USA.	MChiu@its.jnj.com	chiu, mark/AAK-2756-2021; Goulet, Dennis/AAG-8028-2021	Goulet, Dennis/0000-0002-2949-2454; de Jong, Rob N./0000-0002-9300-6633	National Institutes of Health [T32 GM007750]; University of Washington Department of Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Department of Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant T32 GM007750 (to D. R. G.) and the University of Washington Department of Medicinal Chemistry. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Canziani GA, 2012, J MOL RECOGNIT, V25, P136, DOI 10.1002/jmr.2149; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; CREIGHTON TE, 1984, METHOD ENZYMOL, V107, P305; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Durben M, 2015, MOL THER, V23, P648, DOI 10.1038/mt.2015.2; El-Hallag IS, 2011, J CHIL CHEM SOC, V56, P837, DOI 10.4067/S0717-97072011000400003; Fan GW, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0227-0; Gramer Michael J, 2013, MAbs, V5, P962, DOI 10.4161/mabs.26233; Hanson QM, 2015, BIOCHEMISTRY-US, V54, P2931, DOI 10.1021/acs.biochem.5b00299; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Johnson S, 2010, J MOL BIOL, V399, P436, DOI 10.1016/j.jmb.2010.04.001; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Labrijn AF, 2014, NAT PROTOC, V9, P2450, DOI 10.1038/nprot.2014.169; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lee KJ, 2016, THER CLIN RISK MANAG, V12, P1301, DOI 10.2147/TCRM.S84261; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; Liu HC, 2010, ANAL CHEM, V82, P5219, DOI 10.1021/ac100575n; Liu Z, 2015, J BIOL CHEM, V290, P7535, DOI 10.1074/jbc.M114.620260; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Moores SL, 2016, CANCER RES, V76, P3942, DOI 10.1158/0008-5472.CAN-15-2833; Nalivaiko K, 2016, MOL THER, V24, P298, DOI 10.1038/mt.2015.209; National Library of Medicine, 2016, DOS ESC STUD JNJ 611; National Library of Medicine, 2016, STUD EV SAF TOL JNJ; National Library of Medicine, 2016, DOS ESC STUD JNJ 637; Nunes JPM, 2015, CHEM COMMUN, V51, P10624, DOI 10.1039/c5cc03557k; Nunez-Prado N, 2015, DRUG DISCOV TODAY, V20, P588, DOI 10.1016/j.drudis.2015.02.013; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rispens T, 2014, J BIOL CHEM, V289, P6098, DOI 10.1074/jbc.M113.541813; Rispens T, 2013, MOL IMMUNOL, V53, P35, DOI 10.1016/j.molimm.2012.06.012; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sahoo B, 2016, METHODS MOL BIOL, V1345, P67, DOI 10.1007/978-1-4939-2978-8_5; Schuurman J, 2016, CURR OPIN IMMUNOL, V40, pVII, DOI 10.1016/j.coi.2016.04.001; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Thakur A, 2016, EXPERT OPIN BIOL TH, V16, P675, DOI 10.1517/14712598.2016.1150996; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Zhukovsky EA, 2016, CURR OPIN IMMUNOL, V40, P24, DOI 10.1016/j.coi.2016.02.006; ZIMMERMAN B, 1972, BIOCHEMISTRY-US, V11, P78, DOI 10.1021/bi00751a014	48	7	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					651	661		10.1074/jbc.RA117.000303	http://dx.doi.org/10.1074/jbc.RA117.000303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29150443	hybrid, Green Published			2022-12-26	WOS:000419915400020
J	Boutwell, BB; Nelson, EJ; Qian, ZM; Vaughn, MG; Wright, JP; Beaver, KM; Barnes, JC; Petkovsek, M; Lewis, R; Schootman, M; Rosenfeld, R				Boutwell, Brian B.; Nelson, Erik J.; Qian, Zhengmin; Vaughn, Michael G.; Wright, John P.; Beaver, Kevin M.; Barnes, J. C.; Petkovsek, Melissa; Lewis, Roger; Schootman, Mario; Rosenfeld, Richard			Aggregate-level lead exposure, gun violence, homicide, and rape	PLOS ONE			English	Article							CHILDHOOD; CRIME; ADOLESCENCE; BEHAVIOR; IMPACT; IQ	Context An increasing body of research has linked the geographic distribution of lead with various indicators of criminal and antisocial behavior. Objective The current study, using data from an ongoing project related to lead exposure in St. Louis City, MO, analyzed the association between aggregate blood lead levels and specific indicators violent crime within the city. Design Ecological study. Setting St. Louis, Missouri. Exposure measure Blood lead levels. Main outcome measure Official reports of violent crimes were categorized as 1) crimes involving a firearm (yes/no), 2) assault crimes (with or without a firearm), 3) robbery crimes (with or without a firearm), 4) homicides and 5) rape. Results With the exception of rape, aggregate blood-lead levels were statistically significant predictors of violent crime at the census tract level. The risk ratios for each of the outcome measures were as follows: firearm crimes 1.03 (1.03-1.04), assault crimes 1.03 (1.02-1.03), robbery crimes 1.03 (1.02-1.04), homicide 1.03 (1.01, 1.04), and rape 1.01 (0.99-1.03). Conclusions Extending prior research in St. Louis, results suggest that aggregated lead exposure at the census tract level predicted crime outcomes, even after accounting for important sociological variables. Moving forward, a more developed understanding of aggregate level crime may necessitate a shift toward studying the synergy between sociological and biological risk factors such as lead exposure.	[Boutwell, Brian B.; Vaughn, Michael G.] St Louis Univ, Sch Social Work, St Louis, MO 63103 USA; [Boutwell, Brian B.; Qian, Zhengmin; Schootman, Mario] St Louis Univ, Dept Epidemiol & Biostat, St Louis, MO 63103 USA; [Nelson, Erik J.] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Wright, John P.; Barnes, J. C.] Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH USA; [Wright, John P.; Beaver, Kevin M.] King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah, Saudi Arabia; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Petkovsek, Melissa] Univ Cent Missouri, Dept Criminal Justice, Warrensburg, MO USA; [Lewis, Roger] St Louis Univ, Dept Environm & Occupat Hlth, St Louis, MO 63103 USA; [Rosenfeld, Richard] St Louis Univ, Dept Criminol & Criminal Justice, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati; King Abdulaziz University; State University System of Florida; Florida State University; University Central Missouri; Saint Louis University; Saint Louis University	Boutwell, BB (corresponding author), St Louis Univ, Sch Social Work, St Louis, MO 63103 USA.; Boutwell, BB (corresponding author), St Louis Univ, Dept Epidemiol & Biostat, St Louis, MO 63103 USA.	brian.boutwell@slu.edu	Beaver, Kevin M./B-4631-2013; Nelson, Erik/R-7239-2019; Vaughn, Michael/W-2694-2019	Nelson, Erik/0000-0003-1658-8294; Barnes, J.C./0000-0001-6932-5397	HUD; Office of Lead Hazard Control and Healthy Homes [HUDLTSMOLHT0162-07]	HUD; Office of Lead Hazard Control and Healthy Homes	None of the authors received direct funding for the current project. The original lead data was supported with HUD funding, however, that grant (administered by Roger Lewis), played no role in the current study (either conceptualization or analysis). (In particular, the original grant information was as follows: The Office of Lead Hazard Control and Healthy Homes, HUDLTSMOLHT0162-07. Robert F. Weisberg,PhD, grant officer.)	BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boutwell BB, 2016, ENVIRON RES, V148, P79, DOI 10.1016/j.envres.2016.03.023; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Dietrich KN, 2001, NEUROTOXICOL TERATOL, V23, P511, DOI 10.1016/S0892-0362(01)00184-2; Fergusson DM, 2008, J EPIDEMIOL COMMUN H, V62, P1045, DOI 10.1136/jech.2007.072827; Hornung RW, 2009, ENVIRON HEALTH PERSP, V117, P1309, DOI 10.1289/ehp.0800426; Hughes J, 2013, NGSPATIAL CLASSES SP; Hughes J, 2013, J R STAT SOC B, V75, P139, DOI 10.1111/j.1467-9868.2012.01041.x; Kleck G, 2015, J CRIM JUST, V43, P40, DOI 10.1016/j.jcrimjus.2014.12.002; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Malone J., 2014, HLTH HOMES LEAD HAZA; McFarlane AC, 2013, NEUROTOXICOLOGY, V39, P11, DOI 10.1016/j.neuro.2013.08.003; Mielke HW, 2012, ENVIRON INT, V43, P48, DOI 10.1016/j.envint.2012.03.005; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; NEEDLEMAN HL, 1990, NEW ENGL J MED, V322, P83, DOI 10.1056/NEJM199001113220203; Nelson EJ, 2015, ENVIRON RES, V143, P131, DOI 10.1016/j.envres.2015.10.009; Nevin R, 2000, ENVIRON RES, V83, P1, DOI 10.1006/enrs.1999.4045; Nevin R, 2007, ENVIRON RES, V104, P315, DOI 10.1016/j.envres.2007.02.008; Patrick L, 2006, ENVIRON RES, P315; R Core Team, 2021, R LANGUAGE ENV STAT; Raine A, 2008, CURR DIR PSYCHOL SCI, V17, P323, DOI 10.1111/j.1467-8721.2008.00599.x; Raymond J, 2014, MMWR-MORBID MORTAL W, V63, P38; Reuben A, 2017, JAMA-J AM MED ASSOC, V317, P1244, DOI 10.1001/jama.2017.1712; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sariaslan A, 2013, INT J EPIDEMIOL, V42, P1057, DOI 10.1093/ije/dyt066; Stretesky PB, 2004, J HEALTH SOC BEHAV, V45, P214, DOI 10.1177/002214650404500207; Thornberry T. P., 2000, CRIMINAL JUSTICE, V4, P33, DOI DOI 10.2307/1141583; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101	31	9	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187953	10.1371/journal.pone.0187953	http://dx.doi.org/10.1371/journal.pone.0187953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176826	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900025
J	Elbert, NJ; Kiefte-de Jong, JC; Voortman, T; Nijsten, TEC; de Jong, NW; Jaddoe, VWV; de Jongste, JC; van Wijk, RG; Duijts, L; Pasmans, SGMA				Elbert, Niels J.; Kiefte-de Jong, Jessica C.; Voortman, Trudy; Nijsten, Tamar E. C.; de Jong, Nicolette W.; Jaddoe, Vincent W. V.; de Jongste, Johan C.; van Wijk, Roy Gerth; Duijts, Liesbeth; Pasmans, Suzanne G. M. A.			Allergenic food introduction and risk of childhood atopic diseases	PLOS ONE			English	Article							COMPLEMENTARY FOODS; ASTHMA; ECZEMA; SENSITIZATION; DIVERSITY; INFANCY; ALLERGIES; UPDATE; COHORT; ISAAC	Background The role of timing and diversity of allergenic food introduction in the development of childhood allergic sensitization and atopic diseases is controversial. Objective To examine whether timing and diversity of allergenic food introduction are associated with allergic sensitization, allergy and eczema in children until age 10 years. Materials and methods This study among 5,202 children was performed in a population-based prospective cohort. Timing (age <= 6 months vs. >6 months) and diversity (0, 1, 2 and >= 3 foods) of allergenic food (cow's milk, hen's egg, peanut, tree nuts, soy and gluten) introduction were assessed by questionnaires at ages 6 and 12 months. At age 10 years, inhalant and food allergic sensitization were measured by skin prick tests, and physician-diagnosed inhalant and food allergy by questionnaire. Data on parental-reported physician-diagnosed eczema were obtained from birth until age 10 years. Results Children introduced to gluten at age <= 6 months had a decreased risk of eczema (aOR (95% CI): 0.84 (0.72, 0.99)), compared with children introduced to gluten at age >6 months. However, timing of allergenic food introduction was not associated with allergic sensitization or physician-diagnosed allergy. Children introduced to >= 3 allergenic foods at age <= 6 months had a decreased risk of physician- diagnosed inhalant allergy (0.64 ( 0.42, 0.98)), compared with children not introduced to any allergenic food at age <= 6 months. However, diversity of allergenic food introduction was not associated with allergic sensitization, physician-diagnosed food allergy or eczema. Conclusion Neither timing nor diversity of allergenic food introduction was consistently associated with childhood allergic sensitization, allergy or eczema.	[Elbert, Niels J.; Voortman, Trudy; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Elbert, Niels J.; Nijsten, Tamar E. C.; Pasmans, Suzanne G. M. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Dermatol, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica C.; Voortman, Trudy; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Kiefte-de Jong, Jessica C.] Leiden Univ Coll, Dept Global Publ Hlth, The Hague, Netherlands; [de Jong, Nicolette W.; van Wijk, Roy Gerth] Univ Med Ctr Rotterdam, Erasmus MC, Div Allergol, Dept Internal Med, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; Duijts, Liesbeth] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Div Resp Med & Allergol, Rotterdam, Netherlands; [Duijts, Liesbeth] Univ Med Ctr Rotterdam, Erasmus MC, Div Neonatol, Dept Pediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pasmans, SGMA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Dermatol, Rotterdam, Netherlands.	s.pasmans@erasmusmc.nl	Voortman, Trudy/C-2963-2015; Kiefte-de Jong, Jessica/GLV-3216-2022; Pasmans, Suzanne/AAI-6016-2021	Voortman, Trudy/0000-0003-2830-6813; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Pasmans, Suzanne/0000-0003-1018-4475	Erasmus MC, Rotterdam; University Medical Center Rotterdam; Netherlands Organization for Health Research and Development; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; Netherlands Organization for Health Research and Development (ZonMw-VIDI); programme ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL) (ALPHABET project, Horizon) [696295]; Netherlands Organization for Health Research and Development [529051014]; Science Foundation Ireland [SFI/16/ERA-HDHL/3360]; European Union; European Union's Horizon 2020 research and innovation programme [733206]	Erasmus MC, Rotterdam; University Medical Center Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; Netherlands Organization for Health Research and Development (ZonMw-VIDI)(Netherlands Organization for Health Research and Development); programme ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL) (ALPHABET project, Horizon); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission); European Union's Horizon 2020 research and innovation programme	The Generation R Study is made possible by financial support from the Erasmus MC, Rotterdam, the University Medical Center Rotterdam and the Netherlands Organization for Health Research and Development. Jessica Kieftede Jong and Trudy Voortman work in ErasmusAGE, a research center that receives funding from Nestle Nutrition (Nestec Ltd.), and Metagenics Inc. Vincent Jaddoe received an additional grant from the Netherlands Organization for Health Research and Development (ZonMw-VIDI). Liesbeth Duijts received additional funding from the co-funded programme ERA-Net on Biomarkers for Nutrition and Health (ERA HDHL) (ALPHABET project, Horizon 2020 (grant agreement No 696295; 2017), Netherlands Organization for Health Research and Development (No 529051014; 2017), Science Foundation Ireland (No SFI/16/ERA-HDHL/3360), and the European Union). The project received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733206 (LIFECYCLE). The researchers are independent from the funders. The funders had no role in the study design, data collection, data analysis, interpretation of data, and preparation, review or approval of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Breedveld B. C., 2002, ZO ETEN JONGE PEUTER; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Dewey KG., 2003, GUIDING PRINCIPLES C; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fewtrell M, 2017, J PEDIATR GASTR NUTR, V64, P119, DOI 10.1097/MPG.0000000000001454; Flohr C, 2009, BRIT J DERMATOL, V161, P846, DOI 10.1111/j.1365-2133.2009.09261.x; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Hopman EG, 2007, CLIN NUTR, V26, P264, DOI 10.1016/j.clnu.2006.12.003; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Kooijman MN, 2016, EUR J EPIDEMIOL, V31, P1243, DOI 10.1007/s10654-016-0224-9; Martin-Munoz MF, 2016, EUR ANN ALLERGY CLIN, V48, P123; Morgan J, 2004, ARCH DIS CHILD, V89, P309, DOI 10.1136/adc.2002.020065; Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Nwaru BI, 2013, CLIN EXP ALLERGY, V43, P1263, DOI 10.1111/cea.12180; Nwaru BI, 2013, ALLERGY, V68, P507, DOI 10.1111/all.12118; Nwaru BI, 2014, J ALLERGY CLIN IMMUN, V133, P1084, DOI 10.1016/j.jaci.2013.12.1069; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Roberts G, 2012, CLIN EXP ALLERGY, V42, P1501, DOI 10.1111/j.1365-2222.2012.04074.x; Roduit C, 2014, J ALLERGY CLIN IMMUN, V133, P1056, DOI 10.1016/j.jaci.2013.12.1044; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Statistics Netherlands, 2014, ANN REP INT 2014; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Tromp IIM, 2011, ARCH PEDIAT ADOL MED, V165, P933, DOI 10.1001/archpediatrics.2011.93; Twisk JWR, 1997, INT J SPORTS MED, V18, pS216, DOI 10.1055/s-2007-972718; van der Valk JPM, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0092-0; Zutavern A, 2008, PEDIATRICS, V121, pE44, DOI 10.1542/peds.2006-3553	32	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187999	10.1371/journal.pone.0187999	http://dx.doi.org/10.1371/journal.pone.0187999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176842	gold, Green Published			2022-12-26	WOS:000416291900028
J	Fujiwara, A; Morizane, Y; Hosokawa, M; Kimura, S; Shiode, Y; Hirano, M; Doi, S; Toshima, S; Takahashi, K; Hosogi, M; Shiraga, F				Fujiwara, Atsushi; Morizane, Yuki; Hosokawa, Mio; Kimura, Shuhei; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Takahashi, Kosuke; Hosogi, Mika; Shiraga, Fumio			Factors affecting foveal avascular zone in healthy eyes: An examination using swept source optical coherence tomography angiography	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; NERVE-FIBER LAYER; DIABETIC-RETINOPATHY; CAPILLARY NETWORK; PRIMATE AREA; HIGH ACUITY; QUANTITATIVE-ANALYSIS; VASCULAR DENSITY; VISUAL-ACUITY; PIT FORMATION	Objective To examine factors affecting foveal avascular zone (FAZ) area in healthy eyes using swept source optical coherence tomography angiography (OCTA). Methods This prospective, cross-sectional study included 144 eyes of 144 individuals (77 women, 67 men) with a best corrected visual acuity of at least 20/20 and no history of ocular disorders. The area of the superficial FAZ was assessed using OCTA. Age, gender, central retinal thickness (CRT), retinal vascular density, refractive error, and axial length were examined to determine associations with FAZ area. Results The mean age of the subjects was 42.1 +/- 20.2 years (range: 10-79 years). The mean FAZ area was 0.32 +/- 0.11 mm(2), while the mean retinal vascular density was 35.53 +/- 0.92%. Multivariate regression analysis was performed using FAZ area as the dependent variable and age, gender, CRT, retinal vascular density, refractive error, and axial length as independent variables. The results of this analysis demonstrate that CRT and retinal vascular density were significantly associated with FAZ area in our sample (P < 0.001, R-2 = 0.425). Age, gender, refractive error, and axial length were not significantly correlated with FAZ area, while CRT and retinal vascular density were negatively correlated with FAZ area (CRT: P < 0.001, R-2 = 0.356; retinal vascular density: P < 0.001, R-2 = 0.189). Conclusions OCTA results suggest that CRT and retinal vascular density negatively affect FAZ area in healthy eyes.	[Fujiwara, Atsushi; Morizane, Yuki; Hosokawa, Mio; Kimura, Shuhei; Shiode, Yusuke; Hirano, Masayuki; Doi, Shinichiro; Toshima, Shinji; Takahashi, Kosuke; Hosogi, Mika; Shiraga, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan	Okayama University	Morizane, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Japan.	moriza-y@okayama-u.ac.jp						Adhi M, 2016, INVEST OPHTH VIS SCI, V57, pOCT486, DOI 10.1167/iovs.15-18907; Al-Sheikh M, 2016, INVEST OPHTH VIS SCI, V57, P3907, DOI 10.1167/iovs.16-19570; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Bhanushali D, 2016, INVEST OPHTH VIS SCI, V57, pOCT519, DOI 10.1167/iovs.15-18901; Chui TYP, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15446; Chui TYP, 2012, OPTOMETRY VISION SCI, V89, P602, DOI 10.1097/OPX.0b013e3182504227; Conrath J, 2005, EYE, V19, P322, DOI 10.1038/sj.eye.6701456; Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7; Fujiwara A, 2016, AM J OPHTHALMOL, V170, P1, DOI 10.1016/j.ajo.2016.07.006; Gadde SGK, 2016, INVEST OPHTH VIS SCI, V57, P246, DOI 10.1167/iovs.15-18287; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Iafe NA, 2016, INVEST OPHTH VIS SCI, V57, P5780, DOI 10.1167/iovs.16-20045; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Kuehlewein L, 2015, INVEST OPHTH VIS SCI, V56, P3984, DOI 10.1167/iovs.15-16510; LAATIKAINEN L, 1977, INVEST OPHTH VIS SCI, V16, P1154; Littmann H., 1982, OPTOMETRY VISION SCI, V69, P717; Lupidi M, 2016, AM J OPHTHALMOL, V169, P9, DOI 10.1016/j.ajo.2016.06.008; McAllister JT, 2010, VISION RES, V50, P810, DOI 10.1016/j.visres.2010.02.003; Michalewska Z, 2016, AM J OPHTHALMOL, V165, P100, DOI 10.1016/j.ajo.2016.02.003; Miwa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29064; Provis JM, 2008, ARCH OPHTHALMOL-CHIC, V126, P507, DOI 10.1001/archopht.126.4.507; Provis JM, 2000, INVEST OPHTH VIS SCI, V41, P2827; Samara WA, 2017, OPHTHALMOLOGY, V124, P235, DOI 10.1016/j.ophtha.2016.10.008; Samara WA, 2016, AM J OPHTHALMOL, V166, P76, DOI 10.1016/j.ajo.2016.03.033; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Shahlaee A, 2016, AM J OPHTHALMOL, V165, P39, DOI 10.1016/j.ajo.2016.02.018; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 2017, JAMA OPHTHALMOL, V135, P259, DOI 10.1001/jamaophthalmol.2016.5327; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Springer AD, 2005, VISUAL NEUROSCI, V22, P171, DOI 10.1017/S095252380522206X; Springer AD, 2004, VISUAL NEUROSCI, V21, P775, DOI 10.1017/S0952523804215115; Springer AD, 2004, VISUAL NEUROSCI, V21, P53, DOI 10.1017/S0952523804041057; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Suzuki N, 2016, INVEST OPHTH VIS SCI, V57, P5681, DOI 10.1167/iovs-16-20648; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Tan CS, 2016, INVEST OPHTH VIS SCI, V57, pOCT224, DOI 10.1167/iovs.15-18869; Tan CS, 2015, OSLI RETINA, V46, P172, DOI 10.3928/23258160-20150213-23; Tick S, 2011, INVEST OPHTH VIS SCI, V52, P5105, DOI 10.1167/iovs.10-7005; WU LZ, 1985, JPN J OPHTHALMOL, V29, P406; Yasuno Y, 2009, INVEST OPHTH VIS SCI, V50, P405, DOI 10.1167/iovs.08-2272; Yu DY, 2005, INVEST OPHTH VIS SCI, V46, P4728, DOI 10.1167/iovs.05-0694; Yu J, 2015, INVEST OPHTH VIS SCI, V56, P3212, DOI 10.1167/iovs.14-16270	45	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188572	10.1371/journal.pone.0188572	http://dx.doi.org/10.1371/journal.pone.0188572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176837	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900098
J	McMurtrey, C; Harriff, MJ; Swarbrick, GM; Duncan, A; Cansler, M; Null, M; Bardet, W; Jackson, KW; Lewinsohn, DA; Hildebrand, W; Lewinsohn, DM				McMurtrey, Curtis; Harriff, Melanie J.; Swarbrick, Gwendolyn M.; Duncan, Amanda; Cansler, Meghan; Null, Megan; Bardet, Wilfried; Jackson, Kenneth W.; Lewinsohn, Deborah A.; Hildebrand, William; Lewinsohn, David M.			T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells	PLOS ONE			English	Article							LYMPHOCYTES; IDENTIFICATION; ANTIGENS; EXPRESSION; RESPONSES; PROTEINS; BINDING; TARGET	HLA-E is a non-conventional MHC Class I molecule that has been recently demonstrated to present pathogen-derived ligands, resulting in the TCR-dependent activation of alpha beta CD8(+) T cells. The goal of this study was to characterize the ligandome displayed by HLA-E following infection with Mycobacterium tuberculosis (Mtb) using an in-depth mass spectrometry approach. Here we identified 28 Mtb ligands derived from 13 different source proteins, including the Esx family of proteins. When tested for activity with CD8 + T cells isolated from sixteen donors, nine of the ligands elicited an IFN-gamma response from at least one donor, with fourteen of 16 donors responding to the Rv0634A(19-29) peptide. Further evaluation of this immunodominant peptide response confirmed HLA-E restriction and the presence of Rv0634A(19-29)-reactive CD8(+) T cells in the peripheral blood of human donors. The identification of an Mtb HLA-E ligand that is commonly recognized may provide a target for a non-traditional vaccine strategy.	[McMurtrey, Curtis; Bardet, Wilfried; Jackson, Kenneth W.; Hildebrand, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Harriff, Melanie J.; Lewinsohn, David M.] VA Portland Hlth Care Syst, Portland, OR 97239 USA; [Harriff, Melanie J.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA; [Swarbrick, Gwendolyn M.; Duncan, Amanda; Cansler, Meghan; Null, Megan; Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat Med, Portland, OR 97201 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University	Lewinsohn, DM (corresponding author), VA Portland Hlth Care Syst, Portland, OR 97239 USA.; Lewinsohn, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	lewinsod@ohsu.edu	Шмелев, Геннадий/A-2923-2019	Шмелев, Геннадий/0000-0002-2248-7214; Harriff, Melanie/0000-0002-1461-5351	Career Development Award from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Program [IK2 CX000538]; Merit Award from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01 BX000533]; NIH [AI048090, HHSN272200900053C, HHSN266200400081C]; ViTi; Veterans Affairs [I01BX000533] Funding Source: NIH RePORTER	Career Development Award from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Program; Merit Award from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ViTi; Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Career Development Award # IK2 CX000538 from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Program (MJH), Merit Award #I01 BX000533 from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Program (DML), AI048090 (NIH, DML), HHSN272200900053C (NIH, DML), HHSN266200400081C (NIH, DML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OHSU and Drs. David and Deborah Lewinsohn have financial interest in ViTi, a company that may have a commercial interest in the result of this research and technology. Gwendolyn Swarbrick, Megan Null, and Meghan Cansler receive salary support from ViTi. These potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. ViTi had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Caccamo N, 2022, EUR J IMMUNOL, DOI 10.1002/eji.201445193; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Ding J, 2010, IMMUNOL INVEST, V39, P103, DOI 10.3109/08820130903496777; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Hickman HD, 2003, J IMMUNOL, V171, P22, DOI 10.4049/jimmunol.171.1.22; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Kaabinejadian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066298; Kaufmann SHE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4730; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Lee N, 1998, J IMMUNOL, V160, P4951; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2001, J IMMUNOL, V166, P439, DOI 10.4049/jimmunol.166.1.439; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Mazzarino P, 2005, EUR J IMMUNOL, V35, P3240, DOI 10.1002/eji.200535343; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Pietra G, 2003, P NATL ACAD SCI USA, V100, P10896, DOI 10.1073/pnas.1834449100; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Sakai S, 2014, CURR OPIN IMMUNOL, V29, P137, DOI 10.1016/j.coi.2014.06.003; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Strong RK, 2003, J BIOL CHEM, V278, P5082, DOI 10.1074/jbc.M208268200; van Meijgaarden KE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004671; Yaciuk JC, 2014, J VIROL, V88, P12992, DOI 10.1128/JVI.01914-14; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	37	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188288	10.1371/journal.pone.0188288	http://dx.doi.org/10.1371/journal.pone.0188288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176828	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900057
J	Xing, JD; Singh, S; Zhao, YP; Duan, Y; Guo, HN; Hu, CX; Ma, A; George, R; Xing, JZ; Kalluri, A; Macwan, I; Patra, P; Chen, J				Xing, Jida; Singh, Shrishti; Zhao, Yupeng; Duan, Yan; Guo, Huining; Hu, Chenxia; Ma, Allan; George, Rajan; Xing, James Z.; Kalluri, Ankarao; Macwan, Isaac; Patra, Prabir; Chen, Jie			Increasing vaccine production using pulsed ultrasound waves	PLOS ONE			English	Article							GENERAL FORCE-FIELD; MOLECULAR-DYNAMICS; SHOCK-WAVES; BACULOVIRUS; DELIVERY	Vaccination is a safe and effective approach to prevent deadly diseases. To increase vaccine production, we propose that a mechanical stimulation can enhance protein production. In order to prove this hypothesis, Sf9 insect cells were used to evaluate the increase in the expression of a fusion protein from hepatitis B virus (HBV S1/S2). We discovered that the ultrasound stimulation at a frequency of 1.5 MHz, intensity of 60 mW/cm(2), for a duration of 10 minutes per day increased HBV S1/S2 by 27%. We further derived a model for transport through a cell membrane under the effect of ultrasound waves, tested the key assumptions of the model through a molecular dynamics simulation package, NAMD (Nanoscale Molecular Dynamics program) and utilized CHARMM force field in a steered molecular dynamics environment. The results show that ultrasound waves can increase cell permeability, which, in turn, can enhance nutrient / waste exchange thus leading to enhanced vaccine production. This finding is very meaningful in either shortening vaccine production time, or increasing the yield of proteins for use as vaccines.	[Xing, Jida; Chen, Jie] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Singh, Shrishti; Kalluri, Ankarao; Macwan, Isaac; Patra, Prabir] Univ Bridgeport, Dept Biomed Engn, Bridgeport, CT USA; [Zhao, Yupeng; Chen, Jie] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Duan, Yan] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada; [Guo, Huining] Univ Alberta, Dept Physiatry, Edmonton, AB, Canada; [Hu, Chenxia] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Ma, Allan; George, Rajan] Akshaya Bio Inc, Edmonton, AB, Canada; [Xing, James Z.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Patra, Prabir] Univ Bridgeport, Dept Mech Engn, Bridgeport, CT USA	University of Alberta; University of Bridgeport; University of Alberta; University of British Columbia; University of Alberta; Guangzhou University of Chinese Medicine; University of Alberta; University of Bridgeport	Chen, J (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.; Chen, J (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	jchen@ece.ualberta.ca	Macwan, Isaac/P-7093-2018; Singh, Shrishti/AGR-8750-2022; Kalluri, Ankarao/AAE-2440-2019	Macwan, Isaac/0000-0002-6621-7961; Singh, Shrishti/0000-0001-5180-3936; George, Rajan/0000-0002-5633-9754	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The funder (The Natural Sciences and Engineering Research Council of Canada (NSERC)) provided support in the form of salaries for the graduate student, Mr. Jida Xing, and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank funding support from the Natural Sciences and Engineering Research Council of Canada (NSERC). We would also like to thank Dr. Rongzhong Liu for the Western Blot, Dr. Gaser Nagah, Dr. Donghai Lin and Miss Alexandra Savchenko for helping select 2NBDG and providing the suggestions for performing cellular uptake studies. We appreciate Dr. Scott MacKay and Mr. Ray Yang for their valuable inputs to improve the article.	Ang WT, 2010, IEEE T BIOMED CIRC S, V4, P49, DOI 10.1109/TBCAS.2009.2034635; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Farrell P.J., 2005, P475; Grotto I, 1998, VACCINE, V16, P329, DOI 10.1016/S0264-410X(97)00214-4; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Hardy E, 2000, J BIOTECHNOL, V77, P157, DOI 10.1016/S0168-1656(99)00201-1; Hatcher ER, 2009, J CHEM THEORY COMPUT, V5, P1315, DOI 10.1021/ct9000608; Hu YC, 2008, EXPERT REV VACCINES, V7, P363, DOI 10.1586/14760584.7.3.363; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Savchenko O, 2017, SCI REP-UK, V7, DOI 10.1038/srep42003; Schultz MC, 2017, J PROTEOME RES, V16, P2975, DOI 10.1021/acs.jproteome.7b00273; Shaheen M, 2013, RENEW ENERG, V57, P462, DOI 10.1016/j.renene.2013.02.009; STEPHENNE J, 1990, VACCINE, V8, pS69, DOI 10.1016/0264-410X(90)90221-7; van Oers MM, 2006, ADV VIRUS RES, V68, P193, DOI 10.1016/S0065-3527(06)68006-8; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WHO, 2017, HEP; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xing JZ, 2012, ULTRASOUND MED BIOL, V38, P1949, DOI 10.1016/j.ultrasmedbio.2012.06.008; Xu P, 2012, BIOTECHNOL LETT, V34, P1965, DOI 10.1007/s10529-012-0984-6; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067; Zhao YP, 2014, ULTRASONICS, V54, P1439, DOI 10.1016/j.ultras.2014.04.025; Zhao YP, 2012, ULTRASOUND MED BIOL, V38, P1582, DOI 10.1016/j.ultrasmedbio.2012.04.014; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187048	10.1371/journal.pone.0187048	http://dx.doi.org/10.1371/journal.pone.0187048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176801	Green Submitted, gold, Green Published			2022-12-26	WOS:000416291900004
J	Aakre, I; Strand, TA; Moubarek, K; Barikmo, I; Henjum, S				Aakre, Inger; Strand, Tor A.; Moubarek, Khalil; Barikmo, Ingrid; Henjum, Sigrun			Associations between thyroid dysfunction and developmental status in children with excessive iodine status	PLOS ONE			English	Article							CONGENITAL HYPOTHYROIDISM; PREGNANT-WOMEN; PSYCHOMOTOR DEVELOPMENT; MOTOR DEVELOPMENT; EARLY-CHILDHOOD; DRINKING-WATER; HORMONE; OUTCOMES; RISK; HYPOTHYROXINEMIA	Background and objective Adequate iodine status and normal thyroid hormone synthesis are important for optimal child development. In this study, we explored whether young children's developmental status is associated with thyroid dysfunction in an area of chronic excessive iodine exposure. Methods We included 298 children between 18 and 48 months of age residing in Algerian refugee camps. Early child development was measured using the Ages and Stages Questionnaires, third edition (ASQ-3), consisting of five domains: Communication, Gross Motor, Fine Motor, Problem Solving and Personal-Social. Due to poor discriminatory ability in the Gross Motor domain, the total ASQ-3 scores were calculated both including and excluding this domain. Urinary iodine concentration (UIC), thyroid hormones (TSH, FT3 and FT4), thyroid antibodies and serum thyroglobulin (Tg) were measured. Results The median UIC was 451.6 mu g/L, and approximately 72% of the children had a UIC above 300 mu g/L. Furthermore, 14% had thyroid disturbances, of whom 10% had TSH outside the reference range. Children with thyroid disturbances and TSH outside the reference ranges had lower odds of being among the 66% highest total ASQ scores, with adjusted odds ratios (95% CI) of 0.46 (0.23, 0.93) and 0.42 (0.19, 0.94), respectively. Conclusion We found an association between thyroid dysfunction and poorer developmental status among children with excessive iodine intake. The high iodine intake may have caused the thyroid dysfunction and hence the delayed developmental status; however, other influential factors cannot be excluded. Optimal child development is important for a sustainable future. With iodine excess being an increasing problem globally, this subject should be further explored.	[Aakre, Inger; Barikmo, Ingrid; Henjum, Sigrun] Oslo & Akershus Univ Coll, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway; [Aakre, Inger; Strand, Tor A.] Univ Bergen, Fac Med, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Res Dept, Lillehammer, Norway; [Moubarek, Khalil] Saharawi Minist Publ Hlth, Rabouni, Algeria	Oslo Metropolitan University (OsloMet); University of Bergen; Innlandet Hospital Trust	Aakre, I (corresponding author), Oslo & Akershus Univ Coll, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway.; Aakre, I (corresponding author), Univ Bergen, Fac Med, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	inger.aakre@hioa.no	Strand, Tor/D-9836-2016	Strand, Tor/0000-0002-4038-151X; Henjum, Sigrun/0000-0002-0671-2688	Oslo and Akershus University College; Norwegian Church Aid	Oslo and Akershus University College; Norwegian Church Aid	The study was funded by Oslo and Akershus University College (http://www.hioa.no/) to IA and The Norwegian Church Aid (https://www.kirkensnodhjelp.no/) to IA. The funding did not include grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakre I, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070398; Aakre I, 2015, J TRACE ELEM MED BIO, V31, P61, DOI 10.1016/j.jtemb.2015.03.004; Aakre I, 2015, J TRACE ELEM MED BIO, V31, P279, DOI 10.1016/j.jtemb.2014.09.009; [Anonymous], 2007, ASS IOD DEF DIS MON; Barikmo I, 2011, J FOOD COMP ANAL; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Belcari F, 2011, J ENDOCRINOL INVEST, V34, pE308, DOI 10.3275/7795; Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Burgi H, 2010, BEST PRACT RES CL EN, V24, P107, DOI 10.1016/j.beem.2009.08.010; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Casey BM, 2017, NEW ENGL J MED, V376, P815, DOI 10.1056/NEJMoa1606205; Charafeddine L, 2013, EUR J PAEDIATR NEURO, V17, P471, DOI 10.1016/j.ejpn.2013.03.001; Connelly KJ, 2012, J PEDIATR-US, V161, P760, DOI 10.1016/j.jpeds.2012.05.057; Costeira MJ, 2011, J PEDIATR-US, V159, P447, DOI 10.1016/j.jpeds.2011.02.034; Freire C, 2010, EUR J ENDOCRINOL, V163, P901, DOI 10.1530/EJE-10-0495; Gao TS, 2004, CHINESE MED J-PEKING, V117, P1518; Gizak M., 2017, INIODINE DEFICIENCY, pp. 29; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; Henrichs J, 2010, J CLIN ENDOCR METAB, V95, P4227, DOI 10.1210/jc.2010-0415; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kempers MJE, 2006, J CLIN ENDOCR METAB, V91, P418, DOI 10.1210/jc.2005-1209; Kvestad I, 2017, AM J CLIN NUTR; Kvestad I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129915; Kvestad I, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-50; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; Li Y, 2010, CLIN ENDOCRINOL, V72, P825, DOI 10.1111/j.1365-2265.2009.03743.x; Liu HL, 2009, J PUBLIC HEALTH-UK, V31, P32, DOI 10.1093/pubmed/fdn097; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Oerbeck B, 2003, PEDIATRICS, V112, P923, DOI 10.1542/peds.112.4.923; Pakkila F, 2015, THYROID, V25, P1363, DOI 10.1089/thy.2015.0197; Pearce EN, 2016, AM J CLIN NUTR, V104, p918S, DOI 10.3945/ajcn.115.110429; Perez-Lobato R, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0093; Piek JP, 2010, HUM MOVEMENT SCI, V29, P777, DOI 10.1016/j.humov.2010.03.006; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Squires J., 2009, ASQ 3 USERS GUIDE; STRUPP BJ, 1995, J NUTR, V125, pS2221, DOI 10.1093/jn/125.suppl_8.2221S; Sun X, 2014, ENDOCRINOL METAB, V29, P240, DOI 10.3803/EnM.2014.29.3.240; Thaker VV, 2014, J CLIN ENDOCR METAB, V99, P3521, DOI 10.1210/jc.2014-1956; THEODOROPOULOS T, 1979, SCIENCE, V205, P502, DOI 10.1126/science.451615; Trumpff C, 2016, ARCH DIS CHILD, V101, P1100, DOI 10.1136/archdischild-2015-310006; Vanderpas J, 2006, ANNU REV NUTR, V26, P293, DOI 10.1146/annurev.nutr.26.010506.103810; Velasco I, 2009, J CLIN ENDOCR METAB, V94, P3234, DOI 10.1210/jc.2008-2652; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, PROC TRANSL AD INSTR; World Health Organization, WHO ANTHR VERS 3 2 2; World Health Organization (WHO), 2011, BMI CLASSIFICATION; Zimmermann M. B., 2013, ENDOCR PRACT, V19, P1; Zimmermann MB, 2006, AM J CLIN NUTR, V83, P108; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2012, NUTR REV, V70, P553, DOI 10.1111/j.1753-4887.2012.00528.x; Zimmermann MB, 2011, SEMIN CELL DEV BIOL, V22, P645, DOI 10.1016/j.semcdb.2011.07.009; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011; Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x	61	20	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187241	10.1371/journal.pone.0187241	http://dx.doi.org/10.1371/journal.pone.0187241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166388	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300010
J	Schmickl, T; Karsai, I				Schmickl, Thomas; Karsai, Istvan			Resilience of honeybee colonies via common stomach: A model of self-regulation of foraging	PLOS ONE			English	Article							DIVISION-OF-LABOR; COLLECTIVE DECISION-MAKING; INTRACOLONIAL POPULATION-DYNAMICS; APIS-MELLIFERA; NEST CONSTRUCTION; BEES HYMENOPTERA; INSECT SOCIETIES; QUEUING DELAY; BEHAVIOR; TASK	We propose a new regulation mechanism based on the idea of the "common stomach" to explain several aspects of the resilience and homeostatic regulation of honeybee colonies. This mechanism exploits shared pools of substances (pollen, nectar, workers, brood) that modulate recruitment, abandonment and allocation patterns at the colony-level and enable bees to perform several survival strategies to cope with difficult circumstances: Lack of proteins leads to reduced feeding of young brood, to early capping of old brood and to regaining of already spent proteins through brood cannibalism. We modeled this system by linear interaction terms and mass-action law. To test the predictive power of the model of this regulatory mechanism we compared our model predictions to experimental data of several studies. These comparisons show that the proposed regulation mechanism can explain a variety of colony level behaviors. Detailed analysis of the model revealed that these mechanisms could explain the resilience, stability and self-regulation observed in honeybee colonies. We found that manipulation of material flow and applying sudden perturbations to colony stocks are quickly compensated by a resulting counter-acting shift in task selection. Selective analysis of feedback loops allowed us to discriminate the importance of different feedback loops in self-regulation of honeybee colonies. We stress that a network of simple proximate mechanisms can explain significant colony-level abilities that can also be seen as ultimate reasoning of the evolutionary trajectory of honeybees.	[Schmickl, Thomas] Karl Franzens Univ Graz, Artificial Life Lab, Graz, Austria; [Schmickl, Thomas] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Karsai, Istvan] East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	University of Graz; University of Graz; East Tennessee State University	Karsai, I (corresponding author), East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu		Schmickl, Thomas/0000-0001-8598-7462	Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University	Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University	This work was supported by Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University (TS and IK) (http://www.etsu.edu/cas/basler.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145560; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; ARON S, 1989, BIOL BEHAV, V14, P207; BARTHOLDI JJ, 1993, J THEOR BIOL, V160, P23, DOI 10.1006/jtbi.1993.1002; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Collignon B, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150473; COOPER PD, 1985, J EXP BIOL, V114, P1; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P169, DOI 10.1007/BF01417910; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; Dreller C, 2000, ANIM BEHAV, V59, P91, DOI 10.1006/anbe.1999.1303; Dussutour A, 2006, BEHAV ECOL SOCIOBIOL, V61, P17, DOI 10.1007/s00265-006-0233-x; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; EBERLEIN RL, 1992, EUR J OPER RES, V59, P216, DOI 10.1016/0377-2217(92)90018-5; Forrester JW., 1969, URBAN DYN, P358; Franks NR, 2001, ANIM BEHAV, V62, P635, DOI 10.1006/anbe.2001.1794; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; GAROFALO CA, 1977, J APICULT RES, V16, P3; Gautrais J, 2002, J THEOR BIOL, V215, P363, DOI 10.1006/jtbi.2001.2506; Gregson AM, 2003, J THEOR BIOL, V222, P1, DOI 10.1016/S0022-5193(02)00487-3; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Hilbun A, PLOS ONE, V11, P1016; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B, 2008, SUPERORGANISM BEAUTY, P1; Huang MH, 2003, INSECT SOC, V50, P330, DOI 10.1007/s00040-003-0682-4; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; HUANG ZY, 1991, J INSECT BEHAV, V4, P177, DOI 10.1007/BF01054610; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Johnson BR, 2005, BEHAV ECOL SOCIOBIOL, V58, P219, DOI 10.1007/s00265-005-0949-z; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, MATH COMP MODEL DYN, V18, P13, DOI 10.1080/13873954.2011.601423; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Kengyel D, 2015, LECT NOTES ARTIF INT, V9387, P201, DOI 10.1007/978-3-319-25524-8_13; Kernbach S, 2013, INT J ROBOT RES, V32, P35, DOI 10.1177/0278364912468636; Kernbach S, 2009, ADAPT BEHAV, V17, P237, DOI 10.1177/1059712309104966; KORST PJAM, 1982, INSECT SOC, V29, P209, DOI 10.1007/BF02228753; Kovac H, 2010, J INSECT PHYSIOL, V56, P1834, DOI 10.1016/j.jinsphys.2010.08.002; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Middleton EJT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1022; OMHOLT SW, 1986, J APICULT RES, V25, P9, DOI 10.1080/00218839.1986.11100686; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Ratnieks FLW, 1999, AM NAT, V154, P536, DOI 10.1086/303256; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Rotjan RD, 2002, APIDOLOGIE, V33, P367, DOI 10.1051/apido:2002026; Schmickl T, 2008, MATH COMP MODEL DYN, V14, P101, DOI 10.1080/13873950701846662; Schmickl T, 2004, ADAPT BEHAV, V12, P263, DOI 10.1177/105971230401200311; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schmickl T, 2012, ECOLOGICAL MODELING, P223; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmickl T, 2016, J THEOR BIOL, V389, P274, DOI 10.1016/j.jtbi.2015.10.036; Schmickl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114611; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmickl Thomas, 2009, Denisia, V25, P141; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; SEELEY TD, 1994, ANIM BEHAV, V47, P311, DOI 10.1006/anbe.1994.1044; Seeley TD, 2004, APIDOLOGIE, V35, P101, DOI 10.1051/apido:2004004; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1985, FORTS ZOOL, V31, P75; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V31, P375, DOI 10.1007/BF00170604; Seeley TD., 1995, WISDOM HIVE SOCIAL P, P1; Stein W., 2005, SIGSAM Bulletin, V39, P61, DOI 10.1145/1101884.1101889; Szopek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076250; Thenius R, 2008, CONNECT SCI, V20, P193, DOI 10.1080/09540090802091982; TOFTS C, 1993, B MATH BIOL, V55, P891, DOI 10.1007/BF02460691; WEBSTER TC, 1987, PHYSIOL ENTOMOL, V12, P225, DOI 10.1111/j.1365-3032.1987.tb00745.x; WEBSTER TC, 1985, ENVIRON ENTOMOL, V14, P683, DOI 10.1093/ee/14.6.683; Wilson E.O, 1971, INSECT SOC, P1; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WOYKE J, 1977, J APICULT RES, V16, P84, DOI 10.1080/00218839.1977.11099866; Zahadat P, 2013, 12 EUR C ART LIF ECA, P609; Zahadat P, 2016, ADAPT BEHAV, V24, P87, DOI 10.1177/1059712316633028; Zahadat P, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/6/066005	95	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188004	10.1371/journal.pone.0188004	http://dx.doi.org/10.1371/journal.pone.0188004			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161278	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000028
J	Dencker, M; Tanha, T; Karlsson, MK; Wollmer, P; Andersen, LB; Thorsson, O				Dencker, Magnus; Tanha, Tina; Karlsson, Magnus K.; Wollmer, Per; Andersen, Lars B.; Thorsson, Ola			Cystatin B, cathepsin L and D related to surrogate markers for cardiovascular disease in children	PLOS ONE			English	Article							LEFT ATRIAL SIZE; PHYSICAL-ACTIVITY; RISK; ATHEROSCLEROSIS; EXPRESSION; ASSOCIATION; MACROPHAGES; ADULTS; CELLS	Objective This study investigated potential associations between novel biomarkers for cardiovascular disease and other surrogate markers for health. Methods Community sample of 170 (92 boys and 78 girls) children aged 8-11 years. Total fat mass (TBF) and abdominal fat (AFM) were measured by Dual-energy x-ray absorptiometry (DXA). Total body fat was also expressed as percentage of total body mass (BF%), and body fat distribution was calculated as AFM/TBF. Maximal oxygen uptake (VO2PEAK), systolic and diastolic blood pressure (SBP and DBP) and pulse pressure (PP) were measured. Echocardiography was performed. Left atrial size (LA) and left ventricular mass (LVM) were measured. A follow-up DXA scan was available in 152 children (84 boys and 68 girls). Frozen serum samples were analyzed for cystatin B, cathepsin L and cathepsin D. Results Partial correlations between cystatin B versus lnTBF, lnBF%, lnAFM, AFM/TBF, VO2PEAK and PP were; r = 0.38, 0.36, 0.38, 0.29, -0.25 and 0.25, P = 0.001 or less for all. Weaker predominantly non-significant correlations were found for cathepsin L, whereas cathepsin D was not related to any surrogate markers for health. No significant correlations were found between biomarkers and change in body fat over 2 years. Conclusion Findings from this community-based cohort of young children show that surrogate markers for cardiovascular disease such as total fat mass, percent body fat, abdominal fat, body fat distribution, maximal oxygen uptake and pulse pressure were all associated with cystatin B. This was not found for cathepsin L or cathepsin D.	[Dencker, Magnus; Tanha, Tina; Wollmer, Per; Thorsson, Ola] Lund Univ, Dept Translat Med, Unit Med Imaging & Physiol, Skane Univ Hosp, Malmo, Sweden; [Karlsson, Magnus K.] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Skane Univ Hosp, Malmo, Sweden; [Andersen, Lars B.] Sogn & Fjordane Univ Coll, Sogndal, Norway; [Andersen, Lars B.] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Western Norway University of Applied Sciences; Norwegian School of Sport Sciences	Dencker, M (corresponding author), Lund Univ, Dept Translat Med, Unit Med Imaging & Physiol, Skane Univ Hosp, Malmo, Sweden.	magnus.dencker@skane.se	Wollmer, Per/S-5895-2019	Dencker, Magnus/0000-0001-9991-3712	Swedish Heart- Lung Foundation; Gyllenstierna Krapperup's Foundation; Lund University, Skane University Hospital; Region Skane; Gyllenstierna Krapperup 's Foundation	Swedish Heart- Lung Foundation(Swedish Heart-Lung Foundation); Gyllenstierna Krapperup's Foundation; Lund University, Skane University Hospital; Region Skane; Gyllenstierna Krapperup 's Foundation	Financial support for this study was received from the Swedish Heart- Lung Foundation, the Gyllenstierna Krapperup's Foundation and grants from Lund University, Skane University Hospital and Region Skane.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Armstrong N, 2000, PAEDIAT EXERCISE SCI; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Biswas B, 2015, INDIAN J PATHOL MICR, V58, P170, DOI 10.4103/0377-4929.155307; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Dencker M, 2006, J PEDIATR-US, V149, P38, DOI 10.1016/j.jpeds.2006.02.002; DUKE PM, 1980, PEDIATRICS, V66, P918; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; Goncalves I, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000353; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; Jahn LA, 2016, J CLIN ENDOCR METAB, V101, P1198, DOI 10.1210/jc.2015-3293; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li W, 2004, ANN NY ACAD SCI, V1030, P427, DOI 10.1196/annals.1329.053; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu YX, 2009, AM J CARDIOL, V103, P476, DOI 10.1016/j.amjcard.2008.10.011; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Lv BJ, 2013, ATHEROSCLEROSIS, V230, P100, DOI 10.1016/j.atherosclerosis.2013.05.018; Nagarajarao HS, 2008, STROKE, V39, P2701, DOI 10.1161/STROKEAHA.108.515221; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Soltysiak J, 2014, ENDOKRYNOL POL, V65, P479, DOI 10.5603/EP.2014.0067; Walenbergh SMA, 2015, AM J GASTROENTEROL, V110, P462, DOI 10.1038/ajg.2015.29	25	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187494	10.1371/journal.pone.0187494	http://dx.doi.org/10.1371/journal.pone.0187494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149174	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100011
J	Rogal, SS; Udawatta, V; Akpan, I; Moghe, A; Chidi, A; Shetty, A; Szigethy, E; Bielefeldt, K; DiMartini, A				Rogal, Shari S.; Udawatta, Viyan; Akpan, Imo; Moghe, Akshata; Chidi, Alexis; Shetty, Amit; Szigethy, Eva; Bielefeldt, Klaus; DiMartini, Andrea			Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; HEALTH-CARE; OPIOID USE; DEPRESSION; FIBROMYALGIA; INFLAMMATION; MORTALITY; QUALITY; ANXIETY; SLEEP	This study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescription medications, liver disease symptoms and severity, and psychiatric and pain symptoms were assessed at baseline using validated instruments. Inflammatory markers were measured using standardized Luminex assays. Subsequent hospitalizations and the primary admission diagnoses were collected via chart review. Multivariable models were used to evaluate which baseline factors were associated with time to hospitalization and number of hospitalizations. The cohort consisted of 193 outpatients, with an average age of 58 +/- 9 and model for end-stage liver disease (MELD) score of 12 +/- 5. Over follow-up, 57 (30%) were admitted to the hospital. The factors associated with time to hospitalization included the severity of liver disease (HR/MELD point: 1.10, 95% CI: 1.04,1.16), ascites (HR: 1.90, 95% CI: 1.01, 3.58), baseline symptoms of depression (HR: 2.34, 95% CI: 1.28,4.25), sleep medications (HR: 1.81, 95% CI: 1.01, 3.22) and IL-6 (HR: 1.43, 95% CI: 1.10, 1.84). Similarly the number admissions was significantly associated with MELD (IIR: 1.08, CI: 1.07,1.09), ascites (IIR: 4.15, CI: 3.89, 4.43), depressive symptoms (IIR: 1.54, CI: 1.44,1.64), IL-6 (IIR: 1.26, CI: 1.23,1.30), sleep medications (IIR: 2.74, CI: 2.57, 2.93), and widespread pain (IIR: 1.61, CI: 1.50, 1.73). In conclusion, consistent with prior studies, MELD and ascites were associated with subsequent hospitalization. However, this study also identified other factors associated with hospitalization including inflammation, depressive symptoms, sleep medication use, and pain.	[Rogal, Shari S.; DiMartini, Andrea] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Rogal, Shari S.; Chidi, Alexis] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA; [Rogal, Shari S.; Akpan, Imo; Bielefeldt, Klaus] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Udawatta, Viyan; Moghe, Akshata; Chidi, Alexis] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Shetty, Amit] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Szigethy, Eva; DiMartini, Andrea] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Rogal, SS (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	rogalss@upmc.edu	Moghe, Akshata/V-4963-2019; Moghe, Akshata/V-4632-2019	Rogal, Shari/0000-0001-8184-1546	National Institutes of Health [DK063922]; University of Pittsburgh	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh)	The primary data were collected while Shari S. Rogal was a T-32 fellow on the National Institutes of Health DK063922. The funds for the study were provided by the University of Pittsburgh, Thomas E. Starzl Young Investigator Award to Shari S. Rogal. Study sponsors had no involvement in the study design; in collection, analysis, interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication.	Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P2583, DOI 10.1097/MIB.0000000000000537; Andersen NLT, 2013, PSYCHOSOMATICS, V54, P132, DOI 10.1016/j.psym.2012.07.007; [Anonymous], [No title captured]; Berman K, 2011, CLIN GASTROENTEROL H, V9, P254, DOI 10.1016/j.cgh.2010.10.035; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Buysse D J, 1989, Psychiatry Res, V28, P193; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; CHAMPANERIA S, 1989, BIOCHEM CELL BIOL, V67, P128, DOI 10.1139/o89-020; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chojnacki C, 2012, GASTROENT RES PRACT, V2012; Davies S, 2013, HEALTH SERV RES, V48, P1978, DOI 10.1111/1475-6773.12075; DiMartini A, 2011, CLIN LIVER DIS, V15, P727, DOI 10.1016/j.cld.2011.08.002; Dirchwolf M, 2015, WORLD J HEPATOL, V7, P1974, DOI 10.4254/wjh.v7.i16.1974; Fagan KJ, 2014, INTERN MED J, V44, P865, DOI 10.1111/imj.12491; Freedland KE, 2016, CLIN CARDIOL, V39, P257, DOI 10.1002/clc.22520; Ganesh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055140; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Guthrie EA, 2016, J PSYCHOSOM RES, V82, P54, DOI 10.1016/j.jpsychores.2014.10.002; Ho SB, 2015, CLIN GASTROENTEROL H; Kanwal F, 2014, GASTROENTEROLOGY, V147, P1204, DOI 10.1053/j.gastro.2014.10.029; Knudsen KB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2862-5; Lazzarotto Cesar, 2013, Ann Hepatol, V12, P599; Lee FY, 1996, SCAND J GASTROENTERO, V31, P500, DOI 10.3109/00365529609006772; Lotrich FE, 2011, J RHEUMATOL, V38, P48, DOI 10.3899/jrheum.110903; Martinez-Esparza M, 2015, WORLD J GASTROENTERO, V21, P11522, DOI 10.3748/wjg.v21.i41.11522; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Melzack R, 2005, ANESTHESIOLOGY, V103, P199, DOI 10.1097/00000542-200507000-00028; MELZACK R, 1971, ANESTHESIOLOGY, V34, P50; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Moise N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003767; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mosher HJ, 2014, J HOSP MED, V9, P82, DOI 10.1002/jhm.2113; Penn CA, 2016, OBSTET GYNECOL; R Core Team, 2012, R LANG ENV STAT COMP; Rogal SS, 2015, CLIN GASTROENTEROL H, V13, P1009, DOI 10.1016/j.cgh.2014.10.029; Rogal SS, 2013, LIVER INT, V33, P1497, DOI 10.1111/liv.12215; Rogal SS, 2013, DIGEST DIS SCI, V58, P2976, DOI 10.1007/s10620-013-2638-5; Rowan PJ, 2004, J CLIN GASTROENTEROL, V38, P530, DOI 10.1097/01.mcg.0000123203.36471.70; Spahr L, 2007, AM J GASTROENTEROL, V102, P744, DOI 10.1111/j.1572-0241.2006.01028.x; STEINDL PE, 1995, ANN INTERN MED, V123, P274, DOI 10.7326/0003-4819-123-4-199508150-00005; Tsai CF, 2016, ALIMENT PHARM THER; Venables WN., 2002, MODERN APPL STAT S 4; Vignali DA, 2000, J IMMUNOL METHODS, V243, P1; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187176	10.1371/journal.pone.0187176	http://dx.doi.org/10.1371/journal.pone.0187176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149171	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100007
J	Knafl, D; Muller, M; Pajenda, S; Genc, Z; Hecking, M; Wagner, L				Knafl, Daniela; Mueller, Markus; Pajenda, Sahra; Genc, Zeynep; Hecking, Manfred; Wagner, Ludwig			The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck (R) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CELL-CYCLE ARREST; DIAGNOSIS	Background Acute kidney injury (AKI) is frequently observed in serious infections, following nephrotoxic medication, surgery and trauma. Here we tested whether the detection of two recently identified biomarkers for AKI, Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) and Insulin-Like Growth Factor Binding Protein 7 (IGFBP7), depends on the expression of these proteins in cells of the urinary sediment. Method We collected urine samples of 33 kidney transplant recipients and 14 non-transplanted patients who all had AKI (stages 1-3 according to KDIGO), and measured [IGFBP7]x [TIMP-2] using the NephroCheck (R) Astute1 40 (TM) meter. Concomitantly, we analyzed IGFBP7 and TIMP-2 mRNA expression by quantitative polymerase chain reaction (qPCR) from urinary sediment of the same patients, and correlated the results with [IGFBP7] x [TIMP-2] (protein), by linear regression analysis. We also determined the association between [IGFBP7]x[TIMP-2] and estimated glomerular filtration rate (eGFR), and between IGFBP7 and TIMP-2 mRNA expression and markers of inflammation. Light microscopy and confocal immunofluorescence served to illustrate changes in the urinary sediment over the time course of renal function improvement. Results Of the 47 analyzed AKI patients, 14 presented with ascending urinary tract infection. Serum creatinine (sCr), blood urea nitrogen (BUN) and eGFR in all patients were 3.9 +/- 2.28 mg/dL, 47.59 +/- 23.1 mg/dL and 22.88 +/- 16.0 mL/min/1.73m(2), respectively, on average +/- standard deviation. [IGFBP7]x[TIMP-2] was 2.33 +/- 9.95 (ng/ml)(2)/1000, and did not associate with IGFBP7 and TIMP-2 gene expression (r = -0.0220, p = 0.4216; respectively r = 0.0972, p = 0.1909). [ IGFBP7] x[ TIMP-2] did not associate with eGFR; IGFBP7 and TIMP-2 mRNA expression. Improvement of renal function went along with disappearance of casts, decrease in aquaporin1 positive renal epithelial cells and leukocytes from the urinary sediment. Conclusion The gene expression pattern of IGFBP7 and TIMP-2 from urinary sediment, which contains desquamated renal tubular epithelial cells, did not correlate with [ IGFBP7] x[ TIMP-2] protein, indicating that IGFBP7 and TIMP-2 measured in the NephroCheck (R) test originated predominantly from intact but stressed cells of the kidney itself.	[Knafl, Daniela] Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Mueller, Markus] Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; [Pajenda, Sahra; Genc, Zeynep; Hecking, Manfred; Wagner, Ludwig] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Wagner, L (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria.	ludwig.wagner@meduniwien.ac.at	Hecking/AAK-7399-2021	Gerges, Daniela/0000-0001-6810-615X; Hecking, Manfred/0000-0002-8047-2395				Aregger F, 2014, KIDNEY INT, V85, P909, DOI 10.1038/ki.2013.363; Belcher JM, 2014, HEPATOLOGY, V60, P622, DOI 10.1002/hep.26980; Chawla LS, 2008, NEPHRON CLIN PRACT, V110, pC145, DOI 10.1159/000166605; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Daubin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169674; Dewitte A, 2015, CLIN J AM SOC NEPHRO, V10, P1900, DOI 10.2215/CJN.12651214; Druml W, 2015, INTENS CARE MED, V41, P1941, DOI 10.1007/s00134-015-3989-5; DUSSE F, 2016, BMC ANESTHESIOL, V16, DOI DOI 10.1186/S12871-016-0244-8; Emlet DR, 2017, AM J PHYSIOL-RENAL, V312, pF284, DOI 10.1152/ajprenal.00271.2016; Hoste EAJ, 2014, NEPHROL DIAL TRANSPL, V29, P2054, DOI 10.1093/ndt/gfu292; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kellum JA, 2016, NEPHROL DIAL TRANSPL, V31, P16, DOI 10.1093/ndt/gfv130; Koyner JL, 2015, J AM SOC NEPHROL, V26, P2023, DOI 10.1681/ASN.2014060535; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110865; Pajenda S, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0203-5; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wu XH, 2016, AM J INFECT CONTROL, V44, P1261, DOI 10.1016/j.ajic.2016.04.222; Zarbock A, 2015, JAMA-J AM MED ASSOC, V313, P2133, DOI 10.1001/jama.2015.4189	21	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188316	10.1371/journal.pone.0188316	http://dx.doi.org/10.1371/journal.pone.0188316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145491	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800111
J	Feng, YF; Wang, J; Yuan, YZ; Zhang, X; Shen, MQ; Yuan, F				Feng, Yifan; Wang, Jing; Yuan, Yuanzhi; Zhang, Xi; Shen, Minqian; Yuan, Fei			miR-539-5p inhibits experimental choroidal neovascularization by targeting CXCR7	FASEB JOURNAL			English	Article						microRNA; SDF-1; endothelial cells; angiogenesis	RETINAL ENDOTHELIAL-CELLS; MACULAR DEGENERATION; OCULAR NEOVASCULARIZATION; CHEMOKINE RECEPTOR; PROGENITOR CELLS; PROSTATE-CANCER; TUBE FORMATION; TUMOR-GROWTH; IN-VIVO; EXPRESSION	Stromal cell-derived factor-1 (SDF-1) has been previously confirmed to participate in the formation of choroidal neovascularization (CNV) via its receptor, CXC chemokine receptor (CXCR) 4; CXCR7 is a recently identified receptor for SDF-1. The molecular mechanisms and therapeutic value of CXCR7 in CNV remain undefined. In this study, experimental CNV was induced by laser photocoagulation in Brown-Norway pigmented rats, and aberrant CXCR7 overexpression was detected in the retinal pigment epithelial/choroid/sclera tissues of laser-injured eyes. Blockade of CXCR7 activation via CXCR7 knockdown or neutralizing Ab administration inhibited SDF-1-induced cell survival and the tubular formation of human retinal microvascular endothelial cells (HRMECs) in vitro and reduced CNV leakage and lesion size in vivo. By using microRNA array screening and bioinformatic analyses, we identified miR-539-5p as a regulator of CXCR7. Transfection of HRMECs and choroid-retinal endothelial (RF/6A) cells with the miR-539-5p mimic inhibited their survival and tube formation, whereas CXCR7 overexpression rescued the suppressive effect of miR-539-5p. The antiangiogenic activities of the miR-539-5p mimic were additionally demonstrated in vivo by intravitreal injection. ERK1/2 and AKT signaling downstream of CXCR7 is involved in the miR-539-5p regulation of endothelial cell behaviors. These findings suggest that the manipulation of miR-539-5p/CXCR7 levels may have important therapeutic implications in CNV-associated diseases.	[Feng, Yifan; Wang, Jing; Yuan, Yuanzhi; Zhang, Xi; Shen, Minqian; Yuan, Fei] Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, 180 Fenglin Rd, Shanghai 200032, Peoples R China	Fudan University	Yuan, F (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	yuanfeiyk@163.com		wang, jing/0000-0003-3904-488X	National Nature Science Foundation of China [81641157, 81470637, 81600735]; Young Foundation of Zhongshan Hospital [2016ZSQN38]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Foundation of Zhongshan Hospital	This study was supported by grants from the National Nature Science Foundation of China (Grants 81641157, 81470637, and 81600735) and the Young Foundation of Zhongshan Hospital (Grant 2016ZSQN38). The authors declare no conflicts of interest.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berber P, 2017, MOL DIAGN THER, V21, P31, DOI 10.1007/s40291-016-0234-z; Bullard LE, 2003, INVEST OPHTH VIS SCI, V44, P1722, DOI 10.1167/iovs.01-1193; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai JJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-88; Chang SH, 2014, P NATL ACAD SCI USA, V111, P18309, DOI 10.1073/pnas.1412172111; Chen Q, 2015, STEM CELLS, V33, P2574, DOI 10.1002/stem.2022; Chen XF, 2016, BIOMED PHARMACOTHER, V81, P379, DOI [10.1016/j.biopha.2016.04.023, 10.1016/j.biopha.2016.09.038]; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Feng YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136175; Feng YF, 2014, MOL CELL BIOCHEM, V397, P131, DOI 10.1007/s11010-014-2180-6; Garrett KL, 2001, J GENE MED, V3, P373, DOI 10.1002/jgm.197; Gracia A, 2016, FOOD FUNCT, V7, P1680, DOI [10.1039/c5fo01090j, 10.1039/C5FO01090J]; Guerin E, 2008, MICROVASC RES, V75, P302, DOI 10.1016/j.mvr.2007.12.001; Hao HF, 2017, CIRCULATION, V135, P1253, DOI 10.1161/CIRCULATIONAHA.116.023027; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Nagai N, 2014, J NUTR BIOCHEM, V25, P1218, DOI 10.1016/j.jnutbio.2014.05.015; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Peghaire C, 2016, ARTERIOSCL THROM VAS, V36, P2369, DOI 10.1161/ATVBAHA.116.307926; Ren CD, 2017, CELL PHYSIOL BIOCHEM, V41, P1413, DOI 10.1159/000467941; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; SanGiovanni JP, 2017, CLIN CHEM LAB MED, V55, P763, DOI 10.1515/cclm-2016-0898; Sengupta N, 2010, INVEST OPHTH VIS SCI, V51, P2697, DOI 10.1167/iovs.09-4137; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Sheu SJ, 2013, INVEST OPHTH VIS SCI, V54, P6426, DOI 10.1167/iovs.13-12024; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Totonchy JE, 2014, CELL ADHES MIGR, V8, P165, DOI 10.4161/cam.28495; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Tripathi V, 2014, CELL COMMUN ADHES, V21, P221, DOI 10.3109/15419061.2013.876013; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; WANG K, 2014, NAT COMMUN, V5; Wang L, 2016, J PHYSIOL BIOCHEM, V72, P583, DOI 10.1007/s13105-016-0496-2; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wong CW, 2016, PROG RETIN EYE RES, V53, P107, DOI 10.1016/j.preteyeres.2016.04.002; Yamada K, 2015, INT J CANCER, V137, P2825, DOI 10.1002/ijc.29655; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Zhang HT, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0337-8; Zhang ZX, 2011, CURR EYE RES, V36, P838, DOI 10.3109/02713683.2011.593107; Zhang ZL, 2009, EXP EYE RES, V89, P522, DOI 10.1016/j.exer.2009.05.012; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zhu CY, 2016, LIFE SCI, V166, P34, DOI 10.1016/j.lfs.2016.10.002	56	25	26	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1626	1639		10.1096/fj.201700640R	http://dx.doi.org/10.1096/fj.201700640R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146732				2022-12-26	WOS:000427246000040
J	Lau, D; Elezagic, D; Hermes, G; Morgelin, M; Wohl, AP; Koch, M; Hartmann, U; Hollriegl, S; Wagener, R; Paulsson, M; Streichert, T; Klatt, AR				Lau, Daniela; Elezagic, Dzemal; Hermes, Gabriele; Morgelin, Matthias; Wohl, Alexander P.; Koch, Manuel; Hartmann, Ursula; Hoellriegl, Stefan; Wagener, Raimund; Paulsson, Mats; Streichert, Thomas; Klatt, Andreas R.			The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; MATRIX PROTEIN; GROWTH-FACTOR; IN-VITRO; BINDING-PROTEIN; COILED-COIL; TETRANECTIN; EXPRESSION; MINERALIZATION	C-type lectin domain family 3 member A (CLEC3A) is a poorly characterized protein belonging to the superfamily of C-type lectins. Its closest homologue tetranectin binds to the kringle 4 domain of plasminogen and enhances its association with tissue plasminogen activator (tPA) thereby enhancing plasmin production, but whether CLEC3A contributes to plasminogen activation is unknown. Here, we recombinantly expressed murine and human full-length CLEC3As as well as truncated forms of CLEC3A in HEK-293 Epstein-Barr nuclear antigen (EBNA) cells. We analyzed the structure of recombinant CLEC3A by SDS-PAGE and immunoblot, glycan analysis, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, size-exclusion chromatography, circular dichroism spectroscopy, and electron microscopy; compared the properties of the recombinant protein with those of CLEC3A extracted from cartilage; and investigated its tissue distribution and extracellular assembly by immunohistochemistry and immunofluorescence microscopy. We found that CLEC3A mainly occurs as a monomer, but also forms dimers and trimers, potentially via a coiled-coil alpha-helix. We also noted that CLEC3A can be modified with chondroitin/dermatan sulfate side chains and tends to oligomerize to form higher aggregates. We show that CLEC3A is present in resting, proliferating, and hypertrophic growth-plate cartilage and assembles into an extended extracellular network in cultures of rat chondrosarcoma cells. Further, we found that CLEC3A specifically binds to plasminogen and enhances tPA-mediated plasminogen activation. In summary, we have determined the structure, tissue distribution, and molecular function of the cartilage-specific lectin CLEC3A and show that CLEC3A binds to plasminogen and participates in tPA-mediated plasminogen activation.	[Lau, Daniela; Elezagic, Dzemal; Hermes, Gabriele; Streichert, Thomas; Klatt, Andreas R.] Univ Cologne, Inst Clin Chem, D-50924 Cologne, Germany; [Wohl, Alexander P.; Koch, Manuel; Hartmann, Ursula; Wagener, Raimund; Paulsson, Mats] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Biomed Ctr BMC, SE-22100 Lund, Sweden; [Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Fac Med, D-50931 Cologne, Germany; [Wagener, Raimund; Paulsson, Mats] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hoellriegl, Stefan] Dreifaltigkeits Krankenhau, D-50933 Cologne, Germany	University of Cologne; University of Cologne; Lund University; University of Cologne; University of Cologne; University of Cologne	Klatt, AR (corresponding author), Kerpener Str 62, D-50924 Cologne, Germany.	andreas.klatt@uk-koeln.de	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814	European Community's Seventh Framework Programme Grant [602300]	European Community's Seventh Framework Programme Grant	This work was supported by European Community's Seventh Framework Programme Grant 602300 (SYBIL). The authors declare that they have no conflicts of interest with the contents of this article.	Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Furst CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061407; Gebauer JM, 2016, MATRIX BIOL, V49, P106, DOI 10.1016/j.matbio.2015.07.001; HAUDENSCHILD DR, 1995, J BIOL CHEM, V270, P23150, DOI 10.1074/jbc.270.39.23150; Hiraoka A, 1997, P NATL ACAD SCI USA, V94, P7577, DOI 10.1073/pnas.94.14.7577; Holtet TL, 1997, PROTEIN SCI, V6, P1511, DOI 10.1002/pro.5560060715; IBA K, 1995, FEBS LETT, V373, P1, DOI 10.1016/0014-5793(95)00992-I; Iba K, 2009, WOUND REPAIR REGEN, V17, P108, DOI 10.1111/j.1524-475X.2008.00447.x; Jaquinod M, 1999, BIOL CHEM, V380, P1307, DOI 10.1515/BC.1999.166; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Neame PJ, 1999, BBA-GENE STRUCT EXPR, V1446, P193, DOI 10.1016/S0167-4781(99)00087-1; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; Obrist P, 2004, J CLIN PATHOL, V57, P417, DOI 10.1136/jcp.2003.010058; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Salo J, 2008, SPINE, V33, P839, DOI 10.1097/BRS.0b013e31816b1f1d; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Tsunezumi J, 2009, J CELL BIOCHEM, V106, P693, DOI 10.1002/jcb.22062; Westergaard UB, 2003, EUR J BIOCHEM, V270, P1850, DOI 10.1046/j.1432-1033.2003.03549.x; Wewer UM, 1998, DEV BIOL, V200, P247, DOI 10.1006/dbio.1998.8962; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson R, 2016, J PROTEOME RES, V15, P1033, DOI 10.1021/acs.jproteome.5b01115; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	34	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					203	214		10.1074/jbc.M117.818930	http://dx.doi.org/10.1074/jbc.M117.818930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29146595	Green Published, hybrid			2022-12-26	WOS:000419453200018
J	Chan, EYY; Wang, SSX; Ho, JYE; Huang, Z; Liu, SD; Guo, CL				Chan, Emily Ying Yang; Wang, Susan Shuxin; Ho, Janice Ying-en; Huang, Zhe; Liu, Sida; Guo, Chunlan			Socio-demographic predictors of health and environmental co-benefit behaviours for climate change mitigation in urban China	PLOS ONE			English	Article							ACTIVE-TRANSPORT; MEAT; WASTE; WATER; CONTAMINATION; PESTICIDES; ATTITUDES; LANDFILLS; POLICIES; ADULTS	Objective This study aims to examine the patterns and socio-demographic predictors of health and environmental co-benefit behaviours that support climate change mitigation in a densely populated Asian metropolis Hong Kong. Methods A population-based, stratified and cross-sectional random digit dialling telephone survey study was conducted between January and February 2016, among the Cantonese-speaking population aged 15 and above in Hong Kong. Socio-demographic data and the self reported practice of 10 different co-benefit behaviours were solicited. Ethics approval and participant's verbal consent were sought. Findings The study sample consisted of 1,017 respondents (response rate: 63.6%) were comparable to the age, gender and geographical distributions of the Hong Kong population found in the latest 2011 Hong Kong Population Census. Among the co-benefit behaviours, using less packaging and disposable shopping bags were practiced in the highest frequency (70.1%). However, four behaviours were found to have never been practiced by more than half of the respondents, including bringing personal eating utensils when dining in restaurants or small eateries, showering less than five minutes, having one vegetarian meal a week, and buying more organic food. Results of multivariable logistic regression showed that frequency of practicing co-benefit behaviours were consistently associated with gender and age. Conclusion Urban residents in Hong Kong do not engage in the practice of co-benefit behaviours in a uniform way. In general, females and older people are more likely to adopt co-benefit behaviours in their daily lives. Further research to assess the knowledge and attitudes of the population towards these co-benefit behaviours will provide support to relevant climate change mitigation policies and education programmes.	[Chan, Emily Ying Yang; Wang, Susan Shuxin; Ho, Janice Ying-en; Huang, Zhe; Liu, Sida; Guo, Chunlan] Chinese Univ Hong Kong, Collaborating Ctr Oxford Univ, Shatin, Hong Kong, Peoples R China; [Chan, Emily Ying Yang; Wang, Susan Shuxin; Ho, Janice Ying-en; Huang, Zhe; Liu, Sida; Guo, Chunlan] Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Shatin, Hong Kong, Peoples R China; [Chan, Emily Ying Yang; Ho, Janice Ying-en; Huang, Zhe; Liu, Sida] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Chan, Emily Ying Yang] Univ Oxford, Nuffield Dept Med, Oxford, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Oxford	Chan, EYY (corresponding author), Chinese Univ Hong Kong, Collaborating Ctr Oxford Univ, Shatin, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, CUHK Disaster & Med Humanitarian Response CCOUC, Shatin, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.; Chan, EYY (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	emily.chan@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093; Guo, Chunlan/0000-0001-7921-8878; Ho, Janice Ying-en/0000-0001-5756-6855	CUHK Focused Innovations Scheme - Scheme A: Biomedical Sciences (Phase 2); CUHK Climate Change and Health research project fund	CUHK Focused Innovations Scheme - Scheme A: Biomedical Sciences (Phase 2); CUHK Climate Change and Health research project fund	This project was co-funded by the CUHK Focused Innovations Scheme - Scheme A: Biomedical Sciences (Phase 2) and the CUHK Climate Change and Health research project fund.	Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Advisory Council on Food and Environmental Hygiene, 2013, REP CONS STUD ORG FO; Asensio OI, 2015, P NATL ACAD SCI USA, V112, pE510, DOI 10.1073/pnas.1401880112; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Belgiawan PF, 2014, TRANSPORTATION, V41, P1227, DOI 10.1007/s11116-014-9548-z; Busch V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1118; Census and Statistics Department, 2011, 2011 POP CENS SUMM R; Census and Statistics Department, 2016, HONG KONG MONTHL DIG; Chan EYY, 2017, INT J DISAST RISK SC, V8, P134, DOI 10.1007/s13753-017-0127-8; Chan EYY, 2016, PLOS CURR; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Dudeja P, 2017, FOOD SAFETY IN THE 21ST CENTURY: PUBLIC HEALTH PERSPECTIVE, P339, DOI 10.1016/B978-0-12-801773-9.00027-3; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Environmental Protection Department, 2016, ENV LEV SCHEM PLAST; Fisher C., 2012, J TARGET MEAS ANAL M, V20, P172, DOI DOI 10.1057/JT.2012.13; Ganten D, 2010, LANCET, V376, P1802, DOI 10.1016/S0140-6736(10)62139-3; Gilden RC, 2010, JOGNN-J OBST GYN NEO, V39, P103, DOI 10.1111/j.1552-6909.2009.01092.x; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hutchinson J, 2015, INT J ENV RES PUB HE, V12, P4833, DOI 10.3390/ijerph120504833; Key TJ, 1999, P NUTR SOC, V58, P271, DOI 10.1017/S0029665199000373; Kurz T, 2015, WIRES CLIM CHANGE, V6, P113, DOI 10.1002/wcc.327; Lam TH, 2002, TOB CONTROL, V11, P195, DOI 10.1136/tc.11.3.195; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Marlow HJ, 2009, AM J CLIN NUTR, V89, pS1699, DOI 10.3945/ajcn.2009.26736Z; Marsh K, 2007, J FOOD SCI, V72, pR39, DOI 10.1111/j.1750-3841.2007.00301.x; Mattiello A, 2013, INT J PUBLIC HEALTH, V58, P725, DOI 10.1007/s00038-013-0496-8; Messinger M, 2016, ENVIRON POLLUT, V218, P889, DOI 10.1016/j.envpol.2016.08.019; Millward H, 2013, J TRANSP GEOGR, V28, P101, DOI 10.1016/j.jtrangeo.2012.11.012; Muncke J, 2014, J EPIDEMIOL COMMUN H, V68, P592, DOI 10.1136/jech-2013-202593; Muncke J, 2011, J STEROID BIOCHEM, V127, P118, DOI 10.1016/j.jsbmb.2010.10.004; Ohashi Y, 2007, J APPL METEOROL CLIM, V46, P66, DOI 10.1175/JAM2441.1; Olea N, 2007, J EPIDEMIOL COMMUN H, V61, P372, DOI 10.1136/jech.2006.047860; Pachauri R.K., 2014, CONTRIBUTION WORKING; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Rothgerber H, 2013, PSYCHOL MEN MASCULIN, V14, P363, DOI 10.1037/a0030379; Rozin P, 2012, J CONSUM RES, V39, P629, DOI 10.1086/664970; Schosler H, 2015, APPETITE, V89, P152, DOI 10.1016/j.appet.2015.02.013; Singh DK, 2012, TOXICOL AGR ENV, V1, P114; Slack RJ, 2005, SCI TOTAL ENVIRON, V337, P119, DOI 10.1016/j.scitotenv.2004.07.002; Smith A. C., 2015, CLIM POLICY, V16, P37; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Sobal J, 2005, FOOD FOODWAYS, V13, P135, DOI 10.1080/07409710590915409; Spickett J., 2015, CLIMATE CHANGE VULNE; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Thurston GD, 2013, NAT CLIM CHANGE, V3, P863, DOI 10.1038/nclimate2013; Urge-Vorsatz D, 2014, ANNU REV ENV RESOUR, V39, P549, DOI 10.1146/annurev-environ-031312-125456; Valero A, 2017, FOOD CONTROL, V77, P8, DOI 10.1016/j.foodcont.2017.01.013; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; Venigalla MM, 2008, ENV CONSCIOUS TRANSP, P47; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Water Supplies Department, 2015, LETS SAV 10L WAT; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; Wiernik BM, 2013, J MANAGE PSYCHOL, V28, P826, DOI 10.1108/JMP-07-2013-0221; Willis RM, 2011, J ENVIRON MANAGE, V92, P1996, DOI 10.1016/j.jenvman.2011.03.023; Women's Commission, 2010, WHAT DO MEN HONG KON; World Health Organization, 2013, WHO GUID PROT HLTH C; Wunsch C, 2017, HDB ENV CHEM; Xia T, 2015, ENVIRON INT, V74, P281, DOI 10.1016/j.envint.2014.10.004; Yang CZ, 2011, ENVIRON HEALTH PERSP, V119, P989, DOI 10.1289/ehp.1003220; Yeung I, 2000, SOC SCI MED, V50, P1643, DOI 10.1016/S0277-9536(99)00393-7; Yu BF, 2009, INT J REFRIG, V32, P3, DOI 10.1016/j.ijrefrig.2008.05.004	62	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188661	10.1371/journal.pone.0188661	http://dx.doi.org/10.1371/journal.pone.0188661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176879	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900111
J	Fidler, RL; Pelter, MM; Drew, BJ; Palacios, JA; Bai, Y; Stannard, D; Aldrich, JM; Hu, X				Fidler, Richard L.; Pelter, Michele M.; Drew, Barbara J.; Palacios, Jorge Arroyo; Bai, Yong; Stannard, Daphne; Aldrich, J. Matt; Hu, Xiao			Understanding heart rate alarm adjustment in the intensive care units through an analytical approach	PLOS ONE			English	Article							MONITOR ALARMS	Background Heart rate (HR) alarms are prevalent in ICU, and these parameters are configurable. Not much is known about nursing behavior associated with tailoring HR alarm parameters to individual patients to reduce clinical alarm fatigue. Objectives To understand the relationship between heart rate (HR) alarms and adjustments to reduce unnecessary heart rate alarms. Methods Retrospective, quantitative analysis of an adjudicated database using analytical approaches to understand behaviors surrounding parameter HR alarm adjustments. Patients were sampled from five adult ICUs (77 beds) over one month at a quaternary care university medical center. A total of 337 of 461 ICU patients had HR alarms with 53.7% male, mean age 60.3 years, and 39% non-Caucasian. Default HR alarm parameters were 50 and 130 beats per minute (bpm). The occurrence of each alarm, vital signs, and physiologic waveforms was stored in a relational database (SQL server). Results There were 23,624 HR alarms for analysis, with 65.4% exceeding the upper heart rate limit. Only 51% of patients with HR alarms had parameters adjusted, with a median upper limit change of +5 bpm and -1 bpm lower limit. The median time to first HR parameter adjustment was 17.9 hours, without reduction in alarms occurrence (p = 0.57). Conclusions HR alarms are prevalent in ICU, and half of HR alarm settings remain at default. There is a long delay between HR alarms and parameters changes, with insufficient changes to decrease HR alarms. Increasing frequency of HR alarms shortens the time to first adjustment. Best practice guidelines for HR alarm limits are needed to reduce alarm fatigue and improve monitoring precision.	[Fidler, Richard L.; Pelter, Michele M.; Drew, Barbara J.; Palacios, Jorge Arroyo; Bai, Yong; Stannard, Daphne; Hu, Xiao] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Fidler, Richard L.; Aldrich, J. Matt] Univ Calif San Francisco, Dept Anesthesiol & Perioperat Med, San Francisco, CA 94143 USA; [Fidler, Richard L.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Drew, Barbara J.; Aldrich, J. Matt; Hu, Xiao] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Stannard, Daphne; Aldrich, J. Matt] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA; [Aldrich, J. Matt] Univ Calif San Francisco, Dept Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fidler, RL (corresponding author), Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.; Fidler, RL (corresponding author), Univ Calif San Francisco, Dept Anesthesiol & Perioperat Med, San Francisco, CA 94143 USA.; Fidler, RL (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	richard.fidler@ucsf.edu	Drew, Barbara/AAQ-7480-2020; Stannard, Daphne/AAD-2400-2019	Stannard, Daphne/0000-0001-5633-9669; Fidler, Richard/0000-0003-4358-7887; Arroyo Palacios, Jorge/0000-0002-0074-0266	NHLBI NIH HHS [R01 HL128679, U54 HL119893] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119893, R01HL128679] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aboukhalil A, 2008, J BIOMED INFORM, V41, P442, DOI 10.1016/j.jbi.2008.03.003; Association for the Advancement of Medical Instrumentation, 2011, CLIN AL; Bai Y, 2015, J BIOMED INFORM, V53, P81, DOI 10.1016/j.jbi.2014.09.006; Bonafide C, 2015, J HOSP MED; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Chopra V, 2014, JAMA-J AM MED ASSOC, V311, P1199, DOI 10.1001/jama.2014.710; Cvach Maria, 2015, Biomed Instrum Technol, V49, P214, DOI 10.2345/0899-8205-49.3.214; Cvach Maria M, 2013, Nurs Manage, V44, P8, DOI 10.1097/01.NUMA.0000437594.58933.ce; Ding Q, 2015, PHYSIOL MEAS, V36, P2405, DOI 10.1088/0967-3334/36/12/2405; Drew BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110274; ECRI Institute, 2014, TOP 10 HLTH TECHN HA; ECRI Institute, 2015, TOP 10 HLTH TECHN HA; Fidler R, 2015, J ELECTROCARDIOL, V48, P982, DOI 10.1016/j.jelectrocard.2015.08.032; Graham KC, 2010, AM J CRIT CARE, V19, P28, DOI 10.4037/ajcc2010651; Hu X, 2012, J BIOMED INFORM, V45, P913, DOI 10.1016/j.jbi.2012.03.001; Kowalczyk L., 2011, BOSTON GLOBE; LAWLESS ST, 1994, CRIT CARE MED, V22, P981, DOI 10.1097/00003246-199406000-00017; Salas-Boni Rebeca, 2015, AMIA Jt Summits Transl Sci Proc, V2015, P162; Sendelbach S, 2013, ALARM MANAGEMENT; Siebig S, 2010, CRIT CARE MED, V38, P451, DOI 10.1097/CCM.0b013e3181cb0888; The Joint Commission, 2013, JT COMM PERSPECT, V33; Way RB, 2014, INT EMERG NURS, V22, P197, DOI 10.1016/j.ienj.2014.01.001; Whalen DA, 2014, J CARDIOVASC NURS, V29, pE13, DOI 10.1097/JCN.0000000000000114	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187855	10.1371/journal.pone.0187855	http://dx.doi.org/10.1371/journal.pone.0187855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176776	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900017
J	Gregersen, I; Sandanger, O; Askevold, ET; Sagen, EL; Yang, K; Holm, S; Pedersen, TM; Skjelland, M; Krohg-Sorensen, K; Hansen, TV; Dahl, TB; Otterdal, K; Espevik, T; Aukrust, P; Yndestad, A; Halvorsen, B				Gregersen, Ida; Sandanger, Oystein; Askevold, Erik T.; Sagen, Ellen Lund; Yang, Kuan; Holm, Sverre; Pedersen, Turid M.; Skjelland, Mona; Krohg-Sorensen, Kirsten; Hansen, Trond Vidar; Dahl, Tuva Borresdatter; Otterdal, Kari; Espevik, Terje; Aukrust, Pal; Yndestad, Arne; Halvorsen, Bente			Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation	PLOS ONE			English	Article							TNF-ALPHA; T-CELL; IL-27; EXPRESSION; ASSOCIATION; MACROPHAGES; SUPPRESSION; LPS	Aim Interleukin-27 (IL-27) is involved in different inflammatory diseases; however, its role in atherosclerosis is unclear. In this study we investigated the expression of IL-27 and its receptor in patients with carotid atherosclerosis and if IL-27 could modulate the inflammatory effects of the NLRP3 inflammasome in vitro. Methods Plasma IL-27 was measured by enzyme immunoassay in patients with carotid stenosis (n = 140) and in healthy controls (n = 19). Expression of IL-27 and IL-27R was analyzed by quantitative PCR and immunohistochemistry in plaques from patients and in non-atherosclerotic vessels. THP-1 monocytes, primary monocytes and peripheral blood mononuclear cells (PBMCs) were used to s Results Our main findings were: (i) Plasma levels of IL-27 were significantly elevated in patients with carotid atherosclerotic disease compared to healthy controls. (ii) Gene expression of IL-27 and IL-27R was significantly elevated in plaques compared to control vessels, and co-localized to macrophages. (iii) In vitro, IL-27 increased NLRP3 inflammasome activation in monocytes with enhanced release of IL-1 beta. Conclusions We demonstrate increased levels of IL-27 and IL-27R in patients with carotid atherosclerosis. Our in vitro findings suggest an inflammatory role for IL-27, which can possibly be linked to atherosclerotic disease development.tudy effects of IL-27 in vitro.	[Gregersen, Ida; Sandanger, Oystein; Askevold, Erik T.; Sagen, Ellen Lund; Yang, Kuan; Holm, Sverre; Pedersen, Turid M.; Dahl, Tuva Borresdatter; Otterdal, Kari; Aukrust, Pal; Yndestad, Arne; Halvorsen, Bente] Natl Hosp Norway, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Gregersen, Ida; Yang, Kuan; Pedersen, Turid M.; Krohg-Sorensen, Kirsten; Dahl, Tuva Borresdatter; Aukrust, Pal; Yndestad, Arne; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Sandanger, Oystein; Aukrust, Pal; Yndestad, Arne; Halvorsen, Bente] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Askevold, Erik T.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Skjelland, Mona] Natl Hosp Norway, Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Krohg-Sorensen, Kirsten] Natl Hosp Norway, Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, Oslo, Norway; [Hansen, Trond Vidar] Univ Oslo, Sch Pharm, Dept Pharmaceut Chem, Oslo, Norway; [Espevik, Terje] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, Trondheim, Norway; [Aukrust, Pal] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway	Gregersen, I (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway.; Gregersen, I (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	ida.gregersen@rr-research.no	Hansen, Trond Vidar/AAU-3488-2020; Skjelland, Mona/Q-4674-2017	Skjelland, Mona/0000-0001-7950-4882; Holm, Sverre/0000-0003-1064-3926; Dahl, Tuva/0000-0001-7818-9411; Sandanger, Oystein/0000-0001-7475-7362; Yang, Kuan/0000-0002-2246-4864				Anderson GB, 2000, STROKE, V31, P2168, DOI 10.1161/01.STR.31.9.2168; Cao J, 2012, CHEST, V141, P121, DOI 10.1378/chest.10-3297; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dorosz SA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/737310; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Folco EJ, 2014, CIRC RES, V115, P875, DOI 10.1161/CIRCRESAHA.115.304437; Fu H, 2014, BIOCHEM BIOPH RES CO, V452, P881, DOI 10.1016/j.bbrc.2014.08.120; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hirase T, 2013, AM J PHYSIOL-HEART C, V305, pH420, DOI 10.1152/ajpheart.00198.2013; Jafarzadeh A, 2011, CYTOKINE, V56, P153, DOI 10.1016/j.cyto.2011.06.014; Jankowski M, 2010, ARCH IMMUNOL THER EX, V58, P417, DOI 10.1007/s00005-010-0098-6; Jin W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/506283; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Kempe S, 2009, AM J PATHOL, V175, P440, DOI 10.2353/ajpath.2009.080752; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Koltsova EK, 2012, CIRC RES, V111, P1274, DOI 10.1161/CIRCRESAHA.112.277525; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li TT, 2010, J INVEST MED, V58, P737, DOI 10.231/JIM.0b013e3181d88f7b; Lin YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052490; Liu H, 2011, J INTERF CYTOK RES, V31, P459, DOI 10.1089/jir.2010.0115; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Petes C, 2017, J LEUKOCYTE BIOL; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Posadas-Sanchez R, 2017, ONCOTARGET, V8, P64459, DOI 10.18632/oncotarget.16223; Qiu HN, 2016, MOL CELL BIOCHEM, V411, P1, DOI 10.1007/s11010-015-2563-3; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Wang LL, 2014, ARCH MED SCI, V10, P791, DOI 10.5114/aoms.2014.44871; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; World Health Organization, TOP 10 CAUS DEATH; Yoshizaki A, 2011, ANN RHEUM DIS, V70, P194, DOI 10.1136/ard.2009.121053; Zheng F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/507208; Zhu CL, 2010, SCAND J IMMUNOL, V72, P469, DOI 10.1111/j.1365-3083.2010.02460.x; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135	38	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188387	10.1371/journal.pone.0188387	http://dx.doi.org/10.1371/journal.pone.0188387			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176764	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900070
J	Marin, J; Saladie, P; Rodriguez-Hidalgo, A; Carbonell, E				Marin, Juan; Saladie, Palmira; Rodriguez-Hidalgo, Antonio; Carbonell, Eudald			Neanderthal hunting strategies inferred from mortality profiles within the Abric Romani sequence	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; DEER CERVUS-ELAPHUS; RED DEER; LIFE-TABLES; TRANSPORT; PREY; AGE; EXPLOITATION; SUBSISTENCE; CAPELLADES	Ungulate mortality profiles are commonly used to study Neanderthal subsistence strategies. To assess the hunting strategies used by Neanderthals, we studied the ages at death of the cervids and equids found in levels E, H, I, Ja, Jb, K, L and M of the Abric Romani sequence. These levels date between 43.2 +/- 1.1 ka BP (C-14 AMS) and 54.5 +/- 1.7 ka BP (U-series). The degree of eruption and development of the teeth and their wear stages were used to determine the ages of these animals at death, and mortality profiles were constructed using these data. The equids display prime dominated profiles in all of the analyzed levels, whereas the cervids display variable profiles. These results suggest that the Neanderthals of Abric Romani employed both selective and non-selective hunting strategies. The selective strategy focused on the hunting of prime adults and generated prime dominated profiles. On the other hand, non-selective strategies, involved the consumption of animals of variable ages, resulting in catastrophic profiles. It is likely that in the selective hunting events were conducted using selective ambushes in which it was possible to select specific prey animals. On the other hand, encounter hunting or non-selective ambush hunting may have also been used at times, based on the abundances of prey animals and encounter rates. Specific hunting strategies would have been developed accordance with the taxa and the age of the individual to be hunted. The hunting groups most likely employed cooperative hunting techniques, especially in the capture of large animals. Thus, it is not possible to uniquely associate a single mortality profile with the predation tactics of Neanderthals at Abric Romani.	[Marin, Juan] MNHN, IPH, 1 Rue Rene Panhard, Paris, France; [Marin, Juan; Rodriguez-Hidalgo, Antonio] Casa Cultura Rodriguez Monino, Equipo Invest Primeros Pobladores Extremadura, Avd Cervantes S-N, Caceres, Spain; [Saladie, Palmira; Carbonell, Eudald] CSIC, IPHES, Inst Catala Paleoecol Humana & Evolucio Social, Zona Educ 4,Campus Sescelades URV Edifici W3, Tarragona, Spain; [Saladie, Palmira; Carbonell, Eudald] URV, Area Prehist, Avinguda Catalunya 35, Tarragona, Spain; [Saladie, Palmira] GQP CG, UI & D 73 FCT, Macao, Portugal; [Saladie, Palmira] CSIC, Dept Paleobiol, Museo Nacl Ciencias Nat, Madrid, Spain; [Rodriguez-Hidalgo, Antonio] Univ Complutense Madrid, Dept Prehist, Prof Aranguren S-N, Madrid, Spain; [Rodriguez-Hidalgo, Antonio] IDEA Inst Evoluc Africa, Calle Covarrubias 36, Madrid, Spain	Museum National d'Histoire Naturelle (MNHN); Consejo Superior de Investigaciones Cientificas (CSIC); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid	Marin, J (corresponding author), MNHN, IPH, 1 Rue Rene Panhard, Paris, France.; Marin, J (corresponding author), Casa Cultura Rodriguez Monino, Equipo Invest Primeros Pobladores Extremadura, Avd Cervantes S-N, Caceres, Spain.	juan.marin-hernando@edu.mnhn.fr	Marín, Juan/ABE-1453-2020; Saladie, Palmira/AAR-7932-2020; Marín, Juan/O-9893-2016; Rodríguez-Hidalgo, Antonio/B-9694-2019; Rodríguez-Hidalgo, Antonio/H-4128-2019; Saladie, Palmira/G-4019-2015	Marín, Juan/0000-0002-5698-602X; Marín, Juan/0000-0002-5698-602X; Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Saladie, Palmira/0000-0002-1730-8461	Ministerio de Economia, Industria y Competitividad/Fondo Europeo de Desarrollo Regional project [CG L2015-65387-C3-1-P]; Agenda de Gestio d'Ajuts Universitaris i de Recerca project [SGR 2014-899]; Univeristat Rovira i Virgili [PFR-URV-B2-17]; Departament de Cultura; Generalitat de Catalunya [2014/100576]; Ajuntament de Capellades; Departament de Cultura (Servei de Arqueologia i Patrimoni) of the Government of Catalonia; postdoctoral Subprograma Juan de la Cierva fellowship project through the Department of Prehistory, Complutense University of Madrid [FJCI-2015-24144]	Ministerio de Economia, Industria y Competitividad/Fondo Europeo de Desarrollo Regional project; Agenda de Gestio d'Ajuts Universitaris i de Recerca project; Univeristat Rovira i Virgili; Departament de Cultura; Generalitat de Catalunya(Generalitat de Catalunya); Ajuntament de Capellades; Departament de Cultura (Servei de Arqueologia i Patrimoni) of the Government of Catalonia; postdoctoral Subprograma Juan de la Cierva fellowship project through the Department of Prehistory, Complutense University of Madrid	The work was financially supported by the Ministerio de Economia, Industria y Competitividad/Fondo Europeo de Desarrollo Regional project number CG L2015-65387-C3-1-P, the Agenda de Gestio d'Ajuts Universitaris i de Recerca project number SGR 2014-899, The Univeristat Rovira i Virgili projects 2014, 2015 and 2016 PFR-URV-B2-17, the Departament de Cultura. Generalitat de Catalunya project number 2014/100576 and is framed in Centres de Recerca de Catalunya Programme/Generalitat de Catalunya. Funding for fieldwork is provided by the Ajuntament de Capellades and the Departament de Cultura (Servei de Arqueologia i Patrimoni) of the Government of Catalonia. J.M. is the beneficiary of an Erasmus Mundus Doctorate scholarship for an International Doctorate in Quarternary and Prehistory. A. R.-H is the beneficiary of a postdoctoral Subprograma Juan de la Cierva fellowship project number FJCI-2015-24144 through the Department of Prehistory, Complutense University of Madrid.	Adler DS, 2009, VERTEBR PALEOBIOL PA, P127, DOI 10.1007/978-1-4020-9699-0_9; Allue Ethel, 2012, P135; ALVARD M, 1995, CURR ANTHROPOL, V36, P789, DOI 10.1086/204432; [Anonymous], 1982, BAR BRIT SERIES; Aura Tortosa JE, 2002, J ARCHAEOL METHOD TH, V9, P215; Azorit CE, 2011, ANALES, V24; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Binford LR., 1984, FAUNAL REMAINS KLASI; BISCHOFF JL, 1988, NATURE, V332, P68, DOI 10.1038/332068a0; Blasco MF, 1997, J ANTHROPOL RES, V53, P177, DOI 10.1086/jar.53.2.3631276; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocherens H, 2011, VERTEBR PALEOBIOL PA, P73, DOI 10.1007/978-94-007-0415-2_8; BOYD DK, 1994, J WILDLIFE MANAGE, V58, P289, DOI 10.2307/3809393; BROWN WAB, 1991, J ZOOL, V224, P519, DOI 10.1111/j.1469-7998.1991.tb03783.x; Bunn HT, 2014, QUATERN INT, V322, P44, DOI 10.1016/j.quaint.2013.11.002; Bunn HT, 2010, QUATERNARY RES, V74, P395, DOI 10.1016/j.yqres.2010.07.012; Bunn HT, 2010, QUATERNARY RES, V74, P388, DOI 10.1016/j.yqres.2010.07.013; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; Burjachs F, 2012, QUATERN INT, V247, P26, DOI 10.1016/j.quaint.2011.01.035; BURKE A, 1995, J ARCHAEOL SCI, V22, P479, DOI 10.1006/jasc.1995.0047; Caceres Isabel, 1998, Quaternaire, V9, P379; Carbonell E., 2012, HIGH RESOLUTION ARCH; Carbonell E., 2002, ABRIC ROMANI NIVELL; Carranza J., 1758, ENCICLOPEDIA VIRTUAL; CASTROCUREL Z, 1995, J FIELD ARCHAEOL, V22, P376, DOI 10.1179/009346995791974206; Chacon M.G., 2007, COMPLUTUM, V18, P47; Chacon MG, TRANSITIONS RUPTURES; Chacon MG, 2007, RAW MAT SUPPLY AREAS, VWS23; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Costamagno S, 2006, J ANTHROPOL ARCHAEOL, V25, P466, DOI 10.1016/j.jaa.2006.03.008; Fernandez-Laso MC, 2010, QUATERNAIRE, V21, P155, DOI 10.4000/quaternaire.5525; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; de Soler B. Gomez, 2007, AREAS CAPTACION ESTR; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Delpech F., 1983, CAHIERS DUQUATERNAIR; Discamps E, 2015, J ARCHAEOL SCI, V58, P62, DOI 10.1016/j.jas.2015.03.021; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2015, QUATERNARY SCI REV, V126, P67, DOI 10.1016/j.quascirev.2015.08.020; Driver J.C., 1995, MASCA RES PAPERS SCI, P23; Dzigciolowski R., 1970, Acta theriol., V15, P253; Farizy C., 1994, HOMMES BISONS PALEOL; Fernandez P, 2006, J ARCHAEOL SCI, V33, P176, DOI 10.1016/j.jas.2005.07.005; Fernandez P, 2003, J ARCHAEOL SCI, V30, P1577, DOI 10.1016/S0305-4403(03)00054-2; Fernandez P., 2001, ETUDE PALEONTOLOGIQU, P1; Fernandez P, 1998, STRATEGIE CHASSE NEA; Fernandez P, 2009, BULL SOC PREHIST FR, V106, P5, DOI 10.3406/bspf.2009.13826; Ferre A JS, 1996, MANEJO ESPECIE EQUIN; Fiorenza L, 2015, AM J PHYS ANTHROPOL, V156, P43, DOI 10.1002/ajpa.22659; Fox M.W., 1984, WHISTLING HUNTERS FI; FRISON GC, 1984, AM ANTIQUITY, V49, P288, DOI 10.2307/280020; FRISON GC, 1976, AM ANTIQUITY, V41, P28, DOI 10.2307/279040; Gabucio MJ, 2014, QUATERN INT, V330, P36, DOI 10.1016/j.quaint.2013.12.015; GAUDZINSKI S, 1995, J ARCHAEOL SCI, V22, P51, DOI 10.1016/S0305-4403(95)80162-6; Gaudzinski S, 2000, J HUM EVOL, V38, P497, DOI 10.1006/jhev.1999.0359; Gomez de Soler B, 2016, PROCEDENCIA APROVISI; Goodloe RB, 2000, J WILDLIFE MANAGE, V64, P114, DOI 10.2307/3802980; GREENFIELD HJ, 1988, CURR ANTHROPOL, V29, P573, DOI 10.1086/203676; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Jaubert J, 1990, DOCUMENTS ARCHEOLOGI, V27, P128; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Klein R.G., 1984, ANAL ANIMAL BONES AR; KLEIN RG, 1981, J ARCHAEOL SCI, V8, P1, DOI 10.1016/0305-4403(81)90010-8; KLEIN RG, 1982, PALEOBIOLOGY, V8, P151, DOI 10.1017/S0094837300004498; Kurten B., 1953, VARIATION POPULATION; Lee RB, 1976, DOBE DU DA ENV BACK; Lincoln GA, 1970, J REPROD FERTILI S11, V11; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lubinski PM, 2013, QUATERN INT, V297, P167, DOI 10.1016/j.quaint.2012.12.030; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1987, AM ANTIQUITY, V52, P125, DOI 10.2307/281064; Marean CW, 1997, J ANTHROPOL ARCHAEOL, V16, P189, DOI 10.1006/jaar.1997.0309; MARIEZKURRENA K, 1983, Munibe, V35, P149; Marin J, 2017, CR PALEVOL, V16, P103, DOI 10.1016/j.crpv.2015.11.006; Martinez K., 2008, ANALISIS FUNCIONAL I; Martinez K, 2000, 3 C ARQ PEN UTAB 200; Monahan CM, 1998, J ARCHAEOL SCI, V25, P405, DOI 10.1006/jasc.1997.0241; Moncel M.-H., 2004, B SOC PREHISTORIQUE, P257, DOI [DOI 10.3406/bspf.2004.12993, 10.3406/bspf.2004.12993, DOI 10.3406/BSPF.2004.12993]; Moncel MH, 2012, QUATERN INT, V247, P103, DOI 10.1016/j.quaint.2010.10.030; Morant N, 2000, ACT 3 C ARQ PEN; OCONNELL JF, 1988, J ANTHROPOL RES, V44, P113, DOI 10.1086/jar.44.2.3630053; OCONNELL JF, 1990, J ARCHAEOL SCI, V17, P301, DOI 10.1016/0305-4403(90)90025-Z; Patou-Mathis M, 2000, INT J OSTEOARCHAEOL, V10, P379, DOI 10.1002/1099-1212(200009/10)10:5<379::AID-OA558>3.0.CO;2-4; PAYNE S, 1987, J ARCHAEOL SCI, V14, P609, DOI 10.1016/0305-4403(87)90079-3; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Pike-Tay A, 1999, J HUM EVOL, V36, P283, DOI 10.1006/jhev.1998.0271; PIKETAY A, 1991, RED DEER HUNTING UPP; Reher CA, 1980, PLAINS ANTHROPOL, V25, pxvi; Rendu W, 2010, J ARCHAEOL SCI, V37, P1798, DOI 10.1016/j.jas.2010.01.037; Richards MP, 2008, J HUM EVOL, V55, P179, DOI 10.1016/j.jhevol.2008.02.007; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Rodriguez-Hidalgo A, 2015, J QUATERNARY SCI, V30, P679, DOI 10.1002/jqs.2815; Rosell J, 2012, QUATERN INT, V252, P56, DOI 10.1016/j.quaint.2011.02.019; Rosell J, 2012, QUATERN INT, V247, P69, DOI 10.1016/j.quaint.2011.01.020; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; Schaller G. B., 1972, SERENGETI LION; Schoville BJ, 2014, J HUM EVOL, V73, P1, DOI 10.1016/j.jhevol.2014.06.004; Smith BD, 1975, ANTHR PAPERS U MICHI; Smith GM, 2015, J HUM EVOL, V78, P181, DOI 10.1016/j.jhevol.2014.10.007; Sole A, 2013, J ANTHROPOL RES, V69, P535, DOI 10.3998/jar.0521004.0069.406; Speth JD, 2002, ROLE HUNTING SCAVENG, P223; Speth John D., 2013, P19; Steele D. G., 1993, BONES BEHAV ETHNOARC, P9; Steele TE, 2004, INT J OSTEOARCHAEOL, V14, P307, DOI 10.1002/oa.763; Steele TE, 2002, J ARCHAEOL SCI, V29, P317, DOI 10.1006/jasc.2001.0733; Steele TE, 2012, J ARCHAEOL SCI, V39, P2329, DOI 10.1016/j.jas.2012.02.017; Stephens D.W., 1986, pi; Stiner MC, 2013, CURR ANTHROPOL, V54, pS288, DOI 10.1086/673285; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Stiner MC, 2002, J ARCHAEOL SCI, V29, P979, DOI 10.1006/jasc.2001.0798; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; Stiner MC., 2009, TRANSITIONS PREHISTO, P105; Stiner MC, 1994, AM J PHYS ANTHR; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Valensi P, 2004, INT J OSTEOARCHAEOL, V14, P256, DOI 10.1002/oa.760; Vallverdu J, 2005, J HUM EVOL, V48, P157, DOI 10.1016/j.jhevol.2004.10.004; Vallverdu J., 2012, HIGH RESOLUTION ARCH, P77, DOI DOI 10.1007/978-94-007-3922-2_4; Vallverdu J., 2012, HIGH RESOLUTION ARCH, P19, DOI [DOI 10.1007/978-94-007-3922-2, 10.1007/978-94-007-3922-2_2, DOI 10.1007/978-94-007-3922-2_2]; Vallverdu J, 2002, MICROMORFOLOGIA FACI; Vallverdu J, 2010, CURR ANTHROPOL, V51, P137, DOI 10.1086/649499; Vaquero M, 2001, J FIELD ARCHAEOL, V28, P93, DOI 10.1179/jfa.2001.28.1-2.93; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Vaquero M., 2004, SETTLEMENT DYNAMICS; Vaquero M, 2008, J ARCHAEOL SCI, V35, P3178, DOI 10.1016/j.jas.2008.07.006; Vaquero M, 2012, QUATERN INT, V247, P162, DOI 10.1016/j.quaint.2010.12.015; Varin, 1981, CHEVREUIL CERF SANGL; Voorhies MR, 1969, P N AM PALEONTOL C E, P454; Voormolen B., 2008, ANCIENT HUNTERS MODE; Waechter J., 1976, MAN BEFORE HIST; White M, 2016, QUATERNARY SCI REV, V140, P1, DOI 10.1016/j.quascirev.2016.03.004; Wilson MC, 1978, LATE PREHISTORIC BIS, P88; Yeshurun R, 2007, J HUM EVOL, V53, P656, DOI 10.1016/j.jhevol.2007.05.008; Yravedra J, 2015, J HUM EVOL, V78, P12, DOI 10.1016/j.jhevol.2014.10.002	136	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186970	10.1371/journal.pone.0186970	http://dx.doi.org/10.1371/journal.pone.0186970			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166384	Green Submitted, gold, Green Published			2022-12-26	WOS:000416035300008
J	Eidsaa, M; Stubbs, L; Almaas, E				Eidsaa, Marius; Stubbs, Lisa; Almaas, Eivind			Comparative analysis of weighted gene co-expression networks in human and mouse	PLOS ONE			English	Article							ORGANIZATION; CONSERVATION; DISCOVERY; PATTERNS; ELEMENTS; ATLAS	The application of complex network modeling to analyze large co-expression data sets has gained traction during the last decade. In particular, the use of the weighted gene co-expression network analysis framework has allowed an unbiased and systems-level investigation of genotype-phenotype relationships in a wide range of systems. Since mouse is an important model organism for biomedical research on human disease, it is of great interest to identify similarities and differences in the functional roles of human and mouse orthologous genes. Here, we develop a novel network comparison approach which we demonstrate by comparing two gene-expression data sets from a large number of human and mouse tissues. The method uses weighted topological overlap alongside the recently developed network-decomposition method of s-core analysis, which is suitable for making genecentrality rankings for weighted networks. The aim is to identify globally central genes separately in the human and mouse networks. By comparing the ranked gene lists, we identify genes that display conserved or diverged centrality-characteristics across the networks. This framework only assumes a single threshold value that is chosen from a statistical analysis, and it may be applied to arbitrary network structures and edge-weight distributions, also outside the context of biology. When conducting the comparative network analysis, both within and across the two species, we find a clear pattern of enrichment of transcription factors, for the homeobox domain in particular, among the globally central genes. We also perform gene-ontology term enrichment analysis and look at disease-related genes for the separate networks as well as the network comparisons. We find that gene ontology terms related to regulation and development are generally enriched across the networks. In particular, the genes FOXE3, RHO, RUNX2, ALX3 and RARA, which are disease genes in either human or mouse, are on the top-10 list of globally central genes in the human and mouse networks.	[Eidsaa, Marius; Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Stubbs, Lisa] Univ Illinois Urbana Champaigne, Cell & Dev Biol, Inst Genom Biol, Neurosci Program, Urbana, IL 61801 USA; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.; Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway.	eivind.almaas@ntnu.no		Stubbs, Lisa/0000-0002-9556-1972; Almaas, Eivind/0000-0002-9125-326X	NTNU Faculty of Natural Sciences and Technology; Research Council of Norway (RCN) [245160]	NTNU Faculty of Natural Sciences and Technology; Research Council of Norway (RCN)(Research Council of Norway)	ME was supported by a strategic research grant from NTNU Faculty of Natural Sciences and Technology. EA would like to thank The Research Council of Norway (RCN) grant 245160 (ERASysAPP: WineSys) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; [Anonymous], 2016, ONL MEN INH MAN; [Anonymous], 2017, TOOL DISC VIS ENR GO; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eidsaa M, 2016, PHYSICA A, V449, P111, DOI 10.1016/j.physa.2015.12.115; Eidsaa M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062819; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Holder-Espinasse M, 2007, EUR J HUM GENET, V15, P1115, DOI 10.1038/sj.ejhg.5201888; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kultz D, 2015, J PROT; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Monaco G, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0534-7; Netotea S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-106; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsaparas P, 2006, BMC EVOLUTIONARY BIO, V6, P1; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voigt A, INFLUENCE C IN PRESS; Wang SQ, 2016, J CLIN INVEST, V126, P948, DOI 10.1172/JCI83778; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	49	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187611	10.1371/journal.pone.0187611	http://dx.doi.org/10.1371/journal.pone.0187611			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161290	Green Submitted, gold, Green Published			2022-12-26	WOS:000415987000012
J	Siu, JY; Liu, CH; Zhou, YF				Siu, Jun Yang; Liu, Chenhui; Zhou, Yufeng			High-intensity focused ultrasound ablation around the tubing	PLOS ONE			English	Article							LARGE BLOOD-VESSELS; IN-VITRO; HIFU; SIMULATION; EXPOSURE; THERAPY	High-intensity focused ultrasound (HIFU) has been emerging as an effective and noninvasive modality in cancer treatment with very promising clinical results. However, a small vessel in the focal region could be ruptured, which is an important concern for the safety of HIFU ablation. In this study, lesion formation in the polyacrylamide gel phantom embedded with different tubing (inner diameters of 0.76 mm and 3 mm) at varied flow speeds (17-339 cm/s) by HIFU ablation was photographically recorded. Produced lesions have decreased length (similar to 30%) but slightly increased width (similar to 6%) in comparison to that without the embedded tubing. Meanwhile, bubble activities during the exposures were measured by passive cavitation detection (PCD) at the varied pulse repetition frequency (PRF, 10-30 Hz) and duty cycle (DC, 10%-20%) of the HIFU bursts. High DC and low flow speed were found to produce stronger bubble cavitation whereas no significant influence of the PRF. In addition, high-speed photography illustrated that the rupture of tubing was produced consistently after the first HIFU burst within 20 ms and then multiple bubbles would penetrate into the intraluminal space of tubing through the rupture site by the acoustic radiation force. Alignment of HIFU focus to the anterior surface, middle, and posterior surface of tubing led to different characteristics of vessel rupture and bubble introduction. In summary, HIFU-induced vessel rupture is possible as shown in this phantom study; produced lesion sizes and shapes are dependent on the focus alignment to the tubing, flow speed, and tubing properties; and bubble cavitation and the formation liquid jet may be one of the major mechanisms of tubing rupture as shown in the high-speed photography.	[Siu, Jun Yang; Liu, Chenhui; Zhou, Yufeng] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhou, YF (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	yfzhou@ntu.edu.sg	Zhou, Yufeng/A-1127-2011	Zhou, Yufeng/0000-0003-4086-2150				CHEN H, 2011, PHYS REV LETT, V106; Curra FP, 2000, IEEE T ULTRASON FERR, V47, P1077, DOI 10.1109/58.852092; DORR LN, 1992, INT J HYPERTHER, V8, P45, DOI 10.3109/02656739209052878; HAHL J, 1990, LASER SURG MED, V10, P319, DOI 10.1002/lsm.1900100403; Hariharan P, 2007, PHYS MED BIOL, V52, P3493, DOI 10.1088/0031-9155/52/12/011; Hoerig CL, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-14; Hynynen K, 1996, ULTRASOUND MED BIOL, V22, P1071, DOI 10.1016/S0301-5629(96)00143-3; Khokhlova TD, 2011, J ACOUST SOC AM, V130, P3498, DOI 10.1121/1.3626152; Lafon C, 2005, ULTRASOUND MED BIOL, V31, P1383, DOI 10.1016/j.ultrasmedbio.2005.06.004; LANG NP, 1991, AM J SURG, V162, P629, DOI 10.1016/0002-9610(91)90124-V; Mahoney K, 2000, ULTRASON, P1405, DOI 10.1109/ULTSYM.2000.921585; MARTINOT VL, 1994, LASER SURG MED, V15, P168, DOI 10.1002/lsm.1900150204; Miller DL, 2006, ULTRASOUND MED BIOL, V32, P1097, DOI 10.1016/j.ultrasmedbio.2006.03.013; Miller MW, 1996, ULTRASOUND MED BIOL, V22, P1131, DOI 10.1016/S0301-5629(96)00089-0; Nandlall SD, 2011, ULTRASOUND MED BIOL, V37, P922, DOI 10.1016/j.ultrasmedbio.2011.02.016; Nyborg WL, 2001, ULTRASOUND MED BIOL, V27, P301, DOI 10.1016/S0301-5629(00)00333-1; Parsons JE, 2006, ULTRASOUND MED BIOL, V32, P115, DOI 10.1016/j.ultrasmedbio.2005.09.005; Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F; Serrone J, 2012, J CLIN NEUROSCI, V19, P214, DOI 10.1016/j.jocn.2011.07.003; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Solovchuk M, 2015, COMMUN COMPUT PHYS, V18, P1050, DOI 10.4208/cicp.171214.200715s; Solovchuk M, 2013, J ACOUST SOC AM, V134, P3931, DOI 10.1121/1.4821201; Solovchuk MA, 2012, INT J HEAT MASS TRAN, V55, P1261, DOI 10.1016/j.ijheatmasstransfer.2011.09.023; Sturtevant B., 1996, SMITHS TXB ENDOUROLO, P529; Tokarczyk A, 2013, PHYS MED BIOL, V58, P2281, DOI 10.1088/0031-9155/58/7/2281; Tortora G.J., 2012, PRINCIPLES ANATOMY P, V13th ed., P610; Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c; Wu F, 2002, ULTRASOUND MED BIOL, V28, P535, DOI 10.1016/S0301-5629(01)00515-4; Yu T, 2014, SCI WORLD J, V2014; Yu TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026110; Zhang L, 2009, EUR RADIOL, V19, P437, DOI 10.1007/s00330-008-1137-0; Zhou YF, 2011, WORLD J CLIN ONCOL, V2, P8, DOI 10.5306/wjco.v2.i1.8; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131; Zhou YF, 2016, PHYS MED BIOL, V61, P6651, DOI 10.1088/0031-9155/61/18/6651	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188206	10.1371/journal.pone.0188206	http://dx.doi.org/10.1371/journal.pone.0188206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161293	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000036
J	Kyeong, S; Cha, YJ; Ahn, SG; Suh, SH; Son, EJ; Ahn, SJ				Kyeong, Sunghyon; Cha, Yoon Jin; Ahn, Sung Gwe; Suh, Sang Hyun; Son, Eun Ju; Ahn, Sung Jun			Subtypes of breast cancer show different spatial distributions of brain metastases	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; NERVOUS-SYSTEM METASTASES; LUNG-CANCER; PROGNOSTIC-FACTORS; VASCULAR-RESPONSE; SURVIVAL; TRASTUZUMAB; SINGLE; WOMEN; RISK	The aim of our study was to test the hypothesis that the spatial distribution of breast cancer brain metastases (BM) differ according to their biological subtypes. MR images of 100 patients with BM from primary breast cancer were retrospectively reviewed. Patients were divided according to the biological subtype of the primary tumor, (triple-negative: 24, HER2 positive: 48, luminal: 28). All images marked with BMs were standardized to the human brain MRI atlas provided by the Montreal Neurological Institute 152 database. Distribution pattern of BM was evaluated with intra-group and intergroup analysis. In intra-group analysis, hot spots of metastases from triple-negative are evenly distributed in the brain, meanwhile BMs from HER2 positive and luminal type occur dominantly in occipital lobe and cerebellum. In intergroup analysis, BMs from triple-negative type occurred more often in frontal lobe, limbic region, and parietal lobe, compared with other types (P <.05). Breast cancer subtypes tend to demonstrate different spatial distributions of their BMs. These findings may have direct implications for dose modulation in prophylactic irradiation as well as for differential diagnoses. Thus, this result should be validated in future study with a larger population.	[Kyeong, Sunghyon] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Cha, Yoon Jin] Yonsei Univ, Dept Pathol, Gangnam Severance Hosp, Seoul, South Korea; [Ahn, Sung Gwe] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Suh, Sang Hyun; Son, Eun Ju; Ahn, Sung Jun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ahn, SJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	aahng77@yuhs.ac	Suh, Sang Hyun/M-5515-2015	Suh, Sang Hyun/0000-0002-7098-4901; Ahn, Sung Jun/0000-0003-0075-2432; Kyeong, Sunghyon/0000-0002-9095-5219; Son, Eun Ju/0000-0002-7895-0335	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1C1B5014927]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No.2017R1C1B5014927). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Bender ET, 2011, BRIT J RADIOL, V84, P649, DOI 10.1259/bjr/30173406; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; Elkholy, 2008, J CLIN ONCOL, V26; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gandhi AK, 2015, INDIAN J MED PAEDIAT, V36, P77, DOI 10.4103/0971-5851.158822; Gil-Gil MJ, 2014, CLIN TRANSL ONCOL, V16, P436, DOI 10.1007/s12094-013-1110-5; Gori S, 2007, ONCOLOGIST, V12, P766, DOI 10.1634/theoncologist.12-7-766; Hendrikse J, 2004, STROKE, V35, P882, DOI 10.1161/01.STR.0000120312.26163.EC; Hengel K, 2013, INT J CLIN ONCOL, V18, P396, DOI 10.1007/s10147-012-0392-x; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264, DOI 10.1097/00004647-200008000-00011; Lee SS, 2008, BREAST CANCER RES TR, V111, P523, DOI 10.1007/s10549-007-9806-2; Li N, 2015, ANN ONCOL, V26, P504, DOI 10.1093/annonc/mdu567; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagao E, 2011, AM J NEURORADIOL, V32, P664, DOI 10.3174/ajnr.A2343; Nam BH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1870; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Niwinska A, 2011, EJSO-EUR J SURG ONC, V37, P635, DOI 10.1016/j.ejso.2011.05.002; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Quattrocchi CC, 2012, J NEURO-ONCOL, V110, P79, DOI 10.1007/s11060-012-0937-x; Ribatti D, 2006, CLIN EXP MED, V6, P145, DOI 10.1007/s10238-006-0117-4; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sperduto PW, 2013, J NEURO-ONCOL, V112, P467, DOI 10.1007/s11060-013-1083-9; Takano K, 2016, NEURO-ONCOLOGY, V18, P716, DOI 10.1093/neuonc/nov266; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Laar PJ, 2006, NEUROIMAGE, V29, P136, DOI 10.1016/j.neuroimage.2005.07.011; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7	37	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188542	10.1371/journal.pone.0188542	http://dx.doi.org/10.1371/journal.pone.0188542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155879	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700063
J	Pillai, VV; Weber, DM; Phinney, BS; Selvaraj, V				Pillai, Viju Vijayan; Weber, Darren M.; Phinney, Brett S.; Selvaraj, Vimal			Profiling of proteins secreted in the bovine oviduct reveals diverse functions of this luminal microenvironment	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; APOLIPOPROTEIN-A-I; EARLY EMBRYO DEVELOPMENT; SPERM-EGG BINDING; GENE-EXPRESSION; GROWTH-FACTOR; FLUID PROTEINS; RABBIT OVIDUCT; MESSENGER-RNA; VITRO FERTILIZATION	The oviductal microenvironment is a site for key events that involve gamete maturation, fertilization and early embryo development. Secretions into the oviductal lumen by either the lining epithelium or by transudation of plasma constituents are known to contain elements conducive for reproductive success. Although previous studies have identified some of these factors involved in reproduction, knowledge of secreted proteins in the oviductal fluid remains rudimentary with limited definition of function even in extensively studied species like cattle. In this study, we used a shotgun proteomics approach followed by bioinformatics sequence prediction to identify secreted proteins present in the bovine oviductal fluid ( ex vivo) and secretions from the bovine oviductal epithelial cells (in vitro). From a total of 2087 proteins identified, 266 proteins could be classified as secreted, 109 (41%) of which were common for both in vivo and in vitro conditions. Pathway analysis indicated different classes of proteins that included growth factors, metabolic regulators, immune modulators, enzymes, and extracellular matrix components. Functional analysis revealed mechanisms in the oviductal lumen linked to immune homeostasis, gamete maturation, fertilization and early embryo development. These results point to several novel components that work together with known elements mediating functional homeostasis, and highlight the diversity of machinery associated with oviductal physiology and early events in cattle fertility.	[Pillai, Viju Vijayan; Selvaraj, Vimal] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA; [Weber, Darren M.; Phinney, Brett S.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	Cornell University; University of California System; University of California Davis	Selvaraj, V (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA.	vs88@cornell.edu	Selvaraj, Vimal/AAC-2853-2022; Pillai, Viju/L-7557-2019; Phinney, Brett/S-6404-2016	Pillai, Viju/0000-0002-2696-0451; Phinney, Brett/0000-0003-3870-3302	USDA-NIFA [2013-00986]; USDA Multi State [NE1227 NYC-127806]	USDA-NIFA(United States Department of Agriculture (USDA)); USDA Multi State	This study was supported by grants USDA-NIFA 2013-00986 to Vimal Selvaraj and USDA Multi State NE1227 NYC-127806 to Vimal Selvaraj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1995, MOL REPROD DEV, V42, P226, DOI 10.1002/mrd.1080420212; Aguilar J., 2005, Animal Reproduction, V2, P91; AKERLOF E, 1991, BIOCHEMISTRY-US, V30, P8986; Al Darwich A, 2010, PROSTAG OTH LIPID M, V93, P30, DOI 10.1016/j.prostaglandins.2010.06.002; Al-Dossary AA, 2015, J BIOL CHEM, V290, P17710, DOI 10.1074/jbc.M114.633156; Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aleporou-Marinou V, 2001, COMP BIOCHEM PHYS B, V128, P537, DOI 10.1016/S1096-4959(00)00359-6; ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; Argraves WS, 2004, MOL REPROD DEV, V69, P419, DOI 10.1002/mrd.20174; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; Barrera AD, 2017, REPRODUCTION, V154, P1, DOI 10.1530/REP-16-0651; Bauersachs S, 2007, J DAIRY SCI, V90, P4420, DOI 10.3168/jds.2007-0132; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BOICE ML, 1990, BIOL REPROD, V43, P457, DOI 10.1095/biolreprod43.3.457; CARLSON D, 1970, J REPROD FERTIL, V22, P549, DOI 10.1530/jrf.0.0220549; Carrasco LC, 2008, REPROD FERT DEVELOP, V20, P808, DOI 10.1071/RD08113; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P331, DOI 10.1111/j.1439-0531.2012.02157.x; Chen S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42298; Cordova A, 2014, THERIOGENOLOGY, V81, P1163, DOI 10.1016/j.theriogenology.2014.01.012; Coy P, 2012, HUM REPROD, V27, P1985, DOI 10.1093/humrep/des146; D'Souza SS, 2007, BIOL REPROD, V77, P433, DOI 10.1095/biolreprod.107.061317; de Almeida PG, 2016, DEV DYNAM, V245, P520, DOI 10.1002/dvdy.24391; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; DESOUZA MM, 1995, ENDOCRINOLOGY, V136, P2485, DOI 10.1210/en.136.6.2485; Diaz MJ, 2000, MOL REPROD DEV, V55, P47, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;47::AID-MRD7&gt;3.0.CO;2-J; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; FRY RC, 1992, BIOL REPROD, V46, P470, DOI 10.1095/biolreprod46.3.470; Gabler C, 2003, REPRODUCTION, V126, P721, DOI 10.1530/rep.0.1260721; Gabler C, 1996, ARCH TIERZUCHT, V39, P29; Gabler C, 2001, REPRODUCTION, V122, P121, DOI 10.1530/rep.0.1220121; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Garcia EV, 2017, REPRODUCTION, V153, P631, DOI 10.1530/REP-16-0654; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; Georgiou AS, 2005, MOL CELL PROTEOMICS, V4, P1785, DOI 10.1074/mcp.M500119-MCP200; GERENA RL, 1990, J EXP ZOOL, V256, P113, DOI 10.1002/jez.1402560114; Goncalves RF, 2007, THERIOGENOLOGY, V67, P468, DOI 10.1016/j.theriogenology.2006.08.013; Goncalves RF, 2008, REPROD DOMEST ANIM, V43, P720, DOI 10.1111/j.1439-0531.2007.00978.x; Gonella-Diaza AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145321; Guo ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170808; Hao YH, 2008, MOL REPROD DEV, V75, P291, DOI 10.1002/mrd.20794; Hao YH, 2006, BIOL REPROD, V75, P726, DOI 10.1095/biolreprod.106.052589; Hawksworth OA, 2014, STEM CELLS, V32, P3278, DOI 10.1002/stem.1801; Ibrahim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119388; JAFFE RC, 1989, MOL ENDOCRINOL, V3, P1807, DOI 10.1210/mend-3-11-1807; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kan FWK, 2006, MOL REPROD DEV, V73, P756, DOI 10.1002/mrd.20459; Kawakami E, 2004, J VET MED SCI, V66, P1027, DOI 10.1292/jvms.66.1027; KILLIAN GJ, 1989, J REPROD FERTIL, V86, P419, DOI 10.1530/jrf.0.0860419; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamy J, 2016, REPRODUCTION, V152, P629, DOI 10.1530/REP-16-0397; LARSON RC, 1992, J REPROD FERTIL, V96, P289, DOI 10.1530/jrf.0.0960289; LARSON RC, 1992, MOL REPROD DEV, V33, P432, DOI 10.1002/mrd.1080330409; LARSON RC, 1992, DEVELOPMENT, V115, P821; Lavery K, 2004, ANIM REPROD SCI, V84, P13, DOI 10.1016/j.anireprosci.2003.12.010; Lee KF, 2005, J CELL BIOCHEM, V95, P740, DOI 10.1002/jcb.20444; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Libreros S, 2013, IMMUNOL RES, V57, P99, DOI 10.1007/s12026-013-8459-y; Liu Jiangang, 2014, Evid Based Complement Alternat Med, V2014, P141938, DOI 10.1155/2014/141938; Liu Q, 2015, ZYGOTE, V23, P622, DOI 10.1017/S0967199414000483; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; LU R-Z, 1992, Journal of Reproduction and Development, V38, P79, DOI 10.1262/jrd.38.79; Luo HL, 2002, J VET MED SCI, V64, P967, DOI 10.1292/jvms.64.967; Maillo V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.127969; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; Martinez-Leon E, 2015, HUM REPROD, V30, P2138, DOI 10.1093/humrep/dev154; Martus NS, 1998, J REPROD FERTIL, V113, P323, DOI 10.1530/jrf.0.1130323; MCLAUGHLIN KC, 1975, BIOL REPROD, V12, P556, DOI 10.1095/biolreprod12.5.556; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mo XH, 2014, MOL REPROD DEV, V81, P608, DOI 10.1002/mrd.22327; Mugnier S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-129; Nahar A, 2016, REPROD FERT DEVELOP; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OLDS D, 1957, FERTIL STERIL, V8, P345; OLIPHANT G, 1978, BIOL REPROD, V18, P516, DOI 10.1095/biolreprod18.3.516; Palter SF, 2001, J CLIN ENDOCR METAB, V86, P2660, DOI 10.1210/jc.86.6.2660; PANRUCKER DE, 1983, AM J PHYSIOL, V245, pE138, DOI 10.1152/ajpendo.1983.245.2.E138; Pedersen ME, 2005, REPROD FERT DEVELOP, V17, P751, DOI 10.1071/RD05048; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVOST PR, 1995, MOL CELL ENDOCRINOL, V109, P225, DOI 10.1016/0303-7207(95)03506-3; Ptak G, 2006, THERIOGENOLOGY, V65, P1891, DOI 10.1016/j.theriogenology.2005.10.018; Qu F, 2007, REPRODUCTION, V134, P569, DOI 10.1530/REP-07-0145; Reinhart KC, 1998, MOL HUM REPROD, V4, P301, DOI 10.1093/molehr/4.3.301; Rief S, 2002, REPRODUCTION, V124, P543, DOI 10.1530/rep.0.1240543; RIEGER D, 1995, J REPROD FERTIL, V105, P91, DOI 10.1530/jrf.0.1050091; ROBERTS GP, 1976, J REPROD FERTIL, V48, P99; ROBERTS GP, 1975, J REPROD FERTIL, V45, P301, DOI 10.1530/jrf.0.0450301; Rodriguez C, 1998, ANIM REPROD SCI, V54, P1, DOI 10.1016/S0378-4320(98)00139-0; Roldan-Olarte M, 2005, ZYGOTE, V13, P115, DOI 10.1017/S0967199405003175; Roy M, 2008, THERIOGENOLOGY, V70, P836, DOI 10.1016/j.theriogenology.2008.05.042; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Srivastava MD, 1999, AM J REPROD IMMUNOL, V42, P347; STAMBAUGH R, 1974, FERTIL STERIL, V25, P352, DOI 10.1016/S0015-0282(16)40335-3; STANKE DF, 1974, J REPROD FERTIL, V38, P493, DOI 10.1530/jrf.0.0380493; Staros AL, 1998, J REPROD FERTIL, V112, P131, DOI 10.1530/jrf.0.1120131; STONE SL, 1975, GYNECOL OBSTET INVES, V6, P234, DOI 10.1159/000301520; SUAREZ SS, 1982, BIOL REPROD, V27, P473, DOI 10.1095/biolreprod27.2.473; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; Therien I, 1997, BIOL REPROD, V57, P1080, DOI 10.1095/biolreprod57.5.1080; Thimon V, 2006, REPRODUCTION, V132, P899, DOI 10.1530/REP-06-0077; Tse PK, 2008, ENDOCRINOLOGY, V149, P1268, DOI 10.1210/en.2007-1277; Tutuncu L, 2004, DEV BIOL, V270, P246, DOI 10.1016/j.ydbio.2004.02.008; VITAIOLI L, 1985, HISTOCHEM J, V17, P883, DOI 10.1007/BF01004183; VITAIOLI L, 1984, ACTA HISTOCHEM, V75, P141, DOI 10.1016/S0065-1281(84)80050-1; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wijayagunawardane MPB, 2003, BIOL REPROD, V69, P1341, DOI 10.1095/biolreprod.103.017327; Winger QA, 1997, BIOL REPROD, V56, P1415, DOI 10.1095/biolreprod56.6.1415; YOUNIS AI, 1989, GAMETE RES, V23, P189, DOI 10.1002/mrd.1120230206; Zampini R, 2014, REPROD DOMEST ANIM, V49, P492, DOI 10.1111/rda.12317; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zhang K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130278; Zumoffen CM, 2013, HUM REPROD, V28, P1297, DOI 10.1093/humrep/det016	122	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188105	10.1371/journal.pone.0188105	http://dx.doi.org/10.1371/journal.pone.0188105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155854	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700030
J	Graf, M; Riedel, T				Graf, Michael; Riedel, Thomas			Electrical impedance tomography: Amplitudes of cardiac related impedance changes in the lung are highly position dependent	PLOS ONE			English	Article							PULMONARY PERFUSION; EIT; RECONSTRUCTION; VENTILATION; POSTURE; VOLUME	Background Electrical impedance tomography (EIT) is used on the thorax to measure impedance changes due to the presence of air and blood in the lung. This experimental study was performed to investigate the effect of posture on cardiac and respiratory related impedance changes. Methods EIT measurements were performed on 14 healthy subjects in left-, right lateral, prone, supine and upright positions. Simultaneously, tidal volume was recorded with an ultrasonic flowmeter. For image reconstruction, the classic Sheffield back-projection and three variants of the modern GREIT algorithm were applied with two different reference frames. Amplitudes of cardiac-and respiratory impedance changes were extracted and compared between the positions. Results We found significant differences in both cardiac and respiratory amplitudes between postures. Especially, supine and upright positions showed dramatic changes in amplitude. These differences between postures were unaffected by the change of reference frames in all reconstruction methods except of the classic Sheffield back projection. Possible sources that explain the observed posture dependency are discussed. Conclusion Researchers and clinicians need to be aware of this phenomenon when comparing EIT amplitudes in different body positions.	[Graf, Michael; Riedel, Thomas] Univ Childrens Hosp, Inselspital, Dept Paediat, Div Paediat Pulmonol, Bern, Switzerland; [Graf, Michael; Riedel, Thomas] Univ Bern, Bern, Switzerland; [Graf, Michael] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lab Nanoscale Biol, Lausanne, Switzerland; [Riedel, Thomas] Cantonal Hosp Graubuenden, Dept Paediat, Chur, Switzerland	University of Bern; University Hospital of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Riedel, T (corresponding author), Univ Childrens Hosp, Inselspital, Dept Paediat, Div Paediat Pulmonol, Bern, Switzerland.; Riedel, T (corresponding author), Univ Bern, Bern, Switzerland.; Riedel, T (corresponding author), Cantonal Hosp Graubuenden, Dept Paediat, Chur, Switzerland.	thomas.riedel@ksgr.ch		Graf, Michael/0000-0001-6201-7471; Riedel, Thomas/0000-0002-7153-5251				Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; BROWN BH, 1994, IEEE T BIO-MED ENG, V41, P729, DOI 10.1109/10.310088; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Dunlop S, 2006, PHYSIOL MEAS, V27, P1151, DOI 10.1088/0967-3334/27/11/008; Ericsson E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155913; EYUBOGLU BM, 1989, IEEE ENG MED BIOL, V8, P39, DOI 10.1109/51.32404; Fagerberg A, 2009, ACTA ANAESTH SCAND, V53, P152, DOI 10.1111/j.1399-6576.2008.01847.x; Frerichs I, 2000, PHYSIOL MEAS, V21, pR1, DOI 10.1088/0967-3334/21/2/201; Frerichs I, 2009, RESPIRATION, V77, P282, DOI 10.1159/000193994; Grant CA, 2011, CRIT CARE, V15, DOI 10.1186/cc9985; Grychtol B, 2014, PHYSIOL MEAS, V35, P1035, DOI 10.1088/0967-3334/35/6/1035; Grychtol B, 2013, PHYSIOL MEAS, V34, P579, DOI 10.1088/0967-3334/34/6/579; Grychtol B, 2012, IEEE T MED IMAGING, V31, P1754, DOI 10.1109/TMI.2012.2200904; Hahn G, 1996, PHYSIOL MEAS, V17, pA159, DOI 10.1088/0967-3334/17/4A/020; Hall J. E., 2015, TXB MED PHYSL; Harris N D, 1987, Clin Phys Physiol Meas, V8 Suppl A, P155, DOI 10.1088/0143-0815/8/4A/020; Kosuda S, 2000, EUR J NUCL MED, V27, P529, DOI 10.1007/s002590050539; Leonhardt S, 2012, IEEE ENG MED BIO, P122, DOI 10.1109/EMBC.2012.6345886; Oppenheim A. V., 2010, DISCRETE TIME SIGNAL; Riedel T, 2005, INTENS CARE MED, V31, P1522, DOI 10.1007/s00134-005-2734-x; Schnidrig S, 2013, EUR J APPL PHYSIOL, V113, P591, DOI 10.1007/s00421-012-2469-7; Smit HJ, 2004, EUR J APPL PHYSIOL, V92, P45, DOI 10.1007/s00421-004-1043-3; Soille P, 2004, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; WANG Y, 1960, J CLIN INVEST, V39, P1051, DOI 10.1172/JCI104120; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zhao ZQ, 2014, PHYSIOL MEAS, V35, P1083, DOI 10.1088/0967-3334/35/6/1083	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188313	10.1371/journal.pone.0188313	http://dx.doi.org/10.1371/journal.pone.0188313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145478	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800109
J	Haralambieva, IH; Gibson, MJ; Kennedy, RB; Ovsyannikova, IG; Warner, ND; Grill, DE; Poland, GA				Haralambieva, Iana H.; Gibson, Michael J.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Warner, Nathaniel D.; Grill, Diane E.; Poland, Gregory A.			Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CONGENITAL-RUBELLA; HEMAGGLUTINATION INHIBITION; INTERNATIONAL UNITS; VIRUS ANTIBODIES; RESPONSES; INFECTION; MEASLES; IMMUNOASSAYS; PROTECTION	Introduction//Background The lack of standardization of the currently used commercial anti-rubella IgG antibody assays leads to frequent misinterpretation of results for samples with low/equivocal antibody concentration. The use of alternative approaches in rubella serology could add new information leading to a fuller understanding of rubella protective immunity and neutralizing antibody response after vaccination. Methods We applied microarray technology to measure antibodies to all rubella virus proteins in 75 high and 75 low rubella virus-specific antibody responders after two MMR vaccine doses. These data were used in multivariate penalized logistic regression modeling of rubella-specific neutralizing antibody response after vaccination. Results We measured antibodies to all rubella virus structural proteins (i.e., the glycoproteins E1 and E2 and the capsid C protein) and to the non-structural protein P150. Antibody levels to each of these proteins were: correlated with the neutralizing antibody titer (p<0.006); demonstrated differences between the high and the low antibody responder groups (p<0.008); and were components of the model associated with/predictive of vaccine-induced rubella virus-specific neutralizing antibody titers (misclassification error = 0.2). Conclusion Our study supports the use of this new technology, as well as the use of antibody profiles/ patterns (rather than single antibody measures) as biomarkers of neutralizing antibody response and correlates of protective immunity in rubella virus serology.	[Haralambieva, Iana H.; Gibson, Michael J.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Poland, Gregory A.] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Warner, Nathaniel D.; Grill, Diane E.] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	Poland.gregory@mayo.edu		Poland, Gregory/0000-0001-5057-4457; Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R37AI048793, R01AI033144, R37AI048793-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI033144, R01AI048793] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R37AI048793 and R01AI033144 (GAP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Mayo Clinic Vaccine Research Group staff and the study participants. We thank Caroline L. Vitse for her editorial assistance with the manuscript. This work was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R37AI048793-11 and R01AI033144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P226; Bouthry E, 2016, J CLIN MICROBIOL, V54, P1720, DOI 10.1128/JCM.00383-16; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Cordoba P, 2000, CLIN DIAGN LAB IMMUN, V7, P964, DOI 10.1128/CDLI.7.6.964-966.2000; CUSI MG, 1988, ARCH VIROL, V101, P25, DOI 10.1007/BF01314649; CUSI MG, 1989, ARCH VIROL, V106, P63, DOI 10.1007/BF01311038; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Dhiman N, 2010, CYTOKINE, V50, P24, DOI 10.1016/j.cyto.2009.12.002; DIMECH W, 1992, J CLIN MICROBIOL, V30, P633, DOI 10.1128/JCM.30.3.633-641.1992; Dimech W, 2008, J CLIN MICROBIOL, V46, P1955, DOI 10.1128/JCM.00231-08; Dimech W, 2016, VACCINE, V34, P4119, DOI 10.1016/j.vaccine.2016.06.006; Dimech W, 2016, CLIN MICROBIOL REV, V29, P163, DOI 10.1128/CMR.00045-15; Dimech W, 2013, CLIN VACCINE IMMUNOL, V20, P255, DOI 10.1128/CVI.00603-12; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Haralambieva IH, 2015, VIRUSES-BASEL, V7, P1113, DOI 10.3390/v7031113; Haralambieva IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099997; Haralambieva LH, 2014, VACCINE, V32, P1946, DOI 10.1016/j.vaccine.2014.01.090; Huzly D, 2016, J CLIN VIROL, V74, P13, DOI 10.1016/j.jcv.2015.11.022; Hyde TB, 2015, J INFECT DIS, V212, P57, DOI 10.1093/infdis/jiu604; Katow S, 2004, PEDIATR INT, V46, P207, DOI 10.1046/j.1442-200x.2004.01866.x; Katow S, 1998, INTERVIROLOGY, V41, P163, DOI 10.1159/000024931; Kennedy RB, 2014, HUM GENET, V133, P1407, DOI 10.1007/s00439-014-1471-z; Kennedy RB, 2014, IMMUNOGENETICS, V66, P493, DOI 10.1007/s00251-014-0776-3; Kennedy RB, 2014, EXPERT REV VACCINES, V13, P657, DOI 10.1586/14760584.2014.905744; Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Lambert ND, 2015, J INFECT DIS, V211, P898, DOI 10.1093/infdis/jiu553; Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13; Lambert ND, 2014, IMMUNOL RES, V58, P1, DOI 10.1007/s12026-013-8475-y; LeBaron CW, 2009, J INFECT DIS, V200, P888, DOI 10.1086/605410; Lin CC, 2012, CLIN VACCINE IMMUNOL, V19, P1, DOI 10.1128/CVI.05334-11; Luevano M, 2010, VIROLOGY, V405, P31, DOI 10.1016/j.virol.2010.05.011; Matter L, 1997, J INFECT DIS, V175, P749, DOI 10.1086/513967; MAURACHER CA, 1993, J IMMUNOL, V151, P2041; MEEGAN JM, 1982, J CLIN MICROBIOL, V16, P644, DOI 10.1128/JCM.16.4.644-649.1982; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Mitchell LA, 1996, J CLIN MICROBIOL, V34, P2210, DOI 10.1128/JCM.34.9.2210-2218.1996; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Petrova EK, 2016, VACCINE, V34, P1006, DOI 10.1016/j.vaccine.2016.01.010; Plotkin S, 2008, RUBELLA VACCINE VACC, P471; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Tosh PK, 2009, VIRAL IMMUNOL, V22, P451, DOI 10.1089/vim.2009.0068; TRUANT AL, 1983, J CLIN MICROBIOL, V17, P106, DOI 10.1128/JCM.17.1.106-108.1983; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; ZREIN M, 1993, J CLIN MICROBIOL, V31, P1521, DOI 10.1128/JCM.31.6.1521-1524.1993	53	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188149	10.1371/journal.pone.0188149	http://dx.doi.org/10.1371/journal.pone.0188149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145521	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800076
J	Mao, LG; Jiang, HY; Zhang, L; Zhang, YN; Sial, MU; Yu, HT; Cao, AC				Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Sial, Muhammad Umair; Yu, Haitao; Cao, Aocheng			Replacing methyl bromide with a combination of 1,3-dichloropropene and metam sodium for cucumber production in China	PLOS ONE			English	Article							CHEMICAL ALTERNATIVES; STRAWBERRY NURSERIES; DIMETHYL DISULFIDE; SOILBORNE PESTS; SOIL; CHLOROPICRIN; FUMIGANTS; TOMATO; FUMIGATION; EFFICACY	The combination of 1,3-dichloropropene (1,3-D) and metam sodium (MNa) is a potential resource to replace methyl bromide (MB) as a soil fumigant. The efficacy of 1,3-D+MNa as a crucial factor to limit soil-borne pests was evaluated in one laboratory experiment and two cucumber greenhouse studies conducted in commercial operations. Laboratory results revealed that 1,3-D and MNa (10+20 mg a.i.kg(-1) soil) provided the best complementary control of the root-knot nematode, Fusarium oxysporum and two species of weed seeds. Greenhouse trials revealed that the blend of 1,3-D and MNa (10+20 ga. i. m(-2)) greatly inhibited the ability of Meloidogyne incognita to form root galls. In addition, the number of colonyforming units of F. oxysporum declined substantially after growth on media, resulting in higher fruit yields and greater economic benefits. The combined use of 1,3-D and MNa exhibited a higher control efficacy than when 1,3-D or MNa was utilized alone. The ability of this chemical combination to control soil-borne organisms did not differ significantly from the MB treatment and maintained high cucumber yields, enhancing the income of the farmers. Compared to the untreated control group, all the chemical treatments prominently improved the control of the pests. These results show that applying a combination of 1,3-D and MNa provides a promising alternative to MB that enables the sustained growth of cucumber production in China.	[Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Sial, Muhammad Umair; Yu, Haitao; Cao, Aocheng] Chinese Acad Agr Sci, Dept Pesticides, Inst Plant Protect, Minist Agr, Beijing, Peoples R China; [Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Jiang, HY; Cao, AC (corresponding author), Chinese Acad Agr Sci, Dept Pesticides, Inst Plant Protect, Minist Agr, Beijing, Peoples R China.; Jiang, HY; Cao, AC (corresponding author), State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	ptnpc@vip.163.com; aochengcao@ippcaas.cn	Sial, Muhammad Umair/ABH-2902-2021	Sial, Muhammad Umair/0000-0002-5865-8927; Sial, Maqbool/0000-0003-4394-1460	Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China [2016YFD0200500, 2017YFD0201600]	Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China	The funding for this experiment was provided by "Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China (No. 2016YFD0200500 and 2017YFD0201600)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwa Husein A., 2003, Phytopathologia Mediterranea, V42, P220; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; COLBY SR, 1967, WEEDS-U, V15, P20, DOI 10.2307/4041058; Csinos AS, 2002, CROP PROT, V21, P973, DOI 10.1016/S0261-2194(02)00077-7; De Cal A, 2004, PLANT DIS, V88, P210, DOI 10.1094/PDIS.2004.88.2.210; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Garcia-Mendez E, 2008, HORTSCIENCE, V43, P177, DOI 10.21273/HORTSCI.43.1.177; Giannakou IO, 2005, CROP PROT, V24, P499, DOI 10.1016/j.cropro.2004.09.007; Gilreath JP, 2006, CROP PROT, V25, P79, DOI 10.1016/j.cropro.2005.03.007; Gilreath JP, 2004, CROP PROT, V23, P347, DOI 10.1016/j.cropro.2003.09.006; Guo MX, 2005, PEST MANAG SCI, V61, P467, DOI 10.1002/ps.960; Hernandes I, 2017, ACTA AGR SCAND B S P; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Larson K.D., 1998, ANN INT RES C METH B; Liu W, 2000, PLANT PATHOGENIC NEM, P373; Liu XM, 2015, CHEMOSPHERE, V139, P379, DOI 10.1016/j.chemosphere.2015.07.034; Lopez-Aranda JM, 2009, HORTTECHNOLOGY, V19, P187, DOI 10.21273/HORTSCI.19.1.187; Mao LG, 2016, J INTEGR AGR, V15, P145, DOI 10.1016/S2095-3119(15)61065-6; Mao LG, 2012, PEST MANAG SCI, V68, P602, DOI 10.1002/ps.2303; Mao LG, 2014, J AGR FOOD CHEM, V62, P4864, DOI 10.1021/jf501255w; MBTOC, 2010, REP METH BROM TECHN, P72; MBTOC, 2006, REP METH BROM TECHN, P101; McKinney HH, 1923, J AGRIC RES, V26, P0195; Nelson SD, 2002, HORTSCIENCE, V37, P1057, DOI 10.21273/HORTSCI.37.7.1057; Peng D, 2014, PEST MANAG SCI, V70, P258, DOI 10.1002/ps.3551; Qiao K, 2011, J AGR FOOD CHEM, V59, P2362, DOI 10.1021/jf104553f; Santos BM, 2006, CROP PROT, V25, P690, DOI 10.1016/j.cropro.2005.09.015; Thomson W. T., 1992, AGR CHEM, P206; Van Wambeke E, 2009, Commun Agric Appl Biol Sci, V74, P75; Van Wambeke E, 2007, Commun Agric Appl Biol Sci, V72, P61; Wang QX, 2013, CROP PROT, V48, P24, DOI 10.1016/j.cropro.2013.02.002; Yates SR, 2002, PHYTOPATHOLOGY, V92, P1344, DOI 10.1094/PHYTO.2002.92.12.1344; Zheng W, 2004, J AGR FOOD CHEM, V52, P3002, DOI 10.1021/jf0498564	34	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188137	10.1371/journal.pone.0188137	http://dx.doi.org/10.1371/journal.pone.0188137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145472	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800074
J	Silveira, LJ; Strand, M; Van Dyke, MV; Mroz, MM; Faino, AV; Dabelea, DM; Maier, LA; Fingerlin, TE				Silveira, Lori J.; Strand, Matthew; Van Dyke, Michael V.; Mroz, Margaret M.; Faino, Anna V.; Dabelea, Dana M.; Maier, Lisa A.; Fingerlin, Tasha E.			Clinical tool for disease phenotyping in granulomatous lung disease	PLOS ONE			English	Article							CHRONIC BERYLLIUM DISEASE; CYSTIC-FIBROSIS; SEVERITY; HLA-DPB1; RISK; SENSITIZATION; POLYMORPHISMS; EXPOSURE; WORKERS	Background Exposure to beryllium may lead to granuloma formation and fibrosis in those who develop chronic beryllium disease (CBD). Although disease presentation varies from mild to severe, little is known about CBD phenotypes. This study characterized CBD disease phenotypes using longitudinal measures of lung function. Methods Using a case-only study of 207 CBD subjects, subject-specific trajectories over time were estimated from longitudinal pulmonary function and exercise-tolerance tests. To estimate linear combinations of the 30-year values that define underlying patterns of lung function, we conducted factor analysis. Cluster analysis was then performed on all the predicted lung function values at 30 years. These estimates were used to identify underlying features and subgroups of CBD. Results Two factors, or composite measures, explained nearly 70% of the co-variation among the tests; one factor represented pulmonary function in addition to oxygen consumption and workload during exercise, while the second factor represented exercise tests related to gas exchange. Factors were associated with granulomas on biopsy, exposure, steroid use and lung inflammation. Three clusters of patients (n = 53, n = 59 and, n = 95) were identified based on the collection of test values. Lower levels of each of the factor composite scores and cluster membership were associated with baseline characteristics of patients. Conclusions Using factor analysis and cluster analysis, we identified disease phenotypes that were associated with baseline patient characteristics, suggesting that CBD is a heterogeneous disease with varying severity. These clinical tools may be used in future basic and clinical studies to help define the mechanisms and risk factors for disease severity.	[Silveira, Lori J.; Strand, Matthew; Faino, Anna V.] Natl Jewish Hlth, Div Biostat & Informat, Denver, CO USA; [Silveira, Lori J.; Strand, Matthew; Dabelea, Dana M.; Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA; [Van Dyke, Michael V.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Mroz, Margaret M.; Maier, Lisa A.] Natl Jewish Hlth, Div Environm & Occupat Hlth, Denver, CO USA; [Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Fingerlin, Tasha E.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA	National Jewish Health; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado Department of Public Health & Environment; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Fingerlin, TE (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (corresponding author), Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA.	mrozp@njhealth.org; maieril@njhealth.org; fingerlint@njhealth.org	Strand, Matt/AAU-3762-2021; Maier, Lisa/AAA-4378-2020	Strand, Matt/0000-0002-9083-5989; 	National Institute of Environmental Health Sciences [P01 ES11810-A1]; Colorado Clinical and Translational Sciences Institute; National Institutes of Health/National Center for Advancing Translational Sciences [UL1 TR000154]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Colorado Clinical and Translational Sciences Institute; National Institutes of Health/National Center for Advancing Translational Sciences	This work was supported by National Institute of Environmental Health Sciences Grant number P01 ES11810-A1 (to LAM) and by the Colorado Clinical and Translational Sciences Institute, which was supported in part by National Institutes of Health/National Center for Advancing Translational Sciences Grant number UL1 TR000154 to the Colorado Clinical and Translational Science Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SASSTAT 9 2 USER S G; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Deubner D, 2001, Appl Occup Environ Hyg, V16, P579; Kumar M, 2007, COMPUT STAT DATA AN, V51, P6084, DOI 10.1016/j.csda.2006.12.012; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Mack DG, 2010, AM J RESP CRIT CARE, V181, P1241, DOI 10.1164/rccm.201001-0025OC; Maier LA, 1999, AM J RESP CRIT CARE, V159, P1342, DOI 10.1164/ajrccm.159.4.9806106; McCanlies EC, 2003, AM J EPIDEMIOL, V157, P388, DOI 10.1093/aje/kwg001; McCarthy C, 2013, CHEST, V143, P1358, DOI 10.1378/chest.12-2022; Mroz MM, 2009, AM J IND MED, V52, P762, DOI 10.1002/ajim.20736; NEWMAN LS, 1994, AM J RESP CRIT CARE, V150, P135, DOI 10.1164/ajrccm.150.1.8025739; NEWMAN LS, 1992, AM REV RESPIR DIS, V146, P39, DOI 10.1164/ajrccm/146.1.39; Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009; PAPPAS GP, 1993, AM REV RESPIR DIS, V148, P661, DOI 10.1164/ajrccm/148.3.661; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Rodrigues EG, 2008, AM J IND MED, V51, P512, DOI 10.1002/ajim.20585; Rossman MD, 2009, AM J RESP CRIT CARE, V179, P173, DOI 10.1164/ajrccm.179.2.173a; Rummel R., UNDERSTANDING FACTOR; Sarcoidosis, 2011, MED CLIN N AM; Sato H, 2010, EUR RESPIR J, V36, P331, DOI 10.1183/09031936.00107809; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Schuler CR, 2012, SCAND J WORK ENV HEA, V38, P270, DOI 10.5271/sjweh.3192; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; Tinkle SS, 2003, SEMIN RESP CRIT CARE, V24, P169, DOI 10.1055/s-2003-39016; Van Dyke MV, 2011, OCCUP ENVIRON MED, V68, P842, DOI 10.1136/oem.2010.064220; Van Dyke MV, 2011, AM J RESP CRIT CARE, V183, P1680, DOI 10.1164/rccm.201002-0254OC; Wasfi YS, 2006, CHEST, V129, P1234, DOI 10.1378/chest.129.5.1234	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188119	10.1371/journal.pone.0188119	http://dx.doi.org/10.1371/journal.pone.0188119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145499	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800067
J	Gromnitza, S; Lepa, C; Weide, T; Schwab, A; Pavenstadt, H; George, B				Gromnitza, Sascha; Lepa, Carolin; Weide, Thomas; Schwab, Albrecht; Pavenstaedt, Hermann; George, Britta			Tropomyosin-related kinase C (TrkC) enhances podocyte migration by ERK-mediated WAVE2 activation	FASEB JOURNAL			English	Article						actin cytoskeleton; signaling; tyrosine kinase; neurotrophin-3	TYROSINE KINASE; ARP2/3 COMPLEX; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-DISTRIBUTION; ACTIN POLYMERIZATION; REGULATORY COMPLEX; CELL-MIGRATION; FOOT PROCESSES; RECEPTORS; PHOSPHORYLATION	Podocyte malfunction is central to glomerular diseases and is marked by defective podocyte intercellular junctions and actin cytoskeletal dynamics. Podocytes share many morphologic features with neurons, so that similar sets of proteins appear to regulate cell process formation. One such protein is the tropomyosin-related kinase C (TrkC). TrkC deficiency inmice leads to proteinuria as a surrogate of defective kidney filter function. Activation of endogenous TrkC by its ligand neurotrophin-3 resulted in increased podocyte migration-a surrogate of podocyte actin dynamics in vivo. Employing a mutagenesis approach, we found that the Src homologous and collagen-like (Shc) binding site Tyr(516) within the TrkC cytoplasmic domain was necessary for TrkC-induced migration of podocytes. TrkC activation led to a mobility shift of Wiskott-Aldrich syndrome family verprolin-homologous protein (WAVE)-2which is knownto orchestrate Arp2/3 activation and actin polymerization. Chemical inactivation of Erk ormutagenesis of 2 of 4 knownErk target siteswithinWAVE2, Thr(346) and Ser(351), abolishedthe TrkC-induced WAVE2 mobility shift. Knockdown of WAVE2 by shRNA abolished TrkC-induced podocyte migration. In summary, TrkC signals to the podocyte actin cytoskeleton to induce migration by phosphorylating WAVE2 Erk dependently. This signaling mechanism may be important for TrkC-mediated cytoskeletal dynamics in podocyte disease.	[Gromnitza, Sascha; Lepa, Carolin; Weide, Thomas; Pavenstaedt, Hermann; George, Britta] Univ Klinikum Munster, Med Klin D, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Schwab, Albrecht] Westfal Wilhelms Univ Munster, Inst Physiol 2, Munster, Germany	University of Munster; University of Munster	George, B (corresponding author), Univ Klinikum Munster, Med Klin D, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	britta.george@ukmuenster.de	George, Britta/AAL-2031-2021	Hoppe, Sascha/0000-0001-9246-3747; George, Britta/0000-0001-5430-5086	Deutsche Nierenstiftung; Zentrum fur Klinische Forschung [Geo2/003/16]; Deutsche Forschungsgemeinschaft [GE 2158/3-1, SCHW 407/17]; Cells-in-Motion Cluster of Excellence (University of Munster) [EXC 1003-CiM]	Deutsche Nierenstiftung; Zentrum fur Klinische Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cells-in-Motion Cluster of Excellence (University of Munster)	The authors thank Moses Chao (New York University School of Medicine, New York, NY, USA) for providing TrkC plasmids. This work was supported by grants from Deutsche Nierenstiftung (to B.G.), Zentrum fur Klinische Forschung Grant Geo2/003/16 (to B.G.), Deutsche Forschungsgemeinschaft Grants GE 2158/3-1 (to B.G.) and SCHW 407/17 (to A.S.), and Cells-in-Motion Cluster of Excellence (University of Munster) Grant EXC 1003-CiM (to A.S.). The authors declare no conflicts of interest. This article contains parts of the PhD. thesis of S.G., and the M.Sc. thesis of C.L.	Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Dudanova I, 2013, TRENDS NEUROSCI, V36, P295, DOI 10.1016/j.tins.2013.01.007; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gloy J, 2000, AM J PHYSIOL-RENAL, V278, pF999, DOI 10.1152/ajprenal.2000.278.6.F999; GUITON M, 1995, J BIOL CHEM, V270, P20384, DOI 10.1074/jbc.270.35.20384; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mendoza MC, 2013, SEMIN CELL DEV BIOL, V24, P272, DOI 10.1016/j.semcdb.2013.01.007; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mojallal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5557; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakanishi O, 2007, J BIOCHEM, V141, P319, DOI 10.1093/jb/mvm034; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; PHILO J, 1994, J BIOL CHEM, V269, P27840; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schell C, 2013, J AM SOC NEPHROL, V24, P713, DOI 10.1681/ASN.2012080844; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schwab A, 2006, J CELL PHYSIOL, V206, P86, DOI 10.1002/jcp.20434; Scott RP, 2012, J AM SOC NEPHROL, V23, P1149, DOI 10.1681/ASN.2011121206; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Sitek B, 2005, MOL CELL PROTEOMICS, V4, P291, DOI 10.1074/mcp.M400188-MCP200; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tapia R, 2008, KIDNEY INT, V73, P733, DOI 10.1038/sj.ki.5002726; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Weide T, 2009, J AM SOC NEPHROL, V20, P1862, DOI 10.1681/ASN.2009070691; Wennmann DO, 2014, MOL BIOL EVOL, V31, P1710, DOI 10.1093/molbev/msu115; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	49	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1665	1676		10.1096/fj.201700703R	http://dx.doi.org/10.1096/fj.201700703R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29162704				2022-12-26	WOS:000427246000043
J	Kansaku, K; Takeo, S; Itami, N; Kin, A; Shirasuna, K; Kuwayama, T; Iwata, H				Kansaku, Kazuki; Takeo, Shun; Itami, Nobuhiko; Kin, Airi; Shirasuna, Koumei; Kuwayama, Takehito; Iwata, Hisataka			Maternal aging affects oocyte resilience to carbonyl cyanide-m-chlorophenylhydrazone-induced mitochondrial dysfunction in cows	PLOS ONE			English	Article							DNA COPY NUMBER; DEVELOPMENTAL COMPETENCE; BOVINE OOCYTES; IN-VITRO; AGE; MATURATION; FERTILIZATION; RESVERATROL; BIOGENESIS; ACTIVATION	Mitochondrial quality control is important for maintaining cellular and oocyte viability. In addition, aging affects mitochondrial quality in many cell types. In the present study, we examined how aging affects oocyte mitochondrial biogenesis and degeneration in response to induced mitochondrial dysfunction. Cumulus oocyte complexes were harvested from the ovaries of young (21-45 months) and aged (>= 120 months) cows and treated for 2 hours with 10 mu M carbonyl cyanide-m-chlorophenylhydrazone (CCCP), or a vehicle control, after which cumulus oocyte complexes were subjected to in vitro fertilization and culture. CCCP treatment reduced ATP content and increased reactive oxygen species (ROS) levels in the oocytes of both young and aged cows. When CCCP-treated cumulus oocyte complexes were subsequently cultured for 19 hours and/or subjected to fertilization, high ROS levels in oocytes and a low rate of blastocyst development was observed in oocytes derived from aged cows. In addition, we observed differential responses in mitochondrial biogenesis to CCCP treatment between young and aged cows. CCCP treatment enhanced mitochondrial biogenesis concomitant with upregulation of SIRT1 expression in oocytes of young, but not aged, cows. In conclusion, aging affects mitochondrial quality control and recuperation of oocytes following CCCP-induced mitochondrial dysfunction.	[Kansaku, Kazuki; Takeo, Shun; Itami, Nobuhiko; Kin, Airi; Shirasuna, Koumei; Kuwayama, Takehito; Iwata, Hisataka] Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan	Tokyo University of Agriculture	Iwata, H (corresponding author), Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan.	h1iwata@nodai.ac.jp	ITAMI, Nobuhiko/ABA-6806-2020	Iwata, HIsataka/0000-0001-7238-8997	JSPS KAKENHI [16K07996]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by JSPS KAKENHI (Grant number: 16K07996).	Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cheng EH, 2013, HUM REPROD, V28, P929, DOI 10.1093/humrep/det004; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Ge HS, 2012, MOL REPROD DEV, V79, P392, DOI 10.1002/mrd.22042; Itami N, 2015, REPRODUCTION, V150, P97, DOI 10.1530/REP-15-0037; Iwata H, 2011, REPROD FERT DEVELOP, V23, P424, DOI 10.1071/RD10133; Kalfalah F, 2014, EXP GERONTOL, V56, P59, DOI 10.1016/j.exger.2014.03.017; Kansaku K, 2017, DIFFERENTIA IN PRESS; Kujjo LL, 2013, MECH AGEING DEV, V134, P43, DOI 10.1016/j.mad.2012.12.001; Mitsui A, 2009, J ASSIST REPROD GEN, V26, P35, DOI 10.1007/s10815-008-9282-6; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pantos K, 1999, FERTIL STERIL, V71, P1144, DOI 10.1016/S0015-0282(99)00121-1; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rambags BPB, 2014, THERIOGENOLOGY, V81, P959, DOI 10.1016/j.theriogenology.2014.01.020; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Sato D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094488; Scholtes MCW, 1998, FERTIL STERIL, V69, P78, DOI 10.1016/S0015-0282(97)00450-0; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Simsek-Duran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064955; Sosulski ML, 2015, AGING CELL, V14, P774, DOI 10.1111/acel.12357; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; Takeo S, 2013, MOL REPROD DEV, V80, P508, DOI 10.1002/mrd.22187; Takeo S, 2015, THERIOGENOLOGY, V84, P490, DOI 10.1016/j.theriogenology.2015.03.013; Takeo S, 2014, J REPROD DEVELOP, V60, P92, DOI 10.1262/jrd.2013-102; Takeo S, 2013, J REPROD DEVELOP, V59, P174, DOI 10.1262/jrd.2012-148; Takeuchi T, 2005, BIOL REPROD, V72, P584, DOI 10.1095/biolreprod.104.032391; Tilly JL, 2013, CELL METAB, V17, P838, DOI 10.1016/j.cmet.2013.05.007; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Yamamoto T, 2010, MOL REPROD DEV, V77, P595, DOI 10.1002/mrd.21188; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	33	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188099	10.1371/journal.pone.0188099	http://dx.doi.org/10.1371/journal.pone.0188099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182624	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000009
J	Dario, MA; Lisboa, CV; Costa, LM; Moratelli, R; Nascimento, MP; Costa, LP; Leite, YLR; Llewellyn, MS; Xavier, SCD; Roque, ALR; Jansen, AM				Dario, Maria Augusta; Lisboa, Cristiane Varella; Costa, Luciana M.; Moratelli, Ricardo; Nascimento, Monique Pereira; Costa, Leonora Pires; Leite, Yuri Luiz Reis; Llewellyn, Martin S.; das Chagas Xavier, Samanta Cristina; Rodrigues Roque, Andre Luiz; Jansen, Ana Maria			High Trypanosoma spp. diversity is maintained by bats and triatomines in Espirito Santo state, Brazil	PLOS ONE			English	Article							OPOSSUM MONODELPHIS-DOMESTICA; BRUSH-TAILED BETTONG; ACUTE CHAGAS-DISEASE; MEGATRYPANUM MINASENSE; AUSTRALIAN MARSUPIALS; SYLVATIC MAMMALS; CRUZI CLADE; SSU RDNA; RANGELI; TRANSMISSION	The aim of this study was to reevaluate the ecology of an area in the Atlantic Forest, southeast Brazil, where Chagas disease (CD) has been found to occur. In a previous study, immediately after the occurrence of a CD case, we did not observe any sylvatic small mammals or dogs with Trypanosoma cruzi cruzi infections, but Triatoma vitticeps presented high T. c. cruzi infection rates. In this study, we investigated bats together with non-volant mammals, dogs, and triatomines to explore other possible T. c. cruzi reservoirs/hosts in the area. Seventy-three non-volant mammals and 186 bats were captured at three sites within the Guarapari municipality, Espirito Santo state. Rio da Prata and Amarelos sites exhibited greater richness in terms of non-volant mammals and bats species, respectively. The marsupial Metachirus nudicaudatus, the rodent Trinomys paratus, and the bats Artibeus lituratus and Carollia perspicillata were the most frequently captured species. As determined by positive hemocultures, only two non-volant mammals were found to be infected by Trypanosoma species: Monodelphis americana, which was infected by T. cascaveffi, T. dionisii and Trypanosoma sp., and Caffithrix geoffroyi, which was infected by T. minasense. Bats presented T. c. cruziTcl and TcIII/V, T. c. marinkellei, T. dionisii, T. rangeli B and D, and Trypanosoma sp. infections. Seven dogs were infected with T. cruzi based only on serological exams. The triatomines T. vitticeps and Panstrongylus geniculatus were found to be infected by trypanosomes via microscopy. According to molecular characterization, T. vitticeps specimens were infected with T. c. cruziTcl, Tcl I, TcIII/V, and TcIV, T. c. marinkellei and T. dionisii. We observed high trypanosome diversity in a small and fragmented region of the Atlantic Forest. This diversity was primarily maintained by bats and T. vitticeps. Our findings show that the host specificity of the Trypanosoma genus should be thoroughly reviewed. In addition, our data show that CD cases can occur without an enzootic cycle near residential areas.	[Dario, Maria Augusta; Lisboa, Cristiane Varella; das Chagas Xavier, Samanta Cristina; Rodrigues Roque, Andre Luiz; Jansen, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil; [Costa, Luciana M.] Univ Estado Rio de Janeiro, Lab Ecol Mamiferos, Rio De Janeiro, RJ, Brazil; [Moratelli, Ricardo] Fundacao Oswaldo Cruz, Fiocruz Mata Atlantica, Rio De Janeiro, RJ, Brazil; [Nascimento, Monique Pereira; Costa, Leonora Pires; Leite, Yuri Luiz Reis] Univ Fed Espirito Santo, Ctr Ciencias Humanas & Nat, Dept Ciencias Biol, Vitoria, ES, Brazil; [Llewellyn, Martin S.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo; University of Glasgow	Jansen, AM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil.	jansen@ioc.fiocruz.br	Costa, Leonora Pires/G-4259-2011; Pinto, Guilherme/AAT-5848-2021; Roque, André Luiz Rodrigues/W-7528-2019; Leite, Yuri/D-4667-2009; Moratelli, Ricardo/A-5735-2013; de Moraes Costa, Luciana/D-3414-2018	Costa, Leonora Pires/0000-0003-2625-3172; Leite, Yuri/0000-0002-0248-8738; Moratelli, Ricardo/0000-0003-0942-6633; de Moraes Costa, Luciana/0000-0001-8080-4954; Jansen, Ana Maria/0000-0001-5804-6210; Xavier, Samanta Cristina/0000-0002-3475-0075	Instuto Oswaldo Cruz (IOC/Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do estado do Rio de Janeiro (Faperj); Universidade Federal do Espirito Santo (Ufes); Fundacao de Amparo a Pesquisa do estado do Espirito Santo (Fapes); CNPq; Faperj-CAPES; CNPq ("Bolsista de Produtividade, nivel 1", CNPq); CNPq ("Bolsista de Produtividade, nivel 2", CNPq)	Instuto Oswaldo Cruz (IOC/Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Universidade Federal do Espirito Santo (Ufes); Fundacao de Amparo a Pesquisa do estado do Espirito Santo (Fapes); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq ("Bolsista de Produtividade, nivel 1", CNPq); CNPq ("Bolsista de Produtividade, nivel 2", CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Instuto Oswaldo Cruz (IOC/Fiocruz), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do estado do Rio de Janeiro (Faperj), Universidade Federal do Espirito Santo (Ufes) and Fundacao de Amparo a Pesquisa do estado do Espirito Santo (Fapes). A doctoral grant is provided by CNPq to MAD. A post-doctoral grant is provided to LMC by Faperj-CAPES. AMJ is a "Cientista do Nosso Estado", provided by Faperj and is financially supported by CNPq ("Bolsista de Produtividade, nivel 1", CNPq). YL and LPC are financially supported by CNPq ("Bolsista de Produtividade, nivel 2", CNPq). ALRR is a "Jovem Cientista do Nosso Estado" provided by Faperj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; ANDERSON JR, 1968, SCIENCE, V161, P1023, DOI 10.1126/science.161.3845.1023; Andrews S, 2016, FASTQC QUALITY CONTR; [Anonymous], 2011, SICKLE SLIDING WINDO; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Barbosa AD, 2016, VET PARASITOL, V223, P214, DOI 10.1016/j.vetpar.2016.05.002; Bernard Enrico, 2002, Rev. Bras. Zool., V19, P173, DOI 10.1590/S0101-81752002000100016; Borghesan TC, 2013, PROTIST, V164, P129, DOI 10.1016/j.protis.2012.06.001; Botero Adriana, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P77, DOI 10.1016/j.ijppaw.2013.03.001; Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792; Busse S, 2014, NATURWISSENSCHAFTEN, V101, P1003, DOI 10.1007/s00114-014-1226-7; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavazzana M, 2010, INT J PARASITOL, V40, P345, DOI 10.1016/j.ijpara.2009.08.015; Chinchilla Misael, 2005, Parasitologia Latinoamericana, V60, P90; Constantine D.G., 1967, ACTIVITY PATTERNS ME; Cottontail VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108603; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Da Silva FM, 2004, PARASITOLOGY, V129, P549, DOI 10.1017/S0031182004005931; Da Silva FM, 2004, PARASITOLOGY, V128, P283, DOI 10.1017/S0031182003004554; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Dario MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005790; Dario MA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1754-4; Xavier SCD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002878; Xavier SCD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001647; DAWSON TJ, 1988, COMP BIOCHEM PHYS A, V89, P85, DOI 10.1016/0300-9629(88)91143-7; Deane L.M., 1974, Revista Inst Med trop Sao Paulo, V16, P1; DEANE M P, 1986, Memorias do Instituto Oswaldo Cruz, V81, P131; DERESENDE DM, 1994, MEM I OSWALDO CRUZ, V89, P127, DOI 10.1590/S0074-02761994000100025; dos Santos CB, 2006, REV SOC BRAS MED TRO, V39, P89, DOI 10.1590/S0037-86822006000100019; DUNN FL, 1963, AM J TROP MED HYG, V12, P524, DOI 10.4269/ajtmh.1963.12.524; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferreira JIGS, 2017, ACTA TROP, V176, P249, DOI 10.1016/j.actatropica.2017.08.018; Findley J.S., 1993, BATS COMMUNITY PERSP; Martinez MF, 2016, INT J PARASITOL-PAR, V5, P198, DOI 10.1016/j.ijppaw.2016.05.001; Galvao Cleber, 2003, Zootaxa, V202, P1; Garcia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036578; Gardner A.L., 2008, MAMMALS S AM MARSUPI; GARDNER RA, 1988, PARASITOLOGY, V96, P433, DOI 10.1017/S0031182000080082; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Guhl F, 2003, MEM I OSWALDO CRUZ, V98, P435, DOI 10.1590/S0074-02762003000400001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamilton PB, 2009, INFECT GENET EVOL, V9, P81, DOI 10.1016/j.meegid.2008.10.011; Hamilton PB, 2012, TRENDS PARASITOL, V28, P136, DOI 10.1016/j.pt.2012.01.006; Herrera L, 2005, T ROY SOC TROP MED H, V99, P379, DOI 10.1016/j.trstmh.2004.07.006; Hoare C, 1972, TRYPANOSOMES MAMMALS; Jansen AM, 2002, ANIMAIS LABORATORIO, P166; Jansen AM, 2015, ACTA TROP, V151, P1, DOI 10.1016/j.actatropica.2015.07.018; Jansen AM, 2010, ELSEV INSIGHT, P249, DOI 10.1016/B978-0-12-384876-5.00011-3; Kalko, 2002, P WORKSH ID AC MON B, P63; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lent H, 1979, B AM MUS NAT HIST, V163, P496; Lima L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1255-x; Lima L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-221; Lima L, 2012, PROTIST, V163, P856, DOI 10.1016/j.protis.2011.12.003; Lisboa CV, 2015, MEM I OSWALDO CRUZ, V110, P394, DOI 10.1590/0074-02760140400; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marcili A, 2013, J PARASITOL, V99, P1071, DOI 10.1645/12-156.1; MARINKELLE CJ, 1982, REV BIOL TROP, V30, P107; Mayorga S, 2015, PLOS ONE, V10; McCracken G.F., 2003, MONITORING TRENDS BA, P21, DOI DOI 10.3996/122016-JFWM-093.S3; Mendes Poliana, 2010, Pap. Avulsos Zool. (São Paulo), V50, P363, DOI 10.1590/S0031-10492010002200001; MINTERGOEDBLOED E, 1993, PARASITOL RES, V79, P329, DOI 10.1007/BF00932190; Moreira Danielle de Oliveira, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000200017; Noyes HA, 1999, INT J PARASITOL, V29, P331, DOI 10.1016/S0020-7519(98)00167-2; Paglia A.P., 2012, ANNOTATED CHECKLIST; Paparini A, 2011, VET PARASITOL, V183, P21, DOI 10.1016/j.vetpar.2011.07.009; Patton J.L., 2015, MAMMALS S AM, V2; PESSOA S B, 1972, Atas da Sociedade de Biologia do Rio de Janeiro, V15, P67; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REGO S. F. M., 1957, REV BRASIL MALARIOL E DOENCAS TROP, V9, P277; Ronald M Nowak, 1994, WALKERS BATS WORLD; Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483; Sato H, 2008, J PARASITOL, V94, P1128, DOI 10.1645/GE-1513.1; SCHMIDT U, 1973, Zeitschrift fuer Saeugetierkunde, V38, P14; Smith A, 2008, PARASITOLOGY, V135, P1329, DOI 10.1017/S0031182008004824; SOUSA OE, 1974, AM J TROP MED HYG, V23, P862, DOI 10.4269/ajtmh.1974.23.862; SOUSA OE, 1976, AM J TROP MED HYG, V25, P407, DOI 10.4269/ajtmh.1976.25.407; STEINDEL M, 1994, J EUKARYOT MICROBIOL, V41, P261, DOI 10.1111/j.1550-7408.1994.tb01506.x; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 1999, INT J PARASITOL, V29, P749, DOI 10.1016/S0020-7519(99)00016-8; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Telford Jr SR, 1995, PARASIT PROTOZ, P161; Tenorio MS, 2014, VET PARASITOL, V203, P203, DOI 10.1016/j.vetpar.2014.02.010; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Vickerman K., 1976, P1; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Viola LB, 2008, PARASITOLOGY, V135, P595, DOI 10.1017/S0031182008004253; Viola LB, 2009, J EUKARYOT MICROBIOL, V56, P594, DOI 10.1111/j.1550-7408.2009.00444.x; Wilkinson GS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0095; WILKINSON GS, 1986, ANIM BEHAV, V34, P1880, DOI 10.1016/S0003-3472(86)80274-3; Ziccardi M, 1999, MEM I OSWALDO CRUZ, V94, P649, DOI 10.1590/S0074-02761999000500016; Ziccardi M, 2000, MEM I OSWALDO CRUZ, V95, P157, DOI 10.1590/S0074-02762000000200004; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	96	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188412	10.1371/journal.pone.0188412	http://dx.doi.org/10.1371/journal.pone.0188412			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176770	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900073
J	Gaiser, MR; Skorokhod, A; Gransheier, D; Weide, B; Koch, W; Schif, B; Enk, A; Garbe, C; Bauer, J				Gaiser, Maria Rita; Skorokhod, Alexander; Gransheier, Diana; Weide, Benjamin; Koch, Winfried; Schif, Birgit; Enk, Alexander; Garbe, Claus; Bauer, Juergen			Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma	PLOS ONE			English	Article							CUTANEOUS MELANOMA; V600E; SURVIVAL; NEVI	Background The incidence of melanoma, particularly in older patients, has steadily increased over the past few decades. Activating mutations of BRAF, the majority occurring in BRAFV600, are frequently detected in melanoma; however, the prognostic significance remains unclear. This study aimed to define the probability and distribution of BRAFV600 mutations, and the clinico-pathological factors that may affect BRAF mutation status, in patients with advanced melanoma using next-generation sequencing. Materials and methods This was a non-interventional, retrospective study of BRAF mutation testing at two German centers, in Heidelberg and Tu E bingen. Archival tumor samples from patients with histologically confirmed melanoma (stage IIIB, IIIC, IV) were analyzed using PCR amplification and deep sequencing. Clinical, histological, and mutation data were collected. The statistical influence of patient-and tumor-related characteristics on BRAFV600 mutation status was assessed using multiple logistic regression (MLR) and a prediction profiler. Results BRAFV600 mutation status was assessed in 453 samples. Mutations were detected in 57.6% of patients (n = 261), with 48.1% (n = 102) at the Heidelberg site and 66.0% (n = 159) at the Tu E bingen site. The decreasing influence of increasing age on mutation probability was quantified. A main effects MLR model identified age (p = 0.0001), center (p = 0.0004), and melanoma subtype (p = 0.014) as significantly influencing BRAFV600 mutation probability; ultraviolet (UV) exposure showed a statistical trend (p = 0.1419). An interaction model of age versus other variables showed that center (p< 0.0001) and melanoma subtype (p = 0.0038) significantly influenced BRAF mutation probability; age had a statistically significant effect only as part of an interaction with both UV exposure (p = 0.0110) and melanoma subtype (p = 0.0134). Conclusions This exploratory study highlights that testing center, melanoma subtype, and age in combination with UV exposure and melanoma subtype significantly influence BRAFV600 mutation probability in patients with melanoma. Further validation of this model, in terms of reproducibility and broader relevance, is required.	[Gaiser, Maria Rita; Skorokhod, Alexander; Enk, Alexander] Heidelberg Univ Hosp, Dept Dermatol, Heidelberg, Germany; [Gaiser, Maria Rita] Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Gransheier, Diana; Weide, Benjamin; Garbe, Claus; Bauer, Juergen] Univ Med Ctr Tubingen, Dept Dermatol, Tubingen, Germany; [Koch, Winfried] BDS Koch, Schwetzingen, Germany; [Schif, Birgit] Roche Pharma AG, Grenzach Wyhlen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Roche Holding	Gaiser, MR (corresponding author), Heidelberg Univ Hosp, Dept Dermatol, Heidelberg, Germany.; Gaiser, MR (corresponding author), Ruprecht Karl Univ Heidelberg, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany.	maria.gaiser@umm.de	Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021	Garbe, Claus/0000-0001-8530-780X	Roche Pharma AG, Grenzach-Wyhlen, Germany	Roche Pharma AG, Grenzach-Wyhlen, Germany(Roche Holding)	This work was supported by Roche Pharma AG, Grenzach-Wyhlen, Germany. The funder provided support in the form of salaries for one author (BS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. The specific role of this author is articulated in the Author "Contributions" section.	Ardekani GS, 2013, BRIT J DERMATOL, V169, P320, DOI 10.1111/bjd.12351; Berwick M, 2009, DERMATOL CLIN, V27, P205, DOI 10.1016/j.det.2008.12.002; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dummer R, 2015, ANN ONCOL, V26, pV126, DOI 10.1093/annonc/mdv297; Hartmann A, 2016, 31 INT C IAP 28 C ES; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heinzerling L, 2013, BRIT J CANCER, V108, P2164, DOI 10.1038/bjc.2013.143; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Indsto JO, 2007, J CUTAN PATHOL, V34, P448, DOI 10.1111/j.1600-0560.2006.00646.x; Jakob John A, 2012, Cancer, V118, P4014, DOI 10.1002/cncr.26724; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Meckbach D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086194; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; RIGEL DS, 1989, CANCER, V63, P386, DOI 10.1002/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO;2-6; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Saldanha G, 2006, CLIN CANCER RES, V12, P4499, DOI 10.1158/1078-0432.CCR-05-2447; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Skorokhod A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059221; Skorokhod A, 2012, J AM ACAD DERMATOL, V67, P488, DOI 10.1016/j.jaad.2012.03.022; The National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Ugurel S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000236	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188602	10.1371/journal.pone.0188602	http://dx.doi.org/10.1371/journal.pone.0188602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176861	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900106
J	Reyes-Corona, D; Vazquez-Hernandez, N; Escobedo, L; Orozco-Barrios, CE; Ayala-Davila, J; Moreno, MG; Amaro-Lara, ME; Flores-Martinez, YM; Espadas-Alvarez, AJ; Fernandez-Parrilla, MA; Gonzalez-Barrios, JA; Gutierrez-Castillo, ME; Gonzalez-Burgos, I; Martinez-Fong, D				Reyes-Corona, David; Vazquez-Hernandez, Nallely; Escobedo, Lourdes; Orozco-Barrios, Carlos E.; Ayala-Davila, Jose; Gil Moreno, Mario; Amaro-Lara, Miriam E.; Flores-Martinez, Yazmin M.; Espadas-Alvarez, Armando J.; Fernandez-Parrilla, Manuel A.; Gonzalez-Barrios, Juan A.; Gutierrez-Castillo, M. E.; Gonzalez-Burgos, Ignacio; Martinez-Fong, Daniel			Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion	PLOS ONE			English	Article							ADULT SUBSTANTIA-NIGRA; AFFINITY NEUROTENSIN RECEPTOR; NEUROTROPHIC FACTOR GDNF; PARKINSONS-DISEASE; GENE-TRANSFER; AXONAL-TRANSPORT; DENDRITIC SPINES; NERVOUS-SYSTEM; STRIATAL DELIVERY; FAMILY LIGANDS	The structural effect of neurturin (NRTN) on the nigrostriatal dopaminergic system in animals remains unknown, although NRTN has been shown to be effective in Parkinson's disease animal models. Herein, we aimed to demonstrate that NRTN overexpression in dopaminergic neurons stimulates both neurite outgrowths in the nigrostriatal pathway and striatal dendritic spines in aging rats with chronic 6-hydroxydopamine (6-OHDA) lesion. At week 12 after lesion, pTracer-mNRTN-His or pGreenLantern-1 plasmids were intranigrally transfected using the NTS-polyplex nanoparticles system. We showed that the transgenic expression in dopaminergic neurons remained until the end of the study (12 weeks). Only animals expressing NRTN-His showed recovery of tyrosine hydroxylase (TH)+ cells (28 +/- 2%), their neurites (32 +/- 2%) and the neuron-specific cytoskeletal marker beta-III-tubulin in the substantia nigra; striatal TH(+) fibers were also recovered (52 +/- 3%), when compared to the healthy condition. Neurotensin receptor type 1 levels were also significantly recovered in the substantia nigra and striatum. Dopamine recovery was 70 +/- 4% in the striatum and complete in the substantia nigra. The number of dendritic spines of striatal medium spiny neurons was also significantly increased, but the recovery was not complete. Drug-activated circling behavior decreased by 73 +/- 2% (methamphetamine) and 89 +/- 1% (apomorphine). Similar decrease was observed in the spontaneous motor behavior. Our results demonstrate that NRTN causes presynaptic and postsynaptic restoration of the nigrostriatal dopaminergic system after a 6-OHDA-induced chronic lesion. However, those improvements did not reach the healthy condition, suggesting that NRTN exerts lesser neurotrophic effects than other neurotrophic approaches.	[Reyes-Corona, David; Escobedo, Lourdes; Ayala-Davila, Jose; Amaro-Lara, Miriam E.; Flores-Martinez, Yazmin M.; Espadas-Alvarez, Armando J.; Fernandez-Parrilla, Manuel A.; Martinez-Fong, Daniel] Ctr Invest & Estudios Avanzados, Dept Fis Biofis & Neurociencias, Mexico City, DF, Mexico; [Vazquez-Hernandez, Nallely; Gonzalez-Burgos, Ignacio] Ctr Invest Biomed Occidente, IMSS, Div Neurociencias, Lab Psicobiol, Guadalajara, Jalisco, Mexico; [Orozco-Barrios, Carlos E.] Natl Med Ctr Siglo XXI, IMSS, CONACYT Med Res Unit Neurol Dis, Mexico City, DF, Mexico; [Gil Moreno, Mario] Ctr Invest & Estudios Avanzados, Dept Farmacol, Lab Neurobiol Apetito, Mexico City, DF, Mexico; [Gonzalez-Barrios, Juan A.] Hosp Reg 1 Octubre, ISSSTE, Lab Med Genom, Mexico City, DF, Mexico; [Gutierrez-Castillo, M. E.] Inst Politecn Nacl, Ctr Interdisciplinario Invest & Estudio Medio Amb, Dept Biociencias & Ingn, Mexico City, DF, Mexico; [Martinez-Fong, Daniel] Ctr Invest & Estudios Avanzados, Programa Doctorado Nanociencias & Nanotecnol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Mexicano del Seguro Social; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Martinez-Fong, D (corresponding author), Ctr Invest & Estudios Avanzados, Dept Fis Biofis & Neurociencias, Mexico City, DF, Mexico.	martinez.fong@gmail.com		Ayala-Davila, Jose/0000-0002-1865-3662; Fernandez-Parrilla, Manuel A/0000-0001-8225-9283; Espadas, Armando J/0000-0002-5776-9713; Orozco-Barrios, Carlos E./0000-0002-3989-1205; Reyes-Corona, David/0000-0001-6521-661X; Gutierrez-Castillo, Maria Eugenia/0000-0002-1316-0244	Mexican National Council of Science and Technology (Conacyt) [254686]; Finnova from the Mexican National Council of Science and Technology (Conacyt) [224222]	Mexican National Council of Science and Technology (Conacyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Finnova from the Mexican National Council of Science and Technology (Conacyt)	This work was supported by Grants #254686 to DM-F and Finnova #224222 from the Mexican National Council of Science and Technology (Conacyt), http://www.conacyt.mx/	Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akerud P, 1999, J NEUROCHEM, V73, P70, DOI 10.1046/j.1471-4159.1999.0730070.x; Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Anaya-Martinez V, 2006, NEUROSCIENCE, V143, P477, DOI 10.1016/j.neuroscience.2006.08.033; Andressoo JO, 2008, CURR OPIN NEUROBIOL, V18, P297, DOI 10.1016/j.conb.2008.07.005; Anstrom KK, 2007, BEHAV BRAIN RES, V179, P183, DOI 10.1016/j.bbr.2007.01.028; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Barroso-Chinea P, 2005, EUR J NEUROSCI, V21, P1815, DOI 10.1111/j.1460-9568.2005.04024.x; Bartus RT, 2014, MOL THER, V22, P487, DOI 10.1038/mt.2013.281; Bartus RT, 2012, NEUROBIOL DIS, V48, P153, DOI 10.1016/j.nbd.2012.04.004; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Bizon JL, 1999, J COMP NEUROL, V408, P283; Cass WA, 2010, NEUROCHEM INT, V57, P540, DOI 10.1016/j.neuint.2010.06.019; Castillo-Rodriguez RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097151; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cho J, 2004, DEV BRAIN RES, V148, P143, DOI 10.1016/j.devbrainres.2003.11.006; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Orozco-Barrios CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008268; Espadas-Alvarez AJ, 2017, NANOMED-NANOTECHNOL, V13, P1363, DOI 10.1016/j.nano.2017.02.006; FERIA-VELASCO A, 1970, Archivos de Investigacion Medica, V1, P201; Ferraro L, 2014, CURR PROTEIN PEPT SC, V15, P681, DOI 10.2174/1389203715666140901105253; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Gasmi M, 2007, MOL THER, V15, P62, DOI 10.1038/sj.mt.6300010; Burgos IG, 2009, DENDRITIC SPINES: BIOCHEMISTRY, MODELING AND PROPERTIES, P163; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Gonzalez-Burgos I, 2012, BRAIN COGNITION, V80, P177, DOI 10.1016/j.bandc.2012.03.002; GONZALEZBURGOS I, 1992, BIOTECH HISTOCHEM, V67, P288, DOI 10.3109/10520299209110037; Hadaczek P, 2010, NEUROPHARMACOLOGY, V58, P1114, DOI 10.1016/j.neuropharm.2010.02.002; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; HARRIS KM, 1989, NEUROL NEUR, V52, P33; Hernandez ME, 2014, NANOMED-NANOTECHNOL, V10, P745, DOI 10.1016/j.nano.2013.11.013; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hernandez-Baltazar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051341; Hernandez-Chan NG, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0166-7; Herzog CD, 2013, NEUROBIOL DIS, V58, P38, DOI 10.1016/j.nbd.2013.04.011; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hickey P, 2013, EXPERT OPIN BIOL TH, V13, P137, DOI 10.1517/14712598.2013.754420; Hiltunen PH, 2004, MOL CELL NEUROSCI, V26, P450, DOI 10.1016/j.mcn.2004.04.003; Holm PC, 2002, J NEUROCHEM, V81, P1318, DOI 10.1046/j.1471-4159.2002.00926.x; Horger BA, 1998, J NEUROSCI, V18, P4929; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Kordower JH, 2006, ANN NEUROL, V60, P706, DOI 10.1002/ana.21032; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lie DC, 2002, J NEUROSCI, V22, P6639; Lindholm D, 2016, CELL MOL LIFE SCI, V73, P1365, DOI 10.1007/s00018-015-2101-1; Liu WG, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-19; Ordonez-Librado JL, 2010, NEUROSCI LETT, V471, P79, DOI 10.1016/j.neulet.2010.01.015; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; MARTINEZFONG D, 1992, BRAIN RES, V595, P309, DOI 10.1016/0006-8993(92)91065-M; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Olanow CW, 2015, ANN NEUROL, V78, P248, DOI 10.1002/ana.24436; Parkash V, 2009, ACTA CRYSTALLOGR F, V65, P551, DOI 10.1107/S1744309109017722; Perez-Navarro E, 2000, NEUROSCIENCE, V98, P89, DOI 10.1016/S0306-4522(00)00074-9; Razgado-Hernandez LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117391; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Runeberg-Roos P, 2016, NEUROBIOL DIS, V96, P335, DOI 10.1016/j.nbd.2016.07.008; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; SADOUL JL, 1984, BIOCHEM BIOPH RES CO, V125, P395, DOI 10.1016/S0006-291X(84)80381-2; Sarabi A, 2001, J COMP NEUROL, V441, P106, DOI 10.1002/cne.1400; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Schueler-Furman O, 2006, TRENDS PHARMACOL SCI, V27, P72, DOI 10.1016/j.tips.2005.12.004; SCHWARTZ JH, 1979, ANNU REV NEUROSCI, V2, P467, DOI 10.1146/annurev.ne.02.030179.002343; SHOLL DA, 1953, J ANAT, V87, P387; Sidorova Y.A., 2016, [Молекулярная биология, Molekulyarnaya biologiya], V50, P589, DOI 10.7868/S0026898416040108; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Steiner B, 2006, EXP NEUROL, V199, P291, DOI 10.1016/j.expneurol.2005.11.004; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tarelo-Acuna L, 2000, NEUROSCI LETT, V286, P13, DOI 10.1016/S0304-3940(00)01075-2; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Vigers AJ, 2012, NEUROSCIENCE, V212, P1, DOI 10.1016/j.neuroscience.2012.03.031; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; Wang LC, 2000, J NEUROSCI RES, V61, P1; Wang XQ, 2013, BBA-PROTEINS PROTEOM, V1834, P2205, DOI 10.1016/j.bbapap.2012.10.008; Wanigasekara Y, 2004, MOL CELL NEUROSCI, V25, P288, DOI 10.1016/j.mcn.2003.10.019; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Woodlee MT, 2008, EXP NEUROL, V211, P511, DOI 10.1016/j.expneurol.2008.02.024; Worlitzer MMA, 2013, EUR J NEUROSCI, V38, P2684, DOI 10.1111/ejn.12269; Ye M, 2007, BRAIN RES, V1142, P206, DOI 10.1016/j.brainres.2006.12.061; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	85	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188239	10.1371/journal.pone.0188239	http://dx.doi.org/10.1371/journal.pone.0188239			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176874	Green Submitted, gold, Green Published			2022-12-26	WOS:000416291900047
J	Stuby, FM; Lenz, M; Doebele, S; Agarwal, Y; Skulev, H; Ochs, BG; Zwingmann, J; Gueorguiev, B				Stuby, Fabian M.; Lenz, Mark; Doebele, Stefan; Agarwal, Yash; Skulev, Hristo; Ochs, Bjoern G.; Zwingmann, Joern; Gueorguiev, Boyko			Symphyseal fixation in open book injuries cannot fully compensate anterior SI joint injury-A biomechanical study in a two-leg alternating load model	PLOS ONE			English	Article							PELVIC RING INJURIES; PUBIC SYMPHYSIS; INTERNAL-FIXATION; SACRAL FRACTURES; SCREW FIXATION; STABILITY; INSTABILITY; SIMULATION; COMPUTER; FAILURE	Introduction In open book injuries type Tile B1.1 or B1.2 also classified as APC II (anteroposterior compression), it remains controversial, if a fixation of the anterior ring provides sufficient stability or a fixation of the posterior ring should be included. Therefore the relative motion at the sacroiliac joint was quantified in a two-leg alternating load biomechanical pelvis model in the intact, the injured and the restored pelvis. Methods Fresh-frozen intact (I) pelvises (n = 6) were subjected to a non-destructive cyclic test under sinosuidal axial two-leg alternating load with progressively increasing amplitude. Afterwards an open book injury (J) including the anterior ligament complex of the left sacroiliac joint, the sacrospinal and sacrotuberal ligaments (Tile B1.1) was created and the specimens were retested. Finally, the symphysis was stabilized with a modular fixation system (1-, 2-or 4-rod configuration) (R) and specimens were cyclically retested. Relative motion at the sacroiliac joint was captured at both sacroiliac joints by motion tracking system at two load levels of 170 N and 340 N during all tests. Results Relative sacroiliac joint movements at both load levels were significantly higher in the Jstate compared to the I-state, excluding superoinferior translational movement. With exception of the anteroposterior translational movement at 340N, the relative sacroiliac joint movements after each of the three reconstructions (1-, 2-, 4-rod fixation) were significantly smaller compared to the J-state and did not differ significantly to the I-state, but stayed above the values of the latter. Relative movements did not differ significantly in a direct comparison between the 1-rod, 2-rod and 4-rod fixations. Conclusion Symphyseal locked plating significantly reduces relative movement of the sacroiliac joint in open book injuries type Tile B1.1 or B1.2 (APC II) but cannot fully restore the situation of the intact sacroiliac joint.	[Stuby, Fabian M.; Doebele, Stefan; Ochs, Bjoern G.] Eberhard Karls Univ Tubingen, BG Trauma Ctr, Tubingen, Germany; [Lenz, Mark] Univ Hosp Jena, Dept Trauma Hand & Reconstruct Surg, Jena, Germany; [Agarwal, Yash; Gueorguiev, Boyko] AO Res Inst Davos, Davos, Switzerland; [Skulev, Hristo] Tech Univ Varna, Dept Mat Sci & Technol, Varna, Bulgaria; [Zwingmann, Joern] Univ Freiburg, Med Ctr, Dept Orthopaed & Trauma Surg, Freiburg, Germany	Eberhard Karls University of Tubingen; Friedrich Schiller University of Jena; Technical University Varna; University of Freiburg	Doebele, S (corresponding author), Eberhard Karls Univ Tubingen, BG Trauma Ctr, Tubingen, Germany.	stefan.doebele@med.uni-tuebingen.de		Skulev, Hristo/0000-0001-6696-7546; Dobele, Stefan/0000-0002-8827-043X	DGUV (Deutsche Gesetzliche Unfallversicherung) [FR 167]	DGUV (Deutsche Gesetzliche Unfallversicherung)	This investigation was partially financed by a grant of the DGUV (Deutsche Gesetzliche Unfallversicherung) fund number Open Book DGUV FR 167". DePuySynthes is acknowledged for the delivery of all implants. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah A, 2014, INJURY, V45, P1599, DOI 10.1016/j.injury.2014.05.026; Acklin YP, 2016, INJURY, V47, P1456, DOI 10.1016/j.injury.2016.04.013; Agarwal Y, 2014, J BIOMECH, V47, P380, DOI 10.1016/j.jbiomech.2013.11.008; Alton TB, 2014, CLIN ORTHOP RELAT R, V472, P2338, DOI 10.1007/s11999-014-3693-8; Avilucea FR, 2016, J BONE JOINT SURG AM, V98, P944, DOI 10.2106/JBJS.15.00723; Berber O, 2011, J BONE JOINT SURG BR, V93B, P237, DOI 10.1302/0301-620X.93B2.24567; Bohme J, 2011, Z ORTHOP UNFALLCHIR, V149, P83, DOI 10.1055/s-0030-1250471; Bohme J, 2014, J ORTHOP RES, V32, P873, DOI 10.1002/jor.22618; Doro CJ, 2010, J ORTHOP TRAUMA, V24, P610, DOI 10.1097/BOT.0b013e3181cff42c; Gary JL, 2014, J ORTHOP TRAUMA, V28, P41, DOI 10.1097/BOT.0b013e318299ce1b; Genant HK, 1996, J BONE MINER RES, V11, P707; Godinsky RJ, 2016, EUROPEAN J TRAUMA EM; Gorczyca JT, 1996, INJURY, V27, P561, DOI 10.1016/S0020-1383(96)00078-2; Grechenig S, 2015, INJURY, V46, pS125, DOI 10.1016/S0020-1383(15)30031-0; Gruneweller N, 2016, J ORTHOPAEDIC RES OF; Kim WY, 1999, CLIN ORTHOP RELAT R, P237, DOI 10.1097/00003086-199904000-00030; Kraus E, 1998, Unfallchirurgie, V24, P25; MacAvoy MC, 1997, J ORTHOP TRAUMA, V11, P590, DOI 10.1097/00005131-199711000-00008; PANJABI MM, 1981, J BIOMECH, V14, P447, DOI 10.1016/0021-9290(81)90095-6; PANJABI MM, 1974, J BIOMECH, V7, P385, DOI 10.1016/0021-9290(74)90034-7; Pohlemann T, 1993, J Orthop Trauma, V7, P107, DOI 10.1097/00005131-199304000-00002; Sagi HC, 2008, J ORTHOP TRAUMA, V22, P373, DOI 10.1097/BOT.0b013e31817e49ee; SIMONIAN PT, 1994, CLIN ORTHOP RELAT R, P245; SIMONIAN PT, 1994, J ORTHOP TRAUMA, V8, P476, DOI 10.1097/00005131-199412000-00004; Steinke H, 2014, CLIN ANAT, V27, P770, DOI 10.1002/ca.22312; Stuby FM, 2014, CLIN BIOMECH, V29, P657, DOI 10.1016/j.clinbiomech.2014.04.010; Tile M., 2003, FRACTURES PELVIS ACE, V3rd ed; van den Bosch EW, 2003, J TRAUMA, V55, P962, DOI 10.1097/01.TA.0000047899.36102.80; VARGA E, 1995, INJURY, V26, P75, DOI 10.1016/0020-1383(95)92180-I; Vleeming A., SACROILIAC JOINT CLI; WALHEIM G, 1984, ACTA ORTHOP SCAND, V55, P203, DOI 10.3109/17453678408992338; WALHEIM GG, 1984, ACTA ORTHOP SCAND, V55, P319, DOI 10.3109/17453678408992365; WALHEIM GG, 1984, SCAND J REHABIL MED, V16, P163; YOUNG JWR, 1986, RADIOLOGY, V160, P445, DOI 10.1148/radiology.160.2.3726125	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0184000	10.1371/journal.pone.0184000	http://dx.doi.org/10.1371/journal.pone.0184000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176772	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900001
J	Adam, R; Garau, R; Raja, EA; Jones, B; Johnston, M; Murchie, P				Adam, Rosalind; Garau, Roberta; Raja, Edwin Amalraj; Jones, Benedict; Johnston, Marie; Murchie, Peter			Do patients' faces influence General Practitioners' cancer suspicions? A test of automatic processing of sociodemographic information	PLOS ONE			English	Article							DIAGNOSTIC DELAY; PRIMARY-CARE; SYMPTOMS	Background Delayed cancer diagnosis leads to poorer patient outcomes. During short consultations, General Practitioners (GPs) make quick decisions about likelihood of cancer. Patients' facial cues are processed rapidly and may influence diagnosis. Aim To investigate whether patients' facial characteristics influence immediate perception of cancer risk by GPs. Design and setting Web-based binary forced choice experiment with GPs from Northeast Scotland. Method GPs were presented with a series of pairs of face prototypes and asked to quickly select the patient more likely to have cancer. Faces were modified with respect to age, gender, and ethnicity. Choices were analysed using Chi-squared goodness-of-fit statistics with Bonferroni corrections. Results Eighty-two GPs participated. GPs were significantly more likely to suspect cancer in older patients. Gender influenced GP cancer suspicion, but this was modified by age: the male face was chosen as more likely to have cancer than the female face for young (72% of GPs; 95% CI 61.0-87.0) and middle-aged faces (65.9%; 95% CI 54.7-75.5); but 63.4% (95% CI 52.2-73.3) decided the older female was more likely to have cancer than the older male (p = 0.015). GPs were significantly more likely to suspect cancer in the young Caucasian male (65.9% (95% CI 54.7, 75.5)) compared to the young Asian male (p = 0.004). Conclusion GPs' first impressions about cancer risk are influenced by patient age, gender, and ethnicity. Tackling GP cognitive biases could be a promising way of reducing cancer diagnostic delays, particularly for younger patients.	[Adam, Rosalind; Garau, Roberta; Murchie, Peter] Univ Aberdeen, Inst Appl Hlth Sci, Ctr Acad Primary Care, Aberdeen, Scotland; [Raja, Edwin Amalraj] Univ Aberdeen, Inst Appl Hlth Sci, Med Stat, Aberdeen, Scotland; [Jones, Benedict] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Johnston, Marie] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen Hlth Psychol Grp, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Glasgow; University of Aberdeen	Adam, R (corresponding author), Univ Aberdeen, Inst Appl Hlth Sci, Ctr Acad Primary Care, Aberdeen, Scotland.	rosalindadam@abdn.ac.uk	Watson, Eila/R-1182-2019; Jones, Benedict/A-7850-2008	Watson, Eila/0000-0002-3592-1315; Adam, Rosalind/0000-0003-3082-6578; Jones, Benedict/0000-0001-7777-0220; Murchie, Peter/0000-0001-9968-5991	John & Gladys Colquhoun Trust Fund	John & Gladys Colquhoun Trust Fund	Roberta Garau is a medical student who completed this project as part of a BSc (MedSci). She received financial support for this degree from The John & Gladys Colquhoun Trust Fund. No other specific funding was received.	CHRISTENSENSZALANSKI JJJ, 1983, J APPL PSYCHOL, V68, P278, DOI 10.1037/0021-9010.68.2.278; DAVENPORT S, 1987, LANCET, V2, P439; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Dixon WJ., 1983, INTRO STAT ANAL; Elashoff J.D., 2007, NQUERY ADVISOR VERSI; GOLDBERG D, 1982, ARCH GEN PSYCHIAT, V39, P829; Hjertholm P, 2014, BRIT J GEN PRACT, V64, pE346, DOI 10.3399/bjgp14X680125; Information Services Division Scotland, 2014, ISD SCOTL CANC PUBL; Information Services Division Scotland, 2013, ISD SCOTL GEN PRACT; Jiwa M, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-2; Kahneman D., 2002, NOBEL PRIZE LECT, DOI 10.1518/; Kahneman D., 2012, PENSAR RAPIDO PENSAR; Kostopoulou O, 2017, MED DECIS MAKING, V37, P9, DOI 10.1177/0272989X16644563; Little AC, 2011, PHILOS T R SOC B, V366, P1634, DOI 10.1098/rstb.2010.0386; Lyratzopoulos G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7400; Miles A, 2017, PSYCHO-ONCOLOGY, V26, P29, DOI 10.1002/pon.4093; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF NI; NYLENNA M, 1986, BMJ-BRIT MED J, V293, P245, DOI 10.1136/bmj.293.6541.245; PETT M A., 1997, NONPARAMETRIC STAT H, P307; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; ROBBINS JM, 1994, MED CARE, V32, P795, DOI 10.1097/00005650-199408000-00004; Scheel BI, 2013, BRIT J GEN PRACT, V63, pE627, DOI 10.3399/bjgp13X671614; Sirota M, 2017, HLTH PSYCHOL; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Thomas RP, 2008, PSYCHOL REV, V115, P155, DOI 10.1037/0033-295X.115.1.155; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Usher-Smith J, 2015, BRIT J CANCER, V113, P1645, DOI 10.1038/bjc.2015.409; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188222	10.1371/journal.pone.0188222	http://dx.doi.org/10.1371/journal.pone.0188222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166652	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000416035300029
J	Fortune, SME; Koski, WR; Higdon, JW; Trites, AW; Baumgartner, MF; Ferguson, SH				Fortune, Sarah M. E.; Koski, William R.; Higdon, Jeff W.; Trites, Andrew W.; Baumgartner, Mark F.; Ferguson, Steven H.			Evidence of molting and the function of "rocknosing" behavior in bowhead whales in the eastern Canadian Arctic	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; BALAENA-MYSTICETUS; SEALS; WATER; AGE; HABITAT; PELAGE; FLUX	Bowhead whales (Balaena mysticetus) have a nearly circumpolar distribution, and occasionally occupy warmer shallow coastal areas during summertime that may facilitate molting. However, relatively little is known about the occurrence of molting and associated behaviors in bowhead whales. We opportunistically observed whales in Cumberland Sound, Nunavut, Canada with skin irregularities consistent with molting during August 2014, and collected a skin sample from a biopsied whale that revealed loose epidermis and sloughing. During August 2016, we flew a small unmanned aerial system (sUAS) over whales to take video and still images to: 1) determine unique individuals; 2) estimate the proportion of the body of unique individuals that exhibited sloughing skin; 3) determine the presence or absence of superficial lines representative of rock-rubbing behavior; and 4) measure body lengths to infer age-class. The still images revealed that all individuals (n = 81 whales) were sloughing skin, and that nearly 40% of them had mottled skin over more than two-thirds of their bodies. The video images captured bowhead whales rubbing on large rocks in shallow, coastal areas-likely to facilitate molting. Molting and rock rubbing appears to be pervasive during late summer for whales in the eastern Canadian Arctic.	[Fortune, Sarah M. E.; Trites, Andrew W.] Univ British Columbia, Inst Oceans & Fisheries, Dept Zool, Vancouver, BC, Canada; [Fortune, Sarah M. E.; Trites, Andrew W.] Univ British Columbia, Inst Oceans & Fisheries, Marine Mammal Res Unit, Vancouver, BC, Canada; [Fortune, Sarah M. E.; Baumgartner, Mark F.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Koski, William R.] LGL Ltd, King City, ON, Canada; [Higdon, Jeff W.] Higdon Wildlife Consulting, Winnipeg, MB, Canada; [Ferguson, Steven H.] Fisheries & Oceans Canada, Freshwater Inst, Winnipeg, MB, Canada	University of British Columbia; University of British Columbia; Woods Hole Oceanographic Institution; Fisheries & Oceans Canada	Fortune, SME (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Dept Zool, Vancouver, BC, Canada.; Fortune, SME (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Marine Mammal Res Unit, Vancouver, BC, Canada.; Fortune, SME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	s.fortune@oceans.ubc.ca		Trites, Andrew/0000-0003-0342-5322	Fisheries and Oceans Canada [41436-810-120-4D875]; Nunavut Wildlife Research Trust Fund [3-13-29]; Molson Foundation [318366]; Ocean Tracking Network [NSERC NETGP 375118-08]; ArcticNet Centre of Excellence [317588]; World Wildlife Fund Canada (Arctic Species Conservation Fund); Bureau of Ocean Energy Management [M08PG20021]; U.S. Department of Commerce, National Oceanic and Atmospheric Administration, as part of the MMS Alaska Environmental Studies Program	Fisheries and Oceans Canada; Nunavut Wildlife Research Trust Fund; Molson Foundation; Ocean Tracking Network; ArcticNet Centre of Excellence; World Wildlife Fund Canada (Arctic Species Conservation Fund); Bureau of Ocean Energy Management; U.S. Department of Commerce, National Oceanic and Atmospheric Administration, as part of the MMS Alaska Environmental Studies Program	Fieldwork was funded by: Fisheries and Oceans Canada (Emerging Fisheries 41436-810-120-4D875), Nunavut Wildlife Research Trust Fund (project 3-13-29 Bowhead Whale Movement's and Ecology), Molson Foundation (318366), Ocean Tracking Network (NSERC NETGP 375118-08), and ArcticNet Centre of Excellence (317588) awarded to S.H. Ferguson and World Wildlife Fund Canada (Arctic Species Conservation Fund) awarded to W.R. Koski and S.M.E. Fortune. Additional field work support was provided by: U.S. Department of the Interior, Minerals Management Service (MMS; now Bureau of Ocean Energy Management), through Inter-agency Agreement No. M08PG20021 with the U.S. Department of Commerce, National Oceanic and Atmospheric Administration, as part of the MMS Alaska Environmental Studies Program awarded to M.F. Baumgartner. Personnel support was provided by: Natural Sciences and Engineering Research Council Canadian Graduate Scholarship, the W. Garfield Weston Award for Northern Research, University of British Columbia Affiliated Fellowship and Northern Scientific Training Program (Canadian Polar Commission) awarded to S.M.E. Fortune.	BOILY P, 1995, J THEOR BIOL, V172, P235, DOI 10.1006/jtbi.1995.0020; Boily P, 1996, AM J PHYSIOL-REG I, V270, pR1051, DOI 10.1152/ajpregu.1996.270.5.R1051; BOYD I, 1993, PHYSIOL ZOOL, V66, P43, DOI 10.1086/physzool.66.1.30158286; BRAHAM HW, 1984, MAR FISH REV, V46, P45; Chernova O F, 2016, Dokl Biol Sci, V471, P261, DOI 10.1134/S0012496616060028; Cosens SE, 2003, MAR MAMMAL SCI, V19, P284, DOI 10.1111/j.1748-7692.2003.tb01109.x; de Gruijl FR, 2003, PHOTOCH PHOTOBIO SCI, V2, P16, DOI 10.1039/b211156j; Fetter AW, 1982, TISSUE STRUCTURAL ST, V1; Finley K.J., 1982, Cetus, V4, P4; Ford TJ, 2013, ANAT REC, V296, P701, DOI 10.1002/ar.22681; FROST KJ, 1993, ARCTIC, V46, P8; George J., 2009, GROWTH MORPHOLOGY EN; George JC, 2011, CAN J ZOOL, V89, P840, DOI 10.1139/Z11-057; George JC, 2004, INT WHAL COMM SCI CO; Guerin AH, 1845, EDINBURGH NEW PHILOS, V39, P266; Haldiman Jerrold T., 1993, Society for Marine Mammalogy Special Publication, V2, P71; HALDIMAN JT, 1985, ANAT REC, V211, P391, DOI 10.1002/ar.1092110404; Haldiman JT, 1981, TISSUE STRUCTURAL ST, V1; HECKMANN RA, 1987, GREAT BASIN NAT, V47, P355; Higdon JW, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P159, DOI 10.1007/978-90-481-9121-5_8; Koski William R., 1993, Society for Marine Mammalogy Special Publication, V2, P239; Koski WR, 2010, INT WHAL COMM SCI CO, P13; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; Ling J.K., 1974, P1; Ling J.K., 1984, Acta Zoologica Fennica, P23; LING JK, 1970, Q REV BIOL, V45, P16, DOI 10.1086/406361; Ling JK, 1978, PELAGE CHARACTERISTI, P305; MARTINET L, 1983, CAN J ZOOL, V61, P1959, DOI 10.1139/z83-257; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; Martinez-Levasseur LM, 2011, P ROY SOC B-BIOL SCI, V278, P1581, DOI 10.1098/rspb.2010.1903; McConkey S, 2002, NEW ZEAL J ZOOL, V29, P53, DOI 10.1080/03014223.2002.9518289; NWMB, 2000, FIN REP IN BOWH WHAL; O'Hara T. M., 2002, Journal of Cetacean Research and Management, V4, P143; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; Reeb D, 2005, J MAMMAL, V86, P131, DOI 10.1644/1545-1542(2005)086<0131:EOPEIS>2.0.CO;2; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reeves R, 1983, E N AM ARCTIC, V36, P60; Reinhart NR, 2013, POLAR BIOL, V36, P1133, DOI 10.1007/s00300-013-1335-3; RUGH DJ, 1992, CAN J ZOOL, V70, P617, DOI 10.1139/z92-090; Scheffer VB, 1962, N AM FAUNA; SMITH TG, 1981, CAN J ZOOL, V59, P966, DOI 10.1139/z81-135; STAUBIN DJ, 1990, CAN J ZOOL, V68, P359, DOI 10.1139/z90-051; Von Duyke AL, 2016, CYAMUS CETI SUBSISTE, V69, P10; Wagemann R, 2005, SCI TOTAL ENVIRON, V351, P333, DOI 10.1016/j.scitotenv.2004.06.028; WATTS PD, 1991, J THERM BIOL, V16, P57, DOI 10.1016/0306-4565(91)90053-5; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Williams TM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P433, DOI 10.1086/518346; Yablokov A. V., 1974, JPRS621501	48	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186156	10.1371/journal.pone.0186156	http://dx.doi.org/10.1371/journal.pone.0186156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166385	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300003
J	Blackwell, SB; Nations, CS; Thode, AM; Kauffman, ME; Conrad, AS; Norman, RG; Kim, KH				Blackwell, Susanna B.; Nations, Christopher S.; Thode, Aaron M.; Kauffman, Mandy E.; Conrad, Alexander S.; Norman, Robert G.; Kim, Katherine H.			Effects of tones associated with drilling activities on bowhead whale calling rates	PLOS ONE			English	Article							SHALLOW BEAUFORT SEA; ACOUSTIC COMMUNICATION; ANTHROPOGENIC SOUNDS; BALAENA-MYSTICETUS; FREQUENCY-SHIFT; AMBIENT NOISE; URBAN NOISE; INFORMATION; LOCALIZATION; EVOLUTION	During summer 2012 Shell performed exploratory drilling at Sivulliq, a lease holding located in the autumn migration corridor of bowhead whales (Balaena mysticetus), northwest of Camden Bay in the Beaufort Sea. The drilling operation involved a number of vessels performing various activities, such as towing the drill rig, anchor handling, and drilling. Acoustic data were collected with six arrays of directional recorders (DASARs) deployed on the sea-floor over similar to 7 weeks in Aug-Oct. Whale calls produced within 2 km of each DASAR were identified and localized using triangulation. A "tone index" was defined to quantify the presence and amplitude of tonal sounds from industrial machinery. The presence of airgun pulses originating from distant seismic operations was also quantified. For each 10-min period at each of the 40 recorders, the number of whale calls localized was matched with the "dose" of industrial sound received, and the relationship between calling rates and industrial sound was modeled using negative binomial regression. The analysis showed that with increasing tone levels, bowhead whale calling rates initially increased, peaked, and then decreased. This dual behavioral response is similar to that described for bowhead whales and airgun pulses in earlier work. Increasing call repetition rates can be a viable strategy for combating decreased detectability of signals arising from moderate increases in background noise. Meanwhile, as noise increases, the benefits of calling may decrease because information transfer becomes increasingly error-prone, and at some point calling may no longer be worth the effort.	[Blackwell, Susanna B.; Conrad, Alexander S.; Norman, Robert G.; Kim, Katherine H.] Greeneridge Sci Inc, Santa Barbara, CA 93117 USA; [Nations, Christopher S.; Kauffman, Mandy E.] Western EcoSyst Technol Inc, Cheyenne, WY USA; [Thode, Aaron M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Blackwell, SB (corresponding author), Greeneridge Sci Inc, Santa Barbara, CA 93117 USA.	susanna@greeneridge.com		Blackwell, Susanna B./0000-0001-7158-6852	Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc., and Western EcoSystems Technology, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	AU WWL, 1985, J ACOUST SOC AM, V77, P726, DOI 10.1121/1.392341; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Blackwell SB, 2006, J ACOUST SOC AM, V119, P182, DOI 10.1121/1.2140907; Blackwell SB, 2009, JOINT MONITORING PRO; Blackwell SB, 2016, COMPREHENSIVE REPORT; Blackwell SB, 2007, ARCTIC, V60, P255; Blackwell SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125720; Blackwell SB, 2013, MAR MAMMAL SCI, V29, pE342, DOI 10.1111/mms.12001; Brewer KD, 1993, KUVLUM 1 EXPLORATION; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Brumm H, 2011, BEHAVIOUR, V148, P1173, DOI 10.1163/000579511X605759; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Doyle LR, 2008, ENTROPY, V10, P33, DOI 10.3390/entropy-e10020033; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Gallagher ML, 1992, AMOCO PRODUCTION CO; Givens GH, 2013, SCI COMM INT WHAL CO; Greene CR, 2004, J ACOUST SOC AM, V116, P799, DOI 10.1121/1.1765191; Greene Jr CR, 1987, RESPONSES BOWHEAD OF; Hage SR, 2013, P NATL ACAD SCI USA, V110, P4063, DOI 10.1073/pnas.1211533110; Hall JD, 1994, 1993 KUVLUM EXPLORAT, V1; Hall JD, 1993, 1993 KUVLUM EXPLORAT, V2; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Lahiri S. N., 2003, RESAMPLING METHODS D, P115; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; LGL Alaska Research Associates Inc JASCO Applied Sciences Inc and Greeneridge Sciences Inc. Joint Monitoring Program in the Chukchi and Beaufort Seas, 2012, P12722 LGL AL US FIS; LGL and Greeneridge, 1987, RESP BOWH OFFSH DRIL; Moore Sue E., 1993, Society for Marine Mammalogy Special Publication, V2, P313; National Energy Board, 2011, REV OFFSH DRILL CAN; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; RICHARDSON WJ, 1990, MAR ENVIRON RES, V29, P135, DOI 10.1016/0141-1136(90)90032-J; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Scheifele PM, 2005, J ACOUST SOC AM, V117, P1486, DOI 10.1121/1.1835508; Schuster S, 2012, BIOL LETTERS, V8, P913, DOI 10.1098/rsbl.2012.0676; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shannon C. E., 1949, MATH THEORY COMMUNIC; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Thode AM, 2017, J ACOUST SOC AM, V142, P1482, DOI 10.1121/1.5001064; Thode AM, 2016, J ACOUST SOC AM, V140, P4288, DOI 10.1121/1.4968853; Thode AM, 2012, J ACOUST SOC AM, V131, P3726, DOI 10.1121/1.3699247; Van Trees H. L, 2004, OPTIMUM ARRAY PROC 4; Welsch R. E, 2004, REGRESSION DIAGNOSTI	45	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188459	10.1371/journal.pone.0188459	http://dx.doi.org/10.1371/journal.pone.0188459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161308	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000059
J	Koping, M; Shehata-Dieler, W; Cebulla, M; Rak, K; Oder, D; Muntze, J; Nordbeck, P; Wanner, C; Hagen, R; Schraven, S				Koeping, Maria; Shehata-Dieler, Wafaa; Cebulla, Mario; Rak, Kristen; Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph; Hagen, Rudolf; Schraven, Sebastian			Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-ALPHA; SAFETY	Background Fabry disease (FD) is an X-linked recessive hereditary lysosomal storage disorder which results in the accumulation of globotriaosylceramid (Gb3) in tissues of kidney and heart as well as central and peripheral nervous system. Besides prominent renal and cardiac organ involvement, cochlear symptoms like high-frequency hearing loss and tinnitus are frequently found with yet no comprehensive data available in the literature. Objective To examine hearing loss in patients with FD depending on cardiac and renal function. Material and methods Single-center study with 68 FD patients enrolled between 2012 and 2016 at the Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery of the University of Wurzburg. Every subject underwent an oto-rhino-laryngological examination as well as behavioral, electrophysiological and electroacoustical audiological testing. High-frequency thresholds were evaluated by using a modified PTA(6) (0.5, 1, 2, 4, 6, 8) and HF-PTA (6, 8 kHz). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results Sensorineural hearing loss was detected in 58.8% of the cohort, which occurred typically in sudden episodes and affected especially high frequencies. Hearing loss is asymmetric, beginning unilaterally and affecting the contralateral ear later. Tinnitus was reported by 41.2%. Renal and cardiac impairment influenced the severity of hearing loss (p < 0.05). Conclusions High frequency hearing loss is a common problem in patients with FD. Although not life-threatening, it can seriously reduce quality of life and should be taken into account in diagnosis and therapy. Optimized extensive hearing assessment including higher frequency thresholds should be used.	[Koeping, Maria; Shehata-Dieler, Wafaa; Cebulla, Mario; Rak, Kristen; Hagen, Rudolf; Schraven, Sebastian] Univ Hosp Wurzburg, Comprehens Hearing Ctr, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany; [Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Dept Internal Med 1, Wurzburg, Germany; [Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph] Univ Hosp Wurzburg, Fabry Ctr Interdisciplinary Therapy FAZIT, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Koping, M (corresponding author), Univ Hosp Wurzburg, Comprehens Hearing Ctr, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany.	koeping_m@ukw.de	Schraven, Sebastian/AAA-3284-2020; Nordbeck, Peter/D-4771-2018; Rak, Kristen/AFM-2679-2022	Nordbeck, Peter/0000-0002-2560-4068; Rak, Kristen/0000-0003-2109-3536; Koping, Maria/0000-0003-2431-2511	Amicus; Sanofi-Genzyme; Shire; Actelion; Protalix	Amicus; Sanofi-Genzyme; Shire; Actelion; Protalix	DO received speaker's honoraria from Sanofi-Genzyme and travel assistance from Sanofi-Genzyme and Shire. JM received travel assistance from Sanofi-Genzyme, Shire and Amicus. PN received travel assistance, speaker's/advisory board honoraria, and research support from Amicus, Sanofi-Genzyme and Shire. CW received travel assistance, speaker's/advisory board honoraria, and research support from Actelion, Protalix, Sanofi-Genzyme and Shire. The other authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biegstraaten MArngrAomssonR, 2015, ORPHANET J RARE DIS, V10, P3733; Conti G, 2003, ACTA PAEDIATR, V92, P33, DOI 10.1080/08035320310000447; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain Dominique P, 2002, BMC Med Genet, V3, P10, DOI 10.1186/1471-2350-3-10; Hajioff D, 2003, J INHERIT METAB DIS, V26, P787, DOI 10.1023/B:BOLI.0000009948.86528.72; Hegemann S, 2006, EUR J CLIN INVEST, V36, P654, DOI 10.1111/j.1365-2362.2006.01702.x; Hoffmann B, 2009, DTSCH ARZTEBL INT, V106, P440, DOI 10.3238/arztebl.2009.0440; Hughes DA, 2008, HEART, V94, P153, DOI 10.1136/hrt.2006.104026; Hwu WL, 2009, HUM MUTAT, V30, P1397, DOI 10.1002/humu.21074; Keilmann A, 2006, FABRY DIS PERSPECTIV; Keilmann A, 2006, FABRY DIS PERSPECTIV; Kuemmerle-Deschner JB, 2015, PEDIATR RHEUMATOL, V13, P1273; Limberger A, 2007, HNO, V55, P185, DOI 10.1007/s00106-006-1454-z; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Palla A, 2007, J NEUROL, V254, P1433, DOI 10.1007/s00415-007-0575-y; SCHACHERN PA, 1989, ANN OTO RHINOL LARYN, V98, P359, DOI 10.1177/000348948909800509; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Sergi B, 2010, ACTA OTORHINOLARYNGO, V30, P87; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Spoor A, 2009, INT AUDIOL, V6, P48; Vibert D, 2006, ANN OTO RHINOL LARYN, V115, P412, DOI 10.1177/000348940611500603; Wanner C, 2004, MORBUS FABRY KLINIK; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188103	10.1371/journal.pone.0188103	http://dx.doi.org/10.1371/journal.pone.0188103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161295	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000030
J	Pegg, G; Taylor, T; Entwistle, P; Guymer, G; Giblin, F; Carnegie, A				Pegg, Geoff; Taylor, Tamara; Entwistle, Peter; Guymer, Gordon; Giblin, Fiona; Carnegie, Angus			Impact of Austropuccinia psidii (myrtle rust) on Myrtaceae-rich wet sclerophyll forests in south east Queensland	PLOS ONE			English	Article							PUCCINIA-PSIDII; EUCALYPTUS RUST; GUAVA RUST; DISEASE; AUSTRALIA; PATHOGEN	In April 2010, Austropuccinia psidii (formerly Puccinia psidii) was detected for the first time in Australia on the central coast of New South Wales. The fungus spread rapidly along the east coast and can now be found infecting vegetation in a range of native forest ecosystems with disease impacts ranging from minor leaf spots to severe shoot and stem blight and tree dieback. Localised extinction of some plant species has been recorded. In 2014, the impact of A. psidii was observed for the first time in a wet sclerophyll site with a rainforest under-story, dominated by species of Myrtaceae, in Tallebudgera Valley, south east Queensland, Australia. This study aimed to determine the impact of A. psidii on individual species and species composition. Here we provide quantitative and qualitative evidence on the significant impact A. psidii has in native ecosystems, on a broader range of species than previously reported. Archirhodomyrtus beckleri, Decaspermum humile, Gossia hillii and Rhodamnia maideniana are in serious decline, with significant increases in tree mortality over the period of our study. This research further highlights the potential of this invasive pathogen to negatively impact native ecosystems and biodiversity.	[Pegg, Geoff; Giblin, Fiona] Hort & Forestry Sci, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Pegg, Geoff; Carnegie, Angus] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [Taylor, Tamara] Griffith Univ, Nathan, Qld, Australia; [Entwistle, Peter] North East Agr Serv, Parramatta, NSW, Australia; [Guymer, Gordon] Queensland Herbarium, Dept Sci Informat Technol & Innovat, Mt Coot Tha, Qld, Australia; [Carnegie, Angus] NSW Forest Sci, NSW Dept Primary Ind, Parramatta, NSW, Australia	Griffith University; NSW Department of Primary Industries	Pegg, G (corresponding author), Hort & Forestry Sci, Dept Agr & Fisheries, Brisbane, Qld, Australia.; Pegg, G (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.	geoff.pegg@daf.qld.gov.au	Carnegie, Angus James/H-6153-2015	Carnegie, Angus James/0000-0002-6854-4974; Pegg, Geoffrey/0000-0002-0957-9755	Plant Biosecurity Cooperative Research Centre [CRC2063]; Australian Government's Cooperative Research Centres Program	Plant Biosecurity Cooperative Research Centre; Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Financial support was provided by the Plant Biosecurity Cooperative Research Centre CRC2063 (www.pbcrc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Doug and Lyndria Cook for kindly allowing access to their property so that we could complete this study, Kristopher Kupsch for helping provide data from sites in NSW and Dr Helen Nahrung for reviewing the manuscript. The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centres Program.	Ashton D. H., 1981, Fire and the Australian biota., P339; Ashton D.H., 1994, AUSTR VEGETATION, P157; Beadle NCW, 1981, ECOLOGICAL BIOGEOGRA, P407; Beenken L, 2017, PHYTOTAXA, V297, P53, DOI 10.11646/phytotaxa.297.1.5; Booth TH, 2012, AUSTRALAS PLANT PATH, V41, P425, DOI 10.1007/s13313-012-0130-x; Brophy JJ, 1996, FLAVOUR FRAG J, V11, P133, DOI [10.1002/(SICI)1099-1026(199603)11:2<133::AID-FFJ564>3.0.CO;2-2, 10.1002/(SICI)1099-1026(199603)11:2&lt;133::AID-FFJ564&gt;3.0.CO;2-2]; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2016, BIOL INVASIONS, V18, P127, DOI 10.1007/s10530-015-0996-y; Cummings J, 2007, RESTOR ECOL, V15, P156, DOI 10.1111/j.1526-100X.2006.00200.x; de Plessis E, 2017, PLANT DIS, V101, P1676, DOI [10.1094/pdis-04-17-0530-pdn, 10.1094/PDIS-04-17-0530-PDN]; Giblin F. R., 2014, PUCCINIA PSIDII MYRT; Giblin F. R., 2013, MYRTLE RUST REPORT N; Gooden B, 2009, BIOL CONSERV, V142, P2631, DOI 10.1016/j.biocon.2009.06.012; Kimbrough JW, 1980, P FLORIDA STATE HORT, V93, P111; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Machado PD, 2015, AUSTRALAS PLANT PATH, V44, P455, DOI 10.1007/s13313-015-0364-5; Makinson R. O., 2014, Gardens' Bulletin (Singapore), V66, P173; McTaggart AR, 2016, AUSTRALAS PLANT PATH, V45, P83, DOI [10.1007/s13313-014-0323-6, 10.1007/s13313-015-0386-z]; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Myerscough Peter J., 1998, Cunninghamia, V5, P787; Peeters PJ, 2014, WET SCLEROPHYLL FORE; Pegg GS, 2014, PLANT PATHOL, V63, P1005, DOI 10.1111/ppa.12173; Pegg GS, 2012, CRC70186; Roux J, 2013, IMA FUNGUS, V4, P155, DOI 10.5598/imafungus.2013.04.01.14; Schomaker M.E., 2007, SRS102 USDA FOR SERV; Specht R.L., 1981, ECOLOGICAL BIOGEOGRA, P163; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; WESTAWAY JO, 2016, NORTH TERRIT NAT OCT, P13; Winter G, 1884, HEDWIGIA, V23, P164	30	37	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188058	10.1371/journal.pone.0188058	http://dx.doi.org/10.1371/journal.pone.0188058			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161305	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000029
J	Fischhoff, IR; Keesing, F; Ostfeld, RS				Fischhoff, Ilya R.; Keesing, Felicia; Ostfeld, Richard S.			The tick biocontrol agent Metarhizium brunneum (= M. anisopliae) (strain F52) does not reduce non-target arthropods	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; ENTOMOPATHOGENIC FUNGI; LYME-DISEASE; HYPOCREALES CLAVICIPITACEAE; BORRELIA-BURGDORFERI; BEAUVERIA-BASSIANA; STATISTICAL POWER; IXODIDAE; INSECTICIDES; HYMENOPTERA	Previous studies have found that Met52 (R), which contains the entomopathogenic fungus Metarhizium brunneum, is effective in reducing the abundance of Ixodes scapularis, the tick vector for the bacterium causing Lyme disease and for other tick-borne pathogens. Given widespread interest in effective, safe methods for controlling ticks, Met52 has the potential to be used at increasing scales. The non-target impacts of Met52, as applied for tick control, have not yet been assessed. A Before-After-Control-Impact experiment was conducted to assess the effects of Met52 on non-target arthropods in lawn and forest habitats typical of residential yards. Ground-dwelling arthropods were collected using bulk sampling of soil and litter, and pitfall sampling. Arthropods were sampled once before and twice after treatment of plots with either Met52 or water (control). Multivariate general linear models were used to jointly model the abundance of arthropod orders. For each sampling method and post-spray sampling occasion, Akaike Information Criterion values were used to compare the fits of two alternative models: one that included effects of period (before vs. after spray), habitat (lawn vs. forest), and treatment (Met52 vs. control), versus a nested null model that included effects of period, and habitat, but no treatment effect. The null model was consistently better supported by the data. Significant effects were found of period and habitat but not treatment. Retrospective power analysis indicated the study had 80% power to detect a 50% reduction in arthropod abundance, as measured by bulk samples taken before versus one week after treatment. The deployment of Met52 in suburban settings is unlikely to cause meaningful reductions in the abundance of non-target arthropods.	[Fischhoff, Ilya R.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Keesing, Felicia] Bard Coll, Annandale On Hudson, NY USA	Cary Institute of Ecosystem Studies	Fischhoff, IR (corresponding author), Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA.	Fischhoff@gmail.com	Fischhoff, Ilya/B-6303-2014	Fischhoff, Ilya/0000-0001-6956-8284; Ostfeld, Richard/0000-0002-3707-9301	Steven & Alexandra Cohen Foundation	Steven & Alexandra Cohen Foundation	The work was funded by a grant from the Steven & Alexandra Cohen Foundation (http:// www.steveandalex.org) to FK and RSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge major support for The Tick Project from the Steven and Alexandra Cohen Foundation. We thank Mike Fargione for guidance in use of pesticides, and Heather Malcolm for guidance in arthropod sorting. We thank Sophia Raithel for collecting and sorting the pitfall samples, and Alexandra Clarke for sorting bulk samples. We also thank the many other Project Assistants for their hard work gathering and sorting samples. James Burtis and two anonymous reviewers provided valuable comments on previous drafts. We thank Alison Hinckley, Lars Eisen, and Ben Beard for advice. This is a contribution to the program of the Cary Institute of Ecosystem Studies.	Abonyo EA, 2016, INT J TROP INSECT SC, V36, P128, DOI 10.1017/S1742758416000114; Aenishaenslin C, 2014, BMC PUBLIC HEALTH, V1, P1; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Babendreier D, 2015, J APPL ENTOMOL, V139, P457, DOI 10.1111/jen.12229; Barrett PN, 2013, EXPERT REV VACCINES, V12, P101, DOI [10.1586/ERV.12.141, 10.1586/erv.12.141]; Bharadwaj A, 2010, J MED ENTOMOL, V47, P862, DOI 10.1603/ME10020; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Blumel S, 2000, IOBC WPRS, P145; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; Conner MM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5526-6; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; Dromph KM, 2002, APPL SOIL ECOL, V21, P197, DOI 10.1016/S0929-1393(02)00092-6; Duan JJ, 2006, ECOL ENTOMOL, V31, P521, DOI 10.1111/j.1365-2311.2006.00811.x; Eisen L, 2016, J MED ENTOMOL, V53, P1063, DOI 10.1093/jme/tjw103; Elias SP, 2013, J MED ENTOMOL, V50, P126, DOI 10.1603/ME12124; Erler F, 2013, EGYPT J BIOL PEST CO, V23, P233; European Commission, 2008, INT RISK ASS PROV RA; European Commission, 2014, EUR COMM REV REP ACT; European Food Safety Authority, 2012, EFSA J, V8, P1; Fischhoff IR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187675; Garrido-Jurado I, 2011, BIOL CONTROL, V59, P239, DOI 10.1016/j.biocontrol.2011.07.001; Goble TA, 2015, J ECON ENTOMOL, V108, P433, DOI 10.1093/jee/tov013; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; Grear JS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-292; Hinckley AF, 2016, J INFECT DIS, V214, P182, DOI 10.1093/infdis/jiv775; Hornbostel VL, 2005, J VECTOR ECOL, V30, P91; Johnson N. F., 2005, BORROR DELONGS INTRO; Kirchmair M, 2004, IOBC WRPS B, P157; Kivett JM, 2016, J ENTOMOL SCI, V51, P274, DOI 10.18474/JES16-07.1; Kugeler KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P337, DOI 10.1111/zph.12245; Kugeler KJ, 2015, EMERG INFECT DIS, V21, P1455, DOI 10.3201/eid2108.141878; Larson JL, 2012, PEST MANAG SCI, V68, P740, DOI 10.1002/ps.2321; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Mauchline N. A., 2013, New Zealand Plant Protection, V66, P324; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Myrand V, 2015, J ECON ENTOMOL, V108, P34, DOI 10.1093/jee/tou019; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; NIELSEN C, 2004, BIOL CONTROL WEEVILS; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, BIOSCIENCE, V56, P383, DOI 10.1641/0006-3568(2006)056[0383:CTATZW]2.0.CO;2; Peng GX, 2008, CROP PROT, V27, P1244, DOI 10.1016/j.cropro.2008.03.007; Perry JN, 2003, J APPL ECOL, V40, P17, DOI 10.1046/j.1365-2664.2003.00786.x; Peveling R, 1999, CROP PROT, V18, P323, DOI 10.1016/S0261-2194(99)00032-0; R Development Core Team, 2016, R NEWS; Richer LM, 2014, J INFECT DIS, V209, P1972, DOI 10.1093/infdis/jiu005; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Saito T, 2016, BIOL CONTROL, V92, P92, DOI 10.1016/j.biocontrol.2015.10.003; Samish M, 2001, TRENDS PARASITOL, V17, P368, DOI 10.1016/S1471-4922(01)01985-7; Sanchez-Bayo F.P., 2012, J ENV ANAL TOXICOL, VS4, pS4; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Stafford KC, 2010, J MED ENTOMOL, V47, P1107, DOI 10.1603/ME10019; Stehr F.W., 1987, IMMATURE INSECTS; Tangtrakulwanich K., 2014, Journal of Agricultural Science (Toronto), V6, P1; U. S. Environmental Protection Agency, 2000, BIOSP REG ACT DOC ME; Vestergaard Susanne, 2000, IOBC-WPRS Bulletin, V23, P181; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2008, J AM STAT ASSOC, V103, P340, DOI 10.1198/016214508000000021	60	25	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187675	10.1371/journal.pone.0187675	http://dx.doi.org/10.1371/journal.pone.0187675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155838	gold, Green Published			2022-12-26	WOS:000415756700013
J	Wang, SS; Zhang, YX; Yang, F; Huang, ZQ; Tang, J; Hu, KD; Zhang, H				Wang, Sha-Sha; Zhang, Ying-Xin; Yang, Feng; Huang, Zhong-Qin; Tang, Jun; Hu, Kang-Di; Zhang, Hua			Sulfur dioxide alleviates programmed cell death in barley aleurone by acting as an antioxidant	PLOS ONE			English	Article							NITRIC-OXIDE; BETA-AMYLASE; METABOLISM; PLANTS	Sulfur dioxide (SO2), a gaseous signaling molecule in animal cells, has recently been found to play a physiological role in plants. Here we studied the role of SO2 in gibberellic acid (GA3)-induced programmed cell death (PCD) in barley (Hordeum vulgare L.) aleurone layers. The application of the SO2 donor (NaHSO3/Na2SO3, 1: 3 M/ M) effectively alleviated PCD in barley aleurone layers in a dose- dependent manner with an optimal concentration of 50 mu M. Further investigations showed that SO2 reduced the accumulation of hydrogen peroxide (H2O2), superoxide anion (center dot O-2(-)) and malondialdehyde (MDA) in aleurone layers. Moreover, the activities of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX), glutathione reductase (GR) and guaiacol peroxidase (POD) were enhanced by SO2 donor treatment. Meanwhile, lipoxygenase (LOX) activity was attenuated by SO2 donor treatment. Furthermore, an induction of endogenous H2S and NO were also observed in SO2-treated aleurone layers, suggesting interactions of SO2 with other well- known signaling molecules. Taken together, we show that SO2 negatively regulated PCD by acting as an antioxidant to scavenge excessive reactive oxygen species (ROS) generated during PCD.	[Wang, Sha-Sha; Zhang, Ying-Xin; Hu, Kang-Di; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [Yang, Feng; Huang, Zhong-Qin; Tang, Jun] Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Peoples R China	Hefei University of Technology; Jiangsu Academy of Agricultural Sciences	Hu, KD; Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China.	kangdihuhfut@gmail.com; hzhanglab@hfut.edu.cn			National Natural Science Foundation of China [31271803, 31470013, 31670278, 31300133]; Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028, ZD200910]; earmarked fund for China Agriculture Research System [CARS-10-B1]; Anhui Provincial Science and Technology Major Project [6030701073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department; earmarked fund for China Agriculture Research System; Anhui Provincial Science and Technology Major Project	This work was supported by National Natural Science Foundation of China (31271803, 31470013, 31670278 to Dr. Hua Zhang; 31300133 to Dr. Kang-Di Hu), Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, MOE to Dr. Hua Zhang), Natural Science Foundations of Anhui Province (11040606M85 to Dr. Hua Zhang), Anhui Provincial Education Department (2012AJZR0028, ZD200910 to Dr. Hua Zhang), the earmarked fund for China Agriculture Research System (CARS-10-B1 to Jun Tang) and Anhui Provincial Science and Technology Major Project (6030701073 to Dr. Hua Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethke PC, 1999, PLANT CELL, V11, P1033, DOI 10.1105/tpc.11.6.1033; Bethke PC, 2001, PLANT J, V25, P19, DOI 10.1046/j.1365-313x.2001.00930.x; CHRISPEE.MJ, 1967, PLANT PHYSIOL, V42, P398, DOI 10.1104/pp.42.3.398; COLLINS GG, 1972, PLANT PHYSIOL, V49, P404, DOI 10.1104/pp.49.3.404; DELMAESTRO RF, 1981, MICROVASC RES, V22, P239, DOI 10.1016/0026-2862(81)90095-9; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Giraud E, 2012, PLANT CELL ENVIRON, V35, P405, DOI 10.1111/j.1365-3040.2011.02379.x; GUERIN JR, 1992, J CEREAL SCI, V15, P5, DOI 10.1016/S0733-5210(09)80052-0; Hu KD, 2014, BIOL PLANTARUM, V58, P676, DOI 10.1007/s10535-014-0440-7; Huang YQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8961951; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; NOELTING G, 1948, HELV CHIM ACTA, V31, P286, DOI 10.1002/hlca.19480310149; Noji M, 2001, PLANT PHYSIOL, V126, P973, DOI 10.1104/pp.126.3.973; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; REED GA, 1990, CARCINOGENESIS, V11, P1635, DOI 10.1093/carcin/11.9.1635; RENNENBERG H, 1984, ANNU REV PLANT PHYS, V35, P121, DOI 10.1146/annurev.pp.35.060184.001005; Scuffi D, 2014, PLANT PHYSIOL, V166, P2065, DOI 10.1104/pp.114.245373; SHAPIRO R, 1977, MUTAT RES, V39, P149, DOI 10.1016/0165-1110(77)90020-3; SURREY K, 1964, PLANT PHYSIOL, V39, P65, DOI 10.1104/pp.39.1.65; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; TSUCHIYA M, 1994, METHOD ENZYMOL, V233, P128; vanderKooij TAW, 1997, NEW PHYTOL, V135, P101, DOI 10.1046/j.1469-8137.1997.00619.x; Xue YF, 2016, J SCI FOOD AGR, V96, P909, DOI 10.1002/jsfa.7164; Zhang H, 2005, PLANTA, V220, P708, DOI 10.1007/s00425-004-1390-7; Zhu DB, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/612363	29	13	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188289	10.1371/journal.pone.0188289	http://dx.doi.org/10.1371/journal.pone.0188289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155872	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700043
J	Knoop, ST; Skrede, S; Langeland, N; Flaatten, HK				Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina; Flaatten, Hans Kristian			Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study	PLOS ONE			English	Article							UNITED-STATES; COSTS; CODES; CARE	Background Although sepsis is the leading cause of death from infection, there are few population-level epidemiological sepsis reports. The impact of sepsis-related deaths on all-cause hospital mortality is insufficiently described, in particular in Europe where data are non-existent. The objective of this study was to provide nationwide epidemiological results on sepsis hospitalizations in Norway and to estimate sepsis' contribution to overall hospital mortality in a European setting. Methods We performed a retrospective study using data from the Norwegian Patient Registry and Statistics Norway. The occurrence, patient characteristics and outcomes of sepsis hospitalizations during the years 2011 and 2012 were estimated and compared with Norwegian population data. Sepsis was defined as organ dysfunction caused by a dysregulated host response to infection and identified with International Classification of Diseases 10 th revision codes. Results We identified 18 460 sepsis admissions occurring in 13 582 individuals. The annual population incidence of hospitalized sepsis was 140 patients per 100 000 inhabitants; ranging from 10 to 2270 per 100 000 in different age groups and with statistically significant male predominance in all adult cohorts. Hospital mortality for sepsis admissions was 19.4% and overall, 26.4% of the included patients died while hospitalized for sepsis. Sepsis related deaths constituted 12.9% of all hospital fatalities, while hospitalizations with sepsis accounted for 1.0% of the total number of admissions and 3.5% of the total admission days during 2011 and 2012. Conclusions This study confirms that hospitalized sepsis is frequent in Norway and a major contributor to hospital fatalities in a European setting. The incidence is higher among men than women. Sepsis is in particular a disease of the elderly, and its impact on health-care will assumingly continue to increase in parallel with an aging population. Improvements in treatment and survival of sepsis could influence population mortality, and sepsis should receive greater attention in official death statistics in the future.	[Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina] Haukeland Hosp, Dept Med, Bergen, Norway; [Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Flaatten, Hans Kristian] Haukeland Hosp, Dept Anaesthesia & Intens Care, Bergen, Norway; [Flaatten, Hans Kristian] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Knoop, ST (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Knoop, ST (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	siri.knoop@gmail.com	Flaatten, Hans/AAG-7030-2020	Flaatten, Hans/0000-0001-9186-3482; Skrede, Steinar/0000-0003-1615-4453	 [HV 1181]		This study was performed with internal funding only (grant number HV 1181, https://helsebergen.no/fag-og-forsking/innovasion-vedhaukeland-universitetssjukehus). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Bouza C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1497-9; Bouza Carmen, 2014, BMC Infect Dis, V14, P3863, DOI 10.1186/s12879-014-0717-7; Yebenes JC, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0241-1; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Epstein L, 2016, MMWR-MORBID MORTAL W, V65, P342, DOI 10.15585/mmwr.mm6513a2; Fedeli U, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1664-2; Flaatten H, 2004, CRIT CARE, V8, pR180, DOI 10.1186/cc2867; Fleischmann C, 2016, DTSCH ARZTEBL INT, V113, P159, DOI [10.3238/arztebl.2016.0159, 10.3238/arztebl.2016.0660b]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.004; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Mariansdatter SE, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0237-9; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McPherson D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002586; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Nygard ST, 2017, ACTA ANAESTH SCAND, V61, P194, DOI 10.1111/aas.12848; Nygard ST, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-121; Rhee C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1266-9; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Taniguchi LU, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0608-8; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; Wilhelms SB, 2017, ACTA ANAESTH SCAND, V61, P186, DOI 10.1111/aas.12814; Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406; Zhou JF, 2017, CRIT CARE MED, V45, P1168, DOI 10.1097/CCM.0000000000002414	36	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187990	10.1371/journal.pone.0187990	http://dx.doi.org/10.1371/journal.pone.0187990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149187	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100021
J	Prabhala, BK; Aduri, NG; Sharma, N; Shaheen, A; Sharma, A; Iqbal, M; Hansen, PR; Brasen, C; Gajhede, M; Rahman, M; Mirza, O				Prabhala, Bala K.; Aduri, Nanda G.; Sharma, Neha; Shaheen, Aqsa; Sharma, Arpan; Iqbal, Mazhar; Hansen, Paul R.; Brasen, Christoffer; Gajhede, Michael; Rahman, Moazur; Mirza, Osman			The prototypical proton-coupled oligopeptide transporter YdgR from Escherichia coli facilitates chloramphenicol uptake into bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX PUMPS; PEPTIDE TRANSPORTER; E. COLI; HAEMOPHILUS-INFLUENZAE; SALMONELLA-TYPHI; RESISTANCE; PROTEIN; ANTIBIOTICS; RECOGNITION; MDFA	Chloramphenicol (Cam) is a broad-spectrum antibiotic used to combat bacterial infections in humans and animals. Cam export from bacterial cells is one of the mechanisms by which pathogens resist Cam's antibacterial effects, and several different proteins are known to facilitate this process. However, to date no report exists on any specific transport protein that facilitates Cam uptake. The proton-coupled oligopeptide transporter (POT) YdgR from Escherichia coli is a prototypical member of the POT family, functioning in proton-coupled uptake of di- and tripeptides. By following bacterial growth and conducting LC-MS-based assays we show here that YdgR facilitates Cam uptake. Some YdgR variants displaying reduced peptide uptake also exhibited reduced Cam uptake, indicating that peptides and Cam bind YdgR at similar regions. Homology modeling of YdgR, Cam docking, and mutational studies suggested a binding mode that resembles that of Cam binding to the multidrug resistance transporter MdfA. To our knowledge, this is the first report of Cam uptake into bacterial cells mediated by a specific transporter protein. Our findings suggest a specific bacterial transporter for drug uptake that might be targeted to promote greater antibiotic influx to increase cytoplasmic antibiotic concentration for enhanced cytotoxicity.	[Prabhala, Bala K.; Aduri, Nanda G.; Sharma, Neha; Sharma, Arpan; Hansen, Paul R.; Brasen, Christoffer; Gajhede, Michael; Mirza, Osman] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Shaheen, Aqsa; Iqbal, Mazhar; Rahman, Moazur] NIBGE, Hlth Biotechnol Div, Faisalabad, Pakistan	University of Copenhagen; Pakistan Institute of Engineering & Applied Science	Mirza, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark.	om@sund.ku.dk	Rahman, Moazur/C-5515-2019; Iqbal, Mazhar/C-5536-2019	Rahman, Moazur/0000-0003-2892-1250; Iqbal, Mazhar/0000-0002-8675-1125; Gajhede, Michael/0000-0001-9864-2287; Aduri, Nanda Gowtham/0000-0003-4301-7446; Prabhala, Bala Krishna/0000-0002-0165-3113; Mirza, Osman Asghar/0000-0001-9435-0690; Sharma, Neha/0000-0002-8653-4921; Hansen, Paul Robert/0000-0001-9357-8001	Faculty of Health and Medical Sciences, University of Copenhagen	Faculty of Health and Medical Sciences, University of Copenhagen	This work was supported by the Faculty of Health and Medical Sciences, University of Copenhagen (to A.N.G. and P.B.K.). The authors declare that they have no conflicts of interest with the contents of this article.	ABDELSAYED S, 1987, J ANTIMICROB CHEMOTH, V19, P7, DOI 10.1093/jac/19.1.7; Aduri NG, 2015, J BIOL CHEM, V290, P29931, DOI 10.1074/jbc.M115.675603; Aygul A, 2015, MIKROBIYOL BUL, V49, P278, DOI 10.5578/mb.8964; BISSONNETTE L, 1991, J BACTERIOL, V173, P4493, DOI 10.1128/JB.173.14.4493-4502.1991; BURNS JL, 1987, J GEN MICROBIOL, V133, P1273; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Ernst HA, 2009, BIOCHEM BIOPH RES CO, V389, P112, DOI 10.1016/j.bbrc.2009.08.098; Ford D, 2003, HISTOCHEM CELL BIOL, V119, P37, DOI 10.1007/s0418-002-0479-y; Franje CA, 2010, J PHARMACEUT BIOMED, V53, P869, DOI 10.1016/j.jpba.2010.06.013; GRUHZIT OM, 1949, J CLIN INVEST, V28, P943, DOI 10.1172/JCI102184; Guettou F, 2014, NAT STRUCT MOL BIOL, V21, P728, DOI 10.1038/nsmb.2860; Hanekamp JC, 2015, ENVIRON TOXICOL PHAR, V39, P213, DOI 10.1016/j.etap.2014.11.016; Harder D, 2008, FAKULTAT WISSENSCHAF, P121; Harder D, 2008, FEBS J, V275, P3290, DOI 10.1111/j.1742-4658.2008.06477.x; Heng J, 2015, CELL RES, V25, P1060, DOI 10.1038/cr.2015.94; Jensen JM, 2014, INT J BIOCHEM CELL B, V55, P311, DOI 10.1016/j.biocel.2014.09.016; Jensen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047780; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2012, INT J MOL SCI, V13, P4484, DOI 10.3390/ijms13044484; Lee SH, 2013, TOX RESEARCH, V29, P107, DOI 10.5487/TR.2013.29.2.107; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewinson O, 2006, MOL MICROBIOL, V61, P277, DOI 10.1111/j.1365-2958.2006.05254.x; MORTIMER PGS, 1993, J ANTIMICROB CHEMOTH, V32, P195, DOI 10.1093/jac/32.2.195; Newstead S, 2015, BBA-GEN SUBJECTS, V1850, P488, DOI 10.1016/j.bbagen.2014.05.011; Opperman TJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00421; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Prabhala BK, 2017, RES MICROBIOL, V168, P443, DOI 10.1016/j.resmic.2017.01.005; Prabhala BK, 2015, INT J PEPT RES THER, V21, P1, DOI 10.1007/s10989-014-9427-7; Prabhala BK, 2014, FEBS LETT, V588, P560, DOI 10.1016/j.febslet.2014.01.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schindler BD, 2013, FUTURE MICROBIOL, V8, P491, DOI [10.2217/FMB.13.16, 10.2217/fmb.13.16]; Shaheen A, 2015, J INFECT CHEMOTHER, V21, P357, DOI 10.1016/j.jiac.2015.01.002; Srikumar R, 1997, J BIOL CHEM, V272, P13614, DOI 10.1074/jbc.272.21.13614; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; TORO CS, 1990, ANTIMICROB AGENTS CH, V34, P1715, DOI 10.1128/AAC.34.9.1715; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Xu ZL, 2015, ANTIBIOTICS-BASEL, V4, P379, DOI 10.3390/antibiotics4030379	43	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1007	1017		10.1074/jbc.M117.805960	http://dx.doi.org/10.1074/jbc.M117.805960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150447	hybrid, Green Published			2022-12-26	WOS:000422864500021
J	Pereira, AAS; Ferreira, ED; Lima, ACVMD; Tonelli, GB; Rego, FD; Paglia, AP; Andrade, JD; Paz, GF; Gontijo, CMF				Sampaio Pereira, Agnes Antonia; Ferreira, Eduardo de Castro; Mariano da Rocha Lima, Ana Cristina Viana; Tonelli, Gabriel Barbosa; Rego, Felipe Dutra; Paglia, Adriano Pereira; Andrade-Filho, Jose Dilermando; Paz, Gustavo Fontes; Ferreira Gontijo, Celia Maria			Detection of Leishmania spp in silvatic mammals and isolation of Leishmania (Viannia) braziliensis from Rattus rattus in an endemic area for leishmaniasis in Minas Gerais State, Brazil	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; ZOONOTIC LEISHMANIASIS; RESERVOIR HOST; WILD MAMMALS; AMAZONENSIS; INFECTION; DISEASE; PCR; EMERGENCE	Knowledge of potential reservoirs of Leishmania spp. in an anthropic environment is important so that surveillance and control measures can be implemented. The aim of this study was to investigate the infection by Leishmania in small mammals in an area located in Minas Gerais, Brazil, that undergoes changes in its natural environment and presents autochthonous human cases of cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL). For the capture of the animals, Sherman and Tomahawk traps were used and distributed in the peridomicile of houses with reports of autochthonous cases of CL or VL. Six catches were carried out on two consecutive nights with intervals of two months during one year and samples of spleen, liver, tail skin, ear skin and bone marrow of the animals were obtained. Parasitological and molecular methods were used to detect the infection. Identification of the Leishmania species was performed by PCR RFLPhsp70. Twenty five animals of four species were captured: ten Rattus rattus, nine Didelphis albiventris, five Cerradomys subflavus and one Marmosops incanus. In the PCR-hsp70, five animals were positive (20%). The Leishmania species identified in PCR-RFLPhsp70 were: Leishmania braziliensis in D. albiventris (2), C. subflavus (1) and R. rattus (1) and Leishmania infantum in R. rattus (1). The highest positivity rate for L. braziliensis was obtained in the liver samples. The spleen was the only tissue positive for L. infantum. It was isolated in culture medium L. braziliensis from two samples (liver and spleen) of R. rattus. This is the first record of isolation of L. braziliensis from R. rattus in the southeastern region of Brazil. These results are relevant to the knowledge of the epidemiology of leishmaniasis in the region, mainly in the investigation of the presence of hosts and possible reservoirs of the parasite.	[Sampaio Pereira, Agnes Antonia; Mariano da Rocha Lima, Ana Cristina Viana; Tonelli, Gabriel Barbosa; Rego, Felipe Dutra; Andrade-Filho, Jose Dilermando; Paz, Gustavo Fontes; Ferreira Gontijo, Celia Maria] FIOCRUZ MINAS, Inst Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil; [Ferreira, Eduardo de Castro] Fundacao Oswaldo Cruz Mato Grosso Sul, Campo Grande, MS, Brazil; [Paglia, Adriano Pereira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Pereira, AAS (corresponding author), FIOCRUZ MINAS, Inst Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil.	agnes.pereira@cpqrr.fiocruz.br	Andrade Filho, José Dilermando/B-7852-2013; Paglia, Adriano P/A-7965-2012; Rego, Felipe Dutra/V-4646-2019; Gontijo, Celia MF/AAU-7736-2020	Andrade Filho, José Dilermando/0000-0002-9754-8464; Paglia, Adriano P/0000-0001-9957-5506; Rego, Felipe Dutra/0000-0002-2799-8267; Gontijo, Celia MF/0000-0002-7034-535X; Ferreira, Eduardo/0000-0002-4073-6704; Barbosa Tonelli, Gabriel/0000-0002-8415-3199	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CBB - PPM-00420-16]; Conselho Nacional de desenvolvimento Cientifico e Tecnologico [306451/2014-0]; CAPES; CNPq	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Award Number: CBB - PPM-00420-16; Conselho Nacional de desenvolvimento Cientifico e Tecnologico, Award Number: 306451/2014-0. CMFG and JDAF are CNPq research fellows, AASP and FDR received scholarships from CAPES and GBT received scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CMFG and JDAF are CNPq research fellows, AASP and FDR received scholarships from CAPES and GBT received scholarship from CNPq.	Aleixo JA, 2006, T ROY SOC TROP MED H, V100, P79, DOI 10.1016/j.trstmh.2005.06.025; Alexander B, 1998, ACTA TROP, V69, P41, DOI 10.1016/S0001-706X(97)00114-9; Andrade MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004137; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Ashford RW, 1997, BELG J ZOOL, V127, P85; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; Cabrea A., 1960, MAMIFEROS SUDAMERICA; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Cassia-Pires R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003389; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Conti RV, 2016, J VECTOR DIS, V53, P99; CRONIN T M, 1987, Paleontological Society Memoir, P1; Ferreira ED, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0392-y; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; LAINSON R, 1981, T ROY SOC TROP MED H, V75, P530, DOI 10.1016/0035-9203(81)90192-9; Lima Airton Pereira, 2002, An. Bras. Dermatol., V77, P681, DOI 10.1590/S0365-05962002000600005; Lima BS, 2013, T ROY SOC TROP MED H, V107, P592, DOI 10.1093/trstmh/trt062; Oliveira FS, 2005, VET PARASITOL, V129, P219, DOI 10.1016/j.vetpar.2005.01.005; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Quaresma PF, 2011, T ROY SOC TROP MED H, V105, P579, DOI 10.1016/j.trstmh.2011.07.005; Roque ALR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000589; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Schallig HDFH, 2007, VECTOR-BORNE ZOONOT, V7, P387, DOI 10.1089/vbz.2006.0651; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008; Valdivia HO, 2017, SCI REP-UK, V7, DOI 10.1038/srep40804; VASCONCELOS IAB, 1994, AM J TROP MED HYG, V50, P158, DOI 10.4269/ajtmh.1994.50.158	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187704	10.1371/journal.pone.0187704	http://dx.doi.org/10.1371/journal.pone.0187704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176902	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900014
J	Xu, GC; Zhang, M; Wang, Y; Liu, ZA; Huo, CC; Li, ZY; Huo, MY				Xu, Gongcheng; Zhang, Ming; Wang, Yan; Liu, Zhian; Huo, Congcong; Li, Zengyong; Huo, Mengyou			Functional connectivity analysis of distracted drivers based on the wavelet phase coherence of functional near-infrared spectroscopy signals	PLOS ONE			English	Article							ARTERIAL-BLOOD PRESSURE; ELDERLY SUBJECTS; NITRIC-OXIDE; CEREBRAL OXYGENATION; PREFRONTAL CORTEX; BRAIN ACTIVITY; MOTOR IMAGERY; OSCILLATIONS; SYNCHRONIZATION; CLASSIFICATION	The present study aimed to evaluate the functional connectivity (FC) in relevant cortex areas during simulated driving with distraction based on functional near-infrared spectroscopy (fNIRS) method. Twelve subjects were recruited to perform three types of driving tasks, namely, straight driving, straight driving with secondary auditory task, and straight driving with secondary visual vigilance task, on a driving simulator. The wavelet amplitude (WA) and wavelet phase coherence (WPCO) of the fNIRS signals were calculated in six frequency intervals: I, 0.6-2 Hz; II, 0.145-0.6 Hz; III, 0.052-0.145 Hz; IV, 0.021-0.052 Hz; and V, 0.0095-0.021 Hz, VI, 0.005-0.0095Hz. Results showed that secondary tasks during driving led to worse driving performance, brain activity changes, and dynamic configuration of the connectivity. The significantly lower WA value in the right motor cortex in interval IV, and higher WPCO values in intervals II, V, and VI were found with additional auditory task. Significant standard deviation of speed and lower WA values in the left prefrontal cortex and right prefrontal cortex in interval VI, and lower WPCO values in intervals I, IV, V, and VI were found under the additional visual vigilance task. The results suggest that the changed FC levels in intervals IV, V, and VI were more likely to reflect the driver's distraction condition. The present study provides new insights into the relationship between distracted driving behavior and brain activity. The method may be used for the evaluation of drivers' attention level.	[Xu, Gongcheng; Liu, Zhian; Huo, Congcong; Huo, Mengyou] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Mfg, Jinan, Shandong, Peoples R China; [Zhang, Ming; Wang, Yan] Hong Kong Polytech Univ, Fac Engn, Dept Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Li, Zengyong] Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China; [Li, Zengyong] Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China	Shandong University; Hong Kong Polytechnic University	Huo, MY (corresponding author), Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Mfg, Jinan, Shandong, Peoples R China.; Li, ZY (corresponding author), Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China.; Li, ZY (corresponding author), Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China.	lizengyong@nrcrta.cn; hmy2618@sdu.edu.cn	Zhang, Ming/F-8331-2011; WANG, Yan/B-4144-2015	Zhang, Ming/0000-0002-6027-4594; WANG, Yan/0000-0002-5404-4098	National Natural Science Foundation of China [31771071, 11732015]; Fundamental Research Funds for Central Public Welfare Research Institutes [118009001000160001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Public Welfare Research Institutes	This project was supported by the National Natural Science Foundation of China (Grant No. 31771071, 11732015) and the Fundamental Research Funds for Central Public Welfare Research Institutes (118009001000160001).	Aamand R, 2009, AM J PHYSIOL-HEART C, V297, pH2068, DOI 10.1152/ajpheart.00525.2009; Addison PS, 2006, MECH SYST SIGNAL PR, V20, P1429, DOI 10.1016/j.ymssp.2005.03.002; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bandrivskyy A., 2004, CARDIOVASC ENG, V4, P89, DOI [10.1023/B:CARE.0000025126.63253.43, DOI 10.1023/B:CARE.0000025126.63253.43]; Barkana Y, 2004, AM J OPHTHALMOL, V138, P347, DOI 10.1016/j.ajo.2004.04.016; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borst JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012966; Bu LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169279; Bu LG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013357; Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Derosiere G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092045; Fishburn FA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00076; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gao YJ, 2015, BEHAV BRAIN RES, V278, P330, DOI 10.1016/j.bbr.2014.10.019; Giardino ND, 2007, COMPR PSYCHIAT, V48, P103, DOI 10.1016/j.comppsych.2006.11.001; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Han QY, 2014, MICROVASC RES, V95, P108, DOI 10.1016/j.mvr.2014.08.001; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Hsieh L, 2009, BRAIN RES, V1251, P162, DOI 10.1016/j.brainres.2008.10.002; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jaeger MG, 2008, YOU CAN TOUCH YOU CA, P1139; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; Jones WJ, 2003, HYPERTENSION CEREBRO, P144; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kirilina E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00864; Kober SE, 2014, BIOL PSYCHOL, V95, P21, DOI 10.1016/j.biopsycho.2013.05.005; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Li ZY, 2014, PHYSIOL MEAS, V35, P777, DOI 10.1088/0967-3334/35/5/777; Li ZY, 2013, MICROVASC RES, V88, P32, DOI 10.1016/j.mvr.2013.04.003; Li ZY, 2013, J CEREBR BLOOD F MET, V33, P692, DOI 10.1038/jcbfm.2013.4; Liu, 1998, INTRO HUMAN FACTORS; Lotric MB, 2000, PHYSIOL MEAS, V21, P441, DOI 10.1088/0967-3334/21/4/302; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Mandrick K, 2013, NEUROSCI RES, V76, P156, DOI 10.1016/j.neures.2013.04.006; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI 10.1109/MSP.2008.4408445; Medvedev AV, 2014, NEUROIMAGE, V85, P400, DOI 10.1016/j.neuroimage.2013.05.092; Naseer N., 2015, FRONTIERS HUMAN NEUR, V9; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Rehani MT, 2013, CEREBRAL HEMODYNAMIC; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Santosa H, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.5.055002; Sasai S, 2012, NEUROIMAGE, V63, P179, DOI 10.1016/j.neuroimage.2012.06.011; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Schroeter ML, 2004, J CEREBR BLOOD F MET, V24, P1183, DOI 10.1097/01.WCB.0000135231.90164.40; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; Shen H, 2016, NEUROIMAGE, V124, P367, DOI 10.1016/j.neuroimage.2015.09.010; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Stewart JM, 2007, MICROCIRCULATION, V14, P169, DOI 10.1080/10739680601139179; Strayer DL, 2007, CURR DIR PSYCHOL SCI, V16, P128, DOI 10.1111/j.1467-8721.2007.00489.x; Sussman E. D., 1985, TRANSPORT RES REC, V1047, P40; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031405; Tan QT, 2016, MICROVASC RES, V103, P19, DOI 10.1016/j.mvr.2015.10.002; Tan QT, 2015, MED PHYS, V42, P5391, DOI 10.1118/1.4928672; Tomiok H, 2009, NEUROSCI LETT, V451, P252, DOI 10.1016/j.neulet.2008.12.059; Tsimhoni O, 2004, HUM FACTORS, V46, P600, DOI 10.1518/hfes.46.4.600.56813; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; van Duinen H, 2007, NEUROIMAGE, V35, P1438, DOI 10.1016/j.neuroimage.2007.02.008; Wang BT, 2016, BEHAV BRAIN RES, V312, P238, DOI 10.1016/j.bbr.2016.06.037; Wang J-S, 1996, ROLE DRIVER INATTENT, P392; Wang W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00400; Watanuki K, 2013, IEEE SYS MAN CYBERN, P4134, DOI 10.1109/SMC.2013.705; Wickens CD, 2008, HUM FACTORS, V50, P397, DOI 10.1518/001872008X288420; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Xu LL, 2017, J CO2 UTIL, V18, P1, DOI 10.1016/j.jcou.2017.01.003; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00882; Zhang Q, 2007, J BIOMEDICAL OPTICS, V12	86	20	21	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188329	10.1371/journal.pone.0188329	http://dx.doi.org/10.1371/journal.pone.0188329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176895	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900061
J	Chua, ECP; Fang, E; Gooley, JJ				Chua, Eric Chern-Pin; Fang, Eric; Gooley, Joshua J.			Effects of total sleep deprivation on divided attention performance	PLOS ONE			English	Article							PLASMA-LIPIDS; VARIABILITY; METAANALYSIS; VIGILANCE; TRACKING	Dividing attention across two tasks performed simultaneously usually results in impaired performance on one or both tasks. Most studies have found no difference in the dual-task cost of dividing attention in rested and sleep-deprived states. We hypothesized that, for a divided attention task that is highly cognitively-demanding, performance would show greater impairment during exposure to sleep deprivation. A group of 30 healthy males aged 21 - 30 years was exposed to 40 h of continuous wakefulness in a laboratory setting. Every 2 h, subjects completed a divided attention task comprising 3 blocks in which an auditory Go/No-Go task was 1) performed alone (single task); 2) performed simultaneously with a visual Go/No-Go task (dual task); and 3) performed simultaneously with both a visual Go/No-Go task and a visually-guided motor tracking task (triple task). Performance on all tasks showed substantial deterioration during exposure to sleep deprivation. A significant interaction was observed between task load and time since wake on auditory Go/No-Go task performance, with greater impairment in response times and accuracy during extended wakefulness. Our results suggest that the ability to divide attention between multiple tasks is impaired during exposure to sleep deprivation. These findings have potential implications for occupations that require multi-tasking combined with long work hours and exposure to sleep loss.	[Chua, Eric Chern-Pin; Fang, Eric; Gooley, Joshua J.] Duke NUS Med Sch, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore; [Fang, Eric] Singapore Gen Hosp, Dept Diagnost Radiol, Singapore, Singapore	National University of Singapore; Singapore General Hospital	Gooley, JJ (corresponding author), Duke NUS Med Sch, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore.	gmsjjg@nus.edu.sg	Fang, Eric/GXV-4491-2022		Duke-NUS Signature Research Program - Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; National Medical Research Council, Singapore [NIG/1000/2009]; SingHealth Foundation, Singapore [SHF/FG410P/2009]	Duke-NUS Signature Research Program - Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)National University of Singapore); Ministry of Health, Singapore(Ministry of Health-Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore); SingHealth Foundation, Singapore(SingHealth)	This work was supported by the Duke-NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore (www.a-star.edu.sg), and the Ministry of Health, Singapore (www.moh.gov.sg); National Medical Research Council, Singapore (http://www.nmrc.gov.sg) under NIG/1000/2009 (JJG); SingHealth Foundation, Singapore (https://www.singhealth.com.sg/Pages/home.aspx), under SHF/FG410P/2009. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhola P, 2005, MENOPAUSE, V12, P149, DOI 10.1097/00042192-200512020-00008; Almklov EL, 2015, BEHAV SLEEP MED, V13, P324, DOI 10.1080/15402002.2014.905474; Anderson C, 2006, SLEEP, V29, P573, DOI 10.1093/sleep/29.4.573; Baulk SD, 2001, SLEEP, V24, P695, DOI 10.1093/sleep/24.6.695; Beaumont M, 2001, J SLEEP RES, V10, P265, DOI 10.1046/j.1365-2869.2001.00266.x; Bishop C, 1997, EXP CLIN PSYCHOPHARM, V5, P344, DOI 10.1037/1064-1297.5.4.344; BOHNEN HGM, 1994, ERGONOMICS, V37, P1021, DOI 10.1080/00140139408963715; Bratzke D, 2007, PSYCHOL SCI, V18, P456, DOI 10.1111/j.1467-9280.2007.01921.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chua ECP, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12129; Chua ECP, 2015, SLEEP, V38, P1683, DOI 10.5665/sleep.5142; Chua ECP, 2014, SLEEP, V37, P27, DOI 10.5665/sleep.3302; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Chua ECP, 2012, SLEEP, V35, P325, DOI 10.5665/sleep.1688; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Dingus TA, 2016, P NATL ACAD SCI USA, V113, P2636, DOI 10.1073/pnas.1513271113; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Drummond SPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035653; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Fischer R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01366; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Haavisto ML, 2010, J SLEEP RES, V19, P444, DOI 10.1111/j.1365-2869.2010.00823.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Jackson ML, 2011, BRAIN IMAGING BEHAV, V5, P97, DOI 10.1007/s11682-011-9115-6; Jasper I, 2010, CHRONOBIOL INT, V27, P653, DOI 10.3109/07420521003663793; Kahneman D., 1973, ATTENTION EFFORT, P136; Kong DY, 2012, NEUROIMAGE, V61, P50, DOI 10.1016/j.neuroimage.2012.02.081; Kuypers KPC, 2007, PSYCHOPHARMACOLOGY, V192, P111, DOI 10.1007/s00213-006-0679-6; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pilcher JJ, 2007, AVIAT SPACE ENVIR MD, V78, pB15; Redick TS, 2011, J EXP PSYCHOL LEARN, V37, P308, DOI 10.1037/a0022216; Rupp T, 2004, PERCEPT MOTOR SKILL, V99, P739, DOI 10.2466/pms.99.3.739-753; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; van Eekelen A, 2003, ERGONOMICS, V46, P1578, DOI 10.1080/0014013031000121598	37	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187098	10.1371/journal.pone.0187098	http://dx.doi.org/10.1371/journal.pone.0187098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166387	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300009
J	Hestehave, S; Munro, G; Christensen, R; Pedersen, TB; Arvastson, L; Hougaard, P; Abelson, KSP				Hestehave, Sara; Munro, Gordon; Christensen, Rie; Pedersen, Tina Bronnum; Arvastson, Lars; Hougaard, Philip; Abelson, Klas S. P.			Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes?	PLOS ONE			English	Article							SPARED NERVE INJURY; VOLUNTARILY-INGESTED BUPRENORPHINE; CORTICOSTERONE METABOLITES; BODY-WEIGHT; RAT; EXCRETION; BLOOD; CATHETERIZATION; MONONEUROPATHY; QUANTIFICATION	Introduction The induction of neuropathic pain-like behaviors in rodents often requires surgical intervention. This engages acute nociceptive signaling events that contribute to pain and stress post-operatively that from a welfare perspective demands peri-operative analgesic treatment. However, a large number of researchers avoid providing such care based largely on anecdotal opinions that it might interfere with model pathophysiology in the longer term. Objectives To investigate effects of various peri-operative analgesic regimens encapsulating different mechanisms and duration of action, on the development of post-operative stress/welfare and pain-like behaviors in the Spared Nerve Injury (SNI)-model of neuropathic pain. Methods Starting on the day of surgery, male Sprague-Dawley rats were administered either vehicle (s.c.), carprofen (5.0mg/kg, s.c.), buprenorphine (0.1mg/kg s.c. or 1.0mg/kg p.o. in Nutella (R)), lidocaine/bupivacaine mixture (local irrigation) or a combination of all analgesics, with coverage from a single administration, and up to 72 hours. Post-operative stress and recovery were assessed using welfare parameters, bodyweight, food-consumption, and fecal corticosterone, and hindpaw mechanical allodynia was tested for assessing development of neuropathic pain for 28 days. Results None of the analgesic regimes compromised the development of mechanical allodynia. Unexpectedly, the combined treatment with 0.1mg/kg s.c. buprenorphine and carprofen for 72 hours and local irrigation with lidocaine/bupivacaine, caused severe adverse effects with peritonitis. This was not observed when the combination included a lower dose of buprenorphine (0.05mg/kg, s.c.), or when buprenorphine was administered alone (0.1mg/kg s.c. or 1.0mg/kg p.o.) for 72 hours. An elevated rate of wound dehiscence was observed especially in the combined treatment groups, underlining the need for balanced analgesia. Repeated buprenorphine injections had positive effects on body weight the first day after surgery, but depressive effects on food intake and body weight later during the first week. Conclusion Post-operative analgesia does not appear to affect established neuropathic hypersensitivity outcome in the SNI model.	[Hestehave, Sara; Abelson, Klas S. P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark; [Hestehave, Sara; Munro, Gordon; Christensen, Rie] H Lundbeck & Co AS, Dept Neurodegenerat In Vivo, Valby, Denmark; [Munro, Gordon] Glostrup Res Inst, Danish Headache Ctr, Dept Neurol, Glostrup, Denmark; [Pedersen, Tina Bronnum] H Lundbeck & Co AS, Dept Nonclin Safety Res, Valby, Denmark; [Arvastson, Lars; Hougaard, Philip] H Lundbeck & Co AS, Biometr, Valby, Denmark	University of Copenhagen; Lundbeck Corporation; Lundbeck Corporation; Lundbeck Corporation	Hestehave, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark.; Hestehave, S (corresponding author), H Lundbeck & Co AS, Dept Neurodegenerat In Vivo, Valby, Denmark.	sara.kristensen@sund.ku.dk	Hestehave, Sara/AAZ-5283-2021	Hestehave, Sara/0000-0002-1837-521X; Abelson, Klas/0000-0002-4986-7882	Centre for Applied Laboratory Animal Research (CALAR); H. Lundbeck A/S	Centre for Applied Laboratory Animal Research (CALAR); H. Lundbeck A/S	The present study was financially supported by the Centre for Applied Laboratory Animal Research (CALAR) and by H. Lundbeck A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lars Arvastson, Philip Hougaard, Rie Christensen and Tina Bronnum Pedersen are employed by H. Lundbeck A/S who provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abbott FV, 1997, VET REC, V140, P553, DOI 10.1136/vr.140.21.553; Abdi S, 2000, BRIT J ANAESTH, V85, P620, DOI 10.1093/bja/85.4.620; Abelson KSP, 2012, LAB ANIM-UK, V46, P349, DOI 10.1258/la.2012.012028; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BREWSTER D, 1981, J PHARM PHARMACOL, V33, P500, DOI 10.1111/j.2042-7158.1981.tb13848.x; Broom DC, 2004, NEUROSCIENCE, V124, P891, DOI 10.1016/j.neuroscience.2004.01.003; Carlsson HE, 2007, RES VET SCI, V82, P423, DOI 10.1016/j.rvsc.2006.09.005; Curtin LI, 2009, COMPARATIVE MED, V59, P60; Cuvillon P, 2009, ANESTH ANALG, V108, P641, DOI 10.1213/ane.0b013e31819237f8; Dahl JB, 2011, CURR OPIN ANESTHESIO, V24, P331, DOI 10.1097/ACO.0b013e328345afd9; Dahlin J, 2009, SCAND J LAB ANIM SCI, V36, P205; De Winter BY, 1997, EUR J PHARMACOL, V339, P63, DOI 10.1016/S0014-2999(97)01345-9; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DOUGHERTY PM, 1992, BRAIN RES, V570, P109, DOI 10.1016/0006-8993(92)90570-Y; Erichsen HK, 2005, PAIN, V116, P347, DOI 10.1016/j.pain.2005.05.004; Erichsen HK, 2002, PAIN, V98, P151, DOI 10.1016/S0304-3959(02)00039-8; FLECKNELL PA, 1991, LAB ANIM, V25, P50, DOI 10.1258/002367791780808239; FLECKNELL PA, 1984, LAB ANIM, V18, P147, DOI 10.1258/002367784780891226; GALECKI AT, 1994, COMMUN STAT THEORY, V23, P3105, DOI 10.1080/03610929408831436; Goldkuhl R, 2010, IN VIVO, V24, P131; Hampshire VA, 2001, LAB ANIM-UK, V35, P223, DOI 10.1258/0023677011911660; Hau J, 2001, LAB ANIM-UK, V35, P301, DOI 10.1258/0023677011911822; Hellebrekers L, 2011, HDB LAB ANIMAL SCI, V1; Hestehave S, 2017, LAB ANIM-UK, V51, P264, DOI 10.1177/0023677216668553; Jaggi AS, 2011, FUND CLIN PHARMACOL, V25, P1, DOI 10.1111/j.1472-8206.2009.00801.x; Kalliokoski O, 2012, IN VIVO, V26, P213; Kato S, 2005, AM J PHYSIOL-GASTR L, V289, pG64, DOI 10.1152/ajpgi.00397.2004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Kouya PF, 2004, NEUROSCI LETT, V359, P127, DOI 10.1016/j.neulet.2004.02.007; Kouya PF, 2002, EUR J PHARMACOL, V450, P49, DOI 10.1016/S0014-2999(02)02052-6; Martinez V, 2017, PAIN, V158, P775, DOI 10.1097/j.pain.0000000000000838; Mogil JS, 2015, PAIN, V156, pS35, DOI 10.1097/01.j.pain.0000460341.62094.77; Morton D, 2011, HDB LAB ANIMAL SCI, V1, P535; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Namaka M, 2004, CLIN THER, V26, P951, DOI 10.1016/S0149-2918(04)90171-3; Nickel FT, 2012, EUR NEUROPSYCHOPHARM, V22, P81, DOI 10.1016/j.euroneuro.2011.05.005; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Pertin M, 2012, METHODS MOL BIOL, V851, P205, DOI 10.1007/978-1-61779-561-9_15; Royo F, 2004, J ENDOCRINOL, V180, P145, DOI 10.1677/joe.0.1800145; Scott NB, 2010, ANAESTHESIA, V65, P67, DOI 10.1111/j.1365-2044.2010.06241.x; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Simkins MD, 1998, CONTEMP TOP LAB ANIM, V37, P61; Siswanto H, 2008, IN VIVO, V22, P435; Stewart LSA, 2003, COMPARATIVE MED, V53, P29; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Sundbom R, 2011, IN VIVO, V25, P335; Suter MR, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/124898; Suter MR, 2003, ANESTHESIOLOGY, V99, P1402, DOI 10.1097/00000542-200312000-00025; Suzuki K, 2001, DIGESTION, V63, P92, DOI 10.1159/000051876; THORBEK G, 1982, ARCH TIERERNAHR, V32, P827, DOI 10.1080/17450398209421032; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2; Wallace M S, 2001, Curr Pain Headache Rep, V5, P138, DOI 10.1007/s11916-001-0082-2; WOOLF CJ, 1993, ANESTH ANALG, V77, P362, DOI 10.1213/00000539-199377020-00026; Xie WR, 2005, PAIN, V116, P243, DOI 10.1016/j.pain.2005.04.017; Yang F, 2014, PAIN, V155, P356, DOI 10.1016/j.pain.2013.10.024	57	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188113	10.1371/journal.pone.0188113	http://dx.doi.org/10.1371/journal.pone.0188113			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166664	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300025
J	Navarro-Haro, MV; Lopez del Hoyo, Y; Campos, D; Linehan, MM; Hoffman, HG; Garcia-Palacios, A; Modrego-Alarcon, M; Borao, L; Garcia-Campayo, J				Navarro-Haro, Maria V.; Lopez del Hoyo, Yolanda; Campos, Daniel; Linehan, Marsha M.; Hoffman, Hunter G.; Garcia-Palacios, Azucena; Modrego-Alarcon, Marta; Borao, Luis; Garcia-Campayo, Javier			Meditation experts try Virtual Reality Mindfulness: A pilot study evaluation of the feasibility and acceptability of Virtual Reality to facilitate mindfulness practice in people attending a Mindfulness conference.	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; BEHAVIOR-THERAPY; SELF-COMPASSION; PAIN-CONTROL; IMPACT; QUESTIONNAIRE; INDIVIDUALS; BENEFITS; SENSE	Regular mindfulness practice benefits people both mentally and physically, but many populations who could benefit do not practice mindfulness. Virtual Reality (VR) is a new technology that helps capture participants' attention and gives users the illusion of "being there" in the 3D computer generated environment, facilitating sense of presence. By limiting distractions from the real world, increasing sense of presence and giving people an interesting place to go to practice mindfulness, Virtual Reality may facilitate mindfulness practice. Traditional Dialectical Behavioral Therapy (DBT (R)) mindfulness skills training was specifically designed for clinical treatment of people who have trouble focusing attention, however severe patients often show difficulties or lack of motivation to practice mindfulness during the training. The present pilot study explored whether a sample of mindfulness experts would find useful and recommend a new VR Dialectical Behavioral Therapy (DBT (R)) mindfulness skills training technique and whether they would show any benefit. Forty four participants attending a mindfulness conference put on an Oculus Rift DK2 Virtual Reality helmet and floated down a calm 3D computer generated virtual river while listening to digitized DBT (R) mindfulness skills training instructions. On subjective questionnaires completed by the participants before and after the VR DBT (R) mindfulness skills training session, participants reported increases/improvements in state of mindfulness, and reductions in negative emotional states. After VR, participants reported significantly less sadness, anger, and anxiety, and reported being significantly more relaxed. Participants reported a moderate to strong illusion of going inside the 3D computer generated world (i.e., moderate to high "presence" in VR) and showed high acceptance of VR as a technique to practice mindfulness. These results show encouraging preliminary evidence of the feasibility and acceptability of using VR to practice mindfulness based on clinical expert feedback. VR is a technology with potential to increase computerized dissemination of DBT (R) skills training modules. Future research is warranted.	[Navarro-Haro, Maria V.] Hosp Gen Cataluna, Barcelona, Spain; [Lopez del Hoyo, Yolanda] Univ Zaragoza, Zaragoza, Spain; [Lopez del Hoyo, Yolanda; Modrego-Alarcon, Marta; Borao, Luis; Garcia-Campayo, Javier] Red Invest Atenc Primaria REDIAPP, Zaragoza, Spain; [Campos, Daniel; Garcia-Palacios, Azucena] Univ Jaume 1, Castellon de La Plana, Spain; [Linehan, Marsha M.] Univ Washington, Behav Res & Therapy Clin, Seattle, WA 98195 USA; [Hoffman, Hunter G.] Univ Washington, Virtual Real Res Ctr, Human Photon Lab, Mech Engn, Seattle, WA 98195 USA; [Garcia-Palacios, Azucena] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBERobn, CB06-03, Madrid, Spain; [Garcia-Campayo, Javier] Hosp Univ Miguel Servet, ISS Aragon, Zaragoza, Spain	University of Zaragoza; Universitat Jaume I; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Miguel Servet University Hospital	Campos, D (corresponding author), Univ Jaume 1, Castellon de La Plana, Spain.	camposdcb@gmail.com	Haro, Maria Vicenta Navarro/AAM-8500-2020; Bacas, Daniel Campos/AAA-3440-2020; López del Hoyo, Yolanda/W-4602-2018; Hoffman, hunter/AGE-1376-2022	Haro, Maria Vicenta Navarro/0000-0001-9726-3250; Bacas, Daniel Campos/0000-0001-9903-4064; López del Hoyo, Yolanda/0000-0002-1690-4130; Borao, Luis/0000-0002-1437-2353; Garcia-Campayo, Javier/0000-0002-3797-4218; Modrego, Marta/0000-0003-1575-7738	NIH [R01GM042725, R01AR054115, R01-DA026438]; Effat University, Jeddah Saudi Arabia Research and Consultancy Institute; Master of Mindfulness, University of Zaragoza, Zaragoza, Spain; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effat University, Jeddah Saudi Arabia Research and Consultancy Institute; Master of Mindfulness, University of Zaragoza, Zaragoza, Spain; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants to David Patterson R01GM042725, R01AR054115, and an NIH grant to Sam Sharar R01-DA026438, and by Effat University, Jeddah Saudi Arabia Research and Consultancy Institute. This project was also funded by the Master of Mindfulness, University of Zaragoza, Zaragoza, Spain.	Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Banos RM, 2009, BRIT J GUID COUNS, V37, P347, DOI 10.1080/03069880902957064; Banos RM, 2004, CYBERPSYCHOL BEHAV, V7, P734, DOI 10.1089/cpb.2004.7.734; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Botella C, 2007, CLIN PSYCHOL PSYCHOT, V14, P164, DOI 10.1002/cpp.524; Botella J., 2015, META ANAALISIS CIENC; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Campbell D. T., 1963, HDB RES TEACHING, P171; Campos D, 2016, PERS INDIV DIFFER, V93, P80, DOI 10.1016/j.paid.2015.08.040; Cebolla A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-6; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Elices M, 2016, MINDFULNESS, V7, P584, DOI 10.1007/s12671-016-0492-1; Erisman SM, 2010, EMOTION, V10, P72, DOI 10.1037/a0017162; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Hoffman HG, 2000, PAIN, V85, P305, DOI 10.1016/S0304-3959(99)00275-4; Hoffman HG, 2003, INT J HUM-COMPUT INT, V15, P469, DOI 10.1207/S15327590IJHC1503_10; Hoffman HG, 2011, ANN BEHAV MED, V41, P183, DOI 10.1007/s12160-010-9248-7; Irving Julie Anne, 2009, Complement Ther Clin Pract, V15, P61, DOI 10.1016/j.ctcp.2009.01.002; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kabat-Zinn J., 2016, MINDFULNESS COMPASSI, V1, P2, DOI [10.1016/j.mincom.2016.09.007, DOI 10.1016/J.MINCOM.2016.09.007]; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Keune PM., 2010, PSYCHOL TOP, V19, P373; Lancaster Gillian A, 2015, Pilot Feasibility Stud, V1, P1, DOI 10.1186/2055-5784-1-1; Lessiter J, 2001, PRESENCE-TELEOP VIRT, V10, P282, DOI 10.1162/105474601300343612; Linehan M., 2002, SUFFERING FREEDOM AC; Linehan M.M, 2015, DBT R SKILLS TRAININ, Vsecond; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Linehan MM, 2015, JAMA PSYCHIAT, V72, P475, DOI 10.1001/jamapsychiatry.2014.3039; Lopez A, 2016, MINDFULNESS, V7, P1289, DOI 10.1007/s12671-016-0568-y; Maani CV, 2011, J TRAUMA, V71, pS125, DOI 10.1097/TA.0b013e31822192e2; Montero-Marin J, 2016, FRONT PSYCHOL, P7; Montero-Marin J, 2015, FRONT PSYCHOL, P6; Navarro-Haro MV, 2016, FRONT PSYCHOL; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Slater M., 1994, PRESENCE-TELEOP VIRT, V3, P130, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2, DOI 10.1162/PRES.1994.3.2.130, 10.1162/pres.1994.3.2.130]; Soler J, 2012, PSYCHOM PROPR SPANIS, V40, P19; Soler J, 2016, BORDER PERS DIS EMOT, V3, DOI 10.1186/s40479-015-0035-8; Soler J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086622; Soler J, 2012, BEHAV RES THER, V50, P150, DOI 10.1016/j.brat.2011.12.002; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Valentine SE, 2015, J CLIN PSYCHOL, V71, P1, DOI 10.1002/jclp.22114; Wilks CR, 2017, COGN BEHAV PRACT, V24, P288, DOI 10.1016/j.cbpra.2016.06.004	46	51	56	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187777	10.1371/journal.pone.0187777	http://dx.doi.org/10.1371/journal.pone.0187777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166665	gold, Green Published, Green Submitted			2022-12-26	WOS:000416035300019
J	Ramalho, MO; Bueno, OC; Moreau, CS				Ramalho, Manuela Oliveira; Bueno, Odair Correa; Moreau, Corrie Saux			Species-specific signatures of the microbiome from Camponotus and Colobopsis ants across developmental stages	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; BLOCHMANNIA-FLORIDANUS; IMMUNE-RESPONSE; GENOME SEQUENCE; BACTERIAL; COMMUNITY; WOLBACHIA; SYMBIONTS; EVOLUTION; PASTEURELLACEAE	Symbiotic relationships between hosts and bacteria are common in nature, and these may be responsible for the evolutionary success of various groups of animals. Among ants, these associations have been well studied in some genera of the Camponotini, but several questions remain regarding the generality of the previous findings across all the members of this ant tribe and if bacterial communities change across development in these hosts. This study is the first to characterize the bacterial community associated with a colony of the recently recognized genus Colobopsis and three colonies of Camponotus (two distinct species) and show how different the composition of the bacterial community is when compared across the different genera. Our data reveal that Colobopsis (species: Co. riehlii) and Camponotus (species: Ca. floridanus and Ca. planatus) have distinct microbiota, and we were able to verify that the identity of the species contributes more to the bacterial diversity. We also demonstrated that there were no significant differences between colonies of the same species (Camponotus planatus), and between stages of development from different colonies. We did find that some developmental stages have distinct bacteria, confirming that each stage of development could have a specific microbiota. Our results show species are one of the factors that shape the bacterial community in these Camponotini ants. Additional studies of the intra-colonial microbiome of other hosts and across development may reveal additional clues about the function and importance of bacteria in colony recognition, individual and colony health, and nutritional upgrading.	[Ramalho, Manuela Oliveira; Bueno, Odair Correa] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, Dept Biol, Campus Rio Claro, Rio Claro, SP, Brazil; [Ramalho, Manuela Oliveira; Bueno, Odair Correa] Ctr Estudos Insetos Sociais, Rio Claro, SP, Brazil; [Ramalho, Manuela Oliveira; Moreau, Corrie Saux] Field Museum Nat Hist, Dept Sci & Educ, Integrat Res Ctr, Chicago, IL 60605 USA	Universidade Estadual Paulista; Field Museum of Natural History (Chicago)	Ramalho, MO (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, Dept Biol, Campus Rio Claro, Rio Claro, SP, Brazil.; Ramalho, MO (corresponding author), Ctr Estudos Insetos Sociais, Rio Claro, SP, Brazil.; Ramalho, MO (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, Integrat Res Ctr, Chicago, IL 60605 USA.	manuramalho2010@gmail.com			CAPES Foundation [007343/2014-00]; Ministry of Education of Brazil, (Brasilia) [DF 70.040-020]; National Science Foundation [DEB-1442316]; Field Dreams program of The Women's Board of The Field Museum; Lauer Foundation for Paleontology, Science and Education NFP	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil, (Brasilia); National Science Foundation(National Science Foundation (NSF)); Field Dreams program of The Women's Board of The Field Museum; Lauer Foundation for Paleontology, Science and Education NFP	M.O.R. thanks CAPES Foundation (process no. 007343/2014-00) the Ministry of Education of Brazil, (Brasilia DF 70.040-020) for their financial support. C.S.M. acknowledges the National Science Foundation (DEB-1442316) and Field Dreams program of The Women's Board of The Field Museum for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Matt Boot, Kevin Feldheim, Estefany Romero, Andrea Thompson, Max Winston, Brian Wray, and Erica Zahnle, for their invaluable assistance in the laboratory. For advice regarding the experimental design and analyses we thank Sarah Owens, Benjamin Rubin, Jon Sanders, Max Winston and Brian Wray. All laboratory work was completed in the Pritzker Laboratory for Molecular Systematics and Evolution at the Field Museum of Natural History, Chicago, Illinois, USA. We thank all members of the Moreau Lab for various advice and help. We thank Bruce and Rene Lauer and the Lauer Foundation for Paleontology, Science and Education NFP for generous support of the Pritzker Laboratory and the Field Dreams program of The Women's Board of The Field Museum, which made this research possible. We thank the following agencies for permissions and permits to collect ant specimens in the Florida Keys: Florida Department of Environmental Protection Division of Recreation and Parks, United States Department of Interior Fish and Wildlife Service, and The Nature Conservancy. MOR thanks Ana Maria A. O. Ramalho and Roselei Ap. SimOes Sanchez for their very generous support and encouragement during all parts of the study. Lastly we thank the reviewers of this manuscript for helpful suggestions that improved this paper.	Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baumann P., 2005, ANN REV MICROBIOL; BISGAARD M, 1993, ZBL BAKT-INT J MED M, V279, P7, DOI 10.1016/S0934-8840(11)80487-1; Blaimer BB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0552-5; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bolton B., 2020, ONLINE CATALOG ANTS; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brown BP, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0721-8; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BUENO O C, 1975, Studia Entomologica, V18, P605; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Christensen H, 2010, BERL MUNCH TIERARZTL, V123, P20, DOI 10.2376/0005-9366-123-20; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook SC, 2006, ENTOMOL EXP APPL, V118, P1, DOI 10.1111/j.1570-7458.2006.00374.x; Creighton WS, 1967, NAT HIST, V76, P71; Davidson D. W., 2003, SCIENCE, P300; De Souza DJ, 2008, J INSECT PHYSIOL, V54, P828, DOI 10.1016/j.jinsphys.2008.03.001; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Degnan PH, 2004, SYST BIOL, V53, P95, DOI 10.1080/10635150490264842; Dillon RJ, 2010, ANTON LEEUW INT J G, V97, P69, DOI 10.1007/s10482-009-9389-5; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilmus S, 2009, APPL ENVIRON MICROB, V75, P4324, DOI 10.1128/AEM.00455-09; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Evans JD, 2009, J APICULT RES, V48, P300, DOI 10.3896/IBRA.1.48.4.13; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Forel A, 1892, NEUJAHRSBLATT NATURF, V95, P1; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Higgins D., 1992, COMPUT APPL; Holldobler B., 1990, pi; Hu Y, 2014, MOL ECOL, V23, P1284, DOI 10.1111/mec.12607; Hu┬lldobler, 1985, PSYCHE CAMBRIDGE, V91, P201, DOI DOI 10.1155/1984/70141; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628, DOI 10.1128/AEM.57.9.2628-2634.1991; Kautz S., 2013, Psyche: A Journal of Entomology, V2013, P936341, DOI 10.1155/2013/936341; Kellner K, 2015, FEMS MICROBIOL ECOL, P91; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Ley R. E., 2008, SCIENCE, P320; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McMahan E. A., 1969, P387; Miller M, 2017, CIPRES PORTALS; Minkley N, 2006, INSECT SOC, V53, P339, DOI 10.1007/s00040-006-0878-5; Moreau Corrie S., 2014, Halteres, V5, P32; Moreau CS, 2013, EVOLUTION, V67, P2240, DOI 10.1111/evo.12105; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUNSON MA, 1991, J BACTERIOL, V173, P6321, DOI 10.1128/jb.173.20.6321-6324.1991; Oksanen J, 2007, COMMUNITY ECOL; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Pohl S., 1981, Haemophilus, Pasteurella and Actinobacillus, P245; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramalho MO, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0945-8; Ramalho MO, 2017, CURR MICROBIOL; Rubin BER, 2014, MICROBIOLOGYOPEN; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Sameshima S, 1999, ZOOL SCI, V16, P993, DOI 10.2108/zsj.16.993; Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611; Schmid-Hempel P., 1998, Parasites in social insects.; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker DD, 2003, MOL ECOL, V12, P1757, DOI 10.1046/j.1365-294X.2003.01864.x; Stoll S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-308; Stoll S, 2009, ENVIRON MICROBIOL, V11, P877, DOI 10.1111/j.1462-2920.2008.01808.x; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vila R., 2006, SCIENCE, P312; Ward PS, 2016, ZOOTAXA, V4072, P343, DOI 10.11646/zootaxa.4072.3.4; Wernegreen JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-292; WHEELER D E, 1984, Psyche (Cambridge), V91, P171, DOI 10.1155/1984/65369; Wheeler WM, 1904, AM ANTS SUBGENUS COL; Williams LE, 2015, PEERJ, V3, DOI 10.7717/peerj.881; Williams LE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-687; WILSON EO, 1976, ANIM BEHAV, V24, P354, DOI 10.1016/S0003-3472(76)80043-7; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zientz E, 2005, ARCH MICROBIOL, V184, P199, DOI 10.1007/s00203-005-0041-0	89	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187461	10.1371/journal.pone.0187461	http://dx.doi.org/10.1371/journal.pone.0187461			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166404	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300013
J	Senapati, R; Nayak, B; Kar, SK; Dwibedi, B				Senapati, Rashmirani; Nayak, Bhagyalaxmi; Kar, Shantanu Kumar; Dwibedi, Bhagirathi			HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HIGH-RISK; SOUTHERN CHINESE; MULTIPLE TYPES; COSTA-RICA; NEOPLASIA; WOMEN; PROTECTION; EFFICACY; CANCER	HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR: 5.87; 95% CI-1.28-26-29; p=.02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p=.03), multiple genotypes of alpha 9 species(OR = 5.3 95% CI = 1.14-24.03; p=.007), and multiple genotypes of alpha 7 species (OR = 2.5; 95% CI=.49-13.45; p=.2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p=.001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p=.17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR=.44 95% CI (.244-.8) p=.007) and it is statistically significant. Genotypes not targeted by 9-valent vaccines (OR=.40; 95% CI=.19-.85; p=.017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = <.001) were at 4.1 fold higher risk of developing invasive cervical carcinoma. In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections.	[Senapati, Rashmirani; Dwibedi, Bhagirathi] Reg Med Res Ctr ICMR, Viral Res & Diagnost Lab, Nalcosq, Bhubanewar, Odisha, India; [Nayak, Bhagyalaxmi] Acharya Hari Hara Reg Canc Ctr, Dept Gynecol Oncol, Cuttack, Odisha, India; [Kar, Shantanu Kumar] SOA Univ, IMS & SUM Hosp, Directorate Med Res, Bhubaneswar, Odisha, India	Siksha 'O' Anusandhan University	Dwibedi, B (corresponding author), Reg Med Res Ctr ICMR, Viral Res & Diagnost Lab, Nalcosq, Bhubanewar, Odisha, India.	bhagirathidwibedi@yahoo.com	Nayak, Bhagyalaxmi/AAB-2230-2021		Indian council of mrdical research, India [ICMR-80/780/2012-ECD-I]	Indian council of mrdical research, India	This work was supported by the Indian council of mrdical research, India, Grant no-ICMR-80/780/2012-ECD-I (www.icmr.nic.in). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chagas BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132570; Chan DPC, 2005, J INFECT DIS, V192, P1749, DOI 10.1086/497342; Chan PKS, 2007, J MED VIROL, V79, P970, DOI 10.1002/jmv.20805; Chan PKS, 2007, GYNECOL ONCOL, V105, P736, DOI 10.1016/j.ygyno.2007.02.013; Chan PKS, 2006, INT J CANCER, V118, P1430, DOI 10.1002/ijc.21528; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Combita A, 2013, REV COLOMB CANCEROL, V17, P103, DOI 10.1016/S0123-9015(13)70012-X; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Luostarinen T, 1999, INT J CANCER, V80, P818, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;818::AID-IJC4&gt;3.0.CO;2-T; Mori S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-11; Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Raychaudhuri S, 2012, ASIAN PAC J CANCER P, V13, P1093, DOI 10.7314/APJCP.2012.13.4.1093; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Silins I, 1999, J GEN VIROL, V80, P2931, DOI 10.1099/0022-1317-80-11-2931; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; Tao LX, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-1185, 10.1186/1471-2458-14-353]; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129	30	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187844	10.1371/journal.pone.0187844	http://dx.doi.org/10.1371/journal.pone.0187844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161285	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000022
J	Wells, CD; Sebens, KP				Wells, Christopher D.; Sebens, Kenneth P.			Individual marking of soft-bodied subtidal invertebrates in situ - A novel staining technique applied to the giant plumose anemone Metridium farcimen (Tilesius, 1809)	PLOS ONE			English	Article							ANTHOPLEURA-ELEGANTISSIMA BRANDT; TIDAL SEA-ANEMONES; XANTHOGRAMMICA BRANDT; METHYLENE-BLUE; BODY SIZE; DYE; REPRODUCTION; TADPOLES; HABITAT	The ability to recognize individuals and track growth over time is crucial to population dynamics research as well as studies of animal behavior. Invertebrates are particularly difficult to track as they often molt, have regenerative capabilities, or lack hard parts to attach markers. We tested, in laboratory and field studies, a new way of marking sea anemones (order Actiniaria) by injection of three vital stains (i.e., neutral red, methylene blue, and fluorescein). Neutral red and methylene blue did not affect growth or survival, but fluorescein was lethal at high concentrations. Marked individuals could be identified up to seven months after injection with neutral red, six weeks with methylene blue, and three days with low concentrations of fluorescein. Neutral red could be used for long-term monitoring of growth and survival in the field, and in combination with methylene blue could be used to mark individuals in distinguishable patterns for short-term studies such as examining predator-prey interactions, movement of individuals, and recruitment survival.	[Wells, Christopher D.; Sebens, Kenneth P.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Wells, Christopher D.; Sebens, Kenneth P.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Sebens, Kenneth P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington; University of Washington Seattle	Wells, CD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Wells, CD (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	cdwells@uw.edu	Wells, Christopher/ABH-6827-2020	Wells, Christopher/0000-0002-5945-6171	Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department; Richard and Megumi Strathmann Fellowship from Friday Harbor Laboratory; Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory; American Museum of Natural History	Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department; Richard and Megumi Strathmann Fellowship from Friday Harbor Laboratory; Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory; American Museum of Natural History	This research was funded by the Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department (https/www.biology.washington.edu/programs/graduate/awards-and-fellowships) awarded to CDW, the Richard and Megumi Strathmann Fellowship and the Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory (http://depts.washington.edu/fhl/studentFellowships.html) awarded to CDW, and the Lerner-Gray Grant for Marine Research from the American Museum of Natural History (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics -and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships#grants) awarded to CDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOSA P, 1970, ENTOMOL EXP APPL, V13, P293, DOI 10.1007/BF00334315; Carlson BE, 2013, ETHOLOGY, V119, P167, DOI 10.1111/eth.12050; Caswell, 2000, MATRIX POPULATION MO; Drolet D, 2006, J CRUSTACEAN BIOL, V26, P540, DOI 10.1651/S-2717.1; Eerkes-Medrano D, 2015, INVERTEBR BIOL, V134, P1, DOI 10.1111/ivb.12072; Evans TA, 2000, SOCIOBIOLOGY, V36, P517; FEDER HOWARD M., 1955, CALIFORNIA FISH AND GAME, V41, P245; GRANICK MS, 1987, PLAST RECONSTR SURG, V79, P573, DOI 10.1097/00006534-198704000-00011; Hale JR, 2012, J SHELLFISH RES, V31, P789, DOI 10.2983/035.031.0324; HOWARD RK, 1985, MAR ECOL PROG SER, V22, P163, DOI 10.3354/meps022163; Jung RE, 2002, J HERPETOL, V36, P465, DOI 10.1670/0022-1511(2002)036[0465:AEOPIA]2.0.CO;2; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kraus Y, 2007, CURR BIOL, V17, pR874, DOI 10.1016/j.cub.2007.08.017; Kurth J, 2007, J N AM BENTHOL SOC, V26, P253, DOI 10.1899/0887-3593(2007)26[253:PTIEOF]2.0.CO;2; Nishizaki MT, 2015, J THERM BIOL, V54, P37, DOI 10.1016/j.jtherbio.2015.02.002; SEBENS KP, 1981, J EXP MAR BIOL ECOL, V54, P225, DOI 10.1016/0022-0981(81)90159-3; SEBENS KP, 1982, J EXP MAR BIOL ECOL, V59, P103, DOI 10.1016/0022-0981(82)90110-1; SEBENS KP, 1980, BIOL BULL-US, V158, P370, DOI 10.2307/1540863; Sebens KP., 1977, THESIS; Sebens KP, 1976, CAN J FISH AQUAT SCI, V33, P1407; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; TRAVIS J, 1981, COPEIA, P193, DOI 10.2307/1444054; Varghese P, 2008, BREAST J, V14, P61, DOI 10.1111/j.1524-4741.2007.00519.x; Voltzow J, 2015, J MORPHOL, V276, P787, DOI 10.1002/jmor.20379; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Wells C.L., 2013, THESIS	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188263	10.1371/journal.pone.0188263	http://dx.doi.org/10.1371/journal.pone.0188263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161292	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000038
J	Hintze, C; Morgen, TO; Drescher, M				Hintze, Christian; Morgen, Tobias O.; Drescher, Malte			Heavy-atom effect on optically excited triplet state kinetics	PLOS ONE			English	Article							DYNAMIC NUCLEAR-POLARIZATION; NANOMETER DISTANCE MEASUREMENTS; ELECTRON-SPIN ECHO; PROTON POLARIZATION; ORGANIC-MOLECULES; ROOM-TEMPERATURE; DOUBLE-RESONANCE; SPECTROSCOPY; CRYSTALS; ANTHRACENES	In several fields of research, like e.g. photosensitization, photovoltaics, organic electrolumi-nescent devices, dynamic nuclear polarization, or pulsed dipolar electron paramagnetic resonance spectroscopy, triplet state kinetics play an important role. It is therefore desirable to tailor the kinetics of photoexcited triplet states, e.g. by exploiting the intramolecular heavyatom effect, and to determine the respective kinetic parameters. In this work, we set out to systematically investigate the photoexcited triplet state kinetics of a series of haloanthracenes by time-resolved electron paramagnetic resonance spectroscopy in combination with synchronized laser excitation. For this purpose, a procedure to simulate time traces by solving the differential equation system governing the triplet kinetics numerically is developed. This way, spin lattice relaxation rates and zero-field triplet life times are obtained concurrently by a global fit to experimental data measured at three different cryogenic temperatures.	[Hintze, Christian; Morgen, Tobias O.; Drescher, Malte] Univ Konstanz, Fachbereich Chem, Constance, Germany	University of Konstanz	Drescher, M (corresponding author), Univ Konstanz, Fachbereich Chem, Constance, Germany.	malte.drescher@uni-konstanz.de		Morgen, Tobias/0000-0002-3866-1053	Deutsche Forschungsgemeinschaft [DR 743/10-1, SPP 1601]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (DR 743/10-1 and SPP 1601, dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BECKER HD, 1993, CHEM REV, V93, P145, DOI 10.1021/cr00017a008; Bouas-Laurent H, 2000, CHEM SOC REV, V29, P43, DOI 10.1039/a801821i; BROWN R, 1994, J CHEM PHYS, V100, P7182, DOI 10.1063/1.466916; Carbonera D, 2009, PHOTOSYNTH RES, V102, P403, DOI 10.1007/s11120-009-9407-5; CLARKE RH, 1971, J CHEM PHYS, V54, P2962, DOI 10.1063/1.1675279; Cowan DO, 1978, ELEMENTS ORGANIC PHO, P19; Di Valentin M, 2016, CHEM-EUR J, V22, P17204, DOI 10.1002/chem.201603666; Di Valentin M, 2016, BBA-BIOENERGETICS, V1857, P1909, DOI 10.1016/j.bbabio.2016.09.008; Di Valentin M, 2014, J AM CHEM SOC, V136, P6582, DOI 10.1021/ja502615n; Eichhorn TR, 2014, NUCL INSTRUM METH A, V754, P10, DOI 10.1016/j.nima.2014.03.047; ELSAYED MA, 1975, ANNU REV PHYS CHEM, V26, P235, DOI 10.1146/annurev.pc.26.100175.001315; Grivet JP, 1969, CHEM PHYS LETT, V4, P104, DOI 10.1016/0009-2614(69)85082-7; Hintze C, 2017, CHEMPHYSCHEM, V18, P6, DOI 10.1002/cphc.201600868; Hintze C, 2016, J PHYS CHEM LETT, V7, P2204, DOI 10.1021/acs.jpclett.6b00765; HUPPERT D, 1982, J CHEM PHYS, V77, P1214, DOI 10.1063/1.443989; Montalti M., 2006, HDB PHOTOCHEMISTRY; SEIDEL H, 1984, CHEM PHYS LETT, V104, P552, DOI 10.1016/0009-2614(84)80026-3; Singh-Rachford TN, 2010, COORDIN CHEM REV, V254, P2560, DOI 10.1016/j.ccr.2010.01.003; SLOOP DJ, 1981, J CHEM PHYS, V75, P3746, DOI 10.1063/1.442520; Solovyov KN, 2005, PHYS-USP+, V48, P231, DOI 10.1070/PU2005v048n03ABEH001761; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stoll S, 2014, MULTIFREQUENCY ELECTRON PARAMAGNETIC RESONANCE: DATA AND TECHNIQUES, P69; Takeda K, 2004, J PHYS SOC JPN, V73, P2313, DOI 10.1143/JPSJ.73.2313; Thompson NJ, 2014, NAT MATER, V13, P1039, DOI [10.1038/nmat4097, 10.1038/NMAT4097]; YU HL, 1984, J CHEM PHYS, V80, P102, DOI 10.1063/1.446491; Zhao JZ, 2013, CHEM SOC REV, V42, P5323, DOI 10.1039/c3cs35531d	29	3	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0184239	10.1371/journal.pone.0184239	http://dx.doi.org/10.1371/journal.pone.0184239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155822	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700001
J	Liu, CP; Zhang, X; Tan, QL; Xu, WX; Zhou, CY; Luo, M; Li, X; Huang, RY; Zeng, X				Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing			NF-kappa B pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment	PLOS ONE			English	Article							CELLS INDUCE; CANCER; PHENOTYPE; FRIES	Bladder cancer is one of the most malignant tumors closely associated with macrophages. Polyporus polysaccharide (PPS) has shown excellent efficacy in treating bladder cancer with minimal side effects. However, the molecular mechanisms underlying the effects of PPS in inhibiting bladder cancer remain unclear. In this study, we used macrophages cultured alone or with T24 human bladder cancer cell culture supernatant as study models. We found that PPS enhanced the activities of IFN-gamma-stimulated RAW 264.7 macrophages, as shown by the release of inducible nitric oxide synthase (INOS), secretion of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, phagocytosis activity, as well as expression of M1 phenotype indicators, such as CD40, CD284 and CD86. PPS acted upstream in activation cascade of nuclear factor (NF)-kappa B signaling pathways by interfering with I.B phosphorylation. In addition, PPS regulated NF-kappa B (P65) signaling by interfering with Toll-like receptor (TLR)-4, INOS and cyclooxygenase (COX)-2. Our results indicate that PPS activates macrophages through TLR4/NF-kappa B signaling pathways.	[Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Integrated Chinese Med Immunizat, Guangzhou, Guangdong, Peoples R China; [Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Sect Rheumatol Res, Guangzhou, Guangdong, Peoples R China; [Liu, Chun-Ping; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Discipline Integrated Chinese & Western Med, Guangzhou, Guangdong, Peoples R China; [Huang, Run-Yue] Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Integrated Chinese Med Immunizat, Guangzhou, Guangdong, Peoples R China.; Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Sect Rheumatol Res, Guangzhou, Guangdong, Peoples R China.; Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Discipline Integrated Chinese & Western Med, Guangzhou, Guangdong, Peoples R China.; Huang, RY (corresponding author), Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China.	ry_huang@hotmail.com; zengxing-china@163.com			National Natural Science Foundation of China [81573769]; Natural Science Foundation of Guangdong Province [2014A03031345]; Guangzhou University of Chinese Medicine [A1-AFD018161Z1511]; Macao University of Science and Technology [MUST-SKL-2016-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou University of Chinese Medicine; Macao University of Science and Technology	This study was supported by the National Natural Science Foundation of China (No. 81573769), the Natural Science Foundation of Guangdong Province (No.2014A03031345), and the grant from Guangzhou University of Chinese Medicine (A1-AFD018161Z1511) as well as Macao University of Science and Technology (MUST-SKL-2016-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 81573769), the Natural Science Foundation of Guangdong Province (No.2014A03031345), and the grant from Guangzhou University of Chinese Medicine (A1-AFD018161Z1511) as well as Macao University of Science and Technology (MUST-SKL-2016-08).	Ayari C, 2009, EUR UROL, V55, P1386, DOI 10.1016/j.eururo.2009.01.040; Beatty GL, 2017, EXPERT REV ANTICANC, V17, P175, DOI 10.1080/14737140.2017.1270208; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Brandau S, 2009, J UROLOGY, V181, P1532, DOI 10.1016/j.juro.2009.01.066; Dai H, 2012, GLYCOBIOLOGY, V22, P1673, DOI 10.1093/glycob/cws099; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Deng XC, 2015, INT J MOL MED, V36, P449, DOI 10.3892/ijmm.2015.2230; Furudate S, 2016, EXP DERMATOL, V25, P107, DOI 10.1111/exd.12873; Galani V, 2017, CLIN EXP MED, V17, P281, DOI 10.1007/s10238-016-0432-3; [江泽波 Jiang Zebo], 2015, [中国免疫学杂志, Chinese Journal of Immunology], V31, P1049; Pedraza-Brindis EJ, 2016, CELL IMMUNOL, V310, P42, DOI 10.1016/j.cellimm.2016.07.001; Kalathil SG, 2016, CANCER IMMUNOL IMMUN, V65, P813, DOI 10.1007/s00262-016-1810-0; Kim KN, 2016, CHEM-BIOL INTERACT, V258, P108, DOI 10.1016/j.cbi.2016.08.022; Klopfleisch R, 2016, ACTA BIOMATER, V43, P3, DOI 10.1016/j.actbio.2016.07.003; Kolodziej A, 2016, CENT EUR J UROL, V69, P150, DOI 10.5173/ceju.2016.780; Lee JS, 2015, CARBOHYD POLYM, V120, P29, DOI 10.1016/j.carbpol.2014.11.059; Li CaiXia, 2011, Chinese Journal of Immunology, V27, P514; Li XQ, 2011, J ETHNOPHARMACOL, V135, P1, DOI 10.1016/j.jep.2010.06.028; Li XQ, 2010, CELL IMMUNOL, V265, P50, DOI 10.1016/j.cellimm.2010.07.002; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841; Liu XX, 2016, INFLAMMATION, V39, P1421, DOI 10.1007/s10753-016-0374-7; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Price LA, 2010, FITOTERAPIA, V81, P914, DOI 10.1016/j.fitote.2010.06.002; Rhee I, 2016, ARCH PHARM RES, V39, P1588, DOI 10.1007/s12272-016-0820-y; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25595; Sun YX, 2009, INT J BIOL MACROMOL, V44, P14, DOI 10.1016/j.ijbiomac.2008.09.010; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang M, 2017, CARBOHYD POLYM, V156, P390, DOI 10.1016/j.carbpol.2016.09.033; Xu XL, 2014, INFLAMMATION, V37, P956, DOI 10.1007/s10753-014-9816-2; Zeng X, 2010, CHIN J CELL MOL IMMU, V26, P440; Zhang GW, 2011, AM J CHINESE MED, V39, P135, DOI 10.1142/S0192415X11008701; Zhang GW, 2010, J ETHNOPHARMACOL, V128, P433, DOI 10.1016/j.jep.2010.01.032; Zhao YY, 2013, J ETHNOPHARMACOL, V149, P35, DOI 10.1016/j.jep.2013.06.031	36	70	74	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188317	10.1371/journal.pone.0188317	http://dx.doi.org/10.1371/journal.pone.0188317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155869	gold, Green Published, Green Submitted			2022-12-26	WOS:000415756700045
J	Montoliu-Gaya, L; Mulder, SD; Veerhuis, R; Villegas, S				Montoliu-Gaya, Laia; Mulder, Sandra D.; Veerhuis, Robert; Villegas, Sandra			Effects of an A beta-antibody fragment on A beta aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; FIBRIL FORMATION; 3XTG-AD MICE; MOUSE MODEL; IN-VIVO; MECHANISMS; CLEARANCE; TOXICITY; A-BETA-1-42	A beta-Immunotherapy has long been studied in the treatment of Alzheimer's disease (AD), but not how other molecules involved in the disease can affect antibody performance. We previously designed an antibody fragment, scFv-h3D6, and showed that it precludes A beta-induced cytotoxicity by withdrawing A beta oligomers from the amyloid pathway towards a non-toxic, worm-like pathway. ScFv-h3D6 was effective at the behavioral, cellular, and molecular levels in the 3xTg-AD mouse model. Because scFv-h3D6 treatment restored apolipoprotein E (apoE) and J (apoJ) concentrations to non-pathological values, and A beta internalization by glial cells was found to be decreased in the presence of these apolipoproteins, we now aimed to test the influence of scFv-h3D6 on A beta aggregation and cellular uptake by primary human astrocytes in the presence of therapeutic apoE and apoJ mimetic peptides (MPs). Firstly, we demonstrated by CD and FTIR that the molecules used in this work were well folded. Next, interactions between apoE or apoJ-MP, scFv-h3D6 and A beta were studied by CD. The conformational change induced by the interaction of A beta with apoE-MP was much bigger than the induced with apoJ-MP, in line with the observed formation of protective worm-like fibrils by the scFv-h3D6/A beta complex in the presence of apoJ-MP, but not of apoE-MP. ScFv-h3D6, apoJ-MP, and apoE-MP to a different extent reduced A beta uptake by astrocytes, and apoE-MP partially interfered with the dramatic reduction by scFv-h3D6 while apoJ-MP had no effect on scFv-h3D6 action. As sustained A beta uptake by astrocytes may impair their normal functions, and ultimately neuronal viability, this work shows another beneficence of scFv-h3D6 treatment, which is not further improved by the use of apoE or apoJ mimetic peptides.	[Montoliu-Gaya, Laia; Villegas, Sandra] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, Barcelona, Spain; [Mulder, Sandra D.; Veerhuis, Robert] Vrije Univ Amsterdam, Clin Chem Dept, Med Ctr, Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat Dept, Med Ctr, Amsterdam, Netherlands	Autonomous University of Barcelona; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Villegas, S (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, Barcelona, Spain.; Veerhuis, R (corresponding author), Vrije Univ Amsterdam, Clin Chem Dept, Med Ctr, Amsterdam, Netherlands.; Veerhuis, R (corresponding author), Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat Dept, Med Ctr, Amsterdam, Netherlands.	R.Veerhuis@vumc.nl; Sandra.Villegas@uab.cat	Villegas, Sandra/ABF-8206-2021; Villegas, Sandra/D-8789-2011; Mulder, Sandra D/L-5198-2013	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; 	Institute de Salud Carlos III [FIS-PI113-01330]; Generalitat de Catalunya [2014-PROD00032]; FEDER; Stichting Dioraphte [VSM 10030200, 14041401]; PIF-UAB; EMBO [ASTF 36-2016]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); Stichting Dioraphte; PIF-UAB; EMBO(European Molecular Biology Organization (EMBO))	This work was supported by Institute de Salud Carlos III [FIS-PI113-01330] and Generalitat de Catalunya [2014-PROD00032] to SV, both co-funded by FEDER, and Stichting Dioraphte [VSM 10030200 and 14041401] to RV, PIF-UAB student grant (LMG) and EMBO short-term fellowship (ASTF 36-2016) to LMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Benilova I, 2012, NAT NEUROSCI, P349; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Bruggink KA, 2012, J ALZHEIMERS DIS, V28, P735, DOI 10.3233/JAD-2011-111421; Calero M, 1999, BIOCHEM J, V344, P375, DOI 10.1042/0264-6021:3440375; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Datta G, 2010, ATHEROSCLEROSIS, V208, P134, DOI 10.1016/j.atherosclerosis.2009.07.019; Davies DS, 2016, BRAIN PATHOL; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Esquerda-Canals G, 2013, MABS-AUSTIN, V5, P660, DOI 10.4161/mabs.25428; Fu W, 2015, J BIOL CHEM, V290, P12504, DOI 10.1074/jbc.M114.618157; Garwood CJ, 2016, NEUROPATHOL APPL NEU; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Gimenez-Llort L, 2013, MABS-AUSTIN, V5, P665, DOI 10.4161/mabs.25424; Handattu SP, 2013, J ALZHEIMERS DIS, V36, P335, DOI 10.3233/JAD-122377; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Magalhaes J, 2011, J NEUROPATH EXP NEUR, V70, P1097, DOI 10.1097/NEN.0b013e31823a44f4; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marin-Argany M, 2011, BIOCHEM J, V437, P25, DOI 10.1042/BJ20101712; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mishra VK, 2011, BBA-BIOMEMBRANES, V1808, P498, DOI 10.1016/j.bbamem.2010.10.011; Montoliu-Gaya L, 2017, PROTEIN SCI; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Naiki H, 1998, BIOCHEMISTRY-US, V37, P17882, DOI 10.1021/bi980550y; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1932, DOI 10.1161/01.ATV.0000174589.70190.e2; Navab M, 2008, TRENDS CARDIOVAS MED, V18, P61, DOI 10.1016/j.tcm.2007.12.006; Nayyar G, 2010, ATHEROSCLEROSIS, V213, P449, DOI 10.1016/j.atherosclerosis.2010.09.030; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382; Rodriguez JJ, 2016, CURR ALZHEIMER RES, V13, P343, DOI 10.2174/1567205013666160229112911; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Selkoe D J., 2008, BIOCH MOL BIOL AMYLO, P245; Sharifov OF, 2011, AM J CARDIOVASC DRUG, V11, P371, DOI 10.2165/11594190-000000000-00000; Skerrett R, 2015, J BIOL CHEM, V290, P21591, DOI 10.1074/jbc.M115.652008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sollvander S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0098-z; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Veerhuis R, 2005, CNS NEUROL DISORD-DR, V4, P235, DOI 10.2174/1568007054038184; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Winkler K, 1999, J LIPID RES, V40, P447; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; Zhang ZG, 2015, ARCH IMMUNOL THER EX, V63, P333, DOI 10.1007/s00005-015-0351-0	60	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188191	10.1371/journal.pone.0188191	http://dx.doi.org/10.1371/journal.pone.0188191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155887	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700034
J	Nakamura, Y; Sugano, A; Ohta, M; Takaoka, Y				Nakamura, Yutaka; Sugano, Aki; Ohta, Mika; Takaoka, Yutaka			Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma	PLOS ONE			English	Article							TO-SEVERE ASTHMA; GENETIC-VARIANTS; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; UNCONTROLLED ASTHMA; IL-13; SAFETY; IL13; PERIOSTIN; CHILDREN	Interleukin-13 (IL-13) is associated with allergic airway inflammation and airway remodeling. Our group found a variant with a single nucleotide polymorphism in the IL13 gene at position + 2044G>A (rs20541) that was expected to result in the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 144. IL-13Q144 was associated with augmented allergic airway inflammation and bronchial asthma remodeling. There is some indication that anti-IL-13 monoclonal antibodies can demonstrate a positive effect on the clinical course of refractory asthmatic patients. To date, the binding stability of these agents for IL-13Q144 is unknown. The objective of this study was to investigate the prediction efficacy of the anti-IL-13 monoclonal antibodies tralokinumab and lebrikizumab in asthmatic patients with IL-13R144 and IL-13Q144. The three-dimensional (3-D) structure of tralokinumab was obtained from the Protein Data Bank (PDB ID: 5L6Y), and the complete 3-D structure of lebrikizumab was built through homology modeling. For the binding stability analysis, we performed and analyzed docking simulations of IL-13 with tralokinumab or lebrikizumab. The tralokinumab and lebrikizumab structures changed after binding to IL-13 to facilitate binding with IL-13Q144. The stability analysis with tralokinumab and lebrikizumab demonstrated that IL-13Q144 was more stable than IL-13R144 for both the Rosetta energy score and for the free energy of binding. IL-13Q144 might be a promising predictor of responsiveness to tralokinumab and lebrikizumab treatment for bronchial asthma.	[Nakamura, Yutaka] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Sugano, Aki; Ohta, Mika; Takaoka, Yutaka] Kobe Univ, Grad Sch Med, Div Med Informat & Bioinformat, Kobe, Hyogo, Japan	Nippon Medical School; Kobe University	Nakamura, Y (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan.	ICB75097@nifty.com	Nakamura, Yutaka/AAE-1546-2019	Nakamura, Yutaka/0000-0001-8717-1475				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrews AL, 2007, J ALLERGY CLIN IMMUN, V120, P91, DOI 10.1016/j.jaci.2007.04.026; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; Davies DE, 2003, J ALLERGY CLIN IMMUN, V111, P215, DOI 10.1067/mai.2003.128; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Hanania NA, 2015, THORAX, V70, P748, DOI 10.1136/thoraxjnl-2014-206719; He JQ, 2003, GENES IMMUN, V4, P385, DOI 10.1038/sj.gene.6363985; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu X, 2000, J ALLERGY CLIN IMMUN, V106, P167, DOI 10.1067/mai.2000.107935; Luttmann W, 1996, J IMMUNOL, V157, P1678; Murray LA, 2014, AM J RESP CELL MOL, V50, P985, DOI 10.1165/rcmb.2013-0342OC; Nagashima Hiromi, 2011, Allergology International, V60, P291, DOI 10.2332/allergolint.10-OA-0259; Nakamura Y, 2016, CLIN EXP ALLERGY, V46, P1152, DOI 10.1111/cea.12710; Nakamura Y, 2015, ALLERGOL INT, V64, P209, DOI 10.1016/j.alit.2015.01.001; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Ogasawara M, 2016, CANCER CHEMOTH PHARM, V77, P1019, DOI 10.1007/s00280-016-3021-y; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Schwiebert LA, 1996, J ALLERGY CLIN IMMUN, V97, P143, DOI 10.1016/S0091-6749(96)80214-4; Shiobara T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0342-7; Ultsch M, 2013, J MOL BIOL, V425, P1330, DOI 10.1016/j.jmb.2013.01.024	33	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188407	10.1371/journal.pone.0188407	http://dx.doi.org/10.1371/journal.pone.0188407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155876	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700056
J	Mitra, A; Snyder, AZ; Tagliazucchi, E; Laufs, H; Elison, J; Emerson, RW; Shen, MD; Wolff, JJ; Botteron, KN; Dager, S; Estes, AM; Evans, A; Gerig, G; Hazlett, HC; Paterson, SJ; Schultz, RT; Styner, MA; Zwaigenbaum, L; Schlaggar, BL; Piven, J; Pruett, JR; Raichle, M				Mitra, Anish; Snyder, Abraham Z.; Tagliazucchi, Enzo; Laufs, Helmut; Elison, Jed; Emerson, Robert W.; Shen, Mark D.; Wolff, Jason J.; Botteron, Kelly N.; Dager, Stephen; Estes, Annette M.; Evans, Alan; Gerig, Guido; Hazlett, Heather C.; Paterson, Sarah J.; Schultz, Robert T.; Styner, Martin A.; Zwaigenbaum, Lonnie; Schlaggar, Bradley L.; Piven, Joseph; Pruett, John R., Jr.; Raichle, Marcus		IBIS Network	Resting-state fMRI in sleeping infants more closely resembles adult sleep than adult wakefulness	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; SLOW-WAVE SLEEP; FUNCTIONAL CONNECTIVITY; ATTENTION NETWORKS; PRETERM INFANTS; BRAIN ACTIVITY; DEEP SLEEP; CHILDHOOD; EMERGENCE; GRADIENT	Resting state functional magnetic resonance imaging (rs-fMRI) in infants enables important studies of functional brain organization early in human development. However, rs-fMRI in infants has universally been obtained during sleep to reduce participant motion artifact, raising the question of whether differences in functional organization between awake adults and sleeping infants that are commonly attributed to development may instead derive, at least in part, from sleep. This question is especially important as rs-fMRI differences in adult wake vs. sleep are well documented. To investigate this question, we compared functional connectivity and BOLD signal propagation patterns in 6, 12, and 24 month old sleeping infants with patterns in adult wakefulness and non-REM sleep. We find that important functional connectivity features seen during infant sleep closely resemble those seen during adult sleep, including reduced default mode network functional connectivity. However, we also find differences between infant and adult sleep, especially in thalamic BOLD signal propagation patterns. These findings highlight the importance of considering sleep state when drawing developmental inferences in infant rs-fMRI.	[Mitra, Anish; Snyder, Abraham Z.; Botteron, Kelly N.; Raichle, Marcus] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Snyder, Abraham Z.; Schlaggar, Bradley L.; Raichle, Marcus] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Tagliazucchi, Enzo] Univ Buenos Aires, Dept Fis, Buenos Aires, DF, Argentina; [Laufs, Helmut] Christian Albrechts Univ Kiel, Dept Neurol, Kiel, Germany; [Elison, Jed; Wolff, Jason J.] Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA; [Emerson, Robert W.; Shen, Mark D.; Hazlett, Heather C.; Styner, Martin A.; Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Dager, Stephen] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Estes, Annette M.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Evans, Alan] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Gerig, Guido] NYU, Dept Psychiat, 550 1St Ave, New York, NY 10016 USA; [Paterson, Sarah J.; Schultz, Robert T.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Zwaigenbaum, Lonnie; Schlaggar, Bradley L.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Pruett, John R., Jr.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Buenos Aires; University of Kiel; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; McGill University; New York University; University of Pennsylvania; University of Alberta; Washington University (WUSTL)	Mitra, A (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	anishmmitra@gmail.com	Collins, D. Louis/ABD-7708-2021; Schlaggar, Bradley/AAZ-4153-2020; Styner, Martin/AAS-9949-2020; Laufs, Helmut/I-8562-2014; Evans, Alan C/B-2373-2013	Collins, D. Louis/0000-0002-8432-7021; Styner, Martin/0000-0002-8747-5118; Laufs, Helmut/0000-0003-0030-2781; Evans, Alan C/0000-0003-3841-6098; Gerig, Guido/0000-0002-9547-6233; Mitra, Anish/0000-0002-3362-2274; Shen, Mark D./0000-0002-1190-7981	National Institute of Health [NS080675, F30MH106253, R01MH093510, R01HD055741, K01-MH101653, P30-NS048056, U54-HD087011, R01-MH104324, U54-HD86984]; Bundesministerium fur Bildung und Forschung [01EV0703]; McDonnell Center for Systems Neuroscience, Autism Speaks [6020]; Simons Foundation [140209]; Infant Brain Imaging Study (IBIS) Network is an NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091, R01HD055741, U54HD087011, U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093510] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); McDonnell Center for Systems Neuroscience, Autism Speaks; Simons Foundation; Infant Brain Imaging Study (IBIS) Network is an NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Health (NS080675 to MER and AZS, F30MH106253 to AM, R01MH093510 to J.Pruett, R01HD055741 to J.Piven, K01-MH101653 to J.W., P30-NS048056 to A.Z.S., U54-HD087011 to B.L.S, R01-MH104324 to JTE, U54-HD86984 to RTS), the Bundesministerium fur Bildung und Forschung 01EV0703 to E.T. and H.L., the McDonnell Center for Systems Neuroscience, Autism Speaks (grant number #6020 to J.P.), and the Simons Foundation (grant number #140209 to J.P.).; The Infant Brain Imaging Study (IBIS) Network is an NIH funded Autism Centers of Excellence project and consists of a consortium of eight universities in the U.S. and Canada. Clinical Sites: University of North Carolina: J. Piven (IBIS Network PI), H.C. Hazlett, C. Chappell; University of Washington: S. Dager, A. Estes, D. Shaw; Washington University: K. Botteron, R. McKinstry, J. Constantino, J. Pruett; The Children's Hospital of Philadelphia: R. Schultz, S. Paterson; University of Alberta: L. Zwaigenbaum; University of Minnesota: J. Elison; Data Coordinating Center: Montreal Neurological Institute: A.C. Evans, D.L. Collins, G.B. Pike, V. Fonov, P. Kostopoulos; S. Das; Image Processing Core: New York University: G. Gerig; University of North Carolina: M. Styner; Statistical Analysis Core: University of North Carolina: H. Gu.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; [Anonymous], 2016, NEUROIMAGE; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Carskadon MA, 2000, PRINCIPLES PRACTICE, P13; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Conel J.L., 1939, POSTNATAL DEV HUMAN; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Eisermann M, 2013, NEUROPHYSIOL CLIN, V43, P35, DOI 10.1016/j.neucli.2012.09.091; Estes A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9117-6; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Friedrichs-Maeder CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177466; Gao W., 2016, NEUROSCIENTIST; Gao W, 2013, CEREB CORTEX, V23, P594, DOI 10.1093/cercor/bhs043; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gholipour A, 2008, IEEE ENG MED BIO, P94, DOI 10.1109/IEMBS.2008.4649099; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hagne I., 1972, ACTA PAEDIATR, V61, P25, DOI 10.1111/j.1651-2227.1972.tb08271.x; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iber C., 2007, AASM MANUAL SCORING; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lee W, 2013, NEURORADIOLOGY, V55, P105, DOI 10.1007/s00234-013-1232-z; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Mitra A, 2014, J NEUROPHYSIOL, V111, P2374, DOI 10.1152/jn.00804.2013; Mitra A, 2016, P NATL ACAD SCI USA, V113, pE6868, DOI 10.1073/pnas.1607289113; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mitra A, 2015, ELIFE, V4, DOI 10.7554/eLife.10781; Mitra A, 2015, P NATL ACAD SCI USA, V112, pE2235, DOI 10.1073/pnas.1503960112; Nikolic D, 2007, J COMPUT NEUROSCI, V22, P5, DOI 10.1007/s10827-006-9441-7; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Picchioni D, 2013, NEUROIMAGE, V80, P387, DOI 10.1016/j.neuroimage.2013.05.067; Power J.D, 2016, NEUROIMAGE; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pruett JR, 2015, DEV COGN NEUROS-NETH, V12, P123, DOI 10.1016/j.dcn.2015.01.003; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Schneider G, 2006, NEURAL COMPUT, V18, P2387, DOI 10.1162/neco.2006.18.10.2387; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smyser CD, 2014, RESTING STATE NETWOR; Smyser CD, 2016, NEUROIMAGE, V136, P1, DOI 10.1016/j.neuroimage.2016.05.029; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Tagliazucchi E, 2013, P NATL ACAD SCI USA, V110, P15419, DOI 10.1073/pnas.1312848110; Wylie KP, 2014, NEUROPSYCH DIS TREAT, V10, P1349, DOI 10.2147/NDT.S63773	50	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188122	10.1371/journal.pone.0188122	http://dx.doi.org/10.1371/journal.pone.0188122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149191	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100025
J	Talbot, SL; Sage, GK; Sonsthagen, SA; Gravley, MC; Swem, T; Williams, JC; Longmire, JL; Ambrose, S; Flamme, MJ; Lewis, SB; Phillips, L; Anderson, C; White, CM				Talbot, Sandra L.; Sage, George K.; Sonsthagen, Sarah A.; Gravley, Meg C.; Swem, Ted; Williams, Jeffrey C.; Longmire, Jonathan L.; Ambrose, Skip; Flamme, Melanie J.; Lewis, Stephen B.; Phillips, Laura; Anderson, Clifford; White, Clayton M.			Intraspecific evolutionary relationships among peregrine falcons in western North American high latitudes	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ALLELE FREQUENCY DATA; ISLAND POPULATIONS; GENETIC DIVERSITY; CONSERVATION BIOLOGY; MICROSATELLITE LOCI; COALESCENT APPROACH; PLUMAGE COLORATION; STATISTICAL TESTS; DNA POLYMORPHISM	Subspecies relationships within the peregrine falcon (Falco peregrinus) have been long debated because of the polytypic nature of melanin-based plumage characteristics used in subspecies designations and potential differentiation of local subpopulations due to philopatry. In North America, understanding the evolutionary relationships among subspecies may have been further complicated by the introduction of captive bred peregrines originating from non-native stock, as part of recovery efforts associated with mid 20th century population declines resulting from organochloride pollution. Alaska hosts all three nominal subspecies of North American peregrine falcons-F.p. tundrius, anatum, and pealei-for which distributions in Alaska are broadly associated with nesting locales within Arctic, boreal, and south coastal maritime habitats, respectively. Unlike elsewhere, populations of peregrine falcon in Alaska were not augmented by captive-bred birds during the late 20th century recovery efforts. Population genetic differentiation analyses of peregrine populations in Alaska, based on sequence data from the mitochondrial DNA control region and fragment data from microsatellite loci, failed to uncover genetic distinction between populations of peregrines occupying Arctic and boreal Alaskan locales. However, the maritime subspecies, pealei, was genetically differentiated from Arctic and boreal populations, and substructured into eastern and western populations. Levels of interpopulational gene flow between anatum and tundrius were generally higher than between pealei and either anatum or tundrius. Estimates based on both marker types revealed gene flow between augmented Canadian populations and unaugmented Alaskan populations. While we make no attempt at formal taxonomic revision, our data suggest that peregrine falcons occupying habitats in Alaska and the North Pacific coast of North America belong to two distinct regional groupings-a coastal grouping (pealei) and a boreal/Arctic grouping (currently anatum and tundrius)-each comprised of discrete populations that are variously intra-regionally connected.	[Talbot, Sandra L.; Sage, George K.; Sonsthagen, Sarah A.; Gravley, Meg C.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Swem, Ted; Ambrose, Skip] US Fish & Wildlife Serv, Fairbanks Fish & Wildlife Field Off, Fairbanks, AK USA; [Williams, Jeffrey C.] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Longmire, Jonathan L.] Los Alamos Natl Lab, Los Alamos, NM USA; [Flamme, Melanie J.] Natl Pk Serv, Yukon Charley River Natl Preserve & Gates Arctic, Fairbanks, AK USA; [Lewis, Stephen B.] US Fish & Wildlife Serv, Migratory Bird Management, Juneau, AK USA; [Phillips, Laura] Natl Pk Serv, Alaska Reg Off, Anchorage, AK USA; [Anderson, Clifford] Falcon Res Grp, Bow, WA USA; [White, Clayton M.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [White, Clayton M.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of the Interior; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; Brigham Young University; Brigham Young University	Talbot, SL (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	stalbot@usgs.gov		Sonsthagen, Sarah/0000-0001-6215-5874	Alaska Science Center; U. S. Geological Survey; U. S. Fishand Wild life Service; Brigham Young University; National Park Service; Falcon Research Group; Los Alamos National Laboratory; U. S. Bureau of Land Management; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER	Alaska Science Center; U. S. Geological Survey(United States Geological Survey); U. S. Fishand Wild life Service; Brigham Young University; National Park Service; Falcon Research Group; Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); U. S. Bureau of Land Management; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this research was provided by the Alaska Science Center, U. S. Geological Survey (SLT), U. S. Fishand Wild life Service (JCW,TS, SA, SBL), Brigham Young University (CMW), National Park Service (MJF, LP), Falcon Research Group (CA), Los Alamos National Laboratory (JLL), and U. S. Bureau of Land Management (TS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose R.E., 1988, P73; Ambrose S., 1990, PEREGRINE FALCON SUR; Ambrose S, 2016, J WILDLIFE MANAGE, V80, P1; AOU, 1957, CHECKL N AM BIRDS, V5th; BAKER AJ, 1990, EVOLUTION, V44, P981, DOI 10.1111/j.1558-5646.1990.tb03819.x; BANDELT HJ, 1995, GENETICS, V141, P743; BARROWCLOUGH GF, 1982, AUK, V99, P601; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bird Life International, 2015, IUCN RED LIST THREAT, p[2015, 2015]; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; Bruggeman JE, 2016, IBIS, V158, P61, DOI 10.1111/ibi.12313; CADE TJ, 1971, SCIENCE, V172, P955, DOI 10.1126/science.172.3986.955; Cade TJ, 1988, PEREGRINE FALCON POP; Cade TJ, 2003, RETURN PEREGRINE N A; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cooch G., 1961, Auk, V78, P72; Cornuet JM, 1996, GENETICS, V144, P2001; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Diamond J.M., 1984, P824; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Early TJ, 1982, RAPTOR MANAGEMENT BI, P99; Enderson, 2013, PEREGRINE FALCONS WO; ENDERSON JH, 1995, T N AM WILDL NAT RES, P142; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fair J., 2010, ORNITHOLOGICAL COUNC; Fisher R., 1970, STAT METHODS RES WOR; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Galvan I, 2015, J RAPTOR RES, V49, P59, DOI 10.3356/jrr-14-00018.1; Gangoso L, 2015, OECOLOGIA, V178, P1113, DOI 10.1007/s00442-015-3306-6; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Haig S. M., 2010, ORNITHOLOGICAL MONOG, V67, P172, DOI DOI 10.1525/0M.2010.67.1.172; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HAUGH J R, 1976, Canadian Field-Naturalist, V90, P359; Heinrich W., 2009, PEREGRINE FALCON POP, P429; Holroyd GL, 1996, J RAPTOR RES, V30, P145; Hull JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-224; Jacobsen F, 2008, CONSERV GENET, V9, P581, DOI 10.1007/s10592-007-9373-4; Johnson JA, 2007, MOL ECOL, V16, P3145, DOI 10.1111/j.1365-294X.2007.03373.x; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Johnson JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014042; Kiff L.F., 1988, P123; Kuhner MK, 1998, GENETICS, V149, P429; Langella O., 1999, POPULATIONS 1 2 30 P; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Lewis SB, 2015, J RAPTOR RES, V49, P367, DOI 10.3356/rapt-49-04-367-375.1; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; MacCluskie M, 2010, ALASKA PARK SCI, V9, P28; Manly B.F.J., 1985, STAT NATURAL SELECTI; Marshall HD, 2002, MOL ECOL, V11, P685, DOI 10.1046/j.1365-294X.2002.01479.x; MARUYAMA T, 1985, GENETICS, V111, P675; MAYR E, 1982, AUK, V99, P593; MESTA R, 1995, FED REGISTER, V60, P34406; MESTA R., 1999, FED REGISTER, V64, P46542; Miller MP, 2012, J HERED, V103, P503, DOI 10.1093/jhered/ess024; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Murie O. J., 1959, N AM FAUNA, V61, P1, DOI DOI 10.3996/NAFA.61.0001; Myers N, 1979, SINKING ARK NEW LOOK; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pierson BJ, 2017, PEREGRINE FALCON FAL; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowell P, 1997, STATUS PEREGRINE FAL; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALE R., 2005, THE GYRFALCON; SHANK CC, 1993, WILSON BULL, V105, P188; SLATKIN M, 1995, GENETICS, V139, P457; SMITH FDM, 1993, TRENDS ECOL EVOL, V8, P375, DOI 10.1016/0169-5347(93)90223-C; Stangel PW, 1991, ACT 20 C INT ORN, V4, P2442; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 2011, J AVIAN BIOL, V42, P415, DOI 10.1111/j.1600-048X.2011.05280.x; Tarr CL, 1998, MOL ECOL, V7, P719, DOI 10.1046/j.1365-294x.1998.00385.x; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weckworth BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019582; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C.M., 1988, P789; White C.M., 2020, BIRDS OF THE WORLD; White CM, 2013, AUK, V130, P78, DOI 10.1525/auk.2012.11173; WHITE CM, 1968, AUK, V85, P179, DOI 10.2307/4083579; White CM, 1976, CAN F NAT, V90, P262; White CM, 1975, RAPTOR RES, V3, P33; White CM, 1976, P 1 WORLD C BIRDS PR, P63; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhan XJ, 2012, ANIM GENET, V43, P460, DOI 10.1111/j.1365-2052.2011.02263.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	102	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188185	10.1371/journal.pone.0188185	http://dx.doi.org/10.1371/journal.pone.0188185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149202	gold, Green Submitted, Green Published			2022-12-26	WOS:000415646100027
J	Clark, AM; DeDiego, ML; Anderson, CS; Wang, J; Yang, HM; Nogales, A; Martinez-Sobrido, L; Zand, MS; Sangster, MY; Topham, DJ				Clark, Amelia M.; DeDiego, Marta L.; Anderson, Christopher S.; Wang, Jiong; Yang, Hongmei; Nogales, Aitor; Martinez-Sobrido, Luis; Zand, Martin S.; Sangster, Mark Y.; Topham, David J.			Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins	PLOS ONE			English	Article							AMINO-ACID SITES; HEMAGGLUTININ STALK ANTIBODIES; A VIRUS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; FUNCTIONAL BALANCE; RECEPTOR-BINDING; MEMBRANE-FUSION; LINKED LECTIN; NEURAMINIDASE	Antigenic drift of the hemagglutinin (HA) and neuraminidase (NA) influenza virus proteins contributes to reduced vaccine efficacy. To analyze antigenic drift in human seasonal H1N1 viruses derived from the 2009 pandemic H1N1 virus (pH1N1-like viruses) accounts for the limited effectiveness (around 40%) of vaccination against pH1N1-like viruses during the 2015-2016 season, nasal washes/swabs collected from adult subjects in the Rochester, NY area, were used to sequence and isolate the circulating viruses. The HA and NA proteins from viruses circulating during the 2015-2016 season encoded eighteen and fourteen amino acid differences, respectively, when compared to A/California/04/2009, a strain circulating at the origin of the 2009 pandemic. The circulating strains belonged to subclade 6B.1, defined by HA amino acid substitutions S101N, S179N, and I233T. Hemagglutination-inhibiting (HAI) and HA-specific neutralizing serum antibody (Ab) titers from around 50% of pH1N1-like virus-infected subjects and immune ferrets were 2-4 fold lower for the 2015-2016 circulating strains compared to the vaccine strain. In addition, using a luminex-based mPlex HA assay, the binding of human sera from subjects infected with pH1N1-like viruses to the HA proteins from circulating and vaccine strains was not identical, strongly suggesting antigenic differences in the HA protein. Additionally, NA inhibition (NAI) Ab titers in human sera from pH1N1-like virus-infected subjects increased after the infection and there were measurable antigenic differences between the NA protein of circulating strains and the vaccine strain using both ferret and human antisera. Despite having been vaccinated, infected subjects exhibited low HAI Ab titers against the vaccine and circulating strains. This suggests that poor responses to the H1N1 component of the vaccine as well as antigenic differences in the HA and NA proteins of currently circulating pH1N1-like viruses could be contributing to risk of infection even after vaccination.	[Clark, Amelia M.; DeDiego, Marta L.; Anderson, Christopher S.; Sangster, Mark Y.; Topham, David J.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Wang, Jiong; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [Yang, Hongmei] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Nogales, Aitor; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Topham, DJ (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Marta_Lopez@URMC.rohester.edu; David_Topham@URMC.rochester.edu	NOGALES, AITOR/AAY-1590-2020; Demchuk, Andrew M/E-1103-2012; Martinez-Sobrido, Luis/ACJ-7853-2022; DeDiego, Marta L./B-2307-2017	NOGALES, AITOR/0000-0002-2424-7900; Demchuk, Andrew M/0000-0002-4930-7789; Martinez-Sobrido, Luis/0000-0001-7084-0804; Knudsen-Clark, Amelia/0000-0002-1685-9413; Sangster, Mark/0000-0002-1599-5894; Wang, Jiong/0000-0002-4938-5074; DeDiego, Marta L./0000-0002-7888-7372	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS [HHSN272201400005C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042, UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069351, R01AI098112, R01AI129518] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS contract No. HHSN272201400005C, to DJT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160510; Anderson CS, 2017, SCI REPORTS; Appiah GD, 2015, INFLUENZA ACTIVITY U, P583; Baker SF, 2015, VACCINE, V33, P3562, DOI 10.1016/j.vaccine.2015.05.049; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Burke DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112302; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chai N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005702; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; Couzens L, 2014, J VIROL METHODS, V210, P7, DOI 10.1016/j.jviromet.2014.09.003; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Davlin SL, 2016, INFLUENZA ACTIVITY U, P567; DeDiego ML, 2016, J VIROL, V90, P9693, DOI 10.1128/JVI.01039-16; DeDiego ML, 2016, IMMUNOLOGY, V148, P160, DOI 10.1111/imm.12594; ECDC, 2016, INFL VIR CHAR SUMM E; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gambaryan AS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P872, DOI 10.1134/S000629791507007X; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaymard A, 2016, CLIN MICROBIOL INFEC, V22, P975, DOI 10.1016/j.cmi.2016.07.007; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Henry C, 2017, TRENDS IMMUNOL; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; JOHANSSON BE, 1993, J VIROL, V67, P5721, DOI 10.1128/JVI.67.10.5721-5723.1993; Katz J, 2017, RECOMMENDED COMPOSIT; KILBOURNE ED, 1990, P NATL ACAD SCI USA, V87, P786, DOI 10.1073/pnas.87.2.786; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Komissarov A, 2016, INFLUENZA OTHER RESP, V10, P247, DOI 10.1111/irv.12389; Kosik I, 2017, VIROLOGY, V500, P178, DOI 10.1016/j.virol.2016.10.024; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Laguio-Vila MR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu115; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVER WG, 1982, VIROLOGY, V122, P450, DOI 10.1016/0042-6822(82)90244-6; Lee AJ, 2015, J VIROL, V89, P5427, DOI 10.1128/JVI.03636-14; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; Lu XH, 2014, VIROLOGY, V454, P169, DOI 10.1016/j.virol.2014.02.011; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Meyer AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004940; Meyer AG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0334; Monto AS, 2015, J INFECT DIS, V212, P1191, DOI 10.1093/infdis/jiv195; Myers JL, 2013, J VIROL, V87, P11168, DOI 10.1128/JVI.01414-13; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Nielsen R, 1998, GENETICS, V148, P929; Nogales A., 2016, J VIROL; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Petrie JG, 2016, J INFECT DIS, V214, P1947, DOI 10.1093/infdis/jiw479; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Pond S. L., 2007, ESTIMATING SELECTION; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129858; WEBSTER RG, 1978, ANNU REV GENET, V12, P415, DOI 10.1146/annurev.ge.12.120178.002215; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	86	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188267	10.1371/journal.pone.0188267	http://dx.doi.org/10.1371/journal.pone.0188267			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145498	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800104
J	Kang, GX; Liu, K; Hou, BB; Zhang, NB				Kang, Guixia; Liu, Kui; Hou, Beibei; Zhang, Ningbo			3D multi-view convolutional neural networks for lung nodule classification	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS	The 3D convolutional neural network (CNN) is able to make full use of the spatial 3D context information of lung nodules, and the multi-view strategy has been shown to be useful for improving the performance of 2D CNN in classifying lung nodules. In this paper, we explore the classification of lung nodules using the 3D multi-view convolutional neural networks (MV-CNN) with both chain architecture and directed acyclic graph architecture, including 3D Inception and 3D Inception-ResNet. All networks employ the multi-view-one-network strategy. We conduct a binary classification (benign and malignant) and a ternary classification (benign, primary malignant and metastatic malignant) on Computed Tomography (CT) images from Lung Image Database Consortium and Image Database Resource Initiative database (LIDC-IDRI). All results are obtained via 10-fold cross validation. As regards the MV-CNN with chain architecture, results show that the performance of 3D MV-CNN surpasses that of 2D MV-CNN by a significant margin. Finally, a 3D Inception network achieved an error rate of 4.59% for the binary classification and 7.70% for the ternary classification, both of which represent superior results for the corresponding task. We compare the multi-view-one-network strategy with the one-view-one-network strategy. The results reveal that the multi-view-one-network strategy can achieve a lower error rate than the one-view-one-network strategy.	[Kang, Guixia; Liu, Kui; Hou, Beibei; Zhang, Ningbo] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China; [Kang, Guixia] Beijing Ciji Network Technol Co Ltd, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Liu, K (corresponding author), Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China.	liukui_006@126.com		Liu, Kui/0000-0003-2715-5304	National Natural Science Foundation of China [61471064]; National High Technology Research and Development Program of China ("863" Program) [2015AA01A709]; Beijing Ciji Network Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); Beijing Ciji Network Technology Co., Ltd	This work was supported by National Natural Science Foundation of China (61471064) to Guixia Kang and National High Technology Research and Development Program of China ("863" Program, No. 2015AA01A709) to Guixia Kang. Beijing Ciji Network Technology Co., Ltd provided support in the form of a salary for author Guixia Kang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors [Guixia Kang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by National Natural Science Foundation of China (61471064) and National High Technology Research and Development Program of China ("863" Program, No. 2015AA01A709).	Adetiba E, 2015, SCI WORLD J, V2015; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; CEicEekO E, 2016, INT C MED IM COMP CO; Chen L.C., 2014, ARXIV; Chollet, 2015, GITHUB REPOSITORY; Dou Q., 2016, IEEE T BIOMEDICAL EN, VPP, P1; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Du Y, 2015, PROC CVPR IEEE, P1110, DOI 10.1109/CVPR.2015.7298714; Han FF, 2015, J DIGIT IMAGING, V28, P99, DOI 10.1007/s10278-014-9718-8; He K., 2016, CVPR, P770; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Kamnitsas K., 2016, ARXIV160305959; Kim B C, 2016, DEEP FEATURE LEARNIN, P1, DOI [10.1109/iww-bci.2016.7457462, DOI 10.1109/IWW-BCI.2016.7457462]; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar D, 2015, COMP ROB VIS CRV 201; Kumar D, 2017, LECT NOTES COMPUT SC, V10317, P54, DOI 10.1007/978-3-319-59876-5_7; Lampert TA, 2016, IEEE T IMAGE PROCESS; Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee MC, 2010, ARTIF INTELL MED, V50, P43, DOI 10.1016/j.artmed.2010.04.011; Li Q, 2005, SEMIN ULTRASOUND CT, V26, P357, DOI 10.1053/j.sult.2005.07.001; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Liu K, 2017, INT J IMAG SYST TECH, V27, P12, DOI 10.1002/ima.22206; Orozco HM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0003-y; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qi Dou, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P149, DOI 10.1007/978-3-319-46723-8_18; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Shafiee M. J., 2015, ARXIV151103361; Shen W, 2017, PATTERN RECOGN, V61, P663, DOI 10.1016/j.patcog.2016.05.029; Shen Wei, 2015, Inf Process Med Imaging, V24, P588, DOI 10.1007/978-3-319-19992-4_46; Shewaye T N, 2016, ARXIV160508350; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tartar A, 2014, IEEE ENG MED BIO, P4651, DOI 10.1109/EMBC.2014.6944661; Tompson J, 2015, PROC CVPR IEEE, P648, DOI 10.1109/CVPR.2015.7298664	37	68	73	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188290	10.1371/journal.pone.0188290	http://dx.doi.org/10.1371/journal.pone.0188290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145492	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800106
J	Loddo, C; Pupier, E; Amour, R; Monsaingeon-Henry, M; Mohammedi, K; Gatta-Cherifi, B				Loddo, Celine; Pupier, Emilie; Amour, Remy; Monsaingeon-Henry, Maud; Mohammedi, Kamel; Gatta-Cherifi, Blandine			Lifestyle intervention program in deprived obese adult patients and their non-deprived counterparts	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DEPRIVATION; MORTALITY; COMPLICATIONS; ASSOCIATION; HEALTH; RISK	Introduction Although it is known that the prevalence of obesity is high in deprived patients, the link between deprivation and obesity, and the impact of deprivation on compliance and efficacy of a lifestyle intervention program are not known. Materials and methods Deprivation was assessed in 40 patients (23 Females, mean +/- SD age: 49 +/- 17 years) from the diabetology department and 140 patients (101 Females, age: 50 +/- 15 years) from the nutrition department of Bordeaux University hospital. Eighty-seven patients suffering from obesity were evaluated before and after a tailored, multidisciplinary lifestyle intervention. Deprivation was assessed using EPICES scores. Deprivation was defined with an EPICES score > 30. Results Deprived patients suffering from obesity had significantly higher current (43.8 +/- 8.4 versus 40.9 +/- 5.5 kg/m(2), p = 0,02) and maximal BMI (46.1 +/- 8.6 versus 42.3 +/- 5.2 kg/m(2), p = 0.002) compared to non-deprived obese. Percentage of body weight loss was not different according to deprivation (4.74 +/- 0.75 versus 4.65 +/- 1.04%, p = 0.9). EPICES scores were not different according to adherence to lifestyle intervention program (20.5 +/- 8.5 versus 29.9 +/- 3.9 versus 29.0 +/- 2.5, no follow up versus partial follow up versus total follow up, p = 0,58). Conclusion Deprived patients suffering from obesity have a more serious disease than non-deprived patients. However, neither compliance to the lifestyle intervention program nor body weight loss differed between deprived patients with obesity and non-deprived ones. Deprivation should not be a limitation when enrolling patients with obesity in lifestyle intervention programs.	[Loddo, Celine; Pupier, Emilie; Amour, Remy; Monsaingeon-Henry, Maud; Mohammedi, Kamel; Gatta-Cherifi, Blandine] Univ Hosp Bordeaux, Haut Leveque Hosp, Dept Endocrinol Diabetol & Nutr, Pessac, France; [Loddo, Celine; Mohammedi, Kamel; Gatta-Cherifi, Blandine] Univ Bordeaux, UFR Med Sci, Bordeaux, France; [Gatta-Cherifi, Blandine] Neuroctr France Magendie, INSERM, Physiopathol Plasticite Neuronale, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Loddo, C (corresponding author), Univ Hosp Bordeaux, Haut Leveque Hosp, Dept Endocrinol Diabetol & Nutr, Pessac, France.; Loddo, C (corresponding author), Univ Bordeaux, UFR Med Sci, Bordeaux, France.	celine.loddo@chu-bordeauz.fr	Mohammedi, Kamel/AAG-3129-2019	Mohammedi, Kamel/0000-0001-6139-1197; Monsaingeon-Henry, Maud/0000-0002-6382-8337; Cherifi, Blandine/0000-0002-7399-1330				American Thoracic Society, 2002, AM J RESP CRITICAL C; Baillot A, 2009, SCI SPORT, V24, P1, DOI 10.1016/j.scispo.2008.06.003; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Bihan H, 2012, DIABETES METAB, V38, P82, DOI 10.1016/j.diabet.2011.10.004; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Cetaf, 2005, SCOR EPICES IND PREC; Colbert JA, 2013, NEW ENGL J MED, V369, P1389, DOI 10.1056/NEJMp1306460; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Eschwege E, 2013, OBEPI 2012 ENQUETE E; Feuillet T, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0002-z; Fysekidis M, 2016, SURG OBES RELAT DIS, V12, P1403, DOI 10.1016/j.soard.2016.01.028; Gatineau M., 2014, ADULT OBESITY TYPE 2; Gueguen R, 2005, EPICES SCORE INDIV 1; Insee, 2013, FICH THEM COND VIE; Jaffiol C, 2013, DIABETES METAB, V39, P56, DOI 10.1016/j.diabet.2012.09.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laurent Auzet, 2007, NIVEAUX VIE PAUVRETE; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Mari-Dell'Olmo M, 2015, J EPIDEMIOL COMMUN H, V69, P432, DOI 10.1136/jech-2014-204312; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Moulin J-J, 2005, B EPIDEMIOLOGIQUE HE, V43, P1; Moulin JJ, 2006, B EPIDEMIOLOGIQUE HE, V14, P93; Observatoire National de la Pauvrete A et de l'Exclusion Sociale, 2011, IND ONPES 2011; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Sass C, 2006, Sante Publique, V18, P513; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; STUNKARD AJ, 1993, NEW ENGL J MED, V329, P1036, DOI 10.1056/NEJM199309303291411; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P326, DOI 10.6133/apjcn.2013.22.3.19; Webber L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004787; Windenberger F, 2012, EUR J PUBLIC HEALTH, V22, P347, DOI 10.1093/eurpub/ckr029; Wresinski J, 1987, DIRECTION JOURNAUX O; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P590, DOI 10.5604/12321966.1120608	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188297	10.1371/journal.pone.0188297	http://dx.doi.org/10.1371/journal.pone.0188297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145484	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800107
J	Srithanaviboonchai, K; Chariyalertsak, S; Nontarak, J; Assanangkornchai, S; Kessomboon, P; Putwatana, P; Taneepanichskul, S; Aekplakorn, W				Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat; Nontarak, Jiraluck; Assanangkornchai, Sawitri; Kessomboon, Pattapong; Putwatana, Panwadee; Taneepanichskul, Surasak; Aekplakorn, Wichai			Stigmatizing attitudes toward people living with HIV among general adult Thai population: Results from the 5th Thai National Health Examination Survey (NHES)	PLOS ONE			English	Article							TRANSGENDER WOMEN; HIV/AIDS; DISCRIMINATION; TRENDS; SEX; MEN; TRANSMISSION; PREVENTION; BEHAVIORS; EPIDEMIC	Background HIV-related stigma and discrimination is a significant driver of the HIV and AIDS epidemic. UNAIDS encourages all nations to monitor progress toward elimination of this problem. This study measured the level of stigmatizing attitudes toward people living with HIV (PLHIV) among Thai adults in the general population using recommended global tools. Methods Data from the 5th National Health Examination Survey, conducted in 2014 were used. The survey utilized six questions recommended by the Global Stigma and Discrimination Indicator Working Group and was administered to participants aged 20-59 years old. All analyses were weighted to take into account of the probability of sampling the same-age Thai population. Factors related to a discriminatory attitude according to UNAIDS, defined as agreed to at least one of the two discriminatory issues, were evaluated using Chi square tested and multivariable logistic regression. Results Of the 10,522 respondents, the most prevalent stigmatizing attitude was anticipated stigma (76.9%), followed by perceived stigma (69.2%), fear of HIV infection (57.0%), and social judgment (38.2%). Fifty-eight point six percent had discriminatory attitudes according to the UNAIDS global indicator. Independent predictors were being female (AOR = 1.21: 95% CI 1.14-1.29), aged 20-39 (AOR = 1.19: 95% CI 1.09-1.30) or 50-59 (AOR = 1.18: 95% CI 1.12-1.26), being Muslim (AOR = 2.03: 95% CI 1.55-2.66), earning < 10,000 Baht/month (AOR = 0.93: 95%CI 0.88-0.99), and living in the Northeast (AOR = 1.67: 95%CI 1.39-2.00) or in Bangkok (AOR = 1.73: 95% CI 1.45-2.07). Conclusions More than half of the general adult Thai population had stigmatizing attitudes toward PLHIV. The study provided valuable baseline information which could be used as comparison for follow-up surveys with other countries. Interventions to improve Thai society's knowledge and attitudes toward HIV/AIDS are urgently needed.	[Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand; [Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Nontarak, Jiraluck; Aekplakorn, Wichai] Natl Hlth Examinat Survey Off, Bangkok, Thailand; [Assanangkornchai, Sawitri] Prince Songkla Univ, Fac Med, Hat Yai, Thailand; [Kessomboon, Pattapong] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand; [Putwatana, Panwadee; Aekplakorn, Wichai] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand; [Taneepanichskul, Surasak] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	Chiang Mai University; Chiang Mai University; Prince of Songkla University; Khon Kaen University; Mahidol University; Chulalongkorn University	Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Fac Med, Chiang Mai, Thailand.; Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	kriengkrai.s@cmu.ac.th	Aekplakorn, Wichai/AAK-6867-2021; ., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259; Assanangkornchai, Sawitri/0000-0003-2174-3287; Nontarak, Jiraluck/0000-0002-6737-0829				Apinundecha C, 2007, AIDS CARE, V19, P1157, DOI 10.1080/09540120701335204; Boer H, 2004, AIDS CARE, V16, P167, DOI 10.1080/09540120410001641011; Busza JR, 2001, AIDS CARE, V13, P441, DOI 10.1080/09540120120057978; Chan BT, 2016, JAIDS-J ACQ IMM DEF, V72, P558, DOI 10.1097/QAI.0000000000001011; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dapaah JM, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0123-3; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Fongkaew Warunee, 2014, J Int Assoc Provid AIDS Care, V13, P69, DOI 10.1177/1545109712463734; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Hasnain Memoona, 2005, Harm Reduct J, V2, P23, DOI 10.1186/1477-7517-2-23; Heath AJ, 2016, J PUBLIC HEALTH-UK, V38, pE301, DOI 10.1093/pubmed/fdv143; Hua JX, 2014, AIDS BEHAV, V18, pS203, DOI 10.1007/s10461-013-0637-3; Nguyen HV, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-016-0127-9; King EJ, 2013, AIDS BEHAV, V17, P2597, DOI 10.1007/s10461-013-0447-7; Kingori C, 2017, INT J STD AIDS, V28, P910, DOI 10.1177/0956462416680764; Lau J, 2003, DISABIL REHABIL, V25, P1354, DOI 10.1080/09638280310001616349; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2216-0; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; MASON CJ, 1995, AIDS, V9, P1061, DOI 10.1097/00002030-199509000-00012; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; National Health Security Office, ART PROGR MAN UN HLT; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Huy NV, 2016, GLOBAL HEALTH ACTION, V9, P77, DOI 10.3402/gha.v9.29247; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Sapsirisavat V, 2016, AIDS BEHAV, V20, pS398, DOI 10.1007/s10461-016-1456-0; Siraprapasiri T, 2016, J VIRUS ERAD, V2, P7; Srithanaviboonchai K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4172-4; Srithanaviboonchai Kriengkrai, 2014, Journal of the Medical Association of Thailand, V97, P225; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; STAPLETON D, 1986, CAN FAM PHYSICIAN, V32, P2510; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Surkan PJ, 2010, AIDS CARE, V22, P803, DOI 10.1080/09540120903443392; Thai Network of People Living with HIV/AIDS (TNP+), IND STIGM DISCR PEOP; Thailand National AIDS Committee, 2014, THAIL NAT OP PLAN AC; The Global Stigma and Discrimination Indicator Working Group, MEASURING HIV STIGMA; Thisyakorn U, 2017, PAEDIATR INT CHILD H, V37, P99, DOI 10.1080/20469047.2017.1281873; UNAIDS, 2016, UN POL DECL END AIDS; UNAIDS, GUID 2014 GLOB AIDS; UNAIDS, 2007, RED HIV STIGM DISCR; van Griensven F, 2015, LANCET HIV, V2, pE64, DOI 10.1016/S2352-3018(14)00031-9; Vanlandingham MJ, 2005, J HEALTH SOC BEHAV, V46, P392, DOI 10.1177/002214650504600406; Yang Y, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-014-0160-3; Young SD, 2010, JAIDS-J ACQ IMM DEF, V55, P620, DOI 10.1097/QAI.0b013e3181fc6429	45	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187231	10.1371/journal.pone.0187231	http://dx.doi.org/10.1371/journal.pone.0187231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145519	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800012
J	Maeki, M; Fujishima, Y; Sato, Y; Yasui, T; Kaji, N; Ishida, A; Tani, H; Baba, Y; Harashima, H; Tokeshi, M				Maeki, Masatoshi; Fujishima, Yuka; Sato, Yusuke; Yasui, Takao; Kaji, Noritada; Ishida, Akihiko; Tani, Hirofumi; Baba, Yoshinobu; Harashima, Hideyoshi; Tokeshi, Manabu			Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers	PLOS ONE			English	Article							DRUG-DELIVERY; SIRNA; LIPOSOMES; VESICLES; STRATEGY; SYSTEMS; MIXER	Lipid nanoparticles (LNPs) or liposomes are the most widely used drug carriers for nanomedicines. The size of LNPs is one of the essential factors affecting drug delivery efficiency and therapeutic efficiency. Here, we demonstrated the effect of lipid concentration and mixing performance on the LNP size using microfluidic devices with the aim of understanding the LNP formation mechanism and controlling the LNP size precisely. We fabricated microfluidic devices with different depths, 11 mu m and 31 mu m, of their chaotic micromixer structures. According to the LNP formation behavior results, by using a low concentration of the lipid solution and the microfluidic device equipped with the 31 mu m chaotic mixer structures, we were able to produce the smallest-sized LNPs yet with a narrow particle size distribution. We also evaluated the mixing rate of the microfluidic devices using a laser scanning confocal microscopy and we estimated the critical ethanol concentration for controlling the LNP size. The critical ethanol concentration range was estimated to be 60-80% ethanol. Ten nanometer-sized tuning of LNPs was achieved for the optimum residence time at the critical concentration using the microfluidic devices with chaotic mixer structures. The residence times at the critical concentration necessary to control the LNP size were 10, 15-25, and 50 ms time-scales for 30, 40, and 50 nm-sized LNPs, respectively. Finally, we proposed the LNP formation mechanism based on the determined LNP formation behavior and the critical ethanol concentration. The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.	[Maeki, Masatoshi; Ishida, Akihiko; Tani, Hirofumi; Tokeshi, Manabu] Hokkaido Univ, Div Appl Chem, Fac Engn, Kita Ku, Sapporo, Hokkaido, Japan; [Fujishima, Yuka] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Sapporo, Hokkaido, Japan; [Sato, Yusuke; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi, Japan; [Baba, Yoshinobu; Tokeshi, Manabu] Nagoya Univ, ImPACT Res Ctr Adv Nanobiodevices, Chikusa Ku, Nagoya, Aichi, Japan; [Baba, Yoshinobu; Tokeshi, Manabu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi, Japan; [Tokeshi, Manabu] Nagoya Univ, Innovat Res Ctr Prevent Med Engn, Chikusa Ku, Nagoya, Aichi, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Nagoya University; Nagoya University; Nagoya University; Nagoya University	Maeki, M; Tokeshi, M (corresponding author), Hokkaido Univ, Div Appl Chem, Fac Engn, Kita Ku, Sapporo, Hokkaido, Japan.; Tokeshi, M (corresponding author), Nagoya Univ, ImPACT Res Ctr Adv Nanobiodevices, Chikusa Ku, Nagoya, Aichi, Japan.; Tokeshi, M (corresponding author), Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi, Japan.; Tokeshi, M (corresponding author), Nagoya Univ, Innovat Res Ctr Prevent Med Engn, Chikusa Ku, Nagoya, Aichi, Japan.	m.maeki@eng.hokudai.ac.jp; tokeshi@eng.hokudai.ac.jp	Kaji, Noritada/U-1045-2019; Maeki, Masatoshi/T-4051-2019; Yasui, Takao/AHA-8445-2022; Tokeshi, Manabu/B-6257-2012; Tani, Hirofumi/F-6164-2012; Kaji, Noritada/M-8432-2019; Ishida, Akihiko/N-4845-2019	Maeki, Masatoshi/0000-0001-7500-4231; Tokeshi, Manabu/0000-0002-4412-2144; Tani, Hirofumi/0000-0002-5935-0756	Hosokawa Powder Technology Foundation; Tokyo Kasei Chemical Promotion Foundation; JST CREST, Japan [JP17937657]	Hosokawa Powder Technology Foundation; Tokyo Kasei Chemical Promotion Foundation; JST CREST, Japan(Core Research for Evolutional Science and Technology (CREST))	This study was supported by the Hosokawa Powder Technology Foundation (MT), http://www.kona.or.jp/en/index.html; the Tokyo Kasei Chemical Promotion Foundation (MT), http://www.tci-f.or.jp/subsidy; JST CREST grant number JP17937657, Japan (Dr. Manabu Tokeshi).	Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010; Batist G, 2001, J CLIN ONCOL, V19, P1444, DOI 10.1200/JCO.2001.19.5.1444; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Cheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025433; Fang SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175050; Ghazal A, 2017, J PHYS CHEM LETT, V8, P73, DOI 10.1021/acs.jpclett.6b02468; Grimaldi N, 2016, CHEM SOC REV, V45, P6520, DOI 10.1039/c6cs00409a; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; Hood RR, 2015, SMALL, V11, P5790, DOI 10.1002/smll.201501345; Hood RR, 2014, LAB CHIP, V14, P2403, DOI 10.1039/c4lc00334a; Johnson TJ, 2002, ANAL CHEM, V74, P45, DOI 10.1021/ac010895d; Kim SK, 2012, J CONTROL RELEASE, V157, P279, DOI 10.1016/j.jconrel.2011.08.014; Kitazoe K, 2011, LAB CHIP, V11, P3256, DOI 10.1039/c1lc20392d; Lajunen T, 2015, J CONTROL RELEASE, V203, P85, DOI 10.1016/j.jconrel.2015.02.028; LASIC DD, 1988, BIOCHEM J, V256, P1; Liu C, 2017, ACS NANO, V11, P6968, DOI 10.1021/acsnano.7b02277; Maeki M, 2015, RSC ADV, V5, P46181, DOI 10.1039/c5ra04690d; Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01; Noguchi H, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2358983; Olbrich C, 2001, J CONTROL RELEASE, V77, P345, DOI 10.1016/S0168-3659(01)00506-5; Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654; Sato Y, 2016, J CONTROL RELEASE, V229, P48, DOI 10.1016/j.jconrel.2016.03.019; Sato Y, 2012, J CONTROL RELEASE, V163, P267, DOI 10.1016/j.jconrel.2012.09.009; Shin S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08826-w; Shinoda W, 2011, SOFT MATTER, V7, P9012, DOI 10.1039/c1sm05404j; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Tanaka H, 2014, BIOMATERIALS, V35, P1755, DOI 10.1016/j.biomaterials.2013.11.016; Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Xu XY, 2015, TRENDS MOL MED, V21, P223, DOI 10.1016/j.molmed.2015.01.001; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhang L, 2015, ACS NANO, V9, P9912, DOI 10.1021/acsnano.5b05792; Zhang MD, 2015, SCI REP-UK, V5, DOI [10.1038/srep08266, 10.1038/srep10233]; Zhigaltsev IV, 2012, LANGMUIR, V28, P3633, DOI 10.1021/la204833h	36	63	63	13	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0187962	10.1371/journal.pone.0187962	http://dx.doi.org/10.1371/journal.pone.0187962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182626	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000007
J	Basilio, A; Searcy, S; Thompson, AR				Basilio, Anthony; Searcy, Steven; Thompson, Andrew R.			Effects of the Blob on settlement of spotted sand bass, Paralabrax maculatofasciatus, to Mission Bay, San Diego, CA	PLOS ONE			English	Article							SOUTHERN CALIFORNIA BIGHT; CORAL-REEF-FISH; LARVAL-JUVENILE TRANSITION; ZOOPLANKTON GROWTH-RATES; SARDINE SARDINOPS-SAGAX; EGG-PRODUCTION; ACARTIA-TONSA; LIFE-HISTORY; INTERANNUAL VARIABILITY; OCEANOGRAPHIC PROCESSES	The West Coast of the United States experienced variable and sometimes highly unusual oceanographic conditions between 2012 and 2015. In particular, a warm mass of surface water known as the Pacific Warm Anomaly (popularly as "TheBlob") impinged on southern California in 2014, and warm-water conditions remained during the 2015 El Nino. We examine how this oceanographic variability affected delivery and individual characteristics of larval spotted sand bass (Paralabrax maculatofasciatus) to an estuarine nursery habitat in southern California. To quantify P. maculatofasciatus settlement patterns, three larval collectors were installed near the mouth of Mission Bay, San Diego CA, and retrieved weekly from June-October of 2012-2015. During 'Blob' conditions in 2014 and 2015, lower settlement rates of spotted sand bass were associated with higher sea surface temperature and lower wind speed, chlorophyll a (chl a) and upwelling. Overall, the number of settlers per day peaked at intermediate chl a values across weeks. Individual characteristics of larvae that settled in 2014-2015 were consistent with a poor feeding environment. Although settlers were longer in length in 2014-15, fish in these years had slower larval otolith growth, a longer larval duration, and a trend towards lower condition, traits that are often associated with lower survival and recruitment. This study suggests that future settlement and recruitment of P. maculatofasciatus and other fishes with similar life histories may be adversely affected in southern California if ocean temperatures continue to rise in the face of climate change.	[Basilio, Anthony; Searcy, Steven] Univ San Diego, Environm & Ocean Sci, San Diego, CA 92110 USA; [Thompson, Andrew R.] NOAA, Fisheries Serv, Southwest Fisheries Sci Ctr, Fisheries Resources Div, La Jolla, CA USA	University of San Diego; National Oceanic Atmospheric Admin (NOAA) - USA	Searcy, S (corresponding author), Univ San Diego, Environm & Ocean Sci, San Diego, CA 92110 USA.	ssearcy@sandiego.edu			University of San Diegoto Steven Searcy; Department of Environmental and Ocean Sciences at the University of San Diego	University of San Diegoto Steven Searcy; Department of Environmental and Ocean Sciences at the University of San Diego	Funding was provided by a faculty research grant from the University of San Diegoto Steven Searcy as well as from support by the Department of Environmental and Ocean Sciences at the University of San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Constructive comments were provided by N. Reyns and two anonymous reviewers. Fieldwork was accomplished with the help of University of San Diego undergraduates (Tom Remington, Connell Ford, Matt Ray, Caroline Leinung, Colin Phillips, Craig Foxhoven, Diana Fontaine). Help with image analysis was provided by Jenny McDaniel and Emmanis Dorval at Southwest Fisheries Science Center. Funding was provided by a faculty research grant from the University of San Diego to Steven Searcy as well as from support by the Department of Environmental and Ocean Sciences at the University of San Diego.	Allen Larry G., 2012, Bulletin Southern California Academy of Sciences, V111, P15; Allen LG, 1995, CAL COOP OCEAN FISH, V36, P193; AMBLER JW, 1986, ESTUAR COAST SHELF S, V23, P183, DOI 10.1016/0272-7714(86)90053-3; Ammann AJ, 2004, J EXP MAR BIOL ECOL, V299, P135, DOI 10.1016/j.jembe.2003.08.014; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Anderson TW, 2007, MAR ECOL PROG SER, V350, P109, DOI 10.3354/meps07135; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Baumann H, 2005, MAR FRESHWATER RES, V56, P539, DOI 10.1071/MF04140; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BECKMAN BR, 1986, J PLANKTON RES, V8, P917, DOI 10.1093/plankt/8.5.917; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; BERTRAM DF, 1994, MAR ECOL PROG SER, V109, P105, DOI 10.3354/meps109105; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caselle JE, 2010, CAL COOP OCEAN FISH, V51, P91; Caselle JE, 2010, B MAR SCI, V86, P355; Cavole LM, 2016, OCEANOGRAPHY, P29; China V, 2014, P NATL ACAD SCI USA, V111, P8083, DOI 10.1073/pnas.1323205111; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; Cogliani E, 2001, ATMOS ENVIRON, V35, P2871, DOI 10.1016/S1352-2310(01)00071-1; Comerford S, 2013, MAR ECOL PROG SER, V476, P215, DOI 10.3354/meps10118; Connell SD, 1997, J EXP MAR BIOL ECOL, V209, P261, DOI 10.1016/S0022-0981(96)02704-9; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; Criales MM, 2003, ESTUAR COAST SHELF S, V57, P457, DOI 10.1016/S0272-7714(02)00374-8; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; DURBIN EG, 1983, LIMNOL OCEANOGR, V28, P1199, DOI 10.4319/lo.1983.28.6.1199; ELDRIDGE MB, 1981, T AM FISH SOC, V110, P111, DOI 10.1577/1548-8659(1981)110<111:EOFAFF>2.0.CO;2; Fitch J, 1975, TIDEPOOL NEARSHORE F; Fontes J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165648; Fuiman L.A., 2002, FISHERY SCI UNIQUE C; FUIMAN LA, 1994, REV FISH BIOL FISHER, V4, P145, DOI 10.1007/BF00044127; GAUL RD, 1960, J GEOPHYS RES, V65, P1543, DOI 10.1029/JZ065i005p01543; Goddard Jeffrey H. R., 2016, Bulletin Southern California Academy of Sciences, V115, P15; Grorud-Colvert K, 2011, OECOLOGIA, V165, P675, DOI 10.1007/s00442-010-1748-4; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Hopcroft RR, 1998, MAR BIOL, V132, P67, DOI 10.1007/s002270050372; Hopcroft RR, 1998, MAR BIOL, V132, P79, DOI 10.1007/s002270050373; Houde E.D., 1987, American Fisheries Society Symposium, P17; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; HOUDE ED, 1989, FISH B-NOAA, V87, P471; HOUDE ED, 1989, J FISH BIOL, V35, P29, DOI 10.1111/j.1095-8649.1989.tb03043.x; Howell P, 2012, MAR COAST FISH, V4, P481, DOI 10.1080/19425120.2012.685144; HUTCHINS JB, 1994, B MAR SCI, V54, P245; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Kahle D, 2013, R J, V5, P144; KIORBOE T, 1994, LIMNOL OCEANOGR, V39, P493, DOI 10.4319/lo.1994.39.3.0493; LANDRY MR, 1978, INT REV GES HYDROBIO, V63, P77, DOI 10.1002/iroh.19780630106; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Leising AW, 2014, CAL COOP OCEAN FISH, V55, P51; Levin PS, 1996, LIMNOL OCEANOGR, V41, P672, DOI 10.4319/lo.1996.41.4.0672; Liboschik T, 2016, TSCOUNT R PACKAGE AN; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; Logerwell EA, 2001, FISH OCEANOGR, V10, P13, DOI 10.1046/j.1365-2419.2001.00152.x; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; MCGURK MD, 1984, MAR BIOL, V84, P13, DOI 10.1007/BF00394522; MEEKAN MG, 1993, MAR ECOL PROG SER, V93, P217, DOI 10.3354/meps093217; Mendelssohn R., 2015, XTRACTOMATIC EXTRACT; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P135, DOI 10.3354/meps110135; Miller EF, 2006, CALIF FISH GAME, V92, P98; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Moser HG, 2000, CAL COOP OCEAN FISH, V41, P132; Navarrete SA, 2002, LIMNOL OCEANOGR, V47, P791, DOI 10.4319/lo.2002.47.3.0791; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; ODA DL, 1993, CAL COOP OCEAN FISH, V34, P122; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; PEPIN P, 1992, MAR ECOL PROG SER, V81, P1, DOI 10.3354/meps081001; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Ralston S, 2013, FISH OCEANOGR, V22, P288, DOI 10.1111/fog.12022; RANA KJ, 1985, AQUACULTURE, V46, P119, DOI 10.1016/0044-8486(85)90196-6; Rankin TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108871; ROBERTSON DR, 1988, ECOLOGY, V69, P370, DOI 10.2307/1940435; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Searcy SP, 2001, ECOLOGY, V82, P2452; Searcy SP, 2007, CAN J FISH AQUAT SCI, V64, P681, DOI 10.1139/F07-038; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; STEPHENS JS, 1994, B MAR SCI, V55, P1224; Stige LC, 2015, PROG OCEANOGR, V134, P138, DOI 10.1016/j.pocean.2015.01.009; Takahashi M, 2005, FISH OCEANOGR, V14, P223, DOI 10.1111/j.1365-2419.2005.00334.x; Tranah Gregory J., 1999, Bulletin Southern California Academy of Sciences, V98, P103; Vargas CA, 1997, ARCH FISH MAR RES, V45, P201; Voss R, 2006, MAR ECOL PROG SER, V308, P243, DOI 10.3354/meps308243; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Whitney FA, 2015, GEOPHYS RES LETT, V42, P428, DOI 10.1002/2014GL062634; Wilson DT, 1999, MAR BIOL, V134, P29, DOI 10.1007/s002270050522; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; Wing SR, 2003, ESTUAR COAST SHELF S, V57, P859, DOI 10.1016/S0272-7714(02)00416-X; Woodson CB, 2012, LIMNOL OCEANOGR, V57, P582, DOI 10.4319/lo.2012.57.2.0582; Wootton R.J., 1990, ECOLOGY TELEOST FISH; Zaba KD, 2016, GEOPHYS RES LETT, V43, P1241, DOI 10.1002/2015GL067550; [No title captured]	97	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188449	10.1371/journal.pone.0188449	http://dx.doi.org/10.1371/journal.pone.0188449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176818	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900080
J	Chu, TH; Cummins, K; Sparling, JS; Tsutsui, S; Brideau, C; Nilsson, KPR; Joseph, JT; Stys, PK				Chu, Tak-Ho; Cummins, Karen; Sparling, Joseph S.; Tsutsui, Shigeki; Brideau, Craig; Nilsson, K. Peter R.; Joseph, Jeffrey T.; Stys, Peter K.			Axonal and myelinic pathology in 5xFAD Alzheimer's mouse spinal cord	PLOS ONE			English	Article							WHITE-MATTER; NEUROPIL THREADS; TRANSGENIC MICE; DISEASE MICE; PROTEIN; DEGENERATION; BRAIN; TAU; DENDRITES; PRECURSOR	As an extension of the brain, the spinal cord has unique properties which could allow us to gain a better understanding of CNS pathology. The brain and cord share the same cellular components, yet the latter is simpler in cytoarchitecture and connectivity. In Alzheimer's research, virtually all focus is on brain pathology, however it has been shown that transgenic Alzheimer's mouse models accumulate beta amyloid plaques in spinal cord, suggesting that the cord possesses the same molecular machinery and conditions for plaque formation. Here we report a spatial-temporal map of plaque load in 5xFAD mouse spinal cord. We found that plaques started to appear at 11 weeks, then exhibited a time dependent increase and differential distribution along the cord. More plaques were found in cervical than other spinal levels at all time points examined. Despite heavy plaque load at 6 months, the number of cervical motor neurons in 5xFAD mice is comparable to wild type littermates. On detailed microscopic examination, fine beta amyloid-containing and beta sheet-rich thread-like structures were found in the peri-axonal space of many axons. Importantly, these novel structures appear before any plaque deposits are visible in young mice spinal cord and they co-localize with axonal swellings at later stages, suggesting that these thread-like structures might represent the initial stages of plaque formation, and could play a role in axonal damage. Additionally, we were able to demonstrate increasing myelinopathy in aged 5xFAD mouse spinal cord using the lipid probe Nile Red with high resolution. Collectively, we found significant amyloid pathology in grey and white matter of the 5xFAD mouse spinal cord which indicates that this structure maybe a useful platform to study mechanisms of Alzheimer's pathology and disease progression.	[Chu, Tak-Ho; Cummins, Karen; Sparling, Joseph S.; Tsutsui, Shigeki; Brideau, Craig; Stys, Peter K.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Nilsson, K. Peter R.] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Joseph, Jeffrey T.] Alberta Hlth Serv, Dept Clin Neurosci, Calgary, AB, Canada; [Joseph, Jeffrey T.] Alberta Hlth Serv, Dept Pathol & Lab Med, Calgary, AB, Canada	University of Calgary; Linkoping University; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary	Stys, PK (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.	pstys@ucalgary.ca	Sparling, Joseph S/A-2320-2014; Chu, Tak-Ho/AAB-4608-2021	Sparling, Joseph S/0000-0001-8004-0958; Chu, Tak-Ho/0000-0002-3123-207X; Stys, Peter/0000-0003-0326-4194	Dr. Frank Leblanc Chair for Spinal Cord Research; Canadian Institutes of Health Research (CIHR); Canada Research Chairs (CRC); Alberta Prion Research Institute (APRI)	Dr. Frank Leblanc Chair for Spinal Cord Research; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs); Alberta Prion Research Institute (APRI)	This study was supported by grants from the Dr. Frank Leblanc Chair for Spinal Cord Research, Canadian Institutes of Health Research (CIHR), Canada Research Chairs (CRC) and the Alberta Prion Research Institute (APRI).	Ashford JW, 1998, J NEUROPATH EXP NEUR, V57, P972, DOI 10.1097/00005072-199810000-00009; BRAAK H, 1988, NEUROPATH APPL NEURO, V14, P39, DOI 10.1111/j.1365-2990.1988.tb00864.x; BUGIANI O, 1989, NEUROSCI LETT, V103, P263, DOI 10.1016/0304-3940(89)90110-9; Buxbaum JD, 2007, J NEUROSCI, V35, P9629; Christensen DZ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00139; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; Dean DC, 2016, JAMA NEUROL, P1; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Elder GA, MT SINAI J MED, V7, P69; Fletcher E, 2013, JAMA NEUROL, V70, P1389, DOI 10.1001/jamaneurol.2013.3263; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Guo YJ, 2016, NEUROPSYCH DIS TREAT, V12, P445, DOI 10.2147/NDT.S90735; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Heraud C, 2014, NEUROBIOL DIS, V62, P100, DOI 10.1016/j.nbd.2013.09.010; Iwamoto N, 1997, ACTA NEUROPATHOL, V93, P334, DOI 10.1007/s004010050624; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Li JM, 2013, NEUROTOX RES, V24, P1, DOI 10.1007/s12640-012-9355-2; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OGOMORI K, 1989, AM J PATHOL, V134, P243; Ovsepian SV, 2016, J ALZHEIMERS DIS, V49, P13, DOI 10.3233/JAD-150544; Picken M.M., 2012, THIOFLAVIN T STAIN E, P187; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Selmani V, 2015, PROTEIN SCI, V24, P420, DOI 10.1002/pro.2620; Seo JS, 2010, J ALZHEIMERS DIS, V21, P263, DOI 10.3233/JAD-2010-091528; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Watson C, 2012, ANAT REC, V295, P1692, DOI 10.1002/ar.22549; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Wirths O, 2006, ACTA NEUROPATHOL, V111, P312, DOI 10.1007/s00401-006-0041-4; Yuan QJ, 2013, J ALZHEIMERS DIS, V35, P675, DOI 10.3233/JAD-122323	38	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188218	10.1371/journal.pone.0188218	http://dx.doi.org/10.1371/journal.pone.0188218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176903	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900046
J	Hu, JJ; Ding, N; Zhen, SH; Liu, Y; Wen, DL				Hu, Jiajin; Ding, Ning; Zhen, Shihan; Liu, Yang; Wen, Deliang			Who is more likely to be obese or overweight among siblings? A nationally representative study in rural China	PLOS ONE			English	Article							ADULT CARDIOVASCULAR-DISEASE; CHILDHOOD OBESITY; DEVELOPING-COUNTRIES; METABOLIC SYNDROME; BIRTH-ORDER; FAMILY; ASSOCIATIONS; DETERMINANTS; HEIGHT; RISK	Background The aims of this study were to determine the association between sibling rank and childhood obesity among children <= 5 years of age in rural China, and to investigate the effect of child gender and the obesity status of other siblings on this association. Methods Data from the China Family Panel Studies, a nationally representative survey, was used for the analysis. Sibling rank was defined as the birth order of all children with the same biological mother. A total of 1116 children <= 5 years of age were divided into four groups: children without siblings, first-born children, second-born children, and third-born or younger children. For each child, the body mass index and standard deviation (BMI z score) was calculated according to WHO standards; children with BMI z scores > 2 were classified as obese or overweight (ObOw). Logistic regression models were used to estimate the association between sibling rank and ObOw status, and the possible influence of gender and ObOw status among other siblings. Results The second and third-born or younger children had a significantly higher risk of becoming ObOw than children without siblings (odds ratio [OR]: 1.32, 95% confidence interval [CI]: 1.07-1.63 and OR: 1.38, 95% CI: 1.17-1.63, respectively). Specifically, female second-born children and male third-born or younger children had a significantly higher risk of ObOw (OR: 1.50, 95% CI: 1.11-2.01 and OR: 1.57, 95% CI: 1.07-2.32, respectively). Having an ObOw sibling increased the probability of being ObOw and the magnitude of the effect was larger if siblings were younger. Conclusions Sibling rank was shown to be associated with ObOw status among children 0-5 years of age in rural China. Our findings can help healthcare practitioners and authorities to identify children at risk of obesity. Future studies should focus on the mechanisms of this association.	[Hu, Jiajin; Zhen, Shihan; Liu, Yang; Wen, Deliang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Ding, Ning] China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Wen, DL (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.	dlwen@cmu.edu.cn			Shenyang Science and Technology Plan Projects [F14-231-1-57]; Liaoning Distinguished Professor [204]	Shenyang Science and Technology Plan Projects; Liaoning Distinguished Professor	This study was supported by Shenyang Science and Technology Plan Projects (F14-231-1-57 to DW) and Liaoning Distinguished Professor (Liao taught [2013] No. 204 to DW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, LANCET, V382, P1758, DOI 10.1016/S0140-6736(13)62534-9; Beilin L, 2008, CLIN EXP PHARMACOL P, V35, P409, DOI 10.1111/j.1440-1681.2008.04887.x; Brody GH, 2004, CURR DIR PSYCHOL SCI, V13, P124, DOI 10.1111/j.0963-7214.2004.00289.x; Burgess JA, 2005, THORAX; Chen AY, 2010, PREV CHRONIC DIS, V7; DODGE J, 1980, NEW ZEAL MED J, V91, P352; Duarte CS, 2012, PEDIATR OBES, V7, P124, DOI 10.1111/j.2047-6310.2011.00012.x; DUNN J, 1983, CHILD DEV, V54, P787, DOI 10.2307/1129886; Farpour-Lambert NJ, 2015, OBESITY FACTS, V8, P342, DOI 10.1159/000441483; Group BMJP, 2007, BMJ-BRIT MED J, V335, P796; Gruber KJ, 2009, PREV CHRONIC DIS, V6; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Haugaard LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056357; Hesketh K, 2007, INT J PEDIATR OBES, V2, P86, DOI 10.1080/17477160601148554; Jahan S, 2009, INT J DIABETES DEV C, V29, P12, DOI 10.4103/0973-3930.50709; Jelenkovic A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28496; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Liang YJ, 2015, ENDOCRINE, V50, P87, DOI 10.1007/s12020-015-0560-7; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Loke KY, 2014, ANN ACAD MED SINGAP, V43, P57; MINNETT AM, 1983, CHILD DEV, V54, P1064, DOI 10.1111/j.1467-8624.1983.tb00527.x; Mosli RH, 2016, PEDIATR OBES, V11, P40, DOI 10.1111/ijpo.12018; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Pachucki MC, 2014, AM J PREV MED, V47, P382, DOI 10.1016/j.amepre.2014.05.018; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; ROZIN P, 1987, APPETITE, V8, P125, DOI 10.1016/S0195-6663(87)80005-3; Rubin DB, 1989, J MARKETING RES, V137, P180; The National Task Force on Childhood Obesity National epidemiological survey on childhood obesity, 2008, CHIN J PEDIAT, V46, P179; Watson PM, 2011, ANN HUM BIOL, V38, P445, DOI 10.3109/03014460.2011.590531; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Xie Yu, 2015, Chin J Sociol, V1, P471, DOI 10.1177/2057150X15614535	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187693	10.1371/journal.pone.0187693	http://dx.doi.org/10.1371/journal.pone.0187693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176827	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900013
J	Murray, J; Todd, KV; Bakre, A; Orr-Burks, N; Jones, L; Wu, WL; Tripp, RA				Murray, Jackelyn; Todd, Kyle V.; Bakre, Abhijeet; Orr-Burks, Nichole; Jones, Les; Wu, Weilin; Tripp, Ralph A.			A universal mammalian vaccine cell line substrate	PLOS ONE			English	Article							INFLUENZA-A VIRUS; VARICELLA-ZOSTER-VIRUS; MONKEY KIDNEY-CELLS; RNA VIRUSES; RAPID DETECTION; HEPATITIS-A; MUMPS-VIRUS; VERO CELLS; DENGUE; REPLICATION	Using genome-wide small interfering RNA (siRNA) screens for poliovirus, influenza A virus and rotavirus, we validated the top 6 gene hits PV, RV or IAV to search for host genes that when knocked-down (KD) enhanced virus permissiveness and replication over wild type Vero cells or HEp-2 cells. The enhanced virus replication was tested for 12 viruses and ranged from 2-fold to > 1000-fold. There were variations in virus-specific replication (strain differences) across the cell lines examined. Some host genes (CNTD2, COQ9, GCGR, NDUFA9, NEU2, PYCR1, SEC16G, SVOPL, ZFYVE9, and ZNF205) showed that KD resulted in enhanced virus replication. These findings advance platform-enabling vaccine technology, the creation of diagnostic cells substrates, and are informative about the host mechanisms that affect virus replication in mammalian cells.	[Murray, Jackelyn; Todd, Kyle V.; Bakre, Abhijeet; Orr-Burks, Nichole; Jones, Les; Wu, Weilin; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Tripp, RA (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Bakre, Abhijeet A./A-4632-2013	Bakre, Abhijeet A./0000-0002-6755-5233; Todd, Kyle/0000-0001-8475-9337; Tripp, Ralph/0000-0002-2924-9956	Center of Excellence for influenza Research and Surveillance [HHSN272201500004C]; Bill and Melinda Gates foundation; Georgia Research Alliance (GRA)	Center of Excellence for influenza Research and Surveillance; Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); Georgia Research Alliance (GRA)	The funders had no role in study design, data collection and analysis decision to publish, or preparation of this manuscript. This work was in part supported by the Center of Excellence for influenza Research and Surveillance (HHSN272201500004C), the Bill and Melinda Gates foundation, and the Georgia Research Alliance (GRA). The GRA is an independent nonprofit organization that works in partnership with the University System of Georgia and Georgia's Department of Economic Development.	Agbulos DS, 2016, CURRENT PROTOCOLS MI, V43; Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Alsuwaidi AR, 2013, VIROLOGY, V446, P180, DOI 10.1016/j.virol.2013.07.034; ANDZHAPARIDZE OG, 1983, ACTA VIROL, V27, P318; Audsley JM, 2005, J VIROL METHODS, V123, P187, DOI 10.1016/j.jviromet.2004.09.015; Baertling F, 2017, CLIN GENETICS; Bakre A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066796; Barrett PN, 2013, EXPERT REV VACCINES, V12, P395, DOI [10.1586/erv.13.21, 10.1586/ERV.13.21]; Barrett PN, 2010, CURR OPIN MOL THER, V12, P21; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V130, P958, DOI 10.1016/j.jaci.2012.07.013; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Christensen EM, 2017, J BIOL CHEM, V292, P7233, DOI 10.1074/jbc.M117.780288; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; FEINSTONE SM, 1983, DEV BIOL STAND, V54, P429; Gasa L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10770-8; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015; Grahn A, 2015, J INFECTION, V71, P281, DOI 10.1016/j.jinf.2015.06.004; Grimwood Keith, 2010, Paediatr Drugs, V12, P235, DOI 10.2165/11537200-000000000-00000; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Huang CH, 2013, J INFECT DIS, V208, P1898, DOI 10.1093/infdis/jit381; Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703; HUGHES JH, 1993, CLIN MICROBIOL REV, V6, P150, DOI 10.1128/CMR.6.2.150-175.1993; Iida R, 2010, MOL CELL BIOL, V30, P2306, DOI 10.1128/MCB.01025-09; Iwai A, 2013, BIOCHEM BIOPH RES CO, V441, P531, DOI 10.1016/j.bbrc.2013.10.100; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Keating GM, 2016, BIODRUGS, V30, P243, DOI 10.1007/s40259-016-0180-7; Kirkwood CD, 1998, J VIROL, V72, P9348, DOI 10.1128/JVI.72.11.9348-9352.1998; Kuo ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep18846; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Lee JH, 2013, J VIROL METHODS, V191, P16, DOI 10.1016/j.jviromet.2013.03.019; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Li ML, 2016, WIRES RNA, V7, P575, DOI 10.1002/wrna.1351; LIEBHABE.H, 1967, P SOC EXP BIOL MED, V125, P636, DOI 10.3181/00379727-125-32167; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Meliopoulos VA, 2012, FASEB J, V26, P1372, DOI 10.1096/fj.11-193466; Milstien J, 1996, DEV BIOL STAND, V86, P31; Modlin J, 2014, NEW ENGL J MED, V371, P1476, DOI 10.1056/NEJMp1407783; Montomoli E, 2012, EXPERT REV VACCINES, V11, P587, DOI [10.1586/ERV.12.24, 10.1586/erv.12.24]; MOORE AE, 1955, CANCER RES, V15, P598; Muhlbauer D, 2015, J VIROL, V89, P6009, DOI 10.1128/JVI.03531-14; Music S, 2010, VACCINE, V28, P869, DOI 10.1016/j.vaccine.2009.08.006; Nagarajan MM, 1998, J VIROL METHODS, V72, P51, DOI 10.1016/S0166-0934(98)00011-1; Ojha CR, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0292-x; Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029; Poltronieri P, 2015, CURR GENOMICS, V16, P327, DOI 10.2174/1389202916666150707160613; Rao CD, 2015, J VIROL METHODS, V224, P47, DOI 10.1016/j.jviromet.2015.08.007; Roed SN, 2015, J BIOL CHEM, V290, P1233, DOI 10.1074/jbc.M114.592436; Santak M, 2015, MICROBES INFECT, V17, P228, DOI 10.1016/j.micinf.2014.11.006; Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8; Smith DJ, 2016, CHURCH FAITH CULT M, P1; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026; Tripp RA, 2015, CURR TOP MICROBIOL, V386, P459, DOI 10.1007/82_2014_409; Tripp RA, 2009, METHODS MOL BIOL, V555, P43, DOI 10.1007/978-1-60327-295-7_4; van der Sanden SMG, 2016, J VIROL, V90, P1694, DOI 10.1128/JVI.01464-15; Vincent-Falquet J C, 1989, Dev Biol Stand, V70, P153; Virk RK, 2016, EXPERT REV ANTI-INFE, V14, P365, DOI 10.1586/14787210.2016.1155450; Wang Lili, 2016, Ther Adv Vaccines, V4, P20, DOI 10.1177/2051013616655980; Wearing HJ, 2016, PARASITOLOGY, V143, P860, DOI 10.1017/S0031182016000421; Weir JP, 2016, INFLUENZA OTHER RESP, V10, P354, DOI 10.1111/irv.12383; WESTENFELD FW, 1994, AM J CLIN PATHOL, V102, P733, DOI 10.1093/ajcp/102.6.733; Wichmann O, 2017, VACCINE, V35, P5535, DOI 10.1016/j.vaccine.2017.08.066; Wu WL, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.21; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhou H, 2017, VACCINE, V35, P305, DOI 10.1016/j.vaccine.2016.11.051; Zhou Y, 2016, EXPERT REV VACCINES, V15, P803, DOI 10.1080/14760584.2016.1191357; Zou Xing, 2006, Fen Zi Xi Bao Sheng Wu Xue Bao, V39, P22	78	15	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188333	10.1371/journal.pone.0188333	http://dx.doi.org/10.1371/journal.pone.0188333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176782	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900062
J	Nguyen, TA; Kahn, DA; Loewendorf, AI				Nguyen, Tina A.; Kahn, Daniel A.; Loewendorf, Andrea I.			Maternal-Fetal rejection reactions are unconstrained in preeclamptic women	PLOS ONE			English	Article							REGULATORY T-CELLS; HIV-1 INFECTION; TREG CELLS; EXPRESSION; CD4(+); DIFFERENTIATION; LYMPHOCYTES; ACTIVATION; SUBSETS; MEMORY	The risk factors for preeclampsia, extremes of maternal age, changing paternity, concomitant maternal autoimmunity, and/or birth intervals greater than 5 years, suggest an underlying immunopathology. We used peripheral blood and lymphocytes from the UteroPlacental Interface (UPI) of 3rd trimester healthy pregnant women in multicolor flow cytometry D and in vitro suppression assays. The major end-point was the characterization of activation markers, and potential effector functions of different CD4-and CD8 subsets as well as T regulatory cells (Treg). We observed a significant shift of peripheral CD4-and CD8-T cells from naive to memory phenotype in preeclamptic women compared to healthy pregnant women consistent with long-standing immune activation. While the proportions of the highly suppressive Cytokine and Activated Treg were increased in preeclampsia, Treg tolerance toward fetal antigens was dysfunctional. Thus, our observations indicate a long-standing inflammatory derangement driving immune activation in preeclampsia; in how far the Treg dysfunction is caused by/causes this immune activation in preeclampsia will be the object of future studies.	[Nguyen, Tina A.; Kahn, Daniel A.; Loewendorf, Andrea I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA; [Kahn, Daniel A.] Asante Phys Partners, Medford, OR USA; [Loewendorf, Andrea I.] Huntington Med Res Inst, Pasadena, CA 91101 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Huntington Medical Research Institutes	Loewendorf, AI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA.; Loewendorf, AI (corresponding author), Huntington Med Res Inst, Pasadena, CA 91101 USA.	Loewendorf@hmri.org		Loewendorf, Andrea/0000-0001-7150-3316	Harvey L. Karp Discovery Award; UCLA-Caltech Joint Center for Translational Medicine; Reproductive Scientist Development Program (DAK) NIH/NICHD [2K12HD000849-26]	Harvey L. Karp Discovery Award; UCLA-Caltech Joint Center for Translational Medicine; Reproductive Scientist Development Program (DAK) NIH/NICHD	We acknowledge the support of Harvey L. Karp Discovery Award, UCLA-Caltech Joint Center for Translational Medicine, a gift from the UCLA Scholars in Translational Medicine, and Reproductive Scientist Development Program (DAK) NIH/NICHD 2K12HD000849-26 (Moley).	Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Basdeo SA, 2015, J IMMUNOL, V195, P528, DOI 10.4049/jimmunol.1402990; Boualleg S, 2017, ADV MATER SCI ENG, V2017, P1, DOI 10.1155/2017/5634713; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Cudihy D, 2009, J OBSTET GYNAECOL, V29, P576, DOI 10.1080/01443610903061751; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; Dolfi DV, 2007, ADV EXP MED BIOL, V590, P149; Finak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20686; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Kisielewicz A, 2010, CLIN IMMUNOL, V137, P209, DOI 10.1016/j.clim.2010.07.008; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Larbi A, 2006, CELL SIGNAL, V18, P1017, DOI 10.1016/j.cellsig.2005.08.016; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Lau SY, 2013, AM J REPROD IMMUNOL, V70, P412, DOI 10.1111/aji.12138; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Loewendorf AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096723; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; McGovern JL, 2012, ARTHRITIS RHEUM-US, V64, P3129, DOI 10.1002/art.34565; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; NAGEL JE, 1988, J CLIN INVEST, V81, P1096, DOI 10.1172/JCI113422; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Ohl K, 2015, EUR J IMMUNOL, V45, P344, DOI 10.1002/eji.201344280; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Petrelli A, 2015, ARTHRITIS RHEUMATOL; Roederer M, 2001, CYTOMETRY, V45, P56, DOI 10.1002/1097-0320(20010901)45:1<56::AID-CYTO1144>3.0.CO;2-9; SCHWAB R, 1990, INT IMMUNOL, V2, P239, DOI 10.1093/intimm/2.3.239; Scriba TJ, 2005, J CLIN INVEST, V115, P443, DOI 10.1172/JCI200523084; Semmo N, 2005, HEPATOLOGY, V41, P1019, DOI 10.1002/hep.20669; Siddiqui AH, 2010, HYPERTENSION, V55, P386, DOI 10.1161/HYPERTENSIONAHA.109.140061; Steinborn A, 2012, CLIN EXP IMMUNOL, V167, P84, DOI 10.1111/j.1365-2249.2011.04493.x; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wagner MI, 2015, IMMUNOL CELL BIOL, V93, P858, DOI 10.1038/icb.2015.51; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Welten SPM, 2013, J VIROL, V87, P6851, DOI 10.1128/JVI.03305-12; Wick G, 1997, EXP GERONTOL, V32, P401, DOI 10.1016/S0531-5565(96)00152-0; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	45	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188250	10.1371/journal.pone.0188250	http://dx.doi.org/10.1371/journal.pone.0188250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176779	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900049
J	Wallqvist, A; Wang, H; Zavaljevski, N; Memisevic, V; Kwon, K; Pieper, R; Rajagopala, SV; Reifman, J				Wallqvist, Anders; Wang, Hao; Zavaljevski, Nela; Memisevic, Vesna; Kwon, Keehwan; Pieper, Rembert; Rajagopala, Seesandra V.; Reifman, Jaques			Mechanisms of action of Coxiella burnetii effectors inferred from host-pathogen protein interactions	PLOS ONE			English	Article							Q-FEVER; CELL APOPTOSIS; UNITED-STATES; SECRETION; TRAFFICKING; ACTIVATION; RESOURCE; VACUOLE; PATHWAY; GENE	Coxiella burnetii is an obligate Gram-negative intracellular pathogen and the etiological agent of Q fever. Successful infection requires a functional Type IV secretion system, which translocates more than 100 effector proteins into the host cytosol to establish the infection, restructure the intracellular host environment, and create a parasitophorous vacuole where the replicating bacteria reside. We used yeast two-hybrid (Y2H) screening of 33 selected C. burnetii effectors against whole genome human and murine proteome libraries to generate a map of potential host-pathogen protein-protein interactions (PPIs). We detected 273 unique interactions between 20 pathogen and 247 human proteins, and 157 between 17 pathogen and 137 murine proteins. We used orthology to combine the data and create a single host-pathogen interaction network containing 415 unique interactions between 25 C. burnetii and 363 human proteins. We further performed complementary pairwise Y2H testing of 43 out of 91 C. burnetii-human interactions involving five pathogen proteins. We used the combined data to 1) perform enrichment analyses of target host cellular processes and pathways, 2) examine effectors with known infection phenotypes, and 3) infer potential mechanisms of action for four effectors with uncharacterized functions. The host-pathogen interaction profiles supported known Coxiella phenotypes, such as adapting cell morphology through cytoskeletal re-arrangements, protein processing and trafficking, organelle generation, cholesterol processing, innate immune modulation, and interactions with the ubiquitin and proteasome pathways. The generated dataset of PPIs D the largest collection of unbiased Coxiella host-pathogen interactions to date D represents a rich source of information with respect to secreted pathogen effector proteins and their interactions with human host proteins.	[Wallqvist, Anders; Wang, Hao; Zavaljevski, Nela; Memisevic, Vesna; Reifman, Jaques] US Army Med Res & Mat Command, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA; [Kwon, Keehwan; Pieper, Rembert; Rajagopala, Seesandra V.] J Craig Venter Inst, Rockville, MD USA	United States Department of Defense; United States Army; J. Craig Venter Institute	Reifman, J (corresponding author), US Army Med Res & Mat Command, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469	U.S. Defense Threat Reduction Agency [CBS. MEDBIO.02.10.BH.021]; U.S. Army Medical Research and Materiel Command as part of the U.S. Army's Network Science Initiative	U.S. Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); U.S. Army Medical Research and Materiel Command as part of the U.S. Army's Network Science Initiative	This work was supported by U.S. Defense Threat Reduction Agency Award CBS. MEDBIO.02.10.BH.021 (JR) and by the U.S. Army Medical Research and Materiel Command (Ft. Detrick, MD) (JR) as part of the U.S. Army's Network Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; Arampatzi P, 2013, NUCLEIC ACIDS RES, V41, P2202, DOI 10.1093/nar/gks1365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Beare PA, 2014, J BACTERIOL, V196, P1925, DOI 10.1128/JB.01532-14; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bisle S, 2016, VIRULENCE, V7, P400, DOI 10.1080/21505594.2016.1139280; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Boucherit N, 2012, FEMS IMMUNOL MED MIC, V64, P101, DOI 10.1111/j.1574-695X.2011.00852.x; Calverley M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051941; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Case ED, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0014-2015; Chen CH, 2015, J CELL SCI, V128, P3290, DOI 10.1242/jcs.171637; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Chen YQ, 2010, J CELL BIOCHEM, V111, P797, DOI 10.1002/jcb.22838; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eckart RA, 2014, INFECT IMMUN, V82, P2763, DOI 10.1128/IAI.01204-13; Eisenreich W, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00024; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Fernandes TD, 2016, INFECT IMMUN, V84, P2439, DOI 10.1128/IAI.00411-16; Fielden LF, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01046-16; Gilk SD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003107; Gilk SD, 2012, ADV EXP MED BIOL, V984, P199, DOI 10.1007/978-94-007-4315-1_10; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Graham JG, 2013, CELL MICROBIOL, V15, P1012, DOI 10.1111/cmi.12096; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Honstettre A, 2004, J IMMUNOL, V172, P3695, DOI 10.4049/jimmunol.172.6.3695; Hopkins J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004413; Ishii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080297; Justis AV, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12637; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; Klingenbeck L, 2013, CELL MICROBIOL, V15, P675, DOI 10.1111/cmi.12066; Kohler LJ, 2016, MBIO, V7, DOI 10.1128/mBio.01127-16; Kohler LJ, 2015, MICROBES INFECT, V17, P766, DOI 10.1016/j.micinf.2015.08.006; Kubori T, 2014, METHODS MOL BIOL, V1197, P141, DOI 10.1007/978-1-4939-1261-2_8; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Larson CL, 2016, FUTURE MICROBIOL, V11, P919, DOI 10.2217/fmb-2016-0044; Larson CL, 2013, P NATL ACAD SCI USA, V110, pE4770, DOI 10.1073/pnas.1309195110; Latomanski EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006101; Lee EJ, 2016, ADV EXP MED BIOL, V933, P25, DOI 10.1007/978-981-10-2041-4_3; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; de Armentia MML, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010011; Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07; Luhrmann A, 2010, P NATL ACAD SCI USA, V107, P18997, DOI 10.1073/pnas.1004380107; MacDonald E, 2014, TRAFFIC, V15, P879, DOI 10.1111/tra.12180; Man XH, 2015, EUR J CELL BIOL, V94, P162, DOI 10.1016/j.ejcb.2015.01.004; Marini ES, 2015, CELL DEATH DIFFER, V22, P1131, DOI 10.1038/cdd.2014.197; Masu G, 2015, VET ITAL, V51, P107, DOI 10.12834/VetIt.51.3542.1; McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12; McDonough JA, 2012, ADV EXP MED BIOL, V984, P171, DOI 10.1007/978-94-007-4315-1_9; McQuiston JH, 2006, AM J TROP MED HYG, V75, P36, DOI 10.4269/ajtmh.2006.75.1.0750036; Meconi S, 2001, INFECT IMMUN, V69, P2520, DOI 10.1128/IAI.69.4.2520-2526.2001; Memisevic V, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1242-z; Memisevic V, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-244; Memisevic V, 2013, MOL CELL PROTEOMICS, V12, P3036, DOI 10.1074/mcp.M113.029041; Meng XW, 2014, J BIOL CHEM, V289, P20543, DOI 10.1074/jbc.M114.549220; Minnick MF, 2012, ADV EXP MED BIOL, V984, P231, DOI 10.1007/978-94-007-4315-1_12; Moffatt JH, 2015, CELL MICROBIOL, V17, P621, DOI 10.1111/cmi.12432; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; O'Brien KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116824; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Peluso JJ, 2014, BIOL REPROD, V91, DOI [10.1095/biolreprod.114.122986, 10.1095/biolreprod.114.117481]; Personnic N, 2016, TRENDS MICROBIOL, V24, P450, DOI 10.1016/j.tim.2016.02.003; Rajagopala SV, 2015, ADV EXP MED BIOL, V883, P187, DOI 10.1007/978-3-319-23603-2_11; Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rodriguez-Escudero M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148032; Roszer T, 2017, APOPTOSIS, V22, P284, DOI 10.1007/s10495-016-1310-x; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sandoz KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149957; Santos JC, 2016, CELL MICROBIOL, V18, P330, DOI 10.1111/cmi.12567; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schafer W, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12634; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Sekeyova Z, 2010, ACTA VIROL, V54, P173, DOI 10.4149/av_2010_03_173; Shannon JG, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-26; Stead CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-222; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; van Asseldonk MAPM, 2015, PREV VET MED, V121, P115, DOI 10.1016/j.prevetmed.2015.06.010; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Verdino P, 2011, CELL CYCLE, V10, P1341, DOI 10.4161/cc.10.9.15294; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Wallqvist A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2351-1; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; Weber MM, 2016, MICROBES INFECT, V18, P336, DOI 10.1016/j.micinf.2016.01.003; Weber MM, 2013, J BACTERIOL, V195, P3914, DOI 10.1128/JB.00071-13; White B, 2013, TRAVEL MED INFECT DI, V11, P134, DOI 10.1016/j.tmaid.2012.11.001; Winchell CG, 2016, CURR OPIN MICROBIOL, V29, P9, DOI 10.1016/j.mib.2015.09.004; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu XP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012500; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhu Laurence, 2015, Methodist Debakey Cardiovasc J, V11, P160, DOI 10.14797/mdcj-11-3-160	105	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188071	10.1371/journal.pone.0188071	http://dx.doi.org/10.1371/journal.pone.0188071			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176882	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900032
J	Watanabe, K; Kokubo, T				Watanabe, Kiyoshi; Kokubo, Tetsuro			SAGA mediates transcription from the TATA-like element independently of Taf1p/TFIID but dependent on core promoter structures in Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; UPSTREAM ACTIVATING SEQUENCES; PROTEIN-DNA BINDING; AMINO-ACID PERMEASE; IN-VIVO; MESSENGER-RNA; GENE-EXPRESSION; YEAST TATA; MOLECULAR-MECHANISMS; COACTIVATOR COMPLEX	In Saccharomyces cerevisiae, core promoters of class II genes contain a TATA element, either a TATA box (TATA[A/T]A[A/T][A/G]) or TATA-like element (1 or 2 bp mismatched version of the TATA box). The TATA element directs the assembly of the preinitiation complex (PIC) to ensure accurate transcriptional initiation. It has been proposed the PIC is assembled by two distinct pathways in which TBP is delivered by TFIID or SAGA, leading to the widely accepted model that these complexes mediate transcription mainly from TATA-like element-or TATA box-containing promoters, respectively. Although both complexes are involved in transcription of nearly all class II genes, it remains unclear how efficiently SAGA mediates transcription from TATA-like element-containing promoters independently of TFIID. We found that transcription from the TATA box-containing AGP1 promoter was greatly stimulated in a Spt3p-dependent manner after inactivation of Taf1p/TFIID. Thus, this promoter provides a novel experimental system in which to evaluate SAGA-mediated transcription from TATA-like element(s). We quantitatively measured transcription from various TATA-like elements in the Taf1p-dependent CYC1 promoter and Taf1p-independent AGP1 promoter. The results revealed that SAGA could mediate transcription from at least some TATA-like elements independently of Taf1p/TFIID, and that Taf1p-dependence or -independence is highly robust with respect to variation of the TATA sequence. Furthermore, chimeric promoter mapping revealed that Taf1p-dependence or independence was conferred by the upstream activating sequence (UAS), whereas Spt3p-dependent transcriptional stimulation after inactivation of Taf1p/TFIID was specific to the AGP1 promoter and dependent on core promoter regions other than the TATA box. These results suggest that TFIID and/or SAGA are regulated in two steps: the UAS first specifies TFIID or SAGA as the predominant factor on a given promoter, and then the core promoter structure guides the pertinent factor to conduct transcription in an appropriate manner.	[Watanabe, Kiyoshi; Kokubo, Tetsuro] Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa, Japan	Yokohama City University	Kokubo, T (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa, Japan.	kokubo@yokohama-cu.ac.jp			Japan Society for the Promotion of Science [15K06953]; AMED-CREST of the Japan Agency for Medical Research and Development, AMED [JPMJCR11J4]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED-CREST of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by grants from the Japan Society for the Promotion of Science (15K06953) and the AMED-CREST program (JPMJCR11J4) of the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Afek A, 2013, BIOPHYS J, V104, P1107, DOI 10.1016/j.bpj.2013.01.038; Afek A, 2012, BIOPHYS J, V102, P1881, DOI 10.1016/j.bpj.2012.03.044; Auty R, 2004, J BIOL CHEM, V279, P49973, DOI 10.1074/jbc.M409849200; Baptista T, 2017, MOL CELL; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bjornsdottir G, 2008, NUCLEIC ACIDS RES, V36, P2906, DOI 10.1093/nar/gkn130; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; de Jonge WJ, 2017, EMBO J, V36, P274, DOI 10.15252/embj.201695621; Donczew R, 2017, MOL CELL BIOL; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Durand A, 2014, STRUCTURE, V22, P1553, DOI 10.1016/j.str.2014.07.017; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Grunberg S, 2016, EMBO J, V35, P2435, DOI 10.15252/embj.201695020; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Kamenova I, 2014, MOL CELL BIOL, V34, P2929, DOI 10.1128/MCB.01685-13; Ki S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl135; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kubik S, 2017, EMBO J, V36, P248, DOI 10.15252/embj.201696152; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee SK, 2010, GENETICS, V184, P659, DOI 10.1534/genetics.109.113464; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; LI WZ, 1991, MOL CELL BIOL, V11, P666, DOI 10.1128/MCB.11.2.666; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Lubliner S, 2015, GENOME RES, V25, P1008, DOI 10.1101/gr.188193.114; Lubliner S, 2013, NUCLEIC ACIDS RES, V41, P5569, DOI 10.1093/nar/gkt256; Lundblack V., 1998, CURRENT PROTOCOLS MO, V2; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; MARTENS JA, 1994, J BIOL CHEM, V269, P15661; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Nocetti N, 2016, GENE DEV, V30, P660, DOI 10.1101/gad.274910.115; Ohyama Y, 2010, GENES CELLS, V15, P1169, DOI 10.1111/j.1365-2443.2010.01452.x; PONTICELLI AS, 1990, MOL CELL BIOL, V10, P2832, DOI 10.1128/MCB.10.6.2832; Reja R, 2015, GENE DEV, V29, P1942, DOI 10.1101/gad.268896.115; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rodriguez-Molina JB, 2016, MOL CELL, V63, P433, DOI 10.1016/j.molcel.2016.06.036; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Schreve JL, 1998, J BACTERIOL, V180, P2556, DOI 10.1128/JB.180.9.2556-2559.1998; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Takahata S, 2004, MOL CELL BIOL, V24, P3089, DOI 10.1128/MCB.24.8.3089-3099.2004; Takahata S, 2003, J BIOL CHEM, V278, P45888, DOI 10.1074/jbc.M306886200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Tsukihashi Y, 2000, MOL CELL BIOL, V20, P2385, DOI 10.1128/MCB.20.7.2385-2399.2000; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Warfield L, 2017, MOL CELL; Watanabe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129357; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zentner GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9733	84	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188435	10.1371/journal.pone.0188435	http://dx.doi.org/10.1371/journal.pone.0188435			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176831	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900077
J	Bien, SA; Auer, PL; Harrison, TA; Qu, CH; Connolly, CM; Greenside, PG; Chen, S; Berndt, SI; Bezieau, S; Kang, HM; Huyghe, J; Brenner, H; Casey, G; Chan, AT; Hopper, JL; Banbury, BL; Chang-Claude, J; Chanock, SJ; Haile, RW; Hoffmeister, M; Fuchsberger, C; Jenkins, MA; Leal, SM; Lemire, M; Newcomb, PA; Gallinger, S; Potter, JD; Schoen, RE; Slattery, ML; Smith, JD; Le Marchand, L; White, E; Zanke, BW; Abecasis, GR; Carlson, CS; Peters, U; Nickerson, DA; Kundaje, A; Hsu, L				Bien, Stephanie A.; Auer, Paul L.; Harrison, Tabitha A.; Qu, Conghui; Connolly, Charles M.; Greenside, Peyton G.; Chen, Sai; Berndt, Sonja I.; Bezieau, Stephane; Kang, Hyun M.; Huyghe, Jeroen; Brenner, Hermann; Casey, Graham; Chan, Andrew T.; Hopper, John L.; Banbury, Barbara L.; Chang-Claude, Jenny; Chanock, Stephen J.; Haile, Robert W.; Hoffmeister, Michael; Fuchsberger, Christian; Jenkins, Mark A.; Leal, Suzanne M.; Lemire, Mathieu; Newcomb, Polly A.; Gallinger, Steven; Potter, John D.; Schoen, Robert E.; Slattery, Martha L.; Smith, Joshua D.; Le Marchand, Loic; White, Emily; Zanke, Brent W.; Abecasis, Goncalo R.; Carlson, Christopher S.; Peters, Ulrike; Nickerson, Deborah A.; Kundaje, Anshul; Hsu, Li		GECCO CCFR	Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data	PLOS ONE			English	Article							AFRICAN-AMERICANS; CODING VARIANTS; COMMON; RARE; IMPUTATION; LOCI	Background The evaluation of less frequent genetic variants and their effect on complex disease pose new challenges for genomic research. To investigate whether epigenetic data can be used to inform aggregate rare-variant association methods (RVAM), we assessed whether variants more significantly associated with colorectal cancer (CRC) were preferentially located in non-coding regulatory regions, and whether enrichment was specific to colorectal tissues. Methods Active regulatory elements (ARE) were mapped using data from 127 tissues and cell-types from NIH Roadmap Epigenomics and Encyclopedia of DNA Elements (ENCODE) projects. We investigated whether CRC association p-values were more significant for common variants inside versus outside AREs, or 2) inside colorectal (CR) AREs versus AREs of other tissues and cell-types. We employed an integrative epigenomic RVAM for variants with allele frequency <1%. Gene sets were defined as ARE variants within 200 kilobases of a transcription start site (TSS) using either CR ARE or ARE from non-digestive tissues. CRC-set association p-values were used to evaluate enrichment of less frequent variant associations in CR ARE versus non-digestive ARE. Results ARE from 126/127 tissues and cell-types were significantly enriched for stronger CRC-variant associations. Strongest enrichment was observed for digestive tissues and immune cell types. CR-specific ARE were also enriched for stronger CRC-variant associations compared to ARE combined across non-digestive tissues (p-value = 9.6 x 10(-4)). Additionally, we found enrichment of stronger CRC association p-values for rare variant sets of CR ARE compared to non-digestive ARE (p-value = 0.029). Conclusions Integrative epigenomic RVAM may enable discovery of less frequent variants associated with CRC, and ARE of digestive and immune tissues are most informative. Although distance-based aggregation of less frequent variants in CR ARE surrounding TSS showed modest enrichment, future association studies would likely benefit from joint analysis of transcriptomes and epigenomes to better link regulatory variation with target genes.	[Bien, Stephanie A.; Harrison, Tabitha A.; Qu, Conghui; Connolly, Charles M.; Huyghe, Jeroen; Banbury, Barbara L.; Newcomb, Polly A.; Potter, John D.; White, Emily; Carlson, Christopher S.; Peters, Ulrike; Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI USA; [Greenside, Peyton G.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Chen, Sai; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Berndt, Sonja I.; Chanock, Stephen J.] NIH, Div Canc Epidemiol & Genet, Natl Canc Inst, Bldg 10, Bethesda, MD 20892 USA; [Bezieau, Stephane] Ctr Hosp Univ Nantes, Serv Genet Med, Nantes, France; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Casey, Graham] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol C020, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Haile, Robert W.] Stanford Sch Med, Div Med Oncol, Stanford, CA USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Lemire, Mathieu] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON, Canada; [Gallinger, Steven] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [White, Emily; Carlson, Christopher S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Zanke, Brent W.] Univ Ottawa, Div Hematol, Ottawa, ON, Canada; [Zanke, Brent W.] Res Inst, Ottawa Hosp, Clin Epidemiol Program, Ottawa, ON, Canada; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hsu, Li] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Virginia; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Melbourne; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Baylor College of Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Cancer Research Center of Hawaii; University of Hawaii System; University of Washington; University of Washington Seattle; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Stanford University; University of Washington; University of Washington Seattle	Bien, SA; Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Hsu, L (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	sbien@fredhutch.org; lih@fredhutch.org	Brenner, Hermann/B-4627-2017; Auer, Paul/AAC-5060-2019; Hoffmeister, Michael/AAB-2321-2022; Kundaje, Anshul/Y-2739-2019; Brenner, Hermann/ABE-6383-2020; Fuchsberger, Christian/ABD-7127-2021; Hoffmeister, Michael/T-7187-2019; Kundaje, Anshul/Y-2598-2019; Jenkins, Mark/P-7803-2015	Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Kundaje, Anshul/0000-0003-3084-2287; Brenner, Hermann/0000-0002-6129-1572; Fuchsberger, Christian/0000-0002-5918-8947; Hoffmeister, Michael/0000-0002-8307-3197; Kundaje, Anshul/0000-0003-3084-2287; Harrison, Tabitha/0000-0002-4173-7530; Bien, Stephanie/0000-0002-8713-4583; Jenkins, Mark/0000-0002-8964-6160	Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Institutes of Health [R01 CA60987, R01 CA48998, P01 CA 055075, UM1 CM 67552, R01 137178, R01 CA151993, P50 CA127003, R37 CA54281, P01 CA033619, R01 CA63464, U01 CA074783, R01 CA076366, K05 CA154337]; National Cancer Institute [UM1 CM 67551]; Australasian Colorectal Cancer Family Registry [U01 CA074778, U01/U24 CA097735]; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01/U24 CA074800]; Ontario Familial Colorectal Cancer Registry [U01/U24 CA074783]; Seattle Colorectal Cancer Family Registry [U01/U24 CA074794]; University of Hawaii Colorectal Cancer Family Registry [U01/U24 CA074806]; USC Consortium Colorectal Cancer Family Registry [U01/U24 CA074799]; National Cancer Institute, National Institutes of Health [U01 CM 22839, R01 CA143237]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [U01 CM 37088, R01 CA059045, R01 CM 20582, U01 CM 64930]; NHS by the National Institutes of Health [UM1 CM 86107, R01 CM 37178, P01 CA87969, R01 CM 51993, P50 CM 27003]; PHS by the National Institutes of Health [R01 CA042182]; Ontario Research Fund; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200, NIH U01 HG004446, NIH GEI U01 HG 004438]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [R01CA195789, R01CA189532, ZIACP010152, U01CA164930, UM1CA167551, U01CA137088, R01CA120582, R01CA059045] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australasian Colorectal Cancer Family Registry; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies; Ontario Familial Colorectal Cancer Registry; Seattle Colorectal Cancer Family Registry; University of Hawaii Colorectal Cancer Family Registry; USC Consortium Colorectal Cancer Family Registry; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHS by the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS by the National Institutes of Health; Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ASTERISK: a Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). COLO2&3: National Institutes of Health (R01 CA60987). CCFR: This work was supported by grant UM1 CM 67551 from the National Cancer Institute and through cooperative agreements with the following CCFR centers: Australasian Colorectal Cancer Family Registry (U01 CA074778 and U01/U24 CA097735), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800), Ontario Familial Colorectal Cancer Registry (U01/U24 CA074783), Seattle Colorectal Cancer Family Registry (U01/U24 CA074794), University of Hawaii Colorectal Cancer Family Registry (U01/U24 CA074806), and USC Consortium Colorectal Cancer Family Registry U01/U24 CA074799). The Colon CFR GWAS was supported by funding from the National Cancer Institute, National Institutes of Health (U01 CM 22839 and R01 CA143237 to Graham Casey). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Colon Cancer Family Registry (CCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the CCFR. DACHS: German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS: National Institutes of Health (R01 CA48998 to M.L. Slattery). GECCO: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CM 37088; R01 CA059045; R01 CM 20582; U01 CM 64930). HPFS is supported by the National Institutes of Health (P01 CA 055075, UM1 CM 67552, R01 137178, R01 CA151993 and P50 CA127003), NHS by the National Institutes of Health (UM1 CM 86107, R01 CM 37178, P01 CA87969, R01 CM 51993 and P50 CM 27003) and PHS by the National Institutes of Health (R01 CA042182). MEC: National Institutes of Health (R37 CA54281, P01 CA033619, and R01 CA63464). OFCCR: National Institutes of Health, through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section above. Additional funding toward genetic analyses of OFCCR includes the Ontario Research Fund, the Canadian Institutes of Health Research, and the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Additionally, a subset of control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS (Yeager, M et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007 May;39(5):645-9), Colon CGEMS pancreatic cancer scan (PanScan) (Amundadottir, L et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Sep;41(9):986-90, and Petersen, GM et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet.; r 2010 Mar;42(3):224-8), and the Lung Cancer and Smoking study (Landi MT, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009 Nov;85(5):679-91). The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems.cancer.gov/data/) accession numbers phs000207.v1.p1 and phs000206.v3.p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www.ncbi.nlm.nih.gov/gap) through accession number phs000093.v2.p2. Funding for the Lung Cancer and Smoking study was provided by National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) Z01 CP 010200, NIH U01 HG004446, and NIH GEI U01 HG 004438. For the lung study, the GENEVA Coordinating Center provided assistance with genotype cleaning and general study coordination, and the Johns Hopkins University Center for Inherited Disease Research conducted genotyping. PMH: National Institutes of Health (R01 CA076366). VITAL: National Institutes of Health (K05 CA154337). WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Du MM, 2014, HUM MOL GENET, V23, P6607, DOI 10.1093/hmg/ddu361; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao S, 2014, HUM MOL GENET, V23, P3898, DOI 10.1093/hmg/ddu087; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Peters U, 2015, GUT; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; R Core Team, 2021, R LANGUAGE ENV STAT; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Vucicevic D, 2015, CELL CYCLE, V14, P253, DOI 10.4161/15384101.2014.977641; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186518	10.1371/journal.pone.0186518	http://dx.doi.org/10.1371/journal.pone.0186518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161273	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000005
J	Kimuda, SG; Andia-Biraro, I; Egesa, M; Bagaya, BS; Raynes, JG; Levin, J; Elliott, AM; Cose, S				Kimuda, Simon G.; Andia-Biraro, Irene; Egesa, Moses; Bagaya, Bernard S.; Raynes, John G.; Levin, Jonathan; Elliott, Alison M.; Cose, Stephen			Use of QuantiFERON (R)-TB Gold in-tube culture supernatants for measurement of antibody responses	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; ANTIGENS	QuantiFERON (R)-TB Gold in-tube (QFT-GIT) supernatants may be important samples for use in assessment of anti-tuberculosis (TB) antibodies when only limited volumes of blood can be collected and when a combination of antibody and cytokine measurements are required. These analytes, when used together, may also have the potential to differentiate active pulmonary TB (APTB) from latent TB infection (LTBI). However, few studies have explored the use of QFT-GIT supernatants for investigations of antibody responses. This study determined the correlation and agreement between anti-CFP-10 and anti-ESAT-6 antibody concentrations in QFT-GIT nil supernatant and serum pairs from 68 TB household contacts. We also explored the ability of Mycobacterium tuberculosis (M.tb) specific antibodies, or ratios of antibody to interferon gamma (IFN-gamma) in QFT-GIT supernatants, to differentiate 97 APTB cases from 58 individuals with LTBI. Sputum smear microscopy was used to define APTB, whereas the QFT-GIT and tuberculin skin test were used to define LTBI. There were strong and statistically significant correlations between anti-CFP-10 and anti-ESAT-6 antibodies in unstimulated QFT-GIT supernatants and sera (r = 0.89; p<0.0001 for both), and no significant differences in antibody concentration between them. Anti-CFP-10 & anti-ESAT-6 antibodies differentiated APTB from LTBI with sensitivities of 88.7% & 71.1% and specificities of 41.4% & 51.7% respectively. Anti-CFP-10 antibody/M. tb specific IFN-gamma and anti-ESAT-6 antibody/M. tb specific IFN-gamma ratios had sensitivities of 48.5% & 54.6% and specificities of 89.7% and 75.9% respectively. We conclude that QFT-GIT nil supernatants may be used in the place of sera when measuring antibody responses, reducing blood volumes needed for such investigations. Antibodies in QFT-GIT nil supernatants on their own discriminate APTB from LTBI with high sensitivity but have poor specificity, whereas the reverse is true when antibodies are used in combination withM. tb specific cytokines. Further antibody and antibody/cytokine combinations need to be explored to achieve better diagnostic accuracy.	[Kimuda, Simon G.; Egesa, Moses; Cose, Stephen] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Kimuda, Simon G.; Andia-Biraro, Irene; Egesa, Moses; Levin, Jonathan; Elliott, Alison M.; Cose, Stephen] UVRI Uganda Res Unit AIDS, MRC, Entebbe, Uganda; [Andia-Biraro, Irene] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Immunol & Mol Biol, Kampala, Uganda; [Bagaya, Bernard S.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda; [Raynes, John G.; Elliott, Alison M.; Cose, Stephen] London Sch Hyg & Trop Med, London, England	Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Cose, S (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.; Cose, S (corresponding author), UVRI Uganda Res Unit AIDS, MRC, Entebbe, Uganda.; Cose, S (corresponding author), London Sch Hyg & Trop Med, London, England.	stephen.cose@lshtm.ac.uk	Raynes, John G/G-7932-2011	Raynes, John G/0000-0002-8536-1328; Kimuda, Simon/0000-0001-6818-617X; Egesa, Moses/0000-0001-5136-868X; Ssentalo Bagaya, Bernard/0000-0002-3847-2615; Elliott, Alison/0000-0003-2818-9549; Cose, Stephen/0000-0002-5156-037X	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; Commonwealth Scholarship Commission; DELTAS Africa Initiative [107743]; funding scheme of the African Academy of Sciences (AAS); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107743, 095778]; UK Government; MRC [MC_UP_1204/15] Funding Source: UKRI	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; Commonwealth Scholarship Commission; DELTAS Africa Initiative; funding scheme of the African Academy of Sciences (AAS); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by SGK, funded by a Wellcome Trust Strategic Award grant no. 084344. SGK also received support from a Commonwealth Scholarship Commission Split Site PhD Fellowship and through the DELTAS Africa Initiative (grant no. 107743). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (grant no. 107743) and the UK Government. AME received funding from the Wellcome Trust, grant number 095778. The views expressed in this publication are those of the author(s) and not necessarily those of MS, NEPAD Agency, Wellcome Trust or the UK government.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Biraro IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111517; Biraro IA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1201-8; Caraux A, 2010, HAEMATOL-HEMATOL J, V95, P1016, DOI 10.3324/haematol.2009.018689; Cellestis, 2013, QUANTIFERON TB GOLD, V96, P1; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Greenaway C, 2005, INT J TUBERC LUNG D, V9, P1112; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Herrmann J-L, 2009, Pathol Biol (Paris), V57, pe49, DOI 10.1016/j.patbio.2008.02.010; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kimuda SG, 2017, J IMMUNOL RES, V2017, P8; Lalvani A, 2013, THORAX, V68, P204, DOI 10.1136/thoraxjnl-2012-202481; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schnappinger D, 2016, NAT MED, V22, P1076, DOI 10.1038/nm.4186; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080; van Hooij A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34260; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188396	10.1371/journal.pone.0188396	http://dx.doi.org/10.1371/journal.pone.0188396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161328	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000415987000049
J	Labedz, B; Wanczyk, A; Rajfur, Z				Labedz, Bogdan; Wanczyk, Aleksandra; Rajfur, Zenon			Precise mass determination of single cell with cantilever-based microbiosensor system	PLOS ONE			English	Article							ESCHERICHIA-COLI; GROWTH DETECTION; SENSORS; DENSITY; INITIATION; BIOSENSORS	Having determined the mass of a single cell of brewer yeast Saccharomyces cerevisiae by means of a microcantilever-based biosensor Cantisens CSR-801 (Concentris, Basel, Switzerland), it was found that its dry mass is 47,65 +/- 1,05 pg. Found to be crucial in this mass determination was the cell position along the length of the cantilever. Moreover, calculations including cells positions on the cantilever provide a threefold better degree of accuracy than those which assume uniform mass distribution. We have also examined the influence of storage time on the single cell mass. Our results show that after 6 months there is an increase in the average mass of a single yeast cell.	[Labedz, Bogdan; Wanczyk, Aleksandra; Rajfur, Zenon] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland	Jagiellonian University	Rajfur, Z (corresponding author), Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland.	zenon.rajfur@uj.edu.pl		Rajfur, Zenon/0000-0003-1265-6480	European Regional Development Fund [POIG.02.01.00-12-023/08]; Polish Ministry of Science and Higher Education [MNSW: 7150/E-338/M/2016]	European Regional Development Fund(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Part of the research was carried out with equipment purchased thanks to the financial support of the European Regional Development Fund within the framework of the Polish Innovation Economy Operational Program (contract no. POIG.02.01.00-12-023/08). This research was partially funded by Polish Ministry of Science and Higher Education (contract no. MNSW: 7150/E-338/M/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of the research was carried out with equipment purchased thanks to the financial support of the European Regional Development Fund within the framework of the Polish Innovation Economy Operational Program (contract no. POIG.02.01.00-12-023/08).; This research was partially funded by Polish Ministry of Science and Higher Education (contract no. MNSW: 71501E-3381M/2016).	Akiyama T, 1998, SENSOR ACTUAT A-PHYS, V64, P1, DOI 10.1016/S0924-4247(98)80051-4; Alonso-Sarduy L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103674; Cakmak O, 2015, SENSOR ACTUAT A-PHYS, V232, P141, DOI 10.1016/j.sna.2015.05.024; Calleja M, 2005, ULTRAMICROSCOPY, V105, P215, DOI 10.1016/j.ultramic.2005.06.039; Campbell GA, 2005, ANAL SCI, V21, P355, DOI 10.2116/analsci.21.355; Capobianco JA, 2010, BIOSENS BIOELECTRON, V26, P964, DOI 10.1016/j.bios.2010.08.004; Cermak N, 2016, NAT BIOTECHNOL, V34, P1052, DOI 10.1038/nbt.3666; Datar R, 2009, MRS BULL, V34, P449, DOI 10.1557/mrs2009.121; Dohn S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804074; Dohn S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3473761; Du LD, 2009, SENSOR ACTUAT A-PHYS, V155, P66, DOI 10.1016/j.sna.2009.07.019; Du LD, 2009, SENSOR ACTUAT A-PHYS, V151, P35, DOI 10.1016/j.sna.2009.02.003; GIMZEWSKI JK, 1994, CHEM PHYS LETT, V217, P589, DOI 10.1016/0009-2614(93)E1419-H; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Gruber K, 2011, ACS NANO, V5, P3670, DOI 10.1021/nn103626q; Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Johnson BN, 2012, BIOSENS BIOELECTRON, V32, P1, DOI 10.1016/j.bios.2011.10.054; KILLANDER D, 1965, EXP CELL RES, V40, P12, DOI 10.1016/0014-4827(65)90285-5; Kubicz E, 2015, NUKLEONIKA, V60, P749, DOI 10.1515/nuka-2015-0135; Maloney N, 2014, NANOSCALE, V6, P8242, DOI 10.1039/c4nr01610f; Malvar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13452; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mukhopadhyay R, 2005, LANGMUIR, V21, P8400, DOI 10.1021/la0511687; Nugaeva N, 2005, BIOSENS BIOELECTRON, V21, P849, DOI 10.1016/j.bios.2005.02.004; Nugaeva N, 2007, MICROSC MICROANAL, V13, P13, DOI 10.1017/S1431927607070067; Park K, 2010, P NATL ACAD SCI USA, V107, P20691, DOI 10.1073/pnas.1011365107; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5; Rosario R, 2014, SENSOR ACTUAT B-CHEM, V192, P99, DOI 10.1016/j.snb.2013.10.017; Senesac L, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70017-8; Si FW, 2017, CURR BIOL, V27, P1278, DOI 10.1016/j.cub.2017.03.022; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; Tamayo J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388925; Wee KW, 2005, BIOSENS BIOELECTRON, V20, P1932, DOI 10.1016/j.bios.2004.09.023; Ziegler C, 2004, ANAL BIOANAL CHEM, V379, P946, DOI 10.1007/s00216-004-2694-y	38	10	10	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188388	10.1371/journal.pone.0188388	http://dx.doi.org/10.1371/journal.pone.0188388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161333	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000047
J	Rais, A; Jabeen, Z; Shair, F; Hafeez, FY; Hassan, MN				Rais, Afroz; Jabeen, Zahra; Shair, Faluk; Hafeez, Fauzia Yusuf; Hassan, Muhammad Nadeem			Bacillus spp., a bio-control agent enhances the activity of antioxidant defense enzymes in rice against Pyricularia oryzae	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; PHENYLALANINE AMMONIA-LYASE; INDUCED SYSTEMIC RESISTANCE; PLANT DEFENSE; SALICYLIC-ACID; RED ROT; OXIDATIVE STRESS; GENE-EXPRESSION; GROWTH; DISEASE	Plant growth promoting rhizobacteria (PGPR) are found to control the plant diseases by adopting various mechanisms. Induced systemic resistance (ISR) is an important defensive strategy manifested by plants against numerous pathogens especially infecting at aerial parts. Rhizobacteria elicit ISR by inducing different pathways in plants through production of various metabolites. In the present study, potential of Bacillus spp. KFP-5, KFP-7, KFP-17 was assessed to induce antioxidant enzymes against Pyricularia oryzae infection in rice. The antagonistic Bacillus spp. significantly induced antioxidant defense enzymes i-e superoxide dismutase (1.7-1.9-fold), peroxidase (3.5-4.1-fold), polyphenol oxidase (3.0-3.8-fold), phenylalanine ammonia-lyase (3.9-4.4-fold), in rice leaves and roots under hydroponic and soil conditions respectively. Furthermore, the antagonistic Bacillus spp significantly colonized the rice plants (2.0E+00-9.1E+08) and secreted multiple biocontrol determinants like protease (1.1-5.5 U/mg of soil or U/mL of hydroponic solution), glucanase, (1.0-1.3 U/mg of soil or U/mL of hydroponic solution), siderophores (6.5-42.8 mu g/mL or mg) in the rhizosphere of different rice varieties. The results showed that treatment with Bacillus spp. enhanced the antioxidant defense activities in infected rice, thus alleviating P. oryzae induced oxidative damage and suppressing blast disease incidence.	[Rais, Afroz; Jabeen, Zahra; Shair, Faluk; Hafeez, Fauzia Yusuf; Hassan, Muhammad Nadeem] COMSATS Inst Informat Technol, Dept Biosci, Pk Rd, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Hassan, MN (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Pk Rd, Islamabad, Pakistan.	nadeem_hassan@comsats.edu.pk	Jabeen, Zahra/AAN-2584-2020; Hassan, Mohammad/GZA-7507-2022; Hafeez, Fauzia Yusuf/Q-9421-2019; Hassan, Muhammad/GWZ-4054-2022	Hassan, Mohammad/0000-0002-1712-0004; Hassan, Muhammad Nadeem/0000-0001-8219-4440	Pakistan science foundation [141]	Pakistan science foundation	The work was supported by Pakistan science foundation (141).	Ali MB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-84; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anand T, 2007, J PLANT INTERACT, V2, P233, DOI 10.1080/17429140701708985; Antoun H, 2006, PGPR: BIOCONTROL AND BIOFERTILIZATION, P1, DOI 10.1007/1-4020-4152-7_1; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Ashwini N, 2014, 3 BIOTECH, V4, P127, DOI 10.1007/s13205-013-0134-4; Audenaert K, 2002, MOL PLANT MICROBE IN, V15, P1147, DOI 10.1094/MPMI.2002.15.11.1147; Bano A, 2017, PLANT BIOLOGY, V19, P406, DOI 10.1111/plb.12535; Barillot CDC, 2013, ANN MICROBIOL, V63, P471, DOI 10.1007/s13213-012-0491-y; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Chaiharn M, 2009, WORLD J MICROB BIOT, V25, P1919, DOI 10.1007/s11274-009-0090-7; Chandra S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15195; Choi HW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0921-2; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Dewi RTK, 2016, EMIR J FOOD AGR, V28, P116, DOI 10.9755/ejfa.2015-05-195; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Filippi MCC, 2011, BIOL CONTROL, V58, P160, DOI 10.1016/j.biocontrol.2011.04.016; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gupta D, 2016, PLANT CELL ENV, V50; Halo BA, 2015, J PLANT INTERACT, V10, P117, DOI 10.1080/17429145.2015.1033659; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Hammerschmidt R, 1982, PHYSL PLANT PATHOLOG; Hassan MN, 2012, J PLANT PATHOL, V94, P325; Hassan MN, 2015, BIOCONTROL, V60, P691, DOI 10.1007/s10526-015-9673-4; Hassan MN, 2010, BIOCONTROL, V55, P531, DOI 10.1007/s10526-010-9268-z; Henkes GJ, 2011, J EXP BOT, V62, P4337, DOI 10.1093/jxb/err149; Hussain S, 2009, ADV AGRON, V102, P159, DOI 10.1016/S0065-2113(09)01005-0; Ishibashi Y, 2011, J PLANT PHYSIOL, V168, P1562, DOI 10.1016/j.jplph.2011.02.003; Jabeen Z, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1920-x; Jha AB., 2012, J BOT, V2012; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joo HS, 2002, PROCESS BIOCHEM, V38, P155, DOI 10.1016/S0032-9592(02)00061-4; Kombrink E, 2001, EUR J PLANT PATHOL, V107, P69, DOI 10.1023/A:1008736629717; KUC J, 1995, ANNU REV PHYTOPATHOL, V33, P275, DOI 10.1146/annurev.py.33.090195.001423; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Law JW-F, 2017, FRONTIERS MICROBIOLO, V8; Lethbridge G, SOIL BIOL BIOCH; Liu TT, 2011, BIOL TRACE ELEM RES, V144, P1186, DOI 10.1007/s12011-011-9053-6; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Manhas RK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01869; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; MAYER AM, 1966, PHYTOCHEMISTRY, V5, P783, DOI 10.1016/S0031-9422(00)83660-2; MAYERHOFER HJ, 1973, APPL MICROBIOL, V25, P44, DOI 10.1128/AEM.25.1.44-48.1973; Mercado-Blanco J., 2014, CURR BIOTECHNOL, V3, P60, DOI [10.2174/22115501113026660038, DOI 10.2174/22115501113026660038]; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; ODIER E, 1981, APPL ENVIRON MICROB, V41, P337, DOI 10.1128/AEM.41.2.337-341.1981; PELLEGRINI L, 1994, PLANT PHYSIOL, V106, P877, DOI 10.1104/pp.106.3.877; POWELL PE, 1983, APPL ENVIRON MICROB, V46, P1080, DOI 10.1128/AEM.46.5.1080-1083.1983; Purwar S., 2012, AM J PLANT SCI, V3, P261, DOI DOI 10.4236/AJPS.2012.32031; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Qin S, 2011, APPL MICROBIOL BIOT, V89, P457, DOI 10.1007/s00253-010-2923-6; Rais A, 2016, BIOCONTROL, V61, P769, DOI 10.1007/s10526-016-9763-y; Raj TS, 2016, IJAPSA, V02, P106; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Reddy M.S., 2014, RECENT ADV BIOFERTIL; REEVES MW, 1983, J BACTERIOL, V154, P324, DOI 10.1128/JB.154.1.324-329.1983; Rodrigues F, 2013, BRAGANTIA, V72, P292; Rodrigues FA, 2015, J PHYTOPATHOL, V163, P554, DOI [10.1111/jph.12231, 10.1111/jph.12353]; Samalova M, 2014, NEW PHYTOL, V201, P556, DOI 10.1111/nph.12530; Sankaranarayanan R, 2015, APPL MICROBIOL BIOT, V99, P2339, DOI 10.1007/s00253-015-6411-x; Sarma BK, 2015, SOIL BIOL BIOCHEM, V87, P25, DOI 10.1016/j.soilbio.2015.04.001; SAUNDERS JA, 1975, PHYTOCHEMISTRY, V14, P1285, DOI 10.1016/S0031-9422(00)98612-6; Schmitt FJ, 2014, BBA-BIOENERGETICS, V1837, P835, DOI 10.1016/j.bbabio.2014.02.005; Senthilraja G, 2013, PHYSIOL MOL PLANT P, V82, P10, DOI 10.1016/j.pmpp.2012.12.002; Shafi J, 2017, BIOTECHNOL BIOTEC EQ, V31, P446, DOI 10.1080/13102818.2017.1286950; Sharma M., 2014, INT J CURR MICROBIOL, V3, P801, DOI DOI 10.20546/IJCMAS.2017.602.089; Sheridan C, 2016, MICROB ECOL, P1; Shi QingHua, 2006, Agricultural Sciences in China, V5, P767, DOI 10.1016/S1671-2927(06)60122-3; Sindhu SS, 1999, BIOL FERT SOILS, V29, P62, DOI 10.1007/s003740050525; Singh A, 2013, MICROBIOL RES, V168, P33, DOI 10.1016/j.micres.2012.07.001; Singh N, 2005, FOOD CHEM, V89, P253, DOI 10.1016/j.foodchem.2004.02.032; Singh SP, 2017, BIOL CONTROL, V104, P44, DOI 10.1016/j.biocontrol.2016.10.011; Song AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24640; Souguir D, 2011, ECOTOXICOLOGY, V20, P329, DOI 10.1007/s10646-010-0582-0; TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9; Nascimento KJT, 2016, BRAGANTIA, V75, P212, DOI 10.1590/1678-4499.281; Thakur A, 2017, THESIS AGR U ATHENS; Vaikuntapu PR, 2014, INDIAN J MICROBIOL, V54, P403, DOI 10.1007/s12088-014-0470-z; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; van Doorn WG, 2014, POSTHARVEST BIOL TEC, V95, P64, DOI 10.1016/j.postharvbio.2014.04.002; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wada KC, 2014, J PLANT PHYSIOL, V171, P895, DOI 10.1016/j.jplph.2014.03.008; Walters DR., 2005, BIOL, V52, P28; Wang MY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00262; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; YANG GZ, 1994, PATTERN RECOGN, V27, P53, DOI 10.1016/0031-3203(94)90017-5; Yasmin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160688; Zhang X, 2014, PLANT PHYSIOL, P114; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597; Zhao Q, 2014, ANNU REV PHYTOPATHOL, V52, P69, DOI 10.1146/annurev-phyto-082712-102237; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	95	75	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187412	10.1371/journal.pone.0187412	http://dx.doi.org/10.1371/journal.pone.0187412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161274	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000010
J	Yeh, HM; Lin, TT; Yeh, CF; Huang, HS; Chang, SN; Lin, JW; Tsai, CT; Lai, LP; Huang, YY; Chu, CL				Yeh, Huei-Ming; Lin, Ting-Tse; Yeh, Chih-Fan; Huang, Ho-Shiang; Chang, Sheng-Nan; Lin, Jou-Wei; Tsai, Chia-Ti; Lai, Ling-Ping; Huang, Yi-You; Chu, Chun-Lin			Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; BRAIN NATRIURETIC PEPTIDE; ACUTE KIDNEY INJURY; CARDIORENAL SYNDROME; DOPPLER-ECHOCARDIOGRAPHY; FILLING PRESSURES; STRAIN-RATE; DYSFUNCTION; CHILDREN; RELAXATION	The pathophysiology of cardio-renal syndrome (CRS) is complex. Hydronephrosis caused by urolithiasis may cause cytokine release and lead to cardiac dysfunction. The aim of this study was to evaluate cardiac function changes observed in patients who received double J placement using feasible biomarkers and echocardiography. This was a prospective, single-center study. Eighty-seven patients who presented with acute unilateral hydronephrosis and received ureteroscope stone manipulation were enrolled. Echocardiography and cytokines were measured on the day of the operation and 24 hours after the procedure. Changes before and after surgery were assessed by the paired t-test and Wilcoxon test. Correlation analyses between echocardiographic diastolic indices and cytokine levels were performed using Pearson's correlation coefficients. Patients with hydronephrosis showed a higher left atrium volume index (LAVI), decreased E', and increased E/E' ratio, which indicated diastolic dysfunction. Patients with hydronephrosis also exhibited decreased global strain rates during isovolumetric relaxation (SRIVR) and E/SRIVR, which confirmed the diastolic dysfunction. Significant reductions in LAVI, increases in SRIVR and decreases in E/SRIVR were observed after the operation. Biomarkers, such as TGF-beta and serum NT-proBNP, were significantly decreased after surgery. In addition, a significant correlation was observed between the post-surgical decrease in TGF-beta 1 and increase in SRIVR. Unilateral hydronephrosis causes cardiac diastolic dysfunction, and relieving hydronephrosis could improve diastolic function. Improvements in cardiac dysfunction can be evaluated by echocardiography and measuring cytokine levels. The results of this study will inform efforts to improve the early diagnosis of CRS and prevent further deterioration of cardiac function when treating patients with hydronephrosis.	[Yeh, Huei-Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Ting-Tse] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol,Hsinchu Branch, Hsinchu, Taiwan; [Yeh, Chih-Fan; Tsai, Chia-Ti; Lai, Ling-Ping] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Huang, Ho-Shiang] Natl Chengkong Univ Hosp, Dept Urol, Tainan, Taiwan; [Chang, Sheng-Nan; Lin, Jou-Wei] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol,Yunlin Branch, Yunlin, Taiwan; [Huang, Yi-You; Chu, Chun-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Chu, Chun-Lin] Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Yunlin Branch, Yunlin, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chu, CL (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan.; Chu, CL (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Yunlin Branch, Yunlin, Taiwan.	cclgenie@yahoo.com.tw	Yeh, Chih-Fan/AAC-6943-2022	Yeh, Chih-Fan/0000-0002-0678-2264; LAI, LING-PING/0000-0002-9651-7420; Chu, Chun-Lin/0000-0001-9122-4437; LIN, TING-TSE/0000-0002-8810-5127; CHANG, SHENG NAN/0000-0002-2663-5042; TSAI, CHIA-TI/0000-0002-4853-8665				Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Carlstrom M, 2007, ACTA PHYSIOL, V189, P293, DOI 10.1111/j.1748-1716.2006.01637.x; Carlstrom M, 2006, J HYPERTENS, V24, P1437, DOI 10.1097/01.hjh.0000234126.78766.00; Crepaldi C, 2012, CONTRIB NEPHROL, V178, P174, DOI 10.1159/000337849; GOTOH M, 1991, UROL INT, V47, P63, DOI 10.1159/000282253; Kasner M, 2010, EUROPEAN HEART J CAR; Kurishima C, 2015, J CARDIOL, V66, P175, DOI 10.1016/j.jjcc.2014.11.002; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Paulus WJ, 2007, EUROPEAN HEART J; Reinglas J, 2010, CURR OPIN CARDIOL, V25, P141, DOI 10.1097/HCO.0b013e328335fed7; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Stoylen A, 2001, J AM SOC ECHOCARDIOG, V14, P264, DOI 10.1067/mje.2001.110375; Tang WH, 2010, AM J PHYSIOL-CELL PH, V299, pC643, DOI 10.1152/ajpcell.00137.2010; Taub PR, 2012, EXPERT REV CARDIOVAS, V10, P657, DOI [10.1586/ERC.12.26, 10.1586/erc.12.26]; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b; Zieg J, 2011, NEPHROLOGY, V16, P595, DOI 10.1111/j.1440-1797.2011.01459.x; Zoubiri H, 2015, ANN BIOL CLIN-PARIS, V73, P443, DOI 10.1684/abc.2015.1059	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188597	10.1371/journal.pone.0188597	http://dx.doi.org/10.1371/journal.pone.0188597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161313	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000065
J	Allen, A; Allen, S; Rodrigo, R; Perera, L; Shao, W; Li, C; Wang, DL; Olivieri, N; Weatherall, DJ; Premawardhena, A				Allen, Angela; Allen, Stephen; Rodrigo, Rexan; Perera, Lakshman; Shao, Wei; Li, Chao; Wang, Duolao; Olivieri, Nancy; Weatherall, David J.; Premawardhena, Anuja			Iron status and anaemia in Sri Lankan secondary school children: A cross-sectional survey	PLOS ONE			English	Article							MICRONUTRIENT DEFICIENCIES; HEMOGLOBIN CONCENTRATION; TRANSFERRIN RECEPTOR; REFERENCE VALUES; AGE; ADOLESCENTS; FERRITIN; COMMON; SERUM; GIRLS	Background Iron deficiency, the most common micronutrient disorder and cause of anaemia globally, impairs growth, cognition, behaviour and resistance to infection. Methods/Results As part of a national survey of inherited haemoglobin variants in 7526 students from 72 secondary schools purposefully selected from the 25 districts of Sri Lanka, we studied 5912 students with a normal haemoglobin genotype. Median age was 16.0 (IQR 15.0-17.0) years and 3189 (53.9%) students were males. Most students were Sinhalese (65.7%), with fewer Tamils (23.1%) and Muslims (11.2%). Anaemia occurred in 470 students and was more common in females (11.1%) than males (5.6%). Haemoglobin, serum ferritin, transferrin receptor and iron were determined in 1196 students with low red cell indices and a structured sample of those with normal red cell indices (n = 513). The findings were weighted to estimate the frequencies of iron deficiency and iron deficiency anaemia classified according to WHO criteria. Iron depletion (serum ferritin < 15ug/ml) occurred in 19.2% and cellular iron deficiency (low serum ferritin and transferrin receptor > 28.1 nmol/l) in 11.6% students. Iron deficiency anaemia (cellular iron deficiency with low haemoglobin) occurred in only 130/2794 (4.6%) females and 28/2789 (1.0%) males. Iron biomarkers were normal in 83/470 (14.6%) students with anaemia. In multiple regression analysis, the odds for iron depletion and cellular iron deficiency were about one-third in males compared with females, and the odds for iron deficiency anaemia were about one fifth in males compared to females. Tamil ethnicity and age < 16 years increased the risk of all three stages of iron deficiency and living at high altitude significantly reduced the risk of iron depletion. Conclusions Low iron status and anaemia remain common problems in Sri Lankan secondary school students especially females, younger students and the socioeconomically disadvantaged Tamil population. More research is needed to identify factors other than low iron status that contribute to anaemia in adolescents.	[Allen, Angela; Weatherall, David J.] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Allen, Angela; Allen, Stephen; Shao, Wei; Li, Chao; Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Rodrigo, Rexan; Perera, Lakshman; Premawardhena, Anuja] Univ Kelaniya, Fac Med, Ragama, Sri Lanka; [Shao, Wei] Second Mil Med Univ, Shanghai, Peoples R China; [Olivieri, Nancy] Univ Toronto, Dept Med & Publ Hlth Sci, Toronto, ON, Canada	University of Oxford; Liverpool School of Tropical Medicine; University Kelaniya; Naval Medical University; University of Toronto	Allen, A (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England.; Allen, A (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	aallengm@yahoo.co.uk	Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; Allen, Stephen/0000-0001-6675-249X; Wang, Duolao/0000-0003-2788-2464; Rodrigo, Rexan/0000-0002-2194-8453	Wellcome Trust [053267/Z98F]; Medical Research Council [4050189188]; MRC [MC_UU_12009/13, MC_UU_00016/12] Funding Source: UKRI; Medical Research Council [MC_UU_12009/13, MC_UU_00016/12] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust; (www.wellcome.ac.uk) Grant number 053267/Z98F awarded to DJW; Medical Research Council; www.mrc.ac.uk Grant number 4050189188 awarded to DJW; The Anthony Cerami and Ann Dunne Foundation for World Health (www.acadforworldhealth.org) Donation to DJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 1998, CLIN CHEM, V44, P35; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Chong SS, 2000, BLOOD, V95, P360; Clarke GM, 2000, CLIN CHEM, V46, P1284; Cole TJ, 2014, ANN HUM BIOL, V41, P76, DOI 10.3109/03014460.2013.856472; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; DALLMAN PR, 1978, AM J CLIN NUTR, V31, P377, DOI 10.1093/ajcn/31.3.377; Cairo RCD, 2014, NUTR HOSP, V29, P1240, DOI 10.3305/nh.2014.29.6.7245; de Lanerolle-Dias M, 2012, CEYLON MED J, V57, P74, DOI 10.4038/cmj.v57i1.4199; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Garn S M, 1975, J Natl Med Assoc, V67, P91; GARN SM, 1981, AM J CLIN NUTR, V34, P1648, DOI 10.1093/ajcn/34.9.1648; Hess SY, 2010, BEST PRACT RES CL EN, V24, P117, DOI 10.1016/j.beem.2009.08.012; Hettiarachchi M, 2006, ASIA PAC J CLIN NUTR, V15, P56; HURTADO A, 1945, ARCH INTERN MED, V75, P284, DOI 10.1001/archinte.1945.00210290007002; Ji CJ, 2015, CLIN LAB, V61, P1831, DOI 10.7754/Clin.Lab.2015.150423; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Jonker FA, 2014, J INFECT S1, V69, P523, DOI DOI 10.1016/JJINF.2014.08.007; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Lafferty JD, 1996, AM J CLIN PATHOL, V106, P201; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MELIS MA, 1983, BLOOD, V62, P226; Milman N, 1996, INT J HEMATOL, V63, P103; Milman N, 2011, ANN NUTR METAB, V59, P50, DOI 10.1159/000332129; Nagai M, 2007, HEALTH POLICY, V83, P84, DOI 10.1016/j.healthpol.2006.12.001; PAN WH, 1991, AM J EPIDEMIOL, V134, P1410, DOI 10.1093/oxfordjournals.aje.a116046; Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249; PERRY GS, 1992, J NUTR, V122, P1417, DOI 10.1093/jn/122.7.1417; Roy S, 2015, MALAR RES TREAT, V2015; Sekhar DL, 2015, CLIN NUTR ESPEN, V10, pE118, DOI 10.1016/j.clnesp.2015.03.001; Siriwardhana Chesmal, 2014, Confl Health, V8, P22, DOI 10.1186/1752-1505-8-22; Sivarajah N, 2007, WAR HLTH NO SRI LANK; Steenbruggen TG, 2015, NUTRIENTS, V7, P1965, DOI 10.3390/nu7031965; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; The World Bank, SRI LANK OV; Thoradeniya T, 2006, BRIT J NUTR, V95, P511, DOI 10.1079/BJN20051590; Vazquez-Lopez MA, 2015, J PEDIAT HEMATOL ONC, V37, P274, DOI 10.1097/MPH.0000000000000274; WHO, 2007, ASS IR STAT POP INCL; WHO, 2014, WHONMHNHDMNM146; Wickramasinghe V P, 2009, Ceylon Med J, V54, P26; World Health Organization, 2001, IR DEF AN ASS PREV C; Wray K, 2016, AM J HEMATOL	44	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188110	10.1371/journal.pone.0188110	http://dx.doi.org/10.1371/journal.pone.0188110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155855	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000415756700031
J	Bicer, A; Orlando, S; Islam, ABMMK; Gallastegui, E; Besson, A; Aligue, R; Bachs, O; Pujol, MJ				Bicer, Atilla; Orlando, Serena; Islam, Abul B. M. M. K.; Gallastegui, Edurne; Besson, Arnaud; Aligue, Rosa; Bachs, Oriol; Jesuus Pujol, Maria			ChIP-Seq analysis identifies p27(Kip1)-target genes involved in cell adhesion and cell signalling in mouse embryonic fibroblasts	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; TYROSINE PHOSPHORYLATION; CDK INHIBITORS; TRANSCRIPTION; P27; CANCER; REGULATORS; SEQUENCES; BIOLOGY; PROTEIN	The protein p27(Kip1) (p27), a member of the Cip-Kip family of cyclin-dependent kinase inhibitors, is involved in tumorigenesis and a correlation between reduced levels of this protein in human tumours and a worse prognosis has been established. Recent reports revealed that p27 also behaves as a transcriptional regulator. Thus, it has been postulated that the development of tumours with low amounts of p27 could be propitiated by deregulation of transcriptional programs under the control of p27. However, these programs still remain mostly unknown. The aim of this study has been to define the transcriptional programs regulated by p27 by first identifying the p27-binding sites (p27-BSs) on the whole chromatin of quiescent mouse embryonic fibroblasts. The chromatin regions associated to p27 have been annotated to the most proximal genes and it has been considered that the expression of these genes could by regulated by p27. The identification of the chromatin p27-BSs has been performed by Chromatin Immunoprecipitation Sequencing (ChIP-seq). Results revealed that p27 associated with 1839 sites that were annotated to 1417 different genes being 852 of them protein coding genes. Interestingly, most of the p27-BSs were in distal intergenic regions and introns whereas, in contrast, its association with promoter regions was very low. Gene ontology analysis of the protein coding genes revealed a number of relevant transcriptional programs regulated by p27 as cell adhesion, intracellular signalling and neuron differentiation among others. We validated the interaction of p27 with different chromatin regions by ChIP followed by qPCR and demonstrated that the expressions of several genes belonging to these programs are actually regulated by p27. Finally, cell adhesion assays revealed that the adhesion of p27(-/-) cells to the plates was much higher that controls, revealing a role of p27 in the regulation of a transcriptional program involved in cell adhesion.	[Bicer, Atilla; Orlando, Serena; Gallastegui, Edurne; Aligue, Rosa; Bachs, Oriol; Jesuus Pujol, Maria] Univ Barcelona, Dept Biomed Sci, IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Islam, Abul B. M. M. K.] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh; [Besson, Arnaud] Canc Res Ctr Toulouse, INSERM UMR1037, Toulouse, France; [Besson, Arnaud] Univ Toulouse, Toulouse, France; [Besson, Arnaud] CNRS ERL5294, Toulouse, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Dhaka; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bachs, O (corresponding author), Univ Barcelona, Dept Biomed Sci, IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	obachs@ub.edu	Orlando, Serena/AAA-7963-2019; Besson, Arnaud/J-6254-2014; Aligue, Rosa/AAA-2520-2019; Bicer, Atilla/AAA-6738-2019	Besson, Arnaud/0000-0002-9599-3943; Aligue, Rosa/0000-0002-2085-325X; Bicer, Atilla/0000-0003-4032-6534; Islam, Abul/0000-0002-7274-0855; BACHS, ORIOL/0000-0003-1843-5929	Ministerio de Economia y Competitividad [SAF2012-38078, SAF2015-64344-R]; Fundacion La Caixa [2016-052.407]; Institute de Salud Carlos III [RD/120036/0054]; Fondation ARC pour la Reserche sur le Cancer; Ligue National Contre le Cancer; Institut National du Cancer; La Caixa [2016-052.407]	Ministerio de Economia y Competitividad(Spanish Government); Fundacion La Caixa(La Caixa Foundation); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondation ARC pour la Reserche sur le Cancer; Ligue National Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); La Caixa(La Caixa Foundation)	The work was supported by the following: Ministerio de Economia y Competitividad, SAF2012-38078 (OB); Ministerio de Economia y Competitividad, SAF2015-64344-R (OB); Fundacion La Caixa 2016-052.407 (RA); Institute de Salud Carlos III RD/120036/0054.AB is supported by grants from the Fondation ARC pour la Reserche sur le Cancer, Ligue National Contre le Cancer and Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank to Dr. Pedro M. Fernandez for the kind gift of the anti-AHR antibody. This work was supported by grants from the Ministerio de Economia y competitividad (MINECO) SAF2012-38078, SAF2015-64244-R, La Caixa 2016-052.407 and from the Instituto de Salud Carlos III RD12/0036/0054. AB is supported by grants from the Fondation ARC pour la Reserche sur le Cancer, Ligue National Contre le Cancer and Institut National du Cancer. The data set has been deposited in ArrayExpress accession number E-MTAB-5105.	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Alonso-Colmenar LM, CELL ADH MIGR, V6, P100; Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Cante-Barrett K, 2014, ONCOGENE, V33, P403, DOI 10.1038/onc.2013.56; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cowie P, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2014.23; de Sousa EMF, 2016, CANC STEM CELL BIOL, P8; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Gallastegui E, 2016, ONCOGENE; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Groen JN, 2014, INT J BIOCHEM CELL B, V54, P350, DOI 10.1016/j.biocel.2014.05.008; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hukkelhoven E, 2012, J BIOL CHEM, V287, P38523, DOI 10.1074/jbc.M112.366542; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Katagiri T, 2016, COLD SPRING HARB PER, P8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Orlando S, 2015, NUCLEIC ACIDS RES, V43, P6860, DOI 10.1093/nar/gkv593; Ou L, 2011, J BIOL CHEM, V286, P30142, DOI 10.1074/jbc.M111.244095; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Ricciuti Biagio, 2014, Oncoscience, V1, P674; Rosen DG, 2005, CLIN CANCER RES, V11, P632; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187891	10.1371/journal.pone.0187891	http://dx.doi.org/10.1371/journal.pone.0187891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155860	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700021
J	Maghnia, FZ; Abbas, Y; Mahe, F; Kerdouh, B; Tournier, E; Ouadji, M; Tisseyre, P; Prin, Y; El Ghachtouli, N; Yakhlef, SEB; Duponnois, R; Sanguin, H				Maghnia, Fatima Zahra; Abbas, Younes; Mahe, Frederic; Kerdouh, Benaissa; Tournier, Estelle; Ouadji, Mohamed; Tisseyre, Pierre; Prin, Yves; El Ghachtouli, Naima; Yakhlef, Salah Eddine Bakkali; Duponnois, Robin; Sanguin, Herve			Habitat- and soil-related drivers of the root-associated fungal community of Quercus suber in the Northern Moroccan forest	PLOS ONE			English	Article							CENOCOCCUM-GEOPHILUM; LAND-USE; ECTOMYCORRHIZAL COMMUNITIES; PHYLOGENETIC DIVERSITY; FRUITING PATTERNS; SAPROBIC FUNGI; MYCORRHIZAL; WOODLANDS; DROUGHT; L.	Soil fungi associated with plant roots, notably ectomycorrhizal (EcM) fungi, are central in above-and below-ground interactions in Mediterranean forests. They are a key component in soil nutrient cycling and plant productivity. Yet, major disturbances of Mediterranean forests, particularly in the Southern Mediterranean basin, are observed due to the greater human pressures and climate changes. These disturbances highly impact forest cover, soil properties and consequently the root-associated fungal communities. The implementation of efficient conservation strategies of Mediterranean forests is thus closely tied to our understanding of root-associated fungal biodiversity and environmental rules driving its diversity and structure. In our study, the root-associated fungal community of Q. suber was analyzed using high-throughput sequencing across three major Moroccan cork oak habitats. Significant differences in root-associated fungal community structures of Q. suber were observed among Moroccan cork oak habitats (Maa A mora, Benslimane, Chefchaoun) subjected to different human disturbance levels (high to low disturbances, respectively). The fungal community structure changes correlated with a wide range of soil properties, notably with pH, C: N ratio (P = 0.0002), and available phosphorus levels (P = 0.0001). More than 90 belowground fungal indicators (P < 0.01)-either of a type of habitat and/or a soil property-were revealed. The results shed light on the ecological significance of ubiquitous ectomycorrhiza (Tomentella, Russula, Cenococcum), and putative sclerotia-associated/ericoid mycorrhizal fungal taxa (Cladophialophora, Oidiodendron) in the Moroccan cork oak forest, and their intraspecific variability regarding their response to land use and soil characteristics.	[Maghnia, Fatima Zahra; Kerdouh, Benaissa; Ouadji, Mohamed] Forestry Res Ctr, Rabat, Morocco; [Maghnia, Fatima Zahra; Mahe, Frederic; Tournier, Estelle; Prin, Yves; Sanguin, Herve] CIRAD, UMR LSTM, Montpellier, France; [Maghnia, Fatima Zahra; Mahe, Frederic; Tournier, Estelle; Tisseyre, Pierre; Prin, Yves; Duponnois, Robin; Sanguin, Herve] Univ Montpellier, Montpellier SupAgro, INRA, LSTM,CIRAD,IRD, Montpellier, France; [Maghnia, Fatima Zahra; Tisseyre, Pierre; Duponnois, Robin] IRD, UMR LSTM, Montpellier, France; [Abbas, Younes] Univ Sultan Moulay Slimane, Multidisciplinary Fac, Polyvalent Lab, Beni Mellal, Morocco; [El Ghachtouli, Naima] Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Microbial Biotechnol, Fes, Morocco; [Yakhlef, Salah Eddine Bakkali] Minist Agr & Fisheries, Directorat Higher Educ Training & Res, Rabat, Morocco	CIRAD; Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Sultan Moulay Slimane University of Beni Mellal; Sidi Mohamed Ben Abdellah University of Fez	Sanguin, H (corresponding author), CIRAD, UMR LSTM, Montpellier, France.; Sanguin, H (corresponding author), Univ Montpellier, Montpellier SupAgro, INRA, LSTM,CIRAD,IRD, Montpellier, France.	herve.sanguin@cirad.fr	Mahé, Frédéric/AAR-8568-2021; MAGHNIA, Fatima Zahra/N-2549-2018	Mahé, Frédéric/0000-0002-2808-0984; MAGHNIA, Fatima Zahra/0000-0002-4378-0145; EL GHACHTOULI, naima/0000-0002-5452-5406; Sanguin, Herve/0000-0001-7160-2840	Programme de Recherche Agronomique pour le Developpement [PRAD 04/10]; Cirad PhD program "Doctorant du Sud"	Programme de Recherche Agronomique pour le Developpement; Cirad PhD program "Doctorant du Sud"	This study was supported by the "Programme de Recherche Agronomique pour le Developpement" (PRAD 04/10, Gestion et valorisation de la strate arbustive ectotrophe pour la conservation et la productivite durable des suberaies) and the Cirad PhD program "Doctorant du Sud". We thank Morris Traduction (http:// andrewmorris.fr/) for English language editing.; This study was supported by the "Programme de Recherche Agronomique pour le Developpement" (PRAD 04/10, Gestion et valorisation de la strate arbustive ectotrophe pour la conservation et la productivite durable des suberaies) and the Cirad PhD program "Doctorant du Sud". We thank Morris Traduction (http://andrewmorris.fr/) for English language editing.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Alvarado P, 2012, MYCOLOGIA, V104, P894, DOI 10.3852/11-254; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Avis PG, 2003, NEW PHYTOL, V160, P239, DOI 10.1046/j.1469-8137.2003.00865.x; Azul AM, 2010, MYCORRHIZA, V20, P73, DOI 10.1007/s00572-009-0261-2; Azul AM, 2009, CAN J FOREST RES, V39, P2404, DOI 10.1139/X09-148; Bagella S, 2014, CR BIOL, V337, P717, DOI 10.1016/j.crvi.2014.09.005; Bahram M, 2011, FEMS MICROBIOL ECOL, V75, P313, DOI 10.1111/j.1574-6941.2010.01000.x; Baptista P, 2015, ENV MICROBIOL REP, V7, P946, DOI 10.1111/1758-2229.12336; Barrico L, 2010, EUR J SOIL BIOL, V46, P280, DOI 10.1016/j.ejsobi.2010.05.001; Bergero R, 2000, MOL ECOL, V9, P1639, DOI 10.1046/j.1365-294x.2000.01059.x; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Chen H., 2016, VENNDIAGRAM GENERATE; Churchland C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00261; Clemmensen KE, 2015, NEW PHYTOL, V205, P1525, DOI 10.1111/nph.13208; Corcobado T, 2015, FORESTRY, V88, P257, DOI 10.1093/forestry/cpu056; Courty PE, 2008, APPL ENVIRON MICROB, V74, P5792, DOI 10.1128/AEM.01592-08; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Creamer RE, 2016, APPL SOIL ECOL, V97, P112, DOI 10.1016/j.apsoil.2015.08.006; Cudlin P, 2007, PLANT BIOSYST, V141, P406, DOI 10.1080/11263500701626028; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Egerton-Warburton L, 2001, MYCORRHIZA, V11, P283, DOI 10.1007/s005720100134; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; Gao C, 2015, NEW PHYTOL, V205, P771, DOI 10.1111/nph.13068; Gauquelin T., 2016, REGIONAL ENV CHANGE; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Hamilton N, 2017, GGTERN EXTENSION GGP; Heilmann-Clausen J, 2015, CONSERV BIOL, V29, P61, DOI 10.1111/cobi.12388; Herve M., 2017, RVAIDEMEMOIRE DIVERS; Jany JL, 2002, NEW PHYTOL, V154, P651, DOI 10.1046/j.1469-8137.2002.00408.x; Johnson D, 2012, NEW PHYTOL, V194, P614, DOI 10.1111/j.1469-8137.2012.04087.x; Kerner R, 2012, J PROTEOMICS, V75, P3707, DOI 10.1016/j.jprot.2012.04.039; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lancellotti E, 2013, MYCORRHIZA, V23, P533, DOI 10.1007/s00572-013-0493-z; Leopold DR, 2016, FUNGAL ECOL, V24, P114, DOI 10.1016/j.funeco.2016.07.004; LoBuglio KF, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P287; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Maghnia FZ, 2017, CR BIOL, V340, P298, DOI 10.1016/j.crvi.2017.04.001; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Obase K, 2016, MYCORRHIZA, V26, P529, DOI 10.1007/s00572-016-0690-7; Obase K, 2014, FEMS MICROBIOL ECOL, V90, P708, DOI 10.1111/1574-6941.12428; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Peter M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12662; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rice AV, 2006, MICROBIAL ROOT ENDOP, P227; Richard F, 2005, NEW PHYTOL, V166, P1011, DOI 10.1111/j.1469-8137.2005.01382.x; Richard F, 2004, CAN J BOT, V82, P1711, DOI [10.1139/b04-128, 10.1139/B04-128]; Richard F, 2011, ANN FOREST SCI, V68, P57, DOI 10.1007/s13595-010-0007-5; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosling A., 2013, GENOMICS SOIL AND PL, VVolume 3, P333, DOI [10.1007/978-3-642-39339-6_14, DOI 10.1007/978-3-642-39339-6_14, 10.1007/978-3-642-39339-6, DOI 10.1007/978-3-642-39339-6]; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaffhauser A, 2012, CR BIOL, V335, P424, DOI 10.1016/j.crvi.2012.04.006; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Smith ME, 2007, NEW PHYTOL, V174, P847, DOI 10.1111/j.1469-8137.2007.02040.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Suz LM, 2014, MOL ECOL, V23, P5628, DOI 10.1111/mec.12947; Taudiere A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00881; Tedersoo L, 2016, ISME J, V10, P346, DOI 10.1038/ismej.2015.116; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Wickham H., 2017, TIDYVERSE EASILY INS; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yakhlef S. E. B., 2011, Mycology - An International Journal on Fungal Biology, V2, P283; Yakhlef SB, 2009, BIOTECHNOL AGRON SOC, V13, P521	75	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187758	10.1371/journal.pone.0187758	http://dx.doi.org/10.1371/journal.pone.0187758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155841	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700015
J	Wu, YT; Yu, JX; Jin, C; Li, Y; Su, JM; Wei, GQ; Zheng, XM; Gao, JS; Gao, WY; Wu, SL				Wu, Yuntao; Yu, Junxing; Jin, Cheng; Li, Yun; Su, Jinmei; Wei, Guoqing; Zheng, Xiaoming; Gao, Jingsheng; Gao, Wenyuan; Wu, Shouling			Longitudinal fasting blood glucose patterns and arterial stiffness risk in a population without diabetes	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; FOLLOW-UP; CARDIOVASCULAR MORTALITY; GLYCATED HEMOGLOBIN; SAS PROCEDURE; TOLERANCE; CHINESE; EVENTS; ATHEROSCLEROSIS	Objective To identify long-term fasting blood glucose trajectories and to assess the association between the trajectories and the risk of arterial stiffness in individuals without diabetes. Methods We enrolled 16,454 non-diabetic participants from Kailuan cohort. Fasting blood glucose concentrations were measured in 2006, 2008, and 2010 survey. Brachial-ankle pulse wave velocities were measured during 2011 to 2016. Multivariate regression model was used to estimate the difference of brachial-ankle pulse wave velocity levels and logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of arterial stiffness risk, according to the fasting blood glucose trajectories. Results We identified five distinct fasting blood glucose trajectories and each of the trajectories was labeled according to its range and change over 2006-2010 survey: elevated-stable pattern (5.0% of participants), elevated-decreasing pattern (6.6%), moderate-increasing pattern (10.9%), moderate-stable pattern (59.3%), and low-stable pattern (18.2%). After adjustment for potential confounders, individuals with elevated-stable pattern had a 42.6 cm/s (95% CI: 24.7 to 60.6 cm/s) higher brachial-ankle pulse wave velocity level and a 37% (OR 1.37, 95% CI: 1.14 to 1.66) higher arterial stiffness risk, and individuals with moderate-increasing pattern had a 19.6 cm/s (95% CI: 6.9 to 32.3 cm/s) higher brachial-ankle pulse wave velocity level and a 17% (OR 1.17, 95% CI: 1.03 to 1.33) higher arterial stiffness risk, related to individuals with moderate-stable pattern. We did not find significant associations of the elevated- decreasing or low-stable patterns with arterial stiffness. Consistently, the cumulative average, variability, and increased rate of fasting blood glucose during 2006-2010 survey were significantly associated with the arterial stiffness risk. Conclusion Discrete fasting blood glucose trajectories were associated with the arterial stiffness risk in non-diabetic individuals.	[Wu, Yuntao; Gao, Wenyuan] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China; [Wu, Yuntao; Jin, Cheng; Wei, Guoqing; Zheng, Xiaoming; Gao, Jingsheng; Wu, Shouling] North China Univ Sci & Technol, Dept Cardiol, Kailuan Gen Hosp, Tangshan, Peoples R China; [Yu, Junxing] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China; [Li, Yun] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan, Peoples R China; [Su, Jinmei] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing, Peoples R China; [Su, Jinmei] Chinese Acad Med Sci, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China	Tianjin University; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Gao, WY (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China.; Wu, SL (corresponding author), North China Univ Sci & Technol, Dept Cardiol, Kailuan Gen Hosp, Tangshan, Peoples R China.	pharmgao@tju.edu.cn; drwusl@163.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Cang Y, 2012, INTERNAL MED, V51, P2847, DOI 10.2169/internalmedicine.51.7718; CARDOSO CRL, 2016, INT J MOL SCI, V17; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chen S, 2016, ARTERIOSCLEROSIS THR, V116; Chirinos JA, 2013, DIABETES CARE, V36, P2359, DOI 10.2337/dc12-1463; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Genuth S, 2003, DIABETES CARE, V26, P3160; Gottsater M, 2016, ARTERY RES, V16, P83; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Huang Y, 2011, J CLIN ENDOCR METAB, V96, pE1461, DOI 10.1210/jc.2010-2697; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Lee YH, 2016, ATHEROSCLEROSIS, V247, P1, DOI 10.1016/j.atherosclerosis.2016.01.032; Li CH, 2012, J CLIN ENDOCR METAB, V97, pE658, DOI 10.1210/jc.2011-2595; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Maeda Y, 2014, DIABETES CARE, V37, P2383, DOI 10.2337/dc13-1886; Munakata M, 2015, PULSE, V3, P195; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Sui XM, 2012, ANN EPIDEMIOL, V22, P617, DOI 10.1016/j.annepidem.2012.05.005; Takashima N, 2014, J HUM HYPERTENS, V28, P323, DOI 10.1038/jhh.2013.103; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; van Popele NM, 2006, J AM GERIATR SOC, V54, P397, DOI 10.1111/j.1532-5415.2005.00614.x; Venkataraman V, 2012, J DIABETES COMPLICAT, V26, P526, DOI 10.1016/j.jdiacomp.2012.06.002; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang J, 2014, NEUROL RES, V36, P427, DOI 10.1179/1743132814Y.0000000345; Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079; Wang XK, 2015, BIOORGAN MED CHEM, V23, P132, DOI 10.1016/j.bmc.2014.11.016; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Zhao Hai-yan, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P645; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685; 2008, GUIDELINES PREVENTIO	36	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188423	10.1371/journal.pone.0188423	http://dx.doi.org/10.1371/journal.pone.0188423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155890	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700059
J	Valdes, L; Perez, I; de Menorval, LC; Altshuler, E; Fossum, JO; Rivera, A				Valdes, Leslie; Perez, Irela; de Menorval, Louis Charles; Altshuler, Ernesto; Fossum, Jon Otto; Rivera, Aramis			A simple way for targeted delivery of an antibiotic: In vitro evaluation of a nanoclay-based composite	PLOS ONE			English	Article							CLAY-MINERALS; DRUG; CIPROFLOXACIN; ADSORPTION; SYSTEMS; DISSOLUTION; RESISTANCE; MECHANISMS; SMECTITE; HYBRID	The sodium-modified form of fluorohectorite nanoclay (NaFh) is introduced as a potential drug carrier, demonstrating its ability for the controlled release of the broad-spectrum antibiotic Ciprofloxacin through in vitro tests. The new clay-drug composite is designed to target the local infections in the large intestine, where it delivers most of the incorporated drug thanks to its pH-sensitive behavior. The composite has been conceived to avoid the use of coating technology and to decrease the side-effects commonly associated to the burst-release of the ciprofloxacin at the stomach level. NaFh was obtained from lithium-fluorohectorite by ion exchange, and its lack of toxicity was demonstrated by in vivo studies. Ciprofloxacin hydrochloride (Cipro) was encapsulated into the clay at different values of the pH, drug initial concentration, temperature and time. Systematic studies by X-ray diffraction (XRD), infrared and visible spectrophotometry (FT-IR and UV-vis), and thermal analysis (TGA) indicated that the NaFh host exhibits a high encapsulation efficiency for Cipro, which reaches a 90% of the initial Cipro in solution at 65 degrees C, with initial concentration of drug in solution of 1.36 x 10(-2) mol L-1 at acid pH. XRD revealed that a true intercalation of Cipro takes place between clay layers. TG showed an increased thermal stability of the drug when intercalated into the clay, as compared to the "free" Cipro. IR suggested a strong clay-Cipro interaction via ketone group, as well as the establishment of hydrogen bonds between the two materials. In vitro drug release tests revealed that NaFh is a potentially efficient carrier to deliver Cipro in the large intestine, where the release process is mediated by more than just one mechanism.	[Valdes, Leslie; Perez, Irela] Univ Havana, Dept Pharm, Inst Pharm & Food IFAL, Havana, Cuba; [de Menorval, Louis Charles] Univ Montpellier 2, Equipe Agregats Interface & Mat Energie AIME, Inst Charles Gerhardt Montpellier, Montpellier, France; [Altshuler, Ernesto] Univ Havana, Phys Fac, Grp Complex Syst & Stat Phys, Havana, Cuba; [Fossum, Jon Otto] Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway; [Rivera, Aramis] Univ Havana, Inst Mat Sci & Technol IMRE, Zeolites Engn Lab, Havana, Cuba	Universidad de la Habana; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universidad de la Habana; Norwegian University of Science & Technology (NTNU); Universidad de la Habana	Rivera, A (corresponding author), Univ Havana, Inst Mat Sci & Technol IMRE, Zeolites Engn Lab, Havana, Cuba.	aramis@imre.uh.cu	Fossum, Jon Otto/AAL-8903-2021; Fossum, Jon O/L-1510-2016	Fossum, Jon Otto/0000-0002-8952-303X; Fossum, Jon O/0000-0002-8952-303X; Rivera, Aramis/0000-0002-8579-7850; Altshuler, Ernesto/0000-0003-4192-5635	Ministerio de Educacion Superior	Ministerio de Educacion Superior	A. Rivera, L. Valdes, I. Perez and E. Altshuler acknowledge the Ministerio de Educacion Superior for partially funding this investigation, through providing salaries, laboratory area with standard working conditions, as well as basic expendables and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015; Babic S, 2007, TRAC-TREND ANAL CHEM, V26, P1043, DOI 10.1016/j.trac.2007.09.004; Bergaya F, 2006, DEV CLAY SCI, V1, P1, DOI 10.1016/S1572-4352(05)01001-9; BERKHEISER V, 1975, CLAY CLAY MINER, V23, P404, DOI 10.1346/CCMN.1975.0230514; Blandon LM, 2016, COLLOID SURFACE B, V145, P706, DOI 10.1016/j.colsurfb.2016.05.078; Boehling P, 2017, EUR J PHARM SCI, V104, P72, DOI 10.1016/j.ejps.2017.03.031; Calabrese I, 2013, INT J PHARMACEUT, V457, P224, DOI 10.1016/j.ijpharm.2013.09.017; CAMPOLIRICHARDS DM, 1988, DRUGS, V35, P373, DOI 10.2165/00003495-198835040-00003; Carlson L, 2004, BENTONITE MINERALO 1; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; Droy-Lefaix MT, 2006, DEV CLAY SCI, V1, P743, DOI 10.1016/S1572-4352(05)01025-1; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; El-Gamel NEA, 2012, J THERM ANAL CALORIM, V108, P253, DOI 10.1007/s10973-011-1584-8; Ezealisiji K., 2016, INT J DRUG DELIVERY, V8, P99; Farias T, 2009, COLLOID SURFACE A, V345, P51, DOI 10.1016/j.colsurfa.2009.04.022; FRANCES C, 1991, INT J PHARM, V77, P193, DOI 10.1016/0378-5173(91)90317-H; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gu C, 2005, ENVIRON SCI TECHNOL, V39, P9166, DOI 10.1021/es051109f; Hamilton AR, 2014, APPL CLAY SCI, V87, P129, DOI 10.1016/j.clay.2013.10.020; Hansen EL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00618; Hayes AW, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1, DOI 10.1201/b17359; Hemmen H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036315; HoogkampKorstanje JAA, 1997, J ANTIMICROB CHEMOTH, V40, P427, DOI 10.1093/jac/40.3.427; Janicijevic J, 2015, INT J PHARMACEUT, V496, P466, DOI 10.1016/j.ijpharm.2015.10.047; JAYNES WF, 1992, CLAY CLAY MINER, V40, P397, DOI 10.1346/CCMN.1992.0400404; Joshi GV, 2011, MICROPOR MESOPOR MAT, V142, P542, DOI 10.1016/j.micromeso.2010.12.040; Kaviratna PD, 1996, J PHYS CHEM SOLIDS, V57, P1897, DOI 10.1016/S0022-3697(96)00076-5; Kevadiya BD, 2012, EUR J PHARM SCI, V47, P265, DOI 10.1016/j.ejps.2012.04.009; Komadel P, 1996, CLAY CLAY MINER, V44, P228, DOI 10.1346/CCMN.1996.0440208; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; LEBEL M, 1988, PHARMACOTHERAPY, V8, P3; Lopez-Galindo A, 2007, APPL CLAY SCI, V36, P51, DOI 10.1016/j.clay.2006.06.016; Lopez-Galindo A., 2004, INTERFACE SCI TECHNO, V1, P267, DOI DOI 10.1016/S1573-4285(04)80044-9; Molu ZB, 2010, MICROPOR MESOPOR MAT, V127, P50, DOI 10.1016/j.micromeso.2009.06.027; Mura P, 2016, INT J PHARMACEUT, V509, P8, DOI 10.1016/j.ijpharm.2016.05.028; Neugebauer U, 2005, SPECTROCHIM ACTA A, V61, P1505, DOI 10.1016/j.saa.2004.11.014; Organization for Economic Co-operation and Development, 2008, GUIDELINE 425 ACUTE; Organization for Economic Co-operation and Development (OECD), 2008, GUID DOC AC OR TOX T; Rivera A, 2005, MICROPOR MESOPOR MAT, V80, P337, DOI 10.1016/j.micromeso.2005.01.011; Rivera A, 2016, APPL CLAY SCI, P124; Rozynek Z, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12009-x; Schou M, 2001, J AFFECT DISORDERS, V67, P21, DOI 10.1016/S0165-0327(01)00380-9; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Stucki JW, 2006, DEV CLAY SCI, V1, P423, DOI 10.1016/S1572-4352(05)01013-5; Sun J, 2002, EUR J PHARM BIOPHARM, V54, P51, DOI 10.1016/S0939-6411(02)00018-8; Takahashi T, 2005, J CONTROL RELEASE, V107, P408, DOI 10.1016/j.jconrel.2005.03.031; Tenorio RP, 2010, LANGMUIR, V26, P9703, DOI 10.1021/la100377s; Thiebault T, 2015, J COLLOID INTERF SCI, V453, P1, DOI 10.1016/j.jcis.2015.04.029; Tiwari G, 2012, INT J PHARM INVESTIG, V2, P2, DOI 10.4103/2230-973X.96920; Trivedi P, 2007, ENVIRON SCI TECHNOL, V41, P3153, DOI 10.1021/es061921y; USDPI, 1993, DRUG INF HLTH CAR PR; Viseras C, 2008, MATER SCI TECH-LOND, V24, P1020, DOI 10.1179/174328408X341708; Viseras C, 2007, APPL CLAY SCI, V36, P37, DOI 10.1016/j.clay.2006.07.006; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; WOLFSON JS, 1985, ANTIMICROB AGENTS CH, V28, P581, DOI 10.1128/AAC.28.4.581	56	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187879	10.1371/journal.pone.0187879	http://dx.doi.org/10.1371/journal.pone.0187879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149176	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100016
J	Weber, I; Florin, E; von Papen, M; Timmermann, L				Weber, Immo; Florin, Esther; von Papen, Michael; Timmermann, Lars			The influence of filtering and downsampling on the estimation of transfer entropy	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; INFORMATION-TRANSFER; GRANGER CAUSALITY; EFFECTIVE CONNECTIVITY; NEURAL-NETWORKS; TIME-SERIES; EEG; BRAIN; SYNCHRONIZATION; SIGNALS	Transfer entropy (TE) provides a generalized and model-free framework to study Wiener-Granger causality between brain regions. Because of its nonparametric character, TE can infer directed information flow also from nonlinear systems. Despite its increasing number of applications in neuroscience, not much is known regarding the influence of common electrophysiological preprocessing on its estimation. We test the influence of filtering and downsampling on a recently proposed nearest neighborhood based TE estimator. Different filter settings and downsampling factors were tested in a simulation framework using a model with a linear coupling function and two nonlinear models with sigmoid and logistic coupling functions. For nonlinear coupling and progressively lower low-pass filter cut-off frequencies up to 72% false negative direct connections and up to 26% false positive connections were identified. In contrast, for the linear model, a monotonic increase was only observed for missed indirect connections (up to 86%). High-pass filtering (1 Hz, 2 Hz) had no impact on TE estimation. After low-pass filtering interaction delays were significantly underestimated. Downsampling the data by a factor greater than the assumed interaction delay erased most of the transmitted information and thus led to a very high percentage (67-100%) of false negative direct connections. Low-pass filtering increases the number of missed connections depending on the filters cut-off frequency. Downsampling should only be done if the sampling factor is smaller than the smallest assumed interaction delay of the analyzed network.	[Weber, Immo; Timmermann, Lars] Univ Hosp Giessen & Marburg, Dept Neurol, Marburg, Germany; [Florin, Esther; von Papen, Michael] Heinrich Heine Univ, Med Fac, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [von Papen, Michael] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany	University Hospital of Giessen & Marburg; Heinrich Heine University Dusseldorf; University of Cologne	Weber, I; Timmermann, L (corresponding author), Univ Hosp Giessen & Marburg, Dept Neurol, Marburg, Germany.	immo.weber@staff.uni-marburg.de; lars.timmermann@uk-gm.de	Florin, Esther/GWC-1118-2022	Florin, Esther/0000-0001-8276-2508; Timmermann, Lars/0000-0002-5301-3580; Weber, Immo/0000-0003-2979-234X; von Papen, Michael/0000-0001-5030-1643	German Research Foundation [KFO 219, TI 319/2-1]; Volkswagen Foundation [89387]	German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	The study was supported by a grant from the German Research Foundation (http://www.dfg.de/en/, KFO 219; TI 319/2-1). E.Fgratefully acknowledges support from "Volkswagen Foundation'' (https://www.volkswagenstiftung.de/, grant number: 89387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K. L., 2009, CEREB CORTEX; [Anonymous], 1956, MODERN MATH ENG; Barnett L, 2017, J NEUROSCI METH, V275, P93, DOI 10.1016/j.jneumeth.2016.10.016; Barnett L, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.040101; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Boba P, 2015, COMPUT PHYS, V3, P10, DOI DOI 10.3389/FPHY.2015.00010/ABSTRACT; Breitung J, 2002, J TIME SER ANAL, V23, P651, DOI 10.1111/1467-9892.00284; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Canavier CC, 2015, CURR OPIN NEUROBIOL, V31, P206, DOI 10.1016/j.conb.2014.12.003; Chand GB, 2016, NEUROIMAGE, V134, P85, DOI 10.1016/j.neuroimage.2016.04.018; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Dickten H, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062706; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Florin E, 2010, EUR J NEUROSCI, V31, P491, DOI 10.1111/j.1460-9568.2010.07083.x; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Huang CS, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00570; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; Korzeniewska A, 2014, NEUROIMAGE, V101, P96, DOI 10.1016/j.neuroimage.2014.06.078; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kraskov A., 2004, SYNCHRONIZATION INTE; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Ma CF, 2013, COGN NEURODYNAMICS, V7, P253, DOI 10.1007/s11571-012-9239-4; Maki-Marttunen V., 2013, BMC NEUROSCI S1, V14, P83; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; Martini M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011919; May R. M., 2004, THEORY CHAOTIC ATTRA, P85; Montalto A, 2015, NEURAL NETWORKS, V71, P159, DOI 10.1016/j.neunet.2015.08.003; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; Moratti S, 2011, J NEUROSCI, V31, P17278, DOI 10.1523/JNEUROSCI.2917-11.2011; Pashaie R, 2009, IEEE T NEURAL NETWOR, V20, P597, DOI 10.1109/TNN.2008.2010703; Perea G, 2006, J NEURAL ENG, V3, P245, DOI 10.1088/1741-2560/3/3/007; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Protopapa F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00146; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Razak FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099462; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schroeder KE, 2016, NEUROIMAGE, V134, P459, DOI 10.1016/j.neuroimage.2016.04.039; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shao SJ, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON FIELD-PROGRAMMABLE TECHNOLOGY (FPT), P60, DOI 10.1109/FPT.2014.7082754; Sharott A, 2008, BRAIN, V131, P473, DOI 10.1093/brain/awm324; Smirnov DA, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/10005; Smirnov DA, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042917; Solo V, 2016, NEURAL COMPUT, V28, P914, DOI 10.1162/NECO_a_00828; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Trenado C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00325; Tsuda I, 2015, CURR OPIN NEUROBIOL, V31, P67, DOI 10.1016/j.conb.2014.08.011; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2012, IEEE ENG MED BIO, P3676, DOI 10.1109/EMBC.2012.6346764; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Wold H., 1938, STUDY ANAL STATIONAR	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188210	10.1371/journal.pone.0188210	http://dx.doi.org/10.1371/journal.pone.0188210			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149201	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100028
J	Basnett, J; Xie, V; Cisterne, A; Bradstock, K; Bendall, L				Basnett, Jordan; Xie, Vicki; Cisterne, Adam; Bradstock, Ken; Bendall, Linda			Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CELLS	It has been suggested that disruption of the lymphoid niche by G-CSF may be of therapeutic benefit to patients with acute lymphoblastic leukaemia. We used a xenograft model to determine the effect of G-CSF on ALL progression in a minimal residual disease setting. Consistent with the effects on normal murine B cell progenitors, G-CSF slowed disease in the majority of ALL xenografts tested, suggesting that G-CSF may provide benefits beyond neutrophil recovery for ALL patients. However, two of eight xenografts demonstrated accelerated disease progression. G-CSF could be detrimental for these patients due to expansion of the malignant clone.	[Basnett, Jordan; Xie, Vicki; Cisterne, Adam; Bendall, Linda] Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia; [Bradstock, Ken] Westmead Hosp, Dept Haematol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Bendall, L (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia.	linda.bendall@sydney.edu.au	Cisterne, Adam/HGA-8311-2022		NHMRC [352326, 1042305]; Cancer Institute NSW	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This work was supported by an NHMRC project grant (Grant No. 352326) and Senior Research Fellowship (1042305) and Cancer Institute NSW Fellowship to Linda Bendall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDALL LJ, 1993, BLOOD, V82, P3125; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Giebel S, 2012, EUR J CANCER, V48, P360, DOI 10.1016/j.ejca.2011.11.023; Juarez J, 2007, LEUKEMIA, V21, P1249, DOI 10.1038/sj.leu.2404684; Kobbe G, 1998, AM J HEMATOL, V58, P330, DOI 10.1002/(SICI)1096-8652(199808)58:4<330::AID-AJH14>3.0.CO;2-B; MAKRYNIKOLA V, 1991, EXP HEMATOL, V19, P674; MANABE A, 1992, BLOOD, V79, P2370; SHAPOSHNIKOV V L, 1979, Byulleten' Eksperimental'noi Biologii i Meditsiny, V87, P483; TSUCHIYA H, 1993, LEUKEMIA RES, V17, P809, DOI 10.1016/0145-2126(93)90116-3; Uy G, 2015, LEUKEMIA RE IN PRESS; Wallington-Beddoe CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036429; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Winkler IG, 2013, HAEMATOLOGICA, V98, P325, DOI 10.3324/haematol.2012.069260; Wong J, 2014, ONCOTARGET, V5, P10460, DOI 10.18632/oncotarget.2260	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188042	10.1371/journal.pone.0188042	http://dx.doi.org/10.1371/journal.pone.0188042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145456	Green Submitted, gold, Green Published			2022-12-26	WOS:000415378800055
J	McCoy, D; McManus, MA; Kotubetey, K; Kawelo, AH; Young, C; D'Andrea, B; Ruttenberg, KC; Alegado, RA				McCoy, Daniel; McManus, Margaret A.; Kotubetey, Keli'iahonui; Kawelo, Angela Hi'ilei; Young, Charles; D'Andrea, Brandon; Ruttenberg, Kathleen C.; Alegado, Rosanna Anolani			Large-scale climatic effects on traditional Hawaiian fishpond aquaculture	PLOS ONE			English	Article							EL-NINO; NORTH PACIFIC; FREQUENCY; VARIABILITY; EVENTS; IMPACT	Aquaculture accounts for almost one-half of global fish consumption. Understanding the regional impact of climate fluctuations on aquaculture production thus is critical for the sustainability of this crucial food resource. The objective of this work was to understand the role of climate fluctuations and climate change in subtropical coastal estuarine environments within the context of aquaculture practices in He. eia Fishpond, O. ahu Island, Hawai'i. To the best of our knowledge, this was the first study of climate effects on traditional aquaculture systems in the Hawaiian Islands. Data from adjacent weather stations were analyzed together with in situ water quality instrument deployments spanning a 12-year period (November 2004 - November 2016). We found correlations between two periods with extremely high fish mortality at He. eia Fishpond (May and October 2009) and slackening trade winds in the week preceding each mortality event, as well as surface water temperatures elevated 2-3 degrees C higher than the background periods (March-December 2009). We posit that the lack of trade wind-driven surface water mixing enhanced surface heating and stratification of the water column, leading to hypoxic conditions and stress on fish populations, which had limited ability to move within net pen enclosures. Elevated water temperature and interruption of trade winds previously have been linked to the onset of El Nio in Hawai'i. Our results provide empirical evidence regarding El Nico effects on the coastal ocean, which can inform resource management efforts about potential impact of climate variation on aquaculture production. Finally, we provide recommendations for reducing the impact of warming events on fishponds, as these events are predicted to increase in magnitude and frequency as a consequence of global warming.	[McCoy, Daniel; McManus, Margaret A.; Young, Charles; D'Andrea, Brandon; Ruttenberg, Kathleen C.; Alegado, Rosanna Anolani] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Kotubetey, Keli'iahonui; Kawelo, Angela Hi'ilei] Paepae O Heeia, Kaneohe, HI USA; [Ruttenberg, Kathleen C.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Alegado, Rosanna Anolani] Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA; [Young, Charles] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Alegado, RA (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.; Alegado, RA (corresponding author), Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA.	ralegado@hawaii.edu	McManus, Margaret Anne/AAA-2604-2020	McCoy, Daniel/0000-0002-1322-5474; Alegado, Rosanna/0000-0003-3615-5613	NOAA-NMFS [NA05NMF4521188]; Office of Hawaiian Affairs; Kamehameha Schools Bishop Estate; University of Hawaii Sea Grant College Program, SOEST [NA05OAR4171048, NA09OAR4170060, NA14OAR4170071]; NOAA Office of Sea Grant, Department of Commerce [R/EL-42, R/AQ-84, A/AS-1]; Direct For Biological Sciences [1558169] Funding Source: National Science Foundation	NOAA-NMFS(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Hawaiian Affairs; Kamehameha Schools Bishop Estate; University of Hawaii Sea Grant College Program, SOEST; NOAA Office of Sea Grant, Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Pacific threadfin aquaculture was funded by the NOAA-NMFS NA05NMF4521188, the Office of Hawaiian Affairs and the Kamehameha Schools Bishop Estate. Data from Na Kilo Honua o He'eia used in this contribution were collected with the support from the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant Nos. NA05OAR4171048, NA09OAR4170060, and NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce: Project R/EL-42 (KCR, MM, B Glazer), Project R/AQ-84 (KCR, MM, B Glazer) and Project A/AS-1 (RAA).	Barnard PL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047707; Blunden J, 2014, B AM METEOROL SOC, V95, pS1, DOI 10.1175/2014BAMSStateoftheClimate.1; Boyd C. E., 1995, BOTTOM SOILS SEDIMEN, DOI DOI 10.1007/978-1-4615-1785-6; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brix H, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002245; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI [10.1038/nclimate2492, 10.1038/NCLIMATE2492]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Callan CK, 2012, 13 EUR C RAD ITS EFF, P1; Cao GX, 2007, J CLIMATE, V20, P1145, DOI 10.1175/JCLI4033.1; Caputi N, 2016, ECOL EVOL, V6, P3583, DOI 10.1002/ece3.2137; CHU PS, 1995, J CLIMATE, V8, P1697, DOI 10.1175/1520-0442(1995)008<1697:HRAAEN>2.0.CO;2; Cobb JN, 1902, 1901 US FISH COMM RE, P353; Cochrane K., 2009, FAO FISHERIES AQUACU; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; D'Andrea BT, 2015, WATER EXCHANGE CIRCU, P1; De Silva S.S., 2009, CLIMATE CHANGE IMPLI, P151; Demmke A., 2011, VULNERABILITY TROPIC, P733; Di Lorenzo E, 2010, NAT GEOSCI, V3, P762, DOI [10.1038/NGEO984, 10.1038/ngeo984]; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; FAO, 2016, STAT WORLD FISH AQ, P200; Handy Elizabeth Green, 1972, NATIVE PLANTERS OLD; Hargreaves J. A., 2003, POND MIXING, V4802; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hoover RS, 2006, MAR ECOL PROG SER, V318, P187, DOI 10.3354/meps318187; Horel J, 2002, B AM METEOROL SOC, V83, P211, DOI 10.1175/1520-0477(2002)083<0211:MCMITW>2.3.CO;2; Huo WJ, 2016, ATMOS OCEAN SCI LETT, V9, P428, DOI 10.1080/16742834.2016.1231567; Jokiel P.L., 2011, J MAR BIOL, V2011, DOI [10.1155/2011/151682, DOI 10.1155/2011/151682]; Keala G, 2007, COLL TROPICAL AGR HU, P1; Kelly M., 1975, LOKO HEEIA FISHPOND; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; Malo David, 1903, HAWAIIAN ANTIQUITIES; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sanderson M., 1993, PREVAILING TRADE WIN; SANTERRE MT, 1977, AQUACULTURE, V10, P341, DOI 10.1016/0044-8486(77)90125-9; Scannell HA, 2016, GEOPHYS RES LETT, V43, P2069, DOI 10.1002/2015GL067308; Solomon S., 2007, CLIMATE CHANGE 2007; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Yeh SW, 2015, J CLIMATE, V28, P663, DOI 10.1175/JCLI-D-14-00137.1; Young CW, 2011, PERTURBATION NUTR IN	41	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187951	10.1371/journal.pone.0187951	http://dx.doi.org/10.1371/journal.pone.0187951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145446	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800043
J	Bernstock, JD; Ye, D; Smith, JA; Lee, YJ; Gessler, FA; Yasgar, A; Kouznetsova, J; Jadhav, A; Wang, ZR; Pluchino, S; Zheng, W; Simeonov, A; Hallenbeck, JM; Yang, W				Bernstock, Joshua D.; Ye, Daniel; Smith, Jayden A.; Lee, Yang-Ja; Gessler, Florian A.; Yasgar, Adam; Kouznetsova, Jennifer; Jadhav, Ajit; Wang, Zhuoran; Pluchino, Stefano; Zheng, Wei; Simeonov, Anton; Hallenbeck, John M.; Yang, Wei			Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2	FASEB JOURNAL			English	Article						drug repurposing; ischemia; neuroprotection; stroke; SUMOylation	ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; NEUROPROTECTION; SUMOYLATION; HYPOTHERMIA; MECHANISMS; ACTIVATION; PROTEINS; INCREASE; EBSELEN	The development of novel neuroprotective treatments for acute stroke has been fraught with failures, which supports the view of ischemic brain damage as a highly complex multifactorial process. Post-translational modifications such as small ubiquitin-like modifier (SUMO)ylation have emerged as critical molecular regulatory mechanisms in states of both homeostasis and ischemic stress, as evidenced by our previous work. Accordingly, the clinical significance of the selective control of the global SUMOylation process has become apparent in studies of ischemic pathobiology and pathophysiology. Herein, we describe a process capable of identifying and characterizing small molecules with the potential of targeting the SUMO system through inhibition of SUMO deconjugation in an effort to develop novel stroke therapies.	[Bernstock, Joshua D.; Ye, Daniel; Lee, Yang-Ja; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Bernstock, Joshua D.; Smith, Jayden A.; Gessler, Florian A.; Pluchino, Stefano] Univ Cambridge, Div Stem Cell Neurobiol, Dept Clin Neurosci, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Bernstock, Joshua D.; Smith, Jayden A.; Gessler, Florian A.; Pluchino, Stefano] Univ Cambridge, Natl Inst Hlth Res Biomed Res Ctr, Cambridge, England; [Bernstock, Joshua D.] Univ Alabama Birmingham, UAB Med Sch, Birmingham, AL USA; [Yasgar, Adam; Kouznetsova, Jennifer; Jadhav, Ajit; Zheng, Wei; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Wang, Zhuoran; Yang, Wei] Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Perioperat Organ Protect, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; University of Cambridge; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Duke University	Bernstock, JD (corresponding author), NINDS, NIH, Bldg 10,Room 5B06, Bethesda, MD 20892 USA.; Yang, W (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.	bernstockjd@ninds.nih.gov; wei.yang@duke.edu	Zheng, Wei/J-8889-2014; Yang, Wei/ABE-2905-2021; Zheng, Wei/GQQ-8951-2022; Pluchino, Stefano/AAE-9037-2019; Zheng, Wei/GOE-5990-2022	Zheng, Wei/0000-0003-1034-0757; Pluchino, Stefano/0000-0002-6267-9472; Jadhav, Ajit/0000-0001-7955-1451; Smith, Jayden/0000-0003-2307-8452; Bernstock, Joshua/0000-0002-7814-3867; Yasgar, Adam/0000-0001-7350-1402; Ye, Daniel/0000-0002-5417-3279	NIH/NINDS [R01 NS099590]; National Center for Advancing Translational Sciences; American Heart Association [16GRNT30270003]; NIH/OxCam Fellowship; Medical Research Council [MC_PC_12009] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856, R01NS099590, ZIANS002924] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association(American Heart Association); NIH/OxCam Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Gregory K. Friedman (University of Alabama at Birmingham) and Dr. Jorn Karhausen (Duke University Medical Center) for critical reading and editing of the manuscript. The authors also thank Dr. Dragan Maric [Flow Cytometry Core Facility, U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Sciences (NINDS)]. This research was supported by the Intramural Research Program of the NIH/NINDS; the National Center for Advancing Translational Sciences; NIH/NINDS Grant R01 NS099590 and American Heart Association Grant 16GRNT30270003 (to W.Y.); and an NIH/OxCam Fellowship (to J.D.B.). The authors declare no conflicts of interest.	Almqvist H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11040; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstock JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07631-9; Bernstock JD, 2016, J CEREBR BLOOD F MET, V36, P426, DOI 10.1177/0271678X15609939; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chang P, 2017, F1000 RES, V6, P484; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Fisher M, 2011, STROKE, V42, pS24, DOI 10.1161/STROKEAHA.110.592394; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Gu JM, 2014, CARDIOVASC RES, V104, P83, DOI 10.1093/cvr/cvu177; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang R., 2011, SCI TRANSL MED, V3; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2016, J NEUROCHEM, V138, P101, DOI 10.1111/jnc.13643; Lee YJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00416; Lee YJ, 2013, NEUROMOL MED, V15, P771, DOI 10.1007/s12017-013-8239-9; Lee YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047787; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Luo J, 2017, J TOXICOL SCI, V42, P529, DOI 10.2131/jts.42.529; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mendes AV, 2016, BBA-MOL CELL RES, V1863, P139, DOI 10.1016/j.bbamcr.2015.10.020; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; NELSON JA, 1975, CANCER RES, V35, P2872; Noguchi N, 2016, ARCH BIOCHEM BIOPHYS, V595, P109, DOI 10.1016/j.abb.2015.10.024; Parnham MJ, 2013, BIOCHEM PHARMACOL, V86, P1248, DOI 10.1016/j.bcp.2013.08.028; Peters M, 2017, NEUROCHEM INT, V107, P66, DOI 10.1016/j.neuint.2017.03.011; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Sharma P, 2013, CELL REP, V3, P1640, DOI 10.1016/j.celrep.2013.04.016; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tymianski M, 2017, STROKE, V48, P1700, DOI 10.1161/STROKEAHA.117.017040; VOLONTE C, 1992, J NEUROCHEM, V58, P700, DOI 10.1111/j.1471-4159.1992.tb09774.x; Wang LL, 2012, J NEUROCHEM, V123, P349, DOI 10.1111/j.1471-4159.2012.07916.x; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yang W, 2016, STROKE VASC NEUROL, V1, P101, DOI 10.1136/svn-2016-000031; Yang W, 2013, J BIOMOL SCREEN, V18, P621, DOI 10.1177/1087057113479971; Yang W, 2009, J CEREBR BLOOD F MET, V29, P886, DOI 10.1038/jcbfm.2009.16; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Zhang L, 2017, NEUROSCIENCE, V343, P190, DOI 10.1016/j.neuroscience.2016.11.036	63	23	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1677	1691		10.1096/fj.201700711R	http://dx.doi.org/10.1096/fj.201700711R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146736	Green Published			2022-12-26	WOS:000427246000044
J	Ji, WB; Luo, YB; Ahmad, E; Liu, ST				Ji, Wenbin; Luo, Yibo; Ahmad, Ejaz; Liu, Song-Tao			Direct interactions of mitotic arrest deficient 1 (MAD1) domains with each other and MAD2 conformers are required for mitotic checkpoint signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MAD1; MAD2; mitotic checkpoint; MPS1 kinase; mitosis; signal transduction; kinetochore; mitotic spindle; checkpoint control	SPINDLE ASSEMBLY CHECKPOINT; UNATTACHED KINETOCHORES; PROTEIN BUBR1; CHROMOSOME BIORIENTATION; ANAPHASE INHIBITOR; KINASE-ACTIVITY; BUDDING YEAST; CORE COMPLEX; PHOSPHORYLATION; MITOSIS	As a sensitive signaling system, the mitotic checkpoint ensures faithful chromosome segregation by delaying anaphase onset even when a single kinetochore is unattached to mitotic spindle microtubules. The key signal amplification reaction for the checkpoint is the conformational conversion of open mitotic arrest deficient 2 (O-MAD2) into closed MAD2 (C-MAD2). The reaction has been suggested to be catalyzed by an unusual catalyst, a MAD1:C-MAD2 tetramer, but how the catalysis is executed and regulated remains elusive. Here, we report that in addition to the well-characterized middle region of MAD1 containing the MAD2-interaction motif (MIM), both N- and C-terminal domains (NTD and CTD) of MAD1 also contribute to mitotic checkpoint signaling. Unlike the MIM, which stably associated only with C-MAD2, the NTD and CTD in MAD1 surprisingly bound both O- and C-MAD2, suggesting that these two domains interact with both substrates and products of the O-to-C conversion. MAD1(NTD) and MAD1(CTD) also interacted with each other and with the MPS1 protein kinase, which phosphorylated both NTD and CTD. This phosphorylation decreased the NTD:CTD interaction and also CTD's interaction with MPS1. Of note, mutating the phosphorylation sites in the MAD1(CTD), including Thr-716, compromised MAD2 binding and the checkpoint responses. We further noted that Ser-610 and Tyr-634 also contribute to the mitotic checkpoint signaling. Our results have uncovered that the MAD1(NTD) and MAD1(CTD) directly interact with each other and with MAD2 conformers and are regulated by MPS1 kinase, providing critical insights into mitotic checkpoint signaling.	[Ji, Wenbin; Luo, Yibo; Ahmad, Ejaz; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019; Ahmad, Ejaz/L-1506-2013	Ahmad, Ejaz/0000-0002-5713-6713; Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Medicine [NIH R01CA169500]; NATIONAL CANCER INSTITUTE [R01CA169500] Funding Source: NIH RePORTER	National Institutes of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Medicine Grant NIH R01CA169500 (to S.-T.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akera T, 2015, NAT CELL BIOL, V17, P1124, DOI 10.1038/ncb3219; Ballister ER, 2014, J CELL BIOL, V204, P901, DOI 10.1083/jcb.201311113; Campbell MS, 2001, J CELL SCI, V114, P953; Caron D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aah3525; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chi YH, 2008, J BIOL CHEM, V283, P35834, DOI 10.1074/jbc.M804967200; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Elowe S, 2017, CELL CYCLE, V16, P746, DOI 10.1080/15384101.2017.1302632; Faesen AC, 2017, NATURE, V542, P498, DOI 10.1038/nature21384; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Heinrich S, 2014, EMBO REP, V15, P291, DOI 10.1002/embr.201338114; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Ji ZJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22513; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; Kim S, 2010, P NATL ACAD SCI USA, V107, P19772, DOI 10.1073/pnas.1009000107; Kruse T, 2014, EMBO REP, V15, P282, DOI 10.1002/embr.201338101; Kuijt TEF, 2014, CHROMOSOMA, V123, P471, DOI 10.1007/s00412-014-0458-9; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lischetti T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970484; Lischetti T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6563; Liu ST, 2016, AIMS MOL SCI, V3, P597, DOI 10.3934/molsci.2016.4.597; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Moasser MM, 1999, CANCER RES, V59, P6145; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; St-Denis N, 2016, CELL REP, V17, P2488, DOI 10.1016/j.celrep.2016.10.078; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wolanin K, 2010, MOL CANCER THER, V9, P1328, DOI 10.1158/1535-7163.MCT-09-0936; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15822; Zhou HN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10151	69	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					484	496		10.1074/jbc.RA117.000555	http://dx.doi.org/10.1074/jbc.RA117.000555			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162720	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000419915400006
J	Khandelwal, NK; Chauhan, N; Sarkar, P; Esquivel, BD; Coccetti, P; Singh, A; Coste, AT; Gupta, M; Sanglard, D; White, TC; Chauvel, M; d'Enfert, C; Chattopadhyay, A; Gaur, NA; Mondal, AK; Prasad, R				Khandelwal, Nitesh Kumar; Chauhan, Neeraj; Sarkar, Parijat; Esquivel, Brooke D.; Coccetti, Paola; Singh, Ashutosh; Coste, Alix T.; Gupta, Meghna; Sanglard, Dominique; White, Theodore C.; Chauvel, Murielle; d'Enfert, Christophe; Chattopadhyay, Amitabha; Gaur, Naseem A.; Mondal, Alok Kumar; Prasad, Rajendra			Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; membrane transport; mTOR complex (mTORC); multidrug transporter; yeast; Azole resistance; CDR6; TOR signaling	DRUG-RESISTANCE; MEMBRANE-FLUIDITY; HSP90; YEAST; PROTEINS; GROWTH; RAPAMYCIN; FAMILY; GENE; EPIDEMIOLOGY	ATP-binding cassette (ABC) transporters help export various substrates across the cell membrane and significantly contribute to drug resistance. However, a recent study reported an unusual case in which the loss of an ABC transporter in Candida albicans, orf19.4531 (previously named ROA1), increases resistance against antifungal azoles, which was attributed to an altered membrane potential in the mutant strain. To obtain further mechanistic insights into this phenomenon, here we confirmed that the plasma membrane-localized transporter (renamed CDR6/ROA1 for consistency with C. albicans nomenclature) could efflux xenobiotics such as berberine, rhodamine 123, and paraquat. Moreover, a CDR6/ROA1 null mutant, NKKY101, displayed increased susceptibility to these xenobiotics. Interestingly, fluorescence recovery after photobleaching (FRAP) results indicated that NKKY101 mutant cells exhibited increased plasma membrane rigidity, resulting in reduced azole accumulation and contributing to azole resistance. Transcriptional profiling revealed that ribosome biogenesis genes were significantly up-regulated in the NKKY101 mutant. As ribosome biogenesis is a well-known downstream phenomenon of target of rapamycin (TOR1) signaling, we suspected a link between ribosome biogenesis and TOR1 signaling in NKKY101. Therefore, we grew NKKY101 cells on rapamycin and observed TOR1 hyperactivation, which leads to Hsp90-dependent calcineurin stabilization and thereby increased azole resistance. This in vitro finding was supported by in vivo data from a mouse model of systemic infection in which NKKY101 cells led to higher fungal load after fluconazole challenge than wild-type cells. Taken together, our study uncovers a mechanism of azole resistance in C. albicans, involving increased membrane rigidity and TOR signaling.	[Khandelwal, Nitesh Kumar; Singh, Ashutosh; Gupta, Meghna; Mondal, Alok Kumar; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Chauhan, Neeraj] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Sarkar, Parijat; Chattopadhyay, Amitabha] CSIR Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Esquivel, Brooke D.] Univ Missouri, Sch Biol Sci Cell Biol & Biophys, Kansas City, MO 64110 USA; [Coccetti, Paola] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Coccetti, Paola] Ctr Syst Biol, SYSBIO, I-20126 Milan, Italy; [Singh, Ashutosh] Lucknow Univ, Dept Biochem, Lucknow 226024, Uttar Pradesh, India; [Sanglard, Dominique] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Sanglard, Dominique] Univ Hosp Ctr, Rue Bugnon 48, CH-1011 Lausanne, Switzerland; [Gupta, Meghna] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chauvel, Murielle; d'Enfert, Christophe] INRA, Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, F-75015 Paris, France; [Gaur, Naseem A.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Prasad, Rajendra] Amity Univ Haryana, Amity Inst Integrat Sci & Hlth, Amity Educ Valley Gurgao 122413, India	Jawaharlal Nehru University, New Delhi; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Missouri System; University of Missouri Kansas City; University of Milano-Bicocca; Lucknow University; University of Lausanne; University of California System; University of California San Francisco; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Prasad, R (corresponding author), Amity Univ Haryana, Amity Inst Integrat Sci & Hlth, Amity Educ Valley Gurgao 122413, India.	rp47jnu@gmail.com	Gupta, Meghna/AGY-3073-2022; Gupta, Meghna/AAZ-4389-2021; Coccetti, Paola/Y-2365-2019; SINGH, ASHUTOSH/AAR-1283-2021; Sanglard, Dominique/K-6032-2017; Khandelwal, Nitesh Kumar/AAX-6273-2021	Gupta, Meghna/0000-0002-7432-3211; Coccetti, Paola/0000-0001-5898-5883; SINGH, ASHUTOSH/0000-0002-0995-6696; Sanglard, Dominique/0000-0002-5244-4178; Khandelwal, Nitesh Kumar/0000-0002-6319-8048; Gaur, Naseem/0000-0002-1224-8789; Coste, Alix/0000-0001-9481-9778; Sarkar, Parijat/0000-0001-9435-5600	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, BT/PR14879/BRB10/885/2010]; National Institutes of Health [R01AI124499]; DST PURSE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124499] Funding Source: NIH RePORTER	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST PURSE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by the Department of Biotechnology, Ministry of Science and Technology, Government of India, Grants BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, and BT/PR14879/BRB10/885/2010 (to R. P.). Research in the laboratory of N. C. was supported by National Institutes of Health Grant R01AI124499. The research work in the laboratory of A. K. M. was supported by a DST PURSE grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Clarke RJ, 1997, BBA-BIOMEMBRANES, V1323, P223, DOI 10.1016/S0005-2736(96)00188-5; Coccetti P, 2004, MOL MICROBIOL, V51, P447, DOI 10.1046/j.1365-2958.2003.03836.x; Cowen L. E., 2014, COLD SPRING HARB PER, DOI [10. 1101/cshperspect. a019752 25384768, DOI 10.1101/CSHPERSPECT.A01975225384768]; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2013, CURR OPIN MICROBIOL, V16, P377, DOI 10.1016/j.mib.2013.03.005; Croons V, 2009, J PHARMACOL EXP THER, V329, P856, DOI 10.1124/jpet.108.149948; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Dhamgaye S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-396; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; Haldar S, 2012, BIOPHYS J, V102, P1561, DOI 10.1016/j.bpj.2012.03.004; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hawle P, 2007, EUKARYOT CELL, V6, P521, DOI 10.1128/EC.00343-06; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Imai J, 2000, MOL CELL BIOL, V20, P9262, DOI 10.1128/MCB.20.24.9262-9270.2000; Jiang LH, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow024; Khandelwal NK, 2016, BIOCHEM J, V473, P1537, DOI 10.1042/BCJ20160024; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; KOPPEL DE, 1980, BIOPHYS J, V30, P187, DOI 10.1016/S0006-3495(80)85087-9; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lyons CN, 2000, ANTIMICROB AGENTS CH, V44, P2296, DOI 10.1128/AAC.44.9.2296-2303.2000; Mahto KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113664; Mansfield BE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001126; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollinedo F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00140; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Prasad R, 2016, FUNGAL GENET BIOL, V93, P25, DOI 10.1016/j.fgb.2016.05.008; Prasad R, 2015, EUKARYOT CELL, V14, P1154, DOI 10.1128/EC.00137-15; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; RAO SS, 1967, BIOCHEM BIOPH RES CO, V29, P696, DOI 10.1016/0006-291X(67)90273-2; Rawal MK, 2013, J BIOL CHEM, V288, P24480, DOI 10.1074/jbc.M113.488353; Rella A, 2016, PROG LIPID RES, V61, P63, DOI 10.1016/j.plipres.2015.11.003; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Sanchez-Casalongue ME, 2015, J BIOL CHEM, V290, P7221, DOI 10.1074/jbc.M114.626523; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00011; Shah AH, 2014, BIOCHEM J, V460, P223, DOI 10.1042/BJ20140010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Shekhar-Guturja T, 2016, NAT CHEM BIOL, V12, P867, DOI [10.1038/nchembio.2165, 10.1038/NCHEMBIO.2165]; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Starke-Peterkovic T, 2005, AM J PHYSIOL-REG I, V288, pR663, DOI 10.1152/ajpregu.00434.2004; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; SWEENEY R, 1991, GENETICS, V127, P327; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Vandeputte P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026962; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	83	31	33	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					412	432		10.1074/jbc.M117.807032	http://dx.doi.org/10.1074/jbc.M117.807032			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158264	Green Published, hybrid			2022-12-26	WOS:000419915400002
J	Mishra, S; Wu, SY; Fuller, AW; Wang, Z; Rose, KL; Schey, KL; Mchaourab, HS				Mishra, Sanjay; Wu, Shu-Yu; Fuller, Alexandra W.; Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.; Mchaourab, Hassane S.			Loss of B-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; cataract; chaperone; small heat shock protein (sHsp); zebrafish; B-crystallin; lens development; glucocorticoid receptor signaling	ALPHA-A-CRYSTALLIN; CORTICOSTEROID-INDUCED CATARACTS; SHOCK PROTEINS; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONE; CRYOELECTRON MICROSCOPY; DILATED CARDIOMYOPATHY; SUBSTRATE-BINDING; ADULT ZEBRAFISH; DANIO-RERIO	Genetic mutations in the human small heat shock protein B-crystallin have been implicated in autosomal cataracts and skeletal myopathies, including heart muscle diseases (cardiomyopathy). Although these mutations lead to modulation of their chaperone activity in vitro, the in vivo functions of B-crystallin in the maintenance of both lens transparency and muscle integrity remain unclear. This lack of information has hindered a mechanistic understanding of these diseases. To better define the functional roles of B-crystallin, we generated loss-of-function zebrafish mutant lines by utilizing the CRISPR/Cas9 system to specifically disrupt the two B-crystallin genes, Ba and Bb. We observed lens abnormalities in the mutant lines of both genes, and the penetrance of the lens phenotype was higher in Ba than Bb mutants. This finding is in contrast with the lack of a phenotype previously reported in B-crystallin knock-out mice and suggests that the elevated chaperone activity of the two zebrafish orthologs is critical for lens development. Besides its key role in the lens, we uncovered another critical role for B-crystallin in providing stress tolerance to the heart. The B-crystallin mutants exhibited hypersusceptibility to develop pericardial edema when challenged by crowding stress or exposed to elevated cortisol stress, both of which activate glucocorticoid receptor signaling. Our work illuminates the involvement of B-crystallin in stress tolerance of the heart presumably through the proteostasis network and reinforces the critical role of the chaperone activity of B-crystallin in the maintenance of lens transparency.	[Mishra, Sanjay; Wu, Shu-Yu; Fuller, Alexandra W.; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	National Institutes of Health [R01 EY12018, P30 EY008126]; Clinical and Translational Science Award from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center [UL1 RR024975-01]; Vanderbilt University School of Medicine Cell Imaging Shared Resource; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012018, P30EY008126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University School of Medicine Cell Imaging Shared Resource; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12018 (to H.M.), P30 EY008126 (to H.M. and K.L.S.), and the Clinical and Translational Science Award UL1 RR024975-01, from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center, and the Vanderbilt University School of Medicine Cell Imaging Shared Resource. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Asomugha CO, 2011, MOL VIS, V17, P2356; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bidinost C, 2006, INVEST OPHTH VIS SCI, V47, P1274, DOI 10.1167/iovs.05-1095; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BROCKLEBANK JT, 1982, ARCH DIS CHILD, V57, P30; Buhrdel JB, 2015, BIOCHEM BIOPH RES CO, V461, P217, DOI 10.1016/j.bbrc.2015.03.149; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Cain JT, 2017, AM J MED GENET A, V173, P1200, DOI 10.1002/ajmg.a.38162; Castorino JJ, 2011, INVEST OPHTH VIS SCI, V52, P6774, DOI 10.1167/iovs.10-6579; Chen QY, 2016, CHEMOSPHERE, V144, P1162, DOI 10.1016/j.chemosphere.2015.09.089; Cheng XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060213; COSTAGLIOLA C, 1989, BRIT J DERMATOL, V120, P472, DOI 10.1111/j.1365-2133.1989.tb04181.x; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Dickerson JE, 1997, EXP EYE RES, V65, P507, DOI 10.1006/exer.1997.0359; Djabali K, 1997, J CELL SCI, V110, P2759; DONSHIK PC, 1981, ANN OPHTHALMOL, V13, P29; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Forrest KML, 2011, NEUROMUSCULAR DISORD, V21, P37, DOI 10.1016/j.nmd.2010.11.003; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Harding RL, 2008, EXP EYE RES, V86, P807, DOI 10.1016/j.exer.2008.02.009; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; HEAD MW, 1994, J CELL PHYSIOL, V159, P41, DOI 10.1002/jcp.1041590107; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; JAKOB U, 1993, J BIOL CHEM, V268, P1517; James ER, 2007, J OCUL PHARMACOL TH, V23, P403, DOI 10.1089/jop.2006.0067; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kinyamu HK, 2008, MOL CARCINOGEN, V47, P845, DOI 10.1002/mc.20440; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2015, BIOCHEMISTRY-US, V54, P5949, DOI 10.1021/acs.biochem.5b00678; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Krishnamoorthy V, 2013, MOL CELL BIOCHEM, V379, P59, DOI 10.1007/s11010-013-1627-5; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leske MC, 1997, OPHTHALMOLOGY, V104, P1987, DOI 10.1016/S0161-6420(97)30043-8; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Mao L, 2006, GENE EXPR PATTERNS, V6, P127, DOI 10.1016/j.modgep.2005.07.002; Marvin M, 2008, DEV DYNAM, V237, P454, DOI 10.1002/dvdy.21414; McCarty CA, 2000, INVEST OPHTH VIS SCI, V41, P3720; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Muchowski PJ, 1997, J BIOL CHEM, V272, P2578; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nahomi RB, 2013, BIOCHEMISTRY-US, V52, P8126, DOI 10.1021/bi400638s; Neppl RL, 2014, J BIOL CHEM, V289, P17240, DOI 10.1074/jbc.M114.549584; Nesan D, 2012, MOL CELL ENDOCRINOL, V363, P85, DOI 10.1016/j.mce.2012.07.010; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Oakley RH, 2015, J STEROID BIOCHEM, V153, P27, DOI 10.1016/j.jsbmb.2015.03.009; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Posner M, 1999, BBA-GENE STRUCT EXPR, V1447, P271, DOI 10.1016/S0167-4781(99)00155-4; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Reddy VS, 2015, CURR MOL MED, V15, P47, DOI 10.2174/1566524015666150114112853; RENFRO L, 1992, DERMATOL CLIN, V10, P505; Rog-Zielinska EA, 2014, J MOL ENDOCRINOL, V52, pR125, DOI 10.1530/JME-13-0204; Roy SG, 2009, CELL PHYSIOL BIOCHEM, V24, P1, DOI 10.1159/000227803; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Sallin P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160012; Santhoshkumar P, 2009, BIOCHEMISTRY-US, V48, P5066, DOI 10.1021/bi900085v; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1773; Thisse B, 2014, METHODS MOL BIOL, V1211, P53, DOI 10.1007/978-1-4939-1459-3_5; Thornell E, 2015, CELL MOL LIFE SCI, V72, P4127, DOI 10.1007/s00018-015-1996-x; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; Veenstra DL, 1999, AM J KIDNEY DIS, V33, P829, DOI 10.1016/S0272-6386(99)70414-2; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang Z, 2015, INVEST OPHTH VIS SCI, V56, P8349, DOI 10.1167/iovs.15-18273; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	100	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					740	753		10.1074/jbc.M117.808634	http://dx.doi.org/10.1074/jbc.M117.808634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162721	hybrid, Green Published			2022-12-26	WOS:000419915400027
J	Deguignet, M; Arnell, A; Juffe-Bignoli, D; Shi, YC; Bingham, H; MacSharry, B; Kingston, N				Deguignet, Marine; Arnell, Andy; Juffe-Bignoli, Diego; Shi, Yichuan; Bingham, Heather; MacSharry, Brian; Kingston, Naomi			Measuring the extent of overlaps in protected area designations	PLOS ONE			English	Article								Over the past decades, a number of national policies and international conventions have been implemented to promote the expansion of the world's protected area network, leading to a diversification of protected area strategies, types and designations. As a result, many areas are protected by more than one convention, legal instrument, or other effective means which may result in a lack of clarity around the governance and management regimes of particular locations. We assess the degree to which different designations overlap at global, regional and national levels to understand the extent of this phenomenon at different scales. We then compare the distribution and coverage of these multi-designated areas in the terrestrial and marine realms at the global level and among different regions, and we present the percentage of each county's protected area extent that is under more than one designation. Our findings show that almost a quarter of the world's protected area network is protected through more than one designation. In fact, we have documented up to eight overlapping designations. These overlaps in protected area designations occur in every region of the world, both in the terrestrial and marine realms, but are more common in the terrestrial realm and in some regions, notably Europe. In the terrestrial realm, the most common overlap is between one national and one international designation. In the marine realm, the most common overlap is between any two national designations. Multi-designations are therefore a widespread phenomenon but its implications are not well understood. This analysis identifies, for the first time, multi-designated areas across all designation types. This is a key step to understand how these areas are managed and governed to then move towards integrated and collaborative approaches that consider the different management and conservation objectives of each designation.	[Deguignet, Marine; Arnell, Andy; Juffe-Bignoli, Diego; Shi, Yichuan; Bingham, Heather; MacSharry, Brian; Kingston, Naomi] UN Environm World Conservat Monitoring Ctr UNEP W, Cambridge, England; [Shi, Yichuan] Int Union Nat Conservat IUCN, Gland, Switzerland		Deguignet, M (corresponding author), UN Environm World Conservat Monitoring Ctr UNEP W, Cambridge, England.	marine.deguignet@unep-wcmc.org			Proteus Partnership; UNEP-WCMC	Proteus Partnership; UNEP-WCMC	The Proteus Partnership provided funding for this study. Additional internal funding was also provided by UNEP-WCMC. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Diego Juffe-Bignoli receives a salary from The Biodiversity Consultancy; however, this is after the study presented had concluded.	[Anonymous], 2016, MANAGING MIDAS HARMO; [Anonymous], 2016, PROT PLAN WORLD DAT; [Anonymous], 2010, 50 YEARS WORK PROT A; Bingham H., PRIVATELY P IN PRESS; Borrini-Feyerabend G, 2013, BEST PRACT PROTECT A, V20; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Corrigan C., 2016, PARKS, V22, P2; Deguignet M., 2014, 2014 UN LIST PROTECT; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Dudley N, 2014, ORYX, V48, P496, DOI 10.1017/S0030605314000519; Eagles F.J., 2002, SUSTAINABLE TOURISM; Green M., 1997, ICUN WCPA S PROT AR; Holdgate M, 1999, GREEN WEB UNION WORL; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Lockwood M., 2006, MANAGING PROTECTED A; Lopoukhine N., 2012, SAPIENS, V5, P1; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Maxwell S.L, 2016, NATURE, V536; MCNEELY JA, 1994, BIODIVERS CONSERV, V3, P390, DOI 10.1007/BF00057797; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; Stolton S, 2015, PROTECTED AREA GOVERNANCE AND MANAGEMENT, P145; UN Environment -Convention on Biological Diversity, 2003, UNEPCBDSBSTTA9INF28; UNEP, 1999, GLOB ENV OUTL 2 REP; UNEP, 2002, GLOB ENV OUTL 3 REP; UNEP WCMC, 2016, WORLD DAT PROT AR US; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Wang LY, 2007, J GEOGR SCI, V17, P187, DOI 10.1007/s11442-007-0187-6; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	31	23	23	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188681	10.1371/journal.pone.0188681	http://dx.doi.org/10.1371/journal.pone.0188681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176888	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900115
J	Doublier, S; Zennaro, C; Musante, L; Spatola, T; Candiano, G; Bruschi, M; Besso, L; Cedrino, M; Carraro, M; Ghiggeri, GM; Camussi, G; Lupia, E				Doublier, Sophie; Zennaro, Cristina; Musante, Luca; Spatola, Tiziana; Candiano, Giovanni; Bruschi, Maurizio; Besso, Luca; Cedrino, Massimo; Carraro, Michele; Ghiggeri, Gian Marco; Camussi, Giovanni; Lupia, Enrico			Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; IDIOPATHIC NEPHROTIC SYNDROME; UROKINASE RECEPTOR; MESANGIAL CELLS; IN-VITRO; ALBUMIN; PATHWAY; NEPHRIN; PROTEINURIA; EXPRESSION	CD40/CD40 ligand (CD40L) dyad, a co-stimulatory bi-molecular complex involved in the adaptive immune response, has also potent pro-inflammatory actions in haematopoietic and non-haematopoietic cells. We describe here a novel role for soluble CD40L (sCD40L) as modifier of glomerular permselectivity directly acting on glomerular epithelial cells (GECs). We found that stimulation of CD40, constitutively expressed on GEC cell membrane, by the sCD40L rapidly induced redistribution and loss of nephrin in GECs, and increased albumin permeability in isolated rat glomeruli. Pre-treatment with inhibitors of CD40-CD40L interaction completely prevented these effects. Furthermore, in vivo injection of sCD40L induced a significant reduction of nephrin and podocin expression in mouse glomeruli, although no significant increase of urine protein/creatinine ratio was observed after in vivo injection. The same effects were induced by plasma factors partially purified from post-transplant plasma exchange eluates of patients with focal segmental glomerulosclerosis (FSGS), and were blocked by CD40-CD40L inhibitors. Moreover, 17 and 34 kDa sCD40L isoforms were detected in the same plasmapheresis eluates by Western blotting. Finally, the levels of sCD40Lwere significantly increased in serum of children both with steroid- sensitive and steroid-resistant nephrotic syndrome (NS), and in adult patients with biopsy-proven FSGS, compared to healthy subjects, but neither in children with congenital NS nor in patients with membranous nephropathy. Our results demonstrate that sCD40L directly modifies nephrin and podocin distribution in GECs. Moreover, they suggest that sCD40L contained in plasmapheresis eluates from FSGS patients with post-transplant recurrence may contribute, presumably cooperating with other mediators, to FSGS pathogenesis by modulating glomerular permeability.	[Doublier, Sophie] Univ Turin, Dept Oncol, Turin, Italy; [Doublier, Sophie; Spatola, Tiziana; Besso, Luca; Cedrino, Massimo; Camussi, Giovanni; Lupia, Enrico] Univ Turin, Dept Med Sci, Turin, Italy; [Zennaro, Cristina; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Musante, Luca; Candiano, Giovanni; Bruschi, Maurizio; Ghiggeri, Gian Marco] G Gaslini Children Hosp, Nephrol Dialysis Transplantat, Genoa, Italy; [Musante, Luca; Candiano, Giovanni; Bruschi, Maurizio; Ghiggeri, Gian Marco] G Gaslini Children Hosp, Lab Pathophysiol Uremia, Genoa, Italy	University of Turin; University of Turin; University of Trieste; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Camussi, G; Lupia, E (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it; enrico.lupia@unito.it	Bruschi, Maurizio/E-7090-2016; Stefanadis, Christodoulos/ABH-2232-2020; Lupia, Enrico/AAB-7505-2019; Musante, Luca/F-5086-2017; Candiano, Giovanni/J-9357-2018	Bruschi, Maurizio/0000-0001-6036-1500; Stefanadis, Christodoulos/0000-0001-5974-6454; Musante, Luca/0000-0003-0845-275X; Candiano, Giovanni/0000-0002-7385-2787; Ghiggeri, Gian Marco/0000-0003-3659-9062	"Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria"; Renal Child Foundation; Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale"); Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale; Italian Ministry of Health; Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte; Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project"); Fresenius Medical Care	"Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria"; Renal Child Foundation; Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale"); Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale; Italian Ministry of Health(Ministry of Health, Italy); Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte(Regione Piemonte); Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project"); Fresenius Medical Care	This study was supported by "Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria" to Istituto Giannina Gaslini, Renal Child Foundation, and Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale") to G.M.G., by Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale" to C.Z and M.C., by Italian Ministry of Health Local project ex-60% and Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte to E.L., and by Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project") and Fresenius Medical Care to G.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar N, 2013, NEW ENGL J MED, V368, P971, DOI 10.1056/NEJMc1207233; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2001, J AM SOC NEPHROL, V12, P143, DOI 10.1681/ASN.V121143; Castellano G, 2005, J AM SOC NEPHROL, V16, P2003, DOI 10.1681/ASN.2002120972; Cathelin D, 2014, J AM SOC NEPHROL, V25, P1662, DOI 10.1681/ASN.2013040425; Charba DS, 2009, AM J PHYSIOL-RENAL, V297, pF138, DOI 10.1152/ajprenal.00122.2008; Conaldi PG, 1997, J VIROL, V71, P9180, DOI 10.1128/JVI.71.12.9180-9187.1997; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; DANTAL J, 1994, NEW ENGL J MED, V330, P7, DOI 10.1056/NEJM199401063300102; Dantal J, 1998, J AM SOC NEPHROL, V9, P1709; Davin JC, 2016, PEDIATR NEPHROL, V31, P207, DOI 10.1007/s00467-015-3082-x; Deambrosis I, 2005, INT J IMMUNOPATH PH, V18, P327, DOI 10.1177/039463200501800215; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Doublier S, 2005, INT J MOL MED, V16, P49; Esposito P, 2014, INT REV IMMUNOL, V33, P212, DOI 10.3109/08830185.2013.829470; Glassock RJ, 2003, J AM SOC NEPHROL, V14, P541, DOI 10.1097/01.ASN.0000051640.04273.75; Hassan GS, 2015, CANCER TREAT REV, V41, P431, DOI 10.1016/j.ctrv.2015.03.007; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; HESLAN JM, 1986, NEPHRON, V42, P187, DOI 10.1159/000183664; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Jefferson JA, 2013, KIDNEY INT, V84, P235, DOI 10.1038/ki.2013.204; Kairaitis L, 2003, KIDNEY INT, V64, P1265, DOI 10.1046/j.1523-1755.2003.00223.x; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kim EY, 2017, BBA-MOL BASIS DIS, V1863, P2342, DOI 10.1016/j.bbadis.2017.06.010; Klein D, 2005, DIABETOLOGIA, V48, P268, DOI 10.1007/s00125-004-1645-7; Korniluk A, 2014, TUMOR BIOL, V35, P9447, DOI 10.1007/s13277-014-2407-x; Kuo HL, 2017, NEPHROL DIAL TRANSPL; Laxmanan S, 2005, J AM SOC NEPHROL, V16, P2714, DOI 10.1681/ASN.2005010045; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Lee VWS, 2010, NEPHROL DIAL TRANSPL, V25, P717, DOI 10.1093/ndt/gfp569; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Maas RJ, 2014, NEPHROL DIAL TRANSPL, V29, P2207, DOI 10.1093/ndt/gfu355; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Musante L, 2005, CLIN EXP IMMUNOL, V141, P491, DOI 10.1111/j.1365-2249.2005.02862.x; Palacios CRF, 2013, TRANSPLANTATION, V96, P394, DOI 10.1097/TP.0b013e3182977ab1; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Reiser J, 2014, ADV CHRONIC KIDNEY D, V21, P417, DOI 10.1053/j.ackd.2014.05.010; Reynolds J, 2004, KIDNEY INT, V66, P1444, DOI 10.1111/j.1523-1755.2004.00907.x; Rigothier C, 2016, J CELL BIOCHEM, V117, P2737, DOI 10.1002/jcb.25571; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Ruth AJ, 2003, J AM SOC NEPHROL, V14, P2813, DOI 10.1097/01.ASN.0000091381.60059.FB; Savin VJ, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/6232616; Savin VJ, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/714964; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Savin VJ, 2003, SEMIN NEPHROL, V23, P147, DOI 10.1053/snep.2003.50024; Shankland SJ, 2011, NAT MED, V17, P926, DOI 10.1038/nm.2443; Sharma M, 1999, J AM SOC NEPHROL, V10, P552; Tanaka T, 2002, J AM SOC NEPHROL, V13, P2488, DOI 10.1097/01.ASN.0000029588.07166.20; Trimarchi Hernan, 2013, World J Nephrol, V2, P103, DOI 10.5527/wjn.v2.i4.103; Vincenti F, 2005, AM J TRANSPLANT, V5, P1179, DOI 10.1111/j.1600-6143.2005.00968.x; Wada T, 2015, CLIN KIDNEY J, V8, P708, DOI 10.1093/ckj/sfv090; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Xie JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08426-8; Yang X, 2004, NEPHROL DIAL TRANSPL, V19, P1378, DOI 10.1093/ndt/gfh144; Zennaro C, 2016, INT J NANOMED, V11, P4957, DOI 10.2147/IJN.S110201; Zhang BK, 2013, IMMUNOL LETT, V153, P58, DOI 10.1016/j.imlet.2013.07.005	63	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188045	10.1371/journal.pone.0188045	http://dx.doi.org/10.1371/journal.pone.0188045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155846	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700028
J	Liu, C; Dang, XL; Mayes, MA; Chen, LL; Zhang, YL				Liu, Chang; Dang, Xiuli; Mayes, Melanie A.; Chen, Leilei; Zhang, Yulong			Effect of long-term irrigation patterns on phosphorus forms and distribution in the brown soil zone	PLOS ONE			English	Article							FRESH-WATER WETLANDS; MANURE APPLICATIONS; SORPTION CAPACITY; CALCAREOUS SOILS; SANJIANG PLAIN; ORGANIC-CARBON; USE EFFICIENCY; ANIMAL MANURE; AVAILABILITY; PHOSPHATE	Continuous application of P fertilizers under different irrigation patterns can change soil phosphorus (P) chemical behavior and increase soil P levels that are of environmental concern. To assess the effect of long-term different irrigation patterns on soil P fractions and availability, this study examined sequential changes in soil organic P and inorganic P from furrow irrigation (FI), surface drip irrigation (SUR), and subsurface drip irrigation (SDI) in the brown soil zone (0-60 cm) during 1998 to 2011. Analyses of soil P behavior showed that the levels of total P are frequently high on top soil layers. The total P (TP) contents of the entire soil profiles under three irrigation treatments were 830.2-3180.1 mg/kg. The contents of available P (AP) were 72.6-319.3 mg P/kg soil through soil profiles. The greatest TP and AP contents were obtained within the upper soil layers in FI. Results of Hedley's P fractionation indicate that HCl-P is a dominant form and the proportion to TP ranges from 29% to 43% in all three methods. The contents of various fractions of P were positively correlated with the levels of total carbon (TC), total inorganic carbon (TIC), and calcium (Ca), whereas the P fractions had negative correlation with pH in all soil samples. Regression models proved that NaHCO3-P-o was an important factor in determining the amount of AP in FI. H2O-P-o, NaHCO3-P-o, and NaOH-P-i were related to available P values in SUR. NaHCO3-P-o and NaOH-P-o played important roles in SDI. The tomato yield under SUR was higher than SDI and FI. The difference of P availability was also controlled by the physicochemical soil properties under different irrigation schedule. SUR was a reasonable irrigation pattern to improve the utilization efficiency of water and fertilizer.	[Liu, Chang; Dang, Xiuli; Zhang, Yulong] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China; [Mayes, Melanie A.] Climate Change Sci Inst, Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN USA; [Chen, Leilei] Chifeng Environm Monitoring Cent Stn, Integrated Technol Dept, Chifeng, Inner Mongolia, Peoples R China	Shenyang Agricultural University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Zhang, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China.	ylzsau@163.com	dang, xiuli/ABG-4716-2021	dang, xiuli/0000-0002-1702-9745	National Basic Research Program (973) of China [2011CB100502]; National Natural Science Foundation of China [41301530]; Scientific and Technological Projects of Shenyang City [FF11-117-3-00]; Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education [CEPF2012-123-1-7]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Projects of Shenyang City; Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education	This work was supported by the National Basic Research Program (973) of China (No. 2011CB100502), http://program.most.gov.cn/; National Natural Science Foundation of China (41301530), http://www.nsfc.gov.cn/; the Scientific and Technological Projects of Shenyang City (Grant No. FF11-117-3-00) http://www.syscg.gov.cn; and the Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education (No. CEPF2012-123-1-7), http://www.cepfln.com/List.asp?ID=634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami E, 2013, J SOIL SCI PLANT NUT, V13, P11, DOI [10.4067/S0718-95162012005000002, 10.4067/S0718-95162013005000002]; Alam M, 2002, J AM WATER RESOUR AS, V38, P1715, DOI 10.1111/j.1752-1688.2002.tb04376.x; Aldrich R.A, 1994, GREENHOUSE ENG; Alvarez-Rogel J, 2007, SCI TOTAL ENVIRON, V378, P71, DOI 10.1016/j.scitotenv.2007.01.016; Ann Y, 2000, ECOL ENG, V14, P157; [Anonymous], 2015, WETLAND SOILS GENESI; BACON PE, 1982, SOIL SCI SOC AM J, V46, P981, DOI 10.2136/sssaj1982.03615995004600050019x; BARROW NJ, 1984, J SOIL SCI, V35, P283, DOI 10.1111/j.1365-2389.1984.tb00283.x; BARYOSEF B, 1989, AGRON J, V81, P443, DOI 10.2134/agronj1989.00021962008100030009x; BECK MA, 1994, SOIL SCI SOC AM J, V58, P1424, DOI 10.2136/sssaj1994.03615995005800050021x; Ben-Gal A, 2003, SOIL SCI SOC AM J, V67, P1449, DOI 10.2136/sssaj2003.1449; Bertrand I, 2003, AUST J SOIL RES, V41, P61, DOI 10.1071/SR02021; Bisutti I, 2004, TRAC-TREND ANAL CHEM, V23, P716, DOI 10.1016/j.trac.2004.09.003; Bunemann EK, 2011, SOIL BIOL, V26, P37, DOI 10.1007/978-3-642-15271-9_2; Condron LM, 2006, AUST J SOIL RES, V44, P127, DOI 10.1071/SR05065; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Daly K, 2001, SOIL USE MANAGE, V17, P12, DOI 10.1111/j.1475-2743.2001.tb00003.x; de Carvalho AM, 2014, REV BRAS CIENC SOLO, V38, P972, DOI 10.1590/S0100-06832014000300029; Eveborn D, 2014, WATER RES, V64, P42, DOI 10.1016/j.watres.2014.06.034; Fixen P. E., 1990, SOIL TESTING PLANT A, V3, P141, DOI DOI 10.2136/sssabookser3.3ed.c7; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Goyal M.R., 2012, MANAGEMENT DRIP TRIC; Han L, 2010, AGR SCI CHINA, V9, P1175, DOI 10.1016/S1671-2927(09)60205-4; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Hogan DM, 2004, WETLANDS, V24, P573, DOI 10.1672/0277-5212(2004)024[0573:PRASOC]2.0.CO;2; Howell TA, 2001, AGRON J, V93, P281, DOI 10.2134/agronj2001.932281x; Ige DV, 2005, CAN J SOIL SCI, V85, P417, DOI 10.4141/S04-064; Jalali M, 2010, SOIL SEDIMENT CONTAM, V19, P560, DOI 10.1080/15320383.2010.499927; Jensen ME, 1980, MONOGRAPH SERIES AM; Jimenez-Carceles FJ, 2008, GEODERMA, V144, P299, DOI 10.1016/j.geoderma.2007.11.024; Khademi Z, 2010, PLANT SOIL, V334, P151, DOI 10.1007/s11104-009-0215-7; Kleinman PJA, 2002, COMMUN SOIL SCI PLAN, V33, P1825, DOI 10.1081/CSS-120004825; Koopmans GF, 2007, J ENVIRON QUAL, V36, P305, DOI 10.2134/jeq2006.0131; Kumaragamage D, 2012, J ENVIRON QUAL, V41, P845, DOI 10.2134/jeq2011.0415; [罗先香 Luo Xianxiang], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P154; MBAGWU JSC, 1985, PLANT SOIL, V84, P181, DOI 10.1007/BF02143182; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; Pagliari PH, 2012, J ENVIRON QUAL, V41, P901, DOI 10.2134/jeq2011.0451; Reis THP, 2011, REV BRAS CIENC SOLO, V35, P503, DOI 10.1590/S0100-06832011000200019; Pizzeghello D, 2014, AGR ECOSYST ENVIRON, V189, P216, DOI 10.1016/j.agee.2014.03.047; Poach ME, 1998, ESTUAR COAST SHELF S, V46, P195, DOI 10.1006/ecss.1997.0252; Ponce P., 2014, GREENHOUSE DESIGN CO; Sharpley A, 2000, J ENVIRON QUAL, V29, P1462, DOI 10.2134/jeq2000.00472425002900050012x; Sharpley A, 2000, J ENVIRON QUAL, V29, P176, DOI 10.2134/jeq2000.00472425002900010022x; Sharpley AN, 2004, SOIL SCI SOC AM J, V68, P2048, DOI 10.2136/sssaj2004.2048; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shi B, 2002, ENG GEOL, V67, P63, DOI 10.1016/S0013-7952(02)00145-X; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; Sims JT, 1998, J ENVIRON QUAL, V27, P277, DOI 10.2134/jeq1998.00472425002700020006x; Skhiri A, 2012, AGR WATER MANAGE, V103, P130, DOI 10.1016/j.agwat.2011.11.004; Tunesi S, 1999, NUTR CYCL AGROECOSYS, V53, P219, DOI 10.1023/A:1009709005147; Vaananen R., 2008, THESIS, DOI 10.14214/df.60; Valipour M, 2013, IRRIG DRAIN, V9, P2; von Wandruszka R, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-6; Wang GP, 2006, GEODERMA, V132, P59, DOI 10.1016/j.geoderma.2005.04.021; Wang YS, 2010, J PLANT NUTR SOIL SC, V173, P345, DOI 10.1002/jpln.200800284; Xu HC, 2012, WASTE BIOMASS VALORI, V3, P355, DOI 10.1007/s12649-011-9103-5; Yang LJ, 2011, PEDOSPHERE, V21, P712, DOI 10.1016/S1002-0160(11)60174-4; Yang WJ, 2012, GEODERMA, V189, P207, DOI 10.1016/j.geoderma.2012.06.025; Zhang TQ, 1997, PLANT SOIL, V192, P133, DOI 10.1023/A:1004232417658; Zohar I, 2010, GEODERMA, V159, P109, DOI 10.1016/j.geoderma.2010.07.002	63	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188361	10.1371/journal.pone.0188361	http://dx.doi.org/10.1371/journal.pone.0188361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155875	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700051
J	Plazy, M; Perriat, D; Gumede, D; Boyer, S; Pillay, D; Dabis, F; Seeley, J; Orne-Gliemann, J				Plazy, Melanie; Perriat, Delphine; Gumede, Dumile; Boyer, Sylvie; Pillay, Deenan; Dabis, Francois; Seeley, Janet; Orne-Gliemann, Joanna			Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers	PLOS ONE			English	Article							EARLY ANTIRETROVIRAL THERAPY; DIFFERENTIATED CARE; INCOME COUNTRIES; PREVENTION; INITIATION; TRIAL; ART; INFECTION; PERSPECTIVES; ADHERENCE	Background We aimed to describe the field experiences and recommendations of clinic-based health care providers (HCP) regarding the implementation of universal antiretroviral therapy (ART) in rural KwaZulu-Natal, South Africa. Methods In Hlabisa sub-district, the local HIV programme of the Department of Health (DoH) is decentralized in 18 clinics, where ART was offered at a CD4 count <= 500 cells/mu L from January 2015 to September 2016. Within the ANRS 12249 TasP trial, implemented in part of the sub-district, universal ART (no eligibility criteria) was offered in 11 mobile clinics between March 2012 and June 2016. A cross-sectional qualitative survey was conducted in April-July 2016 among clinic-based nurses and counsellors providing HIV care in the DoH and TasP trial clinics. In total, 13 individual interviews and two focus groups discussions (including 6 and 7 participants) were conducted, audio-recorded, transcribed, and thematically analyzed. Results All HCPs reported an overall good experience of delivering ART early in the course of HIV infection, with most patients willing to initiate ART before being symptomatic. Yet, HCPs underlined that not feeling sick could challenge early ART initiation and adherence, and thus highlighted the need to take time for counselling as an important component to achieve universal ART. HCPs also foresaw logistical challenges of universal ART, and were especially concerned about increasing workload and ART shortage. HCPs finally recommended the need to strengthen the existing model of care to facilitate access to ART, e.g., community-based and integrated HIV services. Conclusions The provision of universal ART is feasible and acceptable according to HCPs in this rural South-African area. However their experiences suggest that universal ART, and more generally the 90-90-90 UNAIDS targets, will be difficult to achieve without the implementation of new models of health service delivery.	[Plazy, Melanie; Perriat, Delphine; Dabis, Francois; Orne-Gliemann, Joanna] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Plazy, Melanie; Perriat, Delphine; Dabis, Francois; Orne-Gliemann, Joanna] INSERM, Bordeaux Populat Hlth Res Ctr, ISPED, UMR 1219, Bordeaux, France; [Gumede, Dumile; Pillay, Deenan; Seeley, Janet] Africa Hlth Res Inst, Somkhele, South Africa; [Boyer, Sylvie] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Seeley, Janet] London Sch Hyg & Trop Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Africa Health Research Institute; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Plazy, M (corresponding author), Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France.; Plazy, M (corresponding author), INSERM, Bordeaux Populat Hlth Res Ctr, ISPED, UMR 1219, Bordeaux, France.	melanie.plazy@u-bordeaux.fr	DABIS, FRANCOIS/S-9298-2019; Plazy, Melanie/T-9707-2019; Gumede, Dumile/GXZ-5278-2022; Orne-Gliemann, Joanna/T-2787-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Gumede, Dumile/0000-0002-8628-5726; Perriat, Delphine/0000-0001-7498-1700; Seeley, Janet/0000-0002-0583-5272; PLAZY, Melanie/0000-0002-8971-6878	French National Agency for AIDS and Viral Hepatitis Research (ANRS); ANRS; International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Wellcome Trust; French Charity Sidaction; French Ecole des Hautes Etudes en Sante Publique (EHESP)	French National Agency for AIDS and Viral Hepatitis Research (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Wellcome Trust(Wellcome TrustEuropean Commission); French Charity Sidaction; French Ecole des Hautes Etudes en Sante Publique (EHESP)	The French National Agency for AIDS and Viral Hepatitis Research (ANRS) is the sponsor and co-funder of the TasP trial within which this study was conducted. Research discussed in this publication has been co-funded by ANRS together with the International Initiative for Impact Evaluation, Inc. (3ie) with support from the Bill & Melinda Gates Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of 3ie or the Bill & Melinda Gates Foundation. The Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) co-funded the first part of the trial. Merck & Co. Inc. and Gilead Sciences provided the Atriplat drug supply. The Africa Health Research Institute (AHRI) receives core funding from the Wellcome Trust, which provides the platform for the population- and clinic-based research at Somkhele. Melanie Plazy is supported by the French Charity Sidaction and Delphine Perriat by the French Ecole des Hautes Etudes en Sante Publique (EHESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CONS GUID PERS CTR H; Barnighausen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163960; Bor J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178249; Boyer S, 2016, AIDS CARE, V28, P39, DOI 10.1080/09540121.2016.1164808; Celletti F, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21185; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Dussault G, 2008, SOC SCI MED, V66, P2088, DOI 10.1016/j.socscimed.2008.01.035; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Evans C, 2015, AIDS CARE, V27, P753, DOI 10.1080/09540121.2014.1002826; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21371; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Inzaule SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167492; Iwuji C, 2016, AIDS C 18 22 JUL DUR; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Lebouche Bertrand, 2014, J Int Assoc Provid AIDS Care, V13, P160, DOI 10.1177/2325957413488196; Lebouche B, 2013, AIDS CARE, V25, P1284, DOI 10.1080/09540121.2013.764394; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Mao LM, 2013, AIDS CARE, V25, P1375, DOI 10.1080/09540121.2013.766304; Mbonye M, 2016, AIDS CARE, V28, P33, DOI 10.1080/09540121.2016.1164804; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Nachega JB, 2016, CURR HIV-AIDS REP, V13, P241, DOI 10.1007/s11904-016-0325-9; Orne-Gliemann J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1344-y; Perriat D, J INT AIDS IN PRESS; Peter T, 2017, LANCET INFECT DIS, V17, pE26, DOI 10.1016/S1473-3099(16)30212-2; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Plazy M, 2017, 9 IAS C HIV SCI 23 2; Plazy M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20913; South African Department of Health, 2017, ID CLIN MAN; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; UNAIDS, 2014, 90 90 90 AMB TREATM; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Vernooij E, 2016, AIDS CARE, V28, P7, DOI 10.1080/09540121.2016.1178954; WHO, 2010, ANT THER HIV INF AD; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, CONS GUID US ANT DRU	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186883	10.1371/journal.pone.0186883	http://dx.doi.org/10.1371/journal.pone.0186883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155832	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000415756700006
J	Brini, I; Guerrero, A; Hannachi, N; Bouguila, J; Orth-Holler, D; Bouhlel, A; Boughamoura, L; Hetzer, B; Borena, W; Schiela, B; Von Laer, D; Boukadida, J; Stoiber, H				Brini, Ines; Guerrero, Aida; Hannachi, Naila; Bouguila, Jihene; Orth-Hoeller, Dorothea; Bouhlel, Amira; Boughamoura, Lamia; Hetzer, Benjamin; Borena, Wegene; Schiela, Britta; Von Laer, Dorothee; Boukadida, Jalel; Stoiber, Heribert			Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; HUMAN METAPNEUMOVIRUS; PCR; ETIOLOGY; FEATURES; INFANTS; ASSAYS; UNIT	This study aimed to identify a broad spectrum of respiratory pathogens from hospitalized and not-preselected children with acute respiratory tract infections in the Farhat Hached University-hospital of Sousse, Tunisia. Between September 2013 and December 2014, samples from 372 children aged between 1 month and 5 years were collected, and tested using multiplex real-time RT-PCR by a commercial assay for 21 respiratory pathogens. In addition, samples were screened for the presence of Streptococcus pneumoniae 16S rDNA using real-time PCR. The viral distribution and its association with clinical symptoms were statistically analyzed. Viral pathogens were detected in 342 (91.93%) of the samples of which 28.76% were single positive and 63.17% had multiple infections. The most frequent detected viruses were rhinovirus (55.64%), respiratory syncytial virus A/B (33.06%), adenovirus (25.00%), coronavirus NL63, HKU1, OC43, and 229E (21.50%), and metapneumovirus A/B (16.12%). Children in the youngest age group (1-3 months) exhibited the highest frequencies of infection. Related to their frequency of detection, RSV A/B was the most associated pathogen with patient's demographic situation and clinical manifestations (p<0.05). Parainfluenza virus 1-4 and parechovirus were found to increase the risk of death (p<0.05). Adenovirus was statistically associated to the manifestation of gastroenteritis (p = 0.004). Rhinovirus infection increases the duration of oxygen support (p = 0.042). Coronavirus group was statistically associated with the manifestation of bronchiolitis (p = 0.009) and laryngitis (p = 0.017). Streptococcus pneumoniae DNA was detected in 143 (38.44%) of tested samples. However, only 53 samples had a concentration of C-reactive protein from equal to higher than 20 milligrams per liter, and 6 of them were single positive for Streptocuccus pneumoniae. This study confirms the high incidence of respiratory viruses in children hospitalized for acute respiratory tract infections in the Sousse area, Tunisia.	[Brini, Ines; Hannachi, Naila; Boukadida, Jalel] Univ Sousse, Fac Med Sousse, Lab Microbiol & Immunol, Sousse, Tunisia; [Brini, Ines; Hannachi, Naila; Boukadida, Jalel] Univ Hosp Farhat Hached Sousse, Res Unit Genom Characterizat Infect Agents UR12SP, Sousse, Tunisia; [Brini, Ines] Univ Monastir, Fac Pharm Monastir, Monastir, Tunisia; [Brini, Ines; Hetzer, Benjamin] Innsbruck Med Univ, Innsbruck, Austria; [Guerrero, Aida; Borena, Wegene; Schiela, Britta; Von Laer, Dorothee; Stoiber, Heribert] Innsbruck Med Univ, Div Virol, Innsbruck, Austria; [Bouhlel, Amira; Boughamoura, Lamia] Univ Hosp Farhat Hached Sousse Sousse, Pediat Serv, Sousse, Tunisia; [Orth-Hoeller, Dorothea] Innsbruck Med Univ, Div Hyg & Med Microbiol, Innsbruck, Austria	Universite de Sousse; Universite de Sousse; Hopital Farhat Hached; Universite de Monastir; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Brini, I (corresponding author), Univ Sousse, Fac Med Sousse, Lab Microbiol & Immunol, Sousse, Tunisia.; Brini, I (corresponding author), Univ Hosp Farhat Hached Sousse, Res Unit Genom Characterizat Infect Agents UR12SP, Sousse, Tunisia.; Brini, I (corresponding author), Univ Monastir, Fac Pharm Monastir, Monastir, Tunisia.; Brini, I (corresponding author), Innsbruck Med Univ, Innsbruck, Austria.; Stoiber, H (corresponding author), Innsbruck Med Univ, Div Virol, Innsbruck, Austria.	ines.brini@hotmail.com; Heribert.stoiber@i-med.ac.at		von Laer, Dorothee/0000-0001-5825-7237; Orth-Holler, Dorothea/0000-0003-2904-5192	FWF (Horos doctoral Program) [W1253-B24]; Innsbruck Medical University, Innsbruck, Austria; Unit Research for Genomic Characterization of Infectious Agents at Farhat Hached University-hospital of Sousse, Tunisia [UR12SP34]; Ministry of Higher Education and Scientific Research in Tunisia	FWF (Horos doctoral Program); Innsbruck Medical University, Innsbruck, Austria; Unit Research for Genomic Characterization of Infectious Agents at Farhat Hached University-hospital of Sousse, Tunisia; Ministry of Higher Education and Scientific Research in Tunisia	The FWF (Horos doctoral Program, W1253-B24) and Innsbruck Medical University, Innsbruck, Austria (HS): methodology of study. The Unit Research for Genomic Characterization of Infectious Agents UR12SP34 in Farhat Hached university-hospital of Sousse area in Tunisia and the Ministry of Higher Education and Scientific Research in Tunisia (J Boukadida): study design, data collection. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.; This study was in part supported by the FWF (Horos doctoral Program, W1253-B24), the Unit Research for Genomic Characterization of Infectious Agents UR12SP34 at Farhat Hached University-hospital of Sousse, Tunisia, and the Ministry of Higher Education and Scientific Research in Tunisia. The excellent technical assistance of Vicky Staudinger with the S. pneumoniae-qPCR is greatly appreciated. We thank statisticians from the Epidemiology ward at Farhat Hached University-hospital of Sousse, Tunisia, for providing additional instructions about the statistical calculations. We are also indebted to Pr. Khaled Ben Khadim Allah from the Medical English Department at Sousse Medical University, Tunisia, for improving the manuscript's spelling, vocabulary, and grammar.	Abroug F, 2014, EMERG INFECT DIS, V20, P1527, DOI 10.3201/eid2009.140378; Al-Ayed MS, 2014, SAUDI MED J, V35, P1348; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Ben M'hadheb M, 2015, CURR MICROBIOL, V70, P324, DOI 10.1007/s00284-014-0719-0; Bicer S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-22; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Damak H, 2011, INFLUENZA OTHER RESP, V5, P230, DOI 10.1111/j.1750-2659.2011.00196.x; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Dominguez O, 2005, PEDIATR INFECT DIS J, V24, P733, DOI 10.1097/01.inf.0000172942.96436.2d; El Moussi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074064; Fodha I, 2004, ANN TROP PAEDIATR, V24, P275, DOI 10.1179/027249304225019055; Fodha I, 2004, ANN TROP PAEDIATR, V24, P219, DOI 10.1179/027249304225018966; Fodha I, 2004, J MED VIROL, V72, P683, DOI 10.1002/jmv.20038; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Harada Y, 2013, PEDIATR INFECT DIS J, V32, P441, DOI 10.1097/INF.0b013e31828ba08c; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Jroundi I, 2016, EPIDEMIOL INFECT, V144, P516, DOI 10.1017/S095026881500151X; Jroundi I, 2014, J TROP PEDIATRICS, V60, P270, DOI 10.1093/tropej/fmu010; KADI Z, 1990, Revue Roumaine de Virologie, V41, P197; Khadadah M, 2010, J MED VIROL, V82, P1462, DOI 10.1002/jmv.21823; Liu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087818; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Marzouk M, 2015, MICROB DRUG RESIST, V21, P85, DOI 10.1089/mdr.2014.0084; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Muhlemann K, 2006, CLIN MICROBIOL INFEC, V12, P873, DOI [10.1111/j.1469-0691.2006.1472_1.x, 10.1111/j.1469-0691.2006.01472.x]; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Navne JE, 2016, EPIDEMIOL INFECT, V144, P3226, DOI 10.1017/S0950268816001461; Nemerow GR, 2012, CURR OPIN VIROL, V2, P115, DOI 10.1016/j.coviro.2011.12.008; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Richter J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147041; Saikku Pekka, 1997, Clin Microbiol Infect, V3, P599, DOI 10.1111/j.1469-0691.1997.tb00464.x; Vandini S, 2016, PAEDIAT RESP REV; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606	46	14	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188325	10.1371/journal.pone.0188325	http://dx.doi.org/10.1371/journal.pone.0188325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149199	Green Submitted, Green Published, gold			2022-12-26	WOS:000415646100038
J	Jourdy, Y; Enjolras, N; Le Quellec, S; Bordet, JC; Negrier, C; Vinciguerra, C; Dargaud, Y				Jourdy, Yohann; Enjolras, Nathalie; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim			Why patients with THBD c.1611C > A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?	PLOS ONE			English	Article							PROTEIN-C ACTIVATION; THROMBIN GENERATION; ENDOTHELIAL-CELLS; MECHANISMS; EXPRESSION; COFACTOR; PLASMA; GENE; IDENTIFICATION; RELEASE	Background Recently our group has described a new autosomal dominant bleeding disorder characterized by very high plasma levels of soluble thrombomodulin (TM). The THBD c.1611C>A (p.Cys537X) mutation in heterozygous state was found in the propositus. This mutation leads to the synthesis of a truncated TM which has lost the last three amino-acids of the transmembrane domain and the cytoplasmic tail. Objective We investigated the mechanism responsible for TM shedding in endothelial cells with THBD c.1611C>A mutation. Methods Complementary DNA of TM wild type (TM-WT) was incorporated into a pcDNA3.1 vector for transient transfection in COS-1 cells. Mutagenesis was performed to create the c.1611C<A (TM1-536) mutant and 4 other TM mutants (TM1-515, TM1-525, TM1-533 and TM1-537) with a transmembrane domain having different lengths. The effect of shear stress, metalloprotease inhibitor, certain proteases and reducing agents were tested on TM shedding. Results Western blot and immunofluorescent analysis showed that TM1-536 was produced and a certain amount of TM1-536 was anchored on the cell membrane. A significantly higher levels of soluble TM was observed in the TM1-536 cell medium in comparison with TM-WT (56.3 +/- 5.2 vs 8.8 +/- 1.6 ng/mL, respectively, p = 0.001). The shedding of TM1-536 was 75% decreased in cells cultured in the presence of a metalloprotease inhibitor. No difference was observed between TM1-536 and TM-WT shedding after cell exposure to cathepsin G, elastase, several reducing agents and high shear stress (5000 s(-1)). Significantly higher levels of soluble TM were observed in the cell media of TM1-533, TM1-525, TM1-515 in comparison with TM-WT (p < 0.05). Conclusion The mechanism responsible for TM shedding is complex and is not completely understood: higher sensitivity of the TM1-536 to the proteolysis by metalloproteases and a defect of synthesis due to the decreased size of the transmembrane domain might explain the high levels of soluble TM in plasma of the carriers.	[Jourdy, Yohann; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim] Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Hematol Biol, Bron, France; [Jourdy, Yohann; Enjolras, Nathalie; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim] Univ Claude Bernard, EAM Hemostase & Canc 4609, Lyon, France; [Le Quellec, Sandra; Negrier, Claude; Dargaud, Yesim] Hosp Civils Lyon, Hop Cardiol Louis Pradel, Unite Hemostase Clin, Bron, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Jourdy, Y (corresponding author), Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Hematol Biol, Bron, France.; Jourdy, Y (corresponding author), Univ Claude Bernard, EAM Hemostase & Canc 4609, Lyon, France.	yohann.jourdy@chu-lyon.fr	Jourdy, Yohann/K-8831-2019; Dargaud, Yesim/AAM-3619-2021; Le Quellec, Sandra/B-7490-2018	Jourdy, Yohann/0000-0001-7408-6474; Dargaud, Yesim/0000-0002-4888-1463; VINCIGUERRA, Christine/0000-0002-1676-9872; Chamouard, Valerie/0000-0002-4443-1609; ENJOLRAS, Nathalie/0000-0002-4778-0724; Negrier, Claude/0000-0003-3569-0366; BORDET, Jean-Claude/0000-0003-1498-703X; Le Quellec, Sandra/0000-0002-6203-3946				Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Burley K, 2016, BLOOD, V128, P1879, DOI 10.1182/blood-2016-05-716092; Cheng TL, 2011, J INVEST DERMATOL, V131, P2486, DOI 10.1038/jid.2011.230; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Dargaud Y, 2015, BLOOD, V125, P1497, DOI 10.1182/blood-2014-10-604553; Dargaud Y, 2010, BLOOD, V116, P5734, DOI 10.1182/blood-2010-06-291906; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Dharmasaroja P, 2012, CLIN APPL THROMB-HEM, V18, P289, DOI 10.1177/1076029611432744; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Kunz G, 2000, BLOOD, V95, P569, DOI 10.1182/blood.V95.2.569; Kurosawa S, 2008, CRIT CARE MED, V36, P985, DOI 10.1097/CCM.0B013E318165FDA7; Langdown J, 2014, BLOOD, V124, P1951, DOI 10.1182/blood-2014-02-557538; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Menschikowski M, 2010, THROMB RES, V126, pE88, DOI 10.1016/j.thromres.2010.05.006; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Pike GN, 2015, BLOOD, V126, P397, DOI 10.1182/blood-2014-12-616565; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Trossaert M, 2014, HAEMOPHILIA, V20, P550, DOI 10.1111/hae.12381; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188213	10.1371/journal.pone.0188213	http://dx.doi.org/10.1371/journal.pone.0188213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145514	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800089
J	Vazquez-Rowe, I; Larrea-Gallegos, G; Villanueva-Rey, P; Gilardino, A				Vazquez-Rowe, Ian; Larrea-Gallegos, Gustavo; Villanueva-Rey, Pedro; Gilardino, Alessandro			Climate change mitigation opportunities based on carbon footprint estimates of dietary patterns in Peru	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENT; FOOD; IMPACTS; HOME; CONSUMPTION; QUALITY	Food consumption accounts for an important proportion of the world GHG emissions per capita. Previous studies have delved into the nature of dietary patterns, showing that GHG reductions can be achieved in diets if certain foods are consumed rather than other, more GHG intensive products. For instance, vegetarian and low-meat diets have proved to be less carbon intensive than diets that are based on ruminant meat. These environmental patterns, increasingly analyzed in developed nations, are yet to be assessed in countries liked Peru where food purchase represents a relatively high percentage of the average household expenditure, ranging from 38% to 51% of the same. Therefore, food consumption can be identified as a potential way to reduce GHG emissions in Peru. However, the Peruvian government lacks a specific strategy to mitigate emissions in this sector, despite the recent ratification of the Paris Accord. In view of this, the main objective of this study is to analyze the environmental impacts of a set of 47 Peruvian food diet profiles, including geographical and socioeconomic scenarios. In order to do this, Life Cycle Assessment was used as the methodological framework to obtain the overall impacts of the components in the dietary patterns observed and primary data linked to the composition of diets were collected from the Peruvian National Institute for Statistics (INEI). Life cycle inventories for the different products that are part of the Peruvian diet were obtained from a set of previous scientific articles and reports regarding food production. Results were computed using the IPCC 2013 assessment method to estimate GHG emissions. Despite variations in GHG emissions from a geographical perspective, no significant differences were observed between cities located in the three Peruvian natural regions (i.e., coast, Andes and Amazon basin). In contrast, there appears to be a strong, positive correlation between GHG emissions and social expenditure or academic status. When compared to GHG emissions computed in the literature for developed nations, where the average caloric intake is substantially higher, diet-related emissions in Peru were in the low range. Our results could be used as a baseline for policy support to align nutritional and health policies in Peru with the need to reduce the environmental impacts linked to food production.	[Vazquez-Rowe, Ian; Larrea-Gallegos, Gustavo; Villanueva-Rey, Pedro; Gilardino, Alessandro] Pontificia Univ Catolica Peru, Peruvian LCA Network, Dept Engn, Lima, Peru; [Villanueva-Rey, Pedro] Univ Santiago de Compostela, Dept Chem Engn, Inst Technol, Santiago De Compostela, Galicia, Spain	Pontificia Universidad Catolica del Peru; Universidade de Santiago de Compostela	Vazquez-Rowe, I (corresponding author), Pontificia Univ Catolica Peru, Peruvian LCA Network, Dept Engn, Lima, Peru.	ian.vazquez@pucp.pe	Villanueva-Rey, Pedro/A-4323-2017; Larrea, Gustavo/AAK-7031-2021	Vazquez-Rowe, Ian/0000-0002-7469-2033; Villanueva-Rey, Pedro/0000-0002-6625-384X; Larrea-Gallegos, Gustavo Martin/0000-0002-6283-7039	Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) of the WALAYA project; Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC); Galician Government	Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) of the WALAYA project; Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC); Galician Government	The authors wish to thank the Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) for the financial support of the WALAYA project. The project was won in a competitive call (CAP 2016) and was funded with 50,000 Peruvian soles for a one year period. Gustavo Larrea-Gallegos and Alessandro Gilardino were partially financed in 2016 with funding from the project. BSc Gustavo Larrea-Gallegos wishes to thank the Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) for financial support in the form of a scholarship for his master studies starting in March 2017. Dr. Pedro Villanueva-Rey wishes to thank the Galician Government for financial support (I2C postdoctoral student grants programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) for the financial support of the WALAYA project. BSc Gustavo Larrea-Gallegos wishes to thank the Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) for financial support. Dr. Pedro Villanueva-Rey wishes to thank the Galician Government for financial support (I2C postdoctoral student grants programme). Dr. Rosa Crujeiras, Isabel Quispe, Jair Santillan, Jonatan Rojas, Diego Echegaray, Dr. Karin Bartl and Sonnia Caceres are thanked for valuable scientific exchange.	Acosta AM, 2014, FOOD POLICY, V44, P26, DOI 10.1016/j.foodpol.2013.10.009; Anand S, 2015, J AM COLL CARDIOL, V66; [Anonymous], [No title captured]; [Anonymous], 2016, EL COMERCIO; [Anonymous], 2006, 140402006 ISO; [Anonymous], 2017, MILL DEV GOALS; Asner G, 2014, HIGH RESOLUTION CARB; Avadi A, 2015, AQUACULTURE, V435, P52, DOI 10.1016/j.aquaculture.2014.08.001; Avadi A, 2014, J CLEAN PROD, V70, P118, DOI 10.1016/j.jclepro.2014.01.047; Bartl K, 2012, ENVIRON SCI TECHNOL, V46, P9872, DOI 10.1021/es301644y; Bartl K, 2011, J CLEAN PROD, V19, P1494, DOI 10.1016/j.jclepro.2011.04.010; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Bhargava A, 2015, WORLD BANK RES OBSER, V30, P247, DOI 10.1093/wbro/lku011; Bustamante MMC, 2012, CLIMATIC CHANGE, V115, P559, DOI 10.1007/s10584-012-0443-3; Ciroth A, 2016, INT J LIFE CYCLE ASS, V21, P1338, DOI 10.1007/s11367-013-0670-5; Clune S, 2017, J CLEAN PROD, V140, P766, DOI 10.1016/j.jclepro.2016.04.082; Collins B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130770; El Comercio, 2016, FALT 132 RELL SAN CU; ENAPREF, 2012, CONS CAP PRINC AL 20; F.A.O, 2011, COUNTR PROF FOOD SEC; Fairlie-Reinoso A., 2016, QUINUA PERU CADENA E; Fan Judith, 2013, GASTRONOMICA, V13, P29, DOI DOI 10.1525/GFC.2013.13.2.29; Freon P, 2017, J CLEAN PROD, V145, P50, DOI 10.1016/j.jclepro.2017.01.036; Arancibia RG, 2013, CUAD ECON-BOGOTA, V32, P209; Garnett T, 2015, REV EVIDENCE EFFECTI; Garnett T., 2008, COOKING STORM FOOD G; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hallstrom E, 2015, J CLEAN PROD, V91, P1, DOI 10.1016/j.jclepro.2014.12.008; IDA, 2015, I DEM ALL QUAOT VEBU; INDECI, 2009, LECC APR SISM PISC; INEI, 2016, EVOLUCION POBREZA MO, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; INEI, 2014, PER ENF TRANSM TRANS; INEI, 2015, B AN IND PREC EC 201; IPCC, 2013, WORK GROUP I CONTR 5; Jensen HH, 1996, CAN J AGR ECON, V44, P67, DOI 10.1111/j.1744-7976.1996.tb00143.x; Larrea-Gallegos G, 2017, INT J LIFE CYCLE ASS, V22, P1109, DOI 10.1007/s11367-016-1221-7; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Levell P, 2016, LANCET, V387, P1907, DOI 10.1016/S0140-6736(16)30421-4; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; Manfredi S, 2009, WASTE MANAGE RES, V27, P825, DOI 10.1177/0734242X09348529; Matta R., 2013, ANTHR FOOD, pS8; MINAGRI, 2013, PRINC ASP CAD AGR; MINAGRI, 2017, SER HIST PROD AGR CO; MINAGRI, 2012, PRINC ASP CAD AGR PA; MINAM, 2015, CONSTR PART CONTR NA; MINSA, 2012, TABL PER COMP AL CTR; Munoz I, 2010, INT J LIFE CYCLE ASS, V15, P794, DOI 10.1007/s11367-010-0188-z; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nelson V, 2016, J CULT GEOGR, V33, P208, DOI 10.1080/08873631.2016.1153269; O'Riordan T, 1999, GLOBAL ENVIRON CHANG, V9, P81, DOI 10.1016/S0959-3780(98)00030-2; O'Riordan T, 2015, ENVIRONMENT, V57, P4, DOI 10.1080/00139157.2015.1069093; Pairotti MB, 2015, J CLEAN PROD, V103, P507, DOI 10.1016/j.jclepro.2013.12.082; Parker RWR, 2015, FISH FISH, V16, P684, DOI 10.1111/faf.12087; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; Pulkkinen H, 2016, INT J LIFE CYCLE ASS, V21, P621, DOI 10.1007/s11367-015-0913-8; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Risku-Norja Helmi, 2009, Progress in Industrial Ecology, V6, P340, DOI 10.1504/PIE.2009.032323; Roibas L, 2016, J CLEAN PROD, V112, P2441, DOI 10.1016/j.jclepro.2015.09.074; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; SENASA, 2017, SERV NAC SAN AGR; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Thouret JC, 2014, NAT HAZARDS, V73, P1771, DOI 10.1007/s11069-014-1172-x; *UN, 2017, SUST DEV GOALS 17 GO; USDA, 2017, CHOOS MY PLAT; Vazquez-Rowe I, 2017, INT J LIFE CYCLE ASS, V22, P601, DOI 10.1007/s11367-016-1046-4; Vazquez-Rowe I, 2017, J CLEAN PROD, V142, P4369, DOI 10.1016/j.jclepro.2016.11.136; Vazquez-Rowe I, 2016, J CLEAN PROD, V112, P2505, DOI 10.1016/j.jclepro.2015.09.076; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f; Weidema B.P., 1996, J CLEAN PROD, V4, P167, DOI [10.1016/S0959-6526(96)00043-1, DOI 10.1016/S0959-6526(96)00043-1]; Weidema B, 1998, INT J LIFE CYCLE ASS, V3, P237, DOI 10.1007/BF02977574; Werner LB, 2014, FOOD NUTR RES, V2014, P58; WFP, 2017, WORLD FOOD PROGR; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648	81	33	34	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188182	10.1371/journal.pone.0188182	http://dx.doi.org/10.1371/journal.pone.0188182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145461	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800082
J	Patranabis, S; Bhattacharyya, SN				Patranabis, Somi; Bhattacharyya, Suvendra Nath			P-body-induced inactivation of let-7a miRNP prevents the death of growth factor-deprived neuronal cells	FASEB JOURNAL			English	Article						PC12; P-body proteins; neuronal differentiation; apoptosis; sympathetic neurons	CYTOPLASMIC PROCESSING BODIES; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA DECAY; PC12 CELLS; FACTOR WITHDRAWAL; SYMPATHETIC NEURONS; NEURITE OUTGROWTH; GENE-EXPRESSION; DIFFERENTIATION; PHOSPHORYLATION	RNA processing bodies (P-bodies) are cytoplasmic RNA granules in eukaryotic cells that regulate gene expression by executing the translation suppression and degradation of mRNAs that are targeted to these bodies. P-bodies can also serve as storage sites for translationally repressed mRNAs both in mammalian cells and yeast cells. In this report, a unique role of mammalian P-bodies is documented. Depletion of P-body components dedifferentiate nerve growth factor-treated PC12 cells, whereas ectopic expression of P-body components induces the neuronal differentiation of precursor cells. Trophic factor withdrawal from differentiated cells induces a decrease in cellular P-body size and numbers that are coupled with dedifferentiation and cell death. Here, we report how the expression of P-body proteins-by ensuring the phosphorylation of argonaute protein 2 and the subsequent inactivation let-7a miRNPs-prevents the apoptotic death of growth factor-depleted neuronal cells.	[Patranabis, Somi; Bhattacharyya, Suvendra Nath] Indian Inst Chem Biol, CSIR, Mol Genet Div, RNA Biol Res Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Patranabis, Somi] Amity Univ, Amity Inst Biotechnol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, SN (corresponding author), Indian Inst Chem Biol, CSIR, Mol Genet Div, RNA Biol Res Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	sb@csiriicb.in			Wellcome Trust International Senior Research Fellowship (ISRF); Council of Scientific and Industrial Research (CSIR); Wellcome Trust ISRF fund [084324/Z/07/A]; CSIR Network Project Fund MinD [BSC0215]; Government of India Department of Science and Technology [HRR/2016/000093]	Wellcome Trust International Senior Research Fellowship (ISRF)(Wellcome Trust); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust ISRF fund; CSIR Network Project Fund MinD; Government of India Department of Science and Technology(Department of Science & Technology (India))	The authors thank Witold Filipowicz (Friedrich Miescher Institute (FMI), Basel, Switzerland) and Edouard Bertrand (Institut de Genetique Moleculaire de Montpellier, Montpellier, France) for different plasmids constructs and valuable discussions. S.N.B. is supported by The Wellcome Trust International Senior Research Fellowship (ISRF). S.P. received support from the Council of Scientific and Industrial Research (CSIR). The authors are supported by the Wellcome Trust ISRF fund (084324/Z/07/A) and CSIR Network Project Fund MinD (BSC0215) as well as a High-Risk High Reward Project grant (HRR/2016/000093) from the Government of India Department of Science and Technology. The authors declare no conflicts of interest.	Aizer A, 2014, J CELL SCI, V127, P4443, DOI 10.1242/jcs.152975; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lopez-Orozco J, 2015, RNA, V21, P2030, DOI 10.1261/rna.053207.115; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Mazumder A, 2013, EMBO REP, V14, P1008, DOI 10.1038/embor.2013.149; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Navarro-Tableros V, 2004, DIABETES, V53, P2018, DOI 10.2337/diabetes.53.8.2018; Nicklas S, 2015, NUCLEIC ACIDS RES, V43, P2638, DOI 10.1093/nar/gkv138; Oh JY, 2013, J CELL SCI, V126, P2114, DOI 10.1242/jcs.125690; Patranabis S, 2016, MOL CELL BIOL, V36, P1260, DOI 10.1128/MCB.00054-16; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yao B, 2012, EMBO REP, V13, P1102, DOI 10.1038/embor.2012.160; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zeitelhofer M, 2008, RNA BIOL, V5, P244, DOI 10.4161/rna.6948; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	42	4	4	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1493	1509		10.1096/fj.201700633R	http://dx.doi.org/10.1096/fj.201700633R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29167236				2022-12-26	WOS:000427246000030
J	Chaisri, U; Tungtrongchitr, A; Indrawattana, N; Meechan, P; Phurttikul, W; Tasaniyananda, N; Saelim, N; Chaicumpa, W; Sookrung, N				Chaisri, Urai; Tungtrongchitr, Anchalee; Indrawattana, Nitaya; Meechan, Panisara; Phurttikul, Watchara; Tasaniyananda, Natt; Saelim, Nawannaporn; Chaicumpa, Wanpen; Sookrung, Nitat			Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy	PLOS ONE			English	Article							HOUSE-DUST MITE; REGULATORY B-CELLS; DENDRITIC CELLS; AIRWAY INFLAMMATION; IMMUNOGLOBULIN-E; T-CELLS; ASTHMATIC-CHILDREN; TERTIARY STRUCTURE; PROTEASE ALLERGEN; MOLECULAR-BASIS	Allergen specific immunotherapy (AIT) can modulate the allergic response causing a long-term symptom subsidence/abolishment which leads to reduced drug use and prevention of new sensitization. AIT of house dust mite allergy (HDM) using the mite crude extract (CE) as the therapeutic agent is not only less effective than the AIT for many other allergens, but also frequently causes adverse effects during the treatment course. In this study, mouse model of Dermatophagoides pteronyssinus (Dp) allergy was invented for testing therapeutic efficacies of intranasally administered liposome (L) encapsulated vaccines made of single Dp major allergens (L-Der p 1, L-Der p 2), combined allergens (L-Der p 1 and Der p 2), and crude Dp extract (L-CE). The allergen sparing intranasal route was chosen as it is known that the effective cells induced at the nasal-associated lymphoid tissue can exert their activities at the lower respiratory tissue due to the common mucosal traffic. Liposome was chosen as the vaccine delivery vehicle and adjuvant as the micelles could reduce toxicity of the entrapped cargo. The Dp-CE allergic mice received eight doses of individual vaccines/placebo on alternate days. All vaccine formulations caused reduction of the Th2 response of the Dp allergic mice. However, only the vaccines made of single refined allergens induced expressions of immunosuppressive cytokines (TGF-beta, IL-35 and/or IL-10) which are the imperative signatures of successful AIT. The data emphasize the superior therapeutic efficacy of single refined major allergen vaccines than the crude allergenic extract vaccine.	[Chaisri, Urai] Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Tungtrongchitr, Anchalee; Saelim, Nawannaporn; Chaicumpa, Wanpen] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok, Thailand; [Tungtrongchitr, Anchalee; Meechan, Panisara; Phurttikul, Watchara; Tasaniyananda, Natt; Saelim, Nawannaporn; Chaicumpa, Wanpen; Sookrung, Nitat] Mahidol Univ, Siriraj Hosp, Fac Med, Ctr Res Excellence Therapeut Prot & Antibody Engn, Bangkok, Thailand; [Indrawattana, Nitaya] Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Sookrung, Nitat] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Sookrung, N (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Ctr Res Excellence Therapeut Prot & Antibody Engn, Bangkok, Thailand.; Sookrung, N (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok, Thailand.	nitat.soo@mahidol.ac.th			NSTDA Chair Professor Grant - Crown Property Bureau of Thailand [P-1450624]; Thailand Research Fund [TRF RSA 5780025]; Faculty of Medicine Siriraj Hospital, Mahidol University [TRF RSA 5780025]	NSTDA Chair Professor Grant - Crown Property Bureau of Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Medicine Siriraj Hospital, Mahidol University	The work was supported by the NSTDA Chair Professor Grant (P-1450624) funded by the Crown Property Bureau of Thailand to WC. NSR is supported by the TRF RSA 5780025 grant of the Thailand Research Fund and Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; ALVING CR, 1994, AIDS RES HUM RETROV, V10, pS91; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Batard T, 2006, INT ARCH ALLERGY IMM, V140, P295, DOI 10.1159/000093707; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bukantz Samuel C, 2008, Clin Allergy Immunol, V21, P455; Bussmann C, 2007, CLIN EXP ALLERGY, V37, P1277, DOI 10.1111/j.1365-2222.2007.02783.x; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chauhan AK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00215; Chen KW, 2008, MOL IMMUNOL, V45, P2486, DOI 10.1016/j.molimm.2008.01.006; Chen KW, 2012, J ALLERGY CLIN IMMUN, V130, P435, DOI 10.1016/j.jaci.2012.05.035; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Focke M, 2010, CLIN EXP ALLERGY, V40, P385, DOI 10.1111/j.1365-2222.2009.03443.x; Foged C, 2004, VACCINE, V22, P1903, DOI 10.1016/j.vaccine.2003.11.008; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; GONDAL JA, 1993, EUR J CANCER, V29A, P1536, DOI 10.1016/0959-8049(93)90290-V; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Gutowska-Owsiak D, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0014-8; Hasan AA, 2009, IMMUNOBIOLOGY, V214, P2, DOI 10.1016/j.imbio.2008.04.006; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; HEWITT CRA, 1995, J EXP MED, V182, P1537, DOI 10.1084/jem.182.5.1537; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Kalsheker NA, 1996, BIOCHEM BIOPH RES CO, V221, P59, DOI 10.1006/bbrc.1996.0544; King C, 1998, J IMMUNOL, V161, P3645; Korematsu S, 2000, J IMMUNOL, V165, P2895, DOI 10.4049/jimmunol.165.5.2895; Le Texier L, 2011, AM J TRANSPLANT, V11, P429, DOI 10.1111/j.1600-6143.2010.03336.x; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Lu YP, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8415094; Ludewig B, 2000, VACCINE, V19, P23, DOI 10.1016/S0264-410X(00)00163-8; MARTIN RJ, 1991, AM REV RESPIR DIS, V143, P351, DOI 10.1164/ajrccm/143.2.351; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; McGhee JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001397; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; Meechan P, 2013, INT ARCH ALLERGY IMM, V161, P351, DOI 10.1159/000348314; Moingeon P, 2011, IMMUNOL ALLERGY CLIN, V31, P407, DOI 10.1016/j.iac.2011.03.001; Mueller GA, 1998, BIOCHEMISTRY-US, V37, P12707, DOI 10.1021/bi980578+; NAIR S, 1992, J EXP MED, V175, P609, DOI 10.1084/jem.175.2.609; Nakazawa T, 2005, FEBS LETT, V579, P1988, DOI 10.1016/j.febslet.2005.01.088; Natarajan P, 2014, METHODS MOL BIOL, V1190, P207, DOI 10.1007/978-1-4939-1161-5_15; Neveu WA, 2009, J IMMUNOL, V183, P1732, DOI 10.4049/jimmunol.0802923; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Passalacqua G, 2011, CLIN EXP ALLERGY, V41, P1247, DOI 10.1111/j.1365-2222.2010.03688.x; Pifferi M, 2002, ALLERGY, V57, P785, DOI 10.1034/j.1398-9995.2002.23498.x; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Piyadasa H, 2016, BIOL OPEN, V5, P112, DOI 10.1242/bio.014464; PLATTSMILLS TAE, 1995, ALLERGY, V50, P5, DOI 10.1111/j.1398-9995.1995.tb02729.x; RAO M, 1995, INFECT IMMUN, V63, P2396, DOI 10.1128/IAI.63.7.2396-2402.1995; Ray A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010012; Ray A, 2015, INT IMMUNOL, V27, P531, DOI 10.1093/intimm/dxv033; Rincon-Arevalo H, 2016, INT REV IMMUNOL, V35, P156, DOI 10.3109/08830185.2015.1015719; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Schaut RG, 2016, J IMMUNOL, V196, P4100, DOI 10.4049/jimmunol.1502678; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; SCHULZ O, 1995, EUR J IMMUNOL, V25, P3191, DOI 10.1002/eji.1830251131; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Senna G, 2011, CURR OPIN ALLERGY CL, V11, P375, DOI 10.1097/ACI.0b013e328348a7cd; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Singh B, 2013, INDIAN J MED RES, V138, P591; Sookrung N, 2003, ASIAN PAC J ALLERGY, V21, P1; Stacey MA, 1997, BIOCHEM BIOPH RES CO, V236, P522, DOI 10.1006/bbrc.1997.6997; Sun CM, 2005, IMMUNITY, V22, P467, DOI 10.1016/j.immuni.2005.02.008; Takahashi Toshiya, 2000, Allergology International, V49, P55, DOI 10.1046/j.1440-1592.2000.00159.x; Takai T, 2000, EUR J BIOCHEM, V267, P6650, DOI 10.1046/j.1432-1327.2000.01760.x; Takai T, 1999, MOL IMMUNOL, V36, P1055, DOI 10.1016/S0161-5890(99)00098-X; Taube C, 2003, J IMMUNOL, V170, P4301, DOI 10.4049/jimmunol.170.8.4301; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; Thomas WR, 2012, HUM VACC IMMUNOTHER, V8, P1469, DOI 10.4161/hv.20812; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Varney VA, 2003, CLIN EXP ALLERGY, V33, P1076, DOI 10.1046/j.1365-2222.2003.01735.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wan H, 2001, CLIN EXP ALLERGY, V31, P279, DOI 10.1046/j.1365-2222.2001.00970.x; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Williams Jesse W, 2012, J Allergy (Cairo), V2012, P236075, DOI 10.1155/2012/236075; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	95	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188627	10.1371/journal.pone.0188627	http://dx.doi.org/10.1371/journal.pone.0188627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182623	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000044
J	Arenas, M; Garcia-Heredia, A; Cabre, N; Luciano-Mateo, F; Hernandez-Aguilera, A; Sabater, S; Bonet, M; Gascon, M; Fernandez-Arroyo, S; Fort-Gallifa, I; Camps, J; Joven, J				Arenas, Meritxell; Garcia-Heredia, Anabel; Cabre, Noemi; Luciano-Mateo, Fedra; Hernandez-Aguilera, Anna; Sabater, Sebastia; Bonet, Marta; Gascon, Marina; Fernandez-Arroyo, Salvador; Fort-Gallifa, Isabel; Camps, Jordi; Joven, Jorge			Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; OBESITY-RELATED GENES; OXIDATIVE STRESS; DENSITY-LIPOPROTEIN; RISK; POLYMORPHISMS; PON1; DISEASE; METAANALYSIS; SURVIVAL	Paraoxonase-1 (PON1) is an intra-cellular antioxidant enzyme found also in the circulation associated with high-density lipoproteins. The activity of this enzyme has been shown to be decreased in breast cancer (BC) patients. The aims of our study were to investigate the changes produced by radiotherapy (RT) on activity and concentration of serum PON1 in BC patients, and to evaluate the observed variations in relation to clinical and pathological characteristics of patients and tumors, and the response to treatment. We studied 200 women with BC who were scheduled to receive RT following excision of the tumor. Blood for analyses was obtained before and after the irradiation procedure. The control group was composed of 200 healthy women. Relative to control, BC patients had significantly lower serum PON1 activities pre-RT, while PON1 concentrations were at similar levels. RT was associated with a significant increase in serum PON1 activities and concentrations. We observed significant differences in serum PON1 concentrations post-RT between patients with luminal A or luminal B tumors. Serum PON1 concentration post-RT was markedly lower in BC patients with metastases. We conclude that benefit from RT accrues to the BC patients not only through its direct effect on cancer cells but also indirectly by improving the organism's anti-oxidant defense mechanisms. In addition, our preliminary evidence suggests that the measurement of serum PON1 concentration post-RT could be an efficient prognostic biomarker, and may be used as an index of the efficacy of the RT.	[Arenas, Meritxell; Sabater, Sebastia; Bonet, Marta; Gascon, Marina] Univ Rovira & Virgili, IISPV, Hosp Univ St Joan, Dept Radiat Oncol, Reus, Spain; [Garcia-Heredia, Anabel; Cabre, Noemi; Luciano-Mateo, Fedra; Hernandez-Aguilera, Anna; Fernandez-Arroyo, Salvador; Fort-Gallifa, Isabel; Camps, Jordi; Joven, Jorge] Univ Rovira & Virgili, IISPV, Hosp Univ St Joan, Unitat Recerca Biomed CRB URB, Reus, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Camps, J (corresponding author), Univ Rovira & Virgili, IISPV, Hosp Univ St Joan, Unitat Recerca Biomed CRB URB, Reus, Spain.	jcamps@grupsagessa.com	Sabater, Sebastia/F-6791-2015; Arenas, Meritxell/HCG-8786-2022; Fernández-Arroyo, Salvador/M-6955-2015; Camps, Jordi/AAG-3080-2020; Garcia-Heredia, Anabel/ABC-3161-2021; Fort-Gallifa, Isabel/AAC-3222-2021; Bonet, Marta/AAO-6276-2021; sabater, sebastia/AAA-3987-2022	Sabater, Sebastia/0000-0003-0111-9540; Arenas, Meritxell/0000-0003-0815-2570; Fernández-Arroyo, Salvador/0000-0003-0147-1712; Camps, Jordi/0000-0002-3165-3640; Fort-Gallifa, Isabel/0000-0002-6658-3603; Bonet, Marta/0000-0002-6417-0514; sabater, sebastia/0000-0003-0111-9540; Hernandez-Aguilera, Anna/0000-0003-0954-295X; Cabre, Noemi/0000-0002-7473-8898; Luciano-Mateo, Fedra/0000-0002-8736-2455	Associacio Oncologica Dr. Amadeu Pelegri, Salou, Spain, AODAP	Associacio Oncologica Dr. Amadeu Pelegri, Salou, Spain, AODAP	This work was funded by a grant from Associacio Oncologica Dr. Amadeu Pelegri, Salou, Spain, AODAP/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Nagwa S, 2015, Asian Pac J Cancer Prev, V16, P803; Antognelli C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-115; Arenas M, 2016, CLIN TRANSL ONCOL, V18, P582, DOI 10.1007/s12094-015-1401-0; Aristei C, 2016, BREAST CANCER RES TR, V160, P211, DOI 10.1007/s10549-016-3998-2; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; Bayram F, 2013, J RES MED SCI, V18, P291; Birzniece V, 2017, EUR J ENDOCRINOL, V177, P137, DOI 10.1530/EJE-17-0151; Bobin-Dubigeon C, 2015, CLIN BIOCHEM, V48, P1181, DOI 10.1016/j.clinbiochem.2015.07.020; Bots WTC, 2017, HEAD NECK-J SCI SPEC, V39, P1122, DOI 10.1002/hed.24733; Camps J, 2017, CLIN BIOCHEM, V50, P804, DOI 10.1016/j.clinbiochem.2017.04.016; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; CHANDER R, 1990, BIOCHEM PHARMACOL, V40, P1663, DOI 10.1016/0006-2952(90)90469-2; Chen LN, 2016, 2015 INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION, BIG DATA AND SMART CITY (ICITBS), P1, DOI 10.1109/ICITBS.2015.8; Cheng TYD, 2015, CANCER-AM CANCER SOC, V121, P3684, DOI 10.1002/cncr.29465; Elkiran ET, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-48; Eroglu M, 2013, KAOHSIUNG J MED SCI, V29, P368, DOI 10.1016/j.kjms.2012.11.004; Ferre N, 2002, CLIN CHEM, V48, P261; Fort-Gallifa I, 2016, FREE RADICAL BIO MED, V97, P568, DOI 10.1016/j.freeradbiomed.2016.07.011; Gallicchio L, 2007, CANCER DETECT PREV, V31, P95, DOI 10.1016/j.cdp.2007.02.004; Kaya MO, 2016, J ENZYM INHIB MED CH, V31, P1349, DOI 10.3109/14756366.2015.1134523; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kilickap S, 2014, ASIAN PAC J CANCER P, V15, P1381, DOI 10.7314/APJCP.2014.15.3.1381; Korkmaz H, 2015, SCAND J CLIN LAB INV, V75, P259, DOI 10.3109/00365513.2014.1003597; Langlands FE, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120601; Liu CB, 2011, TUMOR BIOL, V32, P1233, DOI 10.1007/s13277-011-0227-9; Liu T, 2017, P NATL ACAD SCI USA, V114, P7683, DOI 10.1073/pnas.1621486114; Luciano-Mateo F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020121; Lykholat T, 2016, Tsitol Genet, V50, P40; Malik UU, 2014, CLIN CHIM ACTA, V430, P38, DOI 10.1016/j.cca.2013.12.033; Marsillach J, 2008, FREE RADICAL BIO MED, V45, P146, DOI 10.1016/j.freeradbiomed.2008.03.023; Martinelli N, 2013, J LIPID RES, V54, P1484, DOI 10.1194/jlr.P028977; Montero A, 2014, BREAST, V23, P299, DOI 10.1016/j.breast.2014.01.011; Ponce-Ruiz N, 2017, CHEM-BIOL INTERACT, V268, P77, DOI 10.1016/j.cbi.2017.02.005; Prades J, 2017, RADIOTHER ONCOL, V123, P22, DOI 10.1016/j.radonc.2017.01.014; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; Saadat M, 2012, CANCER EPIDEMIOL, V36, pE101, DOI 10.1016/j.canep.2011.10.015; Sehitogullari A, 2014, REDOX REP, V19, P199, DOI 10.1179/1351000214Y.0000000091; Simone V, 2016, ONCOLOGIST, V21, P404, DOI 10.1634/theoncologist.2015-0351; Sloan JA, 2001, J CLIN ONCOL, V19, P3539, DOI 10.1200/JCO.2001.19.15.3539; Soliman NA, 2016, CANCER BIOL MED, V13, P496, DOI 10.20892/j.issn.2095-3941.2016.0066; Stevens VL, 2006, CANCER EPIDEM BIOMAR, V15, P1226, DOI 10.1158/1055-9965.EPI-05-0930; Tenori L, 2015, MOL ONCOL, V9, P128, DOI 10.1016/j.molonc.2014.07.012; Tobin NP, 2015, J INTERN MED, V278, P545, DOI 10.1111/joim.12429; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wen YY, 2015, INT J CLIN EXP MED, V8, P20343; Wu JR, 2017, ONCOTARGET, V8, P25362, DOI 10.18632/oncotarget.15911; ZWEIG MH, 1993, CLIN CHEM, V39, P561	49	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188633	10.1371/journal.pone.0188633	http://dx.doi.org/10.1371/journal.pone.0188633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176871	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900108
J	Lee, IC; Chau, GY; Yeh, YC; Chao, Y; Huo, TI; Su, CW; Lin, HC; Hou, MC; Huang, YH				Lee, I-Cheng; Chau, Gar-Yang; Yeh, Yi-Chen; Chao, Yee; Huo, Teh-Ia; Su, Chien-Wei; Lin, Han-Chieh; Hou, Ming-Chih; Huang, Yi-Hsiang			Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure	PLOS ONE			English	Article							PRACTICE GUIDELINES MANAGEMENT; BODY-MASS INDEX; NUCLEOS(T)IDE ANALOGS; THERAPY; ENTECAVIR; RESECTION; ASSOCIATION; PREDICTORS; CIRRHOSIS; FIBROSIS	Background Nucleos(t)ide analogues (NUCs) treatment can reduce the risk of hepatocellular carcinoma (HCC) development and recurrence in chronic hepatitis B (CHB) patients. However, the risk of recurrence in CHB patients who develop HCC despite NUC treatment remains unclear. Methods 167 consecutive CHB patients receiving curative resection for HCC with NUC therapy after surgery were retrospectively enrolled. Thirty-eight patients who developed HCC despite NUC therapy for more than 1 year were defined as secondary prevention failure. The other 129 patients started NUC therapy after surgery. Factors associated with recurrence-free survival (RFS) and overall survival (OS) were evaluated. Results The 5-year RFS and OS rates were 44.7% and 77.3%, respectively. Sex, BMI, BCLC stage, AFP levels and cirrhosis status were the independent predictors of RFS, while microvascular invasion was the independent predictor of OS. The RFS was comparable between patients with and without NUC secondary prevention. In the subgroup analysis, the RFS was significantly worse in cirrhotic patients with secondary prevention failure (hazard ratio = 2.373, p = 0.009). Secondary prevention failure did not have adverse impact on OS. Among 84 patients with recurrence, 58.3% of the cases remained in BCLC stage A, and 53.6% received a second curative treatment. Long-term NUC therapy may lead to a decline of non-invasive indices of hepatic fibrosis in HCC patients. Conclusions In general, the risk of recurrence and survival are comparable between patients with and without secondary prevention failure. However, a higher risk of recurrence was observed in cirrhotic patients with secondary prevention failure.	[Lee, I-Cheng; Huo, Teh-Ia; Su, Chien-Wei; Lin, Han-Chieh; Hou, Ming-Chih; Huang, Yi-Hsiang] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Lee, I-Cheng; Su, Chien-Wei; Hou, Ming-Chih; Huang, Yi-Hsiang] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Lee, I-Cheng; Su, Chien-Wei; Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chau, Gar-Yang] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yeh, Yi-Chen] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Chao, Yee] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, YH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Huang, YH (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.; Huang, YH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	yhhuang@vghtpe.gov.tw	Lin, Han/GRF-1081-2022; Lee, I-Cheng/AAF-5650-2020; Su, Chien-Wei/C-1521-2012; Su, Chien-Wei/AHC-8307-2022	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425	Taipei Veterans General Hospital, Taipei, Taiwan [V105B-007, V106B-021]; Ministry of Science and Technology, Taiwan [MOST 105-2628-B-075-006-MY2]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by grants from Taipei Veterans General Hospital (V105B-007, V106B-021), Taipei, Taiwan (URL: https://www.vghtpe.gov.tw/Index.action). This study was also supported by the Ministry of Science and Technology, Taiwan (MOST 105-2628-B-075-006-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Cho JY, 2014, GUT, V63, P1943, DOI 10.1136/gutjnl-2013-306409; Chong CCN, 2015, ALIMENT PHARM THER, V41, P199, DOI 10.1111/apt.13034; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Hsu YC, 2014, J ANTIMICROB CHEMOTH, V69, P1920, DOI 10.1093/jac/dku041; Huang G, 2015, ANN SURG, V261, P56, DOI 10.1097/SLA.0000000000000858; Huang YH, 2005, LIVER INT, V25, P236, DOI 10.1111/j.1478-3231.2005.01081.x; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim SS, 2014, AM J GASTROENTEROL, V109, P1223, DOI 10.1038/ajg.2014.145; Kim WR, 2016, J HEPATOL, V64, P773, DOI 10.1016/j.jhep.2015.11.012; Lee IC, 2013, INT J CANCER, V133, P2895, DOI 10.1002/ijc.28311; Lee IC, 2011, CLIN NUTR, V30, P647, DOI 10.1016/j.clnu.2011.05.001; Lee IC, 2011, J CLIN GASTROENTEROL, V45, P278, DOI 10.1097/MCG.0b013e3181dd5357; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Papatheodoridis GV, 2015, J HEPATOL, V62, P363, DOI 10.1016/j.jhep.2014.08.045; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Sohn W, 2014, ANN SURG ONCOL, V21, P2429, DOI 10.1245/s10434-014-3621-x; Su CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066457; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Wong GLH, 2016, ALIMENT PHARM THER, V43, P802, DOI 10.1111/apt.13548; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Wong JS, 2011, METAANALYSIS EFFICAC, V33, P1104; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Yin JH, 2013, J CLIN ONCOL, V31, P3647, DOI 10.1200/JCO.2012.48.5896; Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188552	10.1371/journal.pone.0188552	http://dx.doi.org/10.1371/journal.pone.0188552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176777	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900097
J	Oliva-Olivera, W; Moreno-Indias, I; Coin-Araguez, L; Lhamyani, S; Torres, JA; Fernandez-Veledo, S; Vendrell, J; Camargo, A; El Bekay, R; Tinahones, FJ				Oliva-Olivera, Wilfredo; Moreno-Indias, Isabel; Coin-Araguez, Leticia; Lhamyani, Said; Alcaide Torres, Juan; Fernandez-Veledo, Sonia; Vendrell, Joan; Camargo, Antonio; El Bekay, Rajaa; Jose Tinahones, Francisco			Different response to hypoxia of adipose-derived multipotent cells from obese subjects with and without metabolic syndrome	PLOS ONE			English	Article							IMPROVE POSTNATAL NEOVASCULARIZATION; MESENCHYMAL STEM-CELLS; INSULIN-RESISTANCE; STROMAL CELLS; MACROPHAGE INFILTRATION; TISSUE ANGIOGENESIS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PROGENITOR CELLS; INFLAMMATION	Background/Objectives Multiple studies suggest that hypoxia, together with inflammation, could be one of the phenomena involved in the onset and progression of obesity-related insulin resistance. In addition, dysfunction of adipose tissue in obese subjects with metabolic syndrome is associated with decreased angiogenesis. However, some subjects with a high body mass index do not develop metabolic abnormalities associated with obesity. The aim of the current study was to examine the neovascular properties of visceral adipose tissue-derived multipotent mesenchymal cells subjected to hypoxia (hypox-visASCs) from normal-weight subjects (Nw) and obese patients with metabolic syndrome (MS) and without metabolic syndrome (NonMS). Methods This was a 2-year study to enroll subjects who underwent bariatric surgery or cholecystectomy. Eight patients who underwent either bariatric surgery or cholecystectomy (27 patients) participated in the study. Visceral adipose tissue samples from Nw, MS and NonMS subjects were processed by enzymatic digestion. VisASCs cultured under hypoxic conditions were characterized by tubule formation assay, ELISA, flow cytometry, migration rate, and qRT-PCR, and the effects of visASCs-conditioned medium on survival and endothelial cell tubule formation were evaluated. Results Hypox-visASCs from NonMS subjects showed a greater capacity for tubule formation than hypox-visASCs from Nw and MS subjects. The lower percentage of CD140b(+)/CD44(+) and CD140b(+)/CD184(+) cells observed in hypox-visASCs from NonMS subjects compared to MS subjects was accompanied not only by a lower migration rate from the chemotactic effects of stromal cell derived factor 1 alpha, but also by lower levels of NOX5 mRNA expression. While the levels of monocyte chemoattractant protein 1 mRNA expressed by hypox-visASCs correlated positively with the body mass index and waist circumference of the subjects, the concentration of vascular endothelial growth factor present in hypox-visASC-conditioned culture medium decreased significantly with increasing plasma glucose. The survival rate and tubules formed by endothelial cells cultured in hypox-visASC-conditioned medium decreased significantly with increasing homeostasis model assessment to quantify insulin resistance. Conclusions Our results suggest that hypox-visASCs from NonMS subjects could promote healthy adipose tissue expansion, while hypox-visASCs from MS subjects appear to contribute to the decreased angiogenic potential and increased inflammation underlying adipose tissue dysfunction in obesity. Our results emphasize the importance of taking into account not only the BMI but also the metabolic profile of the subjects during the implementation of ASCs-based therapy to promote neovascularization.	[Oliva-Olivera, Wilfredo; Moreno-Indias, Isabel; Coin-Araguez, Leticia; Alcaide Torres, Juan; El Bekay, Rajaa; Jose Tinahones, Francisco] Univ Malaga UMA, Hosp Malaga Virgen de la Victoria, Dept Clin Endocrinol & Nutr, Inst Biomed Res Malaga IBIMA, Malaga, Spain; [Oliva-Olivera, Wilfredo; Moreno-Indias, Isabel; Coin-Araguez, Leticia; Alcaide Torres, Juan; Camargo, Antonio; El Bekay, Rajaa; Jose Tinahones, Francisco] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nut, Madrid, Spain; [Lhamyani, Said] Univ Malaga UMA, Res Lab, Sci Sch, Malaga, Spain; [Fernandez-Veledo, Sonia; Vendrell, Joan] Univ Rovirai Virgili, Hosp Univ Tarragona Joan 23, Inst Invest Sanitaria Pere Virgili, Tarragona, Spain; [Fernandez-Veledo, Sonia; Vendrell, Joan] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Camargo, Antonio] Univ Cordoba, Reina Sofia Univ Hosp, Lipids & Atherosclerosis Unit, IMIBIC, Cordoba, Spain	Universidad de Malaga; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Cordoba	Oliva-Olivera, W; El Bekay, R; Tinahones, FJ (corresponding author), Univ Malaga UMA, Hosp Malaga Virgen de la Victoria, Dept Clin Endocrinol & Nutr, Inst Biomed Res Malaga IBIMA, Malaga, Spain.; Oliva-Olivera, W; El Bekay, R; Tinahones, FJ (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nut, Madrid, Spain.	oliva_olivera@hotmail.com; elbekay@gmail.com; fjtinahones@hotmail.com	Moreno-Indias, Isabel/B-6595-2017; Fernández-Veledo, Sonia/V-4625-2018; Tinahones, Francisco José/AAB-2882-2020; El Bekay, RAJAA/AGN-6069-2022; Camargo, Antonio/G-9720-2015; LHAMYANI, said/AAQ-1973-2020; Bekay, Rajaa El/AAZ-3959-2020	Moreno-Indias, Isabel/0000-0002-6121-151X; Fernández-Veledo, Sonia/0000-0003-2906-3788; El Bekay, RAJAA/0000-0003-3332-3431; Camargo, Antonio/0000-0002-0415-4184; LHAMYANI, said/0000-0002-9830-9772; Tinahones, Francisco J/0000-0001-6871-4403; Oliva Olivera, Wilfredo/0000-0003-3473-7898	European Union through the European Regional Development Fund (FEDER); Ministry of Economy and Competitiveness, Institute of Health Carlos III [PI15/01114, PI13/02628, PI12/02355]; Ministry of Economy and Knowledge [PI-CTS-08181/2011, CTS-7895/2011]; Fondo de Investigacion Sanitaria (FIS) - European Regional Development Fund (ERDF) [CP10/00438]	European Union through the European Regional Development Fund (FEDER); Ministry of Economy and Competitiveness, Institute of Health Carlos III; Ministry of Economy and Knowledge; Fondo de Investigacion Sanitaria (FIS) - European Regional Development Fund (ERDF)	This work was cofunded by the European Union through the European Regional Development Fund (FEDER). The authors wish to thank all the participants for their collaboration. GIBER Fisiopatologia de la Obesidad y Nutricion (Pathophysiology of Obesity and Nutrition, CIBEROBN) are part of the Institute de Salud del Carlos III (Institute of Health Carlos III, ISCIII) Project. We would also like to thank Maria Repice for her help with the English language version of the text. This work was supported by grants from the Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI15/01114, PI13/02628; PI12/02355) and the Ministry of Economy and Knowledge (PI-CTS-08181/2011; CTS-7895/2011). S.F.V. acknowledges support from the "Miguel Servet" tenure-track program (CP10/00438) from the Fondo de Investigacion Sanitaria (FIS) co-financed by the European Regional Development Fund (ERDF). R.E. is under a contract of "Nicolas Monardes" programme from the Servicio Andaluz de Salud, Regional Ministry of Health of the Andalusia Government, Andalusia, Spain.	Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Barbarroja N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048155; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003; Kihira Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093856; Kim JH, 2015, STEM CELLS, V33, P542, DOI 10.1002/stem.1865; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Kim JH, 2011, STEM CELLS DEV, V20, P1753, DOI 10.1089/scd.2010.0469; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Lemoine AY, 2012, J CLIN ENDOCR METAB, V97, pE775, DOI 10.1210/jc.2011-2649; Mack I, 2009, AM J PHYSIOL-ENDOC M, V297, pE735, DOI 10.1152/ajpendo.90851.2008; Maumus M, 2008, J CLIN ENDOCR METAB, V93, P4098, DOI 10.1210/jc.2008-0044; Meran S, 2013, AM J PATHOL, V182, P2223, DOI 10.1016/j.ajpath.2013.02.038; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Park BS, 2010, BIOMED RES-TOKYO, V31, P27, DOI 10.2220/biomedres.31.27; Park IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122776; Park SG, 2011, EXPERT OPIN THER TAR, V15, P1297, DOI 10.1517/14728222.2011.628315; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Roldan M, 2011, FASEB J, V25, P4111, DOI 10.1096/fj.10-171439; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Silva KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174115; Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206	45	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188324	10.1371/journal.pone.0188324	http://dx.doi.org/10.1371/journal.pone.0188324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166648	Green Submitted, Green Published, gold			2022-12-26	WOS:000416035300031
J	Colombaioni, L; Onor, M; Benedetti, E; Bramanti, E				Colombaioni, Laura; Onor, Massimo; Benedetti, Edoardo; Bramanti, Emilia			Thallium stimulates ethanol production in immortalized hippocampal neurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; ENDOGENOUS ETHANOL; IN-VITRO; ADULT NEUROGENESIS; NORTHERN TUSCANY; TAP WATER; CELLS; APOPTOSIS; MITOCHONDRIAL	Lactate and ethanol (EtOH) were determined in cell culture medium (CCM) of immortalized hippocampal neurons (HN9.10e cell line) before and after incubation with Thallium (Tl). This cell line is a reliable, in vitro model of one of the most vulnerable regions of central nervous system. Cells were incubated for 48 h with three different single Tl doses: 1, 10, 100 mu g/L (corresponding to 4.9, 49 and 490 nM, respectively). After 48 h, neurons were "reperfused" with fresh CCM every 24/48 h until 7 days after the treatment and the removed CCM was collected and analysed. Confocal microscopy was employed to observe morphological changes. EtOH was determined by head space-solid phase microextraction -gas chromatography -mass spectrometry (HS-SPME-GCMS), lactate by RP-HPLC with UV detection. Tl exposure had significant effects on neuronal growth rate and morphology. The damage degree was dose-dependent. In not exposed cells, EtOH concentration was 0.18 +/- 0.013 mM, which represents about 5% of lactate concentration (3.4 +/- 0.10 mM). After Tl exposure lactate and EtOH increased. In CCM of 100 and 10 mu g/L Tl-treated cells, lactate increased 24 h after reperfusion up to 2 and 3.3 times the control value, respectively. In CCM of 10 and 100 mu g/L Tl-treated cells 24 h after reperfusion, EtOH increased up to 0.3 and 0.58 mmol/L. respectively. These results are consistent with significant alterations in energy metabolism, despite the low doses of Tl employed and the relatively short incubation time.	[Colombaioni, Laura] CNR, Area Ric, Neurosci Inst, Pisa, Italy; [Onor, Massimo; Bramanti, Emilia] Inst Chem Organo Metall Cpds ICCOM, Natl Res Council Italy, CNR, Pisa, Italy; [Benedetti, Edoardo] Univ Pisa, Dept Oncol, Hematol Unit, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Pisa	Bramanti, E (corresponding author), Inst Chem Organo Metall Cpds ICCOM, Natl Res Council Italy, CNR, Pisa, Italy.	bramanti@pi.iccom.cnr.it	Colombaioni, Laura/O-2580-2015; Bramanti, Emilia/AAQ-9425-2021; Bramanti, Emilia/E-1114-2011; Onor, Massimo/A-4382-2012; benedetti, edoardo/AAB-3717-2019	Colombaioni, Laura/0000-0001-6273-9239; Bramanti, Emilia/0000-0001-8478-7370; Onor, Massimo/0000-0003-3023-1072; Benedetti, Edorado/0000-0001-5295-2087				AGAPEJEV S, 1992, ACTA NEUROL SCAND, V86, P496, DOI 10.1111/j.1600-0404.1992.tb05131.x; Antoshechkin AG, 2001, ALCOHOL ALCOHOLISM, V36, P608, DOI 10.1093/alcalc/36.6.608; Apple DM, 2017, BRAIN RES, V1655, P270, DOI 10.1016/j.brainres.2016.01.023; Bacman SR, 2006, MOL NEUROBIOL, V33, P113, DOI 10.1385/MN:33:2:113; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Biagi S, 2012, BIOMED CHROMATOGR, V26, P1408, DOI 10.1002/bmc.2713; Biagioni C, 2017, SCI TOTAL ENVIRON, V587, P491, DOI 10.1016/j.scitotenv.2017.02.177; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Campanella B, 2017, TALANTA, V171, P255, DOI 10.1016/j.talanta.2017.05.009; Campanella B, 2016, SCI TOTAL ENVIRON, V548, P33, DOI 10.1016/j.scitotenv.2016.01.010; Caracelli I, 2014, COORDIN CHEM REV, V281, P50, DOI 10.1016/j.ccr.2014.09.001; Casiot C, 2011, ENVIRON SCI TECHNOL, V45, P2056, DOI 10.1021/es102064r; Cerrato L, 2009, TOXICOL APPL PHARM, V238, P111, DOI 10.1016/j.taap.2009.05.005; Cobelo-Garcia A, 2015, ENVIRON SCI POLLUT R, V22, P15188, DOI 10.1007/s11356-015-5221-0; Colombaioni L, 2002, DEV BRAIN RES, V134, P93, DOI 10.1016/S0165-3806(01)00326-1; Colombaioni L, 2002, NEUROCHEM INT, V40, P327, DOI 10.1016/S0197-0186(01)00090-0; Costa J, 2016, CLIN CHIM ACTA, V455, P7, DOI 10.1016/j.cca.2016.01.011; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Doonan F, 2008, METHODS, V44, P200, DOI 10.1016/j.ymeth.2007.11.006; Dorokhov YL, 2015, PHYSIOL REV, V95, P603, DOI 10.1152/physrev.00034.2014; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOUGLAS KT, 1990, INT J BIOCHEM, V22, P429, DOI 10.1016/0020-711X(90)90254-Z; Hanzel CE, 2009, TOXICOL APPL PHARM, V236, P59, DOI 10.1016/j.taap.2008.12.029; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Filipiak W, 2016, CURR MED CHEM, V23, P2112, DOI 10.2174/0929867323666160510122913; Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162; Flynn Kevin C, 2013, Bioarchitecture, V3, P86; Galvan-Arzate S, 1998, TOXICOL LETT, V99, P1, DOI 10.1016/S0378-4274(98)00126-X; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gray E, 2015, AMYOTROPH LAT SCL FR, V16, P456, DOI 10.3109/21678421.2015.1053490; GREGOTTI C, 1992, J TOXICOL ENV HEALTH, V36, P59, DOI 10.1080/15287399209531623; Hanzel CE, 2006, TOXICOL APPL PHARM, V216, P485, DOI 10.1016/j.taap.2006.07.003; Hurtley SM, 2016, SCIENCE, V352, P48; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Rodriguez-Mercado JJ, 2013, DRUG CHEM TOXICOL, V36, P369, DOI 10.3109/01480545.2012.710633; KAYNE FJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P232, DOI 10.1016/0003-9861(71)90204-9; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Komarova TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090239; Korr H, 1980, ADV ANATOMY EMBRYOLO; KRAHWINKEL W, 1988, J NUCL MED, V29, P1582; Krasnodebska-Ostrega B, 2005, J SOIL SEDIMENT, V5, P71, DOI 10.1065/jss2005.05.136; LEE HJ, 1990, J NEUROSCI, V10, P1779; LESTER D, 1961, Q J STUD ALCOHOL, V22, P554; Llorente C, 2015, CELL MOL GASTROENTER, V1, P275, DOI 10.1016/j.jcmgh.2015.04.003; MANZO L, 1988, HDB TOXICITY INORGAN, P677; Martin F, 2004, SOIL SEDIMENT CONTAM, V13, P25, DOI 10.1080/10588330490269769; MCMANUS IR, 1960, SCIENCE, V131, P102, DOI 10.1126/science.131.3393.102; Meshitsuka S, 2001, CLIN CHIM ACTA, V312, P25, DOI 10.1016/S0009-8981(01)00587-3; Mori K, 1998, NEUROL RES, V20, P19; Nava-Ruiz C, POLLUTANT DIS REMEDI, P321; Nordberg M, 2005, ESSENTIALS MED GEOLO, P212; Peter ALJ, 2005, ENVIRON INT, V31, P9; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; REPETTO G, 1994, TOXICOL IN VITRO, V8, P609, DOI 10.1016/0887-2333(94)90028-0; Rietze R, 2000, J COMP NEUROL, V424, P397; Riveros-Rosas H, 1997, ARCH MED RES, V28, P453; Standards CN, 2006, GB57492006 STAND CN; TALAS A, 1983, ARCH TOXICOL, V53, P1, DOI 10.1007/BF01459996; United States Environmental Protection Agency, 2009, EPA635R08001F; van der Voet G.B., 2011, ENCY ENV HLTH, P713, DOI 10.1016 /B978-0-444-52272-6.00236-1; van Waarde A, 1993, SURVIVING HYPOXIA ME; Viraraghavan T, 2011, ENCY ENV HLTH, P39, DOI [10.1016/B978-0-444-63951-6.00643-4, DOI 10.1016/B978-0-444-52272-6.00643-7]; Voccoli V, 2007, BRAIN RES, V1147, P1, DOI 10.1016/j.brainres.2007.01.145; Voccoli V, 2009, BRAIN RES, V1252, P15, DOI 10.1016/j.brainres.2008.11.026; WALKER GW, 1966, NATURE, V210, P1368, DOI 10.1038/2101368a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu KY, 2014, J BIOL CHEM, V289, P20193, DOI 10.1074/jbc.C114.561860; Xiao TF, 2012, SCI TOTAL ENVIRON, V421, P51, DOI 10.1016/j.scitotenv.2011.04.008	74	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188351	10.1371/journal.pone.0188351	http://dx.doi.org/10.1371/journal.pone.0188351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161327	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000044
J	Gao, MZ; Yu, B; Qiu, ZQ; Yin, XG; Li, SW; Liu, Q				Gao, Mingzhong; Yu, Bin; Qiu, Zhiqiang; Yin, Xiangang; Li, Shengwei; Liu, Qiang			Derivation and application of an analytical rock displacement solution on rectangular cavern wall using the inverse mapping method	PLOS ONE			English	Article							STRESS; HOLE	Rectangular caverns are increasingly used in underground engineering projects, the failure mechanism of rectangular cavern wall rock is significantly different as a result of the crosssectional shape and variations in wall stress distributions. However, the conventional computational method always results in a long-winded computational process and multiple displacement solutions of internal rectangular wall rock. This paper uses a Laurent series complex method to obtain a mapping function expression based on complex variable function theory and conformal transformation. This method is combined with the Schwarz-Christoffel method to calculate the mapping function coefficient and to determine the rectangular cavern wall rock deformation. With regard to the inverse mapping concept, the mapping relation between the polar coordinate system within plane. and a corresponding unique plane coordinate point inside the cavern wall rock is discussed. The disadvantage of multiple solutions when mapping from the plane to the polar coordinate system is addressed. This theoretical formula is used to calculate wall rock boundary deformation and displacement field nephograms inside the wall rock for a given cavern height and width. A comparison with ANSYS numerical software results suggests that the theoretical solution and numerical solution exhibit identical trends, thereby demonstrating the method's validity. This method greatly improves the computing accuracy and reduces the difficulty in solving for cavern boundary and internal wall rock displacements. The proposed method provides a theoretical guide for controlling cavern wall rock deformation failure.	[Gao, Mingzhong; Qiu, Zhiqiang; Li, Shengwei; Liu, Qiang] Sichuan Univ, Coll Water Resource & Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu, Sichuan, Peoples R China; [Gao, Mingzhong; Qiu, Zhiqiang; Li, Shengwei; Liu, Qiang] Sichuan Univ, Minist Educ, Key Lab Energy Engn Safety & Mech Disaster, Chengdu, Sichuan, Peoples R China; [Yu, Bin] Datong Coal Mine Grp Co Ltd, Datong, Peoples R China; [Yin, Xiangang] Min Res Co Ltd, Changsha Inst, Changsha, Hunan, Peoples R China	Sichuan University; Sichuan University	Yu, B (corresponding author), Datong Coal Mine Grp Co Ltd, Datong, Peoples R China.	42498410@qq.com			National Key Research and Development Program of China [2016YFC0600701]; National Natural Science Foundation of China [51674170]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the National Key Research and Development Program of China (Grant No. 2016YFC0600701) and National Natural Science Foundation of China (Grant No. 51674170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financially supported by the National Key Research and Development Program of China (Grant No. 2016YFC0600701) and National Natural Science Foundation of China (Grant No. 51674170).	Akbarov SD, 2004, J STRAIN ANAL ENG, V39, P615, DOI 10.1243/0309324042379257; Barber J.R., 2002, ELASTICITY; Charles J, 1988, ROCK MECH ENG; de Saint-Venant B., 1855, ME MOIRE TORSION PRI, P555; Fahimifar A, 2010, TUNN UNDERGR SP TECH, V25, P297, DOI 10.1016/j.tust.2010.01.002; Grigorios T, 2013, 4 ECCOMAS THEM C COM; He M.C., 2004, THEORY PRACTICE BOLT; Huo H, 2006, TUNN UNDERGR SP TECH, V21, P613, DOI 10.1016/j.tust.2005.12.135; [蒋斌松 JIANG Binsong], 2007, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V26, P982; Lei GH, 2001, J ENG MECH-ASCE, V127, P880, DOI 10.1061/(ASCE)0733-9399(2001)127:9(880); Lu A.Z., 1995, CHINESE J ROCK MECH, V14, P269; Lv AZ., 2007, COMPLEX VARIABLE FUN; Muskhelishvili N.I., 1962, SOME BASIC PROBLEMS; Sarason D., 2007, COMPLEX FUNCTION THE, V2, DOI [10.1090/mbk/049, DOI 10.1090/MBK/049]; Savin GM., 1961, STRESS CONCENTRATION; Sellers EJ, 2000, TUNN UNDERGR SP TECH, V15, P463, DOI 10.1016/S0886-7798(01)00015-3; Sharan SK, 2005, INT J ROCK MECH MIN, V42, P542, DOI 10.1016/j.ijrmms.2005.03.019; Sharan SK, 2003, INT J ROCK MECH MIN, V40, P817, DOI 10.1016/S1365-1609(03)00040-6; Sharma DS, 2012, ENG LET, V20, P1; Wang SL, 2012, TUNN UNDERGR SP TECH, V30, P155, DOI 10.1016/j.tust.2012.02.016	20	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188336	10.1371/journal.pone.0188336	http://dx.doi.org/10.1371/journal.pone.0188336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155892	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700048
J	Lucas, JE; Bazemore, TC; Alo, C; Monahan, PB; Voora, D				Lucas, Joseph E.; Bazemore, Taylor C.; Alo, Celan; Monahan, Patrick B.; Voora, Deepak			An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System	PLOS ONE			English	Article							NONADHERENCE; PHYSICIAN; THERAPY; PATIENT	HMG-CoA reductase inhibitors (or "statins") are important and commonly used medications to lower cholesterol and prevent cardiovascular disease. Nearly half of patients stop taking statin medications one year after they are prescribed leading to higher cholesterol, increased cardiovascular risk, and costs due to excess hospitalizations. Identifying which patients are at highest risk for not adhering to long-term statin therapy is an important step towards individualizing interventions to improve adherence. Electronic health records (EHR) are an increasingly common source of data that are challenging to analyze but have potential for generating more accurate predictions of disease risk. The aim of this study was to build an EHR based model for statin adherence and link this model to biologic and clinical outcomes in patients receiving statin therapy. We gathered EHR data from the Military Health System which maintains administrative data for active duty, retirees, and dependents of the United States armed forces military that receive health care benefits. Data were gathered from patients prescribed their first statin prescription in 2005 and 2006. Baseline billing, laboratory, and pharmacy claims data were collected from the two years leading up to the first statin prescription and summarized using non-negative matrix factorization. Follow up statin prescription refill data was used to define the adherence outcome (> 80 percent days covered). The subsequent factors to emerge from this model were then used to build cross-validated, predictive models of 1) overall disease risk using coalescent regression and 2) statin adherence (using random forest regression). The predicted statin adherence for each patient was subsequently used to correlate with cholesterol lowering and hospitalizations for cardiovascular disease during the 5 year follow up period using Cox regression. The analytical dataset included 138 731 individuals and 1840 potential baseline predictors that were reduced to 30 independent EHR "factors". A random forest predictive model taking patient, statin prescription, predicted disease risk, and the EHR factors as potential inputs produced a cross-validated c-statistic of 0.736 for classifying statin non-adherence. The addition of the first refill to the model increased the c-statistic to 0.81. The predicted statin adherence was independently associated with greater cholesterol lowering (correlation = 0.14, p < 1e-20) and lower hospitalization for myocardial infarction, coronary artery disease, and stroke (hazard ratio = 0.84, p = 1.87E-06). Electronic health records data can be used to build a predictive model of statin adherence that also correlates with statins' cardiovascular benefits.	[Lucas, Joseph E.] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Bazemore, Taylor C.; Voora, Deepak] Duke Univ, Dept Med, Durham, NC 27708 USA; [Alo, Celan; Monahan, Patrick B.] US Air Force, Air Force Med Operat Agcy, Joint Base Lackland Kell, TX USA; [Voora, Deepak] Duke Univ, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA	Duke University; Duke University; United States Department of Defense; United States Air Force; Duke University	Voora, D (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.; Voora, D (corresponding author), Duke Univ, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	Deepak.voora@duke.edu		Voora, Deepak/0000-0003-0015-5179	United States Air Force [FA8650-13-2-6375]	United States Air Force(United States Department of Defense)	This work was supported by the United States Air Force (FA8650-13-2-6375).	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Franklin JM, 2015, HLTH SERV RES; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldstein BA, 2016, J AM MED INF ASS; Harrison T, 2011, CLIN MED RES, V9, P150, DOI 10.3121/cmr.2011.1020.c-a4-01; Henao R, 2016, ARXIV E PRINTS, P1608; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Molfenter TD, 2012, PATIENT PREFER ADHER, V6, P643, DOI 10.2147/PPA.S34711; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Ng K, 2014, J BIOMED INFORM, V48, P160, DOI 10.1016/j.jbi.2013.12.012; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pedan A, 2007, J MANAGE CARE PHARM, V13, P487, DOI 10.18553/jmcp.2007.13.6.487; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Raebel MA, 2012, J GEN INTERN MED, V27, P57, DOI 10.1007/s11606-011-1829-z; Ruokoniemi P, 2011, BRIT J CLIN PHARMACO, V71, P766, DOI 10.1111/j.1365-2125.2010.03895.x; Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606; Singer SR, 2012, AM J MANAG CARE, V18; Stojanovic J, 2016, IEEE ACM T COMPUT BI, V99, P1; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thompson Paul D, 2010, Prev Cardiol, V13, P104, DOI 10.1111/j.1751-7141.2009.00063.x; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187809	10.1371/journal.pone.0187809	http://dx.doi.org/10.1371/journal.pone.0187809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155848	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700017
J	Rong-Mullins, X; Ravishankar, A; McNeal, KA; Lonergan, ZR; Biega, AC; Creamer, JP; Gallagher, JEG				Rong-Mullins, Xiaoqing; Ravishankar, Apoorva; McNeal, Kirsten A.; Lonergan, Zachery R.; Biega, Audrey C.; Creamer, J. Philip; Gallagher, Jennifer E. G.			Genetic variation in Dip5, an amino acid permease, and Pdr5, a multiple drug transporter, regulates glyphosate resistance in S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HERBICIDE GLYPHOSATE; MULTIDRUG-RESISTANCE; MOLECULAR-BASIS; YEAST; SYNTHASE; GENOME; AMPLIFICATION; ARCHITECTURE	S. cerevisiae from different environments are subject to a wide range of selective pressures, whether intentional or by happenstance. Chemicals classified by their application, such as herbicides, fungicides and antibiotics, can affect non-target organisms. First marketed as RoundUp T, glyphosate is the most widely used herbicide. In plants, glyphosate inhibits EPSPS, of the shikimate pathway, which is present in many organisms but lacking in mammals. The shikimate pathway produces chorismate which is the precursor to all the aromatic amino acids, para-aminobenzoic acid, and Coenzyme Q10. Crops engineered to be resistant to glyphosate contain a homolog of EPSPS that is not bound by glyphosate. Here, we show that S. cerevisiae has a wide-range of glyphosate resistance. Sequence comparison between the target proteins, i.e., the plant EPSPS and the yeast orthologous protein Aro1, predicted that yeast would be resistant to glyphosate. However, the growth variation seen in the subset of yeast tested was not due to polymorphisms within Aro1, instead, it was caused by genetic variation in an ABC multiple drug transporter, Pdr5, and an amino acid permease, Dip5. Using genetic variation as a probe into glyphosate response, we uncovered mechanisms that contribute to the transportation of glyphosate in and out of the cell. Taking advantage of the natural genetic variation within yeast and measuring growth under different conditions that would change the use of the shikimate pathway, we uncovered a general transport mechanism of glyphosate into eukaryotic cells.	[Rong-Mullins, Xiaoqing; Ravishankar, Apoorva; McNeal, Kirsten A.; Lonergan, Zachery R.; Biega, Audrey C.; Creamer, J. Philip; Gallagher, Jennifer E. G.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Lonergan, Zachery R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	West Virginia University; Vanderbilt University	Gallagher, JEG (corresponding author), West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	jegallagher@mail.wvu.edu		Lonergan, Zachery/0000-0001-7694-2166; Rong-Mullins, Xiaoqing/0000-0002-2122-552X; Creamer, John/0000-0002-5147-3866; Gallagher, Jennifer/0000-0002-6163-3181	West Virginia University PSCoR; West Virginia University Senate Grant; WVU Summer Undergraduate Research Experience; NSF REU-Biological Responses [DBI 1156627]; NSF-MCB [1614573]	West Virginia University PSCoR; West Virginia University Senate Grant; WVU Summer Undergraduate Research Experience; NSF REU-Biological Responses; NSF-MCB(National Science Foundation (NSF))	West Virginia University PSCoR and West Virginia University Senate Grant provided initial funding. ACB was funded by WVU Summer Undergraduate Research Experience. ZRL was funded by NSF REU-Biological Responses to the Environment from Genes to the Ecosystem DBI 1156627. This work was funded by NSF-MCB 1614573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ashok Bidwai for critical reading of the manuscript. Thanks to Luke Evans for suggesting the use of RoundUp (TM). Barbara Dunn and Gavin Sherlock provided the yeast used here and pGS36. Angela Lee generously shared the entire BY4741 yeast knockout collection. Zhenglong Gu and Xiaoxian Guo shared the YJM789 pdr5 knockout. West Virginia University PSCoR and West Virginia University Senate Grant provided initial funding. ACB was funded by WVU Summer Undergraduate Research Experience. ZRL was funded by NSF REU-Biological Responses to the Environment from Genes to the Ecosystem DBI 1156627. This work was funded by NSF-MCB 1614573.	AMRHEIN N, 1980, PLANT PHYSIOL, V66, P830, DOI 10.1104/pp.66.5.830; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bradberry Sally M, 2004, Toxicol Rev, V23, P159, DOI 10.2165/00139709-200423030-00003; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Cakmak I, 2009, EUR J AGRON, V31, P114, DOI 10.1016/j.eja.2009.07.001; Christie KR, 2009, TRENDS MICROBIOL, V17, P286, DOI 10.1016/j.tim.2009.04.005; Collart MA, 2001, PREPARATION YEAST RN; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DUNCAN K, 1987, BIOCHEM J, V246, P375, DOI 10.1042/bj2460375; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Gallagher JEG, 2014, GENE DEV, V28, P409, DOI 10.1101/gad.228940.113; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011309; Haderlie LC, 1972, PLANT PATHOL, V60, P40; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; LEPPERT G, 1990, GENETICS, V125, P13; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MADSEN HEL, 1978, ACTA CHEM SCAND A, V32, P79, DOI 10.3891/acta.chem.scand.32a-0079; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Pollegioni L, 2011, FEBS J, V278, P2753, DOI 10.1111/j.1742-4658.2011.08214.x; Reeds PJ, 2000, J NUTR, V130, p1835S; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; ROGERS SG, 1983, APPL ENVIRON MICROB, V46, P37, DOI 10.1128/AEM.46.1.37-43.1983; Rong-Mullins X, 2017, METALLOMICS, V9, P1304, DOI 10.1039/c7mt00147a; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Sirisattha Sophon, 2004, Environ Sci, V11, P313; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tanney JB, 2010, CAN J MICROBIOL, V56, P138, DOI [10.1139/w09-122, 10.1139/W09-122]; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	44	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187522	10.1371/journal.pone.0187522	http://dx.doi.org/10.1371/journal.pone.0187522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155836	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700011
J	van der Heijden, EMDL; Chileshe, J; Vernooij, JCM; Gortazar, C; Juste, RA; Sevilla, I; Crafford, JE; Rutten, VPMG; Michel, AL				van der Heijden, E. M. D. L.; Chileshe, J.; Vernooij, J. C. M.; Gortazar, C.; Juste, R. A.; Sevilla, I.; Crafford, J. E.; Rutten, V. P. M. G.; Michel, A. L.			Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates	PLOS ONE			English	Article							TUBERCULOUS PLEURITIS; IFN-GAMMA; CATTLE; WILDLIFE; PROTECTION; DIFFERENCE; INFECTION; DIAGNOSIS; ANTIGENS; PROGRESS	Conventional control and eradication strategies for bovine tuberculosis (BTB) face tremendous difficulties in developing countries; countries with wildlife reservoirs, a complex wildlife-livestock- human interface or a lack of veterinary and veterinary public health surveillance. Vaccination of cattle and other species might in some cases provide the only suitable control strategy for BTB, while in others it may supplement existing test-and-slaughter schemes. However, the use of live BCG has several limitations and the global rise of HIV/AIDS infections has furthermore warranted the exploration of inactivated vaccine preparations. The aim of this study was to compare the immune response profiles in response to parenteral vaccination with live BCG and two inactivated vaccine candidates in cattle. Twenty-four mixed breed calves (Bos taurus) aged 4-6 months, were allocated to one of four groups and vaccinated sub-cutaneously with live M. bovis BCG (Danish 1331), formalin-inactivated M. bovis BCG, heat-killed M. bovis or PBS/Montanide T (control). Interferon. responsiveness and antibody production were measured prior to vaccination and at weekly intervals thereafter for twelve weeks. At nine weeks post-priming, animals were skin tested using tuberculins and MTBC specific protein cocktails and subsequently challenged through intranodular injection of live M. bovis BCG. The animals in the heat-killed M. bovis group demonstrated strong and sustained cellmediated and humoral immune responses, significantly higher than the control group in response to vaccination, which may indicate a protective immune profile. Animals in this group showed reactivity to the skin test reagents, confirming good vaccine take. Lastly, although not statistically significant, recovery of BCG after challenge was lowest in the heatkilled M. bovis group. In conclusion, the parenteral heat-killed M. bovis vaccine proved to be clearly immunogenic in cattle in the present study, urging further evaluation of the vaccine in challenge studies using virulent M. bovis and assessment of vaccine efficacy in field conditions.	[van der Heijden, E. M. D. L.; Rutten, V. P. M. G.] Univ Utrecht, Fac Vet Med, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van der Heijden, E. M. D. L.; Chileshe, J.; Crafford, J. E.; Rutten, V. P. M. G.; Michel, A. L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Pretoria, South Africa; [Vernooij, J. C. M.] Univ Utrecht, Dept Farm Anim Hlth, Fac Vet Med, Utrecht, Netherlands; [Gortazar, C.] UCLM, JCCM, CSIC, SaBio Inst Invest Recursos Cinegeticos IREC, Ciudad Real, Spain; [Juste, R. A.; Sevilla, I.] Inst Vasco Invest & Desarrollo Agrario, Dept Anim Hlth, NEIKER, Bizkaia Sci & Technology Pk, Derio, Bizkaia, Spain; [Juste, R. A.] SERIDA, Villaviciosa, Asturias, Spain; [Michel, A. L.] Natl Zool Gardens South Africa, Pretoria, South Africa	Utrecht University; University of Pretoria; Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; National Research Foundation - South Africa; National Zoological Gardens of South Africa	van der Heijden, EMDL (corresponding author), Univ Utrecht, Fac Vet Med, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands.; van der Heijden, EMDL (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Pretoria, South Africa.	e.m.d.l.vanderheijden@uu.nl	Sevilla, Iker A/O-6060-2014; Vernooij, Johannes/J-3991-2019; Rutten, Victor PMG/AAB-6833-2022; Michel, Anita/N-8996-2014; Juste, Ramon A./C-3570-2008; Gortazar, Christian/E-7918-2012	Sevilla, Iker A/0000-0003-3968-3390; Vernooij, Johannes/0000-0002-2646-9216; Rutten, Victor PMG/0000-0002-6171-1805; Michel, Anita/0000-0001-9240-2653; Juste, Ramon A./0000-0001-6037-5873; van der Heijden, Elisabeth Margaretha Diana Louise/0000-0002-8444-6928; Crafford, Jan/0000-0001-7343-8327; Gortazar, Christian/0000-0003-0012-4006	NWO-WOTRO Science for Global Development [W01.65.321.00]; NWO-WOTRO; Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease; Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium; IRT; MINECO; FEDER Plan Nacional [AGL2014-56305]; MINECO FEDER; EUROSA	NWO-WOTRO Science for Global Development; NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease; Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium; IRT; MINECO(Spanish Government); FEDER Plan Nacional; MINECO FEDER(Spanish Government); EUROSA	This work was supported by NWO-WOTRO Science for Global Development (grant W01.65.321.00) to VR & AL (https://www.nwo.nl/en/about-nwo/organisation/nwo-domains/wotro), and NWO-WOTRO funding was used towards all experimental costs, including purchase of animals, consumables, test kits etc.; The Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease and the Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium to VR & AL (https://www.itg.be), and IRT funding was used towards all experimental costs, including purchase of animals, consumables, test kits etc.; MINECO and FEDER Plan Nacional (grant AGL2014-56305) to CG(http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.26172fcf4eb029fa6ec7da6901432ea0/?vgnextoid=4d494d861a299210VgnVCM1000001d04140aRCRD), and MINECO & FEDER funding was used towards coordination among IREC members; and the Erasmus Mundus Action 2 EUROSA scholarship to EvdH (https://www.uantwerpen.be/en/projects/eurosa/), and EUROSA funding was used towards the stipendium of EvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; BARNES PF, 1989, J IMMUNOL, V142, P1114; BARNES PF, 1990, J IMMUNOL, V145, P149; Beltran-Beck B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098048; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Buddle BM, 2013, TRANSBOUND EMERG DIS, V60, P136, DOI 10.1111/tbed.12092; Buddle BM, 2006, VET MICROBIOL, V112, P191, DOI 10.1016/j.vetmic.2005.11.027; Buddle BM, 2003, INT J PARASITOL, V33, P555, DOI 10.1016/S0020-7519(03)00060-2; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2004, VACCINE, V22, P1063, DOI 10.1016/j.vaccine.2003.05.002; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de Lisle GW, 2001, REV SCI TECH OIE, V20, P86, DOI 10.20506/rst.20.1.1262; Dunn PK, DGLM DOUBLE GENERALI; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gcebe N., 2015, OCCURRENCE MOL CHARA; Haile M, 2004, VACCINE, V22, P1498, DOI 10.1016/j.vaccine.2003.10.016; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hewinson RG, 2003, TUBERCULOSIS, V83, P119, DOI 10.1016/S1472-9792(02)00062-8; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Jones GJ, 2012, CLIN VACCINE IMMUNOL, V19, P620, DOI 10.1128/CVI.00024-12; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1344, DOI 10.1128/CVI.00261-10; Juste RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165607; Lopez V, 2016, VET IMMUNOL IMMUNOP, V172, P21, DOI 10.1016/j.vetimm.2016.03.003; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Michel AL, 2014, REV SCI TECH OIE, V33, P583, DOI 10.20506/rst.33.2.2310; Michel AL, 2011, PREV VET MED, V98, P142, DOI 10.1016/j.prevetmed.2010.10.016; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Santema W, 2013, INFECT IMMUN, V81, P1990, DOI 10.1128/IAI.01121-12; SHIMOKATA K, 1982, AM REV RESPIR DIS, V126, P822; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; UNAIDS, 2016, GLOB AIDS UPD REP; Villarreal-Ramos B, 2014, VACCINE; Vordermeier HM, 2014, RES VET SCI, V97, pS53, DOI 10.1016/j.rvsc.2014.04.015; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier M, 2006, VET IMMUNOL IMMUNOP, V112, P38, DOI 10.1016/j.vetimm.2006.03.010; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005; World Organisation for Animal H, MAN DIAGN TESTS VACC	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188448	10.1371/journal.pone.0188448	http://dx.doi.org/10.1371/journal.pone.0188448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155877	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700060
J	Rohani, F; Richter, H; Van den Bogert, AJ				Rohani, Farbod; Richter, Hanz; Van den Bogert, Antonie J.			Optimal design and control of an electromechanical transfemoral prosthesis with energy regeneration	PLOS ONE			English	Article							ANKLE-FOOT PROSTHESIS; AMPUTATION; GAIT; AMBULATION; AMPUTEES; WALKING; LEVEL; COST; LEG	In this paper, we present the design of an electromechanical above-knee active prosthesis with energy storage and regeneration. The system consists of geared knee and ankle motors, parallel springs for each motor, an ultracapacitor, and controllable four-quadrant power converters. The goal is to maximize the performance of the system by finding optimal controls and design parameters. A model of the system dynamics was developed, and used to solve a combined trajectory and design optimization problem. The objectives of the optimization were to minimize tracking error relative to human joint motions, as well as energy use. The optimization problem was solved by the method of direct collocation, based on joint torque and joint angle data from ten subjects walking at three speeds. After optimization of controls and design parameters, the simulated system could operate at zero energy cost while still closely emulating able-bodied gait. This was achieved by controlled energy transfer between knee and ankle, and by controlled storage and release of energy throughout the gait cycle. Optimal gear ratios and spring parameters were similar across subjects and walking speeds.	[Rohani, Farbod] Cleveland State Univ, Dept Elect & Comp Engn, Cleveland, OH 44115 USA; [Rohani, Farbod; Richter, Hanz; Van den Bogert, Antonie J.] Cleveland State Univ, Dept Mech Engn, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Rohani, F (corresponding author), Cleveland State Univ, Dept Elect & Comp Engn, Cleveland, OH 44115 USA.; Rohani, F (corresponding author), Cleveland State Univ, Dept Mech Engn, Cleveland, OH 44115 USA.	f.rohani@csuohio.edu	van den Bogert, Antonie J/A-7809-2009	van den Bogert, Antonie J/0000-0002-3791-3749	National Science Foundation [1344954, 1544702]	National Science Foundation(National Science Foundation (NSF))	Financial support was received from the National Science Foundation under grants No. 1344954 and 1544702. The financial support was received by allauthors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Bellman RD, 2008, P IEEE RAS-EMBS INT, P511, DOI 10.1109/BIOROB.2008.4762887; Betts J.T, 2010, PRACTICAL METHODOP; Bishop R. H., 2007, MECHATRONICS HDB, V2nd; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Conway B. E., 2013, ELECTROCHEMICAL SUPE, DOI DOI 10.1017/CBO9781107415324.004; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fan H., 2014, ANALOG APPL J, P20; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; GITTER A, 1995, AM J PHYS MED REHAB, V74, P332, DOI 10.1097/00002060-199509000-00002; Graham LE, 2007, ARCH PHYS MED REHAB, V88, P801, DOI 10.1016/j.apmr.2007.02.028; HENCH JJ, 1994, IEEE T AUTOMAT CONTR, V39, P1197, DOI 10.1109/9.293179; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Highsmith MJ, 2010, PROSTHET ORTHOT INT, V34, P362, DOI 10.3109/03093646.2010.520054; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; HUANG CT, 1979, ARCH PHYS MED REHAB, V60, P18; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Khademi G, 2016, 55 IEEE C DEC CONTR; Khalaf P, 2016, IEEE ASME INT C ADV, P1424, DOI 10.1109/AIM.2016.7576970; Moore JK, 2015, PEERJ, V3, DOI 10.7717/peerj.918; Orendurff MS, 2006, J REHABIL RES DEV, V43, P239, DOI 10.1682/JRRD.2005.06.0095; Seth B., 1987, THESIS MIT CAMBRIDGE; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Tabor K. A., 1988, THESIS; Unal R, 2012, P IEEE RAS-EMBS INT, P1949, DOI 10.1109/BioRob.2012.6290837; van den Bogert AJ, 2012, P I MECH ENG P-J SPO, V226, P123, DOI 10.1177/1754337112440644; van den Bogert AJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006680; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Warner H. E., 2015, THESIS; WATERS RL, 1976, J BONE JOINT SURG AM, V58, P42, DOI 10.2106/00004623-197658010-00007; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147	31	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188266	10.1371/journal.pone.0188266	http://dx.doi.org/10.1371/journal.pone.0188266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149213	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100034
J	Meleiro, LP; Salgado, JCS; Maldonado, RF; Carli, S; Moraes, LAB; Ward, RJ; Jorge, JA; Furriel, RPM				Meleiro, Luana Parras; Santos Salgado, Jose Carlos; Maldonado, Raquel Fonseca; Carli, Sibeli; Beraldo Moraes, Luiz Alberto; Ward, Richard John; Jorge, Joao Atilio; Melo Furriel, Rosa Prazeres			Engineering the GH1 beta-glucosidase from Humicola insolens: Insights on the stimulation of activity by glucose and xylose	PLOS ONE			English	Article							MICROBIAL METAGENOME; TOLERANT; HYDROLYSIS; CLONING; OVEREXPRESSION; PURIFICATION; PROTEINS	The activity of the GH1 beta-glucosidase from Humicola insolens (Bglhi) against p-nitrophenyl-beta-D-glucopyranoside (pNP-Glc) and cellobiose is enhanced 2-fold by glucose and/or xylose. Kinetic and transglycosylation data showed that hydrolysis is preferred in the absence of monosaccharides. Stimulation involves allosteric interactions, increased transglycosylation and competition of the substrate and monosaccharides for the -1 glycone and the +1/+2 aglycone binding sites. Protein directed evolution has been used to generate 6 mutants of Bglhi with altered stimulation patterns. All mutants contain one of three substitutions (N235S, D237V or H307Y) clustered around the +1/+2 aglycone binding sites. Two mutants with the H307Y substitution preferentially followed the transglycosylation route in the absence of xylose or glucose. The strong stimulation of their pNP-glucosidase and cellobiase activities was accompanied by increased transglycosylation and higher monosaccharide tolerance. The D237V mutation favoured hydrolysis over transglycosylation and the pNP-glucosidase activity, but not the cellobiase activity, was stimulated by xylose. The substitution N235S abolished the preference for hydrolysis or transglycosylation; the cellobiase, but not the pNP-glucosidase activity of the mutants was strongly inhibited by xylose. Both the D237V and N235S mutations lowered tolerance to the monosaccharides. These results provide evidence that the fine modulation of the activity of Bglhi and mutants by glucose and/or xylose is regulated by the relative affinities of the glycone and aglycone binding sites for the substrate and the free monosaccharides.	[Meleiro, Luana Parras; Carli, Sibeli; Beraldo Moraes, Luiz Alberto; Ward, Richard John; Melo Furriel, Rosa Prazeres] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [Santos Salgado, Jose Carlos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Maldonado, Raquel Fonseca] Inst Fed Educ Ciencia & Tecnol Sao Paulo, Sao Jose Dos Campos, SP, Brazil; [Jorge, Joao Atilio] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Federal de Sao Paulo (IFSP); Universidade de Sao Paulo	Meleiro, LP (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil.	luanapm@usp.br	Salgado, Jose CS/S-3128-2016; Moraes, Luiz Alberto B/K-2282-2012; Carli, Sibeli/N-7329-2016; Ward, Richard John/C-2460-2012; Meleiro, Luana/C-2684-2013	Salgado, Jose CS/0000-0002-3422-9474; Moraes, Luiz Alberto B/0000-0002-0853-1944; Ward, Richard John/0000-0003-1136-5737; Meleiro, Luana/0000-0001-7104-0358	FAPESP [2014/14415-0, 2010/18850-2, 2016/17582-0]; CNPq [457960/2014-0, 301560/2013-7, 152972/2012-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP Grants 2014/14415-0 (RPMF) and 2010/18850-2 (RJW), CNPq Grants 457960/2014-0 (RPMF) and 301560/2013-7 (JAJ), FAPESP fellowship 2016/17582-0 (LPM) and CNPq fellowship 152972/2012-9 (JCSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram F, 2016, J MOL CATAL B-ENZYM, V124, P92, DOI 10.1016/j.molcatb.2015.12.005; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; Bras NF, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P117, DOI 10.5772/52019; Cairns JRK, 2015, PLANT SCI, V241, P246, DOI 10.1016/j.plantsci.2015.10.014; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cao L., 2015, SHOCK VIB, V2015, P8, DOI DOI 10.1186/S13068-015-0383-Z; Cota J, 2015, NEW BIOTECHNOL, V32, P13, DOI 10.1016/j.nbt.2014.07.009; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Guo BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147301; Gupta VK, 2016, TRENDS BIOCHEM SCI, V41, P633, DOI 10.1016/j.tibs.2016.04.006; Hodge DB, 2009, APPL BIOCHEM BIOTECH, V152, P88, DOI 10.1007/s12010-008-8217-0; Kuusk S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0690-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Li YD, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-85; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Matsuzawa T, 2017, APPL MICROBIOL BIOT, V101, P633, DOI 10.1007/s00253-016-7803-2; Matsuzawa T, 2016, FEBS J, V283, P2340, DOI 10.1111/febs.13743; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Meleiro LP, 2015, J MOL CATAL B-ENZYM, V122, P131, DOI 10.1016/j.molcatb.2015.09.003; Meleiro LP, 2014, APPL BIOCHEM BIOTECH, V173, P391, DOI 10.1007/s12010-014-0847-9; Souza FHM, 2014, J MOL CATAL B-ENZYM, V106, P1, DOI 10.1016/j.molcatb.2014.04.007; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Souza FHM, 2010, PROCESS BIOCHEM, V45, P272, DOI 10.1016/j.procbio.2009.09.018; Nascimento CV, 2010, J MICROBIOL, V48, P53, DOI 10.1007/s12275-009-0159-x; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Rajasree KP, 2013, J IND MICROBIOL BIOT, V40, P967, DOI 10.1007/s10295-013-1291-5; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Singh KP, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0352-z; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00548; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Xia W, 2016, SCI REP-UK, V6, DOI 10.1038/srep27062; Xu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31108; Yang F, 2015, APPL MICROBIOL BIOT, V99, P8903, DOI 10.1007/s00253-015-6619-9; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17296; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhao LG, 2013, J MOL CATAL B-ENZYM, V95, P62, DOI 10.1016/j.molcatb.2013.05.027	45	17	17	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188254	10.1371/journal.pone.0188254	http://dx.doi.org/10.1371/journal.pone.0188254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145480	gold, Green Published			2022-12-26	WOS:000415378800101
J	Yilmaz, O; Patinote, A; Nguyen, TV; Com, E; Lavigne, R; Pineau, C; Sullivan, CV; Bobe, J				Yilmaz, Ozlem; Patinote, Amelie; Thao Vi Nguyen; Com, Emmanuelle; Lavigne, Regis; Pineau, Charles; Sullivan, Craig V.; Bobe, Julien			Scrambled eggs: Proteomic portraits and novel biomarkers of egg quality in zebrafish (Danio rerio)	PLOS ONE			English	Article							PROTEIN; FISH; GENE; EXPRESSION; MATURATION; AUTOPHAGY; EMBRYOS; LECTIN; WNT	Egg quality is a complex biological trait and a major determinant of reproductive fitness in all animals. This study delivered the first proteomic portraits of egg quality in zebrafish, a leading biomedical model for early development. Egg batches of good and poor quality, evidenced by embryo survival for 24 h, were sampled immediately after spawning and used to create pooled or replicated sample sets whose protein extracts were subjected to different levels of fractionation before liquid chromatography and tandem mass spectrometry. Obtained spectra were searched against a zebrafish proteome database and detected proteins were annotated, categorized and quantified based on normalized spectral counts. Manually curated and automated enrichment analyses revealed poor quality eggs to be deficient of proteins involved in protein synthesis and energy and lipid metabolism, and of some vitellogenin products and lectins, and to have a surfeit of proteins involved in endo-lysosomal activities, autophagy, and apoptosis, and of some oncogene products, lectins and egg envelope proteins. Results of pathway and network analyses suggest that this aberrant proteomic profile results from failure of oocytes giving rise to poor quality eggs to properly transit through final maturation, and implicated Wnt signaling in the etiology of this defect. Quantitative comparisons of abundant proteins in good versus poor quality eggs revealed 17 candidate egg quality markers. Thus, the zebrafish egg proteome is clearly linked to embryo developmental potential, a phenomenon that begs further investigation to elucidate the root causes of poor egg quality, presently a serious and intractable problem in livestock and human reproductive medicine.	[Yilmaz, Ozlem; Patinote, Amelie; Thao Vi Nguyen; Bobe, Julien] INRA, Lab Fish Physiol & Genom, UR1037, Rennes, France; [Com, Emmanuelle; Lavigne, Regis; Pineau, Charles] INSERM, Irset, Protim, U1085, Rennes, France; [Sullivan, Craig V.] Carolina AquaGyn, Raleigh, NC USA; [Yilmaz, Ozlem] Univ Bergen, Dept Biol, Bergen, Norway	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bergen	Bobe, J (corresponding author), INRA, Lab Fish Physiol & Genom, UR1037, Rennes, France.	julien.bobe@inra.fr	, Protim/C-4687-2012; Com, Emmanuelle/E-8656-2011; Yilmaz, Ozlem/W-9645-2019; Com, Emmanuelle/AAD-2312-2020; Pineau, Charles G/D-9185-2013; Bobe, Julien/I-6851-2017	Com, Emmanuelle/0000-0002-7401-817X; Yilmaz, Ozlem/0000-0002-7810-7487; Com, Emmanuelle/0000-0002-7401-817X; Pineau, Charles G/0000-0002-7461-5433; ali, sara/0000-0002-6303-3059; Bobe, Julien/0000-0002-9355-8227	Marie Skfodowska-Curie actions (MSCA) [626272]; Region Bretagne- SAD [FISHEGG (8210)]; French National Research Agency [ANR-13-BSV7-0015]; Carolina Aquagyn	Marie Skfodowska-Curie actions (MSCA); Region Bretagne- SAD; French National Research Agency(French National Research Agency (ANR)); Carolina Aquagyn	This work was supported by: (OY) Marie Skfodowska-Curie actions (MSCA)-FP7-PEOPLE-2013-IEF - 626272, http://cordis.europa.eu/project/ rcn/189931_en.html; (OY) Region Bretagne- SAD (2013)-FISHEGG (8210); (JB) French National Research Agency (ANR-13-BSV7-0015), http: //www.agence-nationale-recherche.fr/?Project=ANR-13-BSV7-0015; and (CVS) Carolina Aquagyn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1983, P NATL ACAD SCI-BIOL, V80, P1397, DOI 10.1073/pnas.80.5.1397; Babin Patrick J., 2007, P39, DOI 10.1007/978-1-4020-6235-3_2; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bobe J., 2015, Animal Frontiers, V5, P66, DOI 10.2527/af.2015-0010; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Castets MD, 2012, THERIOGENOLOGY, V78, P432, DOI 10.1016/j.theriogenology.2012.02.023; Cerda J, 1998, BIOL REPROD, V59, P53, DOI 10.1095/biolreprod59.1.53; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chapman RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096818; Chapovetsky Victoria, 2007, P99, DOI 10.1007/978-1-4020-6235-3_4; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crespel A, 2008, CYBIUM, V32, P205; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Gioacchini G, 2013, REPROD FERT DEVELOP, V25, P1115, DOI 10.1071/RD12187; Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x; Hoo JY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9732780; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imamura Shintaro, 2008, Bulletin of Fisheries Research Agency, P29; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Kohn YY, 2015, FISH PHYSIOL BIOCHEM, V41, P1403, DOI 10.1007/s10695-015-0095-0; Lahnsteiner F., 2009, P149; Lavigne R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012682; Le Menn Francoise, 2007, P1; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Lossner C, 2012, PROTEOMICS, V12, P1879, DOI 10.1002/pmic.201100576; Lubzens E, 2017, AQUACULTURE, V472, P107, DOI 10.1016/j.aquaculture.2016.10.029; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lucitt MB, 2008, MOL CELL PROTEOMICS, V7, P981, DOI 10.1074/mcp.M700382-MCP200; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nejedla M, 2016, MOL BIOL CELL, V27, P2381, DOI 10.1091/mbc.E15-11-0799; OPPENBERNTSEN DO, 1990, DEV BIOL, V137, P258, DOI 10.1016/0012-1606(90)90252-E; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Rime Helene, 2004, Reprod Biol Endocrinol, V2, P26, DOI 10.1186/1477-7827-2-26; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; Sullivan CV, 2003, FISH PHYSIOL BIOCHEM, V28, P481, DOI 10.1023/B:FISH.0000030635.92568.0a; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Ummanni R, 2008, FEBS J, V275, P5703, DOI 10.1111/j.1742-4658.2008.06697.x; van der Plas-Duivesteijn SJ, 2014, J PROTEOME RES, V13, P1537, DOI 10.1021/pr4010585; Verkade Heather, 2008, V469, P225, DOI 10.1007/978-1-60327-469-2_17; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YS, 2016, FISH SHELLFISH IMMUN, V52, P23, DOI 10.1016/j.fsi.2016.03.016; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Ziv T, 2008, COMP BIOCHEM PHYS D, V3, P12, DOI 10.1016/j.cbd.2007.06.004	60	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188084	10.1371/journal.pone.0188084	http://dx.doi.org/10.1371/journal.pone.0188084			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145436	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800063
J	Sukumaran, P; Sun, YY; Antonson, N; Singh, BB				Sukumaran, Pramod; Sun, Yuyang; Antonson, Neil; Singh, Brij B.			Dopaminergic neurotoxins induce cell death by attenuating NF-kappa B-mediated regulation of TRPC1 expression and autophagy	FASEB JOURNAL			English	Article						calcium; SOCE; apoptosis; PD; calcium channels	PROTEIN-KINASE-C; CA2+ ENTRY; ALPHA PHOSPHORYLATES; DISTINCT MECHANISMS; PARKINSONS-DISEASE; SIGNALING PATHWAYS; INDUCED APOPTOSIS; ANIMAL-MODELS; ER STRESS; PKC-DELTA	Alterations in Ca2+ homeostasis affect neuronal survival. However, the identity of Ca2+ channels and the mechanisms underlying neurotoxin-induced neuronal degeneration are not well understood. In this study, the dopaminergic neurotoxins 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridiumions (MPP+)/1-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which mimic Parkinson's disease (PD), induced neuronal degeneration by decreasing store-mediated Ca2+ entry. The function of the transient receptor potential canonical (TRPC)-1 channel was decreased upon exposure to the neurotoxins, followed by a decrease in TRPC1 expression. Similar to neurotoxins, samples from patients with PD exhibited attenuated TRPC1 expression, which was accompanied by a decrease in autophagic markers and a subsequent increase in apoptosis markers. Furthermore, exposure to neurotoxins attenuated PKC phosphorylation, decreased expression of autophagic markers, and increased apoptosis in SHSY-5Y neuroblastoma cells, which was again dependent on TRPC1. Prolonged neurotoxin treatment attenuated the binding of NF-kappa B to the TRPC1 promoter, which resulted in a decrease in TRPC1 expression, thereby attenuating autophagy and activating cell death. Restoration of TRPC1 expression rescued the effects of the dopaminergic neurotoxins in neuroblastoma cells by increasing Ca2+ entry, restoring NF-kappa B activity, and promoting autophagy. Overall, these results suggest that dopaminergic neurotoxins initially decreased Ca2+ entry, which inhibited the binding of NF-kappa B to the TRPC1 promoter, thereby inhibiting TRPC1 expression and resulting in cell death by preventing autophagy.	[Sukumaran, Pramod; Sun, Yuyang; Antonson, Neil; Singh, Brij B.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 501 N Columbia Rd, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Singh, BB (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 501 N Columbia Rd, Grand Forks, ND 58202 USA.	brij.singh@med.und.edu		Singh, Brij/0000-0003-0535-5997	U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE) [P30GM103329]; NIH, National Institute of Dental and Craniofacial Research [R01DE017102, R01DE022765, R21DE024300]; NIH National Institute of General Medical Sciences (NIGMS) [P20GM113123]; NIH/NIGMS [P20GM113123, P20GM103442]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022765, R01DE017102, R21DE024300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329, P20GM113123, P20GM103442] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE); NIH, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Confocal Facility at the University of North Dakota, which is partially supported by the U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE; Grant P30GM103329). This work was supported by the NIH, National Institute of Dental and Craniofacial Research (Grants R01DE017102, R01DE022765, and R21DE024300), and the NIH National Institute of General Medical Sciences (NIGMS; Grant P20GM113123 to B.B.S.). The Flow Cytometer Core is supported by NIH/NIGMS Grants P20GM103442 and P20GM113123. The authors declare no conflicts of interest.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Chauhan A, 2015, ASN NEURO, V7, DOI 10.1177/1759091415592126; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Choi WS, 1999, EXP NEUROL, V159, P274, DOI 10.1006/exnr.1999.7133; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Fan Y, 2014, NEUROL RES, V36, P53, DOI 10.1179/1743132813Y.0000000267; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Kania E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352794; KITAHAMA K, 1991, NEUROSCIENCE, V44, P185, DOI 10.1016/0306-4522(91)90260-U; Kondo I, 2000, JPN J PHARMACOL, V82, P210, DOI 10.1254/jjp.82.210; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lotharius J, 1999, J NEUROSCI, V19, P1284; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Muller J, 2000, NEUROLOGY, V55, P888, DOI 10.1212/WNL.55.6.888; Mut M, 2010, TURK NEUROSURG, V20, P277, DOI 10.5137/1019-5149.JTN.3008-10.1; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Shao CY, 2006, J NEUROPATH EXP NEUR, V65, P327, DOI 10.1097/01.jnen.0000218441.00040.82; Shen S, 2011, ONCOGENE, V30, P4544, DOI 10.1038/onc.2011.168; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Su J, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/193461; Sukumaran P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.7; Sun YY, 2014, BBA-MOL CELL RES, V1843, P1839, DOI 10.1016/j.bbamcr.2014.04.019; Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Yang LX, 2009, PEPTIDES, V30, P1368, DOI 10.1016/j.peptides.2009.04.007; Yap YW, 2016, NEUROCHEM RES, V41, P554, DOI 10.1007/s11064-015-1666-2	44	22	24	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1640	1652		10.1096/fj.201700662RR	http://dx.doi.org/10.1096/fj.201700662RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29150520	Green Published			2022-12-26	WOS:000427246000041
J	Countryman, P; Fan, YL; Gorthi, A; Pan, H; Strickland, J; Kaur, P; Wang, XC; Lin, JG; Lei, XY; White, C; You, CJ; Wirth, N; Tessmer, I; Piehler, J; Riehn, R; Bishop, AJR; Tao, YJ; Wang, H				Countryman, Preston; Fan, Yanlin; Gorthi, Aparna; Pan, Hai; Strickland, Jack; Kaur, Parminder; Wang, Xuechun; Lin, Jiangguo; Lei, Xiaoying; White, Christian; You, Changjiang; Wirth, Nicolas; Tessmer, Ingrid; Piehler, Jacob; Riehn, Robert; Bishop, Alexander J. R.; Tao, Yizhi Jane; Wang, Hong			Cohesin SA2 is a sequence-independent DNA-binding protein that recognizes DNA replication and repair intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; STRAND-BREAK REPAIR; ATOMIC-FORCE MICROSCOPY; ONE-DIMENSIONAL DIFFUSION; HOMOLOGY-DIRECTED REPAIR; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TELOMERIC DNA; QUANTUM-DOT; COMPLEX	Proper chromosome alignment and segregation during mitosis depend on cohesion between sister chromatids, mediated by the cohesin protein complex, which also plays crucial roles in diverse genome maintenance pathways. Current models attribute DNA binding by cohesin to entrapment of dsDNA by the cohesin ring subunits (SMC1, SMC3, and RAD21 in humans). However, the biophysical properties and activities of the fourth core cohesin subunit SA2 (STAG2) are largely unknown. Here, using single-molecule atomic force and fluorescence microscopy imaging as well as fluorescence anisotropy measurements, we established that SA2 binds to both dsDNA and ssDNA, albeit with a higher binding affinity for ssDNA. We observed that SA2 can switch between the 1D diffusing (search) mode on dsDNA and stable binding (recognition) mode at ssDNA gaps. Although SA2 does not specifically bind to centromeric or telomeric sequences, it does recognize DNA structures often associated with DNA replication and double-strand break repair, such as a double-stranded end, single-stranded overhang, flap, fork, and ssDNA gap. SA2 loss leads to a defect in homologous recombination-mediated DNA double-strand break repair. These results suggest that SA2 functions at intermediate DNA structures during DNA transactions in genome maintenance pathways. These findings have important implications for understanding the function of cohesin in these pathways.	[Countryman, Preston; Pan, Hai; Strickland, Jack; Kaur, Parminder; Lin, Jiangguo; White, Christian; Riehn, Robert; Wang, Hong] North Carolina State Univ, Phys Dept, Riddick Hall 421,2401 Stinson Dr, Raleigh, NC 27695 USA; [Wang, Xuechun] North Carolina State Univ, Biomed Engn Dept, Raleigh, NC 27695 USA; [Wang, Hong] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Fan, Yanlin; Lei, Xiaoying; Tao, Yizhi Jane] Rice Univ, Dept BioSci, Houston, TX 77251 USA; [Gorthi, Aparna; Bishop, Alexander J. R.] Univ Texas Hlth, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Gorthi, Aparna; Bishop, Alexander J. R.] Univ Texas Hlth, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Lin, Jiangguo] South China Univ Technol, Sch Biosci & Bioengn, Inst Biomech, Guangzhou 510006, Guangdong, Peoples R China; [Lei, Xiaoying] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China; [You, Changjiang; Piehler, Jacob] Univ Osnabruck, Div Biophys, Barbarstr 11, D-49076 Osnabruck, Germany; [Wirth, Nicolas; Tessmer, Ingrid] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Rice University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; South China University of Technology; Shandong University; University Osnabruck; University of Wurzburg	Wang, H (corresponding author), North Carolina State Univ, Phys Dept, Riddick Hall 421,2401 Stinson Dr, Raleigh, NC 27695 USA.	hong_wang@ncsu.edu	Wang, Hong/F-3164-2014; You, Changjiang/L-3901-2014; Riehn, Robert/A-7195-2011; You, Changjiang/AFK-2816-2022; Tessmer, Ingrid/O-2810-2013	Wang, Hong/0000-0003-0165-3559; You, Changjiang/0000-0002-7839-6397; Riehn, Robert/0000-0002-4408-3560; You, Changjiang/0000-0002-7839-6397; Tessmer, Ingrid/0000-0002-8353-6315; kaur, Parminder/0000-0001-9183-4315; Bishop, Alexander/0000-0002-5742-4387; Gorthi, Aparna/0000-0001-5935-4098; Pan, Hai/0000-0001-6660-9052; Wirth, Nicolas Thilo/0000-0003-0799-1321	National Institutes of Health [ES027641, R01GM107559, K22ES012264, 1R15ES019128, 1R01CA152063, NCI T32 CA 148724, P30 ES025128, R01-GM107559]; Voelcker Fund Young Investigator Award; CPRIT [RP150445]; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82]; Welch Foundation [C-1565]; NATIONAL CANCER INSTITUTE [T32CA148724, R01CA152063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019128, P30ES025128, R21ES027641, K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; CPRIT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES027641 (to H.W.), R01GM107559 (to H.W. and R.R.), K22ES012264, 1R15ES019128, and 1R01CA152063 (to A.J.R.B.), NCI T32 CA 148724 (to A.G.), and P30 ES025128 (through a pilot project grant to H.W. by the Center for Human Health and the Environment (CHHE) at North Carolina State University); a Voelcker Fund Young Investigator Award and CPRIT Grant RP150445 (to A.J.R.B.); Deutsche Forschungsgemeinschaft Forschungszentrum FZ82 (to I.T.); and Welch Foundation Grant C-1565 (to Y.J.T.). This work was also supported by National Institutes of Health Grant R01-GM107559. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atienza JM, 2005, MOL CANCER THER, V4, P361; Balakrishnan L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010173; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bisht KK, 2013, J CELL SCI, V126, P3493, DOI 10.1242/jcs.130872; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Buechner CN, 2013, J MOL RECOGNIT, V26, P605, DOI 10.1002/jmr.2311; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cuadrado A, 2012, CELL CYCLE, V11, P2233, DOI 10.4161/cc.20318; Fuentes-Perez ME, 2013, METHODS, V60, P113, DOI 10.1016/j.ymeth.2013.02.005; Gelot C, 2016, MOL CELL, V61, P15, DOI 10.1016/j.molcel.2015.11.002; Geng H, 2011, ANAL BIOCHEM, V413, P179, DOI 10.1016/j.ab.2011.02.017; Ghodke H, 2014, P NATL ACAD SCI USA, V111, pE1862, DOI 10.1073/pnas.1323856111; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; Iakoucheva LM, 2002, BIOCHEMISTRY-US, V41, P131, DOI 10.1021/bi011041q; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kaur P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20513; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kong XD, 2014, MOL CELL BIOL, V34, P685, DOI 10.1128/MCB.01503-13; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Lee OC, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021906; Leith JS, 2012, P NATL ACAD SCI USA, V109, P16552, DOI 10.1073/pnas.1120452109; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lin JG, 2016, NUCLEIC ACIDS RES, V44, P6363, DOI 10.1093/nar/gkw518; Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Roig MB, 2014, FEBS LETT, V588, P3692, DOI 10.1016/j.febslet.2014.08.015; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schar P, 2004, NUCLEIC ACIDS RES, V32, P3921, DOI 10.1093/nar/gkh716; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 2015, CURR BIOL, V25, pR108, DOI 10.1016/j.cub.2014.12.015; Skibbens RV, 2011, TRENDS GENET, V27, P499, DOI 10.1016/j.tig.2011.08.004; Skibbens RV, 2010, TRENDS CELL BIOL, V20, P507, DOI 10.1016/j.tcb.2010.06.003; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Tittel-Elmer M, 2012, MOL CELL, V48, P98, DOI 10.1016/j.molcel.2012.07.004; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van der Lehr P, 2017, ELIFE, V6, DOI 10.7554/eLife.26980; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wang H, 2008, NANO LETT, V8, P1631, DOI 10.1021/nl080316l; Watrin E, 2016, CURR OPIN GENET DEV, V37, P59, DOI 10.1016/j.gde.2015.12.004; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Zabrady K, 2016, NUCLEIC ACIDS RES, V44, P1064, DOI 10.1093/nar/gkv1021; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	91	24	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1054	1069		10.1074/jbc.M117.806406	http://dx.doi.org/10.1074/jbc.M117.806406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29175904	Green Published, hybrid			2022-12-26	WOS:000422864500025
J	Folci, A; Steinberger, A; Lee, B; Stanika, R; Scheruebel, S; Campiglio, M; Ramprecht, C; Pelzmann, B; Hell, JW; Obermair, GJ; Heine, M; Di Biase, V				Folci, Alessandra; Steinberger, Angela; Lee, Boram; Stanika, Ruslan; Scheruebel, Susanne; Campiglio, Marta; Ramprecht, Claudia; Pelzmann, Brigitte; Hell, Johannes W.; Obermair, Gerald J.; Heine, Martin; Di Biase, Valentina			Molecular mimicking of C-terminal phosphorylation tunes the surface dynamics of Ca(V)1.2 calcium channels in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+ CHANNEL; RECEPTOR; LOCALIZATION; TRAFFICKING; CAV1.2; AKAP79/150; EXPRESSION; PLASTICITY; SUBUNITS	L-type voltage-gated Ca(V)1.2 calcium channels (CaV1.2) are key regulators of neuronal excitability, synaptic plasticity, and excitation-transcription coupling. Surface-exposed Ca(V)1.2 distributes in clusters along the dendrites of hippocampal neurons. A permanent exchange between stably clustered and laterally diffusive extra-clustered channels maintains steady-state levels of Ca(V)1.2 at dendritic signaling domains. A dynamic equilibrium between anchored and diffusive receptors is a common feature among ion channels and is crucial to modulate signaling transduction. Despite the importance of this fine regulatory system, the molecular mechanisms underlying the surface dynamics of Ca(V)1.2 are completely unexplored. Here, we examined the dynamic states of Ca(V)1.2 depending on phosphorylation on Ser1700 and Ser-1928 at the channel C terminus. Phosphorylation at these sites is strongly involved in Ca(V)1.2-mediated nuclear factor of activated T cells (NFAT) signaling, long-term potentiation, and responsiveness to adrenergic stimulation. We engineered Ca(V)1.2 constructs mimicking phosphorylation at Ser-1700 and Ser-1928 and analyzed their behavior at the membrane by immunolabeling protocols, fluorescence recovery after photobleaching, and single particle tracking. We found that the phosphomimetic S1928E variant increases the mobility of Ca(V)1.2 without altering the steady-state maintenance of cluster in young neurons and favors channel stabilization later in differentiation. Instead, mimicking phosphorylation at Ser1700 promoted the diffusive state of Ca(V)1.2 irrespective of the differentiation stage. Together, these results reveal that phos-phorylation could contribute to the establishment of channel anchoring mechanisms depending on the neuronal differentiation state. Finally, our findings suggest a novel mechanism by which phosphorylation at the C terminus regulates calcium signaling by tuning the content of Ca(V)1.2 at signaling complexes.	[Folci, Alessandra; Steinberger, Angela; Scheruebel, Susanne; Ramprecht, Claudia; Pelzmann, Brigitte; Di Biase, Valentina] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria; [Lee, Boram; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Stanika, Ruslan; Campiglio, Marta; Obermair, Gerald J.] Med Univ Innsbruck, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Heine, Martin] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany	Medical University of Graz; University of California System; University of California Davis; Medical University of Innsbruck; Leibniz Institut fur Neurobiologie (LIN)	Di Biase, V (corresponding author), Harrachgasse 21, A-8010 Graz, Austria.	valentina.di-biase@medunigraz.at	, Gerald/AAD-3183-2020; Di Biase, Valentina/AAE-9529-2022; Folci, Alessandra/ABF-8954-2021; Di Biase, Valentina/T-3714-2017; Di Biase, Valentina/AFE-2569-2022; Folci, Alessandra/AAB-7843-2019; Di Biase, Valentina/AFT-6986-2022; Hell, Johannes W./P-5085-2019	Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Folci, Alessandra/0000-0002-8158-118X; Di Biase, Valentina/0000-0002-3292-6516; Campiglio, Marta/0000-0002-9629-2073; Stanika, Ruslan/0000-0002-7651-3131; Hell, Johannes W/0000-0001-7960-7531; Scheruebel, Susanne/0000-0001-8887-2097	Austrian Science Fund (FWF) [P25085, P24079, F44150]; Austrian National Bank [16435]; National Institutes of Health Grants [R01NS078792, R01AG055357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055357] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian National Bank; National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Austrian Science Fund (FWF) Grants P25085 (to V.D.B.), P24079 and F44150 (to G.J.O.), Austrian National Bank (Anniversary Fund) Grant 16435 (to B.P.), and National Institutes of Health Grants R01NS078792 and R01AG055357 (to J.W.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Altier C, 2012, CHANNELS, V6, P157, DOI 10.4161/chan.20865; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Carta M, 2013, EMBO J, V32, P496, DOI 10.1038/emboj.2012.334; Chameu P, 1999, NEUROSCIENCE, V90, P383, DOI 10.1016/S0306-4522(98)00457-6; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Di Biase V, 2011, J NEUROSCI, V31, P13682, DOI 10.1523/JNEUROSCI.2300-11.2011; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hell JW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3141pe33; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Huang G, 2007, J BIOL CHEM, V282, P14283, DOI 10.1074/jbc.M611529200; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kabir ZD, 2016, J PHYSIOL-LONDON, V594, P5823, DOI 10.1113/JP270673; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lyu LT, 2017, J PHARMACOL SCI, V133, P240, DOI 10.1016/j.jphs.2017.03.002; Marshall MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175257; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nystoriak MA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf9647; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oz S, 2017, J PHYSIOL-LONDON, V595, P3181, DOI 10.1113/JP274015; Patriarchi T, 2016, EMBO J, V35, P1330, DOI 10.15252/embj.201593409; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Qian H, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf9659; Rao A, 1998, J NEUROSCI, V18, P1217; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Schneider R, 2015, NEURON, V86, P672, DOI 10.1016/j.neuron.2015.03.050; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Stanika R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34528; van der Kooij MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5995; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Weick JP, 2003, J NEUROSCI, V23, P3446; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	59	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1040	1053		10.1074/jbc.M117.799585	http://dx.doi.org/10.1074/jbc.M117.799585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180451	Green Published, hybrid			2022-12-26	WOS:000422864500024
J	van IJzendoorn, DGP; Forghany, Z; Liebelt, F; Vertegaal, AC; Jochemsen, AG; Bovee, JVMG; Szuhai, K; Baker, DA				van IJzendoorn, David G. P.; Forghany, Zary; Liebelt, Frauke; Vertegaal, Alfred C.; Jochemsen, Aart G.; Bovee, Judith V. M. G.; Szuhai, Karoly; Baker, David A.			Functional analyses of a human vascular tumor FOS variant identify a novel degradation mechanism and a link to tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; c-Fos; cancer biology; protein degradation; transcription regulation; vascular biology	INDEPENDENT PROTEASOMAL DEGRADATION; C-FOS; EPITHELIOID HEMANGIOMA; PROTO-ONCOPROTEIN; DOWN-REGULATION; TEL ETV6; IN-VIVO; AP-1; IDENTIFICATION; ACTIVATION	Epithelioid hemangioma is a locally aggressive vascular neoplasm, found in bones and soft tissue, whose cause is currently unknown, but may involve oncogene activation. FOS is one of the earliest viral oncogenes to be characterized, and normal cellular FOS forms part of the activator protein 1 (AP-1) transcription factor complex, which plays a pivotal role in cell growth, differentiation, and survival as well as the DNA damage response. Despite this, a causal link between aberrant FOS function and naturally occurring tumors has not yet been established. Here, we describe a thorough molecular and biochemical analysis of a mutant FOS protein we identified in these vascular tumors. The mutant protein lacks a highly conserved helix consisting of the C-terminal four amino acids of FOS, which we show is indispensable for fast, ubiquitin-independent FOS degradation via the 20S proteasome. Our work reveals that FOS stimulates endothelial sprouting and that perturbation of normal FOS degradation could account for the abnormal vessel growth typical of epithelioid hemangioma. To the best of our knowledge, this is the first functional characterization of mutant FOS proteins found in tumors.	[van IJzendoorn, David G. P.; Bovee, Judith V. M. G.] LUMC, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Forghany, Zary; Liebelt, Frauke; Vertegaal, Alfred C.; Jochemsen, Aart G.; Szuhai, Karoly; Baker, David A.] LUMC, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Szuhai, K; Baker, DA (corresponding author), LUMC, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.	K.Szuhai@lumc.nl; d.baker@lumc.nl	Vertegaal, Alfred/ABG-8141-2021; Vertegaal, Alfred CO/Y-3875-2018; Szuhai, Karoly/A-1100-2008; van IJzendoorn, David/AAQ-9052-2021; van IJzendoorn, David/N-3932-2017	Vertegaal, Alfred/0000-0002-7989-0493; Vertegaal, Alfred CO/0000-0002-7989-0493; Szuhai, Karoly/0000-0002-1228-4245; Bovee, Judith/0000-0003-1155-0481; van IJzendoorn, David/0000-0002-2249-5919	Dutch Cancer Society [30861]; Netherlands Organization for Scientific Research Grant ZON-MW VICI [016.VICI.170.055]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research Grant ZON-MW VICI	This work was supported by the Dutch Cancer Society Grant 30861 (to D. A. B.) and Netherlands Organization for Scientific Research Grant ZON-MW VICI 016.VICI.170.055 (to J. V. M. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Baker D, 2014, BIOCHEM SOC T, V42, P225, DOI 10.1042/BST20130055; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2708, DOI 10.1021/bi9923555; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; HAAS S, 1995, CARCINOGENESIS, V16, P985, DOI 10.1093/carcin/16.5.985; Han XR, 2016, ONCOGENE, V35, P4179, DOI 10.1038/onc.2015.482; Heo SH, 2010, J CELL PHYSIOL, V224, P734, DOI 10.1002/jcp.22175; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang SC, 2015, AM J SURG PATHOL, V39, P1313, DOI 10.1097/PAS.0000000000000469; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rosenberg AE, 2013, WHO CLASSIFICATION T, P333; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; van IJzendoorn DGP, 2015, GENE CHROMOSOME CANC, V54, P565, DOI 10.1002/gcc.22269; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; WILSON T, 1988, EMBO J, V7, P4193, DOI 10.1002/j.1460-2075.1988.tb03316.x; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733	38	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21282	21290		10.1074/jbc.C117.815845	http://dx.doi.org/10.1074/jbc.C117.815845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29150442	hybrid, Green Published			2022-12-26	WOS:000419013000006
J	Kowalska, K; Olejnik, A; Szwajgier, D; Olkowicz, M				Kowalska, Katarzyna; Olejnik, Anna; Szwajgier, Dominik; Olkowicz, Mariola			Inhibitory activity of chokeberry, bilberry, raspberry and cranberry polyphenol-rich extract towards adipogenesis and oxidative stress in differentiated 3T3-L1 adipose cells	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; BERRY FRUITS; LEPTIN; HYPERGLYCEMIA; ANTHOCYANINS; PREVENTION; SECRETION; HEALTH; GAMMA	Berries are a rich source of antioxidants and phytochemicals that have received considerable interest for their possible relations to human health. In this study, the anti-adipogenic effect of polyphenol-rich extract obtained from chokeberry Aronia melanocarpa (Michx.) Elliot, raspberry Rubus idaeus L., bilberry Vaccinium myrtillus L. and cranberry Vaccinium macrocarpon Aiton fruits and its underlying molecular mechanisms were investigated in differentiated 3T3-L1 adipose cells. Treatment with the extract (25-100 mu g/mL) significantly decreased lipid accumulation and reactive oxygen species generation in adipocytes without showing cytotoxicity. Real-time PCR analysis revealed that the extract at a concentration of 100 mu g/mL suppressed adipogenesis and lipogenesis via the down-regulation of PPAR. (67%), C/EBPa (72%), SREBP1 (62%), aP2 (24%), FAS (32%), LPL (40%), HSL (39%), and PLIN1 (32%) gene expression. Moreover, the extract significantly increased the expression of adiponectin (4.4-fold) and decreased leptin expression (90%) and respectively regulated the production of these adipokines in 3T3-L1 adipocytes. The obtained results suggest that the analyzed extract may be a promising source of bioactive compounds that support long-term weight maintenance and promote the effective management of obesity.	[Kowalska, Katarzyna; Olejnik, Anna; Olkowicz, Mariola] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland; [Szwajgier, Dominik] Univ Life Sci, Dept Biotechnol Human Nutr & Sci Food Commod, Lublin, Poland	Poznan University of Life Sciences	Olejnik, A (corresponding author), Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland.	anna.olejnik@up.poznan.pl	Kowalska, Katarzyna/AAC-7968-2021; Szwajgier, Dominik/ABD-6715-2021; Olkowicz, Mariola/ABF-1182-2020	Kowalska, Katarzyna/0000-0001-7706-4035; Szwajgier, Dominik/0000-0002-2285-0669; Olejnik, Anna/0000-0002-4385-0051	National Science Centre, Poland [2015/19/B/NZ9/01054]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland (grant number 2015/19/B/NZ9/01054 to AO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0080-3; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Efferth T, 2011, CURR DRUG TARGETS, V12, P122, DOI 10.2174/138945011793591626; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Herranz-Lopez M, 2012, PHYTOMEDICINE, V19, P253, DOI 10.1016/j.phymed.2011.12.001; HOSSAIN MK, 2016, INT J MOL SCI, V17; Jeong MY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/475386; Kellogg J, 2010, J AGR FOOD CHEM, V58, P3884, DOI 10.1021/jf902693r; Kim HK, 2012, NUTR RES, V32, P770, DOI 10.1016/j.nutres.2012.06.008; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Koskinen-Kolasa A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1112-0; Kowalska K, 2016, CURR OPIN CLIN NUTR, V19, P446, DOI 10.1097/MCO.0000000000000322; Kowalska K, 2015, FOOD CHEM, V185, P383, DOI 10.1016/j.foodchem.2015.03.152; Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montagnese C, 2015, NUTRITION, V31, P908, DOI 10.1016/j.nut.2015.01.002; Sahagun DO, 2012, PPAR RES, V2012, DOI 10.1155/2012/318613; Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Seeram NP, 2008, J AGR FOOD CHEM, V56, P630, DOI 10.1021/jf072504n; Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673; Suzuki R, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-14; Takahashi A, 2015, J OLEO SCI, V64, P1243, DOI 10.5650/jos.ess15181; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Tsuda T, 2006, BIOCHEM PHARMACOL, V71, P1184, DOI 10.1016/j.bcp.2005.12.042; Tsuda T, 2004, BIOCHEM BIOPH RES CO, V316, P149, DOI 10.1016/j.bbrc.2004.02.031; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Wang Q, 2015, NUTR RES, V35, P317, DOI 10.1016/j.nutres.2014.12.009; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003	32	31	31	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188583	10.1371/journal.pone.0188583	http://dx.doi.org/10.1371/journal.pone.0188583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182628	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000039
J	Ledig, C; Kamnitsas, K; Koikkalainen, J; Posti, JP; Takala, RSK; Katila, A; Frantzen, J; Ala-Seppala, H; Kyllonen, A; Maanpaa, HR; Tallus, J; Lotjonen, J; Glocker, B; Tenovuo, O; Rueckert, D				Ledig, Christian; Kamnitsas, Konstantinos; Koikkalainen, Juha; Posti, Jussi P.; Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Lotjonen, Jyrki; Glocker, Ben; Tenovuo, Olli; Rueckert, Daniel			Regional brain morphometry in patients with traumatic brain injury based on acute- and chronic-phase magnetic resonance imaging	PLOS ONE			English	Article							WHITE-MATTER INJURY; HEAD-INJURY; DIFFUSION-TENSOR; FUNCTIONAL MRI; MILD; SEGMENTATION; ATROPHY; DYSFUNCTION; BIOMARKERS; MODERATE	Traumatic brain injury (TBI) is caused by a sudden external force and can be very heterogeneous in its manifestation. In this work, we analyse T1-weighted magnetic resonance (MR) brain images that were prospectively acquired from patients who sustained mild to severe TBI. We investigate the potential of a recently proposed automatic segmentation method to support the outcome prediction of TBI. Specifically, we extract meaningful cross-sectional and longitudinal measurements from acute-and chronic-phase MR images. We calculate regional volume and asymmetry features at the acute/subacute stage of the injury (median: 19 days after injury), to predict the disability outcome of 67 patients at the chronic disease stage (median: 229 days after injury). Our results indicate that small structural volumes in the acute stage (e. g. of the hippocampus, accumbens, amygdala) can be strong predictors for unfavourable disease outcome. Further, group differences in atrophy are investigated. We find that patients with unfavourable outcome show increased atrophy. Among patients with severe disability outcome we observed a significantly higher mean reduction of cerebral white matter (3.1%) as compared to patients with low disability outcome (0.7%).	[Ledig, Christian; Kamnitsas, Konstantinos; Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Dept Comp, London, England; [Koikkalainen, Juha; Lotjonen, Jyrki] Combinostics, Tampere, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Posti, Jussi P.; Frantzen, Janek; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Dept Clin Med, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Div Clin Neurosci, Dept Neurosurg, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari] Univ Turku, Turku, Finland	Imperial College London; VTT Technical Research Center Finland; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku	Ledig, C (corresponding author), Imperial Coll London, Dept Comp, London, England.	ledig.christian@gmail.com	Posti, Jussi P./Y-2908-2019; Tenovuo, Olli/GYV-6121-2022; Posti, Jussi/GQA-7745-2022; Frantzen, Janek/GMW-5465-2022	Posti, Jussi P./0000-0002-5925-5193; Tenovuo, Olli/0000-0003-1876-3180; Posti, Jussi/0000-0002-5925-5193; Ledig, Christian/0000-0003-4862-3138; Takala, Riikka/0000-0001-6342-0043; Ala-Seppala, Henna/0000-0002-1577-3028	7th Framework Programme by the European Commission [270259]; Engineering and Physical Sciences Research Council [EP/N023668/1]; Imperial College PhD Scholarship; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; EPSRC [EP/N023668/1] Funding Source: UKRI	7th Framework Programme by the European Commission; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College PhD Scholarship; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding for this research was provided by the 7th Framework Programme by the European Commission (270259); BG, CL acknowledge funding support from Engineering and Physical Sciences Research Council (EP/N023668/1); KK acknowledges funding support from Imperial College PhD Scholarship. JPP acknowledges funding support from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) and Emil Aaltonen Foundation. Combinostics provided support in the form of salaries for JK and JL. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus K, 2011, TXB TRAUMATIC BRAIN, P55; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bonilha L, 2013, FRONT PSYCHIATRY, V4, P1; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; Heckemann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129211; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamnitsas K., 2015, ISCHEMIC STROKE LESI, V13, P46; Kamnitsas K, 2017, LECT NOTES COMPUT SC, V10265, P597, DOI 10.1007/978-3-319-59050-9_47; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Langlois JA, 2004, TRAUMATIC BRAIN INJU; Ledig C, 2014, I S BIOMED IMAGING, P673, DOI 10.1109/ISBI.2014.6867960; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Newcombe VFJ, 2015, NEUROREHABILITATION; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith C., 2011, TXB TRAUMATIC BRAIN, P23; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TEASDALE G, 1974, LANCET, V2, P81; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang B, 2013, I S BIOMED IMAGING, P1392; Wang B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1152, DOI 10.1109/ISBI.2012.6235764; Wang B, 2012, PROC SPIE, V8314, DOI 10.1117/12.911043; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007	72	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188152	10.1371/journal.pone.0188152	http://dx.doi.org/10.1371/journal.pone.0188152			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182625	Green Submitted, Green Published, gold			2022-12-26	WOS:000416402000010
J	Natsuike, M; Saito, R; Fujiwara, A; Matsuno, K; Yamaguchi, A; Shiga, N; Hirawake, T; Kikuchi, T; Nishino, S; Imai, I				Natsuike, Masafumi; Saito, Rui; Fujiwara, Amane; Matsuno, Kohei; Yamaguchi, Atsushi; Shiga, Naonobu; Hirawake, Toru; Kikuchi, Takashi; Nishino, Shigeto; Imai, Ichiro			Evidence of increased toxic Alexandrium tamarense dinoflagellate blooms in the eastern Bering Sea in the summers of 2004 and 2005	PLOS ONE			English	Article							LAWRENCE ESTUARY CANADA; CHUKCHI SEA; SHELF; WATER; ABUNDANCE; IMPACTS; CYSTS	The eastern Bering Sea has a vast continental shelf, which contains various endangered marine mammals and large fishery resources. Recently, high numbers of toxic A. tamarense resting cysts were found in the bottom sediment surface of the eastern Bering Sea shelf, suggesting that the blooms have recently occurred. However, little is known about the presence of A. tamarense vegetative cells in the eastern Bering Sea. This study's goals were to detect the occurrence of A. tamarense vegetative cells on the eastern Bering Sea shelf and to find a relationship between environmental factors and their presence. Inter-annual field surveys were conducted to detect A. tamarense cells and environmental factors, such as nutrients, salinity, chlorophyll a, and water temperature, along a transect line on the eastern Bering Sea shelf during the summers of 2004, 2005, 2006, 2009, 2012, and 2013. A. tamarense vegetative cells were detected during every sampling year, and their quantities varied greatly from year to year. The maximum cell densities of A. tamarense observed during the summers of 2004 and 2005 were much higher than the Paralytic shellfish poisoning warning levels, which are greater than 100-1,000 cells L-1, in other subarctic areas. Lower quantities of the species occurred during the summers of 2009, 2012, and 2013. A significant positive correlation between A. tamarense quantity and water temperature and significant negative correlations between A. tamarense quantity and nutrient concentrations (of phosphate, silicate, and nitrite and nitrate) were detected in every sampling period. The surface- and bottom-water temperatures varied significantly from year to year, suggesting that water temperatures, which have been known to affect the cell growth and cyst germination of A. tamarense, might have affected the cells' quantities in the eastern Bering Sea each summer. Thus, an increase in the Bering Sea shelf's water temperature during the summer will increase the frequency and scale of toxic blooms and the toxin contamination of plankton feeders. This poses serious threats to humans and the marine ecosystem.	[Natsuike, Masafumi; Matsuno, Kohei; Yamaguchi, Atsushi; Shiga, Naonobu; Hirawake, Toru; Imai, Ichiro] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan; [Saito, Rui] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Fujiwara, Amane; Kikuchi, Takashi; Nishino, Shigeto] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa, Japan; [Natsuike, Masafumi] Tokyo Inst Technol, Sch Environm & Soc, Tokyo, Japan; [Shiga, Naonobu] Hakodate Jr Coll, Hakodate, Hokkaido, Japan	Hokkaido University; Ehime University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo Institute of Technology	Natsuike, M (corresponding author), Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan.; Natsuike, M (corresponding author), Tokyo Inst Technol, Sch Environm & Soc, Tokyo, Japan.	natsuike.m.aa@m.titech.ac.jp	Saito, Reiko/B-9410-2015; Matsuno, Kohei/AAJ-6510-2021; Yamaguchi, Atsushi/A-8613-2012	Matsuno, Kohei/0000-0001-9793-7622; Yamaguchi, Atsushi/0000-0002-5646-3608; Hirawake, Toru/0000-0003-0274-6642; NISHINO, Shigeto/0000-0002-0560-241X	Japan Society for the Promotion of Science (JSPS) [24248032, 24110005]; GRENE Arctic Climate Change Research Project; Grants-in-Aid for Scientific Research [15H05712] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); GRENE Arctic Climate Change Research Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (A) 24248032 to AY, Grant-in-Aid for Scientific Research on Innovative Areas 24110005 to AY from the Japan Society for the Promotion of Science (JSPS), and GRENE Arctic Climate Change Research Project to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; Blasco D, 2003, SCI MAR, V67, P261, DOI 10.3989/scimar.2003.67n3261; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; COACHMAN LK, 1979, J PHYS OCEANOGR, V9, P278, DOI 10.1175/1520-0485(1979)009<0278:OLWMIC>2.0.CO;2; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Fauchot J, 2005, MAR ECOL PROG SER, V296, P241, DOI 10.3354/meps296241; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Iida T, 2012, CONT SHELF RES, V34, P7, DOI 10.1016/j.csr.2011.11.007; Lefebvre KA, 2016, HARMFUL ALGAE, V55, P13, DOI 10.1016/j.hal.2016.01.007; MacIntyre JG, 1997, MAR ECOL PROG SER, V148, P201, DOI 10.3354/meps148201; Markus T, 2000, IEEE T GEOSCI REMOTE, V38, P1387, DOI 10.1109/36.843033; Natsuike M, 2017, HARMFUL ALGAE, V63, P13, DOI 10.1016/j.hal.2017.01.001; Natsuike M, 2017, HARMFUL ALGAE, V61, P80, DOI 10.1016/j.hal.2016.11.019; Natsuike M, 2013, HARMFUL ALGAE, V27, P52, DOI 10.1016/j.hal.2013.04.006; Ohashi R, 2013, DEEP-SEA RES PT II, V94, P44, DOI 10.1016/j.dsr2.2013.03.018; Perez CC, 1998, J PHYCOL, V34, P242, DOI 10.1046/j.1529-8817.1998.340242.x; Shimada H, 2012, FISHERIES SCI, V78, P865, DOI 10.1007/s12562-012-0513-5; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; TANIGUCHI A, 1976, Journal of the Oceanographical Society of Japan, V32, P99, DOI 10.1007/BF02107038; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Watras CJ, 1982, DEEP RES 2, V52, P2522; Yamamoto T., 1997, JPN J PHYCOL, V43, P91	25	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188565	10.1371/journal.pone.0188565	http://dx.doi.org/10.1371/journal.pone.0188565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182651	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000036
J	Mills, MK; Ruder, MG; Nayduch, D; Michel, K; Drolet, BS				Mills, Mary K.; Ruder, Mark G.; Nayduch, Dana; Michel, Kristin; Drolet, Barbara S.			Dynamics of epizootic hemorrhagic disease virus infection within the vector, Culicoides sonorensis (Diptera: Ceratopogonidae)	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; BLUETONGUE VIRUS; VARIIPENNIS DIPTERA; ORAL INFECTION; AEDES-AEGYPTI; FEEDING-BEHAVIOR; FINE-STRUCTURE; BITING MIDGES; TRANSMISSION; COMPETENCE	Culicoides sonorensis biting midges are confirmed vectors of epizootic hemorrhagic disease virus (EHDV), which causes mortality in white-tailed deer and ruminant populations. Currently, of the seven EHDV serotypes, only 1, 2, and 6 are detected in the USA, and very few studies have focused on the infection time course of these serotypes within the midge. The objective of this current research was to characterize EHDV-2 infection within the midge by measuring infection prevalence, virus dissemination, and viral load over the course of infection. Midges were fed a blood meal containing 10 6.9 PFU/ml EHDV-2, collected every 12 h from 0-2 days post feeding (dpf) and daily from 3-10 dpf, and cohorts of 20 C. sonorensis were processed using techniques that assessed EHDV infection and dissemination. Cytopathic effect assays and quantitative (q) PCR were used to determine infection prevalence, revealing a 50% infection rate by 10 dpf using both methods. Using immunohistochemistry, EHDV-2 infection was detectable at 5 dpf, and shown to disseminate from the midgut to other tissues, including fat body, eyes, and salivary glands by 5 dpf. Stain intensity increased from 5-8 dpf, indicating replication of EHDV-2 in secondary infection sites after dissemination. This finding is also supported by trends in viral load over time as determined by plaque assays and qPCR. An increase in titer between 4-5 dpf correlated with viral replication in the midgut as seen with staining at day 5, while the subsequent gradual increase in viral load from 8-10 dpf suggested viral replication in midges with disseminated infection. Overall, the data presented herein suggest that EHDV-2 disseminates via the hemolymph to secondary infection sites throughout the midge and demonstrate a high potential for transmission at five days at 25 degrees C after an infective blood-meal.	[Mills, Mary K.; Michel, Kristin] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Ruder, Mark G.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Nayduch, Dana; Drolet, Barbara S.] ARS, USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS 66506 USA	Kansas State University; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Michel, K (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.; Drolet, BS (corresponding author), ARS, USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS 66506 USA.	kmichel@ksu.edu; Barbara.Drolet@ARS.USDA.GOV	Mills, Mary/N-6471-2019	Nayduch, Dana/0000-0002-9258-6066; Michel, Kristin/0000-0001-9769-5248; Mills, Mary/0000-0002-9483-5986	USDA-ARS National Programs [103, 104, 58-5430-4-022]; Kansas State University Open Access Publishing Fund	USDA-ARS National Programs; Kansas State University Open Access Publishing Fund	Research reported in this publication was supported by the USDA-ARS National Programs 103 & 104 (B.S.D., D.N.), and through Specific Cooperative Agreement, 58-5430-4-022 (K.M.). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. This is contribution 17-393-J from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks go to Dr. Lee Cohnstaedt and Mr. William E. Yarnell at the Arthropod-Borne Animal Diseases Research Unit, USDA-ARS, Manhattan, KS for provision of all adult C. sonorensis midges and housing materials used in this study. We also thank David Stallknecht at the Southeastern Cooperative Wildflife Disease Study, University of Georgia, Athens, GA for providing the virus used in this research. Research reported in this publication was supported by the USDA-ARS National Programs 103 & 104 (B.S.D., D. N.) and through USDA-ARS Specific Cooperative Agreement 58-5430-4-022 (K.M.). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. This is contribution 17-393-J from the Kansas Agricultural Experiment Station.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Barber TL, 1976, P ANN M AM ASS VET L, V18, P149; BEATY BJ, 1981, SCIENCE, V211, P1433, DOI 10.1126/science.6781068; Blanc S, 2014, ANNU REV PHYTOPATHOL, V52, P403, DOI 10.1146/annurev-phyto-102313-045920; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; BOWNE JG, 1966, VIROLOGY, V30, P127, DOI 10.1016/S0042-6822(66)81016-4; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987; Chandler L.J., 1985, Progress in Clinical and Biological Research, V178, P245; Degner EC, 2016, MOL REPROD DEV, V83, P897, DOI 10.1002/mrd.22653; Drolet BS, 2005, J MED ENTOMOL, V42, P409, DOI 10.1603/0022-2585(2005)042[0409:VCOCSD]2.0.CO;2; FOSTER NM, 1977, J WILDLIFE DIS, V13, P9, DOI 10.7589/0090-3558-13.1.9; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Gaydos JK, 2004, J WILDLIFE DIS, V40, P383, DOI 10.7589/0090-3558-40.3.383; GRIMSTAD PR, 1985, J MED ENTOMOL, V22, P447, DOI 10.1093/jmedent/22.4.447; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Hindle S.J., 2014, FRONT NEUROSCI, V8, P1; HUISMANS H, 1979, ONDERSTEPOORT J VET, V46, P95; Jacquet S, 2015, MOL ECOL, V24, P5707, DOI 10.1111/mec.13422; JENNINGS DM, 1987, ARCH VIROL, V95, P177, DOI 10.1007/BF01310778; JENNINGS M, 1989, VET MICROBIOL, V21, P125, DOI 10.1016/0378-1135(89)90024-2; JONES RH, 1971, MOSQ NEWS, V31, P434; JONES RH, 1977, J WILDLIFE DIS, V13, P2, DOI 10.7589/0090-3558-13.1.2; JONES RH, 1974, J MED ENTOMOL, V11, P316, DOI 10.1093/jmedent/11.3.316; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LINLEY JR, 1985, J MED ENTOMOL, V22, P589, DOI 10.1093/jmedent/22.6.589; Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x; MacLachlan NJ, 2006, JAVMA-J AM VET MED A, V228, P1346, DOI 10.2460/javma.228.9.1346; Masci VL, 2015, ARTHROPOD STRUCT DEV, V44, P378, DOI 10.1016/j.asd.2015.04.003; McDermott EG, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1062-4; Mellor PS, 2009, BIOL ANIM INFECT, P295, DOI 10.1016/B978-012369368-6.50018-6; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Michigan Department of Natural Resources, 2013, EP HEM DIS EHD WHIT; Mills MK, 2015, INSECT MOL BIOL, V24, P105, DOI 10.1111/imb.12139; Mills MK, 2017, CURR OPIN INSECT SCI, V22, P7, DOI 10.1016/j.cois.2017.05.003; Nunamaker RA, 2000, J MED ENTOMOL, V37, P784, DOI 10.1603/0022-2585-37.5.784; NUNAMAKER RA, 1990, COMP BIOCHEM PHYS A, V96, P19, DOI 10.1016/0300-9629(90)90036-R; NUNAMAKER RA, 1989, J MED ENTOMOL, V26, P256, DOI 10.1093/jmedent/26.4.256; Osborne CJ, 2015, J MED ENTOMOL, V52, P274, DOI 10.1093/jme/tju063; Pascini TV, 2013, ANN ENTOMOL SOC AM, V106, P857, DOI 10.1603/AN13079; Pascini TV, 2012, MEM I OSWALDO CRUZ, V107, P705, DOI 10.1590/S0074-02762012000600001; Patel A, 2014, VIRUS RES, V182, P5, DOI 10.1016/j.virusres.2013.12.017; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Purse BV, 2015, ANNU REV ENTOMOL, V60, P373, DOI 10.1146/annurev-ento-010814-020614; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Romoser S, 2005, ARCH VIROL, P89; Ruder MG, 2015, J MED ENTOMOL, V52, P1050, DOI 10.1093/jme/tjv062; Ruder MG, 2015, VECTOR-BORNE ZOONOT, V15, P348, DOI 10.1089/vbz.2014.1703; Ruder MG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-236; Shope RE, 1955, REPORT DEER MORTALIT, V6, P17; SIEBURTH PJ, 1991, J MED ENTOMOL, V28, P74, DOI 10.1093/jmedent/28.1.74; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Stuart DI, 2006, CURR TOP MICROBIOL, V309, P221; TABACHNICK WJ, 1990, J MED ENTOMOL, V27, P24, DOI 10.1093/jmedent/27.1.24; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x; Zuliani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130294	59	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188865	10.1371/journal.pone.0188865	http://dx.doi.org/10.1371/journal.pone.0188865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176848	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900124
J	Sanda, B; Vistad, I; Sagedal, LR; Haakstad, LAH; Lohne-Seiler, H; Torstveit, MK				Sanda, Birgitte; Vistad, Ingvild; Sagedal, Linda Reme; Haakstad, Lene Annette Hagen; Lohne-Seiler, Hilde; Torstveit, Monica Klungland			Effect of a prenatal lifestyle intervention on physical activity level in late pregnancy and the first year postpartum	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; ACTIVITY QUESTIONNAIRE; EXERCISE INTERVENTION; NORWEGIAN FIT; OBESE WOMEN; DIETARY; RISK; RELIABILITY; OVERWEIGHT; RETENTION	Background Despite documented health benefits for mother and baby, physical activity (PA)-level tends to decline in pregnancy. Overweight/obese and physically inactive women are two selected groups at increased risk of pregnancy complications. Thus, efficient strategies to maintain or increase PA-level in pregnancy and the postpartum period, especially among these women, are warranted. This secondary analysis examined the effect of a prenatal lifestyleintervention on PA-level in late pregnancy and the first year postpartum, with subanalysis on initially physically active versus inactive and normal-weight versus overweight/obese women. Method The Norwegian Fit for Delivery (NFFD) randomized controlled trial included healthy primiparous women with singleton pregnancies and body mass index (BMI) >= 19 kg/m(2) assigned to an intervention group, n = 303 (twice weekly group-exercises and dietary counseling) or a control group, n = 303 (standard prenatal care). The International Physical Activity Questionnaire short-form was used to assess PA-levels at inclusion (mean gestational week (GW) 16), GW 36, and six and 12 months postpartum. Results AtGW 36, a positive intervention-effect with a significant between-group difference in total PA-level compared to time of inclusion was found for the total group (530 MET-min/week, p = 0.001) and the subgroups of normal-weight (533 MET-min/week, p = 0.003) and initially active women (717 MET-min/week, p<0.001). Intervention-effect was dependent on exercise-adherence among overweight/obese and inactive women. Compared to time of inclusion, the intervention groups maintained total PA-level at GW 36, while total PA-level decreased in the control groups. The PA-levels increased postpartum, but with no significant differences between the randomization groups. Conclusion The NFFD prenatal combined lifestyle intervention had a significant effect on TPA-level in late pregnancy among women entering pregnancy normal-weight or physically active, thereby preventing the downward trend typically seen during pregnancy. Intervention-effect among overweight/obese and physically inactive women was, however, dependent on exercise-adherence. Long-term intervention-effect was not observed in the postpartum period.	[Sanda, Birgitte; Lohne-Seiler, Hilde; Torstveit, Monica Klungland] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Sanda, Birgitte; Vistad, Ingvild; Sagedal, Linda Reme] Southern Norway Hosp Trust, Dept Obstet & Gynecol, Kristiansand, Norway; [Haakstad, Lene Annette Hagen] Norwegian Sch Sports Sci, Oslo, Norway	University of Agder; Norwegian School of Sport Sciences	Sanda, B (corresponding author), Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway.; Sanda, B (corresponding author), Southern Norway Hosp Trust, Dept Obstet & Gynecol, Kristiansand, Norway.	birgitte.sanda@uia.no			Norwegian South-Eastern Regional Health Authority; municipality of Aust Agder in Norway; municipality of Vest Agder in Norway; University of Agder, Norway	Norwegian South-Eastern Regional Health Authority; municipality of Aust Agder in Norway; municipality of Vest Agder in Norway; University of Agder, Norway	The NFFD trial was funded by the Norwegian South-Eastern Regional Health Authority (https://www.heise-sorost.no/south-eastern-noway-regional-health-authority), with additional funding from the municipalities of Aust Agder and Vest Agder in Norway. The first author is a PhD fellow funded by the University of Agder, Norway (https://www.uia.no/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee Obstetric Practice, 2002, Obstet Gynecol, V99, P171; Andersen LK, 2015, SEX REPROD HEALTHC, V6, P198, DOI 10.1016/j.srhc.2015.04.004; Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Bacchi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166254; Borg E, 2006, SCAND J MED SCI SPOR, V16, P57, DOI 10.1111/j.1600-0838.2005.00448.x; Borodulin Katja, 2009, BMC Womens Health, V9, P32, DOI 10.1186/1472-6874-9-32; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Di Mascio D, 2016, AM J OBSTET GYNECOL; Dodd JM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0161-y; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1796-0; Evenson KR, 2012, PAEDIATR PERINAT EP, V26, P479, DOI 10.1111/j.1365-3016.2012.01311.x; Garnas Kirsti Krohn, 2016, PLoS Med, V13, pe1002079, DOI 10.1371/journal.pmed.1002079; Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006; Haakstad LAH, 2017, MIDWIFERY, V46, P45, DOI 10.1016/j.midw.2017.01.010; Halvorsen S, 2013, PHYSIOTHERAPY, V99, P42, DOI 10.1016/j.physio.2011.11.002; Hawkins M, 2014, AM J PUBLIC HEALTH, V104, pE74, DOI 10.2105/AJPH.2014.302072; Hayes L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0479-2; Health NDo, 2014, PHYS ACT GUID PREGN; Health NDo, 2015, FYS AKT SED BLANT VO; Hillesund ER, 2016, J DEV ORIG HLTH DIS, V7, P538, DOI 10.1017/S2040174416000258; Hui A, 2012, BJOG-INT J OBSTET GY, V119, P70, DOI 10.1111/j.1471-0528.2011.03184.x; Hui AL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-331; Hui HL., 2006, CAN J DIABETES, V30, P169, DOI DOI 10.1016/S1499-2671(06)02010-7; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133564; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Overby NC, 2015, MATERN CHILD NUTR, V11, P20, DOI 10.1111/mcn.12026; Owe KM, 2009, SCAND J MED SCI SPOR, V19, P637, DOI 10.1111/j.1600-0838.2008.00840.x; Perales M, 2015, EVAL HEALTH PROF, V38, P59, DOI 10.1177/0163278714533566; Perales M, 2016, EARLY HUM DEV, V94, P43, DOI 10.1016/j.earlhumdev.2016.01.004; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Price BB, 2012, MED SCI SPORT EXER, V44, P2263, DOI 10.1249/MSS.0b013e318267ad67; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rasmussen, 2009, WEIGHT GAIN PREGN RE; Richardsen KR, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0401-y; Ruchat SM, 2012, MED SCI SPORT EXER, V44, P1419, DOI 10.1249/MSS.0b013e31825365f1; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P97, DOI 10.1111/1471-0528.13862; Sagedal LR, 2017, BJOG-INT J OBSTET GY, V124, P111, DOI 10.1111/1471-0528.13863; Sagedal LR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-132; Sanabria-Martinez G, 2015, BJOG-INT J OBSTET GY, V122, P1167, DOI 10.1111/1471-0528.13429; Sanda B, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0070-4; Santos IA, 2005, OBSTET GYNECOL, V106, P243, DOI 10.1097/01.AOG.0000171113.36624.86; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; US Department of Health and Human Services, PHYS ACT GUID ADV CO; Vinter CA, 2014, ACTA OBSTET GYN SCAN, V93, P794, DOI 10.1111/aogs.12429; WHO, 2010, GLOB REC PHYS ACT HL, V2010; YaB WJ Miller, 2005, LEISURE SCI	51	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188102	10.1371/journal.pone.0188102	http://dx.doi.org/10.1371/journal.pone.0188102			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176762	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000416291900038
J	Shen, C; Li, XM; Zhang, RT; Lin, ZX				Shen, Chao; Li, Ximei; Zhang, Ruiting; Lin, Zhongxu			Genome-wide recombination rate variation in a recombination map of cotton	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; PROVIDES INSIGHTS; EVOLUTION; SEQUENCE; GENES; RESISTANCE; DATABASE; MAIZE; TOOL; HOT	Recombination is crucial for genetic evolution, which not only provides new allele combinations but also influences the biological evolution and efficacy of natural selection. However, recombination variation is not well understood outside of the complex species' genomes, and it is particularly unclear in Gossypium. Cotton is the most important natural fibre crop and the second largest oil-seed crop. Here, we found that the genetic and physical maps distances did not have a simple linear relationship. Recombination rates were unevenly distributed throughout the cotton genome, which showed marked changes along the chromosome lengths and recombination was completely suppressed in the centromeric regions. Recombination rates significantly varied between A-subgenome (At) (range = 1.60 to 3.26 centimorgan/megabase [cM/Mb]) and D-subgenome (Dt) (range = 2.17 to 4.97 cM/Mb), which explained why the genetic maps of At and Dt are similar but the physical map of Dt is only half that of At. The translocation regions between A02 and A03 and between A04 and A05, and the inversion regions on A10, D10, A07 and D07 indicated relatively high recombination rates in the distal regions of the chromosomes. Recombination rates were positively correlated with the densities of genes, markers and the distance from the centromere, and negatively correlated with transposable elements (TEs). The gene ontology (GO) categories showed that genes in high recombination regions may tend to response to environmental stimuli, and genes in low recombination regions are related to mitosis and meiosis, which suggested that they may provide the primary driving force in adaptive evolution and assure the stability of basic cell cycle in a rapidly changing environment. Global knowledge of recombination rates will facilitate genetics and breeding in cotton.	[Shen, Chao; Li, Ximei; Zhang, Ruiting; Lin, Zhongxu] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Li, Ximei] Qingdao Agr Univ, Coll Agron & Plant Protect, Shandong Key Lab Dryland Farming Technol, Qingdao, Shandong, Peoples R China	Huazhong Agricultural University; Qingdao Agricultural University	Lin, ZX (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	linzhongxu@mail.hzau.edu.cn	shen, chao/GZL-3987-2022	Shen, Chao/0000-0001-5483-3348	National Natural Science Foundation of China [31371674]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 31371674). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; BERNATZKY R, 1986, GENETICS, V112, P887; Blenda A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-132; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Gion JM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2884-y; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gore MA, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.07.0023; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Khan MKR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00436; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kunzel G, 2000, GENETICS, V154, P397; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li XM, 2016, DNA RES, V23, P283, DOI 10.1093/dnares/dsw016; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Ott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022306; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rezvoy C, 2007, BIOINFORMATICS, V23, P2188, DOI 10.1093/bioinformatics/btm315; Rodgers-Melnick E, 2015, P NATL ACAD SCI USA, V112, P3823, DOI 10.1073/pnas.1413864112; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Si WN, 2015, NEW PHYTOL, V206, P1491, DOI 10.1111/nph.13319; Sun P, 2011, FEBS J, V278, P3748, DOI 10.1111/j.1742-4658.2011.08293.x; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walling JG, 2006, GENETICS, V172, P1893, DOI 10.1534/genetics.105.051466; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0678-1; Webster MT, 2012, TRENDS GENET, V28, P101, DOI 10.1016/j.tig.2011.11.002; Wu JZ, 2003, PLANT J, V36, P720, DOI 10.1046/j.1365-313X.2003.01903.x; Yang L, 2007, BIOINFORMATICS, V23, P2174, DOI 10.1093/bioinformatics/btm296; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110; Yu J, NUCL ACIDS RES, V42, pD1229; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188682	10.1371/journal.pone.0188682	http://dx.doi.org/10.1371/journal.pone.0188682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176878	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900116
J	Baaziz, H; Gambari, C; Boyeldieu, A; Chaouche, AA; Alatou, R; Mejean, V; Jourlin-Castelli, C; Fons, M				Baaziz, Hiba; Gambari, Cyril; Boyeldieu, Anne; Chaouche, Amine Ali; Alatou, Radia; Mejean, Vincent; Jourlin-Castelli, Cecile; Fons, Michel			ChrA(SO), the chromate efflux pump of Shewanella oneidensis, improves chromate survival and reduction	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; HEXAVALENT CHROMIUM; PSEUDOMONAS-PUTIDA; ESCHERICHIA-COLI; RESISTANCE; GENES; MECHANISMS; EXPRESSION; CLONING; CR(VI)	The chromate efflux pump encoding gene chrA(SO) was identified on the chromosome of Shewanella oneidensis MR1. Although chrA(SO) is expressed without chromate, its expression level increases when Cr(VI) is added. When deleted, the resulting mutant Delta chrA(SO) exhibits a chromate sensitive phenotype compared to that of the wild-type strain. Interestingly, heterologous expression of chrA(SO) in E. coli confers resistance to high chromate concentration. Moreover, expression of chrA(SO) in S. oneidensis and E. coli significantly improves Cr(VI) reduction. This effect could result either from extracytoplasmic chromate reduction or from a better cell survival leading to enhanced Cr(VI) reduction.	[Baaziz, Hiba; Gambari, Cyril; Boyeldieu, Anne; Chaouche, Amine Ali; Mejean, Vincent; Jourlin-Castelli, Cecile; Fons, Michel] Aix Marseille Univ, CNRS, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterrane, Marseille, France; [Baaziz, Hiba; Alatou, Radia] Univ Freres Mentouri Constantine 1, Lab Biol Mol & Cellulaire, Constantine, Algeria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Jourlin-Castelli, C; Fons, M (corresponding author), Aix Marseille Univ, CNRS, Unite Bioenerget & Ingn Prot, Inst Microbiol Mediterrane, Marseille, France.	jourlin@imm.cnrs.fr; mfons@imm.cnrs.fr		Mejean, Vincent/0000-0001-6533-5846; hakim, baaziz/0000-0003-4860-2740; Fons, Michel/0000-0001-8263-3669; Jourlin-Castelli, Cecile/0000-0001-8581-2590	Centre National de la Recherche Scientifique; Aix-Marseille Universite; HTS-BIO [152660]; Universite de Constantine 1; MESR fellowship; Conseil General PACA	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; HTS-BIO; Universite de Constantine 1; MESR fellowship; Conseil General PACA	The authors acknowledge funding by the Centre National de la Recherche Scientifique (www.cnrs.fr), Aix-Marseille Universite (www.univ-amu.fr) and HTS-BIO (www.htsbio.com, Grant No 152660). H.B. was supported by Universite de Constantine 1. A.B. was supported by a MESR fellowship. C.G. was supported by the Conseil General PACA (www.regionpaca.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x; Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Acosta-Navarrete YM, 2014, MICROBIOL-SGM, V160, P287, DOI 10.1099/mic.0.073783-0; Aguilar-Barajas E, 2008, FEMS MICROBIOL LETT, V285, P97, DOI 10.1111/j.1574-6968.2008.01220.x; Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Belchik SM, 2011, APPL ENVIRON MICROB, V77, P4035, DOI 10.1128/AEM.02463-10; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Branco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077987; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1111/j.1574-6976.2001.tb00581.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chardin B, 2003, APPL MICROBIOL BIOT, V63, P315, DOI 10.1007/s00253-003-1390-8; Chourey K, 2009, J PROTEOME RES, V8, P59, DOI 10.1021/pr800776d; Diaz-Perez C, 2007, FEBS J, V274, P6215, DOI 10.1111/j.1742-4658.2007.06141.x; ERASO JM, 1992, J BACTERIOL, V174, P5101, DOI 10.1128/JB.174.15.5101-5109.1992; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00746; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Juhnke S, 2002, ARCH MICROBIOL, V179, P15, DOI 10.1007/s00203-002-0492-5; LLAGOSTERA M, 1986, ENVIRON MOL MUTAGEN, V8, P571, DOI 10.1002/em.2860080408; Michel C, 2001, APPL MICROBIOL BIOT, V55, P95, DOI 10.1007/s002530000467; MILLER J H, 1972, P466; Miranda AT, 2005, MUTAT RES-FUND MOL M, V578, P202, DOI 10.1016/j.mrfmmm.2005.05.018; Muller J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-119; Mugerfeld I, 2009, APPL MICROBIOL BIOT, V82, P1131, DOI 10.1007/s00253-009-1911-1; Myers CR, 2000, J APPL MICROBIOL, V88, P98, DOI 10.1046/j.1365-2672.2000.00910.x; Pal A, 2005, CURR MICROBIOL, V51, P327, DOI 10.1007/s00284-005-0048-4; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Pimentel BE, 2002, FEMS MICROBIOL LETT, V212, P249, DOI 10.1111/j.1574-6968.2002.tb11274.x; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Reyes-Gallegos RI, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1996-x; Thatoi H, 2014, J ENVIRON MANAGE, V146, P383, DOI 10.1016/j.jenvman.2014.07.014; URONE PF, 1955, ANAL CHEM, V27, P1354, DOI 10.1021/ac60104a048; Viamajala S, 2002, BIOTECHNOL BIOENG, V78, P770, DOI 10.1002/bit.10261; Viti C, 2014, FEMS MICROBIOL REV, V38, P633, DOI 10.1111/1574-6976.12051	39	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188516	10.1371/journal.pone.0188516	http://dx.doi.org/10.1371/journal.pone.0188516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166414	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300044
J	Bochaton, T; Mewton, N; Thiam, N; Lavocat, F; Baetz, D; Dufay, N; Prieur, C; Bonnefoy-Cudraz, E; Miossec, P; Ovize, M				Bochaton, Thomas; Mewton, Nathan; NDieme Thiam; Lavocat, Fabien; Baetz, Delphine; Dufay, Nathalie; Prieur, Cyril; Bonnefoy-Cudraz, Eric; Miossec, Pierre; Ovize, Michel			Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; INFLAMMATORY RESPONSE; DISEASE-ACTIVITY; IL-17; MECHANISMS; EXPRESSION; MORTALITY; APOPTOSIS; CELLS; HEART	Background Recently, it was shown that interleukin-17A (IL-17A) is involved in the pathophysiology of reperfusion injury and associated with infarct size (IS) in experimental models of myocardial infarction. Our aim was to evaluate whether the IL-17A serum level and the IL-17A active fraction was correlated with IS in humans. Methods 101 patients presenting with a ST-elevated Myocardial Infarction (STEMI) referred for primary percutaneous coronary intervention (PPCI) and 10 healthy controls were included. For each participant, blood samples at admission (H0) and 4 hours after admission (H4) were collected. IL-17A serum levels were assessed using ELISA and the active fraction was assessed with a functional test. IS was determined by peak troponin and peak CK levels for every patient and by contrast-enhanced cardiac magnetic resonance (ce-CMR) for 20 patients. Results The IL-17A serum level was significantly increased in STEMI patients compared to healthy controls, (0.9 pg/mL IQR [0.0-3.2] at H0 and 1.0 pg/mL IQR [0.2-2.8] at H4 versus 0.2 pg/mL IQR [0.0-0.7] for healthy controls; p<0.005). At either time points, IL-17A levels did not correlate with IS as measured by peak troponin, peak CK pr ce-CMR. Also, no correlation was found between the active fraction of IL-17A and IS. Conclusion Serum IL-17A level is significantly increased in patients at the early phase of acute MI compared to healthy controls. However, the level of IL-17A in the early hours after reperfusion does not correlate with IS.	[Bochaton, Thomas; Baetz, Delphine; Bonnefoy-Cudraz, Eric; Ovize, Michel] Univ Lyon, Grp Hosp Est, CarMeN Lab, INSERM U1060, Bron, France; [Bochaton, Thomas; Prieur, Cyril; Bonnefoy-Cudraz, Eric] Hosp Civils Lyon, Hop Louis Pradel, Unite Soins Intensifs Cardiol, Lyon, France; [Mewton, Nathan; Ovize, Michel] Hosp Civils Lyon, Hop Louis Pradel, Serv Explorat Fonct Cardiovasc, Lyon, France; [Mewton, Nathan; Ovize, Michel] Hosp Civils Lyon, Hop Louis Pradel, Ctr Invest Clin Lyon, Lyon, France; [NDieme Thiam; Lavocat, Fabien; Miossec, Pierre] Hop Edouard Herriot, Immunogen & Inflammat, Pavillon P, Lyon, France; [Dufay, Nathalie] Hop Neurol & Neurochirurg P Wertheimer, Grp Hosp Est, NeuroBioTec, Lyon, France	Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); CHU Lyon	Bochaton, T (corresponding author), Univ Lyon, Grp Hosp Est, CarMeN Lab, INSERM U1060, Bron, France.; Bochaton, T (corresponding author), Hosp Civils Lyon, Hop Louis Pradel, Unite Soins Intensifs Cardiol, Lyon, France.	thomas.bochaton@chu-lyon.fr	Bochaton, Thomas/AAA-9054-2021; Carmen, Team3/Y-7384-2019; Ovize, michel/AAL-9247-2020	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Baetz, Delphine/0000-0001-7678-062X				Al-Saadany HM, 2016, EGYPT RHEUMATOL, V38, P1, DOI 10.1016/j.ejr.2015.01.001; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Chia S, 2009, AM J CARDIOL, V103, P333, DOI 10.1016/j.amjcard.2008.09.085; Deftereos S, 2015, CIRCULATION, V132, P1395, DOI 10.1161/CIRCULATIONAHA.115.017611; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Fischer P, 2008, BRIT J PHARMACOL, V153, pS414, DOI 10.1038/bjp.2008.1; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fuchs M, 2003, FASEB J, V17, P2118, DOI 10.1096/fj.03-0331fje; Gabriel Amon S, 2004, Eur J Intern Med, V15, P523, DOI 10.1016/j.ejim.2004.07.013; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; GINKS WR, 1972, J CLIN INVEST, V51, P2717, DOI 10.1172/JCI107091; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hashmi S, 2006, CORONARY ARTERY DIS, V17, P699, DOI 10.1097/01.mca.0000236288.94553.b4; HERLITZ J, 1994, BRIT HEART J, V71, P238; HERSKOWITZ A, 1995, AM J PATHOL, V146, P419; Knorr M, 2014, FRONTIERS PHYSL; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Liebetrau C, 2014, HEART, V100, P652, DOI 10.1136/heartjnl-2013-305253; Maekawa N, 2002, J AM COLL CARDIOL, V39, P1229, DOI 10.1016/S0735-1097(02)01738-2; Marchant DJ, 2012, CIRC RES, V110, P126, DOI 10.1161/CIRCRESAHA.111.243170; Marioko P, 1972, J CLIN INVEST, V51; Metawi SA, 2011, CLIN RHEUMATOL, V30, P1201, DOI 10.1007/s10067-011-1737-y; Mewton N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0383-8; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Ndongo-Thiam N, 2015, ANN RHEUM DIS, V74, P1629, DOI 10.1136/annrheumdis-2014-207110; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pavlovic V, 2014, J RES MED SCI, V19, P18; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Ritschel Vibeke N, 2014, Results Immunol, V4, P8, DOI 10.1016/j.rinim.2013.11.002; de Oliveira PSS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/819149; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Simon T, 2013, EUR HEART J, V34, P570, DOI 10.1093/eurheartj/ehs263; Suinesiaputra A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0170-9; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Viallon M, 2011, J MAGN RESON IMAGING, V34, P1374, DOI 10.1002/jmri.22783; World Health Organization, 2011, GLOBAL ATLAS CARDIOV; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	45	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188202	10.1371/journal.pone.0188202	http://dx.doi.org/10.1371/journal.pone.0188202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166391	gold, Green Submitted, Green Published			2022-12-26	WOS:000416035300028
J	Delbarre, A; Amor, B; Bardoulat, I; Tetafort, A; Pelletier-Fleury, N				Delbarre, Angellique; Amor, Bernard; Bardoulat, Isabelle; Tetafort, Aymeric; Pelletier-Fleury, Nathalie			Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis - A Cox model analysis	PLOS ONE			English	Article							RESTRICTED MEAN-LIFE; HIP OSTEOARTHRITIS; JOINT REPLACEMENT; EFFICACY; VISCOSUPPLEMENTATION; ARTHROPLASTY; PREVALENCE; BURDEN; COST; EPIDEMIOLOGY	Due to the growing worldwide prevalence of knee osteoarthritis, the optimal management of this issue is critical for reducing its burden. Objectives This study aimed to describe patients treated for knee osteoarthritis between 2006 and 2013 in France and to compare the delay from diagnosis to total knee replacement between patients who received intra-articular hyaluronic acid injections and those who did not receive the injections. A second objective was to compare direct medical costs for ambulatory care between treatment groups. Materials and methods Patients were selected from a representative sample of the real world administrative claims database using an algorithm developed by experts from the scientific committee of the study. Data were matched with the medico-administrative database for hospital care. A Cox proportional hazards model was stratified for the treatment group and adjusted for available socio-demographic and medical covariates to compare restricted mean survival times at different time points (1, 3, 5 and 7.5 years) between groups. Costs were expressed in 2013 euros. Results A total of 14,782 patients were treated for knee osteoarthritis (67% women; mean age = 68 years). Among this population, 1,662 patients had total knee replacement (11.2%). At each time point, restricted mean survival time without total knee replacement was significantly higher (p-values<0.001) for hyaluronic acid group, from +51 to +217 days at 1 and 7.5 years, respectively. For the year preceding total knee replacement, the means for total direct medical costs were similar between groups, (sic)744 vs (sic)805 for treatment and control groups, respectively, (p-value = 0.104). Intra-articular injections accounted for less than 10% of the total costs. Conclusion This is the first retrospective longitudinal study involving knee osteoarthritis patients using medico-administrative databases in France. The results support the effectiveness of hyaluronic acid injections in delaying total knee replacement and show that patients treated with hyaluronic acid have similar direct medical costs for ambulatory care compared to patients treated with corticosteroids only.	[Delbarre, Angellique; Pelletier-Fleury, Nathalie] Univ Paris Sud, INSERM, Ctr Res Epidemiol & Populat Hlth, Univ Paris Saclay,UVSQ, Villejuif, France; [Amor, Bernard] Univ Paris 05, Paris, France; [Bardoulat, Isabelle; Tetafort, Aymeric] QuintilesIMS, Paris 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; IQVIA	Delbarre, A (corresponding author), Univ Paris Sud, INSERM, Ctr Res Epidemiol & Populat Hlth, Univ Paris Saclay,UVSQ, Villejuif, France.	angelique.delbarre@inserm.fr	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863	LCA Pharmaceutical, Chartres	LCA Pharmaceutical, Chartres	This French study was funded by LCA Pharmaceutical, Chartres. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Altman R, 2016, J KNEE SURG, V29, P564, DOI 10.1055/s-0035-1568992; Altman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145776; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Assurance Maladie, 2012, PROP ASS MAL CHARG P; Bannay A, 2016, MED CARE, V54, P188, DOI 10.1097/MLR.0000000000000471; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannuru RR, 2014, SEMIN ARTHRITIS RHEU, V43, P593, DOI 10.1016/j.semarthrit.2013.10.002; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bedard NA, 2017, J ARTHROPLASTY; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Bruyere O, 2015, SEMIN ARTHRITIS RHEU; Campbell KA, 2015, ARTHROSCOPY, V31, P2036, DOI 10.1016/j.arthro.2015.03.030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen PY, 2001, BIOMETRICS, V57, P1030, DOI 10.1111/j.0006-341X.2001.01030.x; Colen S, 2012, BIODRUGS, V26, P257, DOI 10.2165/11632580-000000000-00000; Cooper C., 2017, ARTHRITIS CARE RES; Erturk C, 2016, KNEE SURG SPORT TR A, V24, P3653, DOI 10.1007/s00167-014-3398-2; Fautrel B, 2005, JOINT BONE SPINE, V72, P235, DOI 10.1016/j.jbspin.2004.08.009; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gioe TJ, 2007, CLIN ORTHOP RELAT R, P83, DOI 10.1097/BLO.0b013e31812f79a9; Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Guillemin F, 2012, JOINT BONE SPINE, V79, P597, DOI 10.1016/j.jbspin.2012.03.011; Henrotin Y, 2015, SEMIN ARTHRITIS RHEU, V45, P140, DOI 10.1016/j.semarthrit.2015.04.011; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; KARRISON T, 1987, J AM STAT ASSOC, V82, P1169, DOI 10.2307/2289396; Khan M, 2016, BONE JOINT J, V98B, P105, DOI [10.1302/0301-620X.98B1.36293, 10.1302/0301-620X.9881.36293]; Kostyuk A, 2015, VALUE HEALTH, V18, pA647, DOI 10.1016/j.jval.2015.09.2322; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lanes SF, 1997, ARTHRITIS RHEUM-US, V40, P1475, DOI 10.1002/art.1780400816; Le Pen C, 2005, JOINT BONE SPINE, V72, P567, DOI 10.1016/j.jbspin.2005.01.011; Leardini G, 2004, CLIN EXP RHEUMATOL, V22, P699; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Loza E, 2009, ARTHRIT RHEUM-ARTHR, V61, P158, DOI 10.1002/art.24214; Maheu E, 2016, SEMIN ARTHRITIS RHEU, V45, pS28, DOI 10.1016/j.semarthrit.2015.11.008; Mar J, 2013, Rev Esp Cir Ortop Traumatol, V57, P6, DOI 10.1016/j.recot.2012.08.006; March LM, 1997, BAILLIERE CLIN RHEUM, V11, P817, DOI 10.1016/S0950-3579(97)80011-8; Martin KR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-219; Mazieres B, 2007, JOINT BONE SPINE, V74, P453, DOI 10.1016/j.jbspin.2007.01.037; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Merle-Vincent F, 2007, JOINT BONE SPINE, V74, P612, DOI 10.1016/j.jbspin.2007.01.038; Murphy LB, 2016, ARTHRIT CARE RES, V68, P55, DOI 10.1002/acr.22641; Neustadt DH, 2003, CLIN EXP RHEUMATOL, V21, P307; Nichols CI, 2016, J ARTHROPLASTY, V31, P1400, DOI 10.1016/j.arth.2016.01.022; Ong KL, 2016, J ARTHROPLASTY; Ozturk C, 2006, RHEUMATOL INT, V26, P314, DOI 10.1007/s00296-005-0584-z; Petrella RJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0513-6; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; Riddle DL, 2012, JOINT BONE SPINE, V79, P298, DOI 10.1016/j.jbspin.2011.05.005; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Tanna S, 2013, BACKGROUND PAPER 612; Thomas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173683; Turajane Thana, 2009, J Med Assoc Thai, V92 Suppl 6, pS63; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001; Waddell DD, 2016, J KNEE SURG, V29, P159, DOI 10.1055/s-0034-1395281; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Zhang X, 2013, BIO-ALGORITHMS MED-S, V9, P183, DOI 10.1515/bams-2013-0101; Zucker DM, 1998, J AM STAT ASSOC, V93, P702, DOI 10.2307/2670120	62	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187227	10.1371/journal.pone.0187227	http://dx.doi.org/10.1371/journal.pone.0187227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155833	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700007
J	Dietert, K; Gutbier, B; Wienhold, SM; Reppe, K; Jiang, XH; Yao, L; Chaput, C; Naujoks, J; Brack, M; Kupke, A; Peteranderl, C; Becker, S; von Lachner, C; Baal, N; Slevogt, H; Hocke, AC; Witzenrath, M; Opitz, B; Herold, S; Hackstein, H; Sander, LE; Suttorp, N; Gruber, AD				Dietert, Kristina; Gutbier, Birgitt; Wienhold, Sandra M.; Reppe, Katrin; Jiang, Xiaohui; Yao, Ling; Chaput, Catherine; Naujoks, Jan; Brack, Markus; Kupke, Alexandra; Peteranderl, Christin; Becker, Stephan; von Lachner, Carolin; Baal, Nelli; Slevogt, Hortense; Hocke, Andreas C.; Witzenrath, Martin; Opitz, Bastian; Herold, Susanne; Hackstein, Holger; Sander, Leif E.; Suttorp, Norbert; Gruber, Achim D.			Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ACUTE LUNG INJURY; PNEUMOCOCCAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; LEGIONELLA-PNEUMOPHILA; PULMONARY CLEARANCE; LIPOTEICHOIC ACID; MURINE MODEL; EXPRESSION; INFLUENZA	Pneumonia may be caused by a wide range of pathogens and is considered the most common infectious cause of death in humans. Murine acute lung infection models mirror human pathologies in many aspects and contribute to our understanding of the disease and the development of novel treatment strategies. Despite progress in other fields of tissue imaging, histopathology remains the most conclusive and practical read out tool for the descriptive and semiquantitative evaluation of mouse pneumonia and therapeutic interventions. Here, we systematically describe and compare the distinctive histopathological features of established models of acute pneumonia in mice induced by Streptococcus (S.) pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Legionella pneumophila, Escherichia coli, Middle East respiratory syndrome (MERS) coronavirus, influenza A virus (IAV) and superinfection of IAV-incuced pneumonia with S. pneumoniae. Systematic comparisons of the models revealed striking differences in the distribution of lesions, the characteristics of pneumonia induced, principal inflammatory cell types, lesions in adjacent tissues, and the detectability of the pathogens in histological sections. We therefore identified core criteria for each model suitable for practical semiquantitative scoring systems that take into account the pathogen-and model-specific patterns of pneumonia. Other critical factors that affect experimental pathologies are discussed, including infectious dose, time kinetics, and the genetic background of the mouse strain. The substantial differences between the model-specific pathologies underscore the necessity of pathogen-and model-adapted criteria for the comparative quantification of experimental outcomes. These criteria also allow for the standardized validation and comparison of treatment strategies in preclinical models.	[Dietert, Kristina; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Gutbier, Birgitt; Wienhold, Sandra M.; Reppe, Katrin; Jiang, Xiaohui; Yao, Ling; Chaput, Catherine; Naujoks, Jan; Brack, Markus; Hocke, Andreas C.; Witzenrath, Martin; Opitz, Bastian; Sander, Leif E.; Suttorp, Norbert] Charite Univ Med Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Kupke, Alexandra; Peteranderl, Christin; Becker, Stephan; Herold, Susanne] UGMLC, Sect Infect Dis, Dept Internal Med 2, German Ctr Lung Res DZL, Giessen, Germany; [Kupke, Alexandra; Becker, Stephan] Philipps Univ Marburg, German Ctr Infect Res DZIF, TTU Emerging Infect, Inst Virol, Marburg, Germany; [von Lachner, Carolin; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany; [Baal, Nelli; Hackstein, Holger] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, German Ctr Lung Res DZL, Inst Clin Immunol & Transfus Med,UGMLC, Giessen, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Philipps University Marburg; Friedrich Schiller University of Jena; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Gruber, AD (corresponding author), Free Univ Berlin, Dept Vet Pathol, Berlin, Germany.	achim.gruber@fu-berlin.de	Sander, Leif Erik/AAI-8619-2020; Gruber, Achim D./ABA-4514-2021	Dietert, Kristina/0000-0002-5667-6750; Opitz, Bastian/0000-0003-1276-836X; Peteranderl, Christin/0000-0003-3799-8268; Yao, Ling/0000-0002-0482-9604; Brack, Markus Christian/0000-0002-9012-3957; Suttorp, Norbert/0000-0002-3958-1151	German Research Foundation (DFG) [SFB-TR 84]; DFG [KFO 309, SFB-1021, EXC147]; excellence graduate school Jena School for Microbial Communication	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); excellence graduate school Jena School for Microbial Communication	This work was supported by the German Research Foundation (DFG) SFB-TR 84 (https://www.sfb-tr84.de/) A1, A5 (to B.O.), B2 (to S.H.), B3 (to H.H), C3, C6 (to M.W.), C8 (to L.E.S), Z1a (to A.C.H.), Z1b (to A.D.G.), DFG KFO 309 (http:// www.kfo309.de/) P2 (to S.B., S.H. and C.P.), P8 (to S.H.), DFG SFB-1021 (http://www.sfb1021.de/) C5 (to S.H.), EXC147 (http://www.eccps.de/) (to S.H.) and the excellence graduate school Jena School for Microbial Communication (JSMC, to H.S.)(http:// www.jsmc.uni-jena.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad TA, 2012, VACCINE, V30, P2411, DOI 10.1016/j.vaccine.2011.11.027; Al-Tawfiq JA, 2014, TRENDS MICROBIOL, V22, P573, DOI 10.1016/j.tim.2014.08.001; Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Archer KA, 2009, CELL MICROBIOL, V11, P21, DOI 10.1111/j.1462-5822.2008.01234.x; Aulmann W, 2012, REGUL TOXICOL PHARM, V63, P286, DOI 10.1016/j.yrtph.2012.03.003; Cauvi DM, 2014, SHOCK, V42, P246, DOI 10.1097/SHK.0000000000000207; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; de Almeida SA, 2017, BIOMED PHARMACOTHER, V86, P715, DOI 10.1016/j.biopha.2016.11.146; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Fodah RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107394; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2001, ARCH PEDIATRIE, V8, p742S, DOI 10.1016/S0929-693X(01)80190-1; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Gutbier B, 2015, AM J PHYSIOL-LUNG C, V309, pL250, DOI 10.1152/ajplung.00265.2014; Gutbier B, 2010, PULM PHARMACOL THER, V23, P334, DOI 10.1016/j.pupt.2010.03.007; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hackstein H, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0288-1; Hackstein H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-91; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Harkema JR, 2017, TOXICOL PATHOL, V45, P161, DOI 10.1177/0192623316674274; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Hocke AC, 2007, CYTOKINE, V38, P61, DOI 10.1016/j.cyto.2007.05.009; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; JARVIS WR, 1985, INFECT CONT HOSP EP, V6, P68, DOI 10.1017/S0195941700062639; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Joseph NM, 2009, J INFECT DEV COUNTR, V3, P771, DOI 10.3855/jidc.396; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kipar A, 2007, J VET MED EDUC, V34, P485, DOI 10.3138/jvme.34.4.485; Kipar A, 2007, J VET MED EDUC, V34, P473, DOI 10.3138/jvme.34.4.473; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lammers AJJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-139; Lawrenz MB, 2014, JOVE-J VIS EXP, DOI 10.3791/52261; Leist SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2483-y; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Lode HM, 2007, RESP MED, V101, P1864, DOI 10.1016/j.rmed.2007.04.008; Lorente L, 2007, EUR RESPIR J, V30, P1193, DOI 10.1183/09031936.00048507; Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Muller-Redetzky HC, 2015, J ANTIMICROB CHEMOTH, V70, P830, DOI 10.1093/jac/dku446; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; Patil Harsha V, 2017, J Nat Sci Biol Med, V8, P46, DOI 10.4103/0976-9668.198360; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004; Pletz M W, 2012, Pneumologie, V66, P470; Pletz MW, 2011, DEUT MED WOCHENSCHR, V136, P775, DOI 10.1055/s-0031-1275806; Rello J, 2014, LANCET RESP MED, V2, P764, DOI 10.1016/S2213-2600(14)70171-7; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Reppe K, 2015, INFECT IMMUN, V83, P4617, DOI 10.1128/IAI.00948-15; Reppe K, 2009, AM J RESP CELL MOL, V40, P474, DOI 10.1165/rcmb.2008-0071OC; Sabria Miguel, 2003, Am J Respir Med, V2, P235; Sakthivel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100970; Schauer AE, 2017, J INNATE IMMUN, V9, P403, DOI 10.1159/000469661; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Torres A, 2010, CLIN INFECT DIS, V51, pS48, DOI 10.1086/653049; Vergis EN, 2000, SEMIN RESP CRIT CARE, V21, P295, DOI 10.1055/s-2000-9934; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; West MA, 2017, CRIT REV ONCOL HEMAT, V112, P80, DOI 10.1016/j.critrevonc.2017.02.008; Widagdo W, 2016, J VIROL, V90, P4838, DOI 10.1128/JVI.02994-15; World Health Organization, 2014, MIDDL E RESP SYNDR C; Xiong HZ, 2015, INFECT IMMUN, V83, P3418, DOI 10.1128/IAI.00678-15; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zhou Tao, 2004, Zhonghua Er Ke Za Zhi, V42, P644	85	41	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188251	10.1371/journal.pone.0188251	http://dx.doi.org/10.1371/journal.pone.0188251			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155867	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700039
J	Koessler, J; Schwarz, M; Weber, K; Etzel, J; Koessler, A; Boeck, M; Kobsar, A				Koessler, Juergen; Schwarz, Michaela; Weber, Katja; Etzel, Julia; Koessler, Angela; Boeck, Markus; Kobsar, Anna			The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions	PLOS ONE			English	Article							IN-VITRO; VASP PHOSPHORYLATION; STORED PLATELETS; MOLECULAR-BASIS; ADP RECEPTORS; ACTIVATION; STORAGE; 37-DEGREES-C; AGGREGATION; TRANSFUSION	Background Platelets are important for effective hemostasis and considered to be involved in pathophysiological processes, e.g. in cardiovascular diseases. Platelets provided for research or for therapeutic use are frequently separated from citrated whole blood (WB) stored for different periods of time. Although functionally intact platelets are required, the stability of platelet integrity, e.g. adenosine diphosphate (ADP) mediated responsiveness, has never been thoroughly investigated in citrated WB under ex vivo conditions. Objectives Platelet integrity was evaluated at different time points in citrated WB units, collected from healthy donors and stored for 5 days at ambient temperature. The analysis included the measurement of activation markers, of induced light transmission aggregometry and of purinergic receptor expression or function. Inhibitory pathways were explored by determination of basal vasodilator-stimulated phosphoprotein (VASP)-phosphorylation, intracellular cyclic nucleotide levels and the content of phosphodiesterase 5A. Fresh peripheral blood (PB) samples served as controls. Results On day 5 of storage, thrombin receptor activating peptide-6 (TRAP-6) stimulated CD62P expression and fibrinogen binding were comparable to PB samples. ADP induced aggregation continuously decreased during storage. Purinergic receptor expression remained unchanged, whereas the P2Y1 activity progressively declined in contrast to preserved P2Y12 and P2X1 function. Inhibitory pathways were unaffected except for a slight elevation of VASP phosphorylation at Ser(239) on day 5. Conclusion After 5 days of storage in citrated WB, platelet responsiveness to TRAP-6 is sufficiently maintained. However, ADP-mediated platelet integrity is more sensitive to deterioration, especially after storage for more than 2 days. Decreasing ADP-induced aggregation is particularly caused by the impairment of the purinergic receptor P2Y1 activity. These characteristics should be considered in the use of platelets from stored citrated WB for experimental or therapeutic issues.	[Koessler, Juergen; Schwarz, Michaela; Weber, Katja; Etzel, Julia; Koessler, Angela; Boeck, Markus; Kobsar, Anna] Univ Wurzburg, Inst Transfus Med & Haemotherapy, Wurzburg, Germany	University of Wurzburg	Koessler, J (corresponding author), Univ Wurzburg, Inst Transfus Med & Haemotherapy, Wurzburg, Germany.	koessler_j@ukw.de			German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleil B, 2005, THROMB HAEMOSTASIS, V94, P886; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; BOCK M, 1994, HAEMOSTASIS, V24, P230; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cabeza N, 2004, DIABETES, V53, P2117, DOI 10.2337/diabetes.53.8.2117; Christie DJ, 2008, CLIN LAB STANDARDS I, V27, P46; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Fullard JF, 2004, CURR PHARM DESIGN, V10, P1567, DOI 10.2174/1381612043384682; Goforth CW, 2016, CRIT CARE NURSE, V36, P50, DOI 10.4037/ccn2016780; Gulliksson H, 2014, VOX SANG, V107, P205, DOI 10.1111/vox.12172; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOLME S, 1995, BRIT J HAEMATOL, V91, P212, DOI 10.1111/j.1365-2141.1995.tb05272.x; Hughes JD, 2007, TRANSFUSION, V47, P2050, DOI 10.1111/j.1537-2995.2007.01429.x; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Jobes D, 2011, TRANSFUSION, V51, P43, DOI 10.1111/j.1537-2995.2010.02772.x; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; Kendigelen P, 2016, ULUS TRAVMA ACIL CER, V22, P195, DOI 10.5505/tjtes.2015.40697; Kobsar A, 2014, TRANSFUSION, V54, P1782, DOI 10.1111/trf.12584; Kobsar A, 2014, TRANSFUSION, V54, P1008, DOI 10.1111/trf.12360; Kobsar AL, 2010, PLATELETS, V21, P112, DOI 10.3109/09537100903440937; Koessler J, 2016, BLOOD TRANSFUS-ITALY, V14, P545, DOI 10.2450/2015.0073-15; Koessler J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147370; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Kunapuli SP, 1998, PLATELETS, V9, P343, DOI 10.1080/09537109876401; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Lim YA, 2002, CLIN LAB HAEMATOL, V24, P377, DOI 10.1046/j.1365-2257.2002.00479.x; Liu ECK, 2006, ANAL BIOCHEM, V357, P216, DOI 10.1016/j.ab.2006.06.034; Macher S, 2010, VOX SANG, V99, P332, DOI 10.1111/j.1423-0410.2010.01353.x; McCullough J, 1973, Minn Med, V56, P980; Michelson A D, 1999, Curr Opin Hematol, V6, P342, DOI 10.1097/00062752-199909000-00012; RACZ Z, 1994, PLATELETS, V5, P40, DOI 10.3109/09537109409006039; Ramstrom S, 2008, THROMB RES, V121, P681, DOI 10.1016/j.thromres.2007.06.010; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Rijkers M, 2016, VOX SANG; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Spinella PC, 2016, TRANSFUSION, V56, pS190, DOI 10.1111/trf.13491; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; WALLAS CH, 1979, TRANSFUSION, V19, P210, DOI 10.1046/j.1537-2995.1979.19279160297.x; WALTER U, 1993, ADV EXP MED BIOL, V344, P237	43	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188193	10.1371/journal.pone.0188193	http://dx.doi.org/10.1371/journal.pone.0188193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155852	Green Published, gold			2022-12-26	WOS:000415756700035
J	Stewart, D; Gibson-Smith, K; MacLure, K; Mair, A; Alonso, A; Codina, C; Cittadini, A; Fernandez-Llimos, F; Fleming, G; Gennimata, D; Gillespie, U; Harrison, C; Junius-Walker, U; Kardas, P; Kempen, T; Kinnear, M; Lewek, P; Malva, J; McIntosh, J; Scullin, C; Wiese, B				Stewart, Derek; Gibson-Smith, Kathrine; MacLure, Katie; Mair, Alpana; Alonso, Albert; Codina, Carles; Cittadini, Antonio; Fernandez-Llimos, Fernando; Fleming, Glenda; Gennimata, Dimitra; Gillespie, Ulrika; Harrison, Cathy; Junius-Walker, Ulrike; Kardas, Przemyslaw; Kempen, Thomas; Kinnear, Moira; Lewek, Pawel; Malva, Joao; McIntosh, Jennifer; Scullin, Claire; Wiese, Birgitt			A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people	PLOS ONE			English	Article							NURSING-RESEARCH; CARE; MULTIMORBIDITY; POPULATION; PREVALENCE; GUIDELINES; SAFETY; IMPACT	Background Inappropriate use of multiple medicines (inappropriate polypharmacy) is a major challenge in older people with consequences of increased prevalence and severity of adverse drug reactions and interactions, and reduced medicines adherence. The aim of this study was to determine the levels of consensus amongst key stakeholders in the European Union (EU) in relation to aspects of the management of polypharmacy in older people. Methods Forty-six statements were developed on aspects of healthcare structures, processes and desired outcomes, with consensus defined at >= 80% agreement. Panel members were strategists (e.g. directors, leading clinicians and commissioners) from each of the 28 EU member states, with a target recruitment of five per member state. Three Delphi rounds were conducted via email, with panel members being provided with summative results and collated, anonymised comments at the commencement of Rounds 2 and 3. Results Ninety panel members were recruited (64.3% of target), with high participation levels throughout the three Delphi rounds (91.1%, 83.3%, 72.2%). During Round 1, consensus was obtained for 27/46 statements (58.7%), with an additional two statements in Round 2 and none in Round 3. Consensus was obtained for statements relating to: potential gain arising from polypharmacy management (3/4 statements); strategic development (7/7); change management (5/7) indicator measures (4/6); legislation (0/3); awareness raising (5/5); polypharmacy reviews (5/7); and EU vision (0/7). Analysis of free text comments indicated that the vision statements were too ambitious and not achievable by the specified timeframe of 2025. Conclusion Consensus was obtained amongst key EU strategists around many aspects of polypharmacy management in older people. Notably, no consensus was achieved in relation to statements relating to the need to alter legislation in areas of healthcare delivery, remuneration and practitioner scope of practice. While the vision for the EU by 2025 was considered rather ambitious, there is great potential and clear opportunity to advance polypharmacy management throughout the EU and beyond.	[Stewart, Derek; Gibson-Smith, Kathrine; MacLure, Katie] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Mair, Alpana] Scottish Govt, Effect Prescribing & Therapeut Hlth & Social Care, Edinburgh, Midlothian, Scotland; [Alonso, Albert; McIntosh, Jennifer] FCRB, Directorate Res & Innovat, Barcelona, Spain; [Codina, Carles] Hosp Clin Barcelona, Pharm Dept, Barcelona, Spain; [Cittadini, Antonio] Univ Federico II, Dept Translat Med Sci, Naples, Italy; [Fernandez-Llimos, Fernando] Univ Lisbon, Fac Pharm, Dept Social Pharm, Inst Med Res iMed Ulisboa, Lisbon, Portugal; [Fleming, Glenda] Northern Hlth & Social Care Trust, Med Optimisat Innovat Ctr, Belfast, Antrim, North Ireland; [Gennimata, Dimitra] Univ Peloponnese, Dept Social & Educ Policy, Corinthos, Greece; [Gillespie, Ulrika; Kempen, Thomas] Uppsala Univ Hosp, Pharm Dept, Uppsala, Sweden; [Harrison, Cathy] Dept Hlth Social Serv & Publ Safety, Belfast, Antrim, North Ireland; [Junius-Walker, Ulrike; Wiese, Birgitt] Hannover Med Sch, Inst Gen Med, Hannover, Germany; [Kardas, Przemyslaw; Lewek, Pawel] Med Univ Lodz, Dept Family Med, Lodz, Poland; [Kinnear, Moira] Western Gen Hosp, NHS Lothian Pharm Serv, Edinburgh, Midlothian, Scotland; [Malva, Joao] Univ Coimbra, Fac Med, Coimbra, Portugal; [Scullin, Claire] Queens Univ, Sch Pharm, Belfast, Antrim, North Ireland	Robert Gordon University; University of Barcelona; Hospital Clinic de Barcelona; University of Naples Federico II; Universidade de Lisboa; Uppsala University; Uppsala University Hospital; Hannover Medical School; Medical University Lodz; University of Edinburgh; Universidade de Coimbra; Queens University Belfast	Stewart, D (corresponding author), Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland.	d.stewart@rgu.ac.uk	MacLure, Katie/GRJ-8912-2022; Fernandez-Llimos, Fernando/B-8931-2008; iMed.ULisboa, PEPSocPh/B-4101-2014; Malva, Joao/L-3557-2014	Fernandez-Llimos, Fernando/0000-0002-8529-9595; Lewek, Pawel/0000-0003-3690-7096; Stewart, Derek/0000-0001-7360-8592; fleming, glenda/0000-0001-7321-8092; Kardas, Przemyslaw/0000-0002-6078-2628; Malva, Joao/0000-0002-5438-4447; Alonso, Albert/0000-0003-0921-8033; MacLure, Katie/0000-0003-0686-948X; Kempen, Thomas/0000-0001-5173-5005	SIMPATHY project [663082]; European Commission CHAFEA Health Program; Public Health Agency [SPI/5309/16] Funding Source: researchfish	SIMPATHY project; European Commission CHAFEA Health Program; Public Health Agency	This work has been supported by the SIMPATHY project, grant agreement number 663082, co-funded by the European Commission CHAFEA Health Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beuscart JB, 2017, BRIT J CLIN PHARMACO, V83, P942, DOI 10.1111/bcp.13197; Cadogan CA, 2016, DRUG SAFETY, V39, P109, DOI 10.1007/s40264-015-0378-5; Campbell SM, 2001, J CLIN PHARM THER, V26, P5, DOI 10.1046/j.1365-2710.2001.00331.x; Clayton MJ, 1997, ED PSYCHOL, V17, P373, DOI [DOI 10.1080/0144341970170401, 10.1080/0144341970170401]; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Craig P, 2008, BMJ-BRIT MED J, V337, pa1665; Dwyer LL, 2010, AM J GERIATR PHARMAC, V8, P63, DOI 10.1016/j.amjopharm.2010.01.001; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hazen AC, 2017, RES SOCIAOL IN PRESS; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P218, DOI 10.1258/135581906778476553; Johansson T, 2016, BRIT J CLIN PHARMACO, V82, P532, DOI 10.1111/bcp.12959; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaufmann CP, 2014, EUR J CLIN PHARMACOL, V70, P1, DOI 10.1007/s00228-013-1575-8; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Kenz HE, 2014, HEART CHANGE, V31, P345; Kirkpatrick SA, 2016, ACAD MANAGEMENT P, P10225; Koberlein J, 2013, GRUYTER, V25, P243; Millar AN, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1915-6; Organization WH, 2015, SUMM WORLD REP AG HL; Ornstein SM, 2013, J AM BOARD FAM MED, V26, P518, DOI 10.3122/jabfm.2013.05.130012; Paparella G., 2016, PERSON CTR CARE EURO; Patterson SM, 2014, COCHRANE DB SYST REV, P10, DOI DOI 10.1002/14651858.CD008165.PUB3/FULL; Payne RA, 2014, EUR J CLIN PHARMACOL, V70, P575, DOI 10.1007/s00228-013-1639-9; Payne RA, 2011, BRIT J GEN PRACT, V61, P83, DOI 10.3399/bjgp11X556146; Schien E, 1995, ORG CULTURE LEADERSH; Smith M, 2013, HEALTH AFFAIR, V32, P1963, DOI 10.1377/hlthaff.2013.0542; Stewart D, 2017, EXPERT OPIN DRUG SAF, V16, P203, DOI 10.1080/14740338.2017.1265503; Stewart D, 2012, BRIT J CLIN PHARMACO, V74, P662, DOI 10.1111/j.1365-2125.2012.04204.x; Valentijn PP, 2013, INT J INTEGR CARE, V13; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Walsh EK, 2017, PHARMACOEPIDEM DR S, V26, P481, DOI 10.1002/pds.4188; Weaver SJ, 2013, ANN INTERN MED, V158, P369, DOI 10.7326/0003-4819-158-5-201303051-00002; WHO, 2015, WHO GLOB STRAT PEOPL	39	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188348	10.1371/journal.pone.0188348	http://dx.doi.org/10.1371/journal.pone.0188348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155870	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700050
J	Ben Gharbia, H; Yahia, OKD; Cecchi, P; Masseret, E; Amzil, Z; Herve, F; Rovillon, G; Nouri, H; M'Rabet, C; Couet, D; Triki, HZ; Laabir, M				Ben Gharbia, Hela; Yahia, Ons Kefi-Daly; Cecchi, Philippe; Masseret, Estelle; Amzil, Zouher; Herve, Fabienne; Rovillon, Georges; Nouri, Habiba; M'Rabet, Charaf; Couet, Douglas; Triki, Habiba Zmerli; Laabir, Mohamed			New insights on the species-specific allelopathic interactions between macrophytes and marine HAB dinoflagellates	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; HARMFUL ALGAL BLOOMS; GRACILARIA-LEMANEIFORMIS RHODOPHYTA; ULVA-LINZA CHLOROPHYTA; WATER-SOLUBLE EXTRACTS; CYMODOCEA-NODOSA; PROROCENTRUM-LIMA; MYRIOPHYLLUM-SPICATUM; ZOSTERA-MARINA; MICROCYSTIS-AERUGINOSA	Macrophytes are known to release allelochemicals that have the ability to inhibit the proliferation of their competitors. Here, we investigated the effects of the fresh leaves of two magnoliophytes (Zostera noltei and Cymodocea nodosa) and thalli of the macroalgae Ulva rigida on three HAB-forming benthic dinoflagellates (Ostreopsis cf. ovata, Prorocentrum lima, and Coolia monotis). The effects of C. nodosa and U. rigida were also tested against the neurotoxic planktonic dinoflagellate Alexandrium pacificum Litaker sp. nov (former Alexandrium catenella). Co-culture experiments were conducted under controlled laboratory conditions and potential allelopathic effects of the macrophytes on the growth, photosynthesis and toxin production of the targeted dinoflagellates were evaluated. Results showed that U. rigida had the strongest algicidal effect and that the planktonic A. pacificum was the most vulnerable species. Benthic dinoflagellates seemed more tolerant to potential allelochemicals produced by macrophytes. Depending on the dinoflagellate/macrophyte pairs and the weight of leaves/thalli tested, the studied physiological processes were moderately to heavily altered. Our results suggest that the allelopathic activity of the macrophytes could influence the development of HAB species.	[Ben Gharbia, Hela; Yahia, Ons Kefi-Daly; M'Rabet, Charaf; Triki, Habiba Zmerli] Univ Tunis El Manar, Res Grp Oceanog & Plankton Ecol, Tunisian Natl Inst Agron INAT, IRESA Carthage Univ,UR 13ES36 Marine Biol, Tunis, Tunisia; [Cecchi, Philippe; Masseret, Estelle; Laabir, Mohamed] Montpellier Univ, CNRS, IFREMER,IRD, Ctr Marine Biodivers Exploitat & Conservat MARBEC, Montpellier, France; [Amzil, Zouher; Herve, Fabienne; Rovillon, Georges] IFREMER, Phycotoxins Lab, F-44311 Nantes 03, France; [Nouri, Habiba; Couet, Douglas] IRD, Tunis, Tunisia; [Cecchi, Philippe] CRO, Abidjan, Cote Ivoire	Universite de Tunis-El-Manar; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Ben Gharbia, H (corresponding author), Univ Tunis El Manar, Res Grp Oceanog & Plankton Ecol, Tunisian Natl Inst Agron INAT, IRESA Carthage Univ,UR 13ES36 Marine Biol, Tunis, Tunisia.	hela.bg@hotmail.fr		Masseret, Estelle/0000-0001-6856-8637; Ben Gharbia, Hela/0000-0002-9878-6915; HERVE, Fabienne/0000-0002-5485-7611; Kefi Daly Yahia, Ons/0000-0001-9532-8989	LAGUNOTOX - Fondation TOTAL; LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens); IRD (Institut de Recherche pour le Developpement)	LAGUNOTOX - Fondation TOTAL; LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens); IRD (Institut de Recherche pour le Developpement)	This work was supported by the LAGUNOTOX project funded by Fondation TOTAL. Thanks to LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens) and to IRD (Institut de Recherche pour le Developpement) for funding Hela Ben Gharbia's Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie E, 2016, TOXINS, V8, DOI 10.3390/toxins8050136; Accoroni S, 2015, HARMFUL ALGAE, V49, P147, DOI 10.1016/j.hal.2015.08.007; Achamlale S, 2009, FOOD CHEM, V113, P878, DOI 10.1016/j.foodchem.2008.07.040; Achamlale S, 2009, J APPL PHYCOL, V21, P347, DOI 10.1007/s10811-008-9375-8; Alamsjah MA, 2005, BIOSCI BIOTECH BIOCH, V69, P2186, DOI 10.1271/bbb.69.2186; Alamsjah MA, 2007, BIOSCI BIOTECH BIOCH, V71, P265, DOI 10.1271/bbb.60475; Alamsjah MA, 2008, J APPL PHYCOL, V20, P713, DOI 10.1007/s10811-007-9257-5; Aligizaki K, 2006, HARMFUL ALGAE, V5, P717, DOI 10.1016/j.hal.2006.02.005; Aligizaki K, 2009, HARMFUL ALGAE, V8, P299, DOI 10.1016/j.hal.2008.07.002; Alsufyani T, 2014, CHEM PHYS LIPIDS, V183, P100, DOI 10.1016/j.chemphyslip.2014.05.008; Amzil Z, 2012, MAR DRUGS, V10, P477, DOI 10.3390/md10020477; ANDERSON DM, 1990, MAR BIOL, V104, P511, DOI 10.1007/BF01314358; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Armi Z, 2010, ENVIRON MONIT ASSESS, V164, P423, DOI 10.1007/s10661-009-0903-z; Bechemin C, 1999, AQUAT MICROB ECOL, V20, P157, DOI 10.3354/ame020157; Ben-Gharbia H, 2016, TOXINS, V8, DOI 10.3390/toxins8100297; BOYER GL, 1987, MAR BIOL, V96, P123, DOI 10.1007/BF00394845; Brissard C, 2014, MAR DRUGS, V12, P2851, DOI 10.3390/md12052851; Cecchi P, 2016, MAR POLLUT BULL, V108, P120, DOI 10.1016/j.marpolbul.2016.04.041; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Cohu S., 2012, THESIS; Custodio L, 2016, NAT PROD RES, V30, P724, DOI 10.1080/14786419.2015.1040791; de Wit R, 2012, HYDROBIOLOGIA, V699, P55, DOI 10.1007/s10750-012-1153-6; Dilday RH, 1992, ARKANSAS FARM RES, V41, P14; DREW EA, 1978, NEW PHYTOL, V81, P249, DOI 10.1111/j.1469-8137.1978.tb02631.x; Dziga D, 2007, ENVIRON TOXICOL, V22, P341, DOI 10.1002/tox.20276; Eigemann F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078463; Erhard D, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P433; Fertouna-Bellakhal M, 2015, HARMFUL ALGAE, V48, P69, DOI 10.1016/j.hal.2015.07.007; Foden J, 2005, HARMFUL ALGAE, V4, P1063, DOI 10.1016/j.hal.2005.03.004; FONG P, 1993, MAR ECOL PROG SER, V100, P97, DOI 10.3354/meps100097; Garrido M, 2013, DEEP-SEA RES PT I, V71, P38, DOI 10.1016/j.dsr.2012.09.004; Green E.P., 2003, WORLD ATLAS SEAGRASS, P5; Grignon-Dubois Micheline, 2012, Plants (Basel), V1, P27, DOI 10.3390/plants1010027; Grignon-Dubois M, 2013, BOT MAR, V56, P303, DOI 10.1515/bot-2013-0029; Grignon-Dubois M, 2012, ESTUAR COAST SHELF S, V114, P18, DOI 10.1016/j.ecss.2011.09.010; Gross E. M., 1994, Acta Horticulturae, P710; Gross EM, 1996, PHYTOCHEMISTRY, V41, P133, DOI 10.1016/0031-9422(95)00598-6; Gross EM, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P179; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P290; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Harborne J.B., 1976, BIOCH SYSTEMTICS ECO, V4, P37, DOI [DOI 10.1016/0305-1978(76)90007-7, 10.1016/0305-1978(76)90007-7]; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Haslam E., 1989, PLANT POLYPHENOLS VE; Hilt S, 2006, AQUAT BOT, V85, P252, DOI 10.1016/j.aquabot.2006.05.004; Hongying Hu, 2008, Frontiers of Environmental Science and Engineering in China, V2, P421, DOI 10.1007/s11783-008-0070-4; Huang HM, 2015, TOXINS, V7, P66, DOI 10.3390/toxins7010066; Jeong JH, 2000, J APPL PHYCOL, V12, P37, DOI 10.1023/A:1008139129057; Jin Q, 2003, J EXP MAR BIOL ECOL, V293, P41, DOI 10.1016/S0022-0981(03)00214-4; Jin Q, 2005, EUR J PHYCOL, V40, P31, DOI 10.1080/09670260400019741; John U, 2014, PROTIST, V165, P779, DOI 10.1016/j.protis.2014.10.001; Kim HG, 2006, ECOL STU AN, V189, P327, DOI 10.1007/978-3-540-32210-8_25; Kim Hyung Seop, 2011, Ocean Science Journal, V46, P205, DOI 10.1007/s12601-011-0016-9; Kolsi RB, 2016, CARBOHYD POLYM, V151, P511, DOI 10.1016/j.carbpol.2016.05.098; Kontiza I, 2006, STEROIDS, V71, P177, DOI 10.1016/j.steroids.2005.09.004; Kontiza I, 2005, TETRAHEDRON LETT, V46, P2845, DOI 10.1016/j.tetlet.2005.02.123; Kontiza L, 2008, TETRAHEDRON, V64, P1696, DOI 10.1016/j.tet.2007.12.007; Laabir M, 2013, AQUAT BOT, V111, P16, DOI 10.1016/j.aquabot.2013.07.010; Laabir M, 2013, MAR DRUGS, V11, P1583, DOI 10.3390/md11051583; Laabir M, 2011, J PLANKTON RES, V33, P1550, DOI 10.1093/plankt/fbr050; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Leu E, 2002, PLANT PHYSIOL, V130, P2011, DOI 10.1104/pp.011593; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; MCMILLAN C, 1980, AQUAT BOT, V8, P267, DOI 10.1016/0304-3770(80)90055-8; Mezghani S., 2016, EUR J MED PLANT, V12, P1, DOI [10.9734/EJMP/2016/22935, DOI 10.9734/EJMP/2016/22935]; Mulderij G, 2003, HYDROBIOLOGIA, V491, P261, DOI 10.1023/A:1024483704903; MURAKAMI Y, 1982, B JPN SOC SCI FISH, V48, P69; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Nan CR, 2008, AQUAT BOT, V89, P9, DOI 10.1016/j.aquabot.2008.01.005; Nan CR, 2004, J SEA RES, V52, P259, DOI 10.1016/j.seares.2004.04.001; Nascimento SM, 2005, TOXICON, V45, P633, DOI 10.1016/j.toxicon.2004.12.023; Nelson TA, 2003, J PHYCOL, V39, P874, DOI 10.1046/j.1529-8817.2003.02157.x; Okolodkov YB, 2007, AQUAT MICROB ECOL, V47, P223, DOI 10.3354/ame047223; Pakdel FM, 2013, AQUAT BOT, V110, P24, DOI 10.1016/j.aquabot.2013.04.005; Park TG, 2013, HARMFUL ALGAE, V30, pS131, DOI 10.1016/j.hal.2013.10.012; Parsons ML, 2007, HARMFUL ALGAE, V6, P658, DOI 10.1016/j.hal.2007.01.001; Pelechata A, 2010, OCEANOL HYDROBIOL ST, V39, P95, DOI 10.2478/v10009-010-0004-x; Pichierri S, 2016, AQUAT TOXICOL, V179, P125, DOI 10.1016/j.aquatox.2016.08.018; Plus M, 2003, CONT SHELF RES, V23, P1877, DOI 10.1016/j.csr.2003.03.001; Plus M, 2003, ECOL MODEL, V161, P213, DOI 10.1016/S0304-3800(02)00350-2; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Reigosa M. J., 2006, ALLELOPATHY PHYSL PR; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; RHODES LL, 2017, MAR DRUGS, V15; Rice EL, 1984, ALLELOPATHY; Rojo C, 2013, ECOL ENG, V58, P149, DOI 10.1016/j.ecoleng.2013.06.019; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; ROUNSEFELL GA, 1958, LARGE SCALE EXPT TES; Salon-Barros Jhon, 2016, Harmful Algae News, V53, P9; SFRISO A, 1994, ENVIRON TECHNOL, V15, P1, DOI 10.1080/09593339409385399; Sghaier Y.R., 2012, B LINSTITUT NATL SCI, V39, P117; SICA D, 1984, PHYTOCHEMISTRY, V23, P2609, DOI 10.1016/S0031-9422(00)84109-6; Singh IP, 2006, NAT PROD REP, V23, P558, DOI 10.1039/b600518g; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Smolders AJP, 2000, OIKOS, V91, P307, DOI 10.1034/j.1600-0706.2000.910211.x; Souad Turki, 2001, Harmful Algae News, V22, P10; Strasser RJ, 2000, PROBING PHOTOSYNTHES, V25, P445; Tang YZ, 2015, J APPL PHYCOL, V27, P531, DOI 10.1007/s10811-014-0338-y; Tang YZ, 2011, HARMFUL ALGAE, V10, P480, DOI 10.1016/j.hal.2011.03.003; Thomas S, 2000, FRESHWATER BIOL, V45, P43, DOI 10.1046/j.1365-2427.2000.00616.x; TORIGOE K, 1988, J AM CHEM SOC, V110, P7876, DOI 10.1021/ja00231a048; Treguer P., 1975, MANUEL ANAL SELS NUT; Trigui M, 2013, J APPL PHYCOL, V25, P319, DOI 10.1007/s10811-012-9866-5; Turki S, 2005, CAH BIOL MAR, V46, P29; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vanucci S, 2010, HARMFUL ALGAE, V9, P590, DOI 10.1016/j.hal.2010.04.009; Wang RJ, 2007, J SEA RES, V58, P189, DOI 10.1016/j.seares.2007.03.002; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; WIUMANDERSEN S, 1982, OIKOS, V39, P187, DOI 10.2307/3544484; [吴程 WU Cheng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2595; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; Ye CP, 2013, IERI PROC, V5, P209, DOI 10.1016/j.ieri.2013.11.094; Ye CP, 2014, J SEA RES, V90, P10, DOI 10.1016/j.seares.2014.02.015; ZAPATA O, 1979, AQUAT BOT, V7, P307, DOI 10.1016/0304-3770(79)90032-9; Zhu JY, 2010, AQUAT TOXICOL, V98, P196, DOI 10.1016/j.aquatox.2010.02.011	123	25	25	9	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187963	10.1371/journal.pone.0187963	http://dx.doi.org/10.1371/journal.pone.0187963			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149214	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100019
J	Chipungu, J; Bosomprah, S; Zanolini, A; Thimurthy, H; Chilengi, R; Sharma, A; Holmes, CB				Chipungu, Jenala; Bosomprah, Samuel; Zanolini, Arianna; Thimurthy, Harsha; Chilengi, Roma; Sharma, Anjali; Holmes, Charles B.			Understanding linkage to care with HIV self-test approach in Lusaka, Zambia - A mixed method approach	PLOS ONE			English	Article							COMMUNITY	Introduction HIV self-testing (HIVST) is a novel approach designed to assist in achieving the goal of at least 90% of the population that learn their HIV status. A self-test user with a positive test is required to visit a clinic to link into HIV care, yet little is known about patient preferences for linkage strategies. We examined the intention to link to care amongst potential HIVST users and the suitability of three linkage to care strategies in Lusaka Province, Zambia. Methods We conducted a representative cross sectional survey of 1,617 individuals aged 16-49 years old in Lusaka Province. Participants were shown a video of the HIVST. Data on intention to link to care and preferred linkage to care strategies-text message, phone call and home visits were collected. Eight focus group discussions were held concurrently with survey respondents to understand their preferences between the three linkage to care strategies. Results Of 1617 enrolled, 60% were women, 40% were men, with an average age of 27years (IQR = 22, 35). More men than women had at least secondary education (84% vs 77%) and were either employed or self-employed (67% vs. 41%). 85% (95% CI = 83 to 86) of participants said they would link to care within the first week of a positive self-test. Income > 2,000 Kwacha (USD 200) per month versus income < 2,000 Kwacha (Adjusted odds ratio (AOR) = 0.59; 95% CI: 0.40 to 0.88; p = 0.009) and never versus prior HIV testers (AOR = 0.54; 95% CI: 0.32 to 0.91; p = 0.020) were associated with reduced odds of intention to link to care. 53% (95% CI = 50 to 55) preferred being prompted to link to care by home visits compared to phone call (30%) or SMS (17%). Conclusion We found almost nine out of ten potential HIVST users in the general population intend to link to care shortly after a positive test, and preferred home visits or phone calls to facilitate linkage, rather than SMS. Also, higher income earners and those who never tested for HIV were associated with reduced odds of intention to link to care. Policy guidelines and implementation strategies for HIVST should be responsive to patient preferences for linkage to care strategies to achieve the continuum of HIV care.	[Chipungu, Jenala; Bosomprah, Samuel; Zanolini, Arianna; Chilengi, Roma; Sharma, Anjali; Holmes, Charles B.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Zanolini, Arianna] Amer Inst Res, Lusaka, Zambia; [Thimurthy, Harsha] Univ North Carolina Chapel Hill, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Holmes, Charles B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Ghana; American Institutes for Research; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University	Chipungu, J (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	Jenala.Chipungu@cidrz.org		Sharma, Anjali/0000-0002-8189-0732; Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887	International Initiative for Impact Evaluation [TW2.1.26]; International Initiative for Impact Evaluation, Inc. (3ie)	International Initiative for Impact Evaluation; International Initiative for Impact Evaluation, Inc. (3ie)	This work was funded by the International Initiative for Impact Evaluation (see: www.3ieimpact.org/) Grant Number: TW2.1.26. CBH JC AZ HT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research discussed in this publication has been funded by the International Initiative for Impact Evaluation, Inc. (3ie). The views expressed in this article are not necessarily those of 3ie or its members.; Research discussed in this publication has been funded by the International Initiative for Impact Evaluation, Inc. (3ie). The views expressed in this article are not necessarily those of 3ie or its members. We would like to acknowledge Mazuba Mukanshi Mafwenko for coordinating the data collection process and the research assistants for collecting the data. We thank all the participants for taking part in the study.	Chanda-Kapata P, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0088-1; Cohen J., 2013, APPL MULTIPLE REGRES; Creswell JW, 2011, BEST PRACTICES MIXED, P10; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mekuria LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130649; Organization WH, 2013, HIV SELF TEST SUPPL; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pal K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166129; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Sidibe M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21133; Spyrelis A, 2016, AIDS CARE, P1; World Health Organization, 2012, GLOB HIV AIDS RESP; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	22	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187998	10.1371/journal.pone.0187998	http://dx.doi.org/10.1371/journal.pone.0187998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149194	Green Published, Green Submitted, gold			2022-12-26	WOS:000415646100023
J	Kang, SU; Kim, YS; Kim, YE; Park, JK; Lee, YS; Kang, HY; Jang, JW; Ryeo, JB; Lee, Y; Shin, YS; Kim, CH				Kang, Sung Un; Kim, Yeon Soo; Kim, Yang Eun; Park, Ju-Kyeong; Lee, Yun Sang; Kang, Hee Young; Jang, Jae Won; Ryeo, Jeong Beom; Lee, Yuijina; Shin, Yoo Seob; Kim, Chul-Ho			Opposite effects of non-thermal plasma on cell migration and collagen production in keloid and normal fibroblasts	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; GROWTH-FACTOR-BETA; IN-VITRO; PROLIFERATION; SUPPRESSION; EXPRESSION; PATHOGENESIS; MODULATION; INDUCTION; ARREST	Recent progress in the understanding non-thermal plasma (NTP) properties prompted its application in the treatment of various diseases. However, therapeutic effect of NTP on keloid cells has not been reported previously. We sought to investigate the effect of NTP treatment on keloid by comparing cell migration and collagen production of keloid (KFs) and normal fibroblasts (NFs) and determined the regulatory pathways involved. We assessed NTP effects on cell migration in KFs and NFs by the wound healing assay and measured the expression of the epidermal growth factor receptor (EGFR), signal transducer and activator of transcription-3 (STAT3), and collagen by western blot. Expression of the transforming growth factor-beta and Type I collagen following NTP treatment was determined by reverse transcription-polymerase chain reaction, immunofluorescence staining, and the Sircol collagen assay. NTP treatment increased cell migration and collagen production of NFs. However, it reduced these parameters in KFs. NTP reduced the expression of EGFR, STAT3, and Type I collagen in KFs but increased their levels in NFs. We revealed that NTP suppressed KF cell migration via down-regulation of EGFR and STAT3 and reduced collagen production via supressing transforming growth factor-beta. Our data suggest that NTP may be a new therapeutic strategy for keloids.	[Kang, Sung Un; Lee, Yun Sang; Shin, Yoo Seob; Kim, Chul-Ho] Ajou Univ, Dept Otolaryngol, Suwon, South Korea; [Kang, Sung Un; Kim, Yang Eun; Park, Ju-Kyeong; Lee, Yun Sang; Shin, Yoo Seob; Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Kim, Yeon Soo] Konyang Univ, Myunggok Med Res Inst, Konyang Univ Hosp, Dept Otorhinolaryngol,Coll Med, Daejeon, South Korea; [Kang, Hee Young] Ajou Univ, Dept Dermatol, Suwon, South Korea; [Jang, Jae Won] Chungnam Natl Univ, Dept Otorhinolaryngol, Daejeon, South Korea; [Ryeo, Jeong Beom; Lee, Yuijina] ICD Co LTD, Anseong, South Korea	Ajou University; Ajou University; Konyang University; Konyang University Hospital; Ajou University; Chungnam National University	Kim, CH (corresponding author), Ajou Univ, Dept Otolaryngol, Suwon, South Korea.; Kim, CH (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		National Research Foundation of Korea [2015R1A2A1A01002968]; Bio & Medical Technology Development Program [2012M3A9B2052870]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2016R1D1A3B03933948]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program; Basic Science Research Program through the National Research Foundation of Korea (NRF)	The funder (ICO co.) provided support in the form of salaries for authors JBR and YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by the National Research Foundation of Korea (grant no. 2015R1A2A1A01002968) to CHK, the Bio & Medical Technology Development Program (grant no. 2012M3A9B2052870) to CHK, and the Basic Science Research Program through the National Research Foundation of Korea (NRF) (grant no. 2016R1D1A3B03933948) to YSK. The specific roles of these authors are articulated in the author contributions section.	Barara Meenu, 2012, J Cutan Aesthet Surg, V5, P185, DOI 10.4103/0974-2077.101376; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; CHANDRASEKHAR S, 1988, BIOCHEM BIOPH RES CO, V157, P1352, DOI 10.1016/S0006-291X(88)81024-6; Chang CH, 2014, PLOS ONE, V9; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Chen M, 1999, Zhonghua Yan Ke Za Zhi, V35, P134; Chen M, 1999, ZHONGHUA YAN KE ZHI, V35, P6; Choi JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28829; FERGUSON G, 1994, PLAST RECONSTR SURG, V93, P643; Fujiwara M, 2005, ARCH DERMATOL RES, V297, P161, DOI 10.1007/s00403-005-0596-2; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jagadeesan Jagajeevan, 2007, Int J Surg, V5, P278, DOI 10.1016/j.ijsu.2006.04.007; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kang SU, 2017, EXP DERMATOL, V26, P163, DOI 10.1111/exd.13229; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kramer A, 2008, GMS HYG INFECT CONTR, V3; Kuo YR, 2004, LASER SURG MED, V34, P104, DOI 10.1002/lsm.10206; Lee BS, 2012, CANCER LETT, V322, P45, DOI 10.1016/j.canlet.2012.02.007; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lim CP, 2009, J INVEST DERMATOL, V129, P851, DOI 10.1038/jid.2008.337; Lu Y, 2001, Zhonghua Shao Shang Za Zhi, V17, P345; Manuskiatti W, 2002, ARCH DERMATOL, V138, P1149, DOI 10.1001/archderm.138.9.1149; NARAYANAN AS, 1989, BIOCHEM J, V260, P463, DOI 10.1042/bj2600463; Phan TT, 2005, J PATHOL, V207, P232, DOI 10.1002/path.1826; Phan TT, 2003, BRIT J DERMATOL, V148, P544, DOI 10.1046/j.1365-2133.2003.05174.x; Ragoowansi R, 2003, PLAST RECONSTR SURG, V111, P1853, DOI 10.1097/01.PRS.0000056869.31142.DE; Satish L, 2004, WOUND REPAIR REGEN, V12, P183, DOI 10.1111/j.1067-1927.2004.012111.x; Taylor A, 2016, ACTA DERMATO VENEREO; Watts AE, 2006, AM J VET RES, V67, P2030, DOI 10.2460/ajvr.67.12.2030; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Zippi M, 2012, CLIN TER, V163, pE435	39	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187978	10.1371/journal.pone.0187978	http://dx.doi.org/10.1371/journal.pone.0187978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145520	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800044
J	Jiang, L; Su, HR; Keogh, JM; Chen, Z; Henning, E; Wilkinson, P; Goodyer, I; Farooqi, IS; Rui, LY				Jiang, Lin; Su, Haoran; Keogh, Julia M.; Chen, Zheng; Henning, Elana; Wilkinson, Paul; Goodyer, Ian; Farooqi, I. Sadaf; Rui, Liangyou			Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression	FASEB JOURNAL			English	Article						aggression circuits; brain development; BDNF	NEUROTROPHIC FACTOR; ENERGY-BALANCE; GLUCOSE-METABOLISM; BODY-WEIGHT; MICE; OBESITY; IDENTIFICATION; DIFFERENTIATION; MECHANISMS; BEHAVIORS	Psychiatric disorders are associated with aberrant brain development and/or aggressive behavior and are influenced by genetic factors; however, genes that affect brain aggression circuits remain elusive. Here, we show that neuronal Src-homology-2 (SH2)B adaptor protein-1 (Sh2b1) is indispensable for both brain growth and protection against aggression. Global and brain-specific deletion of Sh2b1 decreased brain weight and increased aggressive behavior. Global and brain-specific Sh2b1 knockout (KO) mice exhibited fatal, intermale aggression. In a resident-intruder paradigm, latency to attack was markedly reduced, whereas the number and the duration of attacks was significantly increased in global and brain-specific Sh2b1 KO mice compared with wild-type littermates. Consistently, core aggression circuits were activated to a higher level in global and brain-specific Sh2b1 KO males, based on c-fos immunoreactivity in the amygdala and periaqueductal gray. Brain-specific restoration of Sh2b1 normalized brain size and reversed pathologic aggression and aberrant activation of core aggression circuits in Sh2b1 KO males. SH2B1 mutations in humans were linked to aberrant brain development and behavior. At the molecular level, Sh2b1 enhanced neurotrophin-stimulated neuronal differentiation and protected against oxidative stress-induced neuronal death. Our data suggest that neuronal Sh2b1 promotes brain development and the integrity of core aggression circuits, likely through enhancing neurotrophin signaling.	[Jiang, Lin; Su, Haoran; Chen, Zheng; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7810 MS 2,1137 E Catherine St, Ann Arbor, MI 48109 USA; [Wilkinson, Paul; Goodyer, Ian; Rui, Liangyou] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Keogh, Julia M.; Henning, Elana; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Wellcome Trust Med Res Council MRC Inst Metab Sci, Box 289, Cambridge CB2 0QQ, England; [Keogh, Julia M.; Henning, Elana; Farooqi, I. Sadaf] Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England; [Wilkinson, Paul; Goodyer, Ian] Dept Psychiat, Cambridge, England; [Wilkinson, Paul; Goodyer, Ian] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7810 MS 2,1137 E Catherine St, Ann Arbor, MI 48109 USA.; Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Wellcome Trust Med Res Council MRC Inst Metab Sci, Box 289, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; ruily@umich.edu	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK114220, DK094014]; Wellcome Trust; National Institutes for Health Research Cambridge Biomedical Research Centre; Bernard Wolfe Health Neuroscience Fund; Wellcome Trust Strategic Award [095844]; Michigan Diabetes Research Center [DK020572]; Michigan Metabolomics and Obesity Center [DK089503]; University of Michigan Gut Peptide Research Center [DK34933]; MRC [MC_UU_12012/5] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091591, R01DK114220, R01DK094014, P60DK020572, P30DK089503, P30DK034933, P30DK020572] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes for Health Research Cambridge Biomedical Research Centre; Bernard Wolfe Health Neuroscience Fund; Wellcome Trust Strategic Award(Wellcome Trust); Michigan Diabetes Research Center; Michigan Metabolomics and Obesity Center; University of Michigan Gut Peptide Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Louis F. Reichardt (University of California, San Francisco, San Francisco, CA, USA) for providing rat TrkB cDNA and Dr. Christin Carter-Su for helpful discussions. The authors thank the patients and their families and the physicians who recruited patients to the Genetics of Obesity Study (GOOS). This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK114220 and DK094014 (to L.R.), the Wellcome Trust, the National Institutes for Health Research Cambridge Biomedical Research Centre, and the Bernard Wolfe Health Neuroscience Fund (to I.S.F.). I.G. was supported by a Wellcome Trust Strategic Award (Grant 095844). This work used the cores supported by the Michigan Diabetes Research Center (DK020572), Michigan Metabolomics and Obesity Center (DK089503), and the University of Michigan Gut Peptide Research Center (DK34933). The authors declare no conflicts of interest.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Barr Christina S, 2014, Curr Top Behav Neurosci, V17, P45, DOI 10.1007/7854_2013_267; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Blair RJR, 2007, BEHAV SCI LAW, V25, P321, DOI 10.1002/bsl.750; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002; Chen Z, 2014, DIABETES, V63, P585, DOI 10.2337/db13-0666; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Dorfman Hayley M, 2014, Curr Top Behav Neurosci, V17, P297, DOI 10.1007/7854_2013_272; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Ito W, 2011, GENES BRAIN BEHAV, V10, P365, DOI 10.1111/j.1601-183X.2010.00676.x; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Niv S., 2013, J CRIM JUSTICE, V41; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pearce LR, 2014, ENDOCRINOLOGY, V155, P3219, DOI 10.1210/en.2014-1264; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rios M, 2014, Handb Exp Pharmacol, V220, P283, DOI 10.1007/978-3-642-45106-5_11; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rui L, 2014, WORLD J DIABETES, V5, P511, DOI 10.4239/wjd.v5.i4.511; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; Takahashi Aki, 2014, Curr Top Behav Neurosci, V17, P3, DOI 10.1007/7854_2013_263; Vilar M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00026; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	35	12	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1830	1840		10.1096/fj.201700831R	http://dx.doi.org/10.1096/fj.201700831R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29180441	Green Submitted, Green Published			2022-12-26	WOS:000429051400008
J	Park, S; Kim, K; Bae, IH; Lee, SH; Jung, J; Lee, TR; Cho, EG				Park, Sunyoung; Kim, Kyuhan; Bae, Il-Hong; Lee, Sung Hoon; Jung, Jiyong; Lee, Tae Ryong; Cho, Eun-Gyung			TIMP3 is a CLOCK-dependent diurnal gene that inhibits the expression of UVB-induced inflammatory cytokines in human keratinocytes	FASEB JOURNAL			English	Article						circadian rhythm; skin inflammation; MMP1; TNF-alpha; chemokine	MAMMALIAN CIRCADIAN CLOCK; INDUCED DNA-DAMAGE; BARRIER FUNCTION; HUMAN SKIN; EPIDERMIS; PROLIFERATION; ALPHA; CELLS; MICE	As the outermost physical barrier of an organism, the skin is diurnally exposed to UV radiation (UVR). Recent studies have revealed that the skin exhibits a circadian rhythm in various functions, and this oscillation is disturbed and reset via a strong environmental cue, the UVR. However, a molecular link between circadian perturbation by UVR and UVR-induced cellular responses has not been investigated. We identified tissue inhibitor of metalloproteinase (TIMP)-3 as a novel circadian locomotor output cycles kaput (CLOCK)-dependent diurnal gene by using a CLOCK-knockdown strategy in human keratinocytes. Among dozens of identified transcripts down-regulated by CLOCK knockdown, TIMP3 displayed a rhythmic expression in a CLOCK-dependent manner, in which the expression of matrix metalloproteinase (MMP)-1 and inflammatory cytokines, such as TNF-alpha, chemokine (C-X-C motif) ligand (CXCL)-1, and IL-8, were inversely regulated. Upon UVB exposure, the expression of CLOCK and TIMP3 was down-regulated, which led to an up-regulation of secretion of MMP1 and TNF-a proteins and in the transcription of CXCL1 and IL-8 via CCAAT-enhancer binding protein (C/EBP)-alpha. UVB-induced TNF-alpha secretion increased further or decreased by knockdown or overexpression of TIMP3, respectively, as well as by CLOCK. As a novel CLOCK-dependent diurnal gene, TIMP3 inhibits the expression of inflammatory cytokines that are up-regulated by UV irradiation inhuman keratinocytes. Thus, our work suggests a molecular link between circadian perturbation by UVR and UVR-induced inflammation.	[Park, Sunyoung; Kim, Kyuhan; Bae, Il-Hong; Lee, Sung Hoon; Jung, Jiyong; Lee, Tae Ryong; Cho, Eun-Gyung] AmorePacific Corp, Basic Res & Innovat Div, Res & Dev Unit, Yongin, South Korea		Lee, TR; Cho, EG (corresponding author), AmorePacific Corp, Basic Res & Innovat Div, R&D Unit, 1920 Yonggu Daero, Yongin, Gyeonggi Do, South Korea.	trlee@amorepacific.com; egcho@amorepacific.com		Bae, Il-Hong/0000-0003-0535-8303	AmorePacific Corp.	AmorePacific Corp.	All authors are employees of AmorePacific Corp. (Seoul, South Korea). AmorePacific Corp. provided all financial support for this study.	Al-Nuaimi Y, 2014, J INVEST DERMATOL, V134, P610, DOI 10.1038/jid.2013.366; Ando N, 2015, J INVEST DERMATOL, V135, P3001, DOI 10.1038/jid.2015.316; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Dakup P, 2017, PHOTOCHEM PHOTOBIOL, V93, P296, DOI 10.1111/php.12662; Denda M, 2000, BRIT J DERMATOL, V142, P881, DOI 10.1046/j.1365-2133.2000.03466.x; Dickmeis T, 2013, MOL CELL ENDOCRINOL, V380, P2, DOI 10.1016/j.mce.2013.05.012; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Geyfman M, 2009, J INVEST DERMATOL, V129, P1063, DOI 10.1038/jid.2008.384; Hardman JA, 2015, J INVEST DERMATOL, V135, P1053, DOI 10.1038/jid.2014.442; Hoffmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102238; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Kawara S, 2002, J INVEST DERMATOL, V119, P1220, DOI 10.1046/j.1523-1747.2002.19619.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui MS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060801; Matsunaga N, 2014, J INVEST DERMATOL, V134, P1636, DOI 10.1038/jid.2014.13; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Plikus MV, 2015, J BIOL RHYTHM, V30, P163, DOI 10.1177/0748730414563537; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sandu C, 2012, CELL MOL LIFE SCI, V69, P3329, DOI 10.1007/s00018-012-1026-1; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; Steude J, 2002, J INVEST DERMATOL, V119, P1254, DOI 10.1046/j.1523-1747.2002.19616.x; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Yosipovitch G, 2004, J INVEST DERMATOL, V122, P824, DOI 10.1111/j.0022-202X.2004.22313.x; Yosipovitch G, 1998, J INVEST DERMATOL, V110, P20, DOI 10.1046/j.1523-1747.1998.00069.x	35	21	22	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1510	1523		10.1096/fj.201700693R	http://dx.doi.org/10.1096/fj.201700693R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29180440	Green Published, hybrid			2022-12-26	WOS:000427246000031
J	Alabdan, N; AlRuthia, Y; Yates, MED; Sales, I; Finch, CK; Hudson, JQ				Alabdan, Numan; AlRuthia, Yazed; Yates, Mary E. D.; Sales, Ibrahim; Finch, Christopher K.; Hudson, Joanna Q.			Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; DARBEPOETIN-ALPHA; ANEMIA MANAGEMENT; EPOETIN-ALPHA; HEMOGLOBIN CONTROL; DIALYSIS; PROTOCOL; TRIAL; END	Background Erythropoiesis-stimulating agents (ESAs) are recommended for treating anemia in patients with chronic kidney disease and end-stage renal disease. However, misappropriate and over-use of these agents can be costly and unnecessary in some settings. Objective The primary aim was to identify predictors of adherence to a newly approved ESA inpatient ordering policy. The secondary aims were to evaluate the impact of a 5-day delay in the initiation of ESA therapy on ESA usage, hemoglobin (Hb) levels, and costs. Methods This retrospective observational record review included a sample of adult patients admitted to four tertiary care hospitals from November 1, 2013 to August 31, 2014. Multivariable logistic and linear regression analyses were used to calculate the odds of adherence to the new ESA inpatient ordering policy and the impact of this policy on discharge Hb level, respectively. Results A total of 242 patients were included. The majority of the prescribers (77%) adhered to the new ESA ordering policy. Hemoglobin (OR = 1.306; 95% CI: 1.03-1.65) and ferritin (OR = 3.91; 95% CI: 1.23-12.51) levels at admission and length of hospital stay were positively correlated with the odds of patients receiving ESAs after day 5 (OR = 1.12; 95% CI: 1.05-1.20). Furthermore, adherence to the new policy did not have a significant impact on discharge Hb level (beta = 0.02349; P = 0.895). Conclusions Prescribers were adherent to a 5-day delay in the initiation of ESA therapy policy which resulted in a reduction in ESA usage, did not impact the discharge Hb levels, and was proven to be cost effective.	[Alabdan, Numan] King Abdul Aziz Med City, Dept Pharm Practice, Riyadh, Saudi Arabia; [AlRuthia, Yazed; Sales, Ibrahim] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia; [Yates, Mary E. D.; Finch, Christopher K.; Hudson, Joanna Q.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, Coll Pharm, Memphis, TN 38163 USA; [Yates, Mary E. D.] Methodist Germantown Hosp, Dept Pharm, Germantown, TN USA; [Finch, Christopher K.] Methodist Univ Hosp, Dept Pharm, Memphis, TN USA; [Hudson, Joanna Q.] Methodist Univ Hosp, Div Nephrol, Dept Med, Memphis, TN USA	King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Saud University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	AlRuthia, Y (corresponding author), King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia.	yazeed@ksu.edu.sa	Sales, Ibrahim/ABD-1682-2020; Finch, Christopher/ABF-1123-2021	Sales, Ibrahim/0000-0002-8279-403X; AlRuthia, Yazed/0000-0002-0029-5924; Finch, Christopher/0000-0003-2340-9178	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	The authors acknowledge financial support from the College of Pharmacy Research Center and the Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amgen, 2016, AR DARB ALF INJ PACK; Aspinall SL, 2013, APPL HEALTH ECON HEA, V11, P653, DOI 10.1007/s40258-013-0057-6; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brimble KS, 2003, J AM SOC NEPHROL, V14, P2654, DOI 10.1097/01.ASN.0000088026.88074.20; Brophy DF, 2010, ANN PHARMACOTHER, V44, P43, DOI 10.1345/aph.1M429; Canaud B, 2008, NEPHROL DIAL TRANSPL, V23, P3654, DOI 10.1093/ndt/gfn320; Charlesworth EC, 2014, AM J NEPHROL, V39, P509, DOI 10.1159/000363115; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hoffmann-La Roche, 2014, MIRCERA METHOXY POLE; Janssen, 2012, PROCR EP ALF INJ PAC; Jordan Jessica, 2012, Can J Hosp Pharm, V65, P443; Kapoian T, 2008, J AM SOC NEPHROL, V19, P372, DOI 10.1681/ASN.2007050606; Levin NW, 2007, LANCET, V370, P1415, DOI 10.1016/S0140-6736(07)61599-2; Majoni SW, 2014, HEMODIAL INT, V18, P740, DOI 10.1111/hdi.12173; Nguyen T, 2007, DIALYSIS TRANSPLANT, V36, P524, DOI 10.1002/dat.20171; Nhan Julie, 2007, CANNT J, V17, P48; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Saunders S, 2013, J CLIN NURS, V22, P2206, DOI 10.1111/jocn.12059; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Spinowitz B, 2008, AM J NEPHROL, V28, P280, DOI 10.1159/000111115; Sulowicz W, 2007, CLIN J AM SOC NEPHRO, V2, P637, DOI 10.2215/CJN.03631006; Swaminathan S, 2012, HEALTH AFFAIR, V31, P2051, DOI 10.1377/hlthaff.2012.0368; To LL, 2001, AM J HEALTH-SYST PH, V58, P2061, DOI 10.1093/ajhp/58.21.2061; US Renal Data System USRDS, 2012, ANN DAT REP ATL CHRO; Wazny LD, 2013, AM J NEPHROL, V38, P496, DOI 10.1159/000357052	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188390	10.1371/journal.pone.0188390	http://dx.doi.org/10.1371/journal.pone.0188390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182650	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000024
J	Moisset, X; Perie, M; Pereira, B; Dumont, E; Lebrun-Frenay, C; Lesage, FX; Dutheil, F; Taithe, F; Clavelou, P				Moisset, Xavier; Perie, Maud; Pereira, Bruno; Dumont, Emilie; Lebrun-Frenay, Christine; Lesage, Francois-Xavier; Dutheil, Frederic; Taithe, Frederic; Clavelou, Pierre			Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; RISK; CYCLOPHOSPHAMIDE; COHORT; CELLS	Background Studies of cancer prevalence have produced conflicting results concerning the relative risk of overall and specific sub-types of cancer in patients with multiple sclerosis (MS). Contemporary controls and information on tobacco use and alcohol consumption are generally missing from previous studies. Objectives To evaluate lifetime cancer prevalence in a large cohort of MS patients relative to appropriate controls. Methods We conducted a case-control study, using a postal survey of a cohort of MS patients. Of the 1574 questionnaires sent, 1107 could be used for statistical analysis. Data from 1568 controls were prospectively collected using the same self-administered survey among consecutive out-patients in a single neurology department. Propensity scores matched on age, gender, and history of smoking and alcohol consumption were calculated. Results Among the MS patients, 7.32% had ever presented with a cancer, whereas 12,63% of the controls had, leading to a bootstrap matched odds ratio (OR) of 0.63; 95% CI 0.57-0.70. Although only exploratory, the use of DMT (immunomodulators or immunosupressants) did not appear to increase this risk (p = 0.42). The disease course also did not affect cancer prevalence. Conclusion MS was associated with a reduced overall cancer risk.	[Moisset, Xavier; Clavelou, Pierre] Univ Clermont Auvergne, INSERM, Neuro Dol, CHU Clermont Ferrand,Serv Neurol Clermont Ferrand, Clermont Ferrand, France; [Perie, Maud; Dumont, Emilie; Taithe, Frederic] CHU Clermont Ferrand, Serv Neurol, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France; [Lebrun-Frenay, Christine] CHU Pasteur 2, Serv Neurol, Nice, France; [Lesage, Francois-Xavier] Univ Montpellier, Univ Paul Valery Montpellier 3, EPSYLON EA, CHU Montpellier,Serv Sante Travail & Pathol Profe, Montpellier, France; [Dutheil, Frederic] Univ Clermont Auvergne, CNRS, CHU Clermont Ferrand,WittyFit,LaPSCo, Stress Physiol & Psychosocial,Serv Sante Travail, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Melbourne, Vic, Australia	CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Nice; Universite de Montpellier; CHU de Montpellier; Universite Paul-Valery; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Australian Catholic University	Moisset, X (corresponding author), Univ Clermont Auvergne, INSERM, Neuro Dol, CHU Clermont Ferrand,Serv Neurol Clermont Ferrand, Clermont Ferrand, France.	xavier.moisset@gmail.com	lebrun-frenay, christine/AAP-9539-2021; Moisset, Xavier/H-2862-2019; Dutheil, Frederic/O-9707-2014	lebrun-frenay, christine/0000-0002-3713-2416; Moisset, Xavier/0000-0002-8799-0750; Clavelou, Pierre/0000-0003-2363-9352; Dutheil, Frederic/0000-0002-1468-6029	"TEVA pharma"	"TEVA pharma"(Teva Pharmaceutical Industries)	We received funding from "TEVA pharma". These funding was used to print questionnaires, and to buy stamps and envelopes to send them. The funders (TEVA-pharma), they had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P4306, DOI 10.1002/sim.6276; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bahmanyar S, 2009, NEUROLOGY, V72, P1170, DOI 10.1212/01.wnl.0000345366.10455.62; Buttmann M, 2016, NEUROLOGY, V86, P2203, DOI 10.1212/WNL.0000000000002745; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Fois AF, 2010, J NEUROL NEUROSUR PS, V81, P215, DOI 10.1136/jnnp.2009.175463; Huang O, 2015, EXP BIOL MED, V240, P426, DOI 10.1177/1535370214554881; Kingwell E, 2014, J NEUROL NEUROSUR PS, V85, P1096, DOI 10.1136/jnnp-2013-307238; Kingwell E, 2012, BRAIN, V135, P2973, DOI 10.1093/brain/aws148; Le Bouc R, 2012, MULT SCLER J, V18, P55, DOI 10.1177/1352458511416839; Lebrun C, 2008, MULT SCLER J, V14, P399, DOI 10.1177/1352458507083625; Lebrun C, 2011, J NEUROL, V258, P1304, DOI 10.1007/s00415-011-5929-9; Machin D, 2011, SAMPLE SIZE TABLES C; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P9, DOI 10.1002/art.25061; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; White C, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7145; Xie X, 2015, BRIT J PHARMACOL, V172, P3929, DOI 10.1111/bph.13184; Yadav SK, 2015, CURR OPIN NEUROL, V28, P206, DOI 10.1097/WCO.0000000000000205	24	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188120	10.1371/journal.pone.0188120	http://dx.doi.org/10.1371/journal.pone.0188120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176769	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900041
J	Wieczorek, A; Dulski, K; Niedzwiecki, S; Alfs, D; Bialas, P; Curceanu, C; Czerwinski, E; Danel, A; Gajos, A; Glowacz, B; Gorgol, M; Hiesmayr, B; Jasinska, B; Kacprzak, K; Kaminska, D; Kaplon, L; Kochanowski, A; Korcyl, G; Kowalski, P; Kozik, T; Krzemien, W; Kubicz, E; Kucharek, M; Mohammed, M; Pawlik-Niedzwiecka, M; Palka, M; Raczynski, L; Rudy, Z; Rundel, O; Sharma, NG; Silarski, M; Uchacz, T; Wislicki, W; Zgardzinska, B; Zielinski, M; Moskal, P				Wieczorek, Anna; Dulski, Kamil; Niedzwiecki, Szymon; Alfs, Dominika; Bialas, Piotr; Curceanu, Catalina; Czerwinski, Eryk; Danel, Andrzej; Gajos, Aleksander; Glowacz, Bartosz; Gorgol, Marek; Hiesmayr, Beatrix; Jasinska, Bozena; Kacprzak, Krzysztof; Kaminska, Daria; Kaplon, Lukasz; Kochanowski, Andrzej; Korcyl, Grzegorz; Kowalski, Pawel; Kozik, Tomasz; Krzemien, Wojciech; Kubicz, Ewelina; Kucharek, Mateusz; Mohammed, Muhsin; Pawlik-Niedzwiecka, Monika; Palka, Marek; Raczynski, Lech; Rudy, Zbigniew; Rundel, Oleksandr; Sharma, Neha G.; Silarski, Michal; Uchacz, Tomasz; Wislicki, Wojciech; Zgardzinska, Bozena; Zielinski, Marcin; Moskal, Pawel			Novel scintillating material 2-(4-styrylphenyl) benzoxazole for the fully digital and MRI compatible J-PET tomograph based on plastic scintillators	PLOS ONE			English	Article							TIME-OF-FLIGHT; HIT-POSITION RECONSTRUCTION; MODEL SIGNALS; DETECTORS; LIBRARY; SCANNER; SHIFTER; STRIPS	A novel plastic scintillator is developed for the application in the digital positron emission tomography (PET). The novelty of the concept lies in application of the 2-(4-styrylphenyl) benzoxazole as a wavelength shifter. The substance has not been used as scintillator dopant before. A dopant shifts the scintillation spectrum towards longer wavelengths making it more suitable for applications in scintillators of long strips geometry and light detection with digital silicon photomultipliers. These features open perspectives for the construction of the cost-effective and MRI-compatible PET scanner with the large field of view. In this article we present the synthesis method and characterize performance of the elaborated scintillator by determining its light emission spectrum, light emission efficiency, rising and decay time of the scintillation pulses and resulting timing resolution when applied in the positron emission tomography. The optimal concentration of the novel wavelength shifter was established by maximizing the light output and it was found to be 0.05 parts per thousand for cuboidal scintillator with dimensions of 14 mm x 14 mm x 20 mm.	[Wieczorek, Anna; Dulski, Kamil; Niedzwiecki, Szymon; Alfs, Dominika; Bialas, Piotr; Czerwinski, Eryk; Gajos, Aleksander; Glowacz, Bartosz; Kacprzak, Krzysztof; Kaminska, Daria; Kaplon, Lukasz; Korcyl, Grzegorz; Kozik, Tomasz; Kubicz, Ewelina; Mohammed, Muhsin; Pawlik-Niedzwiecka, Monika; Palka, Marek; Rudy, Zbigniew; Rundel, Oleksandr; Sharma, Neha G.; Silarski, Michal; Zielinski, Marcin; Moskal, Pawel] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Krakow, Poland; [Wieczorek, Anna] Polish Acad Sci, Inst Met & Mat Sci, Krakow, Poland; [Curceanu, Catalina] Ist Nazl Fis Nucl, Lab Nazl Frascati, Frascati, Italy; [Danel, Andrzej; Kucharek, Mateusz] Univ Agr, Inst Chem, Krakow, Poland; [Gorgol, Marek; Jasinska, Bozena; Zgardzinska, Bozena] Marie Curie Sklodowska Univ, Inst Phys, Lublin, Poland; [Hiesmayr, Beatrix] Univ Vienna, Fac Phys, Vienna, Austria; [Kochanowski, Andrzej; Uchacz, Tomasz] Jagiellonian Univ, Fac Chem, Krakow, Poland; [Kowalski, Pawel; Raczynski, Lech; Wislicki, Wojciech] Natl Ctr Nucl Res, Dept Complex Syst, Otwock, Poland; [Krzemien, Wojciech] Natl Ctr Nucl Res, High Energy Phys Div, Otwock, Poland; [Mohammed, Muhsin] Univ Mosul, Coll Educ Pure Sci, Dept Phys, Mosul, Iraq	Jagiellonian University; Polish Academy of Sciences; Istituto Nazionale di Fisica Nucleare (INFN); Agricultural University Krakow; Maria Curie-Sklodowska University; University of Vienna; Jagiellonian University; National Centre for Nuclear Research; National Centre for Nuclear Research; University of Mosul	Wieczorek, A (corresponding author), Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Krakow, Poland.; Wieczorek, A (corresponding author), Polish Acad Sci, Inst Met & Mat Sci, Krakow, Poland.	anna.wieczorek@uj.edu.pl	Zielinski, Marcin/B-6768-2014; Hiesmayr, Beatrix C./AAB-5010-2020; Hiesmayr, Beatrix C/A-3483-2012; Moskal, Pawel/N-4231-2019; Zgardzińska, Bożena/AAF-6822-2021; Krzemien, Wojciech/ABA-7137-2020; Korcyl, Grzegorz/AFR-6504-2022; Palka, Marek/GXW-2506-2022; Czerwiński, Eryk/U-8295-2018; Pawlik-Niedźwiecka, Monika/N-1599-2018; Kapłon, Łukasz/AAJ-1202-2020; Zgardzinska, Bozena/AAH-3112-2019; Moskal, Pawel/S-9151-2016; Gorgol, Marek/AAG-1640-2021; Kubicz, Ewelina/AAO-7756-2021; Dulski, Kamil/V-2058-2018	Zielinski, Marcin/0000-0002-9540-9911; Hiesmayr, Beatrix C./0000-0001-9062-6039; Hiesmayr, Beatrix C/0000-0001-9062-6039; Moskal, Pawel/0000-0002-4229-3548; Zgardzińska, Bożena/0000-0003-2600-7350; Krzemien, Wojciech/0000-0002-9546-358X; Korcyl, Grzegorz/0000-0001-6244-7287; Palka, Marek/0000-0002-7185-3540; Czerwiński, Eryk/0000-0002-5076-3175; Pawlik-Niedźwiecka, Monika/0000-0002-5693-6751; Kapłon, Łukasz/0000-0002-2203-0425; Moskal, Pawel/0000-0002-4229-3548; Gorgol, Marek/0000-0001-5406-362X; Kubicz, Ewelina/0000-0002-5413-2215; Kisielewska, Daria/0000-0002-1429-3209; Danel, Andrzej/0000-0001-9790-1224; Dulski, Kamil/0000-0002-4093-8162; Wislicki, Wojciech/0000-0001-5765-6308; Kucharek, Mateusz/0000-0002-1705-537X	Foundation for Polish Science through MPD programme; Marian Smoluchowski Krakow Research Consortium "Matter-Energy-Future"; Austrian Science Fund [FWFP 26783]; Polish National Centre for Development and Research [LIDER/274/L-6/14/NCBR/2015, INNOTECH-Kl/IN1/64/159174/NCBR/12]; National Science Centre [2016/21/B/ST2/01222]; EU; MSHE [POIG.02.03.00-161 00-013/09]; Marian Smoluchowski Krakow Research Consortium "Matter-Energy Future"; Polish Ministry of Science and Higher Education [7150/E-338/M/2015];  [INNOTECH-K1/1N1/64/159174/NCBR/12]	Foundation for Polish Science through MPD programme; Marian Smoluchowski Krakow Research Consortium "Matter-Energy-Future"; Austrian Science Fund(Austrian Science Fund (FWF)); Polish National Centre for Development and Research; National Science Centre(National Science Centre, Poland); EU(European Commission); MSHE; Marian Smoluchowski Krakow Research Consortium "Matter-Energy Future"; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); 	This work was supported by INNOTECH-K1/1N1/64/159174/NCBR/12 (http://www.ncbr.gov.pl/), LIDER/274/L-6/14/NCBR/2015 (http://www.ncbr.gov.pl/), POIG.02.03.00-161 00-013/09 (http://www.fnp.org.pl/), 7150/E-338/M/2015 (http://www.nauka.gov.pl/), 2016/21/B/ST2/01222 (https://www.ncn.gov.pl/), the Foundation for Polish Science through MPD programme, Marian Smoluchowski Krakow Research Consortium "Matter-Energy-Future," and the Austrian Science Fund (FWFP 26783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge technical and administrative support of A. Heczko, M. Kajetanowicz, W. Migdal, and the financial support by the Polish National Centre for Development and Research through grant LIDER/274/L-6/14/NCBR/2015, INNOTECH-Kl/IN1/64/159174/NCBR/12, National Science Centre through grant No. 2016/21/B/ST2/01222, the Foundation for Polish Science through MPD programme, the EU and MSHE Grant No. POIG.02.03.00-161 00-013/09 and Marian Smoluchowski Krakow Research Consortium "Matter-Energy Future" and Polish Ministry of Science and Higher Education through grant: 7150/E-338/M/2015. BCH acknowledges gratefully the Austrian Science Fund (FWFP 26783).	Adadurov AF, 2009, NUCL INSTRUM METH A, V599, P167, DOI 10.1016/j.nima.2008.11.014; [Anonymous], 1964, THEORY PRACTICE SCIN, P321; [Anonymous], 2017, ELJEN TECHNOLOGY SWE; [Anonymous], 2004, EUROPEAN J NUCL MED, V33, P133; Bobrovnikov YA, 1970, J APPL SPECTROSC, V13, P1009; Britton EC, 1941, [Google Patents, US Patent], Patent No. [2,256,160, 2256160]; Buvat I., 2012, HDB PARTICLE DETECTI; Conti M, 2011, EUR J NUCL MED MOL I, V38, P1147, DOI 10.1007/s00259-010-1711-y; Conti M, 2009, PHYS MEDICA, V25, P1, DOI 10.1016/j.ejmp.2008.10.001; Funt B, 1959, INT J APPL RADIAT IS, V4, P189; Glowacz B, 2017, tof-pet insert. Google Patents, Patent No. [2016/000,082, 2016000082]; Humm JL, 2003, EUR J NUCL MED MOL I, V30, P1574, DOI 10.1007/s00259-003-1266-2; Ikeda H, 2000, NUCL INSTRUM METH A, V441, P401, DOI 10.1016/S0168-9002(99)00992-4; Kaplon L, 2014, BIO-ALGORITHMS MED-S, V10, P27, DOI 10.1515/bams-2013-0108; Karp JS, 2008, J NUCL MED, V49, P462, DOI 10.2967/jnumed.107.044834; Ko CW, 2001, CHEM MATER, V13, P2441, DOI 10.1021/cm010199u; Korcyl G, 2016, ACTA PHYS POL B, V47, P491, DOI 10.5506/APhysPolB.47.491; Kowalski P, 2015, ACTA PHYS POL A, V127, P1505, DOI 10.12693/APhysPolA.127.1505; Krzemien W, 2016, ACTA PHYS POL B, V47, P561, DOI 10.5506/APhysPolB.47.561; Kubicz E, 2016, ACTA PHYS POL B, V47, P537, DOI 10.5506/APhysPolB.47.537; Moses WW, 2007, NUCL INSTRUM METH A, V580, P919, DOI 10.1016/j.nima.2007.06.038; Moskal P, 2016, PHYS MED BIOL, V61, P2025, DOI 10.1088/0031-9155/61/5/2025; Moskal P, 2015, ACTA PHYS POL A, V127, P1495, DOI 10.12693/APhysPolA.127.1495; Moskal P, 2015, NUCL INSTRUM METH A, V775, P54, DOI 10.1016/j.nima.2014.12.005; Moskal P, 2014, NUCL INSTRUM METH A, V764, P317, DOI 10.1016/j.nima.2014.07.052; Moskal P, 2016, A hybrid tof-pet/mri tomograph. Google Patents, Patent No. [14/915,259, 14915259]; MOSZYNSKI M, 1979, NUCL INSTRUM METHODS, V158, P1, DOI 10.1016/S0029-554X(79)90170-8; MOSZYNSKI M, 1977, NUCL INSTRUM METHODS, V142, P417, DOI 10.1016/0029-554X(77)90676-0; Palka M, 2017, J INSTRUM, V12, DOI 10.1088/1748-0221/12/08/P08001; Raczynski L, 2015, NUCL INSTRUM METH A, V786, P105, DOI 10.1016/j.nima.2015.03.032; Raczynski L, 2014, NUCL INSTRUM METH A, V764, P186, DOI 10.1016/j.nima.2014.07.032; Senchyshyn V, 2006, NUCL INSTRUM METH A, V566, P286, DOI 10.1016/j.nima.2006.06.037; SIEGRIST AE, 1967, HELV CHIM ACTA, V50, P906, DOI 10.1002/hlca.19670500318; Slomka PJ, 2016, SEMIN NUCL MED, V46, P5, DOI 10.1053/j.semnuclmed.2015.09.006; Smyrski J, 2017, NUCL INSTRUM METH A, V851, P39, DOI 10.1016/j.nima.2017.01.045; Tomasz B, 2016, THESIS; Vandenberghe S, 2015, PHYS MED BIOL, V60, pR115, DOI 10.1088/0031-9155/60/4/R115; Vasilchenko VG, 1996, NUCL INSTRUM METH A, V369, P55, DOI 10.1016/0168-9002(95)00774-1; Wieczorek A, 2015, ACTA PHYS POL A, V127, P1487, DOI 10.12693/APhysPolA.127.1487; Wieczorek A, 2017, Google Patents, Patent No. [20,150,744,711, 20150744711]	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0186728	10.1371/journal.pone.0186728	http://dx.doi.org/10.1371/journal.pone.0186728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176834	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900002
J	Fowler, DW				Fowler, Denver Warwick			Revised geochronology, correlation, and dinosaur stratigraphic ranges of the Santonian-Maastrichtian (Late Cretaceous) formations of the Western Interior of North America	PLOS ONE			English	Article							CANYON SANIDINE STANDARD; K-40 DECAY CONSTANTS; 40AR/39AR AGE; KAIPAROWITS FORMATION; HELL CREEK; U-PB; BIOSTRATIGRAPHIC CORRELATION; JOINT DETERMINATION; IMPROVED ACCURACY; SOUTHERN ALBERTA	Interbasinal stratigraphic correlation provides the foundation for all consequent continental-scale geological and paleontological analyses. Correlation requires synthesis of lithostrati-graphic, biostratigraphic and geochronologic data, and must be periodically updated to accord with advances in dating techniques, changing standards for radiometric dates, new stratigraphic concepts, hypotheses, fossil specimens, and field data. Outdated or incorrect correlation exposes geological and paleontological analyses to potential error. The current work presents a high-resolution stratigraphic chart for terrestrial Late Cretaceous units of North America, combining published chronostratigraphic, lithostratigraphic, and biostratigraphic data. 40Ar/(39) Ar radiometric dates are newly recalibrated to both current standard and decay constant pairings. Revisions to the stratigraphic placement of most units are slight, but important changes are made to the proposed correlations of the Aguja and Javelina formations, Texas, and recalibration corrections in particular affect the relative age positions of the Belly River Group, Alberta; Judith River Formation, Montana; Kaiparowits Formation, Utah; and Fruitland and Kirtland formations, New Mexico. The stratigraphic ranges of selected clades of dinosaur species are plotted on the chronostratigraphic framework, with some clades comprising short-duration species that do not overlap stratigraphically with preceding or succeeding forms. This is the expected pattern that is produced by an anagenetic mode of evolution, suggesting that true branching (speciation) events were rare and may have geographic significance. The recent hypothesis of intracontinental latitudinal provinciality of dinosaurs is shown to be affected by previous stratigraphic miscorrelation. Rapid stepwise acquisition of display characters in many dinosaur clades, in particular chasmosaurine ceratopsids, suggests that they may be useful for high resolution biostratigraphy.	[Fowler, Denver Warwick] Dickinson Museum Ctr, Dickinson, ND 58601 USA		Fowler, DW (corresponding author), Dickinson Museum Ctr, Dickinson, ND 58601 USA.	df9465@yahoo.co.uk		Fowler, Denver/0000-0001-9188-4371				Baksi AK, 1996, CHEM GEOL, V129, P307, DOI 10.1016/0009-2541(95)00154-9; BECKINSALE RD, 1969, EARTH PLANET SC LETT, V6, P289, DOI 10.1016/0012-821X(69)90170-8; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Cebula G. T., 1986, TERRA COGNITA, V6, P139; Cifelli Richard L., 2004, P21; COBBAN WA, 1952, GEOL SOC AM BULL, V63, P1011, DOI 10.1130/0016-7606(1952)63[1011:COTCFO]2.0.CO;2; Dalrymple GB, 1993, US GEOL SURV B, V2065, p1 ; DUFFIELD WA, 1990, B VOLCANOL, V52, P475, DOI 10.1007/BF00268927; EATON J.G., 1991, GEOLOGICAL SOC AM SP, V260, P47, DOI DOI 10.1130/SPE260-P47; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 1992, SEPM THEM M; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Eberth DA, 2005, LIFE O PAST, P54; ENDT PM, 1990, NUCL PHYS A, V521, P1, DOI 10.1016/0375-9474(90)90598-G; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130007; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fassett James E., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P239; Fowler DW, 2016, THESIS; Fowler EAF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141304; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates Terry A., 2013, P463; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hartman J.H., 2014, GEOL SOC AM SPEC PAP, V503, P89, DOI DOI 10.1130/2014.2503(02); Hicks J. F., 2003, ROCKY MOUNTAIN GEOLO, V38, P1, DOI DOI 10.2113/GSR0CKY.38.1.1; HICKS JF, 1995, J GEOL, V103, P243, DOI 10.1086/629744; Hicks JF, 2002, GEOL S AM S, P35; Hicks JF, 1999, ABSTRACTS PROGRAMS G, V31, P234; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; IZETT GA, 1994, J GEOPHYS RES-SOL EA, V99, P2925, DOI 10.1029/93JB03085; KRYSTINIK L. F., 1995, AAPG BULL, V64, P11; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lanphere MA, 1990, EOS T AM GEOPHYS UN, V71, p1 ; LAWSON DA, 1976, J PALEONTOL, V50, P158; LeCain R, 2014, GEOLOGICAL SOC AM SP, V503, p137 ; Lehman Thomas M., 2001, P310; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Lerbekmo JF, 2002, CAN J EARTH SCI, V39, P1745, DOI 10.1139/E02-079; Lerbekmo JF, 2002, CAN J EARTH SCI, V39, P539, DOI 10.1139/E01-085; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Longrich NR, 2014, CRETACEOUS RES, V51, P292, DOI 10.1016/j.cretres.2014.06.011; LUCAS SG, 2016, NEW MEXICO MUSEUM NA, P195; Lucas Spencer G., 2012, Journal of Stratigraphy, V36, P436; McDougall I., 1999, GEOCHRONOLOGY THERMO; McLean N., EARTHTIME AR AR TEMP; Meyers SR, 2012, GEOLOGY, V40, P7, DOI 10.1130/G32261.1; Miall AD, 2008, SEDIMENT BASIN WORLD, V5, P329, DOI 10.1016/S1874-5997(08)00009-9; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Obradovich JD, 2002, ROCKY MOUNTAIN GEOLO, V37, p165 ; Obradovich JD, 1975, GEOLOGICAL ASS CANAD, V13, p31 ; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P793, DOI 10.1016/B978-0-444-59425-9.00027-5; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P85, DOI 10.1016/B978-0-444-59425-9.00005-6; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; RENNE PR, 1994, GEOLOGY, V22, P783, DOI 10.1130/0091-7613(1994)022<0783:IOAART>2.3.CO;2; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Rivera TA, 2011, EARTH PLANET SC LETT, V311, P420, DOI 10.1016/j.epsl.2011.09.017; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; Roberts Eric M., 2013, P85; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Rogers RR, 1993, MONT GEOL SOC 1993 F, p61 ; RUSSELL L S, 1975, P137; RUSSELL LORIS S., 1964, ROY ONTARIO MUS LIFE SCI DIV, V61, P1; Sageman BB, 2014, GEOL SOC AM BULL, V126, P956, DOI 10.1130/B30929.1; Sampson Scott D., 2013, P599; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; SAMSON SD, 1987, CHEM GEOL, V66, P27, DOI 10.1016/0168-9622(87)90025-X; Sarna- Wojcicki AM, 1992, EOS T AGU, V73, P43; Scannella JB, 2014, P NATL ACAD SCI USA, V111, P10245, DOI 10.1073/pnas.1313334111; Schmitz MD, 2001, GEOCHIM COSMOCHIM AC, V65, P2571, DOI 10.1016/S0016-7037(01)00616-0; Schoene B, 2006, GEOCHIM COSMOCHIM AC, V70, P426, DOI 10.1016/j.gca.2005.09.007; Singer BS, 2012, AGU FALL M, P21; Sprain CJ, 2015, GEOL SOC AM BULL, V127, P393, DOI 10.1130/B31076.1; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; Sullivan Robert M., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P369; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487	83	65	65	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188426	10.1371/journal.pone.0188426	http://dx.doi.org/10.1371/journal.pone.0188426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166406	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300037
J	Haysom, SS; Vickers, MH; Yu, LH; Reynolds, CM; Firth, EC; McGlashan, SR				Haysom, Samuel S.; Vickers, Mark H.; Yu, Lennex H.; Reynolds, Clare M.; Firth, Elwyn C.; McGlashan, Sue R.			Post-weaning high-fat diet results in growth cartilage lesions in young male rats	PLOS ONE			English	Article							OSTEOCHONDRITIS-DISSECANS; METABOLIC OSTEOARTHRITIS; RELATIVE CONTRIBUTION; 10-TO 13-YEAR-OLDS; SYSTEMIC PROCESSES; MECHANICAL-STRESS; INDUCED OBESITY; KNEE; PATHOGENESIS; INFLAMMATION	To determine if a high-fat diet (HF) from weaning would result in a pro-inflammatory state and affect joint cartilage, we fed male rats either HF or Chow diet post-weaning, and voluntary wheel exercise (EX) or cage only activity (SED) after 9 weeks of age. At 17 weeks body composition, plasma biomarkers and histomorphology scores of femoro-tibial cartilages of HF-SED, HF-EX, Chow-SED and Chow-EX groups were compared. Food intake and activity were not significantly different between groups. HF diet resulted in significantly higher weight gain, % fat, fat: lean ratio, and plasma leptin, insulin and TNF alpha concentrations, with significant interactions between diet and exercise. No abnormal features were detected in the hyaline articular cartilage or in the metaphyseal growth plate in all four groups. However, collagen type X-positive regions of retained epiphyseal growth cartilage (EGC) was present in all HF-fed animals and significantly greater than that observed in Chow-fed sedentary rats. Most lesions were located in the lateral posterior aspect of the tibia and/or femur. The severity of lesions was greater in HF-fed animals. Although exercise had a significantly greater effect in reducing adiposity and associated systemic inflammation in HF-fed rats, it had no effect on lesion incidence or severity. Lesion incidence was also significantly associated with indices of obesity and plasma markers of chronic inflammation. Clinically, EGC lesions induced by HF feeding in rats from very early in life, and possibly by insufficient activity, is typical of osteochondrosis in animals. Such lesions may be the precursor of juvenile osteochondritis dissecans requiring surgery in children/adolescents, conservative management of which could benefit from improved understanding of early changes in cellular and gene expression.	[Haysom, Samuel S.; Yu, Lennex H.; McGlashan, Sue R.] Univ Auckland, Dept Anat & Med Imaging, Auckland, New Zealand; [Vickers, Mark H.; Reynolds, Clare M.; Firth, Elwyn C.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Vickers, Mark H.; Reynolds, Clare M.; Firth, Elwyn C.] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Firth, Elwyn C.] Univ Auckland, Dept Exercise Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	McGlashan, SR (corresponding author), Univ Auckland, Dept Anat & Med Imaging, Auckland, New Zealand.; Firth, EC (corresponding author), Univ Auckland, Liggins Inst, Auckland, New Zealand.; Firth, EC (corresponding author), Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand.; Firth, EC (corresponding author), Univ Auckland, Dept Exercise Sci, Auckland, New Zealand.	e.firth@auckland.ac.nz; s.mcglashan@auckland.ac.nz	Yu, Lennex/GXW-0770-2022	Yu, Lennex/0000-0002-7492-5570; McGlashan, Susan/0000-0002-8666-2456	Arthritis New Zealand [R238]; Gravida National Centre for Growth and Development Masters Scholarship	Arthritis New Zealand; Gravida National Centre for Growth and Development Masters Scholarship	This work was supported by Grant number R238, Arthritis New Zealand (ECF, SRM, MHV), www.arthritis.org.nz; Gravida National Centre for Growth and Development Masters Scholarship (SSH), www.gravida.org.nz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162794; CARLSON CS, 1995, VET PATHOL, V32, P641, DOI 10.1177/030098589503200605; CARLSON CS, 1989, VET PATHOL, V26, P47, DOI 10.1177/030098588902600108; Chalkley SM, 2002, AM J PHYSIOL-ENDOC M, V282, pE1231, DOI 10.1152/ajpendo.00173.2001; Chan G, 2009, CURR OPIN PEDIATR, V21, P65, DOI 10.1097/MOP.0b013e328320a914; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P957, DOI 10.1016/j.joca.2015.01.015; Collins KH, 2016, J ORTHOP RES, V34, P1010, DOI 10.1002/jor.23103; Courties A, 2015, OSTEOARTHR CARTILAGE, V23, P1955, DOI 10.1016/j.joca.2015.05.016; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekman S, 1998, VET CLIN N AM-SMALL, V28, P17, DOI 10.1016/S0195-5616(98)50002-2; Furnes MW, 2009, OBES SURG, V19, P1430, DOI 10.1007/s11695-009-9863-1; Gauthier MS, 2003, J APPL PHYSIOL, V94, P2127, DOI 10.1152/japplphysiol.01164.2002; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Gettys FK, 2011, ORTHOP CLIN N AM, V42, P95, DOI 10.1016/j.ocl.2010.08.005; Gierman LM, 2012, ARTHRITIS RHEUM-US, V64, P1172, DOI 10.1002/art.33443; Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008; Goulding A, 2005, J BONE MINER RES, V20, P2090, DOI 10.1359/JBMR.050820; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; HURTIG MB, 1996, JOINT DIS HORSE, P00335; Jacobs JC, 2014, CLIN SPORT MED, V33, P189, DOI 10.1016/j.csm.2013.11.005; KATO M, 1987, VET PATHOL, V24, P80, DOI 10.1177/030098588702400113; KATO M, 1986, LAB ANIM-UK, V20, P249, DOI 10.1258/002367786780865575; KATO M, 1984, LAB ANIM-UK, V18, P179, DOI 10.1258/002367784780891361; Kc R, 2015, SCI REP-UK, V5, DOI 10.1038/srep16896; Lecocq M, 2008, EQUINE VET J, V40, P442, DOI 10.2746/042516408X297453; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Levin BE, 2000, AM J PHYSIOL-REG I, V278, pR231, DOI 10.1152/ajpregu.2000.278.1.R231; Liu-Bryan R, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0323-5; Mccoy AM, 2013, OSTEOARTHR CARTILAGE, V21, P1638, DOI 10.1016/j.joca.2013.08.011; Mirams M, 2016, J ORTHOP RES, V34, P404, DOI 10.1002/jor.23033; Mirams M, 2009, J ORTHOP RES, V27, P452, DOI 10.1002/jor.20761; Mooney RA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3529; Novais EN, 2012, CLIN ORTHOP RELAT R, V470, P3432, DOI 10.1007/s11999-012-2452-y; OLSSON SE, 1987, VET QUART, V9, P268, DOI 10.1080/01652176.1987.9694112; Olstad K, 2015, VET PATHOL, V52, P785, DOI 10.1177/0300985815588778; REILAND S, 1978, ACTA RADIOL DIAGN, P107; Roach HI, 2003, J HISTOCHEM CYTOCHEM, V51, P373, DOI 10.1177/002215540305100312; Sellam J, 2013, JOINT BONE SPINE, V80, P568, DOI 10.1016/j.jbspin.2013.09.007; Shea KG, 2013, CLIN ORTHOP RELAT R, V471, P1127, DOI 10.1007/s11999-012-2619-6; Styne DM, 2001, PEDIATR CLIN N AM, V48, P823, DOI 10.1016/S0031-3955(05)70344-8; Touati S, 2011, MED SCI SPORT EXER, V43, P398, DOI 10.1249/MSS.0b013e3181eeb12d; Triantaphyllidou IE, 2013, OSTEOARTHR CARTILAGE, V21, P322, DOI 10.1016/j.joca.2012.11.003; Tsiros MD, 2013, PEDIATR OBES, V8, P31, DOI 10.1111/j.2047-6310.2012.00083.x; Tsiros MD, 2013, EUR J APPL PHYSIOL, V113, P1415, DOI 10.1007/s00421-012-2561-z; Uppstrom TJ, 2016, CURR OPIN PEDIATR, V28, P60, DOI 10.1097/MOP.0000000000000308; van Weeren P R, 1999, Equine Vet J Suppl, P16; Visser AW, 2015, ANN RHEUM DIS, V74, P1842, DOI 10.1136/annrheumdis-2013-205012; Visser AW, 2014, OSTEOARTHR CARTILAGE, V22, pS202, DOI 10.1016/j.joca.2014.02.387; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Yeh FJ, 2006, OSTEOPOROSIS INT, V17, P267, DOI 10.1007/s00198-005-2009-y; Ytrehus B, 2007, VET PATHOL, V44, P429, DOI 10.1354/vp.44-4-429; Ytrehus B, 2004, BONE, V35, P1294, DOI 10.1016/j.bone.2004.08.016; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	55	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188411	10.1371/journal.pone.0188411	http://dx.doi.org/10.1371/journal.pone.0188411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166409	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300036
J	Zhao, CQ; Fan, XF; Hou, XC; Zhu, Y; Yue, YS; Wu, JY				Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Wu, Juying			Extended light exposure increases stem digestibility and biomass production of switchgrass	PLOS ONE			English	Article							ENZYMATIC DIGESTIBILITY; PRETREATMENTS; LIGNIN; QUALITY; YIELD; ALAMO	Switchgrass is a photoperiod-sensitive energy grass suitable for growing in the marginal lands of China. We explored the effects of extended photoperiods of low-irradiance light (7 mu mol.m(-2).s(-1), no effective photosynthesis) on the growth, the biomass dry weight, the biomass allocation, and, especially, the stem digestibility and cell wall characteristics of switch-grass. Two extended photoperiods (i.e., 18 and 24 h) were applied over Alamo. Extended light exposure (18 and 24 h) resulted in delayed heading and higher dry weights of vegetative organs (by 32.87 and 35.94%, respectively) at the expense of reducing the amount of sexual organs (by 40.05 and 50.87%, respectively). Compared to the control group (i.e., natural photoperiod), the yield of hexoses (% dry matter) in the stems after a direct enzymatic hydrolysis (DEH) treatment significantly increased (by 44.02 and 46.10%) for those groups irradiated during 18 and 24 h, respectively. Moreover, the yield of hexoses obtained via enzymatic hydrolysis increased after both basic (1% NaOH) and acid (1% H2SO4) pretreatments for the groups irradiated during 18 and 24 h. Additionally, low-irradiance light extension (LILE) significantly increased the content of non-structural carbohydrates (NSCs) while notably reducing the lignin content and the syringyl to guaiacyl (S/G) ratio. These structural changes were in part responsible for the observed improved stem digestibility. Remarkably, LILE significantly decreased the cellulose crystallinity index (CrI) of switchgrass by significantly increasing both the arabinose substitution degree in xylan and the content of ammonium oxalate-extractable uronic acids, both favoring cellulose digestibility. Despite this LILE technology is not applied to the cultivation of switchgrass on a large scale yet, we believe that the present work is important in that it reveals important relationships between extended day length irradiations and biomass production and quality. Additionally, this study paves the way for improving biomass production and digestibility via genetic modification of day length sensitive transcription factors or key structural genes in switchgrass leaves.	[Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Wu, Juying] Beijing Acad Agr & Forestry Sci, Res & Dev Ctr Grass & Environm, Beijing, Peoples R China; [Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Wu, Juying] Minist Agr, Key Lab Urban Agr North, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Fan, XF (corresponding author), Beijing Acad Agr & Forestry Sci, Res & Dev Ctr Grass & Environm, Beijing, Peoples R China.; Fan, XF (corresponding author), Minist Agr, Key Lab Urban Agr North, Beijing, Peoples R China.	fanxifengcau@163.com			Special Funds for Construction of Scientific and Technological Innovation Ability [KJCX20140201, KJCX20150101]; Technology Innovation Team Project of Beijing Academy of Agriculture and Sciences [JNKYT201605]; Research Funds of Beijing Academy of Agriculture and Sciences for the Youth [QNJJ201511]	Special Funds for Construction of Scientific and Technological Innovation Ability; Technology Innovation Team Project of Beijing Academy of Agriculture and Sciences; Research Funds of Beijing Academy of Agriculture and Sciences for the Youth	This work was supported by grants from Special Funds for Construction of Scientific and Technological Innovation Ability (KJCX20140201), Technology Innovation Team Project of Beijing Academy of Agriculture and Sciences (JNKYT201605), Special Funds for Construction of Scientific and Technological Innovation Ability (KJCX20150101) and Research Funds of Beijing Academy of Agriculture and Sciences for the Youth (QNJJ201511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Special Funds for Construction of Scientific and Technological Innovation Ability (KJCX20140201), Technology Innovation Team Project of Beijing Academy of Agriculture and Sciences (JNKYT201605), Special Funds for Construction of Scientific and Technological Innovation Ability (KJCX20150101) and Research Funds of Beijing Academy of Agriculture and Sciences for the Youth (QNJJ201511).	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Alderson J, 1994, GRASS VARIETIES US A; Boe A, 2007, PHOTOPERIODIC RESPON; BOWMAN DALE E., 1964, AGRON J, V56, P177; Castro JC, 2011, CROP SCI, V51, P2607, DOI 10.2135/cropsci2011.03.0142; Chen L, 2002, J AGR FOOD CHEM, V50, P5558, DOI 10.1021/jf020516x; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; COLLINSON ST, 1992, ANN BOT-LONDON, V70, P339, DOI 10.1093/oxfordjournals.aob.a088483; DEINUM B, 1968, Netherlands Journal of Agricultural Science, V16, P217; FERRARIS R, 1978, AUST J AGR RES, V29, P941, DOI 10.1071/AR9780941; Garner WW, 1920, AGR RES, V18, P553; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; HIGHT GK, 1968, NEW ZEAL J AGR RES, V11, P286; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOPKINS AA, 1995, CROP SCI, V35, P125, DOI [10.2135/cropsci1995.0011183X003500010023x, 10.2135/cropsci1995.0011183X003500020047x]; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Jensen E, 2013, J EXP BOT, V64, P541, DOI 10.1093/jxb/ers346; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V169, P447, DOI 10.1016/j.biortech.2014.07.017; Li ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105115; Loch DS, 2004, SEED FORMATION DEV G, P95; LUNDVALL JP, 1994, CROP SCI, V34, P1672, DOI 10.2135/cropsci1994.0011183X003400060046x; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MCMILLAN C, 1959, ECOL MONOGR, V29, P285, DOI 10.2307/1942132; Moser LE, 1995, FORAGES INTRO GRASSL, V1, P409; Nordheim-Viken H, 2009, ANIM FEED SCI TECH, V152, P204, DOI 10.1016/j.anifeedsci.2009.04.012; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pei YJ, 2016, BIORESOURCE TECHNOL, V203, P325, DOI 10.1016/j.biortech.2015.12.072; PHILLIPS TG, 1954, AGRON J, V46, P361, DOI 10.2134/agronj1954.00021962004600080003x; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sluiter A., 2010, NRELTP51042618; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tadege M, 2015, BIOENERG RES, V8, P857, DOI 10.1007/s12155-014-9565-y; Tang Y, 2010, J INTEGR PLANT BIOL, V52, P112, DOI 10.1111/j.1744-7909.2010.00903.x; Thomas B., 1996, PHOTOPERIODISM PLANT; Van Esbroeck GA, 2004, BIORESOURCE TECHNOL, V91, P141, DOI 10.1016/S0960-8524(03)00178-0; Van Esbroeck GA, 2003, CROP SCI, V43, P639; Van Esbroeck GA, 1998, CROP SCI, V38, P342, DOI 10.2135/cropsci1998.0011183X003800020010x; Wang T, 2016, J EXP BOT, V67, P543, DOI 10.1093/jxb/erv488; Wang YT, 2015, BIORESOURCE TECHNOL, V196, P391, DOI 10.1016/j.biortech.2015.07.099; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Xue S, 2016, RENEW SUST ENERG REV, V54, P932, DOI 10.1016/j.rser.2015.10.040; Yang SS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-148; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029; Zhao CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120845	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188349	10.1371/journal.pone.0188349	http://dx.doi.org/10.1371/journal.pone.0188349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166649	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300033
J	Wang, L; Li, YJ; Xiong, Y; Tan, WB; Zhang, LY; Li, X; Wang, XS; Xu, JF; Li, TT; Wang, JS; Cai, MX; Xi, BD; Wang, DH				Wang, Lei; Li, Ying-Jun; Xiong, Ying; Tan, Wen-Bing; Zhang, Lie-Yu; Li, Xiang; Wang, Xiao-Shu; Xu, Jian-Feng; Li, Tong-Tong; Wang, Jin-Sheng; Cai, Ming-Xuan; Xi, Bei-Dou; Wang, Di-Hua			Spectroscopic characterization of DOM and the nitrogen removal mechanism during wastewater reclamation plant	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; REGIONAL-INTEGRATION ANALYSIS; BIO-REFRACTORY ORGANICS; SOIL AQUIFER TREATMENT; MUNICIPAL SOLID-WASTE; RECLAIMED WATER; MEMBRANE BIOREACTOR; NUTRIENT REMOVAL; FLUORESCENCE EXCITATION; LANDFILL LEACHATE	The performance of the Sha-he wastewater reclamation plant was evaluated in this study. To remove residual nitrogen after Anaerobic-Anoxic-Oxic (A(2)O) treatment, three multistage Anoxic-Oxic (A/O) were added to investigate the nitrogen removal efficiency and its mechanism. In addition, the constituents and evolution of dissolved organic matter (DOM) during wastewater reclamation was also investigated using a method combining fluorescence spectroscopy with fluorescence regional integration (FRI). The results suggested that multistage A/O treatment can effectively improve the nitrogen removal ability under low concentrations of carbon sources. The total nitrogen (TN) exhibits significantly positive correlation with fulvic acid-like materials and humic acid-like materials. The correlation coefficient for TN and fulvic acid-like substances (R-2 = 0.810, P < 0.01) removal was greater than that of humic acid-like substances (R-2 = 0.636, P < 0.05). The results indicate that nitrogen removal may be achieved with the fulvic-like and humic-like substances, and the removal effects were higher by fulvic acid-like substances than humic-like substances, mostly due to that the latter were relatively more difficult to be utilized as carbon source during the nitrogen removal process. The effluent water quality of biological treatment reached the first grade A standard of "Cities sewage treatment plant pollutant discharge standard" (GB18918-2002). In addition, the effluent from the membrane bioreactor reached the "Standards of reclaimed water quality" (SL368-2006).	[Wang, Lei; Wang, Xiao-Shu; Xi, Bei-Dou; Wang, Di-Hua] Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Hubei, Peoples R China; [Wang, Lei; Tan, Wen-Bing; Zhang, Lie-Yu; Li, Xiang; Xu, Jian-Feng; Li, Tong-Tong; Wang, Jin-Sheng; Cai, Ming-Xuan; Xi, Bei-Dou] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Simulat & Control, Beijing, Peoples R China; [Li, Ying-Jun] Beijing Vocat Coll Agr, Beijing, Peoples R China; [Xiong, Ying] Beijing Univ Civil Engn & Architecture, Key Lab Urban Storm Water Syst & Water Environm, Minist Educ, Beijing, Peoples R China; [Li, Tong-Tong] Capital Normal Univ, Coll Resource Environm & Tourism, Beijing, Peoples R China; [Cai, Ming-Xuan] Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Peoples R China	Wuhan University; Chinese Research Academy of Environmental Sciences; Beijing University of Civil Engineering & Architecture; Capital Normal University; Guilin University of Technology	Xi, BD; Wang, DH (corresponding author), Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Hubei, Peoples R China.; Xi, BD (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Simulat & Control, Beijing, Peoples R China.	xibeidou@263.net; Dihuawang@whu.edu.cn	Wang, Dihua/G-5728-2011	Wang, Dihua/0000-0003-2364-8718	National Natural Science Foundation of China [51678549]; Fundamental Research Funds for the Central Universities (Wuhan University) [201604398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Wuhan University)	This work was kindly supported by the National Natural Science Foundation of China (51678549) and the Fundamental Research Funds for the Central Universities (Wuhan University Duke initiative project 201604398).	Akizuki S, 2015, BIOCHEM ENG J, V99, P16, DOI 10.1016/j.bej.2015.01.009; Chang J, 2016, J CLEAN PROD, V141, P728; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Chen YZ, 2011, BIORESOURCE TECHNOL, V102, P5722, DOI 10.1016/j.biortech.2011.02.114; Dignac MF, 2000, WATER RES, V34, P4185, DOI 10.1016/S0043-1354(00)00195-0; dos Santos LM, 2010, GEODERMA, V155, P121, DOI 10.1016/j.geoderma.2009.12.006; E. P. A. Chinese, 2012, METH WAT WAST AN; Essandoh HMK, 2011, WATER RES, V45, P4211, DOI 10.1016/j.watres.2011.05.017; Falahti-Marvast H, 2015, INT BIODETER BIODEGR, V104, P363, DOI 10.1016/j.ibiod.2015.07.001; He XS, 2013, CHEMOSPHERE, V93, P2208, DOI 10.1016/j.chemosphere.2013.04.039; He XS, 2011, J HAZARD MATER, V190, P293, DOI 10.1016/j.jhazmat.2011.03.047; He XS, 2011, BIORESOURCE TECHNOL, V102, P2322, DOI 10.1016/j.biortech.2010.10.085; He XS, 2011, CHEMOSPHERE, V82, P541, DOI 10.1016/j.chemosphere.2010.10.057; Hong JM, 2016, BIORESOURCE TECHNOL, V212, P280, DOI 10.1016/j.biortech.2016.04.042; Hu HY, 2016, SCI TOTAL ENVIRON, V551, P133, DOI 10.1016/j.scitotenv.2015.12.111; Hu YS, 2013, J MEMBRANE SCI, V431, P156, DOI 10.1016/j.memsci.2013.01.001; Hu ZR, 2002, WATER RES, V36, P4927, DOI 10.1016/S0043-1354(02)00186-0; Hudson N, 2008, SCI TOTAL ENVIRON, V391, P149, DOI 10.1016/j.scitotenv.2007.10.054; Jaffe R, 2004, MAR CHEM, V84, P195, DOI 10.1016/j.marchem.2003.08.001; Levine AD, 2004, ENVIRON SCI TECHNOL, V38, p201A, DOI 10.1021/es040504n; Lyko S, 2008, J MEMBRANE SCI, V317, P78, DOI 10.1016/j.memsci.2007.07.008; Ma XYY, 2016, J HAZARD MATER, V318, P663, DOI 10.1016/j.jhazmat.2016.07.050; Mannina G, 2016, CHEM ENG J, V296, P289, DOI 10.1016/j.cej.2016.03.114; Meneses M, 2010, CHEMOSPHERE, V81, P266, DOI 10.1016/j.chemosphere.2010.05.053; Michael-Kordatou I, 2015, WATER RES, V77, P213, DOI 10.1016/j.watres.2015.03.011; Peng YZ, 2011, BIORESOURCE TECHNOL, V102, P6405, DOI 10.1016/j.biortech.2011.03.043; Pollice A, 2008, J MEMBRANE SCI, V317, P65, DOI 10.1016/j.memsci.2007.08.051; Qu FS, 2012, WATER RES, V46, P2881, DOI 10.1016/j.watres.2012.02.045; Rice J, 2015, ENVIRON SCI TECHNOL, V49, P982, DOI 10.1021/es5048057; Roccaro P, 2014, CHEM ENGINEER TRANS, V37, P817, DOI 10.3303/CET1437137; Ryu HD, 2014, SEP PURIF TECHNOL, V136, P199, DOI 10.1016/j.seppur.2014.09.003; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; Sun FQ, 2015, J HAZARD MATER, V286, P416, DOI 10.1016/j.jhazmat.2015.01.031; Wang YK, 2013, CHEM ENG SCI, V95, P78, DOI 10.1016/j.ces.2013.03.025; Wang ZC, 2016, BIORESOURCE TECHNOL, V205, P213, DOI 10.1016/j.biortech.2016.01.067; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Wu FC, 2004, BIOGEOCHEMISTRY, V71, P339, DOI 10.1007/s10533-004-0058-5; Wu LN, 2016, BIORESOURCE TECHNOL, V212, P296, DOI 10.1016/j.biortech.2016.04.041; Wu L, 2016, SEP PURIF TECHNOL, V170, P306, DOI 10.1016/j.seppur.2016.06.033; Wu LN, 2015, BIORESOURCE TECHNOL, V198, P207, DOI 10.1016/j.biortech.2015.08.072; Xia XH, 2009, ENVIRON SCI TECHNOL, V43, P3681, DOI 10.1021/es8036675; Xu JY, 2014, J ENVIRON SCI, V26, P1961, DOI 10.1016/j.jes.2014.07.008; Xu M, 2016, INT J HYDROGEN ENERG, V41, P15930, DOI 10.1016/j.ijhydene.2016.05.020; Yang L, 2016, J ENVIRON SCI, V50, P93, DOI 10.1016/j.jes.2016.05.023; Zeng W, 2010, BIORESOURCE TECHNOL, V101, P8074, DOI 10.1016/j.biortech.2010.05.098; Zhang M, 2016, BIOCHEM ENG J, V106, P26, DOI 10.1016/j.bej.2015.10.027; Zhang Zhi-yin, 2006, Fudan Xuebao Zirankexueban, V45, P755; Zhao X, 2014, J ENVIRON SCI-CHINA, V26, P2190, DOI 10.1016/j.jes.2014.09.001	49	8	8	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187355	10.1371/journal.pone.0187355	http://dx.doi.org/10.1371/journal.pone.0187355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149172	gold, Green Submitted, Green Published			2022-12-26	WOS:000415646100010
J	Beurmann, S; Ushijima, B; Videau, P; Svoboda, CM; Smith, AM; Rivers, OS; Aeby, GS; Callahan, SM				Beurmann, Silvia; Ushijima, Blake; Videau, Patrick; Svoboda, Christina Marie; Smith, Ashley Marie; Rivers, Orion Silverstar; Aeby, Greta Smith; Callahan, Sean Michael			Pseudoalteromonas piratica strain OCN003 is a coral pathogen that causes a switch from chronic to acute Montipora white syndrome in Montipora capitata	PLOS ONE			English	Article							DISEASE OUTBREAK; ELKHORN CORAL; BAND DISEASE; KANEOHE BAY; VIBRIO; VIRULENCE; DYNAMICS; BACTERIA; FLAGELLA; PROTEIN	Reports of mass coral mortality from disease have increased over the last two decades. Montipora white syndrome (MWS) is a tissue loss disease that has negatively impacted populations of the coral Montipora capitata in Kane 'ohe Bay, Hawai'i. Two types of MWS have been documented; a progressive disease termed chronic MWS (cMWS), that can be caused by Vibrio owensii strain OCN002, and a comparatively faster disease termed acute MWS (aMWS), that can be caused by Vibrio coralliilyticus strain OCN008. M. capitata colonies exhibiting cMWS can spontaneously switch to aMWS in the field. In this study, a novel Pseudoalteromonas species, P. piratica strain OCN003, fulfilled Koch's postulates of disease causation as another etiological agent of aMWS. Additionally, OCN003 induced a switch from cMWS to aMWS on M. capitata in laboratory infection trials. A comparison of OCN003 and Vibrio coralliilyticus strain OCN008, showed that OCN003 was more effective at inducing the cMWS to aMWS switch in M. capitata than OCN008. This study is the first to demonstrate that similar disease signs on one coral species (aMWS on M. capitata) can be caused by multiple pathogens, and describes the first Pseudoalteromonas species that infects coral.	[Beurmann, Silvia; Svoboda, Christina Marie; Smith, Ashley Marie; Rivers, Orion Silverstar; Callahan, Sean Michael] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Beurmann, Silvia; Svoboda, Christina Marie; Smith, Ashley Marie; Aeby, Greta Smith; Callahan, Sean Michael] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Ushijima, Blake] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Videau, Patrick] Dakota State Univ, Coll Arts & Sci, Madison, SD USA; [Beurmann, Silvia] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University of Hawaii System; University of Hawaii Manoa; Oregon State University; Dakota State University; University System of Maryland; University of Maryland Baltimore	Beurmann, S (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.; Beurmann, S (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.; Beurmann, S (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	sbeurmann@som.umaryland.edu	Smith, Ashley/GZB-0298-2022	Ushijima, Blake/0000-0002-1053-5207; Grant, Silvia/0000-0001-5713-9212	NOAA [NA06NOS4260200, NA12NOS4820070]	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by NOAA grant numbers NA06N0S4260200 and NA12N0S4820070 to GSA and SMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NOAA grant numbers NA06NOS4260200 and NA12NOS4820070 to GSA and SMC. The authors would like to thank I. Booth and A. Unzueta Martinez for laboratory assistance and T. Carvalho for TEM sample preparation. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2016, DIS AQUAT ORGAN, V119, P189, DOI 10.3354/dao02996; ANTONIUS AA, 1973, NEW OBSERVATIONS COR; Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Beurmann S, 2016, DIS AQUAT ORGAN; Beurmann S, 2015, GENOME ANNOUNC  0115, V3; Beurmann S, 2017, INT J SYST EVOL MICR; Bigot A, 2005, INFECT IMMUN, V73, P5530, DOI 10.1128/IAI.73.9.5530-5539.2005; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Brandt ME, 2012, B MAR SCI, V88, P1035, DOI 10.5343/bms.2011.1104; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; FALKOW S, 1988, REV INFECT DIS, V10, pS274; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; LEGNANIFAJARDO C, 1991, CAN J MICROBIOL, V37, P325, DOI 10.1139/m91-052; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Pollock FJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02799-16; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RICHARDSON K, 1991, INFECT IMMUN, V59, P2727, DOI 10.1128/IAI.59.8.2727-2736.1991; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Smith Aaron P., 2008, THESIS; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STEINMETZ M, 1985, MOL GEN GENET, V200, P220, DOI 10.1007/BF00425427; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Ushijima B, 2016, ENVIRON MICROBIOL, V18, P4055, DOI 10.1111/1462-2920.13428; Ushijima B, 2014, APPL ENVIRON MICROB, V80, P2102, DOI 10.1128/AEM.03463-13; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wolk CP, 2007, ARCH MICROBIOL, V188, P551, DOI 10.1007/s00203-007-0276-z; Woodley CM, 2016, DIS OF CORAL; Work TM, 2012, P R SOC B	57	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188319	10.1371/journal.pone.0188319	http://dx.doi.org/10.1371/journal.pone.0188319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145488	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800112
J	Kratzig, T; Mohme, M; Mende, KC; Eicker, SO; Floeth, FW				Kraetzig, Theresa; Mohme, Malte; Mende, Klaus C.; Eicker, Sven O.; Floeth, Frank W.			Impact of the surgical strategy on the incidence of C5 nerve root palsy in decompressive cervical surgery	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; OF-THE-LITERATURE; MYELOPATHY; LAMINECTOMY; ANTERIOR; FUSION; SPINE; INJURY	Objective Our aim was to identify the impact of different surgical strategies on the incidence of C5 palsy. Background Degenerative cervical spinal stenosis is a steadily increasing morbidity in the ageing population. Postoperative C5 nerve root palsy is a common complication with severe impact on the patients A quality of life. Methods We identified 1708 consecutive patients who underwent cervical decompression surgery due to degenerative changes. The incidence of C5 palsy and surgical parameters including type and level of surgery were recorded to identify predictors for C5 nerve palsy. Results The overall C5 palsy rate was 4.8%, with 18.3% of cases being bilateral. For ACDF alone the palsy rate was low (1.13%), compared to 14.0% of C5 palsy rate after corpectomy. The risk increased with extension of the procedures. Hybrid constructs with corpectomy plus ACDF at C3-6 showed significantly lower rates of C5 palsy (10.7%) than corpectomy of two vertebrae (p = 0.005). Multiple regression analysis identified corpectomy of C4 or C5 as a significant predictor. We observed a lower overall incidence for ventral (4.3%) compared to dorsal (10.9%) approaches (p<0.001). When imaging detected a postoperative shift of the spinal cord at index segment C4/5, palsy rate increased significantly (33.3% vs. 12.5%, p = 0.034). Conclusions Extended surgical strategies, such as dorsal laminectomies, multilevel corpectomies and procedures with extensive spinal cord shift were shown to display a high risk of C5 palsy. The use of extended procedures should therefore be employed cautiously. Switching to combined surgical methods like ACDF plus corpectomy can reduce the rate of C5 palsy.	[Kraetzig, Theresa; Mohme, Malte; Mende, Klaus C.; Eicker, Sven O.] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Floeth, Frank W.] Hosp Heilig Geist, Dept Spine Surg, Kempen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kratzig, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	t.kraetzig@uke.de	Mende, Klaus Christian/I-5313-2019	Mende, Klaus Christian/0000-0003-4317-1718				Alleyne CH, 1998, SURG NEUROL, V50, P213, DOI 10.1016/S0090-3019(97)00315-7; Baba S, 2016, ASIAN SPINE J, V10, P298, DOI 10.4184/asj.2016.10.2.298; Basaran R, 2016, EUR SPINE J, V25, P2050, DOI 10.1007/s00586-016-4567-4; Blizzard DJ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0297-2; Bose B, 2007, J NEUROSURG-SPINE, V6, P381, DOI 10.3171/spi.2007.6.5.381; Bydon M, 2014, NEUROSURGERY, V74, P595, DOI 10.1227/NEU.0000000000000322; Chang PY, 2013, J CHIN MED ASSOC, V76, P378, DOI 10.1016/j.jcma.2013.03.008; Chen Y, 2013, ARCH ORTHOP TRAUM SU, V133, P171, DOI 10.1007/s00402-012-1658-5; Chiba K, 2002, SPINE, V27, P2108, DOI 10.1097/00007632-200210010-00006; Choi KC, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2011.03.043; Currier BL, 2012, SPINE, V37, pE328, DOI 10.1097/BRS.0b013e3182417276; Eskander MS, 2012, J BONE JOINT SURG AM, V94A, P1605, DOI 10.2106/JBJS.K.00664; Fan DP, 2002, SPINE, V27, P2499, DOI 10.1097/00007632-200211150-00014; Guo QF, 2011, ARCH ORTHOP TRAUM SU, V131, P631, DOI 10.1007/s00402-010-1181-5; Guzman JZ, 2014, BONE JOINT J, V96B, P950, DOI 10.1302/0301-620X.96B7.33665; Hasegawa K, 2007, SPINE, V32, pE197, DOI 10.1097/01.brs.0000257576.84646.49; HIRABAYASHI K, 1988, SPINE, V13, P870, DOI 10.1097/00007632-198807000-00032; Hung LK, 2003, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000053596.94145.57; Imagama S, 2010, J BONE JOINT SURG BR, V92B, P393, DOI 10.1302/0301-620X.92B3.22786; Jimenez JC, 2005, J NEUROSURG-SPINE, V3, P92, DOI 10.3171/spi.2005.3.2.0092; Katsumi K, 2012, SPINE, V37, P748, DOI 10.1097/BRS.0b013e3182326957; Komagata M, SPINE J, V4, P650; Lim C-H, 2016, EUR SPINE J; Liu Tielong, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100625-08; Lubelski D, 2014, SPINE J, V14, P1895, DOI 10.1016/j.spinee.2013.10.038; Millstone DB, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.00843; Nakashima H, 2012, J NEUROSURG-SPINE, V17, P103, DOI 10.3171/2012.4.SPINE11255; Nassr A, 2012, SPINE, V37, P174, DOI 10.1097/BRS.0b013e318219cfe9; Odate S, 2013, SPINE, V38, P2184, DOI 10.1097/BRS.0000000000000019; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Sasai K, 2003, SPINE, V28, P1972, DOI 10.1097/01.BRS.0000083237.94535.46; SHINOMIYA K, 1994, SPINE, V19, P2501, DOI 10.1097/00007632-199411001-00002; Shou FY, 2015, EUR SPINE J, V24, P2724, DOI 10.1007/s00586-015-4186-5; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001655; Yang LL, 2013, ORTHOPEDICS, V36, pE79, DOI 10.3928/01477447-20121217-23	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188338	10.1371/journal.pone.0188338	http://dx.doi.org/10.1371/journal.pone.0188338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145512	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800115
J	Mainali, KP; Bewick, S; Thielen, P; Mehoke, T; Breitwieser, FP; Paudel, S; Adhikari, A; Wolfe, J; Slud, EV; Karig, D; Fagan, WF				Mainali, Kumar P.; Bewick, Sharon; Thielen, Peter; Mehoke, Thomas; Breitwieser, Florian P.; Paudel, Shishir; Adhikari, Arjun; Wolfe, Joshua; Slud, Eric V.; Karig, David; Fagan, William F.			Statistical analysis of co-occurrence patterns in microbial presence-absence datasets	PLOS ONE			English	Article							NULL MODELS; COMMUNITIES; DISPERSAL; HABITAT; SIMILARITY; DIVERSITY; ABUNDANCE; REGIONS; FOREST; FISH	Drawing on a long history in macroecology, correlation analysis of microbiome datasets is becoming a common practice for identifying relationships or shared ecological niches among bacterial taxa. However, many of the statistical issues that plague such analyses in macroscale communities remain unresolved for microbial communities. Here, we discuss problems in the analysis of microbial species correlations based on presence-absence data. We focus on presence-absence data because this information is more readily obtainable from sequencing studies, especially for whole-genome sequencing, where abundance estimation is still in its infancy. First, we show how Pearson's correlation coefficient (r) and Jaccard's index (J)-two of the most common metrics for correlation analysis of presence-absence data-can contradict each other when applied to a typical microbiome dataset. In our dataset, for example, 14% of species-pairs predicted to be significantly correlated by r were not predicted to be significantly correlated using J, while 37.4% of species-pairs predicted to be significantly correlated by J were not predicted to be significantly correlated using r. Mismatch was particularly common among species-pairs with at least one rare species (<10% prevalence), explaining why r and J might differ more strongly in microbiome datasets, where there are large numbers of rare taxa. Indeed 74% of all species-pairs in our study had at least one rare species. Next, we show how Pearson's correlation coefficient can result in artificial inflation of positive taxon relationships and how this is a particular problem for microbiome studies. We then illustrate how Jaccard's index of similarity (J) can yield improvements over Pearson's correlation coefficient. However, the standard null model for Jaccard's index is flawed, and thus introduces its own set of spurious conclusions. We thus identify a better null model based on a hypergeometric distribution, which appropriately corrects for species prevalence. This model is available from recent statistics literature, and can be used for evaluating the significance of any value of an empirically observed Jaccard's index. The resulting simple, yet effective method for handling correlation analysis of microbial presence-absence datasets provides a robust means of testing and finding relationships and/or shared environmental responses among microbial taxa.	[Mainali, Kumar P.; Bewick, Sharon; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Thielen, Peter; Mehoke, Thomas; Wolfe, Joshua; Karig, David] Johns Hopkins Appl Phys Lab, Res & Exploratory Dev Dept, Laurel, MD USA; [Breitwieser, Florian P.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Ctr Computat Biol, Baltimore, MD USA; [Paudel, Shishir] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Adhikari, Arjun] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Slud, Eric V.] Univ Maryland, Dept Math, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Oklahoma State University System; Oklahoma State University - Stillwater; Montana State University System; Montana State University Bozeman; University System of Maryland; University of Maryland College Park	Mainali, KP (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	kpmainali@gmail.com	Paudel, Shishir/H-6813-2019; Paudel, Shishir/AFU-7369-2022; Mainali, Kumar/AFM-6006-2022; Karig, David/AAT-9108-2020	Paudel, Shishir/0000-0002-0794-5096; Karig, David/0000-0002-9508-6411; Breitwieser, Florian P/0000-0001-6192-0853; Mainali, Kumar/0000-0001-7470-8173; Thielen, Peter/0000-0003-1807-2785	U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-14-1-0490]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number #W911NF-14-1-0490.; Simulation was performed partly at Texas Advanced Computing Center (TACC), The University of Texas at Austin. We thank John Fonner at TACC for assistance with the supercomputer environment and Niti Mishra for making his cluster available for computing. This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number #W911NF-14-1-0490.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adkins JK, 2013, NAT AREA J, V33, P31, DOI 10.3375/043.033.0104; Aitchison J., 1986, THE STATISTICAL ANAL; Aryal Achyut, 2012, Diversity-Basel, V4, P301; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; BARONIURBANI C, 1980, OECOLOGIA, V44, P287, DOI 10.1007/BF00545229; Bauer A, 2016, ECOSCIENCE, V23, P41, DOI 10.1080/11956860.2016.1213107; Beaune D, 2013, J TROP ECOL, V29, P367, DOI 10.1017/S0266467413000515; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Bila K, 2013, J INSECT CONSERV, V17, P257, DOI 10.1007/s10841-012-9504-1; BIRKS HJB, 1987, ANN ZOOL FENN, V24, P165; Brooks JP, 2016, ANN EPIDEMI IN PRESS; Buckley M, 2011, RARE BIOSPHERE REPOR; Casella G., 2002, STAT INFERENCE, V2nd; CHEETHAM A H, 1969, Journal of Paleontology, V43, P1130; Chen SY, 2016, J COMPUT BIOL, V23, P229, DOI 10.1089/cmb.2015.0214; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Dalla Riva G V, 2015, OIKOS; Dapporto L, 2014, J BIOGEOGR, V41, P1639, DOI 10.1111/jbi.12315; Diamond J.M., 1975, P342; Dossou-Yovo HO, 2016, ENV ECOL RES, V4, P200; Fa JE, 2014, CONSERV BIOL, V28, P224, DOI 10.1111/cobi.12151; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Ferenti S, 2012, ARCH BIOL SCI, V64, P1029, DOI [10.2298/ABS12030291, 10.2298/ABS1203029F]; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Garcia-Abad JJ, 2010, LANDSCAPE URBAN PLAN, V95, P138, DOI 10.1016/j.landurbplan.2009.12.011; Garcia-Barros E, 2002, J BIOGEOGR, V29, P109, DOI 10.1046/j.1365-2699.2002.00653.x; Gause GF, 1934, STRUGGLE EXISTENCE; Goodman SM, 2005, ANIM CONSERV, V8, P153, DOI 10.1017/S136794300500199X; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Griffith DM, 2016, J STAT SOFTW, V69, P1; Frias-De Leon MG, 2016, AEROBIOLOGIA, V32, P187, DOI 10.1007/s10453-015-9389-z; Guilford J. P, 1942, FUNDAMENTAL STAT PSY; Hilje B, 2015, TROP CONSERV SCI, V8, P76, DOI 10.1177/194008291500800109; HUBALEK Z, 1982, BIOL REV, V57, P669, DOI 10.1111/j.1469-185X.1982.tb00376.x; Hubbell Stephen P., 2001, V32, pi; Huse S., 2012, SEQUENCING ERRORS DI; JACKSON DA, 1992, AM NAT, V139, P930, DOI 10.1086/285367; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; JANSON S, 1981, OECOLOGIA, V49, P371, DOI 10.1007/BF00347601; Johnston MA, 2010, J APPL MICROBIOL, V108, P965, DOI 10.1111/j.1365-2672.2009.04498.x; Kain EC, 2016, ENVIRON SCI POLLUT R, V23, P23951, DOI 10.1007/s11356-016-7613-1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kittur S, 2010, EUR J WILDLIFE RES, V56, P195, DOI 10.1007/s10344-009-0302-3; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Lashley MA, 2016, WILDLIFE RES, V43, P254, DOI 10.1071/WR15008; Lavers JL, 2016, MAR ENVIRON RES, V113, P1, DOI 10.1016/j.marenvres.2015.10.011; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Li Y, 2014, SCI WORLD J, V2014; Lu J, BIORXIV; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Manjon-Cabeza M. E., 2001, Boletin Instituto Espanol de Oceanografia, V17, P263; Manjon-Cabeza ME, 1998, J NAT HIST, V32, P1619, DOI 10.1080/00222939800771151; Barbosa AM, 2015, METHODS ECOL EVOL, V6, P853, DOI 10.1111/2041-210X.12372; Barbosa AM, 2012, J BIOGEOGR, V39, P1391, DOI 10.1111/j.1365-2699.2012.02762.x; Marquez AL, 2001, ECOGRAPHY, V24, P659, DOI 10.1034/j.1600-0587.2001.240605.x; McLoughlin K., 2016, TECHNICAL REPORT BEN; Meadow JF, 2013, PEERJ, V1, DOI 10.7717/peerj.53; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; Morelli F, 2014, POL J ECOL, V62, P361, DOI 10.3161/104.062.0214; Saiz JCM, 2013, J BIOGEOGR, V40, P90, DOI 10.1111/j.1365-2699.2012.02774.x; Nakamura K, 2009, J BIOGEOGR, V36, P919, DOI 10.1111/j.1365-2699.2008.02057.x; Namgail T, 2013, CURR ZOOL, V59, P116, DOI 10.1093/czoolo/59.1.116; Neto LM, 2016, BRAZ J BOT, V39, P261, DOI 10.1007/s40415-015-0238-7; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Otuoma J., 2014, Journal of Horticulture and Forestry, V6, P38; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pueyo Y, 2008, ECOL APPL, V18, P954, DOI 10.1890/07-1770.1; Quinn LD, 2008, NAT AREA J, V28, P356, DOI 10.3375/0885-8608(2008)28[356:GOIPSA]2.0.CO;2; Real R., 1999, Miscellania Zoologica (Barcelona), V22, P29; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Reyes-Montes MR, 2009, REV ARGENT MICROBIOL, V41, P102; Rivera-Ortiz FA, 2013, REV MEX BIODIVERS, V84, P1200, DOI 10.7550/rmb.34953; Romo H, 2010, J ZOOL, V282, P180, DOI 10.1111/j.1469-7998.2010.00730.x; RYTI RT, 1987, OECOLOGIA, V73, P282, DOI 10.1007/BF00377519; Sala C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0858-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Trosvik P, 2015, ISME J, V9, P533, DOI 10.1038/ismej.2014.147; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Opijnen T, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005869; Vargas JM, 1998, ECOGRAPHY, V21, P371, DOI 10.1111/j.1600-0587.1998.tb00402.x; Veech JA, 2013, GLOBAL ECOL BIOGEOGR, V22, P252, DOI 10.1111/j.1466-8238.2012.00789.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vohnik M, 2009, MICROB ECOL, V57, P203, DOI 10.1007/s00248-008-9402-y; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Widder S, 2014, P NATL ACAD SCI USA, V111, P12799, DOI 10.1073/pnas.1411723111; Wilson JB, 2012, J VEG SCI, V23, P1013, DOI 10.1111/j.1654-1103.2012.01430.x; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zancolli G, 2014, DIVERS DISTRIB, V20, P297, DOI 10.1111/ddi.12161; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185; Zhou XY, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0344-6	108	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187132	10.1371/journal.pone.0187132	http://dx.doi.org/10.1371/journal.pone.0187132			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145425	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800011
J	Schaal, JB; Tran, DQ; Subramanian, A; Patel, R; Laragione, T; Roberts, KD; Trinh, K; Tongaonkar, P; Tran, PA; Minond, D; Fields, GB; Beringer, P; Ouellette, AJ; Gulko, PS; Selsted, ME				Schaal, Justin B.; Tran, Dat Q.; Subramanian, Akshay; Patel, Reshma; Laragione, Teresina; Roberts, Kevin D.; Trinh, Katie; Tongaonkar, Prasad; Tran, Patti A.; Minond, Dmitriy; Fields, Gregg B.; Beringer, Paul; Ouellette, Andre J.; Gulko, Percio S.; Selsted, Michael E.			Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide	PLOS ONE			English	Article							PRISTANE-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; HISTOCOMPATIBILITY COMPLEX; ANTIMICROBIAL ACTIVITIES; THETA-DEFENSINS; CHRONIC DISEASE; JOINT DAMAGE; SEVERITY; ALPHA	theta-defensins constitute a family of macrocyclic peptides expressed exclusively in Old World monkeys. The peptides are pleiotropic effectors of innate immunity, possessing broad spectrum antimicrobial activities and immunoregulatory properties. Here we report that rhesus theta-defensin 1 (RTD-1) is highly effective in arresting and reversing joint disease in a rodent model of rheumatoid arthritis (RA). Parenteral RTD-1 treatment of DA/OlaHsd rats with established pristane-induced arthritis (PIA) rapidly suppressed joint disease progression, restored limb mobility, and preserved normal joint architecture. RTD-1 significantly reduced joint IL-1 beta levels compared with controls. RTD-1 dose-dependently inhibited fibroblast-like synoviocyte (FLS) invasiveness and FLS IL-6 production. Consistent with the inhibition of FLS invasiveness, RTD-1 was a potent inhibitor of arthritogenic proteases including ADAMs 17 and 10 which activate TNF alpha, and inhibited matrix metalloproteases, and cathepsin K. RTD-1 was non-toxic, non-immunogenic, and effective when administered as infrequently as once every five days. Thus theta-defensins, which are absent in humans, have potential as retroevolutionary biologics for the treatment of RA.	[Schaal, Justin B.; Tran, Dat Q.; Subramanian, Akshay; Roberts, Kevin D.; Trinh, Katie; Tongaonkar, Prasad; Tran, Patti A.; Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Dept Pathol & Lab Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Tran, Dat Q.] Oryn Therapeut, Vacaville, CA USA; [Patel, Reshma] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Laragione, Teresina; Gulko, Percio S.] Icahn Sch Med Mt Sinai, Div Rheumatol, Dept Med, New York, NY 10029 USA; [Minond, Dmitriy] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL USA; [Fields, Gregg B.] Scripps Res Inst, Jupiter, FL USA; [Beringer, Paul] Univ Southern Calif, Sch Pharm, Los Angeles, CA USA; [Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA	University of Southern California; Children's Hospital Los Angeles; Icahn School of Medicine at Mount Sinai; Torrey Pines Institute for Molecular Studies, Florida; State University System of Florida; Florida Atlantic University; Scripps Research Institute; University of Southern California; University of Southern California	Selsted, ME (corresponding author), Univ Southern Calif, Dept Pathol & Lab Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Selsted, ME (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.	selsted@usc.edu	Beringer, Paul/AAD-7812-2022	Beringer, Paul/0000-0002-3744-3310; Schaal, Justin/0000-0002-0069-4917; Minond, Dmitriy/0000-0003-2473-5944	National Institute of Allergy and Infectious Diseases [AI22931]; Arthritis Foundation [5997]; National Institute of Dental and Craniofacial Research [DE021341]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR068833]; Wright Foundation; Southern California Clinical and Translational Science Institute [UL1TR000130]; National Cancer Institute [P30CA014089]; Seth MacFarlane Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR068833] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wright Foundation; Southern California Clinical and Translational Science Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Seth MacFarlane Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by National Institute of Allergy and Infectious Diseases #AI22931 (MES) https://www.niaid.nih.gov/. Arthritis Foundation #5997 (MES) http://www.arthritis.org/. National Institute of Dental and Craniofacial Research #DE021341 (MES) http://www.nidcr.nih.gov. National Institute of Arthritis and Musculoskeletal and Skin Diseases #AR068833 (DQT) https://www.niams.nih.gov/. The Wright Foundation (PT) https://research.usc.edu/for-investigators/funding/usc/#wright. The Southern California Clinical and Translational Science Institute #UL1TR000130 (MES) http://www.sc-ctsi.org/. National Cancer Institute #P30CA014089 https://www.cancer.gov/. Seth MacFarlane Foundation. Oryn Therapeutics provided support in the form of salary for D.Q.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bhowmick M, 2015, CHEMBIOCHEM, V16, P1084, DOI 10.1002/cbic.201402716; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Brand DD, 2004, METH MOLEC MED, V102, P295; Brenner M, 2005, ARTHRITIS RHEUM-US, V52, P322, DOI 10.1002/art.20782; Brenner M, 2013, PHYSL GENOMICS; Brenner M, 2012, ARTHRITIS RHEUM-US, V64, P1369, DOI 10.1002/art.33468; Caporali R, 2009, AUTOIMMUN REV, V8, P274, DOI 10.1016/j.autrev.2008.11.003; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gulko PS, 2007, GENES IMMUN, V8, P523, DOI 10.1038/sj.gene.6364419; Hider SL, 2005, J RHEUMATOL, V32, P11; Holmberg J, 2006, J IMMUNOL, V176, P1172, DOI 10.4049/jimmunol.176.2.1172; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Hsu YH, 2010, ARTHRITIS RHEUM-US, V62, P3311, DOI 10.1002/art.27689; Jenkins E, 2012, GENES IMMUN, V13, P221, DOI 10.1038/gene.2011.73; Jiao Z., 2012, CLIN DEV IMMUNOL, V2012, P6, DOI DOI 10.1155/2012/350209; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Keiserman M, 2014, EXPERT REV CLIN IMMU, V10, P1049, DOI 10.1586/1744666X.2014.926219; Laragione T, 2008, ARTHRITIS RHEUM-US, V58, P2296, DOI 10.1002/art.23610; Laragione T, 2012, MOL MED, V18, P1009, DOI 10.2119/molmed.2012.00173; Laragione T, 2012, MOL MED, V18, P194, DOI 10.2119/molmed.2011.00410; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Laragione T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2476; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Olofsson Peter, 2007, V136, P255; Patten C, 2004, ARTHRITIS RHEUM-US, V50, P3334, DOI 10.1002/art.20507; Rau R, 2004, CLIN EXP RHEUMATOL, V22, pS44; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Setoguchi C, 2010, MOD RHEUMATOL, V20, P381, DOI 10.1007/s10165-010-0292-8; Shealy DJ, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar430; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tongaonkar P, 2015, J LEUKOC BIOL; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tuncel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155936; VANDELOO AAJ, 1995, AM J PATHOL, V146, P239; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Wang J, 2012, 2012 6TH ASIA-PACIFIC CONFERENCE ON ENVIRONMENTAL ELECTROMAGNETICS (CEEM' 2012), P10, DOI 10.1109/CEEM.2012.6410661; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Yin GQ, 2005, LAB ANIM-UK, V39, P269, DOI 10.1258/0023677054306926; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhu W, 2012, SCAND J IMMUNOL, V76, P263, DOI 10.1111/j.1365-3083.2012.02724.x	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187868	10.1371/journal.pone.0187868	http://dx.doi.org/10.1371/journal.pone.0187868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145473	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800036
J	Tholking, G; Schuette-Nuetgen, K; Vogl, T; Dobrindt, U; Kahl, BC; Brand, M; Pavenstadt, H; Suwelack, B; Koch, R; Reuter, S				Thoelking, Gerold; Schuette-Nuetgen, Katharina; Vogl, Thomas; Dobrindt, Ulrich; Kahl, Barbara C.; Brand, Marcus; Pavenstaedt, Hermann; Suwelack, Barbara; Koch, Raphael; Reuter, Stefan			Male kidney allograft recipients at risk for urinary tract infection?	PLOS ONE			English	Article							ESCHERICHIA-COLI; IMMUNE-RESPONSES; RENAL-FUNCTION; H-Y; TRANSPLANTATION; SUSCEPTIBILITY; TESTOSTERONE; INTERLEUKIN-8; PREVALENCE; GENDER	Background Urinary tract infection (UTI) is the most common infection after renal transplantation (RTx). Although female sex is a well-known risk factor for the development of UTI after RTx, the role of the donor sex in this context remains unclear. Methods In this case control study 6,763 RTx cases were screened for UTI when presenting at our transplant outpatient clinics. 102 different RTx patients fulfilled the inclusion criteria and were compared to 102 controls. Data on renal function was prospectively followed for 12 months. Results were compared to a previous RTx cohort from our transplant center. Additionally, we assessed the immunological response of leukocytes from 58 kidney recipients and 16 controls to lipopolysaccharide stimulation. Result After identification by univariate analysis, multivariate logistic regression analysis indicated female sex, minor height, advanced age and male kidney allograft sex to be associated with the occurrence of UTI after RTx. Female recipients who received male grafts had the best renal function 12 months after presentation. However, leukocyte response of recipients to lipopolysaccharide was impaired irrespective of donor and recipient sex to the same extend. Conclusions We conclude from our data that male kidney allografts are associated with the occurrence of UTI after RTx but did not influence the response of leukocytes to lipopolysaccharide. Further prospective studies are needed to identify the underlying mechanisms of higher male kidney donor dependent UTI.	[Thoelking, Gerold; Schuette-Nuetgen, Katharina; Brand, Marcus; Pavenstaedt, Hermann; Suwelack, Barbara; Reuter, Stefan] Univ Hosp Munster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, Munster, Germany; [Kahl, Barbara C.] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster	Tholking, G (corresponding author), Univ Hosp Munster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	Gerold.Thoelking@ukmuenster.de	Koch, Raphael/A-7857-2013; Dobrindt, Ulrich/AEU-2378-2022	Koch, Raphael/0000-0002-5581-5122; Dobrindt, Ulrich/0000-0001-9949-1898	Deutsche Forschungsgemeinschaft [CRC 656 C7, CRC 656 A9, CRC 1009 B5, CRC 1009 B8]; University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	This study was supported in part by the Deutsche Forschungsgemeinschaft (CRC 656 C7 and A9 to SR and TV, CRC 1009 B5 and B8 to TV). We acknowledge support by Open Access Publication Fund of University of Munster. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Antus B, 2002, TRANSPL INT, V15, P494, DOI 10.1111/j.1432-2277.2002.tb00205.x; Bodro M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.019; Dessing MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013394; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Gratwohl A, 2008, LANCET, V372, P49, DOI 10.1016/S0140-6736(08)60992-7; Guo ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133270; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Ishigami J, 2016, AM J KIDNEY DIS; Kang MS, 2015, ANN REHABIL MED-ARM, V39, P686, DOI 10.5535/arm.2015.39.5.686; KASISKE BL, 1986, ARCH PATHOL LAB MED, V110, P55; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Liu XJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-70; Magliano E, 2012, SCI WORLD J, DOI 10.1100/2012/349597; Marcus N, 2005, PEDIATR INFECT DIS J, V24, P581, DOI 10.1097/01.inf.0000168743.57286.13; Oregioni O, 2005, CYTOKINE, V31, P415, DOI 10.1016/j.cyto.2005.06.009; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Pruenster M, 2016, PHARMACOL THERAPEUT, V167, P120, DOI 10.1016/j.pharmthera.2016.07.015; Robinson Dudley, 2013, Menopause Int, V19, P155, DOI 10.1177/1754045313511398; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Sotto A, 2001, J CLIN MICROBIOL, V39, P438, DOI 10.1128/JCM.39.2.438-444.2001; Stapleton AE, 2014, INFECT DIS CLIN N AM, V28, P149, DOI 10.1016/j.idc.2013.10.006; Svanborg C, 2001, ANN MED, V33, P563, DOI 10.3109/07853890109002101; Tabibian JH, 2008, J CLIN MICROBIOL, V46, P3980, DOI 10.1128/JCM.00339-08; Tent H, 2011, AM J TRANSPLANT, V11, P2173, DOI 10.1111/j.1600-6143.2011.03687.x; Tholking G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32273; Tholking G, 2016, ANN TRANSPL, V21, P167; Tholking G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111128; Vavallo A, 2014, WORLD J UROL, V32, P709, DOI 10.1007/s00345-013-1137-9; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Wojciechowski D, 2013, TRANSPLANTATION, V96, P400, DOI 10.1097/TP.0b013e3182962cab; Wu XH, 2016, AM J INFECT CONTROL, V44, P1261, DOI 10.1016/j.ajic.2016.04.222	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188262	10.1371/journal.pone.0188262	http://dx.doi.org/10.1371/journal.pone.0188262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145515	gold, Green Submitted, Green Published			2022-12-26	WOS:000415378800103
J	Wegner, KA; Cadena, MT; Trevena, R; Turco, AE; Gottschalk, A; Halberg, RB; Guo, JJ; McMahon, JA; McMahon, AP; Vezina, CM				Wegner, Kyle A.; Cadena, Mark T.; Trevena, Ryan; Turco, Anne E.; Gottschalk, Adam; Halberg, Richard B.; Guo, Jinjin; McMahon, Jill A.; McMahon, Andrew P.; Vezina, Chad M.			An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections	PLOS ONE			English	Article							SMOOTH-MUSCLE; MOLECULAR REGULATION; ANDROGEN RECEPTOR; REACTIVE STROMA; EXPRESSION; CANCER; MODEL; MYOFIBROBLASTS; MARKERS; ORIGIN	Though many methods can be used to identify cell types contained in complex tissues, most require cell disaggregation and destroy information about where cells reside in relation to their microenvironment. Here, we describe a polytomous key for cell type identification in intact sections of adult mouse prostate and prostatic urethra. The key is organized as a decision tree and initiates with one round of immunostaining for nerve, epithelial, fibromuscular/ hematolymphoid, or vascular associated cells. Cell identities are recursively eliminated by subsequent staining events until the remaining pool of potential cell types can be distinguished by direct comparison to other cells. We validated our identification key using wild type adult mouse prostate and urethra tissue sections and it currently resolves sixteen distinct cell populations which include three nerve fiber types as well as four epithelial, five fibromuscular/ hematolymphoid, one nerve-associated, and three vascular-associated cell types. We demonstrate two uses of this novel identification methodology. We first used the identification key to characterize prostate stromal cell type changes in response to constitutive phosphatidylinositide-3-kinase activation in prostate epithelium. We then used the key to map cell lineages in a new reporter mouse strain driven by Wnt10a(em1(cre/ERT2)Amc). The identification key facilitates rigorous and reproducible cell identification in prostate tissue sections and can be expanded to resolve additional cell types as new antibodies and other resources become available.	[Wegner, Kyle A.; Cadena, Mark T.; Trevena, Ryan; Turco, Anne E.; Vezina, Chad M.] Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA; [Wegner, Kyle A.; Turco, Anne E.; Vezina, Chad M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Cadena, Mark T.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Trevena, Ryan; Gottschalk, Adam; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Halberg, Richard B.] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI USA; [Halberg, Richard B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI USA; [Guo, Jinjin; McMahon, Jill A.; McMahon, Andrew P.] Univ Southern Calif, WM Keck Sch Med, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem C, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA; [Vezina, Chad M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Vezina, CM (corresponding author), Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.	chad.vezina@wisc.edu	McMahon, Andrew P/ABE-7520-2020; Vezina, Chad/GRO-2299-2022	Vezina, Chad/0000-0001-7058-5399; Wegner, Kyle/0000-0003-1309-0060	National Institutes of Health [R01ES001332, R01DK099328, U54 DK104310, T32 ES007015, NIH DK094526, R01CA179556, R01 CA123438]; American Motorcycle Association Ride for Research; NATIONAL CANCER INSTITUTE [R01CA179556, R01CA123438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310, U01DK110807, R01DK099328, U01DK094526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015, R01ES001332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Motorcycle Association Ride for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by National Institutes of Health https://www.nih.gov/ grants: R01ES001332 (CMV), R01DK099328 (CMV), U54 DK104310 (CMV), T32 ES007015 (KAW), NIH DK094526 (APM) R01CA179556 (CMV), and R01 CA123438 (RBH) and the American Motorcycle Association Ride for Research http://widualsportriders.org/ content.aspx?page_id=87&club_id=411067&item_id=622955 (RBH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by National Institutes of Health grants: R01ES001332 (CMV), R01DK099328 (CMV), U54 DK104310 (CMV), T32 ES007015 (KAW), NIH DK094526 (APM) R01CA179556 (CMV), and R01 CA123438 (RBH) and the American Motorcycle Association Ride for Research (RBH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abler LL, 2011, DEV DYNAM, V240, P2364, DOI 10.1002/dvdy.22730; Abu El-Asrar AM, 2008, BRIT J OPHTHALMOL, V92, P699, DOI 10.1136/bjo.2007.134346; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bailey AL, 2006, NEUROSCIENCE, V138, P675, DOI 10.1016/j.neuroscience.2005.11.051; Barre A P, 2017, ECOLOGICAL INFORM; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Cheng CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060905; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Cox HM, 2016, CURR OPIN PHARMACOL, V31, P50, DOI 10.1016/j.coph.2016.08.010; Creze M, 2016, MUSCLE NERVE; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; DEERING RE, 1995, PROSTATE, V26, P111, DOI 10.1002/pros.2990260302; Domen J., 2016, BONE MARROW HEMATOPO; Foley SJ, 2000, BJU INT, V85, P70, DOI 10.1046/j.1464-410x.2000.00322.x; Fromont G, 2012, PROSTATE, V72, P542, DOI 10.1002/pros.21456; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gharaee-Kermani M, 2014, AM J PATHOL, V184, P732, DOI 10.1016/j.ajpath.2013.11.024; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Habermacher GM, 2006, ANNU REV MED, V57, P195, DOI 10.1146/annurev.med.57.011205.135654; Hayward SW, 1996, ACTA ANAT, V155, P94; Hayward SW, 2000, RADIOL CLIN N AM, V38, P1, DOI 10.1016/S0033-8389(05)70146-9; Hennenberg M, 2014, INDIAN J UROL, V30, P181, DOI 10.4103/0970-1591.126903; Herum KM, 2017, MOL BIOL CELL, V28, P1871, DOI 10.1091/mbc.E17-01-0014; Hofmann PG, 2013, J ANAT, V222, P170, DOI 10.1111/joa.12002; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kojima M, 1997, ULTRASOUND MED BIOL, V23, P1305, DOI 10.1016/S0301-5629(97)00141-5; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee S, 2016, PROSTATE; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnussen C, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0029-y; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Marques SM, 2011, MICROVASC RES, V82, P246, DOI 10.1016/j.mvr.2011.08.011; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; McMahon A, 2010, GENITOURINARY DEV MO; McMenamin ME, 1999, CANCER RES, V59, P4291; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; Nicholson TM, 2012, ENDOCRINOLOGY, V153, P5556, DOI 10.1210/en.2012-1522; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Ohki K, 2010, INT UROL NEPHROL, V42, P113, DOI 10.1007/s11255-009-9592-3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozawa MG, 2005, CANCER-AM CANCER SOC, V104, P2104, DOI 10.1002/cncr.21436; Peleshok JC, 2011, J COMP NEUROL, V519, P49, DOI 10.1002/cne.22500; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Rehg JE, 2012, TOXICOL PATHOL, V40, P345, DOI 10.1177/0192623311430695; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Russo G, 2012, BJU INT, V110, pE794, DOI 10.1111/j.1464-410X.2012.11444.x; Saeed AW, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0060-z; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schwartz ES, 2016, J UROLOGY, V196, P892, DOI 10.1016/j.juro.2016.03.077; SEEMAYER TA, 1979, AM J SURG PATHOL, V3, P525, DOI 10.1097/00000478-197912000-00005; Shelukhina I, 2015, BRAIN STRUCT FUNCT, V220, P1885, DOI 10.1007/s00429-014-0762-4; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Singh M, 2014, AM J PATHOL, V184, P2598, DOI 10.1016/j.ajpath.2014.06.022; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sun Qing-Zeng, 2010, Zhonghua Nan Ke Xue, V16, P118; Taboga SR, 2008, ANAT REC, V291, P1115, DOI 10.1002/ar.20728; Thielen JL, 2007, DIFFERENTIATION, V75, P49, DOI 10.1111/j.1432-0436.2006.00115.x; Tian HY, 2017, ARTERIOSCL THROM VAS, V37, P1115, DOI 10.1161/ATVBAHA.116.308859; Torkko KC, 2015, J UROLOGY, V194, P454, DOI 10.1016/j.juro.2015.03.103; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROL, V2472-2483; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yin GN, 2015, SCI REP-UK, V5, DOI 10.1038/srep10891; Yucel S, 2004, J UROLOGY, V172, P191, DOI 10.1097/01.ju.0000128704.51870.87; Zaitouna M, 2017, NEUROUROL URODYNAM, V36, P271, DOI 10.1002/nau.22919	88	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188413	10.1371/journal.pone.0188413	http://dx.doi.org/10.1371/journal.pone.0188413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145476	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800118
J	Yang, PS; Park, YA; Kim, TH; Uhm, JS; Joung, B; Lee, MH; Pak, HN				Yang, Pil-Sung; Park, Young-Ah; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam			Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?	PLOS ONE			English	Article							CRITICAL MASS; HYPERTENSION; REDUCTION; HYPOTHESIS; MANAGEMENT; ISTHMUS; MODEL; TRIAL	Introduction The ablation gaps have been known as the main mechanism of recurrence as atrial tachycardia (AT) rather than atrial fibrillation (AF) after AF catheter ablation. However, AF organization due to reduction of critical mass or focal trigger may also be the mechanism of AT recurrence. We sought to find out the main clinical factors of recurrence as AT rather than AF after AF ablation in the absence of antiarrhythmic drug effect. Methods We analyzed 521 patients (70.8% men, 64.1% paroxysmal AF) who experienced AT or AF recurrence without antiarrhythmic drug effect during 44.7 +/- 25.4 months follow-up. Results Among 521 patients with recurrence, 42.0% (219 of 521) recurred with AT. The proportion of AT recurrence was not different between the pulmonary vein isolation only group and additional linear ablation group (45.1% vs. 38.1%, p = 0.128). The absence of hypertension (odds ratio [OR] 0.49, 95% confidence interval [CI] 0.29-0.83, p = 0.007), small left atrial (LA) volume index (OR 0.89 per 10 mL/m(2), 95% CI 0.79-1.00, p = 0.049), and high mean LA bipolar voltage (OR 2.03 per 1 mV, 95% CI 1.30-3.16, p = 0.002) were independently associated with AT recurrence, whereas additional linear ablation was not. Among 90 patients who underwent repeat ablation procedure, rates of PV reconnection (p = 0.358) and gap in prior linear ablations (p = 0.269) were not significantly different between AT recurrence group and AF recurrence group. Conclusion The degree of LA remodeling is significantly associated with recurrence as AT after AF ablation, irrespective of potential ablation gap in linear lesion.	[Yang, Pil-Sung; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea; [Park, Young-Ah] Inje Univ, Busan Paik Hosp, Div Cardiol, Busan, South Korea	Yonsei University; Yonsei University Health System; Inje University	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.	hnpak@yuhs.ac	; Pak, Hui-Nam/C-4266-2015	Joung, Boyoung/0000-0001-9036-7225; Kim, Tae-Hoon/0000-0003-4200-3456; Uhm, Jae-Sun/0000-0002-1611-8172; Pak, Hui-Nam/0000-0002-3256-3620; Lee, Moon-Hyoung/0000-0002-7268-0741; Yang, Pil-sung/0000-0002-6552-1742	Ministry of Health and Welfare [A085136]; National Research Foundation of Korea - Ministry of Education [2014R1A1A2059391, NRF-2017R1A2B4003983]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Research Foundation of Korea - Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH and grant (NRF-2017R1A2B4003983)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anousheh R, 2010, PACE, V33, P460, DOI 10.1111/j.1540-8159.2009.02625.x; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x; Heck PM, 2011, J CARDIOVASC ELECTR, V22, P832, DOI 10.1111/j.1540-8167.2011.02090.x; Hwang ES, 2012, PACE, V35, P1428, DOI 10.1111/j.1540-8159.2012.03517.x; Hwang M, 2015, IEEE T BIO-MED ENG, V62, P673, DOI 10.1109/TBME.2014.2363669; Jais P, 2009, J CARDIOVASC ELECTR, V20, P480, DOI 10.1111/j.1540-8167.2008.01373.x; Kim TH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003894; Kim TH, 2014, INT J CARDIOL, V176, P841, DOI 10.1016/j.ijcard.2014.08.008; Kim YH, 1997, J CLIN INVEST, V100, P2486, DOI 10.1172/JCI119791; Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lee AM, 2013, J THORAC CARDIOV SUR, V146, P593, DOI 10.1016/j.jtcvs.2012.04.021; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Okin PM, 2006, JAMA-J AM MED ASSOC, V296, P1242, DOI 10.1001/jama.296.10.1242; Park JH, 2009, J CARDIOVASC ELECTR, V20, P1349, DOI 10.1111/j.1540-8167.2009.01557.x; Park J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143853; Patel AM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P14, DOI 10.1161/CIRCEP.107.748160; Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067; Takahashi Y, 2009, J CARDIOVASC ELECTR, V20, P623, DOI 10.1111/j.1540-8167.2008.01410.x; Tzou WS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P237, DOI 10.1161/CIRCEP.109.923771; Veenhuyzen GD, 2009, PACE, V32, P393, DOI 10.1111/j.1540-8159.2008.02250.x; Won H, 2013, INT J CARDIOL, V168, P1570, DOI 10.1016/j.ijcard.2013.01.186	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188326	10.1371/journal.pone.0188326	http://dx.doi.org/10.1371/journal.pone.0188326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145517	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800113
J	Ushijima, T; Fujimoto, N; Matsuyama, S; Kan-o, M; Kiyonari, H; Shioi, G; Kage, Y; Yamasaki, S; Takeya, R; Sumimoto, H				Ushijima, Tomoki; Fujimoto, Noriko; Matsuyama, Sho; Kan-o, Meikun; Kiyonari, Hiroshi; Shioi, Go; Kage, Yohko; Yamasaki, Sho; Takeya, Ryu; Sumimoto, Hideki			The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; STRIATED-MUSCLE; HIGH-EFFICIENCY; THIN-FILAMENTS; MOUSE EMBRYO; PHOSPHORYLATION; HYPERTROPHY; DISEASE; KNOCKOUT; ROLES	Cardiac development and function require actin-myosin interactions in the sarcomere, a highly organized contractile structure. Sarcomere assembly mediated by formin homology 2 domain-containing 3 (Fhod3), a member of formins that directs formation of straight actin filaments, is essential for embryonic cardiogenesis. However, the role of Fhod3 in the neonatal and adult stages has remained unknown. Here, we generated floxed Fhod3 mice to bypass the embryonic lethality of an Fhod3 knockout (KO). Perinatal KO of Fhod3 in the heart caused juvenile lethality at around day 10 after birth with enlarged hearts composed of severely impaired myofibrils, indicating that Fhod3 is crucial for postnatal heart development. Tamoxifeninduced conditional KO of Fhod3 in the adult heart neither led to lethal effects nor did it affect sarcomere structure and localization of sarcomere components. However, adult Fhod3-deleted mice exhibited a slight cardiomegaly and mild impairment of cardiac function, conditions that were sustained over 1 year without compensation during aging. In addition to these agerelated changes, systemic stimulation with the alpha 1-adrenergic receptor agonist phenylephrine, which induces sustained hypertension and hypertrophy development, induced expression of fetal cardiac genes that was more pronounced in adult Fhod3deleted mice than in the control mice, suggesting that Fhod3 modulates hypertrophic changes in the adult heart. We conclude that Fhod3 plays a crucial role in both postnatal cardiac development and functional maintenance of the adult heart.	[Ushijima, Tomoki; Fujimoto, Noriko; Matsuyama, Sho; Kan-o, Meikun; Kage, Yohko; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Matsuyama, Sho; Kage, Yohko; Takeya, Ryu] Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi; Shioi, Go] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo 6500047, Japan; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan	Kyushu University; University of Miyazaki; RIKEN; RIKEN; Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan.; Takeya, R (corresponding author), Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan.	takeya@med.miyazaki-u.ac.jp; hsumi@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [26460371]; SHINGAKUJUTSU [25117515]; Takeda Science Foundation; Institute of Seizon and Life Sciences; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University;  [26111009]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SHINGAKUJUTSU; Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Seizon and Life Sciences; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; 	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" Grant 26111009 (to H. S.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 26460371 (to R. T.), SHINGAKUJUTSU Grant 25117515 (to R. T.), grants from the Takeda Science Foundation (to R. T.) and the Institute of Seizon and Life Sciences (to R. T.), and the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University (to R. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajima R, 2015, DEV BIOL, V408, P126, DOI 10.1016/j.ydbio.2015.10.003; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; FARIVAR RS, 1995, HYPERTENSION, V25, P809, DOI 10.1161/01.HYP.25.4.809; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujimoto N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148472; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gotthardt M, 2003, J BIOL CHEM, V278, P6059, DOI 10.1074/jbc.M211723200; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kooij V, 2016, CARDIOVASC RES, V110, P238, DOI 10.1093/cvr/cvw050; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Mori J, 2012, CIRC-HEART FAIL, V5, P493, DOI 10.1161/CIRCHEARTFAILURE.112.966705; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; Randall TS, 2014, EUR J CELL BIOL, V93, P205, DOI 10.1016/j.ejcb.2013.11.004; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Skwarek-Maruszewska A, 2009, J CELL SCI, V122, P2119, DOI 10.1242/jcs.046805; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Yuan BY, 2014, AM J PATHOL, V184, P1967, DOI 10.1016/j.ajpath.2014.04.007; Zhou Q, 2017, HYPERTENSION, V69, P1070, DOI 10.1161/HYPERTENSIONAHA.116.08662	47	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					148	162		10.1074/jbc.M117.813931	http://dx.doi.org/10.1074/jbc.M117.813931			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158260	Green Published, hybrid			2022-12-26	WOS:000419453200014
J	Badea, L; Onu, M; Wu, T; Roceanu, A; Bajenaru, O				Badea, Liviu; Onu, Mihaela; Wu, Tao; Roceanu, Adina; Bajenaru, Ovidiu			Exploring the reproducibility of functional connectivity alterations in Parkinson's disease	PLOS ONE			English	Article							RESTING-STATE FMRI; BRAIN CONNECTIVITY; NETWORK; PARCELLATION; NUCLEUS	Since anatomic MRI is presently not able to directly discern neuronal loss in Parkinson's Disease (PD), studying the associated functional connectivity (FC) changes seems a promising approach toward developing non-invasive and non-radioactive neuroimaging markers for this disease. While several groups have reported such FC changes in PD, there are also significant discrepancies between studies. Investigating the reproducibility of PD-related FC changes on independent datasets is therefore of crucial importance. We acquired restingstate fMRI scans for 43 subjects (27 patients and 16 normal controls, with 2 replicate scans per subject) and compared the observed FC changes with those obtained in two independent datasets, one made available by the PPMI consortium (91 patients, 18 controls) and a second one by the group of Tao Wu (20 patients, 20 controls). Unfortunately, PD-related functional connectivity changes turned out to be non-reproducible across datasets. This could be due to disease heterogeneity, but also to technical differences. To distinguish between the two, we devised a method to directly check for disease heterogeneity using random splits of a single dataset. Since we still observe non-reproducibility in a large fraction of random splits of the same dataset, we conclude that functional heterogeneity may be a dominating factor behind the lack of reproducibility of FC alterations in different rs-fMRI studies of PD. While global PD-related functional connectivity changes were non-reproducible across datasets, we identified a few individual brain region pairs with marginally consistent FC changes across all three datasets. However, training classifiers on each one of the three datasets to discriminate PD scans from controls produced only low accuracies on the remaining two test datasets. Moreover, classifiers trained and tested on random splits of the same dataset (which are technically homogeneous) also had low test accuracies, directly substantiating disease heterogeneity.	[Badea, Liviu] Natl Inst Res & Dev Informat, Artificial Intelligence & Bioinformat Grp, Bucharest, Romania; [Onu, Mihaela] Clin Hosp Prof Dr Th Burghele, Med Imaging Dept, Bucharest, Romania; [Onu, Mihaela] Univ Med & Pharm Carol Davila, Biophys Dept, Bucharest, Romania; [Wu, Tao] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Minist Educ,Key Lab Neurodegenerat Disorders,Dept, Beijing, Peoples R China; [Wu, Tao] Beijing Inst Brain Disorders, Parkinson Dis Ctr, Beijing Key Lab Parkinsons Dis, Beijing, Peoples R China; [Roceanu, Adina; Bajenaru, Ovidiu] Univ Emergency Hosp Bucharest, Neurol Dept, Bucharest, Romania; [Bajenaru, Ovidiu] Univ Med & Pharm Carol Davila, Dept Clin Neurosci, Bucharest, Romania	National Institute R&D Informatics Bucharest; Carol Davila University of Medicine & Pharmacy; Capital Medical University; Carol Davila University of Medicine & Pharmacy	Badea, L (corresponding author), Natl Inst Res & Dev Informat, Artificial Intelligence & Bioinformat Grp, Bucharest, Romania.	badea.liviu@gmail.com	Badea, Liviu/B-8807-2011; Wu, Tao/S-4505-2019; ROCEANU, ADINA MARIA/AAR-2229-2020	ROCEANU, ADINA MARIA/0000-0002-4860-3324; Onu, Mihaela/0000-0002-8614-4579	UEFISCDI, Romania (NEUROCON project) [84/2012]; NEUROCON project - UEFISCDI [84/2012]; Michael J. Fox Foundation; AbbVie; Avid Radiopharmaceuticals; Biogen; Bristol-Myers Squibb; Covance; GE Healthcare; Genentech; GlaxoSmithKline; Eli Lilly and Company; Lundbeck; Merck; Meso Scale Discovery; Pfizer; Piramal Imaging; Roche; Servier; UCB (Union Chimique Belge); GOLUB Capital	UEFISCDI, Romania (NEUROCON project)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); NEUROCON project - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Michael J. Fox Foundation; AbbVie(AbbVie); Avid Radiopharmaceuticals; Biogen(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); Covance; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly and Company(Eli Lilly); Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Piramal Imaging; Roche(Roche Holding); Servier(Servier); UCB (Union Chimique Belge); GOLUB Capital	This study was funded by UEFISCDI, Romania (NEUROCON project - grant number 84/2012).; This work was partially supported by the NEUROCON project (84/2012), financed by UEFISCDI. We are very grateful to the PPMI consortium for granting us access to the Parkinson's Progression Markers Initiative (PPMI) imaging data. Data used in the preparation of this article were obtained from the PPMI database (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. PPMI-a public-private partnership D is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including AbbVie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Eli Lilly and Company, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal Imaging, Roche, Servier, UCB (Union Chimique Belge) and GOLUB Capital.	Agrawal M, 2015, FRONTIERS MOL BIOSCI, P2; [Anonymous], 2003, HUMAN BRAIN FUNCTION; Baggio HC, 2015, HUMAN BRAIN MAPPING, P36; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chen YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124153; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Esposito F, 2013, BRAIN, V136, P710, DOI 10.1093/brain/awt007; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Gordon E.M., 2014, CEREB CORTEX; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hacker C, 2012, BRAIN; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Kurani AS, 2015, NEUROBIOL AGING, V36, P462, DOI 10.1016/j.neurobiolaging.2014.07.004; Kwak Y, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00052; Kwak Y, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00143; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Liu H, 2013, PSYCHIAT RES-NEUROIM, V211, P64, DOI 10.1016/j.pscychresns.2012.10.007; Long DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040150; Luo CY, 2014, NEUROBIOL AGING, V35, P431, DOI 10.1016/j.neurobiolaging.2013.08.018; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Orban P, 2017, SCHIZOPHRENIA RES; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sharman M, 2013, MOVEMENT DISORD, V28, P447, DOI 10.1002/mds.25255; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Skidmore FM, 2013, NEUROIMAGE, V75, P249, DOI 10.1016/j.neuroimage.2011.06.056; Szewczyk-Krolikowski K, 2014, NEUROLOGY, V83, P208, DOI 10.1212/WNL.0000000000000592; Tahmasian M, 2015, CORTEX, V73, P80, DOI 10.1016/j.cortex.2015.08.005; Talairach J., 1988, COPLANAR STEREOTAXIC; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Tuite PJ, 2013, J ALZHEIMERS DIS S1, DOI 10.4172/2161-0460.S1-001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Wu T, 2015, J CEREBR BLOOD F MET, V35, P1764, DOI 10.1038/jcbfm.2015.118; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yu RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059717; Zhang D, 2015, FRONTIERS AGING NEUR, V7	44	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188196	10.1371/journal.pone.0188196	http://dx.doi.org/10.1371/journal.pone.0188196			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182621	gold, Green Submitted, Green Published			2022-12-26	WOS:000416402000012
J	Dia, AA; Hori, M; Onishi, H; Sakane, M; Ota, T; Tsuboyama, T; Tatsumi, M; Okuaki, T; Tomiyama, N				Dia, Aliou Amadou; Hori, Masatoshi; Onishi, Hiromitsu; Sakane, Makoto; Ota, Takashi; Tsuboyama, Takahiro; Tatsumi, Mitsuaki; Okuaki, Tomoyuki; Tomiyama, Noriyuki			Application of non-Gaussian water diffusional kurtosis imaging in the assessment of uterine tumors: A preliminary study	PLOS ONE			English	Article							TENSOR; MRI; FEASIBILITY; GRADE; MODEL	Objectives To evaluate the interobserver reliability and value of diffusional kurtosis imaging (DKI) in the assessment of uterine tumors compared with those of conventional diffusion-weighted imaging (DWI). Methods This retrospective study was approved by our institutional review board, which waived the requirement for informed consent. Fifty-eight women (mean age: 55.0 +/- 13.6 years; range: 30-89 years) with suspected malignant uterine tumors underwent 3-T magnetic resonance imaging using DKI and DWI. Twelve had coexisting leiomyoma. Two observers analyzed region-of-interest measurements of diffusivity (D), kurtosis (K), and the apparent diffusion coefficient (ADC) of uterine lesions and healthy adjacent tissues. Interobserver agreement was evaluated using the intra-class correlation coefficient (ICC). The mean values were compared using one-way analysis of variance with a post-hoc Tukeys honestly significant difference test. The diagnostic accuracy of D and ADC in differentiating malignant tumors from benign leiomyomas was analyzed using receiver operating characteristic (ROC) analysis. Results The ICCs between the two observers in evaluating D, K, and the ADC of the malignant tumors were higher than 0.84, suggesting excellent interobserver agreements. The mean D (X10-3 mm2/s) of uterine cancers (1.05 +/- 0.41 and 1.09 +/- 0.40 for observers 1 and 2, respectively) were significantly lower than those of leiomyoma (1.40 +/- 0.37 and 1.56 +/- 0.33, respectively; P < 0.05), healthy myometrium (1.72 +/- 0.27 and 1.69 +/- 0.30, respectively; P < 0.001), and healthy endometrium (1.53 +/- 0.35 and 1.42 +/- 0.37, respectively; P < 0.005). There was no significant difference in the area under the ROC curve between D and ADC. The mean K of uterine cancers (0.88 +/- 0.28 and 0.90 +/- 0.23, respectively) were higher than those of myometrium (0.72 +/- 0.10 and 0.73 +/- 0.10, respectively; P < 0.001), healthy endometrium (0.65 +/- 0.13 and 0.60 +/- 0.18, respectively; P < 0.001), and leiomyoma (0.76 +/- 0.14 and 0.77 +/- 0.16, respectively; not significant, P > 0.1). Conclusions Interobserver agreements in evaluating D, K, and ADC were moderate to excellent. D performed equally to conventional DWI in differentiating between benign and malignant uterine lesions. The mean K of malignant uterine lesions was significantly higher than that of non-tumorous myometrium or endometrium.	[Dia, Aliou Amadou; Hori, Masatoshi; Onishi, Hiromitsu; Sakane, Makoto; Ota, Takashi; Tsuboyama, Takahiro; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka, Japan; [Tatsumi, Mitsuaki] Osaka Univ Hosp, Dept Radiol, Suita, Osaka, Japan; [Okuaki, Tomoyuki] Philips Healthcare, Tokyo, Japan	Osaka University; Osaka University; Philips; Philips Healthcare	Hori, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Suita, Osaka, Japan.	mhori@radiol.med.osaka-u.ac.jp	Tatsumi, Mitsuaki/GZM-9443-2022	Tatsumi, Mitsuaki/0000-0003-1778-0421; Hori, Masatoshi/0000-0002-2523-3789				Bharwani N, 2011, BRIT J RADIOL, V84, P997, DOI 10.1259/bjr/14980811; Chen JY, 2010, EUR J RADIOL, V74, pE102, DOI 10.1016/j.ejrad.2009.04.025; Collins Y, 2014, GYNECOL ONCOL, V133, P353, DOI 10.1016/j.ygyno.2013.12.039; De Santis S, 2011, MAGN RESON IMAGING, V29, P1410, DOI 10.1016/j.mri.2011.04.006; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Kimura MCG, 2014, J NEUROL SCI, V345, P172, DOI 10.1016/j.jns.2014.07.035; Hori M, 2013, EUR RADIOL, V23, P2296, DOI 10.1007/s00330-013-2815-0; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kamagata K, 2014, NEURORADIOLOGY, V56, P251, DOI 10.1007/s00234-014-1327-1; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Kamiya K, 2016, MAGN RESON MED SCI, V15, P316, DOI 10.2463/mrms.mp.2015-0093; Kido A, 2013, J MAGN RESON IMAGING, V37, P249, DOI 10.1002/jmri.23716; Kilickesmez O, 2009, ACTA RADIOL, V50, P340, DOI 10.1080/02841850902735858; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kuang F, 2013, EUR RADIOL, V23, P1050, DOI 10.1007/s00330-012-2681-1; Lawrence EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159652; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Nogueira L, 2014, EUR RADIOL, V24, P1197, DOI 10.1007/s00330-014-3146-5; Pentang G, 2014, MAGN RESON IMAGING, V32, P413, DOI 10.1016/j.mri.2014.01.006; Quentin M, 2014, MAGN RESON IMAGING, V32, P880, DOI 10.1016/j.mri.2014.04.005; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun K, 2015, RADIOLOGY, V277, P46, DOI 10.1148/radiol.15141625; Suo ST, 2014, MAGN RESON IMAGING, V32, P421, DOI 10.1016/j.mri.2014.01.015; Tamai K, 2008, EUR RADIOL, V18, P723, DOI 10.1007/s00330-007-0787-7; Tamura C, 2014, J MAGN RESON IMAGING, V40, P723, DOI 10.1002/jmri.24379; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Winfield JM, 2017, EUR RADIOL, V27, P627, DOI 10.1007/s00330-016-4417-0; Wu DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113240; Yokosawa S, 2016, MAGN RESON MED SCI, V15, P41, DOI 10.2463/mrms.2014-0139	31	3	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188434	10.1371/journal.pone.0188434	http://dx.doi.org/10.1371/journal.pone.0188434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176867	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900076
J	Du, SY; Xu, YT; Wan, T; Hu, HZ; Zhang, SR; Xu, GL; Zhang, XT				Du, Shaoyi; Xu, Yiting; Wan, Teng; Hu, Huaizhong; Zhang, Sirui; Xu, Guanglin; Zhang, Xuetao			Robust iterative closest point algorithm based on global reference point for rotation invariant registration	PLOS ONE			English	Article							3-D; RECONSTRUCTION; GRAPH	The iterative closest point (ICP) algorithm is efficient and accurate for rigid registration but it needs the good initial parameters. It is easily failed when the rotation angle between two point sets is large. To deal with this problem, a new objective function is proposed by introducing a rotation invariant feature based on the Euclidean distance between each point and a global reference point, where the global reference point is a rotation invariant. After that, this optimization problem is solved by a variant of ICP algorithm, which is an iterative method. Firstly, the accurate correspondence is established by using the weighted rotation invariant feature distance and position distance together. Secondly, the rigid transformation is solved by the singular value decomposition method. Thirdly, the weight is adjusted to control the relative contribution of the positions and features. Finally this new algorithm accomplishes the registration by a coarse-to-fine way whatever the initial rotation angle is, which is demonstrated to converge monotonically. The experimental results validate that the proposed algorithm is more accurate and robust compared with the original ICP algorithm.	[Du, Shaoyi; Xu, Yiting; Wan, Teng; Hu, Huaizhong; Xu, Guanglin; Zhang, Xuetao] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China; [Zhang, Sirui] Xi An Jiao Tong Univ, Sch Software Engn, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Hu, HZ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China.	huhuaizhong@mail.xjtu.edu.cn			National Natural Science Foundation of China [61573274, 61379104]; Fundamental Research Funds for the Central Universities [xjj2017005, xjj2017067]; Program of Introducing Talents of Discipline to University [B13043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program of Introducing Talents of Discipline to University(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (61573274 to SD, 61379104), the Fundamental Research Funds for the Central Universities (xjj2017005 to SD, xjj2017067), and the Program of Introducing Talents of Discipline to University (B13043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 1997, PROC CVPR IEEE, P646, DOI 10.1109/CVPR.1997.609394; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; BENTLEY JL, 1990, PROCEEDINGS OF THE SIXTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY, P187, DOI 10.1145/98524.98564; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chen HM, 2006, J CHIN INST ENG, V29, P945, DOI 10.1080/02533839.2006.9671195; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chetverikov D, 2005, IMAGE VISION COMPUT, V23, P299, DOI 10.1016/j.imavis.2004.05.007; Du SY, 2015, MED IMAGE ANAL, V26, P256, DOI 10.1016/j.media.2015.10.001; Du SY, 2015, NEUROCOMPUTING, V157, P187, DOI 10.1016/j.neucom.2015.01.019; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; GRANGER S, 2002, EUR C COMP VIS, V2353, P418; Gregor J, 2001, GRAPH MODELS, V63, P304, DOI 10.1006/gmod.2001.0562; Latecki LJ, 2000, PROC CVPR IEEE, P424, DOI 10.1109/CVPR.2000.855850; Lee BU, 2000, IEEE T PATTERN ANAL, V22, P1205, DOI 10.1109/34.879805; Ridene T, 2009, IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, P375, DOI 10.1109/CIRA.2009.5423176; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Ying SH, 2014, NEUROIMAGE, V84, P626, DOI 10.1016/j.neuroimage.2013.09.023; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zhao X., 2017, IEEE T NEURAL NETWOR	21	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188039	10.1371/journal.pone.0188039	http://dx.doi.org/10.1371/journal.pone.0188039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176780	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900030
J	Aw, WC; Garvin, MR; Melvin, RG; Ballard, JWO				Aw, Wen C.; Garvin, Michael R.; Melvin, Richard G.; Ballard, J. William O.			Sex-specific influences of mtDNA mitotype and diet on mitochondrial functions and physiological traits in Drosophila melanogaster	PLOS ONE			English	Article							RESPIRATORY COMPLEX I; LIFE-SPAN; ORGANISMAL PHENOTYPE; STARVATION RESISTANCE; OXIDATIVE STRESS; MOTHERS CURSE; DNA VARIANTS; TRADE-OFF; REPRODUCTION; POPULATIONS	Here we determine the sex-specific influence of mtDNA type (mitotype) and diet on mitochondrial functions and physiology in two Drosophila melanogaster lines. In many species, males and females differ in aspects of their energy production. These sex-specific influences may be caused by differences in evolutionary history and physiological functions. We predicted the influence of mtDNA mutations should be stronger in males than females as a result of the organelle's maternal mode of inheritance in the majority of metazoans. In contrast, we predicted the influence of diet would be greater in females due to higher metabolic flexibility. We included four diets that differed in their protein: carbohydrate (P:C) ratios as they are the two-major energy-yielding macronutrients in the fly diet. We assayed four mitochondrial function traits (Complex I oxidative phosphorylation, reactive oxygen species production, superoxide dismutase activity, and mtDNA copy number) and four physiological traits (fecundity, longevity, lipid content, and starvation resistance). Traits were assayed at 11 d and 25 d of age. Consistent with predictions we observe that the mitotype influenced males more than females supporting the hypothesis of a sex-specific selective sieve in the mitochondrial genome caused by the maternal inheritance of mitochondria. Also, consistent with predictions, we found that the diet influenced females more than males.	[Aw, Wen C.; Melvin, Richard G.; Ballard, J. William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Garvin, Michael R.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of New South Wales Sydney; Washington State University	Ballard, JWO (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	w.ballard@unsw.edu.au	Ballard, John William O./ABB-2743-2020	Ballard, John William O./0000-0002-2358-6003; Garvin, Michael/0000-0002-2204-7569; Melvin, Richard George/0000-0001-6428-6763	Australian Research Council Discovery Project [DP160102575]	Australian Research Council Discovery Project(Australian Research Council)	This work was supported by Australian Research Council Discovery Project DP160102575 funded to J.W.O. Ballard, http://www.arc.gov.au/.	Adler MI, 2013, EXP GERONTOL, V48, P539, DOI 10.1016/j.exger.2013.03.007; Ahola S, 2016, EMBO MOL MED, V8, P1234, DOI 10.15252/emmm.201606592; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Aw WC, 2011, MITOCHONDRION, V11, P756, DOI 10.1016/j.mito.2011.06.012; Azevedo RB, 2001, BRAZ J MED BIOL RES, V34, P683, DOI 10.1590/S0100-879X2001000500018; Ballard J., 2016, J RARE DIS RES TREAT, V1, P31, DOI 10.29245/2572-9411/2016/3.1043; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; Ballard JWO, 2007, AGING CELL, V6, P699, DOI 10.1111/j.1474-9726.2007.00331.x; Ballard JWO, 2010, AM NAT, V176, pE98, DOI 10.1086/656263; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Baris TZ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006517; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Brooks RC, 2017, ANN NY ACAD SCI, V1389, P92, DOI 10.1111/nyas.13302; BROWN MD, 1992, GENETICS, V130, P163; Bu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139039; Camus MF, 2015, CURR BIOL, V25, P2717, DOI 10.1016/j.cub.2015.09.012; Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clancy David J., 2001, Drosophila Information Service, V84, P168; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; Correa CC, 2012, MITOCHONDRION, V12, P459, DOI 10.1016/j.mito.2012.06.005; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fanson BG, 2012, P ROY SOC B-BIOL SCI, V279, P4893, DOI 10.1098/rspb.2012.2033; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Garvin MR, 2015, GENOME BIOL EVOL, V7, P1404, DOI 10.1093/gbe/evv078; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Gotoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021139; Hardie DG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006031; HARTFELDER K, 1993, ROUX ARCH DEV BIOL, V202, P176, DOI 10.1007/BF00365308; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hoffmann AA, 2003, J EVOLUTION BIOL, V16, P614, DOI 10.1046/j.1420-9101.2003.00561.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Jensen K, 2015, AGING CELL, V14, P605, DOI 10.1111/acel.12333; Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150; Klepsatel P, 2013, J EVOLUTION BIOL, V26, P1508, DOI 10.1111/jeb.12155; Kokko H., 2008, BIOSCIENCE, V58, P460; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lee KP, 2014, FUNCT ECOL, V28, P1144, DOI 10.1111/1365-2435.12247; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; LONG CE, 1980, BEHAV GENET, V10, P163, DOI 10.1007/BF01066266; Lorenz MW, 2004, ARCH INSECT BIOCHEM, V56, P110, DOI 10.1002/arch.20002; Lundsgaard AM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00195; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Melvin RG, 2006, AGING CELL, V5, P225, DOI 10.1111/j.1474-9726.2006.00211.x; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Moreno-Loshuertos R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001379; Novoseltsev VN, 2003, MECH AGEING DEV, V124, P605, DOI 10.1016/S0047-6374(03)00061-7; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Patel MR, 2016, ELIFE, V5, DOI 10.7554/eLife.16923; Peterman EM, 2015, INFECT IMMUN, V83, P430, DOI 10.1128/IAI.02245-14; Pichaud N, 2013, MITOCHONDRION, V13, P817, DOI 10.1016/j.mito.2013.05.008; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Rand DM, 2001, GENETICS, V159, P173; Rani DS, 2006, FERTIL STERIL, V86, P1783, DOI 10.1016/j.fertnstert.2006.04.044; Rasmussen HN, 2003, ANAL BIOCHEM, V319, P105, DOI 10.1016/S0003-2697(03)00274-4; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rogell B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-330; Salminen TS, 2017, MITOCHONDRION, V34, P75, DOI 10.1016/j.mito.2017.02.001; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Siddiqui MF, 2016, AUTISM OPEN ACCESS, V6; Sisodia S, 2010, J EVOLUTION BIOL, V23, P1979, DOI 10.1111/j.1420-9101.2010.02061.x; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sugihara K, 2006, GENES GENET SYST, V81, P21, DOI 10.1266/ggs.81.21; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18; Tarnopolsky M A, 2000, J Sci Med Sport, V3, P287; Trivers R., 2002, NATURAL SELECTION SO; Trivers RL., 1972, SEXUAL SELECTION DES; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Wade MJ, 2009, EVOLUTION, V63, P1084, DOI 10.1111/j.1558-5646.2009.00614.x; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; Wolff JN, 2016, MITOCHONDRIAL DNA A, V27, P4672, DOI 10.3109/19401736.2015.1106496; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354	96	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187554	10.1371/journal.pone.0187554	http://dx.doi.org/10.1371/journal.pone.0187554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166659	Green Published, gold, Green Submitted			2022-12-26	WOS:000416035300014
J	Milker, Y; Weinkauf, MFG; Titschack, J; Freiwald, A; Kruger, S; Jorissen, FJ; Schmiedl, G				Milker, Yvonne; Weinkauf, Manuel F. G.; Titschack, Juergen; Freiwald, Andre; Krueger, Stefan; Jorissen, Frans J.; Schmiedl, Gerhard			Testing the applicability of a benthic foraminiferal-based transfer function for the reconstruction of paleowater depth changes in Rhodes (Greece) during the early Pleistocene	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURES; PARTIAL LEAST-SQUARES; QUANTITATIVE RECONSTRUCTIONS; INTERTIDAL FORAMINIFERA; PLANKTONIC-FORAMINIFERA; CALCAREOUS NANNOFOSSIL; COASTAL SUBSIDENCE; ATLANTIC-OCEAN; NORTH-CAROLINA; SALT MARSHES	We present paleo-water depth reconstructions for the Pefka E section deposited on the island of Rhodes (Greece) during the early Pleistocene. For these reconstructions, a transfer function (TF) using modern benthic foraminifera surface samples from the Adriatic and Western Mediterranean Seas has been developed. The TF model gives an overall predictive accuracy of similar to 50 m over a water depth range of similar to 1200 m. Two separate TF models for shallower and deeper water depth ranges indicate a good predictive accuracy of 9 m for shallower water depths (0-200 m) but far less accuracy of 130 m for deeper water depths (200-1200 m) due to uneven sampling along the water depth gradient. To test the robustness of the TF, we randomly selected modern samples to develop random TFs, showing that the model is robust for water depths between 20 and 850 m while greater water depths are underestimated. We applied the TF to the Pefka E fossil data set. The goodness-of-fit statistics showed that most fossil samples have a poor to extremely poor fit to water depth. We interpret this as a consequence of a lack of modern analogues for the fossil samples and removed all samples with extremely poor fit. To test the robustness and significance of the reconstructions, we compared them to reconstructions from an alternative TF model based on the modern analogue technique and applied the randomization TF test. We found our estimates to be robust and significant at the 95% confidence level, but we also observed that our estimates are strongly overprinted by orbital, precession-driven changes in paleo-productivity and corrected our estimates by filtering out the precession-related component. We compared our corrected record to reconstructions based on a modified plankton/benthos (P/B) ratio, excluding infaunal species, and to stable oxygen isotope data from the same section, as well as to paleo-water depth estimates for the Lindos Bay Formation of other sediment sections of Rhodes. These comparisons indicate that our orbital-corrected reconstructions are reasonable and reflect major tectonic movements of Rhodes during the early Pleistocene.	[Milker, Yvonne; Schmiedl, Gerhard] Univ Hamburg, Inst Geol, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany; [Weinkauf, Manuel F. G.] Univ Geneva, Dept Earth Sci, Geneva, Switzerland; [Titschack, Juergen] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany; [Titschack, Juergen; Freiwald, Andre] Senckenberg Meer, Dept Marine Res, Wilhelmshaven, Germany; [Krueger, Stefan] Univ Leipzig, Inst Geophys & Geol, Leipzig, Germany; [Jorissen, Frans J.] Univ Angers, UMR CNRS 6112, LPG BIAF Bioindicateurs Actuels & Fossiles, Angers, France	University of Hamburg; University of Geneva; University of Bremen; Senckenberg Gesellschaft fur Naturforschung (SGN); Leipzig University; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers	Milker, Y (corresponding author), Univ Hamburg, Inst Geol, Ctr Earth Syst Res & Sustainabil, Hamburg, Germany.	yvonne.milker@uni-hamburg.de	Weinkauf, Manuel/AAL-5704-2020; Freiwald, Andre/C-2061-2018; Schmiedl, Gerhard/E-6644-2017; Titschack, Jurgen/L-2095-2015	Freiwald, Andre/0000-0002-2335-4042; Schmiedl, Gerhard/0000-0002-2177-6858; Titschack, Jurgen/0000-0001-9373-9688; Weinkauf, Manuel F. G./0000-0002-4640-9659; Jorissen, Frans/0000-0002-9325-6085	DFG [Fr 1134/7]; German Research Foundation (DFG)	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	The sampling campaigns and sample preparation benefitted from funds of the DFG project Fr 1134/7 to Andre Freiwald. The German Research Foundation (DFG) supported for financial support through the Cluster of Excellence CIiSAP (Integrated Climate System Analysis and Prediction) at the University of Hamburg.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Athanasiou M, 2017, GLOBAL PLANET CHANGE, V150, P46, DOI 10.1016/j.gloplacha.2017.01.008; Athanasiou M, 2015, GEO-MAR LETT, V35, P367, DOI 10.1007/s00367-015-0414-6; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; AUSTIN MP, 1976, VEGETATIO, V33, P33, DOI 10.1007/BF00055297; Austin MP, 1999, OIKOS, V86, P170, DOI 10.2307/3546582; Avnaim-Katav S, 2016, MAR GEOL, V376, P26, DOI 10.1016/j.margeo.2016.03.010; Avnaim-Katav S, 2015, J SEA RES, V99, P97, DOI 10.1016/j.seares.2015.02.006; Barlow NLM, 2013, GLOBAL PLANET CHANGE, V106, P90, DOI 10.1016/j.gloplacha.2013.03.003; Bartels-Jonsdottir HB, 2006, MAR MICROPALEONTOL, V59, P83, DOI 10.1016/j.marmicro.2006.01.002; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Birks HJB, 1998, J PALEOLIMNOL, V20, P307, DOI 10.1023/A:1008038808690; Charman DJ, 2007, J QUATERNARY SCI, V22, P209, DOI 10.1002/jqs.1026; Cimerman F, 1991, ACAD SCIERTIARUM ART, V30; Cornee JJ, 2006, EARTH PLANET SC LETT, V250, P281, DOI 10.1016/j.epsl.2006.07.045; De Rijk S, 1999, J FORAMIN RES, V29, P93, DOI 10.2113/gsjfr.29.2.93; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; de Stigter HC, 1999, PALAEOGEOGR PALAEOCL, V149, P67, DOI 10.1016/S0031-0182(98)00193-X; de Stigter HC, 1998, J FORAMIN RES, V28, P40; Dimiza Margarita D., 2016, Revue de Micropaleontologie, V59, P19, DOI 10.1016/j.revmic.2015.10.002; Dimiza MD, 2016, ECOL INDIC, V60, P611, DOI 10.1016/j.ecolind.2015.07.030; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duchemin G, 2008, J SEA RES, V59, P297, DOI 10.1016/j.seares.2008.03.006; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engelhart SE, 2013, GEOLOGY, V41, P1067, DOI 10.1130/G34544.1; Fontanier C, 2003, DEEP-SEA RES PT I, V50, P457, DOI 10.1016/S0967-0637(02)00167-X; Frydas Dimitris, 1994, Muenstersche Forschungen zur Geologie und Palaeontologie, V76, P331; Gehrels WR, 2006, HOLOCENE, V16, P949, DOI 10.1177/0959683606hl986rp; Gehrels WR, 2012, EARTH PLANET SC LETT, V315, P94, DOI 10.1016/j.epsl.2011.08.046; Gehrels WR, 2000, HOLOCENE, V10, P367, DOI 10.1191/095968300670746884; Goineau A, 2011, J SEA RES, V65, P58, DOI 10.1016/j.seares.2010.07.007; Graham JH, 2011, INT J ECOL, V2011; Hanken NM, 1996, GEOL J, V31, P393, DOI 10.1002/(SICI)1099-1034(199612)31:4<393::AID-GJ712>3.3.CO;2-8; Hansen KS, 1999, SEDIMENTOLOGY, V46, P559, DOI 10.1046/j.1365-3091.1999.00238.x; Hastrup Annette, 2005, Cushman Foundation for Foraminiferal Research Special Publication, V39, P159; Hawkes AD, 2011, QUATERNARY SCI REV, V30, P364, DOI 10.1016/j.quascirev.2010.11.017; Hawkes AD, 2010, QUATERN INT, V221, P116, DOI 10.1016/j.quaint.2009.09.019; Hayward BW, 2016, J FORAMIN RES, V46, P285, DOI 10.2113/gsjfr.46.3.285; Hayward BW, 2004, NEW ZEAL J GEOL GEOP, V47, P749, DOI 10.1080/00288306.2004.9515087; HILGEN FJ, 1991, EARTH PLANET SC LETT, V104, P226, DOI 10.1016/0012-821X(91)90206-W; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hohenegger J, 2005, PALAEOGEOGR PALAEOCL, V217, P115, DOI 10.1016/j.palaeo.2004.11.020; Horton Benjamin P., 2006, Cushman Foundation for Foraminiferal Research Special Publication, P3; Horton BP, 1999, PALAEOGEOGR PALAEOCL, V149, P127, DOI 10.1016/S0031-0182(98)00197-7; Huber P. H., 1981, ROBUST STAT; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; HUTSON WH, 1977, QUATERNARY RES, V8, P355, DOI 10.1016/0033-5894(77)90077-1; HUTSON WH, 1980, SCIENCE, V207, P64, DOI 10.1126/science.207.4426.64; Imbrie J., 1971, LATE CENOZOIC GLACIA, P71; Jones R. W., 1994, CHALLENGER FORAMINIF, DOI 10.1046/j.1420-9101.1996.9010124.x; Jorissen F.J. ., 1988, Utrecht Micropaleontological Bulletins, P1; JORISSEN FJ, 1987, MAR MICROPALEONTOL, V12, P21, DOI 10.1016/0377-8398(87)90012-0; Juggins S., 2015, ANAL QUATERNARY SCI; Juggins S, 2013, QUATERNARY SCI REV, V64, P20, DOI 10.1016/j.quascirev.2012.12.014; Juggins Steve, 2012, P431; Karpuz NK, 1990, PALEOCEANOGRAPHY, V5, P557, DOI 10.1029/PA005i004p00557; Kemp AC, 2017, QUATERNARY SCI REV, V160, P13, DOI 10.1016/j.quascirev.2017.01.012; Kemp AC, 2015, EARTH PLANET SC LETT, V428, P217, DOI 10.1016/j.epsl.2015.07.034; Kemp AC, 2009, GEOLOGY, V37, P1035, DOI 10.1130/G30352A.1; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kotthoff U, 2014, CLIM PAST, V10, P1523, DOI 10.5194/cp-10-1523-2014; Kroon D., 1998, ARCTIC, V160, P181, DOI DOI 10.2973/ODP.PROC.SR.160.071.1998(CHAPTER14)160; Kucera M, 2005, QUATERNARY SCI REV, V24, P951, DOI 10.1016/j.quascirev.2004.07.014; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Leorri E, 2010, QUATERN INT, V221, P104, DOI 10.1016/j.quaint.2009.10.033; Lourens L.J., 1998, Proceedings of the Ocean Drilling Program Scientific Results, V160, P191; McDonald J.H., 2009, HDB BIOL STAT; Meulenkamp J.E., 1972, Z DTSCH GEOL GES, V123, P541; Milker Y, 2013, NAT HAZARD EARTH SYS, V13, P3113, DOI 10.5194/nhess-13-3113-2013; Milker Y., 2010, THESIS; Milker Y, 2016, QUATERNARY SCI REV, V142, P143, DOI 10.1016/j.quascirev.2016.04.017; Milker Y, 2015, MAR MICROPALEONTOL, V118, P1, DOI 10.1016/j.marmicro.2015.04.004; Milker Y, 2015, J FORAMIN RES, V45, P146, DOI 10.2113/gsjfr.45.2.146; Milker Y, 2012, PALAEONTOL ELECTRON, V15; Milker Y, 2011, PALAEOGEOGR PALAEOCL, V307, P324, DOI 10.1016/j.palaeo.2011.05.031; Milker Y, 2009, MAR MICROPALEONTOL, V73, P207, DOI 10.1016/j.marmicro.2009.10.003; Moissette P, 1995, PALAEONTOLOGY, V38, P771; Morigi C, 2005, MAR MICROPALEONTOL, V57, P25, DOI 10.1016/j.marmicro.2005.06.001; Mutti E., 1970, ANN GEOLOGIQUES PAYS, V22, P77; Nakagawa T, 2002, QUATERNARY SCI REV, V21, P2099, DOI 10.1016/S0277-3791(02)00014-8; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J, 2022, R PACKAGE VERSION; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Parker F.L., 1958, REPORTS SWEDISH DEEP, V8, P217; Payne RJ, 2016, QUATERNARY SCI REV, V138, P131, DOI 10.1016/j.quascirev.2016.01.030; Perez-Asensio JN, 2012, PALAEOGEOGR PALAEOCL, V326, P135, DOI 10.1016/j.palaeo.2012.02.014; Peyron O, 2001, J QUATERNARY SCI, V16, P699, DOI 10.1002/jqs.651; Pflaumann U, 1999, MAR GEOL, V156, P41, DOI 10.1016/S0025-3227(98)00173-X; Pisias NG, 1997, PALEOCEANOGRAPHY, V12, P381, DOI 10.1029/97PA00583; Quillevere F, 2016, QUATERNARY RES, V86, P79, DOI 10.1016/j.yqres.2016.05.002; R Development Core Team, 2016, R LANG ENV STAT COMP; Rasmussen Tine L., 2005, Cushman Foundation for Foraminiferal Research Special Publication, V39, P15; Rasmussen Tine L., 2005, Cushman Foundation for Foraminiferal Research Special Publication, V39, P53; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rohling EJ, 1999, MODERN FORAMINIFERA, P239; Rohling EJ, 1998, J GEOPHYS RES-OCEANS, V103, P1307, DOI 10.1029/97JC01047; Rossi V, 2009, J FORAMIN RES, V39, P180, DOI 10.2113/gsjfr.39.3.180; ROSSIGNOLSTRICK M, 1982, NATURE, V295, P105, DOI 10.1038/295105a0; Schlitzer R., 2020, OCEAN DATA VIEW; Schmiedl G, 1997, PALAEOGEOGR PALAEOCL, V130, P43, DOI 10.1016/S0031-0182(96)00137-X; Schmiedl G, 2000, MAR MICROPALEONTOL, V40, P167, DOI 10.1016/S0377-8398(00)00038-4; Schmiedl G, 2010, QUATERNARY SCI REV, V29, P3006, DOI 10.1016/j.quascirev.2010.07.002; SCOTT DS, 1978, NATURE, V272, P528, DOI 10.1038/272528a0; Sgarrella Franca, 1993, Bollettino della Societa Paleontologica Italiana, V32, P145; Simpson GL, 2007, J STAT SOFTW, V22, P1; Simpson GL, 2012, TRACKING ENV CHANGE, P579; Spezzaferri S., 2007, EEARTH DISCUSS, V2, P115, DOI DOI 10.5194/EED-2-115-2007; Tanhua T, 2013, OCEAN SCI, V9, P789, DOI 10.5194/os-9-789-2013; Telford R., 2015, PALAEOSIG SIGNIFICAN; Telford RJ, 2011, J PALEOLIMNOL, V46, P99, DOI 10.1007/s10933-011-9523-z; Telford RJ, 2011, QUATERNARY SCI REV, V30, P1272, DOI 10.1016/j.quascirev.2011.03.002; Telford RJ, 2009, QUATERNARY SCI REV, V28, P1309, DOI 10.1016/j.quascirev.2008.12.020; Telford RJ, 2005, QUATERNARY SCI REV, V24, P2173, DOI 10.1016/j.quascirev.2005.05.001; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, CHEMOMETR INTELL LAB, V28, P165, DOI 10.1016/0169-7439(95)00002-E; TERBRAAK CJF, 1993, HYDROBIOLOGIA, V269, P485, DOI 10.1007/BF00028046; TERBRAAK CJF, 1993, N-HOLLAND STAT PROB, V6, P525; Thomsen E, 2001, J MICROPALAEONTOL, V20, P143, DOI 10.1144/jm.20.2.143; Titschack J, 2005, SEDIMENT GEOL, V180, P29, DOI 10.1016/j.sedgeo.2005.06.009; Titschack J, 2013, SEDIMENT GEOL, V283, P15, DOI 10.1016/j.sedgeo.2012.11.001; Tuenter E, 2003, GLOBAL PLANET CHANGE, V36, P219, DOI 10.1016/S0921-8181(02)00196-0; van Hinsbergen DJJ, 2005, PALAEOGEOGR PALAEOCL, V221, P245, DOI 10.1016/j.palaeo.2005.02.013; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; VANDERZWAAN GJ, 1990, MAR GEOL, V95, P1, DOI 10.1016/0025-3227(90)90016-D; Wamelink GWW, 2005, J VEG SCI, V16, P461, DOI 10.1111/j.1654-1103.2005.tb02386.x; WEFER G, 1991, MAR GEOL, V100, P207, DOI 10.1016/0025-3227(91)90234-U; Wright R., 1975, INITIAL REP DEEP SEA, P837; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; Ziegler M, 2010, QUATERNARY SCI REV, V29, P1481, DOI 10.1016/j.quascirev.2010.03.011	131	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188447	10.1371/journal.pone.0188447	http://dx.doi.org/10.1371/journal.pone.0188447			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166653	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300038
J	Schmid, B; Karg, K; Perner, J; Tomasello, M				Schmid, Benjamin; Karg, Katja; Perner, Josef; Tomasello, Michael			Great apes are sensitive to prior reliability of an informant in a gaze following task	PLOS ONE			English	Article							PAN-TROGLODYTES; SPECIES FOLLOW; VERVET MONKEYS; ALARM CALLS; CHIMPANZEES; ONTOGENY; SPEAKERS; WORDS; TRUST; MIND	Social animals frequently rely on information from other individuals. This can be costly in case the other individual is mistaken or even deceptive. Human infants below 4 years of age show proficiency in their reliance on differently reliable informants. They can infer the reliability of an informant from few interactions and use that assessment in later interactions with the same informant in a different context. To explore whether great apes share that ability, in our study we confronted great apes with a reliable or unreliable informant in an object choice task, to see whether that would in a subsequent task affect their gaze following behaviour in response to the same informant. In our study, prior reliability of the informant and habituation during the gaze following task affected both great apes' automatic gaze following response and their more deliberate response of gaze following behind barriers. As habituation is very context specific, it is unlikely that habituation in the reliability task affected the gaze following task. Rather it seems that apes employ a reliability tracking strategy that results in a general avoidance of additional information from an unreliable informant.	[Schmid, Benjamin; Karg, Katja; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Schmid, Benjamin; Perner, Josef] Salzburg Univ, Dept Psychol, Salzburg, Austria	Max Planck Society; Salzburg University	Schmid, B (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.; Schmid, B (corresponding author), Salzburg Univ, Dept Psychol, Salzburg, Austria.	bschmid2@gwdg.de			German Research Foundation (DFG) [RTG 2070]	German Research Foundation (DFG)(German Research Foundation (DFG))	While drafting this manuscript Benjamin Schmid was funded by the German Research Foundation (DFG) as part of the RTG 2070 "Understanding Social Relationships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank all the great apes at Leipzig Zoo who took part in our study, the keepers and research coordinators at Leipzig Zoo for their support conducting the research, Colleen Stephens for her help with the data analysis and Nazli Meltem Yucel and Sarah Eiteljorge as well as two anonymous reviewers for their very helpful comments while drafting this manuscript. This study was conducted as part of Benjamin Schmid's Master thesis at the Department of Psychology at the University of Salzburg. While drafting this manuscript Benjamin Schmid was funded by the German Research Foundation (DFG) as part of the RTG 2070 "Understanding Social Relationships".	Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; CHENEY DL, 1988, ANIM BEHAV, V36, P477, DOI 10.1016/S0003-3472(88)80018-6; Chow V, 2008, DEVELOPMENTAL SCI, V11, P761, DOI 10.1111/j.1467-7687.2008.00726.x; Clement F, 2004, MIND LANG, V19, P360, DOI 10.1111/j.0268-1064.2004.00263.x; Corriveau KH, 2013, DEV PSYCHOL, V49, P470, DOI 10.1037/a0030604; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Field A, 2013, DISCOVERING STAT USI; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Ganea PA, 2011, J EXP CHILD PSYCHOL, V109, P445, DOI 10.1016/j.jecp.2011.02.011; Jaswal VK, 2006, PSYCHOL SCI, V17, P757, DOI 10.1111/j.1467-9280.2006.01778.x; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Koenig MA, 2004, PSYCHOL SCI, V15, P694, DOI 10.1111/j.0956-7976.2004.00742.x; Nurmsoo E, 2010, REV PHILOS PSYCHOL, V1, P551, DOI 10.1007/s13164-010-0043-y; Okamoto-Barth S, 2007, PSYCHOL SCI, V18, P462, DOI 10.1111/j.1467-9280.2007.01922.x; Rakoczy H, 2009, COGNITIVE DEV, V24, P61, DOI 10.1016/j.cogdev.2008.07.004; Scofield J, 2008, COGNITIVE DEV, V23, P278, DOI 10.1016/j.cogdev.2008.01.003; SEYFARTH R, 1990, ANIM BEHAV, V40, P754, DOI 10.1016/S0003-3472(05)80704-3; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Takaoka A, 2015, ANIM COGN, V18, P475, DOI 10.1007/s10071-014-0816-2; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M, 2001, ANIM BEHAV, V61, P335, DOI 10.1006/anbe.2000.1598; von Frisch K., 1967, DANCE LANGUAGE ORIEN	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0187451	10.1371/journal.pone.0187451	http://dx.doi.org/10.1371/journal.pone.0187451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166660	Green Published, gold			2022-12-26	WOS:000416035300012
J	Zellner, A; Bockstahler, B; Peham, C				Zellner, Antonia; Bockstahler, Barbara; Peham, Christian			The effects of Kinesio Taping on the trajectory of the forelimb and the muscle activity of the Musculus brachiocephalicus and the Musculus extensor carpi radialis in horses	PLOS ONE			English	Article							CONTROLLED CROSSOVER TRIAL; HEALTHY-SUBJECTS; CLINICAL-TRIAL; STRENGTH; MOTION; TAPE; TREADMILL; RANGE; BLIND; WOMEN	Background information The present study aimed to investigate the effects of Kinesio Taping on the trajectory of the forelimb and the muscle activity of the M. brachiocephalicus and the M. extensor carpi radialis in horses. 19 horses and ponies of different breeds (body weight: 496 +/- 117 kg), gender (8 mares, 10 geldings and 3 stallions) and ages (14.9 +/- 6.9 years old) were analysed without Kinesio Tape ("no tape"), with Kinesio Tape (muscle facilitation application on both muscles of both sides, "with tape") and immediately after Kinesio Taping ("post tape") through kinematic motion analysis and surface electromyography on a treadmill at the walk (speed: 1.5 +/- 0.1 m/s) and trot (speed: 3.1 +/- 0.3 m/s). Results The results of the surface electromyography (maximum muscle activity at the walk and trot) and the kinematic motion analysis (maximum stride length and maximum height of the forelimbs flight arc at the walk and trot) showed that there were no significant differences between "no tape", "with tape" and "post tape". Conclusion To sum up, Kinesio Taping on the M. brachiocephalicus and the M. extensor carpi radialis does not affect (in a positive or negative manner) the trajectory of the forelimb or the muscle activity of the M. brachiocephalicus and the M. extensor carpi radialis in horses.	[Zellner, Antonia; Bockstahler, Barbara; Peham, Christian] Univ Vet Med, Dept Compan Anim & Horses, Movement Sci Grp, Vienna, Austria	University of Veterinary Medicine Vienna	Peham, C (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Movement Sci Grp, Vienna, Austria.	christian.peham@vetmeduni.ac.at	peham, christian/V-4488-2019; Bockstahler, Barbara/P-3152-2019	peham, christian/0000-0002-8363-5751; Bockstahler, Barbara/0000-0002-1499-5753	Austrian Science Fund [P25832]; FWF (Austrian Science Fund) [P25832]	Austrian Science Fund(Austrian Science Fund (FWF)); FWF (Austrian Science Fund)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund P25832.; The authors would like to thank the FWF (Austrian Science Fund) for funding this project (P25832).	Aktas G, 2011, ISOKINET EXERC SCI, V19, P149, DOI 10.3233/IES-2011-0408; Basset KT, 2010, NZ J PHYSIOTHERAPY, V38, P56; Buchner HHF., 1994, EQUINE VET J S, V26, P13, DOI DOI 10.1111/J.2042-3306.1994.TB04865.X; Cai C, 2016, J SCI MED SPORT, V19, P109, DOI 10.1016/j.jsams.2015.01.010; Chang HY, 2010, PHYS THER SPORT, V11, P122, DOI 10.1016/j.ptsp.2010.06.007; Cools AM, 2002, MANUAL THER, V7, P154, DOI 10.1054/math.2002.0464; Csapo R, 2015, J SCI MED SPORT, V18, P450, DOI 10.1016/j.jsams.2014.06.014; de Hoyo M, 2013, J SPORT REHABIL, V22, P53, DOI 10.1123/jsr.22.1.53; Donec V, 2013, POLISH ANN MED, V19, P98; Aguilar-Ferrandiz ME, 2013, ARCH PHYS MED REHAB, V94, P2315, DOI 10.1016/j.apmr.2013.05.016; Fratocchi G, 2013, J SCI MED SPORT, V16, P245, DOI 10.1016/j.jsams.2012.06.003; Fu TC, 2008, J SCI MED SPORT, V11, P198, DOI 10.1016/j.jsams.2007.02.011; Gomez-Soriano J, 2014, MANUAL THER, V19, P131, DOI 10.1016/j.math.2013.09.002; Gonzalez-Iglesias J, 2009, J ORTHOP SPORT PHYS, V39, P515, DOI 10.2519/jospt.2009.3072; Halseth T, 2004, J SPORT SCI MED, V3, P1; Hodson-Tole E., 2006, Equine and Comparative Exercise Physiology, V3, P61, DOI 10.1079/ECP200681; Hsu YH, 2009, J ELECTROMYOGR KINES, V19, P1092, DOI 10.1016/j.jelekin.2008.11.003; Karwacinska J., 2012, POL ANN MED, V19, P50; Kase K, 2013, CLIN THERAPEUTIC APP; Kienapfel K., 2014, J ANIMAL PHYSL ANIMA, V99, P132; Peham C, 1998, J BIOMECH, V31, P769, DOI 10.1016/S0021-9290(98)00040-2; Ramon T, 2004, EQUINE VET J, V36, P764, DOI 10.2746/0425164044848127; Robert C, 2002, EQUINE VET J, V34, P295; Shim JY, 2003, YONSEI MED J, V44, P1045, DOI 10.3349/ymj.2003.44.6.1045; Slupik A., 2007, EFFECT KINESIO TAPIN, V9, P644; Thelen MD, 2008, J ORTHOP SPORT PHYS, V38, P389, DOI 10.2519/jospt.2008.2791; Tokuriki M, 1999, Equine Vet J Suppl, P231; Tokuriki M., 1991, EQUINE EXERC PHYSL, V3, P146; Vercelli S, 2012, CLIN J SPORT MED, V22, P319, DOI 10.1097/JSM.0b013e31824c835d; Vithoulka I, 2010, ISOKINET EXERC SCI, V18, P1, DOI 10.3233/IES-2010-0352; Whelan PJ, 2003, METHODS, V30, P127, DOI 10.1016/S1046-2023(03)00074-4; Williams S, 2012, SPORTS MED, V42, P153, DOI 10.2165/11594960-000000000-00000; Zsoldos RR, 2010, EQUINE VET J, V42, P523, DOI 10.1111/j.2042-3306.2010.00230.x; Zsoldos RR, 2010, EQUINE VET J, V42, P455, DOI 10.1111/j.2042-3306.2010.00263.x	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0186371	10.1371/journal.pone.0186371	http://dx.doi.org/10.1371/journal.pone.0186371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166657	Green Submitted, Green Published, gold			2022-12-26	WOS:000416035300004
J	Giachin, G; Nepravishta, R; Mandaliti, W; Melino, S; Margon, A; Scaini, D; Mazzei, P; Piccolo, A; Legname, G; Paci, M; Leita, L				Giachin, Gabriele; Nepravishta, Ridvan; Mandaliti, Walter; Melino, Sonia; Margon, Alja; Scaini, Denis; Mazzei, Pierluigi; Piccolo, Alessandro; Legname, Giuseppe; Paci, Maurizio; Leita, Liviana			The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; NMR-SPECTROSCOPY; SECONDARY STRUCTURE; INFRARED-SPECTRA; ORGANIC-MATTER; SOIL PARTICLES; FATE; BINDING; ACID; CONFORMATION	Humic substances (HS) are the largest constituent of soil organic matter and are considered as a key component of the terrestrial ecosystem. HS may facilitate the transport of organic and inorganic molecules, as well as the sorption interactions with environmentally relevant proteins such as prions. Prions enter the environment through shedding from live hosts, facilitating a sustained incidence of animal prion diseases such as Chronic Wasting Disease and scrapie in cervid and ovine populations, respectively. Changes in prion structure upon environmental exposure may be significant as they can affect prion infectivity and disease pathology. Despite its relevance, the mechanisms of prion interaction with HS are still not completely understood. The goal of this work is to advance a structural-level picture of the encapsulation of recombinant, non-infectious, prion protein (PrP) into different natural HS. We observed that PrP precipitation upon addition of HS is mainly driven by a mechanism of "salting-out" whereby PrP molecules are rapidly removed from the solution and aggregate in insoluble adducts with humic molecules. Importantly, this process does not alter the protein folding since insoluble PrP retains its a-helical content when in complex with HS. The observed ability of HS to promote PrP insolubilization without altering its secondary structure may have potential relevance in the context of "prion ecology". These results suggest that soil organic matter interacts with prions possibly without altering the protein structures. This may facilitate prions preservation from biotic and abiotic degradation leading to their accumulation in the environment.	[Giachin, Gabriele; Legname, Giuseppe] SISSA, Dept Neurosci, Trieste, Italy; [Nepravishta, Ridvan; Mandaliti, Walter; Melino, Sonia; Paci, Maurizio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Nepravishta, Ridvan] East Anglia Univ, Sch Pharm, Norwich, Norfolk, England; [Margon, Alja; Leita, Liviana] Council Agr Res & Econ, CREA Consiglio Ric Agr & Anal Econ Agr, Gorizia, Italy; [Scaini, Denis] Univ Trieste, Life Sci Dept, Trieste, Italy; [Scaini, Denis; Legname, Giuseppe] ELETTRA Synchrotron Light Source, Trieste, Italy; [Mazzei, Pierluigi; Piccolo, Alessandro] Univ Naples Federico II, Interdept Res Ctr CERMANU, Naples, Italy; [Giachin, Gabriele] European Synchrotron Radiat Facil, Struct Biol Grp, Grenoble, France	International School for Advanced Studies (SISSA); University of Rome Tor Vergata; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Trieste; Elettra Sincrotrone Trieste; University of Naples Federico II; European Synchrotron Radiation Facility (ESRF)	Giachin, G (corresponding author), SISSA, Dept Neurosci, Trieste, Italy.; Leita, L (corresponding author), Council Agr Res & Econ, CREA Consiglio Ric Agr & Anal Econ Agr, Gorizia, Italy.; Giachin, G (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, Grenoble, France.	gabriele.giachin@esrf.fr; liviana.leita@crea.gov.it	Legname, Giuseppe/C-1723-2012; Giachin, Gabriele/AAE-2348-2020; Nepravishta, Ridvan/AAW-6615-2020; Scaini, Denis/HGU-4752-2022	Legname, Giuseppe/0000-0003-0716-4393; Giachin, Gabriele/0000-0001-7550-0307; Nepravishta, Ridvan/0000-0002-0051-762X; Mazzei, Pierluigi/0000-0002-5312-4969; Scaini, Denis/0000-0001-8398-8074; MELINO, SONIA/0000-0001-7694-5279	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies)	This work was supported by the Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Avena MJ, 2002, ENVIRON SCI TECHNOL, V36, P5100, DOI 10.1021/es025582u; Baumgarte S, 2005, MOL ECOL, V14, P2539, DOI 10.1111/j.1365-294X.2005.02592.x; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Benetti F, 2014, J MOL BIOL, V426, P3796, DOI 10.1016/j.jmb.2014.09.017; Cheng S, 2008, J MICROSC-OXFORD, V231, P384, DOI 10.1111/j.1365-2818.2008.02051.x; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Corsaro A, 2010, J BIOL REG HOMEOS AG, V24, P27; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Dobbss LB, 2010, J AGR FOOD CHEM, V58, P3681, DOI 10.1021/jf904385c; Drosos M, 2017, SCI TOTAL ENVIRON, V586, P807, DOI 10.1016/j.scitotenv.2017.02.059; Giachin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100016; Giachin G, 2013, MOLECULES, V18, P9451, DOI 10.3390/molecules18089451; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hankins NP, 2006, SEP PURIF TECHNOL, V51, P48, DOI 10.1016/j.seppur.2005.12.022; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hsu PH, 2005, GEOCHIM COSMOCHIM AC, V69, P4521, DOI 10.1016/j.gca.2005.05.005; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; IMRAN M, 2011, VIROL J, V8; Ishiguro M, 2007, COLLOID SURFACE A, V306, P29, DOI 10.1016/j.colsurfa.2006.12.024; Jacobson KH, 2013, ENVIRON SCI TECHNOL, V47, P6925, DOI 10.1021/es3045899; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Liu ZG, 2011, MICROSC MICROANAL, V17, P1015, DOI 10.1017/S1431927611012177; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Piccolo A, 2006, ANAL BIOANAL CHEM, V384, P994, DOI 10.1007/s00216-005-0254-8; Piccolo A, 2001, J IND MICROBIOL BIOT, V26, P70, DOI 10.1038/sj.jim.7000028; Piccolo A, 2001, SOIL SCI, V166, P810, DOI 10.1097/00010694-200111000-00007; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saunders SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044051; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Smejkalova D, 2008, ENVIRON SCI TECHNOL, V42, P699, DOI 10.1021/es071828p; Smith CB, 2014, SOIL BIOL BIOCHEM, V68, P309, DOI 10.1016/j.soilbio.2013.10.005; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Wang YQ, 2008, BIOPOLYMERS, V89, P895, DOI 10.1002/bip.21022; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Wyckoff AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01885; Wyckoff AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058630; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zularisam AW, 2007, DESALINATION, V212, P191, DOI 10.1016/j.desal.2006.10.010	60	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188308	10.1371/journal.pone.0188308	http://dx.doi.org/10.1371/journal.pone.0188308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161325	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000415987000043
J	Pauling, JK; Hermansson, M; Hartler, J; Christiansen, K; Gallego, SF; Peng, B; Ahrends, R; Ejsing, CS				Pauling, Josch K.; Hermansson, Martin; Hartler, Juergen; Christiansen, Klaus; Gallego, Sandra F.; Peng, Bing; Ahrends, Robert; Ejsing, Christer S.			Proposal for a common nomenclature for fragment ions in mass spectra of lipids	PLOS ONE			English	Article							OZONE-INDUCED DISSOCIATION; ELECTROSPRAY-IONIZATION; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; STRUCTURAL-CHARACTERIZATION; SHOTGUN LIPIDOMICS; FATTY-ACIDS; SPECTROMETRY; IDENTIFICATION; PHOSPHATIDYLCHOLINES	Advances in mass spectrometry-based lipidomics have in recent years prompted efforts to standardize the annotation of the vast number of lipid molecules that can be detected in biological systems. These efforts have focused on cataloguing, naming and drawing chemical structures of intact lipid molecules, but have provided no guidelines for annotation of lipid fragment ions detected using tandem and multi-stage mass spectrometry, albeit these fragment ions are mandatory for structural elucidation and high confidence lipid identification, especially in high throughput lipidomics workflows. Here we propose a nomenclature for the annotation of lipid fragment ions, describe its implementation and present a freely available web application, termed ALEX(123) lipid calculator, that can be used to query a comprehensive database featuring curated lipid fragmentation information for more than 430,000 potential lipid molecules from 47 lipid classes covering five lipid categories. We note that the nomenclature is generic, extendable to stable isotope-labeled lipid molecules and applicable to automated annotation of fragment ions detected by most contemporary lipidomics platforms, including LC-MS/MS-based routines.	[Pauling, Josch K.; Hermansson, Martin; Christiansen, Klaus; Gallego, Sandra F.; Ejsing, Christer S.] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, Odense, Denmark; [Hartler, Juergen] Graz Univ Technol, Inst Computat Biotechnol, Graz, Austria; [Hartler, Juergen] BioTechMed Graz, Omics Ctr Graz, Graz, Austria; [Peng, Bing; Ahrends, Robert] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany; [Ejsing, Christer S.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	University of Southern Denmark; Graz University of Technology; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); European Molecular Biology Laboratory (EMBL)	Ejsing, CS (corresponding author), Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, Odense, Denmark.; Ejsing, CS (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	cse@bmb.sdu.dk	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365; Ejsing, Christer S./0000-0003-4963-0276; F. Gallego, Sandra/0000-0001-7960-9860; Peng, Bing/0000-0001-5006-7041; Hartler, Jurgen/0000-0002-1095-6458	VILLUM Foundation [VKR023439]; VILLUM Center for Bioanalytical Sciences (Department of Biochemistry and Molecular Biology) [VKR023179]; Lundbeckfonden [R54-A5858]; Villum Fonden [00007292, 00007363] Funding Source: researchfish	VILLUM Foundation(Villum Fonden); VILLUM Center for Bioanalytical Sciences (Department of Biochemistry and Molecular Biology); Lundbeckfonden(Lundbeckfonden); Villum Fonden(Villum Fonden)	This work was supported by the VILLUM Foundation (VKR023439; CSE; http://villumfonden.dk), the VILLUM Center for Bioanalytical Sciences (VKR023179; Department of Biochemistry and Molecular Biology; http://Milumfonden.dk) and the Lundbeckfonden (R54-A5858; CSE; www.lundbeckfoundation com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimo L, 2015, BIOINFORMATICS, V31, P2860, DOI 10.1093/bioinformatics/btv285; Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brown SHJ, 2011, BBA-MOL CELL BIOL L, V1811, P807, DOI 10.1016/j.bbalip.2011.04.015; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Cheng CF, 2000, MASS SPECTROM REV, V19, P398; Cheng JM, 2015, ATHEROSCLEROSIS, V243, P560, DOI 10.1016/j.atherosclerosis.2015.10.022; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ecker J, 2014, PROG LIPID RES, V54, P14, DOI 10.1016/j.plipres.2014.01.002; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Gallego SF, 2017, BBA-MOL CELL BIOL L, V1862, P145, DOI 10.1016/j.bbalip.2016.10.012; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Hill EA, 1900, J AM CHEM SOC, V22, P478, DOI 10.1021/ja02046a005; Hsu FF, 2016, BIOCHIMIE, V130, P63, DOI 10.1016/j.biochi.2016.07.012; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kozlowski RL, 2015, ANAL BIOANAL CHEM, V407, P5053, DOI 10.1007/s00216-014-8430-3; Liebisch G, 2015, CLIN CHEM, V61, P1542, DOI 10.1373/clinchem.2015.244830; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Maccarone AT, 2014, J LIPID RES, V55, P1668, DOI 10.1194/jlr.M046995; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Ovcacikova M, 2016, J CHROMATOGR A, V1450, P76, DOI 10.1016/j.chroma.2016.04.082; Pham HT, 2014, ANALYST, V139, P204, DOI 10.1039/c3an01712e; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sales S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27710; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sato Y, 2013, J LIPID RES, V54, P2687, DOI 10.1194/jlr.M038075; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Tarasov K, 2014, J CLIN ENDOCR METAB, V99, pE45, DOI 10.1210/jc.2013-2559; Thomas MC, 2008, ANAL CHEM, V80, P303, DOI 10.1021/ac7017684; Triebl A, 2017, J CHROMATOGR B, V1053, P72, DOI 10.1016/j.jchromb.2017.03.027; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	59	55	55	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188394	10.1371/journal.pone.0188394	http://dx.doi.org/10.1371/journal.pone.0188394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161304	Green Published, gold			2022-12-26	WOS:000415987000048
J	Quintana-Villamandos, B; de Diego, JJG; Delgado-Martos, MJ; Munoz-Valverde, D; Soto-Montenegro, ML; Desco, M; Delgado-Baeza, E				Quintana-Villamandos, Begona; Gomez de Diego, Jose Juan; Jesus Delgado-Martos, Maria; Munoz-Valverde, David; Luisa Soto-Montenegro, Maria; Desco, Manuel; Delgado-Baeza, Emilio			Dronedarone produces early regression of myocardial remodelling in structural heart disease	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; LEFT-VENTRICULAR HYPERTROPHY; ANTIARRHYTHMIC AGENT; CARDIAC-HYPERTROPHY; NITRIC-OXIDE; AMIODARONE; METAANALYSIS; PERFORMANCE; PRESSURE; THERAPY	Background and aims Left ventricular hypertrophy (LVH) in hypertension is associated with a greater risk of sustained supraventricular/atrial arrhythmias. Dronedarone is an antiarrhythmic agent that was recently approved for the treatment of atrial fibrillation. However, its effect on early regression of LVH has not been reported. We tested the hypothesis that short-term administration of dronedarone induces early regression of LVH in spontaneously hypertensive rats (SHRs). Methods Ten-month-old male SHRs were randomly assigned to an intervention group (SHR-D), where animals received dronedarone treatment (100 mg/kg) for a period of 14 days, or to a control group (SHR) where rats were given vehicle. A third group with normotensive control rats (WKY) was also added. At the end of the treatment with dronedarone we studied the cardiac anatomy and function in all the rats using transthoracic echocardiogram, cardiac metabolism using the PET/CT study (2-deoxy-2[18F] fluoro-D-glucose) and cardiac structure by histological analysis of myocyte size and collagen content. Results The hypertensive vehicle treated SHR rats developed the classic cardiac pattern of hypertensive cardiomyopathy as expected for the experimental model, with increases in left ventricular wall thickness, a metabolic shift towards an increase in glucose use and increases in myocyte and collagen content. However, the SHR-D rats showed statistically significant lower values in comparison to SHR group for septal wall thickness, posterior wall thickness, ventricular mass, glucose myocardial uptake, size of left ventricular cardiomyocytes and collagen content. All these values obtained in SHR-D rats were similar to the values measured in the normotensive WKY control group. Conclusion The results suggest by three alternative and complementary ways ( analysis of anatomy and cardiac function, metabolism and histological structure) that dronedarone has the potential to reverse the LVH induced by arterial hypertension in the SHR model of compensated ventricular hypertrophy.	[Quintana-Villamandos, Begona] Hosp Gen Univ Gregorio Maranon, Dept Anestesiol, Madrid, Spain; [Quintana-Villamandos, Begona] Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid, Spain; [Quintana-Villamandos, Begona; Gomez de Diego, Jose Juan; Jesus Delgado-Martos, Maria; Luisa Soto-Montenegro, Maria; Desco, Manuel; Delgado-Baeza, Emilio] Inst Invest Sanitaria Gregorio Maranon, Dept Med & Cirug Expt, Madrid, Spain; [Gomez de Diego, Jose Juan] Hosp Clin San Carlos, Dept Cardiol, Madrid, Spain; [Gomez de Diego, Jose Juan] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Munoz-Valverde, David] Univ Autonoma Madrid, Dept Cirug Expt, Fac Med, Madrid, Spain; [Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Getafe, Spain; [Quintana-Villamandos, Begona] Hosp Gregorio Maranon, Dept Anaesthesiol, C Doctor Esquerdo, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Universidad Carlos III de Madrid; General University Gregorio Maranon Hospital	Quintana-Villamandos, B (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Anestesiol, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Dept Med & Cirug Expt, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Hosp Gregorio Maranon, Dept Anaesthesiol, C Doctor Esquerdo, Madrid, Spain.	begoquinti@gmail.com	Desco, Manuel/AAD-7137-2019; Soto-Montenegro, María Luisa/AFS-1781-2022	Desco, Manuel/0000-0003-0989-3231; Soto Montenegro, Maria Luisa/0000-0003-4350-4789	Spanish Health Ministry (Fondo de Investigaciones Sanitarias) [FIS 13/01261]; Fondos Feder	Spanish Health Ministry (Fondo de Investigaciones Sanitarias)(Instituto de Salud Carlos IIISpanish Government); Fondos Feder(European Commission)	This work was supported by a grant from the Spanish Health Ministry (Fondo de Investigaciones Sanitarias) under contract FIS 13/01261 and Fondos Feder.	Alexánderson Erick, 2004, Arch. Cardiol. Méx., V74, P220; Baroletti Steven, 2010, Crit Pathw Cardiol, V9, P94, DOI 10.1097/HPC.0b013e3181dda1e6; Brilla CG, 1996, HYPERTENSION, V28, P269, DOI 10.1161/01.HYP.28.2.269; Cappola TP, 2003, PHYSIOL GENOMICS, V14, P25, DOI 10.1152/physiolgenomics.00156.2002; Chatterjee S, 2014, AM J CARDIOL, V114, P1049, DOI 10.1016/j.amjcard.2014.07.015; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; Djandjighian L, 2000, J CARDIOVASC PHARM, V36, P376, DOI 10.1097/00005344-200009000-00014; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Ferreira C, 2010, CLINICS, V65, P723, DOI 10.1590/S1807-59322010000700012; FROHLICH ED, 1986, J HYPERTENS, V4, pS15; Gallego-Delgado J, 2009, HYPERTENS RES, V32, P347, DOI 10.1038/hr.2009.27; Gautier P, 2003, J CARDIOVASC PHARM, V41, P191, DOI 10.1097/00005344-200302000-00007; Guiraudou P, 2004, EUR J PHARMACOL, V496, P119, DOI 10.1016/j.ejphar.2004.05.046; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Handa N, 2007, ANN NUCL MED, V21, P569, DOI 10.1007/s12149-007-0067-2; HODEIGE D, 1995, EUR J PHARMACOL, V279, P25, DOI 10.1016/0014-2999(95)00130-D; Ishimitsu T, 2010, INT HEART J, V51, P359, DOI 10.1536/ihj.51.359; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Lee EJ, 2014, J CLIN PHARM THER, V39, P112, DOI 10.1111/jcpt.12128; Linz W, 1999, HYPERTENSION, V34, P291, DOI 10.1161/01.HYP.34.2.291; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Oyetayo OO, 2010, PHARMACOTHERAPY, V30, P904, DOI 10.1592/phco.30.9.904; Pantos C, 2002, EUR J PHARMACOL, V444, P191, DOI 10.1016/S0014-2999(02)01624-2; Pierdomenico SD, 2010, AM J HYPERTENS, V23, P876, DOI 10.1038/ajh.2010.80; Purushothaman S, 2011, MOL CELL BIOCHEM, V351, P59, DOI 10.1007/s11010-011-0711-y; Quintana-Villamandos B, 2013, LAB ANIM-UK, V47, P320, DOI 10.1177/0023677213495668; Quintana-Villamandos B, 2016, MED HYPOTHESES, V87, P44, DOI 10.1016/j.mehy.2015.12.016; Quintana-Villamandos B, 2017, CARDIOVASC PATHOL, V26, P51, DOI 10.1016/j.carpath.2016.11.002; Quintana-Villamandos B, 2013, HYPERTENS RES, V36, P408, DOI 10.1038/hr.2012.191; Reutter BW, 2011, INT J MOL IMAGING, V2011; Rosa GM, 2014, EXPERT OPIN DRUG MET, V28, P1; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Simko F, 2002, MED HYPOTHESES, V58, P11, DOI 10.1054/mehy.2001.1399; Simko F, 2010, J HYPERTENS, V28, pS1, DOI 10.1097/01.hjh.0000388487.43460.db; Simko F, 2009, J HYPERTENS, V27, pS5, DOI 10.1097/01.hjh.0000358830.95439.e8; Sobrado LF, 2013, J CARDIOVASC ELECTR, V24, P914, DOI 10.1111/jce.12155; Tadros Rafik, 2016, Card Electrophysiol Clin, V8, P453, DOI 10.1016/j.ccep.2016.02.008; Wollert Kai C, 2002, Heart Fail Rev, V7, P317, DOI 10.1023/A:1020706316429	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188442	10.1371/journal.pone.0188442	http://dx.doi.org/10.1371/journal.pone.0188442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161309	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000056
J	Singh, A; Sharma, V; Dikshit, HK; Aski, M; Kumar, H; Thirunavukkarasu, N; Patil, BS; Kumar, S; Sarker, A				Singh, Akanksha; Sharma, Vinay; Dikshit, Harsh Kumar; Aski, Muraleedhar; Kumar, Harish; Thirunavukkarasu, Nepolean; Patil, Basavanagouda S.; Kumar, Shiv; Sarker, Ashutosh			Association mapping unveils favorable alleles for grain iron and zinc concentrations in lentil (Lens culinaris subsp. culinaris)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; GENETIC-LINKAGE MAP; POPULATION-STRUCTURE; MICROSATELLITE MARKERS; TRACE-ELEMENTS; DIVERSITY; DISEQUILIBRIUM; IDENTIFICATION; SEQUENCE	Lentil is a major cool-season grain legume grown in South Asia, West Asia, and North Africa. Populations in developing countries of these regions have micronutrient deficiencies; therefore, breeding programs should focus more on improving the micronutrient content of food. In the present study, a set of 96 diverse germplasm lines were evaluated at three different locations in India to examine the variation in iron (Fe) and zinc (Zn) concentration and identify simple sequence repeat (SSR) markers that associate with the genetic variation. The genetic variation among genotypes of the association mapping (AM) panel was characterized using a genetic distance-based and a general model-based clustering method. The model-based analysis identified six subpopulations, which satisfactorily explained the genetic structure of the AM panel. AM analysis identified three SSRs (PBALC 13, PBALC 206, and GLLC 563) associated with grain Fe concentration explaining 9% to 11% of phenotypic variation and four SSRs (PBALC 353, SSR 317-1, PLC 62, and PBALC 217) were associated with grain Zn concentration explaining 14%, to 21% of phenotypic variation. These identified SSRs exhibited consistent performance across locations. These candidate SSRs can be used in marker-assisted genetic improvement for developing Fe and Zn fortified lentil varieties. Favorable alleles and promising genotypes identified in this study can be utilized for lentil biofortification.	[Singh, Akanksha; Dikshit, Harsh Kumar; Aski, Muraleedhar; Kumar, Harish; Thirunavukkarasu, Nepolean] ICAR Res Complex, Indian Agr Res Inst, Div Genet, New Delhi, India; [Singh, Akanksha; Sharma, Vinay] Banasthali Univ, Dept Biosci & Biotechnol, Banasthali, Rajasthan, India; [Kumar, Harish] Punjab Agr Univ, RRS, Faridkot, Punjab, India; [Patil, Basavanagouda S.] ICAR Res Complex, Indian Agr Res Inst, Reg Ctr, Dharwad, Karnataka, India; [Kumar, Shiv] Rabat Inst, ICARDA, Stn Expt, INRA Quich, BP 6299,Rue Hafiane Cherkaoui Agdal, Rabat, Morocco; [Sarker, Ashutosh] South Asia & China Program ICARDA, NASC Complex, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Banasthali Vidyapith; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Dikshit, HK (corresponding author), ICAR Res Complex, Indian Agr Res Inst, Div Genet, New Delhi, India.	harshgeneticsiari@gmail.com		Singh, Akanksha/0000-0001-6480-2641	ICAR-IARI in house project [CRSIARISIL2014007239]; Harvest Plus through ICARDA	ICAR-IARI in house project; Harvest Plus through ICARDA	The research work was funded through ICAR-IARI in house project CRSIARISIL2014007239 and partial funding for this work was received from Harvest Plus through ICARDA. There was no additional funding received for this study.; Authors are thankful to Director, Joint Director Research and Head, Division of Genetics, for providing the necessary facilities for research. The authors also acknowledge the partial funding support received from Harvest Plus through ICARDA for carrying out the research work.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Andeden E. E., 2013, P PLANT AN GEN C 21; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; [Anonymous], 2001, IRON DEFICIENCY ANAE; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bajait C, 2011, INDIAN J PHARMACOL, V43, P232, DOI 10.4103/0253-7613.81495; Bashir K, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00015, 10.3389/fpls.2013.00090]; Bauer P, 2004, PLANT PHYSIOL, V136, P4169, DOI 10.1104/pp.104.047233; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cubero J. I., 1981, Lentils, P15; de Benoist B, 2008, WHO GLOBAL DATABASE; Decroocq V, 2003, THEOR APPL GENET, V106, P912, DOI 10.1007/s00122-002-1158-z; Diapari M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0252-2; Diapari M, 2014, GENOME, V57, P459, DOI 10.1139/gen-2014-0108; Dikshit HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138101; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El-Haramein F.J., 2008, P 10 INT BARL GEN S; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Fageria NK, 2012, COMMUN SOIL SCI PLAN, V43, P556, DOI 10.1080/00103624.2012.639431; Fageria N. K., 2002, ADV AGRON, V77, P85; Failla ML, 2003, J NUTR, V133, p1443S, DOI 10.1093/jn/133.5.1443S; Ferguson ME, 1998, EUPHYTICA, V102, P265, DOI 10.1023/A:1018331432580; Ford R, 1997, EUPHYTICA, V96, P247, DOI 10.1023/A:1003097600701; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Gernand AD, 2016, NAT REV ENDOCRINOL, V12, P274, DOI 10.1038/nrendo.2016.37; Goldstein DB, 1999, GENETICS, V151, P797; Gorafi YSA, 2018, PLANT GENET RESOUR-C, V16, P9, DOI 10.1017/S1479262116000265; Graham Robin D., 2008, P41; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Gutierrez L, 2011, PLANT GENOME-US, V4, P256, DOI 10.3835/plantgenome2011.07.0020; Gutierrez MV, 2005, THEOR APPL GENET, V110, P1210, DOI 10.1007/s00122-005-1951-6; Gyawali S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0496-5; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jin TT, 2013, BREEDING SCI, V63, P317, DOI 10.1270/jsbbs.63.317; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Koul PM, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0683-z; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kujur A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11166; Kumar S, 2014, LEGUMES IN OMICS ERA, P111, DOI 10.1007/978-1-4614-8370-0_6; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Kushwaha UKS, 2013, INT J APPL SCI BIOTE, V1, P16; Laborda PR, 2005, THEOR APPL GENET, V111, P1288, DOI 10.1007/s00122-005-0055-7; Ladizinski D, 1984, BOT GAZ, V145, P235; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Li XP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00833; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Lim K, 2015, NUTRIENTS, V7, P2983, DOI 10.3390/nu7042983; Lou YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133054; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mallikarjuna MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139067; Mei H, 2013, PLOS ONE, V26; Mekonnen F., 2014, J AGR CROP RES, V2, P104; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Paniego N, 2002, GENOME, V45, P34, DOI 10.1139/g01-120; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; PETERSON CJ, 1986, CEREAL CHEM, V63, P183; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Pritchard JK, 2000, GENETICS, V155, P945; Racedo J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0829-x; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rahman M. M., 2009, The lentil: botany, production and uses, P121, DOI 10.1079/9781845934873.0121; Rawat N, 2009, GENET RESOUR CROP EV, V56, P53, DOI 10.1007/s10722-008-9344-8; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Saha GC, 2010, EUPHYTICA, V175, P261, DOI 10.1007/s10681-010-0187-y; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma SK, 1996, THEOR APPL GENET, V93, P751, DOI 10.1007/BF00224072; Singh D., 2005, MANUAL SOIL; Soranzo N, 1999, GENOME, V42, P158, DOI 10.1139/gen-42-1-158; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Taniguchi H, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-22; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Thavarajah D, 2009, J AGR FOOD CHEM, V57, P5413, DOI 10.1021/jf900786e; Upadhyaya H. D., 2016, SCI REP, V6; Van Inghelandt D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-56; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Wan JianMin, 2006, Acta Agronomica Sinica, V32, P455; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Wei YY, 2012, J AGR FOOD CHEM, V60, P11433, DOI 10.1021/jf3036462; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; West KP, 2012, NUTR GLOBAL HLTH DIS, P271; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; Wu YX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017271; Yamamoto T, 2001, THEOR APPL GENET, V102, P865, DOI 10.1007/s001220000524; Zhang MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094881; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zohary D, 1999, GENET RESOUR CROP EV, V46, P133, DOI 10.1023/A:1008692912820; Zoric M, 2012, GENETICA, V140, P259, DOI 10.1007/s10709-012-9677-2	124	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188296	10.1371/journal.pone.0188296	http://dx.doi.org/10.1371/journal.pone.0188296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161321	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000040
J	Hailemariam, Z; Krucken, J; Baumann, M; Ahmed, JS; Clausen, PH; Nijhof, AM				Hailemariam, Zerihun; Kruecken, Juergen; Baumann, Maximilian; Ahmed, Jabbar S.; Clausen, Peter-Henning; Nijhof, Ard M.			Molecular detection of tick-borne pathogens in cattle from Southwestern Ethiopia	PLOS ONE			English	Article							LINE BLOT HYBRIDIZATION; ANAPLASMA-PHAGOCYTOPHILUM; GENETIC DIVERSITY; IXODID TICKS; EHRLICHIA; THEILERIA; SHEEP; IDENTIFICATION; HEMOPARASITES; INFECTIONS	Tick-borne diseases (TBDs) cause significant losses among livestock and impact the livelihoods of resource-poor farming communities worldwide. In Ethiopia, detailed studies on the epidemiology of tick-borne pathogens (TBPs) in cattle using sensitive molecular detection methods are scarce. The objective of this study was to determine the prevalence and species composition of bovine TBPs of veterinary significance in local cattle populations. A comprehensive cross-sectional epidemiological study was conducted in cattle populations of Illubabor zone in Southwestern Ethiopia from June to August 2013. For this purpose, blood samples were collected from 392 cattle. A combination of polymerase chain reaction (PCR) and a Reverse Line Blot (RLB) hybridization assay was employed for the detection of TBPs in these samples. The PCR/RLB results of the 392 blood samples indicated a high overall prevalence of 96.9% for TBPs, including Theileria mutans (66.1%), Theileria orientalis (51.8%), Anaplasma sp. Omatjenne (25.5%), Anaplasma marginale (14.5%), Babesia bigemina (14.0%) and Theileria velifera (13.0%) and minor occurrences of Ehrlichia ruminantium (0.5%) and Ehrlichia minasensis (0.26%). Moreover, three novel Anaplasma genotypes were detected in bovine blood samples. A phylogenetic analysis revealed that they most likely represent three, but at least two, new species. The prevalence of the three novel Anaplasma species, preliminary designated as Anaplasma sp. Hadesa, Anaplasma sp. Saso and Anaplasma sp. Dedessa, was 12.5%, 14.3% and 5.6%, respectively. Overall, a total of 227 cattle (57.9%) were found to be co-infected with two or more TBPs simultaneously and 86 different species combinations were observed. The findings show a very high burden of infection of cattle with TBPs in Ethiopia. The high frequency of co-infections suggests that clinical manifestations might be complex. Further research is required to determine the pathogenicity, host cell types and vector of the three novel Anaplasma species identified in this study.	[Hailemariam, Zerihun; Kruecken, Juergen; Ahmed, Jabbar S.; Clausen, Peter-Henning; Nijhof, Ard M.] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Hailemariam, Zerihun] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia; [Baumann, Maximilian] Free Univ Berlin, FAO Reference Ctr Vet Publ Hlth, Berlin, Germany	Free University of Berlin; Haramaya University; Free University of Berlin	Nijhof, AM (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	ard.nijhof@fu-berlin.de	Krücken, Jürgen/B-6794-2009; Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/AAE-3133-2021	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Negasi, Zerihun Hailemariam/0000-0002-4028-4269; Nijhof, Ard/0000-0001-7373-2243	German Research Foundation (DFG) [AH 41/7-1]; German Academic Exchange Service (DAAD)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financially supported by the German Research Foundation (DFG) project AH 41/7-1 and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DM, 2014, TICKS TICK-BORNE DIS, V5, P537, DOI 10.1016/j.ttbdis.2014.03.010; ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; Baneth G, 2014, INT J PARASITOL, V44, P591, DOI 10.1016/j.ijpara.2014.03.011; Battilani M, 2017, INFECT GENET EVOL, V49, P195, DOI 10.1016/j.meegid.2017.01.021; Bekker CPJ, 2002, VET MICROBIOL, V89, P223, DOI 10.1016/S0378-1135(02)00179-7; Bhoora R, 2009, VET PARASITOL, V159, P112, DOI 10.1016/j.vetpar.2008.10.004; Butler CM, 2008, VET REC, V162, P216, DOI 10.1136/vr.162.7.216; Cabezas-Cruz A, 2016, INT J SYSTEMATIC EVO; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Chochlakis D, 2010, EMERG INFECT DIS, V16, P1031, DOI 10.3201/eid1606.090175; Cruz AC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-291; CSA, 2013, STAT B, VII; Dobbelaere D., 2002, NONTRANSFORMING THEI, P93; Dreher UM, 2005, CLIN DIAGN LAB IMMUN, V12, P1177, DOI 10.1128/CDLI.12.10.1177-1183.2005; Gachohi JM, 2010, PREV VET MED, V95, P208, DOI 10.1016/j.prevetmed.2010.03.015; Georges K, 2001, VET PARASITOL, V99, P273, DOI 10.1016/S0304-4017(01)00488-5; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Guo WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep38770; Hailemariam Z, 2017, TICKS TICK-BORNE DIS, V8, P185, DOI 10.1016/j.ttbdis.2016.10.016; Herndon DR, 2010, J BACTERIOL, V192, P379, DOI 10.1128/JB.01330-09; IZOARD, 2013, ANN REP ILL ZON OFF; Jado I, 2006, J CLIN MICROBIOL, V44, P4572, DOI 10.1128/JCM.01227-06; Kabi F, 2008, SERO PREVALENCES TIC; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kocan KM, 2015, REV SCI TECH OIE, V34, P577, DOI 10.20506/rst.34.2.2381; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumsa B, 2015, TICKS TICK-BORNE DIS, V6, P8, DOI 10.1016/j.ttbdis.2014.08.001; Kumsa B, 2014, TROP ANIM HEALTH PRO, V46, P27, DOI 10.1007/s11250-013-0442-z; Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4; Lorusso V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1504-7; Malak AK, 2012, PREV VET MED, V104, P216, DOI 10.1016/j.prevetmed.2011.12.001; Mekonnen S., 2007, ETHIOPIAN VET J, V11, P1; Mekonnen S., 1996, EPIDEMIOLOGY TICKS T; Miller M.A., P GAT COMP ENV WORKS; Nijhof AM, 2005, J CLIN MICROBIOL, V43, P5907, DOI 10.1128/JCM.43.12.5907-5911.2005; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Oura CAL, 2004, INT J PARASITOL, V34, P603, DOI 10.1016/j.ijpara.2003.12.012; Putt S., 1987, VET EPIDEMIOLOGY ECO; Schnittger L, 2004, PARASITOL RES, V92, P189, DOI 10.1007/s00436-003-0980-9; Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Teshale S, 2015, TICKS TICK-BORNE DIS, V6, P1, DOI 10.1016/j.ttbdis.2014.04.023; Theiler A, 1911, 1 DEP AGR UOSA; Toma B, 1999, APPL VET EPIDEMIOLOG; Tomassone L, 2012, EXP APPL ACAROL, V56, P391, DOI 10.1007/s10493-012-9528-y; Woolhouse MEJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400026; Yang JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1880-z	51	45	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188248	10.1371/journal.pone.0188248	http://dx.doi.org/10.1371/journal.pone.0188248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155863	Green Submitted, gold, Green Published			2022-12-26	WOS:000415756700038
J	Wullems, JA; Verschueren, SMP; Degens, H; Morse, CI; Onambele, GL				Wullems, Jorgen A.; Verschueren, Sabine M. P.; Degens, Hans; Morse, Christopher I.; Onambele, Gladys L.			Performance of thigh-mounted triaxial accelerometer algorithms in objective quantification of sedentary behaviour and physical activity in older adults	PLOS ONE			English	Article							ACTIVITY RECOGNITION; ENERGY-EXPENDITURE; CALIBRATION; WRIST; HIP; CLASSIFIERS; PREDICTION; MONITORS	Accurate monitoring of sedentary behaviour and physical activity is key to investigate their exact role in healthy ageing. To date, accelerometers using cut-off point models are most preferred for this, however, machine learning seems a highly promising future alternative. Hence, the current study compared between cut-off point and machine learning algorithms, for optimal quantification of sedentary behaviour and physical activity intensities in the elderly. Thus, in a heterogeneous sample of forty participants (aged >= 60 years, 50% female) energy expenditure during laboratory-based activities (ranging from sedentary behaviour through to moderate-to-vigorous physical activity) was estimated by indirect calorimetry, whilst wearing triaxial thigh-mounted accelerometers. Three cut-off point algorithms and a Random Forest machine learning model were developed and cross-validated using the collected data. Detailed analyses were performed to check algorithm robustness, and examine and benchmark both overall and participant-specific balanced accuracies. This revealed that the four models can at least be used to confidently monitor sedentary behaviour and moderate-to-vigorous physical activity. Nevertheless, the machine learning algorithm outperformed the cut-off point models by being robust for all individual's physiological and non-physiological characteristics and showing more performance of an acceptable level over the whole range of physical activity intensities. Therefore, we propose that Random Forest machine learning may be optimal for objective assessment of sedentary behaviour and physical activity in older adults using thigh-mounted triaxial accelerometry.	[Wullems, Jorgen A.; Morse, Christopher I.; Onambele, Gladys L.] Manchester Metropolitan Univ, Hlth Exercise & Act Living Res Ctr, Dept Exercise & Sport Sci, Crewe, England; [Wullems, Jorgen A.; Verschueren, Sabine M. P.] Katholieke Univ Leuven, Dept Rehabil Sci, Musculoskeletal Rehabil Res Grp, Leuven, Belgium; [Degens, Hans] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Degens, Hans] Lithuanian Sports Univ, Kaunas, Lithuania	Manchester Metropolitan University; KU Leuven; Manchester Metropolitan University; Lithuanian Sports University	Wullems, JA (corresponding author), Manchester Metropolitan Univ, Hlth Exercise & Act Living Res Ctr, Dept Exercise & Sport Sci, Crewe, England.; Wullems, JA (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Musculoskeletal Rehabil Res Grp, Leuven, Belgium.	jorgen.a.wullems@stu.mmu.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Morse, Christopher/AAE-7913-2022; Verschueren, Sabine/K-4213-2015	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Morse, Christopher/0000-0002-5261-2637; Degens, Hans/0000-0001-7399-4841; Wullems, Jorgen/0000-0002-4892-1349; Verschueren, Sabine/0000-0003-2592-494X	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme	This research was funded by the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme (2011-2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Attal F, 2015, SENSORS-BASEL, V15, P31314, DOI 10.3390/s151229858; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Bayat A, 2014, PROCEDIA COMPUT SCI, V34, P450, DOI 10.1016/j.procs.2014.07.009; Bedogni L, 2012, IFIP WIREL DAY; Bernmark E, 2002, APPL ERGON, V33, P541, DOI 10.1016/S0003-6870(02)00072-8; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Edwardson CL, 2016, MED SCI SPORT EXER, V48, P1085, DOI 10.1249/MSS.0000000000000865; Ellis K, 2014, FRONT PUBLIC HEALTH, P2; Ellis K, 2016, MED SCI SPORT EXER, V48, P933, DOI 10.1249/MSS.0000000000000840; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gao L, 2014, MED ENG PHYS, V36, P779, DOI 10.1016/j.medengphy.2014.02.012; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Heil DP, 2012, MED SCI SPORT EXER, V44, pS50, DOI 10.1249/MSS.0b013e3182399dcc; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Kerr J, 2016, MED SCI SPORT EXER, V48, P951, DOI 10.1249/MSS.0000000000000841; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lenz EK, 2014, INT J KINESIOL SPORT, V2, P13, DOI [10.7575/aiac.ijkss.v.2n.1p.13, DOI 10.7575/AIAC.IJKSS.V.2N.1P.13]; Liu SP, 2012, MED SCI SPORT EXER, V44, P2138, DOI 10.1249/MSS.0b013e31825e825a; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Mannini A, 2017, MED SCI SPORT EXER, V49, P801, DOI 10.1249/MSS.0000000000001144; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Onambele-Pearson GL, 2010, AGE, V32, P139, DOI 10.1007/s11357-010-9141-0; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; PROFESSIONAL M., 2004, ASSESSMENT FALLS RIS, P1; R Development CT, 2005, R LANG ENV STAT COMP; Rosenberg D, 2017, MED SCI SPORT EXER, V49, P610, DOI 10.1249/MSS.0000000000001121; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224; Ruch N, 2013, J APPL PHYSIOL, V115, P1229, DOI 10.1152/japplphysiol.01443.2012; Sasaki JE, 2016, COMPUTER ASSISTED WE, P33, DOI DOI 10.1016/B978-0-12-802075-3.00002-4; Sasaki JE, 2016, MED SCI SPORT EXER, V48, P941, DOI 10.1249/MSS.0000000000000844; Sport TE, 2015, SPORT TE, V2015; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Szanton SL, 2015, GERIATR NURS, V36, P131, DOI 10.1016/j.gerinurse.2014.12.008; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; Wullems JA, 2016, BIOGERONTOLOGY, V17, P547, DOI 10.1007/s10522-016-9640-1; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	57	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188215	10.1371/journal.pone.0188215	http://dx.doi.org/10.1371/journal.pone.0188215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155839	Green Published, gold, Green Accepted			2022-12-26	WOS:000415756700036
J	Kertesz, M; Aszalos, R; Lengyel, A; Onodi, G				Kertesz, Miklos; Aszalos, Reka; Lengyel, Attila; Onodi, Gabor			Synergistic effects of the components of global change: Increased vegetation dynamics in open, forest-steppe grasslands driven by wildfires and year-to-year precipitation differences	PLOS ONE			English	Article							CLIMATE-CHANGE; FIRE; DIVERSITY; ECOLOGY; IMPACT	Climate change and land use change are two major elements of human-induced global environmental change. In temperate grasslands and woodlands, increasing frequency of extreme weather events like droughts and increasing severity of wildfires has altered the structure and dynamics of vegetation. In this paper, we studied the impact of wildfires and the year-to-year differences in precipitation on species composition changes in semi-arid grasslands of a forest-steppe complex ecosystem which has been partially disturbed by wildfires. Particularly, we investigated both how long-term compositional dissimilarity changes and species richness are affected by year-to-year precipitation differences on burnt and unburnt areas. Study sites were located in central Hungary, in protected areas characterized by partially-burnt, juniper-poplar forest-steppe complexes of high biodiversity. Data were used from two long-term monitoring sites in the Kiskunsa A g National Park, both characterized by the same habitat complex. We investigated the variation in species composition as a function of time using distance decay methodology. In each sampling area, compositional dissimilarity increased with the time elapsed between the sampling events, and species richness differences increased with increasing precipitation differences between consecutive years. We found that both the long-term compositional dissimilarity, and the year-to-year changes in species richness were higher in the burnt areas than in the unburnt ones. The long-term compositional dissimilarities were mostly caused by perennial species, while the year-to-year changes of species richness were driven by annual and biennial species. As the effect of the year-to-year variation in precipitation was more pronounced in the burnt areas, we conclude that canopy removal by wildfires and extreme inter-annual variability of precipitation, two components of global environmental change, act in a synergistic way. They enhance the effect of one another, resulting in greater long-term and year-to-year changes in the composition of grasslands.	[Kertesz, Miklos; Aszalos, Reka; Lengyel, Attila; Onodi, Gabor] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Kertesz, Miklos] GINOP Sustainable Ecosystems Grp, MTA Ctr Ecol Res, Tihany, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Kertesz, M (corresponding author), MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary.; Kertesz, M (corresponding author), GINOP Sustainable Ecosystems Grp, MTA Ctr Ecol Res, Tihany, Hungary.	kertesz.miklos@okologia.mta.hu	Ónodi, Gábor/P-3267-2019	Ónodi, Gábor/0000-0003-4308-7997; Kertesz, Miklos/0000-0002-3565-4624	Orszagos Tudomanyos Kutatasi Alapprogramok (HU) [F5254, T29703, A08-1-2009-0051]; Nemzeti Kutatasi es Fejlesztesi Program (HU) [NKFP 3B-0008/2002, NKFP 6-0013/2005]; Sixth Framework Programme (BE) [GOCE-CT-2003-505298]; LIFE Programme (BE) [LIFE08 ENV/IT/000399]; Seventh Framework Programme (BE) [FP7-262060]; Gazdasagfejlesztesi es Innovacios Operativ Program (HU) [GINOP 2.3.3-15-2016-00019]	Orszagos Tudomanyos Kutatasi Alapprogramok (HU); Nemzeti Kutatasi es Fejlesztesi Program (HU); Sixth Framework Programme (BE); LIFE Programme (BE); Seventh Framework Programme (BE); Gazdasagfejlesztesi es Innovacios Operativ Program (HU)	Orszagos Tudomanyos Kutatasi Alapprogramok (HU) Grant Nos. F5254, T29703, and A08-1-2009-0051 funded field observation design, data acquisition, data managament, analysis, and preparing the publication. Nemzeti Kutatasi es Fejlesztesi Program (HU) Grant Nos. NKFP 3B-0008/2002 and NKFP 6-0013/2005 funded data acquisition and managament. Sixth Framework Programme (BE) GOCE-CT-2003-505298 funded data acquisition and managament. LIFE Programme (BE) Grant No. LIFE08 ENV/IT/000399 funded data acquisition and managament. Seventh Framework Programme (BE) FP7-262060 funded data acquisition and managament. Gazdasagfejlesztesi es Innovacios Operativ Program (HU) GINOP 2.3.3-15-2016-00019 funded preparing the publication.	Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bartholy J, 2007, GLOBAL PLANET CHANGE, V57, P83, DOI 10.1016/j.gloplacha.2006.11.002; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; Csecserits A, 2016, AGR ECOSYST ENVIRON, V226, P88, DOI 10.1016/j.agee.2016.03.024; Deak B, 2014, APPL ECOL ENV RES, V12, P267, DOI 10.15666/aeer/1201_267283; Dray S., 2007, R NEWS, V7, P47; Dudney J, 2017, J ECOL, V105, P484, DOI 10.1111/1365-2745.12671; Erdos L, 2014, ECOL COMPLEX, V17, P107, DOI 10.1016/j.ecocom.2013.11.004; Fekete G, 2002, ACTA ZOOL ACAD SCI H, V48, P137; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; JAMESON DA, 1962, ECOLOGY, V43, P760, DOI 10.2307/1933475; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jones SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20120; Keeley JE, 2005, DIVERS DISTRIB, V11, P525, DOI 10.1111/j.1366-9516.2005.00200.x; Knops JMH, 2006, OECOLOGIA, V150, P477, DOI 10.1007/s00442-006-0535-8; Kovacs-Lang E, 2000, PHYTOCOENOLOGIA, V30, P385; Kovacs-Lang E., 2008, KISKUN LTER LONG TER; Lett MS, 2005, AM MIDL NAT, V153, P217, DOI 10.1674/0003-0031(2005)153[0217:WPEARI]2.0.CO;2; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Molnar Z, 2003, SAND DUNES HUNGARY K; Molnar Z., 2008, KANITZIA, V16, P93; Molnar Zs, 2012, EURASIAN STEPPES ECO, V6, P209, DOI DOI 10.1007/978-94-007-3886-7_7; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Onodi G, 2014, COMMUNITY ECOL, V15, P121, DOI [10.1556/COMEC.15.2014.1.13, 10.1556/ComEc.15.2014.1.13]; Onodi G, 2008, ARID LAND RES MANAG, V22, P273, DOI 10.1080/15324980802388223; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Podani J., 2000, INTRO EXPLORATION MU; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Webb JK, 2005, COPEIA, P894, DOI 10.1643/0045-8511(2005)005[0894:CRRHQF]2.0.CO;2; WINK RL, 1973, J RANGE MANAGE, V26, P326, DOI 10.2307/3896847; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Yan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125300; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zolyomi B, 1997, INT CTR THEORETICAL, V12, P33	44	12	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188260	10.1371/journal.pone.0188260	http://dx.doi.org/10.1371/journal.pone.0188260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149208	gold, Green Accepted, Green Published			2022-12-26	WOS:000415646100033
J	Okada, R; Matsuda, S; Iida, T				Okada, Ryu; Matsuda, Shigeaki; Iida, Tetsuya			Vibrio parahaemolyticus VtrA is a membrane-bound regulator and is activated via oligomerization	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTORS; III SECRETION SYSTEM; DNA-BINDING PROTEIN; PATHOGENICITY ISLAND; SIGNAL-TRANSDUCTION; MEDIATED ACTIVATION; CHOLERAE; TOXR; IDENTIFICATION; GENE	Vibrio parahaemolyticus is a Gram-negative pathogen that causes food-borne gastroenteritis. A major virulence determinant of the organism is a type III secretion system (T3SS2) encoded on a pathogenicity island, Vp-PAI. Vp-PAI gene expression is regulated by two transcriptional regulators, VtrA and VtrB, whose N-terminal regions share homology with an OmpR-family DNA-binding domain. VtrA activates the gene expression of VtrB, which in turn activates Vp-PAI gene expression; however, the mechanism of this transcriptional activation by VtrA is not well understood. In this study, we determined that VtrA is a membrane protein with a transmembrane (TM) domain, which was required for its transcriptional regulatory activity. Although the N-terminal region of VtrA alone is insufficient for its transcriptional regulatory activity, forced oligomerization using the leucine-zipper dimerization domain of yeast GCN4 conferred transcriptional regulatory activity and a greater affinity for the promoter region of vtrB. A ToxR-based assay demonstrated that VtrA oligomerizes in vivo. We also showed that bile, a host-derived activator of VtrA, induces the oligomerization of VtrA, which requires the C-terminal domain. The promoter region of vtrB contained repetitive T-rich DNA elements, which are important for vtrB transcriptional activation and are conserved among T3SS2-possessing Vibrio species. These findings propose that VtrA is active as oligomers, which may facilitate its N-terminus binding the target DNA, thus enhancing its transcriptional regulatory activity.	[Okada, Ryu; Matsuda, Shigeaki; Iida, Tetsuya] Osaka Univ, Res Inst Microbial Dis, Dept Bacterial Infect, Suita, Osaka, Japan; [Okada, Ryu] Osaka Univ, Res Fdn Microbial Dis, Osaka, Kagawa, Japan	Osaka University; Osaka University	Matsuda, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Bacterial Infect, Suita, Osaka, Japan.	matsudas@biken.oska-u.ac.jp			Japan Society for the Promotion of Science [26460526, 17K08828]; Grants-in-Aid for Scientific Research [17K08828] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (Grant numbers 26460526 and 17K08828 to S.M.) from the Japan Society for the Promotion of Science, URL: http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ante VM, 2015, J BACTERIOL, V197, P3499, DOI 10.1128/JB.00419-15; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Dalia AB, 2014, MBIO, V5, DOI 10.1128/mBio.01028-13; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DIRITA VJ, 1991, CELL, V64, P29, DOI 10.1016/0092-8674(91)90206-E; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gauntlett JC, 2008, J BIOL CHEM, V283, P8591, DOI 10.1074/jbc.M709503200; Goss TJ, 2013, INFECT IMMUN, V81, P884, DOI 10.1128/IAI.00889-12; Goss TJ, 2010, INFECT IMMUN, V78, P4122, DOI 10.1128/IAI.00566-10; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Kodama T, 2015, CELL MICROBIOL, V17, P183, DOI 10.1111/cmi.12408; Kodama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008678; Li P, 2016, ELIFE, V5, DOI [10.7554/eLife.15718, 10.7554/elife.15718]; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Lindner E, 2014, J MOL BIOL, V426, P2942, DOI 10.1016/j.jmb.2014.06.006; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Matsuda S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002803; Miller JH., 1972, EXPT MOL GENETICS; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Okada N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-302; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Ottemann KM, 1996, J BACTERIOL, V178, P156, DOI 10.1128/jb.178.1.156-162.1996; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Tetsch L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-74; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	42	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187846	10.1371/journal.pone.0187846	http://dx.doi.org/10.1371/journal.pone.0187846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149170	gold, Green Published, Green Submitted			2022-12-26	WOS:000415646100014
J	Abu-Elsaoud, AM; Nafady, NA; Abdel-Azeem, AM				Abu-Elsaoud, Abdelghafar M.; Nafady, Nivien A.; Abdel-Azeem, Ahmed M.			Arbuscular mycorrhizal strategy for zinc mycoremediation and diminished translocation to shoots and grains in wheat	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; OLIVE TREE; FUNGI; GROWTH; SOIL; L.; PARAMETERS; TOLERANCE; DIVERSITY; TOXICITY	Mycoremediation is an on-site remediation strategy, which employs fungi to degrade or sequester contaminants from the environment. The present work focused on the bioremediation of soils contaminated with zinc by the use of a native mycorrhizal fungi (AM) called Funneliformis geosporum (Nicol. & Gerd.) Walker & SchuBler. Experiments were performed using Triticum aestivum L. cv. Gemmeza-10 at different concentrations of Zn (50, 100, 200 mg kg(-1)) and inoculated with or without F. geosporum. The results showed that the dry weight of mycorrhizal wheat increased at Zn stressed plants as compared to the non-Zn-stressed control plants. The concentrations of Zn also had an inhibitory effect on the yield of dry root and shoot of non-mycorrhizal wheat. The photosynthetic pigment fractions were significantly affected by Zn treatments and mycorrhizal inoculation, where in all treatments, the content of the photosynthetic pigment fractions decreased as the Zn concentration increased in the soil. However, the level of minerals of shoots, roots, and grains was greatly influenced by Zn-treatment and by inoculation with F. geosporum. Treatment with Zn in the soil increased Cu and Zn concentrations in the root, shoot and grains, however, other minerals (P, S, K, Ca and Fe) concentration was decreased. Inoculation of wheat with AM fungi significantly reduced the accumulation of Zn and depressed its translocation in shoots and grains of wheat. In conclusion, inoculation with a native F. geosporum-improves yields of wheat under higher levels of Zn and is possible to be applied for the improvement of zinc contaminated soil.	[Abu-Elsaoud, Abdelghafar M.; Abdel-Azeem, Ahmed M.] Suez Canal Univ, Fac Sci, Dept Bot, Ismailia, Egypt; [Nafady, Nivien A.] Assiut Univ, Fac Sci, Dept Bot & Microbiol, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University	Abu-Elsaoud, AM (corresponding author), Suez Canal Univ, Fac Sci, Dept Bot, Ismailia, Egypt.	Abuelsaoud@science.suez.edu.eg	Nafady, Nivien/ABD-3279-2020; Abdel-Azeem, Ahmed Mohamed Ahmed/I-3637-2015; Abu-Elsaoud, Abdelghafar/F-5115-2011	Abdel-Azeem, Ahmed Mohamed Ahmed/0000-0003-2897-3966; Abu-Elsaoud, Abdelghafar/0000-0002-6269-3418				ABBOTT LK, 1992, METHOD MICROBIOL, V24, P1, DOI 10.1016/S0580-9517(08)70084-9; Abdel-Azeem AM, 2007, WATER AIR SOIL POLL, V186, P233, DOI 10.1007/s11270-007-9480-3; Abdel-Azeem AM, 2015, MYCOSPHERE, V6, P228, DOI 10.5943/mycosphere/6/2/12; Al Naggar YA, 2013, HONEY BEES THEIR PRO; Al Naggar Y, 2014, TOXICOL ENVIRON CHEM, V96, P730, DOI 10.1080/02772248.2014.984496; Al-Karaki GN, 2002, J PLANT NUTR, V25, P1175, DOI 10.1081/PLN-120004381; Al-Karaki GN., 2013, DEV SOIL CLASSIFICAT, P823, DOI DOI 10.1007/978-94-007-5332-7_48; Allsopp D., 2004, INTRO BIODETERIORATI; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Awadalla AA, 1993, THESIS; Barot S, 2004, OIKOS, V106, P185, DOI 10.1111/j.0030-1299.2004.13038.x; Berruti A, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01559; Birhane E, 2012, OECOLOGIA, V169, P895, DOI 10.1007/s00442-012-2258-3; Bohm F, 2012, MOL NUTR FOOD RES, V56, P205, DOI 10.1002/mnfr.201100222; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; CHANEY RL, 1993, ZINC SOILS PLANTS, P135, DOI DOI 10.1007/978-94-011-0878-2_10; Dag A, 2009, CROP PASTURE SCI, V60, P427, DOI 10.1071/CP08143; DENNY HJ, 1987, NEW PHYTOL, V106, P525, DOI 10.1111/j.1469-8137.1987.tb00157.x; El-Sowfy DM, 1998, THESIS; Emsley J., 2011, NATURES BUILDING BLO; Ferrol N, 2002, MYCORRHIZAL TECHNOLOGY IN AGRICULTURE: FROM GENES TO BIOPRODUCTS, P113; Firmin S, 2015, SCI TOTAL ENVIRON, V527, P91, DOI 10.1016/j.scitotenv.2015.04.116; Garcia K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00337; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giasson P, 2005, REMEDIATION, V15, P113, DOI 10.1002/rem.20064; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Hough RL, 2003, SOIL USE MANAGE, V19, P19, DOI 10.1111/j.1475-2743.2003.tb00275.x; JACKSON ML, 1967, SOIL CHEM ANAL, P205, DOI DOI 10.1097/00010694-195806000-00014; Jamal A, 2002, INT J PHYTOREMEDIAT, V4, P205, DOI 10.1080/15226510208500083; Jolly YN, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-385; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Judy JD, 2014, ADV AGRON, V123, P1, DOI 10.1016/B978-0-12-420225-2.00001-7; Kaldorf M, 1999, J PLANT PHYSIOL, V154, P718, DOI 10.1016/S0176-1617(99)80250-8; Khabou W, 2014, ECOL ENG, V73, P290, DOI 10.1016/j.ecoleng.2014.09.054; Kloke A., 1980, DREI BEREICHE SYSTEM, P1117; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Lee EH, 2013, MYCOBIOLOGY, V41, P121, DOI 10.5941/MYCO.2013.41.3.121; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu H, 2015, APPL SOIL ECOL, V89, P44, DOI 10.1016/j.apsoil.2015.01.006; LONERAGAN JF, 1993, DEV PLANT SOIL SCI, V55, P119; Malekzadeh P, 2007, Pak J Biol Sci, V10, P1326, DOI 10.3923/pjbs.2007.1326.1330; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mathur N, 1995, J PLANT PHYSIOL, V147, P328, DOI 10.1016/S0176-1617(11)82161-9; Matsubara M, 2006, ENZYME MICROB TECH, V39, P1365, DOI 10.1016/j.enzmictec.2005.04.025; Mechri B, 2015, J PLANT PHYSIOL, V185, P40, DOI 10.1016/j.jplph.2015.06.015; Mohamed NA, 1990, THESIS; Morton JB, 1990, REVISED CLASSIFICATI; MYCOCALC, 2017, MYC; Navarro-Rodenas A, 2013, MOL PLANT MICROBE IN, V26, P1068, DOI 10.1094/MPMI-07-12-0178-R; Nejat N, 2016, PLANTA DANINHA, V34, P667, DOI [10.1590/S0100-83582016340400006, 10.1590/s0100-83582016340400006]; Noori A, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-016-3650-4; Nriagu J.O., 1980, ZINC ENV 1; PACOVSKY RS, 1986, PLANT SOIL, V95, P379, DOI 10.1007/BF02374618; Page AL., 1982, CHEM MICROBIOLOGICAL, V15, P99, DOI DOI 10.2134/AGRONMONOGR9.2.2ED; Panda S.K., 2005, Braz. J. Plant Physiol., V17, P95, DOI 10.1590/S1677-04202005000100008; Pellegrino E, 2015, SOIL BIOL BIOCHEM, V84, P210, DOI 10.1016/j.soilbio.2015.02.020; PFEIFFER CM, 1988, NEW PHYTOL, V108, P315, DOI 10.1111/j.1469-8137.1988.tb04168.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Piper C.S, 1947, SOIL PLANT ANAL; Rajaie M, 2009, INT J PLANT PROD, V3, P39; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Rolf Wuthrich J.D.A.Z, 2015, MICROMACHINING USING, pIV; Samreen T., 2013, ARAB J CHEM; Sanchez-Blanco MJ, 2004, J PLANT PHYSIOL, V161, P675, DOI 10.1078/0176-1617-01191; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Shafiquzzaman Siddiquee, 2015, Journal of Microbial and Biochemical Technology, V7, P384; Shao HB, 2005, COLLOID SURFACE B, V45, P7, DOI 10.1016/j.colsurfb.2005.06.016; Sharma MP, 2011, INDIAN J MICROBIOL, V51, P384, DOI 10.1007/s12088-011-0134-1; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Singh A, 2014, J CIV ENG ENV TECHNO, V1, p59 ; Singh H., 2006, FRONTMATTER MYCOREME, pi; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Soares CRFS, 2008, BIOL FERT SOILS, V44, P833, DOI 10.1007/s00374-007-0265-z; Srinivasagam Krishnakumar, 2013, African Journal of Agricultural Research, V8, P4706; Tangahu BV, 2011, INT J CHEM ENG, V2011, DOI 10.1155/2011/939161; Tchounwou Paul B, 2012, Exp Suppl, V101, P133, DOI 10.1007/978-3-7643-8340-4_6; Trappe JM, 1986, PHYSL GENETICAL ASPE, P133; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; USEPA, 1986, QUAL CRIT WAT; Varsha Mudgal, 2010, Agriculture and Biology Journal of North America, V1, P40; Vishnoi SR, 2008, ENV SCI, P1016; Walker C, 2004, MYCOLOGICAL RES, p979 ; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang FY, 2005, PLANT SOIL, V269, P225, DOI 10.1007/s11104-004-0517-8; WILLIAMS ML, 1993, NEW PHYTOL, V125, P367, DOI 10.1111/j.1469-8137.1993.tb03888.x; Wright C., 1939, SOIL ANAL HDB PHYS C; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Yang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02937-0; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yousif SA, 2015, WORLD ACAD SCI ENG T, V9, P323; Zayed M. S., 2013, Annals of Agricultural Science (Cairo), V58, P131, DOI 10.1016/j.aoas.2013.07.011; Zhu YG, 2001, ANN BOT-LONDON, V88, P941, DOI 10.1006/anbo.2001.1522	96	15	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188220	10.1371/journal.pone.0188220	http://dx.doi.org/10.1371/journal.pone.0188220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145471	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800092
J	Durand, A; Bourbon, ML; Steunou, AS; Khalfaoui-Hassani, B; Legrand, C; Guitton, A; Astier, C; Ouchane, S				Durand, Anne; Bourbon, Marie-Line; Steunou, Anne-Soisig; Khalfaoui-Hassani, Bahia; Legrand, Camille; Guitton, Audrey; Astier, Chantal; Ouchane, Soufian			Biogenesis of the bacterial cbb(3) cytochrome c oxidase: Active subcomplexes support a sequential assembly model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRADYRHIZOBIUM-JAPONICUM; TERMINAL-OXIDASES; SUBUNIT; CCOQ; ADAPTATION; EXPRESSION; INSIGHTS; PATHWAY; GROWTH; GENES	The cbb(3) oxidase has a high affinity for oxygen and is required for growth of bacteria, including pathogens, in oxygen-limited environments. However, the assembly of this oxidase is poorly understood. Most cbb(3) are composed of four subunits: the catalytic CcoN subunit, the two cytochrome c subunits (CcoO and CcoP) involved in electron transfer, and the small CcoQ subunit with an unclear function. Here, we address the role of these four subunits in cbb(3) biogenesis in the purple bacterium Rubrivivax gelatinosus. Analyses of membrane proteins from different mutants revealed the presence of active CcoNQO and CcoNO sub-complexes and also showed that the CcoP subunit is not essential for their assembly. However, CcoP was required for the oxygen reduction activity in the absence of CcoQ. We also found that CcoQ is dispensable for forming an active CcoNOP subcomplex in membranes. CcoNOP exhibited oxygen reductase activity, indicating that the cofactors (hemes b and copper for CcoN and cyto-chromes c for CcoO and CcoP) were present within the subunits. Finally, we discovered the presence of a CcoNQ subcomplex and showed that CcoN is the required anchor for the assembly of the full CcoNQOP complex. On the basis of these findings, we propose a sequential assembly model in which the CcoQ subunit is required for the early maturation step: CcoQ first associates with CcoN before the CcoNQ-CcoO interaction. CcoP associates to CcoNQO subcomplex in the late maturation step, and once the CcoNQOP complex is fully formed, CcoQ is released for degradation by the FtsH protease. This model could be conserved in other bacteria, including the pathogenic bacteria lacking the assembly factor CcoH as in R. gelatinosus.	[Durand, Anne; Bourbon, Marie-Line; Steunou, Anne-Soisig; Khalfaoui-Hassani, Bahia; Legrand, Camille; Guitton, Audrey; Astier, Chantal; Ouchane, Soufian] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France; [Khalfaoui-Hassani, Bahia] Univ Penn, Dept Biol, 433 S Univ Ave, Philadelphia, PA 19104 USA	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Pennsylvania	Durand, A; Ouchane, S (corresponding author), CNRS, I2BC, UMR9198, F-91198 Gif Sur Yvette, France.	anne.durand@i2bc.paris-saclay.fr; soufian.ouchane@i2bc.paris-saclay.fr	OUCHANE, Soufian/HHM-5430-2022; Ouchane, Soufian/ABE-2609-2020	Ouchane, Soufian/0000-0002-8161-3866; Steunou, Anne Soisig/0000-0002-0731-0226	Agence Nationale de la Recherche [BLAN06-2_147814]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant BLAN06-2_147814. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Azzouzi A, 2013, MOL MICROBIOL, V88, P339, DOI 10.1111/mmi.12188; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Colburn-Clifford J, 2010, MOL PLANT MICROBE IN, V23, P1042, DOI 10.1094/MPMI-23-8-1042; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2013, J BACTERIOL, V195, P261, DOI 10.1128/JB.01415-12; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hassani BK, 2010, J BIOL CHEM, V285, P19891, DOI 10.1074/jbc.M109.086066; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; de Bagues MPJ, 2007, INFECT IMMUN, V75, P531, DOI 10.1128/IAI.01185-06; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kohlstaedt M, 2017, BBA-BIOENERGETICS, V1858, P231, DOI 10.1016/j.bbabio.2016.12.006; Kohlstaedt M, 2016, MBIO, V7, DOI 10.1128/mBio.01921-15; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mendz GL, 2000, ARCH MICROBIOL, V174, P1, DOI 10.1007/s002030000174; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P542, DOI 10.1016/S0966-842X(00)91831-6; O'Gara JP, 1998, J BACTERIOL, V180, P4044; Oh JI, 2002, J BIOL CHEM, V277, P16220, DOI 10.1074/jbc.M200198200; Pawlik G, 2010, J BACTERIOL, V192, P6378, DOI 10.1128/JB.00988-10; Peters A, 2008, J BACTERIOL, V190, P5576, DOI 10.1128/JB.00534-08; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Zufferey R, 1998, J BIOL CHEM, V273, P6452, DOI 10.1074/jbc.273.11.6452; Zufferey R, 1997, FEBS LETT, V412, P75, DOI 10.1016/S0014-5793(97)00746-1; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	37	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					808	818		10.1074/jbc.M117.805184	http://dx.doi.org/10.1074/jbc.M117.805184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150446	hybrid, Green Published			2022-12-26	WOS:000422864500005
J	Montpas, N; St-Onge, G; Nama, N; Rhainds, D; Benredjem, B; Girard, M; Hickson, G; Pons, V; Heveker, N				Montpas, Nicolas; St-Onge, Genevieve; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Hickson, Gilles; Pons, Veronique; Heveker, Nikolaus			Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; DISTINCT CONFORMATIONS; CRYSTAL-STRUCTURE; AGONIST; INTERNALIZATION; ACTIVATION; GRADIENT; PATHWAYS; DYNAMICS	The atypical chemokine receptor ACKR3 contributes to chemotaxis by binding, internalizing, and degrading the chemokines CXCL11 and CXCL12 to shape and terminate chemotactic gradients during development and immune responses. Although unable to trigger G protein activation, both ligands activate G protein-independent ACKR3 responses and prompt arrestin recruitment. This offers a model to specifically study ligand-specific receptor conformations leading to G protein-independent signaling and to functional parameters such as receptor transport and chemokine degradation. We here show chemokine specificity in arrestin recruitment, by different effects of single amino acid substitutions in ACKR3 on arrestin in response to CXCL12 or CXCL11. Chemokine specificity in receptor transport was also observed, as CXCL11 induced faster receptor internalization, slower recycling, and longer intracellular sojourn of ACKR3 than CXCL12. Internalization and recycling rates of the ACKR3 R142(3.50)A substitution in response to each chemokine were similar; however, ACKR3 R1423.50A degraded only CXCL12 and not CXCL11. This suggests that ligand-specific intracellular receptor transport is required for chemokine degradation. Remarkably, the failure of ACKR3 R1423.50A to degrade CXCL11 was not caused by the lack of arrestin recruitment; rather, arrestin was entirely dispensable for scavenging of either chemokine. This suggests the involvement of another, yet unidentified, ACKR3 effector in scavenging. In summary, our study correlates ACKR3 ligand-specific conformational transitions with chemokine-dependent recep-tor transport dynamics and points toward unexpected ligand specificity in the mechanisms of chemokine degradation.	[Montpas, Nicolas; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Heveker, Nikolaus] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Montpas, Nicolas; St-Onge, Genevieve; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Hickson, Gilles; Heveker, Nikolaus] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Hickson, Gilles] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Pons, Veronique] Univ Toulouse, Inst Malad Metab & Cardiovasc, UMR 1048, INSERM, F-31432 Toulouse, France	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Heveker, N (corresponding author), St Justine Hosp, Dept Biochem & Mol Med, Res Ctr, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca	Nama, Nassr/J-1578-2016	Nama, Nassr/0000-0002-0199-3599; PONS, Veronique/0000-0001-5821-8481; Hickson, Gilles/0000-0001-7670-9815	Canadian Institutes of Health Research (CIHR) [MOP123421]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP123421. The authors declare that they have no conflicts of interest with the contents of this article.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Bachelerie F, 2015, BRIT J PHARMACOL, V172, P3945, DOI 10.1111/bph.13182; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benredjem B, 2017, J BIOL CHEM, V292, P31, DOI 10.1074/jbc.M116.762252; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Birdsong WT, 2013, J NEUROSCI, V33, P4118, DOI 10.1523/JNEUROSCI.4187-12.2013; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Bot G, 1998, J PHARMACOL EXP THER, V284, P283; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cabana J, 2015, J BIOL CHEM, V290, P15835, DOI 10.1074/jbc.M114.627356; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Chung KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054942; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Gustavsson M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14135; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Karin N, 2016, J LEUKOCYTE BIOL, V99, P857, DOI 10.1189/jlb.2MR0915-441R; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Valentin-Hansen L, 2015, J BIOL CHEM, V290, P24495, DOI 10.1074/jbc.M115.641944; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	63	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					893	905		10.1074/jbc.M117.814947	http://dx.doi.org/10.1074/jbc.M117.814947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180449	hybrid, Green Published			2022-12-26	WOS:000422864500011
J	Chavez, S; Eastman, G; Smircich, P; Becco, LL; Oliveira-Rizzo, C; Fort, R; Potenza, M; Garat, B; Sotelo-Silveira, JR; Duhagon, MA				Chavez, Santiago; Eastman, Guillermo; Smircich, Pablo; Becco, Lorena Lourdes; Oliveira-Rizzo, Carolina; Fort, Rafael; Potenza, Mariana; Garat, Beatriz; Sotelo-Silveira, Jose Roberto; Duhagon, Maria Ana			Transcriptome-wide analysis of the Trypanosoma cruzi proliferative cycle identifies the periodically expressed mRNAs and their multiple levels of control	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; DIFFERENTIAL GENE-EXPRESSION; CELL-CYCLE; DNA-REPLICATION; MOLECULAR-MECHANISMS; SEQUENCE; ORGANIZATION; DISCOVERY; PROTEIN; BRUCEI	Trypanosoma cruzi is the protozoan parasite causing American trypanosomiasis or Chagas disease, a neglected parasitosis with important human health impact in Latin America. The efficacy of current therapy is limited, and its toxicity is high. Since parasite proliferation is a fundamental target for rational drug design, we sought to progress into its understanding by applying a genome-wide approach. Treating a Tcl linage strain with hydroxyurea, we isolated epimastigotes in late G1, S and G2/M cell cycle stages at 70% purity. The sequencing of each phase identified 305 stage-specific transcripts (1.5-fold change, p <= 0.01), coding for conserved cell cycle regulated proteins and numerous proteins whose cell cycle dependence has not been recognized before. Comparisons with the parasite T. brucei and the human host reveal important differences. The meta-analysis of T. cruzi transcriptomic and ribonomic data indicates that cell cycle regulated mRNAs are subject to sub-cellular compartmentalization. Compositional and structural biases of these genes-including CAI, GC content, UTR length, and polycistron position-may contribute to their regulation. To discover nucleotide motifs responsible for the co-regulation of cell cycle regulated genes, we looked for overrepresented motifs at their UTRs and found a variant of the cell cycle sequence motif at the 3' UTR of most of the S and G2 stage genes. We additionally identified hairpin structures at the 5' UTRs of a high proportion of the transcripts, suggesting that periodic gene expression might also rely on translation initiation in T. cruzi. In summary, we report a comprehensive list of T. cruzi cell cycle regulated genes, including many previously unstudied proteins, we show evidence favoring a multi-step control of their expression, and we identify mRNA motifs that may mediate their regulation. Our results provide novel information of the T. cruzi proliferative proteins and the integrated levels of their gene expression control.	[Chavez, Santiago; Smircich, Pablo; Becco, Lorena Lourdes; Oliveira-Rizzo, Carolina; Fort, Rafael; Garat, Beatriz; Duhagon, Maria Ana] Univ Republica, Sch Sci, Lab Mol Interact, Montevideo, Uruguay; [Chavez, Santiago; Smircich, Pablo; Oliveira-Rizzo, Carolina; Fort, Rafael; Duhagon, Maria Ana] Univ Republica, Sch Med, Dept Genet, Montevideo, Uruguay; [Eastman, Guillermo; Sotelo-Silveira, Jose Roberto] Inst Invest Biol Clemente Estable, Dept Genom, Montevideo, Uruguay; [Potenza, Mariana] Inst Res Genet Engn & Mol Biol Dr NH Torres, Buenos Aires, DF, Argentina; [Sotelo-Silveira, Jose Roberto] Univ Republica, Sch Sci, Dept Cell & Mol Biol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Duhagon, MA (corresponding author), Univ Republica, Sch Sci, Lab Mol Interact, Montevideo, Uruguay.; Duhagon, MA (corresponding author), Univ Republica, Sch Med, Dept Genet, Montevideo, Uruguay.	mduhagon@fcien.edu.uy		Fort, Rafael Sebastian/0000-0002-0161-8860; Smircich, Pablo/0000-0002-3856-3920; Garat, Beatriz/0000-0003-2679-8244; Sotelo-Silveira, Jose Roberto/0000-0002-4758-8556; Duhagon, Maria/0000-0001-6468-1704; Chavez, Santiago/0000-0002-6312-7063	CSIC-INI, Comision Sectorial de Investigacion Cientifica; CSIC-CAP, Comision Sectorial de Investigacion Cientifica; ANII-INI, Agencia Nacional de Investigacion e Innovacion; PEDECIBA, Programa para el desarrollo de las Ciencias Basicas; CSIC-grupos, Comision Sectorial de Investigacion Cientifica	CSIC-INI, Comision Sectorial de Investigacion Cientifica; CSIC-CAP, Comision Sectorial de Investigacion Cientifica; ANII-INI, Agencia Nacional de Investigacion e Innovacion; PEDECIBA, Programa para el desarrollo de las Ciencias Basicas; CSIC-grupos, Comision Sectorial de Investigacion Cientifica	This work was supported by: 1. CSIC-INI 2013, Comision Sectorial de Investigacion Cientifica (http://www.csic.edu.uy/) (SC); 2. CSIC-CAP 2012, Comision Sectorial de Investigacion Cientifica (http://www.csic.edu.uy/) (SC); 3. ANII-INI 2011, Agencia Nacional de Investigacion e Innovacion (http://www.anii.org.uy/) (SC); 4. PEDECIBA 2011-2016, Programa para el desarrollo de las Ciencias Basicas, (http://www.pedeciba.edu.uy/biologia/); 5. CSIC-grupos 2014, Comision Sectorial de Investigacion Cientifica (http://www.csic.edu.uy/) (JRSS, BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Renzo MA, 2016, PARASITOL INT, V65, P196, DOI 10.1016/j.parint.2015.12.007; Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andersson B, 1998, GENOME RES, V8, P809, DOI 10.1101/gr.8.8.809; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Avliyakulov NK, 2003, EUKARYOT CELL, V2, P671, DOI 10.1128/EC.2.4.671-677.2003; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Brandao A, 2008, MEM I OSWALDO CRUZ, V103, P622, DOI 10.1590/S0074-02762008000600021; Bustamante JM, 2011, EXPERT OPIN DRUG DIS, V6, P653, DOI [10.1517/17460441.2011.602063, 10.1517/17460441.2011.573782]; Calderano S, 2014, MOL BIOCHEM PARASIT, V193, P110, DOI 10.1016/j.molbiopara.2014.03.004; Calderano SG, 2011, NUCLEUS-PHILA, V2, P136, DOI 10.4161/nucl.2.2.15134; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Chowdhury AR, 2008, EUKARYOT CELL, V7, P425, DOI 10.1128/EC.00369-07; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2; Cribb P, 2011, INT J PARASITOL, V41, P1149, DOI 10.1016/j.ijpara.2011.06.009; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Cura CI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003765; da Silva M.S., 2012, DNA REPLICATION MUTA; De Gaudenzi JG, 2013, PEERJ, V1, DOI 10.7717/peerj.118; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Duhagon MA, 2011, GENE, V487, P29, DOI 10.1016/j.gene.2011.07.022; Dvorak J A, 1993, Methods Mol Biol, V21, P191; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias MC, 2007, PROTIST, V158, P147, DOI 10.1016/j.protis.2006.10.002; Elias MC, 2009, FUTURE MICROBIOL, V4, P1065, DOI 10.2217/FMB.09.74; Eser Philipp, 2014, Mol Syst Biol, V10, P717, DOI 10.1002/msb.134886; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; GALANTI N, 1994, EXP CELL RES, V214, P225, DOI 10.1006/excr.1994.1252; Gomez EB, 2001, MOL BIOCHEM PARASIT, V113, P97, DOI 10.1016/S0166-6851(00)00382-0; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Grant KM, 2008, CURR PHARM DESIGN, V14, P917, DOI 10.2174/138161208784041042; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kabani S, 2010, MOL BIOCHEM PARASIT, V169, P59, DOI 10.1016/j.molbiopara.2009.08.008; Kaufmann D, 2012, BIOCHEM BIOPH RES CO, V419, P698, DOI 10.1016/j.bbrc.2012.02.082; Kelly S, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120033; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005511; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marques CA, 2016, NUCLEIC ACIDS RES, V44, P4763, DOI 10.1093/nar/gkw147; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mittra B, 2003, J BIOL CHEM, V278, P26564, DOI 10.1074/jbc.M304322200; Munoz MJ, 2006, MOL BIOCHEM PARASIT, V147, P154, DOI 10.1016/j.molbiopara.2006.02.006; Nardelli SC, 2009, CHROMOSOMA, V118, P487, DOI 10.1007/s00412-009-0213-9; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nishimoto KP, 2007, J MICROBIOL METH, V70, P205, DOI 10.1016/j.mimet.2007.03.022; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Pasion SG, 1996, MOL CELL BIOL, V16, P6724; Pastro L, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00008; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Potenza M, 2012, EXP PARASITOL, V132, P537, DOI 10.1016/j.exppara.2012.09.002; Povelones ML, 2014, MOL BIOCHEM PARASIT, V196, P53, DOI 10.1016/j.molbiopara.2014.03.008; Rajkumar AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1767-y; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Recinos RF, 2001, MOL BIOCHEM PARASIT, V113, P215, DOI 10.1016/S0166-6851(01)00214-6; Richardson GM, 2015, CYTOM PART A, V87A, P166, DOI 10.1002/cyto.a.22608; Sabaj V, 2001, J CELL BIOCHEM, V80, P617, DOI 10.1002/1097-4644(20010315)80:4&lt;617::AID-JCB1016&gt;3.0.CO;2-D; Santori MI, 2002, MOL BIOCHEM PARASIT, V121, P225, DOI 10.1016/S0166-6851(02)00039-7; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Savioli L, 2013, SUSTAINING DRIVE OVE, Vxii; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Smircich P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1563-8; Spellman PT, 2004, TRENDS BIOTECHNOL, V22, P270, DOI 10.1016/j.tibtech.2004.04.010; Stumpf CR, 2013, MOL CELL, V52, P574, DOI 10.1016/j.molcel.2013.09.018; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vindry C, 2014, BIOCHEM PHARMACOL, V89, P431, DOI 10.1016/j.bcp.2014.04.003; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhou Q, 2014, INT REV CEL MOL BIO, V308, P127, DOI 10.1016/B978-0-12-800097-7.00004-X; Zick A, 2005, NUCLEIC ACIDS RES, V33, P4235, DOI 10.1093/nar/gki742	96	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188441	10.1371/journal.pone.0188441	http://dx.doi.org/10.1371/journal.pone.0188441			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182646	Green Published, gold, Green Submitted			2022-12-26	WOS:000416402000028
J	Aoyama, R; Takano, H; Kobayashi, Y; Kitamura, M; Asai, K; Amano, Y; Kumita, S; Shimizu, W				Aoyama, Rie; Takano, Hitoshi; Kobayashi, Yasuhiro; Kitamura, Mitsunobu; Asai, Kuniya; Amano, Yasuo; Kumita, Shin-ichiro; Shimizu, Wataru			Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using F-18-fluorodeoxyglucose positron emission tomography	PLOS ONE			English	Article							ALCOHOL SEPTAL ABLATION; LATE GADOLINIUM ENHANCEMENT; OBSTRUCTIVE CARDIOMYOPATHY; MAGNETIC-RESONANCE; HEART-ASSOCIATION; TASK-FORCE; CARDIOLOGY; ISCHEMIA; DYSFUNCTION; GUIDELINES	Background The purposes of this study were to assess the usefulness of myocardial F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET)/computed tomography (CT) for evaluating myocardial metabolic status in hypertrophic cardiomyopathy (HCM) and the therapeutic efficacy of alcohol septal ablation (ASA) in hypertrophic obstructive cardiomyopathy (HOCM). Methods Thirty HCM patients (64.4 +/- 10.5 years, 14 male, 12 hypertrophic non-obstructive cardiomyopathy [HNCM], 16 HOCM, and 2 dilated phase of HCM) underwent F-18-FDG-PET/CT. (18)FFDG uptake was semi-quantitatively evaluated using an uptake score in each 17 segment and the entire LV or regional standardized uptake value (SUV). Results F-18-FDG uptake was observed mostly in a hypertrophied myocardium in HNCM patients, whereas F-18-FDG was extensively accumulated beyond the hypertrophied myocardium in HOCM patients. There was a positive correlation between the summed uptake score of (18)FFDG and high-sensitive troponin T level in HNCM patients (r = 0.603, p = 0.049), whereas the score was positively correlated with brain natriuretic peptide level (r = 0.614, p = 0.011) in HOCM patients. In 10 patients who received ASA, the maximum SUV of the entire LV was significantly reduced from 5.6 +/- 2.6 to 3.2 +/- 2.1 (p = 0.040) after ASA. Reduction of that maximum SUV was particularly significant in the lateral region (from 5.5 +/- 2.6 to 2.9 +/- 2.2, p = 0.024) but not significant in the anteroseptal region (from 4.5 +/- 2.6 to 2.9 +/- 1.6, p = 0.12). Conclusion Extensive F-18-FDG uptake beyond the hypertrophied myocardium was observed in HOCM. ASA attenuates F-18-FDG uptake in a remote lateral myocardium.	[Aoyama, Rie; Takano, Hitoshi; Kitamura, Mitsunobu; Asai, Kuniya; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan; [Kobayashi, Yasuhiro; Kumita, Shin-ichiro] Nippon Med Sch, Dept Radiol, Tokyo, Japan; [Amano, Yasuo] Nihon Univ Hosp, Dept Radiol, Tokyo, Japan; [Aoyama, Rie] Tokyo Metropolitan Geriatr Hosp, Dept Cardiol, Tokyo, Japan	Nippon Medical School; Nippon Medical School; Nihon University; Tokyo Metropolitan Institute of Gerontology	Takano, H (corresponding author), Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan.	htakano@nms.ac.jp	北村, 光信/W-4958-2019; 里恵, 青山/AAN-9000-2020	里恵, 青山/0000-0002-9944-3762; Takano, Hitoshi/0000-0002-8821-4884				Alam Mahboob, 2006, J Interv Cardiol, V19, P319; Amano Y, 2014, J COMPUT ASSIST TOMO, V38, P67, DOI 10.1097/RCT.0b013e3182a2fb01; CANNON RO, 1985, CIRCULATION, V71, P234, DOI 10.1161/01.CIR.71.2.234; Cecchi F, 2009, J CARDIOVASC TRANSL, V2, P452, DOI 10.1007/s12265-009-9142-5; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; CHEN SL, 1995, NUCL MED COMMUN, V16, P336, DOI 10.1097/00006231-199505000-00004; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; GROVERMCKAY M, 1989, J AM COLL CARDIOL, V13, P317, DOI 10.1016/0735-1097(89)90505-6; Handa N, 2007, ANN NUCL MED, V21, P569, DOI 10.1007/s12149-007-0067-2; KAGAYA Y, 1992, AM J CARDIOL, V69, P242, DOI 10.1016/0002-9149(92)91313-S; Kakoi H, 1996, CLIN CARDIOL, V19, P379, DOI 10.1002/clc.4960190510; Kitamura M, 2015, AM J CARDIOL, V116, P945, DOI 10.1016/j.amjcard.2015.06.023; Kobayashi Y, 2013, J CARDIOL, V62, P314, DOI 10.1016/j.jjcc.2013.05.004; KURATA C, 1992, J NUCL MED, V33, P6; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Nagueh SF, 2011, J AM COLL CARDIOL, V58, P2322, DOI 10.1016/j.jacc.2011.06.073; Olivotto I, 2006, J AM COLL CARDIOL, V47, P1043, DOI 10.1016/j.jacc.2005.10.050; Raphael CE, 2016, J AM COLL CARDIOL, V68, P1651, DOI 10.1016/j.jacc.2016.07.751; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Stanley William C., 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS31, DOI 10.1177/107424840400900104; Tadamura E, 1996, J NUCL MED, V37, P572; Timmer SAJ, 2011, AM J PHYSIOL-HEART C, V301, pH129, DOI 10.1152/ajpheart.00077.2011; Uehara A, 1999, ANN NUCL MED, V13, P95, DOI 10.1007/BF03164884; van Dockum WG, 2006, EUR HEART J, V27, P2833, DOI 10.1093/eurheartj/ehl358; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Villa ADM, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0223-8; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Yoshinaga K, 2007, CURR OPIN BIOTECH, V18, P52, DOI 10.1016/j.copbio.2006.11.003	33	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188479	10.1371/journal.pone.0188479	http://dx.doi.org/10.1371/journal.pone.0188479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176885	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900083
J	Baena, S; Moat, J; Whaley, O; Boyd, DS				Baena, Susana; Moat, Justin; Whaley, Oliver; Boyd, Doreen S.			Identifying species from the air: UAVs and the very high resolution challenge for plant conservation	PLOS ONE			English	Article							AERIAL VEHICLE UAV; INDIVIDUAL TREE CROWNS; REMOTELY-SENSED DATA; DELINEATION ALGORITHM; LIDAR; IMAGERY; CLASSIFICATION; BIODIVERSITY; RECOGNITION; FORESTS	The Pacific Equatorial dry forest of Northern Peru is recognised for its unique endemic biodiversity. Although highly threatened the forest provides livelihoods and ecosystem services to local communities. As agro-industrial expansion and climatic variation transform the region, close ecosystem monitoring is essential for viable adaptation strategies. UAVs offer an affordable alternative to satellites in obtaining both colour and near infrared imagery to meet the specific requirements of spatial and temporal resolution of a monitoring system. Combining this with their capacity to produce three dimensional models of the environment provides an invaluable tool for species level monitoring. Here we demonstrate that object based image analysis of very high resolution UAV images can identify and quantify keystone tree species and their health across wide heterogeneous landscapes. The analysis exposes the state of the vegetation and serves as a baseline for monitoring and adaptive implementation of community based conservation and restoration in the area.	[Baena, Susana; Moat, Justin; Whaley, Oliver] Royal Bot Gardens, Richmond, Surrey, England; [Baena, Susana; Moat, Justin; Boyd, Doreen S.] Univ Nottingham, Sch Geog, Nottingham, England	Royal Botanic Gardens, Kew; University of Nottingham	Baena, S (corresponding author), Royal Bot Gardens, Richmond, Surrey, England.; Baena, S (corresponding author), Univ Nottingham, Sch Geog, Nottingham, England.	s.baena@kew.org	Boyd, Doreen/P-9807-2019	Boyd, Doreen/0000-0003-3040-552X	UK Department of Environment, Farming and Rural Affairs (DEFRA); Bentham-Moxon trust; Geography Department at University of Nottingham; STFC [ST/P003281/1] Funding Source: UKRI	UK Department of Environment, Farming and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Bentham-Moxon trust; Geography Department at University of Nottingham; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are indebted to the sponsoring and granting organisations that have supported and contributed to our work, specifically to the UK Department of Environment, Farming and Rural Affairs (DEFRA), the Bentham-Moxon trust and the Geography Department at University of Nottingham.; Working with UAV's in Peru was very rewarding, but also can be very complex to organise without help from others. We have been privileged in working with many partners, organisations, teams and experts to achieve this. We are extremely grateful for their help and expertise, specifically, we would like to thank Mary Carmen Arteaga, Ana Maria Juarez, Amanda Cooper, Tim Wilkinson and Steve Bachman. Also we would like to thank the village of La Pena for their help, expertise, enthusiasm and hospitably. Finally we are indebted to the sponsoring and granting organisations that have supported and contributed to our work, specifically to the UK Department of Environment, Farming and Rural Affairs (DEFRA) and the Bentham-Moxon trust.	Aasen H, 2015, ISPRS J PHOTOGRAMM, V108, P245, DOI 10.1016/j.isprsjprs.2015.08.002; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Asner GP, 2005, REMOTE SENS ENVIRON, V96, P497, DOI 10.1016/j.rse.2005.04.008; Baena S, 2016, REMOTE SENS ECOL CON, V2, P95, DOI 10.1002/rse2.18; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Burnett C, 2003, ECOL MODEL, V168, P233, DOI 10.1016/S0304-3800(03)00139-X; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; CELIS AD, 1995, LOS ALGARROBOS; Chretien L, 2016, WILDL SOC B; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Colomina I, 2014, ISPRS J PHOTOGRAMM, V92, P79, DOI 10.1016/j.isprsjprs.2014.02.013; Cracknell AP, 1998, INT J REMOTE SENS, V19, P2025, DOI 10.1080/014311698214848; Dalponte M, 2013, IEEE T GEOSCI REMOTE, V51, P2632, DOI 10.1109/TGRS.2012.2216272; Dalponte M, 2012, REMOTE SENS ENVIRON, V123, P258, DOI 10.1016/j.rse.2012.03.013; Dandois JP, 2010, REMOTE SENS-BASEL, V2, P1157, DOI 10.3390/rs2041157; De Keersmaecker W, 2014, GLOBAL CHANGE BIOL, V20, P2149, DOI 10.1111/gcb.12495; Dinuls R, 2012, IEEE J-STARS, V5, P594, DOI 10.1109/JSTARS.2012.2196978; Duncanson LI, 2015, REMOTE SENS ENVIRON, V168, P102, DOI 10.1016/j.rse.2015.06.021; Duncanson LI, 2014, REMOTE SENS ENVIRON, V154, P378, DOI 10.1016/j.rse.2013.07.044; Erikson M, 2003, CAN J FOREST RES, V33, P1557, DOI [10.1139/x03-062, 10.1139/X03-062]; Fonstad MA, 2013, EARTH SURF PROC LAND, V38, P421, DOI 10.1002/esp.3366; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Fritz A, 2013, INT ARCH PHOTOGRAMM, P141; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Gong P, 1997, REMOTE SENS ENVIRON, V62, P189, DOI 10.1016/S0034-4257(97)00094-1; Guo Q, 2017, INT J REMOTE SENS, V38, P2954, DOI 10.1080/01431161.2017.1285083; Habib A, 2017, IEEE J-STARS, V10, P262, DOI 10.1109/JSTARS.2016.2520929; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Held A, 2003, INT J REMOTE SENS, V24, P2739, DOI 10.1080/0143116031000066323; Hill RA, 2005, INT J REMOTE SENS, V26, P3763, DOI 10.1080/01431160500114706; Hoffmann H., 2016, BIOGEOSCIENCES DISCU, P1, DOI [10.5194/bg-2016-316, DOI 10.5194/BG-2016-316]; Holmgren J, 2008, INT J REMOTE SENS, V29, P1537, DOI 10.1080/01431160701736471; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Honkavaara E, 2013, REMOTE SENS-BASEL, V5, P5006, DOI 10.3390/rs5105006; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Immitzer M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030166; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Jing LH, 2012, ISPRS J PHOTOGRAMM, V70, P88, DOI 10.1016/j.isprsjprs.2012.04.003; Ke YH, 2010, REMOTE SENS ENVIRON, V114, P1141, DOI 10.1016/j.rse.2010.01.002; Koch B, 2006, PHOTOGRAMM ENG REM S, V72, P357, DOI 10.14358/PERS.72.4.357; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Laliberte AS, 2010, PHOTOGRAMM ENG REM S, V76, P661, DOI 10.14358/PERS.76.6.661; Laliberte AS, 2009, IEEE T GEOSCI REMOTE, V47, P761, DOI 10.1109/TGRS.2008.2009355; Lebourgeois V, 2008, SENSORS-BASEL, V8, P7300, DOI 10.3390/s8117300; Leckie DG, 2005, REMOTE SENS ENVIRON, V94, P311, DOI 10.1016/j.rse.2004.10.011; Lee AC, 2007, REMOTE SENS ENVIRON, V111, P493, DOI 10.1016/j.rse.2007.04.018; Lerner Martínez Tina, 2003, Ecol. apl., V2, P14; Linares-Palomino R, 2010, BIODIVERS CONSERV, V19, P169, DOI 10.1007/s10531-009-9713-4; Lisein J, 2013, FORESTS, V4, P922, DOI 10.3390/f4040922; Lopez-Granados F, 2016, PRECIS AGRIC, V17, P183, DOI 10.1007/s11119-015-9415-8; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Palacios RA, 2012, PLANT SYST EVOL, V298, P165, DOI 10.1007/s00606-011-0535-y; Palumbo I, 2017, REMOTE SENS ECOL CON, V3, P21, DOI 10.1002/rse2.31; Pettorelli N, 2014, J APPL ECOL, V51, P839, DOI 10.1111/1365-2664.12261; Pouliot DA, 2005, CAN J FOREST RES, V35, P2332, DOI 10.1139/x05-145; Pu RL, 2012, REMOTE SENS ENVIRON, V124, P516, DOI 10.1016/j.rse.2012.06.011; Pu RL, 2009, INT J REMOTE SENS, V30, P2759, DOI 10.1080/01431160802555820; Chen Q, 2006, PHOTOGRAMM ENG REM S, V72, P923, DOI 10.14358/PERS.72.8.923; Reich PB, 2014, NAT GEOSCI, V7, P920, DOI [10.1038/NGEO2284, 10.1038/ngeo2284]; Rhodes CJ, 2015, METHODS ECOL EVOL, V6, P772, DOI 10.1111/2041-210X.12385; Roy DP, 2014, REMOTE SENS ENVIRON, V145, P154, DOI 10.1016/j.rse.2014.02.001; Salami E, 2014, REMOTE SENS-BASEL, V6, P11051, DOI 10.3390/rs61111051; Sawaya KE, 2003, REMOTE SENS ENVIRON, V88, P144, DOI 10.1016/j.rse.2003.04.006; Singh M, 2015, PLOS ONE, V10, P1; Smith GM, 1999, INT J REMOTE SENS, V20, P2653, DOI 10.1080/014311699211994; STRAHLER AH, 1986, REMOTE SENS ENVIRON, V20, P121, DOI 10.1016/0034-4257(86)90018-0; Su BF, 2016, INT J AGR BIOL ENG, V9, P119, DOI 10.3965/j.ijabe.20160906.2908; Sugumaran R, 2003, IEEE T GEOSCI REMOTE, V41, P1933, DOI 10.1109/TGRS.2003.815384; Suwanprasit C, 2015, INT J GEOINFORMATICS, V11; TIEDE D., 2005, P ISPRS WORKSH CMRT, P9; Torresan C, 2016, INT J REMOTE SENS, P1, DOI DOI 10.1080/01431161.2016.1252477; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2; Yu Q, 2006, PHOTOGRAMM ENG REM S, V72, P799, DOI 10.14358/PERS.72.7.799; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5; Zhang ZL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01195; Zhen Z, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040333	80	81	82	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188714	10.1371/journal.pone.0188714	http://dx.doi.org/10.1371/journal.pone.0188714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176860	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900118
J	Huber, SE; Lenz, B; Kornhuber, J; Muller, CP				Huber, Sabine E.; Lenz, Bernd; Kornhuber, Johannes; Mueller, Christian P.			Prenatal androgen-receptor activity has organizational morphological effects in mice	PLOS ONE			English	Article							PAW-PREFERENCE; DIGIT RATIOS; INTRAUTERINE POSITION; MALE RATS; ANOGENITAL DISTANCE; PLASMA TESTOSTERONE; ALCOHOL DEPENDENCE; 4TH-DIGIT RATIO; SEXUAL-BEHAVIOR; LENGTH RATIOS	Prenatal sex hormones exert organizational effects. It has been suggested that prenatal sex hormones affect adult morphological parameters, such as the finger length. Especially the second-to-fourth finger length (2D:4D) ratio has been implicated to be modified when exposed to higher androgen levels in utero. Here we show in a mouse model that experimental manipulation of the prenatal androgen level, by blocking the androgen receptor with flutamide or activating the androgen receptor with dihydrotestosterone (DHT), leads to changes in the length of the fingers of all paws in males and females. In addition to that, also total paw length and the 2D:4D ratio was affected. In males treated with DHT, the 2D:4D ratio was increased, while flutamide-treatment in females led to a reduced 2D:4D ratio. We also measured other parameters, such as head size, body length and tail length and demonstrate that body morphology is affected by prenatal androgen exposure with more prominent effects in females. Another factor that is thought to be influenced by early androgens is handedness. We tested mice for handedness, but did not find a significant effect of the prenatal treatment. These findings demonstrate that prenatal androgen activity is involved in the development of body morphology and might be a useful marker for prenatal androgen exposure.	[Huber, Sabine E.; Lenz, Bernd; Kornhuber, Johannes; Mueller, Christian P.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Clin, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg	Muller, CP (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Clin, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Christian.Mueller@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Lenz, Bernd/0000-0001-6086-0924	University Clinic Erlangen; Interdisciplinary Center for Clinical Research (IZKF) Erlangen [E22]	University Clinic Erlangen; Interdisciplinary Center for Clinical Research (IZKF) Erlangen	This research was supported by funds of the University Clinic Erlangen and by funding from the Interdisciplinary Center for Clinical Research (IZKF) Erlangen, Project E22.	ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; Auyeung B, 2013, PFLUG ARCH EUR J PHY, V465, P557, DOI 10.1007/s00424-013-1268-2; Axelson JF, 1999, HORM BEHAV, V36, P109, DOI 10.1006/hbeh.1999.1529; Bailey AA, 2005, GENES BRAIN BEHAV, V4, P318, DOI 10.1111/j.1601-183X.2004.00110.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; BARNEOUD P, 1993, P NATL ACAD SCI USA, V90, P3246, DOI 10.1073/pnas.90.8.3246; BARNEOUD P, 1994, BEHAV BRAIN RES, V62, P157, DOI 10.1016/0166-4328(94)90023-X; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Bergman K, 2010, HORM BEHAV, V57, P306, DOI 10.1016/j.yhbeh.2009.12.012; BETANCUR C, 1991, BEHAV BRAIN RES, V45, P97, DOI 10.1016/S0166-4328(05)80185-8; Branas-Garza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060419; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; BulmanFleming MB, 1997, BEHAV BRAIN RES, V86, P79, DOI 10.1016/S0166-4328(96)02249-8; Casto JM, 2003, PHYSIOL BEHAV, V79, P633, DOI 10.1016/S0031-9384(03)00120-3; Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012; CLEMENS LG, 1978, HORM BEHAV, V10, P40, DOI 10.1016/0018-506X(78)90023-5; COLLINS RL, 1975, SCIENCE, V187, P181, DOI 10.1126/science.1111097; COLLINS RL, 1969, J HERED, V60, P117, DOI 10.1093/oxfordjournals.jhered.a107951; COLLINS RL, 1968, J HERED, V59, P9, DOI 10.1093/oxfordjournals.jhered.a107656; COLLINS RL, 1985, CEREBRAL LATERALIZAT, P41; Darnai G, 2016, NEUROSCI LETT, V615, P33, DOI 10.1016/j.neulet.2015.12.056; EHRHARDT AA, 1979, ANNU REV MED, V30, P417, DOI 10.1146/annurev.me.30.020179.002221; Ellingson JM, 2013, ALCOHOL CLIN EXP RES, V37, P868, DOI 10.1111/acer.12035; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Filova B, 2013, CELLS TISSUES ORGANS, V197, P169, DOI 10.1159/000345567; Fink B, 2004, BIOL PSYCHOL, V67, P375, DOI 10.1016/j.biopsycho.2004.03.012; Fink B, 2006, BRAIN COGNITION, V61, P211, DOI 10.1016/j.bandc.2006.01.001; GIBORI G, 1981, BIOL REPROD, V24, P249, DOI 10.1095/biolreprod24.2.249; Goy R. W., 1980, SEXUAL DIFFERENTIATI; Hodosy J, 2012, PHARMACOL BIOCHEM BE, V102, P191, DOI 10.1016/j.pbb.2012.04.005; HOUTSMULLER EJ, 1995, PHYSIOL BEHAV, V57, P495, DOI 10.1016/0031-9384(94)00291-C; Hurd PL, 2008, ARCH SEX BEHAV, V37, P9, DOI 10.1007/s10508-007-9259-z; Jackson C, 2008, LATERALITY, V13, P34, DOI 10.1080/13576500701692507; KINSLEY C, 1986, HORM BEHAV, V20, P7, DOI 10.1016/0018-506X(86)90025-5; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019332; Lenz B, 2012, J NEURAL TRANSM, V119, P1561, DOI 10.1007/s00702-012-0907-7; Lenz B, 2012, PROG NEUROBIOL, V96, P136, DOI 10.1016/j.pneurobio.2011.11.001; Lilley T, 2009, BEHAV ECOL SOCIOBIOL, V63, P1539, DOI 10.1007/s00265-009-0784-8; Manning JT, 2006, ANN HUM BIOL, V33, P480, DOI 10.1080/03014460600802551; Manning JT, 2005, ARCH SEX BEHAV, V34, P329, DOI 10.1007/s10508-005-3121-y; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Martel MM, 2008, BEHAV NEUROSCI, V122, P273, DOI 10.1037/0735-7044.122.2.273; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Mitsui T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146849; NERI R, 1972, ENDOCRINOLOGY, V91, P427, DOI 10.1210/endo-91-2-427; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; QUADAGNO DM, 1987, PHYSIOL BEHAV, V41, P639, DOI 10.1016/0031-9384(87)90323-4; Ramsey PH, 1993, APPL ANAL VARIANCE B, P25; Rhees RW, 1997, DEV NEUROSCI-BASEL, V19, P430, DOI 10.1159/000111240; Ribeiro AS, 2011, ANIM BEHAV, V81, P249, DOI 10.1016/j.anbehav.2010.10.014; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1980, SCIENCE, V208, P597, DOI 10.1126/science.7367881; Sanchez A, 2014, LEARN INDIVID DIFFER, V36, P110, DOI 10.1016/j.lindif.2014.10.001; SIGNORE P, 1991, PHYSIOL BEHAV, V49, P701, DOI 10.1016/0031-9384(91)90305-8; Sperling W, 2000, ALCOHOL ALCOHOLISM, V35, P394, DOI 10.1093/alcalc/35.4.394; Sperling W, 2010, ALCOHOL ALCOHOLISM, V45, P237, DOI 10.1093/alcalc/agq014; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Tapp AL, 2011, HORM BEHAV, V60, P713, DOI 10.1016/j.yhbeh.2011.08.011; Van Dongen S, 2009, ANN HUM BIOL, V36, P186, DOI 10.1080/03014460802691182; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Yan RHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005801; Yan RHY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003216; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	66	28	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188752	10.1371/journal.pone.0188752	http://dx.doi.org/10.1371/journal.pone.0188752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176856	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900120
J	Talk, A; Anton-Mendez, I; Pennefather, B				Talk, Andrew; Anton-Mendez, Ines; Pennefather, Bronte			Graded expression of source memory revealed by analysis of gaze direction	PLOS ONE			English	Article							DUAL-PROCESS MODEL; EPISODIC MEMORY; STRATEGIC REGULATION; PREFRONTAL CORTEX; BRAIN ACTIVITY; RECOLLECTION; RECOGNITION; FAMILIARITY; RETRIEVAL; ITEM	During source memory studies, knowledge of some detail about the context of a previously experienced item or event is tested. Here, participants attended to different objects presented at different quadrants on a screen. In a later test phase, a single object was presented in all four quadrants, and participants verbally reported whether the object was new or previously seen (item recognition), and if it was previously seen, they indicated the original screen location (source memory). We combined this test with eye-tracking to determine whether attention to an object during encoding would correlate with later recognition of the object and memory of its source location, and whether eye movements at test can reveal attention to the correct source location in the absence of correct explicit verbal responses. The amount of time spent looking at an object during encoding was not related to later object recognition or source recollection. However, we found that eye movements at test reveal retention of source information about an object in the absence of accurate retrieval of source information as assessed by verbal response. When participants correctly recognized an object but incorrectly indicated the source information, significantly more time was spent looking at the correct source location than to incorrect, non-selected locations. Moreover, when participants correctly recognized an object but said they could not remember the source information, significantly more time was spent looking at the correct source location. These results are consistent with the hypothesis that eye movements are sensitive to attention or other graded mental processes which can underlie the retrieval of source memories that can then be expressed verbally in a thresholded manner.	[Talk, Andrew; Pennefather, Bronte] Univ New England, Sch Behav Cognit & Social Sci, Discipline Psychol, Armidale, NSW, Australia; [Anton-Mendez, Ines] Univ New England, Sch Behav Cognit & Social Sci, Discipline Linguist, Armidale, NSW, Australia	University of New England; University of New England	Talk, A (corresponding author), Univ New England, Sch Behav Cognit & Social Sci, Discipline Psychol, Armidale, NSW, Australia.; Anton-Mendez, I (corresponding author), Univ New England, Sch Behav Cognit & Social Sci, Discipline Linguist, Armidale, NSW, Australia.	atalk@une.edu.au; iantonm2@une.edu.au	Anton-Mendez, Ines/L-4013-2019	Anton-Mendez, Ines/0000-0003-1237-8126				Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates MD, 2014, J EDUC BEHAV STAT, V39, P524, DOI 10.3102/1076998614559420; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Cansino S, 2015, BRAIN RES, V1618, P168, DOI 10.1016/j.brainres.2015.05.032; Cansino S, 2009, INT J PSYCHOPHYSIOL, V71, P64, DOI 10.1016/j.ijpsycho.2008.07.005; Cheke LG, 2015, J EXP CHILD PSYCHOL, V137, P164, DOI 10.1016/j.jecp.2015.03.006; Clarke ADF, 2017, Q J EXP PSYCHOL, V70, P2251, DOI 10.1080/17470218.2016.1231208; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; Danker JF, 1991, CEREBRAL CORTEX NEW; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Doerksen S, 2001, EMOTION, V1, P5, DOI 10.1037/1528-3542.1.1.5; Glisky EL, 2001, J EXP PSYCHOL LEARN, V27, P1131, DOI 10.1037//0278-7393.27.5.1131; Goldsmith M, 2005, J MEM LANG, V52, P505, DOI 10.1016/j.jml.2005.01.010; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hayne H, 2011, DEV PSYCHOBIOL, V53, P317, DOI 10.1002/dev.20527; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Jeye BM, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030037; Johnson JD, 2009, NEURON, V63, P697, DOI 10.1016/j.neuron.2009.08.011; Johnson MK, 2005, PSYCHOL AGING, V20, P529, DOI 10.1037/0882-7974.20.3.529; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Kuhl BA, 2014, J NEUROSCI, V34, P8051, DOI 10.1523/JNEUROSCI.4328-13.2014; Kuznetsova A, 2015, FOOD QUAL PREFER, V40, P31, DOI 10.1016/j.foodqual.2014.08.004; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mawdsley M, 2014, J SLEEP RES, V23, P538, DOI 10.1111/jsr.12149; Mickes L, 2009, PSYCHOL SCI, V20, P509, DOI 10.1111/j.1467-9280.2009.02324.x; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Murray JG, 2015, NEUROIMAGE, V120, P298, DOI 10.1016/j.neuroimage.2015.06.069; Onyper SV, 2010, J EXP PSYCHOL GEN, V139, P341, DOI 10.1037/a0018926; Parnell R, 2012, BEHAV BRAIN RES, V232, P77, DOI 10.1016/j.bbr.2012.03.040; R Core Team, 2021, R LANGUAGE ENV STAT; Rolls ET, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00074; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Slotnick SD, 2013, NEUROREPORT, V24, P663, DOI 10.1097/WNR.0b013e328362e47e; Slotnick SD, 2013, NEUROREPORT, V24, P265, DOI 10.1097/WNR.0b013e32835f282d; Slotnick SD, 2005, MEM COGNITION, V33, P151, DOI 10.3758/BF03195305; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Troyer AK, 1999, NEUROPSYCHOLOGY, V13, P467, DOI 10.1037/0894-4105.13.4.467; Weber FD, 2014, LEARN MEMORY, V21, P190, DOI 10.1101/lm.033530.113; Wing EA, 2015, J COGNITIVE NEUROSCI, V27, P679, DOI 10.1162/jocn_a_00740; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Wixted JT, 2010, PSYCHOL REV, V117, P1025, DOI 10.1037/a0020874; Yonelinas AP, 2010, HIPPOCAMPUS, V20, P1178, DOI 10.1002/hipo.20864; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188727	10.1371/journal.pone.0188727	http://dx.doi.org/10.1371/journal.pone.0188727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176901	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900119
J	Ding, WQ; Liu, TR; Liang, JG; Hu, TB; Cui, SY; Zou, GR; Cai, WW; Yang, AK				Ding, Weiquan; Liu, Tianrun; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei; Yang, Ankui			Supraglottic squamous cell carcinomas have distinctive clinical features and prognosis based on subregion	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; LARYNGEAL-CANCER; RADIOTHERAPY; SURVIVAL; NECK; HEAD	Objective To analyze the clinicopathologic characteristics and prognosis of patients with squamous cell carcinoma localized to different supraglottic subregions. Methods Clinicopathologic data were reviewed retrospectively for 111 patients with supraglottic squamous cell carcinoma who were diagnosed between January 1, 1995 and December 31, 2005 and were initially treated with surgery. DNA from human papillomavirus (HPV) 16 and (or/and) HPV 18 were detected in all the 111 supraglottic carcinoma specimens using in situ hybridization. Survival analysis was performed by Kaplan-Meier analysis, factors were compared using log-rank test, and prognostic factors were determined using Cox proportional hazards model. The relationship between subregions and clinicopathologic factors was analyzed using Chi-square tests. Results HPV prevalence differed between patients with aryepiglottic fold carcinoma and ventricle carcinoma (P < .05). The local-regional control rates, overall survival rates or cancer specific survival rates were significantly different between different subregions. Univariate analysis indicated that pTNM classification, pN spread, and subregion were associated with prognosis (P < .05). Multivariate analysis indicated that pTNM classification and subregion were associated with supraglottic carcinoma prognosis. The survival rate was better for patients with carcinoma of the epiglottis or ventricular bands compared to those with carcinoma in the aryepiglottic fold or ventricle (P =.012). Conclusions Subregion may be a new prognostic factor for supraglottic squamous cell carcinoma. Different supraglottic carcinoma subregions have distinct clinical features such as HPV expression, lymph node metastasis rate, local-regional control and prognosis. Therefore, it is necessary to subdivide supraglottic squamous cell carcinomas into several subregion groups to individualize therapy.	[Ding, Weiquan; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei] Panyu Cent Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Ding, Weiquan; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei] Canc Inst Panyu, Guangzhou, Guangdong, Peoples R China; [Liu, Tianrun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ankui] Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ankui] State Key Lab Southern China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liang, JG (corresponding author), Panyu Cent Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China.; Liang, JG (corresponding author), Canc Inst Panyu, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), State Key Lab Southern China, Guangzhou, Guangdong, Peoples R China.	liangjiamgang111@163.com; yangak@sysucc.org.cn			National Natural Science Foundation of China [81272955, 81302368]; Guangdong Province Natural Science Foundation [2015A030313058, 2014A020212100]; Guangdong Province Science and technology Foundation [2011B031800313040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and technology Foundation	This study was supported by the National Natural Science Foundation of China (grant numbers 81272955 and 81302368) to Ankui Yang, the Guangdong Province Natural Science Foundation (grant number 2015A030313058) to Tianrun Liu and (grant number 2014A020212100) to Ankui Yang, and the Guangdong Province Science and technology Foundation (grant number 2011B031800313040) to Tianrun Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 1996, EUR J CANCER, V32A, P783, DOI 10.1016/0959-8049(95)00628-1; Boffetta P, 1997, AM J EPIDEMIOL, V145, P1100; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P1489, DOI 10.1002/hed.21113; Jin YT, 1998, CANCER, V82, P2159, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2159::AID-CNCR10>3.3.CO;2-H; Jones TM, 2016, J LARYNGOL OTOL, V130, pS75, DOI 10.1017/S0022215116000487; Koirala Krishna, 2015, Asian Pac J Cancer Prev, V16, P6541; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Mor N, 2015, OTOLARYNG CLIN N AM, V48, P533, DOI 10.1016/j.otc.2015.04.002; Morshed K, 2010, J MED VIROL, V82, P1017, DOI 10.1002/jmv.21749; Mourad WF, 2013, ONKOLOGIE, V36, P433, DOI 10.1159/000353750; Peller M, 2016, EUR ARCH OTO-RHINO-L, V273, P1481, DOI 10.1007/s00405-016-3922-8; Peretti G, 2016, CURR OPIN OTOLARYNGO, V24, P135, DOI 10.1097/MOO.0000000000000240; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Raitiola H, 2000, Auris Nasus Larynx, V27, P153, DOI 10.1016/S0385-8146(99)00072-3; Santos CR, 1998, ANN OTO RHINOL LARYN, V107, P697; Smee RI, 2013, HEAD NECK-J SCI SPEC, V35, P949, DOI 10.1002/hed.23061; Subspecialty Group of Head and Neck Surgery Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2014, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V49, P620; Vlachtsis K, 2005, EUR ARCH OTO-RHINO-L, V262, P890, DOI 10.1007/s00405-005-0916-3	19	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188322	10.1371/journal.pone.0188322	http://dx.doi.org/10.1371/journal.pone.0188322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155864	Green Published, Green Submitted, gold			2022-12-26	WOS:000415756700046
J	Subarnbhesaj, A; Miyauchi, M; Chanbora, C; Mikuriya, A; Nguyen, PT; Furusho, H; Ayuningtyas, NF; Fujita, M; Toratani, S; Takechi, M; Niida, S; Takata, T				Subarnbhesaj, Ajiravudh; Miyauchi, Mutsumi; Chanbora, Chea; Mikuriya, Aki; Phuong Thao Nguyen; Furusho, Hisako; Ayuningtyas, Nurina Febriyanti; Fujita, Minoru; Toratani, Shigeaki; Takechi, Masaaki; Niida, Shumpei; Takata, Takashi			Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; FACTOR VEGF; BONE-RESORPTION; FACTOR RECEPTOR-1; BREAST-CANCER; EXPRESSION; ANGIOGENESIS; SYSTEM; RANKL	Background Vascular endothelial growth factor (VEGF) is a highly specific signaling protein for vascular endothelial cells that plays a critical role in tumor growth and invasion through angiogenesis, and may contribute to cell migration and activation of pre-osteoclasts, osteoclasts and some tumor cells. Objectives We aimed to clarify the detailed roles of VEGF-Flt-1 signaling in bone invasion of oral squamous cell carcinoma (OSCC) cells. Results Forty-two (42) of 54 cases with gingival SCC (77.8%) strongly expressed VEGF, and had a significantly increased number of Flt-1+ osteoclasts (p<0.01) and more aggressive bone invasion (p<0.05). PlGF, a ligand of Flt-1, induced osteoclastogenesis in single culture of bone marrow cells (BMCs), and inhibition of Flt-1-signaling by VEGF tyrosine kinase inhibitor and It's down stream (Akt and ERK1/2) inhibitos reduced osteoclastogenesis in PlGF-stimulated BMCs (p<0.01). In molecular level, PlGF stimulation significantly upregulated RANKL expression in Flt-1-expressing HSC2 cells via phosphorylation of Akt and ERK1/2. In the co-culture of VEGF-producing HSC2 cells and BMCs, number of TRAP-positive osteoclasts markedly increased (p<0.01). The osteoclastogenesis was significantly inhibited by RANKL-neutralizing antibody (p<0.01) as well as by VEGF tyrosine kinase inhibitor (p<0.01) and it's downstream (Akt and ERK1/2) inhibitors (p<0.01, p<0.05, respectively). Conclusion VEGF-Flt-1 signaling induces osteoclastogenesis in OSCC through two possible ways: 1) VEGF produced from OSCC cells can directly stimulate the Flt-1 pathway in preosteoclasts to induce migration to future bone resorbing area and differentiation into osteoclasts, and 2) VEGF-Flt-1 signaling upregulates RANKL expression in OSCC cells, which indirectly leads to osteoclast differentiation. Therefore, blocking of the VEGF-Flt-1 signaling may help inhibit bone invasion of OSCC.	[Subarnbhesaj, Ajiravudh; Miyauchi, Mutsumi; Chanbora, Chea; Mikuriya, Aki; Furusho, Hisako; Ayuningtyas, Nurina Febriyanti; Takata, Takashi] Hiroshima Univ, Dept Oral & Maxillofacial Pathobiol, Sch Biomed & Hlth Sci, Hiroshima, Japan; [Phuong Thao Nguyen] Hiroshima Univ, Dept Global Dent Med & Pharm Ho Chi Minh city, Integrated Hlth Sci, Sch Biomed & Hlth Sci, Hiroshima, Japan; [Fujita, Minoru] Hiroshima Univ, Dept Oral & Maxillofacial Radiol, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Toratani, Shigeaki] Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Takechi, Masaaki] Hiroshima Univ, Dept Oral & Maxillofacial Surg, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Biobank, Med Genome Ctr, Obu, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; National Center for Geriatrics & Gerontology	Miyauchi, M; Takata, T (corresponding author), Hiroshima Univ, Dept Oral & Maxillofacial Pathobiol, Sch Biomed & Hlth Sci, Hiroshima, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Nguyen, Thao/AAH-7394-2019; Furusho, Hisako/H-2351-2019; Miyauchi, Mutsumi/G-5268-2019	Nguyen, Thao/0000-0003-4651-5168; Ayuningtyas, Nurina Febriyanti/0000-0003-4403-6542	Ministry of Education, Science and Culture [21249088]; Grants-in-Aid for Scientific Research [15K11251] Funding Source: KAKEN	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for scientific research (A) from the Ministry of Education, Science and Culture (#21249088 [T. T.]).	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; [Anonymous], 2009, UICC TNM CLASSIFICAT, V7th; Attar E, 2010, ORAL ONCOL, V46, P591, DOI 10.1016/j.oraloncology.2010.05.002; Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Brown JS, 2002, HEAD NECK-J SCI SPEC, V24, P370, DOI 10.1002/hed.10062; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Deyama Y, 2008, ONCOL REP, V20, P663, DOI 10.3892/or_00000057; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Friedrich RE, 2010, ANTICANCER RES, V30, P1765; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Guan H, 2009, ONCOL RES, V18, P117, DOI 10.3727/096504009789954627; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harry Lorraine E., 2003, Birth Defects Research, V69, P363, DOI 10.1002/bdrc.10024; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jordan RC, 1997, CAN DENT ASS, V63, P517; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Margaritescu C, 2009, ROM J MORPHOL EMBRYO, V50, P527; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; MINKIN C, 1991, BONE MINER, V13, P191, DOI 10.1016/0169-6009(91)90068-B; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Nakai T, 2009, MOL MED REP, V2, P229, DOI 10.3892/mmr_00000088; Nakayama T, 2011, BONE, V49, P1331, DOI 10.1016/j.bone.2011.09.045; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pianka A, 2015, J ORAL MAXIL SURG, V73, P897, DOI 10.1016/j.joms.2014.12.030; Salvi V, 2016, ONCOTARGET, V7, P39256, DOI 10.18632/oncotarget.9684; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Stinga AC, 2011, ROM J MORPHOL EMBRYO, V52, P1269; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wei SC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-39; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Wong RJ, 2000, LARYNGOSCOPE, V110, P65, DOI 10.1097/00005537-200001000-00013; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187092	10.1371/journal.pone.0187092	http://dx.doi.org/10.1371/journal.pone.0187092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149180	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100006
J	Yindom, LM; Mendy, M; Bodimeade, C; Chambion, C; Aka, P; Whittle, HC; Rowland-Jones, SL; Walton, R				Yindom, Louis-Marie; Mendy, Maimuna; Bodimeade, Christopher; Chambion, Caroline; Aka, Peter; Whittle, Hilton C.; Rowland-Jones, Sarah L.; Walton, Robert			KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; KILLER-CELL RECEPTOR; C-VIRUS-INFECTION; HLA CLASS-I; HEPATOCELLULAR-CARCINOMA; NATURAL-KILLER; LIVER-CANCER; WEST-AFRICA; AFLATOXIN EXPOSURE; GENE-CLUSTER	Background Hepatocellular carcinoma (HCC) causes over 800,000 deaths worldwide annually, mainly in low income countries, and incidence is rising rapidly in the developed world with the spread of hepatitis B (HBV) and C (HCV) viruses. Natural Killer (NK) cells protect against viral infections and tumours by killing abnormal cells recognised by Killer-cell Immunoglobulin-like Receptors (KIR). Thus genes and haplotypes encoding these receptors may be important in determining both outcome of initial hepatitis infection and subsequent chronic liver disease and tumour formation. HBV is highly prevalent in The Gambia and the commonest cause of liver disease. The Gambia Liver Cancer Study was a matched case-control study conducted between September 1997 and January 2001 where cases with liver disease were identified in three tertiary referral hospitals and matched with out-patient controls with no clinical evidence of liver disease. Methods We typed 15 KIR genes using the polymerase chain reaction with sequence specific primers (PCR-SSP) in 279 adult Gambians, 136 with liver disease (HCC or Cirrhosis) and 143 matched controls. We investigated effects of KIR genotypes and haplotypes on HBV infection and associations with cirrhosis and HCC. Results Homozygosity for KIR group A gene-content haplotype was associated with HBsAg carriage (OR 3.7, 95% CI 1.4-10.0) whilst telomeric A genotype (t-AA) was associated with reduced risk of e antigenaemia (OR 0.2, 95% CI 0.0-0.6) and lower viral loads (mean log viral load 5.2 vs. 6.9, p(c) = 0.022). One novel telomeric B genotype (t-ABx2) containing KIR3DS1 (which is rare in West Africa) was also linked to e antigenaemia (OR 8.8, 95% CI 1.3-60.5). There were no associations with cirrhosis or HCC. Conclusion Certain KIR profiles may promote clearance of hepatitis B surface antigen whilst others predispose to e antigen carriage and high viral load. Larger studies are necessary to quantify the effects of individual KIR genes, haplotypes and KIR/HLA combinations on long-term viral carriage and risk of liver cancer. KIR status could potentially inform antiviral therapy and identify those at increased risk of complications for enhanced surveillance.	[Yindom, Louis-Marie; Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Yindom, Louis-Marie; Mendy, Maimuna; Bodimeade, Christopher; Chambion, Caroline; Aka, Peter; Whittle, Hilton C.; Rowland-Jones, Sarah L.] Med Res Council UK, Fajara, Gambia; [Mendy, Maimuna] Int Agcy Res Canc, Lyon, France; [Aka, Peter] ICF Int, Demog & Hlth Surveys, Rockville, MD USA; [Whittle, Hilton C.] London Sch Hyg & Trop Med, London, England; [Walton, Robert] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Walton, Robert] Queen Mary Univ, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of London; Queen Mary University London	Yindom, LM (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Yindom, LM (corresponding author), Med Res Council UK, Fajara, Gambia.	louis-marie.yindom@ndm.ox.ac.uk	Mendy, Maimuna/ABD-5038-2021	Bodimeade, Christopher/0000-0002-0607-3062; Walton, Robert/0000-0001-7700-1907; Yindom, Louis-Marie/0000-0001-8078-7146	Medical Research Council (UK); WHO's International Agency for Research on Cancer (IARC); National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA) [N02CP40521]; MRC [MC_U190085854, MC_U190092710, MC_U190081977] Funding Source: UKRI; Medical Research Council [MC_U190092710, MC_U190081977, MC_U190085854] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10076] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WHO's International Agency for Research on Cancer (IARC); National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Medical Research Council (UK), WHO's International Agency for Research on Cancer (IARC) and the National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA) (Contract #N02CP40521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ICF International is currently paying PA salaries, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Faruque, 2008, Prev Chronic Dis, V5, pA74; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Chen YY, 2006, CELL MOL IMMUNOL, V3, P373; CHUANG WL, 1990, CANCER, V65, P926, DOI 10.1002/1097-0142(19900215)65:4<926::AID-CNCR2820650418>3.0.CO;2-U; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Di Bona D, 2017, J VIRAL HEPAT; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao XJ, 2010, CLIN IMMUNOL, V137, P139, DOI 10.1016/j.clim.2010.05.011; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Grebely J, 2007, CAN J GASTROENTEROL, V21, P447, DOI 10.1155/2007/796325; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kirk GD, 2005, ONCOGENE, V24, P5858, DOI 10.1038/sj.onc.1208732; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kovacic MB, 2005, CANCER EPIDEM BIOMAR, V14, P2673, DOI 10.1158/1055-9965.EPI-05-0229; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lemoine M, 2017, J HEPATOL, V66, P645, DOI 10.1016/j.jhep.2016.10.013; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Vazquez A, 2007, TISSUE ANTIGENS, V69, P241, DOI 10.1111/j.1399-0039.2006.77341.x; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2005, CURR OPIN IMMUNOL, V17, P510, DOI 10.1016/j.coi.2005.07.012; Maxwell LD, 2004, HUM IMMUNOL, V65, P613, DOI 10.1016/j.humimm.2004.02.028; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Pan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025682; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Taketomi A, 1998, CANCER, V83, P58, DOI 10.1002/(SICI)1097-0142(19980701)83:1<58::AID-CNCR8>3.0.CO;2-A; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Thons C, 2017, J HEPATOL; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yindom LM, 2012, TISSUE ANTIGENS, V79, P104, DOI 10.1111/j.1399-0039.2011.01818.x; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhi-Ming L, 2007, CROAT MED J, V48, P800, DOI 10.3325/cmj.2007.6.800	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188307	10.1371/journal.pone.0188307	http://dx.doi.org/10.1371/journal.pone.0188307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149205	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000415646100036
J	Hori, A; Nishida, T; Takashiba, S; Kubota, S; Takigawa, M				Hori, Ayaka; Nishida, Takashi; Takashiba, Shogo; Kubota, Satoshi; Takigawa, Masaharu			Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT2A and 5-HT2B receptors in chondrocytes	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; PROTEIN-KINASE-C; GENE-PRODUCT; DIFFERENTIATION; PROLIFERATION; CTGF/HCS24; P38; CHONDROGENESIS; REGENERATION; EXPRESSION	Serotonin (5-hydroxytryptamine: 5-HT) is recognized as a neurotransmitter in the central nerve system and as a regulator of systemic blood pressure in the peripheral tissues. Recently, it was reported that 5-HT2 receptors (5-HT(2)Rs) were expressed in cartilage tissues lacking both vessels and neurons, suggesting possible novel functions of 5-HT during cartilage development and regeneration. Our previous data indicated that CCN family protein 2/connective tissue growth factor (CCN2/CTGF) plays a central role in cartilage development and regeneration. Therefore, the aim of this study was to investigate the effect of 5-HT on the production of CCN2 in chondrocytes. Firstly, we showed that the mRNAs of 5-HT2R subtypes 5-HT2AR and 5-HT2BR, were expressed in a human chondrocytic cell line, HCS-2/8; however, 5-HT2CR mRNA was not detected. In addition, exogenously added 5-HT did not affect the 5-HT2AR and 5-HT2BR expressions. Next, we demonstrated that CCN2 production was increased by treatment with a 5-HT2AR agonist and the combination of 5-HT and 5-HT2BR antagonist. In contrast, treatment with a 5-HT2BR agonist and the combination of 5-HT and 5-HT2AR antagonist decreased CCN2 production. Furthermore, we showed that phosphorylation of Akt and p38 MAPK were increased by treatment with 5-HT2AR agonist, and that phosphorylation of PKC epsilon, PKC zeta, ERK1/2 and JNK were increased by treatment with 5-HT2BR agonist. Finally, we found that 5-HT2AR was localized in the growth plate, whereas 5-HT2BR was localized in the articular cartilage. These findings suggest that 5-HT promotes CCN2 production through the 5-HT2AR in growth plates, and that it represses CCN2 production through the 5-HT2BR in articular cartilage for harmonized development of long bones.	[Hori, Ayaka; Nishida, Takashi; Kubota, Satoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan; [Hori, Ayaka; Takashiba, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama, Japan; [Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Dent Sch, Adv Res Ctr Oral & Craniofacial Sci, Okayama, Japan	Okayama University; Okayama University; Okayama University	Nishida, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan.	tnishida@md.okayama-u.ac.jp	Takashiba, Shogo/C-9830-2010	Takashiba, Shogo/0000-0002-4712-6829	Japan Society for the Promotion of Sciences [JP26462810, JP15H05014, JP17K19757]; Takeda Science Foundation	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the programs Grants-in-Aid for Scientific Research (C) to TN (#JP26462810) and (B) to MT (#JP15H05014) and Challenging Research (Exploratory) to MT (#JP17K19757) from Japan Society for the Promotion of Sciences, and by a grant from the Takeda Science Foundation to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2008, PROG NEURO-PSYCHOPH, V32, P1879, DOI 10.1016/j.pnpbp.2008.08.020; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bhasin N, 2004, ANAT EMBRYOL, V208, P135, DOI 10.1007/s00429-004-0380-7; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chabbi-Achengli Y, 2016, AM J PATHOL, V186, P927, DOI 10.1016/j.ajpath.2015.11.018; Chang JZC, 2013, CLIN ORAL INVEST, V17, P455, DOI 10.1007/s00784-012-0713-5; CHOI B, 1995, BIOCHEM BIOPH RES CO, V216, P1034, DOI 10.1006/bbrc.1995.2724; Di Matteo V, 1998, NEUROPHARMACOLOGY, V37, P265, DOI 10.1016/S0028-3908(98)00014-8; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Hansen M, 2014, ACS CHEM NEUROSCI, V5, P243, DOI 10.1021/cn400216u; Harmon JL, 2016, J PHARMACOL EXP THER, V357, P1, DOI 10.1124/jpet.115.228395; Itoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071156; Iwamoto-Enomoto M, 1992, BIOL REGULATION CHON, P321; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P233, DOI 10.1016/S0028-3908(96)00171-2; KILLAM AL, 1990, J PHARMACOL EXP THER, V252, P1083; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maginnis MS, 2010, J VIROL, V84, P9677, DOI 10.1128/JVI.00978-10; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Nishida T, 2017, OSTEOARTHR CARTILAGE, V25, P759, DOI 10.1016/j.joca.2016.10.003; Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Perbal B, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P1, DOI 10.1142/9781860946899; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Takigawa M, 2017, METHODS MOL BIOL, V1489, P1, DOI 10.1007/978-1-4939-6430-7; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yosimichi G, 2006, BONE, V38, P853, DOI 10.1016/j.bone.2005.11.016	40	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188014	10.1371/journal.pone.0188014	http://dx.doi.org/10.1371/journal.pone.0188014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145495	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800049
J	Ruiz-Remolina, L; Ollauri-Ibanez, C; Perez-Roque, L; Nunez-Gomez, E; Perez-Barriocanal, F; Lopez-Novoa, JM; Pericacho, M; Rodriguez-Barbero, A				Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia			Circulating soluble endoglin modifies the inflammatory response in mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; SUPPRESSES TUMOR-GROWTH; ACUTE KIDNEY INJURY; VASCULAR-PERMEABILITY; PREECLAMPSIA; RECEPTOR; ATHEROSCLEROSIS; ANGIOGENESIS; CYTOKINES	Inflammation is associated with every health condition, and is an important component of many pathologies such as cardiovascular diseases. Circulating levels of soluble endoglin have been shown to be higher in the serum of patients with cardiovascular diseases with a significant inflammatory component. The aim of this study was to evaluate the implication of circulating soluble endoglin in the inflammatory response. For this purpose, a transgenic mouse expressing human soluble endoglin (sEng+) was employed, and three different inflammatory approaches were used to mimic inflammatory conditions in different tissues. This study shows that control sEng+ mice have a normal inflammatory state. The lung and kidney injury induced by the inflammatory agents was reduced in sEng+ mice, especially the intra-alveolar and kidney infiltrates, suggesting a possible reduction in inflammation induced by soluble endoglin. To deepen into this possible effect, the leukocyte number in the bronchoalveolar lavage and air pouch lavage was evaluated and a significant reduction of neutrophil infiltration in LPS-treated lungs and ischemic kidneys from sEng+ with respect to WT mice was observed. Additionally, the mechanisms through which soluble endoglin prevents inflammation were studied. We found that in sEng+ animals the increment of proinflammatory cytokines, TNF alpha, IL1 beta and IL6, induced by the inflammatory stimulus was reduced. Soluble endoglin also prevents the augmented adhesion molecules, ICAM, VCAM and E-selectin induced by the inflammatory stimulus. In addition, vascular permeability increased by inflammatory agents was also reduced by soluble endoglin. These results suggest that soluble endoglin modulates inflammatory-related diseases and open new perspectives leading to the development of novel and targeted approaches for the prevention and treatment of cardiovascular diseases.	[Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia] Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain; [Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain	University of Salamanca	Rodriguez-Barbero, A (corresponding author), Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain.; Rodriguez-Barbero, A (corresponding author), Biomed Res Inst Salamanca IBSAL, Salamanca, Spain.	barberoa@usal.es	Pericacho, Miguel/H-1786-2016; Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Ollauri-Ibáñez, Claudia/D-3817-2018	Pericacho, Miguel/0000-0003-0226-482X; Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Ollauri-Ibáñez, Claudia/0000-0002-7319-4913	Ministerio de Economia y Competitividad of Spain [SAF2013-45784-R]; Junta de Castilla y Leon [GR-100]; Sociedad Espanola de Nefrologia (SENEFRO); Fundacion Renal Inigo Alvarez de Toledo; Kidney Research Network (REDINREN) an initiative of Institute de Salud Carlos III [RD06/0016/0013, RD12/0021/0032]; FEDER; Ministerio de Economia y Competitividad of Spain; Junta de Castilla y Leon; Fondo Social Europeo	Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Sociedad Espanola de Nefrologia (SENEFRO); Fundacion Renal Inigo Alvarez de Toledo; Kidney Research Network (REDINREN) an initiative of Institute de Salud Carlos III; FEDER(European Commission); Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The studies carried out by the authors have been supported by grants from the Ministerio de Economia y Competitividad of Spain (SAF2013-45784-R to ARB), the Junta de Castilla y Leon (Grant No GR-100 to JMLN), Sociedad Espanola de Nefrologia (SENEFRO to ARB), Fundacion Renal Inigo Alvarez de Toledo to JMLN, and Kidney Research Network (REDINREN, grants RD06/0016/0013 and RD12/0021/0032 to JMLN) an initiative of Institute de Salud Carlos III, co-funded by FEDER. C Ollauri-Ibanez and E Nunez-Gomez are supported by a fellowship from the Ministerio de Economia y Competitividad of Spain. L Perez-Roque is supported by Junta de Castilla y Leon and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ANDRAS S, 2010, BMC IMMUNOL, V11; Blaha M, 2008, ATHEROSCLEROSIS, V197, P264, DOI 10.1016/j.atherosclerosis.2007.04.022; Blann AD, 1996, ATHEROSCLEROSIS, V120, P221, DOI 10.1016/0021-9150(95)05713-7; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101925; Claesson-Welsh L, 2015, UPSALA J MED SCI, V120, P135, DOI 10.3109/03009734.2015.1064501; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Cruz-Gonzalez I, 2008, J CELL MOL MED, V12, P955, DOI 10.1111/j.1582-4934.2008.00156.x; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Djurovic S, 2002, BJOG-INT J OBSTET GY, V109, P759, DOI 10.1111/j.1471-0528.2002.01330.x; Durymanov M, 2017, J CONTROL RELEASE, V261, P10, DOI 10.1016/j.jconrel.2017.06.013; GREER IA, 1994, OBSTET GYNECOL, V84, P937; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayakawa S, 2000, J REPROD IMMUNOL, V47, P121, DOI 10.1016/S0165-0378(00)00053-X; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ikemoto T, 2012, HEART VESSELS, V27, P344, DOI 10.1007/s00380-011-0163-z; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jang Young-Saeng, 2014, Immune Netw, V14, P237, DOI 10.4110/in.2014.14.5.237; Jezkova K, 2016, J VASC RES, V53, P149, DOI 10.1159/000448996; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kapur NK, 2010, AM J CARDIOL, V106, P1770, DOI 10.1016/j.amjcard.2010.08.018; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lyall F, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P20; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Malek M, 2015, J RENAL INJ PREV, V4, P20, DOI 10.12861/jrip.2015.06; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mihu D, 2015, TAIWAN J OBSTET GYNE, V54, P160, DOI 10.1016/j.tjog.2014.03.006; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Nemeckova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119665; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Pericacho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054687; Pessler F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2435; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CW, 1988, LANCET LOND ENGL, P1; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rossi E, 2013, BLOOD, P121; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Schneiders J, 2015, BRAIN BEHAV IMMUN, V48, P147, DOI 10.1016/j.bbi.2015.03.008; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Solak Y, 2016, HYPERTENS RES, V39, P567, DOI 10.1038/hr.2016.35; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; ULICH TR, 1991, AM J PATHOL, V138, P1485; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; Varejckova M, 2017, LIFE SCI, V175, P52, DOI 10.1016/j.lfs.2017.03.014; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	67	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188204	10.1371/journal.pone.0188204	http://dx.doi.org/10.1371/journal.pone.0188204			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145462	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800088
J	Smith, DR; Stanley, CM; Foss, T; Boles, RG; McKernan, K				Smith, Douglas R.; Stanley, Christine M.; Foss, Theodore; Boles, Richard G.; McKernan, Kevin			Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans	PLOS ONE			English	Article							RECEPTOR 1 GENE; CANNABIS DEPENDENCE SYMPTOMS; IRRITABLE-BOWEL-SYNDROME; CLINVAR PUBLIC ARCHIVE; DNA-SEQUENCING DATA; MICROGLIAL CELLS; CB2 RECEPTOR; DISORDERS; POLYMORPHISMS; MIGRAINE	Rare genetic variants in the core endocannabinoid system genes CNR1, CNR2, DAGLA, MGLL and FAAH were identified in molecular testing data from 6,032 patients with a broad spectrum of neurological disorders. The variants were evaluated for association with phenotypes similar to those observed in the orthologous gene knockouts in mice. Heterozygous rare coding variants in CNR1, which encodes the type 1 cannabinoid receptor (CB1), were found to be significantly associated with pain sensitivity (especially migraine), sleep and memory disorders D alone or in combination with anxiety D compared to a set of controls without such CNR1 variants. Similarly, heterozygous rare variants in DAGLA, which encodes diacylglycerol lipase alpha, were found to be significantly associated with seizures and neurodevelopmental disorders, including autism and abnormalities of brain morphology, compared to controls. Rare variants in MGLL, FAAH and CNR2 were not associated with any neurological phenotypes in the patients tested. Diacylglycerol lipase alpha synthesizes the endocannabinoid 2-AG in the brain, which interacts with CB1 receptors. The phenotypes associated with rare CNR1 variants are reminiscent of those implicated in the theory of clinical endocannabinoid deficiency syndrome. The severe phenotypes associated with rare DAGLA variants underscore the critical role of rapid 2-AG synthesis and the endocannabinoid system in regulating neurological function and development. Mapping of the variants to the 3D structure of the type 1 cannabinoid receptor, or primary structure of diacylglycerol lipase alpha, reveals clustering of variants in certain structural regions and is consistent with impacts to function.	[Smith, Douglas R.; Stanley, Christine M.; Foss, Theodore; Boles, Richard G.; McKernan, Kevin] Courtagen Life Sci Inc, Woburn, MA 01801 USA; [Stanley, Christine M.; Foss, Theodore] Wuxi Nextcode, Cambridge, MA USA; [Boles, Richard G.] Mitochondrial & Mol Med, Pasadena, CA USA; [McKernan, Kevin] Med Genom Corp, Woburn, MA USA		Smith, DR (corresponding author), Courtagen Life Sci Inc, Woburn, MA 01801 USA.	drclsmith@comcast.net			Courtagen Life Sciences, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Courtagen Life Sciences, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Courtagen Life Sciences, Inc. We thank Josee Dupuis for advice on the statistical analysis, and Ethan Russo and Anne Conyers-Hom for helpful comments on the manuscript.	Agrawal A, 2009, AM J MED GENET B, V150B, P736, DOI 10.1002/ajmg.b.30881; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Basavarajappa BS, 2007, PROTEIN PEPTIDE LETT, V14, P237, DOI 10.2174/092986607780090829; Bilkei-Gorzo A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.009; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Boles RG, 2015, MITOCHONDRION; Bow EW, 2016, PERSPECT MED CHEM, V8, DOI 10.4137/PMC.S32171; Cabral GA, 2015, HANDB EXP PHARMACOL, V231, P185, DOI 10.1007/978-3-319-20825-1_6; Camilleri M, 2013, AM J PHYSIOL-GASTR L, V304, pG553, DOI 10.1152/ajpgi.00376.2012; Carey CE, 2015, J ABNORM PSYCHOL, V124, P860, DOI 10.1037/abn0000079; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke TK, 2013, ADDICT BIOL, V18, P702, DOI 10.1111/j.1369-1600.2011.00346.x; de Miguel-Yanes JM, 2011, OBESITY, V19, P2031, DOI 10.1038/oby.2011.135; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Hartman CA, 2009, DRUG ALCOHOL DEPEN, V104, P11, DOI 10.1016/j.drugalcdep.2009.01.022; Herman AI, 2006, AM J MED GENET B, V141B, P499, DOI 10.1002/ajmg.b.30325; Hu SSJ, 2015, HANDB EXP PHARMACOL, V231, P59, DOI 10.1007/978-3-319-20825-1_3; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Ibsen MS, 2017, CANNABIS CANNABINOID, V2, P48, DOI 10.1089/can.2016.0037; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Juhasz G, 2009, NEUROSCI LETT, V461, P116, DOI 10.1016/j.neulet.2009.06.021; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Keimpema E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02093; Khajehali E, 2015, MOL PHARMACOL, V88, P368, DOI 10.1124/mol.115.099192; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee SH, 2015, J NEUROSCI, V35, P10039, DOI 10.1523/JNEUROSCI.4112-14.2015; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li  H., 2014, BIOINFORMATICS; Lieb W, 2009, OBESITY, V17, P755, DOI 10.1038/oby.2008.608; Litvin Y, 2013, GENES BRAIN BEHAV, V12, P479, DOI 10.1111/gbb.12045; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Long LE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-87; Lowin T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0743-x; Lu AT, 2008, AM J MED GENET B, V147B, P1488, DOI 10.1002/ajmg.b.30693; Maldonado R, 2016, PAIN, V157, pS23, DOI 10.1097/j.pain.0000000000000428; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Martella A, 2016, FASEB J, V30, P4275, DOI 10.1096/fj.201600602R; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096492; McKernan KJ, 2013, NAT BIOTECHNOL, V31, P884, DOI 10.1038/nbt.2703; Melroy-Greif WE, 2016, DRUG ALCOHOL DEPEN, V166, P249, DOI 10.1016/j.drugalcdep.2016.06.021; Pava MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152473; Pertwee RG, 2015, HANDB EXP PHARMACOL, V231, P1, DOI 10.1007/978-3-319-20825-1_1; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Proudnikov D, 2010, PHARMACOGENOMICS J, V10, P232, DOI 10.1038/tpj.2009.59; Pyszniak M, 2016, ONCOTARGETS THER, V9, P4323, DOI 10.2147/OTT.S106944; Ramirez-Franco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088594; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Rhyne DN, 2016, PHARMACOTHERAPY, V36, P505, DOI 10.1002/phar.1673; Riant F, 2010, NEUROLOGY, V75, P967, DOI 10.1212/WNL.0b013e3181f25e8f; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Rimmerman N, 2011, CELL MOL NEUROBIOL, V31, P921, DOI 10.1007/s10571-011-9692-3; Russo EB, 2008, NEUROENDOCRINOL LETT, V29, P192; Russo EB, 2016, CANNABIS CANNABINOID, V1, P154, DOI 10.1089/can.2016.0009; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; Sadhasivam S, 2015, PHARMACOGENOMICS J, V15, P436, DOI 10.1038/tpj.2014.79; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shao Z, 2016, NATURE; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Song W, 2015, GENET MED; Sugaya Y, 2016, CELL REP, V16, P1405, DOI 10.1016/j.celrep.2016.06.083; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Trubetskoy V, 2015, BIOINFORMATICS, V31, P187, DOI 10.1093/bioinformatics/btu591; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Wong BS, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01874.x; Yourshaw M, 2015, BRIEF BIOINFORM, V16, P255, DOI 10.1093/bib/bbu008	81	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187926	10.1371/journal.pone.0187926	http://dx.doi.org/10.1371/journal.pone.0187926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145497	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800039
J	Zhu, HS; Liu, JT; Wen, QF; Chen, MD; Wang, B; Zhang, QR; Xue, ZZ				Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng			De novo sequencing and analysis of the transcriptome during the browning of fresh-cut Luffa cylindrica 'Fusi-3' fruits	PLOS ONE			English	Article							ACTIVE OXYGEN-METABOLISM; PHENOLIC METABOLISM; POLYPHENOL OXIDASE; LITCHI FRUIT; LOTUS ROOT; SHELF-LIFE; ACID; LETTUCE; QUALITY; GENES	Fresh-cut luffa (Luffa cylindrica) fruits commonly undergo browning. However, little is known about the molecular mechanisms regulating this process. We used the RNA-seq technique to analyze the transcriptomic changes occurring during the browning of fresh-cut fruits from luffa cultivar 'Fusi-3'. Over 90 million high-quality reads were assembled into 58,073 Unigenes, and 60.86% of these were annotated based on sequences in four public databases. We detected 35,282 Unigenes with significant hits to sequences in the NCBInr database, and 24,427 Unigenes encoded proteins with sequences that were similar to those of known proteins in the Swiss-Prot database. Additionally, 20,546 and 13,021 Unigenes were similar to existing sequences in the Eukaryotic Orthologous Groups of proteins and Kyoto Encyclopedia of Genes and Genomes databases, respectively. Furthermore, 27,301 Unigenes were differentially expressed during the browning of fresh-cut luffa fruits (i.e., after 1-6 h). Moreover, 11 genes from five gene families (i.e., PPO, PAL, POD, CAT, and SOD) identified as potentially associated with enzymatic browning as well as four WRKY transcription factors were observed to be differentially regulated in fresh-cut luffa fruits. With the assistance of rapid amplification of cDNA ends technology, we obtained the full-length sequences of the 15 Unigenes. We also confirmed these Unigenes were expressed by quantitative real-time polymerase chain reaction analysis. This study provides a comprehensive transcriptome sequence resource, and may facilitate further studies aimed at identifying genes affecting luffa fruit browning for the exploitation of the underlying mechanism.	[Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China; [Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Acad Agr Sci, Vegetable Res Ctr, Fuzhou, Fujian, Peoples R China; [Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Engn Res Ctr Vegetables, Fuzhou, Fujian, Peoples R China	Fujian Academy of Agricultural Sciences; Fujian Academy of Agricultural Sciences	Wen, QF (corresponding author), Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China.; Wen, QF (corresponding author), Fujian Acad Agr Sci, Vegetable Res Ctr, Fuzhou, Fujian, Peoples R China.; Wen, QF (corresponding author), Fujian Engn Res Ctr Vegetables, Fuzhou, Fujian, Peoples R China.	fjvrc@163.com		fang, wen/0000-0002-2961-3914	Natural Science fundation of Fujian Province [2015J01118]; Project of Innovative Team in Fujian Academy of Agricultural Sciences [2016PI-40]; Fujian Provincial Public Research Institute of Fundamental Research [2017R1026-6]; Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team [STIT2017-1-2]	Natural Science fundation of Fujian Province; Project of Innovative Team in Fujian Academy of Agricultural Sciences; Fujian Provincial Public Research Institute of Fundamental Research; Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team	This work was supported by Natural Science fundation of Fujian Province (2015J01118), Project of Innovative Team in Fujian Academy of Agricultural Sciences (2016PI-40), The Fujian Provincial Public Research Institute of Fundamental Research (2017R1026-6), and Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team (STIT2017-1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes-Hernandez F, 2010, POSTHARVEST BIOL TEC, V55, P114, DOI 10.1016/j.postharvbio.2009.09.002; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Cantos E, 2002, J AGR FOOD CHEM, V50, P3015, DOI 10.1021/jf0116350; Carreira A, 2002, J DAIRY RES, V69, P281, DOI 10.1017/S0022029902005393; Chen X, 2015, BIOCHEM BIOPH RES CO, V463, P1243, DOI 10.1016/j.bbrc.2015.06.093; Chi M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-62; Chisari M, 2008, J AGR FOOD CHEM, V56, P132, DOI 10.1021/jf0721491; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dan YH, 2016, PLANT CELL TISS ORG, V127, P229, DOI 10.1007/s11240-016-1045-y; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Degl'Innocenti E, 2007, FOOD CHEM, V104, P209, DOI 10.1016/j.foodchem.2006.11.026; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Docimo T, 2016, J AGR FOOD CHEM, V64, P4675, DOI 10.1021/acs.jafc.6b00662; Dokhanieh AY, 2016, HORTIC ENVIRON BIOTE, V57, P378, DOI 10.1007/s13580-016-0087-8; Dong TT, 2015, POSTHARVEST BIOL TEC, V110, P96, DOI 10.1016/j.postharvbio.2015.07.014; DROILLARD MJ, 1987, PHYSIOL PLANTARUM, V71, P197, DOI 10.1111/j.1399-3054.1987.tb02867.x; Du YJ, 2012, FOOD CHEM, V135, P580, DOI 10.1016/j.foodchem.2012.04.131; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan MC, 2016, LWT-FOOD SCI TECHNOL, V72, P467, DOI 10.1016/j.lwt.2016.05.015; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Fukumoto LR, 2002, J AGR FOOD CHEM, V50, P4503, DOI 10.1021/jf011415m; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Hisaminato H, 2001, BIOSCI BIOTECH BIOCH, V65, P1016, DOI 10.1271/bbb.65.1016; Hong PK, 2016, FOOD CHEM, V212, P234, DOI 10.1016/j.foodchem.2016.05.170; Isutsa D. K., 2013, Journal of Agricultural and Biological Science, V8, P610; Jiang J, 2014, POSTHARVEST BIOL TEC, V92, P164, DOI 10.1016/j.postharvbio.2014.01.025; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lamikanra O, 2001, J FOOD SCI, V66, P1283, DOI 10.1111/j.1365-2621.2001.tb15202.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lante A, 2016, INNOV FOOD SCI EMERG, V34, P141, DOI 10.1016/j.ifset.2015.12.029; Lee HS, 2002, J AGR FOOD CHEM, V50, P1400, DOI 10.1021/jf011230f; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Lin YF, 2014, POSTHARVEST BIOL TEC, V96, P42, DOI 10.1016/j.postharvbio.2014.05.001; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074217; Lu XH, 2011, SCI HORTIC-AMSTERDAM, V130, P97, DOI 10.1016/j.scienta.2011.06.017; Luna MC, 2016, POSTHARVEST BIOL TEC, V119, P84, DOI 10.1016/j.postharvbio.2016.05.001; Maghoumi M, 2013, LWT-FOOD SCI TECHNOL, V54, P389, DOI 10.1016/j.lwt.2013.06.006; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Mellidou I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0328-x; Min T, 2017, POSTHARVEST BIOL TEC, V123, P69, DOI 10.1016/j.postharvbio.2016.08.011; Nath N, 2015, INT J PURE APP BIOSC, V3, P99, DOI 10.18782/2320-7051.2140; Pen LT, 2003, LEBENSM-WISS TECHNOL, V36, P359, DOI 10.1016/S0023-6438(03)00024-0; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Pusittigul I, 2012, SCI HORTIC-AMSTERDAM, V146, P45, DOI 10.1016/j.scienta.2012.08.008; RICHARD FC, 1991, J AGR FOOD CHEM, V39, P841, DOI 10.1021/jf00005a004; Rico D, 2006, J SCI FOOD AGR, V86, P2179, DOI 10.1002/jsfa.2594; Saltveit ME, 2000, POSTHARVEST BIOL TEC, V21, P61, DOI 10.1016/S0925-5214(00)00165-4; Saltveit ME, 2004, POSTHARVEST BIOL TEC, V34, P75, DOI 10.1016/j.postharvbio.2004.05.001; Sangh Partap, 2012, Journal of Natural Product and Plant Resources, V2, P127; Sangwan RS, 2013, GENE, V525, P58, DOI 10.1016/j.gene.2013.04.057; Soliva-Fortuny RC, 2003, TRENDS FOOD SCI TECH, V14, P341, DOI 10.1016/S0924-2244(03)00054-2; Sullivan ML, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00783; Sun Y, 2015, FOOD CHEM, V177, P376, DOI 10.1016/j.foodchem.2015.01.065; Sutharshana V., 2013, J PHARM SCI RES, V5, P184; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wei WL, 2014, SCI REP-UK, V4, DOI 10.1038/srep03564; [温庆放 Wen Qingfang], 2016, [园艺学报, Acta Horticulturae Sinica], V43, P2039; Wu SJ, 2014, FOOD CHEM, V160, P8, DOI 10.1016/j.foodchem.2014.03.088; Xu Chuanjun, 2015, Horticultural Plant Journal, V1, P172, DOI 10.16420/j.issn.2095-9885.2015-0030; Xu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123356; Yang E, 2009, PAK J BOT, V41, P2271; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi C, 2010, FOOD CHEM, V118, P42, DOI 10.1016/j.foodchem.2009.04.074; You YL, 2012, FOOD CHEM, V132, P1191, DOI 10.1016/j.foodchem.2011.11.073; Zhan LJ, 2014, POSTHARVEST BIOL TEC, V88, P17, DOI 10.1016/j.postharvbio.2013.09.006; Zhou D, 2015, FOOD CHEM, V171, P19, DOI 10.1016/j.foodchem.2014.08.115; Zhu HS, 2016, ACTA AGRIC NUCL SIN, V30; 王成, 2012, [江苏农业科学, Jiangsu Agricultural Sciences], V40, P137	74	18	26	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187117	10.1371/journal.pone.0187117	http://dx.doi.org/10.1371/journal.pone.0187117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145430	Green Submitted, gold, Green Published			2022-12-26	WOS:000415378800010
J	Wang, MA; Yao, LC; Cheng, MS; Cai, DY; Martinek, J; Pan, CX; Shi, W; Ma, AH; White, RWD; Airhart, S; Liu, ET; Banchereau, J; Brehm, MA; Greiner, DL; Shultz, LD; Palucka, K; Keck, JG				Wang, Minan; Yao, Li-Chin; Cheng, Mingshan; Cai, Danying; Martinek, Jan; Pan, Chong-Xian; Shi, Wei; Ma, Ai-Hong; White, Ralph W. De Vere; Airhart, Susan; Liu, Edison T.; Banchereau, Jacques; Brehm, Michael A.; Greiner, Dale L.; Shultz, Leonard D.; Palucka, Karolina; Keck, James G.			Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy	FASEB JOURNAL			English	Article						checkpoint inhibitor; mouse model; patient-derived xenograft; pembrolizumab	T-CELL RESPONSES; PD-1 BLOCKADE; IMMUNE CELLS; ANTI-PD-1 ANTIBODY; HUMAN-BLOOD; B7 FAMILY; RECEPTOR; MOUSE; SUBSETS; TUMORS	Establishment of an in vivo small animal model of human tumor and human immune system interaction would enable preclinical investigations into the mechanisms underlying cancer immunotherapy. To this end, nonobese diabetic (NOD). Cg-Prkdc(scid)IL2rg(tm1Wjl)/Sz (null; NSG) mice were transplanted with human (h) CD34(+) hematopoietic progenitor and stem cells, which leads to the development of human hematopoietic and immune systems [humanized NSG (HuNSG)]. HuNSG mice received human leukocyte antigen partially matched tumor implants from patient-derived xenografts [PDX; non-small cell lungcancer (NSCLC), sarcoma, bladder cancer, andtriple-negative breast cancer (TNBC)] or from a TNBC cell line-derived xenograft (CDX). Tumor growth curves were similar in HuNSG compared with nonhuman immune-engrafted NSG mice. Treatment with pembrolizumab, which targets programmed cell death protein 1, produced significant growth inhibition in both CDX and PDX tumors in HuNSG but not in NSG mice. Finally, inhibition of tumor growth was dependent on hCD8(+) T cells, as demonstrated by antibody-mediated depletion. Thus, tumor-bearing HuNSG mice may represent an important, new model for preclinical immunotherapy research.	[Wang, Minan; Yao, Li-Chin; Cheng, Mingshan; Cai, Danying; Keck, James G.] Jackson Lab, Dept In Vivo Pharmacol Serv, 1650 Santa Ana Ave, Sacramento, CA 95838 USA; [Martinek, Jan; Airhart, Susan; Liu, Edison T.; Banchereau, Jacques; Palucka, Karolina] Jackson Lab, Dept Immunol, Farmington, CT USA; [Pan, Chong-Xian; Shi, Wei; White, Ralph W. De Vere] Univ Calif Davis, Davis Comprehens Canc Ctr, Dept Urol, Davis, CA USA; [Ma, Ai-Hong] Univ Calif Davis, Davis Comprehens Canc Ctr, Dept Biochem & Mol Med, Davis, CA USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Dept Mol Med, Worcester, MA 01605 USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, Dept Immunol, Bar Harbor, ME USA	Jackson Laboratory; Jackson Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Wang, MA (corresponding author), Jackson Lab, Dept In Vivo Pharmacol Serv, 1650 Santa Ana Ave, Sacramento, CA 95838 USA.	minan.wang@jax.org		Brehm, Michael/0000-0001-6813-3262	Jackson Laboratory; NATIONAL CANCER INSTITUTE [P30CA093373, P30CA034196, R01CA176803] Funding Source: NIH RePORTER	Jackson Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Flow Contract Site Laboratory (Bothell, WA, USA) for processing and staining samples for flow cytometry, and Pure Transplant Solutions (Oklahoma City, OK, USA) for HLA typing. This study was funded by The Jackson Laboratory. The authors declare no conflicts of interest.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Dong HD, 1999, NAT MED, V5, P1365; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P394, DOI 10.1038/nrclinonc.2016.65; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee J, 2017, J CLIN INVEST, V127, P2433, DOI 10.1172/JCI92030; Li Y, 2016, EUR J IMMUNOL, V46, P1291, DOI 10.1002/eji.201546132; McGee HS, 2010, AM J RESP CELL MOL, V43, P432, DOI 10.1165/rcmb.2009-0258OC; Merryman RW, 2017, BLOOD, V129, P1380, DOI 10.1182/blood-2016-09-738385; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P489, DOI 10.1038/nrd4066; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Waldron-Lynch F, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003401; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zilberberg J, 2015, BIOL BLOOD MARROW TR, V21, P1000, DOI 10.1016/j.bbmt.2014.11.001; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	51	158	163	8	57	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1537	1549		10.1096/fj.201700740R	http://dx.doi.org/10.1096/fj.201700740R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146734	Green Published, hybrid			2022-12-26	WOS:000427246000033
J	Rabbani, S; Fiege, B; Eris, D; Silbermann, M; Jakob, RP; Navarra, G; Maier, T; Ernst, B				Rabbani, Said; Fiege, Brigitte; Eris, Deniz; Silbermann, Marleen; Jakob, Roman Peter; Navarra, Giulio; Maier, Timm; Ernst, Beat			Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial adhesion; circular dichroism (CD); isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); surface plasmon resonance (SPR); chemical shift perturbation (CSP); fluorescence polarization (FP); full length (FL); lectin domain (LD); pilin domain (PD)	CATCH-BOND MECHANISM; ESCHERICHIA-COLI; RECEPTOR-BINDING; TYROSINE GATE; COMPETITIVE-BINDING; CIRCULAR-DICHROISM; PROTEIN COMPLEXES; NMR-SPECTROSCOPY; STRUCTURAL BASIS; CELL-ADHESION	For many biological processes such as ligand binding, enzymatic catalysis, or protein folding, allosteric regulation of protein conformation and dynamics is fundamentally important. One example is the bacterial adhesin FimH, where the C-terminal pilin domain exerts negative allosteric control over binding of the N-terminal lectin domain to mannosylated ligands on host cells. When the lectin and pilin domains are separated under shear stress, the FimH-ligand interaction switches in a so-called catch-bond mechanism from the low- to high-affinity state. So far, it has been assumed that the pilin domain is essential for the allosteric propagation within the lectin domain that would otherwise be conformationally rigid. To test this hypothesis, we generated mutants of the isolated FimH lectin domain and characterized their thermodynamic, kinetic, and structural properties using isothermal titration calorimetry, surface plasmon resonance, nuclear magnetic resonance, and X-ray techniques. Intriguingly, some of the mutants mimicked the conformational and kinetic behaviors of the full-length protein and, even in absence of the pilin domain, conducted the cross-talk between allosteric sites and the mannoside-binding pocket. Thus, these mutants represent a minimalistic allosteric system of FimH, useful for further mechanistic studies and antagonist design.	[Rabbani, Said; Fiege, Brigitte; Eris, Deniz; Silbermann, Marleen; Navarra, Giulio; Ernst, Beat] Univ Basel, Dept Pharmaceut Sci, Pharmactr, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Jakob, Roman Peter; Maier, Timm] Univ Basel, Focal Area Struct Biol, Dept Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Ernst, B (corresponding author), Univ Basel, Dept Pharmaceut Sci, Pharmactr, Klingelbergstr 50, CH-4056 Basel, Switzerland.	beat.ernst@unibas.ch	Ernst, Beat/AAN-8420-2020; Rabbani, Said/GLT-9313-2022; Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Cooper A., 2011, BIOPHYSICAL CHEM; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eris D, 2016, CHEMBIOCHEM, V17, P1012, DOI 10.1002/cbic.201600066; Fiege B, 2015, CHEMBIOCHEM, V16, P1235, DOI 10.1002/cbic.201402714; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grzymajlo K, 2010, MICROBIOL-SGM, V156, P1738, DOI 10.1099/mic.0.039206-0; Han ZF, 2012, J MED CHEM, V55, P3945, DOI 10.1021/jm300165m; Hartmann M, 2011, EUR J ORG CHEM, V2011, P3583, DOI 10.1002/ejoc.201100407; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Interlandi G, 2016, PROTEINS, V84, P990, DOI 10.1002/prot.25050; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kalas V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601944; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kisiela DI, 2013, P NATL ACAD SCI USA, V110, P19089, DOI 10.1073/pnas.1314395110; Kleeb S, 2015, J MED CHEM, V58, P2221, DOI 10.1021/jm501524q; Klein T, 2010, J MED CHEM, V53, P8627, DOI 10.1021/jm101011y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mayer K, 2017, J MED CHEM, V60, P5646, DOI 10.1021/acs.jmedchem.7b00342; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; OSCARSON S, 1993, CARBOHYD RES, V247, P323, DOI 10.1016/0008-6215(93)84266-9; Pang LJ, 2012, CHEMMEDCHEM, V7, P1404, DOI 10.1002/cmdc.201200125; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Rabbani S, 2010, ANAL BIOCHEM, V407, P188, DOI 10.1016/j.ab.2010.08.007; Robinson KA, 2000, ACTA CRYSTALLOGR D, V56, P996, DOI 10.1107/S0907444900007587; Rodriguez VB, 2013, J BIOL CHEM, V288, P24128, DOI 10.1074/jbc.M113.461376; Roos G, 2013, ACS MED CHEM LETT, V4, P1085, DOI 10.1021/ml400269v; Sager CP, 2018, CHEM SCI, V9, P646, DOI 10.1039/c7sc04289b; Salmon L, 2011, BIOCHEMISTRY-US, V50, P2735, DOI 10.1021/bi200177v; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; Scharenberg M, 2014, CHEMMEDCHEM, V9, P78, DOI 10.1002/cmdc.201300349; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Vanwetswinkel S, 2014, J MED CHEM, V57, P1416, DOI 10.1021/jm401666c; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Wellens A, 2012, BIOCHEMISTRY-US, V51, P4790, DOI 10.1021/bi300251r; Yakovenko O, 2015, P NATL ACAD SCI USA, V112, P9884, DOI 10.1073/pnas.1503160112	76	15	17	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1835	1849		10.1074/jbc.M117.802942	http://dx.doi.org/10.1074/jbc.M117.802942			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29180452	Green Published, hybrid			2022-12-26	WOS:000424201700032
J	Conde, BE; Ticktin, T; Fonseca, AS; Macedo, AL; Orsi, TO; Chedier, LM; Rodrigues, E; Pimenta, DS				Conde, Bruno Esteves; Ticktin, Tamara; Fonseca, Amanda Surerus; Macedo, Arthur Ladeira; Orsi, Timothy Ongaro; Chedier, Luciana Moreira; Rodrigues, Eliana; Pimenta, Daniel Sales			Local ecological knowledge and its relationship with biodiversity conservation among two Quilombola groups living in the Atlantic Rainforest, Brazil	PLOS ONE			English	Article							PLANTS; DIVERSITY; ETHNOBOTANY; PRIORITIES; COMMUNITY; COAST	Information on the knowledge, uses, and abundance of natural resources in local communities can provide insight on conservation status and conservation strategies in these locations. The aim of this research was to evaluate the uses, knowledge and conservation status of plants in two Quilombolas (descendants of slaves of African origin) communities in the Atlantic rainforest of Brazil, Sao Sebastiao da Boa Vista (SSBV) and Sao Bento (SB). We used a combination of ethnobotanical and ecological survey methods to ask: 1) What ethnobotanical knowledge do the communities hold? 2) What native species are most valuable to them? 3) What is the conservation status of the native species used? Thirteen local experts described the names and uses of 212 species in SSBV (105 native species) and 221 in SB (96 native species). Shannon Wiener diversity and Pielou's Equitability indices of ethnobotanical knowledge of species were very high (5.27/0.96 and 5.28/0.96, respectively). Species with the highest cultural significance and use-value indexes in SSBV were Dalbergia hortensis (26/2.14), Eremanthus erythropappus (6.88/1), and Tibouchina granulosa (6.02/1); while Piptadenia gonoacantha (3.32/1), Sparattosperma leucanthum (3.32/1) and Cecropia glaziovii (3.32/0.67) were the highest in SB. Thirty-three native species ranked in the highest conservation priority category at SSBV and 31 at SB. D. hortensis was noteworthy because of its extremely high cultural importance at SSBV, and its categorization as a conservation priority in both communities. This information can be used towards generating sustainable use and conservation plans that are appropriate for the local communities.	[Conde, Bruno Esteves; Chedier, Luciana Moreira; Pimenta, Daniel Sales] Univ Fed Juiz de Fora, Dept Bot, Juiz De Fora, MG, Brazil; [Ticktin, Tamara] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Fonseca, Amanda Surerus] Ctr Ensino Super Juiz de Fora, Dept Ciencias Biol, Juiz De Fora, MG, Brazil; [Macedo, Arthur Ladeira] Univ Fed Fluminense, Dept Quim Organ, Niteroi, RJ, Brazil; [Orsi, Timothy Ongaro] Univ Fed Juiz de Fora, Dept Geog, Juiz De Fora, MG, Brazil; [Rodrigues, Eliana] Univ Fed Sao Paulo, Dept Ciencias Ambientais, Diadema, SP, Brazil	Universidade Federal de Juiz de Fora; University of Hawaii System; University of Hawaii Manoa; Centro de Ensino Superior de Juiz de Fora (CES/JF); Universidade Federal Fluminense; Universidade Federal de Juiz de Fora; Universidade Federal de Sao Paulo (UNIFESP)	Pimenta, DS (corresponding author), Univ Fed Juiz de Fora, Dept Bot, Juiz De Fora, MG, Brazil.	bcondebio@hotmail.com	Macedo, Arthur Ladeira/Q-1392-2017; Chedier, Luciana M/D-1032-2019; Rodrigues, Eliana/B-5839-2013; Chedier, Luciana/AAY-1013-2021; Conde, Bruno/I-3681-2016	Macedo, Arthur Ladeira/0000-0002-0398-3167; Chedier, Luciana M/0000-0001-8212-8056; Rodrigues, Eliana/0000-0001-8847-6676; Conde, Bruno/0000-0002-7542-2828	Programa de Pos-Graduacao em Ecologia of Universidade Federal de Juiz de Fora; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); University of Hawaii at Manoa	Programa de Pos-Graduacao em Ecologia of Universidade Federal de Juiz de Fora; Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Hawaii at Manoa	This study was funded by the Programa de Pos-Graduacao em Ecologia of Universidade Federal de Juiz de Fora, the Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank specially to Quilombolas that participate in this study for all host, warmth, and hospitality; to the Programa de Pos-Graduacao em Ecologia of Universidade Federal de Juiz de Fora; to Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) for the Scholarship payment for BEC in the modality 1) doctorate in Brazil and 2) doctorate sandwich at the University of Hawaii at Manoa; to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the Scholarship payment for ALM in the modality doctorate in Brazil; and to taxonomists partners Dr. Adriana Lobao (Jardim Botanico do Rio de Janeiro), Dr. Adriano Maruyama (Universidade Estadual Paulista Julio de Mesquita Filho) and Dr. Rodrigo Camargo (Universidade Estadual de Campinas) for valuable considerations for the identification of the species.	Albuquerque Ulysses Paulino de, 2002, Acta Bot. Bras., V16, P273, DOI 10.1590/S0102-33062002000300004; Amorozo Maria Christina de Mello, 2002, Acta Bot. Bras., V16, P189, DOI 10.1590/S0102-33062002000200006; [Anonymous], REV BRAS BIOL; [Anonymous], ENCY LIFE SUPPORT SY; [Anonymous], COMUNIDADES TRADICIO; [Anonymous], LEAV PLAN REP; [Anonymous], ETNOBOTANICA JARDINS; [Anonymous], PLANTAS MEDIS MATA A; [Anonymous], METODOS TECNICAS PES; [Anonymous], REV HISTEDBR; [Anonymous], J PAN AFR STUD; [Anonymous], EC BOT; [Anonymous], TRADITIONAL KNOWLEDG; [Anonymous], ETNOECOLOGICA; [Anonymous], BRASIL ACTA BOT BRAS; [Anonymous], USODE PLANTAS MED B; [Anonymous], 2004, METODOS TECNICAS PES; [Anonymous], ATLAS REMANESCENTES; [Anonymous], FLORA BRASILIENSIS R; [Anonymous], THESIS; [Anonymous], THESIS; [Anonymous], 2010, RECENT DEV CASE STUD; [Anonymous], THESIS; [Anonymous], BIOD BRAS BRAS MIN M; [Anonymous], ACTA BOT BRAS; [Anonymous], COMUNIDADE QUILOMBOL; [Anonymous], TROPIXEL ARTES CIENC; [Anonymous], AFRICAN BLACK DIASPO; da Silva VA, 2006, FIELD METHOD, V18, P98, DOI 10.1177/1525822X05278025; Da Silva NCB, 2012, B LATINOAM CARIBE PL, V11, P435; BARREIRA T.F., 2015, Rev. bras. plantas med., V17, P964, DOI 10.1590/1983-084X/14_100; Begossi A, 1996, ECON BOT, V50, P280, DOI 10.1007/BF02907333; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bernard H.R., 1988, RES METHODS CULTURAL; Christo AG, 2010, REV BRAS FARMACOGN, V20, P494, DOI 10.1590/S0102-695X2010000400006; Conde B.E., 2014, ETHNOBOTANY RES APPL, V12, P91; Cysneiros VC, 2015, BIOTA NEOTROP, V15, DOI [10.1590/1676-060320150132, 10.1590/1676-06032015013214]; Da Cunha LVFC, 2006, ENVIRON MONIT ASSESS, V114, P1, DOI 10.1007/s10661-006-1074-9; da Cunha SA, 2011, ACTA BOT BRAS, V25, P685, DOI 10.1590/S0102-33062011000300022; de Brito MR, 2012, ACTA BOT BRAS, V26, P735, DOI 10.1590/S0102-33062012000400003; De Lucena RFP, 2013, AN ACAD BRAS CIENC, V85, P169, DOI 10.1590/S0001-37652013005000013; de Oliveira RLC, 2007, ENVIRON MONIT ASSESS, V132, P189, DOI 10.1007/s10661-006-9528-7; Dzerefos CM, 2001, BIODIVERS CONSERV, V10, P1875, DOI 10.1023/A:1013177628331; Espírito-Santo Fernando Del Bon, 2005, Acta Amaz., V35, P155, DOI 10.1590/S0044-59672005000200006; Fonseca-Kruel Viviane Stern da, 2004, Acta Bot. Bras., V18, P177, DOI 10.1590/S0102-33062004000100015; Galeano G, 2000, ECON BOT, V54, P358, DOI 10.1007/BF02864787; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanazaki Natalia, 2006, Acta Bot. Bras., V20, P899, DOI 10.1590/S0102-33062006000400014; Hanazaki N, 2000, BIODIVERS CONSERV, V9, P597, DOI 10.1023/A:1008920301824; KAINER KA, 1992, ECON BOT, V46, P408, DOI 10.1007/BF02866513; LIMA JS, 2011, SITIENTIBUS SER CIEN, V11, P239; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; Meyer L., 2012, REV BRASILEIRA BIOCI, V10, P258; Montero CMG, 2017, SOULS, V19, P75, DOI 10.1080/10999949.2017.1268805; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Pinto Erika de Paula Pedro, 2006, Acta Bot. Bras., V20, P751, DOI 10.1590/S0102-33062006000400001; PRADO HELBERT MEDEIROS, 2015, Ambient. soc., V18, P139, DOI 10.1590/1809-4422ASOC986V1842015; Prandi R, 2008, TEMPO SOC, V20, P155, DOI 10.1590/S0103-20702008000200008; Silva Andrea Leme, 2007, Journal of Ethnobiology, V27, P46, DOI 10.2993/0278-0771(2007)27[46:EORPFT]2.0.CO;2; Crepaldi MOS, 2010, BIODIVERS CONSERV, V19, P37, DOI 10.1007/s10531-009-9700-9; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; Ticktin T, 2012, J APPL ECOL, V49, P774, DOI 10.1111/j.1365-2664.2012.02156.x; Zank S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/563570	63	14	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0187599	10.1371/journal.pone.0187599	http://dx.doi.org/10.1371/journal.pone.0187599			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182637	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000004
J	Bauters, C; Dubois, E; Porouchani, S; Saloux, E; Fertin, M; de Groote, P; Lamblin, N; Pinet, F				Bauters, Christophe; Dubois, Emilie; Porouchani, Sina; Saloux, Eric; Fertin, Marie; de Groote, Pascal; Lamblin, Nicolas; Pinet, Florence			Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-FAILURE; NATRIURETIC PEPTIDE; DYSFUNCTION; CAPTOPRIL; TRIAL; PREVENTION; VALSARTAN; SURVIVAL; REVE-2	Background The association of left ventricular remodeling (LVR) after myocardial infarction (MI) with the subsequent risk of heart failure (HF) and death has not been studied in patients receiving optimal secondary prevention. Methods and results We performed a long-term clinical follow-up of patients included in 2 prospective multicentric studies on LVR after first anterior MI. At 1-year echocardiography, LVR (>= 20% increase in end-diastolic volume from baseline to 1 year) occurred in 67/215 (31%) patients in cohort 1 and in 87/226 (38%) patients in cohort 2. The prescription rate of secondary prevention medications was very high (beta-blockers at 1 year: 90% and 95% for cohorts 1 and 2, respectively; angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACE-I/ARB) at 1 year: 93% and 97% for cohorts 1 and 2, respectively). Median clinical follow-up after LVR assessment was 11.0 years in cohort 1 and 7.8 years in cohort 2. In both cohorts, LVR patients had a progressive increase in the risk of cardiovascular death or hospitalization for HF (p = 0.0007 in cohort 1 and 0.009 in cohort 2) with unadjusted hazard ratios of 2.52 [1.45-4.36] and 2.52 [1.23-5.17], respectively. Similar results were obtained when cardiovascular death was considered as an isolated endpoint. After adjustement on baseline characteristics including ejection fraction, the association with the composite endpoint was unchanged. Conclusion In a context of a modern therapeutic management with a large prescription of evidence-based medications, LVR remains independently associated with HF and cardiovascular death at long-term follow-up after MI.	[Bauters, Christophe; de Groote, Pascal; Lamblin, Nicolas] Univ Lille, Univ Hosp Lille, INSERM, Inst Pasteur,U1167, Lille, France; [Dubois, Emilie; Pinet, Florence] Univ Lille, Inst Pasteur, INSERM, U1167, Lille, France; [Porouchani, Sina; Fertin, Marie] Univ Hosp Lille, Lille, France; [Saloux, Eric] Univ Caen, Univ Hosp Caen, EA 4650, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; CHU de Caen NORMANDIE; Universite de Caen Normandie	Bauters, C (corresponding author), Univ Lille, Univ Hosp Lille, INSERM, Inst Pasteur,U1167, Lille, France.	christophe.bauters@chru-lille.fr	Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Bauters, christophe/0000-0001-8268-8467; de Groote, Pascal/0000-0002-6211-0147; LAMBLIN, NICOLAS/0000-0003-3754-1241; Dubois-Deruy, Emilie/0000-0002-9811-617X	E.U. FP7 HOMAGE [305507, ANR 15-CEA-U16/DGOS 15-013]	E.U. FP7 HOMAGE	This work was supported by grants from the E.U. FP7 HOMAGE (305507), F-CRIN INI-CRT, ANR 15-CEA-U16/DGOS 15-013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauters C, 2007, AM HEART J, V153, P641, DOI 10.1016/j.ahj.2007.01.009; Bauters C, 2017, CORONARY ARTERY DIS, V28, P636, DOI 10.1097/MCA.0000000000000560; Bauters C, 2014, AM J CARDIOL, V113, P1142, DOI 10.1016/j.amjcard.2013.12.019; Carrabba N, 2004, CIRCULATION, V110, P1974, DOI 10.1161/01.CIR.0000143376.64970.4A; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Fertin M, 2012, AM J CARDIOL, V110, P277, DOI 10.1016/j.amjcard.2012.02.069; Fertin M, 2010, AM J CARDIOL, V106, P1410, DOI 10.1016/j.amjcard.2010.06.071; Frey N, 2014, CIRC-CARDIOVASC INTE, V7, P806, DOI 10.1161/CIRCINTERVENTIONS.114.001478; Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055; Ishii H, 2008, CIRCULATION, V118, P2710, DOI 10.1161/CIRCULATIONAHA.107.748772; Kelly D, 2007, EUR HEART J, V28, P711, DOI 10.1093/eurheartj/ehm003; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Lamblin N, 2012, J CARDIOVASC MED, V13, P353, DOI 10.2459/JCM.0b013e328353694b; Lamblin N, 2012, ARCH CARDIOVASC DIS, V105, P18, DOI 10.1016/j.acvd.2011.11.001; Lamblin N, 2011, EUR J HEART FAIL, V13, P1314, DOI 10.1093/eurjhf/hfr137; Lee DS, 2011, CIRC-HEART FAIL, V4, P36, DOI 10.1161/CIRCHEARTFAILURE.110.957480; Lemesle G, 2017, J AM COLL CARDIOL, V69, P2149, DOI 10.1016/j.jacc.2017.02.050; Otterstad JE, 2002, EUR HEART J, V23, P1011, DOI 10.1053/euhj.2001.2969; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Puymirat E, 2017, CIRCULATION; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Solomon SD, 2005, CIRCULATION, V111, P3411, DOI 10.1161/CIRCULATIONAHA.104.508093; SUTTON MS, 1994, CIRCULATION, V89, P68, DOI 10.1161/01.CIR.89.1.68; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353	30	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188884	10.1371/journal.pone.0188884	http://dx.doi.org/10.1371/journal.pone.0188884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176897	gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900125
J	Koch, M; Lunde, LK; Veiersted, KB; Knardahl, S				Koch, Markus; Lunde, Lars-Kristian; Veiersted, Kaj Bo; Knardahl, Stein			Association of objectively measured arm inclination with shoulder pain: A 6-month follow-up prospective study of construction and health care workers	PLOS ONE			English	Article							RISK-FACTORS; MUSCULOSKELETAL SYMPTOMS; NECK/SHOULDER PAIN; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; NECK; POPULATION; DISORDERS; VALIDITY; NURSES	Objectives The aim was to determine the association of occupational arm inclination with shoulder pain in construction and health care workers. Methods Arm inclination relative to the vertical was measured with an accelerometer placed on the dominant upper arm for up to four full days at baseline in 62 construction workers and 63 health care workers. The pain intensity in the shoulder and mechanical and psychosocial work factors were measured by self-reports at baseline and prospectively after 6 months. The associations between exposures and shoulder pain were analyzed with multilevel mixed-effects linear regressions. Results For the total study population working with the dominant arm at inclinations > 30 degrees and >120 degrees was associated with lower levels of shoulder pain both cross-sectionally and after 6 months. Associations were attenuated when adjusting for individual and social factors, psychological state, and exposure during leisure time, especially for the high inclination levels. Analyses, only including subjects with no pain at baseline revealed no significant associations. While stratified analysis showed negative associations in the construction worker group, there were no significant association in health care workers. Compared to the number of hypotheses tested, the number of significant findings was low. Adjustment by Bonferroni-correction made almost all findings insignificant. Conclusions All analyses reflected a negative association between arm inclination and shoulder pain, but few analyses showed these associations to be statistically significant. If there is a relationship between arm inclination and shoulder pain, these findings could indicate that pain-avoidance may modify how workers perform their tasks.	[Koch, Markus; Lunde, Lars-Kristian; Veiersted, Kaj Bo; Knardahl, Stein] Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Gydas Vei 8, Oslo, Norway		Koch, M (corresponding author), Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Gydas Vei 8, Oslo, Norway.	Markus_Koch@aol.de			Norwegian Research council	Norwegian Research council(Research Council of NorwayEuropean Commission)	The Norwegian Research council funded this study (www.forskningsradet.no). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Norwegian Research council supported this study. Gunn-Helen Moen, Therese N. Hanvold, Elisabeth Petersen, Daniel Pietz Jacobsen, Monica Wigemyr and Morten Waersted provided technical assistance. Oivind Skare supported the authors with statistical assistance. We would like to thank the National Research Centre for the Working Environment for their collaboration during the study and for providing the Acti4 software.	Cassou B, 2002, OCCUP ENVIRON MED, V59, P537, DOI 10.1136/oem.59.8.537; Coenen P, 2016, ERGONOMICS, V59, P1182, DOI 10.1080/00140139.2015.1130862; Cook TM, 1996, USITC PUBL; Dallner M, 2000, VALIDATION GEN QUEST, V2000, P12; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Grooten WJA, 2007, EUR SPINE J, V16, P2083, DOI 10.1007/s00586-007-0481-0; Grooten WJA, 2004, J OCCUP ENVIRON MED, V46, P138, DOI 10.1097/01.jom.0000112181.06324.42; Hansson GA, 2001, SCAND J WORK ENV HEA, V27, P30, DOI 10.5271/sjweh.584; Hanvold TN, 2015, APPL ERGON, V47, P43, DOI 10.1016/j.apergo.2014.08.019; Harkness EF, 2003, OCCUP ENVIRON MED, V60, P850, DOI 10.1136/oem.60.11.850; Koch M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162881; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; LARESE F, 1994, ERGONOMICS, V37, P1205, DOI 10.1080/00140139408964898; Larsson B, 2007, BEST PRACT RES CL RH, V21, P447, DOI 10.1016/j.berh.2007.02.015; Leclerc A, 2004, OCCUP ENVIRON MED, V61, P39; Luime JJ, 2004, SCAND J WORK ENV HEA, V30, P279, DOI 10.5271/sjweh.795; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; Lunde LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1075; Macfarlane GJ, 1998, J RHEUMATOL, V25, P1612; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Miranda H, 2001, OCCUP ENVIRON MED, V58, P528, DOI 10.1136/oem.58.8.528; Moreira RFC, 2014, BRAZ J PHYS THER, V18, P323, DOI 10.1590/bjpt-rbf.2014.0026; Punnett L, 2000, SCAND J WORK ENV HEA, V26, P283, DOI 10.5271/sjweh.544; Sim J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-234; Steingrimsdottir OA, 2004, PAIN, V110, P130, DOI 10.1016/j.pain.2004.03.016; Svendsen SW, 2004, OCCUP ENVIRON MED, V61, P844, DOI 10.1136/oem.2003.010637; Teschke K, 2009, ERGONOMICS, V52, P1067, DOI 10.1080/00140130902912811; Trinkoff AM, 2002, AM J IND MED, V41, P170, DOI 10.1002/ajim.10048; Unge J, 2005, ERGONOMICS, V48, P12, DOI 10.1080/00140130412331293364; Van den Heuvel SG, 2007, J OCCUP REHABIL, V17, P370, DOI 10.1007/s10926-007-9095-y; Viikari-Juntura E, 2001, OCCUP ENVIRON MED, V58, P345, DOI 10.1136/oem.58.5.345; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Winstanley S, 2004, J CLIN NURS, V13, P3, DOI 10.1111/j.1365-2702.2004.00807.x	34	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188372	10.1371/journal.pone.0188372	http://dx.doi.org/10.1371/journal.pone.0188372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176761	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900067
J	Sebastian, A; Hum, NR; Murugesh, DK; Hatsell, S; Economides, AN; Loots, GG				Sebastian, Aimy; Hum, Nicholas R.; Murugesh, Deepa K.; Hatsell, Sarah; Economides, Aris N.; Loots, Gabriela G.			Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GENE-EXPRESSION DATA; BONE-MASS; PROMOTES PROLIFERATION; GENOMIC FEATURES; RNA-SEQ; MUTATIONS; MICE; MINERALIZATION; PATHWAY	Wnt3a is a major regulator of bone metabolism however, very few of its target genes are known in bone. Wnt3a preferentially signals through transmembrane receptors Frizzled and co-receptors Lrp5/6 to activate the canonical signaling pathway. Previous studies have shown that the canonical Wnt co-receptors Lrp5 and Lrp6 also play an essential role in normal postnatal bone homeostasis, yet, very little is known about specific contributions by these co-receptors in Wnt3a-dependent signaling. We used high-throughput sequencing technology to identify target genes regulated by Wnt3a in osteoblasts and to elucidate the role of Lrp5 and Lrp6 in mediating Wnt3a signaling. Our study identified 782 genes regulated by Wnt3a in primary calvarial osteoblasts. Wnt3a up-regulated the expression of several key regulators of osteoblast proliferation/early stages of differentiation while inhibiting genes expressed in later stages of osteoblastogenesis. We also found that Lrp6 is the key mediator of Wnt3a signaling in osteoblasts and Lrp5 played a less significant role in mediating Wnt3a signaling.	[Sebastian, Aimy; Hum, Nicholas R.; Murugesh, Deepa K.; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Sebastian, Aimy; Hum, Nicholas R.; Loots, Gabriela G.] UC Merced, Sch Nat Sci, Merced, CA 95340 USA; [Hatsell, Sarah; Economides, Aris N.] Regeneron Pharmaceut, Tarrytown, NY USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; Regeneron	Loots, GG (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.; Loots, GG (corresponding author), UC Merced, Sch Nat Sci, Merced, CA 95340 USA.	Loots1@llnl.gov	Loots, Gabriela G/AGA-4868-2022; Sebastian, Aimy/S-5230-2017	Loots, Gabriela G/0000-0001-9546-5561; Sebastian, Aimy/0000-0002-7822-7040; Hatsell, Sarah/0000-0003-1103-6087; Murugesh, Deepa/0000-0002-4232-8480; Hum, Nicholas/0000-0003-1605-3193	 [LLNL-LDRD-13-ERD-042]		This work was supported by LLNL-LDRD-13-ERD-042.	Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Castilla-Cortazar I, 2014, J PHYSIOL BIOCHEM, V70, P129, DOI 10.1007/s13105-013-0287-y; Caverzasio J, 2013, J BONE MINER RES, V28, P260, DOI 10.1002/jbmr.1748; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Friedman MS, 2009, J BIOL CHEM, V284, P14117, DOI 10.1074/jbc.M808337200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hudson BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142058; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jullien N, 2012, J CELL BIOCHEM, V113, P2047, DOI 10.1002/jcb.24076; Karner CM, 2016, J BIOL CHEM, V291, P13028, DOI 10.1074/jbc.M115.708578; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kook SH, 2015, MOL CELL BIOCHEM, V402, P213, DOI 10.1007/s11010-015-2329-y; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liang BJ, 2012, CALCIFIED TISSUE INT, V90, P76, DOI 10.1007/s00223-011-9550-9; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Niziolek PJ, 2012, BONE, V51, P459, DOI 10.1016/j.bone.2012.05.023; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Riddle RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063323; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sebastian A, 2017, BONE, V96, P76, DOI 10.1016/j.bone.2016.10.009; Shin HR, 2016, J BIOL CHEM, V291, P5555, DOI 10.1074/jbc.M115.698563; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Driel Marjolein, 2014, Bonekey Rep, V3, P493, DOI 10.1038/bonekey.2013.227; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Wu Y, 2014, MOL MED REP, V10, P1349, DOI 10.3892/mmr.2014.2374; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019; Zhou H, 2009, DEVELOPMENT, V136, P427, DOI 10.1242/dev.027706	54	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188264	10.1371/journal.pone.0188264	http://dx.doi.org/10.1371/journal.pone.0188264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176883	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900051
J	White, RSA; McHugh, PA; Glover, CN; McIntosh, AR				White, Richard S. A.; McHugh, Peter A.; Glover, Chris N.; McIntosh, Angus R.			Metabolism drives distribution and abundance in extremophile fish	PLOS ONE			English	Article							FRESH-WATER FISH; BODY-SIZE; VOLUNTARY EMERSION; POPULATION-DENSITY; THRESHOLD FUNCTION; 3/4-POWER LAW; STRATEGIES; EVOLUTION; RESPONSES; ANIMALS	Differences in population density between species of varying size are frequently attributed to metabolic rates which are assumed to scale with body size with a slope of 0.75. This assumption is often criticised on the grounds that 0.75 scaling of metabolic rate with body size is not universal and can vary significantly depending on species and life-history. However, few studies have investigated how interspecific variation in metabolic scaling relationships affects population density in different sized species. Here we predict inter-specific differences in metabolism from niche requirements, thereby allowing metabolic predictions of species distribution and abundance at fine spatial scales. Due to the differences in energetic efficiency required along harsh-benign gradients, an extremophile fish (brown mudfish, Neochanna apoda) living in harsh environments had slower metabolism, and thus higher population densities, compared to a fish species (banded kokopu, Galaxias fasciatus) in physiologically more benign habitats. Interspecific differences in the intercepts for the relationship between body and density disappeared when species mass-specific metabolic rates, rather than body sizes, were used to predict density, implying population energy use was equivalent between mudfish and kokopu. Nevertheless, despite significant interspecific differences in the slope of the metabolic scaling relationships, mudfish and kokopu had a common slope for the relationship between body size and population density. These results support underlying logic of energetic equivalence between different size species implicit in metabolic theory. However, the precise slope of metabolic scaling relationships, which is the subject of much debate, may not be a reliable indicator of population density as expected under metabolic theory.	[White, Richard S. A.; McIntosh, Angus R.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [McHugh, Peter A.] Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA; [McHugh, Peter A.] Eco Log Res Inc, Logan, UT USA; [Glover, Chris N.] Athabasca River Basin Res Inst, Athabasca, AB, Canada; [Glover, Chris N.] Fac Sci, Athabasca, AB, Canada; [Glover, Chris N.] Univ Alberta, Sch Biol Sci, Edmonton, AB, Canada	University of Canterbury; Utah System of Higher Education; Utah State University; University of Alberta	White, RSA (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	richard.sa.white@gmail.com	McIntosh, Angus/B-2992-2011	McIntosh, Angus/0000-0003-2696-8813; Glover, Chris/0000-0001-9170-5759	Brian Mason Scientific and Technical Trust; New Zealand Department of Conservation; University of Canterbury Masters Scholarship; Campus Alberta Innovates Program Research Chair	Brian Mason Scientific and Technical Trust; New Zealand Department of Conservation; University of Canterbury Masters Scholarship; Campus Alberta Innovates Program Research Chair	This project was funded by the Brian Mason Scientific and Technical Trust, http://brianmasontrust.org/; and the New Zealand Department of Conservation, http://www.doc.govt.nz/. Richard White was supported by a University of Canterbury Masters Scholarship, and Chris Glover was supported by a Campus Alberta Innovates Program Research Chair during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGON M, 1986, OIKOS, V46, P122, DOI 10.2307/3565389; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Blackburn TM, 1999, ADV ECOL RES, V28, P181, DOI 10.1016/S0065-2504(08)60033-1; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Chew SF, 2004, J EXP BIOL, V207, P777, DOI 10.1242/jeb.00813; Comor V, 2014, SOIL BIOL BIOCHEM, V72, P203, DOI 10.1016/j.soilbio.2014.02.003; Crawley M.J., 2012, R BOOK, V2nd ed.; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DeLong JP, 2008, OIKOS, V117, P1329, DOI 10.1111/j.0030-1299.2008.16832.x; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HOCHACHKA PW, 1988, COMP BIOCHEM PHYS B, V90, P515, DOI 10.1016/0305-0491(88)90290-8; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; HOFFMANN AA, 1989, BIOL J LINN SOC, V37, P117, DOI 10.1111/j.1095-8312.1989.tb02098.x; HOFFMANN AA, 1989, GENETICS, V122, P837; Homer WS., 1930, J BIOL CHEM, V88, P97; Isaac NJB, 2013, GLOBAL ECOL BIOGEOGR, V22, P1, DOI 10.1111/j.1466-8238.2012.00782.x; Isaac NJB, 2011, BIOL LETTERS, V7, P615, DOI 10.1098/rsbl.2011.0128; Killen SS, 2016, AM NAT, V187, P592, DOI 10.1086/685893; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; King RB, 2002, FUNCT ECOL, V16, P766, DOI 10.1046/j.1365-2435.2002.00678.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lighton JRB, 2001, J EXP BIOL, V204, P607; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McKenzie DJ, 1996, COMP BIOCHEM PHYS A, V114, P43, DOI 10.1016/0300-9629(95)02086-1; Meredith A. S., 1985, THESIS; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Rogers HM, 1999, FOREST ECOL MANAG, V117, P111, DOI 10.1016/S0378-1127(98)00473-3; Sloman KA, 2006, J EXP BIOL, V209, P1197, DOI 10.1242/jeb.02090; Stoffels RJ, 2015, PLOS ONE, V10; Svendsen MBS, 2016, J FISH BIOL, V88, P51, DOI 10.1111/jfb.12851; Svendsen MBS, 2016, J FISH BIOL, V88, P26, DOI 10.1111/jfb.12797; Urbina MA, 2014, J FISH BIOL, V84, P759, DOI 10.1111/jfb.12303; Urbina MA, 2014, COMP BIOCHEM PHYS A, V176, P49, DOI 10.1016/j.cbpa.2014.07.006; Urbina MA, 2013, PHYSIOL BIOCHEM ZOOL, V86, P740, DOI 10.1086/673727; Urbina MA, 2012, J COMP PHYSIOL B, V182, P1057, DOI 10.1007/s00360-012-0678-3; Urbina MA, 2012, COMP BIOCHEM PHYS A, V161, P301, DOI 10.1016/j.cbpa.2011.11.011; Urbina MA, 2011, PHYSIOL BEHAV, V103, P240, DOI 10.1016/j.physbeh.2011.02.009; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White RSA, 2015, J FISH BIOL, V87, P967, DOI 10.1111/jfb.12770; White RSA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0826; White RSA, 2016, GLOBAL CHANGE BIOL, V22, P3341, DOI 10.1111/gcb.13265; White RSA, 2015, ECOGRAPHY, V38, P154, DOI 10.1111/ecog.00526; WINTERBOURN MJ, 1981, NEW ZEAL J MAR FRESH, V15, P321, DOI 10.1080/00288330.1981.9515927	58	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187597	10.1371/journal.pone.0187597	http://dx.doi.org/10.1371/journal.pone.0187597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176819	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900011
J	Andres, M; Gohring-Zwacka, E; Fiebig, L; Priwitzer, M; Richter, E; Rusch-Gerdes, S; Haas, W; Niemann, S; Brodhun, B				Andres, Marta; Goehring-Zwacka, Elke; Fiebig, Lena; Priwitzer, Martin; Richter, Elvira; Ruesch-Gerdes, Sabine; Haas, Walter; Niemann, Stefan; Brodhun, Bonita			Integration of molecular typing results into tuberculosis surveillance in Germany-A pilot study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MIRU-VNTRPLUS; STRAIN; TRANSMISSION; EPIDEMIOLOGY; POPULATION; OUTBREAK; COUNTRY; IDENTIFICATION; IMMIGRANTS	An integrated molecular surveillance for tuberculosis (TB) improves the understanding of ongoing TB transmission by combining molecular typing and epidemiological data. However, the implementation of an integrated molecular surveillance for TB is complex and requires thoughtful consideration of feasibility, demand, public health benefits and legal issues. We aimed to pilot the integration of molecular typing results between 2008 and 2010 in the German Federal State of Baden-Wu(r)ttemberg (population 10.88 Million) as preparation for a nationwide implementation. Culture positive TB cases were typed by IS6110 DNA fingerprinting and results were integrated into routine notification data. Demographic and clinical characteristics of cases and clusters were described and new epidemiological links detected after integrating typing data were calculated. Furthermore, a cross-sectional survey was performed among local public health offices to evaluate their perception and experiences. Overall, typing results were available for 83% of notified culture positive TB cases, out of which 25% were clustered. Age < 15 years (OR = 4.96, 95% CI: 1.69-14.55) and being born in Germany (OR = 2.01, 95% CI: 1.44-2.80) were associated with clustering. At cluster level, molecular typing information allowed the identification of previously unknown epidemiological links in 11% of the clusters. In 59% of the clusters it was not possible to identify any epidemiological link. Clusters extending over different counties were less likely to have epidemiological links identified among their cases (OR = 11.53, 95% CI: 3.48-98.23). The majority of local public health offices found molecular typing useful for their work. Our study illustrates the feasibility of integrating typing data into the German TB notification system and depicts its added public health value as complementary strategy in TB surveillance, especially to uncover transmission events among geographically separated TB patients. It also emphasizes that special efforts are required to strengthen the communication between local public health offices in different counties to enhance TB control.	[Andres, Marta; Fiebig, Lena; Haas, Walter; Brodhun, Bonita] Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Berlin, Germany; [Goehring-Zwacka, Elke] Landesgesundheitsamt Baden Wurttemberg, State Hlth Dept, Stuttgart, Germany; [Priwitzer, Martin] Gesundheitsamt Stuttgart, Local Publ Hlth Off, Stuttgart, Germany; [Richter, Elvira] Labor Dr Limbach TB Lab, Heidelberg, Germany; [Ruesch-Gerdes, Sabine; Niemann, Stefan] Res Ctr Borstel, Natl Reference Ctr NRC Mycobacteria, Borstel, Germany; [Niemann, Stefan] Res Ctr Borstel, Leibniz Ctr Med & Biosci, Mol & Expt Mycobacteriol, Borstel, Germany; [Niemann, Stefan] German Ctr Infect Res, Partner Site Hamburg Borstel Lubeck, Borstel, Germany; [Andres, Marta] UCL, Ear Inst, London, England	Robert Koch Institute; Forschungszentrum Borstel; Forschungszentrum Borstel; German Center for Infection Research; University of London; University College London	Andres, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Resp Infect Unit, Berlin, Germany.; Andres, M (corresponding author), UCL, Ear Inst, London, England.	martaandresm@gmail.com	Niemann, Stefan/C-9327-2011	Niemann, Stefan/0000-0002-6604-0684; Andres, Marta/0000-0003-4369-2898; Fiebig, Lena/0000-0002-5977-0507				Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Bidovec-Stojkovic U, 2011, RESP MED, V105, pS67, DOI 10.1016/S0954-6111(11)70014-2; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004; Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002; European Centre for Disease Prevention and Control (ECDC), 2016, ECDC ROADM INT MOL G; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Fiebig L, 2016, EUR RESPIR J, V47, P667, DOI 10.1183/13993003.01410-2015; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Jonsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095159; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Macaraig M, 2006, J CLIN MICROBIOL, V44, P2890, DOI 10.1128/JCM.00160-06; Mears J, 2015, THORAX; Mears J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005636; Mears J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1023; Nikolayevskyy V, 2016, TUBERCULOSIS, V98, P77, DOI 10.1016/j.tube.2016.02.009; Public Health England, 2015, TUB ENGL 2015; Robert Koch Institut, 2015, CAS DEF R KOCH I SUR; Robert Koch Institut, 2015, INF JB MEL KRANKH; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Smit PW, 2015, EUR RESPIR J, V45, P276, DOI 10.1183/09031936.00125914; Smit PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085027; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Stucki D, 2015, J INFECT DIS, V211, P1306, DOI 10.1093/infdis/jiu601; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vynnycky E, 2003, EMERG INFECT DIS, V9, P176; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188356	10.1371/journal.pone.0188356	http://dx.doi.org/10.1371/journal.pone.0188356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166403	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300034
J	Aoto, Y; Hachiya, T; Okumura, K; Hase, S; Sato, K; Wakabayashi, Y; Sakakibara, Y				Aoto, Yoshimasa; Hachiya, Tsuyoshi; Okumura, Kazuhiro; Hase, Sumitaka; Sato, Kengo; Wakabayashi, Yuichi; Sakakibara, Yasubumi			DEclust: A statistical approach for obtaining differential expression profiles of multiple conditions	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; CANCER	High-throughput RNA sequencing technology is widely used to comprehensively detect and quantify cellular gene expression. Thus, numerous analytical methods have been proposed for identifying differentially expressed genes (DEGs) between paired samples such as tumor and control specimens, but few studies have reported methods for analyzing differential expression under multiple conditions. We propose a novel method, DEclust, for differential expression analysis among more than two matched samples from distinct tissues or conditions. As compared to conventional clustering methods, DEclust more accurately extracts statistically significant gene clusters from multi-conditional transcriptome data, particularly when replicates of quantitative experiments are available. DEclust can be used for any multi-conditional transcriptome data, as well as for extending any DEG detection tool for paired samples to multiple samples. Accordingly, DEclust can be used for a wide range of applications for transcriptome data analysis. DEclust is freely available at http://www.dna.bio.keio.ac.jp/software/DEclust.	[Aoto, Yoshimasa; Hase, Sumitaka; Sato, Kengo; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan; [Hachiya, Tsuyoshi] Iwate Med Univ, Disaster Reconstruct Ctr, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Okumura, Kazuhiro; Wakabayashi, Yuichi] Chiba Canc Ctr, Res Inst, Div Expt Anim Res, Dept Carcinogenesis Res, Chiba, Chiba, Japan	Keio University; Iwate Medical University; Chiba Cancer Center	Sakakibara, Y (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan.	yasu@bio.keio.ac.jp	Sato, Kengo/D-6043-2012; Hachiya, Tsuyoshi/AAM-8691-2021	Sato, Kengo/0000-0001-6744-7390; Hachiya, Tsuyoshi/0000-0002-5274-3266	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002, 23241066]; JSPS KAKENHI [16H06279]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for KAKENHI (Grant-in-Aid for Scientific Research) on Innovative Areas No. 221S0002, and Scientific Research (A) No. 23241066 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and JSPS KAKENHI Grant Number 16H06279. and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kang GL, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1111-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188285	10.1371/journal.pone.0188285	http://dx.doi.org/10.1371/journal.pone.0188285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161291	Green Submitted, gold, Green Published			2022-12-26	WOS:000415987000039
J	Courtney, LP; Goco, N; Woja, J; Farris, T; Cummiskey, C; Smith, E; Makuach, L; Chun, HM				Courtney, Lauren P.; Goco, Norman; Woja, John; Farris, Tonya; Cummiskey, Chris; Smith, Emily; Makuach, Lia; Chun, Helen M.			HIV prevalence and behavioral risk factors in the Sudan People's Liberation Army: Data from South Sudan	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; BORDER-CROSSING ZONES; INFECTION; AFRICAN; AFGHANISTAN; COUNTRIES; IRAQ; CARE	Overview After two decades of civil war, South Sudan has limited published data on HIV prevalence and behavioral determinants of HIV infection risk. A surge in HIV/AIDS prevalence is a real concern for this new country with limited access to medical or HIV preventive services, and low education and literacy levels. We present findings from the first bio-behavioral surveillance survey conducted within the Sudan People's Liberation Army (SPLA). Methods A cross-sectional survey of 1,149 randomly selected soldiers from thirteen SPLA bases was conducted in two phases: July to August 2010 and April to May 2012. Consenting participants received HIV rapid tests, pre- and post-test counseling, and a personal interview. Demographics, knowledge, attitudes, and behaviors, including sexual behavior, alcohol use, and mental health were assessed using computer-assisted interviews. Findings The final sample included 1,063 survey participants (96.7% male). Education levels within the SPLA are low; only 16.4% attended school beyond the primary level. The overall HIV prevalence in the sample was 5.0% (95% confidence interval [CI]: 3.6-6.9). High-risk behaviors (e.g., multiple or concurrent sexual partners, heavy alcohol use, low condom use) were noted among SPLA members. High levels of HIV stigma were identified: 90.6% (n = 916) responded with one or more negative beliefs towards PLHIV, and 60.3% thought a healthy-looking person with HIV should not be allowed to remain in the SPLA. Conclusion Results from this first evaluation of risk behaviors and HIV prevalence among the SPLA highlight high-risk behaviors that may contribute to the spread of HIV. Understanding potential comorbid conditions will be critical to designing strategies to reduce HIV risk. This survey represents the first steps in understanding the HIV epidemic within the SPLA context.	[Courtney, Lauren P.; Farris, Tonya; Cummiskey, Chris; Smith, Emily] RTI Int, BiostatEpi, Washington, DC 20005 USA; [Goco, Norman] RTI Int, BiostatEpi, Res Triangle Pk, NC USA; [Woja, John; Makuach, Lia] Sudan Peoples Liberat Army, HIV Secretariat, Juba, South Sudan; [Chun, Helen M.] Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA USA	Research Triangle Institute; Research Triangle Institute; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Courtney, LP (corresponding author), RTI Int, BiostatEpi, Washington, DC 20005 USA.	lcourtney@rti.org		Goco, Norman/0000-0003-4317-4556; Smith, Emily/0000-0002-3777-3328; Farris, Tonya/0000-0003-1072-8866; Courtney, Lauren/0000-0002-8943-4934; Cummiskey, Christopher/0000-0001-6785-5829	Department of Defense HIV/AIDS Prevention Program [N00244-09-1-0087]; Sudan People's Liberation Army; GoSS	Department of Defense HIV/AIDS Prevention Program; Sudan People's Liberation Army; GoSS	This work was supported by a grant from the Department of Defense HIV/AIDS Prevention Program (grant number N00244-09-1-0087). NG, LPC, TF, CC, ES, JW, LM received this funding. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy,Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. The funder (HMC) played a key role in study design, analysis, decision to publish, and preparation of the manuscript. The funder did not provide support in the form of salaries for authors.; We would like to thank the Sudan People's Liberation Army and GoSS for their leadership and support, the SPLA study participants without whom this research would not have been possible, Dr. Fazle Khan from CDC, Carol Karutu from Intrahealth, and Major Gabriel Chinchilla for their key assistance in study planning discussions. We thank Mr. Kuol Deng Kuol (SPLA) for support and leadership in moving the study forward within the SPLA. We thank Mr. Jeffrey Mathews (RTI) for assistance on the background section and references.	Anastario M, 2011, INT J STD AIDS, V22, P73, DOI 10.1258/ijsa.2010.010274; Anastario MP, 2010, REV PANAM SALUD PUBL, V28, P361; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bing EG, 2008, AIDS BEHAV, V12, P384, DOI 10.1007/s10461-008-9368-2; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V62, P453; Central Intelligence Agency, 2012, WORLD FACTB AFR SO S; Cherpitel CJ, 2005, J STUD ALCOHOL, V66, P428, DOI 10.15288/jsa.2005.66.428; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hussain N. A. A., 2009, African Journal of Clinical and Experimental Microbiology, V10, P128; Iannacchione VG, 1982, P 7 ANN SAS US GROUP, P759; Ibrahim WMA, 2009, SUDAN J MED SCI, V4, P333; Joint United Nations Programme on HIV/AIDS, 2009, HIV REL STIGM DISCR; Joint United Nations Programme on HIV/AIDS, 2002, HIV AIDS UN SERV STO; Karunakara Unni Krishnan, 2004, Afr Health Sci, V4, P83; Mankayi N, 2009, SAHARA J-J SOC ASP H, V5, P33; Ministry of Health Government of Southern Sudan HIV/AIDS/STI Directorate, 2009, SO SUD ANT CAR CLIN; Mitike G, 2002, ETHIOPIA, V2002; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tavarez MI, 2011, AM J MENS HEALTH, V5, P65, DOI 10.1177/1557988310362097; Tull DM., 2005, SWP COMMENTS, V3, P1; United Nations General Assembly Special Session, 2008, HIV AIDS SO SUD HIV, P8; United Nations High Commissioner for Refugees, 2007, HIV BEH SURV SURV JU, P7; van der Ryst E, 2001, S AFR MED J, V91, P587; Wolter K. M., 1985, INTRO VARIANCE ESTIM	27	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187689	10.1371/journal.pone.0187689	http://dx.doi.org/10.1371/journal.pone.0187689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161275	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000016
J	Deng, FY; Guo, TW; Lefebvre, M; Scaglione, S; Antico, CJ; Jing, T; Yang, X; Shan, WX; Ramonell, KM				Deng, Fengyan; Guo, Tingwei; Lefebvre, Mitchell; Scaglione, Steven; Antico, Christopher J.; Jing, Tao; Yang, Xin; Shan, Weixing; Ramonell, Katrina M.			Expression and regulation of ATL9, an E3 ubiquitin ligase involved in plant defense	PLOS ONE			English	Article							RECOGNITION RECEPTOR FLS2; PROGRAMMED CELL-DEATH; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PEST-DOMAIN; NUCLEOCYTOPLASMIC TRAFFICKING; PROTEIN-DEGRADATION; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; CONJUGATING ENZYME	Plants are continually exposed to a variety of pathogenic organisms, including bacteria, fungi and viruses. In response to these assaults, plants have developed various defense pathways to protect themselves from pathogen invasion. An understanding of the expression and regulation of genes involved in defense signaling is essential to controlling plant disease. ATL9, an Arabidopsis RING zinc finger protein, is an E3 ubiquitin ligase that is induced by chitin and involved in basal resistance to the biotrophic fungal pathogen, Golovi-nomyces cichoracearum (G. cichoracearum). To better understand the expression and regulation of ATL9, we studied its expression pattern and the functions of its different protein domains. Using p(ATL9):GUS transgenic Arabidopsis lines we found that ATL9 is expressed in numerous tissues at various developmental stages and that GUS activity was induced rapidly upon wounding. Using a GFP control protein, we showed that ATL9 is a short-lived protein within plant cells and it is degraded via the ubiquitin-proteasome pathway. ATL9 contains two transmembrane domains (TM),a RING zinc-finger domain, and a PEST domain. Using a series of deletion mutants, we found that the PEST domain and the RING domain have effects on ATL9 degradation. Further infection assays with G. cichoracearum showed that both the RING domain and the TM domains are important for ATL9's resistance phenotype. Interestingly, the PEST domain was also shown to be significant for resistance to fungal pathogens. This study demonstrates that the PEST domain is directly coupled to plant defense regulation and the importance of protein degradation in plant immunity.	[Deng, Fengyan; Guo, Tingwei; Lefebvre, Mitchell; Scaglione, Steven; Antico, Christopher J.; Jing, Tao; Ramonell, Katrina M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Deng, Fengyan] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yang, Xin] Univ Alabama, Stat Res & Consulting Lab, Culverhouse Coll Commerce & Business Adm, Tuscaloosa, AL USA; [Shan, Weixing] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	University of Alabama System; University of Alabama Tuscaloosa; Northwest A&F University - China; University of Alabama System; University of Alabama Tuscaloosa; Northwest A&F University - China	Ramonell, KM (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	kramonel@ua.edu	Jing, Tao/AGN-9265-2022	LeFebvre, Mitchell/0000-0002-7641-7043; Jing, Tao/0000-0003-1936-4392; Scaglione, Steven/0000-0002-1947-5837	U.S. Department of Agriculture [2007-01652]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	U.S. Department of Agriculture (grant no. 2007-01652 to K. M. R.) ettps://wvmusda.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2006, PLANT CELL PHYSIOL, V47, P1683, DOI 10.1093/pcp/pcl034; Bae H, 2011, PLANT SCI, V180, P775, DOI 10.1016/j.plantsci.2011.02.008; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Bopopi JM, 2010, J EXP BOT, V61, P297, DOI 10.1093/jxb/erp305; Copeland C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00309; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Downes BP, 2003, PLANT J, V35, P729, DOI 10.1046/j.1365-313X.2003.01844.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Garcia AV, 2009, TRENDS PLANT SCI, V14, P479, DOI 10.1016/j.tplants.2009.07.004; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Guzman P, 2014, PLANT SCI, V215, P69, DOI 10.1016/j.plantsci.2013.10.017; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu HX, 2013, J BIOL CHEM, V288, P20267, DOI 10.1074/jbc.M113.465369; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu YC, 2011, MOL PLANT, V4, P938, DOI 10.1093/mp/ssr030; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Lukov GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012692; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Noda S, 2013, PLANT BIOTECHNOL-NAR, V30, P169, DOI 10.5511/plantbiotechnology.13.0304a; Obiri DD, 2012, ALLERGY, V67, P175, DOI 10.1111/j.1398-9995.2011.02731.x; Park GG, 2010, PLANT MOL BIOL, V74, P467, DOI 10.1007/s11103-010-9687-3; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Pauwels L, 2015, PLANT PHYSIOL, V169, P1405, DOI 10.1104/pp.15.00479; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sportoletti P, 2010, BRIT J HAEMATOL, V151, P404, DOI 10.1111/j.1365-2141.2010.08368.x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Takemoto D, 2012, MOL PLANT MICROBE IN, V25, P379, DOI 10.1094/MPMI-11-10-0272; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Thangasamy S, 2011, NEW PHYTOL, V189, P869, DOI 10.1111/j.1469-8137.2010.03538.x; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wiermer M, 2007, CELL MICROBIOL, V9, P1880, DOI 10.1111/j.1462-5822.2007.00962.x; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255	57	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188458	10.1371/journal.pone.0188458	http://dx.doi.org/10.1371/journal.pone.0188458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161311	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000058
J	Li, XT; Liao, W; Yu, HJ; Liu, MW; Yuan, S; Tang, BW; Yang, XH; Song, Y; Huang, Y; Cheng, SL; Chen, ZY; Towne, SD; Mao, ZF; He, QQ				Li, Xin-tong; Liao, Wei; Yu, Hong-jie; Liu, Ming-wei; Yuan, Shuai; Tang, Bo-wen; Yang, Xu-hao; Song, Yong; Huang, Yao; Cheng, Shi-le; Chen, Zhi-yu; Towne, Samuel D., Jr.; Mao, Zong-fu; He, Qi-qiang			Combined effects of fruit and vegetables intake and physical activity on the risk of metabolic syndrome among Chinese adults	PLOS ONE			English	Article							NUTRITION SURVEY; DIETARY-INTAKE; HEALTH; VALIDITY; QUESTIONNAIRE; RELIABILITY; PREVALENCE; MALES	Background Unbalanced dietary intake and insufficient physical activity (PA) have been recognized as risk factors for metabolic syndrome (MetS). We aimed to examine the independent and combined effects of fruit and vegetables (FV) intake and PA on MetS. Methods and findings A cross-sectional survey was conducted among residents of China in 2009, with fasting blood samples collected. Participants were divided into sufficient/insufficient FV intake and adequate/inadequate PA groups according to self-reported questionnaires. MetS was defined using the NCEP-ATPIII criteria. The difference of individual MetS components was compared across different PA or FV groups. Multivariable logistic regression was used to assess association between FV/PA and the risk of MetS. A total of 7424 adults were included in the current study. MetS was prevalent in 28.7% of participants, with 24.7% and 32.9% in male and female, respectively. Compared with those with inadequate PA and insufficient FV intake, participants with the combination of adequate PA and sufficient FV intake had the lowest risk of MetS (OR = 0.69,95% CI: 0.59-0.82), following by the group with adequate PA time but insufficient FV intake (OR = 0.74, 95% CI: 0.65-0.83). Conclusion Findings of the current study show that the combination of sufficient FV intake and adequate PA was significantly associated with reduced MetS risk among adult residents of China.	[Li, Xin-tong; Liao, Wei; Yu, Hong-jie; Liu, Ming-wei; Yuan, Shuai; Tang, Bo-wen; Yang, Xu-hao; Song, Yong; Huang, Yao; Chen, Zhi-yu; Mao, Zong-fu; He, Qi-qiang] Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China; [Liao, Wei] Ganzhou Hlth & Family Planning Comm, Ganzhou, Peoples R China; [Cheng, Shi-le] Wuhan Univ, Clin Sch 1, Wuhan, Hubei, Peoples R China; [Towne, Samuel D., Jr.] Texas T&M Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Promot & Community Hlth Sci, College Stn, TX USA	Wuhan University; Wuhan University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	He, QQ (corresponding author), Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China.	heqiqiang@gmail.com	Towne, Samuel/AAE-1992-2021; Cheng, Shile/HCH-4475-2022; Yu, Hongjie/GZK-5351-2022; He, Qiqiang/A-7990-2012; Yuan, Shuai/AAA-1161-2021	Yuan, Shuai/0000-0001-5055-5627; Towne, Samuel/0000-0002-7310-5837; Liu, Mingwei/0000-0003-3984-1280; Li, Xintong/0000-0002-6872-5804	China National Institute of Nutrition and Food Safety; China Centre for Disease Control; National Institutes of Health [R01HD30880, P30DK056350, R21DK089306, R01HL108427, R01HD38700]; Fogarty International Center of the National Institutes of Health; China-Japan Friendship Hospital; Chinese Ministry of Health	China National Institute of Nutrition and Food Safety; China Centre for Disease Control; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital; Chinese Ministry of Health	This research was supported by the China National Institute of Nutrition and Food Safety; the China Centre for Disease Control; the National Institutes of Health [grant numbers R01HD30880, P30DK056350, R21DK089306, R01HL108427 and R01HD38700]; the Fogarty International Center of the National Institutes of Health; the China-Japan Friendship Hospital; and the Chinese Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Anderssen SA, 2007, SCAND J MED SCI SPOR, V17, P687, DOI 10.1111/j.1600-0838.2006.00631.x; Baker AH, 2003, APPETITE, V40, P269, DOI 10.1016/S0195-6663(03)00014-X; Calton EK, 2014, NUTR RES, V34, P559, DOI 10.1016/j.nutres.2014.06.012; CARTER P, 2010, BRIT MED J, V341; Chen Yong, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P500; Clarke J, 2014, MED SCI SPORT EXER, V46, P76, DOI 10.1249/MSS.0b013e31829f83a0; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Kesse-Guyot E, 2013, NUTR METAB CARDIOVAS, V23, P677, DOI 10.1016/j.numecd.2012.02.005; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; McCall DO, 2009, CIRCULATION, V119, P2153, DOI 10.1161/CIRCULATIONAHA.108.831297; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Philippaerts RM, 1998, AM J EPIDEMIOL, V147, P982, DOI 10.1093/oxfordjournals.aje.a009389; Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1; Reis JP, 2005, MED SCI SPORT EXER, V37, P2075, DOI 10.1249/01.mss.0000179103.20821.00; Shin JY, 2015, INT J FOOD SCI NUTR, V66, P416, DOI 10.3109/09637486.2015.1025716; Wu SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152896; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Xiao J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147062; Xiao Y, 2011, ZHONGHUA LIU XING BI, V36, P232; Xu SH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040180; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Yang Y, 2005, CHINESE FOOD COMPOSI; Zang JJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0364-z; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119	31	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188533	10.1371/journal.pone.0188533	http://dx.doi.org/10.1371/journal.pone.0188533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161331	Green Published, gold, Green Submitted			2022-12-26	WOS:000415987000064
J	Azuma, K; Uchiyama, I				Azuma, Kenichi; Uchiyama, Iwao			Association between environmental noise and subjective symptoms related to cardiovascular diseases among elderly individuals in Japan	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; POPULATION-BASED SURVEY; ISCHEMIC-HEART-DISEASE; AIR-POLLUTION; TRAFFIC NOISE; UNITED-STATES; EXPOSURE; HEALTH; PREVALENCE	Noise in housing environments may increase the risk of cardiovascular diseases (CVDs); however, the most significant sources of noise among elderly individuals remain poorly understood. A nationwide cross-sectional study comprised of 6,181 elderly people (age >= 65 years) was conducted using a web-based self-reported questionnaire in 2014. Questions pertaining to CVD-related subjective symptoms within the past year addressed symptoms of chest pain, disturbances in pulse, acute impaired tongue movement, limb paralysis, and foot pain or numbness during walking. Questions concerning noise included awakening during the night due to noise, automobile, neighborhood, construction, railway, and aircraft noise. The multivariable analyses revealed that all symptoms were significantly associated with awakening during the night due to noise. Automobile, construction, railway, and aircraft noise were significantly associated with more CVD-related symptoms at nighttime than at daytime. Our results suggest that noise at nighttime is an important risk factor for CVDs. Although several different sources of environmental noise, including automobile, neighborhood, construction, railway, and aircraft noise were found to be significantly associated with CVD-related symptoms, the strongest association was observed for construction noise, followed by neighborhood and automobile noise. The adjusted odds ratios (95% confidence intervals) for construction noise at nighttime were 1.12 (1.06-1.19) with disturbances in pulse, 1.21 (1.08-1.35) in acute impaired tongue movement, 1.25 (1.15-1.36) in limb paralysis, and 1.19 (1.12-1.28) in foot pain or numbness during walking. The associations with railway and aircraft noise were found to be weaker than those with automobile, neighborhood, and construction noise. Our study suggests that CVD-related symptoms may exhibit a greater association with construction, neighborhood, and automobile noise than with railway and aircraft noise.	[Azuma, Kenichi] Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan		Azuma, K (corresponding author), Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan.; Azuma, K (corresponding author), Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan.	kenazuma@med.kindai.ac.jp		Azuma, Kenichi/0000-0002-6382-9807	Japan Automobile Research Institute	Japan Automobile Research Institute	This work was financially supported by Research Grants FY 2014 and FY 2015 provided by Japan Automobile Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x; [Anonymous], 2011, BURDEN DIS ENV NOISE; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; Bareinboim E, 2016, P NATL ACAD SCI USA, V113, P7345, DOI 10.1073/pnas.1510507113; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chum A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1788-0; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; Gan WQ, 2011, OCCUP ENVIRON MED, V68, P183, DOI 10.1136/oem.2010.055269; Golmohammadi R, 2013, J RES HEALTH SCI, V13, P201; Heritier H, 2017, EUR J EPIDEMIOL, V32, P307, DOI [10.1007/s10654-017-0234-2, 10.1007/s10654]; Ishii S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139639; *ISO, 2003, ISOTC43WG; Ito M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122969; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kalsch H, 2014, EUR HEART J, V35, P853, DOI 10.1093/eurheartj/eht426; Konishi M, 2001, J Epidemiol, V11, pS57; Krogsgaard LR, 2013, SCAND J GASTROENTERO, V48, P523, DOI 10.3109/00365521.2013.775328; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macromill, 2013, LIF SURV; McAloon CJ, 2016, INT J CARDIOL, V224, P256, DOI 10.1016/j.ijcard.2016.09.026; Ministry of Health, 2014, SUMM REP COMPR SURV; Ministry of Internal Affairs and Communications (MIAC), 2011, 2010 POP CENS; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Nafiu OO, 2014, J PERIANESTH NURS, V29, P84, DOI 10.1016/j.jopan.2013.03.010; Pyko A, 2015, OCCUP ENVIRON MED, V72, P594, DOI 10.1136/oemed-2014-102516; Reimer C, 2009, SCAND J GASTROENTERO, V44, P394, DOI 10.1080/00365520802600987; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Sasaki M, 2016, ALLERGOL INT, V65, P420, DOI 10.1016/j.alit.2016.03.007; Stansfeld S, 2000, Rev Environ Health, V15, P43; Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307; Vandasova Z, 2016, NOISE HEALTH, V18, P338, DOI 10.4103/1463-1741.195800; Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023; WHO Europe, 2009, NIGHT NOIS GUID EUR; Xiao J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111045	37	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188236	10.1371/journal.pone.0188236	http://dx.doi.org/10.1371/journal.pone.0188236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145457	gold, Green Submitted, Green Published			2022-12-26	WOS:000415378800098
J	Farahzadi, R; Fathi, E; Mesbah-Namin, SA; Zarghami, N				Farahzadi, Raheleh; Fathi, Ezzatollah; Mesbah-Namin, Seyed Alireza; Zarghami, Nosratollah			Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells	PLOS ONE			English	Article							DNA METHYLATION; HTERT EXPRESSION; STROMAL CELLS; HYPERMETHYLATION; DIFFERENTIATION; REGION	The use of mesenchymal stem cells (MSCs) for cell therapy and regenerative medicine has received widespread attention over the past few years, but their application can be complicated by factors such as reduction in proliferation potential, the senescent tendency of the MSCs upon expansion and their age-dependent decline in number and function. It was shown that all the mentioned features were accompanied by a reduction in telomerase activity and telomere shortening. Furthermore, the role of epigenetic changes in aging, especially changes in promoter methylation, was reported. In this study, MSCs were isolated from the adipose tissue with enzymatic digestion. In addition, immunocytochemistry staining and flow cytometric analysis were performed to investigate the cell-surface markers. In addition, alizarin red-S, sudan III, toluidine blue, and cresyl violet staining were performed to evaluate the multi-lineage differentiation of hADSCs. In order to improve the effective application of MSCs, these cells were treated with 1.5 x 10(-8) and 2.99 x 10(-10) M of ZnSO4 for 48 hours. The length of the absolute telomere, human telomerase reverse transcriptase (hTERT) gene expression, telomerase activity, the investigation of methylation status of the hTERT gene promoter and the percentage of senescent cells were analyzed with quantitative real-time PCR, PCR-ELISA TRAP assay, methylation specific PCR (MSP), and beta-galactosidase (SA-beta-gal) staining, respectively. The results showed that the telomere length, the hTERT gene expression, and the telomerase activity had significantly increased. In addition, the percentage of senescent cells had significantly decreased and changes in the methylation status of the CpG islands in the hTERT promoter region under treatment with ZnSO4 were seen. In conclusion, it seems that ZnSO4 as a proper antioxidant could improve the aging-related features due to lengthening of the telomeres, increasing the telomerase gene expression, telomerase activity, decreasing aging, and changing the methylation status of hTERT promoter; it could potentially beneficial for enhancing the application of aged-MSCs.	[Farahzadi, Raheleh] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran; [Farahzadi, Raheleh; Mesbah-Namin, Seyed Alireza] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran; [Fathi, Ezzatollah] Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Dept Med Biotechnol, Fac Adv Med Sci, Tabriz, Iran	Tabriz University of Medical Science; Tarbiat Modares University; University of Tabriz; Tabriz University of Medical Science; Tabriz University of Medical Science	Fathi, E (corresponding author), Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran.	ez.fathi@tabrizu.ac.ir	Farahzadi, Raheleh/W-4103-2019	Farahzadi, Raheleh/0000-0003-3159-9522	University of Tabriz [16-855]; Tarbiat Modares University [d/52/1872]	University of Tabriz; Tarbiat Modares University	Phenotypical characterization and multi lineage differentiation of hADSCs, calculation of PDT, SA-ss-gal staining, absolute telomere length measurement and PCR-ELISA TRAP assay, financially supported by University of Tabriz (No.16-855) and funding regarding the cultivation of hADSCs, hTERT gene expression and methylation specific PCR was supported by Tarbiat Modares University (No.d/52/1872).r The authors wish to thank Dr. Hojjatollah Nozad Charoudeh for donating primers. Phenotypical characterization and multi-lineage differentiation of hADSCs, calculation of PDT, SA-ss-gal staining, absolute telomere length measurement and PCR-ELISA TRAP assay, financially supported by University of Tabriz (No.16-855) and funding regarding the cultivation of hADSCs, hTERT gene expression and methylation specific PCR was supported by Tarbiat Modares University (No.d/52/1872).	Absalan A, 2016, AVICENNA J PHYTOMEDI, V6, P643; Aminizadeh N, 2016, IN VITRO CELL DEV-AN, V52, P772, DOI 10.1007/s11626-016-0021-5; Amirkhani MA, 2016, BIOIMPACTS, V6, P99, DOI 10.15171/bi.2016.14; [Anonymous], 2008, BIOTECHNIQUES, V44, P807; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Bao B, 2013, BIOL SIGNIFICANCE ZI; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Bechter OE, 2002, EXP HEMATOL, V30, P26, DOI 10.1016/S0301-472X(01)00760-3; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; Brazvan B, 2016, ADV PHARM BULL, V6, P153, DOI 10.15171/apb.2016.022; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Desai N, 2010, UROLOGY, V75, P14, DOI 10.1016/j.urology.2009.05.025; Devereux TR, 1999, CANCER RES, V59, P6087; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Farahzadi R, 2016, INT J STEM CELLS, V9, P107, DOI 10.15283/ijsc.2016.9.1.107; Fathi E, 2017, VET RES FORUM; Fathi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173877; Fathi E, 2017, EXP BIOL MED, V242, P482, DOI 10.1177/1535370216685432; Fathi Ezzatollah, 2015, Romanian Journal of Biochemistry, V52, P67; Fathi E, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016150383; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Guilleret I, 2004, BIOCHEM BIOPH RES CO, V325, P1037, DOI 10.1016/j.bbrc.2004.10.137; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Horikawa I, 1999, CANCER RES, V59, P826; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Lai GJ, 2015, INT J NANOMED, V10, P567, DOI 10.2147/IJN.S73780; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liu Q, 2004, BIOL TRACE ELEM RES, V100, P215, DOI 10.1385/BTER:100:3:215; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Mobarak H, 2017, VET RES COMMUN, V41, P41, DOI 10.1007/s11259-016-9670-9; Mortazavi Y, 2016, CELL J, V18; Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061; Nemoto K, 2000, BIOCHEM PHARMACOL, V59, P401, DOI 10.1016/S0006-2952(99)00334-2; Nomoto K, 2002, JPN J CLIN ONCOL, V32, P3, DOI 10.1093/jjco/hyf001; Noori-Zadeh A, 2017, J NEUROL SCI, V375, P203, DOI 10.1016/j.jns.2017.01.060; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Pirmoradi S, 2017, DRUG RES; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Rafi MA, 2011, BIOIMPACTS, V1, P213, DOI 10.5681/bi.2011.030; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ramlee MK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080050; Ren LG, 2007, CHEMBIOCHEM, V8, P775, DOI 10.1002/cbic.200600554; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Saleh M, 2015, ADV PHARM BULL, V5, P299, DOI 10.15171/apb.2015.042; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Wan TSK, 1999, GENE CHROMOSOME CANC, V24, P83, DOI 10.1002/(SICI)1098-2264(199901)24:1<83::AID-GCC12>3.0.CO;2-C; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wright WE, 2005, J AM GERIATRICS SOC, V53; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; Yu KR, 2013, GERONTOLOGY, V59, P557, DOI 10.1159/000353857; Yusa K, 2011, BIOCHEM BIOPH RES CO, V412, P273, DOI 10.1016/j.bbrc.2011.07.082; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	63	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188052	10.1371/journal.pone.0188052	http://dx.doi.org/10.1371/journal.pone.0188052			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145503	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800057
J	Patel, S; Fok, SYY; Stefen, H; Tomanic, T; Paric, E; Herald, R; Brettle, M; Djordjevic, A; Fath, T				Patel, Shrujna; Fok, Sandra Y. Y.; Stefen, Holly; Tomanic, Tamara; Paric, Esmeralda; Herald, Rosanna; Brettle, Merryn; Djordjevic, Aleksandra; Fath, Thomas			Functional characterisation of filamentous actin probe expression in neuronal cells	PLOS ONE			English	Article							DENDRITIC SPINES; F-ACTIN; BINDING DOMAIN; GROWTH CONES; LIVE CELLS; CYTOSKELETON; TROPOMYOSIN; PROTEINS; DYNAMICS; LIFEACT	Genetically encoded filamentous actin probes, Lifeact, Utrophin and F-tractin, are used as tools to label the actin cytoskeleton. Recent evidence in several different cell types indicates that these probes can cause changes in filamentous actin dynamics, altering cell morphology and function. Although these probes are commonly used to visualise actin dynamics in neurons, their effects on axonal and dendritic morphology has not been systematically characterised. In this study, we quantitatively analysed the effect of Lifeact, Utrophin and F-tractin on neuronal morphogenesis in primary hippocampal neurons. Our data show that the expression of actin-tracking probes significantly impacts on axonal and dendrite growth these neurons. Lifeact-GFP expression, under the control of a pBABE promoter, caused a significant decrease in total axon length, while another Lifeact-GFP expression, under the control of a CAG promoter, decreased the length and complexity of dendritic trees. Utr261-EGFP resulted in increased dendritic branching but Utr230-EGFP only accumulated in cell soma, without labelling any neurites. Lifeact-7-mEGFP and F-tractin-EGFP in a pEGFP-C1 vector, under the control of a CMV promoter, caused only minor changes in neuronal morphology as detected by Sholl analysis. The results of this study demonstrate the effects that filamentous actin tracking probes can have on the axonal and dendritic compartments of neuronal cells and emphasise the care that must be taken when interpreting data from experiments using these probes.	[Patel, Shrujna; Fok, Sandra Y. Y.; Stefen, Holly; Tomanic, Tamara; Paric, Esmeralda; Herald, Rosanna; Brettle, Merryn; Djordjevic, Aleksandra; Fath, Thomas] Univ New South Wales, Sch Med Sci, NRU, Sydney, NSW, Australia; [Stefen, Holly; Fath, Thomas] Univ New South Wales, NCCF, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Fath, T (corresponding author), Univ New South Wales, Sch Med Sci, NRU, Sydney, NSW, Australia.; Fath, T (corresponding author), Univ New South Wales, NCCF, Sydney, NSW, Australia.	t.fath@unsw.edu.au	Patel, Shrujna/GRR-4623-2022	Patel, Shrujna/0000-0003-4928-692X; Tomanic, Tamara/0000-0002-3266-1271; Herold, Rosanna/0000-0002-2583-9131; Fath, Thomas/0000-0002-6877-7567	Australian National Health and Medical Research Council (NHMRC) [APP1083209]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC), TF https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff of the Biological Resources Center of the Wallace Wurth animal facility for continuing support with mice. This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC) (T.F.).	BANKER G, 1998, CULTURING NERVE CELL; Belin Brittany J, 2014, Bioarchitecture, V4, P189, DOI 10.1080/19490992.2014.1047714; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Brock AR, 2012, J CELL SCI, V125, P5667, DOI 10.1242/jcs.107490; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chen Q, 2012, J STRUCT BIOL, V177, P32, DOI 10.1016/j.jsb.2011.10.005; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Du J, 2015, CYTOSKELETON, V72, P570, DOI 10.1002/cm.21262; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Falnikar A, 2013, CURR BIOL, V23, P1215, DOI 10.1016/j.cub.2013.05.027; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Frandemiche ML, 2014, J NEUROSCI, V34, P6084, DOI 10.1523/JNEUROSCI.4261-13.2014; Goins LM, 2015, MOL BIOL CELL, V26, P2491, DOI 10.1091/mbc.E14-12-1619; Habig K, 2013, BBA-MOL BASIS DIS, V1832, P2352, DOI 10.1016/j.bbadis.2013.09.009; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Inoue S, 2015, BIOMATER SCI-UK, V3, P1539, DOI 10.1039/c5bm00205b; Jang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039815; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Ladt K, 2016, METHOD CELL BIOL, V131, P91, DOI 10.1016/bs.mcb.2015.07.003; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Mishra M, 2014, FEMS MICROBIOL REV, V38, P213, DOI 10.1111/1574-6976.12064; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Penzes P, 2011, BRAIN RES REV, V67, P184, DOI 10.1016/j.brainresrev.2011.01.003; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Schevzov G, 2012, INT REV CEL MOL BIO, V298, P33, DOI 10.1016/B978-0-12-394309-5.00002-X; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Spracklen AJ, 2014, DEV BIOL, V393, P209, DOI 10.1016/j.ydbio.2014.06.022; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Tanokashira D, 2012, J NEUROSCI, V32, P14583, DOI 10.1523/JNEUROSCI.2380-12.2012; Tsushima H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8781; Wilson C, 2015, J CELL SCI, V128, P2989, DOI 10.1242/jcs.168567; WINDER SJ, 1995, J CELL SCI, V108, P63; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187979	10.1371/journal.pone.0187979	http://dx.doi.org/10.1371/journal.pone.0187979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145435	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800045
J	Sauter, TC; Iten, N; Schwab, PR; Hautz, WE; Ricklin, ME; Exadaktylos, AK				Sauter, Thomas C.; Iten, Nora; Schwab, Patrik R.; Hautz, Wolf E.; Ricklin, Meret E.; Exadaktylos, Aristomenis K.			Out-of-hospital cardiac arrests in Switzerland: Predictors for emergency department mortality in patients with ROSC or on-going CPR on admission to the emergency department	PLOS ONE			English	Article							RESUSCITATION OUTCOMES CONSORTIUM; INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; EURECA ONE-27 NATIONS; STROKE FOUNDATION; SOUTHERN AFRICA; ONE REGISTRY; ONE EUROPE; SURVIVAL; GENDER	Background One of the leading causes of death is out-of-hospital cardiac arrest (OHCA) with an in-hospital mortality of about 70%. To identify predictors for the high mortality of OHCA patients and especially for women, that are considered at high risk for in-hospital mortality, we evaluated one specific setting of in-hospital treatment after OHCA: the emergency department (ED). Methods Retrospective analysis of consecutive ED admissions with OHCA at the Inselspital Bern, Switzerland from 1st June 2012 to 31th Mai 2015. Demographic, preclinical and ED medical data were compared for patient groups with return of circulation (ROSC) and on-going resuscitation (CPR) on admission, as well as for subgroups with and without ED mortality. Predictors for ED mortality were investigated using univariate analysis with logistic regression. Results In 354 patients (228 (64.4%) with ROSC; 126 (35.6%) with on-going CPR) we found an overall ED mortality of 28.5% (5.7% ROSC group; 69.8% on-going CPR group). Female gender (OR 7.053 (CI 95% 2.085; 24.853), p = 0.002) and greater age (OR 1.052 (95% CI 1.006-1.101), p = 0.029) were associated with ED mortality in the ROSC but not in the ongoing CPR group. Ventricular fibrillation as initially monitored rhythm (OR 0.126 (95% CI 0.027-0.582), p = 0.008) and shorter CPR duration (OR 1.055 (95% CI 1.024; 1.088), p = 0.001) were associated with ED survival in patients with ROSC but not in patients with ongoing CPR on admission. In ROSC patients a higher lactate and lower pH were associated with mortality (pH: OR 0.009 (CI95% 0.000; 0.420), p = 0.016; lactate: OR 1.183 (95% CI 1.037; 1.349), p = 0.013); similar in on-going CPR patients (pH 0.061 (95% CI 0.007, 0.558), p = 0.013, lactate: 1.146 (95% CI 1.041; 1.261), p = 0.005). Conclusion Patients with ROSC who died during ED care were predominantly women and older patients, as well as patients with non-shockable initial heart rhythm and long CPR durations. In patients with on-going CPR on admission, no clinical or demographic predictors for ED mortality were found. Higher lactate and lower pH were predictors in both OHCA groups.	[Sauter, Thomas C.; Iten, Nora; Schwab, Patrik R.; Hautz, Wolf E.; Ricklin, Meret E.; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland; [Schwab, Patrik R.] Sanitaetspolizei Bern, Emergency Med Serv, Bern, Switzerland	University of Bern; University Hospital of Bern	Sauter, TC (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland.	thomas.sauter@insel.ch	Ricklin, Meret Elisabeth/AAY-7948-2021	Ricklin, Meret Elisabeth/0000-0003-3047-9350; Sauter, Thomas C/0000-0002-6646-5789; Hautz, Wolf/0000-0002-2445-984X				Bougouin W, 2015, RESUSCITATION, V94, P55, DOI 10.1016/j.resuscitation.2015.06.018; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Exadaktylos A, 2015, ICU MANAG 2015, V15, P160; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hasan OF, 2014, CURR MED RES OPIN, V30, P2169, DOI 10.1185/03007995.2014.936552; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Morrison LJ, 2007, RESUSCITATION, V74, P266, DOI 10.1016/j.resuscitation.2007.01.009; Morrison LJ, 2016, RESUSCITATION, V100, P76, DOI 10.1016/j.resuscitation.2015.12.002; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Verbeek PR, 2002, ACAD EMERG MED, V9, P671, DOI 10.1197/aemj.9.7.671; Whittaker A, 2016, POSTGRAD MED J, V92, P250, DOI 10.1136/postgradmedj-2015-133575; Wnent J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0093-3	16	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188180	10.1371/journal.pone.0188180	http://dx.doi.org/10.1371/journal.pone.0188180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145510	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800081
J	Bratkowski, M; Unarta, IC; Zhu, LZ; Shubbar, M; Huang, XH; Liu, X				Bratkowski, Matthew; Unarta, Ilona Christy; Zhu, Lizhe; Shubbar, Murtada; Huang, Xuhui; Liu, Xin			Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						general transcription factor (GTF); RNA polymerase II; transcription initiation factor; transcription regulation; transcription termination; gene looping; promoter-terminator cross-talk; TFIIB; Ssu72	RNA-POLYMERASE-II; START SITE SELECTION; GENE LOOPS; FACTOR-TFIIB; TATA BOX; CONFORMATIONAL-CHANGE; DOMAIN PHOSPHATASE; CRYSTAL-STRUCTURE; YEAST TFIIB; SSU72	Functional cross-talk between the promoter and terminator of a gene has long been noted. Promoters and terminators are juxtaposed to form gene loops in several organisms, and gene looping is thought to be involved in transcriptional regulation. The general transcription factor IIB (TFIIB) and the C-terminal domain phosphatase Ssu72, essential factors of the transcription preinitiation complex and the mRNA processing and polyadenylation complex, respectively, are important for gene loop formation. TFIIB and Ssu72 interact both genetically and physically, but the molecular basis of this interaction is not known. Here we present a crystal structure of the core domain of TFIIB in two new conformations that differ in the relative distance and orientation of the two cyclin-like domains. The observed extraordinary conformational plasticity may underlie the binding of TFIIB to multiple transcription factors and promoter DNAs that occurs in distinct stages of transcription, including initiation, reinitiation, and gene looping. We mapped the binding interface of the TFIIB-Ssu72 complex using a series of systematic, structure-guided in vitro binding and site-specific photocross-linking assays. Our results indicate that Ssu72 competes with acidic activators for TFIIB binding and that Ssu72 disrupts an intramolecular TFIIB complex known to impede transcription initiation. We also show that the TFIIB-binding site on Ssu72 overlaps with the binding site of symplekin, a component of the mRNA processing and polyadenylation complex. We propose a hand-off model in which Ssu72 mediates a conformational transition in TFIIB, accounting for the role of Ssu72 in transcription reinitiation, gene looping, and promoter-terminator cross-talk.	[Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Unarta, Ilona Christy; Zhu, Lizhe; Huang, Xuhui] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Unarta, Ilona Christy; Zhu, Lizhe; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.; Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA.; Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	xin.liu@utsouthwestern.edu	Huang, Xuhui/ABE-3207-2021; Zhu, Lizhe/K-1139-2012	Huang, Xuhui/0000-0002-7119-9358; Zhu, Lizhe/0000-0001-8252-7807	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM121662, R01GM114576] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shih-Chia Tso, Thomas Scheuermann, and Chad Brautigam for assistance with ITC experiments and Diana Tomchick and Zhe Chen for help with X-ray data collection. We thank Haydn Ball of the UT Southwestern Protein Technology Core for peptide synthesis. We thank Qiong Wu and Jose Rizo-Rey for preliminary NMR analysis. We thank Michael Carey (Department of Biological Chemistry, UCLA, Los Angeles, CA) for generously providing the VP16AD expression plasmid. We thank Peter Schultz (Scripps Research Institute) for generously providing the pEVOL-pBpA plasmid. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract DE-AC02-05CH11231. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIGMS, National Institutes of Health, Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; Blau C, 2013, COMPUT PHYS COMMUN, V184, P2856, DOI 10.1016/j.cpc.2013.07.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burley SK, 1998, CELL, V94, P551, DOI 10.1016/S0092-8674(00)81596-2; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glossop JA, 2004, NUCLEIC ACIDS RES, V32, P1829, DOI 10.1093/nar/gkh504; GONZALEZ TF, 1985, THEOR COMPUT SCI, V38, P293, DOI 10.1016/0304-3975(85)90224-5; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hawkes NA, 2000, CURR BIOL, V10, P273, DOI 10.1016/S0960-9822(00)00363-8; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ibrahim BS, 2009, P NATL ACAD SCI USA, V106, P13242, DOI 10.1073/pnas.0904309106; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; PINTO I, 1994, J BIOL CHEM, V269, P30569; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; ROBERTS SGE, 1995, CURR BIOL, V5, P508, DOI 10.1016/S0960-9822(95)00103-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; St-Pierre B, 2005, NUCLEIC ACIDS RES, V33, P464, DOI 10.1093/nar/gki171; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu WH, 1999, GENETICS, V153, P643; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhang DY, 2000, NUCLEIC ACIDS RES, V28, P1913, DOI 10.1093/nar/28.9.1913	76	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1651	1665		10.1074/jbc.M117.811521	http://dx.doi.org/10.1074/jbc.M117.811521			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29158257	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000424201700017
J	Yang, J; Zhang, R; Jiang, X; Lv, JZ; Li, Y; Ye, HY; Liu, WJ; Wang, G; Zhang, CC; Zheng, N; Dong, M; Wang, Y; Chen, PY; Santosh, K; Jiang, Y; Liu, J				Yang, Jie; Zhang, Rui; Jiang, Xin; Lv, Jingzhang; Li, Ying; Ye, Hongyu; Liu, Wenjuan; Wang, Gang; Zhang, Cuicui; Zheng, Na; Dong, Ming; Wang, Yan; Chen, Peiya; Santosh, Kumar; Jiang, Yong; Liu, Jie			Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca2+ leakage promote cardiac contractile dysfunction in sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; POLYMICROBIAL SEPSIS; THERAPEUTIC STRATEGY; DEFECTIVE REGULATION; FREE-RADICALS; HEART; RELEASE; FKBP12.6; CHANNELS; BINDING	Studies suggest the potential role of a sarcoplasmic reticulum (SR) Ca2+ leak in cardiac contractile dysfunction in sepsis. However, direct supporting evidence is lacking, and the mechanisms underlying this SR leak are poorly understood. Here, we investigated the changes in cardiac Ca2+ handling and contraction in LPS-treated rat cardiomyocytes and a mouse model of polymicrobial sepsis produced by cecal ligation and puncture (CLP). LPS decreased the systolic Ca2+ transient and myocyte contraction as well as SR Ca2+ content. Meanwhile, LPS increased Ca2+ spark-mediated SR Ca2+ leak. Preventing the SR leak with ryanodine receptor (RyR) blocker tetracaine restored SR load and increased myocyte contraction. Similar alterations in Ca2+ handling were observed in cardiomyocytes from CLP mice. Treatment with JTV-519, an anti-SR leak drug, restored Ca2+ handling and improved cardiac function. In the LPS-treated cardiomyocytes, mitochondrial reactive oxygen species and oxidative stress in RyR2 were increased, whereas the levels of the RyR2-associated FK506-binding protein 1B (FKBP12.6) were decreased. The Toll-like receptor 4 (TLR4)-specific inhibitor TAK-242 reduced the oxidative stress in LPS-treated cells, decreased the SR leak, and normalized Ca2+ handling and myocyte contraction. Consistently, TLR4 deletion significantly improved cardiac function and corrected abnormal Ca2+ handling in the CLP mice. This study provides evidence for the critical role of the SR Ca2+ leak in the development of septic cardiomyopathy and highlights the therapeutic potential of JTV-519 by preventing SR leak. Furthermore, it reveals that TLR4 activation-induced mitochondrial reactive oxygen species production and the resulting oxidative stress in RyR2 contribute to the SR Ca2+ leak.	[Yang, Jie; Zhang, Rui; Jiang, Yong; Liu, Jie] Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China; [Yang, Jie; Li, Ying; Liu, Wenjuan; Wang, Gang; Zhang, Cuicui; Zheng, Na; Dong, Ming; Wang, Yan; Chen, Peiya; Santosh, Kumar; Liu, Jie] Shenzhen Univ, Sch Med, Dept Pathophysiol, Shenzhen 518060, Peoples R China; [Jiang, Xin] Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 2, Dept Cardiol, Shenzhen 518000, Peoples R China; [Lv, Jingzhang] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen 518045, Peoples R China; [Ye, Hongyu] Zhongshan Peoples Hosp, Dept Cardiothorac Surg, Zhongshan 528415, Peoples R China	Southern Medical University - China; Shenzhen University; Jinan University	Liu, J (corresponding author), Shenzhen Univ, Sch Med, Dept Pathophysiol, Shenzhen 518060, Peoples R China.; Jiang, Y (corresponding author), Southern Med Univ, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Prote, Guangzhou 510515, Guangdong, Peoples R China.	jiang48231@163.com; liuj@szu.edu.cn	Li, Ying/AAC-1331-2021; liu, wen/HGE-3071-2022		National Science Foundation of China [31371159, 31671179, 81401570, 31400982, 81670211, 81372030]; Basic Research Foundation of SZ [JCYJ20160308091147262]; NSFC-Guangdong Joint Foundation of China [U1601225]; Key Scientific and Technological Program of Guangzhou City [201607020016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Foundation of SZ; NSFC-Guangdong Joint Foundation of China; Key Scientific and Technological Program of Guangzhou City	This work was supported by National Science Foundation of China Grants 31371159 and 31671179 (to J. L.), 81401570 (to J. X.), 31400982 (to W. L.), 81670211 (to G. W.), and 81372030 (to J. Y.); by Basic Research Foundation of SZ Grant JCYJ20160308091147262 (to J. L.); by NSFC-Guangdong Joint Foundation of China Grant U1601225 (to J. Y.); and by Key Scientific and Technological Program of Guangzhou City Grant 201607020016 (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Blayney LM, 2010, CARDIOVASC RES, V85, P68, DOI 10.1093/cvr/cvp273; Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Cimolai MC, 2015, INT J MOL SCI, V16, P17763, DOI 10.3390/ijms160817763; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Deng JX, 2008, FREE RADICAL BIO MED, V44, P375, DOI 10.1016/j.freeradbiomed.2007.09.023; Deng JX, 2012, J MOL CELL CARDIOL, V53, P646, DOI 10.1016/j.yjmcc.2012.08.009; Du B, 2013, CRIT CARE MED, V41, P84, DOI 10.1097/CCM.0b013e31826a4082; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Fauconnier J, 2011, P NATL ACAD SCI USA, V108, P13258, DOI 10.1073/pnas.1100286108; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Gao M, 2012, CRIT CARE MED, V40, P2390, DOI 10.1097/CCM.0b013e3182535aeb; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Kwon OS, 2016, AM J PHYSIOL-REG I, V311, pR879, DOI 10.1152/ajpregu.00253.2016; Li H, 2014, J BIOL CHEM, V289, P23075, DOI 10.1074/jbc.M114.591495; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Ma H, 2016, J INFECT DIS, V214, P1773, DOI 10.1093/infdis/jiw449; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; Neri M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3423450; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Okatan EN, 2013, J NUTR BIOCHEM, V24, P2110, DOI 10.1016/j.jnutbio.2013.08.002; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Raj S, 2014, J PEDIATR-US, V164, P72, DOI 10.1016/j.jpeds.2013.09.027; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roy J, 2015, FREE RADICAL BIO MED, V86, P269, DOI 10.1016/j.freeradbiomed.2015.04.014; Sacherer M, 2012, BRIT J PHARMACOL, V167, P493, DOI 10.1111/j.1476-5381.2012.01995.x; Sepulveda M, 2017, CRIT CARE MED, V45, pE399, DOI 10.1097/CCM.0000000000002101; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Venetucci LA, 2006, CIRC RES, V98, P1299, DOI 10.1161/01.RES.0000222000.35500.65; Wang W, 2010, AM J PHYSIOL-HEART C, V299, pH322, DOI 10.1152/ajpheart.00392.2010; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yancey DM, 2015, AM J PHYSIOL-HEART C, V308, pH651, DOI 10.1152/ajpheart.00638.2014; Yang ZK, 2005, CARDIOVASC RES, V65, P167, DOI 10.1016/j.cardiores.2004.09.008; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang CC, 2014, J MOL CELL CARDIOL, V74, P260, DOI 10.1016/j.yjmcc.2014.06.003; Zhang M, 2014, ANESTHESIOLOGY, V121, P1270, DOI 10.1097/ALN.0000000000000337; Zhang X, 2009, CARDIOVASC RES, V84, P253, DOI 10.1093/cvr/cvp212; Zhao YT, 2017, CARDIOVASC RES, V113, P332, DOI 10.1093/cvr/cvw247; Zheng J, 2010, CELL CALCIUM, V47, P449, DOI 10.1016/j.ceca.2010.03.006; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zhu XS, 2005, CRIT CARE MED, V33, P598, DOI 10.1097/01.ccm.0000152223.27176.A6	64	25	25	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					794	807		10.1074/jbc.M117.812289	http://dx.doi.org/10.1074/jbc.M117.812289			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150444	hybrid, Green Published			2022-12-26	WOS:000422864500004
J	Kebouchi, M; Saul, F; Taher, R; Landier, A; Beaudeau, B; Dubrac, S; Weber, P; Haouz, A; Picardeau, M; Benaroudj, N				Kebouchi, Mounira; Saul, Frederick; Taher, Raleb; Landier, Annie; Beaudeau, Benedicte; Dubrac, Sarah; Weber, Patrick; Haouz, Ahmed; Picardeau, Mathieu; Benaroudj, Nadia			Structure and function of the Leptospira interrogans peroxide stress regulator (PerR), an atypical PerR devoid of a structural metal-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloprotein; microbiology; oxidative stress; reactive oxygen species (ROS); structural biology; transcription regulation; PerR; Leptospira; spirochetes	BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; IRON HOMEOSTASIS; FUR HOMOLOGS; OXYGEN; VIRULENCE; INSIGHTS; REGULON; RESISTANCE	Peroxide sensing is essential for bacterial survival during aerobic metabolism and host infection. Peroxide stress regulators (PerRs) are homodimeric transcriptional repressors with each monomer typically containing both structural and regulatory metal-binding sites. PerR binding to gene promoters is controlled by the presence of iron in the regulatory site, and iron-catalyzed oxidation of PerR by H2O2 leads to the dissociation of PerR from DNA. In addition to a regulatory metal, most PerRs require a structural metal for proper dimeric assembly. We present here a structural and functional characterization of the PerR from the pathogenic spirochete Leptospira interrogans, a rare example of PerR lacking a structural metal-binding site. In vivo studies showed that the leptospiral PerR belongs to the peroxide stimulon in pathogenic species and is involved in controlling resistance to peroxide. Moreover, a perR mutant had decreased fitness in other host-related stress conditions, including at 37 degrees C or in the presence of superoxide anion. In vitro, leptospiral PerR could bind to the perR promoter region in a metal-dependent manner. The crystal structure of the leptospiral PerR revealed an asymmetric homodimer, with one monomer displaying complete regulatory metal coordination in the characteristic caliper-like DNA-binding conformation and the second monomer exhibiting disrupted regulatory metal coordination in an open non-DNA-binding conformation. This structure showed that leptospiral PerR assembles into a dimer in which a metal-induced conformational switch can occur independently in the two monomers. Our study demonstrates that structural metal binding is not compulsory for PerR dimeric assembly and for regulating peroxide stress.	[Kebouchi, Mounira; Taher, Raleb; Landier, Annie; Beaudeau, Benedicte; Picardeau, Mathieu; Benaroudj, Nadia] Inst Pasteur, Unite Biol Spirochetes, F-75015 Paris, France; [Saul, Frederick; Weber, Patrick; Haouz, Ahmed] Inst Pasteur, CNRS, UMR 3528, Plate Forme Cristallog, F-75015 Paris, France; [Dubrac, Sarah] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75015 Paris, France; [Kebouchi, Mounira] Univ Lorraine, INRA, UR AFPA, PB2P, F-54518 Vandoeuvre Les Nancy, France; [Taher, Raleb] Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble 9, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Universite de Lorraine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Picardeau, M; Benaroudj, N (corresponding author), Inst Pasteur, Unite Biol Spirochetes, F-75015 Paris, France.	mathieu.picardeau@pasteur.fr; nadia.benaroudj@pasteur.fr		Sarah, Dubrac/0000-0002-9810-5390; Benaroudj, Nadia/0000-0002-6475-0041; HAOUZ, Ahmed/0000-0003-1196-1635	Institut Pasteur; Agence National de la Recherche [ANR-08-MIE-018]	Institut Pasteur(European Commission); Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by the Institut Pasteur and Agence National de la Recherche Grant ANR-08-MIE-018. The authors declare that they have no conflicts of interest with the contents of this article.	Adler B, 2014, VET MICROBIOL, V172, P353, DOI 10.1016/j.vetmic.2014.06.015; Ahn BE, 2016, P NATL ACAD SCI USA, V113, pE23, DOI 10.1073/pnas.1522687112; Araujo AM, 2014, AM J TROP MED HYG, V90, P719, DOI 10.4269/ajtmh.13-0667; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deng ZQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8642; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdogan HM, 2008, VET RES COMMUN, V32, P333, DOI 10.1007/s11259-008-9036-z; Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; Giedroc DP, 2009, MOL MICROBIOL, V73, P1, DOI 10.1111/j.1365-2958.2009.06752.x; Gryllos I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000145; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hillmann F, 2008, MOL MICROBIOL, V68, P848, DOI 10.1111/j.1365-2958.2008.06192.x; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lin CSH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089027; Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10; Long LH, 1999, BIOCHEM BIOPH RES CO, V262, P605, DOI 10.1006/bbrc.1999.1263; Makthal N, 2013, J BIOL CHEM, V288, P18311, DOI 10.1074/jbc.M113.456590; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P3176, DOI 10.1128/AEM.00173-15; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; ROVIN BH, 1990, KIDNEY INT, V37, P1509, DOI 10.1038/ki.1990.142; Sethu R, 2016, ACS CHEM BIOL, V11, P1438, DOI 10.1021/acschembio.5b01054; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shlyonsky V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9512807; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zhukova A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00010	57	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					497	509		10.1074/jbc.M117.804443	http://dx.doi.org/10.1074/jbc.M117.804443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29146596	Green Published, hybrid			2022-12-26	WOS:000419915400007
J	Skowronska, M; McDonald, M; Velichkovska, M; Leda, AR; Park, M; Toborek, M				Skowronska, Marta; McDonald, Marisa; Velichkovska, Martina; Leda, Ana Rachel; Park, Minseon; Toborek, Michal			Methamphetamine increases HIV infectivity in neural progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADULT HIPPOCAMPAL NEUROGENESIS; LASER CAPTURE MICRODISSECTION; CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; STEM-CELLS; POTENTIAL ROLE; VIRAL LOAD; NEURODEGENERATIVE DISEASES; TYPE-1 INFECTION	HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNF B/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100 M). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH. METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NF B and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NF B/SP1-dependentactivationoftheHIVLTRandwiththesubsequentalterations of NPC neurogenesis. Such events may underlie METH-exacerbated neurocognitive dysfunction in HIV-infected patients.	[Skowronska, Marta; McDonald, Marisa; Velichkovska, Martina; Leda, Ana Rachel; Park, Minseon; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA; [Toborek, Michal] Jerzy Kukuczka Acad Phys Educ, PL-40001 Katowice, Poland	University of Miami; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Skowronska, M; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	m.skowronska@miami.edu; mtoborek@med.miami.edu	Leda, Ana/AAD-9372-2021	Leda, Ana/0000-0003-0276-0487	National Institutes of Health (NIH) [DA039576, DA044579, DA027569, HL126559, MH098891, MH072567]; Miami Center for AIDS Research - NIH [P30AI073961]; NIH [NSC 2015/17/B/NZ7/02985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072567, R01MH098891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA044579, R01DA039576, R01DA027569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Center for AIDS Research - NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) Grants DA039576, DA044579, DA027569, HL126559, MH098891, and MH072567 and by the Miami Center for AIDS Research, funded by NIH Grant P30AI073961. This work was also supported by NIH Grant NSC 2015/17/B/NZ7/02985. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Borgmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01143; Canto-Noges C, 2005, J MOL NEUROSCI, V27, P79, DOI 10.1385/JMN:27:1:079; Carrico AW, 2007, PSYCHOSOM MED, V69, P785, DOI 10.1097/PSY.0b013e318157b142; Chang SL, 2014, INT REV NEUROBIOL, V118, P403, DOI 10.1016/B978-0-12-801284-0.00013-0; Clarke JN, 2006, VIROLOGY, V348, P141, DOI 10.1016/j.virol.2005.12.004; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Curtis MA, 2007, CLIN EXP PHARMACOL P, V34, P528, DOI 10.1111/j.1440-1681.2007.04609.x; Curtis MA, 2003, CELL CYCLE, V2, P428, DOI 10.4161/cc.2.5.526; Demeter K, 2004, EXP NEUROL, V188, P254, DOI 10.1016/j.expneurol.2004.04.011; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Freeman P, 2011, ARCH PEDIAT ADOL MED, V165, P736, DOI 10.1001/archpediatrics.2011.118; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Hahn YK, 2012, GLIA, V60, P1871, DOI 10.1002/glia.22403; Hahn YK, 2010, J NEUROCHEM, V114, P97, DOI 10.1111/j.1471-4159.2010.06744.x; Hauser KF, 2014, INT REV NEUROBIOL, V118, P231, DOI 10.1016/B978-0-12-801284-0.00009-9; Hildebrandt K, 1999, J NEURAL TRANSM, V106, P549, DOI 10.1007/s007020050178; Hong SZ, 2015, BRAIN BEHAV IMMUN, V45, P1, DOI 10.1016/j.bbi.2014.10.008; Jiang JJ, 2016, DRUG ALCOHOL DEPEN, V159, P246, DOI 10.1016/j.drugalcdep.2015.12.027; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; King WD, 2009, AIDS BEHAV, V13, P145, DOI 10.1007/s10461-007-9337-1; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; Le Grand JN, 2015, CELL MOL LIFE SCI, V72, P773, DOI 10.1007/s00018-014-1774-1; Leda AR, 2017, JOVE-J VIS EXP, DOI 10.3791/54804; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee MH, 2011, NEUROBIOL DIS, V41, P678, DOI 10.1016/j.nbd.2010.12.002; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lieberwirth C, 2016, BRAIN RES, V1644, P127, DOI 10.1016/j.brainres.2016.05.015; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Mantri CK, 2014, AM J PATHOL, V184, P92, DOI 10.1016/j.ajpath.2013.09.011; Maragos WF, 2002, J NEUROCHEM, V83, P955, DOI 10.1046/j.1471-4159.2002.01212.x; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Matinella A, 2015, J NEUROL, V262, P1317, DOI 10.1007/s00415-015-7713-8; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; MELEGA WP, 1995, J PHARMACOL EXP THER, V274, P90; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nakamura N, 2011, ARCH SEX BEHAV, V40, P793, DOI 10.1007/s10508-010-9713-1; NICOSIA N, 2009, EC COST METHAMPHETAM; Park M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34111; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rothenaigner I, 2007, AIDS, V21, P2271, DOI 10.1097/QAD.0b013e3282f12f27; Sabri F, 1999, VIROLOGY, V264, P370, DOI 10.1006/viro.1999.9998; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Salamanca SA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00445; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Soontornniyomkij V, 2016, J NEUROIMMUNE PHARM, V11, P495, DOI 10.1007/s11481-016-9699-0; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Torres-Munoz J, 2001, J NEUROPATH EXP NEUR, V60, P885, DOI 10.1093/jnen/60.9.885; Toussi SS, 2009, AIDS RES HUM RETROV, V25, P1117, DOI 10.1089/aid.2008.0282; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Varela-Nallar L, 2010, BIRTH DEFECTS RES C, V90, P284, DOI 10.1002/bdrc.20193; Wang X, 2012, CURR HIV RES, V10, P407, DOI 10.2174/157016212802138797; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Winner B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021287; Wires ES, 2012, J NEUROVIROL, V18, P400, DOI 10.1007/s13365-012-0103-4; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Yuan CJ, 2011, PHARMACOL BIOCHEM BE, V100, P98, DOI 10.1016/j.pbb.2011.08.004; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	75	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					296	311		10.1074/jbc.RA117.000795	http://dx.doi.org/10.1074/jbc.RA117.000795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158267	hybrid, Green Published			2022-12-26	WOS:000419453200025
J	Andres-Blanco, AM; Alvarez, D; Crespo, A; Arroyo, CA; Cerezo-Hernandez, A; Gutierrez-Tobal, GC; Hornero, R; del Campo, F				Andres-Blanco, Ana M.; Alvarez, Daniel; Crespo, Andrea; Arroyo, C. Ainhoa; Cerezo-Hernandez, Ana; Gutierrez-Tobal, Gonzalo C.; Hornero, Roberto; del Campo, Felix			Assessment of automated analysis of portable oximetry as a screening test for moderate-to-severe sleep apnea in patients with chronic obstructive pulmonary disease	PLOS ONE			English	Article							OVERNIGHT PULSE OXIMETRY; CLINICAL-PRACTICE GUIDELINE; OXYGEN-SATURATION; NEURAL-NETWORK; DIAGNOSIS; ADULTS; POLYSOMNOGRAPHY; PREDICTION; MANAGEMENT; UTILITY	Background The coexistence of obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) leads to increased morbidity and mortality. The development of home-based screening tests is essential to expedite diagnosis. Nevertheless, there is still very limited evidence on the effectiveness of portable monitoring to diagnose OSAS in patients with pulmonary comorbidities. Objective To assess the influence of suffering from COPD in the performance of an oximetry-based screening test for moderate-to-severe OSAS, both in the hospital and at home. Methods A total of 407 patients showing moderate-to-high clinical suspicion of OSAS were involved in the study. All subjects underwent (i) supervised portable oximetry simultaneously to inhospital polysomnography (PSG) and (ii) unsupervised portable oximetry at home. A regression- based multilayer perceptron (MLP) artificial neural network (ANN) was trained to estimate the apnea-hypopnea index (AHI) from portable oximetry recordings. Two independent validation datasets were analyzed: COPD versus non-COPD. Results The portable oximetry-based MLP ANN reached similar intra-class correlation coefficient (ICC) values between the estimated AHI and the actual AHI for the non-COPD and the COPD groups either in the hospital (non-COPD: 0.937, 0.909-0.956 CI95%; COPD: 0.936, 0.899-0.960 CI95%) and at home (non-COPD: 0.731, 0.631-0.808 CI95%; COPD: 0.788, 0.678-0.864 CI95%). Regarding the area under the receiver operating characteristics curve (AUC), no statistically significant differences (p > 0.01) between COPD and non-COPD groups were found in both settings, particularly for severe OSAS (AHI >= 30 events/h): 0.97 (0.92-0.99 CI95%) non-COPD vs. 0.98 (0.92-1.0 CI95%) COPD in the hospital, and 0.87 (0.79-0.92 CI95%) non-COPD vs. 0.86 (0.75-0.93 CI95%) COPD at home. Conclusion The agreement and the diagnostic performance of the estimated AHI from automated analysis of portable oximetry were similar regardless of the presence of COPD both in-lab and athome. Particularly, portable oximetry could be used as an abbreviated screening test for moderate-to-severe OSAS in patients with COPD.	[Andres-Blanco, Ana M.; Alvarez, Daniel; Crespo, Andrea; Arroyo, C. Ainhoa; Cerezo-Hernandez, Ana; del Campo, Felix] Rio Hortega Univ Hosp, Pneumol Serv, Valladolid, Spain; [Alvarez, Daniel; Crespo, Andrea; Gutierrez-Tobal, Gonzalo C.; Hornero, Roberto; del Campo, Felix] Univ Valladolid, Biomed Engn Grp, Valladolid, Spain	Hospital del Rio Hortega; Universidad de Valladolid	del Campo, F (corresponding author), Rio Hortega Univ Hosp, Pneumol Serv, Valladolid, Spain.; del Campo, F (corresponding author), Univ Valladolid, Biomed Engn Grp, Valladolid, Spain.	fsas@telefonica.net	Alvarez, Daniel/F-2557-2010; Hornero, Roberto/M-5313-2019; del campo, Felix/G-5716-2017; Gutierrez-Tobal, Gonzalo C./L-8301-2013	Alvarez, Daniel/0000-0003-1027-2395; Hornero, Roberto/0000-0001-9915-2570; del campo, Felix/0000-0002-4554-2167; Gutierrez-Tobal, Gonzalo C./0000-0002-1237-3424; Crespo, Andrea/0000-0002-2709-5797	Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) [265/2012]; Ministerio de Economia y Competitividad [RTC-2015-3446-1, TEC2014-53196-R, IJCI-2014-22664]; European Regional Development Fund (FEDER); Junta de Castilla y Leon [VA037U16, GRS 752/A/13]; FEDER	Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); FEDER(European Commission)	This research has been partially supported by the project 265/2012 of the Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), projects RTC-2015-3446-1 and TEC2014-53196-R from the Ministerio de Economia y Competitividad and the European Regional Development Fund (FEDER), and the projects VA037U16 and GRS 752/A/13 from Junta de Castilla y Leon and FEDER. D. Alvarez was in receipt of a Juan de la Cierva grant IJCI-2014-22664 from the Ministerio de Economia y Competitividad.	Acharya UR, 2011, PHYSIOL MEAS, V32, P287, DOI 10.1088/0967-3334/32/3/002; Nigro CA, 2011, SLEEP BREATH, V15, P679, DOI 10.1007/s11325-010-0421-9; Alvarez D, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500202; Alvarez D, 2012, MED ENG PHYS, V34, P1049, DOI 10.1016/j.medengphy.2011.11.009; Alvarez D, 2010, IEEE T BIO-MED ENG, V57, P2816, DOI 10.1109/TBME.2010.2056924; Bishop C. M, 2006, PATTERN RECOGNITION; Bossuyt PM, 2015, RADIOLOGY, V277, P826, DOI 10.1148/radiol.2015151516; Chiao W, 2017, LARYNGOSCOPE, V127, P2891, DOI 10.1002/lary.26736; Chung F, 2012, ANESTH ANALG, V114, P993, DOI 10.1213/ANE.0b013e318248f4f5; Cohen ME, 1996, IEEE ENG MED BIOL, V15, P97, DOI 10.1109/51.537065; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Cooksey JA, 2016, CHEST, V149, P1074, DOI 10.1378/chest.15-1076; Corlateanu A, 2017, BREATHE, V13, P137, DOI 10.1183/20734735.007717; Dawson A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007956; del Campo F, 2006, ARTIF INTELL MED, V37, P111, DOI 10.1016/j.artmed.2005.10.005; El-Solh AA, 1999, SLEEP, V22, P105, DOI 10.1093/sleep/22.1.105; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Flores M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167031; Garde A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112959; Gutierrez-Tobal GC, 2016, IEEE T BIO-MED ENG, V63, P636, DOI 10.1109/TBME.2015.2467188; Gutierrez-Tobal G, 2013, MED BIOL ENG COMPUT, V51, P1367, DOI 10.1007/s11517-013-1109-7; Hang LW, 2016, INT J CHRONIC OBSTR, V11, DOI 10.2147/COPD.S96504; Iber C., 2007, AASM MANUAL SCORING; Jobson JD, 1991, APPL MULTIVARIATE DA, VI; Jung DW, 2017, IEEE T BIOM IN PRESS; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Karamanli H, 2016, SLEEP BREATH, V20, P509, DOI 10.1007/s11325-015-1218-7; Magalang UJ, 2003, CHEST, V124, P1694, DOI 10.1378/chest.124.5.1694; Marcos JV, 2008, COMPUT METH PROG BIO, V92, P79, DOI 10.1016/j.cmpb.2008.05.006; Masa JF, 2014, SLEEP, V37, P1953, DOI 10.5665/sleep.4248; Masa JF, 2013, EUR RESPIR J, V41, P879, DOI 10.1183/09031936.00186811; McNicholas WT, 2017, CHEST IN PRESS; Mieczkowski B, 2014, INT J CHRONIC OBSTR, V9, P349, DOI 10.2147/COPD.S42394; Nabney IT, 2002, MED BIOL ENG COMPUT; Netzer N, 2001, CHEST, V120, P625, DOI 10.1378/chest.120.2.625; Oliveira MG, 2012, SLEEP MED, V13, P1033, DOI 10.1016/j.sleep.2012.06.011; PEPIN JL, 1991, CHEST, V99, P1151, DOI 10.1378/chest.99.5.1151; Poza J, 2007, MED ENG PHYS, V29, P1073, DOI 10.1016/j.medengphy.2006.11.006; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187; Redline S, 1998, SLEEP, V21, P759; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Saaresranta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163439; Morillo DS, 2013, MED BIOL ENG COMPUT, V51, P305, DOI 10.1007/s11517-012-0995-4; Scott AS, 2014, CAN RESPIR J, V21, P171, DOI 10.1155/2014/948717; Treptow E, 2015, WORLD J RESPIROL, V5, P17; Marcos JV, 2012, IEEE T BIO-MED ENG, V59, P141, DOI 10.1109/TBME.2011.2167971; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zamarron C, 2003, CHEST, V123, P1567, DOI 10.1378/chest.123.5.1567; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	52	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188094	10.1371/journal.pone.0188094	http://dx.doi.org/10.1371/journal.pone.0188094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176802	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900036
J	Hu, SJ; Zhao, GH; Zheng, YX; Qu, M; Jin, Q; Tong, CQ; Li, W				Hu, Sijie; Zhao, Guanhua; Zheng, Yaxu; Qu, Min; Jin, Qiao; Tong, Changqing; Li, Wei			Effect of drying procedures on the physicochemical properties and antioxidant activities of polysaccharides from Crassostrea gigas	PLOS ONE			English	Article							VERA-BARBADENSIS MILLER; MUCILAGE; MICROENCAPSULATION; EXTRACTION	Crassostrea gigas polysaccharides (CGP) were obtained by different drying methods: freeze-drying (FD), spray-drying (SD) or rotary evaporation-drying (RED). The physicochemical properties of CGP were evaluated on the basis of polysaccharide content, protein content, color characteristics, FT-IR spectroscopy, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). Antioxidant activities were researched three different free radicals, including DPPH free radicals, ABTS free radicals and reducing power. The results demonstrated that FDCGP, SDCGP and REDCGP have different physicochemical properties and antioxidant activities. Contrasted with FDCGP and REDCGP, SDCGP exhibited stronger antioxidant abilities. Therefore, considering the polysaccharides appearances and antioxidant activities, the spray drying method is a decent selection for the preparation of such polysaccharides, and it should be selected for application in the food industry.	[Hu, Sijie; Zhao, Guanhua; Zheng, Yaxu; Qu, Min; Jin, Qiao; Tong, Changqing; Li, Wei] Dalian Ocean Univ, Coll Food Sci & Engn, Dalian, Peoples R China	Dalian Ocean University	Tong, CQ; Li, W (corresponding author), Dalian Ocean Univ, Coll Food Sci & Engn, Dalian, Peoples R China.	changqingtong@dlou.edu.cn; aisingioro@hotmail.com	Zhao, Guan-hua/AGL-8404-2022; Zhao, Guanhua/AFY-2201-2022	Zhao, Guan-hua/0000-0002-9040-2622; 	Marine Public Welfare Research Project [201405017-030]; National Natural Science Foundation of China [31571916]	Marine Public Welfare Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Marine Public Welfare Research Project, Grant number 201405017-030, to Dr. Wei Li and the National Natural Science Foundation of China, Grant number 31571916, to Dr. Changqing Tong.	[Anonymous], 1995, FOOD SCI; Ballesteros LF, 2015, CARBOHYD POLYM, V127, P347, DOI 10.1016/j.carbpol.2015.03.047; BOF, 2016, CHIN FISH STAT YB 20; Caparino OA, 2012, J FOOD ENG, V111, P135, DOI 10.1016/j.jfoodeng.2012.01.010; Cave RA, 2009, BIOMACROMOLECULES, V10, P2245, DOI 10.1021/bm900426n; Cerqueira MA, 2011, CARBOHYD POLYM, V83, P179, DOI 10.1016/j.carbpol.2010.07.036; Cervantes-Martinez CV, 2014, LWT-FOOD SCI TECHNOL, V55, P426, DOI 10.1016/j.lwt.2013.09.026; Chen RZ, 2011, FOOD CHEM, V127, P434, DOI 10.1016/j.foodchem.2010.12.143; [陈艳辉 Chen Yanhui], 2010, [中国现代医学杂志, China Journal of Modern Medicine], V20, P1004; Cheng HR, 2013, CARBOHYD POLYM, V92, P63, DOI 10.1016/j.carbpol.2012.09.051; Choi JI, 2009, RADIAT PHYS CHEM, V78, P605, DOI 10.1016/j.radphyschem.2009.04.004; Desobry SA, 1997, J FOOD SCI, V62, P1158, DOI 10.1111/j.1365-2621.1997.tb12235.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; [高蒙蒙 Gao Mengmeng], 2014, [中国海洋药物, Chinese Journal of Marine Drugs], V33, P8; Garcia-Cruz EE, 2013, CARBOHYD POLYM, V91, P394, DOI 10.1016/j.carbpol.2012.08.048; Gharsallaoui A, 2007, FOOD RES INT, V40, P1107, DOI 10.1016/j.foodres.2007.07.004; Gordon M.H., 1990, FOOD ANTIOXIDANTS, P1, DOI [DOI 10.1016/J.BIORTECH.2005.03.016, 10.1007/978-94-009-0753-9_1, DOI 10.1007/978-94-009-0753-9_1]; Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001; [侯丽 Hou Li], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P356; Huang J, 2015, J AGR FOOD CHEM, V63, P2464, DOI 10.1021/jf505581n; Jiang C. Y., 2013, CHINESE TRADITIONAL, V35, P1062, DOI DOI 10.3969/J.ISSN.1001-1528.2013.05.048; Jimenez-Escrig A, 2001, J SCI FOOD AGR, V81, P530, DOI 10.1002/jsfa.842; Kha TC, 2014, DRY TECHNOL, V32, P385, DOI 10.1080/07373937.2013.829854; Kong LS, 2015, CARBOHYD POLYM, V125, P1, DOI 10.1016/j.carbpol.2015.02.042; Leon-Martinez FM, 2010, CARBOHYD POLYM, V81, P864, DOI 10.1016/j.carbpol.2010.03.061; Li XY, 2016, PROCESS BIOCHEM, V51, P1100, DOI 10.1016/j.procbio.2016.05.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LP, 2013, FOOD CHEM TOXICOL, V60, P269, DOI 10.1016/j.fct.2013.07.060; Ma LS, 2013, FOOD RES INT, V50, P633, DOI 10.1016/j.foodres.2011.05.005; Marques GR, 2014, DRY TECHNOL, V32, P861, DOI 10.1080/07373937.2013.873452; Medina-Torres L, 2016, LWT-FOOD SCI TECHNOL, V66, P93, DOI 10.1016/j.lwt.2015.10.023; Minjares-Fuentes R, 2017, CARBOHYD POLYM, V168, P327, DOI 10.1016/j.carbpol.2017.03.087; Nep EI, 2011, CARBOHYD POLYM, V84, P446, DOI 10.1016/j.carbpol.2010.12.005; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Santhalakshmy S, 2015, POWDER TECHNOL, V274, P37, DOI 10.1016/j.powtec.2015.01.016; Shi X, 2015, INT J BIOL MACROMOL, V78, P142, DOI 10.1016/j.ijbiomac.2015.03.056; Sun LQ, 2009, INT J BIOL MACROMOL, V45, P42, DOI 10.1016/j.ijbiomac.2009.03.013; Sun T, 2011, BIOORG MED CHEM LETT, V21, P798, DOI 10.1016/j.bmcl.2010.11.097; Tan SP, 2015, POWDER TECHNOL, V281, P65, DOI 10.1016/j.powtec.2015.04.074; Tian ZhenHua, 2013, Food Research and Development, V34, P23; Varmao AJ, 1997, CARBOHYD POLYM, V32, P1; Wang CC, 2010, FOOD CHEM, V120, P184, DOI 10.1016/j.foodchem.2009.10.005; Wang T, 2016, INT J BIOL MACROMOL, V83, P195, DOI 10.1016/j.ijbiomac.2015.11.078; Wu SJ, 2017, FOOD CHEM, V216, P243, DOI 10.1016/j.foodchem.2016.08.043; Wu SH, 2014, CARBOHYD POLYM, V103, P414, DOI 10.1016/j.carbpol.2013.11.075; Xie MH, 2014, J AGR FOOD CHEM, V62, P9128, DOI 10.1021/jf503207s; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; YORK P, 1983, INT J PHARMACEUT, V14, P1, DOI 10.1016/0378-5173(83)90111-4; Zhang WJ, 2016, INT J BIOL MACROMOL, V93, P448, DOI 10.1016/j.ijbiomac.2016.08.079; Zhang WJ, 1994, SUGAR COMPLEX BIOCH; Zhao QS, 2015, CARBOHYD POLYM, V127, P176, DOI 10.1016/j.carbpol.2015.03.041	52	15	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188536	10.1371/journal.pone.0188536	http://dx.doi.org/10.1371/journal.pone.0188536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176846	Green Submitted, gold, Green Published			2022-12-26	WOS:000416291900092
J	Ueda, I; Sakuma, A; Takahashi, Y; Shoji, W; Nagao, A; Abe, M; Suzuki, Y; Matsuoka, H; Matsumoto, K				Ueda, Ikki; Sakuma, Atsushi; Takahashi, Yoko; Shoji, Wataru; Nagao, Ayami; Abe, Mikika; Suzuki, Yuriko; Matsuoka, Hiroo; Matsumoto, Kazunori			Criticism by community people and poor workplace communication as risk factors for the mental health of local welfare workers after the Great East Japan Earthquake: A cross-sectional study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PSYCHOLOGICAL DISTRESS; DISABILITY PREVALENCE; FUNCTIONAL DISABILITY; DISASTER RELIEF; OLDER-PEOPLE; DEPRESSION; IMPACT; SEVERITY; POPULATION	After a large-scale natural disaster, demand for social welfare services increases, and the mental health of local social welfare workers becomes a matter of great concern because of their dual role as support providers and disaster survivors. We examined whether work-related social stressors, including criticism by community people and poor workplace communication, were associated with increased risk of post-traumatic stress disorder (PTSD), depression, or psychological distress 20-22 months after the Great East Japan Earthquake (GEJE; March 11, 2011) in local social welfare workers. Demographic characteristics, disaster-related risk factors (near-death experience, dead/missing family members, loss of housing), and work-related social risk factors (criticism, lack of communication) were obtained 20-22 months after the GEJE from 822 local workers. Questionnaires measured PTSD, depression, and psychological stress. Bivariate and multivariate regression analyses were applied. More local social welfare workers suffered from mental health problems than would be expected. Criticism by community people was significantly associated with probable PTSD and high psychological distress (adjusted odds ratio = 2.31 and 2.55, respectively). Furthermore, lack of workplace communication was associated with probable PTSD, depression, and high psychological distress (adjusted odds ratio = 3.97, 4.27, and 4.65, respectively). Almost 2 years after the disaster, local relief workers still suffered from mental health problems. Because post-disaster work-related social stressors constitute risk factors for these mental health problems, measures to improve working conditions and prevent and treat mental disorders should be a priority.	[Ueda, Ikki; Matsuoka, Hiroo; Matsumoto, Kazunori] Tohoku Univ, Dept Psychiat, Grad Sch Med, Sendai, Miyagi, Japan; [Ueda, Ikki; Sakuma, Atsushi; Takahashi, Yoko; Shoji, Wataru; Nagao, Ayami; Abe, Mikika; Matsuoka, Hiroo; Matsumoto, Kazunori] Miyagi Disaster Mental Hlth Care Ctr, Sendai, Miyagi, Japan; [Sakuma, Atsushi] Tohoku Univ Hosp, Dept Psychiat, Sendai, Miyagi, Japan; [Takahashi, Yoko; Shoji, Wataru; Nagao, Ayami; Abe, Mikika; Matsuoka, Hiroo; Matsumoto, Kazunori] Tohoku Univ, Dept Prevent Psychiat, Grad Sch Med, Sendai, Miyagi, Japan; [Suzuki, Yuriko] Natl Inst Mental Hlth, Dept Adult Mental Hlth, Natl Ctr Neurol & Psychiat, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; National Center for Neurology & Psychiatry - Japan	Ueda, I (corresponding author), Tohoku Univ, Dept Psychiat, Grad Sch Med, Sendai, Miyagi, Japan.; Ueda, I (corresponding author), Miyagi Disaster Mental Hlth Care Ctr, Sendai, Miyagi, Japan.	u.ik.n.n.a.2226@gmail.com		matsumoto, kazunori/0000-0002-5753-0104	Ministry of Health, Labour and Welfare [H24-seishin-ippan-002-hukkou]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare (grant number: H24-seishin-ippan-002-hukkou, recipient: HM KM, URL: https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201317093A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindag A, 2005, COMPR PSYCHIAT, V46, P328, DOI 10.1016/j.comppsych.2005.01.005; Arnberg FK, 2012, J TRAUMA STRESS, V25, P721, DOI 10.1002/jts.21758; Benedek DM, 2007, ANNU REV PUBL HEALTH, V28, P55, DOI 10.1146/annurev.publhealth.28.021406.144037; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Davis TE, 2010, BEHAV THER, V41, P340, DOI 10.1016/j.beth.2009.09.004; Epstein RS, 1998, AM J PSYCHIAT, V155, P934, DOI 10.1176/ajp.155.7.934; Fussell E, 2014, SOC SCI MED, V113, P137, DOI 10.1016/j.socscimed.2014.05.025; Ishikawa H, 2016, EPIDEMIOL PSYCH SCI, V25, P217, DOI 10.1017/S2045796015000566; Johal SS, 2016, PREHOSP DISASTER MED, V31, P10, DOI 10.1017/S1049023X15005439; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lock S, 2012, PLOS CURR, V4; McLeish AC, 2008, DEPRESS ANXIETY, V25, P416, DOI 10.1002/da.20426; National Information Center of Disaster Mental Health National Institute of Mental Health National Center of Neurology and Psychiatry, 2007, SPEC SUMM REP COMPR; National Police Agency, 2013, NATL POLICE AGENCY D; Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317; North CS, 2002, JAMA-J AM MED ASSOC, V288, P633, DOI 10.1001/jama.288.5.633; Ozer E. J., 2008, PSYCHOL TRAUMA-US, P3, DOI [10.1037/1942-9681.S.1.3.S, DOI 10.1037/1942-9681.S.1.3.S]; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sastry Narayan, 2009, Am J Public Health, V99 Suppl 3, pS725, DOI 10.2105/AJPH.2009.174854; Shigemura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087516; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shiragami K., 2013, J MENT HEALTH, V59, P75, DOI [10.34384/nimh.59.75, DOI 10.34384/NIMH.59.75]; Suzuki Y, 2014, J EPIDEMIOL, V24, P287, DOI 10.2188/jea.JE20130138; Thormar SB, 2010, J NERV MENT DIS, V198, P529, DOI 10.1097/NMD.0b013e3181ea1fa9; Tomata Y, 2015, SOC SCI MED, V147, P296, DOI 10.1016/j.socscimed.2015.11.016; Tomata Y, 2014, J EPIDEMIOL COMMUN H, V68, P530, DOI 10.1136/jech-2013-203541; Ursano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088467; Uscher-Pines L, 2009, DISASTERS, V33, P1, DOI 10.1111/j.1467-7717.2008.01059.x; Wang XL, 2013, QUAL HEALTH RES, V23, P207, DOI 10.1177/1049732312467706; Wang XL, 2011, QUAL HEALTH RES, V21, P465, DOI 10.1177/1049732310386049; Weathers F.W., 1996, MEASUREMENT STRESS T, P250	35	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0185930	10.1371/journal.pone.0185930	http://dx.doi.org/10.1371/journal.pone.0185930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166390	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300002
J	Queen, RA; Steyn, JS; Lord, P; Elson, JL				Queen, Rachel A.; Steyn, Jannetta S.; Lord, Phillip; Elson, Joanna L.			Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: A study across multiple lineages with diagnostic implications	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; HUMAN-DISEASE; MELAS SUBGROUP; POINT MUTATION; AFRICAN; PREVALENCE; PATHOGENICITY; GENE; EVOLUTION; ENCEPHALOMYOPATHIES	Mitochondrial DNA (mtDNA) mutations are well recognized as an important cause of inherited disease. Diseases caused by mtDNA mutations exhibit a high degree of clinical heterogeneity with a complex genotype-phenotype relationship, with many such mutations exhibiting incomplete penetrance. There is evidence that the spectrum of mutations causing mitochondrial disease might differ between different mitochondrial lineages (haplogroups) seen in different global populations. This would point to the importance of sequence context in the expression of mutations. To explore this possibility, we looked for mutations which are known to cause disease in humans, in animals of other species unaffected by mtDNA disease. The mt-tRNA genes are the location of many pathogenic mutations, with the m.3243A>G mutation on the mt-tRNA-Leu(UUR) being the most frequently seen mutation in humans. This study looked for the presence of m.3243A>G in 2784 sequences from 33 species, as well as any of the other mutations reported in association with disease located on mt-tRNA-Leu(UUR). We report a number of disease associated variations found on mt-tRNA-Leu(UUR) in other chordates, as the major population variant, with m.3243A>G being seen in 6 species. In these, we also found a number of mutations which appear compensatory and which could prevent the pathogenicity associated with this change in humans. This work has important implications for the discovery and diagnosis of mtDNA mutations in non-European populations. In addition, it might provide a partial explanation for the conflicting results in the literature that examines the role of mtDNA variants in complex traits.	[Queen, Rachel A.; Steyn, Jannetta S.; Elson, Joanna L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Lord, Phillip] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Elson, Joanna L.] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa	Newcastle University - UK; Newcastle University - UK; North West University - South Africa	Elson, JL (corresponding author), Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.; Elson, JL (corresponding author), North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.	joanna.elson@newcastle.ac.uk		/0000-0002-3551-5624	Newcastle University internal fund	Newcastle University internal fund	Fund from a Newcastle University internal fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baranowska I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000499; Barbieri C, 2014, AM J PHYS ANTHROPOL, V153, P435, DOI 10.1002/ajpa.22441; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6; El Meziane A, 1998, NAT GENET, V18, P350; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Martikainen MH, 2013, ACTA DIABETOL, V50, P737, DOI 10.1007/s00592-012-0393-2; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; McFarland R, 2004, AM J MED GENET A, V131A, P107, DOI 10.1002/ajmg.a.30318; Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305; Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002; Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490; Smuts I, 2010, J INHERIT METAB DIS, V33, pS95, DOI 10.1007/s10545-009-9031-8; SWEENEY MG, 1993, Q J MED, V86, P709; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196; van der Walt EM, 2012, EUR J HUM GENET, V20, P650, DOI 10.1038/ejhg.2011.262; van der Westhuizen FH, 2015, HUM MUTAT, V36, P569, DOI 10.1002/humu.22789; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Yakubovskaya MG, 2010, BIOCHIMIE, V92, P762, DOI 10.1016/j.biochi.2010.02.016; Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009; Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187862	10.1371/journal.pone.0187862	http://dx.doi.org/10.1371/journal.pone.0187862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161289	gold, Green Published			2022-12-26	WOS:000415987000023
J	Sofer, T; Baier, LJ; Browning, SR; Thornton, TA; Talavera, GA; Wassertheil-Smoller, S; Daviglus, ML; Hanson, R; Kobes, S; Cooper, RS; Cai, JW; Levy, D; Reiner, AP; Franceschini, N				Sofer, Tamar; Baier, Leslie J.; Browning, Sharon R.; Thornton, Timothy A.; Talavera, Gregory A.; Wassertheil-Smoller, Sylvia; Daviglus, Martha L.; Hanson, Robert; Kobes, Sayuko; Cooper, Richard S.; Cai, Jianwen; Levy, Daniel; Reiner, Alex P.; Franceschini, Nora			Admixture mapping in the Hispanic Community Health Study/Study of Latinos reveals regions of genetic associations with blood pressure traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFERENCE; VARIANTS; DESIGN; COMMON	Admixture mapping can be used to detect genetic association regions in admixed populations, such as Hispanics/Latinos, by estimating associations between local ancestry allele counts and the trait of interest. We performed admixture mapping of the blood pressure traits systolic and diastolic blood pressure (SBP, DBP), mean arterial pressure (MAP), and pulse pressure (PP), in a dataset of 12,116 participants from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Hispanics/Latinos have three predominant ancestral populations (European, African, and Amerindian), for each of which we separately tested local ancestry intervals across the genome. We identified four regions that were significantly associated with a blood pressure trait at the genome-wide admixture mapping level. A 6p21.31 Amerindian ancestry association region has multiple known associations, but none explained the admixture mapping signal. We identified variants that completely explained this signal. One of these variants had p-values of 0.02 (MAP) and 0.04 (SBP) in replication testing in Pima Indians. A 11q13.4 Amerindian ancestry association region spans a variant that was previously reported (p-value = 0.001) in a targeted association study of Blood Pressure (BP) traits and variants in the vitamin D pathway. There was no replication evidence supporting an association in the identified 17q25.3 Amerindian ancestry association region. For a region on 6p12.3, associated with African ancestry, we did not identify any candidate variants driving the association. It may be driven by rare variants. Whole genome sequence data may be necessary to fine map these association signals, which may contribute to disparities in BP traits between diverse populations.	[Sofer, Tamar] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Sofer, Tamar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Baier, Leslie J.; Hanson, Robert; Kobes, Sayuko] NIDDK, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA; [Browning, Sharon R.; Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Talavera, Gregory A.] San Diego State Univ, Div Hlth Promot & Behav Sci, San Diego, CA 92182 USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Chicago, IL USA; [Cai, Jianwen] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle; California State University System; San Diego State University; Yeshiva University; Albert Einstein College of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Sofer, T (corresponding author), Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA.; Sofer, T (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	tsofer@bwh.harvard.edu	Browning, Sharon/B-1530-2008; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Browning, Sharon/0000-0001-7251-9715; Levy, Daniel/0000-0003-1843-8724; Sofer, Tamar/0000-0001-8520-8860	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237]; National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Neurological Disorders and Stroke; NIH Institution Office of Dietary Supplements; National Institute of Diabetes and Digestive and Kidney Diseases; NHLBI; NIDCR [HHSN268201300005C AM03, MOD03]; NHLBI [R01 HL120393-03S1, 1R35HL135818, R21HL123677-01]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R56 DK104806-01A1]; NIH Institution-Office of Dietary Supplements; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123677, R01HL065234, R35HL135818, U01HL065233, R01HL120393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK104806, ZIADK075012, ZIADK069071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Institution Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Institution-Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke, NIH Institution Office of Dietary Supplements. This study was also supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). This work was supported by the NHLBI [R01 HL120393-03S1 and 1R35HL135818 supported T. S., R21HL123677-01 to N.F.]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R56 DK104806-01A1 to N.F.]. URLs of funders: NHLBI: https://www.nhibi.nih.gov/; National Institute on Minority Health and Health Disparities: https://www.nimhd.nih.gov; National Institute on Deafness and Other Communication Disorders: https://www.nidcd.nih.gov; National Institute of Dental and Craniofacial Research: https://www.nidcr.nih.gov; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): https://www.niddk.nih.gov; National Institute of Neurological Disorders and Stroke: https://www.ninds.nih.gov; NIH Institution-Office of Dietary Supplements: https://ods.od.nih.gov; The Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases: https://www.niddk.nih.gov/about-niddk/offices-divisions/division-intramural-research/Pages/default.aspx.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], GENESIS GENETIC ESTI; Brown LA, 2017, J AM SOC NEPHROL, V28, P2211, DOI 10.1681/ASN.2016091010; Browning SR, 2016, G3-GENES GENOM GENET, V6, P1525, DOI 10.1534/g3.116.028779; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franceschini N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164132; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hanson RL, 2013, DIABETES; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liang J, 2017, PLOS GENET, V13, P1; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Lu X, 2015, HUMAN MOL GENETICS; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Qin HZ, 2012, GENET EPIDEMIOL, V36, P235, DOI 10.1002/gepi.21616; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Sofer T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09019-1; Sofer T, 2017, GENET EPIDEMIOL, V41, P251, DOI 10.1002/gepi.22029; Sorlie PD, 2014, AM J HYPERTENS, V27, P793, DOI 10.1093/ajh/hpu003; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Wang L, 2014, AM J HYPERTENSION; Zhang QS, 2016, BIOINFORMATICS, V32, P2227, DOI 10.1093/bioinformatics/btw220	35	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188400	10.1371/journal.pone.0188400	http://dx.doi.org/10.1371/journal.pone.0188400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155883	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700055
J	Erdogan, C; Kurt, Z; Diri, B				Erdogan, Cihat; Kurt, Zeyneb; Diri, Banu			Estimation of the proteomic cancer co-expression sub networks by using association estimators	PLOS ONE			English	Article							MUTUAL INFORMATION; GENE-EXPRESSION; INFERENCE; ENTROPY	In this study, the association estimators, which have significant influences on the gene network inference methods and used for determining the molecular interactions, were examined within the co-expression network inference concept. By using the proteomic data from five different cancer types, the hub genes/proteins within the disease-associated gene-gene/protein-protein interaction sub networks were identified. Proteomic data from various cancer types is collected from The Cancer Proteome Atlas (TCPA). Correlation and mutual information (MI) based nine association estimators that are commonly used in the literature, were compared in this study. As the gold standard to measure the association estimators' performance, a multi-layer data integration platform on gene-disease associations (DisGeNET) and the Molecular Signatures Database (MSigDB) was used. Fisher's exact test was used to evaluate the performance of the association estimators by comparing the created co-expression networks with the disease-associated pathways. It was observed that the MI based estimators provided more successful results than the Pearson and Spearman correlation approaches, which are used in the estimation of biological networks in the weighted correlation network analysis (WGCNA) package. In correlation-based methods, the best average success rate for five cancer types was 60%, while in MI-based methods the average success ratio was 71% for James-Stein Shrinkage (Shrink) and 64% for Schurmann-Grassberger (SG) association estimator, respectively. Moreover, the hub genes and the inferred sub networks are presented for the consideration of researchers and experimentalists.	[Erdogan, Cihat] Namik Kemal Univ, Dept Comp Engn, Tekirdag, Turkey; [Kurt, Zeyneb] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Kurt, Zeyneb; Diri, Banu] Yildiz Tech Univ, Dept Comp Engn, Istanbul, Turkey	Namik Kemal University; University of California System; University of California Los Angeles; Yildiz Technical University	Erdogan, C (corresponding author), Namik Kemal Univ, Dept Comp Engn, Tekirdag, Turkey.	cerdogan@nku.edu.tr	Erdoğan, Cihat/A-4856-2018; Erdoğan, Cihat/E-4681-2019; Diri, Banu/AAA-1020-2021	Erdoğan, Cihat/0000-0001-5495-7754; Erdoğan, Cihat/0000-0001-5495-7754; Kurt, Zeyneb/0000-0003-3186-8091; Diri, Banu/0000-0002-6652-4339				Akbani R, 2014, MOL CELL PROTEOMICS, V13, P1625, DOI 10.1074/mcp.O113.034918; Altay G, 2017, BIORXIV, P1; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Deu-Pons J, 2015, DATABASE-OXFORD, V2015; Du J, 2016, ONCOGENE, V35, P3314, DOI 10.1038/onc.2015.393; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fisher R. A., 1938, STAT METHODS RES WOR; Fukazawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20113; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Fury W, 2006, 2006 EMBS 06 28 ANN, P5531; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Keehn CA, 2004, J CUTAN PATHOL, V31, P8, DOI 10.1046/j.0303-6987.2004.0158.x; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kurt Z, 2014, BIOINFORMATICS, V30, P2142, DOI 10.1093/bioinformatics/btu182; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liu NN, 2015, ONCOL LETT, V10, P1709, DOI 10.3892/ol.2015.3442; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McDonald J.H., 2009, HDB BIOL STAT, P291; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller G., 1955, INFORM THEORY PSYCHO, P95; Mishima K, 2014, NEUROONCOL, V16; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Queralt-Rosinach N, 2016, NUCLEIC ACIDS RES, V45; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruyssinck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092709; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Senbabaoglu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004765; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simone RE, 2011, PLOS ONE, V6; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Q, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.13; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang J, 2015, INT J CLIN EXP MED, V8, P3136	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188016	10.1371/journal.pone.0188016	http://dx.doi.org/10.1371/journal.pone.0188016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145449	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000415378800051
J	Van Grootel, TJ; Meeson, A; Munk, MHJ; Kourtzi, Z; Movshon, JA; Logothetis, NK; Kiorpes, L				Van Grootel, Tom J.; Meeson, Alan; Munk, Matthias H. J.; Kourtzi, Zoe; Movshon, J. Anthony; Logothetis, Nikos K.; Kiorpes, Lynne			Development of visual cortical function in infant macaques: A BOLD fMRI study	PLOS ONE			English	Article							MONKEYS MACACA-NEMESTRINA; GLASS PATTERNS; HUMAN-BRAIN; POSTNATAL-DEVELOPMENT; CONTRAST SENSITIVITY; V2 NEURONS; HIERARCHICAL DEVELOPMENT; DISPARITY SENSITIVITY; RESPONSE PROPERTIES; OPPOSITE-POLARITY	Functional brain development is not well understood. In the visual system, neurophysiological studies in nonhuman primates show quite mature neuronal properties near birth although visual function is itself quite immature and continues to develop over many months or years after birth. Our goal was to assess the relative development of two main visual processing streams, dorsal and ventral, using BOLD fMRI in an attempt to understand the global mechanisms that support the maturation of visual behavior. Seven infant macaque monkeys (Macaca mulatta) were repeatedly scanned, while anesthetized, over an age range of 102 to 1431 days. Large rotating checkerboard stimuli induced BOLD activation in visual cortices at early ages. Additionally we used static and dynamic Glass pattern stimuli to probe BOLD responses in primary visual cortex and two extrastriate areas: V4 and MTV5. The resulting activations were analyzed with standard GLM and multivoxel pattern analysis (MVPA) approaches. We analyzed three contrasts: Glass pattern present/absent, static/dynamic Glass pattern presentation, and structured/random Glass pattern form. For both GLM and MVPA approaches, robust coherent BOLD activation appeared relatively late in comparison to the maturation of known neuronal properties and the development of behavioral sensitivity to Glass patterns. Robust differential activity to Glass pattern present/ absent and dynamic/static stimulus presentation appeared first in V1, followed by V4 and MT-V5 at older ages; there was no reliable distinction between the two extrastriate areas. A similar pattern of results was obtained with the two analysis methods, although MVPA analysis showed reliable differential responses emerging at later ages than GLM. Although BOLD responses to large visual stimuli are detectable, our results with more refined stimuli indicate that global BOLD activity changes as behavioral performance matures. This reflects an hierarchical development of the visual pathways. Since fMRI BOLD reflects neural activity on a population level, our results indicate that, although individual neurons might be adult-like, a longer maturation process takes place on a population level.	[Van Grootel, Tom J.; Kourtzi, Zoe; Logothetis, Nikos K.; Kiorpes, Lynne] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Van Grootel, Tom J.; Movshon, J. Anthony; Kiorpes, Lynne] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Meeson, Alan; Kourtzi, Zoe] Univ Birmingham, Sch Psychol, Behav & Brain Sci, Birmingham, W Midlands, England; [Munk, Matthias H. J.] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Kourtzi, Zoe] Univ Cambridge, Dept Psychol, Cambridge, England	Max Planck Society; New York University; University of Birmingham; Technical University of Darmstadt; University of Cambridge	Van Grootel, TJ (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.; Van Grootel, TJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	tvg214@nyu.edu	Logothetis, Nikos/U-9282-2019	Kourtzi, Zoe/0000-0001-9441-7832	Max Planck Society; James S. McDonnell Foundation; Biotechnology and Biological Sciences Research Council [BB/H012508/1] Funding Source: researchfish; BBSRC [BB/H012508/1] Funding Source: UKRI	Max Planck Society(Max Planck Society); James S. McDonnell Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Max Planck Society and the James S. McDonnell Foundation.	Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; [Anonymous], 2006, VISUAL BRAIN ACTION; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Bahmani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107628; Baldwin MKL, 2012, J COMP NEUROL, V520, P544, DOI 10.1002/cne.22732; BARONE P, 1995, CEREB CORTEX, V5, P22, DOI 10.1093/cercor/5.1.22; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Biagi L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002260; BOOTHE RG, 1985, ANNU REV NEUROSCI, V8, P495, DOI 10.1146/annurev.ne.08.030185.002431; BOOTHE RG, 1982, INVEST OPHTH VIS SCI, V22, P228; BOOTHE RG, 1988, VISION RES, V28, P387, DOI 10.1016/0042-6989(88)90181-2; Bourne JA, 2006, CEREB CORTEX, V16, P405, DOI 10.1093/cercor/bhi119; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Burr D, 2006, VISION RES, V46, P1139, DOI 10.1016/j.visres.2005.09.018; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; Chung CYL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00195; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Coogan TA, 1996, J COMP NEUROL, V372, P327, DOI 10.1002/(SICI)1096-9861(19960826)372:3<327::AID-CNE1>3.0.CO;2-4; Deen B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13995; Distler C, 1996, CEREB CORTEX, V6, P184, DOI 10.1093/cercor/6.2.184; El-Shamayleh Y, 2010, J VISION, V10, DOI 10.1167/10.11.11; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; GLASS L, 1973, NATURE, V246, P360, DOI 10.1038/246360a0; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Guillery RW, 2005, TRENDS NEUROSCI, V28, P512, DOI 10.1016/j.tins.2005.08.006; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hou C, 2003, J NEUROSCI, V23, P8630; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Joachims T., 1999, MAKING LARGE SCALE S; JONES AKP, 1991, NEUROSCI LETT, V126, P25, DOI 10.1016/0304-3940(91)90362-W; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kennedy H., 2004, VISUAL NEUROSCI, V1, P146; Kiorpes L, 2004, VISUAL NEUROSCI, V21, P851, DOI 10.1017/S0952523804216054; Kiorpes L, 2003, VISUAL NEUROSCI, V20, P567, DOI 10.1017/S0952523803205101; KIORPES L, 1992, VISUAL NEUROSCI, V9, P243, DOI 10.1017/S0952523800010658; Kiorpes L, 1996, VISION RES, V36, P239, DOI 10.1016/0042-6989(95)00097-J; Kiorpes L, 2013, THE NEW VISUAL NEURO, P1423; Kiorpes L, 2004, VISUAL NEUROSCIENCES, P159; Kiorpes L, 2012, VISION RES, V63, P34, DOI 10.1016/j.visres.2012.04.018; Kiorpes L, 2008, PRIMATE MODELS OF CHILDREN'S HEALTH AND DEVELOPMENTAL DISABILITIES, P45, DOI 10.1016/B978-012373743-4.50005-9; Kourtzi Z, 2006, MAGN RESON IMAGING, V24, P359, DOI 10.1016/j.mri.2005.12.025; Krekelberg B, 2005, J NEUROPHYSIOL, V94, P4373, DOI 10.1152/jn.00690.2005; Krekelberg B, 2003, NATURE, V424, P674, DOI 10.1038/nature01852; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lewkowicz D. J., 2004, HDB MULTISENSORY PRO, P655; Li DP, 2013, VISUAL NEUROSCI, V30, P263, DOI 10.1017/S0952523813000394; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malkova L, 2006, EUR J NEUROSCI, V24, P3204, DOI 10.1111/j.1460-9568.2006.05175.x; Mannion DJ, 2009, NEUROIMAGE, V46, P511, DOI 10.1016/j.neuroimage.2009.01.052; Martin E, 1999, PEDIATR RES, V46, P135, DOI 10.1203/00006450-199908000-00001; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MAURER D, 1993, NATO ADV SCI INST SE, V69, P109; McKeefry DJ, 1997, NEUROIMAGE, V5, P1, DOI 10.1006/nimg.1996.0246; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morita T, 2000, NEUROSCI RES, V38, P63, DOI 10.1016/S0168-0102(00)00146-2; Movshon JA, 2013, VISUAL NEUROSCI, V30, P219, DOI 10.1017/S0952523813000527; Movshon JA, 2003, NAT NEUROSCI, V6, P3, DOI 10.1038/nn0103-3a; Nankoo JF, 2012, VISION RES, V72, P55, DOI 10.1016/j.visres.2012.09.008; Or CCF, 2007, VISION RES, V47, P253, DOI 10.1016/j.visres.2006.10.010; Ostwald D, 2008, J NEUROPHYSIOL, V99, P2456, DOI 10.1152/jn.01307.2007; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Palomares M, 2010, J COGNITIVE NEUROSCI, V22, P1557, DOI 10.1162/jocn.2009.21323; Pattinson KTS, 2007, J CEREBR BLOOD F MET, V27, P414, DOI 10.1038/sj.jcbfm.9600347; PFEIFFER A, 1982, BRAIN RES, V248, P87, DOI 10.1016/0006-8993(82)91150-7; Pierre PJ, 2008, BRAIN RES, V1226, P56, DOI 10.1016/j.brainres.2008.06.001; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Rieck A, 2005, EUROPEAN J ANAESTHES, V22; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; RODMAN HR, 1994, CEREB CORTEX, V4, P484, DOI 10.1093/cercor/4.5.484; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Saleem KS, 2012, COMBINED MRI HISTOLO; Sawada K, 2010, NEUROSCIENCE, V167, P735, DOI 10.1016/j.neuroscience.2010.02.045; Sellers KK, 2015, J NEUROPHYSIOL, V113, P3798, DOI 10.1152/jn.00923.2014; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smith MA, 2007, J VISION, V7, DOI 10.1167/7.3.5; Stavros KA, 2008, VISION RES, V48, P1335, DOI 10.1016/j.visres.2008.01.031; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; TELLER DY, 1979, T OPHTHAL SOC UK, V99, P333; Teller DY, 1997, INVEST OPHTH VIS SCI, V38, P2183; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Ungerleider L.G., 2004, VISUAL NEUROSCIENCES, P541; Watanabe H, 2010, NEUROIMAGE, V50, P1536, DOI 10.1016/j.neuroimage.2010.01.068; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Wise RG, 2002, NEUROIMAGE, V16, P999, DOI 10.1006/nimg.2002.1146; Yamada H, 1997, NEUROREPORT, V8, P3775, DOI 10.1097/00001756-199712010-00024; Yamada H, 2000, NEUROLOGY, V55, P218, DOI 10.1212/WNL.55.2.218; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080749; Zhang B, 2005, P NATL ACAD SCI USA, V102, P5862, DOI 10.1073/pnas.0501815102; Zhang B, 2008, J NEUROPHYSIOL, V100, P1476, DOI 10.1152/jn.90446.2008; Zhang B, 2013, J NEUROSCI, V33, P2639, DOI 10.1523/JNEUROSCI.4377-12.2013; Zheng J, 2007, J NEUROPHYSIOL, V97, P3905, DOI 10.1152/jn.01320.2006; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	107	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187942	10.1371/journal.pone.0187942	http://dx.doi.org/10.1371/journal.pone.0187942			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145469	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800040
J	Hatazawa, Y; Ono, Y; Hirose, Y; Kanai, S; Fujii, NL; Machida, S; Nishino, I; Shimizu, T; Okano, M; Kamei, Y; Ogawa, Y				Hatazawa, Yukino; Ono, Yusuke; Hirose, Yuma; Kanai, Sayaka; Fujii, Nobuharu L.; Machida, Shuichi; Nishino, Ichizo; Shimizu, Takahiko; Okano, Masaki; Kamei, Yasutomi; Ogawa, Yoshihiro			Reduced Dnmt3a increases Gdf5 expression with suppressed satellite cell differentiation and impaired skeletal muscle regeneration	FASEB JOURNAL			English	Article						DNA methylation; epigenetics; atrophy; knockout mouse	DNA METHYLATION; TRANSGENIC MICE; PROTEIN; ATROPHY; GENES; FAMILY; AGE	DNA methylation is an epigenetic mechanism regulating gene expression. In this study, we observed that DNA methyltransferase 3a (Dnmt3a) expression is decreased after muscle atrophy. We made skeletal muscle-specific Dnmt3a-knockout (Dnmt3a-KO) mice. The regeneration capacity after muscle injury was markedly decreased in Dnmt3a-KO mice. Diminished mRNA and protein expression of Dnmt3a were observed in skeletal muscles as well as in satellite cells, which are important for muscle regeneration, in Dnmt3a-KO mice. Dnmt3a-KO satellite cell showed smaller in size (length/area), suggesting suppressed myotube differentiation. Microarray analysis of satellite cells showed that expression of growth differentiation factor 5 (Gdf5) mRNA was markedly increased in Dnmt3a-KO mice. The DNA methylation level of the Gdf5 promoter was markedly decreased in Dnmt3a-KO satellite cells. In addition, DNA methylation inhibitor azacytidine treatment increased Gdf5 expression in wild-type satellite cells, suggesting Gdf5 expression is regulated by DNA methylation. Also, we observed increased inhibitor of differentiation (a target of Gdf5) mRNA expression in Dnmt3a-KO satellite cells. Thus, Dnmt3a appears to regulate satellite cell differentiation via DNA methylation. This mechanism may play a role in the decreased regeneration capacity during atrophy such as in aged sarcopenia.	[Hatazawa, Yukino; Kanai, Sayaka; Kamei, Yasutomi; Ogawa, Yoshihiro] TMDU, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Hatazawa, Yukino; Hirose, Yuma; Kamei, Yasutomi] Kyoto Prefectural Univ, Grad Sch Environm & Life Sci, Lab Mol Nutr, Kyoto, Japan; [Hatazawa, Yukino] Japan Soc Promot Sci, Tokyo, Japan; [Ono, Yusuke] Nagasaki Univ, Musculoskeletal Mol Biol Res Grp, Grad Sch Biomed Sci, Nagasaki, Japan; [Ono, Yusuke] Japan Agcy Med Res & Dev AMED, Div Regenerat Med Res, Tokyo, Japan; [Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo, Japan; [Machida, Shuichi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Tokyo, Japan; [Shimizu, Takahiko] Chiba Univ, Dept Adv Aging Med, Grad Sch Med, Chiba, Japan; [Okano, Masaki] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Ogawa, Yoshihiro] Japan Agcy Med Res & Dev AMED, CREST, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; Japan Society for the Promotion of Science; Nagasaki University; Tokyo Metropolitan University; Juntendo University; National Center for Neurology & Psychiatry - Japan; Chiba University; Kumamoto University; Kyushu University; Japan Science & Technology Agency (JST)	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Sakyo Ku, 1-5 Hangi Cho, Kyoto 6068522, Japan.; Ogawa, Y (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	kamei@kpu.ac.jp; yogawa@intmed3.med.kyushu-u.ac.jp	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X; Ono, Yusuke/0000-0002-4802-7507; Ogawa, Yoshihiro/0000-0002-0834-2836	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Adv; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research [16H04926] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Adv; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Microarray data analysis was in part performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by the Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Advancement Institution; NARO). This study was also supported in part by the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University. The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the article. The authors declare no conflicts of interest.	BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; D'Souza DM, 2016, DIABETES, V65, P3053, DOI 10.2337/db15-1577; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Ehara T, 2015, DIABETES, V64, P775, DOI 10.2337/db14-0158; Ehrhardt J, 2005, CURR OPIN NEUROL, V18, P548, DOI 10.1097/01.wco.0000177382.62156.82; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guasconi V, 2008, CURR OPIN CLIN NUTR, V11, P233, DOI 10.1097/MCO.0b013e3282fa1810; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Liu RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35355; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mozdziak PE, 1998, EUR J APPL PHYSIOL O, V78, P136, DOI 10.1007/s004210050398; Naito M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006167; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Reynard LN, 2011, HUM MOL GENET, V20, P3450, DOI 10.1093/hmg/ddr253; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Rudolf R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00099; Salanova M, 2013, IUBMB LIFE, V65, P769, DOI 10.1002/iub.1198; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suchak A, 2009, EUR J ORTHODONT, V31, P196, DOI 10.1093/ejo/cjn095; Tajrishi MM, 2014, J BIOL CHEM, V289, P19985, DOI 10.1074/jbc.M114.568626; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	32	21	21	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1452	1467		10.1096/fj.201700573R	http://dx.doi.org/10.1096/fj.201700573R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146735	Bronze			2022-12-26	WOS:000427246000027
J	Tomati, V; Pesce, E; Caci, E; Sondo, E; Scudieri, P; Marini, M; Amato, F; Castaldo, G; Ravazzolo, R; Galietta, LJV; Pedemonte, N				Tomati, Valeria; Pesce, Emanuela; Caci, Emanuela; Sondo, Elvira; Scudieri, Paolo; Marini, Monica; Amato, Felice; Castaldo, Giuseppe; Ravazzolo, Roberto; Galietta, Luis J. V.; Pedemonte, Nicoletta			High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); high-throughput screening (HTS); small interfering RNA (siRNA); interactome	CFTR CHLORIDE CHANNEL; FUSION PROTEIN; RESCUE; GENE; PROTEOSTASIS; DEGRADATION; EXPRESSION; CORRECTORS; SECRETION; PATHWAY	In cystic fibrosis, deletion of phenylalanine 508 (F508del) in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel causes misfolding and premature degradation. One possible approach to reducing the detrimental health effects of cystic fibrosis could be the identification of proteins whose suppression rescues F508del-CFTR function in bronchial epithelial cells. However, searches for these potential targets have not yet been conducted, particularly in a relevant airway background using a functional readout. To identify proteins associated with F508del-CFTR processing, we used a high-throughput functional assay to screen an siRNA library targeting 6,650 different cellular proteins. We identified 37 proteins whose silencing significantly rescued F508del-CFTR activity, as indicated by enhanced anion transport through the plasma membrane. These proteins included FAU, UBE2I, UBA52, MLLT6, UBA2, CHD4, PLXNA1, and TRIM24, among others. We focused our attention on FAU, a poorly characterized protein with unknown function. FAU knockdown increased the plasma membrane targeting and function of F508del-CFTR, but not of wild-type CFTR. Investigation into the mechanism of action revealed a preferential physical interaction of FAU with mutant CFTR, leading to its degradation. FAU and other proteins identified in our screening may offer a therapeutically relevant panel of drug targets to correct basic defects in F508del-CFTR processing.	[Tomati, Valeria; Pesce, Emanuela; Caci, Emanuela; Sondo, Elvira; Marini, Monica; Ravazzolo, Roberto; Pedemonte, Nicoletta] Ist Giannina Gaslini, Unita Operat Complessa UOC Genet Med, I-16147 Genoa, Italy; [Scudieri, Paolo; Galietta, Luis J. V.] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Amato, Felice; Castaldo, Giuseppe] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80138 Naples, Italy; [Amato, Felice; Castaldo, Giuseppe] CEINGE Adv Biotechnol Scarl, I-80145 Naples, Italy; [Ravazzolo, Roberto] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Genoa	Pedemonte, N (corresponding author), Ist Giannina Gaslini, UOC Genet Med, Via Gerolamo Gaslini 5, I-16147 Genoa, Italy.	nicoletta.pedemonte@unige.it	Pedemonte, Nicoletta/B-3607-2010; Scudieri, Paolo/AAM-9460-2020; Galietta, Luis JV/HCG-8692-2022; Amato, Felice/AAC-6805-2022; Castaldo, Giuseppe/AAC-6782-2022; Tomati, Valeria/AAB-4543-2021; Sondo, Elvira/K-3789-2018; Pesce, Emanuela/AAB-2642-2019	Pedemonte, Nicoletta/0000-0002-5161-1720; Scudieri, Paolo/0000-0002-8112-4800; Castaldo, Giuseppe/0000-0002-4036-0874; Tomati, Valeria/0000-0003-3761-1916; Sondo, Elvira/0000-0003-0971-2082; Pesce, Emanuela/0000-0002-9070-4479	Ricerca Corrente from the Italian Ministry of Health (Linea1); Italian Cystic Fibrosis Foundation [FFC3/2009, FFC 5/2012]; Italian Ministry of Health [GR-2008-1141326]; Telethon Grant [TMLGCBX16TT]	Ricerca Corrente from the Italian Ministry of Health (Linea1); Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of Health(Ministry of Health, Italy); Telethon Grant(Fondazione Telethon)	This work was supported by Ricerca Corrente from the Italian Ministry of Health (Linea1), by Italian Cystic Fibrosis Foundation Grants FFC3/2009 (with the contribution of "Anna Iacomini, Gruppo di Sostegno FFC Rita Verona, Delegazione FFC di Como") and FFC 5/2012 (with the contribution of "Danone S.p.A.") (to N. P.), by Italian Ministry of Health Grant GR-2008-1141326 (to N. P.), and by Telethon Grant TMLGCBX16TT (to L. J. V. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Almaca J, 2013, CELL, V154, P1390, DOI 10.1016/j.cell.2013.08.045; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Caci E, 2009, AM J RESP CELL MOL, V40, P211, DOI 10.1165/rcmb.2007-0456OC; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; Clark KL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.57; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gianotti A, 2013, AM J RESP CELL MOL, V49, P445, DOI 10.1165/rcmb.2012-0408OC; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; KAS K, 1992, BIOCHEM BIOPH RES CO, V187, P927, DOI 10.1016/0006-291X(92)91286-Y; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Lopes-Pacheco M, 2016, CHEMBIOCHEM, V17, P493, DOI 10.1002/cbic.201500620; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MICHIELS L, 1993, ONCOGENE, V8, P2537; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sondo E, 2017, CURR PHARM DESIGN, V23, P176, DOI 10.2174/1381612822666161006161033; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Tomati V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12138; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	32	26	26	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1203	1217		10.1074/jbc.M117.816595	http://dx.doi.org/10.1074/jbc.M117.816595			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158263	Green Published, hybrid			2022-12-26	WOS:000423515000009
J	Jadwin, JA; Curran, TG; Lafontaine, AT; White, FM; Mayer, BJ				Jadwin, Joshua A.; Curran, Timothy G.; Lafontaine, Adam T.; White, Forest M.; Mayer, Bruce J.			Src homology 2 domains enhance tyrosine phosphorylation in vivo by protecting binding sites in their target proteins from dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); growth factor receptor-bound protein 2 (GRB2); phosphorylation; phosphotyrosine; Src homology 2 domain (SH2 domain); crk	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; SH2 DOMAINS; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; INSULIN-RECEPTOR; KINASE DOMAIN; CELL; PHOSPHOTYROSINE; GRB2	Phosphotyrosine (pTyr)-dependent signaling is critical for many cellular processes. It is highly dynamic, as signal output depends not only on phosphorylation and dephosphorylation rates but also on the rates of binding and dissociation of effectors containing phosphotyrosine-dependent binding modules such as Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains. Previous in vitro studies suggested that binding of SH2 and PTB domains can enhance protein phosphorylation by protecting the sites bound by these domains from phosphatase-mediated dephosphorylation. To test whether this occurs in vivo, we used the binding of growth factor receptor bound 2 (GRB2) to phosphorylated epidermal growth factor receptor (EGFR) as a model system. We analyzed the effects of SH2 domain overexpression on protein tyrosine phosphorylation by quantitative Western and far-Western blotting, mass spectrometry, and computational modeling. We found that SH2 overexpression results in a significant, dose-dependent increase in EGFR tyrosine phosphorylation, particularly of sites corresponding to the binding specificity of the overexpressed SH2 domain. Computational models using experimentally determined EGFR phosphorylation and dephosphorylation rates, and pTyr-EGFR and GRB2 concentrations, recapitulated the experimental findings. Surprisingly, both modeling and biochemical analyses suggested that SH2 domain overexpression does not result in a major decrease in the number of unbound phosphorylated SH2 domain-binding sites. Our results suggest that signaling via SH2 domain binding is buffered over a relatively wide range of effector concentrations and that SH2 domain proteins with overlapping binding specificities are unlikely to compete with one another for phosphosites in vivo.	[Jadwin, Joshua A.; Lafontaine, Adam T.; Mayer, Bruce J.] Univ Connecticut, Sch Med, Dept Genet & Genome Sci, Raymond & Beverly Sackler Lab Mol Med, Farmington, CT 06030 USA; [Jadwin, Joshua A.; Lafontaine, Adam T.; Mayer, Bruce J.] Univ Connecticut, Sch Med, Richard B Berlin Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; [Curran, Timothy G.; White, Forest M.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Curran, Timothy G.; White, Forest M.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Connecticut; University of Connecticut; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Mayer, BJ (corresponding author), Univ Connecticut, Sch Med, Dept Genet & Genome Sci, 263 Farmington Ave, Farmington, CT 06030 USA.	bmayer@uchc.edu		White, Forest/0000-0002-1545-1651	National Institutes of Health from the NIGMS [P41 GM103313]; NATIONAL CANCER INSTITUTE [RC1CA146843, U01CA154966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ji Yu for critical reading of this manuscript, Kazuya Machida for technical advice with biochemical experiments, Ahmed Elmokadem and Ji Yu for advice on VCell modeling and reaction kinetics, and Shobhit Jain and Gary Bader (University of Toronto, Ontario, Canada) for help and advice on comparing LOGO plots. The Virtual Cell is supported by National Institutes of Health Grant P41 GM103313 from the NIGMS.	[Anonymous], 2017, QDOAS VERSION 32 SO; Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Beebe KD, 2000, BIOCHEMISTRY-US, V39, P13251, DOI 10.1021/bi0014397; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; BIRGE RB, 1992, J BIOL CHEM, V267, P10588; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Carroll DJ, 1999, DEV BIOL, V206, P232, DOI 10.1006/dbio.1998.9145; Chook YM, 1996, J BIOL CHEM, V271, P30472, DOI 10.1074/jbc.271.48.30472; Creamer MS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-107; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jadwin J. A., 2017, SH2 DOMAINS METHODS, P477; Jadwin JA, 2016, ELIFE, V5, DOI 10.7554/eLife.11835; Jadwin JA, 2012, FEBS LETT, V586, P2586, DOI 10.1016/j.febslet.2012.04.019; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Jones RB, 2013, EXPERT REV PROTEOMIC, V10, P115, DOI [10.1586/epr.12.78, 10.1586/EPR.12.78]; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; LEMMON MA, 1994, J BIOL CHEM, V269, P31653; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; MOTTO DG, 1994, J BIOL CHEM, V269, P21608; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Northrop JP, 1996, MOL CELL BIOL, V16, P2255; Novomestky F, 2012, MATRIXCALC COLLECTIO; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pradip D, 2013, AM J CANCER RES, V3, P173; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; RCore Team, 2017, R LANG ENV STAT COMP; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Rstudio Team, 2019, RSTUDIO INTEGRATED D; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Teyra J, 2017, STRUCTURE, V25, P1598, DOI 10.1016/j.str.2017.07.017; Thompson CM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0169-1; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wagih O, 2015, NAT METHODS, V12, P531, DOI 10.1038/nmeth.3396; Wagner M. J., 2013, COLD SPRING HARB PER, V5, P1; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Wilke C.O., 2017, cowplot: Streamlined plot theme and plot annotations for ``ggplot2''. R package version 0.8.0; Wills MKB, 2017, J CELL SCI, V130, P2808, DOI 10.1242/jcs.198903; Wilson TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092184; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	81	19	19	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					623	637		10.1074/jbc.M117.794412	http://dx.doi.org/10.1074/jbc.M117.794412			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162725	Green Published, hybrid			2022-12-26	WOS:000419915400018
J	Basila, M; Kelley, ML; Smith, AV				Basila, Megan; Kelley, Melissa L.; Smith, Anja van Brabant			Minimal 2 '-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity	PLOS ONE			English	Article							HUMAN T-CELLS; OLIGONUCLEOTIDE SYNTHESIS; CAS9 RIBONUCLEOPROTEINS; GENOME; DELIVERY; DNA; HYBRIDIZATION; ENDONUCLEASE; INTERFERENCE; CRRNA	Since its initial application in mammalian cells, CRISPR-Cas9 has rapidly become a preferred method for genome engineering experiments. The Cas9 nuclease is targeted to genomic DNA using guide RNAs (gRNA), either as the native dual RNA system consisting of a DNA-targeting CRISPR RNA (crRNA) and a trans-activating crRNA (tracrRNA), or as a chimeric single guide RNA (sgRNA). Entirely DNA-free CRISPR-Cas9 systems using either Cas9 protein or Cas9 mRNA and chemically synthesized gRNAs allow for transient expression of CRISPR-Cas9 components, thereby reducing the potential for off-targeting, which is a significant advantage in therapeutic applications. In addition, the use of synthetic gRNA allows for the incorporation of chemical modifications for enhanced properties including improved stability. Previous studies have demonstrated the utility of chemically modified gRNAs, but have focused on one pattern with multiple modifications in co-electroporation with Cas9 mRNA or multiple modifications and patterns with Cas9 plasmid lipid co-transfections. Here we present gene editing results using a series of chemically modified synthetic sgRNA molecules and chemically modified crRNA: tracrRNA molecules in both electroporation and lipid transfection assessing indel formation and/ or phenotypic gene knockout. We show that while modifications are required for co-electroporation with Cas9 mRNA, some modification patterns of the gRNA are toxic to cells compared to the unmodified gRNA and most modification patterns do not significantly improve gene editing efficiency. We also present modification patterns of the gRNA that can modestly improve Cas9 gene editing efficiency when co-transfected with Cas9 mRNA or Cas9 protein (> 1.5-fold difference). These results indicate that for certain applications, including those relevant to primary cells, the incorporation of some, but not all chemical modification patterns on synthetic crRNA: tracrRNA or sgRNA can be beneficial to CRISPR-Cas9 gene editing.	[Basila, Megan; Kelley, Melissa L.; Smith, Anja van Brabant] Dharmacon, Lafayette, CO 80026 USA		Smith, AV (corresponding author), Dharmacon, Lafayette, CO 80026 USA.	anja.smith@horizondiscovery.com	Li, Jie/I-5695-2015	Li, Jie/0000-0003-0189-2787	GE Healthcare Dharmacon, Inc.	GE Healthcare Dharmacon, Inc.	This work was funded by GE Healthcare Dharmacon, Inc. The funder provided support in the form of salaries for authors [MB, MLK, AvBS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; FISHER TL, 1993, NUCLEIC ACIDS RES, V21, P3857, DOI 10.1093/nar/21.16.3857; Ge Q, 2010, RNA, V16, P118, DOI 10.1261/rna.1901810; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kelley ML, 2016, J BIOTECHNOL, V233, P74, DOI 10.1016/j.jbiotec.2016.06.011; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li L, 2015, HUM GENE THER, V26, P452, DOI 10.1089/hum.2015.069; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Scaringe SA, 2001, METHODS, V23, P206, DOI 10.1006/meth.2000.1132; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v; Scaringe SA, 2000, METHOD ENZYMOL, V317, P3; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Strezoska Z, 2017, J BIOTECHNOL, V251, P189, DOI 10.1016/j.jbiotec.2017.04.017; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Yang L, 2014, METHOD MOL BIOL, V1114, P291; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	39	36	38	12	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188593	10.1371/journal.pone.0188593	http://dx.doi.org/10.1371/journal.pone.0188593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176845	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900104
J	Lin, Y; Fan, RL; Mo, L				Lin, Yi; Fan, Ruolin; Mo, Lei			Differences in phonetic discrimination stem from differences in psychoacoustic abilities in learning the sounds of a second language: Evidence from ERP research	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; SPEECH; BRAIN; PERCEPTION; RESPONSES; CHILDREN; DEFICITS; DYSLEXIA; REVEAL	The scientific community has been divided as to the origin of individual differences in perceiving the sounds of a second language (L2). There are two alternative explanations: a general psychoacoustic origin vs. a speech-specific one. A previous study showed that such individual variability is linked to the perceivers' speech-specific capabilities, rather than the perceivers' psychoacoustic abilities. However, we assume that the selection of participants and parameters of sound stimuli might not appropriate. Therefore, we adjusted the sound stimuli and recorded event-related potentials (ERPs) from two groups of early, proficient Cantonese (L1)-Mandarin (L2) bilinguals who differed in their mastery of the Mandarin (L2) phonetic contrast /in-ing/, to explore whether the individual differences in perceiving L2 stem from participants' ability to discriminate various pure tones (frequency, duration and pattern). To precisely measure the participants' acoustic discrimination, mismatch negativity (MMN) elicited by the oddball paradigm was recorded in the experiment. The results showed that significant differences between good perceivers (GPs) and poor perceivers (PPs) were found in the three general acoustic conditions (frequency, duration and pattern), and the MMN amplitude for GP was significantly larger than for PP. Therefore, our results support a general psychoacoustic origin of individual variability in L2 phonetic mastery.	[Lin, Yi; Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Lin, Yi; Mo, Lei] South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Lin, Yi; Mo, Lei] South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Yi] South China Normal Univ, Off Humanities & Social Sci, Guangzhou, Guangdong, Peoples R China; [Fan, Ruolin] Guangdong Univ Finance, Inst Appl Psychol, Guangzhou, Guangdong, Peoples R China; [Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; South China Normal University; South China Normal University; Guangdong University of Finance; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	molei@m.scnu.edu.cn		LIN, YI/0000-0003-4075-909X				Benasich AA, 2003, PROGRESS INFANCY RES, V3, P245; Benasich AA, 2006, NEUROPSYCHOLOGIA, V44, P396, DOI 10.1016/j.neuropsychologia.2005.06.004; Choudhury N, 2011, CLIN NEUROPHYSIOL, V122, P320, DOI 10.1016/j.clinph.2010.05.035; Diaz B, 2008, P NATL ACAD SCI USA, V105, P16083, DOI 10.1073/pnas.0805022105; Espy KA, 2004, ANN DYSLEXIA, V54, P9, DOI 10.1007/s11881-004-0002-3; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lang, 1990, PSYCHOPHYSIOLOGICAL, P294; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; McNicol D., 2005, PRIMER SIGNAL DETECT; Meng XZ, 2005, DYSLEXIA, V11, P292, DOI 10.1002/dys.309; Molfese DL, 2000, BRAIN LANG, V72, P238, DOI 10.1006/brln.2000.2287; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Nenonen S, 2005, BRAIN LANG, V92, P26, DOI 10.1016/j.bandl.2004.05.005; Perani D, 2005, CURR OPIN NEUROBIOL, V15, P202, DOI 10.1016/j.conb.2005.03.007; Sebastian-Galles N, 2005, TWENTY-FIRST CENTURY PSYCHOLINGUISTICS: FOUR CORNERSTONES, P279; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Tervaniemi M, 2006, EUR J NEUROSCI, V23, P2538, DOI 10.1111/j.1460-9568.2006.04752.x; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Winkler I, 1999, PSYCHOPHYSIOLOGY, V36, P638, DOI 10.1111/1469-8986.3650638; Wright BA, 1997, NATURE, V387, P176, DOI 10.1038/387176a0	30	2	2	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187135	10.1371/journal.pone.0187135	http://dx.doi.org/10.1371/journal.pone.0187135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN8QZ	29176886	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900005
J	Pinheiro, D; Leiros, L; Dau, JBT; Stumbo, AC; Thole, AA; Cortez, EAC; Mandarim-de-Lacerda, CA; de Carvalho, L; de Carvalho, SN				Pinheiro, Daphne; Leiros, Luana; Torreao Dau, Juliana Barbosa; Stumbo, Ana Carolina; Thole, Alessandra Alves; Costa Cortez, Erika Afonso; Mandarim-de-Lacerda, Carlos Alberto; de Carvalho, Lais; de Carvalho, Simone Nunes			Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TRANSPLANTATION; ANGIOGENESIS; PATHOGENESIS; MECHANISMS; RESOLUTION; CIRRHOSIS; DISEASE; INJURY; RATS	Bone marrow cells (BMC) migrate to the injured liver after transplantation, contributing to regeneration through multiple pathways, but mechanisms involved are unclear. This work aimed to study BMC migration, characterize cytokine profile, cell populations and proliferation in mice with liver fibrosis transplanted with GFP(+) BMC. Confocal microscopy analysis showed GFP(+) BMC near regions expressing HGF and SDF-1 in the fibrotic liver. Impaired liver cell proliferation in fibrotic groups was restored after BMC transplantation. Regarding total cell populations, there was a significant reduction in CD68(+) cells and increased Ly6G(+) cells in transplanted fibrotic group. BMC contributed to the total populations of CD144, CD11b and Ly6G cells in the fibrotic liver, related to an increment of anti-fibrotic cytokines (IL-10, IL-13, IFN-gamma and HGF) and reduction of pro-inflammatory cytokines (IL-17A and IL-6). Therefore, HGF and SDF-1 may represent important chemoattractants for transplanted BMC in the injured liver, where these cells can give rise to populations of extrahepatic macrophages, neutrophils and endothelial progenitor cells that can interact synergistically with other liver cells towards the modulation of an anti-fibrotic cytokine profile promoting the onset of liver regeneration.	[Pinheiro, Daphne; Leiros, Luana; Torreao Dau, Juliana Barbosa; Stumbo, Ana Carolina; Thole, Alessandra Alves; Costa Cortez, Erika Afonso; de Carvalho, Lais; de Carvalho, Simone Nunes] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Histol & Embryol, Lab Stem Cell Res, Rio De Janeiro, Brazil; [Mandarim-de-Lacerda, Carlos Alberto] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Anat Dept, Lab Morphometry & Cardiovasc Morphol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Carvalho, SN (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Histol & Embryol, Lab Stem Cell Res, Rio De Janeiro, Brazil.	simonenc@yahoo.com.br	Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Mandarim-de-Lacerda, Carlos A/F-7125-2012; Cortez, Erika/G-5067-2019	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Cortez, Erika/0000-0003-0262-061X; Thole, Alessandra/0000-0001-7909-3497; Carvalho, Lais/0000-0002-1790-3674; Carvalho, Simone/0000-0003-3310-2970; Pinheiro, Daphne/0000-0002-0986-971X; Stumbo, Ana/0000-0001-8848-7850	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [444406/2014-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/111.299/2014, E-26/111.047/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundings granted to author Carvalho, SN, which participated in study design, data collection and analysis, and preparation of the manuscript: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-http://www.cnpq.br/ (grant number 444406/2014-0), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)-http://www.faperj.br/ (grants number E-26/111.299/2014 and E-26/111.047/2013). Also, academic scholarship of Master and PhD students enrolled in this study was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)-http://www.capes.gov.br/.	Asri A, 2016, EXCLI J, V15, P134, DOI 10.17179/excli2014-585; Behbahan IS, 2013, STEM CELLS, V31, P2313, DOI 10.1002/stem.1510; Carvalho SN, 2010, HISTOCHEM CELL BIOL, V134, P493, DOI 10.1007/s00418-010-0746-2; de Andrade DC, 2015, EXP CELL RES, V336, P15, DOI 10.1016/j.yexcr.2015.05.002; de Carvalho SN, 2013, CELLS TISSUES ORGANS, V198, P139, DOI 10.1159/000353215; de Carvalho SN, 2013, BIOCHEM CELL BIOL, V91, P88, DOI 10.1139/bcb-2012-0045; Ding WX, 2016, J HEPATOL, V64, P16, DOI 10.1016/j.jhep.2015.10.003; Duval F, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/943497; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Elpek GO, 2014, WORLD J GASTROENTERO, V20, P7260, DOI 10.3748/wjg.v20.i23.7260; Gamal MAH, 2013, J GASTROEN HEPATOL, V2, P434; Gao ZM, 2012, INT J CLIN EXP PATHO, V5, P626; Hammerich Linda, 2015, World J Gastrointest Pathophysiol, V6, P43, DOI 10.4291/wjgp.v6.i3.43; Iwakiri Y, 2014, J HEPATOL, V61, P912, DOI 10.1016/j.jhep.2014.05.047; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kaur S, 2013, HEPATOL INT, V7, P959, DOI 10.1007/s12072-013-9483-7; Kim MD, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.49; Leibacher J, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0271-2; Li L., 2010, TRENDS BIOPHARM IND, V6, P29; Lian J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103603; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Pai M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/307165; Park S, 2015, BIOL PHARM BULL, V38, P980, DOI 10.1248/bpb.b15-00325; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Prystupa A, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/532615; Ramachandran P, 2015, SEMIN LIVER DIS, V35, P119, DOI 10.1055/s-0035-1550057; Ratajczak MZ, 2014, POL ARCH MED WEWN, V124, P417, DOI 10.20452/pamw.2355; Schneider MR, 2014, CARCINOGENESIS, V35, P1855, DOI 10.1093/carcin/bgu109; Suh YG, 2012, HEPATOLOGY, V56, P1902, DOI 10.1002/hep.25817; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tag CG, 2015, JOVE-J VIS EXP, DOI 10.3791/52438; Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03; Wu YJ, 2011, HEPATOB PANCREAT DIS, V10, P151, DOI 10.1016/S1499-3872(11)60024-6; Yoon YJ, 2016, SEMIN LIVER DIS, V36, P87, DOI 10.1055/s-0036-1571295; Zachar L, 2016, J INFLAMM RES, V9, P231, DOI 10.2147/JIR.S121994; Zhang S, 2016, SCAND J IMMUNOL, V83, P102, DOI 10.1111/sji.12395; Zhou WC, 2014, WORLD J GASTROENTERO, V20, P7312, DOI 10.3748/wjg.v20.i23.7312	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0187970	10.1371/journal.pone.0187970	http://dx.doi.org/10.1371/journal.pone.0187970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176797	gold, Green Published, Green Submitted			2022-12-26	WOS:000416291900027
J	Reidenbach, LB; Fernandez, PA; Leal, PP; Noisette, F; McGraw, CM; Revill, AT; Hurd, CL; Kubler, JE				Reidenbach, Leah B.; Fernandez, Pamela A.; Leal, Pablo P.; Noisette, Fanny; McGraw, Christina M.; Revill, Andrew T.; Hurd, Catriona L.; Kubler, Janet E.			Growth, ammonium metabolism, and photosynthetic properties of Ulva australis (Chlorophyta) under decreasing pH and ammonium enrichment	PLOS ONE			English	Article							OCEAN ACIDIFICATION; NUTRIENT ENRICHMENT; ELEVATED CO2; ENTEROMORPHA-INTESTINALIS; CONCENTRATING MECHANISMS; GRACILARIA LEMANEIFORMIS; LACTUCA CHLOROPHYTA; NITRATE REDUCTASE; MACROALGAL BLOOMS; NITROGEN UPTAKE	The responses of macroalgae to ocean acidification could be altered by availability of macronutrients, such as ammonium (NH4+). This study determined how the opportunistic macroalga, Ulva australis responded to simultaneous changes in decreasing pH and NH4+ enrichment. This was investigated in a week-long growth experiment across a range of predicted future pHs with ambient and enriched NH4+ treatments followed by measurements of relative growth rates (RGR), NH4+ uptake rates and pools, total chlorophyll, and tissue carbon and nitrogen content. Rapid light curves (RLCs) were used to measure the maximum relative electron transport rate (rETR(max)) and maximum quantum yield of photosystem II (PSII) photochemistry (F-v/F-m). Photosynthetic capacity was derived from the RLCs and included the efficiency of light harvesting (alpha), slope of photoinhibition (beta), and the light saturation point (Ek). The results showed that NH4+ enrichment did not modify the effects of pH on RGRs, NH4+ uptake rates and pools, total chlorophyll, rETR(max,) alpha, beta, F-v/F-m, tissue C and N, and the C:N ratio. However, E-k was differentially affected by pH under different NH4+ treatments. Ek increased with decreasing pH in the ambient NH4+ treatment, but not in the enriched NH4+ treatment. NH4+ enrichment increased RGRs, NH4+ pools, total chlorophyll, rETRmax, alpha, beta, F-v/F-m, and tissue N, and decreased NH4+ uptake rates and the C:N ratio. Decreased pH increased total chlorophyll content, rETRmax, F-v/F-m, and tissue N content, and decreased the C:N ratio. Therefore, the results indicate that U. australis growth is increased with NH4+ enrichment and not with decreasing pH. While decreasing pH influenced the carbon and nitrogen metabolisms of U. australis, it did not result in changes in growth.	[Reidenbach, Leah B.; Kubler, Janet E.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Fernandez, Pamela A.; Leal, Pablo P.; Noisette, Fanny; McGraw, Christina M.; Hurd, Catriona L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Noisette, Fanny] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [McGraw, Christina M.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Revill, Andrew T.] CSIRO, Oceans & Atmosphere, Hobart, Tas, Australia; [Reidenbach, Leah B.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Fernandez, Pamela A.] Univ Los Lagos, Ctr I Mar, Puerto Montt, Chile; [Leal, Pablo P.] Inst Fomento Pesquero, Puerto Montt, Chile	California State University System; California State University Northridge; University of Tasmania; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Otago; Commonwealth Scientific & Industrial Research Organisation (CSIRO); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidad de Los Lagos; Instituto de Fomento Pesquero (Valparaiso)	Reidenbach, LB (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.; Reidenbach, LB (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	Leah.Reidenbach@stonybrook.edu	Reidenbach, Leah/HHZ-5145-2022; Leal, Pablo/H-6355-2013; Leal, Pablo P./N-3927-2019; Fernandez, Pamela/AAX-1676-2021; Fernandez, Pamela Andrea/K-2021-2014; Revill, Andrew T/B-8733-2011; Hurd, Catriona/J-2411-2013	Leal, Pablo/0000-0002-7616-1850; Leal, Pablo P./0000-0002-7616-1850; Fernandez, Pamela/0000-0003-3122-0084; Fernandez, Pamela Andrea/0000-0003-3122-0084; Revill, Andrew T/0000-0003-2486-5976; Hurd, Catriona/0000-0001-9965-4917; McGraw, Christina/0000-0001-5841-0748	National Science Foundation [OISE 1515267]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant: OISE 1515267 (URL: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1515267) (Author: LBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andria JR, 2001, BOT MAR, V44, P361, DOI 10.1515/BOT.2001.046; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bockmon EE, 2013, BIOGEOSCIENCES, V10, P5967, DOI 10.5194/bg-10-5967-2013; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Chen BB, 2016, J APPL PHYCOL, V28, P1235, DOI 10.1007/s10811-015-0628-z; Chen BB, 2015, AQUACULTURE, V443, P49, DOI 10.1016/j.aquaculture.2015.03.009; Cornwall CE, 2017, INORGANIC CARBON PHY, P1; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; DELIA CF, 1978, J PHYCOL, V14, P266, DOI 10.1111/j.1529-8817.1978.tb00297.x; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fong P, 2004, AQUAT BOT, V78, P83, DOI 10.1016/j.aquabot.2003.09.006; Fong P, 2003, MAR ECOL PROG SER, V262, P111, DOI 10.3354/meps262111; Fong P, 1998, J EXP MAR BIOL ECOL, V231, P63, DOI 10.1016/S0022-0981(98)00085-9; FUJITA RM, 1985, J EXP MAR BIOL ECOL, V92, P283, DOI 10.1016/0022-0981(85)90100-5; GAO K, 1993, J APPL PHYCOL, V5, P563, DOI 10.1007/BF02184635; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hofmann LC, 2014, PLANTA, V239, P231, DOI 10.1007/s00425-013-1982-1; Hofmann LC, 2013, J EXP BOT, V64, P899, DOI 10.1093/jxb/ers369; Hurd CL, 1996, MAR BIOL, V126, P205, DOI 10.1007/BF00347445; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Israel A, 2002, GLOBAL CHANGE BIOL, V8, P831, DOI 10.1046/j.1365-2486.2002.00518.x; Kang JW, 2017, J APPL PHYCOL, V29, P2675, DOI 10.1007/s10811-017-1087-5; Kennison RL, 2011, J PHYCOL, V47, P483, DOI 10.1111/j.1529-8817.2011.00994.x; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; KUBLER JE, 1995, J PHYCOL, V31, P369, DOI 10.1111/j.0022-3646.1995.00369.x; LAPOINTE BE, 1981, J EXP MAR BIOL ECOL, V53, P135, DOI 10.1016/0022-0981(81)90015-0; Li SX, 2016, HYDROBIOLOGIA, V776, P161, DOI 10.1007/s10750-016-2749-z; Liu C.M., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1080/17451000.2015.1062520; Liu CX, 2015, CHIN J OCEANOL LIMN, V33, P419, DOI 10.1007/s00343-015-4057-2; McGlathery KJ, 1996, J PHYCOL, V32, P393, DOI 10.1111/j.0022-3646.1996.00393.x; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; Morand P, 1996, BOT MAR, V39, P491, DOI 10.1515/botm.1996.39.1-6.491; Olischlager M, 2013, PHYCOL RES, V61, P180, DOI 10.1111/pre.12006; Paerl HW, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P529, DOI 10.1016/B978-0-12-372522-6.00011-6; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; PEDERSEN MF, 1994, J PHYCOL, V30, P980, DOI 10.1111/j.0022-3646.1994.00980.x; Rautenberger R, 2015, ECOL EVOL, V5, P874, DOI 10.1002/ece3.1382; Raven J., 2005, OCEAN ACIDIFICATION, P60; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Sabine CL, 2007, GREENHOUSE GAS SINKS, P31, DOI 10.1079/9781845931896.0031; Scherner F, 2013, MAR POLLUT BULL, V76, P106, DOI 10.1016/j.marpolbul.2013.09.019; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Suarez-Alvarez S, 2012, J APPL PHYCOL, V24, P815, DOI 10.1007/s10811-011-9700-5; SYRETT PJ, 1981, CAN B FISH AQUAT SCI, P182; Teichberg M, 2007, MAR BIOL, V151, P1249, DOI 10.1007/s00227-006-0561-4; Teichberg M, 2008, MAR ECOL PROG SER, V368, P117, DOI 10.3354/meps07564; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; TURPIN DH, 1991, J PHYCOL, V27, P14, DOI 10.1111/j.0022-3646.1991.00014.x; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Walsby AE, 1997, NEW PHYTOL, V136, P189, DOI 10.1046/j.1469-8137.1997.00736.x; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Young CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155152; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014; Zou DH, 2009, PHYCOLOGIA, V48, P510, DOI 10.2216/08-99.1	62	13	15	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188389	10.1371/journal.pone.0188389	http://dx.doi.org/10.1371/journal.pone.0188389			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176815	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000416291900071
J	Glendinning, L; McLachlan, G; Vervelde, L				Glendinning, Laura; McLachlan, Gerry; Vervelde, Lonneke			Age-related differences in the respiratory microbiota of chickens	PLOS ONE			English	Article							BACTERIAL-FLORA; MOLECULAR ANALYSIS; BROILER-CHICKENS; TRACT; DIVERSITY; SEVERITY	In this era of next generation sequencing technologies it is now possible to characterise the chicken respiratory microbiota without the biases inherent to traditional culturing techniques. However, little research has been performed in this area. In this study we characterise and compare buccal, nasal and lung microbiota samples from chickens in three different age groups using 16S rRNA gene analysis. Buccal and nasal swabs were taken from birds aged 2 days (n = 5), 3 weeks (n = 5) and 30 months (n = 6). Bronchoalveolar lavage (BAL) samples were also collected alongside reagent only controls. DNA was extracted from these samples and the V2-V3 region of the 16S rRNA gene was amplified and sequenced. Quality control and OTU clustering were performed in mothur. Bacterial DNA was quantified using qPCR, amplifying the V3 region of the 16S rRNA gene. We found significant differences between the quantity and types of bacteria sampled at the three different respiratory sites. We also found significant differences in the composition, richness and diversity of the bacterial communities in buccal, nasal and BAL fluid samples between age groups. We identified several bacteria which had previously been isolated from the chicken respiratory tract in culture based studies, including lactobacilli and staphylococci. However, we also identified bacteria which have not previously been cultured from the respiratory tract of the healthy chicken. We conclude that our study can be used as a baseline that future chicken respiratory microbiota studies can build upon.	[Glendinning, Laura; McLachlan, Gerry] Univ Edinburgh, Roslin Inst, Dev Biol, Edinburgh, Midlothian, Scotland; [Glendinning, Laura; McLachlan, Gerry; Vervelde, Lonneke] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Vervelde, Lonneke] Univ Edinburgh, Infect & Immun, Roslin Inst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Glendinning, L (corresponding author), Univ Edinburgh, Roslin Inst, Dev Biol, Edinburgh, Midlothian, Scotland.; Glendinning, L (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	laura.glendinning@roslin.ed.ac.uk	Vervelde, Lonneke/C-7707-2013	Glendinning, Laura/0000-0003-4789-6644; Vervelde, Lonneke/0000-0003-2241-1743; McLachlan, Gerry/0000-0001-5362-9804	EASTBIO doctoral training program [406 BB/J01446X/1]; Biotechnology and Biological Sciences Research Council; Institute Strategic Program [BB/P013759/1]; Animal Health and Welfare ERA-Net (ANIHWA) project MICHIC [BB/M028305/1]; Biotechnology and Biological Sciences Research Council [1358257, BB/M028305/1, BBS/E/D/30002276] Funding Source: researchfish; BBSRC [BBS/E/D/30002276, BB/M028305/1] Funding Source: UKRI	EASTBIO doctoral training program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Program; Animal Health and Welfare ERA-Net (ANIHWA) project MICHIC; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Laura Glendinning was funded by the EASTBIO doctoral training program (Grant number: 406 BB/J01446X/1). This study was further funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) Institute Strategic Program Grant BB/P013759/1 to The Roslin Institute and the Animal Health and Welfare ERA-Net (ANIHWA) project MICHIC (BB/M028305/1) to Lonneke Vervelde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Devine VT, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/394368; DHO M, 1983, ANN RECH VET, V14, P189; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; ESTY WW, 1986, ANN STAT, V14, P1257, DOI 10.1214/aos/1176350066; Glendinning L, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00515-17; Glendinning L, 2016, APPL ENVIRON MICROB, V82, P3225, DOI 10.1128/AEM.00540-16; Gong JH, 2002, FEMS MICROBIOL ECOL, V41, P171, DOI 10.1111/j.1574-6941.2002.tb00978.x; KAWAGUCHI I, 1992, J VET MED SCI, V54, P261, DOI 10.1292/jvms.54.261; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martin E, 2010, SYST APPL MICROBIOL, V33, P188, DOI 10.1016/j.syapm.2010.03.008; Oh JK, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-016-0130-8; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Poroyko V, 2015, AM J PHYSIOL-LUNG C, V309, pL76, DOI 10.1152/ajplung.00061.2014; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Reiss-Mandel A, 2016, HUM VACC IMMUNOTHER, V12, P351, DOI 10.1080/21645515.2015.1081321; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shabbir MZ, 2015, POULTRY SCI, V94, P612, DOI 10.3382/ps/pev010; SHARMA VD, 1971, POULTRY SCI, V50, P1041, DOI 10.3382/ps.0501041; SMIBERT RM, 1958, POULTRY SCI, V37, P159, DOI 10.3382/ps.0370159; Sohail MU, 2015, AVIAN PATHOL, V44, P67, DOI 10.1080/03079457.2015.1004622; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111228; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138	35	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188455	10.1371/journal.pone.0188455	http://dx.doi.org/10.1371/journal.pone.0188455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN5GQ	29166670	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300040
J	Lopez-Meseguer, M; Quezada, CA; Ramon, MA; Lazaro, M; Dos, L; Lara, A; Lopez, R; Blanco, I; Escribano, P; Roman, A				Lopez-Meseguer, Manuel; Quezada, Carlos A.; Ramon, Maria A.; Lazaro, Maria; Dos, Laura; Lara, Antonio; Lopez, Raquel; Blanco, Isabel; Escribano, Pilar; Roman, Antonio		REHAP Investigators	Lung and heart-lung transplantation in pulmonary arterial hypertension	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; PREDICTING SURVIVAL; REVEAL REGISTRY; MANAGEMENT; INSIGHTS; PROSTACYCLIN; THERAPY; FAILURE; IMPACT; SPAIN	Background Real use of lung (LT) and heart-lung (HLT) transplantation in pulmonary arterial hypertension (PAH) is unknown. The objectives were to describe the indication of these procedures on PAH treatment in a national cohort of PAH patients, and to analyze the potential improvement of its indication in severe patients. Methods Eligibility for LT/HLT was assessed for each deceased patient. Incident patients from REHAP diagnosed between January 2007 and March 2015 and considered eligible for LT/HLT were grouped as follows: those who finally underwent transplantation (LTP) and those who died (D-Non-LT). Findings Of 1391 patients included in REHAP, 36 (3%) were LTP and 375 (27%) died. Among those who died, 36 (3%) were D-Non-LT. LTP and D-Non-LT were equal in terms of age, gender, and clinical status. Ten percent of those who died were functional class I-II. Patients functional class IV were less likely to undergo LT (8.3% LTP vs. 30.6% D-Non-LT, p = 0.017). Patients with idiopathic and drug/toxin-associated PAH were more likely to undergo LT (44.4% LTP vs. 16.7% D-Non-LT, p = 0.011). Conclusions The present results show that the use of LT/HLT could double for this indication. Relevant mortality in early functional class reflects the difficulties in establishing the risk of death in PAH.	[Lopez-Meseguer, Manuel; Ramon, Maria A.; Roman, Antonio] Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain; [Lopez-Meseguer, Manuel; Ramon, Maria A.; Roman, Antonio] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Lopez-Meseguer, Manuel; Ramon, Maria A.; Blanco, Isabel; Roman, Antonio] Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain; [Quezada, Carlos A.; Escribano, Pilar] Hosp Univ Doce Octubre, Cardiol Dept, Pulm Hypertens Unit, Madrid, Spain; [Lazaro, Maria] Hosp Virgen Salud, Dept Cardiol, Toledo, Spain; [Dos, Laura] Dept Cardiol, Unidad CC Adolescente & Adulto Vall dHebron St Pa, Barcelona, Spain; [Lara, Antonio] Hosp Univ Canarias, Dept Cardiol, Santa Cruz De Tenerife, Spain; [Lopez, Raquel] Hosp Univ La Fe, Dept Pneumonol, Valencia, Spain; [Blanco, Isabel] Univ Barcelona, Hosp Clin IDIBAPS, Dept Pulm Med, Barcelona, Spain; [Blanco, Isabel] Univ Barcelona, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario 12 de Octubre; Complejo Hospitalario de Toledo; Universidad de la Laguna; Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Roman, A (corresponding author), Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain.; Roman, A (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.; Roman, A (corresponding author), Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain.	aroman@vhebron.net	Dos Subira, Laura/AEV-6136-2022; Escribano, Pilar/R-5273-2017; Dos Subira, Laura/GRY-6349-2022; Lopez Meseguer, Manuel/D-6177-2018	Escribano, Pilar/0000-0002-6640-4839; Ramon, Maria A/0000-0002-4856-8442; DOS SUBIRA, LAURA/0000-0001-5821-4501; Lopez Meseguer, Manuel/0000-0003-2650-9238	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This work was supported by Bayer HealthCare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Benza RL, 2010, TRANSPLANTATION, V90, P298, DOI 10.1097/TP.0b013e3181e49b83; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Chen H, 2009, AM J RESP CRIT CARE, V180, P468, DOI 10.1164/rccm.200810-1603OC; Corris P, 2014, EUR RESPIR REV, V23, P488, DOI 10.1183/09059180.00007214; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; de Perrot M, 2011, J HEART LUNG TRANSPL, V30, P997, DOI 10.1016/j.healun.2011.03.002; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Escribano-Subias P, 2012, EUR RESPIR J, V40, P596, DOI 10.1183/09031936.00101211; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Farber HW, 2013, J HEART LUNG TRANSPL, V32, P1114, DOI 10.1016/j.healun.2013.08.010; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Gomberg-Maitland M, 2013, J HEART LUNG TRANSPL, V32, P1179, DOI 10.1016/j.healun.2013.08.016; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Lee WTN, 2012, EUR RESPIR J, V40, P604, DOI 10.1183/09031936.00196611; Matesanz R, 2009, TRANSPL P, V41, P3453, DOI 10.1016/j.transproceed.2009.09.011; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Weill D, 2015, J HEART LUNG TRANSPL, V34, P1, DOI 10.1016/j.healun.2014.06.014; Yusen RD, 2015, J HEART LUNG TRANSPL, V34, P1264, DOI 10.1016/j.healun.2015.08.014	26	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187811	10.1371/journal.pone.0187811	http://dx.doi.org/10.1371/journal.pone.0187811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161284	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000021
J	Vetrivel, I; Mahajan, S; Tyagi, M; Hoffmann, L; Sanejouand, YH; Srinivasan, N; de Brevern, AG; Cadet, F; Offmann, B				Vetrivel, Iyanar; Mahajan, Swapnil; Tyagi, Manoj; Hoffmann, Lionel; Sanejouand, Yves-Henri; Srinivasan, Narayanaswamy; de Brevern, Alexandre G.; Cadet, Frederic; Offmann, Bernard			Knowledge-based prediction of protein backbone conformation using a structural alphabet	PLOS ONE			English	Article							SECONDARY STRUCTURE; TERTIARY STRUCTURES; SEQUENCE; PENTAPEPTIDES; RECOGNITION; FRAGMENTS; PROFILES; MOTIFS	Libraries of structural prototypes that abstract protein local structures are known as structural alphabets and have proven to be very useful in various aspects of protein structure analyses and predictions. One such library, Protein Blocks, is composed of 16 standard 5-residues long structural prototypes. This form of analyzing proteins involves drafting its structure as a string of Protein Blocks. Predicting the local structure of a protein in terms of protein blocks is the general objective of this work. A new approach, PB-kPRED is proposed towards this aim. It involves (i) organizing the structural knowledge in the form of a database of pentapeptide fragments extracted from all protein structures in the PDB and (ii) applying a knowledge-based algorithm that does not rely on any secondary structure predictions and/or sequence alignment profiles, to scan this database and predict most probable backbone conformations for the protein local structures. Though PB-kPRED uses the structural information from homologues in preference, if available. The predictions were evaluated rigorously on 15,544 query proteins representing a non-redundant subset of the PDB filtered at 30% sequence identity cut-off. We have shown that the kPRED method was able to achieve mean accuracies ranging from 40.8% to 66.3% depending on the availability of homologues. The impact of the different strategies for scanning the database on the prediction was evaluated and is discussed. Our results highlight the usefulness of the method in the context of proteins without any known structural homologues. A scoring function that gives a good estimate of the accuracy of prediction was further developed. This score estimates very well the accuracy of the algorithm (R-2 of 0.82). An online version of the tool is provided freely for non-commercial usage at http://www.bo-protscience.fr/kpred/.	[Vetrivel, Iyanar; Mahajan, Swapnil; Hoffmann, Lionel; Sanejouand, Yves-Henri; Offmann, Bernard] Univ Nantes, UFIP, UMR CNRS 6286, UFR Sci & Tech, 2 Chemin Houssiniere, Nantes, France; [Mahajan, Swapnil; Cadet, Frederic] Univ La Reunion, DSIMB, INSERM, UMR S 1134,Lab Excellence,GR Ex,Fac Sci & Technol, St Denis, La Reunion, France; [Tyagi, Manoj] Univ La Reunion, St Denis, La Reunion, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [de Brevern, Alexandre G.] Univ Paris Diderot, Univ Sorbonne Paris Cite, Lab Excellence, INSERM UMR S 1134,DSIMB Team,GR Ex,INTS, Rue Alexandre Cabanel, Paris, France; [Cadet, Frederic] PEACCEL SAS, Paris, France; [Tyagi, Manoj] NCI, Bethesda, MA USA	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of La Reunion; University of La Reunion; Indian Institute of Science (IISC) - Bangalore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Offmann, B (corresponding author), Univ Nantes, UFIP, UMR CNRS 6286, UFR Sci & Tech, 2 Chemin Houssiniere, Nantes, France.	bernard.offmann@univ-nantes.fr	de Brevern, Alexandre G./B-4788-2009; OFFMANN, Bernard/B-5901-2011; Mahajan, Swapnil/J-4732-2019	de Brevern, Alexandre G./0000-0001-7112-5626; OFFMANN, Bernard/0000-0002-6845-5883; Mahajan, Swapnil/0000-0003-2136-1801	Region Reunion; Fond Social Europeen [20131528]; Conseil Regional des Pays de la Loire; Ministry of Research (France); National Institute for Blood Transfusion (INTS, France); National Institute for Health and Medical Research (INSERM, France); labex GR-Ex; French National Research Agency [ANR-11-LABX-0051, ANR-11-IDEX-0005-02]; University Paris Diderot, Sorbonne, Paris Cite (France); University de La Reunion, Faculty of Sciences and Technology; Indo-French Centre for the Promotion of Advanced Research / CEFIPRA [5302-2]; Department of Biotechnology, Government of India	Region Reunion; Fond Social Europeen; Conseil Regional des Pays de la Loire(Region Pays de la Loire); Ministry of Research (France)(Ministry of Research, France); National Institute for Blood Transfusion (INTS, France); National Institute for Health and Medical Research (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); labex GR-Ex; French National Research Agency(French National Research Agency (ANR)); University Paris Diderot, Sorbonne, Paris Cite (France); University de La Reunion, Faculty of Sciences and Technology; Indo-French Centre for the Promotion of Advanced Research / CEFIPRA; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Region Reunion and the Fond Social Europeen [grant no. 20131528] to IV. This work was in part supported by Conseil Regional des Pays de la Loire in the framework of GRIOTE project. AdB and FC acknowledge grants from the Ministry of Research (France), National Institute for Blood Transfusion (INTS, France), National Institute for Health and Medical Research (INSERM, France) and labex GR-Ex. The labex GR-Ex, reference ANR-11-LABX-0051 is funded by the program "Investissements d'avenir" of the French National Research Agency, reference ANR-11-IDEX-0005-02. AdB acknowledge supports by University Paris Diderot, Sorbonne, Paris Cite (France), FC acknowledge supports by University de La Reunion, Faculty of Sciences and Technology. NS and AdB acknowledge to Indo-French Centre for the Promotion of Advanced Research / CEFIPRA for collaborative grant (number 5302-2). Research in NS laboratory is also supported by Department of Biotechnology, Government of India. NS is a J.C. Bose National Fellow.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARGOS P, 1987, J MOL BIOL, V197, P331, DOI 10.1016/0022-2836(87)90127-6; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bystroff C, 1996, CURR OPIN BIOTECH, V7, P417, DOI 10.1016/S0958-1669(96)80117-0; Cheng HT, 2007, BIOINFORMATICS, V23, P2628, DOI 10.1093/bioinformatics/btm379; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; Dong QW, 2008, PROTEINS, V72, P163, DOI 10.1002/prot.21904; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Ghouzam Y, 2015, BIOINFORMATICS, V31, P3782, DOI 10.1093/bioinformatics/btv462; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joseph AP, 2011, BIOCHIMIE, V93, P1434, DOI 10.1016/j.biochi.2011.04.010; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2004, PROTEINS, V55, P508, DOI 10.1002/prot.20008; Karypis G, 2006, PROTEINS, V64, P575, DOI 10.1002/prot.21036; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Luo JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00795-4; Mahajan S, 2015, PROTEIN SCI, V24, P145, DOI 10.1002/pro.2581; Nguyen L.A.T., 2014, BIOMEDICAL SCI ENG, V7, P927, DOI DOI 10.4236/JBISE.2014.711090; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Rangwala H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-439; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Schneider B, 2014, NUCLEIC ACIDS RES, V42, P3381, DOI 10.1093/nar/gkt1273; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Suresh V, 2014, PROTEIN PEPTIDE LETT, V21, P736; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Zimmermann O, 2008, J CHEM INF MODEL, V48, P1903, DOI 10.1021/ci800178a	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186215	10.1371/journal.pone.0186215	http://dx.doi.org/10.1371/journal.pone.0186215			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161266	Green Submitted, Green Published, gold			2022-12-26	WOS:000415987000004
J	Buchan, SA; Chung, H; Campitelli, MA; Crowcroft, NS; Gubbay, JB; Karnauchow, T; Katz, K; McGeer, AJ; McNally, JD; Richardson, D; Richardson, SE; Rosella, LC; Simor, A; Smieja, M; Tran, D; Zahariadis, G; Kwong, JC				Buchan, Sarah A.; Chung, Hannah; Campitelli, Michael A.; Crowcroft, Natasha S.; Gubbay, Jonathan B.; Karnauchow, Timothy; Katz, Kevin; McGeer, Allison J.; McNally, J. Dayre; Richardson, David; Richardson, Susan E.; Rosella, Laura C.; Simor, Andrew; Smieja, Marek; Tran, Dat; Zahariadis, George; Kwong, Jeffrey C.			Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; NEW-ZEALAND; TRIVALENT; SURVEILLANCE; SENSITIVITY; HOUSEHOLDS; INFECTION; AUCKLAND; ILLNESS; MODEL	Uncertainty remains regarding the magnitude of effectiveness of influenza vaccines for preventing serious outcomes, especially among young children. We estimated vaccine effectiveness (VE) against laboratory-confirmed influenza hospitalizations among children aged 6-59 months. We used the test-negative design in hospitalized children in Ontario, Canada during the 2010-11 to 2013-14 influenza seasons. We used logistic regression models adjusted for age, season, and time within season to calculate VE estimates by vaccination status (full vs. partial), age group, and influenza season. We also assessed VE incorporating prior history of influenza vaccination. We included specimens from 9,982 patient hospitalization episodes over four seasons, with 12.8% testing positive for influenza. We observed variation in VE by vaccination status, age group, and influenza season. For the four seasons combined, VE was 60% (95% CI, 44%-72%) for full vaccination and 39% (95% CI, 17%-56%) for partial vaccination. VE for full vaccination was 67% (95% CI, 48%-79%) for children aged 24-59 months, 48% (95% CI, 12%-69%) for children aged 6-23 months, 77% (95% CI, 47%-90%) for 2010-11, 59% (95% CI, 13%-81%) for 2011-12, 33% (95% CI, -18% to 62%) for 2012-13, and 72% (95% CI, 42%-86%) for 2013-14. VE in children aged 24-59 months appeared similar between those vaccinated in both the current and previous seasons and those vaccinated in the current season only, with the exception of 2012-13, when VE was lower for those vaccinated in the current season only. Influenza vaccination is effective in preventing pediatric laboratory-confirmed influenza hospitalizations during most seasons.	[Buchan, Sarah A.; Crowcroft, Natasha S.; McGeer, Allison J.; Rosella, Laura C.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chung, Hannah; Campitelli, Michael A.; Rosella, Laura C.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Crowcroft, Natasha S.; Gubbay, Jonathan B.; Rosella, Laura C.; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Crowcroft, Natasha S.; Gubbay, Jonathan B.; Katz, Kevin; McGeer, Allison J.; Richardson, Susan E.; Simor, Andrew] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gubbay, Jonathan B.; Richardson, Susan E.; Tran, Dat] Hosp Sick Children, Toronto, ON, Canada; [Karnauchow, Timothy; McNally, J. Dayre] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Karnauchow, Timothy] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Katz, Kevin] North York Gen Hosp, Toronto, ON, Canada; [McGeer, Allison J.] Sinai Hlth Syst, Toronto, ON, Canada; [Richardson, David] William Osler Hlth Syst, Brampton, ON, Canada; [Simor, Andrew] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Smieja, Marek] McMaster Univ, Hamilton, ON, Canada; [Tran, Dat] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Zahariadis, George] London Hlth Sci Ctr, London, ON, Canada; [Zahariadis, George] Newfoundland & Labrador Publ Hlth Lab, St John, NF, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; London Health Sciences Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kwong, JC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Kwong, JC (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Kwong, JC (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.; Kwong, JC (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	McGeer, Allison/AAB-6885-2020; Gubbay, Jonathan/Q-8580-2019	McGeer, Allison/0000-0001-5647-6137; Gubbay, Jonathan/0000-0003-0026-3786; Buchan, Sarah/0000-0002-5286-8974	Canadian Institutes of Health Research [CIHR MOP 130568]; Canadian Immunization Research Network; Ontario Graduate Scholarship; Canadian Institutes of Health Research; University of Toronto Department of Family and Community Medicine; Canada Research Chair in Population Health Analytics; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Public Health Ontario (PHO) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Immunization Research Network; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Department of Family and Community Medicine; Canada Research Chair in Population Health Analytics; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Public Health Ontario (PHO) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	This work was supported by an operating grant from the Canadian Institutes of Health Research [CIHR MOP 130568]. SAB's doctoral training is supported by a Canadian Immunization Research Network Trainee Award and an Ontario Graduate Scholarship. JCK is supported by a New Investigator Salary Award from the Canadian Institutes of Health Research and a Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine. LCR is supported by a Canada Research Chair in Population Health Analytics. This study was supported by the Institute for Clinical Evaluative Sciences (ICES) and Public Health Ontario (PHO), which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. Parts of this material are based on data and information compiled and provided by the Canadian Institute of Health Information (CIHI) and by Cancer Care Ontario (CCO).	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Blyth CC, 2016, EUROSURVEILLANCE, V21, P25, DOI 10.2807/1560-7917.ES.2016.21.30.30301; Chung JR, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3279; Cowling BJ, 2014, VACCINE, V32, P5278, DOI 10.1016/j.vaccine.2014.07.084; De Serres G, 2013, EURO SURVEILL, V18, P37; Englund H, 2013, EPIDEMIOL INFECT, V141, P1807, DOI 10.1017/S0950268812002282; Feng S, 2016, VACCINE, V34, P1672, DOI 10.1016/j.vaccine.2016.02.039; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Fu C., 2013, HYDROL EARTH SYST SC, V10, P2013, DOI DOI 10.1016/J; Haber M, 2015, EPIDEMIOL INFECT, V143, P1417, DOI 10.1017/S0950268814002179; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Kafatos G, 2013, INFLUENZA OTHER RESP, V7, P1175, DOI 10.1111/irv.12163; Kissling E, 2014, EURO SURVEILL, V19; Kissling E, 2013, EURO SURVEILL, V18; Lane CR, 2016, VACCINE, V34, P1070, DOI 10.1016/j.vaccine.2016.01.002; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Menniti-Ippolito F, 2014, VACCINE, V32, P4466, DOI 10.1016/j.vaccine.2014.06.048; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; National Advisory Committee on Immunization, 2012, CAN COMMUN DIS REP, V38; Ohmit SE, 2016, J INFECT DIS, V213, P1229, DOI 10.1093/infdis/jiv563; Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650; Patel PA, 2011, J CLIN MICROBIOL, V49, P2266, DOI [10.1128/JCM.02431-10, 10.1128/JCM.00698-11]; Pebody R, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/ESE.18.05.20389-EN; Pierse N, 2016, VACCINE, V34, P503, DOI 10.1016/j.vaccine.2015.11.073; Schwartz Kevin L, 2016, CMAJ Open, V4, pE463; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Skowronski DM, 2015, J INFECT DIS, V212, P726, DOI 10.1093/infdis/jiv177; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Szilagyi PG, 2008, ARCH PEDIAT ADOL MED, V162, P943, DOI 10.1001/archpedi.162.10.943; Thompson MG, 2016, PEDIATR INFECT DIS J, V35, P299, DOI 10.1097/INF.0000000000001006; Turner N, 2014, EURO SURVEILL, V19; Turner N, 2014, VACCINE, V32, P3687, DOI 10.1016/j.vaccine.2014.04.013; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; Wang Y, 2016, VACCINE, V34, P2460, DOI 10.1016/j.vaccine.2016.03.056	40	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187834	10.1371/journal.pone.0187834	http://dx.doi.org/10.1371/journal.pone.0187834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149183	gold, Green Published, Green Submitted			2022-12-26	WOS:000415646100013
J	Zaferiou, AM; Ojeda, L; Cain, SM; Vitali, RV; Davidson, SP; Stirling, L; Perkins, NC				Zaferiou, Antonia M.; Ojeda, Lauro; Cain, Stephen M.; Vitali, Rachel V.; Davidson, Steven P.; Stirling, Leia; Perkins, Noel C.			Quantifying performance on an outdoor agility drill using foot-mounted inertial measurement units	PLOS ONE			English	Article							INCREASED ROTATIONAL DEMANDS; IMPULSE GENERATION; TURNS; SENSORS; WALKING; STEP; GAIT; KINEMATICS; NAVIGATION; VELOCITY	Running agility is required for many sports and other physical tasks that demand rapid changes in body direction. Quantifying agility skill remains a challenge because measuring rapid changes of direction and quantifying agility skill from those measurements are difficult to do in ways that replicate real task/game play situations. The objectives of this study were to define and to measure agility performance for a (five-cone) agility drill used within a military obstacle course using data harvested from two foot-mounted inertial measurement units (IMUs). Thirty-two recreational athletes ran an agility drill while wearing two IMUs secured to the tops of their athletic shoes. The recorded acceleration and angular rates yield estimates of the trajectories, velocities and accelerations of both feet as well as an estimate of the horizontal velocity of the body mass center. Four agility performance metrics were proposed and studied including: 1) agility drill time, 2) horizontal body speed, 3) foot trajectory turning radius, and 4) tangential body acceleration. Additionally, the average horizontal ground reaction during each footfall was estimated. We hypothesized that shorter agility drill performance time would be observed with small turning radii and large tangential acceleration ranges and body speeds. Kruskal-Wallis and mean rank post-hoc statistical analyses revealed that shorter agility drill performance times were observed with smaller turning radii and larger tangential acceleration ranges and body speeds, as hypothesized. Moreover, measurements revealed the strategies that distinguish high versus low performers. Relative to low performers, high performers used sharper turns, larger changes in body speed (larger tangential acceleration ranges), and shorter duration footfalls that generated larger horizontal ground reactions during the turn phases. Overall, this study advances the use of foot-mounted IMUs to quantify agility performance in contextually-relevant settings (e.g., field of play, training facilities, obstacle courses, etc.).	[Zaferiou, Antonia M.; Ojeda, Lauro; Cain, Stephen M.; Vitali, Rachel V.; Davidson, Steven P.; Perkins, Noel C.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Zaferiou, Antonia M.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Stirling, Leia] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Rush University; Massachusetts Institute of Technology (MIT)	Zaferiou, AM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Zaferiou, AM (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	Antonia_Zaferiou@rush.edu			US Army Contracting Command-APG, Natick Contracting Division, Natick, MA [435, W911QY-15-C-0053]	US Army Contracting Command-APG, Natick Contracting Division, Natick, MA	This material is based upon work supported by the US Army Contracting Command-APG, 435 Natick Contracting Division, Natick, MA, under contract W911QY-15-C-0053. Contract granted to NP. The funders reviewed study design and submitted material.; The authors thank the participants of this study. This material is based upon work supported by the US Army Contracting Command-APG, 435 Natick Contracting Division, Natick, MA, under contract W911QY-15-C-0053.	Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Beyea J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040934; Cain SM, 2016, GAIT POSTURE, V43, P65, DOI 10.1016/j.gaitpost.2015.10.022; Chardonnens J, 2013, J BIOMECH, V46, P56, DOI 10.1016/j.jbiomech.2012.10.005; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fino PC, 2015, SENSORS-BASEL, V15, P10676, DOI 10.3390/s150510676; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fuller JR, 2007, GAIT POSTURE, V25, P393, DOI 10.1016/j.gaitpost.2006.05.013; Havens KL, 2015, GAIT POSTURE, V42, P240, DOI 10.1016/j.gaitpost.2014.07.022; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Jindrich DL, 2009, CHAOS, V19, DOI 10.1063/1.3143031; Mancini M, 2016, J GERONTOL A-BIOL, V71, P1102, DOI 10.1093/gerona/glw019; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; McGinnis RS, 2017, BIOMED SIGNAL PROCES, V32, P150, DOI 10.1016/j.bspc.2016.10.013; Miranda DL, 2013, J BIOMECH, V46, P567, DOI 10.1016/j.jbiomech.2012.09.023; Novak D, 2014, SENSORS-BASEL, V14, P18800, DOI 10.3390/s141018800; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Orendurff MS, 2006, GAIT POSTURE, V23, P106, DOI 10.1016/j.gaitpost.2004.12.008; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Peruzzi A, 2011, J BIOMECH, V44, P1991, DOI 10.1016/j.jbiomech.2011.04.035; Pham MH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00135; Rebula JR, 2013, GAIT POSTURE, V38, P974, DOI 10.1016/j.gaitpost.2013.05.012; Savage PG, 1998, J GUID CONTROL DYNAM, V21, P208, DOI 10.2514/2.4242; Seel T, 2012, IEEE INTL CONF CONTR, P45, DOI 10.1109/CCA.2012.6402423; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Sporri J, 2012, INT J SPORTS SCI COA, V7, P647, DOI 10.1260/1747-9541.7.4.647; Suzuki Y, 2014, SPORT BIOMECH, V13, P144, DOI 10.1080/14763141.2014.910264; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Vitali RV, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17091970; Wang H, 2010, INT J SPORTS MED, V31, P742, DOI 10.1055/s-0030-1261942; Wilcox R.R., 2012, MODERN STAT SOCIAL B; Willmann RD, 2007, P ANN INT IEEE EMBS, P4015, DOI 10.1109/IEMBS.2007.4353214; Young W, 2006, STRENGTH COND J, V28, P24, DOI 10.1519/1533-4295(2006)28[24:AROAPA]2.0.CO;2; Yu G, 2016, SENSORS SWITZERLAND, V16, P1; Zaferiou AM, 2017, J BIOMECH, V52, P130, DOI 10.1016/j.jbiomech.2016.12.017; Zaferiou AM, 2016, J APPL BIOMECH, V32, P425, DOI 10.1123/jab.2015-0314; Zaferiou AM, 2016, HUM MOVEMENT SCI, V47, P220, DOI 10.1016/j.humov.2016.03.012	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188184	10.1371/journal.pone.0188184	http://dx.doi.org/10.1371/journal.pone.0188184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145504	gold, Green Published, Green Submitted			2022-12-26	WOS:000415378800083
J	Mohammadalipour, A; Burdick, MM; Tees, DFJ				Mohammadalipour, Amina; Burdick, Monica M.; Tees, David F. J.			Deformability of breast cancer cells in correlation with surface markers and cell rolling	FASEB JOURNAL			English	Article						cancer stem cell; cell rheology; mechanical biomarker	MAJOR E-SELECTIN; STEM-CELLS; ENDOTHELIAL-CELLS; SHEAR-FLOW; VISCOELASTIC PROPERTIES; ALDEHYDE DEHYDROGENASE; MECHANICAL-PROPERTIES; CORTICAL TENSION; CARCINOMA CELLS; ADHESION	Although the cancer stem cell (CSC) hypothesis has been around for many years, the reliability of cell-surface markers to classify CSCs has remained debatable. The finding that cancerous cells are significantly more deformable than healthy ones has provided motivation to consider mechanical properties as a possible biomarker for stemness. In this study, using the micropipette aspiration technique, mechanical properties of multiple breast cancer cell lines were investigated and correlated with breast cancer stem cell (BCSC) marker, CD44(+)/CD24(-)/ALDH1(+). The results indicated that Hs578T and MDA-MB-231 cell lines with CD44(+)/CD24(-)/ALDH1(+) phenotype were significantly more deformable than the MDA-MB-468 cell line, which did not express the BCSC marker. The BT-20 cell line with intermediate deformability did not express any CD44(+)/CD24(-) phenotype, but it expressed aldehyde dehydrogenase-1 activity. In addition, more-deformable cell lines were found to roll with shear-independent velocities on E-selectin-coated substrates in a parallel-plate flow chamber, which might be a mediating factor for firm adhesion of CSCs to endothelium during metastasis. Our results indicate that rheological properties can be considered as a biomechanical marker in addition to, or as a complement of, surface markers to find more-definitive evidence of CSC characteristics within tumors.	[Mohammadalipour, Amina; Tees, David F. J.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Mohammadalipour, Amina; Burdick, Monica M.] Ohio Univ, Dept Chem & Biomol Engn, 171 Stocker Ctr, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Mohammadalipour, A (corresponding author), Ohio Univ, Dept Chem & Biomol Engn, 171 Stocker Ctr, Athens, OH 45701 USA.	am131709@ohio.edu	Mohammadalipour, Amina/AAB-2510-2020	Tees, David/0000-0002-7961-7745; Burdick, Monica/0000-0003-3168-0072	U.S. National Science Foundation [CBET-1106118]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the U.S. National Science Foundation (CBET-1106118 to M.M.B. and D.F.J.T.). The authors declare no conflicts of interest.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Bose S, 2010, BIOPHYS J, V99, P3870, DOI 10.1016/j.bpj.2010.10.038; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; BULL BS, 1973, BLOOD, V41, P833, DOI 10.1182/blood.V41.6.833.833; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; CANHAM PB, 1970, J THEOR BIOL, V26, P61, DOI 10.1016/S0022-5193(70)80032-7; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Chu JE, 2011, STEM CELLS BIOL REG, P15, DOI 10.1007/978-1-61779-246-5_2; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; EVANS E, 1984, BLOOD, V64, P1028; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Krebs Matthew G, 2010, Ther Adv Med Oncol, V2, P351, DOI 10.1177/1758834010378414; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lincoln B, 2004, CYTOM PART A, V59A, P203, DOI 10.1002/cyto.a.20050; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Mohammadalipour A, 2017, CELL MOL BIOENG, V10, P235, DOI 10.1007/s12195-017-0485-8; Moss MA, 2000, ANTICANCER RES, V20, P1425; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; NEEDHAM D, 1990, J BIOMECH ENG-T ASME, V112, P269, DOI 10.1115/1.2891184; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Pravincumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043938; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sundd P, 2008, MICROCIRCULATION, V15, P109, DOI 10.1080/10739680701412971; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430; Wakatsuki T, 2001, J CELL SCI, V114, P1025; WARD KA, 1991, BIORHEOLOGY, V28, P301; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wu ZZ, 2000, BIORHEOLOGY, V37, P279; YE CL, 1995, INT J CANCER, V61, P455, DOI 10.1002/ijc.2910610404; YU P, 2010, CHIN GERMAN J CLIN O, V9, P31, DOI DOI 10.1007/S10330-009-0178-4; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826	60	13	13	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1806	1817		10.1096/fj.201700762R	http://dx.doi.org/10.1096/fj.201700762R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162703				2022-12-26	WOS:000429051400006
J	Toth, AD; Prokop, S; Gyombolai, P; Varnai, P; Balla, A; Gurevich, VV; Hunyady, L; Turu, G				Toth, Andras D.; Prokop, Susanne; Gyombolai, Pal; Varnai, Peter; Balla, Andras; Gurevich, Vsevolod V.; Hunyady, Laszlo; Turu, Gabor			Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by beta-arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ANGIOTENSIN-II RECEPTOR; AGONIST-INDUCED INTERNALIZATION; AT(1) ANGIOTENSIN; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; BINDING; TRAFFICKING	beta-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and beta-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether beta-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of beta-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, G(q/11)-coupled GPCR, or epidermal growth factor receptor stimulation promotes beta-arrestin2 recruitment to unliganded AT1 angiotensin receptor (AT1R). We found that this interaction depends on the stability lock, a structure responsible for the sustained binding between GPCRs and beta-arrestins, formed by phosphorylated serine-threonine clusters in the receptor's C terminus and two conserved phosphate-binding lysines in the beta-arrestin2 N-domain. Using improved FlAsH-based serine-threonine clusters beta-arrestin2 conformational biosensors, we also show that the stability lock not only stabilizes the receptor-beta-arrestin interaction, but also governs the structural rearrangements within beta-arrestins. Furthermore, we found that beta-arrestin2 binds to PKC-phosphorylated AT1R in a distinct active conformation, which triggers MAPK recruitment and receptor internalization. Our results provide new insights into the activation of beta- arrestins and reveal their novel role in receptor cross-talk.	[Toth, Andras D.; Prokop, Susanne; Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary; [Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Hungarian Acad Sci, MTA SE Lab Mol Physiol, H-1094 Budapest, Hungary; [Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Semmelweis Univ, H-1094 Budapest, Hungary; [Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Vanderbilt University	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, POB 2, H-1428 Budapest, Hungary.	hunyady.laszlo@med.semmelweis-univ.hu	Gurevich, Vsevolod/A-3236-2008; Tóth, András Dávid/O-5757-2019	Gurevich, Vsevolod/0000-0002-3950-5351; Tóth, András Dávid/0000-0003-2746-9370; Gyombolai, Pal/0000-0001-7117-6351; Balla, Andras/0000-0002-6450-2793; Turu, Gabor/0000-0002-4421-3812	Hungarian National Research, Development and Innovation Fund [NKFI NK100883, K116954, NVKP_16-1-2016-0039]; Ministry of Human Capacities [UNKP-17-3-III-SE-23]; National Institutes of Health [R35 GM122491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109955, R35GM122491] Funding Source: NIH RePORTER	Hungarian National Research, Development and Innovation Fund; Ministry of Human Capacities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Hungarian National Research, Development and Innovation Fund Grants NKFI NK100883, K116954, and NVKP_16-1-2016-0039 (to L.H.), the UNKP-17-3-III-SE-23 New National Excellence Program of the Ministry of Human Capacities (to A.D.T.), and National Institutes of Health Grant R35 GM122491 (to V.V.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfonzo-Mendez MA, 2017, MOL PHARMACOL, V91, P296, DOI 10.1124/mol.116.106583; Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Castillo-Badillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121165; CHUANG TT, 1995, J BIOL CHEM, V270, P18660, DOI 10.1074/jbc.270.31.18660; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gaborik Z, 2004, TRENDS ENDOCRIN MET, V15, P286, DOI 10.1016/j.tem.2004.06.009; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Garcia-Caballero A, 2001, MOL PHARMACOL, V59, P576, DOI 10.1124/mol.59.3.576; Gimenez LE, 2014, CELL SIGNAL, V26, P1523, DOI 10.1016/j.cellsig.2014.03.019; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Gulyas G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125601; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; Gyombolai P, 2013, MOL CELL ENDOCRINOL, V372, P116, DOI 10.1016/j.mce.2013.03.013; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Kumari P, 2017, MOL BIOL CELL, V28, P1003, DOI 10.1091/mbc.E16-12-0818; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V279, pC1978, DOI 10.1152/ajpcell.2000.279.6.C1978; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Qian HW, 1999, BIOCHEM J, V343, P637, DOI 10.1042/0264-6021:3430637; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szalai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109503; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Toth AD, 2017, MOL CELL ENDOCRINOL, V442, P113, DOI 10.1016/j.mce.2016.11.027; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Zhan XZ, 2014, CELL SIGNAL, V26, P766, DOI 10.1016/j.cellsig.2014.01.001; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang M, 1996, HYPERTENSION, V27, P269, DOI 10.1161/01.HYP.27.2.269; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuo Y, 2014, J BIOL CHEM, V289, P20991, DOI 10.1074/jbc.M114.560680; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	77	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					876	892		10.1074/jbc.M117.813139	http://dx.doi.org/10.1074/jbc.M117.813139			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29146594	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000422864500010
J	Bidwell, PA; Haghighi, K; Kranias, EG				Bidwell, Philip A.; Haghighi, Kobra; Kranias, Evangelia G.			The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium transport; heart; cardiac muscle; cardiomyocyte; cardiovascular; contractility; HAX-1; phospholamban; SERCA2a	CARDIAC CONTRACTILITY; SARCOPLASMIC-RETICULUM; MUSCLE; SARCOLIPIN; REGULATOR; SURVIVAL; ABLATION; PEPTIDE; GENE; CA2+	The antiapoptotic protein HAX-1 (HS-associated protein X-1) localizes to sarcoplasmic reticulum (SR) in the heart and interacts with the small membrane protein phospholamban (PLN), inhibiting the cardiac sarco/endoplasmic reticulum calcium ATPase 2a (SERCA2a) in the regulation of overall calcium handling and heart muscle contractility. However, because global HAX-1 deletion causes early lethality, how much endogenous HAX-1 contributes to PLN's inhibitory activity on calcium cycling is unknown. We therefore generated a cardiac-specific and inducible knock-out mouse model. HAX-1 ablation in the adult heart significantly increased contractile parameters and calcium kinetics, associated with increased SR calcium load. These changes occurred without any changes in the protein expression of SERCA2a, PLN, and ryanodine receptor or in the PLN phosphorylation status. The enhanced calcium cycling in the HAX-1-depleted heart was mediated through increases in the calcium affinity of SERCA2a and reduced PLN-SERCA2a binding. Comparison of the HAX-1 deletion-induced stimulatory effects with those elicited by PLN ablation indicated that HAX-1 mediates approximate to 50% of the PLN-associated inhibitory effects in the heart. Stimulation with the inotropic and lusitropic agent isoproterenol eliminated the differences among wild-type, HAX-1-deficient, and PLN-deficient hearts, and maximally stimulated contractile and calcium kinetic parameters were similar among these three groups. Furthermore, PLN overexpression in the HAX-1-null cardiomyocytes did not elicit any inhibitory effects, indicating that HAX-1 may limit PLN activity. These findings suggest that HAX-1 is a major mediator of PLN's inhibitory activity and a critical gatekeeper of SR calcium cycling and contractility in the heart.	[Bidwell, Philip A.; Haghighi, Kobra; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45267 USA; [Kranias, Evangelia G.] Acad Athens, Ctr Basic Res, Dept Mol Biol, Biomed Res Fdn, Athens 11527, Greece	University of Cincinnati; Academy of Athens	Kranias, EG (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45267 USA.; Kranias, EG (corresponding author), Acad Athens, Ctr Basic Res, Dept Mol Biol, Biomed Res Fdn, Athens 11527, Greece.	Litsa.Kranias@uc.edu		Bidwell, Philip/0000-0001-5045-4535	National Institutes of Health [HL-26057, HL-64018, HL-125204]; American Heart Association [13POST13860006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026057, R01HL026057, R01HL064018, T32HL125204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-26057 and HL-64018 (to E. G. K.) and HL-125204 (to P. A. B.) and American Heart Association Postdoctoral Fellowship 13POST13860006 (to P. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bidwell PA, 2016, METHODS MOL BIOL, V1377, P161, DOI 10.1007/978-1-4939-3179-8_16; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Haghighi K, 2014, J MOL CELL CARDIOL, V77, P160, DOI 10.1016/j.yjmcc.2014.10.005; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lam CK, 2015, P NATL ACAD SCI USA, V112, pE6466, DOI 10.1073/pnas.1508760112; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Slack JP, 2001, J MOL CELL CARDIOL, V33, P1031, DOI 10.1006/jmcc.2001.1370; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Wolska BM, 1996, AM J PHYSIOL-CELL PH, V271, pC391, DOI 10.1152/ajpcell.1996.271.1.C391; Zhao W, 2009, P NATL ACAD SCI USA, V106, P20776, DOI 10.1073/pnas.0906998106; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	24	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					359	367		10.1074/jbc.RA117.000128	http://dx.doi.org/10.1074/jbc.RA117.000128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29150445	Green Published, hybrid			2022-12-26	WOS:000419453200030
J	Campos, Z; Mourao, G; Magnusson, WE				Campos, Zilca; Mourao, Guilherme; Magnusson, William E.			The effect of dam construction on the movement of dwarf caimans, Paleosuchus trigonatus and Paleosuchus palpebrosus, in Brazilian Amazonia	PLOS ONE			English	Article							RIVER	Run-of-the-river hydroelectric dams cause changes in seasonal inundation of the flood-plains, and this may cause displacement of semi-aquatic vertebrates present before dam construction. This study evaluated the movement of crocodilians before and after the filling of the Santo Antonio hydroelectric reservoir on the Madeira River in the Brazilian Amazon, which occurred in November 2011. We radio-tracked four adult male Paleosuchus palpebrosus and four adult male Paleosuchus trigonatus before and after the formation of the reservoir between 2011 and 2013. The home ranges of the P. palpebrosus varied from < 1 km(2) to 91 km(2) and the home ranges of the P. trigonatus varied from < 1km(2) to 5 km(2). The species responded differently to time since filling and water level in weekly movement and home range. However, overall the dam appears to have had little effect on the use of space by the individuals that were present before dam construction.	[Campos, Zilca; Mourao, Guilherme] Embrapa Pantanal, Corumba, MS, Brazil; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia	Campos, Z (corresponding author), Embrapa Pantanal, Corumba, MS, Brazil.	zilca.campos@embrapa.br	Mourão, Guilherme M/C-3319-2013	Mourão, Guilherme M/0000-0002-8300-4191	Santo Antonio Energia	Santo Antonio Energia	The study was funded by Santo Antonio Energia. R. Zilca Campos and Guilherme Mourao are employees of Embrapa Pantanal which is a non-profit government company linked to the Ministry of Agriculture of Brazil. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campbell HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062127; Campos Z, 2012, J NAT HIST, V46, P2979, DOI 10.1080/00222933.2012.724723; Campos Z, 2006, HERPETOL J, V16, P123; Campos Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156406; Campos Z, 2015, HERPETOZOA, V28, P101; Campos Z, 2013, J THERM BIOL, V38, P20, DOI 10.1016/j.jtherbio.2012.09.004; Castello L, 2015, GLOBAL CHANGE BIOL; Champion G, 2017, AFR ZOOL, V52, P55, DOI 10.1080/15627020.2016.1238321; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fisch G., 1998, ACTA AMAZONICA, V28, P101, DOI DOI 10.1590/1809-43921998282126; Lang JW, WILDLIFE MANAGEMENT, P273; Magilligan FJ, 2005, GEOMORPHOLOGY, V71, P61, DOI 10.1016/j.geomorph.2004.08.017; Magnusson W.E., 1992, Catalogue of American Amphibians and Reptiles, V554, P1; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; MOURAO G, 1995, BIOL CONSERV, V73, P27, DOI 10.1016/0006-3207(94)00097-A; Paolillo O. A., 1985, Herpetological Review, V16, P27; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Tundisi JG, 2014, ENERG POLICY, V74, P703, DOI 10.1016/j.enpol.2014.07.013; Zuur Alain F., 2009, P1	23	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188508	10.1371/journal.pone.0188508	http://dx.doi.org/10.1371/journal.pone.0188508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176830	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900089
J	Ansell, JM; Wouldes, TA; Harding, JE				Ansell, Judith M.; Wouldes, Trecia A.; Harding, Jane E.		CHYLD Study Grp	Executive function assessment in New Zealand 2-year olds born at risk of neonatal hypoglycemia	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; WORKING-MEMORY; PRETERM CHILDREN; INDIVIDUAL-DIFFERENCES; SOCIOECONOMIC-STATUS; INHIBITORY CONTROL; CHILDHOOD POVERTY; EFFORTFUL CONTROL; AGES 2; PRESCHOOLERS	A growing number of babies are born with perinatal risk factors that may impair later development. These children are often assessed at 2 years to help predict outcome and direct support services. Executive function is an important predictor of academic achievement and behavior, but there are limited assessments of executive function in 2-year-olds and few have been tested in at-risk populations. Therefore, we developed a battery of four age-appropriate tasks to assess executive function in 2-year-olds. At 24 months' corrected age 368 children completed tasks assessing attention, inhibition, working memory and cognitive flexibility. Scores on different tasks were weakly correlated, suggesting that they measured separate aspects of executive function, with combined scores for this cohort approximating a normal distribution. Significantly more boys (67%) than girls (57%) were unable to inhibit their behavior on the Snack Delay Task and girls (M = 3.24, SD = 2.4) had higher mean scores than boys (M = 2.7, SD = 2.7) on the Ducks and Buckets Reverse Categorization Task of working memory. Performance was significantly affected by family socioeconomic status. Mean scores were lower on all four individual tasks and on the global score of overall performance in children from a low household income (<$40,000) compared to those from medium ($40,001-$70,000) and high income households (>$70,001). Maternal education was only associated with scores on the working memory task and the global score; and a measure of neighborhood deprivation was only associated with scores on the two inhibitory tasks and the global score. Our findings confirm the feasibility of assessing executive function in 2-year-olds, and its ability to discriminate effects of socioeconomic status, a common confounder in child development research. Further development and standardization of this test battery comparing at-risk children with a normative population would provide a much-needed measure of executive function in early childhood.	[Ansell, Judith M.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Auckland, New Zealand	University of Auckland; University of Auckland	Wouldes, TA (corresponding author), Univ Auckland, Dept Psychol Med, Auckland, New Zealand.	t.wouldes@auckland.ac.nz		Ansell, Judith/0000-0002-0274-3532	Health Research Council of New Zealand; Auckland Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD069622]; University of Auckland Doctoral Scholarship	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Auckland Doctoral Scholarship	This research was supported by grants from The Health Research Council of New Zealand (www.hrc.govt.nz) and Auckland Medical Research Foundation (www.medicalresearch.org.nz). The project described was supported by Grant Number R01HD069622 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to JEH) or the National Institutes of Health. The first author is supported by a University of Auckland Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from The Health Research Council of New Zealand and Auckland Medical Research Foundation. The project described was supported by Grant Number R01HD069622 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The first author is supported by a University of Auckland Doctoral Scholarship.	Aarnoudse-Moens CSH, 2009, J ABNORM CHILD PSYCH, V37, P981, DOI 10.1007/s10802-009-9327-z; American Psychological Association, 2007, REP APA TASK FORC SO; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; Ansell J, 2016, DEV MED CHILD NEUROL, V58, P111, DOI 10.1111/dmcn.13023; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bayley N., 2019, BAYLEY SCALES INFANT; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Breckenridge K, 2013, BRIT J DEV PSYCHOL, V31, P271, DOI 10.1111/bjdp.12004; Brydges CR, 2012, INTELLIGENCE, V40, P458, DOI 10.1016/j.intell.2012.05.006; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Campbell FA, 2008, EARLY CHILD RES Q, V23, P452, DOI 10.1016/j.ecresq.2008.03.003; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carlson SM, 2004, DEV PSYCHOL, V40, P1105, DOI 10.1037/0012-1649.40.6.1105; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chevalier N, 2011, J EXP CHILD PSYCHOL, V109, P353, DOI 10.1016/j.jecp.2011.01.006; Clark CAC, 2013, DEV PSYCHOL, V49, P1481, DOI 10.1037/a0030578; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Cuevas K, 2013, INFANT ATTENTION EAR; Diamond A, 2005, DEV NEUROPSYCHOL, V28, P689, DOI 10.1207/s15326942dn2802_7; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Diamond A, 2011, PROG BRAIN RES, V189, P319, DOI 10.1016/B978-0-444-53884-0.00032-4; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Espy KA, 2007, DEV NEUROPSYCHOL, V32, P669, DOI 10.1080/87565640701376003; Espy KA, 2011, J CHILD PSYCHOL PSYC, V52, P33, DOI 10.1111/j.1469-7610.2010.02265.x; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fuggetta GP, 2006, CHILD NEUROPSYCHOL, V12, P1, DOI 10.1080/09297040500203418; Fuglestad AJ, 2015, CHILD NEUROPSYCHOL, V21, P716, DOI 10.1080/09297049.2014.933792; Furman LM, 2008, J CHILD NEUROL, V23, P775, DOI 10.1177/0883073808318059; Garcia C, 2013, FRONT PSYCHOL, V4; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gerner G, 2015, CHILD NEUROPSYCHOL, V21, P269, DOI 10.1080/09297049.2014.910301; Goldberg MC, 2005, J AUTISM DEV DISORD, V35, P279, DOI 10.1007/s10803-005-3291-4; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Harris DL, 2013, LANCET, V382, P2077, DOI 10.1016/S0140-6736(13)61645-1; Healey DM, 2015, CHILD NEUROPSYCHOL, V21, P465, DOI 10.1080/09297049.2014.906567; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Hughes C, 2005, DEV NEUROPSYCHOL, V28, P645, DOI 10.1207/s15326942dn2802_5; Hughes C., 2008, CHILD NEUROPSYCHOL, P264; Hughes C, 2008, J ABNORM CHILD PSYCH, V36, P1, DOI 10.1007/s10802-007-9107-6; Hughes C, 2009, INT J BEHAV DEV, V33, P312, DOI 10.1177/0165025408101274; Huijbregts SCJ, 2008, J ABNORM CHILD PSYCH, V36, P323, DOI 10.1007/s10802-007-9180-x; Kochanska G, 1997, CHILD DEV, V68, P263, DOI 10.1111/j.1467-8624.1997.tb01939.x; Kochanska G, 1998, CHILD DEV, V69, P1378, DOI 10.2307/1132272; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Lipina S. J., 2005, INTERAM J PSYCHOL, V39, P49; Lipina S, 2013, DEVELOPMENTAL SCI, V16, P697, DOI 10.1111/desc.12080; Loe IM, 2015, CHILD NEUROPSYCHOL, V21, P331, DOI 10.1080/09297049.2014.906568; Martel MM, 2013, AM J ORTHOPSYCHIAT, V83, P165, DOI 10.1111/ajop.12034; Meltzoff AN, 1999, DEVELOPING THEORIES OF INTENTION, P17; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nelson JM, 2015, CHILD NEUROPSYCHOL, V21, P354, DOI 10.1080/09297049.2014.910300; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Oakes JM, 2012, MEASURING SOCIOECONO; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; Overman WH, 1997, DEV PREFRONTAL CORTE, P337; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Pozzetti T, 2014, CHILD NEUROPSYCHOL, V20, P145, DOI 10.1080/09297049.2012.762759; Roberts G, 2010, ARCH DIS CHILD, V95, P786, DOI 10.1136/adc.2009.160283; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; Salmond C, 2006, SOC SCI MED, V62, P1474, DOI 10.1016/j.socscimed.2005.08.008; Salmond C, 1998, AUST NZ J PUBL HEAL, V22, P835, DOI 10.1111/j.1467-842X.1998.tb01505.x; Swanson HL, 2007, J EXP CHILD PSYCHOL, V96, P249, DOI 10.1016/j.jecp.2006.12.004; van Wassenaer AG, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.032; Wass SV, 2015, CHILD NEUROPSYCHOL, V21, P150, DOI 10.1080/09297049.2014.882888; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willoughby MT, 2012, PSYCHOL ASSESSMENT, V24, P226, DOI 10.1037/a0025361; Zelazo PD, 1998, DEV PSYCHOL, V34, P203, DOI 10.1037/0012-1649.34.2.203; Zelazo PD, 2011, WILEY BLACKWELL HDB; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	86	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2017	12	11							e0188158	10.1371/journal.pone.0188158	http://dx.doi.org/10.1371/journal.pone.0188158			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN5GQ	29166407	Green Published, Green Submitted, gold			2022-12-26	WOS:000416035300027
J	Chalmers, AD; Bursill, CA; Myerscough, MR				Chalmers, Alexander D.; Bursill, Christina A.; Myerscough, Mary R.			Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; GENE-TRANSFER; APOA-I; MATHEMATICAL-MODEL; CONTROLLED-TRIAL; DEFICIENT MICE; TNF-ALPHA	We use a computational model to explore the effect of foam cell accumulation on plaque regression following an increase in high density lipoprotein (HDL) influx into the plaque. Atherosclerotic plaque formation is the outcome of cellular and cytokine responses to low density lipoproteins (LDL) that penetrate the artery wall following an injury to the endothelium and become modified. We modelled the cells and cytokines that are most important in plaque formation using partial differential equations. The model includes monocytes and macrophages, foam cells, macrophage chemoattractants, endothelium-stimulating cytokines, modified low density lipoproteins (mod LDL) and HDL. We included interactions both at the endothelium surface and inside the artery wall. The model predicts that when HDL influx into a well-established plaque with large numbers of foam cells is increased, the plaque may not regress but may continue to grow at a slower rate. If HDL influx is increased when a model plaque is recently established and has fewer foam cells, then the plaque does regress. If modLDL influx into the plaque is lowered at the same time that HDL influx increased or the capacity of the HDL to remove cholesterol from foam cells is increased, then the plaque is more likely to regress. The predictions of the model are in qualitative agreement with experimental studies in mice and rabbits. The results suggest that the intrinsic dynamics of reverse cholesterol transport by HDL are important in determining the success of HDL raising in promoting plaque regression.	[Chalmers, Alexander D.; Myerscough, Mary R.] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Bursill, Christina A.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Myerscough, MR (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.	mary.myerscough@sydney.edu.au		Myerscough, Mary/0000-0002-4993-765X; Bursill, Christina/0000-0002-0682-8760	Australian Research Council Discovery Grant [DP160104685]; University of Sydney; Australian Postgraduate Award	Australian Research Council Discovery Grant(Australian Research Council); University of Sydney(University of Sydney); Australian Postgraduate Award(Australian Government)	MRM and CAB acknowledge an Australian Research Council Discovery Grant (DP160104685). MRM acknowledges a Thompson Fellowship from the University of Sydney. ADC acknowledges an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 2017, CARDIOVASC DIAGN THE, V7, P45, DOI 10.21037/cdt.2017.01.01; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Belalcazar LM, 2003, CIRCULATION, V107, P2726, DOI 10.1161/01.CIR.0000066913.69844.B2; Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chalmers AD, 2015, J MATH BIOL, V71, P1451, DOI 10.1007/s00285-015-0864-5; Cilla M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0866; Cobbold CA, 2002, B MATH BIOL, V64, P65, DOI 10.1006/bulm.2001.0267; Cohen A, 2014, B MATH BIOL, V76, P1117, DOI 10.1007/s11538-014-9948-4; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dabagh M, 2009, AM J PHYSIOL-HEART C, V297, pH983, DOI 10.1152/ajpheart.00324.2009; Di Vito L, 2013, INT J CARDIOL, V168, P1917, DOI 10.1016/j.ijcard.2012.12.082; Doedel E.J., AUTO 07P CONTINUATIO; Easton R, 2014, J CLIN PHARMACOL, V54, P301, DOI 10.1002/jcph.194; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; GUCKENHEIMER J, 1993, B MATH BIOL, V55, P937, DOI 10.1007/BF02460693; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; JIMI S, 1994, ATHEROSCLEROSIS, V107, P109, DOI 10.1016/0021-9150(94)90146-5; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Khera AV, 2017, CIRCULATION, V135, P2494, DOI 10.1161/CIRCULATIONAHA.116.025678; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kojima Y, 2017, CIRCULATION, V135, P476, DOI 10.1161/CIRCULATIONAHA.116.025684; Kootte RS, 2015, J LIPID RES, V56, P703, DOI 10.1194/jlr.M055665; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Li Rongying, 2011, J Genet Syndr Gene Ther, V2, P106; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Morton J, 2013, HEART LUNG AND CIRCU, V22, pS66; Murao K, 2000, BIOCHEM BIOPH RES CO, V276, P791, DOI 10.1006/bbrc.2000.3497; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; Ougrinovskaia A, 2010, B MATH BIOL, V72, P1534, DOI 10.1007/s11538-010-9509-4; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Rohatgi A, 2014, NEW ENGLAND JOURNAL; Rohatgi A, 2015, PROG CARDIOVASC DIS, V58, P32, DOI 10.1016/j.pcad.2015.05.004; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Sanson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074676; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tardif JC, 2014, EUR HEART J, V35, P3277, DOI 10.1093/eurheartj/ehu171; Tardy C, 2014, ATHEROSCLEROSIS, V232, P110, DOI 10.1016/j.atherosclerosis.2013.10.018; Torii R, 2006, COMPUT METHOD APPL M, V195, P1885, DOI 10.1016/j.cma.2005.05.050; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; Wang GP, 1997, ATHEROSCLEROSIS, V133, P31, DOI 10.1016/S0021-9150(97)00109-3; Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723; Zheng KH, 2016, CURR OPIN LIPIDOL, V27, P592, DOI 10.1097/MOL.0000000000000349; Zheng KH, 2016, ATHEROSCLEROSIS, V251, P381, DOI 10.1016/j.atherosclerosis.2016.05.038	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187674	10.1371/journal.pone.0187674	http://dx.doi.org/10.1371/journal.pone.0187674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161303	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000015
J	Woo, CW; Kwon, JI; Kim, KW; Kim, JK; Jeon, SB; Jung, SC; Choi, CG; Kim, ST; Kim, J; Ham, SJ; Shim, WH; Sung, YS; Ha, HK; Choi, Y; Woo, DC				Woo, Chul-Woong; Kwon, Jae-Im; Kim, Kyung-Won; Kim, Jeong-Kon; Jeon, Sang-Beom; Jung, Seung-Chae; Choi, Choong-Gon; Kim, Sang-Tae; Kim, Jinil; Ham, Su Jeong; Shim, Woo-Hyun; Sung, Yu Sub; Ha, Hyun Kwon; Choi, Yoonseok; Woo, Dong-Cheol			The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; BRAIN EDEMA; RATS; PROTECTS; TRANSIENT; MRI; ANGIOGENESIS; GLUTAMATE	Emerging evidence has suggested that hydrogen sulfide (H2S) may alleviate the cellular damage associated with cerebral ischemia/reperfusion (I/R) injury. In this study, we assessed using 1 H-magnetic resonance imaging/magnetic resonance spectroscopy (1 H-MRI/MRS) and histologic analysis whether H2S administration prior to reperfusion has neuroprotective effects. We also evaluated for differences in the effects of H2S treatment at 2 time points. 1 H-MRI/MRS data were obtained at baseline, and at 3, 9, and 24 h after ischemia from 4 groups: sham, control (I/R injury), sodium hydrosulfide (NaHS)-30 and NaHS-1 (NaHS delivery at 30 and 1 min before reperfusion, respectively). The total infarct volume and the midline shift at 24 h post-ischemia were lowest in the NaHS-1, followed by the NaHS-30 and control groups. Peri-infarct volume was significantly lower in the NaHS-1 compared to NaHS-30 and control animals. The relative apparent diffusion coefficient (ADC) in the peri-infarct region showed that the NaHS-1 group had significantly lower values compared to the NaHS-30 and control animals and that NaHS-1 rats showed significantly higher relative T2 values in the peri-infarct region compared to the controls. The relative ADC value, relative T2 value, levels of N-acetylL-aspartate (NAA), and the NAA, glutamate, and taurine combination score (NGT) in the ischemic core region at 24 h post-ischemia did not differ significantly between the 2 NaHS groups and the control except that the NAA and NGT values were higher in the peri-infarct region of the NaHS-1 animals at 9 h post-ischemia. In the ischemic core and peri-infarct regions, the apoptosis rate was lowest in the NaHS-1 group, followed by the NaHS-30 and control groups. Our results suggest that H2S treatment has neuroprotective effects on the peri-infarct region during the evolution of I/R injury. Furthermore, our findings indicate that the administration of H2S immediately prior to reperfusion produces the highest neuroprotective effects.	[Woo, Chul-Woong; Kwon, Jae-Im; Kim, Sang-Tae; Kim, Jinil; Ham, Su Jeong; Shim, Woo-Hyun; Woo, Dong-Cheol] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kim, Kyung-Won; Kim, Jeong-Kon; Jung, Seung-Chae; Choi, Choong-Gon; Sung, Yu Sub] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Jeon, Sang-Beom] Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Ha, Hyun Kwon; Choi, Yoonseok] Gangneung Asan Hosp, Med Res Inst, Gangneung Si, Gangwon Do, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Woo, DC (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.; Choi, Y (corresponding author), Gangneung Asan Hosp, Med Res Inst, Gangneung Si, Gangwon Do, South Korea.	yschoi21rad@gnah.co.kr; dcwoo@amc.seoul.kr	Jeon, Sang-Beom/AAD-6605-2022	Jeon, Sang-Beom/0000-0003-0735-5499	Asan Institute for Life Sciences, Asan Medical Center [2015-651]; Ministry of Science [NRF-2015R1C1A1A02036526]; Korea Health Industry Development Institute [HI14C1090]	Asan Institute for Life Sciences, Asan Medical Center; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by Asan Institute for Life Sciences, Asan Medical Center, grant number 2015-651 to HKH (http://ails.amc.seoul.kr); Ministry of Science, grant number NRF-2015R1C1A1A02036526 to DCW (www.nrf.re.kr); and Korea Health Industry Development Institute, grant number HI14C1090 to DCW (www.khidi.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, NEUROSCI LETT, V388, P54, DOI 10.1016/j.neulet.2005.06.067; Berthet C, 2011, STROKE, V42, P799, DOI 10.1161/STROKEAHA.110.603647; Bonaventura A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121967; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Ginsberg MD, 2016, PROG NEUROBIOL, V145, P46, DOI 10.1016/j.pneurobio.2016.09.002; GREGORAKOS L, 1995, ANGIOLOGY, V46, P1123, DOI 10.1177/000331979504601208; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jang H, 2014, J NEUROSCI RES, V92, P1520, DOI 10.1002/jnr.23427; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; Juenemann M, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0087-y; Khanna A, 2014, TRANSL STROKE RES, V5, P3, DOI 10.1007/s12975-013-0307-9; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Li XJ, 2015, NEURAL REGEN RES, V10, P932, DOI 10.4103/1673-5374.158353; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; O'Shea JM, 2000, MAGN RESON MED, V44, P427, DOI 10.1002/1522-2594(200009)44:3<427::AID-MRM13>3.0.CO;2-B; OH SM, 1991, STROKE, V22, P915, DOI 10.1161/01.STR.22.7.915; Palaniswami M, 2015, INTERV NEUROL, V4, P18, DOI 10.1159/000438774; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PRICHARD JW, 1993, RES P ARNMD, V71, P153; Ren CL, 2010, BRAIN RES, V1345, P197, DOI 10.1016/j.brainres.2010.05.017; Toombs CF, 2010, BRIT J CLIN PHARMACO, V69, P626, DOI 10.1111/j.1365-2125.2010.03636.x; Walberer M, 2007, J NEUROSURG ANESTH, V19, P105, DOI 10.1097/ANA.0b013e31802c7e33; Xing BZ, 2008, J NEUROCHEM, V105, P1737, DOI 10.1111/j.1471-4159.2008.05276.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yin Jun, 2013, Zhonghua Yi Xue Za Zhi, V93, P868; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhao HP, 2014, STROKE, V45, P2417, DOI 10.1161/STROKEAHA.114.006135	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187910	10.1371/journal.pone.0187910	http://dx.doi.org/10.1371/journal.pone.0187910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161281	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000026
J	Kasper-Sonnenberg, M; Wittsiepe, J; Wald, K; Koch, HM; Wilhelm, M				Kasper-Sonnenberg, Monika; Wittsiepe, Juergen; Wald, Katharina; Koch, Holger M.; Wilhelm, Michael			Pre-pubertal exposure with phthalates and bisphenol A and pubertal development	PLOS ONE			English	Article							ENDOCRINE DISRUPTERS; DEVELOPMENT SCALE; RISK-ASSESSMENT; METABOLITES; VARIABILITY; DIESTERS; CHILDREN; GIRLS; POPULATION; VALIDITY	Objective Epidemiological studies indicate associations between childhood exposure with phthalates and bisphenol A (BPA) and the pubertal development. We examined associations between the pre-pubertal phthalate and BPA body burden and the longitudinally assessed sexual maturation of eight-to thirteen-year-old children. Methods We started with eight-to ten-year-old children in the baseline study and quantified phthalate metabolites and BPA in 472 urine samples (250 boys; 222 girls; mean age: 8.8 years). Associations between the pubertal development, assessed in three annual follow-up studies by Puberty Development scale questionnaires (PD scales), and the chemical exposure from the baseline visit were longitudinally analyzed with generalized estimation equations. Results The number of children with both chemical measures and PD scores (calculated from the PD scales) was 408. In the third follow-up, 49% of the girls and 18% of the boys had reached mid-puberty. For girls, we observed a delayed pubertal development with the di-hexyl-ethyl phthalate (DEHP) metabolites (beta: -0.16 to -0.23; p <= 0.05 or p <= 0.1), mono-n-butyl phthalate (beta: -0.15; 95% CI: -0.31; 0.01), mono-benzyl phthalate (beta: -0.11; 95% CI: -0,24; -0,01), and mono-ethyl phthalate (MEP) (beta: -0.15; 95% CI: -0.28; -0.01). In addition, significant nonlinear associations of the DEHP metabolites and BPA with the PD scores were found, when their quadratic effects were included in the GEE models. In boys, no consistent relationships between the PD scores and the chemicals were detected except of an accelerated development with the Sigma DEHP metabolites (beta: 0.16; 95% CI: -0.02; -0.34). Conclusion We found indications that pre-pubertal exposures with phthalates and BPA were associated with pubertal timing in children, particularly in girls. For boys, associations were inconsistent, and not necessarily in line with the known anti-androgenicity of some phthalates during prenatal exposure.	[Kasper-Sonnenberg, Monika; Wittsiepe, Juergen; Wald, Katharina; Wilhelm, Michael] Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany; [Koch, Holger M.] Inst Ruhr Univ Bochum, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kasper-Sonnenberg, M (corresponding author), Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany.	Monika.Kasper-Sonnenberg@rub.de	Kasper-Sonnenberg, Monika/AAH-2769-2021; Koch, Holger M/B-3277-2011	Kasper-Sonnenberg, Monika/0000-0002-9435-1391; Koch, Holger M/0000-0002-8328-2837	Federal Environment Agency of Germany [3708 61 201 3]; DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum	Federal Environment Agency of Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum	This work was supported by the Federal Environment Agency of Germany [3708 61 201 3 (UFO Plan)] until 2011. Since then the research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The publication was supported by the DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany.; We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-University Bochum.	Apel P, 2017, INT J HYG ENVIR HEAL, V220, P152, DOI 10.1016/j.ijheh.2016.09.007; Backhaus T, 2013, INTEGR ENVIRON ASSES, V9, P547, DOI 10.1002/ieam.1475; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Biro FM, 2006, INT J ANDROL, V29, P272, DOI 10.1111/j.1365-2605.2005.00602.x; Bond L, 2006, J ADOLESCENCE, V29, P709, DOI 10.1016/j.adolescence.2005.10.001; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Braun JM, 2013, CURR OPIN PEDIATR, V25, P247, DOI 10.1097/MOP.0b013e32835e1eb6; Cai W, 2008, FITTING GEN ADDITIVE; Cantonwine DE, 2014, ENVIRON INT, V62, P1, DOI 10.1016/j.envint.2013.09.014; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Christensen KLY, 2012, J EXPO SCI ENV EPID, V22, P632, DOI 10.1038/jes.2012.52; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Durmaz E, 2014, J CLIN RES PEDIATR E, V6, P16, DOI 10.4274/Jcrpe.1220; Ferguson KK, 2017, J EXPO SCI ENV EPID, V27, P326, DOI 10.1038/jes.2016.27; Ferguson KK, 2014, REPROD TOXICOL, V47, P70, DOI 10.1016/j.reprotox.2014.06.002; Fisher M, 2015, J EXPO SCI ENV EPID, V25, P231, DOI 10.1038/jes.2014.65; Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x; Frederiksen H, 2013, INT J HYG ENVIR HEAL, V216, P772, DOI 10.1016/j.ijheh.2013.02.006; Johns LE, 2015, ENVIRON INT, V85, P27, DOI 10.1016/j.envint.2015.08.005; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kasper-Sonnenberg M, 2014, INT J HYG ENVIR HEAL, V217, P830, DOI 10.1016/j.ijheh.2014.06.001; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Kay VR, 2013, CRIT REV TOXICOL, V43, P200, DOI 10.3109/10408444.2013.766149; Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044; Koch HM, 2012, J EXPO SCI ENV EPID, V22, P610, DOI 10.1038/jes.2012.39; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Mantovani A, 2006, ANN NY ACAD SCI, V1076, P239, DOI 10.1196/annals.1371.063; Mantovani A, 2014, REPROD TOXICOL, V44, P15, DOI 10.1016/j.reprotox.2013.06.002; Maranghi F, 2012, REPROD TOXICOL, V33, P290, DOI 10.1016/j.reprotox.2012.01.009; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; McGuinn LA, 2015, ENVIRON RES, V136, P381, DOI 10.1016/j.envres.2014.10.037; Miodovnik A, 2014, NEUROTOXICOLOGY, V41, P112, DOI 10.1016/j.neuro.2014.01.007; Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x; Mouritsen A, 2013, J CLIN ENDOCR METAB, V98, P3755, DOI 10.1210/jc.2013-1284; National Research Council (US), 2008, PHTHAL CUM RISK ASS; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Schecker H., 2014, METHODEN NATURWISSEN, P439; Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Su PH, 2015, ENVIRON RES, V136, P324, DOI 10.1016/j.envres.2014.10.026; Tsai YA, 2016, ENVIRON RES, V149, P197, DOI 10.1016/j.envres.2016.05.005; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Walker DM, 2011, NAT REV ENDOCRINOL, V7, P197, DOI 10.1038/nrendo.2010.215; Watkins DJ, 2016, J CLIN ENDOCR METAB, V101, P78, DOI 10.1210/jc.2015-2706; Watkins DJ, 2014, ENVIRON RES, V134, P233, DOI 10.1016/j.envres.2014.08.010; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wolff MS, 2014, HUM REPROD, V29, P1558, DOI 10.1093/humrep/deu081; Xie CM, 2015, MOL CELL ENDOCRINOL, V407, P67, DOI 10.1016/j.mce.2015.03.006; Zhang YH, 2015, ENVIRON INT, V83, P41, DOI 10.1016/j.envint.2015.06.005	56	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187922	10.1371/journal.pone.0187922	http://dx.doi.org/10.1371/journal.pone.0187922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155850	Green Submitted, Green Published, gold			2022-12-26	WOS:000415756700023
J	Schaefer, B; Moriishi, K; Behrends, S				Schaefer, Bianca; Moriishi, Kohji; Behrends, Soenke			Insights into the mechanism of isoenzyme-specific signal peptide peptidase-mediated translocation of heme oxygenase	PLOS ONE			English	Article							VIRUS CORE PROTEIN; CATALYZED INTRAMEMBRANE PROTEOLYSIS; NUCLEAR TRANSLOCATION; VIRAL PROPAGATION; CELL LINE; DEGRADATION; MEMBRANE; CLEAVAGE; PRESENILIN; LOCALIZATION	It has recently been shown that signal peptide peptidase (SPP) can catalyze the intramembrane cleavage of heme oxygenase-1 (HO-1) that leads to translocation of HO-1 into the cytosol and nucleus. While there is consensus that translocated HO-1 promotes tumor progression and drug resistance, the physiological signals leading to SPP-mediated intramembrane cleavage of HO-1 and the specificity of the process remain unclear. In this study, we used co-immunoprecipitation and confocal laser scanning microscopy to investigate the translocation mechanism of HO-1 and its regulation by SPP. We show that HO-1 and the closely related HO-2 isoenzyme bind to SPP under normoxic conditions. Under hypoxic conditions SPP mediates intramembrane cleavage of HO-1, but not HO-2. In experiments with an inactive HO-1 mutant (H25A) we show that translocation is independent of the catalytic activity of HO-1. Studies with HO-1 / HO-2 chimeras indicate that the membrane anchor, the PEST-domain and the nuclear shuttle sequence of HO-1 are necessary for full cleavage and subsequent translocation under hypoxic conditions. In the presence of co-expressed exogenous SPP, the anchor and the PEST-domain are sufficient for translocation. Taken together, we identified the domains involved in HO-1 translocation and showed that SPPmediated cleavage is isoform-specific and independent of HO-activity. A closer understanding of the translocation mechanism of HO-1 is of particular importance because nuclear HO1 seems to lead to tumor progression and drug resistance.	[Schaefer, Bianca; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany; [Moriishi, Kohji] Yamanashi Univ, Fac Med, Dept Microbiol, Yamanashi, Japan	Braunschweig University of Technology; University of Yamanashi	Behrends, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188; Behrends, Sonke/0000-0002-9068-0729	Deutsche Forschungsgemeinschaft [INST 188/286-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Except for funding by Deutsche Forschungsgemeinschaft INST 188/286-1 the authors did not receive other financial support for this work.	Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Allen SJ, 2014, EXP EYE RES, V123, P8, DOI 10.1016/j.exer.2014.04.004; Allen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085360; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGGINS PE, 1986, BIOCHEM BIOPH RES CO, V141, P528, DOI 10.1016/S0006-291X(86)80205-4; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Dennery PA, 2014, ANTIOXID REDOX SIGN, V20, P1743, DOI 10.1089/ars.2013.5674; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haase N, 2010, J NEUROCHEM, V112, P542, DOI 10.1111/j.1471-4159.2009.06484.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hsu F, 2014, ONCOGENE; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; ISHIKAWA K, 1992, BIOCHEM BIOPH RES CO, V182, P981, DOI 10.1016/0006-291X(92)91828-E; ITOMAKI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P253, DOI 10.1006/abbi.1995.1160; Jo EJ, 2016, EUR J PHARMACOL, V788, P321, DOI 10.1016/j.ejphar.2016.06.052; Kemp PJ, 2005, BIOCHEM BIOPH RES CO, V338, P648, DOI 10.1016/j.bbrc.2005.08.110; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; MAINES MD, 1986, J BIOL CHEM, V261, P411; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Schaefer B, 2017, ONCOTARGET, V8, P67406, DOI 10.18632/oncotarget.18684; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Tibullo D, 2016, ONCOTARGET; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188344	10.1371/journal.pone.0188344	http://dx.doi.org/10.1371/journal.pone.0188344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155886	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700049
J	Sethumadhavan, S; Silva, M; Philbrook, P; Nguyen, T; Hatfield, SM; Ohta, A; Sitkovsky, MV				Sethumadhavan, Shalini; Silva, Murillo; Philbrook, Phaethon; Thao Nguyen; Hatfield, Stephen M.; Ohta, Akio; Sitkovsky, Michail V.			Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells	PLOS ONE			English	Article							FACTOR (HIF)-1-ALPHA; PEPTIDE TRANSPORTER; MELANOMA-CELLS; EXPRESSION; CANCER; GENE; IMMUNOTHERAPY; CARCINOMA; MICROENVIRONMENT; IMMUNOGENICITY	Human cancers are known to downregulate Major Histocompatibility Complex (MHC) class I expression thereby escaping recognition and rejection by anti-tumor T cells. Here we report that oxygen tension in the tumor microenvironment (TME) serves as an extrinsic cue that regulates antigen presentation by MHC class I molecules. In support of this view, hypoxia is shown to negatively regulate MHC expression in a HIF-dependent manner as evidenced by (i) lower MHC expression in the hypoxic TME in vivo and in hypoxic 3-dimensional (3D) but not 2-dimensional (2D) tumor cell cultures in vitro; (ii) decreased MHC in human renal cell carcinomas with constitutive expression of HIF due to genetic loss of von Hippel-Lindau (VHL) function as compared with isogenically paired cells with restored VHL function, and iii) increased MHC in tumor cells with siRNA-mediated knockdown of HIF. In addition, hypoxia downregulated antigen presenting proteins like TAP 1/2 and LMP7 that are known to have a dominant role in surface display of peptide-MHC complexes. Corroborating oxygen-dependent regulation of MHC antigen presentation, hyperoxia (60% oxygen) transcriptionally upregulated MHC expression and increased levels of TAP2, LMP2 and 7. In conclusion, this study reveals a novel mechanism by which intra-tumoral hypoxia and HIF can potentiate immune escape. It also suggests the use of hyperoxia to improve tumor cell-based cancer vaccines and for mining novel immune epitopes. Furthermore, this study highlights the advantage of 3D cell cultures in reproducing hypoxia-dependent changes observed in the TME.	[Sethumadhavan, Shalini; Silva, Murillo; Philbrook, Phaethon; Thao Nguyen; Hatfield, Stephen M.; Ohta, Akio; Sitkovsky, Michail V.] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; [Sitkovsky, Michail V.] Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sitkovsky, MV (corresponding author), Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA.; Sitkovsky, MV (corresponding author), Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	m.sitkovsky@neu.edu	Silva, Murillo/I-4863-2017	Silva, Murillo/0000-0003-4668-6290	Northeastern University; NIH [R01 CA-111985, R01GM-097320, R01 CA-112561, R21AT 002788]	Northeastern University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: Northeastern University and NIH grants (PI: M.S.) R01 CA-111985; R01GM-097320; R01 CA-112561; R21AT 002788.	Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Barbash ZS, 2013, MOL CELL BIOL, V33, P4395, DOI 10.1128/MCB.00553-13; Barsoum IB, 2014, CANCER RES, V74, P7185, DOI 10.1158/0008-5472.CAN-14-2598; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Carretero R, 2008, IMMUNOGENETICS, V60, P439, DOI 10.1007/s00251-008-0303-5; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Escors D., 2014, NEW J SCI, V2014; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garrido C, 2011, CANCER IMMUNOL IMMUN, V60, P1257, DOI 10.1007/s00262-011-1027-1; Grandis JR, 2000, CLIN CANCER RES, V6, P2794; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hatfield SM, 2014, J MOL MED, V92, P1283, DOI 10.1007/s00109-014-1189-3; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Jarosinski KW, 2002, J NEUROIMMUNOL, V122, P74, DOI 10.1016/S0165-5728(01)00467-2; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Montoya M, 1999, J IMMUNOL, V163, P1914; Mu J, 2014, J IMMUNOL, V192, P2892, DOI 10.4049/jimmunol.1302847; Ohta A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00027; Oliveira CC, 2011, EUR J IMMUNOL, V41, P3114, DOI 10.1002/eji.201141836; Perier A, 2011, ONCOGENE, V30, P2622, DOI 10.1038/onc.2010.638; Philip B, 2013, CARCINOGENESIS, V34, P1699, DOI 10.1093/carcin/bgt209; Pradeu T, 2006, P NATL ACAD SCI USA, V103, P17858, DOI 10.1073/pnas.0608683103; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schmitt TM, 2015, CLIN CANCER RES, V21, P5191, DOI 10.1158/1078-0432.CCR-15-0860; Seliger B, 2001, CANCER RES, V61, P1095; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siemens DR, 2008, CANCER RES, V68, P4746, DOI 10.1158/0008-5472.CAN-08-0054; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Srivastava PK, 2013, CANCER IMMUNOL IMMUN, V62, P967, DOI 10.1007/s00262-013-1422-x; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; White CA, 1998, INT J CANCER, V75, P590	46	58	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187314	10.1371/journal.pone.0187314	http://dx.doi.org/10.1371/journal.pone.0187314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155844	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700009
J	Kaup, S; Naseer, A; Shivalli, S; Arunachalam, C				Kaup, Soujanya; Naseer, Ansaba; Shivalli, Siddharudha; Arunachalam, Cynthia			Occupational exposure to unburnt tobacco and potential risk of toxic optic neuropathy: A cross-sectional study among beedi rollers in selected rural areas of coastal Karnataka, India	PLOS ONE			English	Article							BIDI INDUSTRY WORKERS; CONTRAST SENSITIVITY; PROCESSORS	Background Beedi also known as poor man's cigarette is manufactured in almost all major states of India. Beedi workers are exposed to various health risks. There is an increased risk of systemic absorption of tobacco through skin and mucous membrane. The optic nerve is susceptible to damage from several toxic substances including tobacco. This group of disorders is known as toxic optic neuropathy (TON). The association of TON with occupational exposure to unburnt tobacco in beedi rollers has not been explored. Objectives Among the beedi rollers in Mangaluru and Bantwal talukas of Dakshina Kannada District, Karnataka, India: to assess the magnitude of potential TON utilizing colour vision and contrast sensitivity as screening tools and to identify the demographic, biological and occupational factors associated with potential TON. Methods A community-based cross-sectional study was conducted from April-Sept 2016 in Mangaluru and Bantwal talukas, of Dakshina Kannada district, Karnataka. Beedi rollers from twelve villages (six from each taluka) were included. In each of the selected villages, the investigators identified beedi collection centres and all the eligible beedi rollers were included in the study till the required number of beedi rollers for that village was achieved. Participants were screened at the study site for visual acuity, colour vision and contrast sensitivity and those with abnormal colour and contrast sensitivity in the presence of good visual acuity were considered to have potential TON. Results A total of 377 beedi rollers were approached; of which 365 consented to take part in the study (response rate: 96.81%). Women constituted the majority of the participants (n = 338, 92.6%). Based on the screening criteria, the prevalence of potential TON was 17.5% (n = 64, 95% CI: 13.5-21.9). On multiple logistic regression analysis, duration of beedi rolling (Adj OR: 1.061; 95% CI 1.015-1.109, p = 0.009), advancing age (Adj OR: 1.096; 95% CI 1.058-1.136, p<0.001) and presence of diabetes (Adj OR: 6.315; 95% CI 1.4572-27.376, p = 0.014) were independent correlates of potential TON. Conclusion In the present study, almost one out of six beedi rollers displayed clinical signs of potential TON. Increased duration of beedi rolling, advancing age and presence of diabetes were the independent correlates of potential TON. However, with this cross-sectional study it is not possible to conclude if these factors play a role individually or collectively or are a serendipitous association, for which large scale analytical studies are required.	[Kaup, Soujanya; Naseer, Ansaba; Arunachalam, Cynthia] Yenepoya Univ, Yenepoya Med Coll, Dept Ophthalmol, Mangalore, Karnataka, India; [Shivalli, Siddharudha] Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangalore, Karnataka, India; [Shivalli, Siddharudha] Program Task Force Global Hlth Inc, TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Kaup, S (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Ophthalmol, Mangalore, Karnataka, India.	drsoujanyak@gmail.com	Shivalli, Siddharudha/AAU-3907-2020	Kaup, Soujanya/0000-0002-5908-5921				[Anonymous], 2017, FARNSWORTH D 15 LANT; BAGWE AN, 1995, CARCINOGENESIS, V16, P1095, DOI 10.1093/carcin/16.5.1095; Bhisey RA, 1999, TOXICOL LETT, V108, P259, DOI 10.1016/S0378-4274(99)00097-1; Devi KR, 2012, NAT ENV POLL TECH, V11, P135; Gella L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129391; Grzybowski A, 2015, ACTA OPHTHALMOL, V93, P402, DOI 10.1111/aos.12515; Gupta P. C., 2008, BIDI SMOKING PUBLIC; International Labour Organization, 2003, EMPL TRENDS TOB SECT; Kerrison John B, 2004, Ophthalmol Clin North Am, V17, P481, DOI 10.1016/j.ohc.2004.05.005; MAHIMKAR MB, 1995, MUTAT RES-ENVIR MUTA, V334, P139, DOI 10.1016/0165-1161(95)90004-7; Malson JL, 2001, TOB CONTROL, V10, P181, DOI 10.1136/tc.10.2.181; Ministry of Labour, 1999, 47 ANN REP 1999 2000; Mittal S, 2008, INDIAN J OPHTHALMOL, V56, P319, DOI 10.4103/0301-4738.41415; Nandi A, 2015, TOB CONTROL, V24, P369, DOI 10.1136/tobaccocontrol-2013-051404; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Phillips PH, 2005, WALSH HOYTS CLIN NEU, P447; Ranjitsingh A, 1995, ENV EC, V13, P875; Reddy SK, 2004, REPORT TOBACCO CONTR; Riordan-Eva P, 2004, EYE, V18, P1161, DOI 10.1038/sj.eye.6701575; ROSS JE, 1985, BRIT J OPHTHALMOL, V69, P51, DOI 10.1136/bjo.69.1.51; SALMON JF, 1987, BRIT J OPHTHALMOL, V71, P192, DOI 10.1136/bjo.71.3.192; Schneck ME, 2014, OPTOMETRY VISION SCI, V91, P284, DOI 10.1097/OPX.0000000000000152; Sharma P, 2011, INDIAN J OPHTHALMOL, V59, P137, DOI 10.4103/0301-4738.77035; SILVETTE H, 1960, AM J OPHTHALMOL, V50, P71, DOI 10.1016/0002-9394(60)90842-4; Swami S, 2006, Indian J Public Health, V50, P231; Vinod V, 2007, ENV DRINKING WATER P	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188378	10.1371/journal.pone.0188378	http://dx.doi.org/10.1371/journal.pone.0188378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149211	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000415646100041
J	Shiao, CC; Huang, YT; Lai, TS; Huang, TM; Wang, JJ; Huang, CT; Wu, PC; Wu, CH; Tsai, IJ; Tseng, LJ; Wang, CH; Chu, TS; Wu, KD; Wu, VC				Shiao, Chih-Chung; Huang, Ya-Ting; Lai, Tai-Shuan; Huang, Tao-Min; Wang, Jian-Jhong; Huang, Chun-Te; Wu, Pei-Chen; Wu, Che-Hsiung; Tsai, I-Jung; Tseng, Li-Jung; Wang, Chih-Hsien; Chu, Tzong-Shinn; Wu, Kwan-Dun; Wu, Vin-Cent		Natl Taiwan Univ Hosp Study Grp Ac	Perioperative body weight change is associated with in-hospital mortality in cardiac surgical patients with postoperative acute kidney injury	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; FAILURE ASSESSMENT SCORE; CRITICALLY-ILL PATIENTS; LONG-TERM SURVIVAL; HEART-FAILURE; CARDIOTHORACIC SURGERY; FLUID BALANCE; DISEASE; RECOVERY; PATHOPHYSIOLOGY	Background Postoperative acute kidney injury (AKI) is common following cardiac surgery (CS). Body weight (BW) may be an amenable variable by representing the summation of the nutritional and the fluid status. However, the predictive role of perioperative BW changes in CS patients with severe postoperative AKI is never explored. This study aimed to evaluate this association. Methods This study was conducted using a prospectively collected multicenter cohort, NSARF (National Taiwan University Hospital Study Group on Acute Renal Failure) database. The adult CS patients with postoperative AKI requiring renal replacement therapy (RRT), who had clear initial consciousness, received CS within 14 days of hospitalization, and underwent RRT within seven days after CS in intensive care units from January 2001 to January 2014 were enrolled. With the endpoint of 30-day postoperative mortality, we evaluated the association between the clinical factors denoting fluid status and patients outcomes. Results A total of 188 patients (70 female, mean age 63.7 +/- 15.2 years) were enrolled. Comparing with the survivors (n = 124), the non-survivors (n = 64) had a significantly higher perioperative BW change [3.6 +/- 6.1% versus 0.1 +/- 8.3%, p = 0.003] but not the postoperative and pre-RRT BW changes. By using multivariate Cox proportional hazards model, the independent indicators of 30-day postoperative mortality included perioperative BW change (p = 0.026) and packed red blood cells transfusion (p = 0.007), postoperative intra-aortic balloon pump (p = 0.001) and central venous pressure level (p = 0.005), as well as heart rate (p = 0.022), sequential organ failure assessment score (p < 0.001), logistic organ dysfunction score (p = 0.001), and blood total bilirubin level (p = 0.044) at RRT initiation. The generalized additive models further demonstrated, in a multivariate manner, that the mortality risk rose significantly during a perioperative BW change of 2% to 15%. Conclusions Perioperative BW change was independently associated with an increased risk for 30-day postoperative mortality in CS patients with RRT-requiring AKI.	[Shiao, Chih-Chung] St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Jr Coll Med Nursing & Management, Yilan, Taiwan; [Huang, Ya-Ting] St Marys Hosp Luodong, Dept Nursing, Yilan, Taiwan; [Huang, Ya-Ting] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lai, Tai-Shuan; Huang, Tao-Min; Chu, Tzong-Shinn; Wu, Kwan-Dun; Wu, Vin-Cent] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Wang, Jian-Jhong] Chi Mei Med Ctr, Div Nephrol, Dept Internal Med, Tainan, Taiwan; [Huang, Chun-Te] Taichung Vet Gen Hosp, Div Internal & Crit Care Med, Dept Crit Care Med, Taichung, Taiwan; [Wu, Pei-Chen] MacKay Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Wu, Che-Hsiung] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Nephrol, Taipei, Taiwan; [Wu, Che-Hsiung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, I-Jung] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; [Tseng, Li-Jung; Wang, Chih-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan	Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; Taichung Veterans General Hospital; Mackay Memorial Hospital; Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	wchemail@gmail.com	Shiao, Chih-Chung/AAM-2716-2020	Shiao, Chih-Chung/0000-0003-2220-7574; WANG, CHIH-HSIEN/0000-0003-3214-6867; Tsai, I-Jung/0000-0003-3967-9412; Lai, Tai-Shuan/0000-0002-0552-372X; WU, VIN-CENT/0000-0001-7935-0991	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4, 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3]; NTUH [106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104S2718, 098-001177, 100-001667]; Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) [MOST 106-2321-13-182-002]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NTUH; Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan)	This study was financially supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4), 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3), NTUH (106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104S2718, and NTUH 098-001177, NTUH 100-001667. This study was also supported by the Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) (grant number, MOST 106-2321-13-182-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4), 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3), NTUH (106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104-S2718, and NTUH 098-001177, NTUH 100-001667. This study was also supported by the Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) (grant number, MOST 106-2321-B-182-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; BASS BH, 1969, LANCET, V2, P438; Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Chau Katrina, 2014, Can J Kidney Health Dis, V1, P19, DOI 10.1186/s40697-014-0019-4; Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4; El-Sharkawy AM, 2014, CLIN NUTR, V33, P6, DOI 10.1016/j.clnu.2013.11.010; Godin M, 2013, NEPHRON CLIN PRACT, V123, P238, DOI 10.1159/000354713; Goren O, 2015, BRIT J ANAESTH, V115, P3, DOI 10.1093/bja/aev380; Heldwein MB, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-110; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; KIM WH, 2015, MEDICINE, V94, P38408; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krupski WC, 2000, VASC MED, V5, P3, DOI 10.1177/1358836X0000500102; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lin YF, 2008, BLOOD PURIFICAT, V26, P547, DOI 10.1159/000178771; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Lopez-Jimenez F, 2008, AM HEART J, V155, P478, DOI 10.1016/j.ahj.2007.10.026; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Maisel AS, 2016, J CARD FAIL, V22, P283, DOI 10.1016/j.cardfail.2015.09.014; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Olivero Juan Jose, 2012, Methodist Debakey Cardiovasc J, V8, P31; Rady MY, 1998, CRIT CARE MED, V26, P225, DOI 10.1097/00003246-199802000-00016; Reider L, 2013, J NUTR HEALTH AGING, V17, P91, DOI 10.1007/s12603-012-0073-5; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Stein A, 2012, CRIT CARE, V16, DOI 10.1186/cc11368; Thiele RH, 2015, CLIN J AM SOC NEPHRO, V10, P500, DOI 10.2215/CJN.07830814; Thongprayoon C, 2015, MAYO CLIN PROC, V90, P857, DOI 10.1016/j.mayocp.2015.03.026; van Venrooij LMW, 2008, AM J CLIN NUTR, V87, P1656, DOI 10.1093/ajcn/87.6.1656; VANDENBROECK J, 1995, J ROY SOC MED, V88, P487; Varadhan KK, 2010, P NUTR SOC, V69, P488, DOI 10.1017/S0029665110001734; Varadhan KK, 2010, CRIT CARE CLIN, V26, P527, DOI 10.1016/j.ccc.2010.04.003; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Wu VC, 2006, CLIN INFECT DIS, V42, P66, DOI 10.1086/498509; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Xu JR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001360; Zhang L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.03.025	44	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187280	10.1371/journal.pone.0187280	http://dx.doi.org/10.1371/journal.pone.0187280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149189	Green Published, gold, Green Submitted			2022-12-26	WOS:000415646100009
J	Yoon, SR; Kim, SH; Lee, HW; Ha, JH				Yoon, So-Ra; Kim, Sung Hyun; Lee, Hae-Won; Ha, Ji-Hyoung			A novel method to rapidly distinguish the geographical origin of traditional fermented-salted vegetables by mass fingerprinting	PLOS ONE			English	Article							MALDI-TOF-MS; SPECTROMETRY; IDENTIFICATION; KIMCHI; FOOD; DEGRADATION; PROTEINS	The geographical origin of kimchi is of interest to consumers and producers because the prices of commercial kimchi products can vary significantly according to the geographical origin. Hence, social issues related to the geographical origin of kimchi in Korea have emerged as a major problem. In this study, the geographical origin of kimchi was determined by comparing the mass fingerprints obtained for Korean and Chinese kimchi samples by MALDI-TOF MS with multivariate analysis. The results obtained herein provide an accurate, powerful tool to clearly discriminate kimchi samples based on their geographical origin within a short time and to ensure food authenticity, which is of significance in the kimchi industry. Furthermore, our MALDI-TOF MS method could be applied to determining the geographical origin of other fermented-salted vegetables at a reduced cost in shorter times.	[Yoon, So-Ra; Kim, Sung Hyun; Lee, Hae-Won; Ha, Ji-Hyoung] World Inst Kimchi, Hygien Safety & Anal Ctr, Gwangju, South Korea		Lee, HW; Ha, JH (corresponding author), World Inst Kimchi, Hygien Safety & Anal Ctr, Gwangju, South Korea.	lhw0875@wikim.re.kr; hajee@wikim.re.kr			World Institute of Kimchi [KE1601-4, KE1701-5]	World Institute of Kimchi	This work was supported by a research grant (KE1601-4 and KE1701-5) from the World Institute of Kimchi.; This study was supported by the World Institute of Kimchi (KE1601-4 and KE1701-5). We thank Dr Young-Ho Chung and Dr Jonghyun Kim (Korea Basic Science Institute, Republic of Korea) for their assistance with the MALDI-TOF MS analysis.	Albrethsen J, 2011, J PROTEOMICS, V74, P765, DOI 10.1016/j.jprot.2011.02.027; Bong YS, 2012, BIOSCI BIOTECH BIOCH, V76, P2096, DOI 10.1271/bbb.120471; Bonizzi I, 2007, J APPL MICROBIOL, V102, P667, DOI 10.1111/j.1365-2672.2006.03131.x; Caligiani A, 2016, FOOD CHEM, V211, P431, DOI 10.1016/j.foodchem.2016.05.072; D'Archivio AA, 2017, FOOD CHEM, V219, P408, DOI 10.1016/j.foodchem.2016.09.169; Dimara E, 2003, AGR ECON-BLACKWELL, V28, P187, DOI [10.1016/S0169-5150(03)00003-3, 10.1111/j.1574-0862.2003.tb00137.x]; EL SHEIKHA A F, 2010, J LIFE SCI, V4, P9; El Sheikha AF, 2011, FOOD BIOTECHNOL, V25, P115, DOI 10.1080/08905436.2011.576556; Flaudrops C, 2015, J FOOD COMPOS ANAL, V41, P104, DOI 10.1016/j.jfca.2015.02.009; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Han Jae-Hwan, 2016, [Journal of Agriculture & Life Science, 농업생명과학연구], V50, P195, DOI 10.14397/jals.2016.50.2.195; Jung JY, 2014, APPL MICROBIOL BIOT, V98, P2385, DOI 10.1007/s00253-014-5513-1; Kim J, 2012, BIOSCI BIOTECH BIOCH, V76, P1752, DOI 10.1271/bbb.120356; Kim MH, 2012, FOOD SCI BIOTECHNOL, V21, P9, DOI 10.1007/s10068-012-0002-8; Lee HW, 2015, TALANTA, V132, P630, DOI 10.1016/j.talanta.2014.08.078; Lopez-Fernandez H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0752-4; Luykx DMAM, 2008, FOOD CHEM, V107, P897, DOI 10.1016/j.foodchem.2007.09.038; Park KY, 2014, J MED FOOD, V17, P6, DOI 10.1089/jmf.2013.3083; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Risticevic S, 2008, ANAL CHIM ACTA, V617, P72, DOI 10.1016/j.aca.2008.04.009; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salla V, 2013, ANAL CHIM ACTA, V794, P55, DOI 10.1016/j.aca.2013.07.014; Santos T, 2015, J PROTEOMICS, V127, P321, DOI 10.1016/j.jprot.2015.02.017; Sugawara R, 2016, ANAL CHIM ACTA, V934, P163, DOI 10.1016/j.aca.2016.05.056; Wang J, 2009, J AGR FOOD CHEM, V57, P10081, DOI 10.1021/jf902286p; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Xu L, 2012, ANAL CHIM ACTA, V754, P31, DOI 10.1016/j.aca.2012.10.011; Yin YL, 2015, INTERDISCIP SCI, V7, P205, DOI 10.1007/s12539-015-0262-0	28	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188217	10.1371/journal.pone.0188217	http://dx.doi.org/10.1371/journal.pone.0188217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149220	Green Submitted, Green Published, gold			2022-12-26	WOS:000415646100029
J	Pereira, LA; Munita, R; Gonzalez, MP; Andres, ME				Alberto Pereira, Luis; Munita, Roberto; Paz Gonzalez, Marcela; Estela Andres, Maria			Long 3'UTR of Nurr1 mRNAs is targeted by miRNAs in mesencephalic dopamine neurons	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; TRANSCRIPTION FACTOR NURR1; ALTERNATIVE POLYADENYLATION; SUBSTANTIA-NIGRA; EXPRESSION; MICRORNAS; NORMALIZATION; RECEPTOR; CLEAVAGE; WIDESPREAD	The development of mesencephalic dopamine neurons and their survival later in life requires the continuous presence of the transcription factor Nurr1 (NR4A2). Nurr1 belongs to the nuclear receptors superfamily. However, it is an orphan member that does not require a ligand to regulate the transcription of its target genes. Therefore, controlling the expression of Nurr1 is an important manner to control its function. Several reports have shown that microRNAs (miRNAs) regulate Nurr1 expression. However, Nurr1 has several splicing variants, posing the question what variants are subjected to miRNA regulation. In this work, we identified a long 3' UTR variant of rat Nurr1 mRNA. We used bioinformatics analysis to identify miRNAs with the potential to regulate Nurr1 expression. Reporter assays performed with the luciferase gene fused to the short (658 bp) or long (1,339 bp) 3' UTR of rat Nurr1 mRNAs, showed that miR-93, miR-204 and miR-302d selectively regulate the mRNA with the longest 3' UTR. We found that the longest variant of Nurr1 mRNA expresses in the rat mesencephalon as assessed by PCR. The transfection of rat mesencephalic neurons with mixed miR-93, miR-204 and miR-302d resulted in a significant reduction of Nurr1 protein levels. In conclusion, Nurr1 mRNA variant with the longest 3' UTR undergoes a specific regulation by miRNAs. It is discussed the importance of fine-tuning Nurr1 protein levels in mesencephalic dopamine neurons.	[Alberto Pereira, Luis; Munita, Roberto; Paz Gonzalez, Marcela; Estela Andres, Maria] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile; [Munita, Roberto] Lund Univ, Div Mol Hematol, Lund Stem Cell Ctr, BMC, Klin Gatan, Lund, Sweden	Pontificia Universidad Catolica de Chile; Lund University	Andres, ME (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile.	mandres@bio.puc.cl	Munita, Roberto/B-3143-2010	Munita, Roberto/0000-0002-6605-7160	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1150200, 1110352]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) Grant Numbers 1150200, 1110352.	Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Bai RP, 2015, INT J CANCER, V137, P2310, DOI 10.1002/ijc.29607; Bannon MJ, 2002, P NATL ACAD SCI USA, V99, P6382, DOI 10.1073/pnas.092654299; Beard JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25108; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Duan XD, 2015, CELL SIGNAL, V27, P61, DOI 10.1016/j.cellsig.2014.10.006; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Eells JB, 2006, BRAIN RES BULL, V70, P186, DOI 10.1016/j.brainresbull.2006.05.004; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Enright AJ, 2004, GENOME BIOL, V5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Honkaniemi J, 1996, J CEREBR BLOOD F MET, V16, P557, DOI 10.1097/00004647-199607000-00005; HONKANIEMI J, 1995, MOL BRAIN RES, V28, P157, DOI 10.1016/0169-328X(94)00200-X; Honkaniemi J, 1997, J CEREBR BLOOD F MET, V17, P636; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Johnson MM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00135; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le W, 1999, J NEUROCHEM, V73, P2218; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Nakki R, 1996, J NEUROSCI RES, V45, P13, DOI 10.1002/(SICI)1097-4547(19960701)45:1<13::AID-JNR2>3.0.CO;2-K; Ohkura N, 1999, BBA-GENE STRUCT EXPR, V1444, P69, DOI 10.1016/S0167-4781(98)00247-4; Ojeda V, 2003, J NEUROSCI RES, V73, P686, DOI 10.1002/jnr.10705; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Slater PG, 2016, P NATL ACAD SCI USA, V113, P4075, DOI 10.1073/pnas.1523745113; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Volakakis N, 2015, J NEUROSCI, V35, P14370, DOI 10.1523/JNEUROSCI.1155-15.2015; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xie L, 2014, ENDOCRINOLOGY, V155, P4975, DOI 10.1210/en.2014-1501; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; You LM, 2015, NUCLEIC ACIDS RES, V43, pD59, DOI 10.1093/nar/gku1076; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	70	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188177	10.1371/journal.pone.0188177	http://dx.doi.org/10.1371/journal.pone.0188177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145474	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800080
J	Harper, E; Rochfort, KD; Forde, H; Davenport, C; Smith, D; Cummins, PM				Harper, Emma; Rochfort, Keith D.; Forde, Hannah; Davenport, Colin; Smith, Diarmuid; Cummins, Philip M.			TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; ARTERIAL CALCIFICATION; RECEPTOR ACTIVATOR; OSTEOCLASTIC DIFFERENTIATION; OSTEOPROTEGERIN; MICE; PATHWAY; DISEASE	Background and objectives Vascular calcification (VC) is a major risk factor for elevated cardiovascular morbidity/mortality. Underlying this process is osteoblastic signalling within the vessel wall involving complex and interlinked roles for receptor-activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin (OPG), and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). RANKL promotes vascular cell osteoblastic differentiation, whilst OPG acts as a neutralizing decoy receptor for RANKL (and TRAIL). With respect to TRAIL, much recent evidence points to a vasoprotective role for this ligand, albeit via unknown mechanisms. In order to shed more light on TRAILs vasoprotective role therefore, we employed in vitro cell models to test the hypothesis that TRAIL can counteract the RANKL-mediated signalling that occurs between the vascular cells that comprise the vessel wall. Methods and results Human aortic endothelial and smooth muscle cell mono-cultures (HAECs, HASMCs) were treated with RANKL (0-25 ng/mL +/- 5 ng/mL TRAIL) for 72 hr. Furthermore, to better recapitulate the paracrine signalling that exists between endothelial and smooth muscle cells within the vessel wall, non-contact transwell HAEC: HASMC co-cultures were also employed and involved RANKL treatment of HAECs (+/- TRAIL), subsequently followed by analysis of pro-calcific markers in the underlying subluminal HASMCs. RANKL elicited robust osteoblastic signalling across both mono-and co-culture models (e.g. increased BMP-2, alkaline phosphatase/ALP, Runx2, and Sox9, in conjunction with decreased OPG). Importantly, several RANKL actions (e.g. increased BMP-2 release from mono-cultured HAECs or increased ALP/Sox9 levels in co-cultured HASMCs) could be strongly blocked by co-incubation with TRAIL. In summary, this paper clearly demonstrates that RANKL can elicit pro-osteoblastic signalling in HAECs and HASMCs both directly and across paracrine signalling axes. Moreover, within these contexts we present clear evidence that TRAIL can block several key signalling actions of RANKL in vascular cells, providing further evidence of its vasoprotective potential.	[Harper, Emma; Rochfort, Keith D.; Forde, Hannah; Davenport, Colin; Cummins, Philip M.] Dublin City Univ, Sch Biotechnol, Dublin, Ireland; [Harper, Emma; Rochfort, Keith D.; Cummins, Philip M.] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland; [Forde, Hannah; Smith, Diarmuid] Beaumont Hosp, Dept Acad Endocrinol, Dublin, Ireland	Dublin City University; Dublin City University	Cummins, PM (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin, Ireland.; Cummins, PM (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland.	phil.cummins@dcu.ie	Rochfort, Keith/R-7009-2019	Rochfort, Keith/0000-0003-1198-5952; Davenport, Colin/0000-0001-6854-6147	DCU O'Hare Scholarship; Government of Ireland/Irish Research Council Postgraduate Scholarship [GOIPG/2015/3758]; Science Foundation Ireland [14/US/B3116]	DCU O'Hare Scholarship; Government of Ireland/Irish Research Council Postgraduate Scholarship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by DCU O'Hare Scholarship (EH), Grant Number: Not applicable, URL: https://www4.dcu.ie/graduatestudies/danielohare.shtml; The Government of Ireland/Irish Research Council Postgraduate Scholarship (EH), Grant Number: GOIPG/2015/3758, URL: http://research.ie/funding-category/postgraduate/ and http://www.sfi.ie/funding/funding-calls/open-calls/us-ireland-rd-partnership-programme.html; and Science Foundation Ireland (PMC), Grant Number: 14/US/B3116, URL: http://www.sfi.ie/funding/funding-calls/open-calls/us-ireland-rd-partnership-programme.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Bernardi S, 2012, CLIN SCI, V123, P547, DOI 10.1042/CS20120176; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Callegari A, 2014, J VASC RES, V51, P118, DOI 10.1159/000358920; Cho IJ, 2015, J HYPERTENS, V33, P1633, DOI 10.1097/HJH.0000000000000607; Davenport C, 2016, INT J BIOCHEM CELL B, V77, P171, DOI 10.1016/j.biocel.2016.06.009; Davenport C, 2015, EUR J ENDOCRINOL, V173, P53, DOI 10.1530/EJE-14-1137; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Deuell KA, 2012, J VASC RES, V49, P510, DOI 10.1159/000341216; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Forde H, 2016, ATHEROSCLEROSIS, V247, P87, DOI 10.1016/j.atherosclerosis.2016.02.002; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Harper E, 2016, VASC PHARMACOL, V82, P30, DOI 10.1016/j.vph.2016.02.003; Henaut L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.220; Higgins CL, 2015, PROTEIN J, V34, P315, DOI 10.1007/s10930-015-9620-3; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Ndip A, 2011, DIABETES, V60, P2187, DOI 10.2337/db10-1220; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Olesen M, 2012, MOL CELL ENDOCRINOL, V362, P149, DOI 10.1016/j.mce.2012.06.004; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Qunibi WY, 2005, KIDNEY INT, V68, P271, DOI 10.1111/j.1523-1755.2005.00402.x; Sakaguchi M, 2016, HEART VESSELS, V31, P1915, DOI 10.1007/s00380-016-0820-3; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Shin V, 2004, J VASC RES, V41, P193, DOI 10.1159/000077394; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Zauli G, 2004, BLOOD, V104, P2044, DOI 10.1182/blood-2004-03-1196; Zauli G, 2008, J CELL PHYSIOL, V214, P117, DOI 10.1002/jcp.21165; Zhan JK, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0153-4; Zhang J, 2014, BIOSCIENCE REP, V34, P663, DOI 10.1042/BSR20140103	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188192	10.1371/journal.pone.0188192	http://dx.doi.org/10.1371/journal.pone.0188192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145460	Green Submitted, Green Published, gold			2022-12-26	WOS:000415378800085
J	Marasco, PD; Bourbeau, DJ; Shell, CE; Granja-Vazquez, R; Ina, JG				Marasco, Paul D.; Bourbeau, Dennis J.; Shell, Courtney E.; Granja-Vazquez, Rafael; Ina, Jason G.			The neural response properties and cortical organization of a rapidly adapting muscle sensory group response that overlaps with the frequencies that elicit the kinesthetic illusion	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; SOMATOSENSORY CORTEX; SPINDLE AFFERENTS; TENDON VIBRATION; HUMAN HAND; AREA 3A; CEREBRAL-CORTEX; ALBINO-RAT; MOVEMENT; REPRESENTATION	Kinesthesia is the sense of limb movement. It is fundamental to efficient motor control, yet its neurophysiological components remain poorly understood. The contributions of primary muscle spindles and cutaneous afferents to the kinesthetic sense have been well studied; however, potential contributions from muscle sensory group responses that are different than the muscle spindles have not been ruled out. Electrophysiological recordings in peripheral nerves and brains of male Sprague Dawley rats with a degloved forelimb preparation provide evidence of a rapidly adapting muscle sensory group response that overlaps with vibratory inputs known to generate illusionary perceptions of limb movement in humans (kinesthetic illusion). This group was characteristically distinct from type Ia muscle spindle fibers, the receptor historically attributed to limb movement sensation, suggesting that type Ia muscle spindle fibers may not be the sole carrier of kinesthetic information. The sensoryneural structure of muscles is complex and there are a number of possible sources for this response group; with Golgi tendon organs being the most likely candidate. The rapidly adapting muscle sensory group response projected to proprioceptive brain regions, the rodent homolog of cortical area 3a and the second somatosensory area (S2), with similar adaption and frequency response profiles between the brain and peripheral nerves. Their representational organization was muscle-specific (myocentric) and magnified for proximal and multi-articulate limb joints. Projection to proprioceptive brain areas, myocentric representational magnification of muscles prone to movement error, overlap with illusionary vibrational input, and resonant frequencies of volitional motor unit contraction suggest that this group response may be involved with limb movement processing.	[Marasco, Paul D.] Vet Affairs Med Ctr, Adv Platform Technol Ctr Excellence, Louis Stokes Cleveland Dept, Cleveland, OH 44106 USA; [Marasco, Paul D.; Shell, Courtney E.; Granja-Vazquez, Rafael] Cleveland Clin, Lab Bion Integrat, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Bourbeau, Dennis J.] Vet Affairs Med Ctr, Funct Elect Stimulat Ctr, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Bourbeau, Dennis J.] Metrohlth Med Ctr, Dept Phys Med & Rehabil, Cleveland, OH USA; [Ina, Jason G.] Vet Affairs Med Ctr, Res Serv, Louis Stokes Cleveland Dept, Cleveland, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; MetroHealth System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Marasco, PD (corresponding author), Vet Affairs Med Ctr, Adv Platform Technol Ctr Excellence, Louis Stokes Cleveland Dept, Cleveland, OH 44106 USA.; Marasco, PD (corresponding author), Cleveland Clin, Lab Bion Integrat, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.	marascp2@ccf.org	Shell, Courtney/AAJ-4823-2021	Shell, Courtney/0000-0003-3764-6836; Marasco, Paul/0000-0002-1689-7161; Ina, Jason/0000-0003-3516-9896	US Taxpayers through a Department of Veterans Affairs CDA-2 [A7253W]; US Taxpayers through a Department of Veterans Affairs CDA-1 [11K1RX000960]; US Taxpayers through a National Institutes of Health Director's Transformative R01 Research Award [1R01NS081710-01]; Defense Advanced Research Projects Agency Contract [61732-LS-DRP Under P-1108-114403/DARPA-BAA-11-08 RPI]	US Taxpayers through a Department of Veterans Affairs CDA-2; US Taxpayers through a Department of Veterans Affairs CDA-1; US Taxpayers through a National Institutes of Health Director's Transformative R01 Research Award; Defense Advanced Research Projects Agency Contract	Financial support provided by the US Taxpayers through a Department of Veterans Affairs CDA-2 #A7253W (PDM), CDA-1 # 11K1RX000960 (DJB), through a National Institutes of Health Director's Transformative R01 Research Award, 1R01NS081710-01 (PDM) and a Defense Advanced Research Projects Agency Contract 61732-LS-DRP Under P-1108-114403/DARPA-BAA-11-08 RPI (PDM).	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; BEIN HJ, 1962, BRIT J PHARM CHEMOTH, V19, P375, DOI 10.1111/j.1476-5381.1962.tb01442.x; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Capaday C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00066; Casini L, 2006, BRAIN RES, V1121, P200, DOI 10.1016/j.brainres.2006.08.124; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; CHAPIN JK, 1986, EXP NEUROL, V91, P502, DOI 10.1016/0014-4886(86)90048-8; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CLARK FJ, 1995, EXP BRAIN RES, V107, P73; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; COLEBATCH JG, 1990, ELECTROEN CLIN NEURO, V75, P44, DOI 10.1016/0013-4694(90)90151-9; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Cooke DF, 2012, CEREB CORTEX, V22, P1959, DOI 10.1093/cercor/bhr228; CORDO P, 1995, J NEUROPHYSIOL, V74, P1675, DOI 10.1152/jn.1995.74.4.1675; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; De-Doncker L, 2003, J NEUROPHYSIOL, V89, P442, DOI 10.1152/jn.00153.2002; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Duncan RO, 2007, CEREB CORTEX, V17, P2878, DOI 10.1093/cercor/bhm015; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1297, DOI 10.1152/jn.1990.63.6.1297; EDIN BB, 1988, J PHYSIOL-LONDON, V400, P101, DOI 10.1113/jphysiol.1988.sp017113; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; FELDMAN SH, 1988, J COMP NEUROL, V277, P80, DOI 10.1002/cne.902770106; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GIOANNI Y, 1987, EXP BRAIN RES, V67, P510; Goldscheider A., 1898, PHYSL MUSKELSINNES, P97; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HORE J, 1976, J NEUROPHYSIOL, V39, P484, DOI 10.1152/jn.1976.39.3.484; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; HUERTA MF, 1990, BRAIN RES, V537, P367, DOI 10.1016/0006-8993(90)90388-R; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; JONES EG, 1980, BRAIN RES REV, V2, P1, DOI 10.1016/0165-0173(80)90002-8; LANDGREN S, 1969, J PHYSIOL-LONDON, V200, P353, DOI 10.1113/jphysiol.1969.sp008698; MATTHEWS PB, 1969, J PHYSIOL-LONDON, V200, P723, DOI 10.1113/jphysiol.1969.sp008719; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Naito E, 2001, NEUROREPORT, V12, P3805, DOI 10.1097/00001756-200112040-00041; Netter FH, 2001, ATLAS HUMAN ANATOMY; OSCARSSON O, 1963, J PHYSIOL-LONDON, V169, P924, DOI 10.1113/jphysiol.1963.sp007305; PETITJEAN M, 1995, EUR J APPL PHYSIOL O, V71, P215, DOI 10.1007/BF00854981; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Popesko P., 1990, COLOUR ATLAS ANATOMY, V1, P89; PROSKE U, 1977, BRAIN RES, V121, P358, DOI 10.1016/0006-8993(77)90159-7; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Remple MS, 2003, J COMP NEUROL, V467, P105, DOI 10.1002/cne.10909; Ribot-Ciscar E, 1998, BRAIN RES, V791, P167, DOI 10.1016/S0006-8993(98)00092-4; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; RUFFINI A, 1897, BRAIN, V20, P368; Saal HP, 2014, TRENDS NEUROSCI, V37, P689, DOI 10.1016/j.tins.2014.08.012; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; Shimazaki H, 2007, NEURAL COMPUT, V19, P1503, DOI 10.1162/neco.2007.19.6.1503; Slutsky DA, 2000, J COMP NEUROL, V416, P521, DOI 10.1002/(SICI)1096-9861(20000124)416:4<521::AID-CNE8>3.0.CO;2-#; SUR M, 1984, J NEUROPHYSIOL, V51, P724, DOI 10.1152/jn.1984.51.4.724; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Uchiyama T, 2011, MED BIOL ENG COMPUT, V49, P1035, DOI 10.1007/s11517-011-0752-0; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P303, DOI 10.1111/j.1748-1716.1974.tb05593.x; WALL JT, 1984, J NEUROSCI, V4, P1499; Wasaka T, 2007, NEUROSCIENCE, V149, P446, DOI 10.1016/j.neuroscience.2007.07.040; WATERS RS, 1995, EXP BRAIN RES, V103, P183; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; White O, 2009, EXP BRAIN RES, V192, P113, DOI 10.1007/s00221-008-1561-z; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163948	77	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188559	10.1371/journal.pone.0188559	http://dx.doi.org/10.1371/journal.pone.0188559			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	29182648	Green Published, Green Submitted, gold			2022-12-26	WOS:000416402000034
J	Akter, T; Atanelishvili, I; Noguchi, A; Silver, RM; Bogatkevich, GS				Akter, Tanjina; Atanelishvili, Ilia; Noguchi, Atsushi; Silver, Richard M.; Bogatkevich, Galina S.			Establishment of an indirect ELISA for detection of the novel antifibrotic peptide M10	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR RECEPTOR; VETERINARY-MEDICINE; SPECIAL SERIES; HALF-LIFE; SAFETY; MET; PHARMACOKINETICS; EXPRESSION; PROTEIN	Objective M10 is a ten amino acid peptide generated from the intracellular cytoplasmic tail of the hepatocyte growth factor (HGF) receptor c-Met following cleavage by caspase-3. Recently we reported that M10 interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo and can be advanced into a novel antifibrotic remedy. The current study was undertaken to develop an immunoassay to measure M10 concentration in biological specimens. Experimental design An Indirect Enzyme-Linked Immunosorbent Assay (ELISA) for detection of M10 in biological fluids was developed using pharmaceutical grade synthetic M10 as a calibrator and commercially available anti-c-Met C12 antibody. Results M10 ELISA specifically detected in plasma M10, but not a scrambled peptide, following a single intraperitoneal administration of M10 (1mg/kg) to mice. The detection limit was 9.6 ng/ml, and the measuring limit was between 15 ng/ml and 200 ng/ml. The recovery limits of M10 were between 80% and 120%; intra-assay coefficient of variation was between 5.3% and 6.3%; inter-assay coefficient of variation was between 5.0% and 8.0% over the buffer concentration tested in the range from 15 ng /ml to 250 ng /ml. The peak of M10 concentration following a single intraperitoneal injection (1mg/kg) was achieved within 6 hours and declined to minimal levels by 48 hours. The experimentally obtained half-life for M10 was comparable to the theoretically predicted half-life for M10. Conclusions We have established a highly sensitive ELISA to detect the antifibrotic peptide M10 in plasma samples, which should prove to be a novel tool to study the pharmacokinetics and efficacy of M10 in the treatment of fibroproliferative disorders.	[Akter, Tanjina; Atanelishvili, Ilia; Noguchi, Atsushi; Silver, Richard M.; Bogatkevich, Galina S.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Noguchi, Atsushi] Hokkaido Univ, Div Rheumatol Endocrinol & Nephrol, Grad Sch Med, Sapporo, Hokkaido, Japan	Medical University of South Carolina; Hokkaido University	Bogatkevich, GS (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	bogatkev@musc.edu			NIH/NIAMS [P60 AR062755]; National Scleroderma Foundation; SC SmartState(R)	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Scleroderma Foundation; SC SmartState(R)	Funded by NIH/NIAMS P60 AR062755 (GSB and RMS), National Scleroderma Foundation http://www.scieroderma.org (GSB) and SC SmartState (R) (RMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by NIH/NIAMS P60 AR062755 (GSB and RMS), National Scleroderma Foundation (GSB) and SC SmartState (RMS).	Aoki S, 1996, J BIOCHEM-TOKYO, V120, P961; Atanelishvili I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162357; Atanelishvili I, 2016, TRANSL RES, V170, P99, DOI 10.1016/j.trsl.2015.12.009; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Fletcher S, 2016, EXPERT OPIN DRUG SAF, V15, P1483, DOI 10.1080/14740338.2016.1218470; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Gibaldi M, 1975, PHARMACOKINETICS, P281; Hammond DE, 2004, CURR TOP MICROBIOL, V286, P21; ICH, 2005, VALID AN P TEXT METH; Kaspar A.A., 2014, DRUG DISCOVERY, P807; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Ma JH, 2014, HEPATOLOGY, V59, P2010, DOI 10.1002/hep.26769; Martinez MN, 1998, J AM VET MED ASSOC, V213, P974; Martinez MN, 1998, J AM VET MED ASSOC, V213, P1122; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Ohmichi H, 1998, DEVELOPMENT, V125, P1315; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Walker DK, 2004, BRIT J CLIN PHARMACO, V58, P601, DOI 10.1111/j.1365-2125.2004.02194.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188588	10.1371/journal.pone.0188588	http://dx.doi.org/10.1371/journal.pone.0188588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176766	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900102
J	Meunier, M; Guyard-Nicodeme, M; Vigouroux, E; Poezevara, T; Beven, V; Quesne, S; Bigault, L; Amelot, M; Dory, D; Chemaly, M				Meunier, Marine; Guyard-Nicodeme, Muriel; Vigouroux, Estelle; Poezevara, Typhaine; Beven, Veronique; Quesne, S.; Bigault, Lionel; Amelot, Michel; Dory, Daniel; Chemaly, Marianne			Promising new vaccine candidates against Campylobacter in broilers	PLOS ONE			English	Article							INTESTINAL COLONIZATION; REVERSE-VACCINOLOGY; ORAL VACCINATION; RISK-ASSESSMENT; FEED ADDITIVES; JEJUNI; CHICKENS; IMMUNITY; GENE; PROTECTION	Campylobacter is the leading cause of human bacterial gastroenteritis in the European Union. Birds represent the main reservoir of the bacteria, and human campylobacteriosis mainly occurs after consuming and/or handling poultry meat. Reducing avian intestinal Campylobacter loads should impact the incidence of human diseases. At the primary production level, several measures have been identified to reach this goal, including vaccination of poultry. Despite many studies, however, no efficient vaccine is currently available. We have recently identified new vaccine candidates using the reverse vaccinology strategy. This study assessed the in vivo immune and protective potential of six newly-identified vaccine antigens. Among the candidates tested on Ross broiler chickens, four (YP_001000437.1, YP_001000562.1, YP_999817.1, and YP_999838.1) significantly reduced cecal Campylobacter loads by between 2 and 4.2 log(10) CFU/g, with the concomitant development of a specific humoral immune response. In a second trial, cecal load reductions results were not statistically confirmed despite the induction of a strong immune response. These vaccine candidates need to be further investigated since they present promising features.	[Meunier, Marine; Guyard-Nicodeme, Muriel; Poezevara, Typhaine; Quesne, S.; Chemaly, Marianne] French Agcy Food Environm & Occupat Hlth & Safety, HQPAP Unit Hyg & Qual Poultry & Pork Prod, Ploufragan, France; [Meunier, Marine; Vigouroux, Estelle; Beven, Veronique; Bigault, Lionel; Dory, Daniel] French Agcy Food Environm & Occupat Hlth & Safety, GVB Viral Genet & Biosafety Unit, Ploufragan, France; [Amelot, Michel] French Agcy Food Environm & Occupat Hlth & Safety, SELEAC Avian Breeding & Expt Dept, Ploufragan, France		Chemaly, M (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, HQPAP Unit Hyg & Qual Poultry & Pork Prod, Ploufragan, France.	marianne.chemaly@anses.fr	Bigault, Lionel/M-4819-2015; Dory, Daniel/ABC-3914-2020	Bigault, Lionel/0000-0001-5545-6089; Guyard, Muriel/0000-0002-1301-7915	European Union's Seventh Framework Program for research, technological development and demonstration [605835]	European Union's Seventh Framework Program for research, technological development and demonstration	This work has received funding from the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement no. 605835 "Campybro".; This work has received funding from the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement no. 605835 "Campybro".	Annamalai T, 2013, POULTRY SCI, V92, P2201, DOI 10.3382/ps.2012-03004; Bahrndorff S, 2015, EPIDEMIOL INFECT, V143, P2381, DOI 10.1017/S0950268814003239; Basta NE, 2016, LANCET, V388, P2719, DOI 10.1016/S0140-6736(16)32061-X; Bolton DJ, 2015, FOOD MICROBIOL, V48, P99, DOI 10.1016/j.fm.2014.11.017; Buckley AM, 2010, VACCINE, V28, P1094, DOI 10.1016/j.vaccine.2009.10.018; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; EFSA, 2016, EUR UN SUMM REP TREN; EFSA, 2008, AN BAS SURV PREV CAM; EFSA, 2010, AN BAS SURV PREV CAM; European Food Safety Authority (EFSA), 2011, SCI OP CAMP BROIL ME; Glunder G, 1997, COST ACTION 97 PATHO; Guyard-Nicodeme M, 2016, POULTRY SCI, V95, P298, DOI 10.3382/ps/pev303; Guyard-Nicodeme M, 2015, 2 INT S PROF ISPROF; Huang JL, 2010, J BIOMEDICINE BIOTEC, V2010; Istivan TS, 2008, FEMS IMMUNOL MED MIC, V54, P224, DOI 10.1111/j.1574-695X.2008.00467.x; Khoury CA, 1995, AVIAN DIS, V39, P812, DOI 10.2307/1592418; Lacharme-Lora L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45090; Laniewski P, 2014, WORLD J MICROB BIOT, V30, P281, DOI 10.1007/s11274-013-1447-5; Layton SL, 2011, CLIN VACCINE IMMUNOL, V18, P449, DOI 10.1128/CVI.00379-10; Meunier M, 2016, J APPL MICROBIOL, V120, P1139, DOI 10.1111/jam.12986; Meunier M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5715790; Michalik M, 2016, METHODS MOL BIOL, V1403, P87, DOI 10.1007/978-1-4939-3387-7_4; Neal-McKinney JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114254; NOOR SM, 1995, BRIT POULTRY SCI, V36, P563, DOI 10.1080/00071669508417802; Nothaft H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26511; Oprea M, 2013, BIOLOGICALS, V41, P148, DOI 10.1016/j.biologicals.2013.03.001; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Poli VFS, 2012, INT J FOOD MICROBIOL, V155, P60, DOI 10.1016/j.ijfoodmicro.2012.01.019; R Core Team, 2021, R LANGUAGE ENV STAT; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; Romero-Barrios P, 2013, FOOD CONTROL, V29, P343, DOI 10.1016/j.foodcont.2012.05.043; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Saint-Cyr MJ, 2016, INT J FOOD MICROBIOL; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; Valdivia-Olarte H, 2015, BIOINFORMATION, V11, P460, DOI 10.6026/97320630011460; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; Widders PR, 1998, VET MICROBIOL, V64, P39, DOI 10.1016/S0378-1135(98)00251-X; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; Xiang ZS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S4-S2; Yeh HY, 2015, ARCH MICROBIOL, V197, P353, DOI 10.1007/s00203-014-1062-3; Ziprin RL, 2002, CURR MICROBIOL, V44, P221, DOI 10.1007/s00284-001-0088-3	44	29	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188472	10.1371/journal.pone.0188472	http://dx.doi.org/10.1371/journal.pone.0188472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176789	Green Published, Green Submitted, gold			2022-12-26	WOS:000416291900082
J	Skandarajah, A; Sunny, SP; Gurpur, P; Reber, CD; D'Ambrosio, MV; Raghavan, N; James, BL; Ramanjinappa, RD; Suresh, A; Kandasarma, U; Birur, P; Kumar, VV; Galmeanu, HC; Itu, AM; Modiga-Arsu, M; Rausch, S; Sramek, M; Kollegal, M; Paladini, G; Kuriakose, M; Ladic, L; Koch, F; Fletcher, D				Skandarajah, Arunan; Sunny, Sumsum P.; Gurpur, Praveen; Reber, Clay D.; D'Ambrosio, Michael V.; Raghavan, Nisheena; James, Bonney Lee; Ramanjinappa, Ravindra D.; Suresh, Amritha; Kandasarma, Uma; Birur, Praveen; Kumar, Vinay V.; Galmeanu, Honorius-Cezar; Itu, Alexandru Mihail; Modiga-Arsu, Mihai; Rausch, Saskia; Sramek, Maria; Kollegal, Manohar; Paladini, Gianluca; Kuriakose, Moni; Ladic, Lance; Koch, Felix; Fletcher, Daniel			Mobile microscopy as a screening tool for oral cancer in India: A pilot study	PLOS ONE			English	Article							CERVICAL SMEARS; TELECYTOLOGY DIAGNOSIS; BRUSH BIOPSY; REPRODUCIBILITY; LESIONS; CARCINOMA; ACCURACY; PROGRAMS; CYTOLOGY; GAP	Oral cancer is the most common type of cancer among men in India and other countries in South Asia. Late diagnosis contributes significantly to this mortality, highlighting the need for effective and specific point-of-care diagnostic tools. The same regions with high prevalence of oral cancer have seen extensive growth in mobile phone infrastructure, which enables widespread access to telemedicine services. In this work, we describe the evaluation of an automated tablet-based mobile microscope as an adjunct for telemedicine-based oral cancer screening in India. Brush biopsy, a minimally invasive sampling technique was combined with a simplified staining protocol and a tablet-based mobile microscope to facilitate local collection of digital images and remote evaluation of the images by clinicians. The tablet-based mobile microscope (CellScope device) combines an iPad Mini with collection optics, LED illumination and Bluetooth-controlled motors to scan a slide specimen and capture high-resolution images of stained brush biopsy samples. Researchers at the Mazumdar Shaw Medical Foundation (MSMF) in Bangalore, India used the instrument to collect and send randomly selected images of each slide for telepathology review. Evaluation of the concordance between gold standard histology, conventional microscopy cytology, and remote pathologist review of the images was performed as part of a pilot study of mobile microscopy as a screening tool for oral cancer. Results indicated that the instrument successfully collected images of sufficient quality to enable remote diagnoses that show concordance with existing techniques. Further studies will evaluate the effectiveness of oral cancer screening with mobile microscopy by minimally trained technicians in low-resource settings.	[Skandarajah, Arunan; Reber, Clay D.; D'Ambrosio, Michael V.; Fletcher, Daniel] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Sunny, Sumsum P.; Suresh, Amritha; Kumar, Vinay V.; Kuriakose, Moni] Mazumdar Shaw Med Ctr, Head & Neck Oncol, NH Hlth City, Bangalore, Karnataka, India; [Sunny, Sumsum P.; James, Bonney Lee; Ramanjinappa, Ravindra D.; Suresh, Amritha; Kuriakose, Moni] Mazumdar Shaw Med Fdn, Mazumdar Shaw Ctr Translat Res, Integrated Head & Neck Oncol Program DSRG 5, NH Hlth City, Bangalore, Karnataka, India; [Gurpur, Praveen; Kollegal, Manohar] Siemens Healthcare Pvt Ltd, Bangalore, Karnataka, India; [Raghavan, Nisheena] Mazumdar Shaw Med Ctr, Dept Pathol, NH Hlth City, Bangalore, Karnataka, India; [Kandasarma, Uma] KLE Soc Inst Dent Sci, Dept Oral & Maxillofacial Pathol, Bangalore, Karnataka, India; [Birur, Praveen] KLE Soc Inst Dent Sci, Dept Oral Med & Radiol, Bangalore, Karnataka, India; [Galmeanu, Honorius-Cezar; Itu, Alexandru Mihail; Modiga-Arsu, Mihai] Siemens SRL, Brasov, Romania; [Rausch, Saskia; Sramek, Maria] Siemens Healthcare GmbH, Erlangen, Germany; [Paladini, Gianluca; Ladic, Lance] Siemens Med Solut USA Inc, Princeton, NJ USA; [Koch, Felix] Johannes Gutenberg Univ Mainz, Dept Oral & Maxillofacial Surg Plast Surg, Mainz, Germany	University of California System; University of California Berkeley; Siemens AG; K.L.E. Academy of Higher Education & Research; K.L.E. Academy of Higher Education & Research; Siemens AG; Siemens AG; Siemens AG; Johannes Gutenberg University of Mainz	Ladic, L (corresponding author), Siemens Med Solut USA Inc, Princeton, NJ USA.	lance.ladic@siemens.com	N, Praveen Birur/J-5307-2019; Galmeanu, Honorius/ABD-2346-2021	N, Praveen Birur/0000-0001-5287-8323; Galmeanu, Honorius/0000-0003-1957-3039; Kumar, Vinay/0000-0002-2279-4281; sunny, sumsum/0000-0001-9488-7615; Kollegal, Manohar/0000-0001-9023-1176; Kuriakose, Moni/0000-0003-4229-752X	Siemens Healthcare; USAID	Siemens Healthcare(Siemens AG); USAID(United States Agency for International Development (USAID))	This study was funded in part by Siemens Healthcare and by USAID through a grant to the UC Berkeley Development Impact Lab, part of USAID's Higher Education Solutions Network. Siemens contributed to study design, data analysis, preparation of the manuscript, and manuscript publication.	Afrogheh A, 2012, OR SURG OR MED OR PA, V113, P799, DOI 10.1016/j.oooo.2012.01.027; Ali F. M., 2012, International Journal of Medicine and Public Health, V2, P3; Birur PN, 2015, J AM DENT ASSOC, V146, P886, DOI 10.1016/j.adaj.2015.05.020; Bouquot J. E., 2010, J IMPLANT ADV DENT, V2, P47; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Falk MM, 2001, MICROSC RES TECHNIQ, V52, P251, DOI 10.1002/1097-0029(20010201)52:3<251::AID-JEMT1011>3.0.CO;2-#; Fedele S, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-5; Galvez J, 1998, ACTA CYTOL, V42, P663, DOI 10.1159/000331823; Goel S, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2688; Gomez I, 2010, ORAL DIS, V16, P333, DOI 10.1111/j.1601-0825.2009.01642.x; Gupta M, 2013, CLIN CANCER INVESTIG, V2, P181, DOI 10.4103/2278-0513.119249; Kldiashvili E, 2011, TELEMED E-HEALTH, V17, P565, DOI 10.1089/tmj.2011.0016; Koch FP, 2011, CLIN ORAL INVEST, V15, P763, DOI 10.1007/s00784-010-0434-6; Kujan O, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004150.pub2; Kumar K., 2012, INT J HEAD NECK SURG, V3, P92, DOI [10.5005/jp-journals-10001-1102, DOI 10.5005/JP-JOURNALS-10001-1102]; Kumaraswamy KL, 2012, J CANCER RES THER, V8, P192, DOI 10.4103/0973-1482.98969; Lashkari AH, 2009, 2009 2ND IEEE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, VOL 2, P48, DOI 10.1109/ICCSIT.2009.5234856; Lee CK, 2012, BIOMED OPT EXPRESS, V3, P1632, DOI 10.1364/BOE.3.001632; Lee ES, 2003, AM J CLIN PATHOL, V119, P356, DOI 10.1309/7YTVAG4XNR48T75H; Lingen MW, 2008, ORAL ONCOL, V44, P10, DOI 10.1016/j.oraloncology.2007.06.011; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; MASHBERG A, 1980, CANCER, V46, P758, DOI 10.1002/1097-0142(19800815)46:4<758::AID-CNCR2820460420>3.0.CO;2-8; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miller DL, 2012, BIOCHEM J, V443, P339, DOI 10.1042/BJ20112017; Oliver RJ, 2004, BRIT DENT J, V196, P329, DOI 10.1038/sj.bdj.4811075; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Pierce MC, 2012, CANCER PREV RES, V5, P801, DOI 10.1158/1940-6207.CAPR-11-0555; Poate TWJ, 2004, ORAL ONCOL, V40, P829, DOI 10.1016/j.oraloncology.2004.02.005; Ram S, 2005, INT J ORAL MAX SURG, V34, P521, DOI 10.1016/j.ijom.2004.10.008; Rescorla E., 2000, INTERNET ENG TASK FO; Sciubba JJ, 1999, J AM DENT ASSOC, V130, P1445, DOI 10.14219/jada.archive.1999.0055; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Skandarajah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096906; Tsilalis T, 2012, TELEMED E-HEALTH, V18, P516, DOI 10.1089/tmj.2011.0167; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; Warnakulasuriya S, 2010, ORAL ONCOL, V46, P407, DOI 10.1016/j.oraloncology.2010.02.015	38	29	32	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188440	10.1371/journal.pone.0188440	http://dx.doi.org/10.1371/journal.pone.0188440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176904	Green Published, gold, Green Submitted			2022-12-26	WOS:000416291900078
J	Zhang, WL; Gao, JY				Zhang, Wenliu; Gao, Jiangyun			Multiple factors contribute to reproductive isolation between two co-existing Habenaria species (Orchidaceae)	PLOS ONE			English	Article							FLORAL ISOLATION; FLOWER CONSTANCY; POLLINATION; EVOLUTIONARY; SPECIATION; HYBRIDIZATION; CONSEQUENCES; LEPIDOPTERA; SPECIFICITY; SELECTION	Reproductive isolation is a key feature that forms barriers to gene flow between distinct plants. In orchids, prezygotic reproductive isolation has been considered to be strong, because their associations with highly specific pollinators. In this study, the reproductive ecology and reproductive isolation of two sympatric Habenaria species, H. davidii and H. fordii, was investigated by floral phenology and morphology, hand-pollination experiments and visitor observation in southwest China. The two species were dependent on insects for pollination and completely self-compatible. A number of factors have been identified to limit gene flow between the two species and achieved full reproductive isolation. Ecogeographic isolation was a weak barrier. H. fordii and H. davidii had completely overlapped flowering periods, and floral morphology plays an important role in floral isolation. The two species shared the same hawkmoth pollinator, Cechenena lineosa, but the pollinaria of the two orchids were attached on different body parts of pollinators. Prezygotic isolation was not complete, but the interspecific pollination treatments of each species resulted in no seed sets, indicating that unlike many other orchid species, in which the postzygotic reproductive isolation is very weak or complete absence, the post-zygotic isolation strongly acted in the stage of seed production between two species. The results illustrate the reproductive isolation between two species involves multiple plant life-history stages and a variety of reproductive barriers can contribute to overall isolation.	[Zhang, Wenliu] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Zhang, Wenliu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Jiangyun] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Lab Ecol & Evolutionary Biol, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University	Gao, JY (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources Y, Lab Ecol & Evolutionary Biol, Kunming, Yunnan, Peoples R China.	jiangyun.gao@ynu.edu.cn			National Key R & D Program of China [2017YFC0505204]; National Natural Science Foundation of China [U1402267]	National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R & D Program of China (2017YFC0505204) and the National Natural Science Foundation of China (grant no. U1402267) to JiangYun Gao.; This work was supported by the National Key R & D Program of China (2017YFC0505204) and the National Natural Science Foundation of China (grant no. U1402267).	Abbott RJ, 2008, PHILOS T R SOC B, V363, P2965, DOI 10.1098/rstb.2008.0096; Agassiz Mayr E., 1959, HARV LIB B, V13, P165; Andersson S, 2003, CHEMOECOLOGY, V13, P13, DOI 10.1007/s000490300001; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Batista JAN, 2006, BRITTONIA, V58, P10, DOI 10.1663/0007-196X(2006)58[10:AROHSM]2.0.CO;2; Brantjes N. B. M., 1978, The pollination of flowers by insects, P13; Chari J, 2001, CAN J BOT, V79, P1439, DOI 10.1139/cjb-79-12-1439; Charlesworth B, 2000, CURR BIOL, V10, pR68, DOI 10.1016/S0960-9822(00)00280-3; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Cortis P, 2009, ANN BOT-LONDON, V104, P497, DOI 10.1093/aob/mcn219; Coyne J.A., 2004, SPECIATION; Cozzolino S, 2005, TAXON, V54, P977, DOI 10.2307/25065482; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; Cozzolino S, 2005, P ROY SOC B-BIOL SCI, V272, P1271, DOI 10.1098/rspb.2005.3069; Cozzolino S, 2004, P ROY SOC B-BIOL SCI, V271, pS259, DOI 10.1098/rsbl.2004.0166; Cozzolino S, 2008, PHILOS T R SOC B, V363, P3037, DOI 10.1098/rstb.2008.0079; Darwin C, 1877, EFFECTS CROSS SELF F; Darwin C., 1877, VARIOUS CONTRIVANCES; Dressler RL, 1993, PHYLOGENY CLASSFICAT; Dressler Robert L., 2005, Selbyana, V26, P155; Gardner M, 2000, BIOL J LINN SOC, V69, P443, DOI 10.1111/j.1095-8312.2000.tb01218.x; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Govaerts R, 2014, WORLD CHECKLIST ORCH; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Ikeuchi Y, 2015, ENTOMOL NEWS, V125, P7, DOI 10.3157/021.125.0103; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kay KM, 2006, EVOLUTION, V60, P538; Kurzweil H., 2009, Thai Forest Bulletin (Botany), P7; Li Qingliang, 2012, Shengwu Duoyangxing, V20, P308, DOI 10.3724/SP.J.1003.2012.09025; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Ma YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19146; NILSSON LA, 1983, BOT J LINN SOC, V87, P325, DOI 10.1111/j.1095-8339.1983.tb00997.x; Pauw A, 2006, AM J BOT, V93, P917, DOI 10.3732/ajb.93.6.917; Pedron M, 2012, BOT J LINN SOC, V170, P141, DOI 10.1111/j.1095-8339.2012.01285.x; Peter CI, 2009, S AFR J BOT, V75, P744, DOI 10.1016/j.sajb.2009.08.007; Plepys D, 2002, OIKOS, V99, P69, DOI 10.1034/j.1600-0706.2002.990107.x; Price TD, 2002, EVOLUTION, V56, P2083; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; Rieseberg LH, 2007, SCIENCE, V318, P198, DOI 10.1126/science.1147892; Roberts DL, 2008, CURR BIOL, V18, pR325, DOI 10.1016/j.cub.2008.02.026; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Schiestl FP, 2002, MOLEC METH PLAN ANAL, V21, P173; Singer R, 1997, BOT ACTA, V110, P328, DOI 10.1111/j.1438-8677.1997.tb00648.x; Singer Rodrigo B., 2001, Darwiniana (San Isidro), V39, P201; Suetsugu K, 2014, ENTOMOL SCI, V17, P122, DOI 10.1111/ens.12035; Sun HQ, 2011, ANN BOT-LONDON, V107, P39, DOI 10.1093/aob/mcq210; Sun M, 2015, J EVOLUTION BIOL, V28, P117, DOI 10.1111/jeb.12544; THIEN LB, 1970, AM J BOT, V57, P1031, DOI 10.2307/2441267; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; Van der Pijl L., 1966, ORCHID FLOWERS THEIR; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Whitehead MR, 2014, EVOLUTION, V68, P1561, DOI 10.1111/evo.12382; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Xiong YZ, 2015, J PLANT ECOL, V8, P136, DOI 10.1093/jpe/rtv016; Xu SQ, 2011, EVOLUTION, V65, P2606, DOI 10.1111/j.1558-5646.2011.01323.x; Yang CF, 2007, BIOL J LINN SOC, V90, P37, DOI 10.1111/j.1095-8312.2007.00709.x; [Zhang Wenliu 张文柳], 2015, [广西植物, Guihaia], V35, P75	60	12	13	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188594	10.1371/journal.pone.0188594	http://dx.doi.org/10.1371/journal.pone.0188594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	29176771	Green Submitted, Green Published, gold			2022-12-26	WOS:000416291900105
J	Igarashi, K; Yamashita, K; Katoh, H; Kojima, K; Ooizumi, Y; Nishizawa, N; Nishiyama, R; Kawamata, H; Tajima, H; Kaizu, T; Kumamoto, Y; Watanabe, M				Igarashi, Kazuharu; Yamashita, Keishi; Katoh, Hiroshi; Kojima, Keita; Ooizumi, Yosuke; Nishizawa, Nobuyuki; Nishiyama, Ryo; Kawamata, Hiroshi; Tajima, Hiroshi; Kaizu, Takashi; Kumamoto, Yusuke; Watanabe, Masahiko			Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease	PLOS ONE			English	Article							XANTHOGRANULOMATOUS CHOLECYSTITIS; METHYLATION; DIAGNOSIS; SURVIVAL; BIOMARKERS; SERUM	Background Aberrant promoter DNA methylation of the cysteine dioxygenase 1 (CDO1) gene is found in various human cancers and is associated with clinical outcome. In this study, we assessed for the first time the clinicopathological significance of CDO1 methylation in primary gallbladder cancer (GBC) in comparison with non-malignant gallbladder disease. Methods CDO1 DNA methylation was quantified using quantitative TaqMan methylation specific PCR (Q-MSP) in 99 primary GBC patients together with the 78 corresponding non-tumor tissues and 26 benign gallbladder disease (including 7 patients with xanthogranulomatous cholecystitis) who underwent surgical resection between 1986 and 2014. Results The average CDO1 TaqMeth value of primary GBCs was 23.5 +/- 26. These values were significantly higher than those of corresponding non-tumor tissues (average 8 +/- 13, p < .0001) and diseased gallbladder tissues from patients with benign gallbladder diseases (average 0.98 +/- 1.6, p < .0001). CDO1 hypermethylation is also found in xanthogranulomatous cholecystitis. Using a cut-off value of 17.7, GBC cases with CDO1 hypermethylation (n = 47) showed significantly poorer prognosis than those with CDO1 hypomethylation (n = 52) (p = 0.0023). Multivariate Cox proportional hazards analysis identified that CDO1 hypermethylation was an independent prognostic factor. Notably, CDO1 hypermethylation showed prognostic relevance, especially in stage II GBC, in which it is highly anticipated to work as a predictive marker for candidates of adjuvant therapy. Conclusions Promoter NA methylation of CDO1 was demonstrated for the first time to be a cancer-associated methylation in primary GBC, and it has the potential to be a prognostic biomarker of GBC for high-risk patients with stage II GBC.	[Igarashi, Kazuharu; Yamashita, Keishi; Katoh, Hiroshi; Kojima, Keita; Ooizumi, Yosuke; Nishizawa, Nobuyuki; Nishiyama, Ryo; Kawamata, Hiroshi; Tajima, Hiroshi; Kaizu, Takashi; Kumamoto, Yusuke; Watanabe, Masahiko] Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Watanabe, M (corresponding author), Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.	intl-aff@kitasato-u.ac.jp						Andresen K, 2015, HEPATOLOGY, V61, P1651, DOI 10.1002/hep.27707; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P811, DOI 10.1245/s10434-014-4044-4; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Martinelli CMD, 2017, ONCOTARGET, V8, P50608, DOI 10.18632/oncotarget.11167; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; Diaz-Lagares A, 2016, CLIN CANCER RES, V22, P3361, DOI 10.1158/1078-0432.CCR-15-2346; DIETRICH D, 2010, BMC CANCER, V10; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kayahara M, 2008, ANN SURG, V248, P807, DOI 10.1097/SLA.0b013e31818a1561; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sikora SS, 2006, J SURG ONCOL, V93, P670, DOI 10.1002/jso.20535; Singh VP, 2016, WORLD J RADIOL, V8, P183, DOI 10.4329/wjr.v8.i2.183; Suzuki H, 2015, WORLD J GASTROENTERO, V21, P10166, DOI 10.3748/wjg.v21.i35.10166; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Waraya M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-397; Waraya M, 2009, ANN SURG ONCOL, V16, P1231, DOI 10.1245/s10434-009-0415-7; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546; Yang Y, 2014, TOHOKU J EXP MED, V232, P187, DOI 10.1620/tjem.232.187	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188178	10.1371/journal.pone.0188178	http://dx.doi.org/10.1371/journal.pone.0188178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161283	gold, Green Submitted, Green Published			2022-12-26	WOS:000415987000034
J	Petta, S; Ciresi, A; Bianco, J; Geraci, V; Boemi, R; Galvano, L; Magliozzo, F; Merlino, G; Craxi, A; Giordano, C				Petta, Salvatore; Ciresi, Alessandro; Bianco, Jessica; Geraci, Vincenzo; Boemi, Roberta; Galvano, Luigi; Magliozzo, Franco; Merlino, Giovanni; Craxi, Antonio; Giordano, Carla			Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; UNITED-STATES; WOMEN; SENSITIVITY; PREVALENCE; IMPACT; SYSTEMS	Background and aims Nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) recognize obesity and insulin resistance (IR) as common pathogenic background. We assessed 1) whether PCOS is a risk factor for steatosis, and 2) the impact, in PCOS patients, of IR and hyperandrogenism on steatosis and fibrosis. Methods We considered 202 consecutive Italian PCOS nondiabetic patients and 101 age-matched controls. PCOS was diagnosed applying the Rotterdam diagnostic criteria. Steatosis was diagnosed if hepatic steatosis index (HSI) > 36, while fibrosis by using the FIB-4 score. As surrogate estimate of insulin sensitivity we considered the insulin sensitivity index (ISI). Free androgen index (FAI) was calculated as estimate of biochemical hyperandrogenism. Results In the entire population, steatosis was observed in 68.8% of patients with PCOS, compared to 33.3 of controls (p<0.001), this association being maintained after adjusting for metabolic confounders (OR 3.73, 95% CI 1.74-8.02; P = 0.001). In PCOS patients, steatosis was independently linked to WC (OR 1.04, 95% CI 1.01-1.08; P = 0.006) and ISI Matsuda (OR 0.69, 95% CI 0.53-0.88; P = 0.004), not to free androgen index (OR 1.10, 95% CI 0.96-1.26; P = 0.14). Notably, ISI Matsuda was confirmed as independently associated with steatosis in both obese (OR 0.42, 95% CI 0.23-0.77, P = 0.005) and nonobese (OR 0.69, 95% CI 0.53-0.91, P = 0.009), patients, while FAI (OR 1.45, 95% CI 1.12-1.87; P = 0.004) emerged as an independent risk factor only in nonobese PCOS. Similarly, higher FIB-4 was independently associated with higher FAI (p = 0.02) in nonobese and with lower ISI Matsuda (p = 0.04) in obese patients. Conclusions We found that PCOS is an independent risk factor for steatosis, and that, IR and hyperandrogenism, this last especially in nonobese patients, are the key players of liver damage in PCOS.	[Petta, Salvatore; Boemi, Roberta; Craxi, Antonio] Univ Palermo, DiBiMIS, Sect Gastroenterol, Palermo, Italy; [Ciresi, Alessandro; Bianco, Jessica; Geraci, Vincenzo; Giordano, Carla] Univ Palermo, DiBiMIS, Sect Endocrinol Diabetol & Metab, Palermo, Italy; [Galvano, Luigi; Magliozzo, Franco; Merlino, Giovanni] Med Gen, Palermo, Italy	University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, DiBiMIS, Sect Gastroenterol, Palermo, Italy.	salvatore.petta@unipa.it		Merlino, Giovanni/0000-0002-4297-0035				Amato MC, 2008, CLIN ENDOCRINOL, V69, P52, DOI 10.1111/j.1365-2265.2007.03145.x; Ayonrinde OT, 2016, J GASTROEN HEPATOL, V31, P980, DOI 10.1111/jgh.13241; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Galluzzo A, 2008, NUTR METAB CARDIOVAS, V18, P511, DOI 10.1016/j.numecd.2008.05.004; Gambarin-Gelwan M, 2007, CLIN GASTROENTEROL H, V5, P496, DOI 10.1016/j.cgh.2006.10.010; Jones H, 2012, J CLIN ENDOCR METAB, V97, P3709, DOI 10.1210/jc.2012-1382; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Musso G, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25677; Petta S, 2016, DIGEST LIVER DIS, V48, P333, DOI 10.1016/j.dld.2015.10.027; Polyzos SA, 2014, HORM-INT J ENDOCRINO, V13, P519, DOI 10.14310/horm.2002.1493; Ramezani-Binabaj M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.23235; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Setiawan VW, 2016, HEPATOLOGY, V64, P1969, DOI 10.1002/hep.28677; Setji TL, 2006, J CLIN ENDOCR METAB, V91, P1741, DOI 10.1210/jc.2005-2774; Tan S, 2010, J CLIN ENDOCR METAB, V95, P343, DOI 10.1210/jc.2009-1834; Targher G, 2009, J ENDOCRINOL INVEST, V32, P695, DOI [10.1007/BF03345743, 10.3275/6375]; Targher G, 2016, ENDOCRINE, V51, P211, DOI 10.1007/s12020-015-0640-8; Turola E, 2015, DIS MODEL MECH, V8, P1037, DOI 10.1242/dmm.019950; Vassilatou E, 2010, HUM REPROD, V25, P212, DOI 10.1093/humrep/dep380; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	31	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186136	10.1371/journal.pone.0186136	http://dx.doi.org/10.1371/journal.pone.0186136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161258	gold, Green Published, Green Submitted			2022-12-26	WOS:000415987000003
J	Shin, DH; Woo, KI; Kim, YD				Shin, Dong Hoon; Woo, Kyung In; Kim, Yoon-Duck			Relationship between lower eyelid epiblepharon and epicanthus in Korean children	PLOS ONE			English	Article							LASH ROTATING SUTURES; BODY-MASS INDEX; SURGICAL-CORRECTION; CONGENITAL ENTROPION; INVERTED EYELASHES; JAPANESE-CHILDREN; ASTIGMATISM; SKIN; FOLD	Purpose This study aimed to determine the relationship between lower eyelid epiblepharon and epicanthus in Korean children. Methods We performed a retrospective review of the medical records and preoperative photographs of 119 patients. These patients were aged 18 years or younger who underwent lower lid epiblepharon repair from January 2010 to December 2012. We also included 119 age-and sex-matched controls. Results The mean age of the patients was 5.7 years (range: 2-16 years) in both groups. The presence of an epicanthal fold was common in each group (98.3%). The inner intercanthal distance/interpupillary distance (IICD/IPD) ratio was significantly greater in the epiblepharon group than in the control group (mean: 0.70 vs 0.67, p<0.001), especially in those aged 5 years or older. The IICD/outer intercanthal distance ratio was also greater in the epiblepharon group than in the control group (mean: 0.48 vs 0.46, p<0.001). The IICD/IPD ratio decreased with growth in the control group, but it did not decrease with growth in the epiblepharon group. The configuration of the epicanthus, in which the upper skin fold formed a confluent fold with the lower eyelid, had a higher prevalence in the epiblepharon group than in the control group (p = 0.001), especially in those aged 5 years or older. Conclusion In early childhood (< 5 years), the relationship between epicanthus and epiblepharon cannot be established because of the high prevalence of epicanthus in children with or without epiblepharon. In children aged >= 5 years, persistent epicanthus was related to severe epiblepharon formation requiring corrective surgery.	[Shin, Dong Hoon; Woo, Kyung In; Kim, Yoon-Duck] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Woo, KI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	eyeminded@skku.edu		SHIN, Dong Hoon/0000-0003-3076-9200				Ahn HB, 2011, J PEDIAT OPHTH STRAB, V48, P57, DOI 10.3928/01913913-20100420-01; Chang M, 2011, BRIT J OPHTHALMOL, V95, P1675, DOI 10.1136/bjophthalmol-2011-300592; Duke-Elder S., 1964, SYSTEM OPHTHALMOLOGY, V3, P851; Gosain AK., 1997, GRABB SMITHS PLASTIC, V5th ed, P223; Hayasaka Y, 2005, J PEDIAT OPHTH STRAB, V42, P300; JOHNSON CC, 1968, AM J OPHTHALMOL, V66, P1172, DOI 10.1016/0002-9394(68)90830-1; JORDAN R, 1993, OPHTHALMIC SURG LAS, V24, P494; Kakizaki H, 2009, CLIN OPHTHALMOL, V3, P247; Khwarg S I, 1997, Korean J Ophthalmol, V11, P111; Khwarg SI, 2002, OPHTHALMIC SURG LAS, V33, P280; Kim MS, 2014, BRIT J OPHTHALMOL, V98, P120, DOI 10.1136/bjophthalmol-2013-303772; Lee Y, 2000, PLAST RECONSTR SURG, V105, P1872, DOI 10.1097/00006534-200004050-00040; LEVITT JM, 1957, AM J OPHTHALMOL, V44, P112, DOI 10.1016/0002-9394(57)91966-9; Liu D, 1986, Ophthalmic Plast Reconstr Surg, V2, P59, DOI 10.1097/00002341-198601050-00001; NODA S, 1989, BRIT J OPHTHALMOL, V73, P126, DOI 10.1136/bjo.73.2.126; Ohmori K., 1990, PLASTIC SURG, V3, P2415; Park J I, 2000, Arch Facial Plast Surg, V2, P43, DOI 10.1001/archfaci.2.1.43; Park SW, 2008, J PEDIAT OPHTH STRAB, V45, P31, DOI 10.3928/01913913-20080101-18; Preechawai P, 2007, AM J OPHTHALMOL, V143, P835, DOI 10.1016/j.ajo.2007.01.043; Scheie H., 1977, TXB OPHTHALMOLOGY, P79; Shih MH, 2007, CORNEA, V26, P1090, DOI 10.1097/ICO.0b013e3181451212; Sohn S. W., 2002, J KOREAN OPHTHALMOLO, V43, P1827; Sundar G, 2010, OPHTHALMOLOGY, V117, P184, DOI 10.1016/j.ophtha.2009.06.044; Tan MCJ, 2012, ORBIT, V31, P107, DOI 10.3109/01676830.2011.638095	24	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187690	10.1371/journal.pone.0187690	http://dx.doi.org/10.1371/journal.pone.0187690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161299	Green Published, Green Submitted, gold			2022-12-26	WOS:000415987000017
J	Cremers, HR; Wager, TD; Yarkoni, T				Cremers, Henk R.; Wager, Tor D.; Yarkoni, Tal			The relation between statistical power and inference in fMRI	PLOS ONE			English	Article							SAMPLE-SIZE; BRAIN; PSYCHOLOGY; METAANALYSIS; ACTIVATION; SCIENCE; EMOTION; MODELS; RULES; BACK	Statistically underpowered studies can result in experimental failure even when all other experimental considerations have been addressed impeccably. In fMRI the combination of a large number of dependent variables, a relatively small number of observations (subjects), and a need to correct for multiple comparisons can decrease statistical power dramatically. This problem has been clearly addressed yet remains controversial-especially in regards to the expected effect sizes in fMRI, and especially for between-subjects effects such as group comparisons and brain-behavior correlations. We aimed to clarify the power problem by considering and contrasting two simulated scenarios of such possible brain-behavior correlations: weak diffuse effects and strong localized effects. Sampling from these scenarios shows that, particularly in the weak diffuse scenario, common sample sizes (n = 20-30) display extremely low statistical power, poorly represent the actual effects in the full sample, and show large variation on subsequent replications. Empirical data from the Human Connectome Project resembles the weak diffuse scenario much more than the localized strong scenario, which underscores the extent of the power problem for many studies. Possible solutions to the power problem include increasing the sample size, using less stringent thresholds, or focusing on a region-of-interest. However, these approaches are not always feasible and some have major drawbacks. The most prominent solutions that may help address the power problem include model-based (multivariate) prediction methods and meta-analyses with related synthesis-oriented approaches.	[Cremers, Henk R.] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Yarkoni, Tal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Amsterdam; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Austin	Cremers, HR (corresponding author), Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	h.r.cremers@uva.nl			16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; National institute of Health [R01MH096906, R01DA035484]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109682, R01MH096906, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035484] Funding Source: NIH RePORTER	16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University; National institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Data analyzed in section 3.2 were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was supported by National institute of Health (https://grants.nih.govigrants/ about grants.htm) award R01MH096906 to TY and R01DA035484 to T.D.W.; The Data analyzed in section 3.2 were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was supported by NIH award R01MH096906 to TY and R01DA035484 to T.D.W.	Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BAROUDI JJ, 1989, MIS QUART, V13, P87, DOI 10.2307/248704; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carruthers P, 2003, ROY I PH S, V53, P67, DOI 10.1017/S1358246100008274; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Chang LJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002180; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; CHASE LJ, 1976, J APPL PSYCHOL, V61, P234, DOI 10.1037/0021-9010.61.2.234; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costa P.T, 1992, REVISED NEOPERSONALI; Cremers HR, 2015, PSYCHOL MED, V45, P1521, DOI 10.1017/S0033291714002657; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Durnez J., 2016, POWER SAMPLE SIZE CA; Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072; Etz A, 2016, PLOS ONE, P11; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher R. A., 1946, Statistical methods for research workers.; Fodor J. A, 1983, MODULARITY MIND; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; Gelman A, 2009, AM SCI, V97, P310, DOI 10.1511/2009.79.310; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Joyce KE, 2012, NEUROINFORMATICS, V10, P351, DOI 10.1007/s12021-012-9152-3; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Krantz DH, 1999, J AM STAT ASSOC, V94, P1372, DOI 10.2307/2669949; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist Martin A, 2013, Neuroimage, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; Loftus GR, 1996, CURR DIR PSYCHOL SCI, V5, P161, DOI 10.1111/1467-8721.ep11512376; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Moeller JR, 2006, INT J BIOMED IMAGING, V2006, DOI 10.1155/IJBI/2006/79862; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Mumford JA, 2012, SOC COGN AFFECT NEUR, V7, P738, DOI 10.1093/scan/nss059; Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Osborne JW, 2008, EDUC PSYCHOL-UK, V28, P151, DOI 10.1080/01443410701491718; Ottenbacher KJ, 1996, AM STAT, V50, P271, DOI 10.2307/2684673; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peterman RM, 2011, CANADIAN J FISHERIES, V47, P2; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Reddan MC, 2017, JAMA PSYCHIAT, V74, P207, DOI 10.1001/jamapsychiatry.2016.3356; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Rosa MJ, 2015, NEUROIMAGE, V105, P493, DOI 10.1016/j.neuroimage.2014.11.021; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmidt FL, 1996, PSYCHOL METHODS, V1, P115, DOI 10.1037/1082-989X.1.2.115; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; van Ast VA, 2016, CEREB CORTEX, V26, P544, DOI 10.1093/cercor/bhu206; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P319, DOI 10.1111/j.1745-6924.2009.01132.x; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wager TD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004066; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wainer H, 2007, AM SCI, V95, P249, DOI 10.1511/2007.65.249; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Westfall Jacob, 2016, Wellcome Open Res, V1, P23, DOI 10.12688/wellcomeopenres.10298.2; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yarkoni T., 2015, APA HDB PERSONALITY, P61, DOI DOI 10.1037/14343-003; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yarkoni T, 2010, TRENDS COGN SCI, V14, P489, DOI 10.1016/j.tics.2010.08.004; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Zhuang XW, 2017, NEUROIMAGE, V149, P63, DOI 10.1016/j.neuroimage.2016.12.081	97	178	180	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0184923	10.1371/journal.pone.0184923	http://dx.doi.org/10.1371/journal.pone.0184923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155843	Green Published, gold, Green Submitted			2022-12-26	WOS:000415756700002
J	Singano, V; Amberbir, A; Garone, D; Kandionamaso, C; Msonko, J; van Lettow, M; Kalima, K; Mataka, Y; Kawalazira, G; Mateyu, G; Kwekwesa, A; Matengeni, A; van Oosterhout, JJ				Singano, Victor; Amberbir, Alemayehu; Garone, Daniela; Kandionamaso, Christopher; Msonko, Jack; van Lettow, Monique; Kalima, Kondwani; Mataka, Yamikani; Kawalazira, Gift; Mateyu, Gabriel; Kwekwesa, Aunex; Matengeni, Alfred; van Oosterhout, Joep J.			The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; EFAVIRENZ; LIPODYSTROPHY; ALGORITHM	Background Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. Methods We conducted a cross-sectional study in males >= 18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. Results We enrolled 1,027 men with median age 44 years (IQR: 38-52). The median ART duration was 57 months (IQR: 27-85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7-7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2-7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04-4.25). Conclusions The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management.	[Singano, Victor; Amberbir, Alemayehu; Garone, Daniela; Kandionamaso, Christopher; Msonko, Jack; van Lettow, Monique; Kalima, Kondwani; Mataka, Yamikani; Mateyu, Gabriel; Kwekwesa, Aunex; Matengeni, Alfred; van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [van Lettow, Monique] Univ Toronto, Dala Lana Sch Publ Hlth, Toronto, ON, Canada; [Kawalazira, Gift] Malawi Minist Hlth, Zomba Dist Hlth Off, Zomba, Malawi; [van Oosterhout, Joep J.] Coll Med, Dept Med, Blantyre, Malawi	University of Toronto; University of Malawi	van Oosterhout, JJ (corresponding author), Dignitas Int, Zomba, Malawi.; van Oosterhout, JJ (corresponding author), Coll Med, Dept Med, Blantyre, Malawi.	j.vanoosterhout@dignitasinternational.org	Amberbir, Alemayehu/HGC-2647-2022	singano, victor/0000-0002-2671-7291	USAID	USAID(United States Agency for International Development (USAID))	Dignitas International's work at the Tisungane HIV clinic at Zomba Central Hospital is funded by USAID. USAID had no role in the study design, data collection, data analysis, decision to publish or preparation of the manuscript.	Abaji OO, 2011, J MED MED SCI, V2, P1221; Biglia A, 2004, CLIN INFECT DIS, V39, P1514, DOI 10.1086/425363; Birbal S, 2016, AJAR-AFR J AIDS RES, V15, P243, DOI 10.2989/16085906.2016.1191519; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; Caso JAA, 2001, AIDS, V15, P1447, DOI 10.1097/00002030-200107270-00018; Cordova A, 2008, J PLAST RECONSTR AES, V61, P41, DOI 10.1016/j.bjps.2007.09.033; Davison SP, 2007, PLAST RECONSTR SURG, V120, P1843, DOI 10.1097/01.prs.0000267341.14550.a7; Deepinder F, 2012, EXPERT OPIN DRUG SAF, V11, P779, DOI 10.1517/14740338.2012.712109; Deonarain J, 2008, INT J SURG PATHOL, V16, P171, DOI 10.1177/1066896907307037; Dickson G, 2012, AM FAM PHYSICIAN, V85, P716; Donovan B, 1999, INT J STD AIDS, V10, P49, DOI 10.1258/0956462991912935; Jover Francisco, 2004, Breast J, V10, P244, DOI 10.1111/j.1075-122X.2004.21392.x; Kandionamaso C., 2015, B5 OR PRES RES DISS; Khan A, 2012, LUNG INDIA, V29, P189, DOI 10.4103/0970-2113.95343; Kim MJ, 2015, INFECT CHEMOTHER, V47, P231, DOI 10.3947/ic.2015.47.4.231; Kwekwesa A, 2015, MALAWI MED J, V27, P115, DOI 10.4314/mmj.v27i3.11; Mercie P, 2001, AIDS, V15, P126, DOI 10.1097/00002030-200101050-00021; Mira JA, 2004, ANTIVIR THER, V9, P511; National Statistical Office, 2010, MAL DEM HLTH SURV; Nuttall FQ, 2015, EUR J CLIN PHARMACOL, V71, P569, DOI 10.1007/s00228-015-1835-x; Piroth L, 2001, SCAND J INFECT DIS, V33, P559, DOI 10.1080/00365540110026476; Rahim Sibtain, 2004, AIDS Read, V14, P23; Schurmann D, 1998, AIDS, V12, P2232; Shet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091028; Tadesse WT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-32; Tapsfield J, 2011, MALAWI MED J, V23, P116; Toma E, 1998, AIDS, V12, P681; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; WHO, 2013, GLOB UPD HIV TREATM	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188379	10.1371/journal.pone.0188379	http://dx.doi.org/10.1371/journal.pone.0188379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155891	gold, Green Submitted, Green Published			2022-12-26	WOS:000415756700053
J	Lindelof, N; Lundin-Olsson, L; Skelton, DA; Lundman, B; Rosendahl, E				Lindelof, Nina; Lundin-Olsson, Lillemor; Skelton, Dawn A.; Lundman, Berit; Rosendahl, Erik			Experiences of older people with dementia participating in a high-intensity functional exercise program in nursing homes: "While it's tough, it's useful"	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; CARE FACILITIES; ADULTS; RESIDENTS; ADHERENCE; COMMUNITY; BALANCE	The objective of the study was to describe the views and experiences of participation in a high-intensity functional exercise (HIFE) program among older people with dementia in nursing homes. The study design was a qualitative interview study with 21 participants (15 women), aged 74-96, and with a Mini-Mental State Examination score of 10-23 at study start. The HIFE-program comprises exercises performed in functional weight-bearing positions and including movements used in everyday tasks. The exercise was individually designed, supervised in small groups in the nursing homes and performed during four months. Interviews were performed directly after exercise sessions and field notes about the sessions were recorded. Qualitative content analysis was used for analyses. The analysis revealed four themes: Exercise is challenging but achievable; Exercise gives pleasure and strength; Exercise evokes body memories; and Togetherness gives comfort, joy, and encouragement. The intense and tailored exercise, adapted to each participant, was perceived as challenging but achievable, and gave pleasure and improvements in mental and bodily strength. Memories of previous physical activities aroused and participants rediscovered bodily capabilities. Importance of individualized and supervised exercise in small groups was emphasized and created feelings of encouragement, safety, and coherence. The findings from the interviews reinforces the positive meaning of intense exercise to older people with moderate to severe dementia in nursing homes. The participants were able to safely adhere to and understand the necessity of the exercise. Providers of exercise should consider the aspects valued by participants, e.g. supervision, individualization, small groups, encouragement, and that exercise involved joy and rediscovery of body competencies.	[Lindelof, Nina; Lundin-Olsson, Lillemor; Rosendahl, Erik] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Lindelof, Nina; Rosendahl, Erik] Umea Univ, Dept Community Med & Rehabil, Geriatr Med, Umea, Sweden; [Skelton, Dawn A.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Lundman, Berit] Umea Univ, Dept Nursing, Umea, Sweden	Umea University; Umea University; Glasgow Caledonian University; Umea University	Lindelof, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Lindelof, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Geriatr Med, Umea, Sweden.	nina.lindelof@umu.se	Skelton, Dawn A/B-7552-2013	Skelton, Dawn A/0000-0001-6223-9840; Lindelof, Nina/0000-0002-4449-049X	Swedish Research Council [K2009-69P-21298-01-4, K2009-69X21299-01-1, K2009-69P-21298-04-4, K2014-99X22610-01-6]; Forte-Swedish Research Council for Health; Working Life and Welfare; Vardal Foundation; Promobilia Foundation; Swedish Society of Medicine; Swedish Dementia Association; Swedish Alzheimer Foundation; County Council of Vasterbotten; Ragnhild and Einar Lundstrom's Memorial Foundation; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Forte-Swedish Research Council for Health; Working Life and Welfare; Vardal Foundation; Promobilia Foundation; Swedish Society of Medicine; Swedish Dementia Association; Swedish Alzheimer Foundation; County Council of Vasterbotten; Ragnhild and Einar Lundstrom's Memorial Foundation; Umea University	The Swedish Research Council, https://www.vr.se/, (K2009-69P-21298-01-4, K2009-69X21299-01-1, K2009-69P-21298-04-4, K2014-99X22610-01-6), to ER, Forte-Swedish Research Council for Health, Working Life and Welfare, http://forte.se/, to ER, The Vardal Foundation, to ER, The Promobilia Foundation, to ER, The Swedish Society of Medicine, to ER, The Swedish Dementia Association, http://www.demensforbundet.se/, to NL, The Swedish Alzheimer Foundation, to ER The County Council of Vasterbotten, http://vll.se, to NL and ER, The Ragnhild and Einar Lundstrom's Memorial Foundation, to NL, and a grant provided by Umea University, http://www.umu.se/, for DS as a visiting Professor, to LLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2014, HIFE PROGRAM HIGH IN; Atchely R., 1999, CONTINUITY ADAPTATIO; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barreto PD, 2016, J AM MED DIR ASSOC, V17, P381, DOI 10.1016/j.jamda.2016.01.021; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Brassington GS, 2002, AM J PREV MED, V23, P80, DOI 10.1016/S0749-3797(02)00477-4; Caddell LS, 2010, CLIN PSYCHOL REV, V30, P113, DOI 10.1016/j.cpr.2009.10.003; Cahill S, 2011, AGING MENT HEALTH, V15, P562, DOI 10.1080/13607863.2010.551342; Cedervall Y, 2015, AGING MENT HEALTH, V19, P679, DOI 10.1080/13607863.2014.962004; Chong TWH, 2014, ASIA-PAC PSYCHIAT, V6, P179, DOI 10.1111/appy.12015; Fjellman-Wiklundl A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166686; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harre R., 1998, SINGULAR SELF INTRO; Hawley-Hague H, 2016, J AGING PHYS ACTIV, V24, P119, DOI 10.1123/japa.2014-0108; Hawley-Hague H, 2014, GERONTOLOGIST, V54, P599, DOI 10.1093/geront/gnt075; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kitwood T., 1995, NEW CULTURE DEMENTIA; Kontos P. C., 2005, DEMENTIA, V4, P553, DOI DOI 10.1177/1471301205058311; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; Lindelof Nina, 2012, Physiotherapy Theory and Practice, V28, P307, DOI 10.3109/09593985.2011.611217; Littbrand H, 2006, PHYS THER, V86, P489, DOI 10.1093/ptj/86.4.489; Littbrand H, 2011, J AM GERIATR SOC, V59, P1274, DOI 10.1111/j.1532-5415.2011.03484.x; Littbrand H, 2011, AM J PHYS MED REHAB, V90, P495, DOI 10.1097/PHM.0b013e318214de26; Littbrand H, 2009, J AM GERIATR SOC, V57, P1741, DOI 10.1111/j.1532-5415.2009.02442.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Mozley CG, 1999, INT J GERIATR PSYCH, V14, P776, DOI 10.1002/(SICI)1099-1166(199909)14:9<776::AID-GPS13>3.0.CO;2-C; Olsen CF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1041-7; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Reid N, 2013, INT J ENV RES PUB HE, V10, P6783, DOI 10.3390/ijerph10126783; Rosendahl E, 2006, AUST J PHYSIOTHER, V52, P105, DOI 10.1016/S0004-9514(06)70045-9; Scandol JP, 2013, INJURY, V44, P776, DOI 10.1016/j.injury.2012.11.023; Stathi A., 2003, J ROYAL SOC HLTH, V124, P18; Stathi A, 2007, J AGING PHYS ACTIV, V15, P272, DOI 10.1123/japa.15.3.272; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Suttanon P, 2012, INT PSYCHOGERIATR, V24, P1172, DOI 10.1017/S1041610211002729; Telenius EW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0151-8; Telenius EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126102; The National Board och Health Care and Welfare, 2010, NAT GUID CAR CAS DEM; Toots A, 2016, J AM GERIATR SOC, V64, P55, DOI 10.1111/jgs.13880; van Alphen HJM, 2016, ARCH GERONTOL GERIAT, V66, P109, DOI 10.1016/j.archger.2016.05.008; von Kutzleben M, 2012, AGING MENT HEALTH, V16, P378, DOI 10.1080/13607863.2011.614594; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Weeks LE, 2008, J GERONTOL NURS, V34, P36, DOI 10.3928/00989134-20080701-11; Westius A, 2009, DEMENTIA, V8, P481, DOI DOI 10.1177/1471301209350287; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Yu F, 2011, RES GERONTOL NURS, V4, P243, DOI 10.3928/19404921-20110303-01	52	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188225	10.1371/journal.pone.0188225	http://dx.doi.org/10.1371/journal.pone.0188225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149198	gold, Green Submitted, Green Published			2022-12-26	WOS:000415646100030
J	de Bruyn, J; Thomson, PC; Bagnoll, B; Maulaga, W; Rukambile, E; Alders, RG				de Bruyn, Julia; Thomson, Peter C.; Bagnoll, Brigitte; Maulaga, Wende; Rukambile, Elpidius; Alders, Robyn G.			The chicken or the egg? Exploring bidirectional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania	PLOS ONE			English	Article							COMMUNITY-BASED CONSERVATION; DEVELOPING-COUNTRIES; POULTRY PRODUCTION; FAMILY POULTRY; DISTRICT; AFRICA; HEALTH; LEVEL	Newcastle disease (ND) is a viral disease of poultry with global importance, responsible for the loss of a potential source of household nutrition and economic livelihood in many low-income food-deficit countries. Periodic outbreaks of this endemic disease result in high mortality amongst free-ranging chicken flocks and may serve as a disincentive for rural households to invest time or resources in poultry-keeping. Sustainable ND control can be achieved through vaccination using a thermotolerant vaccine administered via eyedrop by trained "community vaccinators". This article evaluates the uptake and outcomes of fee-for-service ND vaccination programs in eight rural villages in the semi-arid central zone of Tanzania. It represents part of an interdisciplinary program seeking to address chronic undernutrition in children through improvements to existing poultry and crop systems. Newcastle disease vaccination uptake was found to vary substantially across communities and seasons, with a significantly higher level of vaccination amongst households participating in a longitudinal study of children's growth compared with non-participating households (p = 0.009). Two multivariable model analyses were used to explore associations between vaccination and chicken numbers, allowing for clustered data and socioeconomic and cultural variation amongst the population. Results demonstrated that both (a) households that undertook ND vaccination had a significantly larger chicken flock size in the period between that vaccination campaign and the next compared with those that did not vaccinate (p = 0.018); and (b) households with larger chicken flocks at the time of vaccination were significantly more likely to participate in vaccination programs (p < 0.001). Additionally, households vaccinating in all three vaccination campaigns held over 12 months were identified to have significantly larger chicken flocks at the end of this period (p < 0.001). Opportunities to understand causality and complexity through quantitative analyses are limited, and there is a role for qualitative approaches to explore decisions made by poultry-keeping households and the motivations, challenges and priorities of community vaccinators. Evidence of a bidirectional relationship, however, whereby vaccination leads to greater chicken numbers, and larger flocks are more likely to be vaccinated, offers useful insights into the efficacy of fee-for-service animal health programs. This article concludes that attention should be focused on ways of supporting the participation of vulnerable households in ND vaccination campaigns, and encouraging regular vaccination throughout the year, as a pathway to strengthen food security, promote resilience and contribute to improved human nutrition.	[de Bruyn, Julia; Thomson, Peter C.; Bagnoll, Brigitte; Rukambile, Elpidius; Alders, Robyn G.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [de Bruyn, Julia; Bagnoll, Brigitte; Alders, Robyn G.] Univ Sydney, Charles Perkins Ctr, Johns Hopkins Dr, Sydney, NSW, Australia; [Bagnoll, Brigitte; Alders, Robyn G.] KYEEMA Fdn, Int Rural Poultry Ctr, Brisbane, Qld, Australia; [Bagnoll, Brigitte] Univ Witwatersrand, Dept Anthropol, Johannesburg, South Africa; [Maulaga, Wende; Rukambile, Elpidius] Tanzania Vet Lab Agcy, Cent Vet Lab, Dar Es Salaam, Tanzania	University of Sydney; University of Sydney; University of Witwatersrand	de Bruyn, J (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; de Bruyn, J (corresponding author), Univ Sydney, Charles Perkins Ctr, Johns Hopkins Dr, Sydney, NSW, Australia.	julia.debruyn@sydney.edu.au	Rukambile, Elpidius/GRF-0666-2022; Thomson, Peter/V-7290-2019	Thomson, Peter/0000-0003-4428-444X; de Bruyn, Julia/0000-0001-5222-6464	Australian Centre for International Agricultural Research [FSC/2012/023]	Australian Centre for International Agricultural Research	This work forms part of a study funded by the Australian Centre for International Agricultural Research [FSC/2012/023; http://aciar.gov.au/]: "Strengthening food and nutrition security through family poultry and crop integration in Tanzania and Zambia". RA is Principal Investigator on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers C., 2009, IMPROVING VILLAGE CH; Akinola LAF, 2011, WORLD POULTRY SCI J, V67, P697, DOI 10.1017/S0043933911000778; Alders R, 2003, CONTROLLING NEWCASTL; Alders R, CONTROLLING NE UNPUB; Alders R, 2014, PLANET RISK, V2, P187; Alders R. G., 2001, SADC planning workshop on Newcastle disease control in village chickens. Proceedings of an International Workshop, Maputo, Mozambique, 6-9 March, 2000, P97; Alders RG, 2010, WORLD POULTRY SCI J, V66, P433, DOI 10.1017/S0043933910000516; Alders RG, 2009, WORLD POULTRY SCI J, V65, P181, DOI 10.1017/S0043933909000117; Alders RG, 2000, P INT WORKSH MAP MOZ; Alders RG, 2005, VILLAGE CHICKENS POV, P207; Alders RG, 2014, VET REC, V174, P502, DOI 10.1136/vr.g3209; Bagnol B, 2009, WORLD POULTRY SCI J, V65, P231, DOI 10.1017/S0043933909000191; Bagnol B., 2013, LIVESTOCK RES RURAL, V25; Balint PJ, 2006, ENVIRON MANAGE, V38, P137, DOI 10.1007/s00267-005-0100-y; Banks T, 2003, MT RES DEV, V23, P132, DOI 10.1659/0276-4741(2003)023[0132:CGMIWC]2.0.CO;2; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Buza J., 2001, P SADC PLANN WORKSH, V103, P38; Copland JW, 2005, WORLD POULTRY SCI J, V61, P31, DOI 10.1079/WPS200439; Curtin CG, 2002, CONSERV BIOL, V16, P880, DOI 10.1046/j.1523-1739.2002.00165.x; Dias P. T., 2001, SADC planning workshop on Newcastle disease control in village chickens. Proceedings of an International Workshop, Maputo, Mozambique, 6-9 March, 2000, P91; Dimitrov KM, 2017, VET MICROBIOL, V206, P126, DOI 10.1016/j.vetmic.2016.12.019; Gueye E H, 2000, Dev Pract, V10, P98, DOI 10.1080/09614520052565; Kitala PM, 2000, PREV VET MED, V44, P73, DOI 10.1016/S0167-5877(99)00114-2; Lema M. A., 2009, African Journal of Environmental Science and Technology, V3, P206; Mabilia M, 1996, ECOL FOOD NUTR, V35, P195, DOI 10.1080/03670244.1996.9991489; Mapiye C, 2008, ASIAN AUSTRAL J ANIM, V21, P1680, DOI 10.5713/ajas.2008.r.07; Msoffe PLM, 2010, TROP ANIM HEALTH PRO, V42, P253, DOI 10.1007/s11250-009-9414-8; Mushi E. Z., 2005, Journal of Animal and Veterinary Advances, V4, P768; Njuki J., 2011, ILRI ADD AB 2 MAY; Selemani I. S., 2012, African Journal of Agricultural Research, V7, P5537; Sonaiya EB, 2009, WORLD POULTRY SCI J, V65, P201, DOI 10.1017/S0043933909000130; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188230	10.1371/journal.pone.0188230	http://dx.doi.org/10.1371/journal.pone.0188230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145463	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000415378800096
J	Feig, JL; Mediero, A; Corciulo, C; Liu, HL; Zhang, J; Perez-Aso, M; Picard, L; Wilder, T; Cronstein, B				Feig, Jessica L.; Mediero, Aranzazu; Corciulo, Carmen; Liu, Hailing; Zhang, Jin; Perez-Aso, Miguel; Picard, Laura; Wilder, Tuere; Cronstein, Bruce			The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; EXTRACELLULAR ADENOSINE; OSTEOCLAST FORMATION; DISOPROXIL FUMARATE; PRODUCTION PLAYS; COLLAGEN CONTENT; DERMAL FIBROSIS; RECEPTOR; INFLAMMATION; EXPRESSION	Background Fibrosing diseases are a leading cause of morbidity and mortality worldwide and, therefore, there is a need for safe and effective antifibrotic therapies. Adenosine, generated extracellularly by the dephosphorylation of adenine nucleotides, ligates specific receptors which play a critical role in development of hepatic and dermal fibrosis. Results of recent clinical trials indicate that tenofovir, a widely used antiviral agent, reverses hepatic fibrosis/cirrhosis in patients with chronic hepatitis B infection. Belonging to the class of acyclic nucleoside phosphonates, tenofovir is an analogue of AMP. We tested the hypothesis that tenofovir has direct antifibrotic effects in vivo by interfering with adenosine pathways of fibrosis using two distinct models of adenosine and A2AR-mediated fibrosis. Methods Thioacetamide (100mg/kg IP)-treated mice were treated with vehicle, or tenofovir (75mg/kg, SubQ) (n = 5-10). Bleomycin (0.25U, SubQ)-treated mice were treated with vehicle or tenofovir (75mg/kg, IP) (n = 5-10). Adenosine levels were determined by HPLC, and ATP release was quantitated as luciferase-dependent bioluminescence. Skin breaking strength was analysed and H&E and picrosirus red-stained slides were imaged. Pannexin-1expression was knocked down following retroviral-mediated expression of of Pannexin-1-specific or scrambled siRNA. Results Treatment of mice with tenofovir diminished adenosine release from the skin of bleomycintreated mice and the liver of thioacetamide-treated mice, models of diffuse skin fibrosis and hepatic cirrhosis, respectively. More importantly, tenofovir treatment diminished skin and liver fibrosis in these models. Tenofovir diminished extracellular adenosine concentrations by inhibiting, in a dose-dependent fashion, cellular ATP release but not in cells lacking Pannexin-1. Conclusions These studies suggest that tenofovir, a widely used antiviral agent, could be useful in the treatment of fibrosing diseases.	[Feig, Jessica L.; Mediero, Aranzazu; Corciulo, Carmen; Liu, Hailing; Zhang, Jin; Perez-Aso, Miguel; Picard, Laura; Wilder, Tuere; Cronstein, Bruce] NYU, Langone Med Ctr, Div Translat Med, Dept Med, New York, NY 10003 USA; [Mediero, Aranzazu] IIS Fdn Jimenez Diaz UAM, Bone & Joint Res Unit, Madrid, Spain; [Zhang, Jin] Ningbo Univ, Med Sch, Dept Immmunol & Rheumatol, LiHuili Hosp, Ningbo, Zhejiang, Peoples R China	New York University; NYU Langone Medical Center; Fundacion Jimenez Diaz; Ningbo University	Cronstein, B (corresponding author), NYU, Langone Med Ctr, Div Translat Med, Dept Med, New York, NY 10003 USA.	Bruce.Cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383; Liu, Hailing/0000-0002-4717-3086; Mediero, Aranzazu/0000-0002-5368-574X; Perez-Aso, Miguel/0000-0002-4703-4182; CORCIULO, CARMEN/0000-0002-1865-3494	National Institute of Arthritis, Musculoskeletal and Skin Diseases [R01-AR054897, R01-AR056672]; NYU-HHC Clinical and Translational Science Institute (from the National Center for Advancing Translational Sciences) [UL1-TR000038]; Gilead Pharmaceuticals; Institute de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897, R01AR056672] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NYU-HHC Clinical and Translational Science Institute (from the National Center for Advancing Translational Sciences); Gilead Pharmaceuticals(Gilead Sciences); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis, Musculoskeletal and Skin Diseases (R01-AR054897 and R01-AR056672), the NYU-HHC Clinical and Translational Science Institute (UL1-TR000038 from the National Center for Advancing Translational Sciences) and Gilead Pharmaceuticals. Dr Mediero is funded by Institute de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program.; The authors thank Judith Aberg, MD for her suggestions and discussions and Doreen Tivon, BA and Timothy Cardozo, MD, PhD for their computational biology work on this project. The authors also thank the Histopathology Core of the New York University Langone Medical Center. This work was supported by grants from the National Institute of Arthritis, Musculoskeletal and Skin Diseases (RO1-AR054897 and RO1-AR056672), the NYU-HHC Clinical and Translational Science Institute (UL1-TR000038 from the National Center for Advancing Translational Sciences) and Gilead Pharmaceuticals. Dr Mediero is funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Servet" program.	Abudara V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00306; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P1499, DOI 10.1073/pnas.88.4.1499; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Boyd A, 2010, ANTIVIR THER, V15, P963, DOI 10.3851/IMP1649; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Chan ESL, 2011, ARTHRITIS RHEUM-US, V63, pS907; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Cronstein BN, 2010, J HEPATOL, V53, P207, DOI 10.1016/j.jhep.2010.02.025; CUNDY KC, 1995, ANTIMICROB AGENTS CH, V39, P2401, DOI 10.1128/AAC.39.11.2401; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; FDA, 2005, GUID IND EST MAX SAF; Ferrari D, 2015, FASEB JOURNAL OFFICI; Grunig G, 2003, J CLIN INVEST, V112, P329, DOI 10.1172/JCI200319392; Inc. GS, 2001, VIR TEN PROD MON; JAMES J, 1990, LIVER, V10, P1; Kmonickova E, 2006, EUR J PHARMACOL, V530, P179, DOI 10.1016/j.ejphar.2005.11.037; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li L, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/691310; Liaw YF, 2013, JOURNAL OF HEPATOLOG; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Mary-Krause M, 2012, J CLIN DENSITOM, V15, P422, DOI 10.1016/j.jocd.2012.04.001; Mediero A, 2015, FASEB J OFFICIAL PUB; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nowak M, 2010, EUR J IMMUNOL, V40, P682, DOI 10.1002/eji.200939897; Ohtsuka T, 2010, J IMMUNOL, V185, P1321, DOI 10.4049/jimmunol.0901847; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Peng ZS, 2008, NUCLEOS NUCLEOT NUCL, V27, P821, DOI 10.1080/15257770802146403; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Perez-Aso M, 2013, PURINERGIC SIGNALLIN; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Puhl SL, 2015, BRIT J PHARM; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Schafer JJ, 2013, PHARMACOTHERAPY, V33, P665, DOI 10.1002/phar.1257; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Takedachi M, 2011, J CELLULAR PHYSL; Tang J, 2015, MOL MED REP, V11, P4397, DOI 10.3892/mmr.2015.3320; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017201; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhou Y., 2010, PLOS ONE, V5; Zidek Z, 2004, EUR J PHARMACOL, V501, P79, DOI 10.1016/j.ejphar.2004.08.031	63	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188135	10.1371/journal.pone.0188135	http://dx.doi.org/10.1371/journal.pone.0188135			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145453	Green Published, Green Submitted, gold			2022-12-26	WOS:000415378800073
J	Morchang, A; Lee, RCH; Yenchitsomanus, PT; Sreekanth, GP; Noisakran, S; Chu, JJH; Limjindaporn, T				Morchang, Atthapan; Lee, Regina Ching Hua; Yenchitsomanus, Pa-thai; Sreekanth, Gopinathan Pillai; Noisakran, Sansanee; Chu, Justin Jang Hann; Limjindaporn, Thawornchai			RNAi screen reveals a role of SPHK2 in dengue virus-mediated apoptosis in hepatic cell lines	PLOS ONE			English	Article							SPHINGOSINE KINASE 2; INDUCED LIVER-INJURY; HEMORRHAGIC-FEVER; SPHINGOLIPID METABOLISM; INFECTION; DEATH; SPHINGOSINE-1-PHOSPHATE; INHIBITION; INVOLVEMENT; CANCER	Hepatic dysfunction is a feature of dengue virus (DENV) infection. Hepatic biopsy specimens obtained from fatal cases of DENV infection show apoptosis, which relates to the pathogenesis of DENV infection. However, how DENV induced liver injury is not fully understood. In this study, we aim to identify the factors that influence cell death by employing an apoptosis-related siRNA library screening. Our results show the effect of 558 gene silencing on caspase 3-mediated apoptosis in DENV-infected Huh7 cells. The majority of genes that contributed to apoptosis were the apoptosis-related kinase enzymes. Tumor necrosis factor superfamily member 12 (TNFSF12), and sphingosine kinase 2 (SPHK2), were selected as the candidate genes to further validate their influences on DENV-induced apoptosis. Transfection of siRNA targeting SPHK2 but not TNFSF12 genes reduced apoptosis determined by Annexin V/PI staining. Knockdown of SPHK2 did not reduce caspase 8 activity; however, did significantly reduce caspase 9 activity, suggesting its involvement of SPHK2 in the intrinsic pathway of apoptosis. Treatment of ABC294649, an inhibitor of SPHK2, reduced the caspase 3 activity, suggesting the involvement of its kinase activity in apoptosis. Knockdown of SPHK2 significantly reduced caspase 3 activity not only in DENV-infected Huh7 cells but also in DENV-infected HepG2 cells. Our results were consistent across all of the four sero-types of DENV infection, which supports the pro-apoptotic role of SPHK2 in DENV-infected liver cells.	[Morchang, Atthapan; Yenchitsomanus, Pa-thai; Sreekanth, Gopinathan Pillai; Limjindaporn, Thawornchai] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok, Thailand; [Morchang, Atthapan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol,Grad Program Immunol, Bangkok, Thailand; [Lee, Regina Ching Hua; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Singapore, Singapore; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok, Thailand	Mahidol University; Mahidol University; National University of Singapore; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Limjindaporn, T (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok, Thailand.; Chu, JJH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Singapore, Singapore.; Limjindaporn, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok, Thailand.	miccjh@nus.edu.sg; thawornchai.lim@mahidol.ac.th	Chu, Justin Jang Hann/ABA-8297-2021; Noisakran, Sansanee/H-5186-2011; Sreekanth, Gopinathan Pillai/F-3715-2010	Noisakran, Sansanee/0000-0002-9336-3331; Sreekanth, Gopinathan Pillai/0000-0002-0278-8642; Chu, Justin Jang Hann/0000-0002-1673-6819	Mahidol University [R015810002]; Royal Golden Jubilee (RGJ) Ph.D. Scholarship [PHD/0016/2553]	Mahidol University; Royal Golden Jubilee (RGJ) Ph.D. Scholarship	This study was supported by the Mahidol University Grant (R015810002) to TL and AM was supported by the Royal Golden Jubilee (RGJ) Ph.D. Scholarship (PHD/0016/2553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Mahidol University Grant (R015810002) to TL and AM was supported by the Royal Golden Jubilee (RGJ) Ph.D. Scholarship (PHD/0016/2553).	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Antoon JW, 2011, CANCER BIOL THER, V11, P678, DOI 10.4161/cbt.11.7.14903; Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022; Barbier V, 2017, VIROLOGY, V500, P149, DOI 10.1016/j.virol.2016.10.022; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; Carr JM, 2013, J GEN VIROL, V94, P2437, DOI 10.1099/vir.0.055616-0; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Clarke JN, 2016, J GEN VIROL, V97, P95, DOI 10.1099/jgv.0.000334; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hapuarachchi HC, 2013, J CLIN VIROL, V57, P91, DOI 10.1016/j.jcv.2012.12.021; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee SY, 2015, HEPATOLOGY, V62, P135, DOI 10.1002/hep.27804; Li JL, 2012, BIOCHEM BIOPH RES CO, V418, P622, DOI 10.1016/j.bbrc.2012.01.050; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Michels M, 2015, J INFECTION, V71, P480, DOI 10.1016/j.jinf.2015.06.014; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Morchang A, 2013, BIOCHEM BIOPH RES CO, V438, P20, DOI 10.1016/j.bbrc.2013.07.009; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Panda D, 2012, CURR OPIN VIROL, V2, P784, DOI 10.1016/j.coviro.2012.10.007; Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743; Santos WL, 2015, ACS CHEM BIOL, V10, P225, DOI 10.1021/cb5008426; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Sreekanth GP, 2017, ANTIVIR RES, V141, P7, DOI 10.1016/j.antiviral.2017.02.003; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Sreekanth GP, 2014, VIRUS RES, V188, P15, DOI 10.1016/j.virusres.2014.03.025; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tran AT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.296; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Venkata JK, 2014, BLOOD, V124, P1915, DOI 10.1182/blood-2014-03559385; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhou L, 2015, J VIROL, V89, P10512, DOI 10.1128/JVI.01028-15; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	69	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188121	10.1371/journal.pone.0188121	http://dx.doi.org/10.1371/journal.pone.0188121			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145490	Green Published, gold, Green Submitted			2022-12-26	WOS:000415378800068
J	Islam, MJ; Broidy, L; Baird, K; Mazerolle, P				Islam, Md. Jahirul; Broidy, Lisa; Baird, Kathleen; Mazerolle, Paul			Intimate partner violence around the time of pregnancy and postpartum depression: The experience of women of Bangladesh	PLOS ONE			English	Article							MATERNAL DEPRESSION; POSTNATAL DEPRESSION; RISK-FACTORS; DOMESTIC VIOLENCE; PHYSICAL VIOLENCE; MENTAL-HEALTH; PERINATAL DEPRESSION; PERCEIVED STRESS; SOCIAL SUPPORT; MARRIED-WOMEN	Background and objectives Intimate partner violence (IPV) around the time of pregnancy is a serious public health concern and is known to have an adverse effect on perinatal mental health. In order to craft appropriate and effective interventions, it is important to understand how the association between IPV and postpartum depression (PPD) may differ as a function of the type and timing of IPV victimization. Here we evaluate the influence of physical, sexual and psychological IPV before, during and after pregnancy on PPD. Methods Cross-sectional survey data was collected between October 2015 and January 2016 in the Chandpur District of Bangladesh from 426 new mothers, aged 15-49 years, who were in the first six months postpartum. Multivariate logistic regression models were used to estimate the association between IPV and PPD, adjusted for socio-demographic, reproductive and psychosocial confounding factors. Results Approximately 35.2% of women experienced PPD within the first six months following childbirth. Controlling for confounders, the odds of PPD was significantly greater among women who reported exposure to physical (AOR: 1.79, 95% CI [1.25, 3.43]), sexual (AOR: 2.25, 95% CI [1.14, 4.45]) or psychological (AOR: 6.92, 95% CI [1.71, 28.04]) IPV during pregnancy as opposed to those who did not. However, both before and after pregnancy, only physical IPV evidences a direct effect on PPD. Results highlight the mental health consequences of IPV for women of Bangladesh, as well as the influence of timing and type of IPV on PPD outcomes. Conclusions and implications The findings confirm that exposure to IPV significantly increases the odds of PPD. The association is particularly strong for physical IPV during all periods and psychological IPV during pregnancy. Results reinforce the need to conduct routine screening during pregnancy to identify women with a history of IPV who may at risk for PPD and to offer them necessary support.	[Islam, Md. Jahirul; Broidy, Lisa; Mazerolle, Paul] Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia; [Islam, Md. Jahirul] Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh; [Broidy, Lisa] 1 Univ New Mexico, Dept Sociol, Albuquerque, NM USA; [Baird, Kathleen] Griffith Univ, Sch Nursing & Midwifery, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia	Griffith University; University of New Mexico; Griffith University; Menzies Health Institute Queensland	Islam, MJ (corresponding author), Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia.; Islam, MJ (corresponding author), Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh.	mdjahirul.islam@griffithuni.edu.au	Baird, Kathleen/AAP-1894-2021; Islam, Dr Md Jahirul/J-4093-2019	Baird, Kathleen/0000-0003-0142-6962; Islam, Dr Md Jahirul/0000-0001-6409-6724; Hossain, Mohammad/0000-0003-4615-5086; Mazerolle, Paul/0000-0002-5894-996X; Islam, Mohammad Mainul/0000-0002-0937-5082	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	The study was partially funded by the Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh. The funding authority had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.	Adesina O, 2011, J OBSTET GYNAECOL, V31, P232, DOI 10.3109/01443615.2010.547954; Ahmed A M, 2005, East Mediterr Health J, V11, P164; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Annagur A, 2013, BREASTFEED MED, V8, P53, DOI 10.1089/bfm.2012.0036; Azziz-Baumgartner E, 2014, VIOLENCE AGAINST WOM, V20, P59; Bangladesh Bureau of Statistics (BBS), 2013, VIOL WOM SURV 2011; Beck CT, 2008, MCN-AM J MATERN-CHIL, V33, P151, DOI 10.1097/01.NMC.0000318349.70364.1c; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Beydoun HA, 2010, ANN EPIDEMIOL, V20, P575, DOI 10.1016/j.annepidem.2010.05.011; Bondas T, 2001, QUAL HEALTH RES, V11, P824, DOI 10.1177/104973201129119415; Brownridge DA, 2011, VIOLENCE AGAINST WOM, V17, P858, DOI 10.1177/1077801211412547; Cerulli C, 2010, BREASTFEED MED, V5, P225, DOI 10.1089/bfm.2010.0054; Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce; Chan KL, 2011, J INTERPERS VIOLENCE, V26, P1478, DOI 10.1177/0886260510369134; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Craig M, 2009, CLIN EVIDENCE, V1, P1407; Dalal K, 2009, J BIOSOC SCI, V41, P561, DOI 10.1017/S0021932009990046; Desmarais SL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-132; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Edwards GD, 2006, INT J MENT HEALTH, V35, P62, DOI 10.2753/IMH0020-7411350105; Ege E, 2008, J OBSTET GYNAECOL RE, V34, P585, DOI 10.1111/j.1447-0756.2008.00718.x; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Faisal-Cury A, 2013, MATERN CHILD HLTH J, V17, P1297, DOI 10.1007/s10995-012-1127-3; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher JRW, 2004, BJOG-INT J OBSTET GY, V111, P1353, DOI 10.1111/j.1471-0528.2004.00394.x; Garabedian MJ, 2011, J WOMENS HEALTH, V20, P447, DOI 10.1089/jwh.2010.1960; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gausia K, 2007, J REPROD INFANT PSYC, V25, P308, DOI 10.1080/02646830701644896; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Gulamani SS, 2013, J PERINAT NEONAT NUR, V27, P52, DOI 10.1097/JPN.0b013e31827fcf24; Hegarty K, 2011, BRIT J PSYCHIAT, V198, P169, DOI 10.1192/bjp.bp.110.083758; Henderson JJ, 2003, BIRTH-ISS PERINAT C, V30, P175, DOI 10.1046/j.1523-536X.2003.00242.x; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; Illanes E, 2007, REV MED CHILE, V135, P326; Islam MJ, 2017, MIDWIFERY, V47, P43, DOI 10.1016/j.midw.2017.02.002; Islam MJ, 2017, ARCH WOMEN MENT HLTH, V20, P173, DOI 10.1007/s00737-016-0692-7; Isomaa R, 2013, HEALTH EDUC BEHAV, V40, P392, DOI 10.1177/1090198112445481; James L, 2013, VIOLENCE VICTIMS, V28, P359, DOI 10.1891/0886-6708.VV-D-12-00034; Jeanjot I, 2008, J WOMENS HEALTH, V17, P557, DOI 10.1089/jwh.2007.0639; Johnson PL, 2007, PSYCHIAT ANN, V37, P404; Kabir ZN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24725; Kan ML, 2012, J FAM ISSUES, V33, P115, DOI 10.1177/0192513X11412037; Kantor G. K., 1999, REPORT USAF FAMILY N; Kendall-Tackett KA, 2007, TRAUMA VIOLENCE ABUS, V8, P344, DOI 10.1177/1524838007304406; Klainin P, 2009, INT J NURS STUD, V46, P1355, DOI 10.1016/j.ijnurstu.2009.02.012; Krug E. G., 2002, WORLD HLTH REPORT VI; Leung SSK, 2005, RES NURS HEALTH, V28, P27, DOI 10.1002/nur.20053; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; Malta LA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-153; Marcotte D, 2002, J EMOT BEHAV DISORD, V10, P29, DOI 10.1177/106342660201000104; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P221, DOI 10.1177/1077801205285106; Martin SL, 2004, J FAM VIOLENCE, V19, P201, DOI 10.1023/B:JOFV.0000032630.50593.93; Milgrom J, 2006, STRESS HEALTH, V22, P229, DOI 10.1002/smi.1101; Moraes CL, 2011, PUBLIC HEALTH NUTR, V14, P2148, DOI 10.1017/S1368980011000802; Naved RT, 2013, ARCH SEX BEHAV, V42, P595, DOI 10.1007/s10508-012-0045-1; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Quelopana AM, 2012, WOMEN HEALTH, V52, P437, DOI 10.1080/03630242.2012.687443; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Righetti-Veltema M, 2002, J AFFECT DISORDERS, V70, P291, DOI 10.1016/S0165-0327(01)00367-6; Rodriguez MA, 2010, VIOLENCE AGAINST WOM, V16, P543, DOI 10.1177/1077801210366959; Romito P, 2009, J PSYCHOSOM OBST GYN, V30, P115, DOI 10.1080/01674820802545834; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Saito A, 2012, NURS HEALTH SCI, V14, P345, DOI 10.1111/j.1442-2018.2012.00735.x; Sambisa W, 2010, STUD FAMILY PLANN, V41, P165, DOI 10.1111/j.1728-4465.2010.00241.x; Savarimuthu RJS, 2010, INT J SOC PSYCHIATR, V56, P94, DOI 10.1177/0020764008097756; Scribano PV, 2013, MATERN CHILD HLTH J, V17, P307, DOI 10.1007/s10995-012-0986-y; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Shamu S, 2016, GEN HOSP PSYCHIAT, V38, P109, DOI 10.1016/j.genhosppsych.2015.10.005; Silverman JG, 2006, J WOMENS HEALTH, V15, P934, DOI 10.1089/jwh.2006.15.934; Sorbo MF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-316; Stewart RC, 2008, MATERN CHILD NUTR, V4, P209, DOI 10.1111/j.1740-8709.2008.00147.x; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Swapan G, 2013, J OBSTET GYN INDIA, V63, P223, DOI 10.1007/s13224-013-0399-x; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Tiwari A, 2008, BJOG-INT J OBSTET GY, V115, P377, DOI 10.1111/j.1471-0528.2007.01593.x; Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943; Uddin MK, 2012, J BEHAV SCI, V22, P26; Urquia ML, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-42; Valentine JM, 2011, ARCH WOMEN MENT HLTH, V14, P135, DOI 10.1007/s00737-010-0191-1; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vizcarra Beatriz, 2004, Inj Control Saf Promot, V11, P125, DOI 10.1080/15660970412331292351; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Wang SY, 2006, J PSYCHOSOM RES, V60, P303, DOI 10.1016/j.jpsychores.2005.08.012; Wang SY, 2003, AM J OBSTET GYNECOL, V189, P1407, DOI 10.1067/S0002-9378(03)00673-2; White RS, 2014, J AM GERIATR SOC, V62, P2350, DOI 10.1111/jgs.13135; WHO, 2013, RESPONDING INTIMATE; WHO, 2012, WORLD FED MENT HLTH; WHO UNFPA, 2009, MENT HLTH ASP WOM PE; Woolhouse H, 2012, BJOG-INT J OBSTET GY, V119, P315, DOI 10.1111/j.1471-0528.2011.03219.x; World Health Organization & Pan American Health Organization, 2012, UNDERSTANDING ADDRES; Zlotnick C, 2006, J INTERPERS VIOLENCE, V21, P262, DOI 10.1177/0886260505282564	111	65	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176211	10.1371/journal.pone.0176211	http://dx.doi.org/10.1371/journal.pone.0176211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472056	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500029
